PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kumari, A; Yadav, SK; Ali, S				Kumari, Anju; Yadav, Sandeep Kumar; Ali, Sher			Organizational and Functional Status of the Y-linked Genes and Loci in the Infertile Patients Having Normal Spermiogram	PLOS ONE			English	Article							FACTORS AFFECTING FERTILITY; PARTIAL AZFC DELETIONS; CELL-ONLY-SYNDROME; NUCLEAR-LOCALIZATION; EXPRESSION ANALYSIS; GONADAL-DYSGENESIS; POINT MUTATION; SEX REVERSAL; SRY GENE; CHROMOSOME	Male fertility is an orchestrated interplay of loci on the Y chromosome with a number of genes from across the other chromosomes. In this context, micro-deletions in the Y chromosome have been correlated with spermatogenic failure often leading to infertility. However, causes of infertility in the patients with the normal spermiogram have remained unclear and therefore pose another level of challenge. In the present study, we analyzed 64 STSs, studied different Y-linked genes and loci and conducted single nucleotide variant (SNV) analyses in 31 infertile males with normal spermiogram along with 67 normal fertile males (NFMs) to gain an insight into the organization of their Y chromosome. Further, employing quantitative real-time PCR (qPCR), we studied copy number variation of DYZ1 arrays and three genes and mutational status of SRY by direct sequence analyses. STS analyses of the AZFa, b and c regions in these patients showed known and new mutations. Further, copies of DAZ and BPY2 in the patients were found to be affected (p<0.001) compared to those in NFMs. All the patients had normal copy number of the SRY however its sequence analysis (in silico) showed mutations in eight patients. In four of these eight patients, SRY mutations resulted into truncated proteins. Similarly, DYZ1 analysis showed micro-deletions and it's much reduced copy number (p<0.001) as compared to those in NFMs. Present study in males with unexplained infertility revealed deletions similar to those observed in oligospermic and azoospermic patients. Thus, there are some common but still unknown factors underlying infertility in these patients irrespective of their spermatogenic status. This work is envisaged to augment DNA diagnosis, proving beneficial in the context of in vitro fertilization (IVF) and genetic counselling.	[Kumari, Anju; Yadav, Sandeep Kumar; Ali, Sher] Natl Inst Immunol, Mol Genet Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Kumari, A (corresponding author), Natl Inst Immunol, Mol Genet Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	alisher@nii.ac.in	KUMARI, ANJU/ABH-8502-2020; Yadav, Sandeep Kumar/ABA-8776-2020; Kumar, Vineet/F-2923-2015	Yadav, Sandeep Kumar/0000-0001-6999-040X; Kumar, Vineet/0000-0002-8772-679X; KUMARI, ANJU/0000-0001-5130-4774	Department of Biotechnology (DBT), Government of India [BT/PR11805/MED/12/424/2009, BT/PR14102/AAQ/01/438/2010]; DBT, New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi; Department of Science and Technology, New Delhi, Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); DBT, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, New Delhi, Government of India(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology (DBT), Government of India Grants - BT/PR11805/MED/12/424/2009 and BT/PR14102/AAQ/01/438/2010 to SA and a core grant from DBT, New Delhi, to the National Institute of Immunology, New Delhi. The authors also acknowledge the Council of Scientific and Industrial Research (CSIR), New Delhi, for its financial assistance to SKY and AK as JRF and SRF, respectively. SA is also grateful to Department of Science and Technology, New Delhi, Government of India, for J. C. Bose National Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2003, GENE, V321, P25, DOI 10.1016/j.gene.2003.08.006; Ali S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-35; Alvarez-Nava F, 2001, ANN GENET-PARIS, V44, P155; Blagosklonova O, 2000, MOL HUM REPROD, V6, P795, DOI 10.1093/molehr/6.9.795; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Ferlin A, 2005, CYTOGENET GENOME RES, V111, P310, DOI 10.1159/000086905; Ferlin A, 2004, FERTIL STERIL, V81, P1013, DOI 10.1016/j.fertnstert.2003.08.053; Ferlin A, 2003, J MED GENET, V40, P18, DOI 10.1136/jmg.40.1.18; Ferlin A, 2006, REPROD TOXICOL, V22, P133, DOI 10.1016/j.reprotox.2006.04.016; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Fernandez R, 2002, HUM GENET, V111, P242, DOI 10.1007/s00439-002-0767-6; Fernando L, 2006, ASIAN J ANDROL, V8, P39, DOI 10.1111/j.1745-7262.2006.00100.x; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Foresta C, 2000, J ENDOCRINOL INVEST, V23, P646, DOI 10.1007/BF03343788; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Giachini C, 2007, HUM REPROD, V22, P2398, DOI 10.1093/humrep/dem186; Giachini C, 2005, J MED GENET, V42, P497, DOI 10.1136/jmg.2004.028191; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Hargreave TB, 2000, BRIT MED BULL, V56, P650, DOI 10.1258/0007142001903454; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; Kamp C, 2001, MOL HUM REPROD, V7, P987, DOI 10.1093/molehr/7.10.987; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kleiman SE, 2003, HUM GENET, V113, P486, DOI 10.1007/s00439-003-0990-9; Krausz C, 2006, HUM MOL GENET, V15, P2673, DOI 10.1093/hmg/ddl198; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lee KH, 2003, REPROD FERT DEVELOP, V15, P129, DOI 10.1071/RD03002; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; Luddi A, 2009, NEW ENGL J MED, V360, P881, DOI 10.1056/NEJMoa0806218; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; Marchina E, 2009, FERTIL STERIL, V91, DOI 10.1016/j.fertnstert.2008.07.1722; MOGHISSI KS, 1983, FERTIL STERIL, V39, P5; Moro E, 2000, J CLIN ENDOCR METAB, V85, P4069, DOI 10.1210/jc.85.11.4069; Navarro-Costa P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-342; NEGROVILAR A, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431377; NELSON CMK, 1974, FERTIL STERIL, V25, P503; Paliwal P, 2011, MOL HUM REPROD, V17, P372, DOI 10.1093/molehr/gar002; Pathak D, 2006, DNA RES, V13, P103, DOI 10.1093/dnares/dsl002; Phillips NB, 2006, J MOL BIOL, V358, P172, DOI 10.1016/j.jmb.2006.01.060; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Shahid M, 2004, MOL HUM REPROD, V10, P521, DOI 10.1093/molehr/gah071; Shahid M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-131; Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9; Sharpe RM, 2002, NAT MED, V8, P33; Sinclair A, 2001, GENOME BIOL, V2, P40171; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stouffs K, 2008, HUM REPROD, V23, P1193, DOI 10.1093/humrep/den069; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; VanWaeleghem K, 1996, HUM REPROD, V11, P325, DOI 10.1093/HUMREP/11.2.325; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Vogt PH, 2004, MOL CELL ENDOCRINOL, V224, P1, DOI 10.1016/j.mce.2004.06.008; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499; Younglai EV, 2005, HUM REPROD UPDATE, V11, P43, DOI 10.1093/humupd/dmh055	66	69	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41488	10.1371/journal.pone.0041488	http://dx.doi.org/10.1371/journal.pone.0041488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844483	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700094
J	Lin, CH; Wang, LH; Fan, TY; Kuo, W				Lin, Chiahsin; Wang, Li-Hsueh; Fan, Tung-Yung; Kuo, Wen			Lipid Content and Composition during the Oocyte Development of Two Gorgonian Coral Species in Relation to Low Temperature Preservation	PLOS ONE			English	Article							UNSATURATED FATTY-ACIDS; CHILLING SENSITIVITY; LARVAL DEVELOPMENT; ZOOXANTHELLAE; EMBRYOS; CRYOPRESERVATION; BIOSYNTHESIS; METABOLISM; INDICATORS; RECOVERY	Our previous studies have suggested that chilling sensitivity of coral oocytes may relate to their relatively high lipid intracellular content and lipid composition. The distribution of lipids during the oocyte development was determined here for the first time in two gorgonian species (Junceella juncea and Junceella fragilis). The main lipid classes in the two gorgonian oocytes were total lipid, wax ester, triacylglycerol, total fatty acid, phosphatidylethanolamine and phosphatidylcholine. The results indicated that early stage oocytes of J. juncea and J. fragilis were found to have increased lipid content than late stage oocytes. The content of wax ester was significantly higher in the early stage oocytes of two gorgonian corals (51.0 +/- 2.5 and 41.7 +/- 2.9 mg/mm(3)/oocyte) than those of late stage oocytes (24.0 +/- 1.4 and 30.4 +/- 1.2 mg/mm(3)/oocyte, respectively). A substantial amount of phosphatidylethanolamine and total fatty acid was detected at each stage of oocyte development in two gorgonian ranges from 107 to 42 mg/mm(3)/oocyte and 106 to 48 mg/mm(3)/oocyte, whilst low levels of phosphatidylcholine were found in two gorgonian oocytes. The levels of total lipid in the late stage oocytes of J. juncea were significantly higher than those of J. fragilis. The observed differences may partially be related to different habitat preferences as higher lipid levels in J. juncea, a deeper-water coral species exposed to lower temperature seawater, might relate to adjustments of cell membranes in order to increase membrane fluidity.	[Lin, Chiahsin; Wang, Li-Hsueh; Fan, Tung-Yung; Kuo, Wen] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Lin, Chiahsin; Wang, Li-Hsueh] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Checheng, Pingtung, Taiwan; [Fan, Tung-Yung] Natl Dong Hwa Univ, Grad Inst Marine Biodivers & Evolut, Checheng, Pingtung, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Dong Hwa University	Lin, CH (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	chiahsin@nmmba.gov.tw			National Museum of Marine Biology & Aquarium and National Science Council	National Museum of Marine Biology & Aquarium and National Science Council	Funding was provided by the National Museum of Marine Biology & Aquarium and National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAVA VR, 1993, NIPPON SUISAN GAKK, V59, P345, DOI 10.2331/suisan.59.345; ARAI T, 1993, CORAL REEFS, V12, P71; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; BATTEY JF, 1984, MAR BIOL, V79, P27, DOI 10.1007/BF00404982; Bell MV, 2007, J PLANKTON RES, V29, P417, DOI 10.1093/plankt/fbm025; Blair AC, 2003, THESIS COLL CHARLEST; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Christie WW, 1998, PHYTOCHEM ANALYSIS, V9, P53, DOI 10.1002/(SICI)1099-1565(199803/04)9:2&lt;53::AID-PCA391&gt;3.0.CO;2-U; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; Dobrinsky JR, 2001, THERIOGENOLOGY, V56, P1333, DOI 10.1016/S0093-691X(01)00634-3; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hagedorn M, 2006, CRYOBIOLOGY, V52, P454, DOI 10.1016/j.cryobiol.2006.03.001; Hagedorn M, 2006, CRYOBIOLOGY, V52, P33, DOI 10.1016/j.cryobiol.2005.09.008; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; HARLAND AD, 1993, MAR BIOL, V117, P113, DOI 10.1007/BF00346432; HEYWARD AJ, 1985, AUST J MAR FRESH RES, V36, P441; Holmer L.E., 1989, Fossils and Strata, P1; Imbs AB, 2007, LIPIDS, V42, P1035, DOI 10.1007/s11745-007-3109-6; Imbs AB, 2006, LIPIDS, V41, P721, DOI 10.1007/s11745-006-5023-8; JOBLING M, 1995, J THERM BIOL, V20, P157, DOI 10.1016/0306-4565(94)00044-J; LATYSHEV NA, 1991, MAR ECOL PROG SER, V76, P295, DOI 10.3354/meps076295; Leibo SP, 1995, THERIOGENOLOGY, V43, P265, DOI [DOI 10.1016/0093-691X(95)92419-A, 10. 1016/0093-691X(95)92419-A]; Lin C, 2011, CRYOLETTERS, V32, P141; Lin C, 2011, THERIOGENOL IN PRESS; Martino A, 1996, MOL REPROD DEV, V45, P503, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;503::AID-MRD13&gt;3.0.CO;2-X; MEYERS PA, 1979, MAR BIOL LETT, V1, P69; Moran AL, 2004, J EXP MAR BIOL ECOL, V306, P17, DOI 10.1016/j.jembe.2003.12.021; Moran AL, 2003, BIOL BULL-US, V204, P270, DOI 10.2307/1543598; MOURENTE G, 1990, FISH PHYSIOL BIOCHEM, V8, P93, DOI 10.1007/BF00004436; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; Oku H, 2003, FISHERIES SCI, V69, P625, DOI 10.1046/j.1444-2906.2003.00665.x; Oku H, 2003, CORAL REEFS, V22, P83, DOI 10.1007/s00338-003-0279-4; Oku H, 2002, FISHERIES SCI, V68, P517, DOI 10.1046/j.1444-2906.2002.00456.x; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; PEARSE VB, 1971, BIOL BULL, V141, P350, DOI 10.2307/1540123; Ravid T, 1999, J EXP BIOL, V202, P1819; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Schafer W.G., 1980, P47; Seidel GE, 2006, THERIOGENOLOGY, V65, P228, DOI 10.1016/j.theriogenology.2005.09.025; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; STIMSON JS, 1987, B MAR SCI, V41, P889; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Tsai S, 2011, CRYOLETTERS, V32, P1; Tsai S, 2010, THERIOGENOLOGY, V73, P605, DOI 10.1016/j.theriogenology.2009.10.016; Tsai S, 2009, CRYOBIOLOGY, V58, P279, DOI 10.1016/j.cryobiol.2009.02.002; Ulrich K, 1994, COMP ANIMAL BIOCH; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Yamashiro H, 1999, COMP BIOCHEM PHYS B, V122, P397, DOI 10.1016/S0305-0491(99)00014-0; Zhang TT, 2003, THERIOGENOLOGY, V59, P1545, DOI 10.1016/S0093-691X(02)01199-8; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	52	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e38689	10.1371/journal.pone.0038689	http://dx.doi.org/10.1371/journal.pone.0038689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848343	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200005
J	Shikina, S; Chen, CJ; Liou, JY; Shao, ZF; Chung, YJ; Lee, YH; Chang, CF				Shikina, Shinya; Chen, Chieh-Jhen; Liou, Jhe-Yu; Shao, Zi-Fan; Chung, Yi-Jou; Lee, Yan-Horn; Chang, Ching-Fong			Germ Cell Development in the Scleractinian Coral Euphyllia ancora (Cnidaria, Anthozoa)	PLOS ONE			English	Article							INTERSTITIAL STEM-CELLS; SEXUAL REPRODUCTION; GENETIC-ANALYSIS; SELF-RENEWAL; VASA; EXPRESSION; HYDRA; DROSOPHILA; PROTEIN; PLASM	Sexual reproduction of scleractinian coral is among the most important means of establishing coral populations. However, thus far, little is known about the mechanisms underlying coral gametogenesis. To better understand coral germ cell development, we performed a histological analysis of gametogenesis in Euphyllia ancora and characterized the coral homolog of the Drosophila germline marker gene vasa. The histological analysis revealed that E. ancora gametogenesis occurs in the mesenterial mesoglea between the mesenterial filaments and the retractor muscle bands. The development of germ cells takes approximately one year in females and half a year in males. Staining of tissue sections with an antibody against E. ancora Vasa (Eavas) revealed anti-Eavas immunoreactivity in the oogonia, early oocyte, and developing oocyte, but only faint or undetectable reactivity in developing oocytes that were > 150 mu m in diameters. In males, Eavas could be detected in the spermatogonia and primary spermatocytes but was only faintly detectable in the secondary spermatocytes, spermatids, and sperms. Furthermore, a reverse transcription-polymerase chain reaction analysis and Western blotting analysis of unfertilized mature eggs proved the presence of Eavas transcripts and proteins, suggesting that Eavas may be a maternal factor. Vasa may represent a germ cell marker for corals, and would allow us to distinguish germ cells from somatic cells in coral bodies that have no distinct organs.	[Shikina, Shinya; Chen, Chieh-Jhen; Liou, Jhe-Yu; Shao, Zi-Fan; Chung, Yi-Jou; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan; [Chen, Chieh-Jhen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Lee, Yan-Horn] Fisheries Res Inst, Tungkang Biotechnol Res Ctr, Tungkang, Taiwan; [Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan University; Taiwan Fish Research Institute; National Taiwan Ocean University	Shikina, S (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan.	B0044@mail.ntou.edu.tw			National Science Council [NSC 16 97-2313-B-019-012-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was funded by a grant from the National Science Council (NSC 16 97-2313-B-019-012-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alie A, 2011, DEV BIOL, V350, P183, DOI 10.1016/j.ydbio.2010.10.019; Aoki Y, 2008, DEV DYNAM, V237, P800, DOI 10.1002/dvdy.21448; Bode HR, 1996, J CELL SCI, V109, P1155; BODE HR, 1976, J CELL SCI, V20, P29; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chang TC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-127; Chris W, 1999, CELL, V96, P15; Delvoye L, 1982, ASPECTS SEXUAL REPRO, P93; Extavour CG, 2005, EVOL DEV, V7, P201, DOI 10.1111/j.1525-142X.2005.05023.x; FAN TY, 1995, MAR BIOL, V123, P565, DOI 10.1007/BF00349235; Gilmour JP, 2004, CORAL REEFS, V23, P595, DOI 10.1007/s00338-004-0426-6; Glynn PW, 1996, MAR BIOL, V125, P579; Goffredo S, 2002, MAR ECOL PROG SER, V229, P83, DOI 10.3354/meps229083; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; Harrison P.L., 1990, P133; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hayakawa H, 2006, BIOCHEM BIOPH RES CO, V344, P173, DOI 10.1016/j.bbrc.2006.03.116; Hayakawa H, 2007, ZOOL SCI, V24, P249, DOI 10.2108/zsj.24.249; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Ikenishi K, 1998, DEV GROWTH DIFFER, V40, P1; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Khalturin K, 2007, DEV BIOL, V309, P32, DOI 10.1016/j.ydbio.2007.06.013; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; KOJIS BL, 1986, MAR BIOL, V91, P291, DOI 10.1007/BF00428623; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Kruger A, 1998, MAR BIOL, V132, P703, DOI 10.1007/s002270050434; LIANG L, 1994, DEVELOPMENT, V120, P1201; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; NISHIMIYAFUJISAWA C, 1995, DEV BIOL, V172, P324, DOI 10.1006/dbio.1995.0026; NISHIMIYAFUJISAWA C, 1993, DEV BIOL, V157, P1, DOI 10.1006/dbio.1993.1106; Pechenik J. A., 2010, BIOL INVERTEBRATES; Pierantoni R, 2002, INT REV CYTOL, V218, P69; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Rebscher N, 2008, DEV DYNAM, V237, P1736, DOI 10.1002/dvdy.21562; Richards JS, 2001, ENDOCRINOLOGY, V142, P2184, DOI 10.1210/en.142.6.2184; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; Sakai K, 1997, MAR ECOL PROG SER, V151, P67, DOI 10.3354/meps151067; Sato K, 2006, DEV GROWTH DIFFER, V48, P615, DOI 10.1111/j.1440-169x.2006.00897.x; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Shlesinger Y, 1998, MAR BIOL, V132, P691, DOI 10.1007/s002270050433; Sunanaga T, 2007, DEV GENES EVOL, V217, P1, DOI 10.1007/s00427-006-0112-5; SZMANTFROELICH A, 1980, BIOL BULL, V158, P257, DOI 10.2307/1540935; SZMANTFROELICH A, 1985, B MAR SCI, V37, P880; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Twan WH, 2006, COMP BIOCHEM PHYS A, V144, P247, DOI 10.1016/j.cbpa.2006.01.011; Twan WH, 2006, ENDOCRINOLOGY, V147, P397, DOI 10.1210/en.2005-0584; Twan WH, 2003, BIOL REPROD, V68, P2255, DOI 10.1095/biolreprod.102.012450; Vargas-Angel B, 2006, CORAL REEFS, V25, P110, DOI 10.1007/s00338-005-0070-9; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328	55	29	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41569	10.1371/journal.pone.0041569	http://dx.doi.org/10.1371/journal.pone.0041569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848529	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200071
J	Zhao, HB; Tang, CL; Hou, YL; Xue, LR; Li, MQ; Du, MR; Li, DJ				Zhao, Hong-Bo; Tang, Chuan-Ling; Hou, Yan-Li; Xue, Li-Rong; Li, Ming-Qing; Du, Mei-Rong; Li, Da-Jin			CXCL12/CXCR4 Axis Triggers the Activation of EGF Receptor and ERK Signaling Pathway in CsA-Induced Proliferation of Human Trophoblast Cells	PLOS ONE			English	Article							INVASIVENESS IN-VITRO; CYCLOSPORINE-A; PROTEIN-KINASE; CHEMOKINE RECEPTORS; GROWTH; EXPRESSION; CXCR4; MIGRATION; PREECLAMPSIA; CALCINEURIN	Introduction: Our previous study has demonstrated Cyclosporin A (CsA) promotes the proliferation of human trophoblast cells. Therefore, we further investigate the intracellular signaling pathway involved in the CsA-induced proliferation of human trophoblast cells. Methods: Enzyme-linked immunosorbent assay (ELISA) was performed to evaluate the regulation of CsA on CXCL12 secretion in human trophoblast cells. Immunofluorescence analysis and western blotting analysis were used to investigate the role of CXCL12/CXCR4 axis in the CsA-induced epidermal growth factor receptor (EGFR) phosphorylation in human trophoblast cells. 5-bromo-2'-deoxyuridine (BrdU) cell proliferation assay was performed to analyze the involvement of EGFR and its downstream extracellular signal-regulated protein kinase (ERK) signaling pathway in the CsA-induced proliferation of human trophoblast cells. Results: Low concentration of CsA promoted the secretion of CXCL12, and recombinant human CXCL12 promoted the phosphorylation of EGFR in primary human trophoblast cells and choriocarcinoma cell line JEG-3. The inhibition of CXCL12 or CXCR4 by either neutralizing antibodies or small interfering RNA (siRNA) could completely block the CsA-induced EGFR phosphorylation. The CsA-induced proliferation of human trophoblast cells was effectively abrogated by the EGFR inhibitor AG1478 as well as the ERK inhibitor U0126, but not by the PI3K/PKB inhibitor LY294002. CsA promoted the activation of ERK in JEG-3 cells, which was markedly abrogated in the presence of CXCL12 siRNA, or CXCR4 siRNA, or AG1478. Conclusions: CsA may promote EGFR activation via CXCL12/CXCR4 axis, and EGFR downstream ERK signaling pathway may be involved in the CsA-induced proliferation of human trophoblast cells.	[Zhao, Hong-Bo; Tang, Chuan-Ling; Hou, Yan-Li; Xue, Li-Rong; Li, Ming-Qing; Du, Mei-Rong; Li, Da-Jin] Fudan Univ, Hosp & Inst Obstet & Gynecol, Lab Reprod Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Li, Da-Jin] Hainan Med Coll, Dept Obstet & Gynecol, Affiliated Hosp, Haikou, Peoples R China	Fudan University; Hainan Medical University	Zhao, HB (corresponding author), Fudan Univ, Hosp & Inst Obstet & Gynecol, Lab Reprod Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	djli@shmu.edu.cn		Li, Ming-Qing/0000-0002-9276-0722	Key Project of National Natural Science Foundation of China [30730087]; National Natural Science Foundation of China [30872768, 30670787, 31000657]; National and Shanghai Leading Academic Discipline Project [211XK22]; Research Fund for Doctoral Program from Education Ministry of China [200802461020]; Shanghai Rising-Star Program [11QA1400800]; Open Project Program of Institutes of Biomedical Sciences of Fudan University [IBS0904]	Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National and Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Research Fund for Doctoral Program from Education Ministry of China; Shanghai Rising-Star Program; Open Project Program of Institutes of Biomedical Sciences of Fudan University	This work was supported by Key Project of National Natural Science Foundation of China 30730087 to D.J.L., National Natural Science Foundation of China 30872768 and 30670787 to D.J.L., National and Shanghai Leading Academic Discipline Project 211XK22 to D.J.L., Program for Outstanding Academic Leader to D.J.L., National Natural Science Foundation of China 31000657 to H.B.Z., Research Fund for Doctoral Program from Education Ministry of China 200802461020 to H.B.Z., Shanghai Rising-Star Program 11QA1400800 to H.B.Z., and Open Project Program of Institutes of Biomedical Sciences of Fudan University IBS0904 to H.B.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Du MR, 2008, BIOL REPROD, V78, P1102, DOI 10.1095/biolreprod.107.063503; Du MR, 2007, HUM REPROD, V22, P2528, DOI 10.1093/humrep/dem222; Du MR, 2007, BIOL REPROD, V76, P906, DOI 10.1095/biolreprod.106.056648; Han WN, 2010, J BIOL CHEM, V285, P11369, DOI 10.1074/jbc.M109.028142; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Juarez J, 2004, CURR PHARM DESIGN, V10, P1245, DOI 10.2174/1381612043452640; Lin Y, 2005, REPRODUCTION, V130, P529, DOI 10.1530/rep.1.00575; Lin Y, 2009, FERTIL STERIL, V91, P2687, DOI 10.1016/j.fertnstert.2008.01.109; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Shih Ie-Ming, 2002, Current Molecular Medicine (Hilversum), V2, P1; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; WON YH, 1994, BRIT J DERMATOL, V130, P312, DOI 10.1111/j.1365-2133.1994.tb02926.x; Wu X, 2004, BIOL REPROD, V70, P1877, DOI 10.1095/biolreprod.103.024729; Zhao HB, 2010, BIOL REPROD, V83, P370, DOI 10.1095/biolreprod.110.083402; Zhou WH, 2007, HUM REPROD, V22, P2743, DOI 10.1093/humrep/dem097; Zhou WH, 2008, HUM REPROD, V23, P2669, DOI 10.1093/humrep/den308; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	30	51	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e38375	10.1371/journal.pone.0038375	http://dx.doi.org/10.1371/journal.pone.0038375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848341	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200003
J	Cano, PG; Santacruz, A; Moya, A; Sanz, Y				Gauffin Cano, Paola; Santacruz, Arlette; Moya, Angela; Sanz, Yolanda			Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced Obesity	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; GROUP-SPECIFIC PRIMERS; REAL-TIME PCR; INSULIN-RESISTANCE; WEIGHT-LOSS; IMMUNE-RESPONSES; ENERGY-BALANCE; ADIPOSE-TISSUE; HUMAN FECES; PREDOMINANT BACTERIA	Background: Associations have been made between obesity and reduced intestinal numbers of members of the phylum Bacteroidetes, but there is no direct evidence of the role these bacteria play in obesity. Herein, the effects of Bacteroides uniformis CECT 7771 on obesity-related metabolic and immune alterations have been evaluated. Methods and Findings: Adult (6-8 week) male wild-type C57BL-6 mice were fed a standard diet or a high-fat-diet HFD to induce obesity, supplemented or not with B. uniformis CECT 7771 for seven weeks. Animal weight was monitored and histologic, biochemical, immunocompetent cell functions, and features of the faecal microbiota were analysed after intervention. The oral administration of B. uniformis CECT 7771 reduced body weight gain, liver steatosis and liver cholesterol and triglyceride concentrations and increased small adipocyte numbers in HFD-fed mice. The strain also reduced serum cholesterol, triglyceride, glucose, insulin and leptin levels, and improved oral tolerance to glucose in HFD fed mice. The bacterial strain also reduced dietary fat absorption, as indicated by the reduced number of fat micelles detected in enterocytes. Moreover, B. uniformis CECT 7771 improved immune defence mechanisms, impaired in obesity. HFD-induced obesity led to a decrease in TNF-alpha production by peritoneal macrophages stimulated with LPS, conversely, the administration of B. uniformis CECT 7771 increased TNF-alpha production and phagocytosis. Administering this strain also increased TNF-alpha production by dendritic cells (DCs) in response to LPS stimulation, which was significantly reduced by HFD. B. uniformis CECT 7771 also restored the capacity of DCs to induce a T-cell proliferation response, which was impaired in obese mice. HFD induced marked changes in gut microbiota composition, which were partially restored by the intervention. Conclusions: Altogether, the findings indicate that administration of B. uniformis CECT 7771 ameliorates HFD-induced metabolic and immune dysfunction associated with intestinal dysbiosis in obese mice.	[Gauffin Cano, Paola; Santacruz, Arlette; Moya, Angela; Sanz, Yolanda] Natl Res Council CSIC, Microbial Ecol & Nutr Res Grp, Inst Agrochem & Food Technol IATA, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Sanz, Y (corresponding author), Natl Res Council CSIC, Microbial Ecol & Nutr Res Grp, Inst Agrochem & Food Technol IATA, Valencia, Spain.	yolsanz@iata.csic.es	Gauffin Cano, Paola/ABG-2631-2021; Sanz, Yolanda/H-5498-2012	Sanz, Yolanda/0000-0002-1615-1976; Santacruz, Arlette/0000-0001-5580-3108; Gauffin-Cano, Paola/0000-0001-9397-6034; MOYA PEREZ, ANGELA/0000-0002-2265-3630	Spanish Ministry of Science and Innovation (MICINN, Spain) [AGL2011-25169, Consolider Fun-C-Food CSD2007-00063]; CONACYT (Mexico); CONICET (Argentina); MICINN	Spanish Ministry of Science and Innovation (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This study was supported by public grants AGL2011-25169 and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation (MICINN, Spain) The scholarships of AS from CONACYT (Mexico), PGC from CONICET (Argentina) and AM from MICINN are fully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Ciccocioppo R, 2008, DIGEST LIVER DIS, V40, P927, DOI 10.1016/j.dld.2008.05.005; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hoyles L, 2009, FEMS MICROBIOL LETT, V299, P175, DOI 10.1111/j.1574-6968.2009.01741.x; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Misra A, 2000, J CARDIOVASC RISK, V7, P215; Moreno LA, 2006, EUR J CLIN NUTR, V60, P191, DOI 10.1038/sj.ejcn.1602285; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Parnell JA, 2011, BR J NUTR, V18, P1; Porkka KVK, 1996, CURR OPIN LIPIDOL, V7, P183, DOI 10.1097/00041433-199608000-00002; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Sanchez E, 2011, APPL ENVIRON MICROB, V77, P5316, DOI 10.1128/AEM.00365-11; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Sanz Y, 2010, P NUTR SOC, V69, P434, DOI 10.1017/S0029665110001813; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Solga SF, 2003, J HEPATOL, V38, P681, DOI 10.1016/S0168-8278(03)00097-7; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Verwaerde C, 2006, SCAND J IMMUNOL, V64, P457, DOI 10.1111/j.1365-3083.2006.01791.x; Vieira JMBD, 2009, BIOCHEM BIOPH RES CO, V387, P627, DOI 10.1016/j.bbrc.2009.05.124; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; WHO, 2007, WHO TECH REP SER, V935, P1; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	57	234	244	6	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41079	10.1371/journal.pone.0041079	http://dx.doi.org/10.1371/journal.pone.0041079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844426	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600014
J	Johannsen, DL; Galgani, JE; Johannsen, NM; Zhang, ZY; Covington, JD; Ravussin, E				Johannsen, Darcy L.; Galgani, Jose E.; Johannsen, Neil M.; Zhang, Zhengyu; Covington, Jeffrey D.; Ravussin, Eric			Effect of Short-Term Thyroxine Administration on Energy Metabolism and Mitochondrial Efficiency in Humans	PLOS ONE			English	Article							THYROID-HORMONE REPLACEMENT; HUMAN SKELETAL-MUSCLE; IN-VIVO; BODY-COMPOSITION; WEIGHT-LOSS; TRIIODOTHYRONINE; HYPOTHYROIDISM; EXPENDITURE; INSULIN; RESPIRATION	The physiologic effects of triiodothyronine (T3) on metabolic rate are well-documented; however, the effects of thyroxine (T4) are less clear despite its wide-spread use to treat thyroid-related disorders and other non-thyroidal conditions. Here, we investigated the effects of acute (3-day) T4 supplementation on energy expenditure at rest and during incremental exercise. Furthermore, we used a combination of in situ and in vitro approaches to measure skeletal muscle metabolism before and after T4 treatment. Ten healthy, euthyroid males were given 200 mu g T4 (levothyroxine) per day for 3 days. Energy expenditure was measured at rest and during exercise by indirect calorimetry, and skeletal muscle mitochondrial function was assessed by in situ ATP flux (P-31 MRS) and in vitro respiratory control ratio (RCR, state 3/state 4 rate of oxygen uptake using a Clark-type electrode) before and after acute T4 treatment. Thyroxine had a subtle effect on resting metabolic rate, increasing it by 4% (p = 0.059) without a change in resting ATP demand (i.e., ATP flux) of the vastus lateralis. Exercise efficiency did not change with T4 treatment. The maximal capacity to produce ATP (state 3 respiration) and the coupled state of the mitochondria (RCR) were reduced by approximately 30% with T4 (p = 0.057 and p = 0.04, respectively). Together, the results suggest that T4, although less metabolically active than T3, reduces skeletal muscle efficiency and modestly increases resting metabolism even after short-term supplementation. Our findings may be clinically relevant given the expanding application of T4 to treat non-thyroidal conditions such as obesity and weight loss.	[Johannsen, Darcy L.; Galgani, Jose E.; Johannsen, Neil M.; Zhang, Zhengyu; Covington, Jeffrey D.; Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Galgani, Jose E.] Univ Chile, Fac Med, Dept Nutr, Santiago 7, Chile	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Universidad de Chile	Ravussin, E (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	RavussE@pbrc.edu	Ravussin, Eric/N-1985-2017	Ravussin, Eric/0000-0003-2129-547X; Johannsen, Darcy/0000-0002-6377-1262	National Institutes of Health [P01AG22064, K01DK89005]; NORC Center [2P30DK072476]; NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, K01DK089005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC Center; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health Grants P01AG22064 to ER, K01DK89005 to DLJ, and NORC Center Grant # 2P30DK072476 entitled "Nutritional Programming: Environmental and Molecular Interactions" sponsored by NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AlAdsani H, 1997, J CLIN ENDOCR METAB, V82, P1118, DOI 10.1210/jc.82.4.1118; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Amara CE, 2008, METHODS, V46, P312, DOI 10.1016/j.ymeth.2008.10.001; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bracco D, 1996, OBES RES, V4, P213, DOI 10.1002/j.1550-8528.1996.tb00539.x; Braverman L.E., 1996, THYROID, P125; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Clement K, 2002, GENOME RES, V12, P281, DOI 10.1101/gr.207702; Conley KE, 1997, AM J PHYSIOL-CELL PH, V273, pC306, DOI 10.1152/ajpcell.1997.273.1.C306; DIMITRIADIS G, 1985, AM J PHYSIOL, V248, pE593, DOI 10.1152/ajpendo.1985.248.5.E593; Dubois S, 2008, THYROID, V18, P13, DOI 10.1089/thy.2007.0037; GAESSER GA, 1975, J APPL PHYSIOL, V38, P1132, DOI 10.1152/jappl.1975.38.6.1132; GUSTAFSS.R, 1965, J CELL BIOL, V26, P555, DOI 10.1083/jcb.26.2.555; Harper ME, 2008, THYROID, V18, P145, DOI 10.1089/thy.2007.0250; ISMAILBEIGI F, 1970, P NATL ACAD SCI USA, V67, P1071, DOI 10.1073/pnas.67.2.1071; Jubrias SA, 2001, J APPL PHYSIOL, V90, P1663, DOI 10.1152/jappl.2001.90.5.1663; Kaptein EM, 2009, J CLIN ENDOCR METAB, V94, P3663, DOI 10.1210/jc.2009-0899; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; LADENSON PW, 1982, AM J MED, V73, P467, DOI 10.1016/0002-9343(82)90323-0; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Lovejoy JC, 1997, J CLIN ENDOCR METAB, V82, P765, DOI 10.1210/jc.82.3.765; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Nannipieri M, 2009, INT J OBESITY, V33, P1001, DOI 10.1038/ijo.2009.140; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Newsholme E A, 1976, Biochem Soc Symp, P61; PIOLINO V, 1990, AM J PHYSIOL, V259, pE305, DOI 10.1152/ajpendo.1990.259.3.E305; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; SHULMAN GI, 1985, J CLIN INVEST, V76, P757, DOI 10.1172/JCI112032; SMITH RN, 1970, BRIT MED J, V4, P145, DOI 10.1136/bmj.4.5728.145; Wiersinga WM, 2001, HORM RES, V56, P74, DOI 10.1159/000048140	31	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40837	10.1371/journal.pone.0040837	http://dx.doi.org/10.1371/journal.pone.0040837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844412	gold, Green Submitted, Green Published			2022-12-27	WOS:000309240600011
J	de los Campos, G; Klimentidis, YC; Vazquez, AI; Allison, DB				de los Campos, Gustavo; Klimentidis, Yann C.; Vazquez, Ana I.; Allison, David B.			Prediction of Expected Years of Life Using Whole-Genome Markers	PLOS ONE			English	Article							QUANTITATIVE TRAITS; ENABLED PREDICTION; MOLECULAR MARKERS; WIDE ASSOCIATION; HUMAN LONGEVITY; GENETIC VALUES; HERITABILITY; SELECTION; ACCURACY; PEDIGREE	Genetic factors are believed to account for 25% of the interindividual differences in Years of Life (YL) among humans. However, the genetic loci that have thus far been found to be associated with YL explain a very small proportion of the expected genetic variation in this trait, perhaps reflecting the complexity of the trait and the limitations of traditional association studies when applied to traits affected by a large number of small-effect genes. Using data from the Framingham Heart Study and statistical methods borrowed largely from the field of animal genetics (whole-genome prediction, WGP), we developed a WGP model for the study of YL and evaluated the extent to which thousands of genetic variants across the genome examined simultaneously can be used to predict interindividual differences in YL. We find that a sizable proportion of differences in YL-which were unexplained by age at entry, sex, smoking and BMI-can be accounted for and predicted using WGP methods. The contribution of genomic information to prediction accuracy was even higher than that of smoking and body mass index (BMI) combined; two predictors that are considered among the most important life-shortening factors. We evaluated the impacts of familial relationships and population structure (as described by the first two marker-derived principal components) and concluded that in our dataset population structure explained partially, but not fully the gains in prediction accuracy obtained with WGP. Further inspection of prediction accuracies by age at death indicated that most of the gains in predictive ability achieved with WGP were due to the increased accuracy of prediction of early mortality, perhaps reflecting the ability of WGP to capture differences in genetic risk to deadly diseases such as cancer, which are most often responsible for early mortality in our sample.	[de los Campos, Gustavo; Klimentidis, Yann C.; Vazquez, Ana I.; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	de los Campos, G (corresponding author), Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.	gcampos@uab.edu	Klimentidis, Yann/B-2348-2015	Klimentidis, Yann/0000-0002-6065-4044; Allison, David/0000-0003-3566-9399	National Institutes of Health [P30CA13148, P30DK056336, R01GM077490, R01DK076771, T32HL105346]; KRAFT-grant "University of Alabama at Birmingham doctorate Training Program in Obesity and Nutrition Research"; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076771, P30DK056336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101219, R01GM077490, R01GM099992] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KRAFT-grant "University of Alabama at Birmingham doctorate Training Program in Obesity and Nutrition Research"; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project had funding from National Institutes of Health grants P30CA13148, P30DK056336, R01GM077490, R01DK076771, T32HL105346 and KRAFT-grant "University of Alabama at Birmingham doctorate Training Program in Obesity and Nutrition Research." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2004, EUR HEART J, V25, P409, DOI 10.1016/j.ehj.2003.12.015; [Anonymous], 2010, R LANG ENV STAT COMP; Arias E., 2010, NATL VITAL STAT REP, V58; Braeckman BP, 2007, EXP GERONTOL, V42, P90, DOI 10.1016/j.exger.2006.04.010; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; de los Campos G., 2010, BLR BAYESIAN LINEAR; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Drineas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011892; Finkelstein EA, 2010, OBESITY, V18, P333, DOI 10.1038/oby.2009.253; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Iachine I A, 1998, Twin Res, V1, P196; Lee SH, 2011, AM J HUMAN GENETICS; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Meuwissen THE, 2001, GENETICS, V157, P1819; Newman AB, 2010, J GERONTOL A-BIOL, V65, P478, DOI 10.1093/gerona/glq028; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Poduslo SE, 2010, AM J MED GENET B, V153B, P114, DOI 10.1002/ajmg.b.30963; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rossi P., 2010, BAYESM BAYESIAN INFE; Sebastiani P., 2010, SCIENCE, V2010; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vazquez AI, 2010, J DAIRY SCI, V93, P5942, DOI 10.3168/jds.2010-3335; Weigel KA, 2010, J DAIRY SCI, V93, P5423, DOI 10.3168/jds.2010-3149; Weigel KA, 2009, J DAIRY SCI, V92, P5248, DOI 10.3168/jds.2009-2092; Wheeler B., 2008, SUPPDISTS SUPPLEMENT; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191	44	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40964	10.1371/journal.pone.0040964	http://dx.doi.org/10.1371/journal.pone.0040964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848416	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600032
J	He, HH; Bleby, TM; Veneklaas, EJ; Lambers, H; Kuo, J				He, Honghua; Bleby, Timothy M.; Veneklaas, Erik J.; Lambers, Hans; Kuo, John			Precipitation of Calcium, Magnesium, Strontium and Barium in Tissues of Four Acacia Species (Leguminosae: Mimosoideae)	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; OXALATE CRYSTALS; SOIL PROPERTIES; LEMNA-MINOR; PLANTS; LEAVES; DEFENSE; BRANCHLETS; VEGETATION; PHYSIOLOGY	Precipitation of calcium in plants is common. There are abundant studies on the uptake and content of magnesium, strontium and barium, which have similar chemical properties to calcium, in comparison with those of calcium in plants, but studies on co-precipitation of these elements with calcium in plants are rare. In this study, we compared morphologies, distributional patterns, and elemental compositions of crystals in tissues of four Acacia species grown in the field as well as in the glasshouse. A comparison was also made of field-grown plants and glasshouse-grown plants, and of phyllodes of different ages for each species. Crystals of various morphologies and distributional patterns were observed in the four Acacia species studied. Magnesium, strontium and barium were precipitated together with calcium, mainly in phyllodes of the four Acacia species, and sometimes in branchlets and primary roots. These elements were most likely precipitated in forms of oxalate and sulfate in various tissues, including epidermis, mesophyll, parenchyma, sclerenchyma (fibre cells), pith, pith ray and cortex. In most cases, precipitation of calcium, magnesium, strontium and barium was biologically induced, and elements precipitated differed between soil types, plant species, and tissues within an individual plant; the precipitation was also related to tissue age. Formation of crystals containing these elements might play a role in regulating and detoxifying these elements in plants, and protecting the plants against herbivory.	[He, Honghua; Bleby, Timothy M.; Veneklaas, Erik J.; Lambers, Hans] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Kuo, John] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, Australia	University of Western Australia; University of Western Australia	He, HH (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, Australia.	honghua.he@uwa.edu.au	Lambers, Hans/A-1544-2008; Veneklaas, Erik J/C-8907-2009; HE, HONGHUA/AAG-1519-2019; HE, HONGHUA/E-1110-2013	Lambers, Hans/0000-0002-4118-2272; Veneklaas, Erik J/0000-0002-7030-4056; HE, HONGHUA/0000-0002-5785-2242; HE, HONGHUA/0000-0002-5785-2242	Australian Research Council; Mineral and Energy Research Institute of Western Australia; Newcrest Mining Ltd. (Telfer Gold Mine); School of Plant Biology, The University of Western Australia; Newcrest Mining Ltd's Telfer Gold Mine; China Scholarship Council; University of Western Australia	Australian Research Council(Australian Research Council); Mineral and Energy Research Institute of Western Australia; Newcrest Mining Ltd. (Telfer Gold Mine); School of Plant Biology, The University of Western Australia(University of Melbourne); Newcrest Mining Ltd's Telfer Gold Mine; China Scholarship Council(China Scholarship Council); University of Western Australia	This work was supported by Australian Research Council, Mineral and Energy Research Institute of Western Australia, Newcrest Mining Ltd. (Telfer Gold Mine), and the School of Plant Biology, The University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Newcrest Mining Ltd's Telfer Gold Mine is a commercial funder of the project, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; China Scholarship Council and The University of Western Australia are acknowledged for providing a scholarship for Honghua He. The authors acknowledge the facilities and scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation & Analysis, The University of Western Australia, a facility funded by The University, and State and Commonwealth Governments. We thank Chris Bray who provided the Olympus BX43 microscope and Eleanor Hoy who provided valuable help in sample collection and transport. We are grateful to Peter Golos for providing seeds for this research.	Bell J, 2003, AUST SYST BOT, V16, P131, DOI 10.1071/SB02004; BERG RH, 1994, PROTOPLASMA, V183, P29, DOI 10.1007/BF01276810; Boke NH, 1940, AM J BOT, V27, P73, DOI 10.2307/2436690; Bosca S, 2006, PLANT PHYSIOL, V142, P1353, DOI 10.1104/pp.106.087700; Bose J, 2011, J EXP BOT, V62, P2251, DOI 10.1093/jxb/erq456; BOWEN HJM, 1955, PROC R SOC SER B-BIO, V144, P355, DOI 10.1098/rspb.1955.0063; BOWEN HJM, 1956, J EXP BOT, V7, P264, DOI 10.1093/jxb/7.2.264; Broadley MR, 2008, PLANT PHYSIOL, V146, P1707, DOI 10.1104/pp.107.114645; CIPOLLINI ML, 1986, PLANT SOIL, V92, P159, DOI 10.1007/BF02372630; Conn S, 2010, ANN BOT-LONDON, V105, P1081, DOI 10.1093/aob/mcq027; Finley DS, 1999, REV BIOL TROP, V47, P27; Franceschi V, 2001, TRENDS PLANT SCI, V6, P331, DOI 10.1016/S1360-1385(01)02014-3; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; FRANCESCHI VR, 1989, PROTOPLASMA, V148, P130, DOI 10.1007/BF02079332; FRANCESCHI VR, 1986, PROTOPLASMA, V130, P199, DOI 10.1007/BF01276601; GUNN KB, 1970, PLANT SOIL, V33, P7, DOI 10.1007/BF01378192; Hawkesford M, 2011, MINERAL NUTR HIGHER, P171; He HH, 2012, ANN BOT-LONDON, V109, P887, DOI 10.1093/aob/mcs004; He HH, 2011, PLANT CELL ENVIRON, V34, P2060, DOI 10.1111/j.1365-3040.2011.02403.x; Hudgins JW, 2003, NEW PHYTOL, V159, P677, DOI 10.1046/j.1469-8137.2003.00839.x; HUTTUNEN S, 1990, WATER AIR SOIL POLL, V54, P169, DOI 10.1007/BF00298663; Ilarslan H, 2001, ANN BOT-LONDON, V88, P243, DOI 10.1006/anbo.2001.1453; KIRKBY E., 2011, MINERAL NUTR HIGHER, P3; Kirschbaum MUF, 2008, SOIL BIOL BIOCHEM, V40, P392, DOI 10.1016/j.soilbio.2007.09.003; Korth KL, 2006, PLANT PHYSIOL, V141, P188, DOI 10.1104/pp.106.076737; Ladiges PY, 2006, J ARID ENVIRON, V66, P462, DOI 10.1016/j.jaridenv.2006.01.012; Lersten NR, 2011, AM J BOT, V98, P1, DOI 10.3732/ajb.1000247; Maslin B. R., 1982, EVOLUTION FLORA FAUN, P301; Mazen A. M. A., 1997, Biologia Plantarum (Prague), V40, P411, DOI 10.1023/A:1001174132428; Mazen AMA, 2004, NEW PHYTOL, V161, P435, DOI 10.1111/j.1469-8137.2004.00923.x; Mazen AMA, 2004, RUSS J PLANT PHYSL+, V51, P281, DOI 10.1023/B:RUPP.0000019226.03536.21; MEMON AR, 1983, PLANT SOIL, V70, P367, DOI 10.1007/BF02374893; MENZEL RG, 1954, SOIL SCI, V77, P419, DOI 10.1097/00010694-195406000-00001; Na G, 2011, ENVIRON EXP BOT, V72, P18, DOI 10.1016/j.envexpbot.2010.04.004; Pritchard SG, 2000, INT J PLANT SCI, V161, P917, DOI 10.1086/317560; Prychid CJ, 1999, ANN BOT-LONDON, V84, P725, DOI 10.1006/anbo.1999.0975; RAO DV, 1989, PHYTOPATHOLOGY, V79, P783, DOI 10.1094/Phyto-79-783; Ray J. G., 2010, Journal of Agronomy, V9, P70, DOI 10.3923/ja.2010.70.74; Roca MC, 1997, J ENVIRON QUAL, V26, P1354, DOI 10.2134/jeq1997.00472425002600050022x; SMITH KA, 1971, PLANT SOIL, V34, P369, DOI 10.1007/BF01372791; Steveninck R, 1995, FUNCT PLANT BIOL, V22, P817; STOREY R, 1994, ANN BOT-LONDON, V73, P307, DOI 10.1006/anbo.1994.1036; Storey R, 2004, PLANT PHYSIOL, V136, P3838, DOI 10.1104/pp.104.045674; Szczerba MW, 2009, J PLANT PHYSIOL, V166, P447, DOI 10.1016/j.jplph.2008.12.009; Veresoglou DS, 1996, PLANT SOIL, V178, P95, DOI 10.1007/BF00011167; Volk GM, 2002, PLANT BIOLOGY, V4, P34, DOI 10.1055/s-2002-20434; Watanabe T, 2005, ANN BOT-LONDON, V95, P379, DOI 10.1093/aob/mci032; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Willey N, 2006, ENVIRON EXP BOT, V57, P258, DOI 10.1016/j.envexpbot.2005.06.005; Zindler-Frank E., 1987, ADV LEGUME SYSTEMA 3, P279	52	20	21	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41563	10.1371/journal.pone.0041563	http://dx.doi.org/10.1371/journal.pone.0041563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848528	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600085
J	Leocadio, AM; Whitmarsh, D; Castro, M				Leocadio, Ana Maria; Whitmarsh, David; Castro, Margarida			Comparing Trawl and Creel Fishing for Norway Lobster (Nephrops norvegicus): Biological and Economic Considerations	PLOS ONE			English	Article							DISCARDS; FISHERY; CAUGHT; IMPACT; CATCH	This study compares the fishing activity and landings of the trawl and creel fisheries for Norway lobster (Nephrops norvegicus (L.)) off the Portuguese coast, and evaluates the financial viability of two vessels typical of each fleet. Crustacean trawlers are part of an industrial fleet that, besides Nephrops, targets deep water shrimps. Creels are used by a multi-gear, multi-target artisanal fleet, fishing only in areas unavailable to trawlers and, when catching Nephrops, set specifically to target this species. Trawlers have in recent years contributed with 85% of the landings in weight, but only 74% in value (2005-2009 average). Despite smaller landings, the Nephrops creel fishery provides individuals of larger size and in better condition, thereby obtaining higher unit prices. Economic viability was also higher for the creel vessel, with trawling being only viable if major costs (such as labor and fuel) are covered by the revenue from other target species (e. g., the rose shrimp). At present, Nephrops populations on the South and SW coast are subject to intense fishing and to a recovery plan. The possibility of reallocation of some of the fishing effort directed at Nephrops from trawlers to creels is discussed in terms of the conservation of the resource and economic return.	[Leocadio, Ana Maria] Univ Algarve, Fac Ciencias & Tecnol, Faro, Portugal; [Whitmarsh, David] Univ Portsmouth, Portsmouth Business Sch, Dept Econ, Portsmouth, Hants, England; [Castro, Margarida] Univ Algarve, Ctr Marine Sci, CCMAR, Faro, Portugal	Universidade do Algarve; University of Portsmouth; Universidade do Algarve	Leocadio, AM (corresponding author), CEFAS, Lowestoft, Suffolk, England.	mcastro@ualg.pt	Castro, Margarida/N-1091-2013	Castro, Margarida/0000-0002-7860-2074	Foundation for Science and Technology, Portugal: Project "Nephrops survival when escaping from trawls nets and by-catch escaping devices" [PDCT/MAR/59366/2004]; Foundation for Science and Technology, Portugal: Project "Environmental impact of fixing gears in the southwest coast of Portugal. Combine fisheries and marine ecosystem conservation" [POCTI/CTA/49248/2002]; Fundação para a Ciência e a Tecnologia [PDCT/MAR/59366/2004] Funding Source: FCT	Foundation for Science and Technology, Portugal: Project "Nephrops survival when escaping from trawls nets and by-catch escaping devices"; Foundation for Science and Technology, Portugal: Project "Environmental impact of fixing gears in the southwest coast of Portugal. Combine fisheries and marine ecosystem conservation"; Fundação para a Ciência e a Tecnologia	The present study was partially supported by the following projects (Funded by Foundation for Science and Technology, Portugal): Project "Nephrops survival when escaping from trawls nets and by-catch escaping devices" - PDCT/MAR/59366/2004; Project "Environmental impact of fixing gears in the southwest coast of Portugal. Combine fisheries and marine ecosystem conservation" - POCTI/CTA/49248/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey JM, 2008, MAR ECOL PROG SER, V366, P119, DOI 10.3354/meps07520; Adey J. M., 2007, ASPECTS SUSTAINABILI; Aguzzi J, 2008, REV FISH BIOL FISHER, V18, P235, DOI 10.1007/s11160-007-9071-9; Bell Mike C., 2006, P412, DOI 10.1002/9780470995969.ch13; Bergmann M, 2002, FISH RES, V57, P169, DOI 10.1016/S0165-7836(01)00345-9; Borges TC, 2001, J APPL ICHTHYOL, V17, P104; Castro M, 2003, FISH RES, V65, P475, DOI 10.1016/j.fishres.2003.09.033; Dounas C, 2007, CONT SHELF RES, V27, P2198, DOI 10.1016/j.csr.2007.05.006; Dowling J, 2003, REPORT WORKING GROUP; Eggert H., 1999, MARINE RES EC, V14, P225; Eriksson SP, 2006, MAR BIOL RES, V2, P52, DOI 10.1080/17451000600623803; Erzini K, 2002, FISHERIES MANAG ECOL, V9, P31, DOI 10.1046/j.1365-2400.2002.00284.x; European Commission, 2006, 4 EUR COMM DIR GEN; EVANS SM, 1994, ICES J MAR SCI, V51, P155, DOI 10.1006/jmsc.1994.1017; Figueiredo M, 1989, RELATORIO CIENTIFICO; ICES, 2007, ICES ADV 2007; ICES, 2011, ICES ADV 2011, P24; ICES, 2001, 2001ACFM16 ICES CM; ICES, 2010, ICES ADV 2010, P1; ICES, 2009, ICES ADV 2009, P1; ICES, 2008, ICES ADV 2008; ICES, 2004, 2004ACFM19 ICES CM; *ICES, 2006, ICES ADV 2006; ICES, 1990, 1990ASSESS ICES CM; ICES, 2005, ICES ADV 2005; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Kinnear J, 1996, 296 ENV FISH DEP SCO; Livingstone M, 2001, STUDY EFFECTIVENESS; LUMBY S, 1984, INVESTMENT APPRAISAL; Monteiro P, 2001, HYDROBIOLOGIA, V449, P267, DOI 10.1023/A:1017575429808; Morello EB, 2009, FISH RES, V95, P325, DOI 10.1016/j.fishres.2008.10.002; Newland P, 1982, J CRUSTACEAN BIOL, V12, P342; NEWLAND PL, 1989, FISH RES, V8, P63, DOI 10.1016/0165-7836(89)90041-6; Nilsson HC, 2003, J EXP MAR BIOL ECOL, V285, P453, DOI 10.1016/S0022-0981(02)00543-9; Office for Official Publications of the European Communities, 2004, HARM IND CONS PRIC H; Olsgard F, 2008, J EXP MAR BIOL ECOL, V366, P123, DOI 10.1016/j.jembe.2008.07.036; Queiros AM, 2006, J EXP MAR BIOL ECOL, V335, P91, DOI 10.1016/j.jembe.2006.03.001; Ridgway ID, 2006, J EXP MAR BIOL ECOL, V339, P135, DOI 10.1016/j.jembe.2006.07.008; Viriato A, 1991, RELATORIOS CIENTIFIC; Viriato A, 1996, ATLAS APOIO PESCA AR; Ziegler F, 2008, INT J LIFE CYCLE ASS, V13, P487, DOI 10.1007/s11367-008-0024-x	41	25	26	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39567	10.1371/journal.pone.0039567	http://dx.doi.org/10.1371/journal.pone.0039567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848357	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600007
J	Li, HW; Liu, J; Wu, KL; Chen, Y				Li, Hongwei; Liu, Jing; Wu, Keliang; Chen, Yuan			Insight into Role of Selection in the Evolution of Polyglutamine Tracts in Humans	PLOS ONE			English	Article							AMINO-ACID REPEATS; TRINUCLEOTIDE REPEAT; PROTEINS; TANDEM; EXPANSION; DISEASE; REGIONS	Glutamine tandem repeats are common in eukaryotic proteins. Although some studies have proposed that replication slippage plays an important role in shaping these repeats, the role of natural selection in glutamine tandem repeat evolution is somewhat unclear. In this study, we identified all of the glutamine tandem repeats containing four or more glutamines in human proteins and then estimated the nonsynonymous (d(N)) and synonymous (d(S)) substitution rates for the regions flanking the glutamine tandem repeats and the proteins containing them. The results indicated that most of the proteins containing polyglutamine (polyQ) tracts of four or more glutamines have undergone purifying selection, and that the purifying selection for the regions flanking the repeats is weaker. Additionally, we observed that the conserved repeats were under stronger selection constraints than the nonconserved repeats. Interestingly, we found that there was a higher level of purifying selection for the regions flanking the polyQ tracts encoded by pure CAG codons compared with those encoded by mixed codons. Based on our findings, we propose that selection has played a more important role than was previously speculated in constraining the expansion of polyQ tracts encoded by pure codons.	[Li, Hongwei] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Li, Hongwei; Wu, Keliang] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Liu, Jing; Chen, Yuan] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University	Li, HW (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	lhwcau@163.com	Wu, Ke/HCQ-3503-2022					Alba MM, 1999, MOL BIOL EVOL, V16, P1641, DOI 10.1093/oxfordjournals.molbev.a026077; Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Alba MM, 2001, J MOL EVOL, V52, P249, DOI 10.1007/s002390010153; Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Cruz F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-619; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Faux NG, 2007, GENOME RES, V17, P1118, DOI 10.1101/gr.6255407; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Freiman RN, 2002, SCIENCE, V296, P2149, DOI 10.1126/science.1073845; Golding GB, 1999, PROTEIN SCI, V8, P1358, DOI 10.1110/ps.8.6.1358; GREEN H, 1994, P NATL ACAD SCI USA, V91, P4298, DOI 10.1073/pnas.91.10.4298; Hancock JM, 2001, MOL BIOL EVOL, V18, P1014, DOI 10.1093/oxfordjournals.molbev.a003873; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Keitti A, 2007, MOL BIOL EVOL, V24, P281; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Matteo R, 2009, PLOS ONE, V7; Mularoni L, 2007, GENOMICS, V89, P316, DOI 10.1016/j.ygeno.2006.11.011; Mularoni L, 2010, GENOME RES, V20, P745, DOI 10.1101/gr.101261.109; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Schaefer MH, 2012, NUCL ACIDS RES; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YANG Z, 1997, PHYLOGENETIC ANAL MA; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41167	10.1371/journal.pone.0041167	http://dx.doi.org/10.1371/journal.pone.0041167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848438	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600042
J	Monteiro, WM; Magalhaes, LKC; de Sa, ARN; Gomes, ML; Toledo, MJD; Borges, L; Pires, I; Guerra, JAD; Silveira, H; Barbosa, MDV				Monteiro, Wuelton Marcelo; Costa Magalhaes, Laylah Kelre; Nichi de Sa, Amanda Regina; Gomes, Monica Lucia; de Ornelas Toledo, Max Jean; Borges, Lara; Pires, Isa; de Oliveira Guerra, Jorge Augusto; Silveira, Henrique; Vale Barbosa, Maria das Gracas			Trypanosoma cruzi IV Causing Outbreaks of Acute Chagas Disease and Infections by Different Haplotypes in the Western Brazilian Amazonia	PLOS ONE			English	Article							GENETIC EXCHANGE; AUTOCHTHONOUS PATIENTS; NUCLEOTIDE-SEQUENCES; POPULATION-STRUCTURE; MIXED INFECTIONS; TRIATOMINE BUGS; RIBOSOMAL-RNA; LINEAGE-I; STATE; IDENTIFICATION	Background: Chagas disease is an emergent tropical disease in the Brazilian Amazon Region, with an increasing number of cases in recent decades. In this region, the sylvatic cycle of Trypanosoma cruzi transmission, which constitutes a reservoir of parasites that might be associated with specific molecular, epidemiological and clinical traits, has been little explored. The objective of this work is to genetically characterize stocks of T. cruzi from human cases, triatomines and reservoir mammals in the State of Amazonas, in the Western Brazilian Amazon. Methodology/Principal Findings: We analyzed 96 T. cruzi samples from four municipalities in distant locations of the State of Amazonas. Molecular characterization of isolated parasites from cultures in LIT medium or directly from vectors or whole human blood was performed by PCR of the non-transcribed spacer of the mini-exon and of the 24 S alfa ribosomal RNA gene, RFLP and sequencing of the mitochondrial cytochrome c oxidase subunit II (COII) gene, and by sequencing of the glucose-phosphate isomerase gene. The T. cruzi parasites from two outbreaks of acute disease were all typed as TcIV. One of the outbreaks was triggered by several haplotypes of the same DTU. TcIV also occurred in isolated cases and in Rhodnius robustus. Incongruence between mitochondrial and nuclear phylogenies is likely to be indicative of historical genetic exchange events resulting in mitochondrial introgression between TcIII and TcIV DTUs from Western Brazilian Amazon. TcI predominated among triatomines and was the unique DTU infecting marsupials. Conclusion/Significance: DTU TcIV, rarely associated with human Chagas disease in other areas of the Amazon basin, is the major strain responsible for the human infections in the Western Brazilian Amazon, occurring in outbreaks as single or mixed infections by different haplotypes.	[Monteiro, Wuelton Marcelo; Costa Magalhaes, Laylah Kelre; de Oliveira Guerra, Jorge Augusto; Silveira, Henrique; Vale Barbosa, Maria das Gracas] Trop Med Fdn Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Monteiro, Wuelton Marcelo; Costa Magalhaes, Laylah Kelre; de Oliveira Guerra, Jorge Augusto; Vale Barbosa, Maria das Gracas] Univ State Amazonas, Manaus, Amazonas, Brazil; [Monteiro, Wuelton Marcelo] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Nichi de Sa, Amanda Regina; Gomes, Monica Lucia; de Ornelas Toledo, Max Jean] Univ Estadual Maringa, Maringa, Parana, Brazil; [Borges, Lara; Pires, Isa; Silveira, Henrique] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria Studies, P-1200 Lisbon, Portugal; [Vale Barbosa, Maria das Gracas] Nilton Lins Univ Ctr, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade Federal de Amazonas; Universidade Estadual de Maringa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Centro Universitario Nilton Lins	Monteiro, WM (corresponding author), Trop Med Fdn Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.	hsilveira@ihmt.unl.pt	Silveira, Henrique/AAB-4948-2022; Toledo, Max Jean/AAP-7717-2020; Silveira, Henrique/G-2229-2011; Barbosa Guerra, Maria das Graças/AGZ-7397-2022; Borges, Lara/J-4287-2012	Silveira, Henrique/0000-0002-7939-772X; Toledo, Max Jean/0000-0001-6314-8668; Silveira, Henrique/0000-0002-7939-772X; Pires, Isa/0000-0001-8359-9028	National Counsel of Technological and Scientific Development [410398/2006-3]; Araucaria Foundation [57/2009]; State of Amazonas Foundation for Support to the Research (Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM); Tropical Medicine Foundation	National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); State of Amazonas Foundation for Support to the Research (Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM); Tropical Medicine Foundation	This study was supported by the National Counsel of Technological and Scientific Development (grant number 410398/2006-3) and by the Araucaria Foundation (grant number 57/2009). HS was supported by a grant from State of Amazonas Foundation for Support to the Research (Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM) and to the Tropical Medicine Foundation Dr. Heitor Vieira Dourado (Fundacao de Medicina Tropical Dr. Heitor Vieira Dourado - FMT-HVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolis NG, 2011, ACTA TROP, V120, P167, DOI 10.1016/j.actatropica.2011.08.001; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; Aliaga C, 2011, INFECT GENET EVOL, V11, P1155, DOI 10.1016/j.meegid.2010.11.013; Anez N, 2004, TROP MED INT HEALTH, V9, P1319, DOI 10.1111/j.1365-3156.2004.01333.x; Bosseno MF, 1996, EXP PARASITOL, V83, P275, DOI 10.1006/expr.1996.0075; Brazilian Ministry of Health, 2010, ACT CAS CHAG DIS 200; Brisse S, 2001, INT J PARASITOL, V31, P1218, DOI 10.1016/S0020-7519(01)00238-7; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Broutin H, 2006, EXP PARASITOL, V113, P1, DOI 10.1016/j.exppara.2005.11.014; Brum-Soares LM, 2010, REV SOC BRAS MED TRO, V43, P170, DOI 10.1590/S0037-86822010000200013; Burgos JM, 2008, AM J TROP MED HYG, V78, P294, DOI 10.4269/ajtmh.2008.78.294; Coura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018; COURA José Rodrigues, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P159, DOI 10.1590/S0036-46652002000300009; Coura Jose Rodrigues, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P415, DOI 10.1590/S0036-46651995000500006; Coura JR, 2002, TRENDS PARASITOL, V18, P171, DOI 10.1016/S1471-4922(01)02200-0; Coura JR, 1999, MEM I OSWALDO CRUZ, V94, P379, DOI 10.1590/S0074-02761999000700074; Da Silva FM, 2008, ACTA TROP, V107, P168, DOI 10.1016/j.actatropica.2008.05.015; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; Pinto AYD, 2008, REV SOC BRAS MED TRO, V41, P602; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; de Medeiros MB, 2008, REV SOC BRAS MED TRO, V41, P520, DOI 10.1590/S0037-86822008000500020; del Puerto R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000687; Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5; Florez O, 2010, PARASITOL RES, V107, P439, DOI 10.1007/s00436-010-1874-2; Garzon EA, 2002, T ROY SOC TROP MED H, V96, P378, DOI 10.1016/S0035-9203(02)90367-6; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Herrera L, 2005, T ROY SOC TROP MED H, V99, P379, DOI 10.1016/j.trstmh.2004.07.006; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Lewis MD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001363; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Llewellyn MS, 2011, INT J PARASITOL, V41, P609, DOI 10.1016/j.ijpara.2010.12.004; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; LUQUETTI AO, 1986, T ROY SOC TROP MED H, V80, P462, DOI 10.1016/0035-9203(86)90347-0; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Macedo AM, 2001, MEM I OSWALDO CRUZ, V96, P407, DOI 10.1590/S0074-02762001000300023; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Marcili A, 2009, INFECT GENET EVOL, V9, P1265, DOI 10.1016/j.meegid.2009.07.003; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Mendonca MBA, 2002, PARASITOLOGY, V124, P177, DOI 10.1017/S0031182001001172; MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0; MILES MA, 1977, T ROY SOC TROP MED H, V71, P217, DOI 10.1016/0035-9203(77)90012-8; MILES MA, 1981, LANCET, V1, P1338; MILES MA, 1981, T ROY SOC TROP MED H, V75, P667, DOI 10.1016/0035-9203(81)90145-0; Monteiro WM, 2010, TROP MED INT HEALTH, V15, P1049, DOI 10.1111/j.1365-3156.2010.02577.x; Monteiro WM, 2012, REV SOC BRAS MED TRO, V45, P209, DOI 10.1590/S0037-86822012000200014; Monteiro WM, 2010, REV SOC BRAS MED TRO, V43, P207, DOI 10.1590/S0037-86822010000200021; Noireau F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000100009; Pedroso A, 2007, EXP PARASITOL, V116, P71, DOI 10.1016/j.exppara.2006.10.001; Pinto A Y, 2001, Rev Soc Bras Med Trop, V34, P413; Pinto Ana Yecê das Neves, 2004, Braz J Infect Dis, V8, P454, DOI 10.1590/S1413-86702004000600010; Reis D, 2012, EXP PARASITOL, V30, P321; Rozas N, 2008, PARASITOLOGY, V135, P1157, DOI 10.1017/S0031182008004794; Ruiz-Sanchez R, 2005, MEM I OSWALDO CRUZ, V100, P281, DOI 10.1590/S0074-02762005000300012; Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7; Souza-Lima RC, 2012, REV SOC BRA IN PRESS; Spitzner FL, 2007, ACTA PARASITOL, V52, P74, DOI 10.2478/s11686-007-0005-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teixeira ARL, 2001, EMERG INFECT DIS, V7, P100, DOI 10.3201/eid0701.010115; Teixeira MMG, 2006, TROP MED INT HEALTH, V11, P294, DOI 10.1111/j.1365-3156.2006.01575.x; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024; Yeo M, 2007, INT J PARASITOL, V37, P111, DOI 10.1016/j.ijpara.2006.08.002; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	65	52	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41284	10.1371/journal.pone.0041284	http://dx.doi.org/10.1371/journal.pone.0041284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848457	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600049
J	Reimer, JM; Karlsson, KH; Lovgren-Bengtsson, K; Magnusson, SE; Fuentes, A; Stertman, L				Reimer, Jenny M.; Karlsson, Karin H.; Lovgren-Bengtsson, Karin; Magnusson, Sofia E.; Fuentes, Alexis; Stertman, Linda			Matrix-M (TM) Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen	PLOS ONE			English	Article							QUILLAJA-SAPONARIA MOLINA; DENDRITIC CELLS; NALP3 INFLAMMASOME; LYMPH-NODES; POLYMORPHONUCLEAR NEUTROPHILS; T-CELLS; RESPONSES; INDUCTION; INFLUENZA; VACCINE	Saponin-based adjuvants are widely used to enhance humoral and cellular immune responses towards vaccine antigens, although it is not yet completely known how they mediate their stimulatory effects. The aim of this study was to elucidate the mechanism of action of adjuvant Matrix-M (TM) without antigen and Alum was used as reference adjuvant. Adjuvant Matrix-M (TM) is comprised of 40 nm nanoparticles composed of Quillaja saponins, cholesterol and phospholipid. BALB/c mice were subcutaneously injected once with, 3, 12 or 30 mu g of Matrix-M (TM), resulting in recruitment of leukocytes to draining lymph nodes (dLNs) and spleen 48 h post treatment. Flow cytometry analysis identified CD11b(+) Gr-1(high) granulocytes as the cell population increasing most in dLNs and spleen. Additionally, dendritic cells, F4/80(int) cells, T-, B- and NK-cells were recruited to dLNs and in spleen the number of F4/80(int) cells, and to some extent, B cells and dendritic cells, increased. Elevated levels of early activation marker CD69 were detected on T-, B-and NK-cells, CD11b(+) Gr-1(high) cells, F4/80(int) cells and dendritic cells in dLNs. In spleen CD69 was mainly up-regulated on NK cells. B cells and dendritic cells in dLNs and spleen showed an increased expression of the co-stimulatory molecule CD86 and dendritic cells in dLNs expressed elevated levels of MHC class II. The high-dose (30 mu g) of Matrix-M (TM) induced detectable serum levels of IL-6 and MIP-1 beta 4 h post administration, most likely representing spillover of locally produced cytokines. A lesser increase of IL-6 in serum after administration of 12 mu g Matrix-M (TM) was also observed. In conclusion, early immunostimulatory properties were demonstrated by Matrix-M (TM) alone, as therapeutic doses resulted in a local transient immune response with recruitment and activation of central immune cells to dLNs. These effects may play a role in enhancing uptake and presentation of vaccine antigens to elicit a competent immune response.	[Reimer, Jenny M.; Karlsson, Karin H.; Lovgren-Bengtsson, Karin; Magnusson, Sofia E.; Fuentes, Alexis; Stertman, Linda] Isconova AB, Uppsala, Sweden		Reimer, JM (corresponding author), Isconova AB, Uppsala, Sweden.	jenny.reimer@isconova.com			U.S. Department of Defense, Defense Threat Reduction Agency (DTRA) [HDTRA 1-06-C-0029]	U.S. Department of Defense, Defense Threat Reduction Agency (DTRA)	This work has been supported in part by the U.S. Department of Defense, Defense Threat Reduction Agency (DTRA) under the contract number HDTRA 1-06-C-0029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Behboudi S, 1997, CYTOKINE, V9, P682, DOI 10.1006/cyto.1997.0219; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cloete M, 2008, ONDERSTEPOORT J VET, V75, P17; DALSGAARD K, 1974, ARCH GES VIRUSFORSCH, V44, P243, DOI 10.1007/BF01240612; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Drane D, 2007, EXPERT REV VACCINES, V6, P761, DOI 10.1586/14760584.6.5.761; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Heldens JGM, 2010, VACCINE, V28, P6989, DOI 10.1016/j.vaccine.2010.08.043; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; Madhun AS, 2009, VACCINE, V27, P7367, DOI 10.1016/j.vaccine.2009.09.044; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Marzio R, 1999, IMMUNOPHARM IMMUNOT, V21, P565, DOI 10.3109/08923979909007126; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; McKenzie A, 2010, HUMAN VACCINES, P6; Megiovanni AM, 2006, J LEUKOCYTE BIOL, V79, P977, DOI 10.1189/jlb.0905526; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; MOREIN B, 1984, NATURE, V308, P457, DOI 10.1038/308457a0; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Radosevic K, 2008, VACCINE, V26, P3640, DOI 10.1016/j.vaccine.2008.04.071; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Schnurr M, 2009, J IMMUNOL, V182, P1253, DOI 10.4049/jimmunol.182.3.1253; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Sjolander A, 1997, CELL IMMUNOL, V177, P69, DOI 10.1006/cimm.1997.1088; TAKAHASHI H, 1990, NATURE, V344, P873, DOI 10.1038/344873a0; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Windon RG, 2000, VACCINE, V19, P572, DOI 10.1016/S0264-410X(00)00148-1; Windon RG, 2001, VACCINE, V20, P490, DOI 10.1016/S0264-410X(01)00332-2; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Zanoni I, 2005, J IMMUNOL, V175, P286, DOI 10.4049/jimmunol.175.1.286	40	70	72	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41451	10.1371/journal.pone.0041451	http://dx.doi.org/10.1371/journal.pone.0041451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844480	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700092
J	Szebeni, GJ; Kriston-Pal, E; Blazso, P; Katona, RL; Novak, J; Szabo, E; Czibula, A; Fajka-Boja, R; Hegyi, B; Uher, F; Krenacs, L; Joo, G; Monostori, E				Szebeni, Gabor Janos; Kriston-Pal, Eva; Blazso, Peter; Katona, Robert Laszlo; Novak, Julianna; Szabo, Eniko; Czibula, Agnes; Fajka-Boja, Roberta; Hegyi, Beata; Uher, Ferenc; Krenacs, Laszlo; Joo, Gabriella; Monostori, Eva			Identification of Galectin-1 as a Critical Factor in Function of Mouse Mesenchymal Stromal Cell-Mediated Tumor Promotion	PLOS ONE			English	Article							STEM-CELLS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH; ANGIOGENESIS; MICE; DIFFERENTIATION; MYOFIBROBLASTS; RECRUITMENT; METASTASIS	Bone marrow derived mesenchymal stromal cells (MSCs) have recently been implicated as one source of the tumor-associated stroma, which plays essential role in regulating tumor progression. In spite of the intensive research, the individual factors in MSCs controlling tumor progression have not been adequately defined. In the present study we have examined the role of galectin-1 (Gal-1), a protein highly expressed in tumors with poor prognosis, in MSCs in the course of tumor development. Co-transplantation of wild type MSCs with 4T1 mouse breast carcinoma cells enhances the incidence of palpable tumors, growth, vascularization and metastasis. It also reduces survival compared to animals treated with tumor cells alone or in combination with Gal-1 knockout MSCs. In vitro studies show that the absence of Gal-1 in MSCs does not affect the number of migrating MSCs toward the tumor cells, which is supported by the in vivo migration of intravenously injected MSCs into the tumor. Moreover, differentiation of endothelial cells into blood vessel-like structures strongly depends on the expression of Gal-1 in MSCs. Vital role of Gal-1 in MSCs has been further verified in Gal-1 knockout mice. By administering B16F10 melanoma cells into Gal-1 deficient animals, tumor growth is highly reduced compared to wild type animals. Nevertheless, co-injection of wild type but not Gal-1 deficient MSCs results in dramatic tumor growth and development. These results confirm that galectin-1 is one of the critical factors in MSCs regulating tumor progression.	[Szebeni, Gabor Janos; Kriston-Pal, Eva; Blazso, Peter; Katona, Robert Laszlo; Novak, Julianna; Szabo, Eniko; Czibula, Agnes; Fajka-Boja, Roberta] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Joo, Gabriella; Monostori, Eva] Univ Szeged, Fac Hlth Sci & Social Studies, Szeged, Hungary; [Hegyi, Beata; Uher, Ferenc] Natl Blood Serv, Budapest, Hungary; [Krenacs, Laszlo] Tumor Pathol & Mol Diagnost Lab, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Szebeni, GJ (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	monos@brc.hu	Krenács, László/L-8063-2014	Krenács, László/0000-0001-6541-3031; Blazso, Peter/0000-0003-4404-8068; Szebeni, Gabor J./0000-0002-6998-5632	Bastyai-Holczer Foundation; Hungarian Scientific Research Fund [OTKA PD 75938, NKTH-OTKA CK 78007, NKTH-OTKA CK 78188, OTKA K 69047]	Bastyai-Holczer Foundation; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Bastyai-Holczer Foundation and by grants from the Hungarian Scientific Research Fund: OTKA PD 75938 (http://www.otka.hu/), NKTH-OTKA CK 78007 (http://www.otka.hu/), NKTH-OTKA CK 78188 (http://www.otka.hu/), and OTKA K 69047 (http://www.otka.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157; Bektas S, 2010, PATHOL ONCOL RES, V16, P569, DOI 10.1007/s12253-010-9248-8; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Burns JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021888; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dwyer RM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt25; FIDLER IJ, 1975, CANCER RES, V35, P218; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gieseke F, 2010, BLOOD, V116, P3770, DOI 10.1182/blood-2010-02-270777; Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254; Gong ZD, 2011, METHODS MOL BIOL, V698, P279, DOI 10.1007/978-1-60761-999-4_21; Hartmann MC, 2011, EUR J CANCER, V47, P1669, DOI 10.1016/j.ejca.2011.05.001; Hegyi B, 2012, BIOCHEM BIOPH RES CO, V419, P215, DOI 10.1016/j.bbrc.2012.01.150; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Kovacs-Solyom F, 2010, IMMUNOL LETT, V127, P108, DOI 10.1016/j.imlet.2009.10.003; Le Mercier M, 2008, J NEUROPATH EXP NEUR, V67, P456, DOI 10.1097/NEN.0b013e318170f892; Le Mercier M, 2009, NEOPLASIA, V11, P485, DOI 10.1593/neo.81526; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Placencio VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012920; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; Rabinovich GA, 2009, IMMUNOL REV, V230, P144, DOI 10.1111/j.1600-065X.2009.00787.x; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Roorda BD, 2009, CRIT REV ONCOL HEMAT, V69, P187, DOI 10.1016/j.critrevonc.2008.06.004; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Stannard KA, 2010, CANCER LETT, V299, P95, DOI 10.1016/j.canlet.2010.08.005; Sun B, 2005, STEM CELLS DEV, V14, P292, DOI 10.1089/scd.2005.14.292; Suzuki K, 2011, MOL MED, V17, P579, DOI 10.2119/molmed.2010.00157; Teven CM, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/201371; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Tsunoda S, 2009, AM J PATHOL, V174, P671, DOI 10.2353/ajpath.2009.080471; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; van den Brule FA, 2001, AIDPATH73030CO22; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116	50	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41372	10.1371/journal.pone.0041372	http://dx.doi.org/10.1371/journal.pone.0041372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844466	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700077
J	Via, LE; Tsytsykova, AV; Rajsbaum, R; Falvo, JV; Goldfeld, AE				Via, Laura E.; Tsytsykova, Alla V.; Rajsbaum, Ricardo; Falvo, James V.; Goldfeld, Anne E.			The Transcription Factor NFATp Plays a Key Role in Susceptibility to TB in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA GENE; MYCOBACTERIUM-TUBERCULOSIS INFECTION; CREB-BINDING-PROTEIN; IFN-GAMMA PRODUCTION; HUMAN B-CELLS; INTERFERON-GAMMA; TNF GENE; IN-VIVO; NUCLEAR FACTOR	In T cells, the transcription factor nuclear factor of activated T cells p (NFATp) is a key regulator of the cytokine genes tumor necrosis factor (TNF) and interferon-gamma (IFN-gamma). Here, we show that NFATp-deficient (NFATp(-/-)) mice have a dramatic and highly significant increase in mortality after Mycobacterium tuberculosis (MTb) infection as compared to mortality of control animals after MTb infection. Animals deficient in NFATp have significantly impaired levels of TNF and IFN-gamma transcription and protein expression in naive or total CD4(+) T cells, but display wild-type levels of TNF mRNA or protein from MTb-stimulated dendritic cells (DC). The rapid mortality and disease severity observed in MTb-infected NFATp(-/-) mice is associated with dysregulated production of TNF and IFN-gamma in the lungs, as well as with increased levels of TNF, in their serum. Furthermore, global blocking of TNF production by injection of a TNF neutralizaing agent at 6 weeks, but not 12 weeks, post-MTb-infection further decreased the survival rate of both wild-type and NFATp(-/-) mice, indicating an early role for TNF derived from cells from the monocyte lineage in containment of infection. These results thus demonstrate that NFATp plays a critical role in immune containment of TB disease in vivo, through the NFATp-dependent expression of TNF and IFN-gamma in T cells.	[Via, Laura E.] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Tsytsykova, Alla V.; Rajsbaum, Ricardo; Falvo, James V.; Goldfeld, Anne E.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA USA; [Tsytsykova, Alla V.; Rajsbaum, Ricardo; Falvo, James V.; Goldfeld, Anne E.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Via, LE (corresponding author), NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	goldfeld@idi.harvard.edu	Rajsbaum, Ricardo/F-2046-2014; Goldfeld, Anne/AAF-1818-2019; Rajsbaum, Ricardo/AAD-4775-2020; Via, Laura/AAD-3917-2021	Via, Laura/0000-0001-6074-9521	NIH [HL-059838, GM076685]; NIH, NIAID; Comparative Medicine Branch of NIAID; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Comparative Medicine Branch of NIAID; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH to A. E. G. (HL-059838 and GM076685). In addition, the work was partly supported by the Intramural Research Program of the NIH, NIAID and the Comparative Medicine Branch of NIAID is thankfully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1995, J INFECT DIS, V171, P400, DOI 10.1093/infdis/171.2.400; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Barczak AK, 2005, J INFECT DIS, V192, P600, DOI 10.1086/432006; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Barthel R, 2003, J IMMUNOL, V171, P3612, DOI 10.4049/jimmunol.171.7.3612; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Bean AGD, 1999, J IMMUNOL, V162, P3504; BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006; Biglione S, 2011, J BIOL CHEM, V286, P44126, DOI 10.1074/jbc.M111.272476; Boom WH, 1996, INFECT AGENT DIS, V5, P73; BOUSSIOTIS VA, 1994, P NATL ACAD SCI USA, V91, P7007, DOI 10.1073/pnas.91.15.7007; Broderick A, 1996, AIDSLINK, V1, P3; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Cockerill PN, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe15; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Doffinger R, 2000, MICROBES INFECT, V2, P1553, DOI 10.1016/S1286-4579(00)01311-3; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Erb KJ, 2003, INFECT IMMUN, V71, P6641, DOI 10.1128/IAI.71.11.6641-6647.2003; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Falvo JV, 2008, P NATL ACAD SCI USA, V105, P19637, DOI 10.1073/pnas.0810648105; Falvo JV, 2000, P NATL ACAD SCI USA, V97, P3925, DOI 10.1073/pnas.97.8.3925; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Falvo JV, 2011, AM J RESP CELL  0603; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Goffe B, 2003, J AM ACAD DERMATOL, V49, pS105, DOI 10.1016/mjd.2003.554; GOLDFELD AE, 1992, P NATL ACAD SCI USA, V89, P12198, DOI 10.1073/pnas.89.24.12198; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Goldfeld AE, 2008, HDB TUBERCULOSIS IMM; Goldfeld AE, 2009, AIDS AND TUBERCULOSIS: A DEADLY LIAISON, P209, DOI 10.1002/9783527627905.ch9; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Hernandez-Pando R, 2004, EUR J IMMUNOL, V34, P174, DOI 10.1002/eji.200324253; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MCCAFFREY PG, 1994, J BIOL CHEM, V269, P30445; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; Orme I, 2004, CURR OPIN MICROBIOL, V7, P58, DOI 10.1016/j.mib.2003.11.002; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; Pedroza-Gonzalez A, 2004, INT J EXP PATHOL, V85, P135, DOI 10.1111/j.0959-9673.2004.00381.x; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Prieschl EE, 1996, J IMMUNOL, V157, P2645; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Ranjbar S, 2006, J IMMUNOL, V176, P4182, DOI 10.4049/jimmunol.176.7.4182; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Remus N, 2001, PEDIATR RES, V50, P8, DOI 10.1203/00006450-200107000-00005; Rivas-Santiago Bruno, 2005, Invest. clín, V46, P391; Rosenzweig S, 2002, CLIN IMMUNOL, V102, P25, DOI 10.1006/clim.2001.5135; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Salgame P, 2005, CURR OPIN IMMUNOL, V17, P374, DOI 10.1016/j.coi.2005.06.006; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Serfling Edgar, 2007, Sci STKE, V2007, ppe42, DOI 10.1126/stke.3982007pe42; Smith S, 2002, INFECT IMMUN, V70, P2082, DOI 10.1128/IAI.70.4.2082-2089.2002; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tascon RE, 2000, IMMUNOLOGY, V99, P473, DOI 10.1046/j.1365-2567.2000.00963.x; Taylor JM, 2008, NUCLEIC ACIDS RES, V36, P4845, DOI 10.1093/nar/gkn444; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Tsytsykova AV, 2000, J EXP MED, V192, P581, DOI 10.1084/jem.192.4.581; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230; WHO, 2011, WHO GLOBAL TUBERCULO	90	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41427	10.1371/journal.pone.0041427	http://dx.doi.org/10.1371/journal.pone.0041427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844476	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700088
J	Chamorro, P; Muniz, C; Levi, R; Arroyo, D; Rodriguez, FB; Varona, P				Chamorro, Pablo; Muniz, Carlos; Levi, Rafael; Arroyo, David; Rodriguez, Francisco B.; Varona, Pablo			Generalization of the Dynamic Clamp Concept in Neurophysiology and Behavior	PLOS ONE			English	Article							WEAKLY ELECTRIC FISH; GNATHONEMUS-PETERSII MORMYRIDAE; NEURONAL MECHANISMS; SENSORY NEURONS; BODY ORIENTATION; VIDEO TRACKING; CALCIUM CLAMP; TIME-SERIES; SYSTEM; STIMULATION	The idea of closed-loop interaction in in vitro and in vivo electrophysiology has been successfully implemented in the dynamic clamp concept strongly impacting the research of membrane and synaptic properties of neurons. In this paper we show that this concept can be easily generalized to build other kinds of closed-loop protocols beyond (or in addition to) electrical stimulation and recording in neurophysiology and behavioral studies for neuroethology. In particular, we illustrate three different examples of goal-driven real-time closed-loop interactions with drug microinjectors, mechanical devices and video event driven stimulation. Modern activity-dependent stimulation protocols can be used to reveal dynamics (otherwise hidden under traditional stimulation techniques), achieve control of natural and pathological states, induce learning, bridge between disparate levels of analysis and for a further automation of experiments. We argue that closed-loop interaction calls for novel real time analysis, prediction and control tools and a new perspective for designing stimulus-response experiments, which can have a large impact in neuroscience research.	[Chamorro, Pablo; Muniz, Carlos; Levi, Rafael; Arroyo, David; Rodriguez, Francisco B.; Varona, Pablo] Univ Autonoma Madrid, Grp Neurocomputac Biol, Dpto Ingn Informat, Escuela Politecn Super, Madrid, Spain; [Levi, Rafael] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	Autonomous University of Madrid; University of California System; University of California Irvine	Chamorro, P (corresponding author), Univ Autonoma Madrid, Grp Neurocomputac Biol, Dpto Ingn Informat, Escuela Politecn Super, Madrid, Spain.	pablo.varona@uam.es	Levi, Rafael/Q-8176-2018; de Borja Rodriguez, Francisco/F-7812-2013; Arroyo, David/A-5167-2010; Varona, Pablo/B-5583-2012	Levi, Rafael/0000-0002-0144-2295; de Borja Rodriguez, Francisco/0000-0003-4053-099X; Arroyo, David/0000-0001-8894-9779; Varona, Pablo/0000-0002-1754-8991	Spanish MICINN (Ministerio de Ciencia e Innovacion) [BFU2009-08473, TIN-2010-19607]	Spanish MICINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Spanish MICINN (Ministerio de Ciencia e Innovacion) BFU2009-08473 and TIN-2010-19607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar P, 2007, J NEUROSCI METH, V166, P66, DOI 10.1016/j.jneumeth.2007.06.020; Amigo JM, 2010, INT J BIFURCAT CHAOS, V20, P2915, DOI 10.1142/S0218127410027453; Amigo JM, 2010, SPRINGER SER SYNERG, P1, DOI 10.1007/978-3-642-04084-9; Aragao RD, 2011, J NEUROSCI METH, V195, P216, DOI 10.1016/j.jneumeth.2010.12.016; Arroyo D, 2009, CHAOS, P19; Arshavskii Iu I, 1984, Neirofiziologiia, V16, P269; BAKER PF, 1985, CELL CALCIUM, V6, P5, DOI 10.1016/0143-4160(85)90030-2; Baroni F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015023; BELAN P, 1993, J PHYSIOL-LONDON, V462, P47, DOI 10.1113/jphysiol.1993.sp019542; Brochini L, 2011, J NEUROSCI, V31, P12297, DOI 10.1523/JNEUROSCI.1568-11.2011; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Butera RJ, 2001, IEEE T BIO-MED ENG, V48, P1460, DOI 10.1109/10.966605; Cain P, 2002, J EXP BIOL, V205, P3915; Caputi AA, 1998, J EXP BIOL, V201, P2115; Cole K, 1955, ELECTROCHEMISTRY BIO, P121; Cullen KE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0002.2002; Deliagina TG, 2000, J NEUROPHYSIOL, V83, P367, DOI 10.1152/jn.2000.83.1.367; Deliagina TG, 1998, NATURE, V393, P172, DOI 10.1038/30251; Deliagina TG, 1999, J NEUROPHYSIOL, V82, P687, DOI 10.1152/jn.1999.82.2.687; Destexhe A, 2009, DYNAMIC CLAMP PRINCI; Di Castro A, 2006, P NATL ACAD SCI USA, V103, P4699, DOI 10.1073/pnas.0508005103; Dorval AD, 2001, ANN BIOMED ENG, V29, P897, DOI 10.1114/1.1408929; Economo MN, 2010, J NEUROSCI, V30, P2407, DOI 10.1523/JNEUROSCI.5954-09.2010; Fox JL, 2010, P NATL ACAD SCI USA, V107, P3840, DOI 10.1073/pnas.0912548107; GELLER W, 1984, WATER RES, V18, P1285, DOI 10.1016/0043-1354(84)90034-4; Goaillard JM, 2006, PHYSIOLOGY, V21, P197, DOI 10.1152/physiol.00063.2005; Grunfeld EA, 2000, BRAIN, V123, P277, DOI 10.1093/brain/123.2.277; Huang Z., 2007, Journal of Medical Engineering & Technology, V31, P381, DOI 10.1080/03091900601165314; Idoux E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028685; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kemenes I, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.200; Kullmann PHM, 2004, J NEUROPHYSIOL, V91, P542, DOI 10.1152/jn.00559.2003; Lago-Fernandez LF, 2009, NEURAL COMPUT, V21, P973, DOI 10.1162/neco.2008.07-07-571; Latorre R, 2006, BIOL CYBERN, V95, P169, DOI 10.1007/s00422-006-0077-5; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Lesne A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046208; Levi R, 2005, J NEUROSCI, V25, P9807, DOI 10.1523/JNEUROSCI.2249-05.2005; Levi R, 2004, J NEUROPHYSIOL, V91, P336, DOI 10.1152/jn.00753.2003; Lin RJ, 2010, IEEE ENG MED BIO, P4160, DOI 10.1109/IEMBS.2010.5627397; MARMONT G, 1949, J CELL COMPAR PHYSL, V34, P351, DOI 10.1002/jcp.1030340303; Milenkovic N, 2008, J NEUROPHYSIOL, V100, P2771, DOI 10.1152/jn.90799.2008; MOLLER P, 1973, ANIM BEHAV, V21, P501, DOI 10.1016/S0003-3472(73)80010-7; Muniz C, 2005, LECT NOTES COMPUT SC, V3561, P95; Muniz C, 2009, BMC NEUROSCI S1, V10, pP49, DOI DOI 10.1186/1471-2202-10-S1-P49; Muniz C, 2008, J NEUROSCI METH, V172, P105, DOI 10.1016/j.jneumeth.2008.04.017; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; PANCHIN YV, 1995, J NEUROPHYSIOL, V73, P1924, DOI 10.1152/jn.1995.73.5.1924; Piccardi C, 2004, CHAOS, V14, P1026, DOI 10.1063/1.1796071; Pinto RD, 2001, J NEUROSCI METH, V108, P39, DOI 10.1016/S0165-0270(01)00368-5; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Pusch R, 2008, J EXP BIOL, V211, P921, DOI 10.1242/jeb.014175; Quiroga RQ, 2001, BIOL CYBERN, V84, P291, DOI 10.1007/s004220000212; Rabinovich MI, 2006, BIOL CYBERN, V95, P519, DOI 10.1007/s00422-006-0121-5; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rabinovich MI, 2012, PHYS LIFE REV, V9, P51, DOI 10.1016/j.plrev.2011.11.002; Rabinovich MI, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00024; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Sanchez D, 2007, J NEUROSCI METH, V159, P26, DOI 10.1016/j.jneumeth.2006.06.018; SATTERLIE RA, 1993, J EXP BIOL, V181, P119; Schiff SJ, 2009, IEEE ENG MED BIO, P3318, DOI 10.1109/IEMBS.2009.5333752; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Szucs A, 2005, EUR J NEUROSCI, V21, P763, DOI 10.1111/j.1460-9568.2005.03894.x; Szucs A, 2000, NEUROREPORT, V11, P563; Szucs A, 2003, J NEUROPHYSIOL, V89, P1363, DOI 10.1152/jn.00732.2002; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Varona P, 2004, NEUROCOMPUTING, V58, P549, DOI 10.1016/j.neucom.2004.01.093; Varona P, 2002, CHAOS, V12, P672, DOI 10.1063/1.1498155; Varona P, 2001, BIOL CYBERN, V84, P91, DOI 10.1007/s004220000198; Venaille A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061909; Witschi R, 2011, J NEUROSCI, V31, P8134, DOI 10.1523/JNEUROSCI.6328-10.2011	70	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40887	10.1371/journal.pone.0040887	http://dx.doi.org/10.1371/journal.pone.0040887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829895	Green Published, gold			2022-12-27	WOS:000306956300033
J	Cheng, JW; Cheng, SW; Lu, GC; Wei, RL				Cheng, Jin-Wei; Cheng, Shi-Wei; Lu, Guo-Cai; Wei, Rui-Li			Effect of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy on the Risk of Arterial Thromboembolic Events: A Meta-Analysis	PLOS ONE			English	Article							RETINAL VEIN OCCLUSION; VERTEPORFIN PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SUSTAINED BENEFITS; PEGAPTANIB SODIUM; 12-MONTH OUTCOMES; RANIBIZUMAB; BEVACIZUMAB	Background: Intravitreal anti-vascular endothelial growth factor (VEGF) monoclonal antibodies are used in ocular neovascular diseases. A consensus has emerged that intravenous anti-VEGF can increase the risk of arterial thromboembolic events. However, the role of intravitreal anti-VEGF in arterial thromboembolism is controversial. Therefore, we did a systematic review and meta-analysis to investigate the effects of intravitreal anti-VEGF on the risk of arterial thromboembolic events. Methods: Electronic databases were searched to identify relevant randomized clinical trials comparing intravitreal anti-VEGF with controls. Criteria for inclusion in our meta-analysis included a study duration of no less than 12 months, the use of a randomized control group not receiving any intravitreal active agent, and the availability of outcome data for arterial thromboembolic events, myocardial infarction, cerebrovascular accidents, and vascular death. The risk ratios and 95% CIs were calculated using a fixed-effects or random-effects model, depending on the heterogeneity of the included studies. Results: A total of 4942 patients with a variety of ocular neovascular diseases from 13 randomized controlled trials were identified and included for analysis. There was no significant difference between intravitreal anti-VEGF and control in the risk of all events, with risk ratios of 0.87 (95% CI, 0.64 to 1.19) for arterial thromboembolic events, 0.96 (95% CI, 0.55-1.68) for cerebrovascular accidents, 0.69 (95% CI 0.40-1.21) for myocardial infarctions, and 0.68 (95% CI, 0.37-1.27) for vascular death. Conclusions: The strength evidence suggests that the intravitreal use of anti-VEGF antibodies is not associated with an increased risk of arterial thromboembolic events.	[Cheng, Jin-Wei; Wei, Rui-Li] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Cheng, Shi-Wei] Ludong Univ, Sch Life Sci, Yantai, Peoples R China; [Lu, Guo-Cai] Second Mil Med Univ, Inst Basic Med Sci, Ctr New Drug Evaluat, Shanghai, Peoples R China	Naval Medical University; Ludong University; Naval Medical University	Cheng, JW (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Ophthalmol, Shanghai, Peoples R China.	newdrug@smmu.edu.cn; ruiliwei@gmail.com			Shanghai Municipal Natural Science Foundation [10ZR1439300]; National Natural Science Foundation of China [81000374, 81170874]	Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by Shanghai Municipal Natural Science Foundation (Grant No. 10ZR1439300), and National Natural Science Foundation of China (Grant No. 81000374 and 81170874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2010, AM J OPHTHALMOL, V150, P315, DOI 10.1016/j.ajo.2010.04.011; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Antoszyk AN, 2008, AM J OPHTHALMOL, V145, P862, DOI 10.1016/j.ajo.2007.12.029; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Ciulla TA, 2009, CURR OPIN OPHTHALMOL, V20, P166, DOI 10.1097/ICU.0b013e328329d173; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; D'Amico DJ, 2006, OPHTHALMOLOGY, V113, P992, DOI 10.1016/j.ophtha.2006.02.027; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; French DD, 2011, RETINA-J RET VIT DIS, V31, P1036, DOI 10.1097/IAE.0b013e31821dc66f; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; MANTEL N, 1959, J NATL CANCER I, V22, P719; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Moshfeghi AA, 2005, EXPERT OPIN INV DRUG, V14, P671, DOI 10.1517/13543784.14.5.671; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pieramici DJ, 2006, EXPERT OPIN BIOL TH, V6, P1237, DOI 10.1517/14712598.6.11.1237; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Schmucker C, 2011, BRIT J OPHTHALMOL, V95, P308, DOI 10.1136/bjo.2009.178574; Sultan MB, 2011, OPHTHALMOLOGY, V118, P1107, DOI 10.1016/j.ophtha.2011.02.045; Trempe C, 2011, NEW ENGL J MED, V364, P581, DOI 10.1056/NEJMc1013316; Tufail A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2459; Ueta T, 2009, OPHTHALMOLOGY, V116, P362, DOI 10.1016/j.ophtha.2008.09.046; Wong TY, 2005, OPHTHALMOLOGY, V112, P540, DOI 10.1016/j.ophtha.2004.10.039	41	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41325	10.1371/journal.pone.0041325	http://dx.doi.org/10.1371/journal.pone.0041325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829940	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300079
J	Pilfold, NW; Derocher, AE; Stirling, I; Richardson, E; Andriashek, D				Pilfold, Nicholas W.; Derocher, Andrew E.; Stirling, Ian; Richardson, Evan; Andriashek, Dennis			Age and Sex Composition of Seals Killed by Polar Bears in the Eastern Beaufort Sea	PLOS ONE			English	Article							PHOCA-HISPIDA PUPS; RINGED SEAL; URSUS-MARITIMUS; BREEDING HABITAT; PREDATION RISK; HUDSON-BAY; SERUM UREA; BEHAVIOR; ECOLOGY; SVALBARD	Background: Polar bears (Ursus maritimus) of the Beaufort Sea enter hyperphagia in spring and gain fat reserves to survive periods of low prey availability. We collected information on seals killed by polar bears (n = 650) and hunting attempts on ringed seal (Pusa hispida) lairs (n = 1396) observed from a helicopter during polar bear mark-recapture studies in the eastern Beaufort Sea in spring in 1985-2011. We investigated how temporal shifts in ringed seal reproduction affect kill composition and the intraspecific vulnerabilities of ringed seals to polar bear predation. Principal Findings: Polar bears primarily preyed on ringed seals (90.2%) while bearded seals (Erignathus barbatus) only comprised 9.8% of the kills, but 33% of the biomass. Adults comprised 43.6% (150/344) of the ringed seals killed, while their pups comprised 38.4% (132/344). Juvenile ringed seals were killed at the lowest proportion, comprising 18.0% (62/344) of the ringed seal kills. The proportion of ringed seal pups was highest between 2007-2011, in association with high ringed seal productivity. Half of the adult ringed seal kills were >= 21 years (60/121), and kill rates of adults increased following the peak of parturition. Determination of sex from DNA revealed that polar bears killed adult male and adult female ringed seals equally (0.50, n = 78). The number of hunting attempts at ringed seal subnivean lair sites was positively correlated with the number of pup kills (r(2) = 0.30, P = 0.04), but was not correlated with the number of adult kills (P = 0.37). Conclusions/Significance: Results are consistent with decadal trends in ringed seal productivity, with low numbers of pups killed by polar bears in spring in years of low pup productivity, and conversely when pup productivity was high. Vulnerability of adult ringed seals to predation increased in relation to reproductive activities and age, but not gender.	[Pilfold, Nicholas W.; Derocher, Andrew E.; Stirling, Ian; Richardson, Evan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stirling, Ian; Richardson, Evan; Andriashek, Dennis] Environm Canada, Sci & Technol Branch, Wildlife Res Div, Edmonton, AB, Canada	University of Alberta; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada	Pilfold, NW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	pilfold@ualberta.ca	Pilfold, Nick/J-1376-2012; Derocher, Andrew/J-4469-2012	Derocher, Andrew/0000-0002-1104-7774; Chiaradia, Andre/0000-0002-6178-4211; Pilfold, Nicholas/0000-0001-5324-5499	ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Circumpolar/Boreal Alberta Research; Environment Canada; Inuvialuit Game Council; Natural Sciences and Engineering Research Council of Canada; Northern Scientific Training Program; Northwest Territories Department of Environment and Natural Resources; Polar Continental Shelf Project; Polar Bears International; Quark Expeditions; United States Geological Survey; United States Department of the Interior; World Wildlife Fund (Canada)	ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Circumpolar/Boreal Alberta Research; Environment Canada(CGIAR); Inuvialuit Game Council; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Northern Scientific Training Program; Northwest Territories Department of Environment and Natural Resources; Polar Continental Shelf Project(Natural Resources Canada); Polar Bears International; Quark Expeditions; United States Geological Survey(United States Geological Survey); United States Department of the Interior; World Wildlife Fund (Canada)	The authors gratefully acknowledge the financial and logistic support from ArcticNet, Canadian Association of Zoos and Aquariums, Canadian Wildlife Federation, Circumpolar/Boreal Alberta Research, Environment Canada, Inuvialuit Game Council, Natural Sciences and Engineering Research Council of Canada (A.E.D.), Northern Scientific Training Program, Northwest Territories Department of Environment and Natural Resources, Polar Continental Shelf Project, Polar Bears International, Quark Expeditions, United States Geological Survey, United States Department of the Interior, and World Wildlife Fund (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA L, 1995, ANIM BEHAV, V49, P1461, DOI 10.1016/0003-3472(95)90067-5; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chambellant M, 2012, J MAMMAL, V93, P267, DOI 10.1644/10-MAMM-A-253.1; Cherry SG, 2009, POLAR BIOL, V32, P383, DOI 10.1007/s00300-008-0530-0; Crawford JA, 2012, POLAR BIOL, V35, P241, DOI 10.1007/s00300-011-1067-1; Curio E., 1976, ETHOLOGY PREDATION; Derocher AE, 2002, POLAR BIOL, V25, P448, DOI 10.1007/s00300-002-0364-0; Derocher AE, 1999, ARCTIC, V52, P307; DEROCHER AE, 1990, CAN J ZOOL, V68, P1395, DOI 10.1139/z90-208; DEROCHER AE, 1990, MAR MAMMAL SCI, V6, P196, DOI 10.1111/j.1748-7692.1990.tb00243.x; FETTERER F, 2009, SEA ICE INDEX; Furgal CM, 1996, CAN J ZOOL, V74, P858, DOI 10.1139/z96-100; FURNELL DJ, 1980, CAN FIELD NAT, V94, P88; GJERTZ I, 1986, Polar Research, V4, P65; HAMMILL MO, 1991, MAR MAMMAL SCI, V7, P123, DOI 10.1111/j.1748-7692.1991.tb00559.x; HARDY MH, 1991, CAN J ZOOL, V69, P189, DOI 10.1139/z91-029; Harwood LA, 2000, ARCTIC, V53, P422, DOI 10.14430/arctic872; Harwood LA, 2012, RINGED SEALS SEA ICE; Hindle AG, 2009, J EXP BIOL, V212, P790, DOI 10.1242/jeb.025387; HURST RJ, 1982, CAN J ZOOL, V60, P40, DOI 10.1139/z82-005; IMS RA, 1990, AM NAT, V136, P485, DOI 10.1086/285109; KELLY BP, 1990, CAN J ZOOL, V68, P2503, DOI 10.1139/z90-350; Kelly BP, 1996, CAN J ZOOL, V74, P1547, DOI 10.1139/z96-169; Kelly BP, 2010, POLAR BIOL, V33, P1095, DOI 10.1007/s00300-010-0796-x; Kingsley M. C. S., 1998, RINGED SEALS N ATLAN, P197; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; Krafft BA, 2007, MAR ECOL PROG SER, V335, P199, DOI 10.3354/meps335199; LYDERSEN C, 1987, CAN J ZOOL, V65, P1021, DOI 10.1139/z87-162; LYDERSEN C, 1993, CAN J ZOOL, V71, P991, DOI 10.1139/z93-131; Lydersen C, 1995, DEV MAR BIO, V4, P319; Lydersen C, 1999, MAR ECOL PROG SER, V187, P265, DOI 10.3354/meps187265; LYDERSEN C, 1993, J COMP PHYSIOL B, V163, P433; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MARASCUILO LA, 1966, PSYCHOL BULL, V65, P280, DOI 10.1037/h0023189; McLaren IA, 1958, B FISH RES BOARD CAN, V118, P1; Mech L. David, 1970, WOLF ECOLOGY BEHAV E; MESSIER F, 1992, J ZOOL, V226, P219, DOI 10.1111/j.1469-7998.1992.tb03835.x; MESSIER F, 1994, J MAMMAL, V75, P420, DOI 10.2307/1382563; NELSON RA, 1987, MAYO CLIN PROC, V62, P850, DOI 10.1016/S0025-6196(12)62341-6; Quinn TP, 1999, OECOLOGIA, V121, P273, DOI 10.1007/s004420050929; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; RAMSAY MA, 1991, CAN J ZOOL, V69, P298, DOI 10.1139/z91-048; RYG M, 1992, J ZOOL, V226, P681, DOI 10.1111/j.1469-7998.1992.tb07509.x; Schafer JL., 1997, ANAL INCOMPLETE MULT, V1st, P430; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Smith T., 1987, CANADIAN B FISHERIES, V216, P1; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; SMITH TG, 1991, ARCTIC, V44, P124; SMITH TG, 1975, CAN J ZOOL, V53, P1297, DOI 10.1139/z75-155; Sommer S, 2000, ANIM BEHAV, V59, P1087, DOI 10.1006/anbe.2000.1381; Stewart REA, 1996, MAR MAMMAL SCI, V12, P383, DOI 10.1111/j.1748-7692.1996.tb00591.x; STIRLING I, 1977, J FISH RES BOARD CAN, V34, P1126, DOI 10.1139/f77-169; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; STIRLING I, 1975, CAN J ZOOL, V53, P1021, DOI 10.1139/z75-117; Stirling I, 2002, ARCTIC, V55, P59; STIRLING I, 1990, INT C BEAR, V8, P189; STIRLING I, 1982, DISTRIBUTION ABUNDAN; STIRLING I, 1997, ECOLOGY ARCTIC ENV, P167; Stirling Ian, 1993, Polar Record, V29, P13; TAYLOR M, 1985, ARCTIC, V38, P303; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Thiemann GW, 2011, OIKOS, V120, P1469, DOI 10.1111/j.1600-0706.2011.19277.x; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	63	41	42	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41429	10.1371/journal.pone.0041429	http://dx.doi.org/10.1371/journal.pone.0041429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829949	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300089
J	Qin, W; Zhang, M; Piao, YS; Guo, DY; Zhu, ZX; Tian, X; Li, KC; Yu, CS				Qin, Wen; Zhang, Min; Piao, Yueshan; Guo, Deyu; Zhu, Zixin; Tian, Xin; Li, Kuncheng; Yu, Chunshui			Wallerian Degeneration in Central Nervous System: Dynamic Associations between Diffusion Indices and Their Underlying Pathology	PLOS ONE			English	Article							TENSOR IMAGING DETECTS; WHITE-MATTER DAMAGE; SPONTANEOUS REGENERATION; PYRAMIDAL TRACT; CORTICOSPINAL TRACT; MULTIPLE-SCLEROSIS; SPINAL-CORD; AXONAL DEGENERATION; FUNCTIONAL RECOVERY; WATER DIFFUSION	Background: Although diffusion tensor imaging has been used to monitor Wallerian degeneration, the exact relationship between the evolution of diffusion indices and its underlying pathology, especially in central nervous system, remains largely unknown. Here we aimed to address this question using a cat Wallerian degeneration model of corticospinal tract. Methodology/Principal Findings: Twenty-five domestic mature Felis catus were included in the present study. The evolution of diffusion indices, including mean diffusivity (MD), fractional anisotropy (FA), primary (lambda 1) and transverse eigenvalues (lambda 23) of the degenerated corticospinal tract, were observed at baseline (before modeling) and at 2, 4, 6, 8, 10, 15, 20, 25, 30, 45 and 60 days after modeling in 4 cats. Pathological examinations were performed at eight time points mentioned above. Wallerian degeneration can be detected as early as the 2nd day after modeling by both diffusion tensor imaging and pathology. According to the evolution of diffusion indices, Wallerian degeneration can be classified into 2 stages. During the early stage (within 8 days after modeling), progressive disintegration of axons and myelin sheaths underlies the decreases in FA and lambda 1 and the increase in lambda 23. However, during the late stage (after 8 days), the gradual increases in FA, MD and lambda 1 and the unchanged lambda 23 seem to be a comprehensive reflection of the pathological processes including microglia activation, myelin clearance, and astrocytosis. Conclusions/Significance: Our findings help the understanding of the altered diffusion indices in the context of pathology and suggest that diffusion tensor imaging has the potential to monitor the processes of Wallerian degeneration in the central nervous system in vivo after acute damage.	[Qin, Wen; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Qin, Wen; Zhang, Min; Li, Kuncheng; Yu, Chunshui] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Piao, Yueshan] Capital Med Univ, Xuanwu Hosp, Dept Pathol, Beijing, Peoples R China; [Guo, Deyu; Zhu, Zixin; Tian, Xin] Capital Med Univ, Xuanwu Hosp, Dept Expt Anim, Beijing, Peoples R China	Tianjin Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Qin, W (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	kunchengli1955@yahoo.com.cn; chunshuiyu@yahoo.cn	QIN, WEN/F-3783-2015	QIN, WEN/0000-0002-9121-8296; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [30670601]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (no. 30670601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Buss A, 2005, BRAIN, V128, P356, DOI 10.1093/brain/awh355; Buss A, 2003, GLIA, V42, P424, DOI 10.1002/glia.10220; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Ciccarelli O, 2003, J NEUROL, V250, P287, DOI 10.1007/s00415-003-0992-5; DeVetten G, 2010, STROKE, V41, P751, DOI 10.1161/STROKEAHA.109.573287; Dziedzic T, 2010, BRAIN PATHOL, V20, P976, DOI 10.1111/j.1750-3639.2010.00401.x; Foerster AP, 1999, EUR J NEUROSCI, V11, P3151, DOI 10.1046/j.1460-9568.1999.00735.x; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Hunsche S, 2001, RADIOLOGY, V221, P550, DOI 10.1148/radiol.2212001823; Inoue T, 1998, NEUROSCI LETT, V247, P151, DOI 10.1016/S0304-3940(98)00297-3; Iseda T, 2004, NEUROSCIENCE, V126, P365, DOI 10.1016/j.neuroscience.2004.03.056; Iseda T, 2003, J COMP NEUROL, V464, P343, DOI 10.1002/cne.10786; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Kim H, 2008, EPILEPSY RES, V81, P136, DOI 10.1016/j.eplepsyres.2008.05.005; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lehmann HC, 2010, EXP NEUROL, V223, P238, DOI 10.1016/j.expneurol.2009.10.012; Liang ZJ, 2008, CEREBROVASC DIS, V25, P209, DOI 10.1159/000113858; Liang ZJ, 2007, J NEUROL NEUROSUR PS, V78, P581, DOI 10.1136/jnnp.2006.099077; Lin F, 2007, AM J NEURORADIOL, V28, P278; MacLullich AMJ, 2009, STROKE, V40, P3869, DOI 10.1161/STROKEAHA.109.547877; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Qin W, 2009, MAGN RESON MED, V61, P755, DOI 10.1002/mrm.21920; Radlinska BA, 2009, ANN NEUROL, V66, P825, DOI 10.1002/ana.21796; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stoll G, 1999, BRAIN PATHOL, V9, P313; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; VAN CREVEL, 1963, J Anat, V97, P495; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Weigel M, 2006, MAGN RESON MED, V55, P826, DOI 10.1002/mrm.20816; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066; Yuan WH, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-19; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010	53	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41441	10.1371/journal.pone.0041441	http://dx.doi.org/10.1371/journal.pone.0041441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829950	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300090
J	Qu, B; Han, X; Tang, YJ; Shen, N				Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan			A Novel Vector-Based Method for Exclusive Overexpression of Star-Form MicroRNAs	PLOS ONE			English	Article							SHORT-INTERFERING RNAS; EXPRESSION; BIOGENESIS; MECHANISMS; SYSTEM; SUPPRESSION; SIRNAS	The roles of microRNAs (miRNAs) as important regulators of gene expression have been studied intensively. Although most of these investigations have involved the highly expressed form of the two mature miRNA species, increasing evidence points to essential roles for star-form microRNAs (miRNA*), which are usually expressed at much lower levels. Owing to the nature of miRNA biogenesis, it is challenging to use plasmids containing miRNA coding sequences for gain-of-function experiments concerning the roles of microRNA* species. Synthetic microRNA mimics could introduce specific miRNA* species into cells, but this transient overexpression system has many shortcomings. Here, we report that specific miRNA* species can be overexpressed by introducing artificially designed stem-loop sequences into short hairpin RNA (shRNA) overexpression vectors. By our prototypic plasmid, designed to overexpress hsa-miR-146b-3p, we successfully expressed high levels of hsa-miR-146b-3p without detectable change of hsa-miR-146b-5p. Functional analysis involving luciferase reporter assays showed that, like natural miRNAs, the overexpressed hsa-miR-146b-3p inhibited target gene expression by 3'UTR seed pairing. Our demonstration that this method could overexpress two other miRNAs suggests that the approach should be broadly applicable. Our novel strategy opens the way for exclusively stable overexpression of miRNA* species and analyzing their unique functions both in vitro and in vivo.	[Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan] Chinese Acad Sci, Inst Hlth Sci, Joint Mol Rheumatol Lab, Shanghai, Peoples R China; [Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Renji Hosp, Shanghai, Peoples R China; [Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Shen, Nan] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH USA; [Shen, Nan] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Qu, B (corresponding author), Chinese Acad Sci, Inst Hlth Sci, Joint Mol Rheumatol Lab, Shanghai, Peoples R China.	nanshensibs@gmail.com	Qu, Bo/V-6675-2019; Shen, Nan/AGK-6807-2022	Han, Xiao/0000-0003-1707-5079; tang, yuan jia/0000-0002-2044-5424; Shen, Nan/0000-0002-5875-4417	National Natural Science Foundation of China [30971632, 81025016]; Program of the Shanghai Commission of Science and Technology [10JC1409300, 09411951800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of the Shanghai Commission of Science and Technology	This work was supported by the National Natural Science Foundation of China (No. 30971632, No. 81025016) and the Program of the Shanghai Commission of Science and Technology (No. 10JC1409300, No. 09411951800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Broderick JA, 2011, GENE THER; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Tsang WP, 2009, CARCINOGENESIS, V30, P953, DOI 10.1093/carcin/bgp094; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	48	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41504	10.1371/journal.pone.0041504	http://dx.doi.org/10.1371/journal.pone.0041504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829954	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300094
J	Gupta, A; Ahmad, FJ; Ahmad, F; Gupta, UD; Natarajan, M; Katoch, V; Bhaskar, S				Gupta, Ankan; Ahmad, Farhan J.; Ahmad, Faiz; Gupta, Umesh D.; Natarajan, Mohan; Katoch, Vishwamohan; Bhaskar, Sangeeta			Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung	PLOS ONE			English	Article							RESISTANT PULMONARY TUBERCULOSIS; GUINEA-PIG LYMPHOCYTES; INTERFERON-GAMMA; BCG VACCINATION; PROTECTIVE EFFICACY; DNA VACCINE; BOVIS BCG; MICE; VACCAE; INFECTION	Background: The 9-month-long chemotherapy of tuberculosis often results in poor compliance and emergence of drug-resistant strains. So, improved therapeutic strategy is urgently needed. Immunotherapy could be beneficial for the effective management of the disease. Previously we showed the protective efficacy of Mycobacterium indicus pranii (MIP) when given as prophylactic vaccine in animal models of tuberculosis. Methods: We sought to investigate whether MIP can be used as an adjunct to the chemotherapy in guinea pig models of tuberculosis. Efficacy of MIP was evaluated when given subcutaneously or by aerosol. Results: MIP-therapy as an adjunct to the chemotherapy was found to be effective in accelerating bacterial killing and improving organ pathology. MIP-immunotherapy resulted in higher numbers of activated antigen-presenting cells and lymphocytes in the infected lungs and also modulated the granulomatous response. Early increase in protective Th1 immune response was observed in the immunotherapy group. Following subsequent doses of MIP, decrease in the inflammatory response and increase in the immunosuppressive response was observed, which resulted in the improvement of lung pathology. Conclusion: MIP immunotherapy is a valuable adjunct to chemotherapy for tuberculosis. Aerosol route of immunotherapy can play a crucial role for inducing immediate local immune response in the lung.	[Gupta, Ankan; Ahmad, Faiz; Bhaskar, Sangeeta] Natl Inst Immunol, Delhi, India; [Ahmad, Farhan J.] Jamia Hamdard, Fac Pharm, Delhi, India; [Gupta, Umesh D.; Natarajan, Mohan; Katoch, Vishwamohan] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Expt Anim Facil, Agra, Uttar Pradesh, India; [Gupta, Umesh D.; Natarajan, Mohan; Katoch, Vishwamohan] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Pathol, Agra, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Hamdard University; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra	Bhaskar, S (corresponding author), Natl Inst Immunol, Delhi, India.	sangeeta@nii.ac.in		Ahmad, Farhan/0000-0002-0740-8573; Bhaskar, Sangeeta/0000-0001-7902-5267; Ahmad, Faiz/0000-0002-0450-042X	National Institute of Immunology from the Department of Biotechnology, Ministry of Science and Technology, Government of India; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PRS340/Med/14/619/2005]	National Institute of Immunology from the Department of Biotechnology, Ministry of Science and Technology, Government of India; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This research work was supported by the core research grant of the National Institute of Immunology and a research grant (BT/PRS340/Med/14/619/2005) from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHR GM, 1990, TUBERCLE, V71, P259, DOI 10.1016/0041-3879(90)90038-A; Barnes PF, 2003, AM J RESP CRIT CARE, V168, P142, DOI 10.1164/rccm.2305001; Cho H, 2005, INFECT IMMUN, V73, P1367, DOI 10.1128/IAI.73.3.1367-1376.2005; Condos R, 1997, LANCET, V349, P1513, DOI 10.1016/S0140-6736(96)12273-X; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dlugovitzky D, 2006, RESP MED, V100, P1079, DOI 10.1016/j.rmed.2005.09.026; Dlugovitzky D, 2011, IMMUNOTHERAPY-UK, V3, P557, DOI [10.2217/IMT.11.6, 10.2217/imt.11.6]; Dlugovitzky D, 2010, IMMUNOTHERAPY-UK, V2, P159, DOI 10.2217/IMT.09.90; Fotedar A, 1978, Lepr India, V50, P520; Garner P, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001166 [doi], DOI 10.1002/14651858.CD001166]; Giosue S, 2000, EUR CYTOKINE NETW, V11, P99; Giri PK, 2006, J INFECTION, V53, P350, DOI 10.1016/j.jinf.2005.12.017; Grahmann PR, 2008, INT J TUBERC LUNG D, V12, P636; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Ha SJ, 2005, GENE THER, V12, P634, DOI 10.1038/sj.gt.3302465; Ha SJ, 2003, GENE THER, V10, P1592, DOI 10.1038/sj.gt.3302057; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Jeyanathan M, 2008, J IMMUNOL, V181, P5618, DOI 10.4049/jimmunol.181.8.5618; Jeyanathan M, 2010, TRENDS IMMUNOL, V31, P247, DOI 10.1016/j.it.2010.05.002; Jeyanathan M, 2010, AM J RESP CRIT CARE, V181, P862, DOI 10.1164/rccm.200910-1583OC; Johnson B, 1998, NOVART FDN SYMP, V217, P99, DOI 10.1002/0470846526.ch7; JOHNSON BJ, 1995, CYTOKINES MOL THER, V1, P185; Johnson BJ, 1998, INFECT IMMUN, V66, P2426, DOI 10.1128/IAI.66.6.2426-2433.1998; Johnson CM, 2005, ANTIMICROB AGENTS CH, V49, P4335, DOI 10.1128/AAC.49.10.4335-4338.2005; Johnson JL, 2003, AM J RESP CRIT CARE, V168, P185, DOI 10.1164/rccm.200211-1359OC; Koh WJ, 2004, J KOREAN MED SCI, V19, P167, DOI 10.3346/jkms.2004.19.2.167; KRAAL G, 1986, EUR J IMMUNOL, V16, P1515, DOI 10.1002/eji.1830161208; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC; Mustafa A S, 1978, Lepr India, V50, P534; Mustafa A S, 1978, Lepr India, V50, P498; Mustafa A S, 1978, Lepr India, V50, P509; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477; Park SK, 2007, INT J INFECT DIS, V11, P434, DOI 10.1016/j.ijid.2006.12.004; Petrofsky M, 1999, CLIN IMMUNOL, V91, P354, DOI 10.1006/clim.1999.4709; REDDI PP, 1994, INT J LEPROSY, V62, P229; Rodriguez-Guell E, 2008, CLIN VACCINE IMMUNOL, V15, P893, DOI 10.1128/CVI.00477-07; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; SCHAFER H, 1991, EUR J IMMUNOL, V21, P701, DOI 10.1002/eji.1830210324; Silva CL, 2005, GENE THER, V12, P281, DOI 10.1038/sj.gt.3302418; Skwor TA, 2006, TUBERCULOSIS, V86, P419, DOI 10.1016/j.tube.2005.12.002; STANFORD JL, 1990, TUBERCLE, V71, P87, DOI 10.1016/0041-3879(90)90002-P; STUCK AE, 1989, REV INFECT DIS, V11, P954; TALWAR GP, 1983, INT J LEPROSY, V51, P550; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Turner J, 2000, INFECT IMMUN, V68, P1706, DOI 10.1128/IAI.68.3.1706-1709.2000; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Xu LJ, 2009, CELL MOL IMMUNOL, V6, P67, DOI 10.1038/cmi.2009.9; YADAVA A, 1991, SCAND J IMMUNOL, V34, P23, DOI 10.1111/j.1365-3083.1991.tb01517.x; Yamada H, 2005, EXP ANIM TOKYO, V54, P163, DOI 10.1538/expanim.54.163; Yu DH, 2008, GENE THER, V15, P652, DOI 10.1038/gt.2008.13; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	58	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e39215	10.1371/journal.pone.0039215	http://dx.doi.org/10.1371/journal.pone.0039215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844392	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600002
J	Su, YL; Wang, SC; Chiang, PY; Lin, NY; Shen, YF; Chang, GD; Chang, CJ				Su, Yu-Lun; Wang, Shun-Chang; Chiang, Pei-Yu; Lin, Nien-Yi; Shen, Yu-Fang; Chang, Geen-Dong; Chang, Ching-Jin			Tristetraprolin Inhibits Poly(A)-Tail Synthesis in Nuclear mRNA that Contains AU-Rich Elements by Interacting with Poly(A)-Binding Protein Nuclear 1	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; BINDING-PROTEIN; TRANSLATION INITIATION; TAIL LENGTH; DEGRADATION; DECAY; DEADENYLATION; RECRUITMENT; STABILITY; TTP	Background: Tristetraprolin binds mRNA AU-rich elements and thereby facilitates the destabilization of mature mRNA in the cytosol. Methodology/Principal Findings: To understand how tristetraprolin mechanistically functions, we biopanned with a phage-display library for proteins that interact with tristetraprolin and retrieved, among others, a fragment of poly(A)-binding protein nuclear 1, which assists in the 3'-polyadenylation of mRNA by binding to immature poly(A) tails and thereby increases the activity of poly(A) polymerase, which is directly responsible for polyadenylation. The tristetraprolin/poly(A)-binding protein nuclear 1 interaction was characterized using tristetraprolin and poly(A)-binding protein nuclear 1 deletion mutants in pull-down and co-immunoprecipitation assays. Tristetraprolin interacted with the carboxyl-terminal region of poly(A)-binding protein nuclear 1 via its tandem zinc finger domain and another region. Although tristetraprolin and poly(A)-binding protein nuclear 1 are located in both the cytoplasm and the nucleus, they interacted in vivo in only the nucleus. In vitro, tristetraprolin bound both poly(A)-binding protein nuclear 1 and poly(A) polymerase and thereby inhibited polyadenylation of AU-rich element-containing mRNAs encoding tumor necrosis factor alpha, GM-CSF, and interleukin-10. A tandem zinc finger domain-deleted tristetraprolin mutant was a less effective inhibitor. Expression of a tristetraprolin mutant restricted to the nucleus resulted in downregulation of an AU-rich element-containing tumor necrosis factor alpha/luciferase mRNA construct. Conclusion/Significance: In addition to its known cytosolic mRNA-degrading function, tristetraprolin inhibits poly(A) tail synthesis by interacting with poly(A)-binding protein nuclear 1 in the nucleus to regulate expression of AU-rich element-containing mRNA.	[Su, Yu-Lun; Chiang, Pei-Yu; Shen, Yu-Fang; Chang, Geen-Dong; Chang, Ching-Jin] Natl Taiwan Univ, Grad Inst Biochem Sci, Coll Life Sci, Taipei 10764, Taiwan; [Wang, Shun-Chang; Lin, Nien-Yi; Chang, Ching-Jin] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Chang, CJ (corresponding author), Natl Taiwan Univ, Grad Inst Biochem Sci, Coll Life Sci, Taipei 10764, Taiwan.	chingjin@gate.sinica.edu.tw	Chang, Ching-Jin/G-4511-2019	Chang, Ching-Jin/0000-0001-7129-8092	Academia Sinica; National Science Council [NSC97-2311-B-001-019-MY3]; National Taiwan University [98R0066-32]; Department of Medical Research in NTUH (National Taiwan University Hospital)	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Department of Medical Research in NTUH (National Taiwan University Hospital)	This work was supported by grants from Academia Sinica and National Taiwan University (98R0066-32 to G.-D. Chang) and the National Science Council (NSC97-2311-B-001-019-MY3 to C.-J. Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Sheng-Wei Lin of the Institute of Biological Chemistry, Academia Sinica for his technical expertise during protein purification, and Ms Yi-Li Liu and Ms I.-Ching Huang for their technical expertise during DNA sequencing, supported in part by the Department of Medical Research in NTUH (National Taiwan University Hospital).	Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kedar VP, PLOS ONE, V5, pe9588; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Lemieux C, 2009, NUCLEIC ACIDS RES, V37, P3418, DOI 10.1093/nar/gkp207; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Murata T, 2002, BIOCHEM BIOPH RES CO, V293, P1242, DOI 10.1016/S0006-291X(02)00363-7; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Prouteau M, 2008, EMBO J, V27, P2966, DOI 10.1038/emboj.2008.212; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V295, pG421, DOI 10.1152/ajpgi.00508.2007; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; SALLES FJ, 1995, PCR METH APPL, V4, P317; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shim J, 2002, MOL CELLS, V14, P323; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Tan BCM, 2004, J BIOL CHEM, V279, P9321, DOI 10.1074/jbc.M311477200; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41313	10.1371/journal.pone.0041313	http://dx.doi.org/10.1371/journal.pone.0041313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844456	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600021
J	Thevenin, JM; Rossi, V; Ducamp, M; Doare, F; Condina, V; Lachenaud, P				Thevenin, Jean-Marc; Rossi, Vivien; Ducamp, Michel; Doare, Fabien; Condina, Virgile; Lachenaud, Philippe			Numerous Clones Resistant to Phytophthora palmivora in the "Guiana" Genetic Group of Theobroma cacao L	PLOS ONE			English	Article							FOLIAR RESISTANCE; POD RESISTANCE; FRENCH-GUIANA; FIELD; INDICATOR; ROT	Cocoa black pod rot, a disease caused by Stramenopiles of the genus Phytophthora, and particularly by the pan-tropical species P. palmivora, causes serious production losses worldwide. In order to reduce the impact of these pests and diseases, preference is given to genetic control using resistant varieties and, to that end, breeders seek sources of resistance in wild cocoa trees. For instance, surveys of spontaneous cocoa trees in French Guiana between 1985 and 1995 led to the collection of abundant plant material forming a particular genetic group (the "Guiana" group). Following numerous one-off studies demonstrating the merits of this group as a source of resistance to Phytophthora, this article presents the results of a comprehensive study assessing the resistance of 186 "Guiana" clones in relation to the Guianan strain (GY 27) of P. palmivora. This study, undertaken in French Guiana, using an efficient methodology (ten series of tests and a statistical test adapted to the ordinal nature of the data) confirmed that the "Guiana" genetic group does indeed constitute an important source of resistance to P. palmivora, though with some variations depending on the demes of origin. Numerous clones (59) proved to be as resistant as the SCAVINA 6 resistance control, whilst nine were statistically more resistant. The "Resistant" and "Moderately Resistant" Guianan clones totalled 108 (58% of the total tested). Some of the clones more resistant than SCAVINA 6 could be incorporated into numerous cocoa breeding programmes, particularly those that also display other notable qualities. The same applies for numerous other clones equivalent to SCAVINA 6, especially the "elite"' clones GU 134-B, GU 139-A and GU 285-A.	[Thevenin, Jean-Marc; Doare, Fabien; Condina, Virgile; Lachenaud, Philippe] CIRAD, UPR Bioagresseurs Anal & Maitrise Risque, Kourou, Guyane, France; [Rossi, Vivien] CIRAD, UMR Ecofog, Kourou, Guyane, France; [Ducamp, Michel] CIRAD, UMR BGPI, Montpellier, France	CIRAD; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD	Thevenin, JM (corresponding author), CIRAD, UPR Bioagresseurs Anal & Maitrise Risque, Kourou, Guyane, France.	jean-marc.thevenin@cirad.fr	Rossi, Vivien/C-9721-2009	Rossi, Vivien/0000-0001-5458-1523				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Akaza M. J., 2009, Asian Journal of Plant Pathology, V3, P106; [Anonymous], 2001, CFC ICCO IPGRI PROJE; [Anonymous], 2004, FINAL INDIVIDUAL REP, V1; [Anonymous], 2004, FINAL INDIVIDUAL REP, V2; Bowers J.H., 2001, PLANT HLTH PROG, V2, P12, DOI DOI 10.1094/PHP-2001-0709-01-RV; End MJ, 2010, REVISED FAO IPGRI TE; Eskes AB, 2001, ACT 13 C INT RECH CA, P11; Lachenaud P., 1997, Plantations Recherche Developpement, V4, P25; LACHENAUD P, 1994, CAFE CACAO THE, V38, P91; LACHENAUD P, 1993, CAFE CACAO THE, V37, P101; Lachenaud P, 2007, SCI HORTIC-AMSTERDAM, V113, P313, DOI 10.1016/j.scienta.2007.05.016; McCullagh P, 1989, GEN LINEAR MODELS; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Nyasse S, 1995, CROP PROT, V14, P657, DOI 10.1016/0261-2194(95)00054-2; Paulin D, 2008, CROP PROT, V27, P1143, DOI 10.1016/j.cropro.2008.01.004; Paulin D, 2007, GLOBAL APPROACHES CO, P124; PAULIN D, 2005, C INT RECH CAC 14 20, V1, P85; Paulin D, 2010, 15 C INT RECH CAC SA, V1, P41; Pokou ND, 2008, CROP PROT, V27, P302, DOI 10.1016/j.cropro.2007.07.012; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Tahi GM, 2007, PLANT PATHOL, V56, P219, DOI 10.1111/j.1365-3059.2006.01547.x; Tahi GM, 2006, PLANT PATHOL, V55, P776, DOI 10.1111/j.1365-3059.2006.01453.x; Tahi GM, 2006, EUPHYTICA, V149, P35, DOI 10.1007/s10681-005-9052-9; Tahi GM, 2003, THESIS U COCODY ABID; Tahi M, 2000, EUR J PLANT PATHOL, V106, P87, DOI 10.1023/A:1008747800191	26	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40915	10.1371/journal.pone.0040915	http://dx.doi.org/10.1371/journal.pone.0040915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848411	Green Published, gold			2022-12-27	WOS:000309240600012
J	Jang, H; Ehrenreich, IM				Jang, Hyosik; Ehrenreich, Ian M.			Genome-Wide Characterization of Genetic Variation in the Unicellular, Green Alga Chlamydomonas reinhardtii	PLOS ONE			English	Article							POPULATION-STRUCTURE; LABORATORY STRAINS; DNA-SEQUENCES; RECOMBINATION; MAP; POLYMORPHISMS; INTERFERTILE; CHLOROPHYTA; HYPOTHESIS; DROSOPHILA	Chlamydomonas reinhardtii is a model system for studying cilia, photosynthesis, and other core features of eukaryotes, and is also an emerging source of biofuels. Despite its importance to basic and applied biological research, the level and pattern of genetic variation in this haploid green alga has yet to be characterized on a genome-wide scale. To improve understanding of C. reinhardtii's genetic variability, we generated low coverage whole genome resequencing data for nearly all of the available isolates of this species, which were sampled from a number of sites in North America over the past,70 years. Based on the analysis of more than 62,000 single nucleotide polymorphisms, we identified two groups of isolates that represent geographical subpopulations of the species. We also found that measurements of genetic diversity were highly variable throughout the genome, in part due to technical factors. We studied the level and pattern of linkage disequilibrium (LD), and observed one chromosome that exhibits elevated LD. Furthermore, we detected widespread evidence of recombination across the genome, which implies that outcrossing occurs in natural populations of this species. In summary, our study provides multiple insights into the sequence diversity of C. reinhardtii that will be useful to future studies of natural genetic variation in this organism.	[Jang, Hyosik; Ehrenreich, Ian M.] Univ So Calif, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	University of Southern California	Jang, H (corresponding author), Univ So Calif, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	Ian.Ehrenreich@usc.edu		Jang, Hyo Sik/0000-0001-9654-4448	University of Southern California	University of Southern California	This research was supported by startup funds from the University of Southern California to IME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; BELL G, 1990, PROC R SOC SER B-BIO, V240, P295, DOI 10.1098/rspb.1990.0039; Bell G, 1997, HEREDITY, V78, P49; Brown WRA, 2011, G3-GENES GENOM GENET, V1, P615, DOI 10.1534/g3.111.001123; Dutcher SK, 2012, G3-GENES GENOM GENET, V2, P15, DOI 10.1534/g3.111.000919; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Halligan DL, 2004, GENOME RES, V14, P273, DOI 10.1101/gr.1329204; Harris EH, 1998, MOL BIOL CHLOROPLAST, P1; Harris EH, 2009, CHLAMYDOMONAS SOURCE, V1; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HOSHAW RW, 1966, J PHYCOL, V2, P93, DOI 10.1111/j.1529-8817.1966.tb04600.x; HUDSON RR, 1985, GENETICS, V111, P147; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kathir P, 2003, EUKARYOT CELL, V2, P362, DOI 10.1128/EC.2.2.362-379.2003; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Kubo T, 2002, CURR GENET, V41, P115, DOI 10.1007/s00294-002-0284-0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liss M, 1997, CURR GENET, V31, P214, DOI 10.1007/s002940050198; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Macdonald SJ, 2007, GENETICS, V176, P1261, DOI 10.1534/genetics.106.069641; McVean G, 2002, GENETICS, V160, P1231; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Nei M., 1987, MOL EVOLUTIONARY GEN; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Rymarquis LA, 2005, PLANT PHYSIOL, V137, P557, DOI 10.1104/pp.104.054221; SACK L, 1994, J PHYCOL, V30, P770, DOI 10.1111/j.0022-3646.1994.00770.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Smith DR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-120; SPANIER JG, 1992, J PHYCOL, V28, P822, DOI 10.1111/j.0022-3646.1992.00822.x; Stern D. B., 2009, CHLAMYDOMONAS SOURCE, V2; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Watterson G. A., 1974, Advances in Applied Probability, V6, P463, DOI 10.2307/1426228; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Witman G. B., 2009, CHLAMYDOMONAS SOURCE, V3	48	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41307	10.1371/journal.pone.0041307	http://dx.doi.org/10.1371/journal.pone.0041307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848460	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600050
J	Johnston-Cox, H; Koupenova, M; Yang, D; Corkey, B; Gokce, N; Farb, MG; LeBrasseur, N; Ravid, K				Johnston-Cox, Hillary; Koupenova, Milka; Yang, Dan; Corkey, Barbara; Gokce, Noyan; Farb, Melissa G.; LeBrasseur, Nathan; Ravid, Katya			The A2b Adenosine Receptor Modulates Glucose Homeostasis and Obesity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; NF-KAPPA-B; CARDIOVASCULAR-DISEASE; A(2B) RECEPTORS; ABDOMINAL FAT; TNF-ALPHA; IKK-BETA; INFLAMMATION; MICE	Background: High fat diet and its induced changes in glucose homeostasis, inflammation and obesity continue to be an epidemic in developed countries. The A2b adenosine receptor (A2bAR) is known to regulate inflammation. We used a diet-induced obesity murine knockout model to investigate the role of this receptor in mediating metabolic homeostasis, and correlated our findings in obese patient samples. Methodology/Principal Findings: Administration of high fat, high cholesterol diet (HFD) for sixteen weeks vastly upregulated the expression of the A2bAR in control mice, while A2bAR knockout ( KO) mice under this diet developed greater obesity and hallmarks of type 2 diabetes (T2D), assessed by delayed glucose clearance and augmented insulin levels compared to matching control mice. We identified a novel link between the expression of A2bAR, insulin receptor substrate 2 (IRS-2), and insulin signaling, determined by Western blotting for IRS-2 and tissue Akt phosphorylation. The latter is impaired in tissues of A2bAR KO mice, along with a greater inflammatory state. Additional mechanisms involved include A2bAR regulation of SREBP-1 expression, a repressor of IRS-2. Importantly, pharmacological activation of the A2bAR by injection of the A2bAR ligand BAY 60-6583 for four weeks post HFD restores IRS-2 levels, and ameliorates T2D. Finally, in obese human subjects A2bAR expression correlates strongly with IRS-2 expression. Conclusions/Significance: Our study identified the A2bAR as a significant regulator of HFD-induced hallmarks of T2D, thereby pointing to its therapeutic potential.	[Johnston-Cox, Hillary; Koupenova, Milka; Yang, Dan; Corkey, Barbara; LeBrasseur, Nathan; Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Koupenova, Milka; Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Johnston-Cox, Hillary; Koupenova, Milka; Gokce, Noyan; Farb, Melissa G.; Ravid, Katya] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Corkey, Barbara; Gokce, Noyan; Farb, Melissa G.; Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Johnston-Cox, H (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	kravid@bu.edu	Koupenova, Milka/L-3576-2019	Ravid, Katya/0000-0002-9918-3024; LeBrasseur, Nathan/0000-0002-2002-0418; Gokce, Noyan/0000-0003-2920-3445	National Heart, Lung and Blood Institute Grant [HL93149]; Boston Nutrition Obesity Research Center [DK046200]; CTSI NIH Grant [UL1-TR000157]; National Institutes of Health [R01 HL084213, P01 HL081587, HL007969, HL007224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, R01HL084213, P01HL081587, T32HL007224, R01HL114675, R01HL093149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, P30DK046200] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Nutrition Obesity Research Center; CTSI NIH Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung and Blood Institute Grant (HL93149) to KR, and by the Boston Nutrition Obesity Research Center (DK046200) to KR, and CTSI NIH Grant (UL1-TR000157) to KR, an established Investigator with the American Heart Association. Dr. Gokce is supported by National Institutes of Health grants R01 HL084213 and P01 HL081587. MK was supported by Cardiovascular pre-doctoral and post-doctoral Training Grants from the National Institutes of Health (HL007969, and HL007224 respectively), and HJC was supported by Cardiovascular Training Grant from the National Institutes of Health (HL007969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; BODEN G, 1995, DIABETES, V44, P1239, DOI 10.2337/diabetes.44.10.1239; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen HJ, 2009, EXP HEMATOL, V37, P533, DOI 10.1016/j.exphem.2009.02.001; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; CRESPIN SR, 1973, J CLIN INVEST, V52, P1979, DOI 10.1172/JCI107382; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; DESPRES JP, 1989, DIABETES, V38, P304, DOI 10.2337/diabetes.38.3.304; Dhaliwal SS, 2009, AM J CARDIOL, V103, P1403, DOI 10.1016/j.amjcard.2008.12.048; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Farb MG, 2011, ARTERIOLAR FUNCTION; Figler RA, 2011, DIABETES, V60, P669, DOI 10.2337/db10-1070; FLATT JP, 1985, J CLIN INVEST, V76, P1019, DOI 10.1172/JCI112054; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Han DH, 1998, DIABETES, V47, P1671, DOI 10.2337/diabetes.47.11.1671; Hilaire CS, 2009, J CELL PHYSIOL, V218, P35, DOI 10.1002/jcp.21579; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hu LP, 2005, AM J PHYSIOL-ENDOC M, V289, pE1085, DOI 10.1152/ajpendo.00210.2005; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Koupenova M, 2011, CIRCULATION; LAW WR, 1988, DIABETES, V37, P842, DOI 10.2337/diabetes.37.6.842; Maeda T, 2009, AM J PHYSIOL-REG I, V296, pR693, DOI 10.1152/ajpregu.90363.2008; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nemeth ZH, 2007, FASEB J, V21, P2379, DOI 10.1096/fj.07-8213com; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olefsky JM, 2009, CELL, V138, P834, DOI 10.1016/j.cell.2009.08.018; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Persaud SJ, 2011, DIABETOLOGIA, V54, P1109, DOI 10.1007/s00125-011-2050-7; Rendell M, 2001, J CLIN ENDOCR METAB, V86, P744, DOI 10.1210/jc.86.2.744; Rusing D, 2006, J PHARM PHARMACOL, V58, P1639, DOI 10.1211/jpp.58.12.0011; Schoelch C, 2004, DIABETES, V53, P1920, DOI 10.2337/diabetes.53.7.1920; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; TUCKER AL, 1993, CARDIOVASC RES, V27, P62, DOI 10.1093/cvr/27.1.62; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008	53	84	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40584	10.1371/journal.pone.0040584	http://dx.doi.org/10.1371/journal.pone.0040584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848385	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600021
J	Ku, PX; Abu Osman, NA; Yusof, A; Abas, WAW				Ku, Pei Xuan; Abu Osman, Noor Azuan; Yusof, Ashril; Abas, Wan Abu Bakar Wan			The Effect on Human Balance of Standing with Toe-Extension	PLOS ONE			English	Article							POSTURAL STABILITY; PRESSURE; POSITION; GRAVITY; FORCES; RISK	Background: Postural balance is vital for safely carrying out many daily activities, such as locomotion. The purpose of this study was to determine how changes in normal standing (NS) and standing with toe-extension (SWT) impact postural control during quiet standing. Furthermore, the research aimed to examine the extent to which the effect of these factors differed between genders. Methodology/Principal Findings: Thirty healthy young adults (age = 21.2 +/- 1.3 y; height = 1.63 +/- 0.07 m; mass = 56.0 +/- 9.3 kg) with no prior lower limb injuries participated in the study. A postural stability test using the Biodex Balance System was used for both NS and SWT conditions. The three measurements from the BBS were Overall Stability Index (OSI), Medial-Lateral Stability Index (MLSI) and Anterior-Posterior Stability Index (APSI). No significant difference was found between NS and SWT in the OSI, MLSI or APSI (F-2,F- (28) = 3.357, p = 0.077). The main difference between the stability index scores was significant (F-2,F- (28) = 275.1, p < 0.001). The Bonferroni post-hoc test showed significant differences between the OSI and MLSI (p < 0.001); the OSI and APSI (p < 0.001); and the MLSI and the APSI (p < 0.001). Significant differences were found during NS (p < 0.001), for the MLSI when compared with the APSI, but this was not found during the SWT condition. Additionally, no gender effects were proven to exist that altered postural sway during quiet standing. Conclusions/Significance: This study reveals significant interaction between the stability indices measured; OSI, APSI and MLSI in both NS and SWT. Standing with toe extended does not have a significant impact on an individual's ability to control their balance during normal quiet standing. However, the findings revealed that the sway tendency in the medial-lateral direction might serve as a factor in an individual's ability to regain balance.	[Ku, Pei Xuan; Abu Osman, Noor Azuan; Abas, Wan Abu Bakar Wan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Yusof, Ashril] Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Ku, PX (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	kupeixuan@gmail.com	YUSOF, ASHRIL/B-8252-2010; xuan, ku pei/B-2964-2013; ABU OSMAN, NOOR AZUAN/B-9265-2010	YUSOF, ASHRIL/0000-0002-8117-6440; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Ku, Pei Xuan/0000-0002-7438-5092	High Impact Research Grant [UM.C/HIR/MOHE/ENG/10 D000010-16001]	High Impact Research Grant	This study was supported by High Impact Research Grant (UM.C/HIR/MOHE/ENG/10 D000010-16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Patricia E, 2011, Vital Health Stat 10, P1; Arnold BL, 1998, J ATHL TRAINING, V33, P323; CAVANAGH PR, 1987, FOOT ANKLE, V7, P262, DOI 10.1177/107110078700700502; Cronin NJ, 2012, J APPL PHYSIOL, V112, P1054, DOI 10.1152/japplphysiol.01402.2011; Csapo R, 2010, J EXP BIOL, V213, P2582, DOI 10.1242/jeb.044271; Fessler DMT, 2005, ANN HUM BIOL, V32, P44, DOI 10.1080/03014460400027581; Gefen A, 2002, GAIT POSTURE, V15, P56, DOI 10.1016/S0966-6362(01)00180-1; Gravante G, 2003, CLIN BIOMECH, V18, P780, DOI 10.1016/S0268-0033(03)00123-2; Hasan S. S., 1996, GAIT POSTURE, V4, P1; Hellebrandt FA, 1938, AM J PHYSIOL, V121, P471, DOI 10.1152/ajplegacy.1938.121.2.471; Hernandez A, 2009, GAIT POSTURE, V30, P217, DOI 10.1016/j.gaitpost.2009.05.006; Herrington L, 2004, CLIN BIOMECH, V19, P1070, DOI 10.1016/j.clinbiomech.2004.07.010; HICKS JH, 1954, J ANAT, V88, P25; HUGHES J, 1990, J BONE JOINT SURG BR, V72, P245, DOI 10.1302/0301-620X.72B2.2312564; Karimi N., 2008, JPMI J POSTGRAD MED, V22, P95; Ku PX, 2012, J BIOMECH, V45, P1638, DOI 10.1016/j.jbiomech.2012.03.029; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Menant JC, 2008, J REHABIL RES DEV, V45, P1167, DOI 10.1682/JRRD.2007.10.0168; Mickle KJ, 2011, J SCI MED SPORT, V14, P243, DOI 10.1016/j.jsams.2010.11.002; MURRAY MP, 1967, J APPL PHYSIOL, V23, P831, DOI 10.1152/jappl.1967.23.6.831; Nolan L, 2004, GAIT POSTURE, V19, P11, DOI 10.1016/S0966-6362(03)00007-9; OMOLOLU BB, 2009, J BONE JOINT SURG, V467, P2073, DOI DOI 10.1007/S11999-008-0637-1; Pereira HM, 2008, GAIT POSTURE, V28, P668, DOI 10.1016/j.gaitpost.2008.05.003; Powers CM, 2010, J ORTHOP SPORT PHYS, V40, P42, DOI 10.2519/jospt.2010.3337; Rai D., 2006, POLISH J MED PHYS EN, V12, P25; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; Tortolero X, 2008, ARTIF ORGANS, V32, P5, DOI 10.1111/j.1525-1594.2007.00451.x; Watkins J, 1999, STRUCTURE FUNCTION M; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; WINTER EM, 1991, J PHYSIOL-LONDON, V438, pP175	31	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41539	10.1371/journal.pone.0041539	http://dx.doi.org/10.1371/journal.pone.0041539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848523	Green Published, Green Accepted, gold			2022-12-27	WOS:000306806600081
J	Li, S; Li, YR; Su, Y; Rao, LL				Li, Shu; Li, Yue-Ran; Su, Yin; Rao, Li-Lin			Is an Idea Different from Cake: Can You Have It and Eat It, Too? A Violation of Permanence in Information Consumption	PLOS ONE			English	Article							PUBLIC-EXPENDITURE	One of the basic features of information is permanence. This feature states that the consumption of information by one consumer does not affect the availability of that information to other consumers. We present examples in two studies indicating that both laymen and experts of information exchange may be motivated to make choices that violate the permanence feature in accepting (Study 1) and offering (Study 2) information. When they possess, but have not yet consumed information, people may suffer from the appearance of wastefulness. This apparent wastefulness may provide a potential explanation for the observed violation of the permanence feature. Our findings indicate that, as the material age evolves into the information age, information-exchange behavior has not evolved significantly away from material-exchange behavior.	[Li, Shu; Li, Yue-Ran; Su, Yin; Rao, Li-Lin] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Li, S (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	raoll@psych.ac.cn		li, shu/0000-0003-4402-1674	Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-YW-R-130]; National Natural Science Foundation of China [70632003, 70871110]	Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially supported by the Knowledge Innovation Project of the Chinese Academy of Sciences (No. KSCX2-YW-R-130) and the National Natural Science Foundation of China (Nos. 70632003, 70871110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arkes HR, 1996, J BEHAV DECIS MAKING, V9, P213, DOI 10.1002/(SICI)1099-0771(199609)9:3<213::AID-BDM230>3.0.CO;2-1; Bates BJ, 1990, MEDIATION INFORM COM, P379; BSA, 2010, 7 ANN BSA IDC GLOB S; Ericsson K.A., 1991, GEN THEORY EXPERTISE; Freiden J., 1998, MARK INTELL PLAN, V16, P210, DOI DOI 10.1108/02634509810217327; Raban DR, 2006, J AM SOC INF SCI TEC, V57, P321, DOI 10.1002/asi.20280; Rafaeli S, 2005, INT J KNOWL LEARN, V1, P62, DOI 10.1504/IJKL.2005.006251; Rowley J., 2002, Library Hi Tech, V20, P352, DOI 10.1108/07378830210444540; SAMUELSON PA, 1958, REV ECON STAT, V40, P332, DOI 10.2307/1926336; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Shapiro C., 1999, INFORM RULES STRATEG; Zultan R, 2010, JUDGM DECIS MAK, V5, P489	12	0	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41490	10.1371/journal.pone.0041490	http://dx.doi.org/10.1371/journal.pone.0041490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848511	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600074
J	Liu, SX; Shi, W; Xiao, HQ; Liang, XL; Deng, CY; Ye, ZM; Mei, P; Wang, SX; Liu, XY; Shan, ZX; Liang, YZ; Zhang, B; Wang, WJ; Liu, YH; Xu, LX; Xia, YF; Ma, JC; Li, ZL				Liu, Shuangxin; Shi, Wei; Xiao, Houqin; Liang, Xinling; Deng, Chunyu; Ye, Zhiming; Mei, Ping; Wang, Suxia; Liu, Xiaoying; Shan, Zhixin; Liang, Yongzheng; Zhang, Bin; Wang, Wenjian; Liu, Yanhui; Xu, Lixia; Xia, Yunfeng; Ma, Jianchao; Li, Zhilian			Receptor Activator of NF-kappaB and Podocytes: Towards a Function of a Novel Receptor-Ligand Pair in the Survival Response of Podocyte Injury	PLOS ONE			English	Article							SEGMENTAL GLOMERULOSCLEROSIS; 1,25-DIHYDROXYVITAMIN D-3; RANK LIGAND; PROLIFERATION; OSTEOCLAST; INDUCTION; PROTEIN; GROWTH; NEPHROPATHY; EXPRESSION	Background: Glomerulosclerosis correlates with reduction in podocyte number that occurs through mechanisms which include apoptosis. Podocyte injury or podocyte loss in the renal glomerulus has been proposed as the crucial mechanism in the development of glomerulosclerosis. However, the mechanism by which podocytes respond to injury is poorly understood. TNF and TNF receptor superfamilies are important in the pathogenesis of podocyte injury and apoptosis. The ligand of receptor activator of NF-kappaB (RANKL) and receptor activator of NF-kappaB (RANK) are members of the TNF and receptor superfamilies. We investigated whether RANK - RANKL is a receptor - ligand complex for podocytes responding to injury. Methodology/Principal Findings: In this study, RANKL and RANK were examined in human podocyte diseases and a rat model of puromycin aminonucleoside nephrosis (PAN). Compared with controls, RANK and RANKL were increased in both human podocyte diseases and the rat PAN model; double immunofluorescence staining revealed that RANK protein expression was mainly attributed to podocytes. Immunoelectron microscopy showed that RANK was localized predominantly at the top of the foot process membrane and the cytoplasm of rat podocyte. In addition, RANK was upregulated in mouse podocytes in vitro after injury induced by puromycin aminonucleoside (PA). Knockdown of RANK expression by small interference RNA (siRNA) exacerbated podocyte apoptosis induced by PA. However, RANKL inhibited significantly the apoptosis of podocytes induced by PA. Conclusions/Significance: These findings suggest the increase in RANK-RANKL expression is a response to podocyte injury, and RANK-RANKL may be a novel receptor-ligand complex for the survival response during podocyte injury.	[Liu, Shuangxin; Shi, Wei; Xiao, Houqin; Liang, Xinling; Ye, Zhiming; Liang, Yongzheng; Zhang, Bin; Wang, Wenjian; Xu, Lixia; Xia, Yunfeng; Ma, Jianchao; Li, Zhilian] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Liu, Shuangxin] So Med Univ, Guangzhou, Guangdong, Peoples R China; [Deng, Chunyu; Liu, Xiaoying; Shan, Zhixin] Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Mei, Ping; Liu, Yanhui] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wang, Suxia] Peking Univ, Hosp 1, Dept Pathol, Beijing 100871, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Peking University	Liu, SX (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	shiw_ggh@126.com	liu, shuangxin/AAS-7429-2020		Guangdong Provincial Natural Science Foundation [06020902, 8151008004000022, 9305, 2011B031800303]	Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by Guangdong Provincial Natural Science Foundation (No. 06020902, 8151008004000022, 9305, 2011B031800303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON DR, 1987, AM J PHYSIOL, V253, pF783, DOI 10.1152/ajprenal.1987.253.5.F783; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6; Bao LH, 2009, J CLIN INVEST, V119, P1264, DOI 10.1172/JCI36000; Barisoni L, 2003, AM J NEPHROL, V23, P353, DOI 10.1159/000072917; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bharti AC, 2004, APOPTOSIS, V9, P677, DOI 10.1023/B:APPT.0000045780.10463.c6; Bollain-Y-Goytia J J, 2011, Indian J Nephrol, V21, P166, DOI 10.4103/0971-4065.83029; Chen SD, 2005, NEPHROL DIAL TRANSPL, V20, P1320, DOI 10.1093/ndt/gfh837; Cheng HF, 2011, J AM SOC NEPHROL, V22, P1240, DOI 10.1681/ASN.2010111149; Cheng HF, 2009, J AM SOC NEPHROL, V20, P1953, DOI 10.1681/ASN.2009010039; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; D'Agati VD, 2008, KIDNEY INT, V73, P399, DOI 10.1038/sj.ki.5002655; Sanchez-Nino MD, 2009, J AM SOC NEPHROL, V20, P353, DOI 10.1681/ASN.2008020194; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Durvasula RV, 2006, CURR OPIN NEPHROL HY, V15, P1, DOI 10.1097/01.mnh.0000199012.79670.0b; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Gagliardini E, 2010, J AM SOC NEPHROL, V21, P2081, DOI 10.1681/ASN.2010020199; George S, 2010, CURR ONCOL REP, V12, P80, DOI 10.1007/s11912-010-0088-1; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Hess E, 2012, J IMMUNOL, V188, P1245, DOI 10.4049/jimmunol.1101513; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kim HH, 2003, FASEB J, V17, P2163, DOI 10.1096/fj.03-0215fje; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Lee SC, 2009, KIDNEY INT, V76, P838, DOI 10.1038/ki.2009.286; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Saito Y, 2010, AM J PHYSIOL-RENAL, V298, pF1436, DOI 10.1152/ajprenal.00512.2009; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; SOIFER NE, 1993, J CLIN INVEST, V92, P2850, DOI 10.1172/JCI116905; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Ueland T, 2005, CIRCULATION, V111, P2461, DOI 10.1161/01.CIR.0000165119.62099.14; Vega-Warner V, 2004, KIDNEY INT, V66, P1881, DOI 10.1111/j.1523-1755.2004.00962.x; Wall NR, 2003, LANCET, V362, P1401, DOI 10.1016/S0140-6736(03)14637-5; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wiethe C, 2003, J IMMUNOL, V171, P4121, DOI 10.4049/jimmunol.171.8.4121; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Xiao HQ, 2009, CLIN EXP PHARMACOL P, V36, P682, DOI 10.1111/j.1440-1681.2008.05133.x; Xiao HQ, 2009, AM J NEPHROL, V30, P34, DOI 10.1159/000200769; Xu L, 2010, MODERN PATHOL, V23, P1241, DOI 10.1038/modpathol.2010.110; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9	48	17	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41331	10.1371/journal.pone.0041331	http://dx.doi.org/10.1371/journal.pone.0041331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848465	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600052
J	Pontzer, H; Raichlen, DA; Wood, BM; Mabulla, AZP; Racette, SB; Marlowe, FW				Pontzer, Herman; Raichlen, David A.; Wood, Brian M.; Mabulla, Audax Z. P.; Racette, Susan B.; Marlowe, Frank W.			Hunter-Gatherer Energetics and Human Obesity	PLOS ONE			English	Article							DOUBLY LABELED WATER; PHYSICAL-ACTIVITY LEVELS; ENERGY-EXPENDITURE; BODY-COMPOSITION; HADZA FORAGERS; WEIGHT; RESTRICTION; PREGNANCY; FRUCTOSE; EXERCISE	Western lifestyles differ markedly from those of our hunter-gatherer ancestors, and these differences in diet and activity level are often implicated in the global obesity pandemic. However, few physiological data for hunter-gatherer populations are available to test these models of obesity. In this study, we used the doubly-labeled water method to measure total daily energy expenditure (kCal/day) in Hadza hunter-gatherers to test whether foragers expend more energy each day than their Western counterparts. As expected, physical activity level, PAL, was greater among Hadza foragers than among Westerners. Nonetheless, average daily energy expenditure of traditional Hadza foragers was no different than that of Westerners after controlling for body size. The metabolic cost of walking (kcal kg(-1) m(-1)) and resting (kcal kg(-1) s(-1)) were also similar among Hadza and Western groups. The similarity in metabolic rates across a broad range of cultures challenges current models of obesity suggesting that Western lifestyles lead to decreased energy expenditure. We hypothesize that human daily energy expenditure may be an evolved physiological trait largely independent of cultural differences.	[Pontzer, Herman] CUNY Hunter Coll, Dept Anthropol, New York, NY 10021 USA; [Pontzer, Herman] New York Consortium Evolutionary Primatol, New York, NY USA; [Raichlen, David A.] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Wood, Brian M.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Mabulla, Audax Z. P.] Univ Dar Es Salaam, Dept Archeol, Dar Es Salaam, Tanzania; [Racette, Susan B.] Washington Univ, Sch Med, St Louis, MO USA; [Marlowe, Frank W.] Univ Cambridge, Div Biol Anthropol, Cambridge, England	City University of New York (CUNY) System; Hunter College (CUNY); University of Arizona; Yale University; University of Dar es Salaam; Washington University (WUSTL); University of Cambridge	Pontzer, H (corresponding author), CUNY Hunter Coll, Dept Anthropol, New York, NY 10021 USA.	herman.pontzer@hunter.cuny.edu	Racette, Susan B/GLS-6669-2022; Wood, Brian/AAQ-4410-2020; Racette, Susan/GXV-8800-2022; Mabulla, Audax ZP/ABE-2455-2020; Marlowe, Frank/G-9752-2012	Racette, Susan B/0000-0002-6932-1887; Wood, Brian/0000-0002-8187-9429; Pontzer, Herman/0000-0003-2397-6543	National Science Foundation; Washington University; University of Arizona	National Science Foundation(National Science Foundation (NSF)); Washington University; University of Arizona	Funding was received from the National Science Foundation, Washington University, and the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowles S, 2011, P NATL ACAD SCI USA, V108, P4760, DOI 10.1073/pnas.1010733108; Bribiescas RG, 2001, AM J PHYS ANTHROPOL, V115, P297, DOI 10.1002/ajpa.1085; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P1010, DOI 10.1079/PHN2005793; Chaput JP, 2011, J OBES, V2011, DOI 10.1155/2011/360257; Davidson L, 1997, BRIT J NUTR, V78, P695, DOI 10.1079/BJN19970188; Davidsson L., 2009, ASSESSMENT BODY COMP; Dufour DL, 2008, AM J HUM BIOL, V20, P249, DOI 10.1002/ajhb.20764; Dufour DL, 2002, AM J HUM BIOL, V14, P584, DOI 10.1002/ajhb.10071; Dugas LR, 2011, AM J CLIN NUTR, V93, P427, DOI 10.3945/ajcn.110.007278; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; Esparza J, 2000, INT J OBESITY, V24, P55, DOI 10.1038/sj.ijo.0801085; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Goran MI, 1997, INT J OBESITY, V21, P171, DOI 10.1038/sj.ijo.0800383; Hayes M, 2005, INT J OBESITY, V29, P151, DOI 10.1038/sj.ijo.0802842; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Ischayek JI, 2006, J AM DIET ASSOC, V106, P1260, DOI 10.1016/j.jada.2006.05.003; Isganaitis E, 2005, ARTERIOSCL THROM VAS, V25, P2451, DOI 10.1161/01.ATV.0000186208.06964.91; Kanade AN, 2001, EUR J CLIN NUTR, V55, P708, DOI 10.1038/sj.ejcn.1601211; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; KASHIWAZAKI H, 1995, AM J CLIN NUTR, V62, P901, DOI 10.1093/ajcn/62.5.901; Kashiwazaki H, 2009, AM J HUM BIOL, V21, P337, DOI 10.1002/ajhb.20864; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Marlowe FW, 2009, AM J PHYS ANTHROPOL, V140, P751, DOI 10.1002/ajpa.21040; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; Murray SS, 2001, J FOOD COMPOS ANAL, V14, P3, DOI 10.1006/jfca.2000.0960; O'DEA K, 1991, Ethnicity and Disease, V1, P171; Pontzer H, 2010, P NATL ACAD SCI USA, V107, P14048, DOI 10.1073/pnas.1001031107; Pontzer H, 2009, P NATL ACAD SCI USA, V106, P192, DOI 10.1073/pnas.0806105106; Popkin BM, 2005, PUBLIC HEALTH NUTR, V8, P724, DOI 10.1079/PHN2005776; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; PRENTICE AM, 1986, BRIT MED J, V292, P983, DOI 10.1136/bmj.292.6526.983; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; RACETTE SB, 1995, AM J CLIN NUTR, V61, P486, DOI 10.1093/ajcn/61.3.486; RACETTE SB, 1995, AM J CLIN NUTR, V62, P345, DOI 10.1093/ajcn/62.2.345; Racette SB, 2006, J GERONTOL A-BIOL, V61, P943, DOI 10.1093/gerona/61.9.943; Rubenson J, 2007, J EXP BIOL, V210, P3513, DOI 10.1242/jeb.000992; Sahlins M., 1972, STONE AGE EC; Schoeninger MJ, 2001, J FOOD COMPOS ANAL, V14, P15, DOI 10.1006/jfca.2000.0961; Schulz S, 1989, AM J CLIN NUTR; SEALE JL, 1990, AM J CLIN NUTR, V52, P66, DOI 10.1093/ajcn/52.1.66; Snodgrass JJ, 2006, AM J CLIN NUTR, V84, P798, DOI 10.1093/ajcn/84.4.798; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; Stanhope KL, 2008, AM J CLIN NUTR, V88, p1733S, DOI 10.3945/ajcn.2008.25825D; STEIN TP, 1988, AM J CLIN NUTR, V47, P196, DOI 10.1093/ajcn/47.2.196; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; WELLE S, 1992, AM J CLIN NUTR, V55, P14, DOI 10.1093/ajcn/55.1.14; Westerterp KR, 2010, NUTR REV, V68, P148, DOI 10.1111/j.1753-4887.2010.00270.x; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2016, OB OV	51	188	187	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40503	10.1371/journal.pone.0040503	http://dx.doi.org/10.1371/journal.pone.0040503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848382	Green Published, gold			2022-12-27	WOS:000306806600018
J	Song, L; Qin, JG; Su, SQ; Xu, JH; Clarke, S; Shan, YC				Song, Liang; Qin, Jian G.; Su, Shengqi; Xu, Jianhe; Clarke, Stephen; Shan, Yichu			Micronutrient Requirements for Growth and Hydrocarbon Production in the Oil Producing Green Alga Botryococcus braunii (Chlorophyta)	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; STATISTICAL OPTIMIZATION; ENZYMATIC-HYDROLYSIS; EXPERIMENTAL-DESIGN; CULTURE-CONDITIONS; CARBON; NICKEL; ACCUMULATION; IRON; BIOMASS	The requirements of micronutrients for biomass and hydrocarbon production in Botryococcus braunii UTEX 572 were studied using response surface methodology. The concentrations of four micronutrients (iron, manganese, molybdenum, and nickel) were manipulated to achieve the best performance of B. braunii in laboratory conditions. The responses of algal biomass and hydrocarbon to the concentration variations of the four micronutrients were estimated by a second order quadratic regression model. Genetic algorithm calculations showed that the optimal level of micronutrients for algal biomass were 0.266 mu M iron, 0.707 mu M manganese, 0.624 mu M molybdenum and 3.38 mu M nickel. The maximum hydrocarbon content could be achieved when the culture media contained 10.43 mu M iron, 6.53 mu M manganese, 0.012 mu M molybdenum and 1.73 mu M nickel. The validation through an independent test in a photobioreactor suggests that the modified media with optimised concentrations of trace elements can increase algal biomass by 34.5% and hydrocarbon by 27.4%. This study indicates that micronutrients play significant roles in regulating algal growth and hydrocarbon production, and the response surface methodology can be used to optimise the composition of culture medium in algal culture.	[Song, Liang; Qin, Jian G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Su, Shengqi] Southwest Univ, Sch Anim Sci & Technol, Chongqing, Peoples R China; [Xu, Jianhe] Huaihai Inst Technol, Key Lab Marine Biotechnol Jiangsu Prov, Lianyungang, Peoples R China; [Clarke, Stephen] Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Adelaide, SA 5001, Australia; [Shan, Yichu] Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog Res & Anal Ctr, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China	Flinders University South Australia; Southwest University - China; Jiangsu Ocean University; Flinders University South Australia; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Song, L (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	jian.qin@flinders.edu.au	Clarke, Stephen R/B-3621-2013; shan, yichu/Q-9068-2017	Clarke, Stephen R/0000-0001-8164-6775; shan, yichu/0000-0002-5227-6864; Qin, Jianguang/0000-0003-2448-8058				Azma M, 2011, BIOCHEM ENG J, V53, P187, DOI 10.1016/j.bej.2010.10.010; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; BROWN AC, 1969, PHYTOCHEMISTRY, V8, P543, DOI 10.1016/S0031-9422(00)85397-2; Carvalho AP, 2006, ENZYME MICROB TECH, V38, P358, DOI 10.1016/j.enzmictec.2005.05.014; Castro IA, 2000, NUTR RES, V20, P1341, DOI 10.1016/S0271-5317(00)00209-8; Chernikova AA, 2006, RUSS J PLANT PHYSL+, V53, P800, DOI 10.1134/S1021443706060112; CHIRAC C, 1985, J PHYCOL, V21, P380; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; CLOEZ I, 1987, TOXICOLOGY, V46, P65, DOI 10.1016/0300-483X(87)90138-7; Cui FJ, 2006, BIORESOURCE TECHNOL, V97, P1209, DOI 10.1016/j.biortech.2005.05.005; Dayananda C, 2005, PROCESS BIOCHEM, V40, P3125, DOI 10.1016/j.procbio.2005.03.006; De Rijck G, 1998, SCI HORTIC-AMSTERDAM, V76, P149, DOI 10.1016/S0304-4238(98)00126-5; Ghadge SV, 2006, BIORESOURCE TECHNOL, V97, P379, DOI 10.1016/j.biortech.2005.03.014; Goldberg DavidE., 1989, GENETIC ALGORITHMS S, V1st; Gu XB, 2005, PROCESS BIOCHEM, V40, P3196, DOI 10.1016/j.procbio.2005.02.011; Herney-Ramirez J, 2008, IND ENG CHEM RES, V47, P284, DOI 10.1021/ie070990y; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; Isleten-Hosoglu M, 2012, BIOCHEM ENG J, V61, P11, DOI 10.1016/j.bej.2011.12.001; Jacob-Lopes E, 2008, BIOCHEM ENG J, V40, P27, DOI 10.1016/j.bej.2007.11.013; Jin X, 1996, MICROBIAL ECOL, V31, P103, DOI 10.1007/BF00175079; Kammoun R, 2008, BIORESOURCE TECHNOL, V99, P5602, DOI 10.1016/j.biortech.2007.10.045; Kaushik R, 2006, J MOL CATAL B-ENZYM, V40, P121, DOI 10.1016/j.molcatb.2006.02.019; KNIGHTS BA, 1970, PHYTOCHEMISTRY, V9, P1317, DOI 10.1016/S0031-9422(00)85325-X; Kunamneni A, 2005, BIOCHEM ENG J, V27, P179, DOI 10.1016/j.bej.2005.08.027; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; LEE YK, 1994, J PHYCOL, V30, P445, DOI 10.1111/j.0022-3646.1994.00445.x; Li Y, 2005, J APPL PHYCOL, V17, P551, DOI 10.1007/s10811-005-9005-7; Liu ZY, 2008, BIORESOURCE TECHNOL, V99, P4717, DOI 10.1016/j.biortech.2007.09.073; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Metzger P, 1999, CHEM MICROALGAE, P205; Mohammady Nagwa Gamal-Eldin, 2007, International Journal of Botany, V3, P64; Mojaat M, 2008, BIOCHEM ENG J, V39, P177, DOI 10.1016/j.bej.2007.09.009; Myers RH., 2016, RESPONSE SURFACE MET; Niedz RP, 2007, SCI HORTIC-AMSTERDAM, V112, P349, DOI 10.1016/j.scienta.2006.12.044; Nilsang S, 2005, J FOOD ENG, V70, P571, DOI 10.1016/j.jfoodeng.2004.10.011; OHMORI M, 1984, ARCH MICROBIOL, V140, P101, DOI 10.1007/BF00454910; Okada S, 2004, ARCH BIOCHEM BIOPHYS, V422, P110, DOI 10.1016/j.abb.2003.12.004; Oliveira R, 2006, IND ENG CHEM RES, V45, P1266, DOI 10.1021/ie0509544; Ozer EA, 2006, INT J FOOD SCI TECH, V41, P289, DOI 10.1111/j.1365-2621.2005.01062.x; Pan CM, 2008, BIORESOURCE TECHNOL, V99, P3146, DOI 10.1016/j.biortech.2007.05.055; Peers G, 2004, LIMNOL OCEANOGR, V49, P1774, DOI 10.4319/lo.2004.49.5.1774; PRICE NM, 1991, LIMNOL OCEANOGR, V36, P1071, DOI 10.4319/lo.1991.36.6.1071; PROVASOLI L, 1957, ARCH MIKROBIOL, V25, P392, DOI 10.1007/BF00446694; Qin JG, 2006, J FRESHWATER ECOL, V21, P169, DOI 10.1080/02705060.2006.9664110; Qin JG., 2010, HDB HYDROCARBON LIPI, P2817; Qin JG, 2005, DEVELOPMENT, V5, P1; Rao KJ, 2000, PROCESS BIOCHEM, V35, P639, DOI 10.1016/S0032-9592(99)00129-6; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Raven JA, 1990, NEW PHYTOL, P116; Ren J, 2008, BIORESOURCE TECHNOL, V99, P7923, DOI 10.1016/j.biortech.2008.03.027; Rousch JM, 1999, WATER RES, V33, P2448, DOI 10.1016/S0043-1354(98)00474-6; SHAY LK, 1987, J IND MICROBIOL, V2, P79, DOI 10.1007/BF01569506; Shieh CJ, 2000, J AGR FOOD CHEM, V48, P1124, DOI 10.1021/jf990460f; Sunda WG, 2004, LIMNOL OCEANOGR, V49, P1742, DOI 10.4319/lo.2004.49.5.1742; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; WAKE LV, 1980, BIOTECHNOL BIOENG, V22, P1637, DOI 10.1002/bit.260220808; Wake LV, 1991, AUST J MAR FRESHWATE, V32, P353; Wang JP, 2007, COLLOID SURFACE A, V302, P204, DOI 10.1016/j.colsurfa.2007.02.023; Wang Z, 2010, 4 INT C BIOINF BIOM, P1, DOI DOI 10.1109/ICBBE.2010.5518179; Wong JPK, 2000, BIORESOURCE TECHNOL, V73, P133, DOI 10.1016/S0960-8524(99)00175-3; Yang SL, 2004, BIOTECHNOL LETT, V26, P239, DOI 10.1023/B:BILE.0000013722.45527.18; Zheng ZM, 2008, BIORESOURCE TECHNOL, V99, P1052, DOI 10.1016/j.biortech.2007.02.038	63	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41459	10.1371/journal.pone.0041459	http://dx.doi.org/10.1371/journal.pone.0041459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848502	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600069
J	Thangapandian, S; John, S; Lazar, P; Choi, S; Lee, KW				Thangapandian, Sundarapandian; John, Shalini; Lazar, Prettina; Choi, Sun; Lee, Keun Woo			Structural Origins for the Loss of Catalytic Activities of Bifunctional Human LTA4H Revealed through Molecular Dynamics Simulations	PLOS ONE			English	Article							LEUKOTRIENE A(4) HYDROLASE; FREQUENCY VIBRATIONS PHONONS; 5-LIPOXYGENASE-ACTIVATING PROTEIN; BIOLOGICAL FUNCTIONS; COLLECTIVE MOTION; AMINOPEPTIDASE; INHIBITORS; MECHANISM; BINDING; ACID	Human leukotriene A4 hydrolase (hLTA4H), which is the final and rate-limiting enzyme of arachidonic acid pathway, converts the unstable epoxide LTA4 to a proinflammatory lipid mediator LTB4 through its hydrolase function. The LTA4H is a bi-functional enzyme that also exhibits aminopeptidase activity with a preference over arginyl tripeptides. Various mutations including E271Q, R563A, and K565A have completely or partially abolished both the functions of this enzyme. The crystal structures with these mutations have not shown any structural changes to address the loss of functions. Molecular dynamics simulations of LTA4 and tripeptide complex structures with functional mutations were performed to investigate the structural and conformation changes that scripts the observed differences in catalytic functions. The observed protein-ligand hydrogen bonds and distances between the important catalytic components have correlated well with the experimental results. This study also confirms based on the structural observation that E271 is very important for both the functions as it holds the catalytic metal ion at its location for the catalysis and it also acts as N-terminal recognition residue during peptide binding. The comparison of binding modes of substrates revealed the structural changes explaining the importance of R563 and K565 residues and the required alignment of substrate at the active site. The results of this study provide valuable information to be utilized in designing potent hLTA4H inhibitors as anti-inflammatory agents.	[Thangapandian, Sundarapandian; John, Shalini; Lazar, Prettina; Lee, Keun Woo] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Syst & Synthet Agrobiotech Ctr, Div Appl Life Sci,Program BK21,Res Inst Nat Sci, Jinju, South Korea; [Thangapandian, Sundarapandian; Choi, Sun] Ewha Womans Univ, Div Life & Pharmaceut Sci, Coll Pharm, Seoul, South Korea; [Thangapandian, Sundarapandian; Choi, Sun] Ewha Womans Univ, Natl Core Res Ctr Cell Signaling & Drug Discovery, Seoul, South Korea	Gyeongsang National University; Ewha Womans University; Ewha Womans University	Thangapandian, S (corresponding author), Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Syst & Synthet Agrobiotech Ctr, Div Appl Life Sci,Program BK21,Res Inst Nat Sci, Jinju, South Korea.	kwlee@gnu.ac.kr	Choi, Sun/AAQ-9407-2020	Choi, Sun/0000-0002-7669-7954	National Research Foundation of Korea (NRF) [2009-0073267, 2009-0081539, 2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Rural Development Administration (RDA) [PJ008038]; National Leading Research Lab (NLRL) program of Republic of Korea [2011-0028885]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); National Leading Research Lab (NLRL) program of Republic of Korea	This research was supported by Basic Science Research Program (2009-0073267), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) and a grant from National Leading Research Lab (NLRL) program (2011-0028885) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Barnes PJ, 2002, NAT REV DRUG DISCOV, V1, P437, DOI 10.1038/nrd820; BLOMSTER M, 1995, EUR J BIOCHEM, V231, P528, DOI 10.1111/j.1432-1033.1995.tb20728.x; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Cheng F, 2008, PROTEINS, V70, P1228, DOI 10.1002/prot.21615; CHOU KC, 1984, BIOPHYS CHEM, V20, P61, DOI 10.1016/0301-4622(84)80005-8; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; CHOU KC, 1987, BIOPOLYMERS, V26, P285, DOI 10.1002/bip.360260209; CHOU KC, 1989, TRENDS BIOCHEM SCI, V14, P212, DOI 10.1016/0968-0004(89)90026-1; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 1999, BIOCHEM BIOPH RES CO, V259, P420, DOI 10.1006/bbrc.1999.0792; CHOU KC, 1988, BIOPOLYMERS, V27, P1795, DOI 10.1002/bip.360271109; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1984, BIOPHYS J, V45, P881, DOI 10.1016/S0006-3495(84)84234-4; CHOU KC, 1994, BIOPOLYMERS, V34, P143, DOI 10.1002/bip.360340114; Davies DR, 2009, J MED CHEM, V52, P4694, DOI 10.1021/jm900259h; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Drazen JM, 1997, PHARMACOTHERAPY, V17, pS22; Du QS, 2007, MED CHEM, V3, P1, DOI 10.2174/157340607779317616; Gompertz S, 2002, CHEST, V122, P289, DOI 10.1378/chest.122.1.289; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; HAEGGSTROM JZ, 1990, BIOCHEM BIOPH RES CO, V172, P965, DOI 10.1016/0006-291X(90)91540-9; Haeggstrom JZ, 2002, PROSTAG OTH LIPID M, V68-9, P495, DOI 10.1016/S0090-6980(02)00051-5; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; HENDERSON WR, 1994, ANN INTERN MED, V121, P684, DOI 10.7326/0003-4819-121-9-199411010-00010; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Housaindokht MR, 2008, J THEOR BIOL, V254, P294, DOI 10.1016/j.jtbi.2008.04.036; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Iversen L, 1997, SKIN PHARMACOL, V10, P169, DOI 10.1159/000211501; Jiang XL, 2010, CHEMBIOCHEM, V11, P1120, DOI 10.1002/cbic.200900788; KENNEDY BP, 1991, J BIOL CHEM, V266, P8511; Kirkland TA, 2008, BIOORGAN MED CHEM, V16, P4963, DOI 10.1016/j.bmc.2008.03.042; MALFROY B, 1989, BIOCHEM BIOPH RES CO, V161, P236, DOI 10.1016/0006-291X(89)91586-6; MANCINI JA, 1993, FEBS LETT, V318, P277, DOI 10.1016/0014-5793(93)80528-3; MAYCOCK AL, 1982, J BIOL CHEM, V257, P3911; MINAMI M, 1990, BIOCHEM BIOPH RES CO, V173, P620, DOI 10.1016/S0006-291X(05)80080-4; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; MUELLER MJ, 1995, P NATL ACAD SCI USA, V92, P8383, DOI 10.1073/pnas.92.18.8383; ORNING L, 1994, J BIOL CHEM, V269, P11269; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Rao NL, 2007, J PHARMACOL EXP THER, V321, P1154, DOI 10.1124/jpet.106.115436; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; ROUZER CA, 1986, P NATL ACAD SCI USA, V83, P857, DOI 10.1073/pnas.83.4.857; Rudberg PC, 2004, J BIOL CHEM, V279, P27376, DOI 10.1074/jbc.M401031200; Rudberg PC, 2002, P NATL ACAD SCI USA, V99, P4215, DOI 10.1073/pnas.072090099; Rudberg PC, 2002, J BIOL CHEM, V277, P1398, DOI 10.1074/jbc.M106577200; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sandanayaka V, 2010, J MED CHEM, V53, P573, DOI 10.1021/jm900838g; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; SHIMIZU T, 1986, P NATL ACAD SCI USA, V83, P4175, DOI 10.1073/pnas.83.12.4175; Steele VE, 1999, CANCER EPIDEM BIOMAR, V8, P467; Thangapandian S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034593; Thangapandian S, 2011, EUR J MED CHEM, V46, P1593, DOI 10.1016/j.ejmech.2011.02.007; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Thunnissen MMGM, 2002, FASEB J, V16, P1648, DOI 10.1096/fj.01-1017fje; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tsuji F, 1998, LIFE SCI, V64, pPL51, DOI 10.1016/S0024-3205(98)00556-6; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang SQ, 2007, BIOCHEM BIOPH RES CO, V354, P634, DOI 10.1016/j.bbrc.2006.12.235; WETTERHOLM A, 1992, P NATL ACAD SCI USA, V89, P9141, DOI 10.1073/pnas.89.19.9141; Zhang JW, 2002, PROTEINS, V48, P447, DOI 10.1002/prot.10173	67	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41063	10.1371/journal.pone.0041063	http://dx.doi.org/10.1371/journal.pone.0041063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848428	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600036
J	Boyer, P; Lienard, P; Xu, J				Boyer, Pascal; Lienard, Pierre; Xu, Jing			Cultural Differences in Investing in Others and in the Future: Why Measuring Trust Is Not Enough	PLOS ONE			English	Article								Standard measures of generalized trust in others are often taken to provide reliable indicators of economic attitudes in different countries. Here we compared three highly distinct groups, in Kenya, China and the US, in terms of more specific attitudes, [a] people's willingness to invest in the future, [b] their willingness to invest in others, and [c] their trust in institutions. Results suggest that these measures capture deep differences in economic attitudes that are not detected by standard measures of generalized trust.	[Boyer, Pascal] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Boyer, Pascal; Xu, Jing] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Lienard, Pierre] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA	Washington University (WUSTL); Washington University (WUSTL); Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Boyer, P (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	pboyer@artsci.wustl.edu			Air Force Office of Scientific Research [FA9550-10-1-0443]; UNLV; Centre for New Institutional Social Science, Washington University in St. Louis	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); UNLV; Centre for New Institutional Social Science, Washington University in St. Louis	Research reported here was partly funded by an Air Force Office of Scientific Research grant to PB and PL (FA9550-10-1-0443) and by UNLV internal funding to PL. JX's research was supported by a grant from the Centre for New Institutional Social Science, Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornskov C, 2007, PUBLIC CHOICE, V130, P1, DOI 10.1007/s11127-006-9069-1; Cook Karen S, 2005, COOPERATION TRUST, P52; CSUKAS CSONGOR, 2008, Journal of Economic Development, V33, P71; Delhey J, 2011, AM SOCIOL REV, V76, P786, DOI 10.1177/0003122411420817; Du WJ, 2002, PSYCHOL REC, V52, P479, DOI 10.1007/BF03395199; Ensminger J., 1992, MAKING MARKET I TRAN; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Igarashi T, 2008, ASIAN J SOC PSYCHOL, V11, P88, DOI 10.1111/j.1467-839X.2007.00246.x; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Kipnis Andrew B., 1997, PRODUCING GUANXI SEN; Legatum Institute, 2009, 2009 LEG PROPS IND I; Lienard P, 2003, THESIS U LIBRE BRUXE; Liou FM, 2007, INT J DEV ISSUES, V6, P63; McCabe JT, 2008, CATTLE BRING US OUR; North D. C., 1990, I I CHANGE EC PERFOR; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Oxfeld Ellen, 2010, DRINK WATER REMEMBER; Putnam R.D., 2002, DEMOCRACIES FLUX EVO; Rachlin H, 2008, J BEHAV DECIS MAKING, V21, P29, DOI 10.1002/bdm.567; Rothstein B., 1998, JUST I MATTER MORAL; Wang M, 2010, TIME PREFERENCES DIF; World Values Survey Association, 2011, WORLD VAL SURV 5 WAV; World Values Survey Association, 2011, VAL CULT CHANG SOC A; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397	25	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40750	10.1371/journal.pone.0040750	http://dx.doi.org/10.1371/journal.pone.0040750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22848399	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300013
J	Kopfer, DA; Hahn, U; Ohmert, I; Vriend, G; Pongs, O; de Groot, BL; Zachariae, U				Koepfer, David A.; Hahn, Ulrike; Ohmert, Iris; Vriend, Gert; Pongs, Olaf; de Groot, Bert L.; Zachariae, Ulrich			A Molecular Switch Driving Inactivation in the Cardiac K+ Channel hERG	PLOS ONE			English	Article							LONG-QT-SYNDROME; C-TYPE INACTIVATION; GENE POTASSIUM CHANNEL; SELECTIVITY FILTER; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; DYNAMICS SIMULATIONS; VOLTAGE-DEPENDENCE; XENOPUS-OOCYTES; PORE REGION	K+ channels control transmembrane action potentials by gating open or closed in response to external stimuli. Inactivation gating, involving a conformational change at the K+ selectivity filter, has recently been recognized as a major K+ channel regulatory mechanism. In the K+ channel hERG, inactivation controls the length of the human cardiac action potential. Mutations impairing hERG inactivation cause life-threatening cardiac arrhythmia, which also occur as undesired side effects of drugs. In this paper, we report atomistic molecular dynamics simulations, complemented by mutational and electrophysiological studies, which suggest that the selectivity filter adopts a collapsed conformation in the inactivated state of hERG. The selectivity filter is gated by an intricate hydrogen bond network around residues S620 and N629. Mutations of this hydrogen bond network are shown to cause inactivation deficiency in electrophysiological measurements. In addition, drug-related conformational changes around the central cavity and pore helix provide a functional mechanism for newly discovered hERG activators.	[Koepfer, David A.; de Groot, Bert L.; Zachariae, Ulrich] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, Gottingen, Germany; [Hahn, Ulrike; Ohmert, Iris; Pongs, Olaf] Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany; [Vriend, Gert; Zachariae, Ulrich] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Zachariae, Ulrich] Univ Edinburgh, Sch Phys & Astron, Scottish Univ Phys Alliance, Edinburgh, Midlothian, Scotland	Max Planck Society; University of Hamburg; Radboud University Nijmegen; University of Edinburgh	Kopfer, DA (corresponding author), Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, Gottingen, Germany.	uzachari@ph.ed.ac.uk	Vriend, G./H-8112-2014	Zachariae, Ulrich/0000-0003-3287-8494	Dutch TI Pharma project [D2-101]; Deutsche Forschungsgemeinschaft [Po137/39-1]	Dutch TI Pharma project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partially funded by the Dutch TI Pharma project D2-101 (GV, BLdG, UZ; URL: www.ti-pharma.nl) and a grant of the Deutsche Forschungsgemeinschaft to OP (Po137/39-1; URL: www.dfg.de). No additional external funding has been received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader C, 2008, NAT STRUCT MOL BIOL, V15, P605, DOI 10.1038/nsmb.1430; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Bian JS, 2004, CELL BIOCHEM BIOPHYS, V41, P25, DOI 10.1385/CBB:41:1:025; Boukharta L, 2011, BIOCHEMISTRY-US, V50, P6146, DOI 10.1021/bi200173n; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cheng WWL, 2011, P NATL ACAD SCI USA, V108, P5272, DOI 10.1073/pnas.1014186108; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cordeiro JM, 2005, CARDIOVASC RES, V67, P498, DOI 10.1016/j.cardiores.2005.02.018; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durdagi S, 2010, CURR MED CHEM, V17, P3514, DOI 10.2174/092986710792927886; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Garg V, 2011, MOL PHARMACOL, V80, P630, DOI 10.1124/mol.111.073809; Gerlach AC, 2010, MOL PHARMACOL, V77, P58, DOI 10.1124/mol.109.059543; Gomez-Varela D, 2006, FEBS LETT, V580, P5059, DOI 10.1016/j.febslet.2006.08.030; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Lees-Miller JP, 2000, CIRC RES, V86, P507, DOI 10.1161/01.RES.86.5.507; Lemmen C., 2010, FLEXX; Liu J, 2002, J GEN PHYSIOL, V120, P723, DOI 10.1085/jgp.20028687; Mitcheson JS, 2008, CHEM RES TOXICOL, V21, P1005, DOI 10.1021/tx800035b; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Perry M, 2009, P NATL ACAD SCI USA, V106, P20075, DOI 10.1073/pnas.0906597106; Sackin H, 2009, BIOPHYS J, V97, P1058, DOI 10.1016/j.bpj.2009.05.056; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Stary A, 2010, CHEMMEDCHEM, V5, P455, DOI 10.1002/cmdc.200900461; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Torres AM, 2003, J BIOL CHEM, V278, P42136, DOI 10.1074/jbc.M212824200; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Wang HZ, 2002, CANCER RES, V62, P4843; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Witchel HJ, 2007, EXPERT OPIN THER TAR, V11, P321, DOI 10.1517/14728222.11.3.321; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Zachariae U, 2008, STRUCTURE, V16, P747, DOI 10.1016/j.str.2008.01.018; Zachariae U, 2009, J MED CHEM, V52, P4266, DOI 10.1021/jm900002x; Zhang ST, 2003, J PHYSIOL-LONDON, V548, P691, DOI 10.1113/jphysiol.2003.039198; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x	59	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41023	10.1371/journal.pone.0041023	http://dx.doi.org/10.1371/journal.pone.0041023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848423	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300021
J	Zhu, WY; Ventevogel, MS; Knilans, KJ; Anderson, JE; Oldach, LM; McKinnon, KP; Hobbs, MM; Sempowski, GD; Duncan, JA				Zhu, Weiyan; Ventevogel, Melissa S.; Knilans, Kayla J.; Anderson, James E.; Oldach, Laurel M.; McKinnon, Karen P.; Hobbs, Marcia M.; Sempowski, Gregory D.; Duncan, Joseph A.			Neisseria gonorrhoeae Suppresses Dendritic Cell-Induced, Antigen-Dependent CD4 T Cell Proliferation	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; OPACITY PROTEINS; GENITAL-TRACT; RESPONSES; ACTIVATION; RESISTANCE; CHLAMYDIA; PROMOTES; BETA; INTERLEUKIN-10	Neisseria gonorrhoeae is the second most common sexually transmitted bacterial pathogen worldwide. Diseases associated with N. gonorrhoeae cause localized inflammation of the urethra and cervix. Despite this inflammatory response, infected individuals do not develop protective adaptive immune responses to N. gonorrhoeae. N. gonorrhoeae is a highly adapted pathogen that has acquired multiple mechanisms to evade its host's immune system, including the ability to manipulate multiple immune signaling pathways. N. gonorrhoeae has previously been shown to engage immunosuppressive signaling pathways in B and T lymphocytes. We have now found that N. gonorrhoeae also suppresses adaptive immune responses through effects on antigen presenting cells. Using primary, murine bone marrow-derived dendritic cells and lymphocytes, we show that N. gonorrhoeae-exposed dendritic cells fail to elicit antigen-induced CD4+ T lymphocyte proliferation. N. gonorrhoeae exposure leads to upregulation of a number of secreted and dendritic cell surface proteins with immunosuppressive properties, particularly Interleukin 10 (IL-10) and Programmed Death Ligand 1 (PD-L1). We also show that N. gonorrhoeae is able to inhibit dendritic cell-induced proliferation of human T-cells and that human dendritic cells upregulate similar immunosuppressive molecules. Our data suggest that, in addition to being able to directly influence host lymphocytes, N. gonorrhoeae also suppresses development of adaptive immune responses through interactions with host antigen presenting cells. These findings suggest that gonococcal factors involved in host immune suppression may be useful targets in developing vaccines that induce protective adaptive immune responses to this pathogen.	[Zhu, Weiyan; Anderson, James E.; Oldach, Laurel M.; Hobbs, Marcia M.; Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA; [Ventevogel, Melissa S.; Sempowski, Gregory D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Ventevogel, Melissa S.; Sempowski, Gregory D.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA; [Knilans, Kayla J.; McKinnon, Karen P.; Hobbs, Marcia M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [McKinnon, Karen P.; Duncan, Joseph A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhu, WY (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA.	jaduncan@med.unc.edu		Sempowski, Gregory/0000-0003-0391-6594; Oldach, Laurel/0000-0003-1491-608X	Burroughs Wellcome Fund Career Awards for Medical Scientists; NIH [U19-AI031496, UC6-AI058607]; UNC STD; HIV Training Program [T32-AI007001]; American Society for Pharmacology and Experimental Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001, UC6AI058607, U19AI031496] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Awards for Medical Scientists; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC STD; HIV Training Program; American Society for Pharmacology and Experimental Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work reported in this publication was supported by the Burroughs Wellcome Fund Career Awards for Medical Scientists awarded to J.A.D. and the following NIH grants and contracts: U19-AI031496 (Southeastern Sexually Transmitted Infection Cooperative Research Center) to J.A.D., M. M. H., and G. D. S. and UC6-AI058607 (Regional Biocontainment Laboratory at Duke University Medical Center) awarded to G. D. S et al. K.J.K. is an awardee of the UNC STD and HIV Training Program (T32-AI007001). L.M.O. received support from the American Society for Pharmacology and Experimental Therapeutics through a grant to the Carolina Summer Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright CA, 2009, IMMUNOL LETT, V123, P77, DOI 10.1016/j.imlet.2009.02.010; Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bellinghausen I, 2006, CLIN EXP ALLERGY, V36, P1546, DOI 10.1111/j.1365-2222.2006.02601.x; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Cohen CR, 1999, AIDS, V13, P327, DOI 10.1097/00002030-199902250-00004; COHEN IR, 1967, J BACTERIOL, V94, P141, DOI 10.1128/JB.94.1.141-148.1967; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cole JG, 2010, INFECT IMMUN, V78, P1629, DOI 10.1128/IAI.00996-09; COOKSON BT, 1989, BIOCHEMISTRY-US, V28, P1744, DOI 10.1021/bi00430a048; Criss AK, 2009, CELL MICROBIOL, V11, P1074, DOI 10.1111/j.1462-5822.2009.01308.x; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Feinen B, 2010, MUCOSAL IMMUNOL, V3, P312, DOI 10.1038/mi.2009.139; Fields RC, 1998, J IMMUNOTHER, V21, P323, DOI 10.1097/00002371-199809000-00001; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Gagliardi MC, 2011, FEMS IMMUNOL MED MIC, V61, P129, DOI 10.1111/j.1574-695X.2010.00759.x; Geisler WM, 2008, SEX TRANSM DIS, V35, P656, DOI 10.1097/OLQ.0b013e31816b6593; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Goldman W E, 1985, Dev Biol Stand, V61, P103; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Hewitt RE, 2012, CLIN IMMUNOLOGY; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Jounai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032588; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Liu YR, 2011, MBIO, V2, DOI 10.1128/mBio.00095-11; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; MONDINO A, 1994, J LEUKOCYTE BIOL, V55, P805, DOI 10.1002/jlb.55.6.805; Morel C, 2008, EUR J IMMUNOL, V38, P437, DOI 10.1002/eji.200737905; Ohman H, 2009, J INFECT DIS, V199, P1353, DOI 10.1086/597620; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Peng B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-347; Plant LJ, 2006, INFECT IMMUN, V74, P442, DOI 10.1128/IAI.74.1.442-448.2006; Pridmore AC, 2003, INFECT IMMUN, V71, P3901, DOI 10.1128/IAI.71.7.3901-3908.2003; Serre K, 2008, MOL IMMUNOL, V45, P3558, DOI 10.1016/j.molimm.2008.05.010; SINHA RK, 1980, INFECT IMMUN, V29, P914; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Svensson M, 2000, INFECT IMMUN, V68, P6311, DOI 10.1128/IAI.68.11.6311-6320.2000; TAPCHAISRI P, 1976, BRIT J VENER DIS, V52, P374; Tapsall JW, 2005, CLIN INFECT DIS, V41, pS263, DOI 10.1086/430787; van Vliet SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000625; Vlad G, 2010, INT REV IMMUNOL, V29, P119, DOI 10.3109/08830180903281185; Wan YY, 2008, J CLIN IMMUNOL, V28, P647, DOI 10.1007/s10875-008-9251-y; WITT K, 1976, J MED MICROBIOL, V9, P1, DOI 10.1099/00222615-9-1-1; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103	60	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41260	10.1371/journal.pone.0041260	http://dx.doi.org/10.1371/journal.pone.0041260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844448	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700061
J	Le, XF; Almeida, MI; Mao, WQ; Spizzo, R; Rossi, S; Nicoloso, MS; Zhang, S; Wu, Y; Calin, GA; Bast, RC				Le, Xiao-Feng; Almeida, Maria I.; Mao, Weiqun; Spizzo, Riccardo; Rossi, Simona; Nicoloso, Milena S.; Zhang, Shu; Wu, Yun; Calin, George A.; Bast, Robert C., Jr.			Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer	PLOS ONE			English	Article							KINASE INHIBITOR P27(KIP1); MONOCLONAL-ANTIBODY; ANTI-HER2 ANTIBODY; GROWTH-INHIBITION; CYCLE ARREST; HERCEPTIN; HER2; EXPRESSION; TALIN; THERAPY	Trastuzumab, a humanized monoclonal antibody directed against the extracellular domain of the HER2 oncoprotein, can effectively target HER2-positive breast cancer through several mechanisms. Although the effects of trastuzumab on cancer cell proliferation, angiogenesis and apoptosis have been investigated in depth, the effect of trastuzumab on microRNA (miRNA) has not been extensively studied. We have performed miRNA microarray profiling before and after trastuzumab treatment in SKBr3 and BT474 human breast cancer cells that overexpress HER2. We found that trastuzumab treatment of SKBr3 cells significantly decreased five miRNAs and increased three others, whereas treatment of BT474 cells significantly decreased two miRNAs and increased nine. The only change in miRNA expression observed in both cell lines following trastuzumab treatment was upregulation of miRNA-194 (miR-194) that was further validated in vitro and in vivo. Forced expression of miR-194 in breast cancer cells that overexpress HER2 produced no effect on apoptosis, modest inhibition of proliferation, significant inhibition of cell migration/invasion in vitro and significant inhibition of xenograft growth in vivo. Conversely, knockdown of miR-194 promoted cell migration. Increased miR-194 expression markedly reduced levels of the cytoskeletal protein talin2 and specifically inhibited luciferase reporter activity of a talin2 wild-type 39-untranslated region, but not that of a mutant reporter, indicating that talin2 is a direct downstream target of miR-194. Trastuzumab treatment inhibited breast cancer cell migration and reduced talin2 expression in vitro and in vivo. Knockdown of talin2 inhibited cell migration/invasion. Knockdown of trastuzumab-induced miR-194 expression with a miR-194 inhibitor compromised trastuzumab-inhibited cell migration in HER2-overexpressing breast cancer cells. Consequently, trastuzumab treatment upregulates miR-194 expression and may exert its cell migration-inhibitory effect through miR-194-mediated downregulation of cytoskeleton protein talin2 in HER2-overexpressing human breast cancer cells.	[Le, Xiao-Feng; Almeida, Maria I.; Mao, Weiqun; Spizzo, Riccardo; Rossi, Simona; Nicoloso, Milena S.; Zhang, Shu; Calin, George A.; Bast, Robert C., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Almeida, Maria I.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Universidade do Minho; University of Texas System; UTMD Anderson Cancer Center	Le, XF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	xfle@mdanderson.org; rbast@mdanderson.org	Almeida, Maria Ines/AAP-3249-2021; Calin, George/E-9390-2011; Almeida, Maria Ines/N-3196-2013; Nicoloso, Milena S/K-6411-2012; Bast, Robert C/E-6585-2011; Spizzo, Riccardo/V-1057-2019; Zhang, Shuxing/F-9942-2014; Almeida, Maria Ines/AAP-2376-2021	Almeida, Maria Ines/0000-0003-2072-8587; Nicoloso, Milena S/0000-0003-4231-9303; Bast, Robert C/0000-0003-4621-8462; Spizzo, Riccardo/0000-0001-7772-0960; Almeida, Maria Ines/0000-0003-2072-8587; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578; Zhang, Shu/0000-0003-0928-6503	Anne and Henry Zarrow Foundation; Laura and John Arnold Foundation; RGK Foundation; MD Anderson NCI CCSG [P30 CA16672]; CLL Global Research Foundation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Anne and Henry Zarrow Foundation; Laura and John Arnold Foundation; RGK Foundation; MD Anderson NCI CCSG; CLL Global Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Anne and Henry Zarrow Foundation, kind gifts from Stuart and Gaye Lynn Zarrow and from Mrs. Delores Wilkenfeld, the Laura and John Arnold Foundation, the RGK Foundation, and the MD Anderson NCI CCSG P30 CA16672. G.A.C. is supported as a Fellow at the University of Texas MD Anderson Research Trust, as a University of Texas System Regents Research Scholar and by the CLL Global Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arnould L, 2006, BRIT J CANCER, V94, P259, DOI 10.1038/sj.bjc.6602930; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Baselga J, 2001, ANN ONCOL, V12, P35, DOI 10.1023/A:1011163824080; Beano A, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-25; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; BURRIDGE K, 1983, CELL MOTIL CYTOSKEL, V3, P405, DOI 10.1002/cm.970030509; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Burstein HJ, 2001, J CLIN ONCOL, V19, P2722, DOI 10.1200/JCO.2001.19.10.2722; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; CARDOSO F, 2002, CLIN BREAST CANCER, V3, P258; Cardoso Fatima, 2002, Clin Breast Cancer, V3, P247, DOI 10.3816/CBC.2002.n.028; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Franco-Cea A, 2010, DEV BIOL, V345, P64, DOI 10.1016/j.ydbio.2010.06.027; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Guler M, 2009, AM J OPHTHALMOL, V147, P703, DOI 10.1016/j.ajo.2008.09.022; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hino Kimihiro, 2007, Nucleic Acids Symp Ser (Oxf), P415, DOI 10.1093/nass/nrm208; Hortobagyi GN, 2001, SEMIN ONCOL, V28, P41, DOI 10.1053/sonc.2001.28549; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734; Kono K, 2002, CANCER RES, V62, P5813; Kos KS, 2003, CANCER-AM CANCER SOC, V98, P1377, DOI 10.1002/cncr.11656; Koukourakis MI, 2003, ANTICANCER RES, V23, P1673; Lane HA, 2001, ANN ONCOL, V12, P21, DOI 10.1023/A:1011155606333; Le XF, 2005, CELL CYCLE, V4, P87, DOI 10.4161/cc.4.1.1360; Le XF, 2005, J BIOL CHEM, V280, P2092, DOI 10.1074/jbc.M403080200; Le XF, 2003, J BIOL CHEM, V278, P23441, DOI 10.1074/jbc.M300848200; Le XF, 2000, CLIN CANCER RES, V6, P260; Le XF, 2000, CANCER RES, V60, P3522; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Le XF, 2006, CELL CYCLE, V5, P1654, DOI 10.4161/cc.5.15.3007; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Le XF, 2010, CANCER-AM CANCER SOC, V116, P4980, DOI 10.1002/cncr.25426; Le XF, 2008, CELL CYCLE, V7, P3747, DOI 10.4161/cc.7.23.7212; Lee S, 2002, CANCER RES, V62, P5703; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Mohsin SK, 2005, J CLIN ONCOL, V23, P2460, DOI 10.1200/JCO.2005.00.661; Molina MA, 2001, CANCER RES, V61, P4744; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Monkley SJ, 2011, DEV BIOL, V349, P494, DOI 10.1016/j.ydbio.2010.11.010; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pegram MD, 1999, SEMIN ONCOL, V26, P89; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Rukov JL, 2011, TRENDS MOL MED, V17, P412, DOI 10.1016/j.molmed.2011.04.003; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sansing HA, 2011, BIOCHEM BIOPH RES CO, V406, P171, DOI 10.1016/j.bbrc.2011.01.109; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Song Y, 2011, ANN SURG ONCOL; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wen XF, 2006, ONCOGENE, V25, P6986, DOI 10.1038/sj.onc.1209685; Yakes FM, 2002, CANCER RES, V62, P4132; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	70	56	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41170	10.1371/journal.pone.0041170	http://dx.doi.org/10.1371/journal.pone.0041170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829924	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300063
J	Ren, Y; Liu, ZZ; Feng, J; Wan, H; Li, JH; Wang, H; Lin, X				Ren, Yuan; Liu, Zhi-zhong; Feng, Jie; Wan, Hong; Li, Jun-hua; Wang, Hao; Lin, Xin			Association of a BMP9 Haplotype with Ossification of the Posterior Longitudinal Ligament (OPLL) in a Chinese Population	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; BODY-MASS INDEX; CERVICAL-SPINE; GENE-THERAPY; POLYMORPHISMS; RISK; SUSCEPTIBILITY; JAPAN	Direct or ex vivo BMP9 adenoviral gene therapy can induce massive bone formation at the injection sites and clearly promote spinal fusion. A comprehensive analysis of the osteogenic activity indicated that BMP9 was one of the most potent inducers of osteogenic differentiation both in vitro and in vivo among 14 types of human BMPs. However, genetic variations and whether they correlated with OPLL were not considered. We have sequenced the complete BMP9 gene in 450 patients with OPLL and in 550 matched controls. Analyses were performed on single markers and haplotypes. Single marker tests identified 6 SNPs, among which the minor alleles of rs7923671 (T > C; P = 0.0026; OR: 1.33, CI: 1.10-1.60), rs75024165 (C > T, Thr304Met; P < 0.001; OR: 1.76, CI: 1.47-2.12) and rs34379100 (A > C; P < 0.001; OR: 1.52, CI: 1.27-1.82) were associated with OPLL. Logistic regression analysis showed that the additive model of rs75024165 (TT vs. CT vs. CC; P < 0.001; OR: 1.74) and rs34379100 (CC vs. AC vs. AA; P = 0.003; OR: 1.95) retained statistical significance when adjusted for clinical and demographic characteristics. Linkage disequilibrium (LD) analysis identified one 3 kb block of intense LD in BMP9 and one specific haplotype, CTCA (P < 0.001; OR: 2.37), that contained the OPLL-associated risk alleles and was a risk factor for OPLL. This haplotype is associated with increased severity of OPLL, as shown by the distribution of ossified vertebrae in patients with OPLL (P = 0.001). In summary, in the Chinese population studied, SNPs in the BMP9 gene appear to contribute to the risk of OPLL in association with certain clinical and demographic characteristics. The severity of OPLL seems to be mediated predominantly by genetic variations in a 3kb BMP9 locus with the specific haplotype CTCA.	[Ren, Yuan; Wang, Hao; Lin, Xin] Capital Med Univ, Dept Orthopaed, Beijing Tiantan Hosp, Beijing, Peoples R China; [Liu, Zhi-zhong] Capital Med Univ, Dept Clin Lab, Beijing Tiantan Hosp, Beijing, Peoples R China; [Feng, Jie; Wan, Hong; Li, Jun-hua] Capital Med Univ, Dept Inst Neurosurg, Beijing Tiantan Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Ren, Y (corresponding author), Capital Med Univ, Dept Orthopaed, Beijing Tiantan Hosp, Beijing, Peoples R China.	Spine001@hotmail.com		Ren, Yuan/0000-0001-5857-9535	National Natural Science Foundation of China [30872599]; Beijing Natural Science Foundation of China [7092028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This research was supported by grants from the National Natural Science Foundation of China (No. 30872599) and the Beijing Natural Science Foundation of China (No. 7092028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaal MM, 2004, J CRANIOFAC SURG, V15, P736, DOI 10.1097/00001665-200409000-00007; Alden TD, 2000, J CRANIOFAC SURG, V11, P24, DOI 10.1097/00001665-200011010-00005; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Dumont RJ, 2002, NEUROSURGERY, V51, P1239, DOI 10.1097/00006123-200211000-00020; Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191; Inamasu J, 2006, NEUROSURGERY, V58, P1027, DOI 10.1227/01.NEU.0000215867.87770.73; Jiang Biao, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P723; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kawaguchi Y, 2003, SPINE, V28, P1424, DOI 10.1097/00007632-200307010-00013; Kim TJ, 2008, JOINT BONE SPINE, V75, P471, DOI 10.1016/j.jbspin.2007.07.019; Kimelman-Bleich N, 2011, MOL THER, V19, P53, DOI 10.1038/mt.2010.190; Kobashi G, 2004, SPINE, V29, P1006, DOI 10.1097/00007632-200405010-00011; Kong QQ, 2007, SPINE, V32, P2834, DOI 10.1097/BRS.0b013e31815b761c; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Li Z, 1999, CHIN J SPINE SPINAL, V9, P285; Liu K C, 1990, Nihon Seikeigeka Gakkai Zasshi, V64, P401; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Matsunaga S, 1999, SPINE, V24, P937, DOI 10.1097/00007632-199905150-00002; Matsunaga Shunji, 2009, Clin Calcium, V19, P1415, DOI CliCa091014151420; Meng XL, 2010, CHINESE MED J-PEKING, V123, P2537, DOI 10.3760/cma.j.issn.0366-6999.2010.18.008; Nakamura I, 1999, HUM GENET, V104, P492, DOI 10.1007/s004390050993; Okamoto K, 2004, J BONE MINER METAB, V22, P612, DOI 10.1007/s00774-004-0531-1; OSTE C, 1988, BIOTECHNIQUES, V6, P162; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; SAKOU T, 1991, SPINE, V16, P1249, DOI 10.1097/00007632-199111000-00001; Sakou T, 2000, J Orthop Sci, V5, P310, DOI 10.1007/s007760050169; Schmidt MH, 2002, SEMIN NEUROL, V22, P143, DOI 10.1055/s-2002-36537; Shingyouchi Y, 1996, SPINE, V21, P2474, DOI 10.1097/00007632-199611010-00013; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Tahara M, 2005, SPINE, V30, P877, DOI 10.1097/01.brs.0000160686.18321.ad; TAKETOMI E, 1992, SPINE, V17, pS55; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; Wang H, 2008, EUR SPINE J, V17, P956, DOI 10.1007/s00586-008-0651-8; Washio M, 2004, J EPIDEMIOL, V14, P168, DOI 10.2188/jea.14.168; Yamauchi T, 1999, J BONE MINER METAB, V17, P296, DOI 10.1007/s007740050098	38	31	34	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40587	10.1371/journal.pone.0040587	http://dx.doi.org/10.1371/journal.pone.0040587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829878	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300016
J	Beazley, MJ; Martinez, RJ; Rajan, S; Powell, J; Piceno, YM; Tom, LM; Andersen, GL; Hazen, TC; Van Nostrand, JD; Zhou, JZ; Mortazavi, B; Sobecky, PA				Beazley, Melanie J.; Martinez, Robert J.; Rajan, Suja; Powell, Jessica; Piceno, Yvette M.; Tom, Lauren M.; Andersen, Gary L.; Hazen, Terry C.; Van Nostrand, Joy D.; Zhou, Jizhong; Mortazavi, Behzad; Sobecky, Patricia A.			Microbial Community Analysis of a Coastal Salt Marsh Affected by the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							GULF-OF-MEXICO; POLYCYCLIC AROMATIC-HYDROCARBONS; PETROLEUM-HYDROCARBONS; DEGRADING BACTERIA; RIBOSOMAL-RNA; CRUDE-OIL; SEDIMENTS; DEGRADATION; BIODEGRADATION; PHYTOREMEDIATION	Coastal salt marshes are highly sensitive wetland ecosystems that can sustain long-term impacts from anthropogenic events such as oil spills. In this study, we examined the microbial communities of a Gulf of Mexico coastal salt marsh during and after the influx of petroleum hydrocarbons following the Deepwater Horizon oil spill. Total hydrocarbon concentrations in salt marsh sediments were highest in June and July 2010 and decreased in September 2010. Coupled PhyloChip and GeoChip microarray analyses demonstrated that the microbial community structure and function of the extant salt marsh hydrocarbon-degrading microbial populations changed significantly during the study. The relative richness and abundance of phyla containing previously described hydrocarbon-degrading bacteria (Proteobacteria, Bacteroidetes, and Actinobacteria) increased in hydrocarbon-contaminated sediments and then decreased once hydrocarbons were below detection. Firmicutes, however, continued to increase in relative richness and abundance after hydrocarbon concentrations were below detection. Functional genes involved in hydrocarbon degradation were enriched in hydrocarbon-contaminated sediments then declined significantly (p<0.05) once hydrocarbon concentrations decreased. A greater decrease in hydrocarbon concentrations among marsh grass sediments compared to inlet sediments (lacking marsh grass) suggests that the marsh rhizosphere microbial communities could also be contributing to hydrocarbon degradation. The results of this study provide a comprehensive view of microbial community structural and functional dynamics within perturbed salt marsh ecosystems.	[Beazley, Melanie J.; Martinez, Robert J.; Rajan, Suja; Powell, Jessica; Mortazavi, Behzad; Sobecky, Patricia A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Piceno, Yvette M.; Tom, Lauren M.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Hazen, Terry C.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Mortazavi, Behzad] Dauphin Isl Sea Lab, Dauphin Isl, AL USA	University of Alabama System; University of Alabama Tuscaloosa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tennessee System; University of Tennessee Knoxville; University of Oklahoma System; University of Oklahoma - Norman; Dauphin Island Sea Lab	Beazley, MJ (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	psobecky@as.ua.edu	Piceno, Yvette/I-6738-2016; Hazen, Terry C/C-1076-2012; Beazley, Melanie J./R-5716-2019; Mortazavi, Behzad/D-3864-2013; Andersen, Gary/G-2792-2015; Tom, Lauren/E-9739-2015; 吴, 昊/AAB-1620-2020; Van Nostrand, Joy D/F-1740-2016; Mortazavi, Behzad/ABC-4483-2020	Piceno, Yvette/0000-0002-7915-4699; Hazen, Terry C/0000-0002-2536-9993; Beazley, Melanie J./0000-0001-9973-7798; Mortazavi, Behzad/0000-0002-1912-1940; Andersen, Gary/0000-0002-1618-9827; Van Nostrand, Joy D/0000-0001-9548-6450; Mortazavi, Behzad/0000-0002-1912-1940; Martinez, Robert/0000-0003-0836-4776	National Science Foundation-CBET [RAPID 1042743]; Dauphin Island Sea Lab/Marine Environmental Science Consortium [2423 Jv, T4-005UA]	National Science Foundation-CBET(National Science Foundation (NSF)); Dauphin Island Sea Lab/Marine Environmental Science Consortium	This work was supported by National Science Foundation-CBET (RAPID 1042743) and Dauphin Island Sea Lab/Marine Environmental Science Consortium 2423 Jv, T4-005UA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; AMUND OO, 1991, TRIBOL INT, V24, P235, DOI 10.1016/0301-679X(91)90049-F; Anderson RT, 2000, ENVIRON SCI TECHNOL, V34, P2261, DOI 10.1021/es991211a; Andrade ML, 2004, J ENVIRON QUAL, V33, P2103, DOI 10.2134/jeq2004.2103; Arulazhagan P, 2011, MAR POLLUT BULL, V62, P388, DOI 10.1016/j.marpolbul.2010.09.020; ATLAS RM, 1981, MICROBIOL REV, V45, P180, DOI 10.1128/MMBR.45.1.180-209.1981; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; Bognolo G, 1999, COLLOID SURFACE A, V152, P41, DOI 10.1016/S0927-7757(98)00684-0; BRENDEL PJ, 1995, ENVIRON SCI TECHNOL, V29, P751, DOI 10.1021/es00003a024; Burke DJ, 2002, APPL ENVIRON MICROB, V68, P1157, DOI 10.1128/AEM.68.3.1157-1164.2002; BURNS KA, 1993, MAR POLLUT BULL, V26, P239, DOI 10.1016/0025-326X(93)90062-O; Camilli R, 2012, P NATL ACAD SCI USA, V109, P20235, DOI 10.1073/pnas.1100385108; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Cervantes FJ, 2001, APPL ENVIRON MICROB, V67, P4471, DOI 10.1128/AEM.67.10.4471-4478.2001; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; De la Rosa-Garcia SC, 2007, LETT APPL MICROBIOL, V45, P289, DOI 10.1111/j.1472-765X.2007.02185.x; Deppe U, 2005, EXTREMOPHILES, V9, P461, DOI 10.1007/s00792-005-0463-2; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Edlund A, 2008, FEMS MICROBIOL ECOL, V65, P513, DOI 10.1111/j.1574-6941.2008.00513.x; Edwards BR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035301; Gilfillan ES, 1995, MAR POLLUT BULL, V30, P780, DOI 10.1016/0025-326X(95)00069-Y; Hamann C, 1999, FEMS MICROBIOL LETT, V173, P255, DOI 10.1111/j.1574-6968.1999.tb13510.x; Harvey PJ, 2002, ENVIRON SCI POLLUT R, V9, P29, DOI 10.1007/BF02987315; Hayworth JS, 2011, HYDROL EARTH SYST SC, V15, P3639, DOI 10.5194/hess-15-3639-2011; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He ZL, 2008, T NONFERR METAL SOC, V18, P1319, DOI 10.1016/S1003-6326(09)60004-2; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Hegazi AH, 2004, CHEMOSPHERE, V55, P1053, DOI 10.1016/j.chemosphere.2004.01.019; Heider J, 1998, FEMS MICROBIOL REV, V22, P459, DOI 10.1111/j.1574-6976.1998.tb00381.x; Hoff R. Z., 1995, 961 NOAA HAZMAT; Horel A, 2012, ENVIRON TOXICOL CHEM, V31, P1004, DOI 10.1002/etc.1770; Ilori MO, 2005, CHEMOSPHERE, V61, P985, DOI 10.1016/j.chemosphere.2005.03.066; Juhasz AL, 2000, LETT APPL MICROBIOL, V30, P396, DOI 10.1046/j.1472-765x.2000.00733.x; Kokaly R. F, 2011, 20111022 US GEOL SUR; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Lasher C, 2009, MICROB ECOL, V58, P244, DOI 10.1007/s00248-008-9481-9; Lee RF, 1997, MAR POLLUT BULL, V34, P928, DOI 10.1016/S0025-326X(97)00078-7; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lin QX, 2009, ECOL ENG, V35, P85, DOI 10.1016/j.ecoleng.2008.09.010; Lin QX, 1998, ECOL ENG, V10, P263, DOI 10.1016/S0925-8574(98)00015-9; Lobao MM, 2010, MAR POLLUT BULL, V60, P2263, DOI 10.1016/j.marpolbul.2010.08.008; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Luther GW, 1996, GEOCHIM COSMOCHIM AC, V60, P951, DOI 10.1016/0016-7037(95)00444-0; MacDonald IR, 2002, GEOFLUIDS, V2, P95, DOI 10.1046/j.1468-8123.2002.00023.x; Mann KH, 2000, ECOLOGY COASTAL WATE; Martinez RJ, 2006, ENVIRON MICROBIOL, V8, P1783, DOI 10.1111/j.1462-2920.2006.01063.x; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Oka AR, 2011, ENVIRON SCI TECHNOL, V45, P3407, DOI 10.1021/es103859t; Operational Science Advisory Team II, 2011, SUMM REP FAT EFF REM; Page DS, 1999, MAR POLLUT BULL, V38, P247, DOI 10.1016/S0025-326X(98)00142-8; Pearson A, 2008, APPL ENVIRON MICROB, V74, P1157, DOI 10.1128/AEM.01014-07; Phelps CD, 1999, BIODEGRADATION, V10, P15, DOI 10.1023/A:1008303729431; Prince R, 2005, BIOREMEDIATION: APPLIED MICROBIAL SOLUTIONS FOR REAL-WORLD ENVIRONMENTAL CLEANUP, P269; Prince RC, 2005, PETROLEUM MICROBIOLOGY, P317; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Roberts HH, 1997, ECON GEOL BULL SOC, V92, P863, DOI 10.2113/gsecongeo.92.7-8.863; Ron EZ, 2002, CURR OPIN BIOTECH, V13, P249, DOI 10.1016/S0958-1669(02)00316-6; SASSEN R, 1993, OIL GAS J, V91, P64; SCHNOOR JL, 1995, ENVIRON SCI TECHNOL, V29, pA318, DOI [10.1021/es00007a002, 10.1021/es00007a747]; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Taillefert M, 2007, GEOCHEM T, V8, DOI 10.1186/1467-4866-8-6; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Wang M, 2007, PEDOSPHERE, V17, P545, DOI 10.1016/S1002-0160(07)60065-4; Yumoto I, 2002, INT J SYST EVOL MICR, V52, P85, DOI 10.1099/00207713-52-1-85; Zhu X., 2004, GUIDELINES BIOREMEDI	67	145	151	0	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41305	10.1371/journal.pone.0041305	http://dx.doi.org/10.1371/journal.pone.0041305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815990	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900109
J	Forgione, N; Tropepe, V				Forgione, Nicole; Tropepe, Vincent			Toll-Like Signaling and the Cytokine IL-6 Regulate Histone Deacetylase Dependent Neuronal Survival	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; CORTICAL-NEURONS; VALPROIC ACID; INHIBITION; BRAIN; INTERLEUKIN-6; ASTROCYTES; DEATH; NEUROPROTECTION; CULTURES	Histone deacetylase (HDAC) proteins have a role in promoting neuronal survival in vitro, but the mechanism underlying this function has not been identified. Here we provide evidence that components of the neuronal microenvironment, including non-neuronal cells and defined culture media, can mitigate midbrain neuronal cell death induced by HDAC inhibitor treatment. Using microarrays we further identified gene expression changes taking place in non-neuronal cells as a result of HDAC inhibition. This analysis demonstrated that HDAC inhibitor treatment results in the down-regulation of immunity related signaling factors, in particular the Toll-like receptors (TLR). TLR signaling is active in cultured midbrain cells, yet blocking TLR receptors is not sufficient to cause neuronal cell death. In contrast, selective activation of this pathway using TLR ligands can modestly block the effects of HDAC inhibition. Furthermore, we observed that the negative effects of HDAC inhibitor treatment on neuronal survival could be more substantially blocked by the cytokine Interleukin-6 (IL-6), which is a major downstream target of TLR signaling. These data suggest that HDACs function to promote neuronal survival by activating a TLR and IL-6 dependent pathway.	[Forgione, Nicole; Tropepe, Vincent] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Tropepe, Vincent] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Forgione, N (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	v.tropepe@utoronto.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; Faraco G, 2009, NEUROBIOL DIS, V36, P269, DOI 10.1016/j.nbd.2009.07.019; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Forgione N, 2011, MOL CELL NEUROSCI, V48, P117, DOI 10.1016/j.mcn.2011.06.012; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; KUSHIMA Y, 1992, NEUROSCI LETT, V143, P110, DOI 10.1016/0304-3940(92)90244-2; LaBonte MJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-67; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; NORRIS JG, 1993, J NEUROIMMUNOL, V45, P137; Okun E, 2011, TRENDS NEUROSCI; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shaked M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002668; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Steelman AJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-89; Sub HS, 2010, J NEUROIMMUNE PHARM, V5, P521, DOI 10.1007/s11481-010-9192-0	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41033	10.1371/journal.pone.0041033	http://dx.doi.org/10.1371/journal.pone.0041033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848425	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200039
J	Kadoya, T; Osada, Y; Takimoto, G				Kadoya, Taku; Osada, Yutaka; Takimoto, Gaku			IsoWeb: A Bayesian Isotope Mixing Model for Diet Analysis of the Whole Food Web	PLOS ONE			English	Article							STABLE-ISOTOPES; TROPHIC INTERACTIONS; INTERACTION STRENGTH; TEMPORAL VARIATION; UNCERTAINTY	Quantitative description of food webs provides fundamental information for the understanding of population, community, and ecosystem dynamics. Recently, stable isotope mixing models have been widely used to quantify dietary proportions of different food resources to a focal consumer. Here we propose a novel mixing model (IsoWeb) that estimates diet proportions of all consumers in a food web based on stable isotope information. IsoWeb requires a topological description of a food web, and stable isotope signatures of all consumers and resources in the web. A merit of IsoWeb is that it takes into account variation in trophic enrichment factors among different consumer-resource links. Sensitivity analysis using realistic hypothetical food webs suggests that IsoWeb is applicable to a wide variety of food webs differing in the number of species, connectance, sample size, and data variability. Sensitivity analysis based on real topological webs showed that IsoWeb can allow for a certain level of topological uncertainty in target food webs, including erroneously assuming false links, omission of existent links and species, and trophic aggregation into trophospecies. Moreover, using an illustrative application to a real food web, we demonstrated that IsoWeb can compare the plausibility of different candidate topologies for a focal web. These results suggest that IsoWeb provides a powerful tool to analyze food-web structure from stable isotope data. We provide R and BUGS codes to aid efficient applications of IsoWeb.	[Kadoya, Taku] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Osada, Yutaka] Univ Tokyo, Sch Agr & Life Sci, Dept Ecosyst Studies, Bunkyo Ku, Tokyo, Japan; [Takimoto, Gaku] Toho Univ, Fac Sci, Dept Biol, Funabashi, Chiba 274, Japan	National Institute for Environmental Studies - Japan; University of Tokyo; Toho University	Kadoya, T (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	kadoya@nies.go.jp	Kadoya, Taku/L-7536-2013	Kadoya, Taku/0000-0002-7816-5484	Japan Society for the Promotion of Science [22510249]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by the Japan Society for the Promotion of Science (no. 22510249 http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banasek-Richter C, 2004, J THEOR BIOL, V226, P23, DOI 10.1016/S0022-5193(03)00305-9; DEANGELIS DL, 1980, ECOLOGY, V61, P764, DOI 10.2307/1936746; DERUITER PC, 1994, TRENDS ECOL EVOL, V9, P378, DOI 10.1016/0169-5347(94)90059-0; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; GREER ALLEN E., 1967, BREVIORA, V268, P1; Hardy LM, 2006, AFR J HERPETOL, V55, P143, DOI 10.1080/21564574.2006.9635546; Jeffrery H, 1961, THEORY PROBABILITY; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Opitz S., 1996, 43 ICLARM; PAINE RT, 1980, J ANIM ECOL, V49, P667; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pringle RM, 2008, ECOL LETT, V11, P1328, DOI 10.1111/j.1461-0248.2008.01252.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x; Yodzis P, 1999, OIKOS, V87, P327, DOI 10.2307/3546748	32	34	35	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41057	10.1371/journal.pone.0041057	http://dx.doi.org/10.1371/journal.pone.0041057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848427	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200040
J	Rosen, MJ; Sarro, EC; Kelly, JB; Sanes, DH				Rosen, Merri J.; Sarro, Emma C.; Kelly, Jack B.; Sanes, Dan H.			Diminished Behavioral and Neural Sensitivity to Sound Modulation Is Associated with Moderate Developmental Hearing Loss	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; AMPLITUDE-MODULATION; TEMPORAL RESOLUTION; MONGOLIAN GERBIL; SPEECH COMPREHENSION; FREQUENCY-MODULATION; INFERIOR COLLICULUS; IMPAIRED HEARING; BINAURAL HEARING; VISUAL-MOTION	The acoustic rearing environment can alter central auditory coding properties, yet altered neural coding is seldom linked with specific deficits to adult perceptual skills. To test whether developmental hearing loss resulted in comparable changes to perception and sensory coding, we examined behavioral and neural detection thresholds for sinusoidally amplitude modulated (sAM) stimuli. Behavioral sAM detection thresholds for slow (5 Hz) modulations were significantly worse for animals reared with bilateral conductive hearing loss (CHL), as compared to controls. This difference could not be attributed to hearing thresholds, proficiency at the task, or proxies for attention. Detection thresholds across the groups did not differ for fast (100 Hz) modulations, a result paralleling that seen in humans. Neural responses to sAM stimuli were recorded in single auditory cortex neurons from separate groups of awake animals. Neurometric analyses indicated equivalent thresholds for the most sensitive neurons, but a significantly poorer detection threshold for slow modulations across the population of CHL neurons as compared to controls. The magnitude of the neural deficit matched that of the behavioral differences, suggesting that a reduction of sensory information can account for limitations to perceptual skills.	[Rosen, Merri J.] NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Sarro, Emma C.; Sanes, Dan H.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Sanes, Dan H.] NYU, Dept Biol, New York, NY 10003 USA; [Kelly, Jack B.] Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada	Northeast Ohio Medical University (NEOMED); New York University; New York University; Carleton University	Rosen, MJ (corresponding author), NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA.	mrosen@neomed.edu	Rosen, Merri J/N-7309-2015	Rosen, Merri J/0000-0002-1973-2207	National Institutes of Health [DC009165, DC009237]; National Organization for Hearing Research Foundation; New York University Research Challenge Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC009165, R01DC009237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Organization for Hearing Research Foundation; New York University Research Challenge Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health DC009165 (MJR), National Organization for Hearing Research Foundation (MJR), National Institutes of Health DC009237 (DHS), and New York University Research Challenge Fund (DHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; BACON SP, 1992, J SPEECH HEAR RES, V35, P642, DOI 10.1044/jshr.3503.642; Bacon SP, 2002, J SPEECH LANG HEAR R, V45, P392, DOI 10.1044/1092-4388(2002/031); BACON SP, 1985, AUDIOLOGY, V24, P117; Banai K, 2011, HEARING RES, V280, P219, DOI 10.1016/j.heares.2011.05.019; Beitel RE, 2011, J NEUROPHYSIOL, V106, P944, DOI 10.1152/jn.00731.2010; Briscoe J, 2001, J CHILD PSYCHOL PSYC, V42, P329, DOI 10.1111/1469-7610.00726; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Busby PA, 1999, J ACOUST SOC AM, V105, P1841, DOI 10.1121/1.426721; CLEMENTS M, 1978, J COMP PHYSIOL PSYCH, V92, P34, DOI 10.1037/h0077424; Cook RD, 2002, HEARING RES, V164, P127, DOI 10.1016/S0378-5955(01)00424-5; David SV, 2012, P NATL ACAD SCI USA, V109, P2144, DOI 10.1073/pnas.1117717109; Davis MH, 2003, J NEUROSCI, V23, P3423; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; ELLIOTT DN, 1972, PSYCHOL BULL, V77, P198, DOI 10.1037/h0032281; FEUERSTEIN JF, 1992, EAR HEARING, V13, P80, DOI 10.1097/00003446-199204000-00003; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Gravel JS, 1996, ACTA OTO-LARYNGOL, V116, P219, DOI 10.3109/00016489609137827; Guo F, 2012, BEHAV BRAIN RES, V229, P301, DOI 10.1016/j.bbr.2011.12.041; HALL JW, 1994, J ACOUST SOC AM, V96, P150, DOI 10.1121/1.410474; Halliday LF, 2006, BRAIN LANG, V97, P200, DOI 10.1016/j.bandl.2005.10.007; Heffner H.E., 1995, METHODS COMP PSYCHOA, P79; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kale S, 2010, JARO-J ASSOC RES OTO, V11, P657, DOI 10.1007/s10162-010-0223-6; Kelly JB, 2006, J COMP PSYCHOL, V120, P98, DOI 10.1037/0735-7036.120.2.98; KERR LM, 1979, J EXP PSYCHOL-ANIM B, V5, P97, DOI 10.1037/0097-7403.5.2.97; King AJ, 2000, P NATL ACAD SCI USA, V97, P11821, DOI 10.1073/pnas.97.22.11821; Kiorpes L, 2006, STRABISMUS, V14, P3, DOI 10.1080/09273970500536193; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; KNUDSEN EI, 1984, J NEUROSCI, V4, P1001; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Kotak VC, 2008, CEREB CORTEX, V18, P2098, DOI 10.1093/cercor/bhm233; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Lorenzi C, 2000, J SPEECH LANG HEAR R, V43, P1367, DOI 10.1044/jslhr.4306.1367; Malone BJ, 2001, J NEUROPHYSIOL, V86, P1113, DOI 10.1152/jn.2001.86.3.1113; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Malone BJ, 2010, J NEUROSCI, V30, P767, DOI 10.1523/JNEUROSCI.4170-09.2010; McCoy SL, 2005, Q J EXP PSYCHOL-A, V58, P22, DOI 10.1080/02724980443000151; Mody M, 1999, J SPEECH LANG HEAR R, V42, P1069, DOI 10.1044/jslhr.4205.1069; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Moore DR, 1999, J NEUROSCI, V19, P8704; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Ohl FW, 1999, LEARN MEMORY, V6, P347; Oxenham AJ, 2003, EAR HEARING, V24, P352, DOI 10.1097/01.AUD.0000090470.73934.78; Park M-H, 2011, C IMPL AUD PROSTH PA, P109; Parsons CH, 1999, J NEUROPHYSIOL, V82, P2294, DOI 10.1152/jn.1999.82.5.2294; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; Pisoni DB, 2003, EAR HEARING, V24, p106S, DOI 10.1097/01.AUD.0000051692.05140.8E; Poelmans H, 2011, RES DEV DISABIL, V32, P2810, DOI 10.1016/j.ridd.2011.05.025; Poldrack RA, 2001, J COGNITIVE NEUROSCI, V13, P687, DOI 10.1162/089892901750363235; Popescu MV, 2010, NEURON, V65, P718, DOI 10.1016/j.neuron.2010.02.019; Rabbitt P, 1990, Acta Otolaryngol Suppl, V476, P167; Rabbitt P, 1990, ACTA OTOLARYNGO S189, V476, P176; Rabbitt P., 1966, PSYCHON SCI, V6, P383, DOI [10.3758/BF03330948, DOI 10.3758/BF03330948]; Rakerd B, 1996, EAR HEARING, V17, P97, DOI 10.1097/00003446-199604000-00002; Rocheron I, 2002, NEUROREPORT, V13, P1683, DOI 10.1097/00001756-200209160-00023; Rosen MJ, 2010, J NEUROSCI, V30, P15509, DOI 10.1523/JNEUROSCI.3340-10.2010; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Rybalko N, 2010, BEHAV BRAIN RES, V209, P123, DOI 10.1016/j.bbr.2010.01.028; SALVI RJ, 1982, J ACOUST SOC AM, V71, P424, DOI 10.1121/1.387445; Sarampalis A, 2009, J SPEECH LANG HEAR R, V52, P1230, DOI 10.1044/1092-4388(2009/08-0111); Sarro EC, 2010, DEV NEUROBIOL, V70, P636, DOI 10.1002/dneu.20801; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Stuermer IW, 2000, HEARING RES, V146, P185, DOI 10.1016/S0378-5955(00)00113-1; Sumner CJ, 2005, J NEUROPHYSIOL, V94, P4234, DOI 10.1152/jn.00401.2005; SWETS JA, 1973, SCIENCE, V182, P990, DOI 10.1126/science.182.4116.990; Takesian AE, 2011, J NEUROPHYSIOL; Takesian AE, 2012, J NEUROPHYSIOL, V107, P937, DOI 10.1152/jn.00515.2011; Takesian AE, 2010, J NEUROSCI, V30, P2716, DOI 10.1523/JNEUROSCI.3903-09.2010; Ter-Mikaelian M, 2007, J NEUROSCI, V27, P6091, DOI 10.1523/JNEUROSCI.4848-06.2007; THOMAS H, 1993, EUR J NEUROSCI, V5, P882, DOI 10.1111/j.1460-9568.1993.tb00940.x; TUCCI DL, 1985, J COMP NEUROL, V238, P371, DOI 10.1002/cne.902380402; Tucci DL, 1999, LARYNGOSCOPE, V109, P1359, DOI 10.1097/00005537-199909000-00001; Tucci DL, 2001, JARO-J ASSOC RES OTO, V3, P89, DOI DOI 10.1007/S101620010091; Vale C, 2003, J NEUROSCI, V23, P7516; Vale C, 2002, EUR J NEUROSCI, V16, P2394, DOI 10.1046/j.1460-9568.2002.02302.x; Wasner GL, 2008, CLIN NEUROPHYSIOL, V119, P2389, DOI 10.1016/j.clinph.2008.07.223; WEBSTER DB, 1983, EXP NEUROL, V79, P130, DOI 10.1016/0014-4886(83)90384-9; Whitton JP, 2011, JARO-J ASSOC RES OTO, V12, P535, DOI 10.1007/s10162-011-0271-6; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WIGHTMAN F, 1989, CHILD DEV, V60, P611, DOI 10.1111/j.1467-8624.1989.tb02742.x; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Xu H, 2007, J NEUROSCI, V27, P9417, DOI 10.1523/JNEUROSCI.1992-07.2007; Xu H, 2010, J NEUROSCI, V30, P331, DOI 10.1523/JNEUROSCI.4554-09.2010; YANZ JL, 1984, EAR HEARING, V5, P64, DOI 10.1097/00003446-198403000-00002; Yin PB, 2011, J NEUROPHYSIOL, V105, P582, DOI 10.1152/jn.00621.2010; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	93	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41514	10.1371/journal.pone.0041514	http://dx.doi.org/10.1371/journal.pone.0041514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848517	gold, Green Submitted, Green Published			2022-12-27	WOS:000309240600031
J	Annibali, D; Gioia, U; Savino, M; Laneve, P; Caffarelli, E; Nasi, S				Annibali, Daniela; Gioia, Ubaldo; Savino, Mauro; Laneve, Pietro; Caffarelli, Elisa; Nasi, Sergio			A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and-103, Target the Differentiation Inhibitor ID2	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; HUMAN NEUROBLASTOMA-CELLS; NEURONAL DIFFERENTIATION; RETINOBLASTOMA PROTEIN; CANCER METASTASIS; PROGENITOR CELLS; CODING REGIONS; IN-VIVO; EXPRESSION; RNA	The transcription factor ID2 is an important repressor of neural differentiation strongly implicated in nervous system cancers. MicroRNAs (miRNAs) are increasingly involved in differentiation control and cancer development. Here we show that two miRNAs upregulated on differentiation of neuroblastoma cells - miR-9 and miR-103 - restrain ID2 expression by directly targeting the coding sequence and 39 untranslated region of the ID2 encoding messenger RNA, respectively. Notably, the two miRNAs show an inverse correlation with ID2 during neuroblastoma cell differentiation induced by retinoic acid. Overexpression of miR-9 and miR-103 in neuroblastoma cells reduces proliferation and promotes differentiation, as it was shown to occur upon ID2 inhibition. Conversely, an ID2 mutant that cannot be targeted by either miRNA prevents retinoic acid-induced differentiation more efficient than wild-type ID2. These findings reveal a new regulatory module involving two microRNAs upregulated during neural differentiation that directly target expression of the key differentiation inhibitor ID2, suggesting that its alteration may be involved in neural cancer development.	[Annibali, Daniela; Savino, Mauro; Laneve, Pietro; Caffarelli, Elisa; Nasi, Sergio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, CNR IBPM, Rome, Italy; [Caffarelli, Elisa] Univ Roma La Sapienza, Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome	Annibali, D (corresponding author), Vesalius Res Ctr, Louvain, Belgium.	elisa.caffarelli@uniroma1.it; sergio.nasi@uniroma1.it	Annibali, Daniela/AAE-3004-2019; Annibali, Daniela/AAC-5270-2019; Gioia, Ubaldo/GZL-7436-2022; Gioia, Ubaldo/O-1660-2014; laneve, pietro/ABD-1633-2020; laneve, pietro/M-3386-2014	Annibali, Daniela/0000-0001-8413-7669; Gioia, Ubaldo/0000-0002-4993-5283; Gioia, Ubaldo/0000-0002-4993-5283; laneve, pietro/0000-0002-8865-4038	Agenzia Spaziale Italiana, Fondazione Guido Berlucchi, Associazione Italiana per la Ricerca sul Cancro, European Commission SIROCCO project [LSHGCT-2006-037900]; Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) PRIN project; Istituto Italiano di Tecnologia SEED-project; Epigenomics Flagship Project EPIGEN; MIURCNR; Consiglio Nazionale delle Ricerche	Agenzia Spaziale Italiana, Fondazione Guido Berlucchi, Associazione Italiana per la Ricerca sul Cancro, European Commission SIROCCO project(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) PRIN project; Istituto Italiano di Tecnologia SEED-project(Istituto Italiano di Tecnologia - IIT); Epigenomics Flagship Project EPIGEN; MIURCNR(Ministry of Education, Universities and Research (MIUR)Consiglio Nazionale delle Ricerche (CNR)); Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by grants from Agenzia Spaziale Italiana, Fondazione Guido Berlucchi, Associazione Italiana per la Ricerca sul Cancro, European Commission SIROCCO project (LSHGCT-2006-037900), Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) PRIN project, Istituto Italiano di Tecnologia SEED-project, and Epigenomics Flagship Project EPIGEN, MIURCNR. Funding for open access charge: Consiglio Nazionale delle Ricerche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT REV MOL CELL BIO; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Hamo R, 2011, GENOME MED, V3, DOI 10.1186/gm293; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chassot AA, 2007, ONCOGENE, V26, P5772, DOI 10.1038/sj.onc.1210386; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; CICCARONE V, 1989, CANCER RES, V49, P219; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; DiRocco G, 1997, MOL CELL BIOL, V17, P1244, DOI 10.1128/MCB.17.3.1244; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Hoesel B, 2010, GENE EXPR PATTERNS, V10, P265, DOI 10.1016/j.gep.2010.06.002; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Iavarone A, 2006, TRENDS MOL MED, V12, P588, DOI 10.1016/j.molmed.2006.10.007; Itahana Y, 2003, CANCER RES, V63, P7098; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2006, P NATL ACAD SCI USA, V103, P4976, DOI 10.1073/pnas.0600168103; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012976; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nagasaki K, 1999, NEUROSCI LETT, V267, P177, DOI 10.1016/S0304-3940(99)00359-6; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Paolella BR, 2011, STEM CELLS, V29, P1090, DOI 10.1002/stem.660; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; ROSSI A, 1992, INT J DEV NEUROSCI, V10, P527, DOI 10.1016/0736-5748(92)90053-3; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Tweddle DA, 2001, AM J PATHOL, V158, P2067, DOI 10.1016/S0002-9440(10)64678-0; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; Wu N, 2011, J BIOL CHEM; Yao WL, 2010, NEUROREPORT, V21, P39, DOI 10.1097/WNR.0b013e32833312fe; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zhang CQ, 2010, BRAIN RES, V1315, P1, DOI 10.1016/j.brainres.2009.12.013; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	66	51	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40269	10.1371/journal.pone.0040269	http://dx.doi.org/10.1371/journal.pone.0040269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848373	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600014
J	Bhati, M; Lee, C; Gadd, MS; Jeffries, CM; Kwan, A; Whitten, AE; Trewhella, J; Mackay, JP; Matthews, JM				Bhati, Mugdha; Lee, Christopher; Gadd, Morgan S.; Jeffries, Cy M.; Kwan, Ann; Whitten, Andrew E.; Trewhella, Jill; Mackay, Joel P.; Matthews, Jacqueline M.			Solution Structure of the LIM-Homeodomain Transcription Factor Complex Lhx3/Ldb1 and the Effects of a Pituitary Mutation on Key Lhx3 Interactions	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; HORMONE DEFICIENCY; MOTOR-NEURONS; TARGET GENES; ACTIVE-SITE; PROTEIN; SPECIFICATION; BINDING; DOMAIN	Lhx3 is a LIM-homeodomain (LIM-HD) transcription factor that regulates neural cell subtype specification and pituitary development in vertebrates, and mutations in this protein cause combined pituitary hormone deficiency syndrome (CPHDS). The recently published structures of Lhx3 in complex with each of two key protein partners, Isl1 and Ldb1, provide an opportunity to understand the effect of mutations and posttranslational modifications on key protein-protein interactions. Here, we use small-angle X-ray scattering of an Ldb1-Lhx3 complex to confirm that in solution the protein is well represented by our previously determined NMR structure as an ensemble of conformers each comprising two well-defined halves (each made up of LIM domain from Lhx3 and the corresponding binding motif in Ldb1) with some flexibility between the two halves. NMR analysis of an Lhx3 mutant that causes CPHDS, Lhx3(Y114C), shows that the mutation does not alter the zinc-ligation properties of Lhx3, but appears to cause a structural rearrangement of the hydrophobic core of the LIM2 domain of Lhx3 that destabilises the domain and/or reduces the affinity of Lhx3 for both Ldb1 and Isl1. Thus the mutation would affect the formation of Lhx3-containing transcription factor complexes, particularly in the pituitary gland where these complexes are required for the production of multiple pituitary cell types and hormones.	[Bhati, Mugdha; Lee, Christopher; Gadd, Morgan S.; Jeffries, Cy M.; Kwan, Ann; Whitten, Andrew E.; Trewhella, Jill; Mackay, Joel P.; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Bhati, M (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	Jacqui.Matthews@sydney.edu.au	Matthews, Jacqueline/A-7322-2013; Mackay, Joel P/D-6834-2011	Mackay, Joel P/0000-0001-7508-8033; Gadd, Morgan/0000-0001-6124-0858; /0000-0002-8718-7343; Kwan, Ann/0000-0002-1506-2226; Matthews, Jacqueline/0000-0001-8518-3472; Whitten, Andrew/0000-0001-8856-3120; Trewhella, Jill/0000-0002-8555-6766	Australian Postgraduate Awards; National Health and Medical Research Council Senior Research Fellowships; Australian Research Council	Australian Postgraduate Awards(Australian Government); National Health and Medical Research Council Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	MB, CL and MG were supported by Australian Postgraduate Awards. JMM and JPM were supported by National Health and Medical Research Council Senior Research Fellowships. JT was supported in part by a Federation Fellowship from the Australian Research Council. This work was supported by grants from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bhati M, 2008, ACTA CRYSTALLOGR F, V64, P297, DOI 10.1107/S174430910800691X; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gadd MS, 2011, J BIOL CHEM, V286, P42971, DOI 10.1074/jbc.M111.248559; Gadd MS, 2009, ACTA CRYSTALLOGR F, V65, P151, DOI 10.1107/S1744309108043431; Goddard TD, 2007, SPARKY NMR ASSIGNMEN; Howard PW, 2000, J BIOL CHEM, V275, P13336, DOI 10.1074/jbc.275.18.13336; Howard PW, 2001, J BIOL CHEM, V276, P19020, DOI 10.1074/jbc.M101782200; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2006, PROTEIN SCI, V15, P2612, DOI 10.1110/ps.062377006; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee C, 2005, J BIOMOL NMR, V33, P198, DOI 10.1007/s10858-005-3209-7; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Meier BC, 1999, MOL CELL ENDOCRINOL, V147, P65, DOI 10.1016/S0303-7207(98)00213-5; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Parker GE, 2005, J CELL BIOCHEM, V94, P67, DOI 10.1002/jcb.20287; PELTON JG, 1993, PROTEIN SCI, V2, P543; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pfaeffle RW, 2007, J CLIN ENDOCR METAB, V92, P1909, DOI 10.1210/jc.2006-2177; Rajab A, 2008, HUM MOL GENET, V17, P2150, DOI 10.1093/hmg/ddn114; Savage JJ, 2007, GENE, V400, P44, DOI 10.1016/j.gene.2007.05.017; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Sloop KW, 1999, MOL ENDOCRINOL, V13, P2212, DOI 10.1210/me.13.12.2212; Sloop KW, 2001, GENE, V265, P61, DOI 10.1016/S0378-1119(01)00369-9; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Trewhella J, 2001, ENCY LIFE SCI; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yarden BC, 2005, MOL BIOL REP, V32, P1	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40719	10.1371/journal.pone.0040719	http://dx.doi.org/10.1371/journal.pone.0040719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848397	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600024
J	Thorlund, K; Imberger, G; Johnston, BC; Walsh, M; Awad, T; Thabane, L; Gluud, C; Devereaux, PJ; Wetterslev, J				Thorlund, Kristian; Imberger, Georgina; Johnston, Bradley C.; Walsh, Michael; Awad, Tahany; Thabane, Lehana; Gluud, Christian; Devereaux, P. J.; Wetterslev, Jorn			Evolution of Heterogeneity (I-2) Estimates and Their 95% Confidence Intervals in Large Meta-Analyses	PLOS ONE			English	Article							PUBLICATION BIAS; STATISTICAL SIGNIFICANCE	Background: Assessment of heterogeneity is essential in systematic reviews and meta-analyses of clinical trials. The most commonly used heterogeneity measure, I-2, provides an estimate of the proportion of variability in a meta-analysis that is explained by differences between the included trials rather than by sampling error. Recent studies have raised concerns about the reliability of I-2 estimates, due to their dependence on the precision of included trials and time-dependent biases. Authors have also advocated use of 95% confidence intervals (CIs) to express the uncertainty associated with I-2 estimates. However, no previous studies have explored how many trials and events are required to ensure stable and reliable I-2 estimates, or how 95% CIs perform as evidence accumulates. Methodology/Principal Findings: To assess the stability and reliability of I-2 estimates and their 95% CIs, in relation to the cumulative number of trials and events in meta-analysis, we looked at 16 large Cochrane meta-analyses - each including a sufficient number of trials and events to reliably estimate I-2 - and monitored the I-2 estimates and their 95% CIs for each year of publication. In 10 of the 16 meta-analyses, the I-2 estimates fluctuated more than 40% over time. The median number of events and trials required before the cumulative I-2 estimates stayed within +/-20% of the final I-2 estimate was 467 and 11. No major fluctuations were observed after 500 events and 14 trials. The 95% confidence intervals provided good coverage over time. Conclusions/Significance: I-2 estimates need to be interpreted with caution when the meta-analysis only includes a limited number of events or trials. Confidence intervals for I-2 estimates provide good coverage as evidence accumulates, and are thus valuable for reflecting the uncertainty associated with estimating I-2.	[Thorlund, Kristian; Johnston, Bradley C.; Walsh, Michael; Thabane, Lehana; Devereaux, P. J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Thorlund, Kristian; Imberger, Georgina; Awad, Tahany; Gluud, Christian; Wetterslev, Jorn] Univ Copenhagen Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit,Dept 3344, DK-2100 Copenhagen, Denmark; [Johnston, Bradley C.] Hosp Sick Children, Dept Anaesthesia & Pain Med, Toronto, ON M5G 1X8, Canada; [Walsh, Michael] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Father Sean OSullivan Res Ctr, Biostat Unit, Hamilton, ON, Canada; [Devereaux, P. J.] McMaster Univ, Publ Hlth Res Inst, Hamilton, ON, Canada	McMaster University; Rigshospitalet; University of Copenhagen; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University; McMaster University	Thorlund, K (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	thorluk@mcmaster.ca	Devereaux, PJ/AAY-1757-2021; Gluud, Christian/AAY-1027-2021; Wetterslev, Jørn/ABF-1251-2020; Devereaux, PJ/AAF-2862-2019; Gluud, Christian/HGB-3191-2022; Walsh, Michael/ABE-1278-2021	Gluud, Christian/0000-0002-8861-0799; Wetterslev, Jørn/0000-0001-7778-1771; Walsh, Michael/0000-0001-8292-2014; Awad, Tahany/0000-0002-4766-9794; Devereaux, PJ/0000-0003-2935-637X				Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Copenhagen: The Nordic Cochrane Centre The Cochrane Collaboration, 2008, REV MAN REVMAN VERS; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; Gluud C, 2006, J HEPATOL, V44, P607, DOI 10.1016/j.jhep.2005.12.006; Guyatt G., 2008, USERS GUIDE MED LIT; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Ioannidis JPA, 2008, J EVAL CLIN PRACT, V14, P951, DOI 10.1111/j.1365-2753.2008.00986.x; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jackson D, 2007, BIOMETRICS, V63, P187, DOI 10.1111/j.1541-0420.2006.00663.x; Jackson D, 2006, STAT MED, V25, P2911, DOI 10.1002/sim.2293; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Rucker G, 2008, BMC MED RES METHODOL, P79; Thorlund K, 2012, RES SYNTH METHODS, V4, P238; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Thorlund K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025491; Tricco AC, 2009, J CLIN EPIDEMIOL, V62, P380, DOI 10.1016/j.jclinepi.2008.08.008; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86	29	135	136	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39471	10.1371/journal.pone.0039471	http://dx.doi.org/10.1371/journal.pone.0039471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848355	Green Submitted, gold, Green Published			2022-12-27	WOS:000306806600006
J	Schaetti, C; Ali, SM; Chaignat, CL; Khatib, AM; Hutubessy, R; Weiss, MG				Schaetti, Christian; Ali, Said M.; Chaignat, Claire-Lise; Khatib, Ahmed M.; Hutubessy, Raymond; Weiss, Mitchell G.			Improving Community Coverage of Oral Cholera Mass Vaccination Campaigns: Lessons Learned in Zanzibar	PLOS ONE			English	Article							SOCIOCULTURAL DETERMINANTS; CULTURAL EPIDEMIOLOGY; RURAL MAHARASHTRA; SOUTHERN GHANA; PRIVATE DEMAND; POLICY-MAKERS; TYPHOID-FEVER; VACCINES; INDIA; GENDER	Background: Recent research in two cholera-endemic communities of Zanzibar has shown that a majority (similar to 94%) of the adult population was willing to receive free oral cholera vaccines (OCVs). Since OCV uptake in the 2009 campaign reached only similar to 50% in these communities, an evaluation of social and cultural factors and of barriers was conducted to understand this difference for future cholera control planning. Methodology/Principal Findings: A random sample of 367 adult peri-urban and rural community residents (46.6% immunized vs. 53.4% unimmunized) was studied with a semi-structured interview that inquired about social and cultural features of cholera depicted in a vignette and barriers to OCV uptake. Symptoms (rectal pain, loose skin only in rural community) and perceived causes (uncovered food, contact with contaminated water) specific for severe diarrhea were associated with uptake. Purchasing drugs from pharmacies to stop diarrhea and vomiting was negatively associated with uptake. Increasing household size, age and previous enteric illness episode were positively related to uptake, the latter only at the rural site. The most prominent barrier to uptake was competing obligations or priorities (reported by 74.5%, identified as most important barrier by 49.5%). Next most prominent barriers were lacking information about the campaign (29.6%, 12.2%), sickness (14.3%, 13.3%) and fear of possible vaccine side effects (15.3%, 5.6%). The majority of unvaccinated respondents requested repetition of the vaccination with free OCVs. Conclusions/Significance: Factors associated with uptake indicated a positive impact of the vaccination campaign and of sensitization activities on vaccine acceptance behavior. Unlike communities opposed to cholera control or settings where public confidence in vaccines is lacking, identified barriers to uptake indicated a good campaign implementation and trust in the health system. Despite prospects and demand for repeating the vaccination, local decision-makers should reconsider how careful logistical arrangements may improve community coverage and thus effectiveness of vaccination campaigns.	[Schaetti, Christian; Weiss, Mitchell G.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Schaetti, Christian; Weiss, Mitchell G.] Univ Basel, Basel, Switzerland; [Ali, Said M.] Publ Hlth Lab Ivo de Carneri, Chake Chake, Pemba, Tanzania; [Chaignat, Claire-Lise] World Hlth Org, Global Task Force Cholera Control, Geneva, Switzerland; [Khatib, Ahmed M.] Minist Hlth Zanzibar, Zanzibar, Tanzania; [Hutubessy, Raymond] World Hlth Org, Initiat Vaccine Res, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; World Health Organization; World Health Organization	Schaetti, C (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	christian.schaetti@unibas.ch			Bill and Melinda Gates Foundation, Seattle, USA	Bill and Melinda Gates Foundation, Seattle, USA(Bill & Melinda Gates Foundation)	This study was supported by a grant from the Bill and Melinda Gates Foundation, Seattle, USA (http://www.gatesfoundation.org), managed by the World Health Organization, Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-47; Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Ali M, 2010, J HEALTH POPUL NUTR, V28, P450, DOI 10.3329/jhpn.v28i5.6153; Ali M, 2010, B WORLD HEALTH ORGAN, V88, P556, DOI 10.2471/BLT.09.070334; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Atre S, 2011, GLOB PUBLIC HEALTH, V6, P56, DOI 10.1080/17441690903334240; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; DeRoeck D, 2004, J HEALTH POPUL NUTR, V22, P322; DeRoeck D, 2005, VACCINE, V23, P2762, DOI 10.1016/j.vaccine.2004.11.044; Dillip A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-144; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kim D, 2008, VALUE HEALTH, V11, P119, DOI 10.1111/j.1524-4733.2007.00220.x; Kleinman A., 1980, PATIENTS HEALERS CON; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Lucas MES, 2007, VACCINE, V25, P2599, DOI 10.1016/j.vaccine.2006.12.027; Nations MK, 1996, SOC SCI MED, V43, P1007, DOI 10.1016/0277-9536(96)00083-4; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Paralikar V, 2011, TRANSCULT PSYCHIATRY, V48, P257, DOI 10.1177/1363461511404623; Renne E, 2006, SOC SCI MED, V63, P1857, DOI 10.1016/j.socscimed.2006.04.025; Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schaetti C, 2011, HUM VACCINES, V7, P1299, DOI 10.4161/hv.7.12.18012; Schaetti C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-339; Schaetti C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-99; Shin S, 2011, CLIN INFECT DIS, V52, P1343, DOI 10.1093/cid/cir141; Stanton BF, 2004, J HEALTH POPUL NUTR, V22, P286; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Sur D, 2009, HUM VACCINES, V5, P614, DOI 10.4161/hv.9313; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Thiem VD, 2003, J HEALTH POPUL NUTR, V21, P304; Weiss, 1997, TRANSCULT PSYCHIATRY, V34, P235, DOI [DOI 10.1177/136346159703400204, 10.1177/136346159703400204]; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P837; Weiss M.G., 2001, ANTHROPOL MED, V8, P5, DOI [10.1080/13648470120070980, DOI 10.1080/13648470120070980]; World Health Organization, 2010, Weekly Epidemiological Record, V85, P293; World Health Organization, 2011, CHOL FACT SHEET 107; World Health Organization Global Task Force on Cholera Control, 2006, CHOL COUNTR PROF ZAN; World Health Organization Global Task Force on Cholera Control, 2006, US 2 DOS CHOL VACC C	43	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41527	10.1371/journal.pone.0041527	http://dx.doi.org/10.1371/journal.pone.0041527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844489	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000306687700101
J	Kuznetsova, IM; Sulatskaya, AI; Povarova, OI; Turoverov, KK				Kuznetsova, Irina M.; Sulatskaya, Anna I.; Povarova, Olga I.; Turoverov, Konstantin K.			Reevaluation of ANS Binding to Human and Bovine Serum Albumins: Key Role of Equilibrium Microdialysis in Ligand - Receptor Binding Characterization	PLOS ONE			English	Article							THIOFLAVINE-T INTERACTION; AMYLOID FIBRILS; MOLTEN GLOBULE; FLUOROMETRIC-DETERMINATION; FLUORESCENCE DECAY; STEADY-STATE; BOUND DYE; PROTEINS; SITES; PROBE	In this work we return to the problem of the determination of ligand-receptor binding stoichiometry and binding constants. In many cases the ligand is a fluorescent dye which has low fluorescence quantum yield in free state but forms highly fluorescent complex with target receptor. That is why many researchers use dye fluorescence for determination of its binding parameters with receptor, but they leave out of account that fluorescence intensity is proportional to the part of the light absorbed by the solution rather than to the concentration of bound dye. We showed how ligand-receptor binding parameters can be determined by spectrophotometry of the solutions prepared by equilibrium microdialysis. We determined the binding parameters of ANS - human serum albumin (HSA) and ANS - bovine serum albumin (BSA) interaction, absorption spectra, concentration and molar extinction coefficient, as well as fluorescence quantum yield of the bound dye. It was found that HSA and BSA have two binding modes with significantly different affinity to ANS. Correct determination of the binding parameters of ligand-receptor interaction is important for fundamental investigations and practical aspects of molecule medicine and pharmaceutics. The data obtained for albumins are important in connection with their role as drugs transporters.	[Kuznetsova, Irina M.; Sulatskaya, Anna I.; Povarova, Olga I.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Kuznetsova, Irina M.] St Petersburg State Polytech Univ, Dept Biophys, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Peter the Great St. Petersburg Polytechnic University	Kuznetsova, IM (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@incras.ru	Sulatskaya, Anna/I-6042-2014; Kuznetsova, Irina M./R-9844-2017; Povarova, Olga I/F-9060-2017; Turoverov, Konstantin/S-2079-2016	Sulatskaya, Anna/0000-0002-1207-3384; Kuznetsova, Irina M./0000-0002-3336-4834; Povarova, Olga/0000-0003-1568-7493; Turoverov, Konstantin/0000-0002-6977-1896	Russian Academy of Sciences; Dmitry Zimin's Russian Charitable Foundation "Dynasty"	Russian Academy of Sciences(Russian Academy of Sciences); Dmitry Zimin's Russian Charitable Foundation "Dynasty"	This work was supported in part by the Program "Molecular and Cell Biology" of the Russian Academy of Sciences and Dmitry Zimin's Russian Charitable Foundation "Dynasty" (A.I.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2009, J AM CHEM SOC, V131, P17068, DOI 10.1021/ja908319m; ANUFRIEVA EV, 1994, VYSOKOMOL SOEDIN, V36, P449; Bagatolli LA, 1996, J PHARM SCI, V85, P1131, DOI 10.1021/js960142k; Bismuto E, 2001, BIOPHYS J, V81, P3510, DOI 10.1016/S0006-3495(01)75982-6; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Collini M, 2000, PROTEIN SCI, V9, P1968, DOI 10.1110/ps.9.10.1968; Dzwolak W, 2005, FEBS LETT, V579, P6601, DOI 10.1016/j.febslet.2005.10.048; Fan YX, 1998, PROTEIN SCI, V7, P2631, DOI 10.1002/pro.5560071217; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Georgiou ME, 1999, ANAL CHEM, V71, P2541, DOI 10.1021/ac981019b; Groenning M, 2009, J CHEM BIOL, DOI [10.1007/s12154-2009-0027-12155, DOI 10.1007/S12154-2009-0027-12155]; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hazra P, 2004, BIOCHEM BIOPH RES CO, V314, P543, DOI 10.1016/j.bbrc.2003.12.118; Ivy MA, 2012, CHEM SCI, V3, P1773, DOI 10.1039/c2sc20083j; JAIN TK, 1989, J PHYS CHEM-US, V93, P7409, DOI 10.1021/j100358a032; Konkoli Z, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-10; Kubarych CJ, 2010, ORG LETT, V12, P4780, DOI 10.1021/ol101906g; Kurganov BI, 2000, BIOPHYS CHEM, V87, P185; LEE AG, 1978, FEBS LETT, V94, P171, DOI 10.1016/0014-5793(78)80930-2; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; NAIK DV, 1975, J PHARM SCI, V64, P1677, DOI 10.1002/jps.2600641020; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Oravcova J, 1996, J CHROMATOGR B, V677, P1, DOI 10.1016/0378-4347(95)00425-4; PANJEHSHAHIN MR, 1989, BIOCHEM PHARMACOL, V38, P155, DOI 10.1016/0006-2952(89)90162-7; Peters T., 1996, ALL ALBUMIN BIOCH GE; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Takehara K, 2009, ANAL SCI, V25, P115, DOI 10.2116/analsci.25.115; Togashi DM, 2008, J FLUORESC, V18, P519, DOI 10.1007/s10895-007-0294-x; Togashi DM, 2010, BIOPHYS CHEM, V152, P55, DOI 10.1016/j.bpc.2010.07.006; Turoverov K K, 1998, Tsitologiia, V40, P806; Uversky VN, 1998, BBA-PROTEIN STRUCT M, V1388, P133, DOI 10.1016/S0167-4838(98)00173-3; Uversky VN, 1996, BIOPHYS CHEM, V60, P79, DOI 10.1016/0301-4622(96)00009-9; VARELA AS, 1992, J PHARM SCI, V81, P842, DOI 10.1002/jps.2600810825; Voropai E. S., 2003, Journal of Applied Spectroscopy, V70, P868, DOI 10.1023/B:JAPS.0000016303.37573.7e; WEBER G, 1964, J BIOL CHEM, V239, P1415; WEBER G, 1952, BIOCHEM J, V51, P155, DOI 10.1042/bj0510155	49	62	65	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40845	10.1371/journal.pone.0040845	http://dx.doi.org/10.1371/journal.pone.0040845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829890	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300028
J	Zhang, Q; Fan, XD; Wang, YJ; Sun, MA; Sun, SSM; Guo, DJ				Zhang, Qing; Fan, Xiaodan; Wang, Yejun; Sun, Mingan; Sun, Samuel S. M.; Guo, Dianjing			A Model-Based Method for Gene Dependency Measurement	PLOS ONE			English	Article							REGULATORY NETWORKS; EXPRESSION DATA; INFERENCE; ALGORITHM	Many computational methods have been widely used to identify transcription regulatory interactions based on gene expression profiles. The selection of dependency measure is very important for successful regulatory network inference. In this paper, we develop a new method-DBoMM (Difference in BIC of Mixture Models)-for estimating dependency of gene by fitting the gene expression profiles into mixture Gaussian models. We show that DBoMM out-performs 4 other existing methods, including Kendall's tau correlation (TAU), Pearson Correlation (COR), Euclidean distance (EUC) and Mutual information (MI) using Escherichia coli, Saccharomyces cerevisiae, Drosophila melanogaster, Arabidopsis thaliana data and synthetic data. DBoMM can also identify condition-dependent regulatory interactions and is robust to noisy data. Of the 741 Escherichia coli regulatory interactions inferred by DBoMM at a 60% true positive rate, 65 are previously known interactions and 676 are novel predictions. To validate the new prediction, the promoter sequences of target genes regulated by the same transcription factors were analyzed and significant motifs were identified.	[Zhang, Qing; Wang, Yejun; Sun, Mingan; Sun, Samuel S. M.; Guo, Dianjing] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Zhang, Qing; Wang, Yejun; Sun, Mingan; Sun, Samuel S. M.; Guo, Dianjing] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Fan, Xiaodan] Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Zhang, Q (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	djguo@cuhk.edu.hk	Sun, Mingan/D-7141-2019; Fan, Xiaodan/Q-2208-2018	Sun, Mingan/0000-0002-4661-3027; Fan, Xiaodan/0000-0002-2744-9030	Hong Kong UGC/AoE Plant & Agricultural Biotechnology Project [AoE-B-07/09]; Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK400709]	Hong Kong UGC/AoE Plant & Agricultural Biotechnology Project; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	This work is supported by a grant from Hong Kong UGC/AoE Plant & Agricultural Biotechnology Project AoE-B-07/09. Xiaodan Fan is partially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project no. CUHK400709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2010, NUCLEIC ACIDS RES, V39; Akutsu T, 1999, Pac Symp Biocomput, P17; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bailey TL, 1994, P INT C INT SYST MOL, V2, p[2836, 1994]; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Ben-Dor A., 1999, J COMPUT BIOL, V6; Ben-Dor A, 2000, J COMPUT BIOL, V7; Bolstad B, 2005, BIOINFORMATICS COMPU; Brent R, 1980, P NATL ACAD SCI USA, V77; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Butte AJ, 2000, PAC S BIOC PAC S BIO; Chen X, 2002, MOL BIOL CELL, V13; CRAIG NL, 1980, NATURE, V283, P26, DOI 10.1038/283026a0; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; DARI R, 1985, BIOCHIMIE, V67, P343, DOI 10.1016/S0300-9084(85)80077-8; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Davis GK, 2000, EUROPEAN J HEART FAI, V2; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Ding B, 2011, BIODIST DIFFERENT DI; Dudoit S, 1998, YEAST CELL CYCLE MIC; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2008, NUCLEIC ACIDS RES, V36; Fernndez De Henestrosa AR, 2000, MOL MICROBIOL, V35; Fraley C, 2007, AB BAF MU MAG KASH B; Fraley C, 2000, J AM STAT ASSOC, V97; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gama-Castro S, 2010, NUCL ACIDS RES; Geng W, 2003, GENETICS, V165, P1117; Ghosh S, 1987, AM STAT, V41; Hastie T, 2011, IMPUTE IMPUTE IMPUTA; Herwig R, 1999, GENOME RES, V9, P1093, DOI 10.1101/gr.9.11.1093; HERZEL H, 1995, PHYSICA A, V216, P518, DOI 10.1016/0378-4371(95)00104-F; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kilian J, 2007, PLANT J CELL MOL BIO, V50; Ko Younhee, 2010, Int J Bioinform Res Appl, V6, P402, DOI 10.1504/IJBRA.2010.036002; Ko Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-54; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kurths J, 2002, BIOINFORMATICS S2, V18; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matsushiro A, 1999, J BACTERIOL, V181; Michaels GS, 1998, PAC S BIOC PAC S BIO, P4253; Mnch R, 2003, NUCLEIC ACIDS RES, V31; Monteiro PT, 2007, NUCLEIC ACIDS RES, V36; Murali T, 2011, NUCLEIC ACIDS RES, V39; Nuzhdin SV, 2008, EVOL DEV, V10; OGAWA T, 1979, COLD SPRING HARB SYM, V43, P909, DOI 10.1101/SQB.1979.043.01.099; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pacifico S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-195; Priness I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-111; Qin XL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r63; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segal E, 2003, NAT GENET, V34; Shannon C. E., 2001, ACM SIGMOBILE MOBILE, V5, P355; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Team RDC, 2010, R LANG ENV STAT COMP; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; van Delft JHM, 2004, CARCINOGENESIS, V25; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Wanke D, 2010, INSIGHTS ARABIDOPSIS; Wu M, 2011, BRIEFINGS BIOINFORMA; Xing EP, 2001, ISMB SUPPL BIOINF 01; Ye C, 2007, BIOINFORMATICS, V23, pE84, DOI 10.1093/bioinformatics/btl315; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	72	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40918	10.1371/journal.pone.0040918	http://dx.doi.org/10.1371/journal.pone.0040918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829898	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300036
J	Higuera, C; Villaverde, AF; Banga, JR; Ross, J; Moran, F				Higuera, Clara; Villaverde, Alejandro F.; Banga, Julio R.; Ross, John; Moran, Federico			Multi-Criteria Optimization of Regulation in Metabolic Networks	PLOS ONE			English	Article							GENETIC-ALGORITHM; PATHWAYS	Determining the regulation of metabolic networks at genome scale is a hard task. It has been hypothesized that biochemical pathways and metabolic networks might have undergone an evolutionary process of optimization with respect to several criteria over time. In this contribution, a multi-criteria approach has been used to optimize parameters for the allosteric regulation of enzymes in a model of a metabolic substrate-cycle. This has been carried out by calculating the Pareto set of optimal solutions according to two objectives: the proper direction of flux in a metabolic cycle and the energetic cost of applying the set of parameters. Different Pareto fronts have been calculated for eight different "environments'' (specific time courses of end product concentrations). For each resulting front the so-called knee point is identified, which can be considered a preferred trade-off solution. Interestingly, the optimal control parameters corresponding to each of these points also lead to optimal behaviour in all the other environments. By calculating the average of the different parameter sets for the knee solutions more frequently found, a final and optimal consensus set of parameters can be obtained, which is an indication on the existence of a universal regulation mechanism for this system. The implications from such a universal regulatory switch are discussed in the framework of large metabolic networks.	[Higuera, Clara; Moran, Federico] Univ Complutense, Dept Biochem & Mol Biol, E-28040 Madrid, Spain; [Villaverde, Alejandro F.; Banga, Julio R.] Spanish Natl Res Council, Bio Proc Engn Grp IIM CSIC, Vigo, Spain; [Ross, John] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Stanford University	Moran, F (corresponding author), Univ Complutense, Dept Biochem & Mol Biol, E-28040 Madrid, Spain.	fmoran@bio.ucm.es	Banga, Julio R./ABD-8629-2020; Moran, Federico/L-1297-2014; Banga, Julio R./A-8388-2008; Villaverde, Alejandro F./B-8936-2015	Banga, Julio R./0000-0002-4245-0320; Moran, Federico/0000-0003-3992-8829; Banga, Julio R./0000-0002-4245-0320; Villaverde, Alejandro F./0000-0001-7401-7380	Ministerio de Economia y Competitividad [BFU 2009-12895-C02-02, PI2011-28112-C04-03]; Consejo Superior de Investigaciones Cientificas (CSIC) Intramural Project [PIE-201170E018]; EU [EC FP7-BBE-2011-5, 289434]; National Science Foundation [CHE 0847073]; Ministerio de Economia y Competitividad (Spain)	Ministerio de Economia y Competitividad(Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC) Intramural Project; EU(European Commission); National Science Foundation(National Science Foundation (NSF)); Ministerio de Economia y Competitividad (Spain)(Spanish Government)	Ministerio de Economia y Competitividad: grants BFU 2009-12895-C02-02 and Project MultiScales: PI2011-28112-C04-03 http://www.micinn.es/. Consejo Superior de Investigaciones Cientificas (CSIC) Intramural Project "BioREDES: PIE-201170E018 http://www.csic.es/. EU project BioPreDyn (EC FP7-BBE-2011-5 Grant number 289434). National Science Foundation: CHE 0847073 http://www.nsf.gov/. CH holds a FPI PhD scholarship from Ministerio de Economia y Competitividad (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Berg JM, 2006, BIOCHEMISTRY; Chubukov V, 2012, P NATL ACAD SCI USA, V109, P5127, DOI 10.1073/pnas.1114235109; Das I, 1998, SIAM J OPTIMIZ, V8, P631, DOI 10.1137/S1052623496307510; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Deb K, 2011, ENG OPTIMIZ, V43, P1175, DOI 10.1080/0305215X.2010.548863; Ebenhoh O, 2001, B MATH BIOL, V63, P21, DOI 10.1006/bulm.2000.0197; Egea JA, 2010, COMPUT OPER RES, V37, P315, DOI 10.1016/j.cor.2009.05.003; Esmaeili A, 2009, BIOSYSTEMS, V98, P127, DOI 10.1016/j.biosystems.2009.09.002; GILMAN A, 1995, BIOPHYS J, V69, P1321, DOI 10.1016/S0006-3495(95)79999-4; Goodacre R, 2005, J EXP BOT, V56, P245, DOI 10.1093/jxb/eri043; Guo HL, 2009, BIOSYSTEMS, V98, P193, DOI 10.1016/j.biosystems.2009.05.003; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; KOSKI J, 1987, INT J NUMER METH ENG, V24, P1101, DOI 10.1002/nme.1620240606; Marchisio MA, 2009, CURR OPIN BIOTECH, V20, P479, DOI 10.1016/j.copbio.2009.08.007; MELENDEZHEVIA E, 1994, J THEOR BIOL, V166, P201, DOI 10.1006/jtbi.1994.1018; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Miettinen K, 2012, NONLINEAR MULTIOBJEC, V12; MORAN F, 1984, BIOPHYS CHEM, V20, P149, DOI 10.1016/0301-4622(84)80014-9; Nielsen J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100169; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Sendin JOH, 2010, IET SYST BIOL, V4, P236, DOI 10.1049/iet-syb.2009.0045; Sendin JOH, 2009, IND ENG CHEM RES, V48, P3014, DOI 10.1021/ie800319m; Sendin JOH, 2009, ADV SOFT COMP, V49, P197; Sendin OH, 2006, MATH COMP MODEL DYN, V12, P469, DOI 10.1080/13873950600723442; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Tkacik G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031920; van Someren EP, 2003, SIGNAL PROCESS, V83, P763, DOI 10.1016/S0165-1684(02)00473-5; Walczak AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041905	30	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41122	10.1371/journal.pone.0041122	http://dx.doi.org/10.1371/journal.pone.0041122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848435	Green Published, gold			2022-12-27	WOS:000309240600016
J	Buhler, S; Nunes, JM; Nicoloso, G; Tiercy, JM; Sanchez-Mazas, A				Buhler, Stephane; Nunes, Jose Manuel; Nicoloso, Grazia; Tiercy, Jean-Marie; Sanchez-Mazas, Alicia			The Heterogeneous HLA Genetic Makeup of the Swiss Population	PLOS ONE			English	Article							HISTOCOMPATIBILITY TYPING TERMS; STEM-CELL TRANSPLANTATION; LEUKOCYTE ANTIGEN LOCI; BONE-MARROW DONORS; HAPLOTYPE FREQUENCIES; NATIONAL REGISTRY; ALLELES; DIVERSITY; DISEQUILIBRIUM; POLYMORPHISMS	This study aims at investigating the HLA molecular variation across Switzerland in order to determine possible regional differences, which would be highly relevant to several purposes: optimizing donor recruitment strategies in hematopoietic stem cell transplantation (HSCT), providing reliable reference data in HLA and disease association studies, and understanding the population genetic background(s) of this culturally heterogeneous country. HLA molecular data of more than 20,000 HSCT donors from 9-13 recruitment centers of the whole country were analyzed. Allele and haplotype frequencies were estimated by using new computer tools adapted to the heterogeneity and ambiguity of the data. Nonparametric and resampling statistical tests were performed to assess Hardy-Weinberg equilibrium, selective neutrality and linkage disequilibrium among different loci, both in each recruitment center and in the whole national registry. Genetic variation was explored through genetic distance and hierarchical analysis of variance taking into account both geographic and linguistic subdivisions in Switzerland. The results indicate a heterogeneous genetic makeup of the Swiss population: first, allele frequencies estimated on the whole national registry strongly deviate from Hardy-Weinberg equilibrium, by contrast with the results obtained for individual centers; second, a pronounced differentiation is observed for Ticino, Graubunden, and, to a lesser extent, Wallis, suggesting that the Alps represent(ed) a barrier to gene flow; finally, although cultural (linguistic) boundaries do not represent a main genetic differentiation factor in Switzerland, the genetic relatedness between population from south-eastern Switzerland and Italy agrees with historical and linguistic data. Overall, this study justifies the maintenance of a decentralized donor recruitment structure in Switzerland allowing increasing the genetic diversity of the national-and hence global-donor registry. It also indicates that HLA data of local donor recruitment centers can be used as reference data in both epidemiological and population genetic studies focusing on the genetic history of present European populations.	[Buhler, Stephane; Nunes, Jose Manuel; Sanchez-Mazas, Alicia] Univ Geneva, Lab Anthropol Genet & Peopling Hist, Dept Genet & Evolut, Anthropol Unit, Geneva, Switzerland; [Nicoloso, Grazia] Fdn Swiss Blood Stem Cells, Bern, Switzerland; [Tiercy, Jean-Marie] Univ Hosp Geneva, Natl Reference Lab Histocompatibil, Geneva, Switzerland	University of Geneva; University of Geneva	Buhler, S (corresponding author), Univ Geneva, Lab Anthropol Genet & Peopling Hist, Dept Genet & Evolut, Anthropol Unit, Geneva, Switzerland.	stephane.buhler@unige.ch		Buhler, Stephane/0000-0001-6675-5287; SANCHEZ-MAZAS, Alicia/0000-0002-7714-2432	Swiss State Secretariat for Education and Research (SER) [C08.0131]; European Science Foundation (ESF COST Action) [BM0803]; Swiss National Science Foundation (FNS) [3100-49771.96, 3100A0-112651]	Swiss State Secretariat for Education and Research (SER); European Science Foundation (ESF COST Action); Swiss National Science Foundation (FNS)(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Swiss State Secretariat for Education and Research (SER grant #C08.0131), by the European Science Foundation (ESF COST Action BM0803 "HLA-NET"), and by the Swiss National Science Foundation (FNS # 3100-49771.96 and 3100A0-112651 to A. Sanchez-Mazas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bettens F, 2012, BIOL BLOOD MARROW TR, V18, P608, DOI 10.1016/j.bbmt.2011.09.011; Bodmer J, 1997, HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL I: WORKSHOP, P269; Brown J, 2000, BONE MARROW TRANSPL, V25, P475, DOI 10.1038/sj.bmt.1702197; Buhler S, 2006, TISSUE ANTIGENS, V68, P44, DOI 10.1111/j.1399-0039.2006.00621.x; Buhler S, 2007, THESIS U GENEVE GENE; Buhler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014643; Buhler S, 2010, TISSUE ANTIGENS, V75, P500, DOI 10.1111/j.1399-0039.2010.01469.x; Castelli EC, 2010, TISSUE ANTIGENS; Claas F, 2011, HLA NET MC WG M COST; Currat M, 1999, THESIS U GENEVE GENE; Currat M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-237; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eberhard HP, 2010, TISSUE ANTIGENS, V76, P352, DOI 10.1111/j.1399-0039.2010.01518.x; Excoffier L, 2003, SCIENCE, V300; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; GRUNDSCHOBER C, 1994, EUR J IMMUNOGENET, V21, P143, DOI 10.1111/j.1744-313X.1994.tb00186.x; Hollenbach JA, 2011, TISSUE ANTIGENS, V78, P333, DOI 10.1111/j.1399-0039.2011.01777.x; Irwin DE, 2002, EVOLUTION, V56, P2383; Johansen KA, 2008, TRANSFUSION MED, V18, P250, DOI 10.1111/j.1365-3148.2008.00865.x; Kollman C, 2004, TRANSPLANTATION, V78, P89, DOI 10.1097/01.TP.0000132327.40702.97; Kollman C, 2007, HUM IMMUNOL, V68, P950, DOI 10.1016/j.humimm.2007.10.009; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LONG JC, 1995, AM J HUM GENET, V56, P799; LONJOU C, 1995, TRANSPLANTATION, V60, P375, DOI 10.1097/00007890-199508270-00013; Mack SJ, 2007, TISSUE ANTIGENS, V69, P188, DOI 10.1111/j.1399-0039.2006.00768.x; Mack SJ, 2009, TISSUE ANTIGENS, V73, P17, DOI 10.1111/j.1399-0039.2008.01151.x; Mack S. J., 2006, IMMUNOBIOLOGY HUMAN, P580; Mack SJ, 2006, IMMUNOBIOLOGY HUMAN, P564; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Manni F, 2010, HUM BIOL, V82, P457, DOI 10.3378/027.082.0407; MANTEL N, 1967, CANCER RES, V27, P209; Marsh SGE, 2010, BONE MARROW TRANSPL, V45, P846, DOI 10.1038/bmt.2010.79; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Meyer-Monard S, 2009, BONE MARROW TRANSPL, V43, P771, DOI 10.1038/bmt.2008.391; Michalakis Y, 1996, GENETICS, V142, P1061; Muller CR, 2003, HUM IMMUNOL, V64, P137, DOI 10.1016/S0198-8859(02)00706-1; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Nunes E, 2011, BLOOD, V118, pE180, DOI 10.1182/blood-2011-05-353490; Nunes E, 2011, HUM IMMUNOL, V72, P1214, DOI 10.1016/j.humimm.2011.06.002; Nunes J, 2006, IMMUNOBIOLOGY HUMAN, P143; Nunes J, 2005, THESIS U PORTO; Nunes JM, 2009, COST MC WG M COST AC; Nunes JM, 2006, GENERATE TOOLS ANAL; Nunes JM, 2011, HUM BIOL, V83, P437, DOI 10.3378/027.083.0307; Rendine S, 1998, TISSUE ANTIGENS, V52, P135, DOI 10.1111/j.1399-0039.1998.tb02277.x; REYNOLDS J, 1983, GENETICS, V105, P767; Robinson James, 2007, V409, P43, DOI 10.1007/978-1-60327-118-9_3; Rohlf F.J., 2000, NTSYSPC NUMERICAL TA; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sanchez-Mazas A, 2000, TISSUE ANTIGENS, V56, P303, DOI 10.1034/j.1399-0039.2000.560402.x; Sanchez-Mazas A, 2001, HUM IMMUNOL, V62, P937, DOI 10.1016/S0198-8859(01)00293-2; Sanchez-Mazas A, 2012, INT J IMMUNOGENET; Sanchez-Mazas A, 2007, TISSUE ANTIGENS, V69, P198, DOI 10.1111/j.1399-0039.2006.00802.x; Sanchez-Mazas A, 2012, PHILOS T R SOC B, V367, P830, DOI 10.1098/rstb.2011.0312; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; SANCHEZMAZAS A, 2009, PEUPLEMENT MEDITERRA, P15; Schlenk RF, 2010, J CLIN ONCOL, V28, P4642, DOI 10.1200/JCO.2010.28.6856; Schmidt AH, 2010, TISSUE ANTIGENS, V76, P362, DOI 10.1111/j.1399-0039.2010.01520.x; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shaw BE, 2010, BRIT J HAEMATOL, V150, P251, DOI 10.1111/j.1365-2141.2010.08224.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Venables WN., 2002, MODERN APPL STAT S 4; Zapata C, 2001, ANN HUM GENET, V65, P395, DOI 10.1017/S0003480001008697	70	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41400	10.1371/journal.pone.0041400	http://dx.doi.org/10.1371/journal.pone.0041400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848484	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600061
J	Gavello, D; Rojo-Ruiz, J; Marcantoni, A; Franchino, C; Carbone, E; Carabelli, V				Gavello, Daniela; Rojo-Ruiz, Jonathan; Marcantoni, Andrea; Franchino, Claudio; Carbone, Emilio; Carabelli, Valentina			Leptin Counteracts the Hypoxia-Induced Inhibition of Spontaneously Firing Hippocampal Neurons: A Microelectrode Array Study	PLOS ONE			English	Article							GLUCOSE DEPRIVATION; CALCIUM-CHANNELS; OXIDATIVE STRESS; CA1 NEURONS; K+ CHANNELS; ACTIVATION; EXPRESSION; RECEPTOR; NETWORKS; OXYGEN	Besides regulating energy balance and reducing body-weight, the adipokine leptin has been recently shown to be neuroprotective and antiapoptotic by promoting neuronal survival after excitotoxic and oxidative insults. Here, we investigated the firing properties of mouse hippocampal neurons and the effects of leptin pretreatment on hypoxic damage (2 hours, 3% O-2). Experiments were carried out by means of the microelectrode array (MEA) technology, monitoring hippocampal neurons activity from 11 to 18 days in vitro (DIV). Under normoxic conditions, hippocampal neurons were spontaneously firing, either with prevailing isolated and randomly distributed spikes (11 DIV), or with patterns characterized by synchronized bursts (18 DIV). Exposure to hypoxia severely impaired the spontaneous activity of hippocampal neurons, reducing their firing frequency by 54% and 69%, at 11 and 18 DIV respectively, and synchronized their firing activity. Pretreatment with 50 nM leptin reduced the firing frequency of normoxic neurons and contrasted the hypoxia-induced depressive action, either by limiting the firing frequency reduction (at both ages) or by increasing it to 126% (in younger neurons). In order to find out whether leptin exerts its effect by activating large conductance Ca2+-activated K+ channels (BK), as shown on rat hippocampal neurons, we applied the BK channel blocker paxilline (1 mu M). Our data show that paxilline reversed the effects of leptin, both on normoxic and hypoxic neurons, suggesting that the adipokine counteracts hypoxia through BK channels activation in mouse hippocampal neurons.	[Gavello, Daniela; Rojo-Ruiz, Jonathan; Marcantoni, Andrea; Franchino, Claudio; Carbone, Emilio; Carabelli, Valentina] Univ Turin, CNISM, NIS Ctr, Dept Drug Sci & Technol, Turin, Italy	University of Turin	Gavello, D (corresponding author), Univ Turin, CNISM, NIS Ctr, Dept Drug Sci & Technol, Turin, Italy.	valentina.carabelli@unito.it	Rojo, Jonathan/K-5942-2014; carabelli, valentina/AAN-1998-2020; Carbone, Emilio/W-5763-2019; MARCANTONI, Andrea/S-1288-2017	Rojo, Jonathan/0000-0003-1155-2858; carabelli, valentina/0000-0002-8718-1208; Carbone, Emilio/0000-0003-2239-6280; MARCANTONI, Andrea/0000-0001-5825-7827; GAVELLO, Daniela/0000-0001-5882-4836	San Paolo Foundation [2008.1155]; Marie Curie Research Training Network "CavNET" [MRTN-CT-2006-035367]	San Paolo Foundation(Compagnia di San Paolo); Marie Curie Research Training Network "CavNET"	This work was supported by the San Paolo Foundation, Grant # 2008.1155 to V. C. (Neuroscience Programme), and by the Marie Curie Research Training Network "CavNET" Contract MRTN-CT-2006-035367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Berretta N, 2011, J PHYSL 10, V588, P1719; Bertinaria M, 2011, J MED CHEM, V54, P611, DOI 10.1021/jm101394n; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Cai ZY, 2009, NEUROCHEM RES, V34, P1226, DOI 10.1007/s11064-008-9899-y; Chen CP, 2006, BIOSYSTEMS, V85, P137, DOI 10.1016/j.biosystems.2005.12.006; Cohen D, 2011, J NEUROPHYSIOL, V106, P2314, DOI 10.1152/jn.00969.2010; Dal-Cim T, 2011, NEUROSCIENCE, V183, P212, DOI 10.1016/j.neuroscience.2011.03.022; Galan RF, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00131; Geracitano R, 2005, J PHYSIOL-LONDON, V568, P97, DOI 10.1113/jphysiol.2005.092510; Greco SJ, 2011, BIOCHEM BIOPH RES CO, V414, P170, DOI 10.1016/j.bbrc.2011.09.050; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hepp S, 2005, J NEUROPHYSIOL, V94, P1091, DOI 10.1152/jn.00291.2005; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Huang L, 2009, EUR J PHARMACOL, V602, P238, DOI 10.1016/j.ejphar.2008.11.053; Huang XF, 1996, NEUROREPORT, V7, P2635, DOI 10.1097/00001756-199611040-00045; Jayalakshmi K, 2005, BRAIN RES, V1046, P97, DOI 10.1016/j.brainres.2005.03.054; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kumral A, 2012, J MATERN-FETAL NEO M, V25, P141, DOI 10.3109/14767058.2011.565834; Li XN, 2007, BIOSENS BIOELECTRON, V22, P1538, DOI 10.1016/j.bios.2006.05.030; Li YL, 2007, BIOSENS BIOELECTRON, V22, P2976, DOI 10.1016/j.bios.2006.12.018; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015601; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Lukyanetz EA, 2003, BBA-BIOMEMBRANES, V1618, P33, DOI 10.1016/j.bbamem.2003.10.003; MacLaren EJ, 2011, MOL CELL NEUROSCI, V47, P93, DOI 10.1016/j.mcn.2010.12.014; Marcantoni A, 2007, CELL CALCIUM, V42, P397, DOI 10.1016/j.ceca.2007.04.015; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Merlo S, 2010, TRENDS ENDOCRIN MET, V21, P537, DOI 10.1016/j.tem.2010.05.005; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Runden-Pran E, 2002, NEUROSCIENCE, V112, P277, DOI 10.1016/S0306-4522(02)00092-1; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Shanley LJ, 2002, J PHYSIOL-LONDON, V545, P933, DOI 10.1113/jphysiol.2002.029488; Shanley LJ, 2002, NAT NEUROSCI, V5, P299, DOI 10.1038/nn824; Stett A, 2003, ANAL BIOANAL CHEM, V377, P486, DOI 10.1007/s00216-003-2149-x; Swensen AM, 2003, J NEUROSCI, V23, P9650; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Vandael DH, 2010, MOL NEUROBIOL, V42, P185, DOI 10.1007/s12035-010-8151-3; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wahl AS, 2009, NEUROSCIENCE, V158, P344, DOI 10.1016/j.neuroscience.2008.06.018; Walker CD, 2007, J NEUROSCI RES, V85, P816, DOI 10.1002/jnr.21173; Weng Z, 2007, J BIOL CHEM, V282, P34479, DOI 10.1074/jbc.M705426200; Yamamoto S, 1997, J NEUROPHYSIOL, V77, P386, DOI 10.1152/jn.1997.77.1.386; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; Zhang JY, 2011, EUR J PHARMACOL, V671, P61, DOI 10.1016/j.ejphar.2011.09.170	53	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41530	10.1371/journal.pone.0041530	http://dx.doi.org/10.1371/journal.pone.0041530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848520	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600079
J	Reinius, LE; Acevedo, N; Joerink, M; Pershagen, G; Dahlen, SE; Greco, D; Soderhall, C; Scheynius, A; Kere, J				Reinius, Lovisa E.; Acevedo, Nathalie; Joerink, Maaike; Pershagen, Goran; Dahlen, Sven-Erik; Greco, Dario; Soderhall, Cilla; Scheynius, Annika; Kere, Juha			Differential DNA Methylation in Purified Human Blood Cells: Implications for Cell Lineage and Studies on Disease Susceptibility	PLOS ONE			English	Article							WIDE ASSOCIATION; GENOME; MICROARRAY; METHYLOME; EPIGENOME	Methylation of cytosines at CpG sites is a common epigenetic DNA modification that can be measured by a large number of methods, now even in a genome-wide manner for hundreds of thousands of sites. The application of DNA methylation analysis is becoming widely popular in complex disorders, for example, to understand part of the "missing heritability". The DNA samples most readily available for methylation studies are derived from whole blood. However, blood consists of many functionally and developmentally distinct cell populations in varying proportions. We studied whether such variation might affect the interpretation of methylation studies based on whole blood DNA. We found in healthy male blood donors there is important variation in the methylation profiles of whole blood, mononuclear cells, granulocytes, and cells from seven selected purified lineages. CpG methylation between mononuclear cells and granulocytes differed for 22% of the 8252 probes covering the selected 343 genes implicated in immune-related disorders by genome-wide association studies, and at least one probe was differentially methylated for 85% of the genes, indicating that whole blood methylation results might be unintelligible. For individual genes, even if the overall methylation patterns might appear similar, a few CpG sites in the regulatory regions may have opposite methylation patterns (i.e., hypo/hyper) in the main blood cell types. We conclude that interpretation of whole blood methylation profiles should be performed with great caution and for any differences implicated in a disorder, the differences resulting from varying proportions of white blood cell types should be considered.	[Reinius, Lovisa E.; Greco, Dario; Soderhall, Cilla; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Acevedo, Nathalie; Joerink, Maaike; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Translat Immunol Unit, Stockholm, Sweden; [Pershagen, Goran; Dahlen, Sven-Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Kere, Juha] Sci Life Lab, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Helsinki	Reinius, LE (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	juha.kere@ki.se	Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Reinius, Lovisa/C-4555-2014; Greco, Dario/T-7113-2019; Söderhäll, Cilla/E-3940-2012	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Reinius, Lovisa/0000-0001-5029-0120; Greco, Dario/0000-0001-9195-9003; Söderhäll, Cilla/0000-0002-8397-3080; Acevedo, Nathalie/0000-0002-5154-2964; Pershagen, Goran/0000-0002-9701-1130	Swedish Foundation for Strategic Research [RBc08-0027]; Swedish Research Council; Osher Initiative for Research on Severe Asthma at Karolinska Institutet; Karolinska Institutet; Marie Curie Intra-European Fellowship [PIEF-GA-2008-219680]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Osher Initiative for Research on Severe Asthma at Karolinska Institutet; Karolinska Institutet(Karolinska Institutet); Marie Curie Intra-European Fellowship(European Commission)	This study was supported by a grant from the Swedish Foundation for Strategic Research (RBc08-0027) and the Swedish Research Council. LER was supported by the Osher Initiative for Research on Severe Asthma at Karolinska Institutet, NA was supported by a PhD grant from Karolinska Institutet, and MJ was supported by a Marie Curie Intra-European Fellowship (PIEF-GA-2008-219680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Moundhri MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015585; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Cheong HS, 2011, ALLERGY, V66, P637, DOI 10.1111/j.1398-9995.2010.02514.x; Choi JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013020; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016506; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isagawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026052; Jeffries MA, 2011, EPIGENETICS-US, V6, P593, DOI 10.4161/epi.6.5.15374; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Johansson C, 2009, INT ARCH ALLERGY IMM, V150, P51, DOI 10.1159/000210380; Kitamura E, 2007, GENOMICS, V89, P326, DOI 10.1016/j.ygeno.2006.11.006; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Liang P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-231; Lin SY, 2012, GENES IMMUN, V13, P214, DOI 10.1038/gene.2011.74; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Nadeau K, 2010, J ALLERGY CLIN IMMUN, V126, P845, DOI 10.1016/j.jaci.2010.08.008; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Pedersen KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018223; Prokunina-Olsson L, 2009, HUM MOL GENET, V18, P3795, DOI 10.1093/hmg/ddp321; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Toperoff G, 2011, HUM MOL GENET; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Zaidi SK, 2011, J BIOL CHEM, V286, P18355, DOI 10.1074/jbc.R110.197061; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	47	680	695	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41361	10.1371/journal.pone.0041361	http://dx.doi.org/10.1371/journal.pone.0041361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848472	Green Published, gold			2022-12-27	WOS:000306806600056
J	Farbstein, R; Radic, D; Brajkovic, D; Miracle, PT				Farbstein, Rebecca; Radic, Dinko; Brajkovic, Dejana; Miracle, Preston T.			First Epigravettian Ceramic Figurines from Europe (Vela Spila, Croatia)	PLOS ONE			English	Article							EASTERN-EUROPE; CAVE	Recent finds of 36 ceramic artifacts from the archaeological site of Vela Spila, Croatia, offer the first evidence of ceramic figurative art in late Upper Palaeolithic Europe, c. 17,500-15,000 years before present ( BP). The size and diversity of this artistic ceramic assemblage indicate the emergence of a social tradition, rather than more ephemeral experimentation with a new material. Vela Spila ceramics offer compelling technological and stylistic comparisons with the only other evidence of a developed Palaeolithic ceramic tradition found at the sites of Pavlov I and Dolni Vestonice I, in the Czech Republic, c. 31,000-27,000 cal BP. Because of the 10,000-year gap between the two assemblages, the Vela Spila ceramics are interpreted as evidence of an independent invention of this technology. Consequently, these artifacts provide evidence of a new social context in which ceramics developed and were used to make art in the Upper Palaeolithic.	[Farbstein, Rebecca] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Radic, Dinko] Ctr Culture Archaeol Collect, Vela Luka, Croatia; [Brajkovic, Dejana] Croatian Acad Sci & Arts, Inst Quaternary Paleontol & Geol, Zagreb, Croatia; [Miracle, Preston T.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England	University of Cambridge; Croatian Academy of Sciences & Arts; University of Cambridge	Farbstein, R (corresponding author), Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England.	rebecca.farbstein@gmail.com			Ministry of Science, Education and Sports of Republic of Croatia [101-2690680-2270]; University of Cambridge; St. John's College, Cambridge	Ministry of Science, Education and Sports of Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); University of Cambridge(University of Cambridge); St. John's College, Cambridge	Research at Vela Spila was supported by the Ministry of Science, Education and Sports of the Republic of Croatia (Project 101-2690680-2270). Travel grants were provided by the University of Cambridge and St. John's College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adovasio JD, 1997, I PAVLOV NW UPPER PA, P403; Boaretto E, 2009, P NATL ACAD SCI USA, V106, P9595, DOI 10.1073/pnas.0900539106; Bougard E, 2010, BRIT ARCHAEOLOGICAL, V2069; Cecuk B, 2005, VELA SPILA; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Dolukhanov P, 2001, J ARCHAEOL SCI, V28, P699, DOI 10.1006/jasc.2000.0579; Einwogerer T, 2000, MITTEILUNGEN PRAHIST; Farbstein R, 2011, CURR ANTHROPOL, V52, P401, DOI 10.1086/660057; Farbstein R, 2011, J ARCHAEOL METHOD TH, V18, P125, DOI 10.1007/s10816-010-9085-9; Fugazzola Delpino M. A., 2002, CERAMICHE IMPRESSE N, P373; Kralik M, 2005, I PAVLOV SE WINDOW G, P449; Novotny M., 2002, ANTHROPOLOGIE, V40, P107; Pawlikowski M, 2000, ARCHAEOLOGY ETHNOLOG, V4, P19; Saxon EC, 1976, P PREHIST SOC, V42, P327; Sinopoli C.M., 1991, APPROACHES ARCHAEOLO; Smith CS, 1981, SEARCH STRUCTURE SEL, P242; Soffer O, 2000, ANTIQUITY, V74, P812, DOI 10.1017/S0003598X00060464; Soffer O, 1994, I PAVLOV EXCAVATIONS, P163; Soffer O., 1993, LASCAUX COMPLEX RECO, P259; Soffer O, 2005, I PAVLOV SE WINDOW G, P415; Soffer O, 1997, I PAVLOV NW UPPER PA, P383; Spry-Marques VP, BRIT ARCHAE IN PRESS; VANDIVER PB, 1989, SCIENCE, V246, P1002, DOI 10.1126/science.246.4933.1002; Vandiver PB, 2002, MATER RES SOC SYMP P, V712, P421; Verpoorte A, 2001, TRACES ART PLACES FI; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002	26	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41437	10.1371/journal.pone.0041437	http://dx.doi.org/10.1371/journal.pone.0041437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	978NX	22848495	Green Accepted, gold, Green Published			2022-12-27	WOS:000306751300040
J	Fels, J; Jeggle, P; Kusche-Vihrog, K; Oberleithner, H				Fels, Johannes; Jeggle, Pia; Kusche-Vihrog, Kristina; Oberleithner, Hans			Cortical Actin Nanodynamics Determines Nitric Oxide Release in Vascular Endothelium	PLOS ONE			English	Article								The release of the main vasodilator nitric oxide (NO) by the endothelial NO synthase (eNOS) is a hallmark of endothelial function. We aim at elucidating the underlying mechanism how eNOS activity depends on cortical stiffness (K-cortex) of living endothelial cells. It is hypothesized that cortical actin dynamics determines K-cortex and directly influences eNOS activity. By combined atomic force microscopy and fluorescence imaging we generated mechanical and optical sections of single living cells. This approach allows the discrimination between K-cortex and bulk cell stiffness (K-bulk) and, additionally, the simultaneous analysis of submembranous actin web dynamics. We show that K-cortex softens when cortical F-actin depolymerizes and that this shift from a gel-like stiff cortex to a soft G-actin rich layer, triggers the stiffness-sensitive eNOS activity. The results implicate that stiffness changes in the similar to 100 nm phase of the submembranous actin web, without affecting K-bulk, regulate NO release and thus determines endothelial function.	[Fels, Johannes; Jeggle, Pia; Kusche-Vihrog, Kristina; Oberleithner, Hans] Univ Munster, Inst Physiol 2, Munster, Germany	University of Munster	Fels, J (corresponding author), Univ Munster, Inst Physiol 2, Munster, Germany.	felsj@uni-muenster.de			graduate program "Cell Dynamics and Disease" of the University of Muenster; Deutsche Forschungsgemeinschaft [OB 63/17-1, OB 63/18]	graduate program "Cell Dynamics and Disease" of the University of Muenster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work was supported by the graduate program "Cell Dynamics and Disease" of the University of Muenster (international PhD scholarship to first author) and by grants from the Deutsche Forschungsgemeinschaft (OB 63/17-1 and Koselleck Grant OB 63/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 1998, ISOLATION CHARACTERI; Barrera NP, 2008, DETERMINATION ARCHIT; Callies C, 2011, MEMBRANE POTENTIAL D; Callies C, 2009, SIMULTANEOUS MECH ST; Carl P, 2008, ELASTICITY MEASUREME; Cooper JA, 1987, EFFECTS CYTOCHALASIN; Deibler M, 2011, ACTIN FUSION PROTEIN; Fels J, 2010, NITRIC OXIDE RELEASE; Francis LW, 2010, ATOMIC FORCE MICROSC; Franz CM, 2011, METHODS MOL BIOL, V736, P97, DOI 10.1007/978-1-61779-105-5_7; Grinspan JB, 1983, BOVINE ENDOTHELIAL C; Hinterdorfer P, 2006, DETECTION LOCALIZATI; Hofmann UG, 1997, INVESTIGATING CYTOSK; Ju H, 1997, DIRECT INTERACTION E; Kasas S, 2008, PROBING NANOMECHANIC; Kasas S, 2005, SUPERFICIAL DEEP CHA; Kliche K, 2011, ROLE CELLULAR MECH F; Kofuji P, 2004, POTASSIUM BUFFERING; Kojima H, 1999, FLUORESCENT INDICATO; Kondrikov D, 2010, BETA ACTIN ASS ENDOT; Lang F, 2011, STIFF ENDOTHELIAL CE; Laurent VM, 2005, GRADIENT RIGIDITY LA; Martens JC, 2008, SOFTENING ACTIN CYTO; Miranda AF, 1974, ACTION CYTOCHALASIN; Muller DJ, 2009, NEW FRONTIERS ATOMIC; Naseem KM, 2005, ROLE NITRIC OXIDE CA; Nordsborg N, 2003, MUSCLE INTERSTITIAL; Oberleithner H, 2009, POTASSIUM SOFTENS VA; Oberleithner H, 2005, ALDOSTERONE MAKES HU; Oberleithner H, 2007, PLASMA SODIUM STIFFE; Oberleithner H, 2011, SODIUM WOLF SHEEPS C; Oberleithner H, 2006, ALDOSTERONE REMODELS; Oberleithner H, 2010, ENDOTHELIAL CELLS VA; Palmer RM, 1987, NITRIC OXIDE RELEASE; Pedersen SF, 2001, CYTOSKELETON CELL VO; Pesen D, 2005, MICROMECHANICAL ARCH; Riedl J, 2008, LIFEACT VERSATILE MA; Roduit C, 2009, STIFFNESS TOMOGRAPHY; Rotsch C, 1999, DIMENSIONAL MECH DYN; Rotsch C, 2000, DRUG INCUCED CHANGES; Sanchez D, 2008, NONCONTACT MEASUREME; Schillers H, 2010, REAL TIME MONITORING; Sokolov I, 2006, RECOVERY ELASTICITY; Stewart MP, 2011, HYDROSTATIC PRESSURE; Szczygiel AM, 2011, ELASTICITY CHANGES A; Trepat X, 2007, UNIVERSAL PHYS RESPO	46	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41520	10.1371/journal.pone.0041520	http://dx.doi.org/10.1371/journal.pone.0041520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844486	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700098
J	Huber-Keener, KJ; Liu, XP; Wang, Z; Wang, YQ; Freeman, W; Wu, S; Planas-Silva, MD; Ren, XC; Cheng, Y; Zhang, Y; Vrana, K; Liu, CG; Yang, JM; Wu, RL				Huber-Keener, Kathryn J.; Liu, Xiuping; Wang, Zhong; Wang, Yaqun; Freeman, Willard; Wu, Song; Planas-Silva, Maricarmen D.; Ren, Xingcong; Cheng, Yan; Zhang, Yi; Vrana, Kent; Liu, Chang-Gong; Yang, Jin-Ming; Wu, Rongling			Differential Gene Expression in Tamoxifen-Resistant Breast Cancer Cells Revealed by a New Analytical Model of RNA-Seq Data	PLOS ONE			English	Article							MICROARRAY DATA-ANALYSIS; NUCLEAR FACTOR 4-ALPHA; ESTROGEN-RECEPTOR; ENDOCRINE RESISTANCE; GROWTH; PROLIFERATION; PROGRESSION; TARGETS; ENZYMES; ALPHA	Resistance to tamoxifen (Tam), a widely used antagonist of the estrogen receptor (ER), is a common obstacle to successful breast cancer treatment. While adjuvant therapy with Tam has been shown to significantly decrease the rate of disease recurrence and mortality, recurrent disease occurs in one third of patients treated with Tam within 5 years of therapy. A better understanding of gene expression alterations associated with Tam resistance will facilitate circumventing this problem. Using a next generation sequencing approach and a new bioinformatics model, we compared the transcriptomes of Tam-sensitive and Tam-resistant breast cancer cells for identification of genes involved in the development of Tam resistance. We identified differential expression of 1215 mRNA and 513 small RNA transcripts clustered into ER alpha functions, cell cycle regulation, transcription/translation, and mitochondrial dysfunction. The extent of alterations found at multiple levels of gene regulation highlights the ability of the Tam-resistant cells to modulate global gene expression. Alterations of small nucleolar RNA, oxidative phosphorylation, and proliferation processes in Tam-resistant cells present areas for diagnostic and therapeutic tool development for combating resistance to this anti-estrogen agent.	[Huber-Keener, Kathryn J.; Freeman, Willard; Planas-Silva, Maricarmen D.; Ren, Xingcong; Cheng, Yan; Zhang, Yi; Vrana, Kent; Yang, Jin-Ming] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pharmacol,Penn State Canc Inst, Hershey, PA 17033 USA; [Wang, Zhong; Wang, Yaqun; Wu, Rongling] Penn State Univ, Coll Med, Ctr Stat Genet, Hershey, PA 17033 USA; [Liu, Xiuping; Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Wu, Song] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Texas System; UTMD Anderson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Huber-Keener, KJ (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pharmacol,Penn State Canc Inst, Hershey, PA 17033 USA.	cgliu@mdanderson.org; juy16@psu.edu; rwu@hes.hmc.psu.edu	Freeman, Willard/GYQ-5841-2022; Wang, Zhong/C-3737-2014	Huber-Keener, Kathryn/0000-0002-1981-7251; Vrana, Kent/0000-0003-4902-7733; Freeman, Willard/0000-0001-7027-999X	Penn State College of Medicine	Penn State College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study is supported by the Penn State College of Medicine and a gift from the Elsa U. Pardee Foundation: http://www.pardeefoundation.org/ (J. Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; AKAIKE H, 1981, CC/ENG TECH APPL SCI, P22; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Butte A J, 2001, Pac Symp Biocomput, P6; Cardoso CMP, 2001, TOXICOL APPL PHARM, V176, P145, DOI 10.1006/taap.2001.9265; Clarke R, 2001, J STEROID BIOCHEM, V76, P71, DOI 10.1016/S0960-0760(00)00193-X; Clarke R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2870; Cordero Francesca, 2007, Briefings in Functional Genomics & Proteomics, V6, P265, DOI 10.1093/bfgp/elm034; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dorssers LCJ, 2001, DRUGS, V61, P1721, DOI 10.2165/00003495-200161120-00004; Dumont JA, 1996, CELL GROWTH DIFFER, V7, P351; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gao Dexiang, 2010, Human Genomics, V5, P56; Garcia V, 2008, CANCER LETT, V263, P312, DOI 10.1016/j.canlet.2008.01.008; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Honma N, 2008, J CLIN ONCOL, V26, P3727, DOI 10.1200/JCO.2007.14.2968; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Huang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022274; Huang WC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr592; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Jia L, 1996, BLOOD, V87, P2401, DOI 10.1182/blood.V87.6.2401.bloodjournal8762401; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Kilker RL, 2004, J STEROID BIOCHEM, V92, P63, DOI 10.1016/j.jsbmb.2004.05.005; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Liu M, 2011, FEBS LETT, V585, P2998, DOI 10.1016/j.febslet.2011.08.014; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Luo JQ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2616; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Masri S, 2008, CANCER RES, V68, P4910, DOI 10.1158/0008-5472.CAN-08-0303; Mendes-Pereira AM, 2011, P NATL ACAD SCI US; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Omoto Yoko, 2002, Breast Cancer, V9, P308, DOI 10.1007/BF02967609; Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Santen RJ, 2005, ENDOCR-RELAT CANCER, V12, pS61, DOI 10.1677/erc.1.01018; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Sugai M, 2008, PATHOL INT, V58, P681, DOI 10.1111/j.1440-1827.2008.02293.x; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001	54	43	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41333	10.1371/journal.pone.0041333	http://dx.doi.org/10.1371/journal.pone.0041333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844461	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700073
J	Vinzon, SE; Marino-Buslje, C; Rivera, E; Bonino, MBD				Vinzon, Sabrina E.; Marino-Buslje, Cristina; Rivera, Elena; de Jimenez Bonino, Mirtha Biscoglio			A Naturally Occurring Hypoallergenic Variant of Vespid Antigen 5 from Polybia scutellaris Venom as a Candidate for Allergen-Specific Immunotherapy	PLOS ONE			English	Article							CROSS-REACTIVITY; AMINO-ACID; RECOMBINANT ALLERGENS; HYMENOPTERA VENOM; YELLOW JACKET; MODEL; ANTIBODIES; BINDING	Stings by insects from the Hymenoptera order are known to cause life-threatening allergic reactions and impair life quality. Despite the effectiveness of conventional vespid venom immunotherapy, more standardized and safer allergy vaccines are required and recombinant hypoallergenic variants are important clinical tools. Antigen 5 is a major allergen of vespid venoms and it was previously reported that Antigen 5 from Polybia scutellaris (Poly s 5) could be a hypoallergenic variant. In this work we assess the immunological behavior and allergenic activity of Poly s 5 in order to explore its suitability for specific immunotherapy. With this aim, recombinant Poly s 5 was expressed in Pichia pastoris and the presence of cross-reactive epitopes with Pol a 5, a known allergenic Antigen 5, was investigated both at the IgG and IgE levels, by ELISA assays and a basophil-mediator release assay respectively. A molecular model was also built to better understand the relationship between immunological and structural aspects. In mice, Poly s 5 induced IgG antibodies which cross-reacted with Pol a 5. However, Poly s 5 induced only minimal amounts of IgE and was a poor inducer of basophil-mediator release, even when the cells were sensitized with Pol a 5-specific IgE. Moreover, Poly s 5-specific serum showed a specific protective activity and was able to inhibit the Pol a 5-induced basophil degranulation. Structural analysis from the molecular model revealed that a few amino acid substitutions in the N-terminal region of Poly s 5 should lead to an alteration of the surface topography and electrostatic potential of the epitopes which could be responsible for its hypoallergenic behavior. These findings, taken as a whole, show that Poly s 5 is likely a naturally occurring hypoallergenic Antigen 5 variant.	[Vinzon, Sabrina E.; Marino-Buslje, Cristina; de Jimenez Bonino, Mirtha Biscoglio] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Vinzon, Sabrina E.; Marino-Buslje, Cristina; de Jimenez Bonino, Mirtha Biscoglio] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol IQUIFIB, RA-1113 Buenos Aires, DF, Argentina; [Rivera, Elena] Univ Buenos Aires, Fac Farm & Bioquim, Dept Fisicomatemat, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Vinzon, SE (corresponding author), German Canc Res Ctr, Div Viral Transformat Mech, Res Program Infect & Canc, D-6900 Heidelberg, Germany.	s.vinzon@dkfz.de	Vinzon, Sabrina/HFZ-9144-2022; Vinzón, Sabrina/Q-1631-2019; Marino-Buslje, Cristina/J-7438-2019	Vinzón, Sabrina/0000-0002-1330-9125; Marino-Buslje, Cristina/0000-0002-6564-1920	Universidad of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina	Universidad of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was partially supported by grants from the Universidad of Buenos Aires and the Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse R, 2011, ALLERGY, V66, P28, DOI 10.1111/j.1398-9995.2011.02628.x; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Amaral V, 1996, 16 NAT M ALL IMM BUE; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; CASCONE O, 1995, TOXICON, V33, P659, DOI 10.1016/0041-0101(95)00001-3; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Gafvelin G, 2007, J BIOL CHEM, V282, P3778, DOI 10.1074/jbc.M607938200; Gehlhar K, 2006, INT ARCH ALLERGY IMM, V140, P285, DOI 10.1159/000093706; Golden DBK, 2005, J ALLERGY CLIN IMMUN, V115, P439, DOI 10.1016/j.jaci.2005.01.005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V92, P707, DOI 10.1016/0091-6749(93)90014-7; Hoffmann A, 1997, J ALLERGY CLIN IMMUN, V99, P227, DOI 10.1016/S0091-6749(97)70101-5; King TP, 2001, J IMMUNOL, V166, P6057, DOI 10.4049/jimmunol.166.10.6057; King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Muller Ulrich, 2008, Clin Allergy Immunol, V21, P377; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Niederberger V, 2009, IMMUNOL LETT, V122, P131, DOI 10.1016/j.imlet.2008.11.012; Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026; Pirpignani ML, 2002, ARCH BIOCHEM BIOPHYS, V407, P224, DOI 10.1016/S0003-9861(02)00554-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025; VANOSS CJ, 1995, MOL IMMUNOL, V32, P199, DOI 10.1016/0161-5890(94)00124-J; Vinzon SE, 2010, PROTEIN EXPRES PURIF, V73, P23, DOI 10.1016/j.pep.2010.03.029; Wachholz PA, 2004, CURR OPIN ALLERGY CL, V4, P313, DOI 10.1097/01.all.0000136753.35948.c0; Winkler B, 2003, IMMUNOLOGY, V110, P376, DOI 10.1046/j.1365-2567.2003.01751.x	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41351	10.1371/journal.pone.0041351	http://dx.doi.org/10.1371/journal.pone.0041351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844463	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700075
J	Zot, HG; Hasbun, JE; Minh, NV				Zot, Henry G.; Hasbun, Javier E.; Nguyen Van Minh			Second-Chance Signal Transduction Explains Cooperative Flagellar Switching	PLOS ONE			English	Article							TORQUE-GENERATING UNITS; RESPONSE REGULATOR CHEY; BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; CONFORMATIONAL SPREAD; MOTOR; MECHANISM; BINDING; DIRECTION; PROTEINS	The reversal of flagellar motion (switching) results from the interaction between a switch complex of the flagellar rotor and a torque-generating stationary unit, or stator (motor unit). To explain the steeply cooperative ligand-induced switching, present models propose allosteric interactions between subunits of the rotor, but do not address the possibility of a reaction that stimulates a bidirectional motor unit to reverse direction of torque. During flagellar motion, the binding of a ligand-bound switch complex at the dwell site could excite a motor unit. The probability that another switch complex of the rotor, moving according to steady-state rotation, will reach the same dwell site before that motor unit returns to ground state will be determined by the independent decay rate of the excited-state motor unit. Here, we derive an analytical expression for the energy coupling between a switch complex and a motor unit of the stator complex of a flagellum, and demonstrate that this model accounts for the cooperative switching response without the need for allosteric interactions. The analytical result can be reproduced by simulation when (1) the motion of the rotor delivers a subsequent ligand-bound switch to the excited motor unit, thereby providing the excited motor unit with a second chance to remain excited, and (2) the outputs from multiple independent motor units are constrained to a single all-or-none event. In this proposed model, a motor unit and switch complex represent the components of a mathematically defined signal transduction mechanism in which energy coupling is driven by steady-state and is regulated by stochastic ligand binding. Mathematical derivation of the model shows the analytical function to be a general form of the Hill equation (Hill AV (1910) The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 40: iv-vii).	[Zot, Henry G.] Univ W Georgia, Dept Biol, Carrollton, GA 30118 USA; [Hasbun, Javier E.] Univ W Georgia, Dept Phys, Carrollton, GA USA; [Nguyen Van Minh] Univ W Georgia, Dept Math, Carrollton, GA USA	University System of Georgia; University of West Georgia; University System of Georgia; University of West Georgia; University System of Georgia; University of West Georgia	Zot, HG (corresponding author), Univ W Georgia, Dept Biol, Carrollton, GA 30118 USA.	hzot@westga.edu			National Science Foundation (NSF.gov) [MCB-0508203]	National Science Foundation (NSF.gov)(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (NSF.gov) to HGZ (MCB-0508203). The NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Amsler CD., 1995, 2 COMPONENT SIGNAL T, P89; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG HC, 1975, NATURE, V254, P389, DOI 10.1038/254389a0; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bren A, 2001, J MOL BIOL, V312, P699, DOI 10.1006/jmbi.2001.4992; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; Eisenbach M, 1996, MOL MICROBIOL, V20, P903, DOI 10.1111/j.1365-2958.1996.tb02531.x; Fahrner KA, 2003, NATURE, V423, P938, DOI 10.1038/423938a; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Lawrence KL, 2010, NATURE, V466, P996; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Sagi Y, 2003, J BIOL CHEM, V278, P25867, DOI 10.1074/jbc.M303201200; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Tu Y, 2008, P NATL ACAD SCI USA, V105, P11737, DOI 10.1073/pnas.0804641105; Turner L, 1999, BIOPHYS J, V77, P597, DOI 10.1016/S0006-3495(99)76916-X; van Albada SB, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.74; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105; Zot HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008052	30	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41098	10.1371/journal.pone.0041098	http://dx.doi.org/10.1371/journal.pone.0041098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844429	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700043
J	Ardekani, R; Huang, YM; Sancheti, P; Stanciauskas, R; Tavare, S; Tower, J				Ardekani, Reza; Huang, Yichuan Michelle; Sancheti, Prathamesh; Stanciauskas, Ramunas; Tavare, Simon; Tower, John			Using GFP Video to Track 3D Movement and Conditional Gene Expression in Free-Moving Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; FLUORESCENT PROTEINS; FLYING INSECTS; TRANSGENES; BEHAVIOR; SYSTEM; CELLS	Background: In vivo imaging and quantification of fluorescent reporter molecules is increasingly useful in biomedical research. For example, tracking animal movement in 3D with simultaneous quantification of fluorescent transgenic reporters allows for correlations between behavior, aging and gene expression. However implementation has been hindered in the past by the complexity of operating the systems. Results: We report significant technical improvements and user-friendly software (called FluoreScore) that enables tracking of 3D movement and the dynamics of gene expression in adult Drosophila, using two cameras and recorded GFP videos. Expression of a transgenic construct encoding eGFP was induced in free-moving adult flies using the Gene-Switch system and RU486 drug feeding. The time course of induction of eGFP expression was readily quantified from internal tissues including central nervous tissue. Conclusions: FluoreScore should facilitate a variety of future studies involving quantification of movement behaviors and fluorescent molecules in free-moving animals.	[Ardekani, Reza; Huang, Yichuan Michelle; Sancheti, Prathamesh; Stanciauskas, Ramunas; Tavare, Simon; Tower, John] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Ardekani, R (corresponding author), Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	jtower@usc.edu			Department of Health and Human Services [HG02790, AG011833]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011833] Funding Source: NIH RePORTER	Department of Health and Human Services; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Department of Health and Human Services (http://www.hhs.gov/) to ST (HG02790) and to JT (AG011833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Burcin MM, 1999, P NATL ACAD SCI USA, V96, P355, DOI 10.1073/pnas.96.2.355; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Fry SN, 2000, J NEUROSCI METH, V101, P59, DOI 10.1016/S0165-0270(00)00253-3; Frye MA, 2004, J EXP BIOL, V207, P123, DOI 10.1242/jeb.00725; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; Grover Dhruv, 2009, BMC Res Notes, V2, P58, DOI 10.1186/1756-0500-2-58; Grover D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007580; Grover D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-93; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Marden JH, 1997, J EXP BIOL, V200, P2747; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Roman G, 2002, GENESIS, V34, P127, DOI 10.1002/gene.10133; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Shen J, 2009, AGING-US, V1, P191, DOI 10.18632/aging.100018; Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Zisserman A., 2004, MULTIPLE VIEW GEOMET; Zou SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018151	30	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40506	10.1371/journal.pone.0040506	http://dx.doi.org/10.1371/journal.pone.0040506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829875	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300013
J	Gotsman, I; Zwas, D; Lotan, C; Keren, A				Gotsman, Israel; Zwas, Donna; Lotan, Chaim; Keren, Andre			Heart Failure and Preserved Left Ventricular Function: Long Term Clinical Outcome	PLOS ONE			English	Article							NORMAL EJECTION FRACTION; SYSTOLIC FUNCTION; MORTALITY; READMISSION; COMMUNITY; STIFFNESS; REGISTRY	Background: Patients with heart failure (HF) have a poor prognosis. The proportion of patients with HF and preserved left ventricular function (LVF) is increasing. Long term prognosis of HF with preserved LVF may not be so benign. Objectives: To evaluate the long term clinical outcome of patients with HF and preserved LVF and predictors of outcome. Methods: We prospectively evaluated 309 patients hospitalized with a definite clinical diagnosis of HF. Patients were followed for a mean of 6.5 years for clinical outcome. Results: More than a third (36%) of the patients had preserved systolic LVF based on echocardiography. The long term survival rate in this group was poor and not significantly different from patients with reduced LVF (28% vs 23% respectively, P = 0.2). The adjusted survival rate by Cox regression analysis was also not significantly different (hazard ratio 1.16, 95% confidence interval 0.87-1.55, P = 0.31). The event free survival from death or heart failure re-hospitalization was also low in both groups and not significantly different between patients with preserved vs. reduced LVF (12% vs. 10% respectively, P = 0.2). Predictors of mortality in patients with preserved LVF were age, functional capacity and serum urea levels. Conclusions: The long term clinical outcome of patients with heart failure and preserved LVF is poor and not significantly different from patients with reduced LVF.	[Gotsman, Israel; Zwas, Donna; Lotan, Chaim; Keren, Andre] Hadassah Univ Hosp, Inst Heart, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Gotsman, I (corresponding author), Hadassah Univ Hosp, Inst Heart, IL-91120 Jerusalem, Israel.	igotsman@bezeqint.net	Gotsman, Israel/AAH-8833-2021	Gotsman, Israel/0000-0001-9608-2298				[Anonymous], 2011, EUR HEART J     0411; Berry C, 2005, HEART, V91, P907, DOI 10.1136/hrt.2004.041996; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Gotsman I, 2008, AM J MED, V121, P997, DOI 10.1016/j.amjmed.2008.06.031; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Lewis BS, 2007, ISRAEL MED ASSOC J, V9, P234; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; Miyagishima K, 2009, CIRC J, V73, P92, DOI 10.1253/circj.CJ-07-1016; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Orea-Tejeda A, 2007, REV INVEST CLIN, V59, P103; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Tribouilloy C, 2007, EUR HEART J     0411; Tsutsui H, 2001, AM J CARDIOL, V88, P530, DOI 10.1016/S0002-9149(01)01732-5; Varela-Roman A, 2005, HEART, V91, P489, DOI 10.1136/hrt.2003.031922; Westermann D, 2008, CIRCULATION, V117, P2051, DOI 10.1161/CIRCULATIONAHA.107.716886; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	25	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41022	10.1371/journal.pone.0041022	http://dx.doi.org/10.1371/journal.pone.0041022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829907	gold, Green Submitted, Green Published			2022-12-27	WOS:000306956300045
J	Larsson, C; Luna, B; Ammerman, NC; Maiga, M; Agarwal, N; Bishai, WR				Larsson, Christer; Luna, Brian; Ammerman, Nicole C.; Maiga, Mamoudou; Agarwal, Nisheeth; Bishai, William R.			Gene Expression of Mycobacterium tuberculosis Putative Transcription Factors whiB1-7 in Redox Environments	PLOS ONE			English	Article							NITRIC-OXIDE; HYPOXIC RESPONSE; PROTEIN; STREPTOMYCES; HOMOLOG; MODEL; WHMD	The seven WhiB proteins of Mycobacterium tuberculosis (M.tb) are widely believed to be redox-sensing transcription factors due to their binding of iron-sulfur clusters and similarities to DNA binding proteins. Here, we explored the nature of this hypothesized relationship. We exposed M.tb to physiologic conditions such as gradual hypoxia, nitric oxide (NO), cyclic AMP and in vivo conditions, and measured transcription of the whiB genes. We found whiB3 to be induced both by hypoxia and NO, whiB7 to be induced in macrophage-like cells, and whiB4 to be induced in mouse lung. Cyclic AMP induced whiB1,-2, -4, -6 and -7. Our data indicate that the M.tb whiB genes are induced independently by various stimuli which may add versatility to their suggested redox-sensing properties.	[Larsson, Christer; Luna, Brian; Ammerman, Nicole C.; Maiga, Mamoudou; Bishai, William R.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Agarwal, Nisheeth] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, Haryana, India; [Bishai, William R.] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Bishai, William R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Howard Hughes Medical Institute	Larsson, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	wbishai@jhmi.edu		Ammerman, Nicole C./0000-0001-9359-9144; Luna, PhD, Brian/0000-0001-6718-4551; Larsson, Christer/0000-0002-5714-924X	Swedish Research Council (VR); Swedish Society for Medical Research (SSMF); National Institute of Health (NIH) [AI36973, AI37856]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037856, R29AI036973, R01AI036973] Funding Source: NIH RePORTER	Swedish Research Council (VR)(Swedish Research Council); Swedish Society for Medical Research (SSMF); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The Swedish Research Council (VR) www.vr.se, the Swedish Society for Medical Research (SSMF) www.ssmf.se, and the National Institute of Health (NIH) www.nih.gov AI36973 and AI37856. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Swedish Research Council (VR) and Swedish Society for Medical Research (SSMF) are gratefully acknowledged for their support (awarded to CL). This research was also supported by NIH AI36973 and AI37856 (awarded to WRB) and the Howard Hughes Medical Institute (WRB).	Agarwal N, 2007, INFECT IMMUN, V75, P452, DOI 10.1128/IAI.01395-06; Agarwal N, 2006, MICROBIOL-SGM, V152, P2749, DOI 10.1099/mic.0.28924-0; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Banaiee N, 2006, INFECT IMMUN, V74, P6449, DOI 10.1128/IAI.00190-06; Burian J, 2011, J BIOL CHEM; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; DAVIS NK, 1992, MOL GEN GENET, V232, P351, DOI 10.1007/BF00266237; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Drapier JC, 1997, METHODS, V11, P319, DOI 10.1006/meth.1996.0426; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hutter B, 1999, RES MICROBIOL, V150, P295, DOI 10.1016/S0923-2508(99)80055-2; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Kamath AB, 2003, INFECT IMMUN, V71, P4112, DOI 10.1128/IAI.71.7.4112-4118.2003; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Kramnik I, 1998, NOVART FDN SYMP, V217, P120, DOI 10.1002/0470846526.ch9; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Raghunand TR, 2006, MICROBIOL-SGM, V152, P2735, DOI 10.1099/mic.0.28911-0; Raghunand TR, 2006, INT J ANTIMICROB AG, V28, P36, DOI 10.1016/j.ijantimicag.2006.01.012; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WHO, 2011, WHO GLOBAL TUBERCULO	37	47	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e37516	10.1371/journal.pone.0037516	http://dx.doi.org/10.1371/journal.pone.0037516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829866	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300004
J	Guan, QJ; Takano, T; Liu, SK				Guan, Qingjie; Takano, Tetsuo; Liu, Shenkui			Genetic Transformation and Analysis of Rice OsAPx2 Gene in Medicago sativa	PLOS ONE			English	Article							2 ASCORBATE PEROXIDASES; HYDROGEN-PEROXIDE; EXPRESSION; STRESS; PURIFICATION; PROTEIN; CLONING	The OsAPx2 gene from rice was cloned to produce PBI121::OsAPx2 dual-expression plants, of which expression level would be increasing under stressful conditions. The enzyme ascorbate peroxidase (APX) in the leaves and roots of the plants increased with increasing exposure time to different sodium chloride (NaCl) and hydrogen peroxide (H2O2) concentrations, as indicated by protein gel blot analysis. The increased enzyme yield improved the ability of the plants to resist the stress treatments. The OsAPx2 gene was localized in the cytoplasm of epidermal onion cells as indicated by the instantaneous expression of green fluorescence. An 80% regeneration rate was observed in Medicago sativa L. plants transformed with the OsAPx2 gene using Agrobacterium tumefaciens, as indicated by specific primer PCR. The OsAPx2 gene was expressed at the mRNA level and the individual M. sativa (T#1, T#2, T#5) were obtained through assaying the generation of positive T2 using RNA gel blot analysis. When the seeds of the wild type (WT) and the T2 (T#1, T#5) were incubated in culture containing MS with NaCl for 7 days, the results as shown of following: the root length of transgenic plant was longer than WT plants, the H2O2 content in roots of WT was more than of transgenic plants, the APX activity under stresses increased by 2.89 times compared with the WT, the malondialdehyde (MDA) content of the WT was higher than the transgenic plants, the leaves of the WT turned yellow, but those of the transgenic plants remained green and remained healthy. The chlorophyll content in the WT leaves was less than in the transgenic plants, after soaking in solutions of H2O2, sodium sulfite (Na2SO3), and sodium bicarbonate (NaHCO3). Therefore, the OsAPx2 gene overexpression in transgenic M. sativa improves the removal of H2O2 and the salt-resistance compared with WT plants. A novel strain of M. sativa carrying a salt-resistance gene was obtained.	[Guan, Qingjie; Liu, Shenkui] NE Forestry Univ, ASNESC, Minist Educ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Harbin, Peoples R China; [Takano, Tetsuo] Univ Tokyo, ANESC, Nishitokyo City, Tokyo, Japan	Northeast Forestry University - China; University of Tokyo	Guan, QJ (corresponding author), NE Forestry Univ, ASNESC, Minist Educ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Harbin, Peoples R China.	shenkuiliu@nefu.edu.cn	Liu, Shenkui/AAC-5405-2019	Liu, Shenkui/0000-0001-5294-4765	Fundamental Research Funds for the Central Universities [DL11CA05]; State Forestry Administration 948 Program of China [2008429]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Forestry Administration 948 Program of China	This work was supported by the Fundamental Research Funds for the Central Universities (Grant no. DL11CA05) and the State Forestry Administration 948 Program of China (Grant no. 2008429) to Professor Shenkui Liu.'' The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Agrawal GK, 2003, GENE, V322, P93, DOI 10.1016/j.gene.2003.08.017; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Bl Li, 1989, ACTA PHOTOPHYSIOLOGI, V15, P62; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAWN K, 1981, ARCH BIOCHEM BIOPHYS, V206, P414, DOI 10.1016/0003-9861(81)90108-9; Bunkelmann JR, 1996, PLANT PHYSIOL, V110, P589, DOI 10.1104/pp.110.2.589; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Chen JB, 2009, J PLANT PHYSIOL, V166, P12, DOI 10.1016/j.jplph.2008.02.010; Chou TS, 2012, J PLANT PHYSIOL, V169, P478, DOI 10.1016/j.jplph.2011.11.012; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; DEAK M, 1986, PLANT CELL REP, V5, P97, DOI 10.1007/BF00269243; Du XM, 2003, J CHINESE BIOTECHNOL, V23, P49; Gaspard S, 1997, BIOCHEMISTRY-US, V36, P4852, DOI 10.1021/bi9616864; Ghazi HB, 2004, PHYSL PLANTRUM, V121, P231; HIGHTOWER R, 1991, PLANT MOL BIOL, V17, P1013, DOI 10.1007/BF00037141; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hong CY, 2008, PLANT SIGNAL BEHAV, V3, P199, DOI 10.4161/psb.3.3.5541; [金淑梅 Jin Shume], 2006, [分子植物育种, Molecular Plant Breeding], V4, P571; Liang Zheng, 1996, Acta Phytophysiologica Sinica, V22, P161; Ling JS, 1998, PLANT PHYSL COMMUNIC, V34, P329; Lu ZQ, 2007, PLANT CELL REP, V26, P1909, DOI 10.1007/s00299-007-0395-7; Lu ZQ, 2005, BIOTECHNOL LETT, V27, P63, DOI 10.1007/s10529-004-6587-0; [马长乐 Ma Changle], 2002, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V28, P261; MITTLER R, 1992, J BIOL CHEM, V267, P21802; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MIYAKE C, 1992, PLANT CELL PHYSIOL, V33, P541; Nishikawa F, 2003, POSTHARVEST BIOL TEC, V27, P147, DOI 10.1016/S0925-5214(02)00094-7; Nounjan N, 2012, J PLANT PHYSIOL, V169, P596, DOI 10.1016/j.jplph.2012.01.004; Qian HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019451; Ralph H, 1999, PLANT PHYSIOL, V119, P1251; Sambrook J., 2001, MOL CLONING LAB MANU, P1474; Sambrook J, 1989, MOL CLONING LAB MANU, P1566; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; SHIGEOKA S, 1980, BIOCHEM J, V186, P377, DOI 10.1042/bj1860377; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; SHIGEOKA S, 1980, ARCH BIOCHEM BIOPHYS, V201, P121, DOI 10.1016/0003-9861(80)90495-6; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; Trinh TH, 1998, PLANT CELL REP, V17, P345, DOI 10.1007/s002990050405; Wang J, 1999, PLANT CELL PHYSIOL, V40, P725, DOI 10.1093/oxfordjournals.pcp.a029599; Winicov I, 1999, PLANT PHYSIOL, V120, P473, DOI 10.1104/pp.120.2.473; Wu Guang-hong, 2001, Forest Research, V14, P633; Xie CP, 2003, XINJIANG AGR SCI TEC, V5, P43; Xu ZhenZhu, 1997, Acta Agronomica Sinica, V23, P370; [杨永兴 Yang Yongxing], 2002, [地理科学进展, Progress in geography], V21, P111; Yoshimura K, 2000, PLANT PHYSIOL, V123, P223, DOI 10.1104/pp.123.1.223; Zhao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028086; Zhao SJ, 1998, LAB MANUAL PLANT PHY, P305	48	16	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41233	10.1371/journal.pone.0041233	http://dx.doi.org/10.1371/journal.pone.0041233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848448	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200049
J	Kachooei, E; Moosavi-Movahedi, AA; Khodagholi, F; Ramshini, H; Shaerzadeh, F; Sheibani, N				Kachooei, Ehsan; Moosavi-Movahedi, Ali Akbar; Khodagholi, Fariba; Ramshini, Hassan; Shaerzadeh, Fatemeh; Sheibani, Nader			Oligomeric Forms of Insulin Amyloid Aggregation Disrupt Outgrowth and Complexity of Neuron-Like PC12 Cells	PLOS ONE			English	Article							AIR-WATER-INTERFACE; SURFACE-TENSION; ENDOPLASMIC-RETICULUM; ELECTRON-MICROSCOPY; MISFOLDING DISEASES; GLOBULAR-PROTEINS; OXIDATIVE STRESS; A-BETA; FIBRILS; FIBRILLATION	Formation of protein amyloid fibrils consists of a series of intermediates including oligomeric aggregates, proto-fibrillar structures, and finally mature fibrils. Recent studies show higher toxicity for oligomeric and proto-fibrillar intermediates of protein relative to their mature fibrils. Here the kinetic of the insulin amyloid fibrillation was evaluated using a variety of techniques including ThT fluorescence, Congo red absorbance, circular dichroism, and atomic force microscopy (AFM). The solution surface tension changes were attributed to hydrophobic changes in insulin structure and were detected by Du Nouy Ring method. Determination of the surface tension of insulin oligomeric, proto-fibrillar and fibrillar forms indicated that the hydrophobicity of solution is enhanced by the formation of the oligomeric forms of insulin compared to other forms. In order to investigate the toxicity of the different forms of insulin we monitored morphological alterations of the differentiated neuron-like PC12 cells following incubation with native, oligomeric aggregates, proto-fibrillar, and fibrillar forms of insulin. The cell body area, average neurite length, neurite width, number of primary neurites, and percent of bipolar cells and node/primary neurite ratios were used to assess the growth and complexity of PC12 cells exposed to different forms of insulin. We observed that the oligomeric form of insulin impaired the growth and complexity of PC12 cells compared to other forms. Together our data suggest that the lower surface tension of oligomers and their perturbation affects the morphology of PC12 cells, mainly due to their enhanced hydrophobicity and detergent-like structures.	[Kachooei, Ehsan; Moosavi-Movahedi, Ali Akbar; Ramshini, Hassan] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Khodagholi, Fariba; Shaerzadeh, Fatemeh] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA	University of Tehran; Shahid Beheshti University Medical Sciences; University of Wisconsin System; University of Wisconsin Madison	Kachooei, E (corresponding author), Univ Tehran, Inst Biochem & Biophys, Tehran, Iran.	moosavi@ibb.ut.ac.ir	Moosavi-Movahedi, Ali A./K-7453-2013; Ramshini(fazelinejad), hassan/GQQ-9129-2022; Sheibani, Nader/AAG-2379-2020; Khodagholi, Fariba/AAZ-4436-2020; Shaerzadeh, Fatemeh/L-4425-2017	Sheibani, Nader/0000-0003-2723-9217; Khodagholi, Fariba/0000-0002-4911-4530; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432; Shaerzadeh, Fatemeh/0000-0002-3342-4139; Kachooei, Ehsan/0000-0001-6362-6463	NEI NIH HHS [P30 EY016665] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Arora A, 2004, PROTEIN SCI, V13, P2429, DOI 10.1110/ps.04823504; Arora A, 2004, FEBS LETT, V564, P121, DOI 10.1016/S0014-5793(04)00326-6; Austen BM, 2008, BIOCHEMISTRY-US, V47, P1984, DOI 10.1021/bi701415b; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Eisert R, 2006, ANAL BIOCHEM, V353, P144, DOI 10.1016/j.ab.2006.03.015; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Grudzielanek S, 2007, J MOL BIOL, V370, P372, DOI 10.1016/j.jmb.2007.04.053; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; KARP G, 2005, CELL MOL BIOL CONCEP; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim JR, 2003, J BIOL CHEM, V278, P40730, DOI 10.1074/jbc.M305466200; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kourie JI, 2002, CLIN EXP PHARMACOL P, V29, P741, DOI 10.1046/j.1440-1681.2002.03737.x; Lashuel HA., 2005, SCI AGING KNOWLEDGE; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Lin F., 1995, COLLOID SURFACE B, V3, P281; Lin TY, 1996, PROTEIN SCI, V5, P372; Liu XY, 2010, NEUROCHEM INT, V57, P588, DOI 10.1016/j.neuint.2010.07.007; Makievski AV, 1998, J PHYS CHEM B, V102, P417, DOI 10.1021/jp9725036; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045; Messina P, 2006, BIOPOLYMERS, V82, P261, DOI 10.1002/bip.20494; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; NARSIMHAN G, 1992, BIOTECHNOL PROGR, V8, P187, DOI 10.1021/bp00015a003; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen L, 2001, J PHARM SCI-US, V90, P29, DOI 10.1002/1520-6017(200101)90:1<29::AID-JPS4>3.0.CO;2-4; Nieto-Suarez M, 2008, THIN SOLID FILMS, V516, P8873, DOI 10.1016/j.tsf.2007.11.062; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Smith MI, 2008, BIOPHYS J, V95, P3400, DOI 10.1529/biophysj.108.131482; Smith MI, 2007, BIOPHYS J, V93, P2143, DOI 10.1529/biophysj.107.105338; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Treuheit MJ, 2002, PHARM RES-DORDR, V19, P511, DOI 10.1023/A:1015108115452; Tusi SK, 2011, BIOMATERIALS, V32, P5438, DOI 10.1016/j.biomaterials.2011.04.024; Wang SSS, 2010, BBA-MOL BASIS DIS, V1802, P519, DOI 10.1016/j.bbadis.2010.02.008; Zako T, 2009, BIOPHYS J, V96, P3331, DOI 10.1016/j.bpj.2008.12.3957; Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4	55	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41344	10.1371/journal.pone.0041344	http://dx.doi.org/10.1371/journal.pone.0041344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848469	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200057
J	Wack, DS; Cox, JL; Schirda, CV; Magnano, CR; Sussman, JE; Henderson, D; Burkard, RF				Wack, David S.; Cox, Jennifer L.; Schirda, Claudiu V.; Magnano, Christopher R.; Sussman, Joan E.; Henderson, Donald; Burkard, Robert F.			Functional Anatomy of the Masking Level Difference, an fMRI Study	PLOS ONE			English	Article							AUDITORY-CORTEX; INTERAURAL PHASE; INFERIOR COLLICULUS; MASKED THRESHOLD; CORPUS-CALLOSUM; SIGNAL-DURATION; NOISE; ATTENTION; LANGUAGE; FREQUENCY	Introduction: Masking level differences (MLDs) are differences in the hearing threshold for the detection of a signal presented in a noise background, where either the phase of the signal or noise is reversed between ears. We use N0/N pi to denote noise presented in-phase/out-of-phase between ears and S0/S pi to denote a 500 Hz sine wave signal as in/out-ofphase. Signal detection level for the noise/signal combinations N0S pi and N pi S0 is typically 10-20 dB better than for N0S0. All combinations have the same spectrum, level, and duration of both the signal and the noise. Methods: Ten participants (5 female), age: 22-43, with N0S pi-N0S0 MLDs greater than 10 dB, were imaged using a sparse BOLD fMRI sequence, with a 9 second gap (1 second quiet preceding stimuli). Band-pass (400-600 Hz) noise and an enveloped signal (. 25 second tone burst, 50% duty-cycle) were used to create the stimuli. Brain maps of statistically significant regions were formed from a second-level analysis using SPM5. Results: The contrast N pi S0-N0S pi had significant regions of activation in the right pulvinar, corpus callosum, and insula bilaterally. The left inferior frontal gyrus had significant activation for contrasts N0S pi-N0S0 and N pi S0-N0S0. The contrast N0S0-N0S pi revealed a region in the right insula, and the contrast N0S0-N pi S0 had a region of significance in the left insula. Conclusion: Our results extend the view that the thalamus acts as a gating mechanism to enable dichotic listening, and suggest that MLD processing is accomplished through thalamic communication with the insula, which communicate across the corpus callosum to either enhance or diminish the binaural signal (depending on the MLD condition). The audibility improvement of the signal with both MLD conditions is likely reflected by activation in the left inferior frontal gyrus, a late stage in the what/where model of auditory processing.	[Wack, David S.; Cox, Jennifer L.; Schirda, Claudiu V.; Magnano, Christopher R.] SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Wack, David S.] SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA; [Schirda, Claudiu V.] Univ Pittsburgh, Dept Radiol, MR Res Ctr, Pittsburgh, PA 15260 USA; [Wack, David S.; Sussman, Joan E.; Henderson, Donald] SUNY Buffalo, Dept Commun Disorders & Sci, Buffalo, NY 14260 USA; [Burkard, Robert F.] SUNY Buffalo, Dept Rehabil Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wack, DS (corresponding author), SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.	dswack@buffalo.edu		Schirda, Claudiu/0000-0002-5036-0640				Ackermann H, 2001, NEUROREPORT, V12, P1683, DOI 10.1097/00001756-200106130-00033; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; BARAN JA, 1986, EAR HEARING, V7, P359, DOI 10.1097/00003446-198612000-00003; Barker D, 2012, CEREB CORTEX, V22, P745, DOI 10.1093/cercor/bhr065; Bernstein LR, 1999, J ACOUST SOC AM, V105, P1776, DOI 10.1121/1.426715; Bethmann A, 2007, BRAIN RES, V1133, P145, DOI 10.1016/j.brainres.2006.11.057; BLODGETT HC, 1958, AM J PSYCHOL, V71, P283, DOI 10.2307/1419217; Budd TW, 2003, NEUROIMAGE, V20, P1783, DOI 10.1016/j.neuroimage.2003.07.026; Chait M, 2006, CEREB CORTEX, V16, P835, DOI 10.1093/cercor/bhj027; DIERCKS KJ, 1962, J ACOUST SOC AM, V34, P981, DOI 10.1121/1.1918234; DURLACH NI, 1986, J ACOUST SOC AM, V79, P1548, DOI 10.1121/1.393681; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; EGAN JP, 1965, J ACOUST SOC AM, V38, P1043, DOI 10.1121/1.1909836; EGAN JP, 1964, J ACOUST SOC AM, V36, P1992; EIMAS PD, 1973, COGNITIVE PSYCHOL, V4, P99, DOI 10.1016/0010-0285(73)90006-6; Ernst SMA, 2008, NEUROIMAGE, V43, P321, DOI 10.1016/j.neuroimage.2008.07.046; Ernst SMA, 2010, NEUROIMAGE, V49, P835, DOI 10.1016/j.neuroimage.2009.07.014; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; Fowler C G, 1996, J Am Acad Audiol, V7, P23; FOWLER CG, 1992, J SPEECH HEAR RES, V35, P216, DOI 10.1044/jshr.3501.216; GARNER WR, 1947, J EXP PSYCHOL, V37, P293, DOI 10.1037/h0055734; Guo YQ, 2003, HEARING RES, V178, P12, DOI 10.1016/S0378-5955(03)00023-6; HAFTER ER, 1970, J ACOUST SOC AM, V47, P1041, DOI 10.1121/1.1912003; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2007, NEUROREPORT, V18, P323, DOI 10.1097/WNR.0b013e32802b70ce; Hall DA, 2009, CEREB CORTEX, V19, P576, DOI 10.1093/cercor/bhn108; Hart HC, 2004, HUM BRAIN MAPP, V21, P178, DOI 10.1002/hbm.10156; Hashimoto R, 2000, NEUROIMAGE, V12, P147, DOI 10.1006/nimg.2000.0603; HENNING GB, 1973, J ACOUST SOC AM, V54, P1160, DOI 10.1121/1.1914363; HIRSH IJ, 1948, J ACOUST SOC AM, V20, P536, DOI 10.1121/1.1906407; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Hugdahl K, 2003, ASYMMETRICAL BRAIN, P441; Hugdahl K, 2000, HUM BRAIN MAPP, V10, P87, DOI 10.1002/(SICI)1097-0193(200006)10:2<87::AID-HBM50>3.0.CO;2-V; HUGDAHL K, 1990, BRAIN LANG, V39, P1, DOI 10.1016/0093-934X(90)90001-W; Ishida IM, 2009, EAR HEARING, V30, P713, DOI 10.1097/AUD.0b013e3181b61cc8; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Jancke L, 2002, NEUROLOGY, V58, P736, DOI 10.1212/WNL.58.5.736; Jancke L, 2001, BRAIN LANG, V78, P349, DOI 10.1006/brln.2000.2476; JEFFRESS LA, 1952, J ACOUST SOC AM, V24, P523, DOI 10.1121/1.1906930; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; Jiang D, 1997, J NEUROSCI, V17, P9331; Karbe H, 1998, J CEREBR BLOOD F MET, V18, P1157, DOI 10.1097/00004647-199810000-00012; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; LANGFORD TL, 1964, J ACOUST SOC AM, V36, P1455, DOI 10.1121/1.1919224; LICKLIDER JCR, 1948, J ACOUST SOC AM, V20, P150, DOI 10.1121/1.1906358; Lipschutz B, 2002, NEUROIMAGE, V17, P643, DOI 10.1006/nimg.2002.1184; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MCFADDEN D, 1968, J ACOUST SOC AM, V44, P212, DOI 10.1121/1.1911057; METZ PJ, 1968, J ACOUST SOC AM, V43, P1085, DOI 10.1121/1.1910943; Musiek F, 1986, 2 HEMISPHERES ONE BR, P423; OJEMANN GA, 1975, BRAIN LANG, V2, P101, DOI 10.1016/S0093-934X(75)80057-5; Palmer AR, 2000, J NEUROPHYSIOL, V84, P844, DOI 10.1152/jn.2000.84.2.844; Pollmann S, 2002, NEUROPSYCHOLOGY, V16, P56, DOI 10.1037//0894-4105.16.1.56; Pratt H, 2007, AUDITORY EVOKED POTE; Puschmann S, 2010, NEUROIMAGE, V49, P1641, DOI 10.1016/j.neuroimage.2009.09.045; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Reinvang I., 1994, NEUROPSYCHOLOGY, V8, P445; ROBINSON DE, 1972, J ACOUST SOC AM, V51, P1945, DOI 10.1121/1.1913053; SAWUSCH JR, 1981, J EXP PSYCHOL HUMAN, V7, P408, DOI 10.1037/0096-1523.7.2.408; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; SONDHI MM, 1966, J ACOUST SOC AM, V40, P600, DOI 10.1121/1.1910124; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; SUGISHITA M, 1995, BRAIN, V118, P417, DOI 10.1093/brain/118.2.417; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Thomsen T, 2004, NEUROIMAGE, V21, P211, DOI 10.1016/j.neuroimage.2003.08.039; TOWNSEND TH, 1972, J ACOUST SOC AM, V51, P621, DOI 10.1121/1.1912884; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van de Par S, 1998, J ACOUST SOC AM, V103, P2100, DOI 10.1121/1.421356; van de Par S, 1999, J ACOUST SOC AM, V106, P1940, DOI 10.1121/1.427942; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Westerhausen R, 2006, NEUROPSYCHOLOGY, V20, P272, DOI 10.1037/0894-4105.20.3.272; WIGHTMAN FL, 1971, J ACOUST SOC AM, V50, P623, DOI 10.1121/1.1912678; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64; YOST WA, 1988, J ACOUST SOC AM, V83, P1517, DOI 10.1121/1.395907	75	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41263	10.1371/journal.pone.0041263	http://dx.doi.org/10.1371/journal.pone.0041263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848453	Green Published, gold			2022-12-27	WOS:000306950200051
J	Li, HY; Chen, M; Yang, JF; Yang, CQ; Xu, L; Wang, F; Tong, JB; Lv, Y; Suonan, C				Li, Hong-yi; Chen, Min; Yang, Jie-fu; Yang, Chong-qing; Xu, Liang; Wang, Fang; Tong, Jia-bin; Lv, You; Suonan, Caidan			Fluid Flow along Venous Adventitia in Rabbits: Is It a Potential Drainage System Complementary to Vascular Circulations?	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; INTERSTITIAL FLUID; THERAPEUTIC CONSEQUENCES; TRANSPORT; COLLAGEN; MACROMOLECULES; MERIDIANS; PATHWAYS; EXCHANGE; TISSUES	Background: Our previous research and other studies with radiotracers showed evidence of a centripetal drainage pathway, separate from blood or lymphatic vessels, that can be visualized when a small amount of low molecular weight tracer is injected subcutaneously into a given region on skin of humans. In order to further characterize this interesting biological phenomenon, animal experiments are designed to elucidate histological and physiologic characteristics of these visualized pathways. Methods: Multiple tracers are injected subcutaneously into an acupuncture point of KI3 to visualize centripetal pathways by magnetic resonance imaging or fluorescein photography in 85 healthy rabbits. The pathways are compared with venography and indirect lymphangiography. Fluid flow through the pathways is observed by methods of altering their hydrated state, hydrolyzing by different collagenases, and histology is elucidated by optical, fluorescein and electron microscopy. Results: Histological and magnetic imaging examinations of these visualized pathways show they consist of perivenous loose connective tissues. As evidenced by examinations of tracers' uptake, they appear to function as a draining pathway for free interstitial fluid. Fluorescein sodium from KI3 is found in the pathways of hind limbs and segments of the small intestines, partial pulmonary veins and results in pericardial effusion, suggesting systematical involvement of this perivenous pathway. The hydraulic conductivity of these pathways can be compromised by the collapse of their fiber-rich beds hydrolyzed by either of collagenase type I, III, IV or V. Conclusions: The identification of pathways comprising perivenous loose connective tissues with a high hydraulic conductivity draining interstitial fluid in hind limbs of a mammal suggests a potential drainage system complementary to vascular circulations. These findings may provide new insights into a systematically distributed collagenous connective tissue with a circulatory function and their potential relevance to the nature of acupuncture meridians.	[Li, Hong-yi; Yang, Jie-fu; Wang, Fang; Lv, You] Minist Hlth, Div Cardiol, Beijing Hosp, Beijing, Peoples R China; [Chen, Min; Xu, Liang] Minist Hlth, Div Radiol, Beijing Hosp, Beijing, Peoples R China; [Yang, Chong-qing] Minist Hlth, Div Pathol, Beijing Hosp, Beijing, Peoples R China; [Suonan, Caidan] Qinhai Prov Tibetan Hosp, Dipping Therapy Dept, Xining, Peoples R China	Beijing Hospital; Beijing Hospital; Beijing Hospital	Li, HY (corresponding author), Minist Hlth, Div Cardiol, Beijing Hosp, Beijing, Peoples R China.	godspeedlhy@gmail.com	wang, fang/GYD-4295-2022		National Natural Science Foundation of China [30840100]; 973 program [2012CB518500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (Grant No. 30840100) and 973 program (No. 2012CB518500), and Ms. SiuTuen Lucy Chan Lau and Mr. WaiChun Tin for their personal financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Ahn Andrew C, 2005, BMC Complement Altern Med, V5, P10, DOI 10.1186/1472-6882-5-10; Ahn AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011907; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; BORKOWSKI GL, 1990, LAB ANIM SCI, V40, P270; Chen CT, 1998, BIORHEOLOGY, V35, P103, DOI 10.1016/S0006-355X(99)80001-8; Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]; Coleman PJ, 2005, MICROCIRCULATION, V12, P209, DOI 10.1080/10739680590905143; Deng LY., 1999, CHINESE ACUPUNCTURE, P115; Deng LY.GanYJ, 1999, CHINESE ACUPUNCTURE, P59; Driessen NJB, 2003, J BIOMECH, V36, P1151, DOI 10.1016/S0021-9290(03)00082-4; Foley CP, 2012, ANN BIOMED ENG, V40, P292, DOI 10.1007/s10439-011-0440-0; Gao XY, 2011, BRAIN RES, V1397, P19, DOI 10.1016/j.brainres.2011.04.034; Gossl M, 2003, ANAT REC PART A, V272A, P526, DOI 10.1002/ar.a.10060; Knopp MV, 2006, INVEST RADIOL, V41, P491, DOI 10.1097/01.rli.0000209657.16115.42; KOVACS FM, 1992, J NUCL MED, V33, P403; Kovacs FM, 2000, EUR RADIOL, V10, P1019, DOI 10.1007/s003300051056; Lee Byung-Cheon, 2005, Anatomical Record Part B:The New Anatomist, V286, P1, DOI 10.1002/ar.b.20076; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Levick JR, 1997, INT J MICROCIRC, V17, P241, DOI 10.1159/000179236; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Li HY, 2008, J ALTERN COMPLEM MED, V14, P621, DOI 10.1089/acm.2007.0606; Ma WT, 2003, J ALTERN COMPLEM MED, V9, P851, DOI 10.1089/107555303771952208; Magzoub M, 2008, FASEB J, V22, P276, DOI 10.1096/fj.07-9150com; Meng J B, 1987, Zhen Ci Yan Jiu, V12, P77; Mohan R, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026846, 10.1371/journal.pone.0026432]; Napadow V, 2008, J ALTERN COMPLEM MED, V14, P861, DOI 10.1089/acm.2008.SAR-3; Netti PA, 2000, CANCER RES, V60, P2497; Pathak AP, 2005, CANCER RES, V65, P1425, DOI 10.1158/0008-5472.CAN-04-3682; Sander Edward A, 2003, Crit Rev Biomed Eng, V31, P1, DOI 10.1615/CritRevBiomedEng.v31.i12.10; Sekine Y, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3058616; Shimizu H, 2008, ZOOLOGY, V111, P410, DOI 10.1016/j.zool.2007.11.004; Soh KS, 2009, J ACUPUNCT MERIDIAN, V2, P93, DOI 10.1016/S2005-2901(09)60041-8; Stanton AWB, 1999, MICROVASC RES, V57, P320, DOI 10.1006/mvre.1998.2141; TIBERIU R, 1981, AM J ACUPUNCTURE, V9, P251; Viljoen M, 2003, East Afr Med J, V80, P324; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wiig H, 2003, ACTA ANAESTH SCAND, V47, P111, DOI 10.1034/j.1399-6576.2003.00050.x; Wiig H, 2008, MICROCIRCULATION, V15, P283, DOI 10.1080/10739680701671105; Wiig H, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-12; Yao W, 2011, ACTA MECH SINICA-PRC, V27, P602, DOI 10.1007/s10409-011-0439-7; Yuthok Yonten Gonpo, 1982, 4 TANTR TIB MED RGYU, P18	42	20	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41395	10.1371/journal.pone.0041395	http://dx.doi.org/10.1371/journal.pone.0041395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848483	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600025
J	Srinivasan, VB; Venkataramaiah, M; Mondal, A; Vaidyanathan, V; Govil, T; Rajamohan, G				Srinivasan, Vijaya Bharathi; Venkataramaiah, Manjunath; Mondal, Amitabha; Vaidyanathan, Vasanth; Govil, Tanvi; Rajamohan, Govindan			Functional Characterization of a Novel Outer Membrane Porin KpnO, Regulated by PhoBR Two-Component System in Klebsiella pneumoniae NTUH-K2044	PLOS ONE			English	Article							ESCHERICHIA-COLI; BETA-LACTAMASES; ANTIBIOTIC-RESISTANCE; CARBAPENEM RESISTANCE; SIGNAL-TRANSDUCTION; BIOFILM FORMATION; LIVER-ABSCESS; EFFLUX; EXPRESSION; VIRULENCE	Background: The diffusion of antibiotics through the outer membrane is primarily affected by the porin super family, changes contribute to antibiotic resistance. Recently we demonstrated that the CpxAR two-component signaling system alters the expression of an uncharacterized porin OmpC(KP), to mediate antimicrobial resistance in K. pneumoniae. Principal Findings: In this study, functional characterization of the putative porin OmpC(KP) (denoted kpnO) with respect to antimicrobial susceptibility and virulence was evaluated by generating an isogenic mutant, Delta kpnO in a clinical isolate of K. pneumoniae. Estimation of uronic acid content confirmed that Delta kpnO produced similar to 2.0 fold lesser capsular polysaccharide than the wild-type. The Delta kpnO displayed higher sensitivity to hyper osmotic and bile conditions. Disruption of kpnO increased the susceptibility of K. pneumoniae to oxidative and nitrostative stress by similar to 1.6 fold and > 7 fold respectively. The loss of the Klebsiella porin led to an increase in the minimum inhibitory concentration of tetracycline (3-fold), nalidixic acid (4-fold), tobramycin (4-fold), streptomycin (10-fold), and spectinomycin (10-fold), which could be restored following complementation. The single deletion of kpnO reduced the survival of the pathogen by 50% when exposed to disinfectants. In Caenorhabditis elegans model, the kpnO mutant exhibited significantly (P < 0.01) lower virulence. To dissect the role of PhoBR signaling system in regulating the expression of the kpnO, a phoB(KP) isogenic mutant was constructed. The phoB(KP) mutant exhibited impaired gastrointestinal stress response and decreased antimicrobial susceptibility. The mRNA levels of kpnO were found to be 4-fold less in phoB(KP) mutant compared to wild type. A regulatory role of PhoB(KP) for the expression of kpnO was further supported by the specific binding of PhoB(KP) to the putative promoter of kpnO. Conclusions and Significance: Loss of PhoBR regulated porin KpnO resulted in increased antimicrobial resistance, increased susceptibility to gastrointestinal stress, and reduced virulence in K. pneumoniae NTUH-K2044.	[Srinivasan, Vijaya Bharathi; Venkataramaiah, Manjunath; Mondal, Amitabha; Vaidyanathan, Vasanth; Govil, Tanvi; Rajamohan, Govindan] Inst Microbial Technol, CSIR, Sect 39 A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Srinivasan, VB (corresponding author), Inst Microbial Technol, CSIR, Sect 39 A, Chandigarh, India.	vijirmohan@gmail.com; rmohan@imtech.res.in		Govindan, Rajamohan/0000-0002-0208-3546	Institute of Microbial Technology (IMTECH); Department of Biotechnology [BT/01/1YBAl2009]	Institute of Microbial Technology (IMTECH); Department of Biotechnology	The research has been supported by intramural funds from the Institute of Microbial Technology (IMTECH) (http://www.imtech.res.in/) and Department of Biotechnology (http://dbtindia.nic.in) (No. BT/01/1YBAl2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Begic S, 2006, MICROBIOL-SGM, V152, P485, DOI 10.1099/mic.0.28428-0; Bialek S, 2010, ANTIMICROB AGENTS CH, V54, P4373, DOI 10.1128/AAC.01607-09; Bradford PA, 1997, ANTIMICROB AGENTS CH, V41, P563, DOI 10.1128/AAC.41.3.563; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Clinical and Laboratory Standards Institute, 2010, M100S20U CLSI; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; Crowley B, 2002, ANTIMICROB AGENTS CH, V46, P3679, DOI 10.1128/AAC.46.11.3679-3682.2002; Daikos GL, 2011, CLIN MICROBIOL INFEC, V17, P1135, DOI 10.1111/j.1469-0691.2011.03553.x; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; De Wulf P, 2000, J BACTERIOL, V182, P1423, DOI 10.1128/JB.182.5.1423-1426.2000; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Domenech-Sanchez A, 1999, J BACTERIOL, V181, P2726; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Garcia-Sureda L, 2011, ANTIMICROB AGENTS CH, V55, P4742, DOI 10.1128/AAC.00309-11; Garcia-Sureda L, 2011, ANTIMICROB AGENTS CH, V55, P1803, DOI 10.1128/AAC.01441-10; GLAUERT AM, 1969, ANNU REV MICROBIOL, V23, P159, DOI 10.1146/annurev.mi.23.100169.001111; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; HALL MN, 1981, ANNU REV GENET, V15, P91, DOI 10.1146/annurev.ge.15.120181.000515; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Hernandez-Alles S, 1999, MICROBIOL-UK, V145, P673, DOI 10.1099/13500872-145-3-673; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Hu WS, 2011, ANTIMICROB AGENTS CH, V55, P3829, DOI 10.1128/AAC.00216-11; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Karatzas KAG, 2007, J ANTIMICROB CHEMOTH, V60, P947, DOI 10.1093/jac/dkm314; Khanfar HS, 2009, J INFECT DEV COUNTR, V3, P295; Krachler AM, 2011, J CELL BIOL, V195, P1083, DOI 10.1083/jcb.201107132; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lee K, 2007, INT J ANTIMICROB AG, V29, P201, DOI 10.1016/j.ijantimicag.2006.09.006; Low AS, 2001, MOL MICROBIOL, V42, P619, DOI 10.1046/j.1365-2958.2001.02647.x; Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P1669, DOI 10.1128/AAC.43.7.1669; Mena A, 2006, J CLIN MICROBIOL, V44, P2831, DOI 10.1128/JCM.00418-06; MOLLER JK, 1990, DAN MED BULL, V37, P263; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nishino K, 2009, BBA-PROTEINS PROTEOM, V1794, P834, DOI 10.1016/j.bbapap.2009.02.002; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; Shemesh M, 2010, J BACTERIOL, V192, P6352, DOI 10.1128/JB.01025-10; Srinivasan VB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033777; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Wang H, 2011, INT J ANTIMICROB AG, V38, P376, DOI 10.1016/j.ijantimicag.2011.06.015; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Yum JH, 2005, J KOREAN MED SCI, V20, P961, DOI 10.3346/jkms.2005.20.6.961	53	32	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41505	10.1371/journal.pone.0041505	http://dx.doi.org/10.1371/journal.pone.0041505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848515	Green Submitted, gold, Green Published			2022-12-27	WOS:000306806600077
J	Chen, XR; Xiu, FM; Horvath, CN; Damjanovic, D; Thanthrige-Don, N; Jeyanathan, M; Xing, Z				Chen, Xuerong; Xiu, Fangming; Horvath, Carly N.; Damjanovic, Daniela; Thanthrige-Don, Niroshan; Jeyanathan, Mangalakumari; Xing, Zhou			Regulation of TB Vaccine-Induced Airway Luminal T Cells by Respiratory Exposure to Endotoxin	PLOS ONE			English	Article							MUCOSAL IMMUNIZATION; LUNG AIRWAYS; NEUTRALIZING ANTIBODIES; TUBERCULOSIS VACCINES; RECRUITMENT; ADENOVIRUS; MECHANISMS; PROTECTION; IMMUNITY; VECTORS	Tuberculosis (TB) vaccine-induced airway luminal T cells (ALT) have recently been shown to be critical to host defense against pulmonary TB. However, the mechanisms that maintain memory ALT remain poorly understood. In particular, whether respiratory mucosal exposure to environmental agents such as endotoxin may regulate the size of vaccine-induced ALT population is still unclear. Using a murine model of respiratory genetic TB vaccination and respiratory LPS exposure, we have addressed this issue in the current study. We have found that single or repeated LPS exposure increases the number of antigen-specific ALT which are capable of robust secondary responses to pulmonary mycobacterial challenge. To investigate the potential mechanisms by which LPS exposure modulates the ALT population, we have examined the role of ALT proliferation and peripheral T cell recruitment. We have found that LPS exposure-increased ALT is not dependent on increased ALT proliferation as respiratory LPS exposure does not significantly increase the rate of proliferation of ALT. But rather, we find it to be dependent upon the recruitment of peripheral T cells into the airway lumen as blockade of peripheral T cell supplies markedly reduces the initially increased ALT. Thus, our data suggest that environmental exposure to airborne agents such as endotoxin has a profound modulatory effect on TB vaccine-elicited T cells within the respiratory tract. Our study provides a new, M.tb antigen-independent mechanism by which the respiratory mucosal anti-TB memory T cells may be maintained.	[Chen, Xuerong] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University	Chen, XR (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada.	xingz@mcmaster.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study is supported by funds from the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Horvath CN, 2012, MUCOSAL IMMUNOL, V5, P420, DOI 10.1038/mi.2012.19; Jeyanathan M, 2010, TRENDS IMMUNOL, V31, P247, DOI 10.1016/j.it.2010.05.002; Jeyanathan M, 2010, AM J RESP CRIT CARE, V181, P862, DOI 10.1164/rccm.200910-1583OC; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kohlmeier JE, 2006, CURR OPIN IMMUNOL, V18, P357, DOI 10.1016/j.coi.2006.03.012; Larsson L, 2004, INDOOR AIR, V14, P421, DOI 10.1111/j.1600-0668.2004.00290.x; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mu JY, 2010, J GENE MED, V12, P693, DOI 10.1002/jgm.1487; Nilsson A, 2004, INDOOR AIR, V14, P74, DOI 10.1046/j.1600-0668.2003.00178.x; Park JH, 2004, APPL ENVIRON MICROB, V70, P262, DOI 10.1128/aEM.70.1.262-267.2004; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Walrath JR, 2011, AM J RESP CELL MOL, V45, P24, DOI 10.1165/rcmb.2010-0241OC; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; XING Z, 1993, AM J PATHOL, V143, P1009; Xing Z, 2006, TUBERCULOSIS, V86, P211, DOI 10.1016/j.tube.2006.01.017	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41666	10.1371/journal.pone.0041666	http://dx.doi.org/10.1371/journal.pone.0041666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844510	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700136
J	Einarsdottir, K; Kemp, A; Haggar, FA; Moorin, RE; Gunnell, AS; Preen, DB; Stanley, FJ; Holman, CDJ				Einarsdottir, Kristjana; Kemp, Anna; Haggar, Fatima A.; Moorin, Rachael E.; Gunnell, Anthony S.; Preen, David B.; Stanley, Fiona J.; Holman, C. D'Arcy J.			Increase in Caesarean Deliveries after the Australian Private Health Insurance Incentive Policy Reforms	PLOS ONE			English	Article							OBSTETRIC INTERVENTION; EARLY DISCHARGE; SECTION; TERM; OUTCOMES; RISK; CARE; TRENDS; IMPACT; RATES	Background: The Australian Private Health Insurance Incentive (PHII) policy reforms implemented in 1997-2000 increased PHI membership in Australia by 50%. Given the higher rate of obstetric interventions in privately insured patients, the reforms may have led to an increase in surgical deliveries and deliveries with longer hospital stays. We aimed to investigate the effect of the PHII policy introduction on birth characteristics in Western Australia (WA). Methods and Findings: All 230,276 birth admissions from January 1995 to March 2004 were identified from administrative birth and hospital data-systems held by the WA Department of Health. Average quarterly birth rates after the PHII introduction were estimated and compared with expected rates had the reforms not occurred. Rate and percentage differences (including 95% confidence intervals) were estimated separately for public and private patients, by mode of delivery, and by length of stay in hospital following birth. The PHII policy introduction was associated with a 20% (-21.4 to -19.3) decrease in public birth rates, a 51% (45.1 to 56.4) increase in private birth rates, a 5% (-5.3 to -5.1) and 8% (-8.9 to -7.9) decrease in unassisted and assisted vaginal deliveries respectively, a 5% (-5.3 to -5.1) increase in caesarean sections with labour and 10% (8.0 to 11.7) increase in caesarean sections without labour. Similarly, birth rates where the infant stayed 0-3 days in hospital following birth decreased by 20% (-21.5 to -18.5), but rates of births with >3 days in hospital increased by 15% (12.2 to 17.1). Conclusions: Following the PHII policy implementation in Australia, births in privately insured patients, caesarean deliveries and births with longer infant hospital stays increased. The reforms may not have been beneficial for quality obstetric care in Australia or the burden of Australian hospitals.	[Einarsdottir, Kristjana; Stanley, Fiona J.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Kemp, Anna; Haggar, Fatima A.; Moorin, Rachael E.; Preen, David B.; Holman, C. D'Arcy J.] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [Moorin, Rachael E.] Curtin Univ Technol, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Ctr Populat Hlth Res, Perth, WA, Australia; [Gunnell, Anthony S.] Edith Cowan Univ, Hlth & Wellness Inst, Joondalup, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; Curtin University; Edith Cowan University	Einarsdottir, K (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	keinarsdottir@ichr.uwa.edu.au	Einarsdóttir, Kristjana/E-8337-2011; Preen, David B/H-5663-2014; Kemp-Casey, Anna/F-1283-2013; Moorin, Rachael/AAQ-3650-2020; Holman, Cashel DJ/B-6173-2009; Kemp-Casey, Anna/AAU-7292-2021	Einarsdóttir, Kristjana/0000-0003-4931-7650; Preen, David B/0000-0002-2982-2169; Kemp-Casey, Anna/0000-0002-0018-962X; Moorin, Rachael/0000-0001-8742-7151; Kemp-Casey, Anna/0000-0002-0018-962X; Gunnell, Anthony/0000-0002-5432-6685	Australia's National Health and Medical Research Council [634533, 573122]	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The research was funded by the Australia's National Health and Medical Research Council (grants 634533 and 573122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VM, 2003, OBSTET GYNECOL, V102, P477, DOI 10.1016/S0029-7844(03)00570-2; [Anonymous], 2002, COCHRANE DB SYST REV; Australian Bureau of Statistics, 2011, POP AG SEX AUSTR STA; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bodner K, 2011, ARCH GYNECOL OBSTET, V283, P1193, DOI 10.1007/s00404-010-1525-y; Brameld Kate, 2006, J Health Serv Res Policy, V11, P94, DOI 10.1258/135581906776318901; Brown S, 2004, PAEDIATR PERINAT EP, V18, P202, DOI 10.1111/j.1365-3016.2004.00558.x; Brown S, 1997, BIRTH-ISS PERINAT C, V24, P148, DOI 10.1111/j.1523-536X.1997.tb00579.x; Brown SJ, 2005, MIDWIFERY, V21, P109, DOI 10.1016/j.midw.2004.09.006; Butler James R G, 2002, Aust Health Rev, V25, P33; Chigbu CO, 2007, BJOG-INT J OBSTET GY, V114, P1261, DOI 10.1111/j.1471-0528.2007.01440.x; Cormack Mark, 2002, Aust Health Rev, V25, P38; FISHER J, 1995, J PSYCHOSOM OBST GYN, V16, P1, DOI 10.3109/01674829509025651; Fogelson NS, 2005, AM J OBSTET GYNECOL, V192, P1433, DOI 10.1016/j.ajog.2005.01.010; Forster Della A, 2008, BMC Pregnancy Childbirth, V8, P27, DOI 10.1186/1471-2393-8-27; Foster M., 2008, HLTH CARE PRACTICE A, P46; Geller EJ, 2010, J PERINATOL, V30, P258, DOI 10.1038/jp.2009.150; HAMILTON BE, 2007, NATL VITAL STAT REPO; Harper LM, 2010, WOMENS HEALTH, V6, P365, DOI 10.2217/WHE.10.14; Harris M G, 1998, J Health Hum Serv Adm, V20, P442; Hatem M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub2; Hildingsson IM, 2010, MIDWIFERY; Hindle Don, 2004, Aust Health Rev, V28, P119; Knight M, 2008, OBSTET GYNECOL, V111, P97, DOI 10.1097/01.AOG.0000296658.83240.6d; Kolas T, 2006, AM J OBSTET GYNECOL, V195, P1538, DOI 10.1016/j.ajog.2006.05.005; Lancaster P., 1994, AUSTR MOTHERS BABIES; Laws P. J., 2010, PERINATAL STAT SERIE; Levine EM, 2001, OBSTET GYNECOL, V97, P439, DOI 10.1016/S0029-7844(00)01150-9; Liston FA, 2008, ARCH DIS CHILD-FETAL, V93, pF176, DOI 10.1136/adc.2006.112565; Liu Shiliang, 2004, J Obstet Gynaecol Can, V26, P735; Moore HC, 2011, ARCH DIS CHILDHOOD; O'Leary CM, 2007, BJOG-INT J OBSTET GY, V114, P855, DOI 10.1111/j.1471-0528.2007.01307.x; Palangkaraya A, 2009, EUR J HEALTH ECON, V10, P135, DOI 10.1007/s10198-008-0111-8; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Penn Z, 2001, BEST PRACT RES CL OB, V15, P1, DOI 10.1053/beog.2000.0146; Roberts CL, 2000, BRIT MED J, V321, P137, DOI 10.1136/bmj.321.7254.137; Robson SJ, 2009, BIRTH-ISS PERINAT C, V36, P208, DOI 10.1111/j.1523-536X.2009.00331.x; Scott A, 1994, Aust J Public Health, V18, P96; Segal Leonie, 2004, Aust Health Rev, V27, P3; Shorten A, 1995, Aust Health Rev, V18, P19; Shorten A, 1999, Aust Health Rev, V22, P18; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Statistical Bulletin, 2005, STAT B NHS MATERNITY, P2003; Stavrou EP, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-8; Thompson JF, 2000, MED J AUSTRALIA, V172, P532, DOI 10.5694/j.1326-5377.2000.tb124098.x; Tracy SK, 2007, BIRTH-ISS PERINAT C, V34, P301, DOI 10.1111/j.1523-536X.2007.00188.x; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walker AE, 2007, AUST HEALTH REV, V31, P305, DOI 10.1071/AH070305; Zwecker P, 2011, AM J PERINAT, V28, P277, DOI 10.1055/s-0030-1271213	50	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41436	10.1371/journal.pone.0041436	http://dx.doi.org/10.1371/journal.pone.0041436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844477	Green Published, gold			2022-12-27	WOS:000306687700089
J	Findlay, B; Szelemej, P; Zhanel, GG; Schweizer, F				Findlay, Brandon; Szelemej, Paul; Zhanel, George G.; Schweizer, Frank			Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; PEPTIDE; PATHOGENS; MIMICS	Background: Cationic antimicrobial peptides (CAMPs) are attractive scaffolds for the next generation of antimicrobial compounds, due to their broad spectrum of activity against multi-drug resistant bacteria and the reduced fitness of CAMP-insensitive mutants. Unfortunately, they are limited by poor in vivo performance, including ready cleavage by endogenous serum proteases. Methodology/Principal Findings: To explore the potential for peptoid residues to replace well studied CAMP scaffolds we have produced a series of antimicrobial lipopeptoids, with sequences similar to previously reported lipopeptides. The activity of the peptoids was assessed against a panel of clinically relevant and laboratory reference bacteria, and the potential for non-specific binding was determined through hemolytic testing and repeating the antimicrobial testing in the presence of added bovine serum albumin (BSA). The most active peptoids displayed good to moderate activity against most of the Gram positive strains tested and moderate to limited activity against the Gram negatives. Antimicrobial activity was positively correlated with toxicity towards eukaryotic cells, but was almost completely eliminated by adding BSA. Conclusion/Significance: The lipopeptoids had similar activities to the previously reported lipopeptides, confirming their potential to act as replacement, proteolytically stable scaffolds for CAMPs.	[Findlay, Brandon; Szelemej, Paul; Schweizer, Frank] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Zhanel, George G.; Schweizer, Frank] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Findlay, B (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.	schweize@cc.umanitoba.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding of this work was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Baker TJ, 2000, J ORG CHEM, V65, P9054, DOI 10.1021/jo001142e; Bera S, 2010, J ANTIMICROB CHEMOTH; Chan WC, 2000, FMOC SOLID PHASE PEP; Chongsiriwatana NP, 2011, ANTIMICROB AGENTS CH, V55, P417, DOI 10.1128/AAC.01080-10; Chongsiriwatana NP, 2010, METHODS MOL BIOL, V618, P171, DOI 10.1007/978-1-60761-594-1_12; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; Findlay B, 2012, INT J ANTIMICROB AG, V40, P36, DOI 10.1016/j.ijantimicag.2012.03.013; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Koprivnjak T, 2011, CELL MOL LIFE SCI, V68, P2243, DOI 10.1007/s00018-011-0716-4; Makovitzki A, 2005, BIOCHEMISTRY-US, V44, P9775, DOI 10.1021/bi0502386; MARIS P, 1991, ANN RECH VET, V22, P11; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Rennie RP, 2006, PROTOCOLS EVALUATING, P1; Svenson J, 2008, BIOCHEMISTRY-US, V47, P3777, DOI 10.1021/bi7019904; Svenson J, 2007, J MED CHEM, V50, P3334, DOI 10.1021/jm0703542; Wright GD, 2012, TRENDS MICROBIOL; Yang LH, 2008, P NATL ACAD SCI USA, V105, P20595, DOI 10.1073/pnas.0806456105; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zhanel GG, 2008, ANTIMICROB AGENTS CH, V52, P1430, DOI 10.1128/AAC.01538-07; Zhanel GG, 2011, DIAGN MICR INFEC DIS, V69, P291, DOI 10.1016/j.diagmicrobio.2010.10.025	23	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41141	10.1371/journal.pone.0041141	http://dx.doi.org/10.1371/journal.pone.0041141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844435	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700048
J	Gu, Z; Liu, YH; Zhang, YJ; Jin, SL; Chen, Q; Goltzman, D; Karaplis, A; Miao, DS				Gu, Zhen; Liu, Yahong; Zhang, Yongjie; Jin, Shulei; Chen, Qi; Goltzman, David; Karaplis, Andrew; Miao, Dengshun			Absence of PTHrP Nuclear Localization and Carboxyl Terminus Sequences Leads to Abnormal Brain Development and Function	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; SELF-RENEWAL; CELL-PROLIFERATION; PEPTIDE RECEPTOR; UP-REGULATION; MICE LACKING; GROWTH; SENESCENCE; NEUROGENESIS; INDUCTION	We assessed whether the nuclear localization sequences (NLS) and C terminus of parathyroid hormone-related protein (PTHrP) play critical roles in brain development and function. We used histology, immunohistochemistry, histomorphometry, Western blots and electrophysiological recordings to compare the proliferation and differentiation of neural stem cells, neuronal hippocampal synaptic transmission, and brain phenotypes including shape and structures, in Pthrp knock-in mice, which express PTHrP (1-84), a truncated form of the protein that is missing the NLS and the C-terminal region of the protein, and their wild-type littermates. Results showed that Pthrp knock-in mice display abnormal brain shape and structures; decreased neural cell proliferative capacity and increased apoptosis associated with up-regulation of cyclin dependent kinase inhibitors p16, p21, p27 and p53 and down-regulation of the Bmi-1 oncogene; delayed neural cell differentiation; and impaired hippocampal synaptic transmission and plasticity. These findings provide in vivo experimental evidence that the NLS and C-terminus of PTHrP are essential not only for the regulation of neural cell proliferation and differentiation, but also for the maintenance of normal neuronal synaptic transmission and plasticity.	[Gu, Zhen; Liu, Yahong; Zhang, Yongjie; Jin, Shulei; Miao, Dengshun] Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chen, Qi] Nanjing Med Univ, Dept Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Goltzman, David; Karaplis, Andrew] McGill Univ, Dept Med, Montreal, PQ, Canada	Nanjing Medical University; Nanjing Medical University; McGill University	Gu, Z (corresponding author), Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	dsmiao@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502; Zhang, Yongjie/0000-0002-8674-4566	National Nature and Scientific Foundation of China [30830103]; National Basic Research Program of China [2012CB966902]; Nature and Scientific Basic Research Foundation of Jiangsu Province [07KJB310078]; Scientific Development Foundation of Nanjing Medical University [06NMUZ003]; Canadian Institutes for Health Research; Nature and Scientific Foundation of Jiangsu Province [BK2010539]; Natural Science Foundation for the Youth [81100942]; College of Basic Medicine of Nanjing Medical University [JX1011780114]	National Nature and Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Nature and Scientific Basic Research Foundation of Jiangsu Province; Scientific Development Foundation of Nanjing Medical University; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Nature and Scientific Foundation of Jiangsu Province; Natural Science Foundation for the Youth(National Natural Science Foundation of China (NSFC)); College of Basic Medicine of Nanjing Medical University	This work was supported by the Key Project grant (no. 30830103) from National Nature and Scientific Foundation of China and by the National Basic Research Program of China (2012CB966902) to D.M.; by the grant (07KJB310078) from Nature and Scientific Basic Research Foundation of Jiangsu Province and the Key Project grant (no. 06NMUZ003) from Scientific Development Foundation of Nanjing Medical University to Z.G.; by operating grants from the Canadian Institutes for Health Research to A.C.K. and D.G.; by the Nature and Scientific Foundation of Jiangsu Province (BK2010539), Natural Science Foundation for the Youth (no. 81100942) to Y.Z. and the grant (JX1011780114) from College of Basic Medicine of Nanjing Medical University to Y.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008; Berzhanskaya J, 1998, J NEUROPHYSIOL, V79, P2111, DOI 10.1152/jn.1998.79.4.2111; BURTIS WJ, 1987, J BIOL CHEM, V262, P7151; Chatterjee O, 2002, BRAIN RES, V930, P58, DOI 10.1016/S0006-8993(01)03407-2; Clemens TL, 2001, BRIT J PHARMACOL, V134, P1113, DOI 10.1038/sj.bjp.0704378; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fiaschi-Taesch N, 2009, ENDOCRINOLOGY, V150, P1429, DOI 10.1210/en.2008-0737; Fiaschi-Taesch NM, 2003, ENDOCRINOLOGY, V144, P407, DOI 10.1210/en.2002-220818; FUKAYAMA S, 1995, P NATL ACAD SCI USA, V92, P10182, DOI 10.1073/pnas.92.22.10182; Funk JL, 2001, BRAIN RES, V915, P195, DOI 10.1016/S0006-8993(01)02850-5; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Hildreth BE, 2010, J SURG RES, V162, pE9, DOI 10.1016/j.jss.2010.02.023; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kumari R, 2006, INT J CANCER, V119, P49, DOI 10.1002/ijc.21802; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Macica CM, 2006, GLIA, V53, P637, DOI 10.1002/glia.20319; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; Massa F, 2011, P NATL ACAD SCI USA, V108, P6644, DOI 10.1073/pnas.1016928108; Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105; Miao DS, 2004, ENDOCRINOLOGY, V145, P3554, DOI 10.1210/en.2003-1695; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Qian J, 2003, ENDOCRINOLOGY, V144, P1053, DOI 10.1210/en.2002-220993; Sepulveda VAT, 2002, REGUL PEPTIDES, V105, P109, DOI 10.1016/S0167-0115(02)00007-1; Srivastava RK, 2007, CELL CYCLE, V6, P2953, DOI 10.4161/cc.6.23.4951; URENA P, 1993, ENDOCRINOLOGY, V133, P617, DOI 10.1210/en.133.2.617; WEIR EC, 1990, P NATL ACAD SCI USA, V87, P108, DOI 10.1073/pnas.87.1.108; Wu TL, 1996, J BIOL CHEM, V271, P24371, DOI 10.1074/jbc.271.40.24371; Wysolmerski JJ, 2001, J CLIN ENDOCR METAB, V86, P1788, DOI 10.1210/jc.86.4.1788; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yamamoto S, 2002, ENDOCRINOLOGY, V143, P1521, DOI 10.1210/en.143.4.1521	34	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41542	10.1371/journal.pone.0041542	http://dx.doi.org/10.1371/journal.pone.0041542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844494	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700106
J	Narita, R; Kitaura, H; Torii, A; Tashiro, E; Miyazawa, M; Ariga, H; Iguchi-Ariga, SMM				Narita, Rina; Kitaura, Hirotake; Torii, Ayako; Tashiro, Erika; Miyazawa, Makoto; Ariga, Hiroyoshi; Iguchi-Ariga, Sanae M. M.			Rabring7 Degrades c-Myc through Complex Formation with MM-1	PLOS ONE			English	Article							MONO-UBIQUITINATION; TUMOR-SUPPRESSOR; BINDING PROTEIN; DEGRADATION; EXPRESSION; PROTEASOME; REPRESSION; STABILITY; MECHANISM; PREFOLDIN	We have reported that a novel c-Myc-binding protein, MM-1, repressed E-box-dependent transcription and transforming activities of c-Myc and that a mutation of A157R in MM-1, which is often observed in patients with leukemia or lymphoma, abrogated all of the repressive activities of MM-1 toward c-Myc, indicating that MM-1 is a novel tumor suppressor. MM-1 also binds to the ubiquitin-proteasome system, leading to degradation of c-Myc. In this study, we identified Rabring7, a Rab7-binding and RING finger-containing protein, as an MM-1-binding protein, and we found that Rabring7 monoubiquitinated MM-1 in the cytoplasm without degradation of MM-1. Rabring7 was also found to bind to c-Myc and to ubiquitinate c-Myc in a threonine 58-dependent manner. When c-Myc was co-transfected with MM-1 and Rabring7, c-Myc was degraded. Furthermore, it was found that c-Myc was stabilized in MM-1-knockdown cells even when Rabring7 was transfected and that Rabring7 was bound to and co-localized with MM-1 and c-Myc after MM-1 and Rabring7 had been translocated from the cytoplasm to the nucleus. These results suggest that Rabring7 stimulates c-Myc degradation via mono-ubiquitination of MM-1.	[Narita, Rina; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Kitaura, Hirotake; Torii, Ayako; Tashiro, Erika; Miyazawa, Makoto; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Narita, R (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	hiro@pharm.hokudai.ac.jp; myan@res.agr.hokudai.ac.jp	Ariga, Sanae/H-9647-2013; Ariga, Hiroyoshi/B-5895-2013	Ariga, Hiroyoshi/0000-0001-7384-2143	Ministry of Education, Science, Culture and Sports; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research [22300119, 24650191] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Burger AM, 2005, CANCER RES, V65, P10401, DOI 10.1158/0008-5472.CAN-05-2103; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Geissler S, 1998, EMBO J, V145, P265; Hagio Y, 2006, J CELL BIOCHEM, V97, P145, DOI 10.1002/jcb.20619; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kimura Y, 2007, INT J ONCOL, V31, P829; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Miyazawa M, 2011, J BIOL CHEM, V286, P19191, DOI 10.1074/jbc.M110.216259; Mizuno K, 2003, MOL BIOL CELL, V14, P3741, DOI 10.1091/mbc.E02-08-0495; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Ogawa Y, 2005, BIOCHEM BIOPH RES CO, V336, P204, DOI 10.1016/j.bbrc.2005.08.046; Sakane A, 2007, BIOCHEM BIOPH RES CO, V357, P1058, DOI 10.1016/j.bbrc.2007.04.052; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Satou A, 2004, FEBS LETT, V572, P211, DOI 10.1016/j.febslet.2004.07.034; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Taira T, 1999, J BIOL CHEM, V274, P24270, DOI 10.1074/jbc.274.34.24270; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang B, 2008, BIOCHEM BIOPH RES CO, V376, P288, DOI 10.1016/j.bbrc.2008.08.143; Watanabe K, 2002, J BIOL CHEM, V277, P15113, DOI 10.1074/jbc.M111281200; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002	35	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41891	10.1371/journal.pone.0041891	http://dx.doi.org/10.1371/journal.pone.0041891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844532	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700162
J	Noorai, RE; Freese, NH; Wright, LM; Chapman, SC; Clark, LA				Noorai, Rooksana E.; Freese, Nowlan H.; Wright, Lindsay M.; Chapman, Susan C.; Clark, Leigh Anne			Genome-Wide Association Mapping and Identification of Candidate Genes for the Rumpless and Ear-tufted Traits of the Araucana Chicken	PLOS ONE			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; HOMEOBOX GENE; DIGEORGE-SYNDROME; FOWL; MUTATION; MOUSE; TBX1; COMPARTMENT; CAUPOLICAN; PHENOTYPE	Araucana chickens are known for their rounded, tailless rumps and tufted ears. Inheritance studies have shown that the rumpless (Rp) and ear-tufted (Et) loci each act in an autosomal dominant fashion, segregate independently, and are associated with an increased rate of embryonic mortality. To find genomic regions associated with Rp and Et, we generated genome-wide SNP profiles for a diverse population of 60 Araucana chickens using the 60 K chicken SNP BeadChip. Genome-wide association studies using 40 rumpless and 11 tailed birds showed a strong association with rumpless on Gga 2 (P-raw = 2.45x10(-10), P-genome = 0.00575), and analysis of genotypes revealed a 2.14 Mb haplotype shared by all rumpless birds. Within this haplotype, a 0.74 Mb critical interval containing two Iroquois homeobox genes, Irx1 and Irx2, was unique to rumpless Araucana chickens. Irx1 and Irx2 are central for developmental prepatterning, but neither gene is known to have a role in mechanisms leading to caudal development. A second genome-wide association analysis using 30 ear-tufted and 28 non-tufted birds revealed an association with tufted on Gga 15 (P-raw = 6.61x10(-7), P-genome = 0.0981). We identified a 0.58 Mb haplotype common to tufted birds and harboring 7 genes. Because homozygosity for Et is nearly 100% lethal, we employed a heterozygosity mapping approach to prioritize candidate gene selection. A 60 kb region heterozygous in all Araucana chickens contains the complete coding sequence for TBX1 and partial sequence for GNB1L. TBX1 is an important transcriptional regulator of embryonic development and a key genetic determinant of human DiGeorge syndrome. Herein, we describe localization of Rp and Et and identification of positional candidate genes.	[Noorai, Rooksana E.; Wright, Lindsay M.; Clark, Leigh Anne] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29631 USA; [Freese, Nowlan H.; Chapman, Susan C.] Clemson Univ, Dept Biol Sci, Clemson, SC USA	Clemson University; Clemson University	Noorai, RE (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29631 USA.	schapm2@clemson.edu; lclark4@clemson.edu	Chapman, Susan C/J-2688-2013; Noorai, Rooksana E/E-9785-2019	Chapman, Susan C/0000-0002-4314-9193; Noorai, Rooksana E/0000-0002-9992-5198; Piel, Lindsay/0000-0003-0428-6467	NIH/NIDCD [DC009236]; American Recovery and Reinvestment Act; NIFA/USDA [SC-1700374]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009236] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Recovery and Reinvestment Act; NIFA/USDA(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by NIH/NIDCD (DC009236), with supplemental funding from the American Recovery and Reinvestment Act to SCC. Technical Contribution No. 6029 of the Clemson University Experiment Station. This material is based upon work supported by NIFA/USDA, under project number SC-1700374 to SCC. http://www.nidcd.nih.gov/Pages/default.aspx http://www.recovery.gov/Pages/default.aspx http://www.clemson.edu/public/experiment_station/faculty_staff/research_projects.html http://www.csrees.usda.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Browman DL, 1978, ADV ANDEAN ARCHAEOLO, P189; Butts SC, 2009, INT J PEDIATR OTORHI, V73, P343, DOI 10.1016/j.ijporl.2008.10.011; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Cheng CW, 2006, MECH DEVELOP, V123, P252, DOI 10.1016/j.mod.2005.12.001; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Dunn LC, 1934, J GENET, V29, P217, DOI 10.1007/BF02982198; Dunn LC, 1936, J GENET, V33, P401, DOI 10.1007/BF02982895; Ekarius C, 2007, STOREYS ILLUSTRATED, P23; GomezSkarmeta JL, 1996, GENE DEV, V10, P2935, DOI 10.1101/gad.10.22.2935; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Itoh M, 2002, DEVELOPMENT, V129, P2317; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kimura W, 2011, GENESIS, V49, P2, DOI 10.1002/dvg.20688; Lebel M, 2003, MOL CELL BIOL, V23, P8216, DOI 10.1128/MCB.23.22.8216-8225.2003; Li Y, 2011, PSYCHIAT RES, V187, P457, DOI 10.1016/j.psychres.2010.04.019; PABILONIA MS, 1983, POULTRY SCI, V62, P1539, DOI 10.3382/ps.0621539; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; SOMES RG, 1981, J HERED, V72, P121, DOI 10.1093/oxfordjournals.jhered.a109439; SOMES RG, 1978, J HERED, V69, P91, DOI 10.1093/oxfordjournals.jhered.a108911; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Volker M, 2010, GENOME RES, V20, P503, DOI 10.1101/gr.103663.109; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zwilling E, 1942, GENETICS, V27, P641	32	17	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40974	10.1371/journal.pone.0040974	http://dx.doi.org/10.1371/journal.pone.0040974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844420	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700030
J	Noulin, F; Borlon, C; van den Eede, P; Boel, L; Verfaillie, CM; D'Alessandro, U; Erhart, A				Noulin, Florian; Borlon, Celine; van den Eede, Peter; Boel, Luc; Verfaillie, Catherine M.; D'Alessandro, Umberto; Erhart, Annette			Cryopreserved Reticulocytes Derived from Hematopoietic Stem Cells Can Be Invaded by Cryopreserved Plasmodium vivax Isolates	PLOS ONE			English	Article							RED-BLOOD-CELLS; FALCIPARUM; MALARIA; CHLOROQUINE; RESISTANCE; GENERATION; INVASION	The development of a system for the continuous culture of Plasmodium vivax in vitro would benefit from the use of reticulocytes derived from differentiated hematopoietic stem cells (HCS). At present, the need to use both fresh reticulocytes and fresh P. vivax isolates represents a major obstacle towards this goal, particularly for laboratories located in non-endemic countries. Here, we describe a new method for the cryopreservation of HSC-derived reticulocytes to be used for both P. falciparum and P. vivax invasion tests. Cryopreserved P. falciparum and P. vivax isolates could invade both fresh and cryopreserved HSC-derived reticulocytes with similar efficiency. This new technique allows the storage of HSC-derived reticulocytes which can be used for later invasion tests and represents an important step towards the establishment of a continuous P. vivax culture.	[Noulin, Florian; Borlon, Celine; van den Eede, Peter; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med Antwerp, Unit Malariol, Antwerp, Belgium; [Boel, Luc] Inst Trop Med Antwerp, Immunol Unit, Antwerp, Belgium; [Noulin, Florian; Verfaillie, Catherine M.] Katholieke Univ Leuven, Stem Cells Inst, Louvain, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); KU Leuven; University of London; London School of Hygiene & Tropical Medicine	Noulin, F (corresponding author), Inst Trop Med Antwerp, Unit Malariol, Antwerp, Belgium.	fnoulin@itg.be	noulin, florian/J-3809-2013; D'Alessandro, Umberto/D-3457-2015; Verfaillie, Catherine/H-5148-2013	noulin, florian/0000-0001-7430-8073; D'Alessandro, Umberto/0000-0001-6341-5009; Verfaillie, Catherine/0000-0001-7564-4079	ITM Secondary Research Funding (SOFI-B) [755023]	ITM Secondary Research Funding (SOFI-B)	Funding was provided by ITM Secondary Research Funding (SOFI-B), http://www.itg.be/itgtool_v2/Projecten/Project.asp?PNr=755023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; DIGGS C, 1975, AM J TROP MED HYG, V24, P760, DOI 10.4269/ajtmh.1975.24.760; Douay Luc, 2009, V482, P127, DOI 10.1007/978-1-59745-060-7_8; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Giarratana MC, 2011, BLOOD; GOLDMAN JM, 1978, BRIT J HAEMATOL, V40, P185, DOI 10.1111/j.1365-2141.1978.tb03656.x; Golenda CF, 1997, P NATL ACAD SCI USA, V94, P6786, DOI 10.1073/pnas.94.13.6786; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; KLEIHAUER E, 1957, KLIN WOCHENSCHR, V35, P637, DOI 10.1007/BF01481043; Kosaisavee V, 2006, EXP PARASITOL, V114, P34, DOI 10.1016/j.exppara.2006.02.006; LAFOREST J, 1968, Revue Francaise de Transfusion, V11, P23, DOI 10.1016/S0035-2977(68)80078-1; LORETZ LJ, 1989, XENOBIOTICA, V19, P489, DOI 10.3109/00498258909042288; MECHETNER EB, 1991, AM J HEMATOL, V38, P61, DOI 10.1002/ajh.2830380110; MONS B, 1990, BLOOD CELLS, V16, P299; Nienhuis AW, 1979, METHODS CELL SCI, V1, P111; PASVOL G, 1982, LANCET, V2, P947; Prajapati SK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-102; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; RIVADENEIRA EM, 1983, J PROTOZOOL, V30, P367, DOI 10.1111/j.1550-7408.1983.tb02932.x; ROSSAN RN, 1985, AM J TROP MED HYG, V34, P207, DOI 10.4269/ajtmh.1985.34.207; Russell B, 2011, BLOOD; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Tamez PA, 2009, BLOOD, V114, P3652, DOI 10.1182/blood-2009-07-231894; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Udomsangpetch R, 2007, PARASITOL INT, V56, P65, DOI 10.1016/j.parint.2006.12.005; Yohannes AM, 2011, AM J TROP MED HYG, V84, P137, DOI 10.4269/ajtmh.2011.09-0723	31	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40798	10.1371/journal.pone.0040798	http://dx.doi.org/10.1371/journal.pone.0040798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844411	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700018
J	Pansani, MC; Azevedo, PS; Rafacho, BPM; Minicucci, MF; Chiuso-Minicucci, F; Zorzella-Pezavento, SG; Marchini, JS; Padovan, GJ; Fernandes, AAH; Matsubara, BB; Matsubara, LS; Zornoff, LAM; Paiva, SAR				Pansani, Mariele Castilho; Azevedo, Paula S.; Murino Rafacho, Bruna Paola; Minicucci, Marcos F.; Chiuso-Minicucci, Fernanda; Zorzella-Pezavento, Sofia Goncalves; Marchini, Julio Sergio; Padovan, Gilberto Joao; Henrique Fernandes, Ana Angelica; Matsubara, Beatriz B.; Matsubara, Luiz S.; Zornoff, Leonardo A. M.; Paiva, Sergio A. R.			Atrophic Cardiac Remodeling Induced by Taurine Deficiency in Wistar Rats	PLOS ONE			English	Article							PROTEIN-CALORIE MALNUTRITION; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; HEART-FAILURE; AMINO-ACID; DEPLETION; DAMAGE; TISSUE; PURIFICATION; HYPERTENSION	Introduction: Micronutrient deficiency is observed in heart failure patients. Taurine, for example, represents 50% of total free amino acids in the heart, and in vivo studies have linked taurine deficiency with cardiomyopathy. Methods: Thirty-four male Wistar rats (body weight = 100 g) were weighed and randomly assigned to one of two groups: Control (C) or taurine-deficient (T (-)). Beta-alanine at a concentration of 3% was added to the animals' water to induce taurine deficiency in the T (-) group. On day 30, the rats were individually submitted to echocardiography; morphometrical and histopathological evaluation and metalloproteinase activity, oxidative stress and inflammation evaluation were performed. Tissue samples were collected to determine the taurine concentration in the heart. Results: Taurine deficiency led to decreases in: ventricular wall thickness, left ventricle dry weight, myocyte sectional area, left ventricle posterior wall thickness and ventricular geometry. With regard to heart function, the velocity of the A wave, the ratio between the E and A wave, the ejection fraction, fractional shortening and cardiac output values were decreased in T () rats, suggesting abnormal diastolic and systolic function. Increased fibrosis, inflammation and increased activation of metalloproteinases were not observed. Oxidative stress was increased in deficient animals. Conclusions: These data suggest that taurine deficiency promotes structural and functional cardiac alterations with unique characteristics.	[Pansani, Mariele Castilho; Azevedo, Paula S.; Murino Rafacho, Bruna Paola; Minicucci, Marcos F.; Matsubara, Beatriz B.; Matsubara, Luiz S.; Zornoff, Leonardo A. M.; Paiva, Sergio A. R.] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Internal Med, Botucatu, SP, Brazil; [Chiuso-Minicucci, Fernanda; Zorzella-Pezavento, Sofia Goncalves] Univ Estadual Paulista UNESP, Inst Biociencias Botucatu, Dept Microbiol & Immunol, Botucatu, SP, Brazil; [Henrique Fernandes, Ana Angelica] Univ Estadual Paulista UNESP, Inst Biociencias Botucatu, Dept Chem & Biochem, Botucatu, SP, Brazil; [Marchini, Julio Sergio; Padovan, Gilberto Joao] Univ Sao Paulo FMRP USP, Fac Med Ribeirao Preto, Dept Internal Med, Ribeirao Preto, SP, Brazil	Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo	Pansani, MC (corresponding author), Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Internal Med, Botucatu, SP, Brazil.	paiva@fmb.unesp.br	Minicucci, Fernanda C/A-9220-2015; Zorzella-Pezavento, Sofia Fernanda Gonçalves/B-2568-2013; Matsubara, Luiz S/D-5061-2009; Rafacho, Bruna Paola Murino/AGW-5794-2022; Marchini, Julio S/K-1992-2016; Minicucci, Marcos F/A-9094-2008; Azevedo, Paula S/F-2701-2012; Azevedo, Paula Schmidt/S-1597-2019; Fernandes, Ana Angelica Henrique/D-5291-2012; Paiva, Sergio AR/A-5101-2008; Rafacho, Bruna Paola Murino/B-5460-2013; Zornoff, Leonardo/A-5612-2008	Minicucci, Fernanda C/0000-0002-4155-6414; Zorzella-Pezavento, Sofia Fernanda Gonçalves/0000-0001-9030-0768; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Marchini, Julio S/0000-0001-9999-9149; Minicucci, Marcos F/0000-0002-5980-4367; Azevedo, Paula S/0000-0002-5843-6232; Azevedo, Paula Schmidt/0000-0002-5843-6232; Paiva, Sergio AR/0000-0003-4412-1990; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Zornoff, Leonardo/0000-0002-9831-8820	CAPES; Faculdade de Medicina de Botucatu - UNESP	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Faculdade de Medicina de Botucatu - UNESP	This work was supported by the CAPES (MCP scholarship) and Faculdade de Medicina de Botucatu - UNESP (FC-M, SGZ-P, JSM, GJP, AAHF, PSA, BBM, LSM, BPMR, MFM, LAMZ and SARP salaries). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard ML, 2006, HEART FAIL REV, V11, P75, DOI 10.1007/s10741-006-9195-3; Baskin KK, 2011, CARDIOVASC RES, V90, P243, DOI 10.1093/cvr/cvr060; Birdsall T C, 1998, Altern Med Rev, V3, P128; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004; CAMPBELL SE, 1991, CIRC RES, V68, P984, DOI 10.1161/01.RES.68.4.984; Das J, 2012, TOXICOL APPL PHARM, V258, P296, DOI 10.1016/j.taap.2011.11.009; Dawson R, 2002, AMINO ACIDS, V22, P309; de Paiva SAR, 2003, AM J PHYSIOL-HEART C, V284, pH2242, DOI 10.1152/ajpheart.00646.2002; Deminice R, 2009, ANN NUTR METAB, V54, P202, DOI 10.1159/000218707; Denipote F, 2011, CELL PHYSIOL BIOCHEM, V27, P291, DOI 10.1159/000327955; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Fioretto JR, 2002, AM J PHYSIOL-HEART C, V282, pH1327, DOI 10.1152/ajpheart.00431.2001; Ghosh J, 2009, TOXICOL APPL PHARM, V240, P73, DOI 10.1016/j.taap.2009.07.008; Gokce G, 2009, BIOCHEMISTRY-US, V48, P4980, DOI 10.1021/bi900030z; Hobson RM, 2012, AMINO ACIDS, V43, P25, DOI 10.1007/s00726-011-1200-z; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LOSER C, 1988, J CHROMATOGR-BIOMED, V430, P249, DOI 10.1016/S0378-4347(00)83160-6; Metayer S, 2008, J NUTR BIOCHEM, V19, P207, DOI 10.1016/j.jnutbio.2007.05.006; Minicucci MF, 2010, CELL PHYSIOL BIOCHEM, V26, P523, DOI 10.1159/000322320; Mozaffari MS, 2000, AMINO ACIDS, V19, P625, DOI 10.1007/s007260070012; NAKAMURA W, 1974, BIOCHIM BIOPHYS ACTA, V358, P251, DOI 10.1016/0005-2744(74)90455-0; NUTTER DO, 1979, CIRC RES, V45, P144, DOI 10.1161/01.RES.45.1.144; Okoshi MP, 2001, CAN J PHYSIOL PHARM, V79, P754, DOI 10.1139/cjpp-79-9-754; Parildar H, 2008, J NUTR SCI VITAMINOL, V54, P61, DOI 10.3177/jnsv.54.61; PAULETTO P, 1986, J HYPERTENS, V4, pS135; PISSAIA O, 1980, J NUTR, V110, P2035, DOI 10.1093/jn/110.10.2035; Rafacho BPM, 2011, CELL PHYSIOL BIOCHEM, V27, P305, DOI 10.1159/000327957; Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, pC413, DOI 10.1152/ajpcell.00362.2007; Roysommuti S, 2009, ADV EXP MED BIOL, V643, P123, DOI 10.1007/978-0-387-75681-3_13; Schaffer SW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S2; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; Siddiq T, 1996, BIOCHEM MOL MED, V57, P19, DOI 10.1006/bmme.1996.0004; SPAETH DG, 1974, P SOC EXP BIOL MED, V147, P855; Stellingwerff T, 2012, AMINO ACIDS, V43, P57, DOI 10.1007/s00726-012-1245-7; SUSSMAN MR, 1988, ANAL BIOCHEM, V169, P395, DOI 10.1016/0003-2697(88)90302-8; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; TYAGI SC, 1993, CLIN BIOCHEM, V26, P191, DOI 10.1016/0009-9120(93)90025-2; Welsh DC, 2001, AM J PHYSIOL-HEART C, V281, pH1131, DOI 10.1152/ajpheart.2001.281.3.H1131; Witte KKA, 2001, J AM COLL CARDIOL, V37, P1765, DOI 10.1016/S0735-1097(01)01227-X; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; Xu Yan-Jun, 2008, Exp Clin Cardiol, V13, P57; Yndestad Arne, 2007, Curr Cardiol Rep, V9, P236, DOI 10.1007/BF02938356	46	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41439	10.1371/journal.pone.0041439	http://dx.doi.org/10.1371/journal.pone.0041439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844478	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700090
J	Zuo, Z; Medeiros, LJ; Chen, Z; Liu, DS; Bueso-Ramos, CE; Luthra, R; Wang, SA				Zuo, Zhuang; Medeiros, L. Jeffrey; Chen, Zhao; Liu, Dingsheng; Bueso-Ramos, Carlos E.; Luthra, Rajyalakshmi; Wang, Sa A.			Acute Myeloid Leukemia (AML) with Erythroid Predominance Exhibits Clinical and Molecular Characteristics that Differ from Other Types of AML	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; WORLD-HEALTH-ORGANIZATION; MYELODYSPLASTIC SYNDROMES; NPM1 MUTATIONS; ACUTE ERYTHROLEUKEMIA; FAVORABLE PROGNOSIS; GENE-MUTATIONS; JAK2 V617F; CLASSIFICATION; RARE	The clinical importance of erythroid predominance in bone marrow of patients with acute myeloid leukemia (AML) is controversial. These cases represent a heterogeneous group of diseases that historically have been classified into different categories. We studied 313 AML patients and specifically compared the clinical, cytogenetic, and molecular features of cases of AML with erythroid predominance, arbitrarily defined as >= 50% erythroid precursors, to AML cases without erythroid predominance. We also assessed 51 patients with a high-grade myelodysplastic syndrome (MDS), refractory anemia with excess blasts (RAEB). All neoplasms were classified according to the World Health Organization classification. With the exception of therapy-related AML/MDS, the presence of erythroid predominance in variously classified categories of AML was associated with a survival advantage. In addition, AML with erythroid predominance had a lower frequency of cytogenetic abnormalities as well as a lower frequency of mutations involving NPM1, NRAS and FLT3 as compared with AML without erythroid predominance. We conclude that the clinical, cytogenetic, and molecular features of AML with erythroid predominance in the non-therapy-related setting are much closer to those of a high-grade myelodysplastic syndrome than they are to other types of AML.	[Zuo, Zhuang; Medeiros, L. Jeffrey; Chen, Zhao; Liu, Dingsheng; Bueso-Ramos, Carlos E.; Luthra, Rajyalakshmi; Wang, Sa A.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Zuo, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	zzuo@mdanderson.org	Medeiros, L. Jeffrey/AAB-1018-2019					Bacher U, 2007, HAEMATOLOGICA, V92, P744, DOI 10.3324/haematol.10869; Bacher U, 2011, HAEMATOL-HEMATOL J, V96, P1284, DOI 10.3324/haematol.2011.043687; Bains A, 2011, AM J CLIN PATHOL, V135, P62, DOI 10.1309/AJCPEI9XU8PYBCIO; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Di Guglielmo G, 1917, FOLIA MEDICA PAVIA, V13, P386; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Ebert BL, 2010, BEST PRACT RES CL HA, V23, P457, DOI 10.1016/j.beha.2010.09.006; Frohling S, 2006, BLOOD, V107, P1242, DOI 10.1182/blood-2005-09-3644; Galton DAGDJ, 1975, BR J HAEMATOL, P31; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hasserjian RP, 2010, BLOOD, V115, P1985, DOI 10.1182/blood-2009-09-243964; Hopfer O, 2012, EUR J HAEMATOL, V88, P144, DOI 10.1111/j.1600-0609.2011.01715.x; Kasyan A, 2010, MODERN PATHOL, V23, P1113, DOI 10.1038/modpathol.2010.96; Lin P, 2006, AM J CLIN PATHOL, V126, P530, DOI 10.1309/JT5BE2L1FGG8P8Y6; OLOPADE OI, 1992, BLOOD, V80, P2873; Ruan GR, 2009, ANN HEMATOL, V88, P159, DOI 10.1007/s00277-008-0591-8; Santos FPS, 2009, LEUKEMIA, V23, P2275, DOI 10.1038/leu.2009.181; Santos FPS, 2010, EXPERT REV HEMATOL, V3, P705, DOI [10.1586/ehm.10.62, 10.1586/EHM.10.62]; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Shimizu R, 2008, NAT REV CANCER, V8, P279, DOI 10.1038/nrc2348; Steensma DP, 2006, LEUKEMIA, V20, P971, DOI 10.1038/sj.leu.2404206; Suzuki T, 2005, BLOOD, V106, P2854, DOI 10.1182/blood-2005-04-1733; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang SA, 2008, MODERN PATHOL, V21, P1394, DOI 10.1038/modpathol.2008.142; Zuo ZA, 2010, ARCH PATHOL LAB MED, V134, P1261, DOI 10.1043/2009-0350-RA.1; Zuo Z, 2009, MODERN PATHOL, V22, P1023, DOI 10.1038/modpathol.2009.59	27	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41485	10.1371/journal.pone.0041485	http://dx.doi.org/10.1371/journal.pone.0041485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844482	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700093
J	Barros, CC; Haro, A; Russo, FJVP; Schadock, I; Almeida, SS; Ribeiro, RA; Vanzela, EC; Lanzoni, VP; Barros, FC; Moraes, MR; Mori, MA; Bacurau, RFP; Wurtele, M; Boschero, AC; Carneiro, EM; Bader, M; Pesquero, JB; Araujo, RC				Barros, Carlos C.; Haro, Anderson; Russo, Fernanda J. V. P.; Schadock, Ines; Almeida, Sandro S.; Ribeiro, Rosane A.; Vanzela, Emerielle C.; Lanzoni, Valeria P.; Barros, Flavio C.; Moraes, Milton R.; Mori, Marcelo A.; Bacurau, Reury F. P.; Wurtele, Martin; Boschero, Antonio C.; Carneiro, Everardo M.; Bader, Michael; Pesquero, Joao B.; Araujo, Ronaldo C.			Altered Glucose Homeostasis and Hepatic Function in Obese Mice Deficient for Both Kinin Receptor Genes	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; GLUT4 TRANSLOCATION; HYPERGLYCEMIC MICE; B-2 RECEPTOR; OB/OB MICE; BRADYKININ; SYSTEM; LEPTIN; EXPRESSION	The Kallikrein-Kinin System (KKS) has been implicated in several aspects of metabolism, including the regulation of glucose homeostasis and adiposity. Kinins and des-Arg-kinins are the major effectors of this system and promote their effects by binding to two different receptors, the kinin B2 and B1 receptors, respectively. To understand the influence of the KKS on the pathophysiology of obesity and type 2 diabetes (T2DM), we generated an animal model deficient for both kinin receptor genes and leptin (obB1B2KO). Six-month-old obB1B2KO mice showed increased blood glucose levels. Isolated islets of the transgenic animals were more responsive to glucose stimulation releasing greater amounts of insulin, mainly in 3-month-old mice, which was corroborated by elevated serum C-peptide concentrations. Furthermore, they presented hepatomegaly, pronounced steatosis, and increased levels of circulating transaminases. This mouse also demonstrated exacerbated gluconeogenesis during the pyruvate challenge test. The hepatic abnormalities were accompanied by changes in the gene expression of factors linked to glucose and lipid metabolisms in the liver. Thus, we conclude that kinin receptors are important for modulation of insulin secretion and for the preservation of normal glucose levels and hepatic functions in obese mice, suggesting a protective role of the KKS regarding complications associated with obesity and T2DM.	[Barros, Carlos C.; Haro, Anderson; Russo, Fernanda J. V. P.; Almeida, Sandro S.; Moraes, Milton R.; Mori, Marcelo A.; Pesquero, Joao B.; Araujo, Ronaldo C.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Schadock, Ines; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Ribeiro, Rosane A.; Vanzela, Emerielle C.; Boschero, Antonio C.; Carneiro, Everardo M.] Univ Estadual Campinas, Campinas, SP, Brazil; [Barros, Flavio C.] Univ Estadual Paulista, Sao Paulo, Brazil; [Bacurau, Reury F. P.] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil; [Wurtele, Martin] Univ Fed Sao Paulo, Dept Sci & Technol, Sao Jose Dos Campos, Brazil; [Lanzoni, Valeria P.] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Barros, CC (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.	araujo.ronaldo@unifesp.br	Boschero, Antonio/O-7525-2014; Barros, Carlos Castilho C/D-5378-2012; Barros, Carlos Castilho/V-8659-2019; Vanzela, Emerielle/AAJ-1679-2021; Bader, Michael/K-2124-2013; Ribeiro, Rosane/C-2180-2013; Carneiro, Everardo/D-4758-2012; Almeida, Sandro Soares/D-9042-2012; Araujo, Ronaldo Carvalho/O-7569-2019; Mori, Marcelo A/R-2881-2018; Würtele, Martin/D-2686-2012; Moraes, Milton Rocha/D-9774-2018; Almeida, Sandro Soares/AAL-2366-2020; Barros, Carlos/D-5378-2012	Boschero, Antonio/0000-0003-3829-8570; Barros, Carlos Castilho C/0000-0002-6926-734X; Barros, Carlos Castilho/0000-0002-6926-734X; Almeida, Sandro Soares/0000-0002-4392-0953; Araujo, Ronaldo Carvalho/0000-0003-0095-4608; Mori, Marcelo A/0000-0001-7112-5263; Almeida, Sandro Soares/0000-0002-4392-0953; Bader, Michael/0000-0003-4780-4164; Vanzela, Emerielle C/0000-0001-8487-9320; Barros, Carlos/0000-0003-3244-7467; Schadock, Ines/0000-0002-6717-6276	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present study was supported by public research grants from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2010, NEUROPEPTIDES, V44, P69, DOI 10.1016/j.npep.2009.09.004; Al Mamun A, 2009, OBESITY, V17, P1255, DOI 10.1038/oby.2008.660; Araujo RC, 2006, BIOL CHEM, V387, P431, DOI 10.1515/BC.2006.057; Barros CC, 2009, INT J OBESITY, V33, P938, DOI 10.1038/ijo.2009.95; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; Carlsson PO, 1998, AM J PHYSIOL-ENDOC M, V275, pE594, DOI 10.1152/ajpendo.1998.275.4.E594; Carvalho CRO, 1997, DIABETES, V46, P1950, DOI 10.2337/diabetes.46.12.1950; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; DUCKWORTH WC, 1988, AM J MED, V85, P71, DOI 10.1016/0002-9343(88)90399-3; Duka I, 2001, HYPERTENSION, V38, P1355, DOI 10.1161/hy1201.096574; Enriquez A, 1999, BIOCHEM BIOPH RES CO, V255, P300, DOI 10.1006/bbrc.1999.0202; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Ginsberg HN, 2009, J CLIN HYPERTENS, V11, P520, DOI 10.1111/j.1559-4572.2009.00060.x; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Ikejima K, 2001, HEPATOLOGY, V34, P288, DOI 10.1053/jhep.2001.26518; Isami S, 1996, DIABETOLOGIA, V39, P412, DOI 10.1007/s001250050460; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lattuada G, 2011, CURR DIABETES REP, V11, P167, DOI 10.1007/s11892-011-0190-2; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Li TG, 2009, BBA-MOL CELL BIOL L, V1791, P991, DOI 10.1016/j.bbalip.2009.05.004; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Miyata T, 1998, EUR J ENDOCRINOL, V138, P344, DOI 10.1530/eje.0.1380344; Mora MEV, 2003, J AM COLL NUTR, V22, P487, DOI 10.1080/07315724.2003.10719326; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Mori MA, 2008, DIABETES, V57, P1491, DOI 10.2337/db07-1508; Mulhall BP, 2002, J GASTROEN HEPATOL, V17, P1136, DOI 10.1046/j.1440-1746.2002.02881.x; Pesquero JB, 1998, BRAZ J MED BIOL RES, V31, P1197, DOI 10.1590/S0100-879X1998000900013; Phillips J, 2009, AUST FAM PHYSICIAN, V38, P699; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P205, DOI 10.1079/PHN2001295; Potter JJ, 1998, BIOCHEM BIOPH RES CO, V244, P178, DOI 10.1006/bbrc.1997.8193; Pruneau D, 2010, CURR OPIN INVEST DR, V11, P507; Riad A, 2007, CURR OPIN NEPHROL HY, V16, P22, DOI 10.1097/MNH.0b013e328011a20c; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Sancho-Bru P, 2007, GASTROENTEROLOGY, V133, P2019, DOI 10.1053/j.gastro.2007.09.023; SATO H, 1991, DIABETOLOGIA, V34, P613, DOI 10.1007/BF00400989; Shiuchi T, 2002, HYPERTENSION, V40, P329, DOI 10.1161/01.HYP.0000028979.98877.0C; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Torsoni MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE216, DOI 10.1152/ajpendo.00031.2003; Tschope C, 2008, BIOL CHEM, V389, P707, DOI 10.1515/BC.2008.082; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wang PHM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003050; Westman S, 1968, Diabetologia, V4, P141, DOI 10.1007/BF01219435	49	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40573	10.1371/journal.pone.0040573	http://dx.doi.org/10.1371/journal.pone.0040573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829877	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306956300015
J	Brentville, VA; Metheringham, RL; Gunn, B; Durrant, LG				Brentville, Victoria A.; Metheringham, Rachael L.; Gunn, Barbara; Durrant, Lindy G.			High Avidity Cytotoxic T Lymphocytes Can Be Selected into the Memory Pool but They Are Exquisitely Sensitive to Functional Impairment	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; ENHANCED TUMOR-GROWTH; IN-VIVO; PEPTIDE VACCINATION; MELANOMA PATIENTS; CELL RESPONSE; CD8; ANTIGEN; PD-1; ACTIVATION	High avidity cytotoxic T lymphocytes (CTL) are important in viral clearance and anti-tumor immunity, however, mechanisms for their optimal generation and maintenance in vivo remain unclear. Immunizing mice with an antibody-DNA vaccine encoding a single CTL epitope, induces a 100 fold higher avidity response than peptide vaccination with the identical epitope. The high avidity response is retained into memory and can be efficiently reactivated with an antibody-DNA boost. In contrast, reactivation of high avidity CTL with peptide, stimulated responses with a significant drop in avidity, suggesting loss or conversion of the high avidity CTL to lower avidity. Similarly, high avidity T cells maintained ex vivo were exquisitely sensitive to signaling with low doses of peptide (1 ng/ml) giving optimal TCR stimulation and resulting in retained avidity, proliferation and ability to kill specific targets. In contrast, high avidity T cells maintained ex vivo with supraoptimal TCR stimulation (10 mg/ml peptide) resulted in reduced avidity and failure to kill tumor cells. They also failed to proliferate, showed a significant increase in apoptosis and expressed high levels of the exhaustion marker programmed death-1 (PD-1) and low levels of the lymphocyte-activation gene 3 (LAG-3). This suggests high avidity T cells are recruited to the memory pool but can be lost by supraoptimal stimulation in vitro and in vivo. This is characterized by loss of function and an increase in cell death. The remaining CTL, exhibit low functional avidity that is reflected in reduced anti-tumor activity. This could contribute to failure of the immune system to control the growth of tumors and has implications for vaccination strategies and adoptive transfer of T cells.	[Brentville, Victoria A.; Metheringham, Rachael L.; Gunn, Barbara; Durrant, Lindy G.] Univ Nottingham, Acad Dept Clin Oncol, Scancell Holdings Plc, Nottingham NG7 2RD, England	University of Nottingham	Brentville, VA (corresponding author), Univ Nottingham, Acad Dept Clin Oncol, Scancell Holdings Plc, City Hosp Campus, Nottingham NG7 2RD, England.	lindy.durrant@nottingham.ac.uk		Metheringham, Rachael/0000-0002-0594-8189	Scancell Holdings plc	Scancell Holdings plc	The work was funded by Scancell Holdings plc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; Alexander-Miller MA, 1998, J EXP MED, V188, P1391, DOI 10.1084/jem.188.8.1391; AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Ayyoub M, 2003, CANCER RES, V63, P5601; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chapon M, 2011, J INVEST DERMATOL, V131, P1300, DOI 10.1038/jid.2011.30; den Boer AT, 2001, J IMMUNOL, V167, P2522; Derby MA, 2001, EUR J IMMUNOL, V31, P2951, DOI 10.1002/1521-4141(2001010)31:10<2951::AID-IMMU2951>3.0.CO;2-Q; Durrant LG, 2010, EXPERT OPIN BIOL TH, V10, P735, DOI 10.1517/14712591003769790; Dutoit V, 2001, CANCER RES, V61, P5850; Fourcade J, 2009, J IMMUNOL, V182, P5240, DOI 10.4049/jimmunol.0803245; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Goldberg MV, 2007, BLOOD, V110, P186, DOI 10.1182/blood-2006-12-062422; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; HILL AB, 1992, IMMUNOL CELL BIOL, V70, P259, DOI 10.1038/icb.1992.33; Kroger CJ, 2007, IMMUNOLOGY, V122, P167, DOI 10.1111/j.1365-2567.2007.02622.x; LIU YP, 2007, J JISHOU UNIV, V28, P1; Muraoka D, 2010, J IMMUNOL, V185, P3768, DOI 10.4049/jimmunol.0903649; Pudney VA, 2010, EUR J IMMUNOL, V40, P899, DOI 10.1002/eji.200939857; Rezvani K, 2008, BLOOD, V111, P236, DOI 10.1182/blood-2007-08-108241; Rocha B, 2006, IMMUNOL REV, V211, P182, DOI 10.1111/j.0105-2896.2006.00378.x; Sandberg JK, 2000, J IMMUNOL, V165, P25, DOI 10.4049/jimmunol.165.1.25; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Stoklasek TA, 2010, J IMMUNOL, V185, P6857, DOI 10.4049/jimmunol.1001601; Terheyden P, 2003, SCAND J IMMUNOL, V58, P566, DOI 10.1046/j.1365-3083.2003.01324.x; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yee C, 1999, J IMMUNOL, V162, P2227; Zeh HJ, 1999, J IMMUNOL, V162, P989	42	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41112	10.1371/journal.pone.0041112	http://dx.doi.org/10.1371/journal.pone.0041112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829916	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300055
J	Wang, LF; Wang, F; Li, JT; Wen, WH; Zhao, J; Jia, LT; Meng, YL; Cao, YX; Yao, LB; Chen, SY; Xu, YM; Yang, AG				Wang, Li-Feng; Wang, Fang; Li, Jun-Tang; Wen, Wei-Hong; Zhao, Jing; Jia, Lin-Tao; Meng, Yan-Ling; Cao, Yun-Xin; Yao, Li-Bo; Chen, Si-Yi; Xu, Yan-Ming; Yang, An-Gang			Ectopically Expressed Perforin-1 Is Proapoptotic in Tumor Cell Lines by Increasing Caspase-3 Activity and the Nuclear Translocation of Cytochrome c	PLOS ONE			English	Article							GRANZYME-B; TARGET-CELLS; CYTOTOXIC LYMPHOCYTES; DEPENDENT ENDOCYTOSIS; DEFICIENT MICE; T-LYMPHOCYTES; IN-VIVO; APOPTOSIS; ACTIVATION; PATHWAYS	Perforin-1 (PRF), a cytotoxic lymphocyte pore-forming protein, plays an important role in the action of cytotoxic T cells and natural killer cells in that it causes the lysis of abnormal body cells and the elimination of virus-infected cells and tumors. Upon degranulation, PRF inserts itself into the target cell's plasma membrane, forming a pore. The subsequent translocation of pro-apoptotic granzymes (including granzyme B, A, M et al.) into the cytoplasm provides the proteases with access to numerous protein substrates that promote apoptosis after cleavage. These proteases are believed to be the main executioners of target cell apoptosis. Although the PRF and granzyme components are both critical to this process and in some way involved in inducing cell death in target cells, the inhibition of tumor growth could still be efficient in granzyme-deficient mice. It is unclear whether PRF alone can suppress tumors. In this study, we discovered that forced ectopic expression of PRF alone, in the absence of granzymes, could mediate cell death in cancer cells. Notably, transient expression of both full-length and truncated active-form PRF in human Hep G2, SK-BR-3, and HeLa cells was found to induce apparent cell growth inhibition and cell death, as evidenced by chromosome condensation and DNA fragmentation, increased caspase-3 activity, and the release of apoptosis inducing factor (AIF) and cytochrome c from the mitochondria. This PRF-induced cell death could be abrogated by pan-caspase inhibitor (Z-VAD) and mitochondria protector (TAT-BH4). The implication of these results is that ectopically expressed PRF has apoptosis-inducing abilities, and PRF alone is sufficient to induce apoptotic cell death in cells with ectopic expression. Taking this into consideration, our results suggest the possibility of using PRF as a pro-apoptotic gene for tumor therapeutics.	[Wang, Li-Feng; Zhao, Jing; Jia, Lin-Tao; Yao, Li-Bo] Fourth Mil Med Univ, State Key Lab Canc Biol, Sch Basic Med Sci, Dept Biochem, Xian 710032, Peoples R China; [Wang, Li-Feng; Zhao, Jing; Jia, Lin-Tao; Yao, Li-Bo] Fourth Mil Med Univ, State Key Lab Canc Biol, Sch Basic Med Sci, Dept Mol Biol, Xian 710032, Peoples R China; [Li, Jun-Tang; Wen, Wei-Hong; Meng, Yan-Ling; Cao, Yun-Xin; Yang, An-Gang] Fourth Mil Med Univ, Dept Immunol, Sch Basic Med Sci, Xian 710032, Peoples R China; [Wang, Fang] Fourth Mil Med Univ, Dept Microbiol, Sch Basic Med Sci, Xian 710032, Peoples R China; [Chen, Si-Yi] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Xu, Yan-Ming] Shantou Univ, Coll Med, Dept Cell Biol & Genet, Shantou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; University of Southern California; Shantou University	Wang, LF (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Sch Basic Med Sci, Dept Biochem, Xian 710032, Peoples R China.	amyymxu@stu.edu.cn; agyang@fmmu.edu.cn	meng, yan/GSE-2653-2022; Xu, yanming/Q-4931-2019; 温, 家琦/GYV-3177-2022; Meng, Yan/HGC-0394-2022		National High Technology Research and Development Program of China [2007AA021104, 30870497, 30901359, 81001015]; NATIONAL CANCER INSTITUTE [R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084811] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant support: National High Technology Research and Development Program of China grant 2007AA021104 (to A-G Yang), 30870497 (to Y-M Xu), 30901359 (to L-F Wang) and 81001015(to F Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Baran K, 2006, J BIOL CHEM, V281, P30485, DOI 10.1074/jbc.M602007200; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bolitho P, 2007, CURR OPIN IMMUNOL, V19, P339, DOI 10.1016/j.coi.2007.04.007; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan AJ, 2011, IMMUNITY, V34, P879, DOI 10.1016/j.immuni.2011.04.007; Catalfamo M, 2003, CURR OPIN IMMUNOL, V15, P522, DOI 10.1016/S0952-7915(03)00114-6; de Koning PJA, 2009, CRIT REV IMMUNOL, V29, P307, DOI 10.1615/CritRevImmunol.v29.i4.20; FINK TM, 1992, GENOMICS, V13, P1300, DOI 10.1016/0888-7543(92)90050-3; Froelich C, 2011, IMMUNITY, V34, P823, DOI 10.1016/j.immuni.2011.06.008; Guo YM, 2008, MOL IMMUNOL, V45, P2225, DOI 10.1016/j.molimm.2007.11.020; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; MASSON D, 1985, J BIOL CHEM, V260, P9069; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Packard BZ, 2007, J IMMUNOL, V179, P3812, DOI 10.4049/jimmunol.179.6.3812; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; SAUER H, 1991, ANAL BIOCHEM, V194, P418, DOI 10.1016/0003-2697(91)90251-N; Smyth MJ, 2003, J IMMUNOL, V171, P515, DOI 10.4049/jimmunol.171.2.515; Sutton VR, 2007, J CELL BIOL, V176, P425, DOI 10.1083/jcb.200609077; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wowk ME, 2004, MICROBES INFECT, V6, P752, DOI 10.1016/j.micinf.2004.03.008; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429; Zur SU, 2002, PRENAT DIAGN, V22, P80	40	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40639	10.1371/journal.pone.0040639	http://dx.doi.org/10.1371/journal.pone.0040639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829880	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300018
J	Wang, T; Chen, GP; Zan, QJ; Wang, CB; Su, YJ				Wang, Ting; Chen, Guopei; Zan, Qijie; Wang, Chunbo; Su, Ying-Juan			AFLP Genome Scan to Detect Genetic Structure and Candidate Loci under Selection for Local Adaptation of the Invasive Weed Mikania micrantha	PLOS ONE			English	Article							POPULATION-STRUCTURE; DIVERGENT SELECTION; LINKAGE DISEQUILIBRIUM; ADAPTIVE EVOLUTION; BIOLOGICAL-CONTROL; RAPID EVOLUTION; LIFE-HISTORY; DIFFERENTIATION; MARKERS; PLANT	Why some species become successful invaders is an important issue in invasive biology. However, limited genomic resources make it very difficult for identifying candidate genes involved in invasiveness. Mikania micrantha H.B.K. (Asteraceae), one of the world's most invasive weeds, has adapted rapidly in response to novel environments since its introduction to southern China. In its genome, we expect to find outlier loci under selection for local adaptation, critical to dissecting the molecular mechanisms of invasiveness. An explorative amplified fragment length polymorphism (AFLP) genome scan was used to detect candidate loci under selection in 28 M. micrantha populations across its entire introduced range in southern China. We also estimated population genetic parameters, bottleneck signatures, and linkage disequilibrium. In binary characters, such as presence or absence of AFLP bands, if all four character combinations are present, it is referred to as a character incompatibility. Since character incompatibility is deemed to be rare in populations with extensive asexual reproduction, a character incompatibility analysis was also performed in order to infer the predominant mating system in the introduced M. micrantha populations. Out of 483 AFLP loci examined using stringent significance criteria, 14 highly credible outlier loci were identified by Dfdist and Bayescan. Moreover, remarkable genetic variation, multiple introductions, substantial bottlenecks and character compatibility were found to occur in M. micrantha. Thus local adaptation at the genome level indeed exists in M. micrantha, and may represent a major evolutionary mechanism of successful invasion. Interactions between genetic diversity, multiple introductions, and reproductive modes contribute to increase the capacity of adaptive evolution.	[Wang, Ting; Chen, Guopei] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Peoples R China; [Chen, Guopei; Wang, Chunbo; Su, Ying-Juan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zan, Qijie] Shenzhen Wildlife Rescue & Rehabil Ctr, Shenzhen, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Sun Yat Sen University	Wang, T (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Peoples R China.	suyj@mail.sysu.edu.cn			National Natural Science Foundation of China [30970290, 31070594]; Opening Fund of Laboratory Sun Yat-sen University; Guangdong Key Laboratory of Plant Resources [plant01k13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Fund of Laboratory Sun Yat-sen University; Guangdong Key Laboratory of Plant Resources	This work was supported by the National Natural Science Foundation of China (Grant Nos. 30970290, 31070594), the Opening Fund of Laboratory Sun Yat-sen University (2010), and Guangdong Key Laboratory of Plant Resources (plant01k13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Allan E, 2009, OIKOS, V118, P1053, DOI 10.1111/j.1600-0706.2009.17135.x; Amsellem L, 2001, AM J BOT, V88, P2243, DOI 10.2307/3558386; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Baker SA, 2011, CONSERV GENET, V12, P793, DOI 10.1007/s10592-011-0186-0; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Barrett S.C.H., 1986, P21; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BROWN AHD, 1980, GENETICS, V96, P523; BURDON JJ, 1981, J APPL ECOL, V18, P649, DOI 10.2307/2402423; Butlin RK, 2010, GENETICA, V138, P409, DOI 10.1007/s10709-008-9321-3; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Campbell D, 2004, MOL BIOL EVOL, V21, P945, DOI 10.1093/molbev/msh101; Chapman H, 2004, HEREDITY, V92, P182, DOI 10.1038/sj.hdy.6800392; Cock M. J. W., 2000, Proceedings of the X International Symposium on Biological Control of Weeds, Bozeman, Montana, USA, 4-14 July, 1999, P155; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Egan SP, 2008, EVOLUTION, V62, P1162, DOI 10.1111/j.1558-5646.2008.00352.x; Ellison CA, 2008, BIOL CONTROL, V45, P133, DOI 10.1016/j.biocontrol.2007.12.001; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Fjellheim S, 2005, THEOR APPL GENET, V111, P640, DOI 10.1007/s00122-005-2006-8; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gagnaire PA, 2009, MOL ECOL, V18, P1678, DOI 10.1111/j.1365-294X.2009.04142.x; Galindo J, 2009, MOL ECOL, V18, P919, DOI 10.1111/j.1365-294X.2008.04076.x; Geleta M, 2007, HEREDITAS, V144, P53, DOI 10.1111/j.2007.0018-0661.01983.x; Godwin ID, 1997, ELECTROPHORESIS, V18, P1524, DOI 10.1002/elps.1150180906; Haldimann P, 2003, MOL ECOL, V12, P2541, DOI 10.1046/j.1365-294X.2003.01915.x; Hassel K, 2005, AM J BOT, V92, P1684, DOI 10.3732/ajb.92.10.1684; Haubold B, 1998, GENETICS, V150, P1341; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2000, GENETICS POPULATIONS; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Herrera CM, 2009, MOL ECOL, V18, P2602, DOI 10.1111/j.1365-294X.2009.04229.x; Herrera CM, 2008, MOL ECOL, V17, P5378, DOI 10.1111/j.1365-294X.2008.04004.x; Holm L. G., 1977, WORLDS WORST WEEDS D; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Holt RD, 2009, MOL ECOL, V18, P4347, DOI 10.1111/j.1365-294X.2009.04358.x; Hong L, 2007, WEED RES, V47, P280, DOI 10.1111/j.1365-3180.2007.00575.x; Houliston GJ, 2004, AM J BOT, V91, P37, DOI 10.3732/ajb.91.1.37; Huang Zhong-liang, 2000, Journal of Tropical and Subtropical Botany, V8, P131; HUSBAND BC, 1991, HEREDITY, V66, P287, DOI 10.1038/hdy.1991.36; Ismail B. S., 2002, Weed Biology and Management, V2, P31, DOI 10.1046/j.1445-6664.2002.00045.x; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jorgensen S, 2004, MOL ECOL, V13, P3403, DOI 10.1111/j.1365-294X.2004.02329.x; Kanarek AR, 2010, EVOL APPL, V3, P122, DOI 10.1111/j.1752-4571.2009.00112.x; Kaufman SR, 2001, OECOLOGIA, V127, P487, DOI 10.1007/s004420000621; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kim Y, 2008, GENET EPIDEMIOL, V32, P301, DOI 10.1002/gepi.20305; Klekowski EJ, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P227; Kong GH, 2000, J TROPICAL SUBTROPIC, V8, P27; Kuchma O, 2011, ENVIRON POLLUT, V159, P1606, DOI 10.1016/j.envpol.2011.02.049; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leroux Sophie, 2010, BMC Res Notes, V3, P214, DOI 10.1186/1756-0500-3-214; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 1999, BOTTLENECK PROGRAM D; Manel S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-288; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; Mealor BA, 2006, MOL ECOL, V15, P2291, DOI 10.1111/j.1365-294X.2006.02931.x; Menchari Y, 2007, MOL ECOL, V16, P3161, DOI 10.1111/j.1365-294X.2007.03390.x; Mes THM, 1998, MOL ECOL, V7, P1719, DOI 10.1046/j.1365-294x.1998.00508.x; Meyer CL, 2009, MOL ECOL, V18, P2050, DOI 10.1111/j.1365-294X.2009.04159.x; Michalski SG, 2010, THEOR APPL GENET, V120, P1151, DOI 10.1007/s00122-009-1242-8; Miller NJ, 2007, J APPL ENTOMOL, V131, P378, DOI 10.1111/j.1439-0418.2007.01190.x; Milne RI, 2000, MOL ECOL, V9, P541, DOI 10.1046/j.1365-294x.2000.00906.x; Murray MC, 2006, MOL ECOL, V15, P4229, DOI 10.1111/j.1365-294X.2006.03060.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Ni GY, 2006, ALLELOPATHY J, V17, P247; Nielsen LR, 2004, HEREDITY, V93, P434, DOI 10.1038/sj.hdy.6800520; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Nunes VL, 2011, MOL ECOL, V20, P193, DOI 10.1111/j.1365-294X.2010.04936.x; Paris M, 2010, MOL ECOL, V19, P325, DOI 10.1111/j.1365-294X.2009.04437.x; Parisod C, 2010, ANN BOT-LONDON, V105, P655, DOI 10.1093/aob/mcq014; Paun O, 2006, MOL ECOL, V15, P897, DOI 10.1111/j.1365-294X.2006.02800.x; Pellegrin D, 1999, AQUAT BOT, V63, P241, DOI 10.1016/S0304-3770(98)00120-X; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Prentis PJ, 2010, ANN BOT-LONDON, V106, P1009, DOI 10.1093/aob/mcq201; PRICE SC, 1981, OECOLOGIA, V49, P283, DOI 10.1007/BF00349202; Pritchard JK, 2000, GENETICS, V155, P945; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; Rannala B, 1996, GENET RES, V67, P147, DOI 10.1017/S0016672300033607; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rottenberg A, 2004, P ROY SOC B-BIOL SCI, V271, pS206, DOI 10.1098/rsbl.2003.0135; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Schonswetter P, 2003, MOL ECOL, V12, P3373, DOI 10.1046/j.1365-294X.2003.01984.x; Shimada Y, 2011, MOL BIOL EVOL, V28, P181, DOI 10.1093/molbev/msq181; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Smith TB, 2008, MOL ECOL, V17, P58, DOI 10.1111/j.1365-294X.2007.03478.x; Su YJ, 2005, MOL PHYLOGENET EVOL, V34, P323, DOI 10.1016/j.ympev.2004.10.016; SWAMY PS, 1987, AGR ECOSYST ENVIRON, V18, P195, DOI 10.1016/0167-8809(87)90083-1; Tice KA, 2011, J EVOLUTION BIOL, V24, P1814, DOI 10.1111/j.1420-9101.2011.02314.x; Tollenaere C, 2011, MOL ECOL, V20, P1026, DOI 10.1111/j.1365-294X.2010.04633.x; Van Buskirk J, 2006, EVOLUTION, V60, P2428, DOI 10.1111/j.0014-3820.2006.tb01879.x; van der Hulst RGM, 2000, MOL ECOL, V9, P1, DOI 10.1046/j.1365-294x.2000.00704.x; Van Treuren R, 2005, MOL ECOL, V14, P39, DOI 10.1111/j.1365-294X.2004.02391.x; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walker NF, 2003, MOL ECOL, V12, P1747, DOI 10.1046/j.1365-294X.2003.01866.x; [王伯荪 Wang Bosun], 2003, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V42, P47; Wang JY, 2007, PLANT MOL BIOL REP, V25, P37, DOI 10.1007/s11105-007-0005-4; Wen D, 2000, J TROP SUB BOT, V8, P139; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wilkinson M., 2001, PICA 4 0 SOFTWARE DO; Williams LM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-282; Wirjahardja S., 1976, Proceedings of 5th Asian-Pacific Weed Science Society Conference, Tokyo, Japan, 1975., P70; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114; Xu CY, 2010, ECOL LETT, V13, P32, DOI 10.1111/j.1461-0248.2009.01395.x; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zan Q.J., 2000, CHINESE J ECOL, V19, P58, DOI DOI 10.13292/J.1000; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x; Zhou XM, 2001, WORLD AGR, V10, P42; [No title captured]	139	39	40	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41310	10.1371/journal.pone.0041310	http://dx.doi.org/10.1371/journal.pone.0041310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829939	gold, Green Submitted, Green Published			2022-12-27	WOS:000306956300078
J	Lu, WB; Fu, C; Chen, Y; Lu, J; Yao, YY; Shen, CX; Gu, ZZ				Lu, Wenbin; Fu, Cong; Chen, Yong; Lu, Jun; Yao, Yuyu; Shen, Chengxing; Gu, Zhongze			Multiplex Detection of B-Type Natriuretic Peptide, Cardiac Troponin I and C-Reactive Protein with Photonic Suspension Array	PLOS ONE			English	Article							COLLOIDAL CRYSTAL BEADS; SEMICONDUCTOR NANOCRYSTALS; ASSAY SYSTEM; BIOMOLECULES; IMMUNOASSAY; FABRICATION; NANOWIRES; MARKERS; SPHERES	A novel photonic suspension array has been developed for multiplex immunoassay. The carriers of this array were silica colloidal crystal beads (SCCBs). The codes of these carriers have characteristic reflection peaks originating from their structural periodicity; therefore they do not suffer from fading, bleaching, quenching or chemical instability. In addition, the fluorescence background of SCCBs is negligible because no fluorescence materials or dyes are involved. With a sandwich method, the proposed suspension array was used for simultaneous multiplex detection of heart failure (HF) and coronary heart disease (CAD) biomarkers in one test tube. The results showed that the three biomarkers: cardiac troponin I (cTnI), C-reactive protein (CRP) and B-type natriuretic peptide (BNP) could be assayed in the ranges of 0.1-500 ng/ml, 1-500 mg/L and 0.02-50 ng/ml with detection limits of 0.01 ng/ml, 0.36 mg/L and 0.004 ng/ml at 3 sigma, respectively. There were no significant differences between the photonic suspension array and traditional parallel single-analyte test. This novel method demonstrated acceptable accuracy, high detection sensitivity and reproducibility and excellent storage stability. This technique provides a new strategy for low cost, automated, and simultaneous multiplex immunoassays of bio-markers.	[Lu, Wenbin; Shen, Chengxing] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Lu, Wenbin; Fu, Cong; Chen, Yong; Lu, Jun; Yao, Yuyu] Southeast Univ, ZhongDa Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Gu, Zhongze] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Southeast University - China; Southeast University - China	Lu, WB (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	shenchienx2@hotmail.com; gu@seu.edu.cn	Mondy, William L/G-4883-2012		State Key Laboratory of Bioelectronics Southeast University [853-2010HX15]	State Key Laboratory of Bioelectronics Southeast University	This research was supported by Open Research Fund of State Key Laboratory of Bioelectronics Southeast University (853-2010HX15). http://www.lmbe.seu.edu.cn/lmbenew/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzazy HME, 2002, CLIN BIOCHEM, V35, P13, DOI 10.1016/S0009-9120(02)00277-1; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Christodoulides N, 2005, LAB CHIP, V5, P261, DOI 10.1039/b414194f; Christodoulides N, 2002, ANAL CHEM, V74, P3030, DOI 10.1021/ac011150a; Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702; Dilic M, 2011, COLLEGIUM ANTROPOL, V35, P155; Fu Z, 2007, ANAL CHEM, V79, P7376, DOI 10.1021/ac0711900; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Jankowska EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014506; Kuang M, 2005, ADV MATER, V17, P267, DOI 10.1002/adma.200400818; Nakbi Amel, 2011, Tunis Med, V89, P621; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Stoermer RL, 2006, J AM CHEM SOC, V128, P13243, DOI 10.1021/ja0637200; Stoermer RL, 2005, CHEM MATER, V17, P4356, DOI 10.1021/cm050910l; Sun C, 2008, SMALL, V4, P592, DOI 10.1002/smll.200701026; Trau M, 2001, ADV MATER, V13, P975, DOI 10.1002/1521-4095(200107)13:12/13<975::AID-ADMA975>3.0.CO;2-#; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Wang L, 2005, NANO LETT, V5, P37, DOI 10.1021/nl048417g; Yang L, 2001, GENOME RES, V11, P1888, DOI 10.1101/gr.190901; Zhan JY, 2008, ADV FUNCT MATER, V18, P1; Zhao YJ, 2009, ANGEW CHEM INT EDIT, V48, P7350, DOI 10.1002/anie.200903472; Zhao YJ, 2008, ANAL CHEM, V80, P1598, DOI 10.1021/ac702249a; Zhao YJ, 2009, ADV MATER, V21, P569, DOI 10.1002/adma.200802339; Zhao YJ, 2009, ANAL CHIM ACTA, V633, P103, DOI 10.1016/j.aca.2008.11.035; Zhou HH, 2001, TRENDS BIOTECHNOL, V19, pS34, DOI 10.1016/S0167-7799(01)01798-X	28	6	6	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41448	10.1371/journal.pone.0041448	http://dx.doi.org/10.1371/journal.pone.0041448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848497	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200064
J	Deng, HK; Le Rhun, D; Le Naour, E; Bonnet, S; Vayssier-Taussat, M				Deng, Hon Kuan; Le Rhun, Danielle; Le Naour, Evelyne; Bonnet, Sarah; Vayssier-Taussat, Muriel			Identification of Bartonella Trw Host-Specific Receptor on Erythrocytes	PLOS ONE			English	Article							IV SECRETION SYSTEMS; PLASMODIUM-FALCIPARUM MEROZOITES; RED-CELL MEMBRANES; ENDOTHELIAL-CELLS; AGROBACTERIUM-TUMEFACIENS; MALARIAL INVASION; SURFACE-PROTEINS; BINDING LIGAND; GLYCOPHORIN-C; IN-VITRO	Each Bartonella species appears to be highly adapted to one or a limited number of reservoir hosts, in which it establishes long-lasting intraerythrocytic bacteremia as the hallmark of infection. Recently, we identified Trw as the bacterial system involved in recognition of erythrocytes according to their animal origin. The T4SS Trw is characterized by a multiprotein complex that spans the inner and outer bacterial membranes, and possesses a hypothetical pilus structure. TrwJ, I, H and trwL are present in variable copy numbers in different species and the multiple copies of trwL and trwJ in the Bartonella trw locus are considered to encode variant forms of surface-exposed pilus components. We therefore aimed to identify which of the candidate Trw pilus components were located on the bacterial surface and involved in adhesion to erythrocytes, together with their erythrocytic receptor. Using different technologies (electron microscopy, phage display, invasion inhibition assay, far western blot), we found that only TrwJ1 and TrwJ2 were expressed and localized at the cell surface of B. birtlesii and had the ability to bind to mouse erythrocytes, and that their receptor was band3, one of the major outer-membrane glycoproteins of erythrocytes, (anion exchanger). According to these results, we propose that the interaction between TrwJ1, TrwJ2 and band 3 leads to the critical host-specific adherence of Bartonella to its host cells, erythrocytes.	[Deng, Hon Kuan; Le Rhun, Danielle; Le Naour, Evelyne; Bonnet, Sarah; Vayssier-Taussat, Muriel] French Natl Inst Agr Res INRA, Unite Contrat Bipar, Maisons Alfort, France; [Deng, Hon Kuan] Jilin Univ, Key Lab Zoonosis Res, Inst Zoonosis, Changchun 130023, Peoples R China	INRAE; Jilin University	Vayssier-Taussat, M (corresponding author), French Natl Inst Agr Res INRA, Unite Contrat Bipar, Maisons Alfort, France.	mvayssier@vet-alfort.fr	Bonnet, Sarah I/AAD-4191-2020	Bonnet, Sarah I/0000-0002-6365-6117	French National Institute for Agricultural Research (INRA)	French National Institute for Agricultural Research (INRA)	This work was supported by the French National Institute for Agricultural Research (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502; Battisti JM, 1999, APPL ENVIRON MICROB, V65, P3441; BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986; Boulouis HJ, 2007, B ACAD NAT MED PARIS, V191, P1037, DOI 10.1016/S0001-4079(19)32978-4; Buckles EL, 2000, MICROB PATHOGENESIS, V29, P165, DOI 10.1006/mpat.2000.0381; CABANTCHIK ZI, 1978, BIOCHIM BIOPHYS ACTA, V515, P239; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; CLOUGH B, 1995, MOL BIOCHEM PARASIT, V69, P19, DOI 10.1016/0166-6851(94)00185-P; DAVIDSON EA, 1988, INDIAN J BIOCHEM BIO, V25, P90; Dehio C, 1999, CURR OPIN MICROBIOL, V2, P78, DOI 10.1016/S1369-5274(99)80013-7; Dehio C, 1997, J CELL SCI, V110, P2141; Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9; Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Greub G, 2002, J MED MICROBIOL, V51, P915, DOI 10.1099/0022-1317-51-11-915; Iwaki-Egawa S, 1997, FEMS MICROBIOL LETT, V157, P207, DOI 10.1111/j.1574-6968.1997.tb12775.x; Jiang LB, 2009, MOL BIOCHEM PARASIT, V168, P49, DOI 10.1016/j.molbiopara.2009.06.006; JONES GL, 1991, BIOCHIM BIOPHYS ACTA, V1097, P71, DOI 10.1016/0925-4439(91)90026-6; Kariuki MM, 2005, BIOCHEM BIOPH RES CO, V338, P1690, DOI 10.1016/j.bbrc.2005.10.154; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Le Rhun D, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2008.02188.x; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Mandle T, 2005, BLOOD, V106, P1215, DOI 10.1182/blood-2004-12-4670; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; MCPHERSON RA, 1993, MOL BIOCHEM PARASIT, V62, P233, DOI 10.1016/0166-6851(93)90112-B; Mehock JR, 1998, INFECT IMMUN, V66, P3462, DOI 10.1128/IAI.66.7.3462-3466.1998; MILLER LH, 1983, J CLIN INVEST, V72, P1357, DOI 10.1172/JCI111092; MINNICK MF, 1994, INFECT IMMUN, V62, P2644, DOI 10.1128/IAI.62.6.2644-2648.1994; Minnick MF, 1996, TRENDS MICROBIOL, V4, P343, DOI 10.1016/0966-842X(96)10055-X; MITCHELL GH, 1986, BLOOD, V67, P1519; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; OKOYE VCN, 1985, SCIENCE, V227, P169, DOI 10.1126/science.3880920; PERKINS ME, 1984, J EXP MED, V160, P788, DOI 10.1084/jem.160.3.788; Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018; Roggwiller E, 1996, MOL BIOCHEM PARASIT, V82, P13, DOI 10.1016/0166-6851(96)02714-4; Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38; SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; Schmiederer M, 2001, INFECT IMMUN, V69, P6495, DOI 10.1128/IAI.69.10.6495-6502.2001; Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008; Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077; Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946; Vayssier-Taussat M, 2009, ANN NY ACAD SCI, V1166, P127, DOI 10.1111/j.1749-6632.2009.04531.x; WALKER TS, 1981, INFECT IMMUN, V31, P480, DOI 10.1128/IAI.31.1.480-486.1981	53	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41447	10.1371/journal.pone.0041447	http://dx.doi.org/10.1371/journal.pone.0041447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848496	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600027
J	Fodor, AA; DeSantis, TZ; Wylie, KM; Badger, JH; Ye, YZ; Hepburn, T; Hu, P; Sodergren, E; Liolios, K; Huot-Creasy, H; Birren, BW; Earl, AM				Fodor, Anthony A.; DeSantis, Todd Z.; Wylie, Kristine M.; Badger, Jonathan H.; Ye, Yuzhen; Hepburn, Theresa; Hu, Ping; Sodergren, Erica; Liolios, Konstantinos; Huot-Creasy, Heather; Birren, Bruce W.; Earl, Ashlee M.			The "Most Wanted'' Taxa from the Human Microbiome for Whole Genome Sequencing	PLOS ONE			English	Article							DIVERSITY; RARE; COMMUNITY	The goal of the Human Microbiome Project (HMP) is to generate a comprehensive catalog of human-associated microorganisms including reference genomes representing the most common species. Toward this goal, the HMP has characterized the microbial communities at 18 body habitats in a cohort of over 200 healthy volunteers using 16S rRNA gene (16S) sequencing and has generated nearly 1,000 reference genomes from human-associated microorganisms. To determine how well current reference genome collections capture the diversity observed among the healthy microbiome and to guide isolation and future sequencing of microbiome members, we compared the HMP's 16S data sets to several reference 16S collections to create a 'most wanted' list of taxa for sequencing. Our analysis revealed that the diversity of commonly occurring taxa within the HMP cohort microbiome is relatively modest, few novel taxa are represented by these OTUs and many common taxa among HMP volunteers recur across different populations of healthy humans. Taken together, these results suggest that it should be possible to perform whole-genome sequencing on a large fraction of the human microbiome, including the 'most wanted', and that these sequences should serve to support microbiome studies across multiple cohorts. Also, in stark contrast to other taxa, the 'most wanted' organisms are poorly represented among culture collections suggesting that novel culture-and single-cell-based methods will be required to isolate these organisms for sequencing.	[Hepburn, Theresa; Birren, Bruce W.; Earl, Ashlee M.] Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA USA; [Hu, Ping] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA; [Liolios, Konstantinos] US DOE, Microbial Genom & Metagen Program, Joint Genome Inst, Walnut Creek, CA USA; [Huot-Creasy, Heather] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Ye, Yuzhen] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Fodor, Anthony A.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [DeSantis, Todd Z.] Second Genome Inc, Bioinformat Dept, San Bruno, CA USA; [Wylie, Kristine M.; Sodergren, Erica] Washington Univ, Sch Med, Dept Genet, Genome Inst, St Louis, MO 63110 USA; [Badger, Jonathan H.] J Craig Venter Inst, Microbial & Environm Genom Dept, San Diego, CA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Charlotte; Washington University (WUSTL); J. Craig Venter Institute	Earl, AM (corresponding author), Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA USA.	aearl@broadinstitute.org	Hu, Ping/G-2384-2015	Earl, Ashlee/0000-0001-7857-9145	National Institutes of Health; National Human Genome Research Institute; National Institute of Allergy and Infectious Diseases [HHSN2722009000018C, U54HG004969, U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, U54HG004969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was undertaken on behalf of the Human Microbiome Project Consortium (http://commonfund.nih.gov/hmp/and http://www.hmpdacc.org) and generously supported by the National Institutes of Health, National Human Genome Research Institute and National Institute of Allergy and Infectious Diseases (HHSN2722009000018C and U54HG004969 to Bruce W. Birren and U54HG004968 to George M. Weinstock). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, PLOS ONE UNPUB; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Burmolle M, 2003, MICROBIAL ECOL, V45, P226, DOI 10.1007/s00248-002-2028-6; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; DeSantis TZ, 2003, BIOINFORMATICS, V19, P1461, DOI 10.1093/bioinformatics/btg200; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamp TJ, 2009, APPL ENVIRON MICROB, V75, P3263, DOI 10.1128/AEM.01931-08; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Lasken RS, 2012, NATURE REV MICROBIOL; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Pride DT, 2011, GENOME RES, V21, P126, DOI 10.1101/gr.111732.110; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wylie KMTR, 2012, PLOS ONE, V7; Ye Y, 2011, P IEEE INT C BIOINFO, V2010, P153, DOI DOI 10.1109/BIBM.2010.5706555; Young VB, 2012, CURR OPIN GASTROENTE; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004	48	74	79	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41294	10.1371/journal.pone.0041294	http://dx.doi.org/10.1371/journal.pone.0041294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848458	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600020
J	Huang, WW; Huang, C; Liu, J; Zheng, HY; Lin, L				Huang, Wei-Wei; Huang, Cheng; Liu, Jian; Zheng, Hong-Yu; Lin, Lin			Zoledronic Acid as an Adjuvant Therapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; BONE METASTASES; PREVENTION; EFFICACY	Background: Zoledronic acid is widely used as adjuvant chemotherapy for the treatment of breast cancer. However, previous trials reported inconsistent findings regarding their clinical efficacy and safety. We carried out a comprehensive systematic review and meta-analysis to evaluate the effects of zoledronic acid on disease-free survival (DFS), overall survival (OS), and drug-related toxicities. Methodology and Principal Findings: We systematically searched Medline, EmBase, the Cochrane Central Register of Controlled Trials, reference lists of articles and proceedings of major meetings for relevant literatures with a time limit of Dec. 1, 2011. Randomized controlled trials evaluated the effects of zoledronic acid on OS, DFS, and RFS compared with control were eligible for inclusion in our research. Of 175 identified studies, we collected data from 7 randomized controlled trials of zoledronic acid that had OS, DFS, and RFS reported as one of the endpoint. Overall, we noted that patients receiving zoledronic acid therapy had significant longer OS than the group with non-zoledronic acid therapy (HR, 0.85, 95%CI, 0.73 to 1.00, P = 0.047). Furthermore, zoledronic acid therapy also had a clear effect on frature events (RR, 0.66, 95%CI, 0.52 to 0.84, P < 0.001). Subgroup analysis indicated that zoledronic acid therapy showed a great beneficial effect on disease recurrence in patients with early-stage breast cancer, however, it also significantly increased the harm of disease recurrence in patients with advanced breast cancer. Bone pain, neutropenic fever, pyrexia, rash were more frequent in the zoledronic acid therapy group. Conclusion/Significance: Treatment with zoledronic acid had a clear effect on fracture events, and it might contribute an important role for overall survival.	[Huang, Wei-Wei; Huang, Cheng; Liu, Jian; Zheng, Hong-Yu; Lin, Lin] Fujian Med Univ, Teaching Hosp, Fujian Prov Canc Hosp, Dept Med Oncol, Fuzhou, Peoples R China	Fujian Medical University	Huang, WW (corresponding author), Fujian Med Univ, Teaching Hosp, Fujian Prov Canc Hosp, Dept Med Oncol, Fuzhou, Peoples R China.	joneying0202@msn.cn						Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1; Aviles A, 2007, MED ONCOL, V24, P227, DOI 10.1007/BF02698044; Brufsky AM, 2009, CLIN BREAST CANCER, V9, P77, DOI 10.3816/CBC.2009.n.015; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Coleman R, 2007, CLIN BREAST CANCER, V7, pS29, DOI 10.3816/CBC.2007.s.004; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eidtmann H, 2010, ANN ONCOL, V21, P2188, DOI 10.1093/annonc/mdq217; Gnant M, 2011, LANCET ONCOL, V12, P631, DOI 10.1016/S1470-2045(11)70122-X; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Gnant MFX, 2007, J CLIN ONCOL, V25, P820, DOI 10.1200/JCO.2005.02.7102; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Kimmel DB, 2007, J DENT RES, V86, P1022, DOI 10.1177/154405910708601102; Leal T, 2010, CLIN BREAST CANCER, V10, P471, DOI 10.3816/CBC.2010.n.062; Li CI, 2003, J CLIN ONCOL, V21, P28, DOI 10.1200/JCO.2003.03.088; Lipton A, 2007, ONCOLOGIST, V12, P1035, DOI 10.1634/theoncologist.12-9-1035; Llombart A, 2012, CLIN BREAST CANCER, V12, P40, DOI 10.1016/j.clbc.2011.08.002; Mystakidou K, 2005, MED ONCOL, V22, P195, DOI 10.1385/MO:22:2:195; Nagy Z, 2005, PATHOL ONCOL RES, V11, P186, DOI 10.1007/BF02893400; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Saad Fred, 2005, Future Oncol, V1, P149, DOI 10.1517/14796694.1.2.149; Santini D, 2007, CLIN CANCER RES, V13, P4482, DOI 10.1158/1078-0432.CCR-07-0551; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Yan TT, 2012, EUR J CANCER, V48, P187, DOI 10.1016/j.ejca.2011.10.021	28	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40783	10.1371/journal.pone.0040783	http://dx.doi.org/10.1371/journal.pone.0040783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844410	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600009
J	Muley, VY; Ranjan, A				Muley, Vijaykumar Yogesh; Ranjan, Akash			Effect of Reference Genome Selection on the Performance of Computational Methods for Genome-Wide Protein-Protein Interaction Prediction	PLOS ONE			English	Article							ESCHERICHIA-COLI; FUNCTIONAL LINKAGES; PHYLOGENETIC PROFILES; CONTEXT METHODS; GENE ORDER; NETWORKS; DATABASE; COEVOLUTION; EVOLUTION; CONSERVATION	Background: Recent progress in computational methods for predicting physical and functional protein-protein interactions has provided new insights into the complexity of biological processes. Most of these methods assume that functionally interacting proteins are likely to have a shared evolutionary history. This history can be traced out for the protein pairs of a query genome by correlating different evolutionary aspects of their homologs in multiple genomes known as the reference genomes. These methods include phylogenetic profiling, gene neighborhood and co-occurrence of the orthologous protein coding genes in the same cluster or operon. These are collectively known as genomic context methods. On the other hand a method called mirrortree is based on the similarity of phylogenetic trees between two interacting proteins. Comprehensive performance analyses of these methods have been frequently reported in literature. However, very few studies provide insight into the effect of reference genome selection on detection of meaningful protein interactions. Methods: We analyzed the performance of four methods and their variants to understand the effect of reference genome selection on prediction efficacy. We used six sets of reference genomes, sampled in accordance with phylogenetic diversity and relationship between organisms from 565 bacteria. We used Escherichia coli as a model organism and the gold standard datasets of interacting proteins reported in DIP, EcoCyc and KEGG databases to compare the performance of the prediction methods. Conclusions: Higher performance for predicting protein-protein interactions was achievable even with 100-150 bacterial genomes out of 565 genomes. Inclusion of archaeal genomes in the reference genome set improves performance. We find that in order to obtain a good performance, it is better to sample few genomes of related genera of prokaryotes from the large number of available genomes. Moreover, such a sampling allows for selecting 50-100 genomes for comparable accuracy of predictions when computational resources are limited.	[Muley, Vijaykumar Yogesh; Ranjan, Akash] Ctr DNA Fingerprinting & Diagnost, Computat & Funct Genom Grp, Hyderabad, Andhra Pradesh, India; [Muley, Vijaykumar Yogesh] Dr Babasaheb Ambedkar Marathwada Univ, Dept Biotechnol, Subctr, Osmanabad, Maharashtra, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Dr. Babasaheb Ambedkar Marathwada University (BAMU)	Ranjan, A (corresponding author), Ctr DNA Fingerprinting & Diagnost, Computat & Funct Genom Grp, Hyderabad, Andhra Pradesh, India.	akash@cdfd.org.in	Muley, Vijaykumar/HGC-7068-2022; Muley, Vijaykumar/A-4700-2011	Muley, Vijaykumar/0000-0001-5329-600X; Ranjan, Akash/0000-0002-4582-1553	Department of Biotechnology, Ministry of Science and Technology, Government of India fellowship; Department of Biotechnology, Ministry of Science and Technology, Government of India research grant	Department of Biotechnology, Ministry of Science and Technology, Government of India fellowship; Department of Biotechnology, Ministry of Science and Technology, Government of India research grant	Funding was provided by a Department of Biotechnology, Ministry of Science and Technology, Government of India fellowship to VYM, and a Department of Biotechnology, Ministry of Science and Technology, Government of India research grant to AR (Website:http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Choi K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-423; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Cokus S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S7; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Doerks T, 2004, NUCLEIC ACIDS RES, V32, P6321, DOI 10.1093/nar/gkh973; Enault F, 2003, BIOINFORMATICS, V19, pi105, DOI 10.1093/bioinformatics/btg1013; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferrer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-493; Gaasterland T, 1998, Microb Comp Genomics, V3, P199; Gertz J, 2003, BIOINFORMATICS, V19, P2039, DOI 10.1093/bioinformatics/btg278; Harrington ED, 2008, FEBS LETT, V582, P1251, DOI 10.1016/j.febslet.2008.02.033; Herman D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-363; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Janga SC, 2011, METAB ENG, V13, P1, DOI 10.1016/j.ymben.2010.07.001; Janga SC, 2005, NUCLEIC ACIDS RES, V33, P2521, DOI 10.1093/nar/gki545; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karimpour-Fard A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-397; Karimpour-Fard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-393; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kim Y, 2006, BIOINFORMATICS, V22, P40, DOI 10.1093/bioinformatics/bti723; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Marcotte EM, 2000, CURR OPIN STRUC BIOL, V10, P359, DOI 10.1016/S0959-440X(00)00097-X; Moreno-Hagelsieb G, 2008, PROTEINS, V70, P344, DOI 10.1002/prot.21564; Mushegian AR, 1996, TRENDS GENET, V12, P289, DOI 10.1016/0168-9525(96)20006-X; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh AH, 2008, P NATL ACAD SCI USA, V105, P7500, DOI 10.1073/pnas.0709764105; Slonim N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100047; Snitkin ES, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-420; Sun JC, 2005, BIOINFORMATICS, V21, P3409, DOI 10.1093/bioinformatics/bti532; Sun JC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-414; Sun JC, 2007, BIOCHEM BIOPH RES CO, V353, P985, DOI 10.1016/j.bbrc.2006.12.146; Tamames J, 1997, J MOL EVOL, V44, P66, DOI 10.1007/PL00006122; Tamames J, 2001, GENOME BIOL, V2; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; van Dongen S. M., 2000, GRAPH CLUSTERING FLO; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Zheng Y, 2002, GENOME BIOL, V3; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	72	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42057	10.1371/journal.pone.0042057	http://dx.doi.org/10.1371/journal.pone.0042057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844541	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600066
J	Bavamian, S; Pontes, H; Cancela, J; Charollais, A; Startchik, S; Van De Ville, D; Meda, P				Bavamian, Sabine; Pontes, Helena; Cancela, Jose; Charollais, Anne; Startchik, Sergei; Van De Ville, Dimitri; Meda, Paolo			The Intercellular Synchronization of Ca2+ Oscillations Evaluates Cx36-Dependent Coupling	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN-SECRETION; B-CELLS; INVIVO MODULATION; GAP-JUNCTIONS; ISLET; EXPRESSION; CONNEXINS; CHANNELS; RELEASE	Connexin36 (Cx36) plays an important role in insulin secretion by controlling the intercellular synchronization of Ca2+ transients induced during stimulation. The lack of drugs acting on Cx36 channels is a major limitation in further unraveling the molecular mechanism underlying this effect. To screen for such drugs, we have developed an assay allowing for a semiautomatic, fluorimetric quantification of Ca2+ transients in large populations of MIN6 cells. Here, we show that (1) compared to control cells, MIN6 cells with reduced Cx36 expression or function showed decreased synchrony of glucose-induced Ca2+ oscillations; (2) glibenclamide, a sulphonylurea which promotes Cx36 junctions and coupling, increased the number of synchronous MIN6 cells, whereas quinine, an antimalarial drug which inhibits Cx36-dependent coupling, decreased this proportion; (3) several drugs were identified that altered the intercellular Ca2+ synchronization, cell coupling and distribution of Cx36; (4) some of them also affected insulin content. The data indicate that the intercellular synchronization of Ca2+ oscillations provides a reliable and non-invasive measurement of Cx36-dependent coupling, which is useful to identify novel drugs affecting the function of beta-cells, neurons, and neuron-related cells that express Cx36.	[Bavamian, Sabine; Pontes, Helena; Cancela, Jose; Charollais, Anne; Meda, Paolo] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Startchik, Sergei] Univ Geneva, Sch Med, Bioimaging Core Facil, CH-1211 Geneva, Switzerland; [Van De Ville, Dimitri] Univ Hosp Geneva, Dept Radiol & Med Informat, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Bavamian, S (corresponding author), Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland.	sabine@broadinstitute.org	Van De Ville, Dimitri/A-5364-2008	Van De Ville, Dimitri/0000-0002-2879-3861	Swiss National Science Foundation [310000-141162, IZ73Z0_127935, CR32I3_129987]; Juvenile Diabetes Research Foundation [40-2011-11, 5-2012-281]; European Union [BETAIMAGE 222980, IMIDIA C2008-T7, BETATRAIN 289932]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission)	The authors are supported by grants from the Swiss National Science Foundation (310000-141162, IZ73Z0_127935, CR32I3_129987), the Juvenile Diabetes Research Foundation (40-2011-11, 5-2012-281), and the European Union (BETAIMAGE 222980; IMIDIA C2008-T7, BETATRAIN 289932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allagnat F, 2007, DIABETOLOGIA, V50, pS45; Ball AJ, 2000, EUR J PHARMACOL, V408, P327, DOI 10.1016/S0014-2999(00)00782-2; Bavamian S, 2007, DIABETES OBES METAB, V9, P118, DOI 10.1111/j.1463-1326.2007.00780.x; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; BOYD AE, 1990, AM J MED, V89, pS3, DOI 10.1016/0002-9343(90)90330-G; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Calabrese A, 2001, CELL COMMUN ADHES, V8, P387, DOI 10.3109/15419060109080759; Caton D, 2003, J CELL SCI, V116, P2285, DOI 10.1242/jcs.00442; Charpantier E, 2007, DIABETOLOGIA, V50, P2332, DOI 10.1007/s00125-007-0807-9; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; FELDMAN JM, 1985, PHARMACOTHERAPY, V5, P43; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; HENQUIN JC, 1982, ENDOCRINOLOGY, V110, P1325, DOI 10.1210/endo-110-4-1325; HENQUIN JC, 1975, FEBS LETT, V57, P280, DOI 10.1016/0014-5793(75)80317-6; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; MATTHEWS DR, 1983, DIABETOLOGIA, V24, P231; MEDA P, 1979, J CELL BIOL, V82, P441, DOI 10.1083/jcb.82.2.441; MEDA P, 1980, SCIENCE, V209, P1026, DOI 10.1126/science.6773144; MEDA P, 1991, EXP CELL RES, V192, P469, DOI 10.1016/0014-4827(91)90066-4; MEDA P, 1983, DIABETES, V32, P858, DOI 10.2337/diabetes.32.9.858; Meda P, 2000, METHODS, V20, P232, DOI 10.1006/meth.1999.0940; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nlend RN, 2012, J MEMBRANE BIOL, V245, P263, DOI 10.1007/s00232-012-9447-1; Nyholm B, 2000, METABOLISM, V49, P896, DOI 10.1053/meta.2000.6737; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rustenbeck I, 2004, DIABETES, V53, pS140, DOI 10.2337/diabetes.53.suppl_3.S140; Serre-Beinier V, 2000, DIABETES, V49, P727, DOI 10.2337/diabetes.49.5.727; Srinivas M, 2001, P NATL ACAD SCI USA, V98, P10942, DOI 10.1073/pnas.191206198; Suter DM, 2009, J CELL MOL MED, P1; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Verkman AS, 2004, AM J PHYSIOL-CELL PH, V286, pC465, DOI 10.1152/ajpcell.00397.2003; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309	34	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41535	10.1371/journal.pone.0041535	http://dx.doi.org/10.1371/journal.pone.0041535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848521	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600080
J	Borghesi, C; Chiche, J; Nadal, JP				Borghesi, Christian; Chiche, Jean; Nadal, Jean-Pierre			Between Order and Disorder: A 'Weak Law' on Recent Electoral Behavior among Urban Voters?	PLOS ONE			English	Article								A new viewpoint on electoral involvement is proposed from the study of the statistics of the proportions of abstentionists, blank and null, and votes according to list of choices, in a large number of national elections in different countries. Considering 11 countries without compulsory voting (Austria, Canada, Czech Republic, France, Germany, Italy, Mexico, Poland, Romania, Spain, and Switzerland), a stylized fact emerges for the most populated cities when one computes the entropy associated to the three ratios, which we call the entropy of civic involvement of the electorate. The distribution of this entropy (over all elections and countries) appears to be sharply peaked near a common value. This almost common value is typically shared since the 1970s by electorates of the most populated municipalities, and this despite the wide disparities between voting systems and types of elections. Performing different statistical analyses, we notably show that this stylized fact reveals particular correlations between the blank/null votes and abstentionists ratios. We suggest that the existence of this hidden regularity, which we propose to coin as a 'weak law on recent electoral behavior among urban voters', reveals an emerging collective behavioral norm characteristic of urban citizen voting behavior in modern democracies. Analyzing exceptions to the rule provides insights into the conditions under which this normative behavior can be expected to occur.	[Borghesi, Christian; Nadal, Jean-Pierre] CNRS, CAMS, Paris, France; [Borghesi, Christian; Nadal, Jean-Pierre] Ecole Hautes Etud Sci Sociales, Paris, France; [Borghesi, Christian] CNRS, LPTM, Cergy Pontoise, France; [Borghesi, Christian] Univ Cergy Pontoise, Cergy Pontoise, France; [Chiche, Jean] CNRS, Ctr Rech Polit Sci Po CEVIPOF, Paris, France; [Chiche, Jean] Sci Po, Paris, France; [Nadal, Jean-Pierre] Univ Paris Diderot, Univ Paris 06, Ecole Normale Super, CNRS,LPS, Paris, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CY Cergy Paris Universite; Centre National de la Recherche Scientifique (CNRS); Institut d'Etudes Politiques Paris (Sciences Po); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite	Borghesi, C (corresponding author), CNRS, CAMS, Paris, France.	borghesi@msh-paris.fr	Nadal, Jean-Pierre/HHM-8804-2022	Nadal, Jean-Pierre/0000-0003-0022-0647				Araripe LE, 2009, PHYSICA A, V388, P4167, DOI 10.1016/j.physa.2009.06.023; Araujo NAM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012446; Borghesi C, 2010, EUR PHYS J B, V75, P395, DOI 10.1140/epjb/e2010-00151-1; Borghesi C., 2010, ETUDE PHYS ELECTIONS; Borghesi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036289; Chou C-I, 2009, GROWTH MODEL VOTE DI; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; Dalton Russell, 1996, CITIZEN POLITICS PUB; De Winter L, 1996, CHOOSING EUROPE, P59; Diu B., 1989, ELEMENTS PHYS STAT; Feldman David P., BRIEF TUTORIAL INFOR; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Franklin MarkN., 2004, VOTER TURNOUT DYNAMI, DOI DOI 10.1017/CBO9780511616884; Franklin MN, 1996, COMP DEMOCRACIES ELE, P216; Gonzalez MC, 2004, INT J MOD PHYS C, V15, P45, DOI 10.1142/S0129183104005577; Hernandez-Saldana H, 2009, PHYSICA A, V388, P2699, DOI 10.1016/j.physa.2009.03.016; IDEA, WHAT AFF TURN; Klimek Peter, 2012, ITS NOT VOTING THATS; Lancelot A, 1968, ABSTENTIONNISME LECT; Lyra ML, 2003, EUROPHYS LETT, V62, P131, DOI 10.1209/epl/i2003-00371-6; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; Mayer N., 2010, SOCIOLOGIE COMPORTEM; Topf Richard, 1995, CITIZENS STATE; Verba S, 1995, AM POLIT SCI REV, V90, P1; Zulfikarpasic A., 2001, REV FRANCAISE SCI PO, V51, P247	25	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39916	10.1371/journal.pone.0039916	http://dx.doi.org/10.1371/journal.pone.0039916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848365	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600012
J	Faria, D; Schlicker, A; Pesquita, C; Bastos, H; Ferreira, AEN; Albrecht, M; Falcao, AO				Faria, Daniel; Schlicker, Andreas; Pesquita, Catia; Bastos, Hugo; Ferreira, Antonio E. N.; Albrecht, Mario; Falcao, Andre O.			Mining GO Annotations for Improving Annotation Consistency	PLOS ONE			English	Article							DATABASE	Despite the structure and objectivity provided by the Gene Ontology (GO), the annotation of proteins is a complex task that is subject to errors and inconsistencies. Electronically inferred annotations in particular are widely considered unreliable. However, given that manual curation of all GO annotations is unfeasible, it is imperative to improve the quality of electronically inferred annotations. In this work, we analyze the full GO molecular function annotation of UniProtKB proteins, and discuss some of the issues that affect their quality, focusing particularly on the lack of annotation consistency. Based on our analysis, we estimate that 64% of the UniProtKB proteins are incompletely annotated, and that inconsistent annotations affect 83% of the protein functions and at least 23% of the proteins. Additionally, we present and evaluate a data mining algorithm, based on the association rule learning methodology, for identifying implicit relationships between molecular function terms. The goal of this algorithm is to assist GO curators in updating GO and correcting and preventing inconsistent annotations. Our algorithm predicted 501 relationships with an estimated precision of 94%, whereas the basic association rule learning methodology predicted 12,352 relationships with a precision below 9%.	[Faria, Daniel; Pesquita, Catia; Bastos, Hugo; Falcao, Andre O.] Univ Lisbon, Fac Sci, Dept Informat, P-1699 Lisbon, Portugal; [Schlicker, Andreas] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Schlicker, Andreas; Albrecht, Mario] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany; [Ferreira, Antonio E. N.] Univ Lisbon, Fac Sci, Dept Chem & Biochem, Ctr Chem & Biochem, P-1699 Lisbon, Portugal; [Albrecht, Mario] Univ Med Greifswald, Inst Biometr & Med Informat, Dept Bioinformat, Greifswald, Germany	Universidade de Lisboa; Netherlands Cancer Institute; Max Planck Society; Universidade de Lisboa; Greifswald Medical School	Faria, D (corresponding author), Univ Lisbon, Fac Sci, Dept Informat, P-1699 Lisbon, Portugal.	dfaria@xldb.di.fc.ul.pt	Albrecht, Mario/B-6694-2008; Ferreira, Antonio/GXH-7620-2022; Falcao, Andre O./A-3545-2010; Pesquita, Catia LSC/O-8883-2015; Ferreira, António EN/E-6488-2012; FT-ICR-MS, Lisboa/T-5273-2018	Albrecht, Mario/0000-0002-3103-9624; Ferreira, Antonio/0000-0001-5239-8020; Falcao, Andre O./0000-0002-3588-8746; Pesquita, Catia LSC/0000-0002-1847-9393; Ferreira, António EN/0000-0002-9625-8115; Schlicker, Andreas/0000-0002-6588-7883; Faria, Daniel/0000-0003-1511-277X	Portuguese Foundationfor Science and Technology (FCT) [SFRH/BD/29797/2006, SFRH/BD/42481/2007, SFRH/BD/48035/2008]; FCT through the Multiannual Funding Program [COMP-LVT-Lisboa-408]; FCT [PEst-OE/QUI/UI0612/2011]; German Federal Ministry of Education and Research (BMBF) through the German National Genome Research Network (NGFN); Greifswald Approach to Individualized Medicine (GANI_MED); German Research Foundation (DFG) [KFO 129/1-2]	Portuguese Foundationfor Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT through the Multiannual Funding Program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); German Federal Ministry of Education and Research (BMBF) through the German National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Greifswald Approach to Individualized Medicine (GANI_MED); German Research Foundation (DFG)(German Research Foundation (DFG))	DF was funded by the doctoral grant SFRH/BD/29797/2006, CP was funded by the doctoral grant SFRH/BD/42481/2007 and HB was funded by the doctoral grant SFRH/BD/48035/2008, all from the Portuguese Foundationfor Science and Technology (FCT). DF, CP, HB and AOF were also funded by the FCT through the Multiannual Funding Program to LASIGE (COMP-LVT-Lisboa-408). AENF was funded by the FCT through research project PEst-OE/QUI/UI0612/2011. AS and MA were funded by the German Federal Ministry of Education and Research (BMBF) through the German National Genome Research Network (NGFN) and the Greifswald Approach to Individualized Medicine (GANI_MED) as well as by the German Research Foundation (DFG), contract number KFO 129/1-2. The work was conducted in the context of the DFG-funded Cluster of Excellence for Multimodal Computing in Saarbrucken. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Alterovitz G, 2010, NAT BIOTECHNOL, V28, P128, DOI 10.1038/nbt0210-128; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bada N, 2004, SIGMOD REC, V33, P27, DOI 10.1145/1024694.1024699; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bodenreider O, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P91; Camon EB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S17; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Dolan ME, 2005, BIOINFORMATICS, V21, pI136, DOI 10.1093/bioinformatics/bti1019; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huttenhower C, 2009, BIOINFORMATICS, V25, P2404, DOI 10.1093/bioinformatics/btp397; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; KUMAR A, 2004, P 3 INT WORKSH COMP, P31; Leonelli S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-325; MUNGALL CJ, 2010, J BIOMED IN IN PRESS; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schlicker A, 2010, NUCLEIC ACIDS RES, V38, pD244, DOI 10.1093/nar/gkp979; Srikant R, 1995, 9963 RJ IBM ALM RES	21	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40519	10.1371/journal.pone.0040519	http://dx.doi.org/10.1371/journal.pone.0040519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848383	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600019
J	Rocco, CA; Mecikovsky, D; Aulicino, P; Bologna, R; Sen, L; Mangano, A				Rocco, Carlos A.; Mecikovsky, Debora; Aulicino, Paula; Bologna, Rosa; Sen, Luisa; Mangano, Andrea			Hypercholesterolemia Is Associated with the Apolipoprotein C-III (APOC3) Genotype in Children Receiving HAART: An Eight-Year Retrospective Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SINGLE-NUCLEOTIDE POLYMORPHISMS; ANTIRETROVIRAL THERAPY; LIPID ABNORMALITIES; DYSLIPIDEMIA; INDIVIDUALS; CHILDHOOD; GENES; ADOLESCENTS; DISORDERS	Polymorphisms in apolipoprotein genes have shown to be predictors of plasma lipid levels in adult cohorts receiving highly active antiretroviral therapy (HAART). Our objective was to confirm the association between the APOC3 genotype and plasma lipid levels in an HIV-1-infected pediatric cohort exposed to HAART. A total of 130 HIV-1-infected children/adolescents that attended a reference center in Argentina were selected for an 8-year longitudinal study with retrospective data collection. Longitudinal measurements of plasma triglycerides, total cholesterol, HDL-C and LDL-C were analyzed under linear or generalized linear mixed models. The contribution of the APOC3 genotype at sites -482, -455 and 3238 to plasma lipid levels prediction was tested after adjusting for potential confounders. Four major APOC3 haplotypes were observed for sites -482/-455/3238, with estimated frequencies of 0.60 (C/T/C), 0.14 (T/C/C), 0.11 (C/C/C), and 0.11 (T/C/G). The APOC3 genotype showed a significant effect only for the prediction of total cholesterol levels (p < 0.0001). However, the magnitude of the differences observed was dependent on the drug combination (p = 0.0007) and the drug exposure duration at the time of the plasma lipid measurement (p = 0.0002). A lower risk of hypercholesterolemia was predicted for double and triple heterozygous individuals, mainly at the first few months after the initiation of Ritonavir-boosted protease inhibitor-based regimens. We report for the first time a significant contribution of the genotype to total cholesterol levels in a pediatric cohort under HAART. The genetic determination of APOC3 might have an impact on a large portion of HIV-1-infected children at the time of choosing the treatment regimens or on the counter-measures against the adverse effects of drugs.	[Rocco, Carlos A.; Aulicino, Paula; Sen, Luisa; Mangano, Andrea] Hosp Pediat Juan P Garrahan, Lab Biol Celular & Retrovirus, Buenos Aires, DF, Argentina; [Mecikovsky, Debora; Bologna, Rosa] Hosp Pediat Juan P Garrahan, Serv Epidemiol & Infectol, Buenos Aires, DF, Argentina; [Aulicino, Paula; Sen, Luisa; Mangano, Andrea] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Rocco, CA (corresponding author), Hosp Pediat Juan P Garrahan, Lab Biol Celular & Retrovirus, Buenos Aires, DF, Argentina.	roccocar@yahoo.com			Agencia Nacional de Promocion Cientifica y Tecnologica award [PICT 2006-1235]; CONICET PIP [6057]; Fundacion Fiorini; Fogarty AITRP [D43TW001037]; FOGARTY INTERNATIONAL CENTER [D43TW001037] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica award; CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Fiorini; Fogarty AITRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica award No PICT 2006-1235, CONICET PIP No 6057, Fundacion Fiorini and partially supported by Fogarty AITRP Grant #D43TW001037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, MMWR-MORBID MORTAL W, V43, P1; Arnedo M, 2007, PHARMACOGENET GENOM, V17, P755, DOI 10.1097/FPC.0b013e32814db8b7; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Bonnet E, 2007, CLIN CHEM LAB MED, V45, P815, DOI 10.1515/CCLM.2007.140; Brewinski M, 2011, J TROP PEDIATRICS, V57, P324, DOI 10.1093/tropej/fmq089; Carter RJ, 2006, JAIDS-J ACQ IMM DEF, V41, P453, DOI 10.1097/01.qai.0000218344.88304.db; Dallinga-Thie GM, 2001, J LIPID RES, V42, P1450; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Fauvel J, 2001, AIDS, V15, P2397, DOI 10.1097/00002030-200112070-00007; Foulkes AS, 2006, PLOS MED, V3, P337, DOI 10.1371/journal.pmed.0030052; Hallman DM, 2006, METABOLISM, V55, P1574, DOI 10.1016/j.metabol.2006.07.018; Juonala M, 2008, ARTERIOSCL THROM VAS, V28, P1012, DOI 10.1161/ATVBAHA.108.163329; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kwiterovich PO, 2008, J CLIN ENDOCR METAB, V93, P4200, DOI 10.1210/jc.2008-1270; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; McCrindle BW, 2007, CIRCULATION, V115, P1948, DOI 10.1161/CIRCULATIONAHA.107.181946; Miserez AR, 2001, AIDS, V15, P2045, DOI 10.1097/00002030-200110190-00020; Resino S, 2008, AIDS RES HUM RETROV, V24, P1477, DOI 10.1089/aid.2008.0037; Rodriguez-Novoa S, 2006, PHARMACOGENOMICS J, V6, P234, DOI 10.1038/sj.tpj.6500374; Rotger M, 2009, CIRC-CARDIOVASC GENE, V2, P621, DOI 10.1161/CIRCGENETICS.109.874412; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Seldin MF, 2007, AM J PHYS ANTHROPOL, V132, P455, DOI 10.1002/ajpa.20534; Tarr PE, 2005, J INFECT DIS, V191, P1419, DOI 10.1086/429295; Taylor P, 2004, PEDIATRICS, V114, P235; Werner MLF, 2010, J PEDIAT-BRAZIL, V86, P27, DOI [10.1590/S0021-75572010000100006, 10.2223/JPED.1961]; Yang AM, 2003, AIDS, V17, P2142, DOI 10.1097/00002030-200309260-00024	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39678	10.1371/journal.pone.0039678	http://dx.doi.org/10.1371/journal.pone.0039678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848358	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600008
J	Tsai, SH; Huang, PH; Chang, WC; Tsai, HY; Lin, CP; Leu, HB; Wu, TC; Chen, JW; Lin, SJ				Tsai, Shih-Hung; Huang, Po-Hsun; Chang, Wei-Chou; Tsai, Hsiao-Ya; Lin, Chih-Pei; Leu, Hsin-Bang; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong			Zoledronate Inhibits Ischemia-Induced Neovascularization by Impairing the Mobilization and Function of Endothelial Progenitor Cells	PLOS ONE			English	Article							GROWTH-FACTOR; PAGETS-DISEASE; BONE; ACID; MATRIX-METALLOPROTEINASE-9; BISPHOSPHONATES; ANGIOGENESIS; OSTEOCLASTS; MICE; PAMIDRONATE	Background: Bisphosphonates are a class of pharmacologic compounds that are commonly used to treat postmenopausal osteoporosis and malignant osteolytic processes. Studies have shown that bone marrow-derived endothelial progenitor cells (EPCs) play a significant role in postnatal neovascularization. Whether the nitrogen-containing bisphosphonate zoledronate inhibits ischemia-induced neovascularization by modulating EPC functions remains unclear. Methodology/Principal Findings: Unilateral hindlimb ischemia was surgically induced in wild-type mice after 2 weeks of treatment with vehicle or zoledronate (low-dose: 30 mu g/kg; high-dose: 100 mu g/kg). Doppler perfusion imaging demonstrated that the ischemic limb/normal side blood perfusion ratio was significantly lower in wild-type mice treated with low-dose zoledronate and in mice treated with high-dose zoledronate than in controls 4 weeks after ischemic surgery (control vs. low-dose vs. high-dose: 87 +/- 7% vs. *61 +/- 18% vs. **49 +/- 17%, *p<0.01, **p<0.005 compared to control). Capillary densities were also significantly lower in mice treated with low-dose zoledronate and in mice treated with high-dose zoledronate than in control mice. Flow cytometry analysis showed impaired mobilization of EPC-like cells (Sca-1(+)/Flk-1(+)) after surgical induction of ischemia in mice treated with zoledronate but normal levels of mobilization in mice treated with vehicle. In addition, ischemic tissue from mice that received zoledronate treatment exhibited significantly lower levels of the active form of MMP-9, lower levels of VEGF, and lower levels of phosphorylated eNOS and phosphorylated Akt than ischemic tissue from mice that received vehicle. Results of the in vitro studies showed that incubation with zoledronate inhibited the viability, migration, and tube-forming capacities of EPC. Conclusions/Significance: Zoledronate inhibited ischemia-induced neovascularization by impairing EPC mobilization and angiogenic functions. These findings suggest that administration of zoledronate should be withheld in patients with ischemic events such as acute limb ischemia.	[Tsai, Shih-Hung] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Tsai, Shih-Hung; Huang, Po-Hsun; Tsai, Hsiao-Ya; Leu, Hsin-Bang; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Huang, Po-Hsun; Leu, Hsin-Bang; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Huang, Po-Hsun; Tsai, Hsiao-Ya; Leu, Hsin-Bang; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chang, Wei-Chou] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Lin, Chih-Pei] Taipei Vet Gen Hosp, Div Gen Lab, Dept Pathol & Lab Med, Taipei, Taiwan; [Lin, Chih-Pei; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Lin, Chih-Pei; Chen, Jaw-Wen] Natl Yang Ming Univ, Dept Pharmacol, Taipei 112, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Tsai, SH (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan.	huangbs@vghtpe.gov.tw; sjlin@vghtpe.gov.tw		Tsai, Hsaio Ya/0000-0002-5704-507X; Tsai, Shih-Hung/0000-0003-0215-3193	NSC [98-2314-B-075-035, 100-2314-B-016-012]; UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council [NSC-99-2911-I-009-101-A2]; Taipei Veterans General Hospital [VGH-V100E2-002]; Tri-Service General Hospital, the National Defense Medical Center, Taipei, Taiwan [TSGH-C-100-116, TSGH-C101-063, TSGH-C101-064]; Ministry of Education "Aim for the Top University" Plan	NSC(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Tri-Service General Hospital, the National Defense Medical Center, Taipei, Taiwan; Ministry of Education "Aim for the Top University" Plan(Ministry of Education, Taiwan)	This study was supported in part by research grants from the NSC 98-2314-B-075-035, NSC 100-2314-B-016-012, and the UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101-A2 from the National Science Council; VGH-V100E2-002 from the Taipei Veterans General Hospital, and the Tri-Service General Hospital, the National Defense Medical Center, Taipei, Taiwan (TSGH-C-100-116, TSGH-C101-063, TSGH-C101-064) and also a grant from the Ministry of Education "Aim for the Top University" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Basi DL, 2011, J ORAL MAXIL SURG, V69, P2698, DOI 10.1016/j.joms.2011.02.065; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Cornish J, 2011, BONE, V49, P710, DOI 10.1016/j.bone.2011.07.020; Coukell AJ, 1998, DRUG AGING, V12, P149, DOI 10.2165/00002512-199812020-00007; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Fournier P, 2002, CANCER RES, V62, P6538; Fujita H, 2011, BASIC CLIN PHARMACOL, V109, P78, DOI 10.1111/j.1742-7843.2011.00685.x; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gutteridge DH, 1996, BONE, V19, P387, DOI 10.1016/S8756-3282(96)00224-4; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hikita H, 2009, J BONE MINER METAB, V27, P663, DOI 10.1007/s00774-009-0090-6; Hirbe AC, 2009, BONE, V44, P908, DOI 10.1016/j.bone.2009.01.010; Huang PH, 2010, ATHEROSCLEROSIS, V212, P426, DOI 10.1016/j.atherosclerosis.2010.06.034; Huang PH, 2010, J HYPERTENS, V28, P1655, DOI 10.1097/HJH.0b013e32833a4d0a; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Itzstein Cecile, 2011, Small GTPases, V2, P117; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kobayashi Y, 2010, J BONE MINER METAB, V28, P165, DOI 10.1007/s00774-009-0128-9; Kuiper JW, 2011, BRIT J PHARMACOL, V165, P532; Lacy MQ, 2006, MAYO CLIN PROC, V81, P1047, DOI 10.4065/81.8.1047; Li YY, 2011, ANTI-CANCER DRUG, V22, P89, DOI 10.1097/CAD.0b013e3283400a05; Matsumoto T, 2011, ARTHRITIS RHEUM-US, V63, P3908, DOI 10.1002/art.30646; Rogers Maurice, 2011, Scottish Forestry, V65, P34; Russell HV, 2011, PEDIATR BLOOD CANCER, V57, P275, DOI 10.1002/pbc.22821; Russell RGG, 2006, ANN NY ACAD SCI, V1068, P367, DOI 10.1196/annals.1346.041; Santini D, 2003, CLIN CANCER RES, V9, P2893; Selander KS, 1996, MOL PHARMACOL, V50, P1127; SMINIA T, 1986, CALCIFIED TISSUE INT, V39, P263, DOI 10.1007/BF02555216; Stresing V, 2011, BONE, V48, P259, DOI 10.1016/j.bone.2010.09.035; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Woodward EJ, 2010, CURR PHARM DESIGN, V16, P2998; Yamada J, 2009, J SURG RES, V151, P115, DOI 10.1016/j.jss.2008.01.031; Yamagishi S, 2004, AM J PATHOL, V165, P1865, DOI 10.1016/S0002-9440(10)63239-7; Yamashita J, 2011, CLIN CANCER RES, V17, P1405, DOI 10.1158/1078-0432.CCR-10-1614; Zhao XM, 2010, BREAST CANCER RES TR, V124, P733, DOI 10.1007/s10549-010-1183-6	41	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41065	10.1371/journal.pone.0041065	http://dx.doi.org/10.1371/journal.pone.0041065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848429	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600037
J	Chang, CH; Hinkula, J; Loo, M; Falkeborn, T; Li, RX; Cardillo, TM; Rossi, EA; Goldenberg, DM; Wahren, B				Chang, Chien-Hsing; Hinkula, Jorma; Loo, Meiyu; Falkeborn, Tina; Li, Rongxiu; Cardillo, Thomas M.; Rossi, Edmund A.; Goldenberg, David M.; Wahren, Britta			A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; FUSION-INHIBITOR; LOCK METHOD; MULTIFUNCTIONAL STRUCTURES; ANTIRETROVIRAL ACTIVITY; DEFINED COMPOSITION; ENTRY INHIBITORS; RATIONAL DESIGN; HIGHLY POTENT	We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtide, the first such therapeutic in this class. The three prototypes generated by the Dock-and-Lock (DNL) technology to comprise four copies of enfuvirtide tethered site-specifically to the Fc end of different humanized monoclonal antibodies potently neutralize primary isolates (both R5-tropic and X4-tropic), as well as T-cell-adapted strains of HIV-1 in vitro. All three prototypes show EC50 values in the subnanomolar range, which are 10- to 100-fold lower than enfuvirtide and attainable whether or not the constitutive antibody targets HIV-1. The potential of such conjugates to purge latently infected cells was also demonstrated in a cell-to-cell viral inhibition assay by measuring their efficacy to inhibit the spread of HIV-1(LAI) from infected human peripheral blood mononuclear cells to Jurkat T cells over a period of 30 days following viral activation with 100 nM SAHA (suberoylanilide hydroxamic acid). The IgG-like half-life was not significantly different from that of the parental antibody, as shown by the mean serum concentration of one prototype in mice at 72 h. These encouraging results provide a rationale to develop further novel anti-HIV agents by coupling additional antibodies of interest with alternative HIV-inhibitors via recombinantly-produced, self-assembling, modules.	[Chang, Chien-Hsing; Li, Rongxiu; Cardillo, Thomas M.; Goldenberg, David M.] Immunomedics Inc, Morris Plains, NJ USA; [Chang, Chien-Hsing; Loo, Meiyu; Rossi, Edmund A.; Goldenberg, David M.] IBC Pharmaceut Inc, Morris Plains, NJ USA; [Hinkula, Jorma; Wahren, Britta] Karolinska Inst, Dept Microbiol & Tumor Biol, Stockholm, Sweden; [Hinkula, Jorma; Falkeborn, Tina] Linkoping Univ, Dept Mol Virol, Linkoping, Sweden; [Goldenberg, David M.] Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA	Immunomedics Inc; Karolinska Institutet; Linkoping University	Chang, CH (corresponding author), Immunomedics Inc, Morris Plains, NJ USA.	kchang@immunomedics.com; britta.wahren@ki.se	Hinkula, Jorma/P-6849-2018	Hinkula, Jorma/0000-0003-1908-5609				Asmuth DM, 2010, J INFECT DIS, V201, P1686, DOI 10.1086/652420; Berger EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000803; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; BROLIDEN PA, 1990, J VIROL, V64, P936, DOI 10.1128/JVI.64.2.936-940.1990; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Chang CH, 2007, CLIN CANCER RES, V13, p5586S, DOI 10.1158/1078-0432.CCR-07-1217; Chang CH, 2009, BIOCONJUGATE CHEM, V20, P1899, DOI 10.1021/bc9001773; CHANG SYP, 1993, NATURE, V363, P466, DOI 10.1038/363466a0; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Dadachova E, 2006, PLOS MED, V3, P2094, DOI 10.1371/journal.pmed.0030427; Devito C, 2004, J IMMUNOL, V173, P7078, DOI 10.4049/jimmunol.173.11.7078; Devito C, 2000, J IMMUNOL METHODS, V238, P69, DOI 10.1016/S0022-1759(00)00141-1; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Huet T, 2010, ANTIMICROB AGENTS CH, V54, P134, DOI 10.1128/AAC.00827-09; Ji CH, 2009, J BIOL CHEM, V284, P5175, DOI 10.1074/jbc.M808745200; Johansson S, 2006, AIDS, V20, P1911, DOI 10.1097/01.aids.0000247111.58961.60; Kagiampakis I, 2011, ANTIMICROB AGENTS CH, V55, P264, DOI 10.1128/AAC.00376-10; Kopetzki E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-56; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Luo XM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001225; Makinson A, 2009, CURR OPIN HIV AIDS, V4, P150, DOI 10.1097/COH.0b013e32832498d8; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Nagashima KA, 2001, J INFECT DIS, V183, P1121, DOI 10.1086/319284; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Neff CP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001581; Paulik M, 1999, BIOCHEM PHARMACOL, V58, P1781, DOI 10.1016/S0006-2952(99)00272-5; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rossi EA, 2006, P NATL ACAD SCI USA, V103, P6841, DOI 10.1073/pnas.0600982103; Rossi EA, 2008, CANCER RES, V68, P8384, DOI 10.1158/0008-5472.CAN-08-2033; Rossi EA, 2012, BIOCONJUGATE CHEM, V23, P309, DOI 10.1021/bc2004999; Rossi EA, 2009, BLOOD, V114, P3864, DOI 10.1182/blood-2009-06-228890; Rossi EA, 2009, BLOOD, V113, P6161, DOI 10.1182/blood-2008-10-187138; Rowcliffe E, 2004, SCAND J INFECT DIS, V36, P360, DOI 10.1080/00365540410020208; Schweighardt B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; Stoiber H, 2009, CURR OPIN HIV AIDS, V4, P394, DOI 10.1097/COH.0b013e32832f0108; Vangelista L, 2008, VACCINE, V26, P3008, DOI 10.1016/j.vaccine.2007.12.023; West AP, 2009, J VIROL, V83, P98, DOI 10.1128/JVI.01564-08; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2007, CURR PHARM DESIGN, V13, P203, DOI 10.2174/138161207779313669; Zhang XQ, 2006, ANTIMICROB AGENTS CH, V50, P2231, DOI 10.1128/AAC.00761-05; Zhao B, 2011, J BIOL CHEM, V286, P28370, DOI 10.1074/jbc.M111.234799	51	14	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41235	10.1371/journal.pone.0041235	http://dx.doi.org/10.1371/journal.pone.0041235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844444	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700058
J	Fatima, N; Schooley, JF; Claycomb, WC; Flagg, TP				Fatima, Naheed; Schooley, James F., Jr.; Claycomb, Willliam C.; Flagg, Thomas P.			Promoter DNA Methylation Regulates Murine SUR1 (Abcc8) and SUR2 (Abcc9) Expression in HL-1 Cardiomyocytes	PLOS ONE			English	Article							K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNEL; SUBUNITS KIR6.2; CPG ISLANDS; CELLS; STOICHIOMETRY; ASSOCIATION; ACTIVATION; DIVERSITY; MUTATION	Two mammalian genes encode the SURx (SUR1, Abcc8 and SUR2, Abcc9) subunits that combine with Kir6.2 (Kcnj11) subunits to form the ATP-sensitive potassium (KATP) channel in cardiac myocytes. Different isoform combinations endow the channel with distinct physiological and pharmacological properties, and we have recently reported that the molecular composition of sarcolemmal KATP channels is chamber specific in the mouse heart. KATP channel composition is determined by what subunits are expressed in a cell or tissue. In the present study, we explore the role of CpG methylation in regulating SUR1 and SUR2 expression. In HL-1 cardiomyocytes, as in atrial myocytes, SUR1 expression is markedly greater than SUR2. Consistent with CpG methylation-dependent silencing of SUR2 expression, bisulfite sequencing of genomic DNA isolated from HL-1 cells demonstrates that 57.6% of the CpGs in the promoter region of the SUR2 gene are methylated, compared with 0.14% of the the CpG residues in the SUR1 sequence. Moreover, treatment with 10 mu M 5-aza-2'-deoxycytidine (Aza-dC) significantly increased both the unmethylated fraction of the SUR2 CpG island and mRNA expression. However, we cannot rule out additional mechanisms of Aza-dC action, as Aza-dC also causes a decrease in SUR1 expression and lower doses of Aza-dC do not alter the unmethylated DNA fraction but do elicit a small increase in SUR2 expression. The conclusion that DNA methylation alone is not the only regulator of SUR subunit expression is also consistent with observations in native myocytes, where the CpG islands of both SUR genes are essentially unmethylated in both atrial and ventricular myocytes. Collectively, these data demonstrate the potential for CpG methylation to regulate SURx subunit expression and raises the possibility that regulated or aberrant CpG methylation might play a role in controlling channel structure and function under different physiological conditions or different species.	[Fatima, Naheed; Schooley, James F., Jr.; Flagg, Thomas P.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Claycomb, Willliam C.] LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA	Uniformed Services University of the Health Sciences - USA; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Fatima, N (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	Thomas.Flagg@usuhs.edu			American Heart Association [11SDG7210070]; Henry M. Jackson Foundation; Department of Defense [R0702O]	American Heart Association(American Heart Association); Henry M. Jackson Foundation; Department of Defense(United States Department of Defense)	This work was supported in part by awards from the American Heart Association Scientist Development Grant (11SDG7210070 to TPF), the Henry M. Jackson Foundation (to TPF), and the Department of Defense (R0702O to TPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Ashfield R, 1998, DIABETES, V47, P1274, DOI 10.2337/diabetes.47.8.1274; Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132; Bao L, 2011, CIRC-ARRHYTHMIA ELEC, V4, P926, DOI 10.1161/CIRCEP.111.964643; Chan KW, 2008, J GEN PHYSIOL, V131, P43, DOI 10.1085/jgp.200709894; Cheng WWL, 2008, RANDOM ASSEMBLY SUR, V2; Chutkow WA, 1999, J BIOL CHEM, V274, P13656, DOI 10.1074/jbc.274.19.13656; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Chutkow WA, 2001, P NATL ACAD SCI USA, V98, P11760, DOI 10.1073/pnas.201390398; Clark RH, 2010, SCIENCE, V329, P458, DOI 10.1126/science.1186146; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Crawford RM, 2003, J BIOL CHEM, V278, P31444, DOI 10.1074/jbc.M303051200; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Flagg TP, 2005, J MOL CELL CARDIOL, V39, P647, DOI 10.1016/j.yjmcc.2005.06.003; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Glukhov AV, 2010, J MOL CELL CARDIOL, V48, P152, DOI 10.1016/j.yjmcc.2009.08.026; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Hernandez-Sanchez C, 1999, J BIOL CHEM, V274, P18261, DOI 10.1074/jbc.274.26.18261; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; INAGAKI N, 1995, GENOMICS, V30, P102, DOI 10.1006/geno.1995.0018; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kao YH, 2010, CRIT CARE MED, V38, P217, DOI 10.1097/CCM.0b013e3181b4a854; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Koster JC, 2001, CIRC RES, V89, P1022, DOI 10.1161/hh2301.100342; Lader JM, 2011, AM J PHYSIOL-HEART C, V301, pH964, DOI 10.1152/ajpheart.00410.2011; Li RA, 2000, CIRC RES, V87, P837, DOI 10.1161/01.RES.87.10.837; Lorenz E, 1999, J MOL CELL CARDIOL, V31, P425, DOI 10.1006/jmcc.1998.0876; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Oki Y, 2007, CRIT REV ONCOL HEMAT, V61, P140, DOI 10.1016/j.critrevonc.2006.07.010; Palbykin B, 2011, CARDIOVASC TOXICOL, V11, P204, DOI 10.1007/s12012-011-9113-3; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Pountney DJ, 2001, J MOL CELL CARDIOL, V33, P1541, DOI 10.1006/jmcc.2001.1407; Remedi MS, 2009, CELL METAB, V9, P140, DOI 10.1016/j.cmet.2008.12.005; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Saegusa N, 2005, CARDIOVASC RES, V67, P60, DOI 10.1016/j.cardiores.2005.03.011; Shi NQ, 2005, J MOL CELL CARDIOL, V39, P51, DOI 10.1016/j.yjmcc.2004.11.024; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570; Takai Daiya, 2003, In Silico Biology, V3, P235; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; Wheeler A, 2008, MOL PHARMACOL, V74, P1333, DOI 10.1124/mol.108.048355; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Zheng ZX, 2012, FASEB J, V26, P449, DOI 10.1096/fj.11-190025; Zingman LV, 2011, J MOL CELL CARDIOL, V51, P72, DOI 10.1016/j.yjmcc.2011.03.010	55	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41533	10.1371/journal.pone.0041533	http://dx.doi.org/10.1371/journal.pone.0041533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844491	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700103
J	Huang, HJ; Chen, YH; Liang, KC; Jheng, YS; Jhao, JJ; Su, MT; Lee-Chen, GJ; Hsieh-Li, HM				Huang, Hei-Jen; Chen, Yen-Hsu; Liang, Keng-Chen; Jheng, Yu-Syuan; Jhao, Jhih-Jhen; Su, Ming-Tsan; Lee-Chen, Guey-Jen; Hsieh-Li, Hsiu Mei			Exendin-4 Protected against Cognitive Dysfunction in Hyperglycemic Mice Receiving an Intrahippocampal Lipopolysaccharide Injection	PLOS ONE			English	Article							NF-KAPPA-B; BETA-INDUCED NEUROTOXICITY; NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE; PEPTIDE-1 RECEPTOR; METABOLIC SYNDROME; CELL APOPTOSIS; BRAIN; EXPRESSION; PATHWAY	Background: Chronic hyperglycemia-associated inflammation plays critical roles in disease initiation and the progression of diabetic complications, including Alzheimer's disease (AD). However, the association of chronic hyperglycemia with acute inflammation of the central nervous system in the progression of AD still needs to be elucidated. In addition, recent evidence suggests that Glucagon-like peptide-1 receptor (GLP-1R) protects against neuronal damage in the brain. Therefore, the neuroprotective effects of the GLP-1R agonist exendin-4 (EX-4) against hyperglycemia/lipopolysaccharides (LPS) damage were also evaluated in this study. Methodology/Principal Findings: Ten days after streptozotocin (STZ) or vehicle (sodium citrate) treatment in mice, EX-4 treatment (10 mu g/kg/day) was applied to the mice before intrahippocampal CA1 injection of LPS or vehicle (saline) and continued for 28 days. This study examined the molecular alterations in these mice after LPS and EX4 application, respectively. The mouse cognitive function was evaluated during the last 6 days of EX-4 treatment. The results showed that the activation of NF-kappa B-related inflammatory responses induced cognitive dysfunction in both the hyperglycemic mice and the mice that received acute intrahippocampal LPS injection. Furthermore, acute intrahippocampal LPS injection exacerbated the impairment of spatial learning and memory through a strong decrease in monoaminergic neurons and increases in astrocytes activation and apoptosis in the hyperglycemic mice. However, EX-4 treatment protected against the cognitive dysfunction resulting from hyperglycemia or/and intrahippocampal LPS injection. Conclusions/Significance: These findings reveal that both hyperglycemia and intrahippocampal LPS injection induced cognitive dysfunction via activation of NF-kappa B-related inflammatory responses. However, acute intrahippocampal LPS injection exacerbated the progression of cognitive dysfunction in the hyperglycemic mice via a large increase in astrocytes activation-related responses. Furthermore, EX-4 might be considered as a potential adjuvant entity to protect against neurodegenerative diseases.	[Huang, Hei-Jen; Jheng, Yu-Syuan; Jhao, Jhih-Jhen] Mackay Med Nursing & Management Coll, Dept Nursing, Taipei, Taiwan; [Chen, Yen-Hsu; Su, Ming-Tsan; Lee-Chen, Guey-Jen; Hsieh-Li, Hsiu Mei] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Liang, Keng-Chen] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan	Mackay Junior College of Medicine, Nursing & Management; National Taiwan Normal University; National Taiwan University	Huang, HJ (corresponding author), Mackay Med Nursing & Management Coll, Dept Nursing, Taipei, Taiwan.	hmhsieh@ntnu.edu.tw	Chen, Chiung-Mei/AAL-6260-2020	Liang, Keng-Chen/0000-0002-3292-6882; Chen, Yen-hsu/0000-0002-8667-4844	National Science Council [NSC100-2325-B-003-002]; National Taiwan Normal University [NTNU100-D-02]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan Normal University	This work was supported in part by research grants from the National Science Council (NSC100-2325-B-003-002) and National Taiwan Normal University (NTNU100-D-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Aid S, 2010, J CEREBR BLOOD F MET, V30, P370, DOI 10.1038/jcbfm.2009.223; Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014; Alvarez E, 1996, J NEUROCHEM, V66, P920; Alvarez EO, 2009, BEHAV BRAIN RES, V198, P224, DOI 10.1016/j.bbr.2008.11.001; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Booz GW, 2011, FREE RADICAL BIO MED, V51, P1054, DOI 10.1016/j.freeradbiomed.2011.01.007; Brown SB, 2010, CARDIOVASC DRUG THER, V24, P197, DOI 10.1007/s10557-010-6242-z; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cai ZY, 2011, PHARMACOL REP, V63, P381, DOI 10.1016/S1734-1140(11)70504-7; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Clouatre DL, 2011, J MED FOOD; Colton CA, 2008, J ALZHEIMERS DIS, V15, P571; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Cunningham C, 2012, J NEUROIMMUNE PHARM, V7, P60, DOI 10.1007/s11481-011-9312-5; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; de Oliveira AC, 2012, ENDOCRINOLOGY; Drucker Thomas B, 2008, Md Med, V9, P5; Elovich R, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-23; Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214; Ferret-Bernard S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013705; Francis P T, 2009, Curr Mol Pharmacol, V2, P77; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hertz L, 2004, CNS NEUROL DISORD-DR, V3, P239, DOI 10.2174/1568007043337535; Hwang J, 2010, NEUROPHARMACOLOGY, V58, P1122, DOI 10.1016/j.neuropharm.2010.02.003; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Jardanhazi-Kurutz D, 2011, NEUROSCIENCE, V176, P396, DOI 10.1016/j.neuroscience.2010.11.052; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kang JH, 2009, J ENDOCRINOL, V202, P65, DOI 10.1677/JOE-08-0507; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; LEE SC, 1993, J IMMUNOL, V150, P2659; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lichtenstein MP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00142; Morley JE, 2002, PEPTIDES, V23, P589, DOI 10.1016/S0196-9781(01)00630-1; Muller N, 1998, PROG NEURO-PSYCHOPH, V22, P1, DOI 10.1016/S0278-5846(97)00179-6; Nareika A, 2008, J ENDOCRINOL, V196, P45, DOI 10.1677/JOE-07-0145; O'Neil JN, 2007, J CHEM NEUROANAT, V34, P102, DOI 10.1016/j.jchemneu.2007.05.008; Pavlovic DM, 2008, SRP ARK CELOK LEK, V136, P170, DOI 10.2298/SARH0804170P; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Perez JL, 2010, EXP NEUROL, V223, P410, DOI 10.1016/j.expneurol.2009.10.013; Potter PE, 2010, J AM OSTEOPATH ASSOC, V110, pS27; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Saravanan R, 2012, J PHYSL BIOCH; Sharifi AM, 2009, NEUROSCI LETT, V459, P47, DOI 10.1016/j.neulet.2009.03.100; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Taepavarapruk P, 2010, J NEUROCHEM, V112, P1054, DOI 10.1111/j.1471-4159.2009.06524.x; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang G, 2012, J BIOL CHEM; Yaffe K, 2007, ALZ DIS ASSOC DIS, V21, P167, DOI 10.1097/WAD.0b013e318065bfd6; Zablocka A, 2010, BIOMED PHARMACOTHER, V64, P16, DOI 10.1016/j.biopha.2009.01.009	60	69	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e39656	10.1371/journal.pone.0039656	http://dx.doi.org/10.1371/journal.pone.0039656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844396	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700006
J	Jin, EJ; Chan, CC; Agi, E; Cherry, S; Hanacik, E; Buszczak, M; Hiesinger, PR				Jin, Eugene Jennifer; Chan, Chih-Chiang; Agi, Egemen; Cherry, Smita; Hanacik, Elizabeth; Buszczak, Michael; Hiesinger, P. Robin			Similarities of Drosophila rab GTPases Based on Expression Profiling: Completion and Analysis of the rab-Gal4 Kit	PLOS ONE			English	Article							MUTATIONS; MEMBRANE; PROTEINS; MANIPULATION; DISTINCT; GENES	We recently generated rab-Gal4 lines for 25 of 29 predicted Drosophila rab GTPases. These lines provide tools for the expression of reporters, mutant rab variants or other genes, under control of the regulatory elements of individual rab loci. Here, we report the generation and characterization of the remaining four rab-Gal4 lines. Based on the completed 'rab-Gal4 kit' we performed a comparative analysis of the cellular and subcellular expression of all rab GTPases. This analysis includes the cellular expression patterns in characterized neuronal and non-neuronal cells and tissues, the subcellular localization of wild type, constitutively active and dominant negative rab GTPases and colocalization with known intracellular compartment markers. Our comparative analysis identifies all Rab GTPases that are expressed in the same cells and localize to the same intracellular compartments. Remarkably, similarities based on these criteria are typically not predicted by primary sequence homology. Hence, our findings provide an alternative basis to assess potential roles and redundancies based on expression in developing and adult cell types, compartment identity and subcellular localization.	[Jin, Eugene Jennifer; Chan, Chih-Chiang; Agi, Egemen; Cherry, Smita; Hanacik, Elizabeth; Hiesinger, P. Robin] Univ Texas SW, Med Ctr, Dept Physiol, Dallas, TX USA; [Buszczak, Michael] Univ Texas SW, Med Ctr, Dept Mol Biol, Dallas, TX USA; [Hiesinger, P. Robin] Univ Texas SW, Med Ctr, Green Ctr Syst Biol, Dallas, TX USA; [Hanacik, Elizabeth] Univ Texas Dallas, UT SW Green Fellow Program, Dallas, TX 75230 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas	Jin, EJ (corresponding author), Univ Texas SW, Med Ctr, Dept Physiol, Dallas, TX USA.	robin.hiesinger@utsouthwestern.edu	CHAN, CHIH-CHIANG/AGM-3463-2022	CHAN, CHIH-CHIANG/0000-0003-2626-3805; Buszczak, Michael/0000-0001-6361-3654	National Institute of Health [RO1EY018884, RO1GM086647]; Cancer Prevention Research Institute of Texas [RP100516]; Whitehall Foundation; Welch Foundation [I-1657]; Visual Science Core grant [EY020799]; Green Fellow fellowship; NATIONAL EYE INSTITUTE [P30EY020799, R01EY018884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086647] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Whitehall Foundation; Welch Foundation(The Welch Foundation); Visual Science Core grant; Green Fellow fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health to Dr. Hiesinger (RO1EY018884) and to Dr. Buszczak (RO1GM086647), a grant by the Cancer Prevention Research Institute of Texas to Dr. Buszczak and Dr. Hiesinger (RP100516), the Whitehall Foundation to Dr. Hiesinger and the Welch Foundation (I-1657) to Dr. Hiesinger, a Green Fellow fellowship to Dr. Hanacik and a Visual Science Core grant (EY020799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BR, 2005, BIOCHEM SOC T, V33, P652, DOI 10.1042/BST0330652; Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan Chih-Chiang, 2012, Commun Integr Biol, V5, P179, DOI 10.4161/cib.18788; Chan CC, 2011, CURR BIOL, V21, P1704, DOI 10.1016/j.cub.2011.08.058; Chinchore Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000377; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Hutter P, 2007, ADV GENET, V58, P1, DOI 10.1016/S0065-2660(06)58001-0; Jiang SY, 2006, PHYSIOL GENOMICS, V24, P235, DOI 10.1152/physiolgenomics.00210.2005; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Mitra S, 2011, SEMIN CELL DEV BIOL, V22, P57, DOI 10.1016/j.semcdb.2010.12.005; Molendijk AJ, 2004, CURR OPIN PLANT BIOL, V7, P694, DOI 10.1016/j.pbi.2004.09.014; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Williamson W. R., 2010, J VIS EXP; Williamson WR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000553; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	30	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40912	10.1371/journal.pone.0040912	http://dx.doi.org/10.1371/journal.pone.0040912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844416	gold, Green Published			2022-12-27	WOS:000306687700023
J	Martin, R; Miana, M; Jurado-Lopez, R; Martinez-Martinez, E; Gomez-Hurtado, N; Delgado, C; Bartolome, MV; San Roman, JA; Cordova, C; Lahera, V; Nieto, ML; Cachofeiro, V				Martin, Ruben; Miana, Maria; Jurado-Lopez, Raquel; Martinez-Martinez, Ernesto; Gomez-Hurtado, Nieves; Delgado, Carmen; Visitacion Bartolome, Maria; Alberto San Roman, Jose; Cordova, Claudia; Lahera, Vicente; Luisa Nieto, Maria; Cachofeiro, Victoria			DIOL Triterpenes Block Profibrotic Effects of Angiotensin II and Protect from Cardiac Hypertrophy	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; OLIVE OIL; EXTRACELLULAR-MATRIX; CARDIOVASCULAR-DISEASES; DIASTOLIC DYSFUNCTION; ALDOSTERONE SYSTEM; HEART-FAILURE; URSOLIC ACIDS; RAT; FIBROBLASTS	Background: The natural triterpenes, erythrodiol and uvaol, exert anti-inflammatory, vasorelaxing and anti-proliferative effects. Angiotensin II is a well-known profibrotic and proliferative agent that participates in the cardiac remodeling associated with different pathological situations through the stimulation and proliferation of cardiac fibroblasts. Therefore, the aim of the study was to investigate the preventive effects of the natural triterpenes erythrodiol and uvaol on the proliferation and collagen production induced by angiotensin II in cardiac myofibroblasts. Their actions on cardiac hypertrophy triggered by angiotensin II were also studied. Methodology/Principal Findings: The effect of erythrodiol and uvaol on angiotensin II-induced proliferation was evaluated in cardiac myofibroblasts from adult rats in the presence or the absence of the inhibitors of PPAR-gamma, GW9662 or JNK, SP600125. The effect on collagen levels induced by angiotensin II was evaluated in cardiac myofibroblasts and mouse heart. The presence of low doses of both triterpenes reduced the proliferation of cardiac myofibroblasts induced by angiotensin II. Pretreatment with GW9662 reversed the effect elicited by both triterpenes while SP600125 did not modify it. Both triterpenes at high doses produced an increase in annexing-V binding in the presence or absence of angiotensin II, which was reduced by either SP600125 or GW9662. Erythrodiol and uvaol decreased collagen I and galectin 3 levels induced by angiotensin II in cardiac myofribroblasts. Finally, cardiac hypertrophy, ventricular remodeling, fibrosis, and increases in myocyte area and brain natriuretic peptide levels observed in angiotensin II-infused mice were reduced in triterpene-treated animals. Conclusions/Significance: Erythrodiol and uvaol reduce cardiac hypertrophy and left ventricle remodeling induced by angiotensin II in mice by diminishing fibrosis and myocyte area. They also modulate growth and survival of cardiac myofibroblasts. They inhibit the angiotensin II-induced proliferation in a PPAR-gamma-dependent manner, while at high doses they activate pathways of programmed cell death that are dependent on JNK and PPAR-gamma.	[Martin, Ruben; Alberto San Roman, Jose] Hosp Clin, Inst Ciencias Corazon ICICOR, Valladolid, Spain; [Miana, Maria; Jurado-Lopez, Raquel; Martinez-Martinez, Ernesto; Lahera, Vicente; Cachofeiro, Victoria] Univ Complutense, Fac Med, Dept Fisiol, E-28040 Madrid, Spain; [Gomez-Hurtado, Nieves; Delgado, Carmen] Univ Complutense, Fac Med, Dept Farmacol, E-28040 Madrid, Spain; [Delgado, Carmen] CSIC, Ctr Invest Biol, Madrid, Spain; [Visitacion Bartolome, Maria] Univ Complutense, Fac Psicol, Dept Oftalmol & Otorrinolaringol, E-28040 Madrid, Spain; [Cordova, Claudia; Luisa Nieto, Maria] CSIC UVA, Inst Biol & Genet Mol, Valladolid, Spain	Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Martin, R (corresponding author), Hosp Clin, Inst Ciencias Corazon ICICOR, Valladolid, Spain.	vcara@med.ucm.es	Martinez-Martinez, Ernesto/M-1376-2017; Velasco, Berta/D-4325-2014; Delgado, Carmen/H-2251-2016; San Roman, Jose A/A-9963-2012; Gomez-Hurtado, Nieves/C-7112-2011; Nieto, Maria L/G-7492-2015	Martinez-Martinez, Ernesto/0000-0002-3011-2041; Velasco, Berta/0000-0002-8390-3867; Delgado, Carmen/0000-0002-0047-4674; Gomez-Hurtado, Nieves/0000-0001-5338-7884; Nieto, Maria L/0000-0001-6842-799X; Lahera, Vicente/0000-0002-9688-4503; Jurado Lopez, Raquel/0000-0002-9149-1073; San Roman Calvar, Jose Alberto/0000-0003-0764-0839; Cordova Marcos, Claudia/0000-0002-2108-2629; Cachofeiro, Victoria/0000-0001-6959-6293; Miana, Maria/0000-0002-0801-8024	Fondo de Investigaciones Sanitarias [PI09/0871]; Red Cardiovascular del FIS [RD06/0014/0007]; La Fundacion General de la Universidad de Valladolid (FGUVa) [060/053186]; FPI Program from the Government of Castilla y Leon; FSE	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Red Cardiovascular del FIS; La Fundacion General de la Universidad de Valladolid (FGUVa); FPI Program from the Government of Castilla y Leon; FSE(European Social Fund (ESF))	This work was supported by grants from Fondo de Investigaciones Sanitarias (PI09/0871). and Junta de Castilla y Leon (CSI11A08). Maria Miana and Raquel Jurado-Lopez were paid with a Grant from Red Cardiovascular del FIS (RD06/0014/0007). Ruben Martin was paid with a Grant from La Fundacion General de la Universidad de Valladolid (FGUVa) (060/053186). Claudia Cordova was funded by the FPI Program from the Government of Castilla y Leon (co-funded by FSE). All the authors are members of the Red Cardiovascular del FIS (RECAVA, RD06/0014/0007 and RD06/0014/0000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007; Bian GX, 2008, BIOL PHARM BULL, V31, P458, DOI 10.1248/bpb.31.458; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Burlew BS, 2002, HERZ, V27, P92, DOI 10.1007/s00059-002-2354-y; CAMPBELL SE, 1995, J MOL CELL CARDIOL, V27, P1545, DOI 10.1016/S0022-2828(95)90359-3; CAPASSO JM, 1990, AM J PHYSIOL, V259, pH1086, DOI 10.1152/ajpheart.1990.259.4.H1086; Carluccioll MA, 2007, MOL NUTR FOOD RES, V51, P1225, DOI 10.1002/mnfr.200600305; Chintharlapalli S, 2007, CARCINOGENESIS, V28, P2337, DOI 10.1093/carcin/bgm189; de las Heras N, 2006, J RENIN-ANGIO-ALDO S, V7, P192, DOI 10.3317/jraas.2006.037; Escrich E, 2006, NUTR REV, V64, pS40, DOI 10.1111/j.1753-4887.2006.tb00262.x; Hao GH, 2008, BRIT J PHARMACOL, V153, P1409, DOI 10.1038/bjp.2008.21; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Kohl P, 2004, CARDIOVASC RES, V64, P195, DOI 10.1016/j.cardiores.2004.08.011; Li J, 2008, J INT MED RES, V36, P329; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lin YH, 2009, CLIN CHIM ACTA, V409, P96, DOI 10.1016/j.cca.2009.09.001; Lopez-Andres N, 2012, EUR J HEART FAIL, V14, P74, DOI 10.1093/eurjhf/hfr151; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; Mair J, 2002, CLIN CHEM, V48, P977; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Martin R, 2010, BIOCHEM PHARMACOL, V79, P198, DOI 10.1016/j.bcp.2009.08.002; Martin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005975; Menendez JA, 2008, INT J MOL MED, V22, P433, DOI 10.3892/ijmm_00000039; Montilla MP, 2003, PLANTA MED, V69, P472, DOI 10.1055/s-2003-39698; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Pellman J, 2010, J MOL CELL CARDIOL, V48, P461, DOI 10.1016/j.yjmcc.2009.09.001; Perez-Camino MC, 1999, J AGR FOOD CHEM, V47, P1558, DOI 10.1021/jf980881h; Perez-Jimenez F, 2007, MOL NUTR FOOD RES, V51, P1199, DOI 10.1002/mnfr.200790023; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Sciarretta S, 2009, CLIN SCI, V116, P467, DOI 10.1042/CS20080390; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007; Smani T, 2010, CARDIOVASC RES, V87, P459, DOI 10.1093/cvr/cvq063; Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Sotiroudis TG, 2008, EUR J NUTR, V47, P69, DOI 10.1007/s00394-008-2008-9; Sudhahar V, 2007, VASC PHARMACOL, V46, P412, DOI 10.1016/j.vph.2006.12.005; Sun Y, 2000, J LAB CLIN MED, V135, P316, DOI 10.1067/mlc.2000.105971; Tsao T, 2010, CANCER RES, V70, P4949, DOI 10.1158/0008-5472.CAN-09-1962; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Bartolome MV, 2009, BRAIN RES REV, V60, P341, DOI 10.1016/j.brainresrev.2009.02.001; Weber KT, 2004, J HYPERTENS, V22, P47, DOI 10.1097/00004872-200401000-00011; Xi SG, 2009, EXP MOL MED, V41, P538, DOI 10.3858/emm.2009.41.8.059; Yamada K, 2008, BIOL PHARM BULL, V31, P651, DOI 10.1248/bpb.31.651; Yamai H, 2009, INT J CANCER, V125, P952, DOI 10.1002/ijc.24433; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	49	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41545	10.1371/journal.pone.0041545	http://dx.doi.org/10.1371/journal.pone.0041545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844495	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700107
J	Schellenberg, JJ; Dumonceaux, TJ; Hill, JE; Kimani, J; Jaoko, W; Wachihi, C; Mungai, JN; Lane, M; Fowke, KR; Ball, TB; Plummer, FA				Schellenberg, John J.; Dumonceaux, Tim J.; Hill, Janet E.; Kimani, Joshua; Jaoko, Walter; Wachihi, Charles; Mungai, Jane Njeri; Lane, Margo; Fowke, Keith R.; Ball, T. Blake; Plummer, Francis A.			Selection, Phenotyping and Identification of Acid and Hydrogen Peroxide Producing Bacteria from Vaginal Samples of Canadian and East African Women	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEQUENCE DATABASE; GENITAL-TRACT; SEX WORKERS; VAGINOSIS; LACTOBACILLUS; INFECTION; RESISTANCE; ENIGMA; HIV	The common but poorly understood condition known as bacterial vaginosis (BV) increases vulnerability to HIV infection and is associated with the absence of H2O2-producing Lactobacillus. Vaginal lactic acid bacteria (LAB) produce anti-HIV factors such as organic acids and hydrogen peroxide (H2O2), and may bind and inactivate HIV particles during scavenging of mannose. These factors define potential criteria for initial selection of candidate probiotics to block heterosexual transmission of HIV. Therefore, the primary goal of this study was to characterize acid production on mannose and H2O2 production in vaginal isolates from Canadian adolescents (192 isolates, 16 individuals) and commercial sex workers in Nairobi, Kenya (576 isolates, 96 individuals). Selection of isolates from H2O2-detecting media suggested an idiosyncratic individual-level profile and extensive phenotypic diversity, including the identification of a subset of "double-strong" acid- and H2O2-producers with phenotypes similar to well-characterized probiotic strains. Molecular fingerprinting of all isolates by capillary electrophoresis of 16S-23S rRNA interspacer amplicons was coupled with chaperonin-60 universal target (cpn60 UT) sequencing in a subset, tentatively identifying 96% of isolates although only 19% were sequenced. Most isolates belonged to Lactobacillus, Streptococcus, Bifidobacterium or Gardnerella, with a total of 37 species in 15 genera, as well as 5 potentially novel organisms, identified in this study. This sensitivity was likely enhanced by phenotype-based selection on two chromogenic media formulations. Identification of double-strong isolates may provide a rational basis for selection and further characterization of vaginal probiotics, with potential application as part of HIV prevention initiatives in western Canada and East Africa.	[Schellenberg, John J.; Fowke, Keith R.; Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Fowke, Keith R.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Lane, Margo] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Dumonceaux, Tim J.] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Hill, Janet E.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Kimani, Joshua; Jaoko, Walter; Wachihi, Charles; Mungai, Jane Njeri; Fowke, Keith R.; Ball, T. Blake; Plummer, Francis A.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Ball, T. Blake; Plummer, Francis A.] Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Agriculture & Agri Food Canada; University of Saskatchewan; University of Nairobi; Canadian Science Centre for Human & Animal Health	Schellenberg, JJ (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	schellej@cc.umanitoba.ca	Hill, Janet E./B-5001-2011; Dumonceaux, Tim/H-4751-2019; Jaoko, Walter/AAN-5048-2020	Hill, Janet E./0000-0002-2187-6277; Dumonceaux, Tim/0000-0001-5165-0343; Schellenberg, John/0000-0003-3970-1608; Jaoko, Walter/0000-0002-7134-6581; Fowke, Keith/0000-0001-8227-6649	Canadian Institutes of Health Research; National Institutes of Health; Bill & Melinda Gates Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this study was provided by the Canadian Institutes of Health Research, National Institutes of Health and the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mushrif S., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P63; Anukam KC, 2006, SEX TRANSM DIS, V33, P59, DOI 10.1097/01.olq.0000175367.15559.c4; Beigi RH, 2005, J INFECT DIS, V191, P924, DOI 10.1086/428288; Bolton M, 2008, SEX TRANSM DIS, V35, P214, DOI 10.1097/OLQ.0b013e31815b017a; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; FONTAINE EA, 1990, J APPL BACTERIOL, V69, P326, DOI 10.1111/j.1365-2672.1990.tb01523.x; Forsum U, 2005, APMIS, V113, P153, DOI 10.1111/j.1600-0463.2005.apm1130301.x; Forsum U, 2005, APMIS, V113, P81, DOI 10.1111/j.1600-0463.2005.apm1130201.x; Fowke KR, 1998, AIDS RES HUM RETROV, V14, P1521, DOI 10.1089/aid.1998.14.1521; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Hummelen R, 2010, PLOS ONE, V5; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Kilic AO, 2001, CLIN DIAGN LAB IMMUN, V8, P31, DOI 10.1128/CDLI.8.1.31-39.2001; KLEBANOFF SJ, 1991, J EXP MED, V174, P289, DOI 10.1084/jem.174.1.289; Larsson PG, 2005, APMIS, V113, P233, DOI 10.1111/j.1600-0463.2005.apm_01.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Reid G, 2006, PREBIOTICS DEV APPL, P201; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Ronnqvist PDJ, 2006, ACTA OBSTET GYN SCAN, V85, P726, DOI 10.1080/00016340600578357; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schellenberg J, 2008, J MICROBIOL METH, V73, P216, DOI 10.1016/j.mimet.2008.03.004; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Song YL, 1999, J CLIN MICROBIOL, V37, P3062, DOI 10.1128/JCM.37.9.3062-3064.1999; Tao L, 2005, BEN MICR C APR 17 21; Westrom L, 1984, SCAND J UROL NEPHR S, V86, P259	37	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41217	10.1371/journal.pone.0041217	http://dx.doi.org/10.1371/journal.pone.0041217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844440	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700054
J	Chen, HB; Tian, Y; Shu, WJ; Bo, XC; Wang, SQ				Chen, Hebing; Tian, Yao; Shu, Wenjie; Bo, Xiaochen; Wang, Shengqi			Comprehensive Identification and Annotation of Cell Type-Specific and Ubiquitous CTCF-Binding Sites in the Human Genome	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; C-MYC GENE; CHROMATIN INSULATORS; HISTONE MODIFICATIONS; PROTEIN CTCF; REGULATORY MOTIFS; X-INACTIVATION; CONTROL REGION; H19 GENE; TRANSCRIPTION	Chromatin insulators are DNA elements that regulate the level of gene expression either by preventing gene silencing through the maintenance of heterochromatin boundaries or by preventing gene activation by blocking interactions between enhancers and promoters. CCCTC-binding factor (CTCF), a ubiquitously expressed 11-zinc-finger DNA-binding protein, is the only protein implicated in the establishment of insulators in vertebrates. While CTCF has been implicated in diverse regulatory functions, CTCF has only been studied in a limited number of cell types across human genome. Thus, it is not clear whether the identified cell type-specific differences in CTCF-binding sites are functionally significant. Here, we identify and characterize cell type-specific and ubiquitous CTCF-binding sites in the human genome across 38 cell types designated by the Encyclopedia of DNA Elements (ENCODE) consortium. These cell type-specific and ubiquitous CTCF-binding sites show uniquely versatile transcriptional functions and characteristic chromatin features. In addition, we confirm the insulator barrier function of CTCF-binding and explore the novel function of CTCF in DNA replication. These results represent a critical step toward the comprehensive and systematic understanding of CTCF-dependent insulators and their versatile roles in the human genome.	[Chen, Hebing; Tian, Yao; Shu, Wenjie; Bo, Xiaochen; Wang, Shengqi] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Chen, HB (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	shuwj@bmi.ac.cn; boxc@bmi.ac.cn; sqwang@bmi.ac.cn		Shu, Wenjie/0000-0001-9044-2352; Chen, Hebing/0000-0003-4102-356X; Bo, Xiao-chen/0000-0003-1911-7922	National Nature Science Foundation of China [31070639]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Nature Science Foundation of China (No. 31070639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boden M, 2008, NUCLEIC ACIDS RES, V36, P4108, DOI 10.1093/nar/gkn374; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; Gombert WM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006109; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuhn EJ, 2003, CURR OPIN CELL BIOL, V15, P259, DOI 10.1016/S0955-0674(03)00039-5; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lu L, 1997, MOL CELL BIOL, V17, P2202, DOI 10.1128/MCB.17.4.2202; Lu L, 2001, GENE DEV, V15, P134, DOI 10.1101/gad.822101; Lutz M, 2003, EMBO J, V22, P1579, DOI 10.1093/emboj/cdg147; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Shu WJ, 2011, NUCLEIC ACIDS RES, V39, P7428, DOI 10.1093/nar/gkr443; Simon I, 2001, EMBO J, V20, P6150, DOI 10.1093/emboj/20.21.6150; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Vostrov AA, 2002, J BIOL CHEM, V277, P1619, DOI 10.1074/jbc.M109748200; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	96	96	98	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41374	10.1371/journal.pone.0041374	http://dx.doi.org/10.1371/journal.pone.0041374			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829947	Green Submitted, gold, Green Published			2022-12-27	WOS:000306956300086
J	Schuyler, Q; Hardesty, BD; Wilcox, C; Townsend, K				Schuyler, Qamar; Hardesty, Britta Denise; Wilcox, Chris; Townsend, Kathy			To Eat or Not to Eat? Debris Selectivity by Marine Turtles	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; CARETTA-CARETTA; PLASTIC DEBRIS; FEEDING ECOLOGY; CHELONIA-MYDAS; INGESTION; GREEN; ACCUMULATION; PATTERNS; BEHAVIOR	Marine debris is a growing problem for wildlife, and has been documented to affect more than 267 species worldwide. We investigated the prevalence of marine debris ingestion in 115 sea turtles stranded in Queensland between 2006-2011, and assessed how the ingestion rates differ between species (Eretmochelys imbricata vs. Chelonia mydas) and by turtle size class (smaller oceanic feeders vs. larger benthic feeders). Concurrently, we conducted 25 beach surveys to estimate the composition of the debris present in the marine environment. Based on this proxy measurement of debris availability, we modeled turtles' debris preferences (color and type) using a resource selection function, a method traditionally used for habitat and food selection. We found no significant difference in the overall probability of ingesting debris between the two species studied, both of which have similar life histories. Curved carapace length, however, was inversely correlated with the probability of ingesting debris; 54.5% of pelagic sized turtles had ingested debris, whereas only 25% of benthic feeding turtles were found with debris in their gastrointestinal system. Benthic and pelagic sized turtles also exhibited different selectivity ratios for debris ingestion. Benthic phase turtles had a strong selectivity for soft, clear plastic, lending support to the hypothesis that sea turtles ingest debris because it resembles natural prey items such as jellyfish. Pelagic turtles were much less selective in their feeding, though they showed a trend towards selectivity for rubber items such as balloons. Most ingested items were plastic and were positively buoyant. This study highlights the need to address increasing amounts of plastic in the marine environment, and provides evidence for the disproportionate ingestion of balloons by marine turtles.	[Schuyler, Qamar; Townsend, Kathy] Univ Queensland, Sch Biol Sci, Moreton Bay Res Stn, Dunwich, Qld, Australia; [Hardesty, Britta Denise] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Atherton, Qld, Australia; [Wilcox, Chris] Commonwealth Sci & Ind Res Org, Marine & Atmospher Res, Hobart, Tas, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schuyler, Q (corresponding author), Univ Queensland, Sch Biol Sci, Moreton Bay Res Stn, Dunwich, Qld, Australia.	q.schuyler@uq.edu.au	Hardesty, Britta Denise/A-3189-2011; Wilcox, Chris/A-3585-2010; Schuyler, Qamar A/L-2586-2014; Townsend, Kathy Ann/K-9486-2016	Hardesty, Britta Denise/0000-0003-1948-5098; Wilcox, Chris/0000-0002-5983-657X; Schuyler, Qamar A/0000-0002-2473-4311; Townsend, Kathy Ann/0000-0002-2581-2158	ARC Linkage Grant [LP110200216]; Goldring Marine Emerging Scientist Fellowship (CSIRO Top up fellowship); Earthwatch Institute Australia; Brother Pty Ltd; Australian Postgraduate Award, the Margaret Middleton Fund; Goodman Foundation; Brother, Australia	ARC Linkage Grant(Australian Research Council); Goldring Marine Emerging Scientist Fellowship (CSIRO Top up fellowship); Earthwatch Institute Australia; Brother Pty Ltd; Australian Postgraduate Award, the Margaret Middleton Fund; Goodman Foundation; Brother, Australia	Funding was provided by an ARC Linkage Grant (LP110200216; http://www.arc.gov.au/), a Goldring Marine Emerging Scientist Fellowship (CSIRO Top up fellowship; www.csiro.au), Earthwatch Institute Australia (http://www.earthwatch.org/australia/), Brother Pty Ltd (www.brother.com.au/), an Australian Postgraduate Award, the Margaret Middleton Fund (http://www.science.org.au/awards/awards/conservation.html), and the Goodman Foundation. The funders contributed only financially to the research reported here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partially sponsored by the commercial company Brother, Australia. The authors have no agreements regarding employment, consultancy, patents, products in development or marketed products. This sponsorship does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2011, TRACKING TRASH 25 YE; [Anonymous], 2011, UNDERSTANDING TYPES; Arthur KE, 2007, MAR TECHNOL SOC J, V41, P9, DOI 10.4031/002533207787441953; Balazs G., 1985, P WORKSH FAT IMP MAR, P387; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Bartol SM, 2003, CRC MAR BIOL SER, P79; BJORNDAL KA, 1994, MAR POLLUT BULL, V28, P154, DOI 10.1016/0025-326X(94)90391-3; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bjorndal Karen A., 1997, P199; Bolten AB, 2003, CRC MAR BIOL SER, P243; Boyle MC, 2008, MAR BIOL, V155, P233, DOI 10.1007/s00227-008-1022-z; Boyle MC, 2006, THESIS J COOK U TOWN; Boyle MC, 2006, MARINE POLLUTION B; Bugoni L, 2001, MAR POLLUT BULL, V42, P1330, DOI 10.1016/S0025-326X(01)00147-3; Burchette D, 1989, STUDY EFFECT BALLOON; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calix M., 2018, EUROPEAN RED LIST SA; Cannon A.C., 1998, NOAA, V143, P81; CARR A, 1987, MAR POLLUT BULL, V18, P352, DOI 10.1016/S0025-326X(87)80025-5; Cheshire A.C., 2009, UNEP REGIONAL SEAS R, V186; Constantino MA, 2003, ZOOLOGY, V106, P173, DOI 10.1078/0944-2006-00114; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; DIXON TR, 1981, MAR POLLUT BULL, V12, P289, DOI 10.1016/0025-326X(81)90078-3; Duguy R., 2000, Annales de la Societe des Sciences Naturelles de la Charente-Maritime, V8, P1035; Duguy R., 1997, Annales de la Societe des Sciences Naturelles de la Charente-Maritime, V8, P633; FEHRING WK, 1972, ANIM BEHAV, V20, P632, DOI 10.1016/S0003-3472(72)80135-0; Frick Michael G., 2010, Endangered Species Research, V9, P91, DOI 10.3354/esr00227; Granda A.M., 1979, P247; HEISEY DM, 1985, ECOLOGY, V66, P1744, DOI 10.2307/2937370; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Kershaw P., 2011, PLASTIC DEBRIS OCEAN; Laist D.W., 1997, SPRINGER SERIES ENV; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lazar B, 2011, MAR POLLUT BULL, V62, P43, DOI 10.1016/j.marpolbul.2010.09.013; Leon YM, 2002, MARINE ECOLOGY PROGR, V245; Limpus C., 2009, BIOL REV AUSTR MARIN; LIMPUS CJ, 1992, WILDLIFE RES, V19, P489, DOI 10.1071/WR9920489; McCauley SJ, 1999, CONSERV BIOL, V13, P925, DOI 10.1046/j.1523-1739.1999.98264.x; Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268; Mrosovsky N, 2009, MAR POLLUT BULL, V58, P287, DOI 10.1016/j.marpolbul.2008.10.018; Mrosovsky N, 1981, MARINE TURTLE NEWSLE, V17; Parker DM, 2005, FISH B-NOAA, V103, P142; PLOTKIN PT, 1993, MAR BIOL, V115, P1, DOI 10.1007/BF00349379; Plotkin PT, 1990, P 2 INT C MAR DEBR, P736; Pritchard PCH, 1973, IUCN MONOGRAPH, V2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; RYAN PG, 1993, NATURE, V361, P23, DOI 10.1038/361023a0; SHAVER DJ, 1991, J HERPETOL, V25, P327, DOI 10.2307/1564592; SHEAVLY S, 2007, NATL MARINE DEBRIS M, DOI DOI 10.1098/RSTB.2008.0207; Stamper MA, 2009, J ZOO WILDLIFE MED, V40, P196, DOI 10.1638/2007-0101.1; Swimmer Y, 2005, MAR ECOL PROG SER, V295, P273, DOI 10.3354/meps295273; Swimmer Y, 2006, SEA TURTLE PELAGIC F; Tomas J, 2002, MAR POLLUT BULL, V44, P211, DOI 10.1016/S0025-326X(01)00236-3; Tourinho PS, 2010, MAR POLLUT BULL, V60, P396, DOI 10.1016/j.marpolbul.2009.10.013; Venables WN., 2002, MODERN APPL STAT S 4; Vorobyev M, 2001, COLOR RES APPL, V26, pS214, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL45>3.0.CO;2-A; Wallace N, 1985, P WORKSH FAT IMP MAR; Windell J. T., 1978, METHODS ASSESSMENT F, P219; Witherington BE, 2002, MAR BIOL, V140, P843, DOI 10.1007/s00227-001-0737-x; Wyneken J., 2001, ANATOMY SEA TURTLES	61	105	112	5	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40884	10.1371/journal.pone.0040884	http://dx.doi.org/10.1371/journal.pone.0040884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829894	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300032
J	Apte-Deshpande, A; Paingankar, M; Gokhale, MD; Deobagkar, DN				Apte-Deshpande, Anjali; Paingankar, Mandar; Gokhale, Mangesh D.; Deobagkar, Dileep N.			Serratia odorifera a Midgut Inhabitant of Aedes aegypti Mosquito Enhances Its Susceptibility to Dengue-2 Virus	PLOS ONE			English	Article							ANOPHELES-STEPHENSI; SPOROGONIC DEVELOPMENT; PROTEOMICS ANALYSIS; BRUGIA-MALAYI; PROHIBITIN; BACTERIA; INFECTION; CELLS; CULICIDAE; PROTEINS	Mosquito midgut plays a crucial role in its vector susceptibility and pathogen interaction. Identification of the sustainable microflora of the midgut environment can therefore help in evaluating its contribution in mosquito-pathogen interaction and in turn vector competence. To understand the bacterial diversity in the midgut of Aedes aegypti mosquitoes, we conducted a screening study of the gut microbes of these mosquitoes which were either collected from fields or reared in the laboratory "culture-dependent'' approach. This work demonstrated that the microbial flora of larvae and adult Ae. aegypti midgut is complex and is dominated by Gram negative proteobacteria. Serratia odorifera was found to be stably associated in the midguts of field collected and laboratory reared larvae and adult females. The potential influence of this sustainable gut microbe on DENV-2 susceptibility of this vector was evaluated by co-feeding S. odorifera with DENV-2 to adult Ae. aegypti females (free of gut flora). The observations revealed that the viral susceptibility of these Aedes females enhanced significantly as compared to solely dengue-2 fed and another gut inhabitant, Microbacterium oxydans co-fed females. Based on the results of this study we proposed that the enhancement in the DENV-2 susceptibility of Ae. aegypti females was due to blocking of prohibitin molecule present on the midgut surface of these females by the polypeptide of gut inhabitant S. odorifera.	[Apte-Deshpande, Anjali; Paingankar, Mandar; Deobagkar, Dileep N.] Univ Pune, Ctr Adv Studies, Dept Zool, Mol Biol Res Lab, Pune, Maharashtra, India; [Gokhale, Mangesh D.] Natl Inst Virol, Dept Med Entomol & Zool, Pune, Maharashtra, India; [Deobagkar, Dileep N.] Goa Univ, Taleigaon Plateau, Goa, India	Savitribai Phule Pune University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Goa University	Apte-Deshpande, A (corresponding author), Univ Pune, Ctr Adv Studies, Dept Zool, Mol Biol Res Lab, Pune, Maharashtra, India.	dileep_deobagkar@hotmail.com	Paingankar, Mandar/H-9254-2019	Paingankar, Mandar/0000-0002-9359-1879	UGC-CAS; ICMR	UGC-CAS(University Grants Commission, IndiaChinese Academy of Sciences); ICMR(Indian Council of Medical Research (ICMR))	This research was supported by UGC-CAS and ICMR grants to Dileep Deobagkar. Mandar Paingankar is a CSIR Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnoult D, 2009, SEMIN IMMUNOL, V21, P223, DOI 10.1016/j.smim.2009.05.009; Artal-Sanz M, 2010, AGING-US, V2, P1004, DOI 10.18632/aging.100246; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Degallier N, 2010, CLIMATIC CHANGE, V98, P581, DOI 10.1007/s10584-009-9747-3; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gusamo DS, 2007, MEM I O CRUZ, V102, P919; ILKAL MA, 1984, INDIAN J MED RES, V79, P587; JADIN J, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P514; Joyce JD, 2011, J MED ENTOMOL, V48, P389, DOI 10.1603/ME09268; KAY BH, 1989, MED VET ENTOMOL, V3, P415, DOI 10.1111/j.1365-2915.1989.tb00249.x; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; MACDONALD WW, 1965, ANN TROP MED PARASIT, V59, P64, DOI 10.1080/00034983.1965.11686284; MACDONALD WW, 1962, ANN TROP MED PARASIT, V56, P368, DOI 10.1080/00034983.1962.11686134; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; MCGREEVY PB, 1974, ANN TROP MED PARASIT, V68, P97, DOI 10.1080/00034983.1974.11686929; Mishra S, 2007, MOL IMMUNOL, V44, P1897, DOI 10.1016/j.molimm.2006.09.025; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Mourya D. T., 2002, Dengue Bulletin, V26, P190; Mourya DT, 1998, INDIAN J MED RES, V107, P10; Mourya DT, 2000, INDIAN J MED RES, V111, P157; Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859; Paingankar MS, 2010, ARCH VIROL, V155, P1453, DOI 10.1007/s00705-010-0728-7; Patil NS, 1996, MED VET ENTOMOL, V10, P277, DOI 10.1111/j.1365-2915.1996.tb00743.x; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; SEITZ HM, 1987, ZBL BAKT-INT J MED M, V266, P155; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Toure AM, 2000, J MED ENTOMOL, V37, P246, DOI 10.1603/0022-2585-37.2.246; Tsutsumi T, 2009, HEPATOLOGY, V50, P378, DOI 10.1002/hep.22998; Wang JH, 2009, PROTEOMICS, V9, P1672, DOI 10.1002/pmic.200800621; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	48	122	126	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40401	10.1371/journal.pone.0040401	http://dx.doi.org/10.1371/journal.pone.0040401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848375	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200017
J	McBrayer, SK; Yarrington, M; Qian, J; Feng, G; Shanmugam, M; Gandhi, V; Krett, NL; Rosen, ST				McBrayer, Samuel K.; Yarrington, Michael; Qian, Jun; Feng, Gang; Shanmugam, Mala; Gandhi, Varsha; Krett, Nancy L.; Rosen, Steven T.			Integrative Gene Expression Profiling Reveals G6PD-Mediated Resistance to RNA-Directed Nucleoside Analogues in B-Cell Neoplasms	PLOS ONE			English	Article							MULTIPLE-MYELOMA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE G6PD; LEUKEMIA-CELLS; IN-VITRO; 8-CHLORO-ADENOSINE; DEPLETION; ILLUMINA; 8-AMINO-ADENOSINE; 8-CHLOROADENOSINE; CLASSIFICATION	The nucleoside analogues 8-amino-adenosine and 8-chloro-adenosine have been investigated in the context of B-lineage lymphoid malignancies by our laboratories due to the selective cytotoxicity they exhibit toward multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and mantle cell lymphoma (MCL) cell lines and primary cells. Encouraging pharmacokinetic and pharmacodynamic properties of 8-chloro-adenosine being documented in an ongoing Phase I trial in CLL provide additional impetus for the study of these promising drugs. In order to foster a deeper understanding of the commonalities between their mechanisms of action and gain insight into specific patient cohorts positioned to achieve maximal benefit from treatment, we devised a novel two-tiered chemoinformatic screen to identify molecular determinants of responsiveness to these compounds. This screen entailed: 1) the elucidation of gene expression patterns highly associated with the anti-tumor activity of 8-chloro-adenosine in the NCI-60 cell line panel, 2) characterization of altered transcript abundances between paired MM and MCL cell lines exhibiting differential susceptibility to 8-amino-adenosine, and 3) integration of the resulting datasets. This approach generated a signature of seven unique genes including G6PD which encodes the rate-determining enzyme of the pentose phosphate pathway (PPP), glucose-6-phosphate dehydrogenase. Bioinformatic analysis of primary cell gene expression data demonstrated that G6PD is frequently overexpressed in MM and CLL, highlighting the potential clinical implications of this finding. Utilizing the paired sensitive and resistant MM and MCL cell lines as a model system, we go on to demonstrate through loss-of-function and gain-offunction studies that elevated G6PD expression is necessary to maintain resistance to 8-amino- and 8-chloro-adenosine but insufficient to induce de novo resistance in sensitive cells. Taken together, these results indicate that G6PD activity antagonizes the cytotoxicity of 8-substituted adenosine analogues and suggests that administration of these agents to patients with B-cell malignancies exhibiting normal levels of G6PD expression may be particularly efficacious.	[McBrayer, Samuel K.; Qian, Jun; Shanmugam, Mala; Krett, Nancy L.; Rosen, Steven T.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Rosen, Steven T.] Northwestern Univ, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Feng, Gang] Northwestern Univ, Biomed Informat Ctr, Chicago, IL 60611 USA; [Gandhi, Varsha] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	McBrayer, SK (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	s-mcbrayer@northwestern.edu	Shanmugam, Mala/M-6491-2019	Shanmugam, Mala/0000-0002-4415-8083; Rosen, Steven/0000-0002-8818-7724	National Institutes of Health [RO1CA85919]; National Institutes of Health/National Cancer Institute [T32CA09560]; American Cancer Society (IL Division) [140565, 188679]; Wendy Will Case Cancer Fund Foundation [SP0012544]; National Cancer Institute Lymphoma SPORE [CA136411]; NATIONAL CANCER INSTITUTE [R01CA085915, T32CA009560, P30CA060553, P50CA136411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society (IL Division)(American Cancer Society); Wendy Will Case Cancer Fund Foundation; National Cancer Institute Lymphoma SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health RO1CA85919 (S.T. Rosen), National Institutes of Health/National Cancer Institute grant T32CA09560 (S.K. McBrayer), American Cancer Society (IL Division) grants 140565 and 188679 (M. Shanmugam), Wendy Will Case Cancer Fund Foundation grant SP0012544 (M. Shanmugam) and grants from the National Cancer Institute Lymphoma SPORE CA136411 (V. Gandhi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Balakrishnan K, 2005, CLIN CANCER RES, V11, P6745, DOI 10.1158/1078-0432.CCR-05-0553; Balakrishnan K, 2005, BLOOD, V105, P4455, DOI 10.1182/blood-2004-05-1699; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Blair A, 1997, BLOOD, V89, P3104, DOI 10.1182/blood.V89.9.3104; Cervantes-Gomez F, 2011, J PHARMACOL EXP THER, V339, P545, DOI 10.1124/jpet.111.184903; Chan WC, 1997, BLOOD, V89, P3909; Chen LS, 2010, BIOCHEM PHARMACOL, V79, P669, DOI 10.1016/j.bcp.2009.09.028; Chen LS, 2009, BIOCHEM PHARMACOL, V78, P583, DOI 10.1016/j.bcp.2009.05.019; CHRESTA CM, 1990, CANCER RES, V50, P4067; Dennison JB, 2010, BLOOD, V116, P5622, DOI 10.1182/blood-2010-05-285866; Dennison JB, 2010, J BIOL CHEM, V285, P8022, DOI 10.1074/jbc.M109.085803; Dennison JB, 2009, BRIT J HAEMATOL, V147, P297, DOI 10.1111/j.1365-2141.2009.07850.x; Drose S, 2009, BBA-GEN SUBJECTS, V1790, P558, DOI 10.1016/j.bbagen.2009.01.011; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Gandhi V, 2002, CANCER CHEMOTH PHARM, V50, P85, DOI 10.1007/S00280-002-0456-0; Gandhi V, 2001, CANCER RES, V61, P5474; Ghias K, 2005, MOL CANCER THER, V4, P569, DOI 10.1158/1535-7163.MCT-04-0303; GOLDMANLEIKIN RE, 1989, J LAB CLIN MED, V113, P335; Gribben JG, 2010, BLOOD, V115, P187, DOI 10.1182/blood-2009-08-207126; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Hadzic T, 2010, FREE RADICAL BIO MED, V48, P1024, DOI 10.1016/j.freeradbiomed.2010.01.018; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Jadayel DM, 1997, LEUKEMIA, V11, P64, DOI 10.1038/sj.leu.2400555; Jiang J, 2011, ONCOGENE; Krett NL, 2004, MOL CANCER THER, V3, P1411; Kuo WY, 2000, INT J CANCER, V85, P857, DOI 10.1002/(SICI)1097-0215(20000315)85:6<857::AID-IJC20>3.3.CO;2-L; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Leonard JP, 2001, CURR OPIN ONCOL, V13, P342, DOI 10.1097/00001622-200109000-00005; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Martini G, 1996, BIOESSAYS, V18, P631, DOI 10.1002/bies.950180806; Moreaux J, 2011, HAEMATOL-HEMATOL J, V96, P574, DOI 10.3324/haematol.2010.033456; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Murphy L, 2008, BBA-PROTEINS PROTEOM, V1784, P1184, DOI 10.1016/j.bbapap.2008.04.014; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Rodrigues MS, 2008, ANTIOXID REDOX SIGN, V10, P1813, DOI 10.1089/ars.2008.2071; Shanmugam M, 2009, J BIOL CHEM, V284, P26816, DOI 10.1074/jbc.M109.000646; STANTON RC, 1991, J BIOL CHEM, V266, P12442; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stellrecht CM, 2007, CANCER RES, V67, P9913, DOI 10.1158/0008-5472.CAN-07-0770; Stellrecht CM, 2003, CANCER RES, V63, P7968; STINSON SF, 1992, ANTICANCER RES, V12, P1035; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; TIAN WN, 1994, J BIOL CHEM, V269, P14798; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yamamoto-Sugitani M, 2011, P NATL ACAD SCI USA, V108, P17468, DOI 10.1073/pnas.1111138108; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; YUAN ZM, 1991, DRUG METAB DISPOS, V19, P625; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077	57	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41455	10.1371/journal.pone.0041455	http://dx.doi.org/10.1371/journal.pone.0041455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848499	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200065
J	Nie, W; Chen, JQ; Xiu, QY				Nie, Wei; Chen, Jiquan; Xiu, Qingyu			Cytotoxic T-Lymphocyte Associated Antigen 4 Polymorphisms and Asthma Risk: A Meta-Analysis	PLOS ONE			English	Article							INHIBITS AIRWAY EOSINOPHILIA; GENOME-WIDE ASSOCIATION; SERUM IGE LEVELS; GENE POLYMORPHISMS; ALLERGIC-ASTHMA; SOLUBLE CTLA-4; ATOPIC ASTHMA; MURINE MODEL; BRONCHIAL-ASTHMA; PUBLICATION BIAS	Background: A number of studies assessed the association of cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) gene polymorphisms with asthma in different populations. However, the results were contradictory. We performed a meta-analysis to examine the association between CTLA-4 polymorphisms and asthma susceptibility. Methods: Pubmed, EMBASE, HuGE Navigator, and Wanfang Database were searched. Data were extracted independently by two reviewers. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. Results: Seventeen studies involving 6378 cases and 8674 controls were included. Significant association between +49 A/G polymorphism and asthma was observed for AA vs. AG+GG (OR = 1.18, 95% CI 1.01-1.37, P = 0.04). There were no significant associations between -318 C/T, -1147 C/T, CT60 A/G, -1722 C/T, or rs926169 polymorphisms and asthma risk. Conclusions: This meta-analysis suggested that the +49 A/G polymorphism in CTLA-4 was a risk factor for asthma.	[Nie, Wei; Chen, Jiquan; Xiu, Qingyu] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China	Naval Medical University	Xiu, QY (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China.	xiu_qingyu@126.com			National Natural Science Foundation of China [81170025]; National Ministry of Science and Technology [2011ZX09302-003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Science and Technology	This study was supported by grants NO. 81170025 from National Natural Science Foundation of China and projects of "Major New Drugs Innovation and Development" from the National Ministry of Science and Technology (NO. 2011ZX09302-003-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 1998, J IMMUNOL, V161, P3347; Anantharaman R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-170; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berce V, 2010, BIOMARKERS, V15, P158, DOI 10.3109/13547500903384318; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Chan IHS, 2008, ALLERGY, V63, P1031, DOI 10.1111/j.1398-9995.2008.01639.x; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Daley D, 2009, HUM GENET, V125, P445, DOI 10.1007/s00439-009-0643-8; Deurloo DT, 2001, AM J RESP CELL MOL, V25, P751, DOI 10.1165/ajrcmb.25.6.4607; DeWan AT, 2010, J ALLERGY CLIN IMMUN, V126, P871, DOI 10.1016/j.jaci.2010.06.051; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Heinzmann A, 2000, EUR J IMMUNOGENET, V27, P57, DOI 10.1046/j.1365-2370.2000.00198.x; Hizawa N, 2001, J ALLERGY CLIN IMMUN, V108, P74, DOI 10.1067/mai.2001.116119; Howard TD, 2002, J ALLERGY CLIN IMMUN, V110, P743, DOI 10.1067/mai.2002.128723; Ip WK, 2006, PEDIATR PULM, V41, P674, DOI 10.1002/ppul.20432; Jasek M, 2006, INT ARCH ALLERGY IMM, V141, P223, DOI 10.1159/000095292; Jones G, 2006, BRIT J DERMATOL, V154, P467, DOI 10.1111/j.1365-2133.2005.07080.x; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; Lee SY, 2002, CHEST, V122, P171, DOI 10.1378/chest.122.1.171; Li YF, 2008, RESP MED, V102, P984, DOI 10.1016/j.rmed.2008.02.008; Ligers A, 2001, GENES IMMUN, V2, P145, DOI 10.1038/sj.gene.6363752; Lin KW, 2010, J IMMUNOL, V184, P6343, DOI 10.4049/jimmunol.0901947; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Miyake Y, 2011, HEPATOL RES, V41, P151, DOI 10.1111/j.1872-034X.2010.00757.x; Munoz-Valle JF, 2010, CLIN CHIM ACTA, V411, P725, DOI 10.1016/j.cca.2010.02.001; Munthe-Kaas MC, 2004, J ALLERGY CLIN IMMUN, V114, P280, DOI 10.1016/j.jaci.2004.03.050; Nakao F, 2000, EXP CLIN IMMUNOGENET, V17, P179, DOI 10.1159/000019137; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Oh KY, 2010, ALLERGY ASTHMA IMMUN, V2, P127, DOI 10.4168/aair.2010.2.2.127; Oosterwegel MA, 1999, J IMMUNOL, V163, P2634; Padrid PA, 1998, AM J RESP CELL MOL, V18, P453, DOI 10.1165/ajrcmb.18.4.3055; Park KS, 2009, TISSUE ANTIGENS, V74, P222, DOI 10.1111/j.1399-0039.2009.01303.x; Qian L, 2006, J CLIN PEDIAT, V25, P660; Qin XJ, 2005, ALLERGY, V60, P774, DOI 10.1111/j.1398-9995.2005.00784.x; Schubert K, 2006, DIS MARKERS, V22, P127, DOI 10.1155/2006/373620; Shi HZ, 2005, J ASTHMA, V42, P133, DOI 10.1081/JAS-51331; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Sohn MH, 2007, PEDIATR PULM, V42, P542, DOI 10.1002/ppul.20622; Sun T, 2008, CANCER RES, V68, P7025, DOI 10.1158/0008-5472.CAN-08-0806; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Undarmaa S, 2010, J HUM GENET, V55, P342, DOI 10.1038/jhg.2010.32; VanOosterhout AJM, 1997, AM J RESP CELL MOL, V17, P386, DOI 10.1165/ajrcmb.17.3.2679; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Wilson DH, 2006, MED J AUSTRALIA, V184, P226, DOI 10.5694/j.1326-5377.2006.tb00207.x; Wong CK, 2005, CLIN EXP IMMUNOL, V141, P122, DOI 10.1111/j.1365-2249.2005.02815.x; Yang KD, 2004, CLIN EXP ALLERGY, V34, P32, DOI 10.1111/j.1365-2222.2004.01776.x	52	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42062	10.1371/journal.pone.0042062	http://dx.doi.org/10.1371/journal.pone.0042062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844542	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600067
J	Xiao, L; Li, ZY; Xu, PJ; Li, ZG; Xu, J; Yang, Z				Xiao, Lu; Li, Zhanyong; Xu, Pengjuan; Li, Zhigui; Xu, Jing; Yang, Zhuo			The Expression of EPOR in Renal Cortex during Postnatal Development	PLOS ONE			English	Article							ERYTHROPOIETIN ENHANCES RECOVERY; RECEPTOR; CELLS; PROTECTS; MOUSE; RAT; FAILURE; KIDNEY; INJURY; BRAIN	Erythropoietin (EPO), known for its role in erythroid differentiation, has been shown to be an important growth factor for brain and heart. EPO is synthesized by fibroblast-like cells in the renal cortex. Prompted by this anatomical relationship and its significant impact on the maturation process of brain and heart, we asked whether EPO could play a role during the development of renal cortex. The relationship between the development of renal cortex and the change of EPO receptor (EPOR), through which EPO could act as a renotropic cytokine, became interesting to us. In this study, the day of birth was recorded as postnatal day 0(P0). P7, P14, P21, P28, P35, P42 and mature mice (postnatal days. 56) were used as the animal model of different developmental stages. Immunohistochemistry and Western blotting were used to detect the expression of EPOR in mouse renal cortex. Results showed that expression of EPOR decreased with the development of renal cortex and became stable when kidney became mature. The expression of EPOR was detected at the renal tubule of all developmental stages and a relatively higher expression was observed at P14. However, at the renal corpuscle the expression was only observed at P7 and quickly became undetectable after that. All these suggested that a translocation of EPOR from renal corpuscle to renal tubule may take place during the developmental process of renal cortex. Also, EPO may be an essential element for the maturation of renal cortex, and the requirement for EPO was changed during postnatal development process.	[Xiao, Lu; Xu, Pengjuan; Li, Zhigui; Xu, Jing; Yang, Zhuo] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Li, Zhanyong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Yang, Z (corresponding author), Nankai Univ, Coll Med, Tianjin 300071, Peoples R China.	zhuoyang@nankai.edu.cn	Li, Zhigui/I-9108-2019; xu, jing/GRR-8698-2022; Jingjun, Xu/A-1282-2010	Li, Zhigui/0000-0003-1317-8679; 	National Basic Research Program of China [2011CB944003]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by a grant from the National Basic Research Program of China (2011CB944003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammarguellat F, 1996, NEPHROL DIAL TRANSPL, V11, P687, DOI 10.1093/oxfordjournals.ndt.a027361; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; BACALLAO R, 1989, AM J PHYSIOL, V257, pF913, DOI 10.1152/ajprenal.1989.257.6.F913; Bagnis C, 2001, NEPHROL DIAL TRANSPL, V16, P932, DOI 10.1093/ndt/16.5.932; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; EKBLOM P, 1981, J CELL BIOL, V91, P1, DOI 10.1083/jcb.91.1.1; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Juul SE, 1999, PEDIATR DEVEL PATHOL, V2, P148, DOI 10.1007/s100249900103; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; KOURY ST, 1991, BLOOD, V77, P2497; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Liu C, 1997, J BIOL CHEM, V272, P32395, DOI 10.1074/jbc.272.51.32395; MASUDA S, 1994, J BIOL CHEM, V269, P19488; NARBAITZ R, 1991, ANAT EMBRYOL, V183, P353; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Sasaki R, 2001, NEWS PHYSIOL SCI, V16, P110; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; Starck J, 1999, EXP HEMATOL, V27, P630, DOI 10.1016/S0301-472X(99)00006-5; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; VAZIRI ND, 1994, AM J PHYSIOL, V266, pF360, DOI 10.1152/ajprenal.1994.266.3.F360; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Westenfelder C, 1999, KIDNEY INT, V55, P808, DOI 10.1046/j.1523-1755.1999.055003808.x; Westenfelder C, 2002, EXP NEPHROL, V10, P294, DOI 10.1159/000065304; Wu H, 1999, DEVELOPMENT, V126, P3597; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223; Yu XB, 2002, DEVELOPMENT, V129, P505; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41993	10.1371/journal.pone.0041993	http://dx.doi.org/10.1371/journal.pone.0041993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844537	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600060
J	Chang, MY; Huang, DY; Ho, FM; Huang, KC; Lin, WW				Chang, Mei-Ying; Huang, Duen-Yi; Ho, Feng-Ming; Huang, Kuo-Chin; Lin, Wan-Wan			PKC-Dependent Human Monocyte Adhesion Requires AMPK and Syk Activation	PLOS ONE			English	Article							PROTEIN-KINASE-C; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; TYROSINE KINASES; PHOSPHORYLATION; EXPRESSION; PATHWAY; INHIBITION	PKC plays a pivotal role in mediating monocyte adhesion; however, the underlying mechanisms of PKC-mediated cell adhesion are still unclear. In this study, we elucidated the signaling network of phorbol ester PMA-stimulated human monocyte adhesion. Our results with pharmacological inhibitors suggested the involvement of AMPK, Syk, Src and ERK in PKC-dependent adhesion of THP-1 monocytes to culture plates. Biochemical analysis further confirmed the ability of PMA to activate these kinases, as well as the involvement of AMPK-Syk-Src signaling in this event. Direct protein interaction between AMPK and Syk, which requires the kinase domain of AMPK and linker region of Syk, was observed following PMA stimulation. Notably, we identified Syk as a novel downstream target of AMPK; AICAR can induce Syk phosphorylation at Ser178 and activation of this kinase. However, activation of AMPK alone, either by stimulation with AICAR or by overexpression, is not sufficient to induce monocyte adhesion. Studies further demonstrated that PKC-mediated ERK signaling independent of AMPK activation is also involved in cell adhesion. Moreover, AMPK, Syk, Src and ERK signaling were also required for PMA to induce THP-1 cell adhesion to endothelial cells as well as to induce adhesion response of human primary monocytes. Taken together, we propose a bifurcated kinase signaling pathway involved in PMA-mediated adhesion of monocytes. PKC can activate LKB1/AMPK, leading to phosphorylation and activation of Syk, and subsequent activation of Src and FAK. In addition, PKC-dependent ERK activation induces a coordinated signal for cytoskeleton rearrangement and cell adhesion. For the first time we demonstrate Syk as a novel substrate target of AMPK, and shed new light on the role of AMPK in monocyte adhesion, in addition to its well identified functions in energy homeostasis.	[Chang, Mei-Ying; Huang, Duen-Yi; Lin, Wan-Wan] Natl Taiwan Univ, Dept Pharmacol, Coll Med, Taipei 10764, Taiwan; [Ho, Feng-Ming] Tao Yuan Gen Hosp, Dept Internal Med, Dept Hlth Execut Yuan, Tao Yuan, Taiwan; [Ho, Feng-Ming] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Huang, Kuo-Chin] Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Wan-Wan] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	National Taiwan University; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Chang, MY (corresponding author), Natl Taiwan Univ, Dept Pharmacol, Coll Med, Taipei 10764, Taiwan.	wwllaura1119@ntu.edu.tw		Lin, Wan Wan/0000-0002-3207-734X; HUANG, KUO-CHIN/0000-0002-6029-5520	National Science Council [NSC 100-2314-B-002-075]; National Health Research Institute, Taiwan [NHRI-EX100-10052SI];  [PTH9801]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); 	This work was supported by the National Science Council (NSC 100-2314-B-002-075), the National Health Research Institute, Taiwan (NHRI-EX100-10052SI) and PTH9801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2007, IMMUNOL REV, V218, P29, DOI 10.1111/j.1600-065X.2007.00531.x; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Borowski P, 1998, BIOCHEM J, V331, P649, DOI 10.1042/bj3310649; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chang MY, 2010, BIOCHEM PHARMACOL, V80, P1210, DOI 10.1016/j.bcp.2010.06.049; Ewart MA, 2008, ARTERIOSCL THROM VAS, V28, P2255, DOI 10.1161/ATVBAHA.108.175919; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Hai CM, 2006, EUR J CELL BIOL, V85, P305, DOI 10.1016/j.ejcb.2005.08.008; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Kurihara Y, 2011, CELL IMMUNOL, V270, P25, DOI 10.1016/j.cellimm.2011.03.017; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Pullikuth AK, 2010, MOL CELL BIOL, V30, P3233, DOI 10.1128/MCB.01178-09; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsai JS, 2010, J CELL BIOCHEM, V110, P1410, DOI 10.1002/jcb.22657; Wang YH, 2009, EUR J CELL BIOL, V88, P701, DOI 10.1016/j.ejcb.2009.06.001; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yang RS, 2005, TOXICON, V46, P387, DOI 10.1016/j.toxicon.2005.05.002; Zarbock A, 2011, ARCH BIOCHEM BIOPHYS, V510, P112, DOI 10.1016/j.abb.2011.02.009; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	45	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40999	10.1371/journal.pone.0040999	http://dx.doi.org/10.1371/journal.pone.0040999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848421	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600033
J	Diao, YP; Lu, AR; Yang, B; Hu, WL; Peng, Q; Ling, QZ; Beerntsen, BT; Soderhall, K; Ling, EJ				Diao, Yupu; Lu, Anrui; Yang, Bing; Hu, Wenli; Peng, Qing; Ling, Qing-Zhi; Beerntsen, Brenda T.; Soderhall, Kenneth; Ling, Erjun			Existence of Prophenoloxidase in Wing Discs: A Source of Plasma Prophenoloxidase in the Silkworm, Bombyx mori	PLOS ONE			English	Article							HEMATOPOIETIC ORGANS; CIRCULATING HEMOCYTES; IDENTIFICATION; PHENOLOXIDASE; IMMUNITY; CLONING; OXIDASE	In insects, hemocytes are considered as the only source of plasma prophenoloxidase (PPO). PPO also exists in the hemocytes of the hematopoietic organ that is connected to the wing disc of Bombyx mori. It is unknown whether there are other cells or tissues that can produce PPO and release it into the hemolymph besides circulating hemocytes. In this study, we use the silkworm as a model to explore this possibility. Through tissue staining and biochemical assays, we found that wing discs contain PPO that can be released into the culture medium in vitro. An in situ assay showed that some cells in the cavity of wing discs have PPO1 and PPO2 mRNA. We conclude that the hematopoietic organ may wrongly release hemocytes into wing discs since they are connected through many tubes as repost in previous paper. In wing discs, the infiltrating hemocytes produce and release PPO probably through cell lysis and the PPO is later transported into hemolymph. Therefore, this might be another source of plasma PPO in the silkworm: some infiltrated hemocytes sourced from the hematopoietic organ release PPO via wing discs.	[Diao, Yupu; Lu, Anrui; Yang, Bing; Hu, Wenli; Peng, Qing; Ling, Erjun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China; [Ling, Qing-Zhi] Zhejiang Pharmaceut Coll, Dept Appl Biol, Ningbo, Zhejiang, Peoples R China; [Beerntsen, Brenda T.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA; [Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, Uppsala, Sweden	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Missouri System; University of Missouri Columbia; Uppsala University	Diao, YP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China.	erjunling@sippe.ac.cn		Ling, Qingzhi Ling/0000-0002-4451-1537	National Basic Research Program of China [2012CB114605]; National Natural Science Foundation of China [30970408, 31172151]; Ministry of Agriculture of China [2011ZX08009-003, 2012ZX08011001-004]; Chinese Academy of Sciences [KSCX2-EW-J-12]; Swedish Science Research Council [319-2010-6250]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Chinese Academy of Sciences(Chinese Academy of Sciences); Swedish Science Research Council	This work was supported by the National Basic Research Program of China (2012CB114605), National Natural Science Foundation of China (30970408, 31172151), Ministry of Agriculture of China (2011ZX08009-003, 2012ZX08011001-004), Chinese Academy of Sciences (KSCX2-EW-J-12) and the Swedish Science Research Council (319-2010-6250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI H, 1971, J INSECT PHYSIOL, V17, P1665, DOI 10.1016/0022-1910(71)90062-X; Asano T, 2009, INSECT MOL BIOL, V18, P223, DOI 10.1111/j.1365-2583.2008.00858.x; Ashida Masaaki, 1998, P135; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Dittmer NT, 2012, J PROTEOME RES, V11, P269, DOI 10.1021/pr2009803; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Fouda MMA, 2010, J INSECT PHYSIOL, V56, P1728, DOI 10.1016/j.jinsphys.2010.07.003; Han SS, 1998, ZOOL SCI, V15, P371, DOI 10.2108/zsj.15.371; Hillyer JF, 2004, MICROBES INFECT, V6, P448, DOI 10.1016/j.micinf.2004.01.005; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kawasaki H, 2004, GENE, V343, P133, DOI 10.1016/j.gene.2004.08.013; Kawasaki H., 1989, Journal of Tissue Culture Methods, V12, P31, DOI 10.1007/BF01578005; Kiguchi K, 1985, REP SERICULT EXP STN, V30, P83; Ling E, 2006, DEV COMP IMMUNOL, V30, P531, DOI 10.1016/j.dci.2005.08.003; Ling E, 2005, TISSUE CELL, V37, P101, DOI 10.1016/j.tice.2004.10.007; Ling Erjun, 2003, Journal of Insect Biotechnology and Sericology, V72, P101; Ling Erjun, 2003, Journal of Insect Biotechnology and Sericology, V72, P95; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Liu F, 2012, DEV COMP IMMUNOL, V36, P619, DOI 10.1016/j.dci.2011.12.001; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Ryazanova AD, 2011, J ENZYM INHIB MED CH, P1; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tan Anjiang, 2003, Journal of Insect Biotechnology and Sericology, V72, P41; Trovaslet M, 2007, ENZYME MICROB TECH, V41, P368, DOI 10.1016/j.enzmictec.2007.03.007; Tsao IY, 2009, INSECT BIOCHEM MOLEC, V39, P96, DOI 10.1016/j.ibmb.2008.10.007; Wang CL, 2010, INSECT SCI, V17, P7, DOI 10.1111/j.1744-7917.2009.01288.x; Wang ZX, 2011, EXP PARASITOL, V127, P135, DOI 10.1016/j.exppara.2010.07.005	31	12	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41416	10.1371/journal.pone.0041416	http://dx.doi.org/10.1371/journal.pone.0041416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848488	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600064
J	Koshkin, V; Krylov, SN				Koshkin, Vasilij; Krylov, Sergey N.			Correlation between Multi-Drug Resistance-Associated Membrane Transport in Clonal Cancer Cells and the Cell Cycle Phase	PLOS ONE			English	Article							P-GLYCOPROTEIN; DRUG-RESISTANCE; NEOADJUVANT CHEMOTHERAPY; TOPOISOMERASE-II; KINETIC-ANALYSIS; BREAST-CANCER; FLOW-CYTOMETRY; SOLID TUMORS; SINGLE-STEP; PROTEIN	Multidrug resistance driven by ABC membrane transporters is one of the major reasons for treatment failure in human malignancy. Some limited evidence has previously been reported on the cell cycle dependence of ABC transporter expression. However, it has never been demonstrated that the functional activity of these transporters correlates with the cell cycle position. Here, we studied the rate of intrinsic ABC transport in different phases of the cell cycle in cultured MCF-7 breast cancer cells. The rate was characterized in terms of the efflux kinetics from cells loaded with an ABC transporter substrate. As averaging the kinetics over a cell population could lead to errors, we studied kinetics of ABC transport at the single-cell level. We found that the rate of ABC transport in MCF-7 cells could be described by Michaelis-Menten kinetics with two classical parameters, V-max and K-M. Each of these parameters showed similar unimodal distributions with different positions of maxima for cell subpopulations in the 2c and 4c states. Compared to the 2c cells, the 4c cells exhibited greater V-max values, indicating a higher activity of transport. They also exhibited a greater V-max/K-M ratio, indicating a higher efficiency of transport. Our findings suggest that cell cycle-related modulation of MDR may need to be taken into account when designing chemotherapy regimens which include cytostatic agents.	[Koshkin, Vasilij; Krylov, Sergey N.] York Univ, Ctr Res Biomol Interact, Toronto, ON M3J 2R7, Canada	York University - Canada	Koshkin, V (corresponding author), York Univ, Ctr Res Biomol Interact, Toronto, ON M3J 2R7, Canada.	skrylov@yorku.ca			Natural Sciences and Engineering Research Council Canada [238990-1011]	Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council Canada (http://www.nserc-crsng.gc.ca/), Grant number: 238990-1011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2000, CANCER RES, V60, P5761; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; [Anonymous], ABC TRANSPORTERS MUL; BAILLY JD, 1995, LEUKEMIA, V9, P799; BAUER TW, 1990, AM J CLIN PATHOL, V93, P322, DOI 10.1093/ajcp/93.3.322; Bidwell GL, 2006, BIOCHEM PHARMACOL, V71, P248, DOI 10.1016/j.bcp.2005.10.041; Boumendjel A, 2009, ABC TRANSPORTERS MUL, P459; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; Calcagno AM, 2010, METHODS MOL BIOL, V596, P77, DOI 10.1007/978-1-60761-416-6_5; CLAUD RD, 1989, MODERN PATHOL, V2, P463; Cnubben Nicole H P, 2005, Expert Opin Drug Metab Toxicol, V1, P219, DOI 10.1517/17425255.1.2.219; DUGGLEBY RG, 1995, METHOD ENZYMOL, V249, P61; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; Essodaigui M, 1998, BIOCHEMISTRY-US, V37, P2243, DOI 10.1021/bi9718043; Faggad A, 2009, HISTOPATHOLOGY, V54, P657, DOI 10.1111/j.1365-2559.2009.03297.x; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Judson PL, 1999, CANCER RES, V59, P2425; Kars MD, 2006, ANTICANCER RES, V26, P4559; Koslikin V, 2011, ANAL CHEM, V83, P6132, DOI 10.1021/ac201690t; KRISHAN A, 1984, CELL BIOL INT REP, V8, P449, DOI 10.1016/0309-1651(84)90166-8; Krylov SN, 1999, CYTOMETRY, V37, P14, DOI 10.1002/(SICI)1097-0320(19990901)37:1<14::AID-CYTO2>3.0.CO;2-J; Langer R, 2010, J SURG ONCOL, V102, P503, DOI 10.1002/jso.21641; Lechner C, 2010, EUR J PHARM BIOPHARM, V75, P284, DOI 10.1016/j.ejpb.2010.03.008; Li JA, 2010, LUNG CANCER, V69, P116, DOI 10.1016/j.lungcan.2009.09.013; Mao QQ, 2010, MOL NUTR FOOD RES, V54, P1574, DOI 10.1002/mnfr.200900392; Marbeuf-Gueye C, 1998, MOL PHARMACOL, V53, P141, DOI 10.1124/mol.53.1.141; MORENOOTERO R, 1987, J SURG ONCOL, V36, P130, DOI 10.1002/jso.2930360212; Ninomiya M, 2005, DRUG METAB DISPOS, V33, P225, DOI 10.1124/dmd.104.002196; PROSPERI E, 1986, CYTOMETRY, V7, P70, DOI 10.1002/cyto.990070110; RAMACHANDRAN C, 1995, BIOCHEM PHARMACOL, V49, P545, DOI 10.1016/0006-2952(94)00443-P; Saengkhae C, 2003, BIOCHEM PHARMACOL, V65, P969, DOI 10.1016/S0006-2952(02)01662-3; Saengkhae C, 2003, BIOPHYS J, V85, P2006, DOI 10.1016/S0006-3495(03)74628-1; SCHNEIDER E, 1994, CANCER RES, V54, P152; Schwab R, 2007, ASSAY DRUG DEV TECHN, V5, P541, DOI 10.1089/adt.2007.067; Sciuto R, 2002, J NUCL MED, V43, P745; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Stein RL, 2000, BIOCHEMISTRY-US, V39, P7973, DOI 10.1021/bi000352i; Sun HY, 2001, BIOCHEM BIOPH RES CO, V284, P863, DOI 10.1006/bbrc.2001.5062; Sunray M, 2002, CYTOMETRY, V47, P8, DOI 10.1002/cyto.10029; Wartenberg M, 2002, BBA-MOL CELL RES, V1589, P49, DOI 10.1016/S0167-4889(01)00185-9; Wong WW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100172; Zhang FY, 2009, PHARM RES-DORDR, V26, P914, DOI 10.1007/s11095-008-9793-y; Zhang WD, 2000, J CELL PHYSIOL, V184, P17, DOI 10.1002/(SICI)1097-4652(200007)184:1<17::AID-JCP2>3.0.CO;2-U; Zuo KQ, 2010, J INT MED RES, V38, P1428, DOI 10.1177/147323001003800424	46	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41368	10.1371/journal.pone.0041368	http://dx.doi.org/10.1371/journal.pone.0041368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848474	gold, Green Published			2022-12-27	WOS:000306806600057
J	Blanc, P; Coste, K; Pouchin, P; Azais, JM; Blanchon, L; Gallot, D; Sapin, V				Blanc, Pierre; Coste, Karen; Pouchin, Pierre; Azais, Jean-Marc; Blanchon, Loic; Gallot, Denis; Sapin, Vincent			A Role for Mesenchyme Dynamics in Mouse Lung Branching Morphogenesis	PLOS ONE			English	Article							FGF10 EXPRESSION; ARCHITECTURE; MECHANISMS; FORCE; MODEL; GROWTH	Mammalian airways are highly ramified tree-like structures that develop by the repetitive branching of the lung epithelium into the surrounding mesenchyme through reciprocal interactions. Based on a morphometric analysis of the epithelial tree, it has been recently proposed that the complete branching scheme is specified early in each lineage by a programme using elementary patterning routines at specific sites and times in the developing lung. However, the coupled dynamics of both the epithelium and mesenchyme have been overlooked in this process. Using a qualitative and quantitative in vivo morphometric analysis of the E11.25 to E13.5 mouse whole right cranial lobe structure, we show that beyond the first generations, the branching stereotypy relaxes and both spatial and temporal variations are common. The branching pattern and branching rate are sensitive to the dynamic changes of the mesoderm shape that is in turn mainly dependent upon the volume and shape of the surrounding intrathoracic organs. Spatial and temporal variations of the tree architecture are related to local and subtle modifications of the mesoderm growth. Remarkably, buds never meet after suffering branching variations and continue to homogenously fill the opening spaces in the mesenchyme. Moreover despite inter-specimen variations, the growth of the epithelial tree and the mesenchyme remains highly correlated over time at the whole lobe level, implying a long-range regulation of the lung lobe morphogenesis. Together, these findings indicate that the lung epithelial tree is likely to adapt in real time to fill the available space in the mesenchyme, rather than being rigidly specified and predefined by a global programme. Our results strongly support the idea that a comprehensive understanding of lung branching mechanisms cannot be inferred from the branching pattern or behavior alone. Rather it needs to be elaborated upon with the reconsideration of mesenchyme-epithelium coupled growth and lung tissues mechanics.	[Blanc, Pierre; Coste, Karen; Blanchon, Loic; Gallot, Denis; Sapin, Vincent] Auvergne Univ, Sch Med, Retinoids Dev & Dev Dis EA 7281, Clermont Ferrand, France; [Blanc, Pierre; Sapin, Vincent] Univ Hosp, Dept Biochem & Mol Biol, Clermont Ferrand, France; [Pouchin, Pierre] Clermont Univ, UMR, INSERM 1103, CNRS 6247,GReD, Clermont Ferrand, France; [Azais, Jean-Marc] Univ Toulouse 3, Math Inst, F-31062 Toulouse, France; [Coste, Karen] Univ Hosp, Dept Pediat, Clermont Ferrand, France; [Gallot, Denis] Univ Hosp, Dept Obstet, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); Universite de Franche-Comte; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Clermont Ferrand; CHU Clermont Ferrand	Blanc, P (corresponding author), Auvergne Univ, Sch Med, Retinoids Dev & Dev Dis EA 7281, Clermont Ferrand, France.	pblanc@chu-clermontferrand.fr	Pouchin, Pierre/P-5954-2016	Pouchin, Pierre/0000-0003-3858-3152; Coste, Karen/0000-0003-0429-6964; BLANCHON, LOIC/0000-0001-8842-0162; BLANC, Pierre/0000-0003-3802-0923	Auvergne University; Medecine School of Clermont-Ferrand; University Hospital of Clermont-ferrand	Auvergne University; Medecine School of Clermont-Ferrand; University Hospital of Clermont-ferrand	This research was supported by the Auvergne University, the Medecine School of Clermont-Ferrand and the University Hospital of Clermont-ferrand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bejan A., 2000, SHAPE STRUCTURE ENG; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Florens M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178104; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j; Hirashima T, 2009, DEV DYNAM, V238, P2813, DOI 10.1002/dvdy.22108; Kojic N, 2010, BIOPHYS J, V99, P3517, DOI 10.1016/j.bpj.2010.09.044; Lai-Fook SJ, 2004, PHYSIOL REV, V84, P385, DOI 10.1152/physrev.00026.2003; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Lozoya OA, 2012, J BIOMECH, V45, P319, DOI 10.1016/j.jbiomech.2011.10.013; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lubkin SR, 2002, BIOMECH MODEL MECHAN, V1, P5, DOI 10.1007/s10237-002-0001-4; Lubkin SR, 2008, CURR TOP DEV BIOL, V81, P249, DOI 10.1016/S0070-2153(07)81008-8; LUBKIN SR, 1995, J MATH BIOL, V34, P77, DOI 10.1007/BF00180137; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Menshykau D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002377; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Miura T, 2002, MECH DEVELOP, V116, P29, DOI 10.1016/S0925-4773(02)00132-6; Miura T, 2009, MECH DEVELOP, V126, P160, DOI 10.1016/j.mod.2008.11.006; Miura T, 2008, CURR TOP DEV BIOL, V81, P291, DOI 10.1016/S0070-2153(07)81010-6; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelson CM, 2009, BBA-MOL CELL RES, V1793, P903, DOI 10.1016/j.bbamcr.2008.12.014; Peralta CFA, 2006, ULTRASOUND OBST GYN, V27, P551, DOI 10.1002/uog.2752; Reis AH, 2004, MED PHYS, V31, P1135, DOI 10.1118/1.1705443; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Tebockhorst S, 2007, J APPL PHYSIOL, V102, P294, DOI 10.1152/japplphysiol.00665.2006; Tschumperlin DJ, 2010, J BIOMECH, V43, P99, DOI 10.1016/j.jbiomech.2009.09.015; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Tuysuz B, 2009, AM J MED GENET A, V149A, P1727, DOI 10.1002/ajmg.a.32962; Unbekandt M, 2008, MECH DEVELOP, V125, P314, DOI 10.1016/j.mod.2007.10.013; VILOS G A, 1982, Journal of Developmental Physiology (Eynsham), V4, P247; Wan XH, 2008, BIOMECH MODEL MECHAN, V7, P417, DOI 10.1007/s10237-007-0105-y; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Warburton D, 2008, NATURE, V453, P733, DOI 10.1038/453733a; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009; Yinon Y, 2008, BEST PRACT RES CL OB, V22, P77, DOI 10.1016/j.bpobgyn.2007.09.004; Zhao XY, 2009, SURG RADIOL ANAT, V31, P85, DOI 10.1007/s00276-008-0404-8	45	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41643	10.1371/journal.pone.0041643	http://dx.doi.org/10.1371/journal.pone.0041643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844507	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700132
J	Qiu, WJ; Zhou, Y; Jiang, L; Fang, L; Chen, L; Su, WF; Tan, RY; Zhang, CY; Han, X; Yang, JW				Qiu, Wenjing; Zhou, Yang; Jiang, Lei; Fang, Li; Chen, Lu; Su, Weifang; Tan, Ruoyun; Zhang, Chen-yu; Han, Xiao; Yang, Junwei			Genipin Inhibits Mitochondrial Uncoupling Protein 2 Expression and Ameliorates Podocyte Injury in Diabetic Mice	PLOS ONE			English	Article							BETA-CELL DYSFUNCTION; NEPHROPATHY; GLUCOSE; GLOMERULOSCLEROSIS; MECHANISMS; TRANSITION; PREVENTION; APOPTOSIS; DEPLETION; MELLITUS	Diabetic nephropathy (DN) is one of the most common causes of end stage renal disease (ESRD) in China, which requires renal replacement therapy. Recent investigations have suggested an essential role of podocyte injury in the initial stage of DN. This study investigated the potential therapeutic role of genipin, an active extract from a traditional Chinese medicine, on progression of DN in diabetic mice induced by intraperitoneally injection of streptozocin (STZ). In diabetic mice, orally administration of genipin postponed the progression of DN, as demonstrated by ameliorating body weight loss and urine albumin leakage, attenuating glomerular basement membrane thickness, restoring the podocyte expression of podocin and WT1 in diabetic mice. The protective role of genipin on DN is probably through suppressing the up-regulation of mitochondrial uncoupling protein 2 (UCP2) in diabetic kidneys. Meanwhile, through inhibiting the up-regulation of UCP2, genipin restores podocin and WT1 expression in cultured podocytes and attenuates glucose-induced albumin leakage through podocytes monolayer. Therefore, these results revealed that genipin inhibited UCP2 expression and ameliorated podocyte injury in DN mice.	[Qiu, Wenjing; Zhou, Yang; Jiang, Lei; Fang, Li; Chen, Lu; Su, Weifang; Tan, Ruoyun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Chen-yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing, Jiangsu, Peoples R China; [Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing Medical University	Qiu, WJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn	QIU, WENJING/GZL-9992-2022		National Science Foundation of China [30871201]; "973'' Science Program of the Ministry of Science and Technology, China [2011CB504005]; Jiangsu Province's Outstanding Medical Academic Leader Program [SWKJ 2006-50]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973'' Science Program of the Ministry of Science and Technology, China; Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by National Science Foundation of China Grants 30871201, "973'' Science Program of the Ministry of Science and Technology, China (2011CB504005), and Jiangsu Province's Outstanding Medical Academic Leader Program (SWKJ 2006-50) to J.W. Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS4, DOI 10.2337/dc11-S004; Baker MK, 2011, DIABETES RES CLIN PR, V91, P1, DOI 10.1016/j.diabres.2010.06.030; Bu X, 2011, AM J PHYSIOL-RENAL, V301, pF784, DOI 10.1152/ajprenal.00210.2011; Buse JB, 2011, NAT REV ENDOCRINOL, V7, P67, DOI 10.1038/nrendo.2010.230; Campbell KN, 2011, CURR DIABETES REV, V7, P3, DOI 10.2174/157339911794273973; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Deedwania P, 2011, J CLIN HYPERTENS, V13, P52, DOI 10.1111/j.1751-7176.2010.00386.x; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; Gao Q, 2010, NEPHROL DIAL TRANSPL, V25, P3539, DOI 10.1093/ndt/gfq245; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Liu S., 2002, PREV CHRONIC DIS, V8, pA13; Lu B, 2010, DIABETES RES CLIN PR, V88, P289, DOI 10.1016/j.diabres.2010.02.002; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Mathieson PW, 2009, CURR OPIN NEPHROL HY, V18, P206, DOI 10.1097/MNH.0b013e328326f3ca; Okada T, 2006, DIABETES, V55, P1666, DOI 10.2337/db05-1285; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Rajpathak SN, 2011, J IMMIGR MINOR HEALT, V13, P181, DOI 10.1007/s10903-010-9356-2; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wolf G, 2003, J AM SOC NEPHROL, V14, P1396, DOI 10.1097/01.ASN.0000065639.19190.CF; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang PP, 2011, NEPHROLOGY, V16, P100, DOI 10.1111/j.1440-1797.2010.01369.x; Zheng SR, 2008, J AM SOC NEPHROL, V19, P2077, DOI 10.1681/ASN.2007080967; Ziyadeh FN, 2003, J AM SOC NEPHROL, V14, P1355, DOI 10.1097/01.ASN.0000065608.37756.58	41	37	39	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41391	10.1371/journal.pone.0041391	http://dx.doi.org/10.1371/journal.pone.0041391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22848482	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300087
J	Jean, K; Anglaret, X; Moh, R; Lert, F; Dray-Spira, R				Jean, Kevin; Anglaret, Xavier; Moh, Raoul; Lert, France; Dray-Spira, Rosemary			Barriers to HIV Testing in Cote d'Ivoire: The Role of Individual Characteristics and Testing Modalities	PLOS ONE			English	Article							OPT-OUT; PREVENTION; TRANSMISSION; SEROSTATUS; COUNTRIES; SERVICES; CARE	Background: Expanding HIV testing requires a better understanding of barriers to its uptake. We investigated barriers to HIV testing in Cote d'Ivoire, taking into account test circumstances (client vs. provider-initiated). Methods: We used data from the 2005 nationally representative Demographic and Health Survey conducted in Cote d'Ivoire. Socio-demographic characteristics, sexual behaviour and knowledge and attitudes toward HIV/AIDS associated with recent (<2 years) HIV testing were identified using gender-specific univariate and multivariate logistic regressions. Among women, differential effects of barriers to testing according to test circumstance (whether they have been offered for a prenatal test or not) were assessed through interaction tests. Results: Recent HIV testing was reported by 6.1% of men and 9.5% of women (including 4.6% as part of antenatal care). Among men, having a low socioeconomic status, having a low HIV-related knowledge level and being employed [ compared to those inactive: adjusted Odds Ratio (aOR) 0.46; 95% confidence interval (CI) 0.25-0.87] were associated with lower proportions of recent HIV testing. Among women without a prenatal HIV testing offer, living outside the capital (aOR 0.38; CI 0.19-0.77) and reporting a unique lifetime sexual partner constituted additional barriers to HIV testing. By contrast, among women recently offered to be tested in prenatal care, none of these variables was found to be associated with recent HIV testing. Conclusions: Various dimensions of individuals' characteristics constituted significant barriers to HIV testing in Cote d'Ivoire in 2005, with gender specificities. Such barriers are substantially reduced when testing was proposed in the framework of antenatal care. This suggests that provider-initiated testing strategies may help overcome individual barriers to HIV testing.	[Jean, Kevin; Lert, France; Dray-Spira, Rosemary] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Jean, Kevin; Lert, France; Dray-Spira, Rosemary] Univ Versailles St Quentin, UMRS 1018, Villejuif, France; [Anglaret, Xavier] Univ Bordeaux Segalen, INSERM, U897, Bordeaux, France; [Anglaret, Xavier; Moh, Raoul] CHU Treichville, PAC CI Program, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Jean, K (corresponding author), INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France.	kevin.jean@inserm.fr	Anglaret, Xavier/F-7333-2013; Anglaret, Xavier/T-2757-2019; Jean, Kevin/ABA-6355-2020	Jean, Kevin/0000-0001-6462-7185; Anglaret, Xavier/0000-0003-3319-8423; Moh, Desmorys Raoul/0000-0002-1678-3340; Dray-Spira, Rosemary/0000-0001-7646-3667	EHESP (Ecole des Hautes Etudes en Sante Publique)-School of Public Heath, Rennes, France	EHESP (Ecole des Hautes Etudes en Sante Publique)-School of Public Heath, Rennes, France	Kevin Jean is the recipient of a PhD grant from the EHESP (Ecole des Hautes Etudes en Sante Publique)-School of Public Heath, Rennes, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], SAMPL MAN; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Coffie PA, 2011, JAIDS-J ACQ IMM DEF, V57, pS3, DOI 10.1097/QAI.0b013e31821ea539; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Conseil National de Lutte contre le SIDA Republique de Cote d'Ivoire, 2011, PLAN STRAT NAT LUTT; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Cremin I, 2009, PATTERNS UPTAKE HIV; Cremin I, 2010, AIDS BEHAV, V14, P708, DOI 10.1007/s10461-009-9592-4; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; De Cock KM, 2003, LANCET, V362, P1847, DOI 10.1016/S0140-6736(03)14906-9; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinstead OA, 2001, AIDS, V15, P1045, DOI 10.1097/00002030-200105250-00013; Hendriksen ES, 2009, AIDS BEHAV, V13, P1213, DOI 10.1007/s10461-009-9608-0; Institut National de la Statistique (INS) & Ministere de la Lutte contre le Sida [Cote d'Ivoire] & ORC Macro, 2006, AIDS IND SURV COT IV; Koku EF, 2011, J COMMUN HEALTH, V36, P289, DOI 10.1007/s10900-010-9310-1; Mitchell S, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-23; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Mutale W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-347; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Peltzer K, 2010, AIDS BEHAV, V14, P1115, DOI 10.1007/s10461-009-9662-7; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Perez F, 2006, JAIDS-J ACQ IMM DEF, V41, P514, DOI 10.1097/01.qai.0000191285.70331.a0; Rutstein SO., 2004, DHS COMP REPORTS DHS; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2000, NATL AIDS PROGRAMMES; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Wringe A, 2008, TROP MED INT HEALTH, V13, P319, DOI 10.1111/j.1365-3156.2008.02005.x; Young SD, 2010, J ACQUIR IMMUNE DEFI	39	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41353	10.1371/journal.pone.0041353	http://dx.doi.org/10.1371/journal.pone.0041353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815995	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900113
J	Dreesen, L; Rinaldi, M; Chiers, K; Li, R; Geurden, T; Van den Broeck, W; Goddeeris, B; Vercruysse, J; Claerebout, E; Geldhof, P				Dreesen, Leentje; Rinaldi, Manuela; Chiers, Koen; Li, Robert; Geurden, Thomas; Van den Broeck, Wim; Goddeeris, Bruno; Vercruysse, Jozef; Claerebout, Edwin; Geldhof, Peter			Microarray Analysis of the Intestinal Host Response in Giardia duodenalis Assemblage E Infected Calves	PLOS ONE			English	Article							GENE-EXPRESSION; LAMBLIA; NORMALIZATION; INFLAMMATION; VARIANCE; GENOTYPE; ROLES	Despite Giardia duodenalis being one of the most commonly found intestinal pathogens in humans and animals, little is known about the host-parasite interactions in its natural hosts. Therefore, the objective of this study was to investigate the intestinal response in calves following a G. duodenalis infection, using a bovine high-density oligo microarray to analyze global gene expression in the small intestine. The resulting microarray data suggested a decrease in inflammation, immune response, and immune cell migration in infected animals. These findings were examined in more detail by histological analyses combined with quantitative real-time PCR on a panel of cytokines. The transcription levels of IL-6, IL-8, IL-13, IL-17, and IFN-gamma showed a trend of being downregulated in the jejunum of infected animals compared to the negative controls,. No immune cell recruitment could be seen after infection, and no intestinal pathologies, such as villus shortening or increased levels of apoptosis. Possible regulators of this intestinal response are the nuclear peroxisome proliferator-activated receptors alpha (PPAR alpha), and gamma (PPAR gamma) and the enzyme adenosine deaminase (ADA), all for which an upregulated expression was found in the microarray and qRT-PCR analyses.	[Dreesen, Leentje; Rinaldi, Manuela; Geurden, Thomas; Goddeeris, Bruno; Vercruysse, Jozef; Claerebout, Edwin; Geldhof, Peter] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Chiers, Koen] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Li, Robert] USDA ARS, Bovine Funct Genom Lab, Anim & Nat Resources Inst, Beltsville, MD USA; [Van den Broeck, Wim] Univ Ghent, Fac Vet Med, Dept Morphol, Merelbeke, Belgium	Ghent University; Ghent University; United States Department of Agriculture (USDA); Ghent University	Dreesen, L (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	peter.geldhof@UGent.be	Goddeeris, Bruno Maria/L-2440-2015	Goddeeris, Bruno Maria/0000-0003-3729-7592; Claerebout, Edwin/0000-0002-8292-2791	Ghent University [BOF09/GOA/002]	Ghent University(Ghent University)	The project was funded by the Concerted Research Actions of Ghent University (grant number BOF09/GOA/002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bansal D, 2005, BRIT J BIOMED SCI, V62, P63, DOI 10.1080/09674845.2005.11732686; Barigye R, 2008, VET PARASITOL, V157, P196, DOI 10.1016/j.vetpar.2008.07.033; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chan MM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/828951; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Das S, 2002, INT J PARASITOL, V32, P655, DOI 10.1016/S0020-7519(02)00006-1; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Eckmann L, 2003, PARASITE IMMUNOL, V25, P259, DOI 10.1046/j.1365-3024.2003.00634.x; Farthing MJG, 1996, GASTROENTEROL CLIN N, V25, P493, DOI 10.1016/S0889-8553(05)70260-0; Fraser D, 2000, CLIN INFECT DIS, V30, P419, DOI 10.1086/313722; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Geurden T, 2004, INT J PARASITOL, V34, P1121, DOI 10.1016/j.ijpara.2004.05.007; Geurden T, 2010, EXP PARASITOL, V124, P98, DOI 10.1016/j.exppara.2009.03.001; GILMAN RH, 1988, LANCET, V1, P343, DOI 10.1016/S0140-6736(88)91131-2; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hanevik K, 2011, J INFECT DIS, V204, P1779, DOI 10.1093/infdis/jir639; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Homan WL, 2001, INT J PARASITOL, V31, P822, DOI 10.1016/S0020-7519(01)00183-7; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; ISHHOROWICZ M, 1989, PEDIATR INFECT DIS J, V8, P773, DOI 10.1097/00006454-198911000-00009; Kamda JD, 2009, INFECT IMMUN, V77, P685, DOI 10.1128/IAI.00718-08; KATELARIS P, 1991, PARASITOLOGY, V103, P35, DOI 10.1017/S0031182000059266; Koudela B, 1998, VET PARASITOL, V74, P9, DOI 10.1016/S0304-4017(97)00146-5; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Newman RD, 2001, TROP MED INT HEALTH, V6, P624, DOI 10.1046/j.1365-3156.2001.00757.x; O'Handley RM, 2006, VET CLIN N AM-FOOD A, V22, P623, DOI 10.1016/j.cvfa.2006.07.002; Oberhuber G, 1997, SCAND J GASTROENTERO, V32, P48, DOI 10.3109/00365529709025062; Read C, 2002, INT J PARASITOL, V32, P229, DOI 10.1016/S0020-7519(01)00340-X; RENDTORFF ROBERT C., 1954, AMER JOUR HYG, V59, P209; Rishniw M, 2010, J VET INTERN MED, V24, P293, DOI 10.1111/j.1939-1676.2010.0475.x; Roxstrom-Lindquist K, 2005, INFECT IMMUN, V73, P8204, DOI 10.1128/IAI.73.12.8204-8208.2005; Ruest N, 1997, VET PARASITOL, V69, P177, DOI 10.1016/S0304-4017(96)01121-1; Singer SM, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P451, DOI 10.1079/9781845933913.0451; Singer SM, 2000, INFECT IMMUN, V68, P170, DOI 10.1128/IAI.68.1.170-175.2000; Solaymani-Mohammadi S, 2011, J IMMUNOL, V187, P3769, DOI 10.4049/jimmunol.1100606; Solaymani-Mohammadi S, 2010, EXP PARASITOL, V126, P292, DOI 10.1016/j.exppara.2010.06.014; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Sweeny JPA, 2011, MOL BIOCHEM PARASIT, V180, P62, DOI 10.1016/j.molbiopara.2011.07.007; Tsuji K, 2009, BIOORG MED CHEM LETT, V19, P1643, DOI 10.1016/j.bmcl.2009.02.004; Vangeel L, 2012, VET PARASITOL, V183, P224, DOI 10.1016/j.vetpar.2011.07.048; Xiao LH, 1996, VET PARASITOL, V61, P165, DOI 10.1016/0304-4017(95)00802-0; Zhang K, 2010, ADV EXP MED BIOL, V688, P238	46	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40985	10.1371/journal.pone.0040985	http://dx.doi.org/10.1371/journal.pone.0040985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848418	Green Published, gold			2022-12-27	WOS:000306950200036
J	Jawhara, S; Habib, K; Maggiotto, F; Pignede, G; Vandekerckove, P; Maes, E; Dubuquoy, L; Fontaine, T; Guerardel, Y; Poulain, D				Jawhara, Samir; Habib, Khalid; Maggiotto, Francois; Pignede, Georges; Vandekerckove, Pascal; Maes, Emmanuel; Dubuquoy, Laurent; Fontaine, Thierry; Guerardel, Yann; Poulain, Daniel			Modulation of Intestinal Inflammation by Yeasts and Cell Wall Extracts: Strain Dependence and Unexpected Anti-Inflammatory Role of Glucan Fractions	PLOS ONE			English	Article							CHEMICALLY-INDUCED COLITIS; CANDIDA-ALBICANS; SACCHAROMYCES-BOULARDII; BETA-GLUCAN; ESCHERICHIA-COLI; DENDRITIC CELLS; BOWEL-DISEASE; MOUSE MODEL; MICE; INFECTION	Yeasts and their glycan components can have a beneficial or adverse effect on intestinal inflammation. Previous research has shown that the presence of Saccharomyces cerevisiae var. boulardii (Sb) reduces intestinal inflammation and colonization by Candida albicans. The aim of this study was to identify dietary yeasts, which have comparable effects to the anti-C. albicans and anti-inflammatory properties of Sb and to assess the capabilities of yeast cell wall components to modulate intestinal inflammation. Mice received a single oral challenge of C. albicans and were then given 1.5% dextran-sulphatesodium (DSS) for 2 weeks followed by a 3-day restitution period. S. cerevisiae strains (Sb, Sc1 to Sc4), as well as mannoprotein (MP) and beta-glucan crude fractions prepared from Sc2 and highly purified beta-glucans prepared from C. albicans were used in this curative model, starting 3 days after C. albicans challenge. Mice were assessed for the clinical, histological and inflammatory responses related to DSS administration. Strain Sc1-1 gave the same level of protection against C. albicans as Sb when assessed by mortality, clinical scores, colonization levels, reduction of TNF alpha and increase in IL-10 transcription. When Sc1-1 was compared with the other S. cerevisiae strains, the preparation process had a strong influence on biological activity. Interestingly, some S. cerevisiae strains dramatically increased mortality and clinical scores. Strain Sc4 and MP fraction favoured C. albicans colonization and inflammation, whereas beta-glucan fraction was protective against both. Surprisingly, purified beta-glucans from C. albicans had the same protective effect. Thus, some yeasts appear to be strong modulators of intestinal inflammation. These effects are dependent on the strain, species, preparation process and cell wall fraction. It was striking that beta-glucan fractions or pure beta-glucans from C. albicans displayed the most potent anti-inflammatory effect in the DSS model.	[Jawhara, Samir; Habib, Khalid; Maggiotto, Francois; Dubuquoy, Laurent; Poulain, Daniel] Univ Lille Nord France, Lille, France; [Jawhara, Samir; Habib, Khalid; Maggiotto, Francois; Dubuquoy, Laurent; Poulain, Daniel] UDSL, Lille, France; [Jawhara, Samir; Habib, Khalid; Maggiotto, Francois; Dubuquoy, Laurent; Poulain, Daniel] INSERM, U995, F-59045 Lille, France; [Poulain, Daniel] Serv Parasitol Mycol, Lille, France; [Poulain, Daniel] CHRU Lille, Lille, France; [Maes, Emmanuel; Guerardel, Yann] Univ Lille 1, UGSF, F-59655 Villeneuve Dascq, France; [Maes, Emmanuel; Guerardel, Yann] Univ Lille 1, Ctr Hyperfrequences & Semicond, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France; [Pignede, Georges; Vandekerckove, Pascal] Lesaffre Int, Div R&D, Marcq En Baroeul, France; [Fontaine, Thierry] Inst Pasteur, Unite Aspergillus, Paris, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jawhara, S (corresponding author), Univ Lille Nord France, Lille, France.	dpoulain@univ-lille2.fr	Dubuquoy, laurent/J-4978-2015; Fontaine, Thierry/F-8227-2011; Jawhara, Samir/A-9310-2019; Fontaine, thierry/Q-2201-2018; Poulain, Daniel/C-8683-2014; Dubuquoy, Laurent/N-1623-2019; Jawhara, Samir/AAC-5789-2019; Poulain, Daniel/I-6095-2018	Dubuquoy, laurent/0000-0003-3596-5497; Jawhara, Samir/0000-0002-2759-975X; Fontaine, thierry/0000-0002-8184-789X; Jawhara, Samir/0000-0002-2759-975X; Guerardel, Yann/0000-0003-4967-9512; Poulain, Daniel/0000-0002-0729-5468	French Government [082906131]; European funds FEDER; Region Nord-Pas de Calais, Lille Me tropole Communaute Urbaine; FP7 Health "ALLFUN'' project [260338]	French Government; European funds FEDER(European Commission); Region Nord-Pas de Calais, Lille Me tropole Communaute Urbaine(Region Hauts-de-France); FP7 Health "ALLFUN'' project	This work was funded by the program LEVACI issued from the French Government research plan FUI 5th AAP (DGE- Lille University contract number 082906131, European funds FEDER and local funds from the Region Nord-Pas de Calais, Lille Me tropole Communaute Urbaine). LEVACI partners belong to research clusters Nutrition-Sante-Longe vite and Vegepolys. This work was also funded by the FP7 Health 260338 "ALLFUN'' project "Fungi in the setting of inflammation, allergy and auto-immune diseases: translating basic science into clinical practices.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HM, 2010, PHARMACOTHERAPY, V30, P361, DOI 10.1592/phco.30.4.361; Avalueva E B, 2010, Eksp Klin Gastroenterol, P103; Bonifazi P, 2009, MUCOSAL IMMUNOL, V2, P362, DOI 10.1038/mi.2009.17; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Buddington KK, 2002, J NUTR, V132, P472, DOI 10.1093/jn/132.3.472; Buts JP, 2006, DIGEST DIS SCI, V51, P1485, DOI 10.1007/s10620-005-9016-x; Buts JP, 2010, SCAND J GASTROENTERO, V45, P175, DOI 10.3109/00365520903453141; Canonici A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018427; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Chung YH, 2011, J DAIRY SCI, V94, P2431, DOI 10.3168/jds.2010-3277; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Driscoll M, 2009, CANCER BIOL THER, V8, P214; Edwards-Ingram L, 2007, APPL ENVIRON MICROB, V73, P2458, DOI 10.1128/AEM.02201-06; Fidan I, 2009, MYCOSES, V52, P29, DOI 10.1111/j.1439-0507.2008.01545.x; Forsyth CB, 2002, INFECT IMMUN, V70, P517, DOI 10.1128/IAI.70.2.517-527.2002; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; Garner RE, 1996, INFECT IMMUN, V64, P4561, DOI 10.1128/IAI.64.11.4561-4566.1996; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Guslandi M, 2000, DIGEST DIS SCI, V45, P1462, DOI 10.1023/A:1005588911207; Guslandi M, 2003, EUR J GASTROEN HEPAT, V15, P697, DOI 10.1097/00042737-200306000-00017; HASHIMOTO K, 1983, J PHARMACOBIO-DYNAM, V6, P668; Hetland G, 2000, FEMS IMMUNOL MED MIC, V27, P111, DOI 10.1111/j.1574-695X.2000.tb01420.x; Hida S, 2007, BIOL PHARM BULL, V30, P1589, DOI 10.1248/bpb.30.1589; HILENSKI LL, 1986, J GEN MICROBIOL, V132, P1441; Ishibashia K, 2002, INT IMMUNOPHARMACOL, V2, P1109, DOI 10.1016/S1567-5769(02)00062-0; Jawhara S, 2012, J BIOL CHEM IN PRESS; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Jawhara S, 2007, MED MYCOL, V45, P691, DOI 10.1080/13693780701523013; Kuhle AVA, 2003, SYST APPL MICROBIOL, V26, P564, DOI 10.1078/072320203770865873; Lee JN, 2001, BIOSCI BIOTECH BIOCH, V65, P837, DOI 10.1271/bbb.65.837; Li J, 2006, J ANIM SCI, V84, P2374, DOI 10.2527/jas.2004-541; Liang JS, 1998, INT J IMMUNOPHARMACO, V20, P595, DOI 10.1016/S0192-0561(98)00007-1; Lourens-Hattingh A, 2001, FOOD RES INT, V34, P791, DOI 10.1016/S0963-9969(01)00085-0; Martins FS, 2009, LETT APPL MICROBIOL, V49, P738, DOI 10.1111/j.1472-765X.2009.02732.x; Martins FS, 2005, J GEN APPL MICROBIOL, V51, P83, DOI 10.2323/jgam.51.83; Mitterdorfer G, 2002, PROTEOMICS, V2, P1532, DOI 10.1002/1615-9861(200211)2:11<1532::AID-PROT1532>3.0.CO;2-H; Murzyn A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012050; Murzyn A, 2010, FEMS MICROBIOL LETT, V310, P17, DOI 10.1111/j.1574-6968.2010.02037.x; Pannerden CMFVT, 2011, DRUGS, V71, P853, DOI 10.2165/11591230-000000000-00000; Periti P, 2001, J CHEMOTHERAPY, V13, P473, DOI 10.1179/joc.2001.13.5.473; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; Reed KL, 2005, DIGEST DIS SCI, V50, P2366, DOI 10.1007/s10620-005-3066-y; Rousseau V, 2005, ANAEROBE, V11, P145, DOI 10.1016/j.anaerobe.2004.12.002; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Samonis G, 2011, MED MYCOL, V49, P395, DOI 10.3109/13693786.2010.533203; Sendid B, 2008, CLIN VACCINE IMMUNOL, V15, P1868, DOI 10.1128/CVI.00200-08; Sendid B, 2007, J MED MICROBIOL, V56, P495, DOI 10.1099/jmm.0.46715-0; Sener G, 2006, INT IMMUNOPHARMACOL, V6, P724, DOI 10.1016/j.intimp.2005.10.010; Shanahan F, 2000, INFLAMM BOWEL DIS, V6, P107, DOI 10.1097/00054725-200005000-00007; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Sindhu Sangeeta C., 2002, Nutrition and Health (Bicester), V16, P173; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thomas S, 2011, AM J PHYSL GASTROINT; Thornton BP, 1996, J IMMUNOL, V156, P1235; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Yanaba K, 2011, AM J PATHOL, V178, P735, DOI 10.1016/j.ajpath.2010.10.022; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	64	75	78	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40648	10.1371/journal.pone.0040648	http://dx.doi.org/10.1371/journal.pone.0040648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848391	Green Published, gold			2022-12-27	WOS:000306950200025
J	Ni, K; Li, SM; Xia, QL; Zang, N; Deng, Y; Xie, XH; Luo, ZX; Luo, Y; Wang, LJ; Fu, Z; Liu, EM				Ni, Ke; Li, Simin; Xia, Qiuling; Zang, Na; Deng, Yu; Xie, Xiaohong; Luo, Zhengxiu; Luo, Yan; Wang, Lijia; Fu, Zhou; Liu, Enmei			Pharyngeal Microflora Disruption by Antibiotics Promotes Airway Hyperresponsiveness after Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; BACTERIAL-COLONIZATION; MICE; BRONCHIOLITIS; DISEASE; HYPERREACTIVITY; SENSITIZATION; PERSPECTIVE; PERSISTENCE; ALLERGEN	Background: Regulatory T cells (Treg cells), which are essential for regulation of immune response to respiratory syncytial virus (RSV) infection, are promoted by pharyngeal commensal pneumococcus. The effects of pharyngeal microflora disruption by antibiotics on airway responsiveness and relative immune responses after RSV infection have not been clarified. Methods: Female BALB/c mice (aged 3 weeks) were infected with RSV and then treated with either oral antibiotics or oral double distilled water (ddH(2)O) from 1 d post infection (pi). Changes in pharyngeal microflora were analyzed after antibiotic treatment for 7 d and 14 d. At 8 d pi and 15 d pi, the inflammatory cells in bronchoalveolar lavage fluid (BALF) were investigated in combination with tests of pulmonary histopathology, airway hyperresponsiveness (AHR), pulmonary and splenic Treg cells responses. Pulmonary Foxp3 mRNA expression, IL-10 and TGF-beta 1 in BALF and lung homogenate were investigated at 15 d pi. Ovalbumin (OVA) challenge was used to induce AHR after RSV infection. Results: The predominant pharyngeal commensal, Streptococcus, was cleared by antibiotic treatment for 7 d. Same change also existed after antibiotic treatment for 14 d. After RSV infection, AHR was promoted by antibiotic treatment at 15 d pi. Synchronous decreases of pulmonary Treg cells, Foxp3 mRNA and TGF-beta 1 were detected. Similar results were observed under OVA challenge. Conclusions: After RSV infection, antibiotic treatment cleared pharyngeal commensal bacteria such as Streptococcus, which consequently, might induce AHR and decrease pulmonary Treg cells.	[Deng, Yu; Xie, Xiaohong; Luo, Zhengxiu; Fu, Zhou; Liu, Enmei] Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China; [Ni, Ke; Li, Simin; Xia, Qiuling; Zang, Na; Luo, Yan; Wang, Lijia] Chongqing Med Univ, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing, Minist Educ,Key Lab Child Dev & Disorders, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Liu, EM (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China.	emliu186@hotmail.com			National Natural Science Foundation of China [NSFC 30972698, NSFC 81170010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant numbers: NSFC 30972698, NSFC 81170010)(http://isis.nsfc.gov.cn/portal/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2007, AM J RESP CRIT CARE, V176, P974, DOI 10.1164/rccm.200702-334OC; Antonow JA, 1998, PEDIATR INFECT DIS J, V17, P231, DOI 10.1097/00006454-199803000-00011; Basset C, 2010, TOXINS, V2, P1774, DOI 10.3390/toxins2071774; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Burchell JT, 2009, AM J PHYSIOL-LUNG C, V296, pL307, DOI 10.1152/ajplung.00521.2007; Chavez-Bueno S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-46; Cusi Maria Grazia, 2010, Immun Ageing, V7, P14, DOI 10.1186/1742-4933-7-14; de Gutierrez RC, 1999, MEM I OSWALDO CRUZ, V94, P701, DOI 10.1590/S0074-02761999000500027; DELPRETE G, 1993, J IMMUNOL, V150, P353; Estripeaut D, 2008, J INFECT DIS, V198, P1435, DOI 10.1086/592714; Fjaerli Hans-Olav, 2005, BMC Pediatr, V5, P31, DOI 10.1186/1471-2431-5-31; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Gordon ED, 2012, CLIN EXP ALLERGY, V42, P144, DOI 10.1111/j.1365-2222.2011.03840.x; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Lee DCP, 2010, J VIROL, V84, P8790, DOI 10.1128/JVI.00796-10; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Nagayama Y, 2007, PEDIAT ALLERG IMM-UK, V18, P110, DOI 10.1111/j.1399-3038.2006.00492.x; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; O'Flaherty S, 2010, GUT MICROBES, V1, P293, DOI 10.4161/gmic.1.5.12924; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Penders J, 2011, EUR RESP J; Presser K, 2008, J IMMUNOL, V181, P7751, DOI 10.4049/jimmunol.181.11.7751; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Samson L, 1999, Paediatr Child Health, V4, P195; Scerbo MJ, 2012, J NEUROIMMUNOL, V242, P16, DOI 10.1016/j.jneuroim.2011.11.006; Schwarze J, 1999, J IMMUNOL, V163, P5729; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub2; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Steiner RWP, 2004, AM FAM PHYSICIAN, V69, P325; Sun Da-qing, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P473; Uhl EW, 1996, AM J RESP CRIT CARE, V154, P1834, DOI 10.1164/ajrccm.154.6.8970378; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zhang QB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002175	40	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41104	10.1371/journal.pone.0041104	http://dx.doi.org/10.1371/journal.pone.0041104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844430	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600015
J	Fargione, J; Kiesecker, J; Slaats, MJ; Olimb, S				Fargione, Joseph; Kiesecker, Joseph; Slaats, M. Jan; Olimb, Sarah			Wind and Wildlife in the Northern Great Plains: Identifying Low-Impact Areas for Wind Development	PLOS ONE			English	Article							ENERGY FACILITIES; MORTALITY; BAT; FATALITIES	Wind energy offers the potential to reduce carbon emissions while increasing energy independence and bolstering economic development. However, wind energy has a larger land footprint per Gigawatt (GW) than most other forms of energy production and has known and predicted adverse effects on wildlife. The Northern Great Plains (NGP) is home both to some of the world's best wind resources and to remaining temperate grasslands, the most converted and least protected ecological system on the planet. Thus, appropriate siting and mitigation of wind development is particularly important in this region. Steering energy development to disturbed lands with low wildlife value rather than placing new developments within large and intact habitats would reduce impacts to wildlife. Goals for wind energy development in the NGP are roughly 30 GW of nameplate capacity by 2030. Our analyses demonstrate that there are large areas where wind development would likely have few additional impacts on wildlife. We estimate there are similar to 1,056 GW of potential wind energy available across the NGP on areas likely to have low-impact for biodiversity, over 35 times development goals. New policies and approaches will be required to guide wind energy development to low-impact areas.	[Fargione, Joseph; Slaats, M. Jan] Nature Conservancy, Minneapolis, MN USA; [Kiesecker, Joseph] Nature Conservancy, Ft Collins, CO USA; [Olimb, Sarah] World Wildlife Fund, Bozeman, MT USA	Nature Conservancy; Nature Conservancy; World Wildlife Fund	Fargione, J (corresponding author), Nature Conservancy, Minneapolis, MN USA.	jfargione@TNC.ORG		Fargione, Joseph/0000-0002-0636-5380; Olimb, Sarah/0000-0001-5714-6586				Alberta Electric System Operator, 2011, CONN QUEUE PROJ LIST; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Barclay RMR, 2007, CAN J ZOOL, V85, P381, DOI 10.1139/Z07-011; BirdLife International, 2010, IMP BIRD AR CAN; Chaundy R, 2001, CANADIAN IMPORTANT B; Conservation Biology Institute, 2010, PROT AR DAT US CBI E; Copeland HE, 2010, ECOL INDIC, V10, P869, DOI 10.1016/j.ecolind.2010.01.011; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; Department of Energy, 2008, 20 PERC WIND EN 2030; Desholm M, 2009, J ENVIRON MANAGE, V90, P2672, DOI 10.1016/j.jenvman.2009.02.005; Doherty KE, 2010, BREEDING DENSITIES G; Environment Canada, 2008, CAN WIND EN ATL; Fletcher RJ, 2011, FRONT ECOL ENVIRON, V9, P161, DOI 10.1890/090091; Geobase, 2011, LAND COV CIRC 2000 V; Glick D, 2005, SMITHSONIAN, V36, P54; Good RE, 2007, J WILDLIFE MANAGE, V71, P395, DOI 10.2193/2005-593; Hebblewhite M, 2008, LIT REV EFFECTS ENER; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hoffman SW, 2003, CONDOR, V105, P397, DOI 10.1650/7146; Johnson CJ, 2005, WILDLIFE MONOGR, P1; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Knick ST, 2011, STUD AVIAN BIOL, P1; Mead MW, 2011, GREATER SAGE GROUSE; Montana Fish Wildlife and Parks, 2008, CRUC AR PLANN SYST; Montana Fish Wildlife & Parks, 2010, GREAT SAG GROUS COR; Montana Natural Heritage Program, 2011, LAND MAN MAPP; Multi-Resolution Land Characteristics Consortium, 2010, NAT LAND COV DAT; National Renewable Energy Lab, 2011, HIGH RES 50 MET WIND; Natural Regions Committee, 2006, NAT REG SUBR ALB; Nature Conservancy of Canada, 2007, FORC NAT ALB; Naugle DE, 2010, ENERGY DEV WILDLIFE, P55; Nebraska Game and Parks Commission, 2011, NEBR WIND WILDL; Niemuth ND, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P533, DOI 10.1016/B978-0-12-373631-4.00020-4; Obermeyer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026698; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Piorkowski MD, 2010, AM MIDL NAT, V164, P260, DOI 10.1674/0003-0031-164.2.260; Playa Lakes Joint Venture, 2011, PLAYA COUNT MAPS PRO; Pruett CL, 2009, CONSERV BIOL, V23, P1253, DOI 10.1111/j.1523-1739.2009.01254.x; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; Reynolds RE, 2006, WILDLIFE SOC B, V34, P963, DOI 10.2193/0091-7648(2006)34[963:TFBADP]2.0.CO;2; SaskPower, 2011, POW SUST EN FUT SASK; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Stein BA, 2000, PRECIOUS HERITAGE ST; Stewart GB, 2007, ENVIRON CONSERV, V34, P1, DOI 10.1017/S0376892907003554; The Nature Conservancy, 2011, CONS PRIOR AR; The Nature Conservancy, 2011, CONS EAS WYOM; U.S. Census Bureau, 2009, 2009 TIGER LIN SHAP; U.S. Fish and Wildlife Service, 2011, SPEC PROF WHOOP CRAN; United States Geologic Survey, 2008, SIGN TOP CHANG US; US Fish and Wildlife Service, 2009, WHOOP CRAN WIND DEV; Ventyx Corporation, 2012, VEL SUIT EV EN MAP; Ventyx Corporation, 2012, VEL SUIT NEW ENTR; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wyoming Game & Fish Department, 2010, WYOM STAT WILDL ACT; Wyoming Game & Fish Department, 2009, HAB PRIOT AR; Yang LM, 2003, CAN J REMOTE SENS, V29, P230, DOI 10.5589/m02-098	60	44	46	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41468	10.1371/journal.pone.0041468	http://dx.doi.org/10.1371/journal.pone.0041468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848505	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600070
J	Kolodecik, TR; Shugrue, CA; Thrower, EC; Levin, LR; Buck, J; Gorelick, FS				Kolodecik, Thomas R.; Shugrue, Christine A.; Thrower, Edwin C.; Levin, Lonny R.; Buck, Jochen; Gorelick, Fred S.			Activation of Soluble Adenylyl Cyclase Protects against Secretagogue Stimulated Zymogen Activation in Rat Pancreaic Acinar Cells	PLOS ONE			English	Article							PH-REGULATORY MECHANISMS; ENZYME ACTIVATION; CAMP; CALCIUM; IDENTIFICATION; SECRETION; MICRODOMAINS; EXPRESSION; AUTOPHAGY; RESPONSES	An early feature of acute pancreatitis is activation of zymogens, such as trypsinogen, within the pancreatic acinar cell. Supraphysiologic concentrations of the hormone cholecystokinin (CCK; 100 nM), or its orthologue cerulein (CER), induce zymogen activation and elevate levels of cAMP in pancreatic acinar cells. The two classes of adenylyl cyclase, transmembrane (tmAC) and soluble (sAC), are activated by distinct mechanisms, localize to specific subcellular domains, and can produce locally high concentrations of cAMP. We hypothesized that sAC activity might selectively modulate acinar cell zymogen activation. sAC was identified in acinar cells by PCR and immunoblot. It localized to the apical region of the cell under resting conditions and redistributed intracellularly after treatment with supraphysiologic concentrations of cerulein. In cerulein-treated cells, pre-incubation with a trans-membrane adenylyl cyclase inhibitor did not affect zymogen activation or amylase secretion. However, treatment with a sAC inhibitor (KH7), or inhibition of a downstream target of cAMP, protein kinase A (PKA), significantly enhanced secretagogue-stimulated zymogen activation and amylase secretion. Activation of sAC with bicarbonate significantly inhibited secretagogue-stimulated zymogen activation; this response was decreased by inhibition of sAC or PKA. Bicarbonate also enhanced secretagogue-stimulated cAMP accumulation; this effect was inhibited by KH7. Bicarbonate treatment reduced secretagogue-stimulated acinar cell vacuolization, an early marker of pancreatitis. These data suggest that activation of sAC in the pancreatic acinar cell has a protective effect and reduces the pathologic activation of proteases during pancreatitis.	[Kolodecik, Thomas R.; Shugrue, Christine A.; Thrower, Edwin C.; Gorelick, Fred S.] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA; [Gorelick, Fred S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Kolodecik, Thomas R.; Shugrue, Christine A.; Thrower, Edwin C.; Gorelick, Fred S.] Vet Adm Connecticut Healthcare, West Haven, CT USA; [Levin, Lonny R.; Buck, Jochen] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Yale University; Yale University; Cornell University	Kolodecik, TR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA.	fred.gorelick@yale.edu		Gorelick, Fred/0000-0001-8293-6803; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [DK-54021]; Veterans Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health R01 Grant DK-54021 and a Veterans Administration Merit Award to Fred S. Gorelick. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Akiyama T, 1998, AM J PHYSIOL-GASTR L, V275, pG1202, DOI 10.1152/ajpgi.1998.275.5.G1202; BAHNSON TD, 1993, J BIOL CHEM, V268, P10808; Bhoomagoud M, 2009, GASTROENTEROLOGY, V137, P1083, DOI 10.1053/j.gastro.2009.05.041; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; BRAUN T, 1977, BIOCHIM BIOPHYS ACTA, V481, P227, DOI 10.1016/0005-2744(77)90155-3; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chaloupka JA, 2006, MOL REPROD DEV, V73, P361, DOI 10.1002/mrd.20409; Chaudhuri A, 2005, AM J PHYSIOL-GASTR L, V288, pG235, DOI 10.1152/ajpgi.00334.2004; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Halm ST, 2010, AM J PHYSIOL-GASTR L, V299, pG81, DOI 10.1152/ajpgi.00035.2010; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; HAYMOVITS A, 1976, P NATL ACAD SCI USA, V73, P156, DOI 10.1073/pnas.73.1.156; Hilvo M, 2004, J HISTOCHEM CYTOCHEM, V52, P1313, DOI 10.1369/jhc.3A6225.2004; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; KOPELMAN H, 1995, AM J PHYSIOL-CELL PH, V269, pC626, DOI 10.1152/ajpcell.1995.269.3.C626; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Lu Z, 2003, AM J PHYSIOL-GASTR L, V285, pG822, DOI 10.1152/ajpgi.00213.2003; Lu Z, 2002, AM J PHYSIOL-GASTR L, V282, pG501, DOI 10.1152/ajpgi.00388.2001; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; MARINO CR, 1993, FEBS LETT, V316, P48, DOI 10.1016/0014-5793(93)81734-H; MUALLEM S, 1990, J BIOL CHEM, V265, P12813; MUALLEM S, 1990, J BIOL CHEM, V265, P12806; Nomura M, 2005, GENE, V353, P231, DOI 10.1016/j.gene.2005.04.034; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Salonikidis PS, 2008, BIOPHYS J, V95, P5412, DOI 10.1529/biophysj.107.125666; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Strazzabosco M, 2009, HEPATOLOGY, V50, P244, DOI 10.1002/hep.22926; Thrower EC, 2006, AM J PHYSIOL-GASTR L, V290, pG894, DOI 10.1152/ajpgi.00373.2005; Warrier S, 2007, J PHYSIOL-LONDON, V580, P765, DOI 10.1113/jphysiol.2006.124891; Whisnant RE, 1996, P NATL ACAD SCI USA, V93, P6621, DOI 10.1073/pnas.93.13.6621; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Wuttke M S, 2001, JOP, V2, P154; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	51	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41320	10.1371/journal.pone.0041320	http://dx.doi.org/10.1371/journal.pone.0041320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844459	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700071
J	Petkeviciene, J; Smalinskiene, A; Luksiene, DI; Jureniene, K; Ramazauskiene, V; Klumbiene, J; Lesauskaite, V				Petkeviciene, Janina; Smalinskiene, Alina; Luksiene, Dalia Ieva; Jureniene, Kristina; Ramazauskiene, Vitalija; Klumbiene, Jurate; Lesauskaite, Vaiva			Associations between Apolipoprotein E Genotype, Diet, Body Mass Index, and Serum Lipids in Lithuanian Adult Population	PLOS ONE			English	Article							CORONARY HEART-DISEASE; E POLYMORPHISM; CARDIOVASCULAR-DISEASE; PLASMA-LIPOPROTEINS; RURAL-POPULATION; FATTY-ACIDS; CHOLESTEROL; RISK; OBESITY; HABITS	Background: Apolipoprotein E (APOE) polymorphism is associated with lipid levels. Some studies have reported that blood lipid response to diet or obesity varies depending on APOE genotypes. The aim of this study was to assess the effect of APOE genotypes, the intake of saturated fatty acids (SFA), and obesity on serum lipid levels in Lithuanian adult population. Methodology/Principal Findings: A cross-sectional health survey was carried out in five municipalities of Lithuania. The random sample was obtained from lists of 25-64 year-old inhabitants registered at primary health care centres. The data from 996 subjects (416 men and 580 women) were analysed in this study. Two single-nucleotide polymorphisms (rs429358 and rs7412) were assessed using a real-time polymerase chain reaction. 24-hour recall and food frequency questionnaire were used for evaluation of dietary habits. Serum lipids were determined using enzymatic methods. Men and women with the APOE2 genotype had the lowest level of total cholesterol (TC) (p = 0.002 for men, and p = 0.02 for women) and low-density lipoprotein cholesterol (LDL-C) (p<0.001). Multivariate linear regression analysis showed that age, genotype APOE2, SFA intake, and body mass index (BMI) were significant determinants of TC and LDL-C level (with p values ranging from 0.043 to 0.001). Our data did not reveal any statistically significant interactions between APOE genotype and SFA intake or between APOE genotype and BMI regarding TC and LDL-C level (all p>0.05). However, the predictive power of the regression model for LDL-C improved when gene-BMI interaction and gene-BMI interaction plus gene-nutrient interaction were added (p = 0.04 and p = 0.032 for R-2 change, respectively). Conclusions/Significance: APOE genotypes, SFA intake, and obesity were found to be associated with blood lipid levels in Lithuanian adult population. Analysis of gene-diet and gene-obesity interactions did not confirm that the effects of diet and obesity on TC and LDL-C level significantly depended on APOE genotype.	[Petkeviciene, Janina; Ramazauskiene, Vitalija; Klumbiene, Jurate] Lithuanian Univ Hlth Sci, Med Acad, Fac Publ Hlth, Kaunas, Lithuania; [Smalinskiene, Alina; Luksiene, Dalia Ieva; Jureniene, Kristina; Lesauskaite, Vaiva] Lithuanian Univ Hlth Sci, Med Acad, Inst Cardiol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Petkeviciene, J (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Fac Publ Hlth, Kaunas, Lithuania.	janpet@vector.kmu.lt		Lesauskaite, Vaiva/0000-0003-2736-3111	Research Council of Lithuania [LIG-02/2010]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	The study was supported by research grant from the Research Council of Lithuania for National Research Programme 'Chronic Noncommunicable Diseases' (Agreement No LIG-02/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzda A, 2005, PATIEKALU SUDETIS MA; Bednarska-Makaruk M, 2001, EUR J EPIDEMIOL, V17, P789, DOI 10.1023/A:1015657709060; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Campos H, 2001, GENET EPIDEMIOL, V20, P117, DOI 10.1002/1098-2272(200101)20:1<117::AID-GEPI10>3.0.CO;2-C; Corella D, 2009, CIRC-CARDIOVASC GENE, V2, P637, DOI 10.1161/CIRCGENETICS.109.891366; de Andrade FM, 2010, BIOCHEM GENET, V48, P342, DOI 10.1007/s10528-010-9331-6; Emerging Risk Factors Collaboration, 2009, JAMA-J AM MED ASSOC, V302, P1999; Franssen R, 2008, ENDOCRIN METAB CLIN, V37, P623, DOI 10.1016/j.ecl.2008.06.003; Frikke-Schmidt R, 2000, J LIPID RES, V41, P1812; Frikke-Schmidt R, 2000, J AM COLL CARDIOL, V35, P1192, DOI 10.1016/S0735-1097(00)00520-9; Grabauskas V, 2011, HLTH BEHAV LITHUANIA; Grabauskas V, 2008, MEDICINA-LITHUANIA, V44, P633, DOI 10.3390/medicina44080082; Health Statistics of Lithuania, 2009, HLTH STAT LITHUANIA; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hubacek JA, 2003, PHYSIOL RES, V52, P195; Kofler BM, 2012, ATHEROSCLEROSIS, V221, P467, DOI 10.1016/j.atherosclerosis.2012.01.042; Kriaucioniene V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-218; Lefevre M, 1997, ARTERIOSCL THROM VAS, V17, P2914, DOI 10.1161/01.ATV.17.11.2914; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marques-Vidal P, 2003, OBES RES, V11, P1200, DOI 10.1038/oby.2003.165; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Ordovas JM, 2006, AM J CLIN NUTR, V83, p443S; Prattalla R., 2011, SOCIAL DETERMINANTS; Ramazauskiene V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-447; REILLY SL, 1994, AM J HUM GENET, V55, P1001; Reklaitiene R, 2001, MEDICINA, V37, P1544; Salminen M, 2006, PUBLIC HEALTH NUTR, V9, P859, DOI 10.1017/PHN2006972; Sarkkinen E, 1998, AM J CLIN NUTR, V68, P1215, DOI 10.1093/ajcn/68.6.1215; Schiele F, 2000, ATHEROSCLEROSIS, V152, P475, DOI 10.1016/S0021-9150(99)00501-8; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513; Suciliene S, 2002, MAISTO PRODUKTU SUDE; Tikkanen MJ, 1997, WORLD REV NUTR DIET, V80, P15; UTERMANN G, 1980, AM J HUM GENET, V32, P339; Ward H, 2009, ARCH INTERN MED, V169, P1424, DOI 10.1001/archinternmed.2009.234; Weggemans RM, 2001, ATHEROSCLEROSIS, V154, P547, DOI 10.1016/S0021-9150(00)00720-6; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WHO, 2003, WHO TECHN REP SER; Wu K, 2007, EUR HEART J, V28, P2930, DOI 10.1093/eurheartj/ehm482	40	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41525	10.1371/journal.pone.0041525	http://dx.doi.org/10.1371/journal.pone.0041525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844488	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700099
J	Pednekar, MS; Hakama, M; Gupta, PC				Pednekar, Mangesh S.; Hakama, Matti; Gupta, Prakash C.			Tobacco Use or Body Mass - Do They Predict Tuberculosis Mortality in Mumbai, India? Results from a Population-Based Cohort Study	PLOS ONE			English	Article							EXCLUDING EARLY DEATHS; ALL-CAUSE; SMOKING; INDEX; ASSOCIATION; BOMBAY; RISK; HEALTH	Tobacco use and under-nutrition are major public health concerns and tuberculosis is a major cause of morbidity and mortality in India. Using a cohort of 148,173 persons (recruited 1991-1997 and followed-up 1997-2003) the joint effects of tobacco use and BMI on tuberculosis mortality was studied. Tobacco use in any form and low-BMI had joint effect on tuberculosis mortality and the interaction effect was synergistic in men and antagonistic in women. Self-reported tuberculosis was associated with increased risk of tuberculosis mortality. In contrast, no such association was observed for self-reported diabetes persons. The risk pattern remained unchanged even after excluding tuberculosis deaths occurred within 1 st two years of follow-up. This study highlights importance of age consideration of individual while excluding early deaths. Around 27% male tuberculosis deaths were attributable to their being underweight and smoker, while 22% male and 37% female deaths were attributable to their being underweight and smokeless tobacco user.	[Pednekar, Mangesh S.; Gupta, Prakash C.] Sekhsaria Inst Publ Hlth, Cbd Belapur, India; [Hakama, Matti] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland	Tampere University	Pednekar, MS (corresponding author), Sekhsaria Inst Publ Hlth, Cbd Belapur, India.	pednekarmangesh@rediffmail.com		Pednekar, Mangesh/0000-0001-6266-5356	International Agency for Research on Cancer, Lyon, France; Clinical Trial Service Unit of the University of Oxford, Oxford, United Kingdom; World Health Organization Geneva, Switzerland; Centre for Global Health Research, University of Toronto, Toronto, Canada	International Agency for Research on Cancer, Lyon, France; Clinical Trial Service Unit of the University of Oxford, Oxford, United Kingdom; World Health Organization Geneva, Switzerland(World Health Organization); Centre for Global Health Research, University of Toronto, Toronto, Canada	The authors appreciate the collaborative efforts of the International Agency for Research on Cancer, Lyon, France; the Clinical Trial Service Unit of the University of Oxford, Oxford, United Kingdom; the World Health Organization Geneva, Switzerland; and Centre for Global Health Research, University of Toronto, Toronto, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Allison DB, 1999, ANN EPIDEMIOL, V9, P132, DOI 10.1016/S1047-2797(98)00039-8; Allison DB, 1999, OBES RES, V7, P342, DOI 10.1002/j.1550-8528.1999.tb00417.x; [Anonymous], 2011, GLOB TUB CONTR; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Corwin Elizabeth J, 2002, Biol Res Nurs, V3, P222, DOI 10.1177/109980040200300407; COX DR, 1972, J R STAT SOC B, V34, P187; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Ezzati M, 2004, COMP QUANTIFICATION, V2; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Keusch GT, 2003, J NUTR, V133, p336S, DOI 10.1093/jn/133.1.336S; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; MARTI B, 1989, BRIT MED J, V298, P1287, DOI 10.1136/bmj.298.6683.1287; Maurya V, 2002, INT J TUBERC LUNG D, V6, P942; Moszczynski P, 2001, TOXICOL LETT, V118, P121, DOI 10.1016/S0378-4274(00)00270-8; Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Pednekar MS, 2008, AM J EPIDEMIOL, V167, P330, DOI 10.1093/aje/kwm293; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Pednekar MS, 2012, ALCOHOL, V46, P139, DOI 10.1016/j.alcohol.2011.08.006; Pednekar MS, 2009, CANCER EPIDEMIOL, V33, P424, DOI 10.1016/j.canep.2009.09.007; Pednekar MS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-70; Pednekar MS, 2008, ACTA U TAMPERENSIS, V1340; Reddy KS, 2004, REPORT TOBACCO CONTR; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Shukla HC, 2002, J EPIDEMIOL COMMUN H, V56, P876, DOI 10.1136/jech.56.11.876; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Sorensen G, 2005, AM J PUBLIC HEALTH, V95, P1003, DOI 10.2105/AJPH.2004.045039; Stevens J, 2001, AM J EPIDEMIOL, V153, P946, DOI 10.1093/aje/153.10.946; Yew WW, 2006, AM J RESP CRIT CARE, V174, P236, DOI 10.1164/rccm.200605-669ED	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39443	10.1371/journal.pone.0039443	http://dx.doi.org/10.1371/journal.pone.0039443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848354	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200010
J	Siegrist, CA; van Delden, C; Bel, M; Combescure, C; Delhumeau, C; Cavassini, M; Clerc, O; Meier, S; Hadaya, K; Soccal, PM; Yerly, S; Kaiser, L; Hirschel, B; Calmy, A				Siegrist, Claire-Anne; van Delden, Christian; Bel, Michael; Combescure, Christophe; Delhumeau, Cecile; Cavassini, Matthias; Clerc, Olivier; Meier, Sara; Hadaya, Karine; Soccal, Paola M.; Yerly, Sabine; Kaiser, Laurent; Hirschel, Bernard; Calmy, Alexandra		H1N1 Study Grp; SHCS	Higher Memory Responses in HIV-Infected and Kidney Transplanted Patients than in Healthy Subjects following Priming with the Pandemic Vaccine	PLOS ONE			English	Article							INFLUENZA-A H1N1; SPLIT VIRION; RECIPIENTS; IMMUNOGENICITY	Background: Memory responses require immune competence. We assessed the influence of priming with AS03-adjuvanted pandemic vaccine (Pandemrix (R)) on memory responses of HIV patients, kidney recipients (SOT) and healthy controls (HC). Method: Participants (HIV: 197, SOT: 53; HC: 156) were enrolled in a prospective study and 390/406 (96%) completed it. All had been primed in 2009/2010 with 1 (HC) or 2 (patients) doses of Pandemrix (R), and were boosted with the 2010/2011 seasonal influenza vaccine. Geometric mean titres and seroprotection rates were measured 12 months after priming and 4 weeks after boosting. Primary and memory responses were directly compared in 191 participants (HCW: 69, HIV: 71, SOT: 51) followed during 2 consecutive seasons. Results: Most participants (HC: 77.8%, HIV: 77.6%, SOT: 66%) remained seroprotected at 12 months post-priming. Persisting A/09/H1N1 titers were high in HIV (100.2) and HC (120.1), but lower in SOT (61.4) patients. Memory responses reached higher titers in HIV (507.8) than in HC (253.5) and SOT (136.9) patients. Increasing age and lack of HAART reduced persisting and memory responses, mainly influenced by residual antibody titers. Comparing 2009/2010 and 2010/2011 titers in 191 participants followed for 2 seasons indicated lower post-2010/2011 titers in HC (240.2 vs 313.9), but higher titers in HIV (435.7 vs 338.0) and SOT (136 vs 90.3) patients. Conclusions: Priming with 2 doses of Pandemrix (R) elicited persistent antibody responses and even stronger memory responses to non-adjuvanted seasonal vaccine in HIV patients than 1 dose in healthy subjects. Adjuvanted influenza vaccines may improve memory responses of immunocompromised patients.	[Siegrist, Claire-Anne; Bel, Michael; Meier, Sara] Univ Hosp Geneva, Dept Pathol Immunol & Paediat, Geneva, Switzerland; [Siegrist, Claire-Anne; van Delden, Christian; Bel, Michael; Combescure, Christophe; Delhumeau, Cecile; Meier, Sara; Hadaya, Karine; Soccal, Paola M.; Yerly, Sabine; Kaiser, Laurent; Hirschel, Bernard; Calmy, Alexandra] Univ Geneva, Fac Med, Geneva, Switzerland; [van Delden, Christian; Hadaya, Karine; Soccal, Paola M.] Univ Hosp Geneva, Dept Surg, Geneva, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Clin Res Ctr, Geneva, Switzerland; [Cavassini, Matthias; Clerc, Olivier] CHU Vaudois, Infect Dis Serv, Lausanne, Switzerland; [Yerly, Sabine; Kaiser, Laurent] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Yerly, Sabine; Kaiser, Laurent] Univ Hosp Geneva, Dept Genet & Lab Med, Swiss Natl Ctr Influenza, Geneva, Switzerland; [Yerly, Sabine; Kaiser, Laurent] Univ Hosp Geneva, Dept Med Special, Geneva, Switzerland; [Delhumeau, Cecile; Hirschel, Bernard; Calmy, Alexandra] Univ Hosp Geneva, Dept Internal Med, Div Infect Dis, HIV Unit, Geneva, Switzerland; [Cavassini, Matthias; Clerc, Olivier] Univ Lausanne, Univ Hosp, Div Infect Dis, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Siegrist, CA (corresponding author), Univ Hosp Geneva, Dept Pathol Immunol & Paediat, Geneva, Switzerland.	alexandra.calmy@hcuge.ch	Posfay-Barbe, Klara M/E-9131-2013; Pantaleo, Giuseppe/K-6163-2016; cavassini, matthias/F-8987-2017	Posfay-Barbe, Klara M/0000-0001-9464-5704; Kaiser, Laurent/0000-0002-0857-2252; Passweg, Jakob R/0000-0001-7092-3351; cavassini, matthias/0000-0003-0933-7833	Centre de Recherche Clinique of the University Hospitals of Geneva and Medical Faculty of Geneva; Louis Jeantet Foundation; Centre of Vaccinology of the Swiss HIV Cohort Study; Swiss National Science Foundation [33CS30_134277]; Swiss Federal Office of Public Health	Centre de Recherche Clinique of the University Hospitals of Geneva and Medical Faculty of Geneva; Louis Jeantet Foundation; Centre of Vaccinology of the Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Office of Public Health	This work was supported by an Institutional grant of the Centre de Recherche Clinique of the University Hospitals of Geneva and Medical Faculty of Geneva, by the Louis Jeantet Foundation, by the Centre of Vaccinology and in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant # 33CS30_134277). MB and Y. Thomas were supported by the Swiss Federal Office of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel M, 2011, CLIN INFECT DIS, V52, P122, DOI 10.1093/cid/ciq003; Bickel M, 2010, AIDS, V24, pF31, DOI 10.1097/QAD.0b013e3283398da1; Brakemeier S, 2011, NEPHROL DIAL TRANSPL; Cagigi A, 2010, LANCET INFECT DIS, V10, P499, DOI 10.1016/S1473-3099(10)70117-1; Calmy A, 2011, HIV MED; Cordero E, 2012, CLIN MICROBIOL INFEC, V18, P67, DOI 10.1111/j.1469-0691.2011.03537.x; Cordero E, 2011, EUR J CLIN MICROBIOL; Crespo M, 2011, CLIN J AM SOC NEPHRO, V6, P2208, DOI 10.2215/CJN.02160311; Crum-Cianflone NF, 2011, VACCINE, V29, P3183, DOI 10.1016/j.vaccine.2011.02.040; Feiterna-Sperling C, 2010, CLIN INFECT DIS, V51, pE90, DOI 10.1086/657121; Gabay C, 2011, ARTHRITIS RHEUM-US, V63, P1486, DOI 10.1002/art.30325; Hatakeyama S, 2011, VACCINE, V29, P9224, DOI 10.1016/j.vaccine.2011.09.106; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; L'Huillier AG, 2012, HIV MED, V13, P54, DOI 10.1111/j.1468-1293.2011.00936.x; Lagler H, 2011, VACCINE, V29, P6888, DOI 10.1016/j.vaccine.2011.07.050; Launay O, 2011, J INFECT DIS, V204, P124, DOI 10.1093/infdis/jir211; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Low CY, 2010, TRANSPLANTATION, V90, P1016, DOI 10.1097/TP.0b013e3181f546cf; Manuel O, 2011, CLIN INFECT DIS, V52, P248, DOI 10.1093/cid/ciq104; Martinez E, 2011, HIV MED, V12, P236, DOI 10.1111/j.1468-1293.2010.00905.x; Miraglia JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027214; Ormsby CE, 2011, AIDS, V25, P435, DOI 10.1097/QAD.0b013e3283434844; Perez CM, 2010, AIDS, V24, P2867, DOI 10.1097/QAD.0b013e32833e92d5; Riera M, 2010, AIDS, V24, P2460, DOI 10.1097/QAD.0b013e32833e508f; Siegrist C, RESPONSES S IN PRESS; Smud A, 2010, TRANSPLANTATION, V90, P1458, DOI 10.1097/TP.0b013e3181fc09fe; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Tremblay CL, 2011, VACCINE, V29, P1359, DOI 10.1016/j.vaccine.2010.12.023	31	8	8	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40428	10.1371/journal.pone.0040428	http://dx.doi.org/10.1371/journal.pone.0040428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848378	Green Published, gold			2022-12-27	WOS:000306950200020
J	Gismondi, E; Rigaud, T; Beisel, JN; Cossu-Leguille, C				Gismondi, Eric; Rigaud, Thierry; Beisel, Jean-Nicolas; Cossu-Leguille, Carole			Effect of Multiple Parasitic Infections on the Tolerance to Pollutant Contamination	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; POMPHORHYNCHUS-LAEVIS ACANTHOCEPHALA; AMPHIPOD GAMMARUS-ROESELI; INTERMEDIATE HOST; MICROSPORIDIA PARASITES; TRANSMISSION STRATEGIES; POLYMORPHUS-MINUTUS; NONHOST PREDATOR; CADMIUM EXPOSURE; FIELD EVIDENCE	The horizontally-transmitted acanthocephalan parasite Polymorphus minutus and the vertically-transmitted microsporidian parasite Dictyocoela roeselum have both been shown to influence on the antitoxic responses of mono-infected Gammarus roeseli exposed to cadmium. The present study investigates the effect of this co-infection on the antitoxic defence responses of naturally infected females exposed to cadmium stress. Our results revealed that, depending on the cadmium dose, bi-infection induced only slight, significant increased cell damage in G. roeseli as compared to non-infection. In addition, the antitoxic defence pattern of cadmium-exposed bi-infected hosts was similar to the pattern of cadmium-exposed D. roeselum-infected hosts. Reduced glutathione concentrations, carotenoid levels and c-glutamylcystein ligase activity decreased, while metallothionein concentrations increased. This similar pattern indicates that host physiology can be controlled to some extent by microsporidia under stress conditions. It supports the hypothesis of a disruption of acanthocephalan effects in the presence of microsporidia. However, the global negative effects of bi-infection on host condition should be tested on more biological models, since competition between parasites depends on life history trade-off.	[Gismondi, Eric; Beisel, Jean-Nicolas; Cossu-Leguille, Carole] UdL, LIEBE, Metz, France; [Rigaud, Thierry] Univ Bourgogne, Equipe Ecol Evolut, Dijon, France	Universite de Lorraine; Universite de Bourgogne	Gismondi, E (corresponding author), UdL, LIEBE, Campus Bridoux,Bat IBiSE, Metz, France.	eric.gismondi@hotmail.fr	Gismondi, Eric/ABC-4356-2020; Rigaud, Thierry/ABE-2552-2020; Rigaud, Thierry/T-4053-2017; Beisel, Jean-Nicolas/H-4392-2011	Rigaud, Thierry/0000-0002-0163-6639; Rigaud, Thierry/0000-0002-0163-6639; Beisel, Jean-Nicolas/0000-0002-1935-7689; Cossu-Leguille, Carole/0000-0002-6284-4415; Gismondi, Eric/0000-0003-3102-3443	French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche); research program EC2CO (Ecosphere Continentale et Cotiere)	French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche); research program EC2CO (Ecosphere Continentale et Cotiere)	This study was supported by the French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche). The present work was funded by the research program EC2CO (Ecosphere Continentale et Cotiere). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhama J, 2006, J CHROMATOGR A, V1107, P52, DOI 10.1016/j.chroma.2005.11.057; Allan IJ, 2006, TALANTA, V69, P302, DOI 10.1016/j.talanta.2005.09.043; Baudrimont M, 2007, PARASITOLOGY, V134, P237, DOI 10.1017/S0031182006001375; Bauer A, 2000, INT J PARASITOL, V30, P1453, DOI 10.1016/S0020-7519(00)00138-7; BEHRENS WA, 1991, LIPIDS, V26, P232, DOI 10.1007/BF02543977; Beisel JN, 2010, ETHOL ECOL EVOL, V22, P265, DOI 10.1080/03949370.2010.502321; Beliaeff B, 2002, ENVIRON TOXICOL CHEM, V21, P1316, DOI 10.1002/etc.5620210629; Ben-Ami F, 2011, J EVOLUTION BIOL, V24, P1307, DOI 10.1111/j.1420-9101.2011.02264.x; Bigot A, 2011, ENVIRON TOXICOL, V26, P623, DOI 10.1002/tox.20599; Bollache L, 2002, J INVERTEBR PATHOL, V79, P102, DOI 10.1016/S0022-2011(02)00027-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; CARGILL AS, 1985, FRESHWATER BIOL, V15, P455, DOI 10.1111/j.1365-2427.1985.tb00215.x; Cezilly F, 2000, PARASITOLOGY, V120, P625, DOI 10.1017/S0031182099005910; Dezfuli BS, 2003, J FISH DIS, V26, P155, DOI 10.1046/j.1365-2761.2003.00446.x; Dianne L, 2011, EVOLUTION, V65, P2692, DOI 10.1111/j.1558-5646.2011.01330.x; GILCHRIST BM, 1972, COMP BIOCHEM PHYSIOL, V42, P263, DOI 10.1016/0305-0491(72)90273-8; Gismondi E, 2012, PARASITOLOGY, V139, P1054, DOI 10.1017/S0031182012000315; Gismondi E, ECOTOXICOLO IN PRESS; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Haine ER, 2004, INT J PARASITOL, V34, P1137, DOI 10.1016/j.ijpara.2004.06.006; Haine ER, 2005, P ROY SOC B-BIOL SCI, V272, P2505, DOI 10.1098/rspb.2005.3244; Hughes WOH, 2004, P ROY SOC B-BIOL SCI, V271, pS104, DOI 10.1098/rsbl.2003.0115; Hynes H. B. N., 1963, Journal of Helminthology, V37, P185, DOI 10.1017/S0022149X00003771; Jones EO, 2007, J THEOR BIOL, V246, P10, DOI 10.1016/j.jtbi.2006.12.007; Jones EO, 2010, EVOLUTION, V64, P2408, DOI 10.1111/j.1558-5646.2010.00992.x; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1, DOI 10.2277/ 0521850088; Kunz PY, 2010, REV ENVIRON CONTAM T, V205, P1, DOI 10.1007/978-1-4419-5623-1_1; Lagrue C, 2007, ECOLOGY, V88, P2839, DOI 10.1890/06-2105.1; LEROY P, 1993, CHROMATOGRAPHIA, V36, P130, DOI 10.1007/BF02263849; Lohr JN, 2010, PARASITOLOGY, V137, P1493, DOI 10.1017/S0031182010000296; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marcogliese DJ, 2005, DIS AQUAT ORGAN, V63, P77, DOI 10.3354/dao063077; Maynard BJ, 1998, J PARASITOL, V84, P1102, DOI 10.2307/3284656; MCCAHON CP, 1991, FRESHWATER BIOL, V25, P507, DOI 10.1111/j.1365-2427.1991.tb01393.x; Medoc V, 2006, INT J PARASITOL, V36, P1351, DOI 10.1016/j.ijpara.2006.07.001; Medoc V, 2009, NATURWISSENSCHAFTEN, V96, P513, DOI 10.1007/s00114-008-0503-8; Medoc V, 2009, ANIM BEHAV, V77, P1235, DOI 10.1016/j.anbehav.2009.01.029; Minguez L, 2009, ENVIRON RES, V109, P843, DOI 10.1016/j.envres.2009.07.012; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; PALOZZA P, 1992, METHOD ENZYMOL, V213, P403; Parmentier C, 1998, J CHROMATOGR B, V719, P37, DOI 10.1016/S0378-4347(98)00414-9; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Perrot-Minnot MJ, 2004, INT J PARASITOL, V34, P45, DOI 10.1016/j.ijpara.2003.10.005; Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1; Rauque CA, 2009, J INVERTEBR PATHOL, V100, P35, DOI 10.1016/j.jip.2008.10.001; Rigaud T, 2005, BEHAV PROCESS, V68, P259, DOI 10.1016/j.beproc.2004.09.005; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; ROESIJADI G, 1992, AQUAT TOXICOL, V22, P81, DOI 10.1016/0166-445X(92)90026-J; Sparkes TC, 1996, OECOLOGIA, V106, P166, DOI 10.1007/BF00328595; Sures B, 2007, J HELMINTHOL, V81, P191, DOI 10.1017/S0022149X07751465; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Thomas MB, 2003, ECOL LETT, V6, P183, DOI 10.1046/j.1461-0248.2003.00414.x; Vasseur P, 2004, ENVIRON TOXICOL, V19, P433, DOI 10.1002/tox.20024	56	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41950	10.1371/journal.pone.0041950	http://dx.doi.org/10.1371/journal.pone.0041950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844535	Green Published, gold			2022-12-27	WOS:000309240600058
J	Li, SW; He, J; Li, S; Cao, GQ; Tang, ST; Tong, QS; Joshi, HC				Li, Shiwang; He, Jing; Li, Shuai; Cao, Guoqing; Tang, Shaotao; Tong, Qiangsong; Joshi, Harish C.			Noscapine Induced Apoptosis via Downregulation of Survivin in Human Neuroblastoma Cells Having Wild Type or Null p53	PLOS ONE			English	Article							CANCER CELLS; AGENTS; EXPRESSION; PROTEIN; GROWTH; GENE; INHIBITOR; PATHWAY; ASSAY; IAPS	Neuroblastoma is the most common extracranial solid tumor of childhood. It accounts for 15% of pediatric cancer deaths. Chemotherapy is the mainstay of treatment in children with advanced neuroblastoma. Noscapine, a nontoxic natural compound, can trigger apoptosis in many cancer types. We now show that p53 is dispensable for Noscapine-induced cell death in neuroblastoma cell lines, proapoptotic response to this promising chemopreventive agent is mediated by suppression of survivin protein expression. The Noscapine treatment increased levels of total and Ser(15)-phosphorylated p53 protein in SK-SY5Y cells, but the proapoptotic response to this agent was maintained even after knockdown of the p53 protein level. Exposure of SK-SY5Y and LA1-5S cells to Noscapine resulted in a marked decrease in protein and mRNA level of survivin as early as 12 hours after treatment. Ectopic expression of survivin conferred statistically significant protection against Noscapine-mediated cytoplasmic histone-associated apoptotic DNA fragmentation. Also, the Noscapine-induced apoptosis was modestly but statistically significantly augmented by RNA interference of survivin in both cell lines. Furthermore, Noscapine-induced apoptotic cell death was associated with activation of caspase-3 and cleavage of PARP. In conclusion, the present study provides novel insight into the molecular circuitry of Noscapine-induced apoptosis to indicate suppression of survivin expression as a critical mediator of this process.	[He, Jing] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430074, Peoples R China; [Li, Shiwang; Li, Shuai; Cao, Guoqing; Tang, Shaotao; Tong, Qiangsong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat Surg, Wuhan 430074, Peoples R China; [Joshi, Harish C.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Emory University	He, J (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430074, Peoples R China.	jing937@hotmail.com	Tong, Qiangsong/B-4500-2014	Tong, Qiangsong/0000-0002-2615-6404	National Natural Science Foundation of China (NSFC) [81070429, 30600278, 30772359]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Grant support: the National Natural Science Foundation of China (NSFC) grants 81070429 (Jing He), 30600278 and 30772359 (Qiangsong Tong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Anderson JT, 2005, J MED CHEM, V48, P7096, DOI 10.1021/jm050674q; Anderson JT, 2005, J MED CHEM, V48, P2756, DOI 10.1021/jm0494220; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2007, CANCER RES, V67, P3862, DOI 10.1158/0008-5472.CAN-06-4282; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Arkin M, 2005, CURR OPIN CHEM BIOL, V9, P317, DOI 10.1016/j.cbpa.2005.03.001; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Duflos Alain, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P55, DOI 10.2174/1568011023354452; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gu L, 2011, ONCOGENE; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; He J, 2011, CELL CYCLE, V10, P2994, DOI 10.4161/cc.10.17.17118; Heidari N, 2007, ANTI-CANCER DRUG, V18, P1139, DOI 10.1097/CAD.0b013e3282eea257; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Ke Y, 2000, CANCER IMMUNOL IMMUN, V49, P217, DOI 10.1007/s002620000109; Landen JW, 2004, CLIN CANCER RES, V10, P5187, DOI 10.1158/1078-0432.CCR-04-0360; Landen JW, 2002, CANCER RES, V62, P4109; Lens SMA, 2003, CELL CYCLE, V2, P507, DOI 10.4161/cc.2.6.559; Li FZ, 1999, CANCER RES, V59, P3143; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Reed JC, 2000, CELL, V102, P545, DOI 10.1016/S0092-8674(00)00076-3; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Rowinsky EK, 1997, ANNU REV MED, V48, P353; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Tamm I, 2004, CLIN CANCER RES, V10, P3737, DOI 10.1158/1078-0432.CCR-03-0642; Tamm I, 1998, CANCER RES, V58, P5315; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tanaka N, 2008, INT J ONCOL, V33, P815, DOI 10.3892/ijo_00000069; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; von Reitzenstein C, 2001, EUR J BIOCHEM, V268, P326, DOI 10.1046/j.1432-1327.2001.01883.x; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	40	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40076	10.1371/journal.pone.0040076	http://dx.doi.org/10.1371/journal.pone.0040076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848370	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600006
J	Bomtorin, AD; Barchuk, AR; Moda, LM; Simoes, ZLP				Bomtorin, Ana Durvalina; Barchuk, Angel Roberto; Moda, Livia Maria; Paulino Simoes, Zila Luz			Hox Gene Expression Leads to Differential Hind Leg Development between Honeybee Castes	PLOS ONE			English	Article							BEE APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; CUTICLE GENE; CUTICULAR PROTEINS; JUVENILE-HORMONE; ULTRABITHORAX; EVOLUTION; TOOL; MECHANORECEPTORS; CYTOCHROME-P450	Beyond the physiological and behavioural, differences in appendage morphology between the workers and queens of Apis mellifera are pre-eminent. The hind legs of workers, which are highly specialized pollinators, deserve special attention. The hind tibia of worker has an expanded bristle-free region used for carrying pollen and propolis, the corbicula. In queens this structure is absent. Although the morphological differences are well characterized, the genetic inputs driving the development of this alternative morphology remain unknown. Leg phenotype determination takes place between the fourth and fifth larval instar and herein we show that the morphogenesis is completed at brown-eyed pupa. Using results from the hybridization of whole genome-based oligonucleotide arrays with RNA samples from hind leg imaginal discs of pre-pupal honeybees of both castes we present a list of 200 differentially expressed genes. Notably, there are castes preferentially expressed cuticular protein genes and members of the P450 family. We also provide results of qPCR analyses determining the developmental transcription profiles of eight selected genes, including abdominal-A, distal-less and ultrabithorax (Ubx), whose roles in leg development have been previously demonstrated in other insect models. Ubx expression in workers hind leg is approximately 25 times higher than in queens. Finally, immunohistochemistry assays show that Ubx localization during hind leg development resembles the bristles localization in the tibia/basitarsus of the adult legs in both castes. Our data strongly indicate that the development of the hind legs diphenism characteristic of this corbiculate species is driven by a set of caste-preferentially expressed genes, such as those encoding cuticular protein genes, P450 and Hox proteins, in response to the naturally different diets offered to honeybees during the larval period.	[Bomtorin, Ana Durvalina; Moda, Livia Maria] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil; [Barchuk, Angel Roberto] Univ Fed Alfenas, Inst Ciencias Biomed, Dept Biol Celular Tecidual & Desenvolvimento, Alfenas, MG, Brazil; [Paulino Simoes, Zila Luz] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Alfenas; Universidade de Sao Paulo	Bomtorin, AD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil.	zlpsimoe@usp.br	Simoes, Zila Luz Paulino/H-7314-2014; Bomtorin, Ana/I-8817-2012; Moda, Livia M/I-6451-2012	Bomtorin, Ana/0000-0002-3331-7843; Moda, Livia M/0000-0001-6381-7788; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) [2005/03926-5, 2011/03171-5, 2009/05675-0, 2004/08868-0]	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by the Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP grants 2005/03926-5 and 2011/03171-5), which also provided a fellowship to ADB (2009/05675-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Luiz Roberto Aguiar for technical assistance in the apiary of Ribeira ~ o Preto; Marcela A. F. B. Laure for technical assistance during dissections; Jose ' Augusto Maulin and Maria Dolores Seabra Ferreira for help with the scanning electron microscope; Dr. Rodrigo Panepucci for the Axon Genepix 4000B scanner; Lenaldo Branco Rocha for help with Laser Confocal Microscopy [ facility at FMRP- USP ( FAPESP grant number 2004/08868-0)]; Robert White for the FP6.87 antibody and Ricardo G. P. Ramos for secondary antibodies. We also thank Dr. Alexandre S. Cristino for his help with the Limma package for microarray analyses, and Dr. Klaus Hartfelder and anonymous reviewers for critical comments on an earlier version of this manuscript.	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alonso CR, 2002, CURR BIOL, V12, pR776, DOI 10.1016/S0960-9822(02)01291-5; Andersen SO, 2011, INSECT BIOCHEM MOLEC, V41, P620, DOI 10.1016/j.ibmb.2011.03.015; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Charroux B, 2006, DEV BIOL, V291, P278, DOI 10.1016/j.ydbio.2005.12.012; COHEN SM, 1989, EMBO J, V8, P2045, DOI 10.1002/j.1460-2075.1989.tb03613.x; Crickmore MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000633; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; FORD DM, 1981, J INSECT PHYSIOL, V27, P339, DOI 10.1016/0022-1910(81)90080-9; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809; Hartfelder K, 2012, 11 ENDOCRINE CONTROL, P464; Haydak MH, 1943, J ECON ENTOMOL, V36, P778, DOI 10.1093/jee/36.5.778; Hewes RS, 2000, GENETICS, V155, P1711; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Kawasaki H, 2002, DEV GROWTH DIFFER, V44, P419, DOI 10.1046/j.1440-169X.2002.00655.x; Kayashima Y, 2005, DEV GENES EVOL, V215, P545, DOI 10.1007/s00427-005-0013-z; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; Kojima T, 2004, DEV GROWTH DIFFER, V46, P115; Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Mahfooz NS, 2004, P NATL ACAD SCI USA, V101, P4877, DOI 10.1073/pnas.0401216101; Maibeche-Coisne M, 2000, BIOCHEM BIOPH RES CO, V273, P1132, DOI 10.1006/bbrc.2000.3058; MARDON G, 1994, DEVELOPMENT, V120, P3473; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MCIVER SB, 1975, ANNU REV ENTOMOL, V20, P381, DOI 10.1146/annurev.en.20.010175.002121; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Michener C.D., 1990, University of Kansas Science Bulletin, V54, P75; Michener Charles D., 2000, pi; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pepple KL, 2008, DEVELOPMENT, V135, P4071, DOI 10.1242/dev.028951; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Rozowski M, 2002, GENE DEV, V16, P1150, DOI 10.1101/gad.219302; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Satterfield TF, 2002, GENETICS, V162, P1687; Snodgrass R.E., 1956, ANATOMY HONEY BEE, P334; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; THURM U, 1964, SCIENCE, V145, P1063, DOI 10.1126/science.145.3636.1063; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Walldorf U, 2000, DEV GENES EVOL, V210, P483, DOI 10.1007/s004270000091; Willingham AT, 2004, MECH DEVELOP, V121, P1289, DOI 10.1016/j.mod.2004.04.017; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001	60	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40111	10.1371/journal.pone.0040111	http://dx.doi.org/10.1371/journal.pone.0040111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848371	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600013
J	Cachay, ER; Agmas, W; Mathews, WC				Cachay, Edward R.; Agmas, Wollelaw; Mathews, William C.			Relative Accuracy of Cervical and Anal Cytology for Detection of High Grade Lesions by Colposcope Guided Biopsy: A Cut-Point Meta-Analytic Comparison	PLOS ONE			English	Article							LIQUID-BASED CYTOLOGY; HIV-INFECTED PATIENTS; HYBRID CAPTURE-II; INTRAEPITHELIAL NEOPLASIA; VISUAL INSPECTION; PAPANICOLAOU TEST; THIN-LAYER; PAP-SMEAR; CANCER; WOMEN	Background: We recently reported, using a receiver operating characteristic area metric, the first meta-analytic comparison of the relative accuracy of cervical and anal cytology in detecting moderate or severe histopathologic lesions by magnification directed punch biopsy. The aim of the present research was to meta-analytically examine cut-point specific operating characteristics (sensitivity, specificity) of cervical and anal cytology in detecting high grade squamous intraepithelial lesion (HSIL) histopathology by colposcope directed punch biopsy. Methodology/Principal Findings: The primary eligibility requirement was availability of tabulated cytology (normal, atypical cells of unclear significance [ASCUS], low grade squamous intraepithelial lesion, HSIL or atypical squamous cells cannot rule out high grade [ASC-H]) and biopsy (<HSIL, >= HSIL) counts. Meta-analysis and meta-regression of diagnostic accuracy was performed with examination of study quality criteria and heterogeneity. Thirty-three cervical and 11 anal publications were eligible between 1990 and 2010. Meta-analytically cut-point analysis showed that using a cut-point of ASCUS the sensitivity in both settings is similar while anal cytology is less specific than cervical cytology (specificity [95% confidence interval] 0.33 [0.20-0.49] vs. 0.53[0.40-0.66], p = 0.04) for the detection of HSIL histopathology by colposcope directed punch biopsy. Conclusions/Significance: Using a cytology cut-point of HSIL or ASC-H, anal cytology is less sensitive but comparably specific to cervical cytology. However, using a cut-point of ASCUS, differences in accuracy were of borderline significance.	[Cachay, Edward R.; Agmas, Wollelaw; Mathews, William C.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego	Cachay, ER (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	ecachay@ucsd.edu	Mathews, William C/E-4451-2010	Mathews, William C/0000-0002-2352-0725	Clinical Investigation Core of the University of California San Diego Center for AIDS Research [AI036214]; CFAR Network of Integrated Clinical Systems (CNICS) [R24 AI067039-01A1]; Pacific AIDS Education and Training Center (PAETC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R24AI067039] Funding Source: NIH RePORTER	Clinical Investigation Core of the University of California San Diego Center for AIDS Research; CFAR Network of Integrated Clinical Systems (CNICS); Pacific AIDS Education and Training Center (PAETC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Clinical Investigation Core of the University of California San Diego Center for AIDS Research [AI036214], the CFAR Network of Integrated Clinical Systems (CNICS) [R24 AI067039-01A1], and the Pacific AIDS Education and Training Center (PAETC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou M, 2009, ANTICANCER RES, V29, P3401; AIDS Institute New York Department of Health, 2007, NEW YORK STAT GUID R; Andersson S, 2009, AM J PATHOL, V175, P1831, DOI 10.2353/ajpath.2009.090122; Angstetra D, 2009, AUST NZ J OBSTET GYN, V49, P681, DOI 10.1111/j.1479-828X.2009.01095.x; Antonishyn NA, 2009, ARCH PATHOL LAB MED, V133, P1577, DOI 10.1043/1543-2165-133.10.1577; Baer A, 2002, OBSTET GYNECOL, V99, P1053, DOI 10.1016/S0029-7844(02)01998-1; Belinson JL, 2002, ACTA CYTOL, V46, P470, DOI 10.1159/000326863; Benevolo M, 2008, AM J CLIN PATHOL, V129, P606, DOI 10.1309/BEPQXTCQD61RGFMJ; Berry JM, 2009, DIS COLON RECTUM, V52, P239, DOI 10.1007/DCR.0b013e31819793d9; Bigras G, 2005, BRIT J CANCER, V93, P575, DOI 10.1038/sj.bjc.6602728; Carns B, 2008, INT J CLIN EXP PATHO, V1, P285; Chung JH, 2005, GYNECOL ONCOL, V99, P597, DOI 10.1016/j.ygyno.2005.06.059; Cohn JA, 2001, AM J OBSTET GYNECOL, V184, P322, DOI 10.1067/mob.2001.109938; Cranston RD, 2004, JAIDS-J ACQ IMM DEF, V36, P915, DOI 10.1097/00126334-200408010-00004; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Silva ITDE, 2011, CANCER CYTOPATHOL, V119, P167, DOI 10.1002/cncy.20143; de Castro Ferraz MDG, 2004, DIAGN CYTOPATHOL, V30, P220, DOI 10.1002/dc.10409; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DIBONITO L, 1993, CANCER-AM CANCER SOC, V72, P3002, DOI 10.1002/1097-0142(19931115)72:10<3002::AID-CNCR2820721023>3.0.CO;2-4; Alves RRF, 2009, DIAGN CYTOPATHOL, V37, P68, DOI 10.1002/dc.20976; Guerra B, 1998, J REPROD MED, V43, P647; Guo M, 2005, ACTA CYTOL, V49, P132, DOI 10.1159/000326120; Guo M, 2007, ACTA CYTOL, V51, P749, DOI 10.1159/000325838; Harkness CB, 2003, J REPROD MED, V48, P681; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Howard M, 2002, OBSTET GYNECOL, V100, P972, DOI 10.1016/S0029-7844(02)02315-3; Jones BA, 1996, ARCH PATHOL LAB MED, V120, P523; Kumar K, 2007, INDIAN J MED RES, V126, P39; Lee GY, 2005, INT J GYNECOL CANCER, V15, P81, DOI 10.1111/j.1048-891x.2005.14417.x; Lorenzato F, 2000, INT J GYNECOL CANCER, V10, P143, DOI 10.1046/j.1525-1438.2000.00007.x; Lytwyn A, 2005, CANCER-AM CANCER SOC, V103, P1447, DOI 10.1002/cncr.20927; Mao Constance, 2005, J Low Genit Tract Dis, V9, P82, DOI 10.1097/00128360-200504000-00003; Mathews WC, 2004, JAIDS-J ACQ IMM DEF, V37, P1610, DOI 10.1097/00126334-200412150-00014; Mathews WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012284; Mathews WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024946; Nahas CSR, 2009, DIS COLON RECTUM, V52, P1854, DOI 10.1007/DCR.0b013e3181b98f36; NATHAN M, 2010, 17 INT AIDS C MEX CI, V24, P373, DOI DOI 10.1097/QAD.0B013E328333AB8E; Palefsky J, 2012, ANAL CANC INFO; Palefsky JM, 1997, J ACQ IMMUN DEF SYND, V14, P415, DOI 10.1097/00042560-199704150-00004; Pan QJ, 2003, ACTA CYTOL, V47, P45, DOI 10.1159/000326474; Panther LA, 2004, CLIN INFECT DIS, V38, P1495; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Pimple SA, 2010, INDIAN J CANCER, V47, P308, DOI 10.4103/0019-509X.64726; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; SALIT IE, 2010, 17 INT AIDS C MEX CI, V24, P1307, DOI DOI 10.1097/QAD.0B013E328339E592; Sangiva-Lugoma G, 2006, INT J CANCER, V119, P1389, DOI 10.1002/ijc.21972; Simsir A, 2001, ACTA CYTOL, V45, P23, DOI 10.1159/000327183; Sun XR, 2005, CELL ONCOL, V27, P33; Taylor S, 2006, INT J CANCER, V118, P957, DOI 10.1002/ijc.21434; Williams VM, 2010, SEX HEALTH, V7, P346, DOI 10.1071/SH09118; Witt A., 2003, Archives of Gynecology and Obstetrics, V268, P29; Yu BKJ, 2003, EUR J GYNAECOL ONCOL, V24, P495	52	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e38956	10.1371/journal.pone.0038956	http://dx.doi.org/10.1371/journal.pone.0038956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848345	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600001
J	Chen, S; Chen, CM; Zhou, Y; Zhou, RJ; Yu, KD; Shao, ZM				Chen, Sheng; Chen, Can-Ming; Zhou, Ying; Zhou, Ruo-Ji; Yu, Ke-Da; Shao, Zhi-Ming			Obesity or Overweight Is Associated with Worse Pathological Response to Neoadjuvant Chemotherapy among Chinese Women with Breast Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; PRIMARY TUMOR; WEIGHT; PROGNOSIS; RISK; DIAGNOSIS; SURVIVAL; SIZE	Background: To evaluate the relationship between body mass index (BMI) and response to neoadjuvant chemotherapy (NCT) for breast cancer among Chinese women. Patients and Methods: A total of 307 eligible patients were assigned to receive four cycles of paclitaxel and carboplatin before standard surgery for breast cancer from 2007 to 2011 at Shanghai Cancer Hospital. The patients were categorized as obese, overweight, normal weight, or underweight based on BMI according to World Health Organization (WHO) criteria. Pathological complete response (pCR) was defined as no invasive cancer in the breast or axillary tissue. A logistic regression and the Chi-squared test were used for detecting the predictors of pCR and determining the relationship between BMI category and pCR rate in the subgroup analysis with respect to other variables. Results: Categorical BMI, estrogen receptor (ER), and progesterone receptor (PR) status were independent predictors of pCR according to the multivariate analysis. Patients with BMI >= 25 were less likely to achieve a pCR to NCT compared with patients with BMI, 25 (Odds ratio: 0.454, p = 0.033, multivariate analysis). In the subgroup analysis, the predictive value of BMI for pCR to NCT was significantly shown in post-menopausal patients (p = 0.004) and hormonal receptor status-negative patients (p = 0.038). The incidence of treatment-induced toxicity was similar among the different BMI categories. Conclusion: Higher BMI was associated with worse pCR to NCT. Further approaches to investigating the mechanism of this influence of BMI on treatment response and a more appropriate schedule for calculating NCT dose for high-BMI-patients should be considered.	[Chen, Sheng; Chen, Can-Ming; Zhou, Ying; Yu, Ke-Da; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Dept Breast Surg, Shanghai 200433, Peoples R China; [Chen, Sheng; Chen, Can-Ming; Zhou, Ying; Zhou, Ruo-Ji; Yu, Ke-Da; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Zhou, Ruo-Ji] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Dept Pathol, Shanghai 200433, Peoples R China; [Shao, Zhi-Ming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Chen, S (corresponding author), Fudan Univ, Shanghai Canc Ctr, Inst Canc, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com		Zhou, Ruoji/0000-0001-7474-7156	Multidiscipline Comprehensive Treatment Cooperation Group, Foundation of Fudan University Cancer Hospital, Shanghai, China [DXK200801]; Key Clinical Program of the Ministry of Health; Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; National Natural Science Foundation of China [30971143, 30972936, 81001169]; Shanghai Committee of Science and Technology Fund for Qimingxing Project [11QA1401400]	Multidiscipline Comprehensive Treatment Cooperation Group, Foundation of Fudan University Cancer Hospital, Shanghai, China; Key Clinical Program of the Ministry of Health; Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; Shanghai United Developing Technology Project of Municipal Hospitals; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology Fund for Qimingxing Project	This research was supported by Multidiscipline Comprehensive Treatment Cooperation Group, Foundation of Fudan University Cancer Hospital, Shanghai, China (DXK200801), the Key Clinical Program of the Ministry of Health (2010-2012), the 2009 Youth Foundation of Shanghai Public Health Bureau, the 2009 Youth Foundation of Shanghai Medical College, the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the National Natural Science Foundation of China (30971143, 30972936, 81001169), and the Shanghai Committee of Science and Technology Fund for 2011 Qimingxing Project (11QA1401400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, AM J CLIN NUTR, V68, P899; Caan BJ, 2008, CANCER CAUSE CONTROL, V19, P1319, DOI 10.1007/s10552-008-9203-0; Carmichael AR, 2006, OBES REV, V7, P333, DOI 10.1111/j.1467-789X.2006.00261.x; Carmichael AR, 2004, BREAST, V13, P85, DOI 10.1016/j.breast.2003.03.001; Carmichael AR, 2004, BREAST, V13, P93, DOI 10.1016/j.breast.2003.03.002; Chen XS, 2010, ANN ONCOL, V21, P961, DOI 10.1093/annonc/mdq041; Chen XL, 2010, BREAST CANCER RES TR, V122, P823, DOI 10.1007/s10549-009-0708-3; Dal Maso L, 2008, INT J CANCER, V123, P2188, DOI 10.1002/ijc.23747; Dawood S, 2008, CLIN CANCER RES, V14, P1718, DOI 10.1158/1078-0432.CCR-07-1479; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Enger SM, 2000, CANCER EPIDEM BIOMAR, V9, P681; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Kroenke CH, 2005, J CLIN ONCOL, V23, P1370, DOI 10.1200/JCO.2005.01.079; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Kwan ML, 2010, ARCH SURG-CHICAGO, V145, P1055, DOI 10.1001/archsurg.2010.231; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Litton JK, 2008, J CLIN ONCOL, V26, P4072, DOI 10.1200/JCO.2007.14.4527; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Maehle BO, 2001, BREAST CANCER RES TR, V68, P159, DOI 10.1023/A:1011977118921; Nahleh Z, 2011, EXPERT REV ANTICANC, V11, P817, DOI [10.1586/era.11.67, 10.1586/ERA.11.67]; Poikonen P, 2001, ACTA ONCOL, V40, P67; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; SCHAPIRA DV, 1991, CANCER, V67, P523, DOI 10.1002/1097-0142(19910115)67:2<523::AID-CNCR2820670234>3.0.CO;2-O; TARTTER PI, 1981, CANCER, V47, P2222, DOI 10.1002/1097-0142(19810501)47:9<2222::AID-CNCR2820470919>3.0.CO;2-5; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514	25	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41380	10.1371/journal.pone.0041380	http://dx.doi.org/10.1371/journal.pone.0041380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848477	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600058
J	Fracanzani, AL; Valenti, L; Russello, M; Miele, L; Bertelli, C; Bellia, A; Masetti, C; Cefalo, C; Grieco, A; Marchesini, G; Fargion, S				Fracanzani, Anna Ludovica; Valenti, Luca; Russello, Maurizio; Miele, Luca; Bertelli, Cristina; Bellia, Alessandro; Masetti, Chiara; Cefalo, Consuelo; Grieco, Antonio; Marchesini, Giulio; Fargion, Silvia			Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; NATURAL-HISTORY; GALLBLADDER-DISEASE; DIABETES-MELLITUS; RISK-FACTOR; STEATOHEPATITIS; CHOLECYSTECTOMY; CHOLELITHIASIS; EPIDEMIOLOGY	Background: Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) are both highly prevalent in the general population and associated with obesity and insulin resistance. We aimed to evaluate the prevalence of GD in a cross sectional study of NAFLD patients and to define whether the presence of GD is associated with diabetes and predicts more severe liver disease. Methodology/Principal Findings: We merged databases of four Liver Units, comprising 524 consecutive biopsy-proven NAFLD (373 males) observed between January 2003 and June 2010. GD was diagnosed in 108 (20%), and 313 cases (60%) were classified by liver biopsy as nonalcoholic steatohepatitis (NASH). The GD subgroup was characterized by a significantly higher prevalence of females, prediabetes/diabetes, abdominal obesity and metabolic syndrome, older age, higher BMI, fasting glucose, HOMA-IR and lower ALT. The prevalence of GD progressively increased with advancing fibrosis and with the severity of necroinflammatory activity (p for trend = 0.0001 and = 0.01, respectively), without differences in the severity of steatosis. At multivariate analysis GD was associated with female gender (OR 1.37, 95% CI 1.04-1.8), age (OR 1.027, 95% CI1.003-1.05), fasting glucose (OR 1.21, 95% CI 1.10-1.33) and NASH (OR 1.40,95% CI 1.06-1.89), whereas ALT levels were associated with a lower GD risk (OR 0.98, 95% CI 0.97-0.99). When subjects with cirrhosis were excluded from analysis, the association between GD and fasting glucose, female gender, and NASH was maintained. Conclusion: Patients with NAFLD have a high prevalence of GD, which characterizes subjects with altered glucose regulation and more advanced liver disease.	[Fracanzani, Anna Ludovica; Valenti, Luca; Bertelli, Cristina; Masetti, Chiara; Fargion, Silvia] Univ Milan, Ctr Studi Malattie Metab Fegato, Maggiore Policlin Hosp, Dept Internal Med,IRCCS Ca Granda Fdn, Milan, Italy; [Russello, Maurizio; Bellia, Alessandro] Garibaldi Hosp, ARNAS, Liver Unit, Catania, Italy; [Miele, Luca; Cefalo, Consuelo; Grieco, Antonio] Cattolica Univ, Dept Internal Med, Rome, Italy; [Marchesini, Giulio] Alma Mater Studiorum Univ, Dept Internal Med, Bologna, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Catholic University of the Sacred Heart; University of Bologna	Fracanzani, AL (corresponding author), Univ Milan, Ctr Studi Malattie Metab Fegato, Maggiore Policlin Hosp, Dept Internal Med,IRCCS Ca Granda Fdn, Milan, Italy.	silvia.fargion@unimi.it	Valenti, Luca/B-3695-2009; Masetti, Chiara/AAB-9911-2019; Miele, Luca/C-2255-2015; Fracanzani, Anna Ludovica/J-8986-2018	Valenti, Luca/0000-0001-8909-0345; Miele, Luca/0000-0003-3464-0068; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Masetti, Chiara/0000-0002-1689-4876; grieco, antonio/0000-0002-0544-8993; Marchesini, Giulio/0000-0003-2407-9860	FIRST Universita di Milano; Ricerca Corrente Ospedale Maggiore Policlinico; Centro Studi Malattie Metaboliche del Fegato	FIRST Universita di Milano; Ricerca Corrente Ospedale Maggiore Policlinico(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Centro Studi Malattie Metaboliche del Fegato	The work was supported by the following grants: FIRST Universita di Milano 2007-2009 (ALF, SF), Ricerca Corrente Ospedale Maggiore Policlinico 2007-2009, and Centro Studi Malattie Metaboliche del Fegato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BARBARA L, 1995, AM J EPIDEMIOL, V141, P158, DOI 10.1093/oxfordjournals.aje.a117403; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Bodmer M, 2011, DIGEST LIVER DIS, V43, P742, DOI 10.1016/j.dld.2011.04.014; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Chang Y, 2008, J KOREAN MED SCI, V23, P644, DOI 10.3346/jkms.2008.23.4.644; DeSantis A, 1997, HEPATOLOGY, V25, P787, DOI 10.1002/hep.510250401; Diehl AK, 2000, HEPATOLOGY, V31, P528, DOI 10.1002/hep.510310238; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fracanzani AL, 2008, AM J MED, V121, P72, DOI 10.1016/j.amjmed.2007.08.041; Fracanzani AL, 2011, J HEPATOL, V54, P1244, DOI 10.1016/j.jhep.2010.09.037; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Ioannou GN, 2010, AM J GASTROENTEROL, V105, P1364, DOI 10.1038/ajg.2009.737; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Liew PL, 2008, OBES SURG, V18, P847, DOI 10.1007/s11695-007-9355-0; Loria P, 2005, J GASTROEN HEPATOL, V20, P1176, DOI 10.1111/j.1440-1746.2005.03924.x; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755; Olokoba AB, 2007, JCPSP-J COLL PHYSICI, V17, P594; Padda MS, 2009, ALIMENT PHARM THER, V29, P1011, DOI 10.1111/j.1365-2036.2009.03956.x; Ramos-De la Medina A, 2008, J GASTROINTEST SURG, V12, P2097, DOI 10.1007/s11605-008-0704-7; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Ruhl CE, 2000, HEPATOLOGY, V31, P299, DOI 10.1002/hep.510310206; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tsai CJ, 2008, AM J GASTROENTEROL, V103, P2932, DOI 10.1111/j.1572-0241.2008.02189.x; Tsai CJ, 2009, GASTROENTEROLOGY, V136, P1593, DOI 10.1053/j.gastro.2009.01.042; Tsai CJ, 2006, GUT, V55, P708, DOI 10.1136/gut.2005.076133; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200; Yilmaz Y, 2010, ATHEROSCLEROSIS, V211, P182, DOI 10.1016/j.atherosclerosis.2010.01.049; Younossi ZM, 2008, ALIMENT PHARM THER, V28, P2, DOI 10.1111/j.1365-2036.2008.03710.x	38	41	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41183	10.1371/journal.pone.0041183	http://dx.doi.org/10.1371/journal.pone.0041183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848440	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600044
J	Greenberg, R; Cadena, V; Danner, RM; Tattersall, G				Greenberg, Russell; Cadena, Viviana; Danner, Raymond M.; Tattersall, Glenn			Heat Loss May Explain Bill Size Differences between Birds Occupying Different Habitats	PLOS ONE			English	Article							EVOLUTION; TEMPERATURE; ADAPTATION; MORPHOLOGY; ECOLOGY; POPULATION; RESPONSES; SPARROW; FINCHES; WATER	Background: Research on variation in bill morphology has focused on the role of diet. Bills have other functions, however, including a role in heat and water balance. The role of the bill in heat loss may be particularly important in birds where water is limiting. Song sparrows localized in coastal dunes and salt marsh edge (Melospiza melodia atlantica) are similar in size to, but have bills with a 17% greater surface area than, those that live in mesic habitats (M. m. melodia), a pattern shared with other coastal sparrows. We tested the hypotheses that sparrows can use their bills to dissipate "dry" heat, and that heat loss from the bill is higher in M. m. atlantica than M. m. melodia, which would indicate a role of heat loss and water conservation in selection for bill size. Methodology/Principal Findings: Bill, tarsus, and body surface temperatures were measured using thermal imaging of sparrows exposed to temperatures from 15-37 degrees C and combined with surface area and physical modeling to estimate the contribution of each body part to total heat loss. Song sparrow bills averaged 5-10 degrees C hotter than ambient. The bill of M. m atlantica dissipated up to 33% more heat and 38% greater proportion of total heat than that of M. m. melodia. This could potentially reduce water loss requirements by approximately 7.7%. Conclusions/Significance: This >30% higher heat loss in the bill of M. m. atlantica is independent of evaporative water loss and thus could play an important role in the water balance of sparrows occupying the hot and exposed dune/salt marsh environments during the summer. Heat loss capacity and water conservation could play an important role in the selection for bill size differences between bird populations and should be considered along with trophic adaptations when studying variation in bill size.	[Greenberg, Russell; Danner, Raymond M.] Smithsonian Conservat Biol Inst, Smithsonian Migratory Bird Ctr, Washington, DC USA; [Cadena, Viviana; Tattersall, Glenn] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Danner, Raymond M.] Virginia Polytech Inst & State Univ, Avian Ecol Grp, Dept Biol Sci, Blacksburg, VA 24061 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Brock University; Virginia Polytechnic Institute & State University	Greenberg, R (corresponding author), Smithsonian Conservat Biol Inst, Smithsonian Migratory Bird Ctr, Natl Zool Pk, Washington, DC USA.	greenbergr@si.edu	Tattersall, Glenn J/D-3469-2009; Danner, Raymond/J-8350-2013	Tattersall, Glenn J/0000-0002-6591-6760; Danner, Raymond/0000-0002-3999-8141	Abbott Endowment; Smithsonian Institution	Abbott Endowment; Smithsonian Institution(Smithsonian Institution)	Research was supported by the Abbott Endowment, short-term visitor award, and Research Equipment Pool Grants of the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1877, RADICAL REV, V1, P108, DOI DOI 10.1038/SCIENTIFICAMERICAN05251907-26247SUPP; Badyaev AV, 2008, EVOLUTION, V62, P1951, DOI 10.1111/j.1558-5646.2008.00428.x; BARTHOLOMEW GEORGE A., 1963, AUK, V80, P504; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BAUDINETTE RV, 1976, AM J PHYSIOL, V230, P920, DOI 10.1152/ajplegacy.1976.230.4.920; BENKMAN CW, 1993, ECOL MONOGR, V63, P305, DOI 10.2307/2937103; Blaxter K, 1986, ENERGY METABOLISM AN; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Bowman R.I., 1961, MORPHOLOGICAL DIFFER; Buchholz R, 1996, AUK, V113, P310, DOI 10.2307/4088897; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; DAWSON WR, 1982, COMP BIOCHEM PHYS A, V71, P495, DOI 10.1016/0300-9629(82)90198-0; EHRENFELD JG, 1990, REV AQUAT SCI, V2, P437; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GRANT PR, 1965, EVOLUTION, V19, P355, DOI 10.1111/j.1558-5646.1965.tb01727.x; Greenberg R, 2012, ECOGRAPHY, V35, P146, DOI 10.1111/j.1600-0587.2011.07002.x; Greenberg R, 2010, ECOLOGY, V91, P2428, DOI 10.1890/09-1136.1; Grenier JL, 2005, EVOLUTION, V59, P1588; HAGAN AA, 1980, J THERM BIOL, V5, P95, DOI 10.1016/0306-4565(80)90006-6; Haynie D. T, 2001, BIOL THERMODYNAMICS; Herrel A, 2005, FUNCT ECOL, V19, P43, DOI 10.1111/j.0269-8463.2005.00923.x; HESP PA, 1991, J ARID ENVIRON, V21, P165, DOI 10.1016/S0140-1963(18)30681-5; JOHANSEN K, 1973, J COMP PHYSIOL, V85, P47, DOI 10.1007/BF00694140; Lucas A., 1972, AVIAN ANATOMY INTEGU; Matessi G, 2002, BIOL J LINN SOC, V75, P21, DOI 10.1046/j.1095-8312.2002.00003.x; MATTHYSEN E, 1989, ARDEA, V77, P117; Mazerolle MJ, 2011, AICCMODAVG MODEL SEL; Millard R.W., 1970, J APPL PHYSIOL, V38, P26; MITCHELL JW, 1976, BIOPHYS J, V16, P561, DOI 10.1016/S0006-3495(76)85711-6; Nudds RL, 2007, EVOLUTION, V61, P2839, DOI 10.1111/j.1558-5646.2007.00242.x; Patten MA, 2009, SYST BIODIVERS, V7, P33, DOI 10.1017/S1477200008002867; PHILLIPS PK, 1994, J THERM BIOL, V19, P423, DOI 10.1016/0306-4565(94)90042-6; PULLIAM HR, 1971, ECOLOGY, V52, P557, DOI 10.2307/1934143; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Remsen J. V. J., 1991, COMMUNITY ECOLOGY NE; Rensch B., 1938, Proceedings of the Linnean Society of London, V150, P275; SCHOLANDER PF, 1955, EVOLUTION, V9, P15, DOI 10.1111/j.1558-5646.1955.tb01510.x; Scott GR, 2008, J EXP BIOL, V211, P1326, DOI 10.1242/jeb.015958; SEAMANS TW, 1995, IBIS, V137, P424; SMITH TB, 1990, ECOLOGY, V71, P1246, DOI 10.2307/1938261; SNOW DW, 1954, EVOLUTION, V8, P19, DOI 10.1111/j.1558-5646.1954.tb00105.x; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Symonds MRE, 2010, AM NAT, V176, P188, DOI 10.1086/653666; Tattersall GJ, 2009, SCIENCE, V325, P468, DOI 10.1126/science.1175553; Van Hemert C, 2012, J MORPHOL, V273, P226, DOI 10.1002/jmor.11023; VanderWerf E.A., 2012, ORNITHOLOGICAL MONOG, V73, P1, DOI DOI 10.1525/OM.2011.73.1.1; WALSBERG GE, 1978, J EXP BIOL, V76, P185; Ward S, 2005, J AVIAN BIOL, V36, P280, DOI 10.1111/j.0908-8857.2005.03379.x; Williams JB, 2005, BIOSCIENCE, V55, P416, DOI 10.1641/0006-3568(2005)055[0416:PAIDB]2.0.CO;2; Wolf BO, 1996, J EXP BIOL, V199, P451; YARBROUGH CG, 1971, COMP BIOCHEM PHYSIOL, V39, P235, DOI 10.1016/0300-9629(71)90082-X; Zuur Alain F., 2009, P1	52	86	87	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40933	10.1371/journal.pone.0040933	http://dx.doi.org/10.1371/journal.pone.0040933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848413	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600030
J	Nishimura, Y; Applegate, K; Davidson, MW; Danuser, G; Waterman, CM				Nishimura, Yukako; Applegate, Kathryn; Davidson, Michael W.; Danuser, Gaudenz; Waterman, Clare M.			Automated Screening of Microtubule Growth Dynamics Identifies MARK2 as a Regulator of Leading Edge Microtubules Downstream of Rac1 in Migrating Cells	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; ACTIN-FILAMENTS; IN-VIVO; DIRECTLY PHOSPHORYLATES; STABLE MICROTUBULES; EPITHELIAL-CELLS; MOTILE CELLS; RHO-GTPASES; PROTEIN; CYTOSKELETON	Polarized microtubule (MT) growth in the leading edge is critical to directed cell migration, and is mediated by Rac1 GTPase. To find downstream targets of Rac1 that affect MT assembly dynamics, we performed an RNAi screen of 23 MT binding and regulatory factors and identified RNAi treatments that suppressed changes in MT dynamics induced by constitutively activated Rac1. By analyzing fluorescent EB3 dynamics with automated tracking, we found that RNAi treatments targeting p150(glued), APC2, spastin, EB1, Op18, or MARK2 blocked Rac1-mediated MT growth in lamellipodia. MARK2 was the only protein whose RNAi targeting additionally suppressed Rac1 effects on MT orientation in lamellipodia, and thus became the focus of further study. We show that GFP-MARK2 rescued effects of MARK2 depletion on MT growth lifetime and orientation, and GFP-MARK2 localized in lamellipodia in a Rac1-activity-dependent manner. In a wound-edge motility assay, MARK2-depleted cells failed to polarize their centrosomes or exhibit oriented MT growth in the leading edge, and displayed defects in directional cell migration. Thus, automated image analysis of MT assembly dynamics identified MARK2 as a target regulated downstream of Rac1 that promotes oriented MT growth in the leading edge to mediate directed cell migration.	[Nishimura, Yukako; Waterman, Clare M.] NHLBI, NIH, Cell Biol & Physiol Ctr, Bethesda, MD 20892 USA; [Applegate, Kathryn; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute; State University System of Florida; Florida State University; Harvard University; Harvard Medical School	Nishimura, Y (corresponding author), NHLBI, NIH, Cell Biol & Physiol Ctr, Bldg 10, Bethesda, MD 20892 USA.	watermancm@nhlbi.nih.gov		Waterman, Clare/0000-0001-6142-6775; Danuser, Gaudenz/0000-0001-8583-2014	National Heart Lung and Blood Institute, National Institutes of Health [U01 GM067230]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM067230] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work supported by National Heart Lung and Blood Institute intramural research program National Institutes of Health U01 GM067230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; Doerflinger H, 2003, DEVELOPMENT, V130, P3965, DOI 10.1242/dev.00616; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9143; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Harumoto T, 2010, DEV CELL, V19, P389, DOI 10.1016/j.devcel.2010.08.004; Hayashi K, 2011, J NEUROSCI, V31, P12094, DOI 10.1523/JNEUROSCI.0751-11.2011; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Kosuga S, 2005, J BIOL CHEM, V280, P42715, DOI 10.1074/jbc.M507941200; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; McDonald JA, 2008, CURR BIOL, V18, P1659, DOI 10.1016/j.cub.2008.09.041; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Myers KA, 2011, J CELL BIOL, V192, P321, DOI 10.1083/jcb.201006009; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Parton RM, 2011, J CELL BIOL, V194, P121, DOI 10.1083/jcb.201103160; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sapir T, 2008, J NEUROSCI, V28, P5710, DOI 10.1523/JNEUROSCI.0911-08.2008; SATTILARO RF, 1986, BIOCHEMISTRY-US, V25, P2003, DOI 10.1021/bi00356a025; Shintani T, 2009, J NEUROSCI, V29, P11628, DOI 10.1523/JNEUROSCI.2394-09.2009; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Stepanova T, 2003, J NEUROSCI, V23, P2655; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Wadsworth P, 1999, CELL MOTIL CYTOSKEL, V42, P48, DOI 10.1002/(SICI)1097-0169(1999)42:1<48::AID-CM5>3.3.CO;2-#; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082	60	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41413	10.1371/journal.pone.0041413	http://dx.doi.org/10.1371/journal.pone.0041413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848487	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300037
J	Galle, M; Jin, SG; Bogaert, P; Haegman, M; Vandenabeele, P; Beyaert, R				Galle, Marlies; Jin, Shouguang; Bogaert, Pieter; Haegman, Mira; Vandenabeele, Peter; Beyaert, Rudi			The Pseudomonas aeruginosa Type III Secretion System Has an Exotoxin S/T/Y Independent Pathogenic Role during Acute Lung Infection	PLOS ONE			English	Article							PROTEIN SECRETION; IN-VITRO; NEUTROPHIL APOPTOSIS; MACROPHAGE APOPTOSIS; TRANSLOCATION; EFFECTORS; CELLS; PORE; INDUCTION; PYOCYANIN	The type III secretion system (T3SS) is a complex nanomachine of many pathogenic Gram-negative bacteria. It forms a proteinaceous channel that is inserted into the host eukaryotic cell membrane for injection of bacterial proteins that manipulate host cell signaling. However, few studies have focused on the effector-independent functions of the T3SS. Using a murine model of acute lung infection with Pseudomonas aeruginosa, an important human opportunistic pathogen, we compared the pathogenicity of mutant bacteria that lack all of the known effector toxins (Delta STY), with mutant bacteria that also lack the major translocator protein PopB (Delta STY/Delta PopB) and so cannot form a functional T3SS channel in the host cell membrane. Mortality was higher among mice challenged with Delta STY compared to mice challenged with Delta STY/Delta PopB mutant bacteria. In addition, mice infected with Delta STY showed decreased bacterial clearance from the lungs compared to those infected with Delta STY/Delta PopB. Infection was in both cases associated with substantial killing of lung infiltrating macrophages. However, macrophages from Delta STY-infected mice died by pro-inflammatory necrosis characterized by membrane permeabilization and caspase-1 mediated IL-1 beta production, whereas macrophages from Delta STY/Delta PopB infected mice died by apoptosis, which is characterized by annexin V positive staining of the cell membrane and caspase-3 activation. This was confirmed in macrophages infected in vitro. These results demonstrate a T3SS effector toxin independent role for the T3SS, in particular the T3SS translocator protein PopB, in the pathogenicity of P. aeruginosa during acute lung infection.	[Galle, Marlies; Bogaert, Pieter; Haegman, Mira; Vandenabeele, Peter; Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Galle, Marlies; Haegman, Mira; Beyaert, Rudi] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Ghent, Belgium; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Bogaert, Pieter; Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signaling & Cell Death, Ghent, Belgium; [Bogaert, Pieter] Univ Ghent VIB, Cell Culture & Sorting Core Facil, Dept Mol Biomed Res, Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; State University System of Florida; University of Florida; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Galle, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.	rudi.beyaert@dmbr.vib-UGent.be	Jin, Shouguang/N-5548-2016; Beyaert, Rudi/B-2589-2009; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Vandenabeele, Peter/0000-0002-6669-8822; Haegman, Mira/0000-0002-4883-312X; Beyaert, Rudi/0000-0002-5704-582X	Special Research Fund (BOF) of Ghent University; "Interuniversity Attraction Poles Program" (IAP-VII); "Fonds voor Wetenschappelijk Onderzoek-Vlaanderen" (FWO) [G.0089.10, G.0619.10]; Belgian Foundation against Cancer; "Strategic Basic Research program" of the IWT; Centrum voor Gezwelziekten; "Concerted Research Actions" (GOA) [01G06B6]; Methusalem [BOF09/01M00709]; 'Group-ID MRP' grants from Ghent University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Special Research Fund (BOF) of Ghent University(Ghent University); "Interuniversity Attraction Poles Program" (IAP-VII); "Fonds voor Wetenschappelijk Onderzoek-Vlaanderen" (FWO)(FWO); Belgian Foundation against Cancer; "Strategic Basic Research program" of the IWT; Centrum voor Gezwelziekten; "Concerted Research Actions" (GOA); Methusalem; 'Group-ID MRP' grants from Ghent University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	M. Galle was supported by a predoctoral fellowship from the Special Research Fund (BOF) of Ghent University. Work in the authors' lab is supported by research grants from the "Interuniversity Attraction Poles Program" (IAP-VII), the "Fonds voor Wetenschappelijk Onderzoek-Vlaanderen" (FWO; G.0089.10 and G.0619.10), the "Belgian Foundation against Cancer", the "Strategic Basic Research program" of the IWT, the "Centrum voor Gezwelziekten" and the "Concerted Research Actions" (GOA; 01G06B6), 'Methusalem' (BOF09/01M00709) and 'Group-ID MRP' grants from Ghent University. R. Beyaert is member of the EU COST Action BM1003 (Microbial cell surface determinants of virulence as targets for new therapeutics in CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader F, 2005, INFECT IMMUN, V73, P4263, DOI 10.1128/IAI.73.7.4263-4271.2005; Aiello D, 2010, ANTIMICROB AGENTS CH, V54, P1988, DOI 10.1128/AAC.01598-09; Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Broms JE, 2003, J INFECT DIS, V188, P1909; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Cowell BA, 2005, FEMS MICROBIOL LETT, V250, P71, DOI 10.1016/j.femsle.2005.06.044; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Desmedt M, 1998, J IMMUNOL, V160, P5300; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Faure K, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-1; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Francois B, 2012, CRIT CARE MED, V40, P2320, DOI 10.1097/CCM.0b013e31825334f6; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galle M, 2008, J CELL MOL MED, V12, P1767, DOI 10.1111/j.1582-4934.2007.00190.x; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Imamura Y, 2007, EUR RESPIR J, V29, P965, DOI 10.1183/09031936.00147406; Kaufman MR, 2000, MICROBIOL-UK, V146, P2531, DOI 10.1099/00221287-146-10-2531; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kooguchi K, 1998, INFECT IMMUN, V66, P3164, DOI 10.1128/IAI.66.7.3164-3169.1998; Lee VT, 2007, INFECT IMMUN, V75, P1089, DOI 10.1128/IAI.01184-06; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Ojielo CI, 2003, J IMMUNOL, V171, P4416, DOI 10.4049/jimmunol.171.8.4416; Poot M, 1997, CYTOMETRY, V27, P358, DOI 10.1002/(SICI)1097-0320(19970401)27:4<358::AID-CYTO7>3.0.CO;2-8; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sawa T, 1998, INFECT IMMUN, V66, P3242, DOI 10.1128/IAI.66.7.3242-3249.1998; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Shafikhani SH, 2008, CELL MICROBIOL, V10, P994, DOI 10.1111/j.1462-5822.2007.01102.x; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Urbanowski ML, 2007, INFECT IMMUN, V75, P4432, DOI 10.1128/IAI.00664-07; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Valencia M, 2009, CURR OPIN CRIT CARE, V15, P30, DOI 10.1097/MCC.0b013e3283220e78; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Viboud GI, 2003, MOL MICROBIOL, V47, P1305, DOI 10.1046/j.1365-2958.2003.03350.x; Wangdi T, 2010, INFECT IMMUN, V78, P4744, DOI 10.1128/IAI.00744-10; Wullaert A, 2005, HEPATOLOGY, V42, P381, DOI 10.1002/hep.20785; Yang HJ, 2007, J BACTERIOL, V189, P2599, DOI 10.1128/JB.01680-06; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	55	31	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41547	10.1371/journal.pone.0041547	http://dx.doi.org/10.1371/journal.pone.0041547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844497	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700109
J	Grenier, E; Garofalo, C; Delvin, E; Levy, E				Grenier, Emilie; Garofalo, Carole; Delvin, Edgard; Levy, Emile			Modulatory Role of PYY in Transport and Metabolism of Cholesterol in Intestinal Epithelial Cells	PLOS ONE			English	Article							COENZYME-A REDUCTASE; PEPTIDE YY PYY; LIVER 3-HYDROXY-3-METHYLGLUTARYL COENZYME; TRIGLYCERIDE TRANSFER PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; TRANSIENT MOSAIC PATTERNS; LOW-DENSITY-LIPOPROTEIN; INDUCED ILEAL BRAKE; CACO-2 CELLS; RAT-LIVER	Background: Gastrointestinal peptides are involved in modulating appetite. Other biological functions attributed to them include the regulation of lipid homeostasis. However, data concerning PYY remain fragmentary. The objectives of the study were: (i) To determine the effect of PYY on intestinal transport and synthesis of cholesterol, the biogenesis of apolipoproteins (apos) and assembly of lipoproteins and (ii) To analyze whether the effects of PYY are similar according to whether cells are exposed to PYY on apical or basolateral surface. Methodology/Principal Findings: Caco-2/15 cells were incubated with PYY (1-36) administered either to the apical or basolateral medium, at concentrations of 50 or 200 nM for 24 hours. De novo synthesis of cholesterol, cholesterol uptake, and assembly of lipoproteins were evaluated through the incorporation of [C-14]-acetate, [C-14]-cholesterol, and [C-14]-oleate, respectively. Biogenesis of apos (A-I, A-IV, E, B-48 and B-100) was examined by the incorporation of [S-35]-methionine. The influence of PYY on protein and mRNA levels of many key mediators of lipid metabolism was analyzed by Western blot and PCR, respectively. Our results show that PYY influenced cholesterol metabolism in Caco-2/15 cells depending on the site of PYY delivery. Apical addition of PYY significantly lowered the incorporation of [C-14]-cholesterol likely via the reduction of NPC1L1, stimulated intracellular cholesterol synthesis probably through an increase in SREBP-2 expression, whereas it concomitantly increased apo A-I synthesis and decreased LDL secretion. In contrast, basolateral PYY reduced the production of chylomicrons (CM) as well as the biogenesis of apos B-48 and B-100, while lowering the expression of the transcription factors RXR alpha and PPAR(alpha, beta). Conclusions/Significance: PYY is capable of influencing cholesterol homeostasis in intestinal Caco-2/15 cells depending on the site delivery. Apical PYY was able to decrease cholesterol uptake via NPC1L1 downregulation, whereas basolateral PYY diminished CM output through the biogenesis decline of apos B-48 and B-100.	[Grenier, Emilie; Garofalo, Carole; Delvin, Edgard; Levy, Emile] Ctr Hosp Univ CHU Ste Justine, Res Ctr, Montreal, PQ, Canada; [Grenier, Emilie; Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Delvin, Edgard] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Grenier, E (corresponding author), Ctr Hosp Univ CHU Ste Justine, Res Ctr, Montreal, PQ, Canada.	emile.levy@recherche-ste-Justine.qc.ca			JA deSeve Research Chair in nutrition; Natural Sciences and Engineering Research Council of Canada; Diabete Quebec; "Fonds de la Recherche en Sante du Quebec"	JA deSeve Research Chair in nutrition; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Diabete Quebec; "Fonds de la Recherche en Sante du Quebec"(Fonds de la Recherche en Sante du Quebec)	The current work was supported by research grants from the JA deSeve Research Chair in nutrition (EL), Natural Sciences and Engineering Research Council of Canada (EL), Diabete Quebec (ED), and the scholarship award from the "Fonds de la Recherche en Sante du Quebec" (EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P494, DOI 10.1016/0016-5085(85)90442-1; Ahren Bo, 2003, Curr Diab Rep, V3, P365, DOI 10.1007/s11892-003-0079-9; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Aponte GW, 2002, PEPTIDES, V23, P367, DOI 10.1016/S0196-9781(01)00613-1; Arantes RME, 1997, CELL TISSUE RES, V290, P61, DOI 10.1007/s004410050908; ARMSTRONG DN, 1993, GUT, V34, P483, DOI 10.1136/gut.34.4.483; Ballantyne GH, 2006, OBES SURG, V16, P651, DOI 10.1381/096089206776944959; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Boey D, 2007, PEPTIDES, V28, P390, DOI 10.1016/j.peptides.2006.07.031; BOTTCHER G, 1984, REGUL PEPTIDES, V8, P261, DOI 10.1016/0167-0115(84)90034-X; BRODISH RJ, 1992, INT J PANCREATOL, V12, P153; Cahill F, 2011, AM J CLIN NUTR, V93, P741, DOI 10.3945/ajcn.110.003624; CHANG TY, 1981, J BIOL CHEM, V256, P6174; Cheng MHY, 2009, APPETITE, V52, P193, DOI 10.1016/j.appet.2008.09.015; CLARKE CF, 1983, P NATL ACAD SCI-BIOL, V80, P3305, DOI 10.1073/pnas.80.11.3305; Cox HM, 2002, BRIT J PHARMACOL, V135, P1505, DOI 10.1038/sj.bjp.0704604; COX HM, 1995, BRIT J PHARMACOL, V116, P2673, DOI 10.1111/j.1476-5381.1995.tb17225.x; Cuche G, 2000, AM J PHYSIOL-GASTR L, V279, pG925, DOI 10.1152/ajpgi.2000.279.5.G925; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Duval C, 2006, BIOCHEM BIOPH RES CO, V340, P1259, DOI 10.1016/j.bbrc.2005.12.137; FAUST JR, 1982, P NATL ACAD SCI-BIOL, V79, P5205, DOI 10.1073/pnas.79.17.5205; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Fu-Cheng XM, 1999, PEPTIDES, V20, P987, DOI 10.1016/S0196-9781(99)00092-3; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; GRANDT D, 1994, REGUL PEPTIDES, V51, P151, DOI 10.1016/0167-0115(94)90204-6; Grenier E, 2007, AM J PHYSIOL-GASTR L, V293, pG1178, DOI 10.1152/ajpgi.00295.2007; Hallden G, 1999, J BIOL CHEM, V274, P27914, DOI 10.1074/jbc.274.39.27914; Hanusch-Enserer U, 2007, WIEN KLIN WOCHENSCHR, V119, P291, DOI 10.1007/s00508-007-0776-5; JAKOI L, 1974, J BIOL CHEM, V249, P5840; Jones TE, 2009, OBESITY, V17, P1189, DOI 10.1038/oby.2009.11; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kalogeris TJ, 1998, AM J PHYSIOL-GASTR L, V275, pG668, DOI 10.1152/ajpgi.1998.275.4.G668; KIRSTEN ES, 1974, J BIOL CHEM, V249, P6104; LEHRER G, 1981, J BIOL CHEM, V256, P5612; Levy E, 2004, J CELL SCI, V117, P327, DOI 10.1242/jcs.00856; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Lin HC, 1996, GASTROENTEROLOGY, V110, P1491, DOI 10.1053/gast.1996.v110.pm8613054; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Liu CD, 1997, DIS COLON RECTUM, V40, P478, DOI 10.1007/BF02258396; LIU CD, 1995, J SURG RES, V59, P80; Mailhot G, 2009, AM J PHYSIOL-GASTR L, V297, pG1239, DOI 10.1152/ajpgi.00206.2009; Mannon PJ, 2000, BIOCHEM J, V350, P655, DOI 10.1042/0264-6021:3500655; Marcil V, 2003, J NUTR, V133, P2180, DOI 10.1093/jn/133.7.2180; MCFADDEN DW, 1989, J SURG RES, V46, P380, DOI 10.1016/0022-4804(89)90206-0; Montoudis A, 2006, BIOCHEM BIOPH RES CO, V339, P248, DOI 10.1016/j.bbrc.2005.10.202; Neary NM, 2005, ENDOCRINOLOGY, V146, P5120, DOI 10.1210/en.2005-0237; Pasman WJ, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-10; Peretti N, 2007, J CELL BIOCHEM, V100, P421, DOI 10.1002/jcb.20882; PIRONI L, 1993, GASTROENTEROLOGY, V105, P733, DOI 10.1016/0016-5085(93)90890-O; PLAYFORD RJ, 1990, LANCET, V335, P1555, DOI 10.1016/0140-6736(90)91378-N; Pshezhetsky AV, 2007, PROTEOMICS, V7, P2201, DOI 10.1002/pmic.200600956; Ravid Z, 2008, AM J PHYSIOL-GASTR L, V295, pG873, DOI 10.1152/ajpgi.90376.2008; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; RICHERT L, 1984, BIOCHEM BIOPH RES CO, V120, P192, DOI 10.1016/0006-291X(84)91432-3; ROITELMAN J, 1984, J BIOL CHEM, V259, P870; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Sanchez D, 2012, J MED FOOD, V15, P223, DOI 10.1089/jmf.2011.0072; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; SAVAGE AP, 1987, GUT, V28, P166, DOI 10.1136/gut.28.2.166; Schmidt PT, 2005, EUR J GASTROEN HEPAT, V17, P207, DOI 10.1097/00042737-200502000-00012; SCHMITZ J, 1973, DEUT MED WOCHENSCHR, V98, P2436, DOI 10.1055/s-0028-1107272; SERVIN AL, 1989, ENDOCRINOLOGY, V124, P692, DOI 10.1210/endo-124-2-692; Sgambati S A, 1997, J Gastrointest Surg, V1, P561, DOI 10.1016/S1091-255X(97)80073-X; Slight I, 2004, EXP CELL RES, V300, P11, DOI 10.1016/j.yexcr.2004.05.038; Sonnier DI, 2010, J GASTROINTEST SURG, V14, P1592, DOI 10.1007/s11605-010-1321-9; Sonoyama K, 2000, P SOC EXP BIOL MED, V223, P270, DOI 10.1046/j.1525-1373.2000.22338.x; SPILLER RC, 1988, GUT, V29, P1042, DOI 10.1136/gut.29.8.1042; Ueno H, 2008, REGUL PEPTIDES, V145, P12, DOI 10.1016/j.regpep.2007.09.011; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; Vachon PH, 1996, J CELL PHYSIOL, V166, P198, DOI 10.1002/(SICI)1097-4652(199601)166:1<198::AID-JCP21>3.0.CO;2-A; Valasek MA, 2007, J LIPID RES, V48, P2725, DOI 10.1194/jlr.M700345-JLR200; Van Citters Gregg W, 2006, Curr Gastroenterol Rep, V8, P367, DOI 10.1007/s11894-006-0021-9; van der Veen JN, 2005, J LIPID RES, V46, P526, DOI 10.1194/jlr.M400400-JLR200; Velhote MCP, 2010, OBES SURG, V20, P1710, DOI 10.1007/s11695-008-9520-0; VOLPE JJ, 1981, J BIOL CHEM, V256, P2016; Walther C, 2011, J PEPT SCI, V17, P233, DOI 10.1002/psc.1357; Witte AB, 2009, REGUL PEPTIDES, V158, P57, DOI 10.1016/j.regpep.2009.07.013; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Yakovich AJ, 2010, J CELL PHYSIOL, V224, P398, DOI 10.1002/jcp.22135; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Zwirska-Korczala K, 2008, J PHYSIOL PHARMACOL, V59, P161; Zwirska-Korczala K, 2007, J PHYSIOL PHARMACOL, V58, P13	84	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40992	10.1371/journal.pone.0040992	http://dx.doi.org/10.1371/journal.pone.0040992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844422	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700033
J	van Dijk, SJ; Mensink, M; Esser, D; Feskens, EJM; Muller, M; Afman, LA				van Dijk, Susan J.; Mensink, Marco; Esser, Diederik; Feskens, Edith J. M.; Muller, Michael; Afman, Lydia A.			Responses to High-Fat Challenges Varying in Fat Type in Subjects with Different Metabolic Risk Phenotypes: A Randomized Trial	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; BLOOD MONONUCLEAR-CELLS; POSTPRANDIAL LIPEMIA; NONFASTING TRIGLYCERIDES; INSULIN SENSITIVITY; VISCERAL ADIPOSITY; GLUCOSE-TOLERANCE; RICH LIPOPROTEINS; HEALTHY-SUBJECTS; MEN	Background: The ability of subjects to respond to nutritional challenges can reflect the flexibility of their biological system. Nutritional challenge tests could be used as an indicator of health status but more knowledge on metabolic and immune responses of different subjects to nutritional challenges is needed. The aim of this study was to compare the responses to high-fat challenges varying in fat type in subjects with different metabolic risk phenotypes. Methodology/Principal Findings: In a cross-over design 42 men (age 50-70 y) consumed three high-fat shakes containing saturated fat (SFA), monounsaturated fat (MUFA) or n-3 polyunsaturated (PUFA). Men were selected on BMI and health status (lean, obese or obese diabetic) and phenotyped with MRI for adipose tissue distribution. Before and 2 and 4 h after shake consumption blood was drawn for measurement of expression of metabolic and inflammation-related genes in peripheral blood mononuclear cells (PBMCs), plasma triglycerides (TAG), glucose, insulin, cytokines and ex vivo PBMC immune response capacity. The MUFA and n-3 PUFA challenge, compared to the SFA challenge, induced higher changes in expression of inflammation genes MCP1 and IL1 beta in PBMCs. Obese and obese diabetic subjects had different PBMC gene expression and metabolic responses to high-fat challenges compared to lean subjects. The MUFA challenge induced the most pronounced TAG response, mainly in obese and obese diabetic subjects. Conclusion/Significance: The PBMC gene expression response and metabolic response to high-fat challenges were affected by fat type and metabolic risk phenotype. Based on our results we suggest using a MUFA challenge to reveal differences in response capacity of subjects.	[van Dijk, Susan J.; Mensink, Marco; Esser, Diederik; Feskens, Edith J. M.; Muller, Michael; Afman, Lydia A.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Muller, Michael] TI Food & Nutr, Netherlands Nutrigen Ctr, Wageningen, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition	van Dijk, SJ (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	lydia.afman@wur.nl	Feskens, Edith/ABI-1446-2020; van Dijk, Susan/H-8910-2013; Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008	Feskens, Edith/0000-0001-5819-2488; van Dijk, Susan/0000-0001-7019-0418; Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Mensink, Marco/0000-0002-9725-5709	Dutch Diabetes Research Foundation [20060052]	Dutch Diabetes Research Foundation	The study was funded by the Dutch Diabetes Research Foundation (20060052, www.diabetesfonds.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljada A, 2004, AM J CLIN NUTR, V79, P682; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Blackburn P, 2003, DIABETES CARE, V26, P3303, DOI 10.2337/diacare.26.12.3303; Blackburn P, 2006, OBESITY, V14, P1747, DOI 10.1038/oby.2006.201; Bouwens M, 2007, AM J CLIN NUTR, V86, P1515, DOI 10.1093/ajcn/86.5.1515; Bouwens M, 2010, AM J CLIN NUTR, V91, P208, DOI 10.3945/ajcn.2009.28586; Couillard C, 1998, DIABETES, V47, P953, DOI 10.2337/diabetes.47.6.953; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dolores Mayas M, 2010, BR J NUTR, P1; Elliott R, 2007, BRIT J NUTR, V98, P1095, DOI 10.1017/S0007114507803400; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Huber M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4163; Jackson KG, 2005, BRIT J NUTR, V93, P693, DOI 10.1079/BJN20051410; Jensen J, 1999, BRIT J NUTR, V82, P469, DOI 10.1017/S0007114599001725; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Koska J, 2008, AM J CLIN NUTR, V87, P295, DOI 10.1093/ajcn/87.2.295; Kussmann M, 2008, CURR OPIN BIOTECH, V19, P83, DOI 10.1016/j.copbio.2008.02.003; Lopez S, 2008, AM J CLIN NUTR, V88, P638, DOI 10.1093/ajcn/88.3.638; Lozano A, 2010, NUTR METAB CARDIOVAS; Mekki N, 1999, J CLIN ENDOCR METAB, V84, P184, DOI 10.1210/jc.84.1.184; Mekki N, 2002, J NUTR, V132, P3642, DOI 10.1093/jn/132.12.3642; Nabeno-Kaeriyama Y, 2010, CLIN CHIM ACTA; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Pocathikorn A, 2007, J NUTR, V137, P2062, DOI 10.1093/jn/137.9.2062; Positano V, 2004, J MAGN RESON IMAGING, V20, P684, DOI 10.1002/jmri.20167; Rasmussen O, 1996, AM J CLIN NUTR, V63, P249, DOI 10.1093/ajcn/63.2.249; Roche HM, 1998, BRIT J NUTR, V79, P419, DOI 10.1079/BJN19980071; Shah M, 2007, DIABETES CARE, V30, P2993, DOI 10.2337/dc07-1026; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Takamura T, 2007, BIOCHEM BIOPH RES CO, V361, P379, DOI 10.1016/j.bbrc.2007.07.006; Thomsen C, 1999, AM J CLIN NUTR, V69, P1135; Tushuizen ME, 2010, ATHEROSCLEROSIS, V211, P308, DOI 10.1016/j.atherosclerosis.2010.02.002; van Dijk SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014422; van Ommen B, 2009, MOL NUTR FOOD RES, V53, P795, DOI 10.1002/mnfr.200800390; van Oostrom AJHHM, 2004, ATHEROSCLEROSIS, V177, P175, DOI 10.1016/j.atherosclerosis.2004.07.004; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525	37	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41388	10.1371/journal.pone.0041388	http://dx.doi.org/10.1371/journal.pone.0041388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844471	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700082
J	Kuntner, M; Gregoric, M; Zhang, SC; Kralj-Fiser, S; Li, DQ				Kuntner, Matjaz; Gregoric, Matjaz; Zhang, Shichang; Kralj-Fiser, Simona; Li, Daiqin			Mating Plugs in Polyandrous Giants: Which Sex Produces Them, When, How and Why?	PLOS ONE			English	Article							ORB-WEB SPIDER; SEXUALLY CANNIBALISTIC SPIDER; SPERM COMPETITION; COPULATORY PLUGS; ARGIOPE-BRUENNICHI; GENITAL MUTILATION; ARANEAE ARANEIDAE; NEPHILID SPIDERS; SPECIES ARANEAE; MALE ADAPTATION	Background: Males usually produce mating plugs to reduce sperm competition. However, females can conceivably also produce mating plugs in order to prevent unwanted, superfluous and energetically costly matings. In spiders-appropriate models for testing plugging biology hypotheses-mating plugs may consist of male genital parts and/or of amorphous covers consisting of glandular or sperm secretions. In the giant wood spider Nephila pilipes, a highly sexually dimorphic and polygamous species, males are known to produce ineffective embolic plugs through genital damage, but nothing is known about the origin and function of additional conspicuous amorphous plugs (AP) covering female genitals. Methodology: We tested alternative hypotheses of the nature and function of AP in N. pilipes by staging mating trials with varying degrees of polyandry. No APs were ever formed during mating trials, which rules out the possibility of male AP formation. Instead, those females that oviposited produced the AP from a liquid secreted during egg sac formation. Polyandrous females were more likely to lay eggs and to produce the AP, as were those that mated longer and with more total insertions. Our further tests revealed that, in spite of being a side product of egg sac production, AP, when hardened, prevented any subsequent copulation. Conclusions: We conclude that in the giant wood spider (Nephila pilipes), the amorphous mating plugs are not produced by the males, that repeated copulations (most likely polyandrous) are necessary for egg fertilization and AP formation, and that the AP represents a female adaptation to sexual conflict through prevention of unwanted, excessive copulations. Considering the largely unknown origin of amorphous plugs in spiders, we predict that a similar pattern might be detected in other clades, which would help elucidate the evolutionary interplay of various selection pressures responsible for the origin and maintenance of mating plugs.	[Kuntner, Matjaz; Gregoric, Matjaz; Kralj-Fiser, Simona] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia; [Kuntner, Matjaz] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kuntner, Matjaz; Li, Daiqin] Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China; [Zhang, Shichang; Li, Daiqin] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Smithsonian Institution; Smithsonian National Museum of Natural History; Hubei University; National University of Singapore	Kuntner, M (corresponding author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.	kuntner@gmail.com	Kuntner, Matjaz/AAE-2195-2020; Gregorič, Matjaž/AAG-5913-2021; Li, Daiqin/CAH-3746-2022; Li, Daiqin/D-6922-2013	Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734; Gregoric, Matjaz/0000-0002-4882-4282; Kralj-Fiser, Simona/0000-0001-6604-2332	Slovenian Research Agency [J1-2063]; Raffles Museum of Biodiversity Research Fellowship; Ministry of Education Academic Research Fund [AcRF: R-154-000-435-112]; Humboldt Postdoctoral Fellowship; ARRS Postdoctoral Fellowship [Z1-4194]; Humboldt Return Fellowship	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Raffles Museum of Biodiversity Research Fellowship; Ministry of Education Academic Research Fund; Humboldt Postdoctoral Fellowship; ARRS Postdoctoral Fellowship; Humboldt Return Fellowship	This research was supported by the Slovenian Research Agency (grant J1-2063) and a Raffles Museum of Biodiversity Research Fellowship to M. Kuntner, by the Ministry of Education Academic Research Fund (AcRF: R-154-000-435-112) to D. Li, and by Humboldt Postdoctoral and Return Fellowships, and an ARRS Postdoctoral Fellowship Z1-4194 to S. Kralj-Fiser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN RB, 1992, ETHOL ECOL EVOL, V4, P245, DOI 10.1080/08927014.1992.9523136; Aisenberg A, 2011, NATURWISSENSCHAFTEN, V98, P605, DOI 10.1007/s00114-011-0807-y; Aisenberg A, 2009, BEHAV ECOL, V20, P1236, DOI 10.1093/beheco/arp117; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Baer B, 2000, J CHEM ECOL, V26, P1869, DOI 10.1023/A:1005596707591; Baer B, 2001, P NATL ACAD SCI USA, V98, P3926, DOI 10.1073/pnas.061027998; Baer B, 2011, MYRMECOL NEWS, V14, P55; BARKER DM, 1994, ANIM BEHAV, V48, P147, DOI 10.1006/anbe.1994.1221; BAUER RT, 1994, J EXP MAR BIOL ECOL, V182, P205, DOI 10.1016/0022-0981(94)90052-3; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Bretman A, 2010, J INSECT PHYSIOL, V56, P107, DOI 10.1016/j.jinsphys.2009.09.010; Burger M, 2010, ZOOLOGY, V113, P19, DOI 10.1016/j.zool.2009.04.002; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Colonello NA, 2005, APIDOLOGIE, V36, P231, DOI 10.1051/apido:2005012; Contreras-Garduno J, 2006, ETHOLOGY, V112, P152, DOI 10.1111/j.1439-0310.2006.01149.x; DICKINSON JL, 1989, ANIM BEHAV, V38, P154, DOI 10.1016/S0003-3472(89)80074-0; Dixson AF, 2002, FOLIA PRIMATOL, V73, P63, DOI 10.1159/000064784; Eberhard WG, 1998, J ARACHNOL, V26, P342; Eberhard WG, 2004, J ARACHNOL, V32, P545, DOI 10.1636/0161-8202(2004)032[0545:WSSSST]2.0.CO;2; Eberhard WG, 1996, TECHNICAL BOOKS; Engelhardt Victor v., 1910, Zeitschrift fuer Wissenschaftliche Zoologie Leipzig, V96; Foellmer MW, 2008, EVOL ECOL RES, V10, P449; Fromhage L, 2006, BEHAV ECOL, V17, P353, DOI 10.1093/beheco/arj037; Fromhage L, 2012, EVOLUTION, V66, P31, DOI 10.1111/j.1558-5646.2011.01406.x; Ghione S, 2011, J ARACHNOL, V39, P197, DOI 10.1636/Hi10-92.1; Gillott C, 1996, INVERTEBR REPROD DEV, V30, P199, DOI 10.1080/07924259.1996.9672546; Groot AT, 2000, INVERTEBR REPROD DEV, V38, P143, DOI 10.1080/07924259.2000.9652449; Jia ZY, 2002, J MAMMAL, V83, P1035, DOI 10.1644/1545-1542(2002)083<1035:CPIMPC>2.0.CO;2; Jivoff P, 1997, BEHAV ECOL SOCIOBIOL, V40, P175, DOI 10.1007/s002650050331; Johnston SD, 1997, J REPROD FERTIL, V109, P319, DOI 10.1530/jrf.0.1090319; Knoflach B, 1998, J NAT HIST, V32, P545, DOI 10.1080/00222939800770301; KOPROWSKI JL, 1992, J MAMMAL, V73, P572, DOI 10.2307/1382026; Kralj-Fiser S, 2011, ANIM BEHAV, V81, P933, DOI 10.1016/j.anbehav.2011.02.010; Kuntner M, 2005, INVERTEBR SYST, V19, P391, DOI 10.1071/IS05024; Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x; Kuntner M, J ARACHNOLO IN PRESS; Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x; Kuntner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007516; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Lemaitre JF, 2011, P ROY SOC B-BIOL SCI, V278, P1171, DOI 10.1098/rspb.2010.1828; Lung O, 2001, INSECT BIOCHEM MOLEC, V31, P543, DOI 10.1016/S0965-1748(00)00154-5; MASUMOTO T, 1993, J ARACHNOL, V21, P55; Moreira PL, 2007, BEHAV ECOL SOCIOBIOL, V62, P281, DOI 10.1007/s00265-007-0463-6; Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074; Nessler S, 2009, BEHAV ECOL SOCIOBIOL, V63, P355, DOI 10.1007/s00265-008-0669-2; O'Donnell RP, 2004, ANIM BEHAV, V68, P677, DOI 10.1016/j.anbehav.2003.09.020; ORR AG, 1991, J NAT HIST, V25, P703, DOI 10.1080/00222939100770461; Parga JA, 2003, INT J PRIMATOL, V24, P889, DOI 10.1023/A:1024637024088; Polak M, 2001, BEHAV ECOL SOCIOBIOL, V49, P196, DOI 10.1007/s002650000281; Poulin R, 2000, J ZOOL, V250, P551, DOI 10.1017/S0952836900004118; Robinson M.H., 1973, Smithsonian Contributions to Zoology, VNo. 149, P1; Robinson M. H., 1976, SMITHSON CONTRIB ZOO, V218, P1; Sauter A, 2001, P ROY SOC B-BIOL SCI, V268, P1449, DOI 10.1098/rspb.2001.1680; Schneider JM, 2001, BEHAV ECOL SOCIOBIOL, V49, P410, DOI 10.1007/s002650000307; Schneider Jutta, 2011, P215; Snow LSE, 2006, ETHOLOGY, V112, P379, DOI 10.1111/j.1439-0310.2006.01163.x; Strand E, 1906, Z WISS ZOOL ABT A, V80, P515; Suhm M, 1996, ZOOL ANZ, V234, P191; Timmermeyer N, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-28; Uhl G, 2007, ZOOLOGY, V110, P398, DOI 10.1016/j.zool.2007.07.003; Uhl G, 2010, GENETICA, V138, P75, DOI 10.1007/s10709-009-9388-5; WING S, 1983, FLA ENTOMOL, V66, P86, DOI 10.2307/3494553; Yasui Y, 1997, EXP APPL ACAROL, V21, P651, DOI 10.1023/A:1018456618435; Zhang SC, 2011, ANIM BEHAV, V82, P1299, DOI 10.1016/j.anbehav.2011.09.010	64	19	19	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40939	10.1371/journal.pone.0040939	http://dx.doi.org/10.1371/journal.pone.0040939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829900	Green Submitted, gold, Green Published			2022-12-27	WOS:000306956300038
J	Ho, JY; Cira, NJ; Crooks, JA; Baeza, J; Weibel, DB				Ho, Jack Y.; Cira, Nate J.; Crooks, John A.; Baeza, Josue; Weibel, Douglas B.			Rapid Identification of ESKAPE Bacterial Strains Using an Autonomous Microfluidic Device	PLOS ONE			English	Article							RESISTANCE; PATHOGENS	This article describes (Bac) under bar teria ID (Chips) under bar ('BacChips'): an inexpensive, portable, and autonomous microfluidic platform for identifying pathogenic strains of bacteria. BacChips consist of a set of microchambers and channels molded in the elastomeric polymer, polydimethylsiloxane) PDMS). Each microchamber is preloaded with mono-, di-, or trisaccharides and dried. Pressing the layer of PDMS into contact with a glass coverslip forms the device; the footprint of the device in this article is similar to 6 cm(2). After assembly, BacChips are degased under large negative pressure and are stored in vacuum-sealed plastic bags. To use the device, the bag is opened, a sample containing bacteria is introduced at the inlet of the device, and the degased PDMS draws the sample into the central channel and chambers. After the liquid at the inlet is consumed, air is drawn into the BacChip via the inlet and provides a physical barrier that separates the liquid samples in adjacent microchambers. A pH indicator is admixed with the samples prior to their loading, enabling the metabolism of the dissolved saccharides in the microchambers to be visualized. Importantly, BacChips operate without external equipment or instruments. By visually detecting the growth of bacteria using ambient light after similar to 4 h, we demonstrate that BacChips with ten microchambers containing different saccharides can reproducibly detect the ESKAPE panel of pathogens, including strains of: Enterococcus faecalis, Enteroccocus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter aerogenes, and Enterobacter cloacae. This article describes a BacChip for point-of-care detection of ESKAPE pathogens and a starting point for designing multiplexed assays that identify bacterial strains from clinical samples and simultaneously determine their susceptibility to antibiotics.	[Ho, Jack Y.; Weibel, Douglas B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA; [Cira, Nate J.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Crooks, John A.; Baeza, Josue; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Ho, JY (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA.	weibel@biochem.wisc.edu		Baeza, Josue/0000-0003-4960-3905	Searle Scholar Award; Alfred P. Sloan Research Foundation; National Science Foundation; Keck Foundation	Searle Scholar Award; Alfred P. Sloan Research Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation)	This research was supported by a Searle Scholar Award (to D.B.W.), the Alfred P. Sloan Research Foundation (Alfred P. Sloan Fellowship to D.B.W.), a National Science Foundation Graduate Research Fellowship (N.J.C.), and the Keck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, BERGEYS MANUAL SYSTE; Barenfanger J, 1999, J CLIN MICROBIOL, V37, P1415, DOI 10.1128/JCM.37.5.1415-1418.1999; Bergeron MG, 1998, J CLIN MICROBIOL, V36, P2169, DOI 10.1128/JCM.36.8.2169-2172.1998; Biolog Inc, 2008, GEN 3 MICROPLATETM I; bioMerieux, 2010, DIVERSILAB PROD BROC; bioMerieux, 2010, 20500 BIOMERIEUX INC; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Chen CH, 2010, ANAL CHEM, V82, P1012, DOI 10.1021/ac9022764; Cira NJ, 2012, LAB CHIP, V12, P1052, DOI 10.1039/c2lc20887c; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; DOERN GV, 1994, J CLIN MICROBIOL, V32, P1757, DOI 10.1128/JCM.32.7.1757-1762.1994; Eveillard M, 2010, CLIN MICROBIOL INFEC, V16, P1084, DOI 10.1111/j.1469-0691.2009.03044.x; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Holt J., 1994, BERGEYS MANUAL DETER; Hosokawa K, 2004, LAB CHIP, V4, P181, DOI 10.1039/b403930k; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Liang DY, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3584003; Pincus, 2006, ENCY RAPID MICROBIOL; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; VINCE A, 1973, GUT, V14, P171, DOI 10.1136/gut.14.3.171; Vos P., 2009, BERGEYS MANUAL SYSTE, V3; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	27	14	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41245	10.1371/journal.pone.0041245	http://dx.doi.org/10.1371/journal.pone.0041245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848451	gold, Green Published			2022-12-27	WOS:000306950200050
J	Suwinski, R; Klusek, A; Tyszkiewicz, T; Kowalska, M; Szczesniak-Klusek, B; Gawkowska-Suwinska, M; Tukiendorf, A; Kozielski, J; Jarzab, M				Suwinski, Rafal; Klusek, Artur; Tyszkiewicz, Tomasz; Kowalska, Maria; Szczesniak-Klusek, Bogna; Gawkowska-Suwinska, Marzena; Tukiendorf, Andrzej; Kozielski, Jerzy; Jarzab, Michal			Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SIGNATURE; PROGNOSIS; SURVIVAL; RECURRENCE; PROFILES; KINASE	Background: Several studies have shown the prognostic and predictive potential of molecular markers in combined therapy for lung cancer. Most of them referred, however, to operable early stage NSCLC. The aim of the present study is to correlate the expression of multiple mRNA markers in bronchoscopy obtained cancer specimens with clinical outcome of advanced lung cancer. Methods: Bronchoscopy cancer specimens were taken from 123 patients with radiological diagnosis of advanced lung tumor. Out of 123 patients 50 were diagnosed with squamous cell cancer, 17 with adenocarcinoma, 12 with NOS, 32 with SCLC and one with large cell neuroendocrinal cancer. In 11 patients other tumours were diagnosed. The group was heterogeneous with respect to clinical stage, performance of the patients and treatment. Quantitative real time PCR was carried out by ABI 7900 HT machine, with Universal Probe Library (Roche) fluorescent probes. The genes selected for the analysis were ERCC1, EGFR, BRCA1, CSF1, CA9, DUSP6, STAT1, ERBB3, MMD, FN1, and CDKN1B. Results: More than 50 ng of RNA (the amount considered sufficient for the analysis) was isolated in 82 out of 112 lung cancer specimens (73%), including 60/80 (75.0%) of NSCLC specimens and 22/32 (68,7%) of SCLC samples. The highest Cohen's kappa coefficient for discrimination between small cell, squamous cell and adenocarcinoma was found for CDKN1B, CSF and EGFR1 (kappa = 0.177, p = 0.0041). A multivariate Cox regression model has shown a significant impact of clinical stage (p<0.001, RR = 4.19), ERCC1 (p = 0.01, RR = 0.43) and CA9 (p = 0.03, RR = 2.11) expression on overall survival in a group of 60 patients with NSCLC. Conclusion: These results show the feasibility of multiple gene expression analysis in bronchoscopy obtained cancer specimens as prognostic markers in radiotherapy and chemotherapy for advanced lung cancer. A limiting factor was relatively high proportion of samples from which sufficient amount of RNA could not be isolated.	[Suwinski, Rafal; Gawkowska-Suwinska, Marzena; Jarzab, Michal] M Sklodowska Curie Mem Canc Ctr, Radiotherapy Clin, Gliwice, Poland; [Suwinski, Rafal; Gawkowska-Suwinska, Marzena; Jarzab, Michal] M Sklodowska Curie Mem Canc Ctr, Teaching Hosp, Gliwice, Poland; [Suwinski, Rafal; Tyszkiewicz, Tomasz; Kowalska, Maria; Szczesniak-Klusek, Bogna; Gawkowska-Suwinska, Marzena; Tukiendorf, Andrzej; Jarzab, Michal] Inst Oncol, Gliwice, Poland; [Klusek, Artur] Gen Hosp, Dept Pulmonol, Chorzow, Poland; [Tyszkiewicz, Tomasz; Kowalska, Maria] M Sklodowska Curie Mem Canc Ctr, Dept Nucl Med & Clin Endocrinol, Gliwice, Poland; [Szczesniak-Klusek, Bogna] M Sklodowska Curie Mem Canc Ctr, Dept Pathol, Gliwice, Poland; [Tukiendorf, Andrzej] M Sklodowska Curie Mem Canc Ctr, Dept Biostat, Gliwice, Poland; [Kozielski, Jerzy] Silesian Med Univ, Pumonol Clin, Zabrze, Poland; [Kozielski, Jerzy] Silesian Med Univ, Teaching Hosp, Zabrze, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University Silesia; Medical University Silesia	Suwinski, R (corresponding author), M Sklodowska Curie Mem Canc Ctr, Radiotherapy Clin, Gliwice, Poland.	rafals@io.gliwice.pl	Jarząb, Michał/G-4319-2012	Jarząb, Michał/0000-0002-2642-9724; Suwinski, Rafal/0000-0002-3895-7938; Gawkowska, Marzena/0000-0002-4396-9618; Kozielski, Jerzy/0000-0001-7245-5432; Tyszkiewicz, Tomasz/0000-0003-4863-0143	Ministry of Science and Higher Education of the Republic of Poland [N N 403 290636]	Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	This study was sponsored by a research grant N N 403 290636 provided by the Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baty F, 2010, AM J RESP CRIT CARE, V181, P181, DOI 10.1164/rccm.200812-1807OC; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; Inamura K, 2005, ONCOGENE, V24, P7105, DOI 10.1038/sj.onc.1208858; Kawano O, 2008, J SURG RES, V146, P43, DOI 10.1016/j.jss.2007.05.030; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Shapiro GI, 2001, CLIN CANCER RES, V7, P1590; Skrzypski M, 2008, CLIN CANCER RES, V14, P4794, DOI 10.1158/1078-0432.CCR-08-0576; Soria JC, 2011, CANC TREAT IN PRESS; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132	18	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41379	10.1371/journal.pone.0041379	http://dx.doi.org/10.1371/journal.pone.0041379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848476	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200059
J	Torbensen, R; Moller, HD; Gresham, D; Alizadeh, S; Ochmann, D; Boles, E; Regenberg, B				Torbensen, Rasmus; Moller, Henrik Devitt; Gresham, David; Alizadeh, Sefa; Ochmann, Doreen; Boles, Eckhard; Regenberg, Birgitte			Amino Acid Transporter Genes Are Essential for FLO11-Dependent and FLO11-Independent Biofilm Formation and Invasive Growth in Saccharomyces cerevisiae	PLOS ONE			English	Article							PROTEIN-KINASE; PSEUDOHYPHAL DIFFERENTIATION; HIGH-AFFINITY; MAP KINASE; CELL-CELL; YEAST; EXPRESSION; PERMEASE; SPECIFICITY; AMMONIUM	Amino acids can induce yeast cell adhesion but how amino acids are sensed and signal the modulation of the FLO adhesion genes is not clear. We discovered that the budding yeast Saccharomyces cerevisiae CEN.PK evolved invasive growth ability under prolonged nitrogen limitation. Such invasive mutants were used to identify amino acid transporters as regulators of FLO11 and invasive growth. One invasive mutant had elevated levels of FLO11 mRNA and a Q320STOP mutation in the SFL1 gene that encodes a protein kinase A pathway regulated repressor of FLO11. Glutamine-transporter genes DIP5 and GNP1 were essential for FLO11 expression, invasive growth and biofilm formation in this mutant. Invasive growth relied on known regulators of FLO11 and the Ssy1-Ptr3-Ssy5 complex that controls DIP5 and GNP1, suggesting that Dip5 and Gnp1 operates downstream of the Ssy1-Ptr3-Ssy5 complex for regulation of FLO11 expression in a protein kinase A dependent manner. The role of Dip5 and Gnp1 appears to be conserved in the S. cerevisiae strain Sigma 1278b since the dip5 gnp1 Sigma 1278b mutant showed no invasive phenotype. Secondly, the amino acid transporter gene GAP1 was found to influence invasive growth through FLO11 as well as other FLO genes. Cells carrying a dominant loss-of-function PTR3(647::CWNKNPLSSIN) allele had increased transcription of the adhesion genes FLO1, 5, 9, 10, 11 and the amino acid transporter gene GAP1. Deletion of GAP1 caused loss of FLO11 expression and invasive growth. However, deletions of FLO11 and genes encoding components of the mitogen-activated protein kinase pathway or the protein kinase A pathway were not sufficient to abolish invasive growth, suggesting involvement of other FLO genes and alternative pathways. Increased intracellular amino acid pools in the PTR3(647::CWNKNPLSSIN)-containing strain opens the possibility that Gap1 regulates the FLO genes through alteration of the amino acid pool sizes.	[Torbensen, Rasmus; Moller, Henrik Devitt; Alizadeh, Sefa; Regenberg, Birgitte] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Gresham, David] NYU, Ctr Genom & Syst Biol, New York, NY USA; [Gresham, David] NYU, Dept Biol, New York, NY 10003 USA; [Ochmann, Doreen; Boles, Eckhard] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany	University of Copenhagen; New York University; New York University; Goethe University Frankfurt	Regenberg, B (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	BRegenberg@bio.ku.dk	Møller, Henrik/K-5415-2014; Regenberg, Brigit/C-2699-2009	Møller, Henrik/0000-0002-1886-3053; Regenberg, Brigit/0000-0003-4996-7012; Boles, Eckhard/0000-0002-5713-1883	Danish Agency for Science Technology and Innovation [FNU 09-062220, 272-06-0287]; National Institutes of Health Research Grant [GM046406]; National Institute of General Medical Sciences Center for Quantitative Biology [GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046406, R37GM046406, P50GM071508] Funding Source: NIH RePORTER	Danish Agency for Science Technology and Innovation; National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Center for Quantitative Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this work was received from the Danish Agency for Science Technology and Innovation FNU 09-062220 and 272-06-0287, http://en.fi.dk/; a National Institutes of Health Research Grant GM046406, http://www.nihr.ac.uk/Pages/default.aspx; the National Institute of General Medical Sciences Center for Quantitative Biology (GM071508), http://www.nigms.nih.gov/News/Results/quantitative_bio_center.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braus GH, 2003, MOL BIOL CELL, V14, P4272, DOI 10.1091/mbc.e03-01-0042; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; COFFMAN JA, 1995, J BACTERIOL, V177, P6910, DOI 10.1128/jb.177.23.6910-6918.1995; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; DELFORGE J, 1975, EUR J BIOCHEM, V57, P231, DOI 10.1111/j.1432-1033.1975.tb02295.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Douglas LM, 2007, EUKARYOT CELL, V6, P2214, DOI 10.1128/EC.00284-06; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Fichtner L, 2007, MOL MICROBIOL, V66, P1276, DOI 10.1111/j.1365-2958.2007.06014.x; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Gresham D, 2010, P NATL ACAD SCI USA, V107, P18551, DOI 10.1073/pnas.1014023107; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Lambrechts MG, 1996, P NATL ACAD SCI USA, V93, P8419, DOI 10.1073/pnas.93.16.8419; LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Mosch HU, 1999, MOL BIOL CELL, V10, P1325, DOI 10.1091/mbc.10.5.1325; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Regenberg B, 1998, CURR GENET, V33, P171, DOI 10.1007/s002940050324; Regenberg B, 2000, YEAST, V16, P1111, DOI 10.1002/1097-0061(20000915)16:12<1111::AID-YEA611>3.0.CO;2-3; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Rupp S, 2007, FUTURE MICROBIOL, V2, P141, DOI 10.2217/17460913.2.2.141; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TEUNISSEN AWRH, 1995, YEAST, V11, P435, DOI 10.1002/yea.320110506; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Usaite R, 2006, APPL ENVIRON MICROB, V72, P6194, DOI 10.1128/AEM.00548-06; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Vanhalewyn M, 1999, MOL MICROBIOL, V33, P363, DOI 10.1046/j.1365-2958.1999.01479.x; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Zhu X, 1996, CURR GENET, V30, P107, DOI 10.1007/s002940050108	49	18	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41272	10.1371/journal.pone.0041272	http://dx.doi.org/10.1371/journal.pone.0041272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844449	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600019
J	Kasch, R; Mensel, B; Schmidt, F; Drescher, W; Pfuhl, R; Ruetten, S; Merk, HR; Kayser, R				Kasch, Richard; Mensel, Birger; Schmidt, Florian; Drescher, Wolf; Pfuhl, Ralf; Ruetten, Sebastian; Merk, Harry R.; Kayser, Ralph			Percutaneous Disc Decompression with Nucleoplasty-Volumetry of the Nucleus Pulposus Using Ultrahigh-Field MRI	PLOS ONE			English	Article							MAGNETIC-RESONANCE; INTRADISCAL PRESSURE; INTERVERTEBRAL DISC; DOUBLE-BLIND; IN-VIVO; LUMBAR; HERNIATION; SPINE; CHEMONUCLEOLYSIS; FUSION	Purpose: To evaluate changes in nucleus pulposus volume as a potential parameter for the effects of disc decompression. Methods: Fifty-two discs (T8 to L1) were extracted from 26 pigs and separated into thoracic (T8 to T11) and thoracolumbar discs (T12 to L1). The discs were imaged using 7.1 Tesla ultrahigh-field magnetic resonance imaging (MRI) with acquisition of axial T2-weighted turbo spin-echo sequences for determination of baseline and postinterventional nucleus pulposus volumes. Volumes were calculated using OsiriX (R) (http://www.osirix-viewer.com). After randomization, one group was treated with nucleoplasty, while the placebo group was treated with an identical procedure but without coblation current. The readers analyzing the MR images were blinded to the kind of procedure performed. Baseline and postinterventional volumes were compared between the nucleoplasty and placebo group. Results: Average preinterventional nucleus volume was 0.799 (SD: 0.212) ml. Postinterventional volume reduction in the nucleoplasty group was significant at 0.052 (SD: 0.035) ml or 6.30% (p<0.0001) (thoracic discs) and 0.082 (SD: 0.042) ml or 7.25% (p = 0.0078) (thoracolumbar discs). Nucleoplasty achieved volume reductions of 0.114 (SD: 0.054) ml or 14.72% (thoracic) and 0.093 (SD: 0.081) ml or 11.61% (thoracolumbar) compared with the placebo group. Conclusions: Nucleoplasty significantly reduces thoracic and thoracolumbar nucleus pulposus volumes in porcine discs.	[Kasch, Richard; Schmidt, Florian; Merk, Harry R.; Kayser, Ralph] Univ Med Greifswald, Clin & Outpatient Clin Orthoped & Orthoped Surg, Greifswald, Germany; [Mensel, Birger] Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Drescher, Wolf] Rhein Westfal TH Aachen, Dept Orthoped & Trauma Surg, Aachen, Germany; [Pfuhl, Ralf] Leibnitz Inst Farm Anim Biol, Dummerstorf, Germany; [Ruetten, Sebastian] St Anna Hosp, Ctr Orthoped & Traumatol, Dept Spine Surg & Pain Therapy, Herne, Germany	Greifswald Medical School; Greifswald Medical School; RWTH Aachen University; Forschungsinstitut fur Nutztierbiologie (FBN); Saint Anna Hospital	Kasch, R (corresponding author), Univ Med Greifswald, Clin & Outpatient Clin Orthoped & Orthoped Surg, Greifswald, Germany.	richard.kasch@uni-greifswald.de		Pfuhl, Ralf/0000-0001-5008-479X				Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Arun R, 2009, SPINE, V34, P2324, DOI 10.1097/BRS.0b013e3181b4df92; Baghi M, 2007, HEAD NECK-J SCI SPEC, V29, P104, DOI 10.1002/hed.20488; Birnbaum K, 2009, SURG RADIOL ANAT, V31, P379, DOI 10.1007/s00276-009-0462-6; Bokov A, 2010, PAIN PHYSICIAN, V13, P469; Case R B, 1995, J Clin Laser Med Surg, V13, P143; Chen SS, 1998, J BIOMECH, V31, P211, DOI 10.1016/S0021-9290(97)00121-8; Chen YC, 2003, SPINE, V28, P661, DOI 10.1097/00007632-200304010-00008; Chen Yung C, 2003, Spine J, V3, P466, DOI 10.1016/S1529-9430(03)00143-8; Choi JY, 2001, LASER SURG MED, V28, P248, DOI 10.1002/lsm.1046; Choy D S, 1992, J Clin Laser Med Surg, V10, P435; Choy D S, 1995, J Clin Laser Med Surg, V13, P149; Choy DSJ, 2004, PHOTOMED LASER SURG, V22, P407, DOI 10.1089/pho.2004.22.407; Choy DSJ, 1992, J CLIN LASER MED SUR, V10, P433; COTTERILL PC, 1986, J ORTHOPAED RES, V4, P298, DOI 10.1002/jor.1100040306; Dang L, 2010, EUR SPINE J, V19, P205, DOI 10.1007/s00586-009-1202-7; Freeman BJC, 2005, SPINE, V30, P2369, DOI 10.1097/01.brs.0000186587.43373.f2; Gerges FJ, 2010, PAIN PHYSICIAN, V13, P117; Groschel K, 2004, NEUROIMAGE, V21, P714, DOI 10.1016/j.neuroimage.2003.09.070; Helm S, 2009, PAIN PHYSICIAN, V12, P207; Kallewaard JW, 2010, PAIN PRACT, V10, P560, DOI 10.1111/j.1533-2500.2010.00408.x; Kapural L, 2008, PAIN MED, V9, P68, DOI 10.1111/j.1526-4637.2007.00410.x; Karlo C, 2010, EUR J RADIOL, V75, pE107, DOI 10.1016/j.ejrad.2009.09.005; Kim YJ, 2007, SPINE, V32, P2653, DOI 10.1097/BRS.0b013e31815a5a9d; Krug R, 2009, INVEST RADIOL, V44, P613, DOI 10.1097/RLI.0b013e3181b4c055; Kutschera HP, 1998, LASER SURG MED, V22, P275, DOI 10.1002/(SICI)1096-9101(1998)22:5<275::AID-LSM3>3.0.CO;2-M; Lee Michael S, 2003, Pain Physician, V6, P439; Levin JH, 2009, SPINE J, V9, P690, DOI 10.1016/j.spinee.2008.06.447; Lotjonen JMP, 2008, J MAGN RESON IMAGING, V28, P626, DOI 10.1002/jmri.21520; Lundin O, 1998, SPINE, V23, P2574, DOI 10.1097/00007632-199812010-00012; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P561; Mayer H, 2008, EUR SPINE J, V17, P1670, DOI 10.1007/s00586-008-0830-7; McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a; Nau WH, 2004, PHYS MED BIOL, V49, P1583, DOI 10.1088/0031-9155/49/8/015; NORDBY EJ, 1993, CLIN ORTHOP RELAT R, P122; OsiriX&REG;, 2010, OSIRIX VERS 3 6 1 32; Pauza Kevin J, 2004, Spine J, V4, P27, DOI 10.1016/j.spinee.2003.07.001; Pfirrmann CWA, 2006, J ORTHOP RES, V24, P1086, DOI 10.1002/jor.20113; Podhajsky RJ, 2007, SPINE J, V7, P229, DOI 10.1016/j.spinee.2006.04.019; Schenk B, 2006, LASER MED SCI, V21, P245, DOI 10.1007/s10103-006-0393-y; Singh V, 2009, PAIN PHYSICIAN, V12, P573; Steppan J, 2010, J VASC INTERV RADIOL, V21, P534, DOI 10.1016/j.jvir.2009.12.393; Timms MS, 2002, J LARYNGOL OTOL, V116, P450, DOI 10.1258/0022215021911031; VernonRoberts B, 1997, SPINE, V22, P2641, DOI 10.1097/00007632-199711150-00012; Violas P, 2007, SPINE, V32, pE405, DOI 10.1097/BRS.0b013e318074d69f; Weintraub MI, 2007, J NEUROIMAGING, V17, P241, DOI 10.1111/j.1552-6569.2007.00118.x; Yetkinler DN, 2002, CLIN SPORT MED, V21, P649, DOI 10.1016/S0278-5919(02)00015-7; Yetkinler DN, 2002, CLIN SPORTS MED, V21, pviii; Zhu H, 2011, INT ORTHOP	49	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41497	10.1371/journal.pone.0041497	http://dx.doi.org/10.1371/journal.pone.0041497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848512	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600075
J	Kreuzer, HW; Quaroni, L; Podlesak, DW; Zlateva, T; Bollinger, N; McAllister, A; Lott, MJ; Hegg, EL				Kreuzer, Helen W.; Quaroni, Luca; Podlesak, David W.; Zlateva, Theodora; Bollinger, Nikki; McAllister, Aaron; Lott, Michael J.; Hegg, Eric L.			Detection of Metabolic Fluxes of O and H Atoms into Intracellular Water in Mammalian Cells	PLOS ONE			English	Article							PHASE ESCHERICHIA-COLI; HYDROGEN; OXYGEN; TRANSFORMATION; FRACTIONATION; ISOTOPES; HAIR	Metabolic processes result in the release and exchange of H and O atoms from organic material as well as some inorganic salts and gases. These fluxes of H and O atoms into intracellular water result in an isotopic gradient that can be measured experimentally. Using isotope ratio mass spectroscopy, we revealed that slightly over 50% of the H and O atoms in the intracellular water of exponentially-growing cultured Rat-1 fibroblasts were isotopically distinct from growth medium water. We then employed infrared spectromicroscopy to detect in real time the flux of H atoms in these same cells. Importantly, both of these techniques indicate that the H and O fluxes are dependent on metabolic processes; cells that are in lag phase or are quiescent exhibit a much smaller flux. In addition, water extracted from the muscle tissue of rats contained a population of H and O atoms that were isotopically distinct from body water, consistent with the results obtained using the cultured Rat-1 fibroblasts. Together these data demonstrate that metabolic processes produce fluxes of H and O atoms into intracellular water, and that these fluxes can be detected and measured in both cultured mammalian cells and in mammalian tissue.	[Kreuzer, Helen W.; Bollinger, Nikki] Pacific NW Natl Lab, Richland, WA 99352 USA; [Quaroni, Luca] Paul Scherrer Inst, Villigen, Switzerland; [Podlesak, David W.; Lott, Michael J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Zlateva, Theodora] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada; [Zlateva, Theodora] Univ Saskatchewan, Saskatchewan Canc Res Unit, Saskatoon, SK, Canada; [McAllister, Aaron; Hegg, Eric L.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Utah System of Higher Education; University of Utah; University of Saskatchewan; University of Saskatchewan; Utah System of Higher Education; University of Utah; Michigan State University	Kreuzer, HW (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	helen.kreuzer@pnnl.gov; Luca.Quaroni@psi.ch; erichegg@msu.edu	Quaroni, Luca/O-4629-2019; Quaroni, Luca/G-3604-2013; Quaroni, Luca/I-3027-2014; Source, Mid IR Beamline Canadian Light/I-2869-2014	Quaroni, Luca/0000-0002-0225-9775; 	National Institutes of Health [GM 66236]; University of Utah Research Foundation; Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory, a multiprogram laboratory operated by Battelle for the United States Department of Energy [DE-AC05-76RL01830]; United States Department of Energy, Office of Biological and Environmental Research (BER) as part of BER's Genomic Science Program; Canadian Light Source and the Paul Scherrer Institut; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Utah Research Foundation; Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory, a multiprogram laboratory operated by Battelle for the United States Department of Energy; United States Department of Energy, Office of Biological and Environmental Research (BER) as part of BER's Genomic Science Program(United States Department of Energy (DOE)); Canadian Light Source and the Paul Scherrer Institut; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research funding was provided by National Institutes of Health (GM 66236) (ELH), the University of Utah Research Foundation (ELH), the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory, a multiprogram laboratory operated by Battelle for the United States Department of Energy under Contract DE-AC05-76RL01830 (HK), by the United States Department of Energy, Office of Biological and Environmental Research (BER) as part of BER's Genomic Science Program (HK), and the Canadian Light Source and the Paul Scherrer Institut (LQ). The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coplen T.B., 1996, GEOCHIM COSMOCHIM AC, V60, P3359, DOI [10.1016/0016-7037(96)00263-3, DOI 10.1016/0016-7037(96)00263-3]; FREEMAN AE, 1970, J NATL CANCER I, V44, P65; FREEMAN AE, 1973, P NATL ACAD SCI USA, V70, P2415, DOI 10.1073/pnas.70.8.2415; Garcia-Martin ML, 2001, PROG NUCL MAG RES SP, V39, P41, DOI 10.1016/S0079-6565(01)00031-0; Gehre M, 2004, RAPID COMMUN MASS SP, V18, P2650, DOI 10.1002/rcm.1672; Goff KL, 2009, ANALYST, V134, P2216, DOI 10.1039/b915810c; Gretebeck RJ, 1997, J APPL PHYSIOL, V82, P563, DOI 10.1152/jappl.1997.82.2.563; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kreuzer H, 2010, ELEMENTAL ISOTOPE RA, P968; Kreuzer-Martin HW, 2006, BIOCHEMISTRY-US, V45, P13622, DOI 10.1021/bi0609164; Kreuzer-Martin HW, 2005, P NATL ACAD SCI USA, V102, P17337, DOI 10.1073/pnas.0506531102; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Nagy K.A., 1989, Ecological Studies, V68, P270; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Quaroni L, 2011, ANALYST, V136, P3219, DOI 10.1039/c1an15060j; Robins Richard J., 2003, Phytochemistry Reviews, V2, P87, DOI 10.1023/B:PHYT.0000004301.52646.a8; Sachs JP, 2011, GEOCHIM COSMOCHIM AC, V75, P444, DOI 10.1016/j.gca.2010.10.013; Sachse D, 2008, GEOCHIM COSMOCHIM AC, V72, P793, DOI 10.1016/j.gca.2007.11.022; SCHIMMELMANN A, 1991, ANAL CHEM, V63, P2456, DOI 10.1021/ac00021a013; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; STERNBERG LDL, 1986, PLANT PHYSIOL, V82, P423, DOI 10.1104/pp.82.2.423; STERNBERG LDLO, 1983, GEOCHIM COSMOCHIM AC, V47, P2271	24	21	21	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39685	10.1371/journal.pone.0039685	http://dx.doi.org/10.1371/journal.pone.0039685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848359	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000306806600009
J	Vaesen, K				Vaesen, Krist			Cumulative Cultural Evolution and Demography	PLOS ONE			English	Article							TRANSMISSION; EMERGENCE; MODEL	The idea that demographic change may spur or slow down technological change has become widely accepted among evolutionary archaeologists and anthropologists. Two models have been particularly influential in promoting this idea: a mathematical model by Joseph Henrich, developed to explain the Tasmanian loss of culture during the Holocene; and an agent-based adaptation thereof, devised by Powell et al. to explain the emergence of modern behaviour in the Late Pleistocene. However, the models in question make rather strong assumptions about the distribution of skills among social learners and about the selectivity of social learning strategies. Here I examine the behaviour of these models under more conservative and, on empirical and theoretical grounds, equally reasonable assumptions. I show that, some qualifications notwithstanding, Henrich's model largely withstands my robustness tests. The model of Powell et al., in contrast, does not-a finding that warrants a fair amount of skepticism towards Powell et al.'s explanation of the Upper Paleolithic transition. More generally, my evaluation of the accounts of Henrich and of Powell et al. helpfully clarify which inferences their popular models do and not support.	Eindhoven Univ Technol, Sch Innovat Sci, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology	Vaesen, K (corresponding author), Eindhoven Univ Technol, Sch Innovat Sci, POB 513, NL-5600 MB Eindhoven, Netherlands.	k.vaesen@tue.nl		Vaesen, Krist/0000-0002-7496-7463	Netherlands Organization for Scientic Research (NWO)	Netherlands Organization for Scientic Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work was supported by the Netherlands Organization for Scientic Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley R, 2011, J EVOL PSYCH, V9, P1; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Castillo E., 2005, EXTREME VALUE RELATE; Chen CC, 1999, COMMUN STAT-SIMUL C, V28, P177, DOI 10.1080/03610919908813542; Enquist M, 2010, ANIM BEHAV, V79, P1353, DOI 10.1016/j.anbehav.2010.03.009; Eriksson K., 2009, J EVOL PSYCHOL, V7, P5, DOI [10.1556/JEP.7.2009.1.3, DOI 10.1556/JEP.7.2009.1.3]; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2001, AM ANTHROPOL, V103, P1; Henrich J., 2009, INNOVATION CULTURAL; Henrich J, 2011, PHILOS T R SOC B, V366, P1139, DOI 10.1098/rstb.2010.0323; Henrich Joseph, 2002, J COGN CULT, P87; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; Kremer M, 1993, Q J ECON, V108, P681, DOI 10.2307/2118405; Mesoudi A, 2006, BEHAV BRAIN SCI, V29, P329, DOI 10.1017/S0140525X06009083; Mesoudi A, 2011, EVOL HUM BEHAV, V32, P334, DOI 10.1016/j.evolhumbehav.2010.12.001; Mesoudi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018239; Mesoudi A, 2009, PSYCHOL REV, V116, P929, DOI 10.1037/a0017062; Mesoudi A, 2009, EVOL HUM BEHAV, V30, P41, DOI 10.1016/j.evolhumbehav.2008.07.005; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Richerson P, 2010, P NATL ACAD SCI USA, V107; Richerson PJ., 2005, NOT GENES ALONE CULT; Schlag KH, 1999, J MATH ECON, V31, P493, DOI 10.1016/S0304-4068(97)00068-2; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Shennan S., 2002, GENES MEMES CULTURAL; Shennan SJ., 1999, MAMMALIAN SOCIAL LEA; Sterelny K, 2007, PHILOS T R SOC B, V362, P719, DOI 10.1098/rstb.2006.2006; van Schaik CP, 2003, J HUM EVOL, V44, P645, DOI 10.1016/S0047-2484(03)00041-1; Willinger W, 2004, PROCEEDINGS OF THE 2004 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P130	30	41	41	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40989	10.1371/journal.pone.0040989	http://dx.doi.org/10.1371/journal.pone.0040989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22848419	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300019
J	Ochoa-Alvarez, JA; Krishnan, H; Shen, YQ; Acharya, NK; Han, M; McNulty, DE; Hasegawa, H; Hyodo, T; Senga, T; Geng, JG; Kosciuk, M; Shin, SS; Goydos, JS; Temiakov, D; Nagele, RG; Goldberg, GS				Ochoa-Alvarez, Jhon Alberto; Krishnan, Harini; Shen, Yongquan; Acharya, Nimish K.; Han, Min; McNulty, Dean E.; Hasegawa, Hitoki; Hyodo, Toshinori; Senga, Takeshi; Geng, Jian-Guo; Kosciuk, Mary; Shin, Seung S.; Goydos, James S.; Temiakov, Dmitry; Nagele, Robert G.; Goldberg, Gary S.			Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and Migration	PLOS ONE			English	Article							LYMPHATIC MARKER PODOPLANIN; MAACKIA-AMURENSIS HEMAGGLUTININ; PLATELET-AGGREGATION; BREAST-CANCER; MALIGNANT-MELANOMA; PA2.26 ANTIGEN; ORAL-CANCER; IN-VITRO; EXPRESSION; TUMOR	Cancer is a leading cause of death of men and women worldwide. Tumor cell motility contributes to metastatic invasion that causes the vast majority of cancer deaths. Extracellular receptors modified by alpha 2,3-sialic acids that promote this motility can serve as ideal chemotherapeutic targets. For example, the extracellular domain of the mucin receptor podoplanin (PDPN) is highly O-glycosylated with alpha 2,3-sialic acid linked to galactose. PDPN is activated by endogenous ligands to induce tumor cell motility and metastasis. Dietary lectins that target proteins containing alpha 2,3-sialic acid inhibit tumor cell growth. However, anti-cancer lectins that have been examined thus far target receptors that have not been identified. We report here that a lectin from the seeds of Maackia amurensis (MASL) with affinity for O-linked carbohydrate chains containing sialic acid targets PDPN to inhibit transformed cell growth and motility at nanomolar concentrations. Interestingly, the biological activity of this lectin survives gastrointestinal proteolysis and enters the cardiovascular system to inhibit melanoma cell growth, migration, and tumorigenesis. These studies demonstrate how lectins may be used to help develop dietary agents that target specific receptors to combat malignant cell growth.	[Ochoa-Alvarez, Jhon Alberto; Krishnan, Harini; Acharya, Nimish K.; Han, Min; Temiakov, Dmitry; Nagele, Robert G.; Goldberg, Gary S.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ USA; [Ochoa-Alvarez, Jhon Alberto; Krishnan, Harini; Shen, Yongquan; Goldberg, Gary S.] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA; [McNulty, Dean E.] GlaxoSmithKline, Mol Discovery Res, Prote & Biol Mass Spectrometry, Collegeville, PA USA; [Hasegawa, Hitoki; Hyodo, Toshinori; Senga, Takeshi] Nagoya Univ, Sch Med, Div Canc Biol, Nagoya, Aichi 466, Japan; [Geng, Jian-Guo] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Acharya, Nimish K.; Han, Min; Kosciuk, Mary; Nagele, Robert G.] Univ Med & Dent New Jersey, New Jersey Inst Successful Aging, Stratford, NJ USA; [Shin, Seung S.; Goydos, James S.] Canc Inst New Jersey, Dept Surg, New Brunswick, NJ USA; [Temiakov, Dmitry] Univ Med & Dent New Jersey, Dept Cell Biol, Stratford, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; GlaxoSmithKline; Nagoya University; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ochoa-Alvarez, JA (corresponding author), Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ USA.	gary.goldberg@umdnj.edu	Goydos, James/AAR-8990-2020; Krishnan, Harini/J-5632-2019	Goydos, James/0000-0001-9811-939X; Krishnan, Harini/0000-0003-0286-0322; Shin, Seung-Shick/0000-0002-8536-2056; Han, Min/0000-0002-8350-687X; Hyodo, Toshinori/0000-0003-3046-5338; Han, Min/0000-0002-7348-9121	NIH [R01CA126897]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Research Foundation of UMDNJ; Northarvest Bean Growers Association; Sentrimed; NATIONAL CANCER INSTITUTE [R01CA126897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation of UMDNJ; Northarvest Bean Growers Association; Sentrimed; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the NIH (R01CA126897) to J-GG, the Ministry of Education, Culture, Sports, Science and Technology of Japan to TS, and the Research Foundation of UMDNJ, the Northarvest Bean Growers Association, and Sentrimed to GSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DB, 2004, CANCER RES, V64, P1347, DOI 10.1158/0008-5472.CAN-03-2558; [Anonymous], 1955, ILUSTRATED MANUAL CH; Augustin M, 2005, ARZNEIMITTELFORSCH, V55, P38; Bange J, 2001, NAT MED, V7, P548, DOI 10.1038/87872; Beuth J, 2008, ANTICANCER RES, V28, P523; Buonaccorsi JN, 2012, AM J DERMATOPATH; Cerna A, 2002, ACTA HISTOCHEM, V104, P339, DOI 10.1078/0065-1281-00669; Chovanec M, 2004, ONCOL REP, V12, P297; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; CROW DS, 1992, ONCOGENE, V7, P999; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; Cui HX, 2011, ONCOL REP, V25, P1365, DOI 10.3892/or.2011.1192; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Estler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-478; Fedoreev SA, 2010, PHARM CHEM J, V38, P605, DOI DOI 10.1007/s11094-005-0039-6; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gandarillas A, 1997, MOL CARCINOGEN, V20, P10, DOI 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M; Grimaldo S, 2010, LYMPHOLOGY, V43, P128; Hasan SS, 2007, CANCER LETT, V253, P25, DOI 10.1016/j.canlet.2006.11.030; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Icirsch A, 2007, J ALTERN COMPLEM MED, V13, P443, DOI 10.1089/acm.2007.6175; Imberty A, 2000, J BIOL CHEM, V275, P17541, DOI 10.1074/jbc.M000560200; Inagaki Y, 2007, HEPATO-GASTROENTEROL, V54, P53; Ingrassia L, 2006, CURR MED CHEM, V13, P3513, DOI 10.2174/092986706779026219; Ito M, 2012, CHEST; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson KA, 2010, SEMIN ONCOL, V37, P345, DOI 10.1053/j.seminoncol.2010.05.012; Kapoor S, 2008, LEUKEMIA RES, V32, P559, DOI 10.1016/j.leukres.2007.08.007; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kato Y, 2010, NUCL MED BIOL, V37, P785, DOI 10.1016/j.nucmedbio.2010.03.010; Kawaguchi H, 2008, J CLIN ONCOL, V26, P354, DOI 10.1200/JCO.2007.13.4072; KAWAGUCHI T, 1974, J BIOL CHEM, V249, P2786; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kono T, 2007, INT J ONCOL, V31, P501; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Li X, 2009, CHEM PHARM BULL, V57, P302, DOI 10.1248/cpb.57.302; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Liang HH, 2007, AM J SURG PATHOL, V31, P304, DOI 10.1097/01.pas.0000213388.47913.f1; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Loos B, 2009, AUTOPHAGY, V5, P590, DOI 10.4161/auto.5.5.8479; Los M, 2007, ONCOLOGIST, V12, P443, DOI 10.1634/theoncologist.12-4-443; Maenuma K, 2008, PROTEOMICS, V8, P3274, DOI 10.1002/pmic.200800037; Maenuma K, 2009, J PROTEOME RES, V8, P3617, DOI 10.1021/pr800816w; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Martin-Villar E, 2009, INT J BIOCHEM CELL B, V41, P1421, DOI 10.1016/j.biocel.2008.12.010; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; Navarro A, 2010, ATLAS LIBRO ROJO FLO; Nelson MH, 2006, ANN PHARMACOTHER, V40, P261, DOI 10.1345/aph.1G387; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; NOSE K, 1990, CELL GROWTH DIFFER, V1, P511; Ogasawara S, 2008, HYBRIDOMA, V27, P259, DOI 10.1089/hyb.2008.0017; Pryme IF, 2006, HISTOL HISTOPATHOL, V21, P285, DOI 10.14670/HH-21.285; Pryme IF, 2002, HISTOL HISTOPATHOL, V17, P261, DOI 10.14670/HH-17.261; Pryme IF, 1999, CANCER LETT, V146, P87, DOI 10.1016/S0304-3835(99)00242-6; Pryme IF, 2007, CANC THERAPY, V5, P287; Pula B, 2011, HISTOPATHOLOGY, V59, P1249, DOI 10.1111/j.1365-2559.2011.04060.x; Pusztai A, 2008, FRONT BIOSCI-LANDMRK, V13, P1130, DOI 10.2741/2750; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Scholl FG, 1999, J CELL SCI, V112, P4601; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shen YQ, 2010, J BIOL CHEM, V285, P9649, DOI 10.1074/jbc.M109.047696; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Theiss C, 2007, EXP CELL RES, V313, P38, DOI 10.1016/j.yexcr.2006.09.029; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; VanDamme EJM, 1997, GLYCOCONJUGATE J, V14, P449, DOI 10.1023/A:1018595300863; Wang FL, 2009, CANCER DETECT PREV, V32, P437, DOI 10.1016/j.cdp.2009.01.001; Wang HX, 2000, INT J BIOCHEM CELL B, V32, P365, DOI 10.1016/S1357-2725(99)00130-2; Wang Q, 1998, LANCET, V352, P1831, DOI 10.1016/S0140-6736(05)79894-9; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Witz IP, 2006, IMMUNOL LETT, V104, P89, DOI 10.1016/j.imlet.2005.11.008; Witz IP, 2006, CANC TREAT, V130, P125; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yamamoto K, 1997, J BIOCHEM-TOKYO, V121, P756; Yu HB, 2007, AM J CLIN PATHOL, V128, P767, DOI 10.1309/4GMREAULY257R3AY; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061	87	47	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41845	10.1371/journal.pone.0041845	http://dx.doi.org/10.1371/journal.pone.0041845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844530	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700158
J	Bordino, I; Battiston, S; Caldarelli, G; Cristelli, M; Ukkonen, A; Weber, I				Bordino, Ilaria; Battiston, Stefano; Caldarelli, Guido; Cristelli, Matthieu; Ukkonen, Antti; Weber, Ingmar			Web Search Queries Can Predict Stock Market Volumes	PLOS ONE			English	Article							ASSET TREES; NETWORKS; VOLATILITY; BEHAVIOR; MODELS	We live in a computerized and networked society where many of our actions leave a digital trace and affect other people's actions. This has lead to the emergence of a new data-driven research field: mathematical methods of computer science, statistical physics and sociometry provide insights on a wide range of disciplines ranging from social science to human mobility. A recent important discovery is that search engine traffic (i.e., the number of requests submitted by users to search engines on the www) can be used to track and, in some cases, to anticipate the dynamics of social phenomena. Successful examples include unemployment levels, car and home sales, and epidemics spreading. Few recent works applied this approach to stock prices and market sentiment. However, it remains unclear if trends in financial markets can be anticipated by the collective wisdom of on-line users on the web. Here we show that daily trading volumes of stocks traded in NASDAQ-100 are correlated with daily volumes of queries related to the same stocks. In particular, query volumes anticipate in many cases peaks of trading by one day or more. Our analysis is carried out on a unique dataset of queries, submitted to an important web search engine, which enable us to investigate also the user behavior. We show that the query volume dynamics emerges from the collective but seemingly uncoordinated activity of many users. These findings contribute to the debate on the identification of early warnings of financial systemic risk, based on the activity of users of the www.	[Bordino, Ilaria; Ukkonen, Antti; Weber, Ingmar] Yahoo Res, Barcelona, Spain; [Battiston, Stefano] ETH Chair Syst Design, Zurich, Switzerland; [Caldarelli, Guido; Cristelli, Matthieu] Univ Roma La Sapienza, Inst Complex Syst CNR, Rome, Italy; [Caldarelli, Guido] London Inst Math Sci, London, England; [Caldarelli, Guido] IMT Inst Adv Studies, Lucca, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; IMT School for Advanced Studies Lucca	Bordino, I (corresponding author), Yahoo Res, Barcelona, Spain.	matthieu.cristelli@roma1.infn.it	/M-1612-2017; Ukkonen, Antti/E-8512-2013; Caldarelli, Guido/AAB-8206-2022; Weber, Ingmar/AAE-6909-2020; Battiston, Stefano/I-2624-2012; Caldarelli, Guido/A-5274-2010	/0000-0002-0051-973X; Weber, Ingmar/0000-0003-4169-2579; Battiston, Stefano/0000-0002-0051-973X; Caldarelli, Guido/0000-0001-9377-3616	EU Grant FET [255987]	EU Grant FET	This work was supported by the EU Grant FET Open Project 255987 "FOC." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asur S., 2010, ARXIV10035699; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Bouchaud JP, 2008, NATURE, V455, P1181, DOI 10.1038/4551181a; Bouchaud JP, 2009, PHYS WORLD, V22, P28; Bouchaud JP., 2009, THEORY FINANCIAL RIS; Choi H, 2009, AB BAF MU MAG KASH B; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; Easley D, 2010, NETWORKS CROWS MARKE; Evans J, 2010, SCIENCE, V329, P399, DOI 10.1126/science.1189416; Garlaschelli D, 2005, PHYSICA A, V350, P491, DOI 10.1016/j.physa.2004.11.040; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liu YH, 1999, PHYS REV E, V60, P1390, DOI 10.1103/PhysRevE.60.1390; Mitchell TM, 2009, SCIENCE, V326, P1644, DOI 10.1126/science.1174459; Onnela JP, 2003, PHYS SCRIPTA, VT106, P48, DOI 10.1238/Physica.Topical.106a00048; Onnela JP, 2002, EUR PHYS J B, V30, P285, DOI 10.1140/epjb/e2002-00380-9; Pastor-Satorras R, 2010, NAT PHYS, V6, P480, DOI 10.1038/nphys1722; Plerou V, 2000, PHYSICA A, V279, P443, DOI 10.1016/S0378-4371(00)00010-8; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Saavedra S, 2011, P NATL ACAD SCI USA, V108, P5296, DOI 10.1073/pnas.1018462108; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Yamasaki K, 2005, P NATL ACAD SCI USA, V102, P9424, DOI 10.1073/pnas.0502613102	32	127	129	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40014	10.1371/journal.pone.0040014	http://dx.doi.org/10.1371/journal.pone.0040014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829871	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000306956300009
J	Dasgupta, N; Davis, J; Funk, MJ; Dart, R				Dasgupta, Nabarun; Davis, Jonathan; Funk, Michele Jonsson; Dart, Richard			Using Poison Center Exposure Calls to Predict Methadone Poisoning Deaths	PLOS ONE			English	Article							PRESCRIPTION OPIOID ANALGESICS; UNITED-STATES; CANCER PAIN; ABUSE; SURVEILLANCE; MORTALITY; ASSOCIATION; MANAGEMENT; TEXAS	Purpose: There are more drug overdose deaths in the Untied States than motor vehicle fatalities. Yet the US vital statistics reporting system is of limited value because the data are delayed by four years. Poison centers report data within an hour of the event, but previous studies suggested a small proportion of poisoning deaths are reported to poison centers (PC). In an era of improved electronic surveillance capabilities, exposure calls to PCs may be an alternate indicator of trends in overdose mortality. Methods: We used PC call counts for methadone that were reported to the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS (R)) System in 2006 and 2007. US death certificate data were used to identify deaths due to methadone. Linear regression was used to quantify the relationship of deaths and poison center calls. Results: Compared to decedents, poison center callers tended to be younger, more often female, at home and less likely to require medical attention. A strong association was found with PC calls and methadone mortality (b = 0.88, se = 0.42, t = 9.5, df = 1, p<0.0001, R-2 = 0.77). These findings were robust to large changes in a sensitivity analysis assessing the impact of underreporting of methadone overdose deaths. Conclusions: Our results suggest that calls to poison centers for methadone are correlated with poisoning mortality as identified on death certificates. Calls received by poison centers may be used for timely surveillance of mortality due to methadone. In the midst of the prescription opioid overdose epidemic, electronic surveillance tools that report in real-time are powerful public health tools.	[Dasgupta, Nabarun; Funk, Michele Jonsson] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Davis, Jonathan; Dart, Richard] Denver Hlth, Rocky Mt Poison & Drug Ctr, Denver, CO USA; [Dart, Richard] Univ Colorado, Sch Med, Denver, CO USA	University of North Carolina; University of North Carolina Chapel Hill; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Dasgupta, N (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	nabarund@unc.edu	Funk, Michele Jonsson/F-6885-2011	Funk, Michele Jonsson/0000-0002-3756-7540; Dasgupta, Nabarun/0000-0002-4098-605X; Dart, Richard/0000-0001-5989-9354	UNC/GSK Center for Excellence in Pharmacoepidemiology and Public Health through the University of North Carolina at Chapel Hill	UNC/GSK Center for Excellence in Pharmacoepidemiology and Public Health through the University of North Carolina at Chapel Hill	Dr. Dasgupta received a graduate student fellowship from the UNC/GSK Center for Excellence in Pharmacoepidemiology and Public Health through the University of North Carolina at Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angalakuditi MV, 2006, AM J HEALTH-SYST PH, V63, P323, DOI 10.2146/ajhp050227; Ayonrinde OT, 2000, MED J AUSTRALIA, V173, P536, DOI 10.5694/j.1326-5377.2000.tb139323.x; Banerji S, 2001, AM J HEALTH-SYST PH, V58, P1811, DOI 10.1093/ajhp/58.19.1811; BLANC PD, 1995, WESTERN J MED, V162, P505; Brands B, 2002, DRUG ALCOHOL DEPEN, V66, P11, DOI 10.1016/S0376-8716(01)00176-4; Breiding MJ, 2006, INJURY PREV, V12, P49, DOI 10.1136/ip.2006.012591; Bryner JK, 2006, ARCH PEDIAT ADOL MED, V160, P1217, DOI 10.1001/archpedi.160.12.1217; Bunn TL, 2010, PHARMACOEPIDEM DR S, V19, P124, DOI 10.1002/pds.1901; Cicero TJ, 2007, PAIN MED, V8, P157, DOI 10.1111/j.1526-4637.2006.00259.x; Cicero TJ, 2005, J PAIN, V6, P662, DOI 10.1016/j.jpain.2005.05.004; Dart RC, 2011, ANN PHARMACOTHER, V45, P424, DOI 10.1345/aph.1P064b; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Dasgupta N, 2008, GEOGRAPHY DRUG ADDIC; Dasgupta N, 2010, PAIN MED, V11, P1078, DOI 10.1111/j.1526-4637.2010.00877.x; Dasgupta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007758; Donaldson AE, 2006, INJURY PREV, V12, P338, DOI 10.1136/ip.2005.011171; Forrester MB, 2007, J TOXICOL ENV HEAL A, V70, P534, DOI 10.1080/15287390600870924; Forrester MB, 2006, J TOXICOL ENV HEAL A, V69, P1145, DOI 10.1080/15287390500360273; Hayes BD, 2009, CLIN TOXICOL, V47, P905, DOI 10.3109/15563650903301702; Hoppe-Roberts JM, 2000, ANN EMERG MED, V35, P440, DOI 10.1067/mem.2000.105932; Hughes AA, 2007, CLIN TOXICOL, V45, P144, DOI 10.1080/15563650600981137; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; KleinSchwartz W, 1997, ANN EMERG MED, V29, P232, DOI 10.1016/S0196-0644(97)70274-9; Kreshak AA, 2009, ANN PHARMACOTHER, V43, P1986, DOI 10.1345/aph.1M454; LINAKIS JG, 1993, ANN EMERG MED, V22, P1822, DOI 10.1016/S0196-0644(05)80408-1; Marquardt KA, 2005, ANN PHARMACOTHER, V39, P1039, DOI 10.1345/aph.1E577; Matlock A, 2011, CLIN TOXICOL, V49, P443, DOI 10.3109/15563650.2011.564585; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Reifler LM, 2012, PAIN MED; Ripamonti C, 2001, DRUGS, V61, P955, DOI 10.2165/00003495-200161070-00005; Rosenblum A, 2007, DRUG ALCOHOL DEPEN, V90, P64, DOI 10.1016/j.drugalcdep.2007.02.012; Schneider MF, 2009, PHARMACOEPIDEM DR S, V18, P778, DOI 10.1002/pds.1780; Sims SA, 2007, J BIOMED INFORM, V40, P382, DOI 10.1016/j.jbi.2006.10.004; Smith MY, 2008, PHARMACOEPIDEM DR S, V17, P1050, DOI 10.1002/pds.1658; Smith MY, 2006, AM J DRUG ALCOHOL AB, V32, P465, DOI 10.1080/00952990600753982; SOSLOW AR, 1992, AM J EMERG MED, V10, P124, DOI 10.1016/0735-6757(92)90043-W; Spiller HA, 1997, J TOXICOL-CLIN TOXIC, V35, P167, DOI 10.3109/15563659709001188; Spiller HA, 2010, ANN PHARMACOTHER, V44, P1016, DOI 10.1345/aph.1P064; Stephens BG, 2004, AM J FOREN MED PATH, V25, P11, DOI 10.1097/01.paf.0000114041.70865.24; Tormoehlen LM, 2011, CLIN TOXICOL, V49, P492, DOI 10.3109/15563650.2011.587819; Toxic Exposure Surveillance System (TESS), 2002, INSTR AM ASS POIS CO; Vassilev ZP, 2003, J TOXICOL ENV HEAL A, V66, P1905, DOI 10.1080/713853953; Webster LR, 2011, PAIN MED, V12, pS86, DOI 10.1111/j.1526-4637.2011.01132.x; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	46	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41181	10.1371/journal.pone.0041181	http://dx.doi.org/10.1371/journal.pone.0041181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829925	gold, Green Published			2022-12-27	WOS:000306956300064
J	Vitoriano-Souza, J; Moreira, ND; Teixeira-Carvalho, A; Carneiro, CM; Siqueira, FAM; Vieira, PMD; Giunchetti, RC; Moura, SAD; Fujiwara, RT; Melo, MN; Reis, AB				Vitoriano-Souza, Juliana; Moreira, Nadia das Dores; Teixeira-Carvalho, Andrea; Carneiro, Claudia Martins; Mathias Siqueira, Fernando Augusto; de Abreu Vieira, Paula Melo; Giunchetti, Rodolfo Cordeiro; de Lima Moura, Sandra Aparecida; Fujiwara, Ricardo Toshio; Melo, Maria Norma; Reis, Alexandre Barbosa			Cell Recruitment and Cytokines in Skin Mice Sensitized with the Vaccine Adjuvants: Saponin, Incomplete Freund's Adjuvant, and Monophosphoryl Lipid A	PLOS ONE			English	Article							ANTIGEN DELIVERY; NEUTROPHILS; INNATE; EXPRESSION; IMMUNIZATION; ACTIVATION; INCREASES; RESPONSES; EFFECTOR; IMMUNITY	Vaccine adjuvants are substances associated with antigens that are fundamental to the formation of an intense, durable, and fast immune response. In this context, the use of vaccine adjuvants to generate an effective cellular immune response is crucial for the design and development of vaccines against visceral leishmaniasis. The objective of this study was to evaluate innate inflammatory response induced by the vaccine adjuvants saponin (SAP), incomplete Freund's adjuvant (IFA), and monophosphoryl lipid A (MPL). After a single dose of adjuvant was injected into the skin of mice, we analyzed inflammatory reaction, selective cell migration, and cytokine production at the injection site, and inflammatory cell influx in the peripheral blood. We found that all vaccine adjuvants were able to promote cell recruitment to the site without tissue damage. In addition, they induced selective migration of neutrophils, macrophages, and lymphocytes. The influx of neutrophils was notable at 12 h in all groups, but at other time points it was most evident after inoculation with SAP. With regard to cytokines, the SAP led to production of interleukin (IL)-2, IL-6, and IL-4. IFA promoted production of tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, IL-6, IL-17, IL-4, and IL-10. We also observed that MPL induced high production of IL-2, TNF-alpha, and IFN-gamma, in addition to IL-6, IL-17, and IL-10. In peripheral blood, values of certain cell populations in the local response changed after stimulation. Our data demonstrate that the three vaccine adjuvants stimulate the early events of innate immune response at the injection site, suggesting their ability to increase the immunogenicity of co-administered antigens. Moreover, this work provides relevant information about elements of innate and acquired immune response induced by vaccine adjuvants administered alone.	[Vitoriano-Souza, Juliana; Fujiwara, Ricardo Toshio; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Vitoriano-Souza, Juliana; Moreira, Nadia das Dores; Carneiro, Claudia Martins; Mathias Siqueira, Fernando Augusto; de Abreu Vieira, Paula Melo; Giunchetti, Rodolfo Cordeiro; de Lima Moura, Sandra Aparecida; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz, Lab Biomarcadores Diagnost & Monitoracao, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Carneiro, Claudia Martins; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Dept Anal Clin, Escola Farm, Ouro Preto, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto	Vitoriano-Souza, J (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	alexreis@nupeb.ufop.br	Reis, Alexandre Barbosa/I-9945-2014; Giunchetti, Rodolfo/O-9878-2014; de Moura, Sandra Aparecida Lima/AAW-3214-2021; carneiro, Claudia Martins/AAP-4455-2020; carneiro, claudia m/B-6205-2013; Fujiwara, Ricardo Toshio/J-7579-2012	Reis, Alexandre Barbosa/0000-0001-8123-4164; carneiro, Claudia Martins/0000-0002-6002-857X; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Vieira, Paula/0000-0001-7033-7686; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546; Siqueira Mathias, Fernando Augusto/0000-0003-2071-0344	FAPEMIG; CNPq; CAPES	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPEMIG, CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLGOWER M, 1995, BURNS, V21, pS7, DOI 10.1016/0305-4179(95)90028-4; Aucouturier J, 2006, VACCINE, V24, pS44, DOI 10.1016/j.vaccine.2005.01.116; Becker PFL, 1997, PATOLOGIA GERAL, P140; Behboudi S, 1999, SCAND J IMMUNOL, V50, P371, DOI 10.1046/j.1365-3083.1999.00603.x; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; CASTRO AP, 1993, CLIN EXP IMMUNOL, V92, P466; CHAMPION RH, 1998, TXB DERMATOLOGY; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Dahl MV, 1996, CLIN IMMUNODERMATOLO; Debenedictis C, 2001, CLIN DERMATOL, V19, P573, DOI 10.1016/S0738-081X(00)00173-5; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Firestein GS, 2004, CECIL TXB MED; Fogg CN, 2007, VACCINE, V25, P2787, DOI 10.1016/j.vaccine.2006.12.037; FREUND J, 1947, ANNU REV MICROBIOL, V1, P291, DOI 10.1146/annurev.mi.01.100147.001451; Gerdts V, 2011, EXPERT REV VACCINES, V10, P433, DOI [10.1586/erv.11.31, 10.1586/ERV.11.31]; Giunchetti RC, 2007, VACCINE, V25, P7674, DOI 10.1016/j.vaccine.2007.08.009; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; HAY JB, 1974, CELL IMMUNOL, V10, P145, DOI 10.1016/0008-8749(74)90158-0; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kensil CR, 2004, FRONT BIOSCI-LANDMRK, V9, P2972, DOI 10.2741/1452; Kensil CR, 1998, DEV BIOL STAND, V92, P41; Korsholm KS, 2010, IMMUNOLOGY, V129, P75, DOI 10.1111/j.1365-2567.2009.03164.x; Liu G, 2002, VACCINE, V20, P2808, DOI 10.1016/S0264-410X(02)00209-8; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Moreira ND, 2009, VET IMMUNOL IMMUNOP, V128, P418, DOI 10.1016/j.vetimm.2008.11.030; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; MUSSENER A, 1995, SCAND J IMMUNOL, V42, P128, DOI 10.1111/j.1365-3083.1995.tb03635.x; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; O'Hagan DT, 2000, VACCINES ADJUVANTS P; Ravindran R, 2004, CURR MOL MED, V4, P697, DOI 10.2174/1566524043360212; Schijns VEJC, 2002, VET IMMUNOL IMMUNOP, V87, P195, DOI 10.1016/S0165-2427(02)00072-7; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; Shen SS, 2012, VACCINE, V30, P1560, DOI 10.1016/j.vaccine.2011.12.120; Singh M, 2002, PHARM RES-DORDR, V19, P715, DOI 10.1023/A:1016104910582; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Singh M., 2007, VACCINE ADJUVANTS DE; Smith RE, 1999, J IMMUNOL, V162, P5536; STEWART RJ, 1984, AUST NZ J SURG, V54, P565, DOI 10.1111/j.1445-2197.1984.tb05447.x; TAYLOR CE, 1995, INFECT IMMUN, V63, P3241, DOI 10.1128/IAI.63.9.3241-3244.1995; Wang W., 2011, WORLD J VACCINE, V01, P33, DOI DOI 10.4236/WJV.2011.12007; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Zhang WW, 2008, INFECT IMMUN, V76, P3777, DOI 10.1128/IAI.01527-07	50	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40745	10.1371/journal.pone.0040745	http://dx.doi.org/10.1371/journal.pone.0040745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829882	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300020
J	Xiao, Y; Karnati, S; Qian, GF; Nenicu, A; Fan, W; Tchatalbachev, S; Holand, A; Hossain, H; Guillou, F; Luers, GH; Baumgart-Vogt, E				Xiao, Yu; Karnati, Srikanth; Qian, Guofeng; Nenicu, Anca; Fan, Wei; Tchatalbachev, Svetlin; Hoeland, Anita; Hossain, Hamid; Guillou, Florian; Lueers, Georg H.; Baumgart-Vogt, Eveline			Cre-Mediated Stress Affects Sirtuin Expression Levels, Peroxisome Biogenesis and Metabolism, Antioxidant and Proinflammatory Signaling Pathways	PLOS ONE			English	Article							HORMONE RECEPTOR SUPERFAMILY; STRAND BREAK REPAIR; ZELLWEGER-SYNDROME; OXIDATIVE STRESS; GERM-CELLS; CONDITIONAL CONTROL; GENE-EXPRESSION; BETA-OXIDATION; MICE; MOUSE	Cre-mediated excision of loxP sites is widely used in mice to manipulate gene function in a tissue-specific manner. To analyze phenotypic alterations related to Cre-expression, we have used AMH-Cre-transgenic mice as a model system. Different Cre expression levels were obtained by investigation of C57BL/6J wild type as well as heterozygous and homozygous AMH-Cre-mice. Our results indicate that Cre-expression itself in Sertoli cells already has led to oxidative stress and lipid peroxidation (4-HNE lysine adducts), inducing PPAR alpha/gamma, peroxisome proliferation and alterations of peroxisome biogenesis (PEX5, PEX13 and PEX14) as well as metabolic proteins (ABCD1, ABCD3, MFP1, thiolase B, catalase). In addition to the strong catalase increase, a NRF2- and FOXO3-mediated antioxidative response (HMOX1 of the endoplasmic reticulum and mitochondrial SOD2) and a NF-kappa B activation were noted. TGF beta 1 and proinflammatory cytokines like IL1, IL6 and TNF alpha were upregulated and stress-related signaling pathways were induced. Sertoli cell mRNA-microarray analysis revealed an increase of TNFR2-signaling components. 53BP1 recruitment and expression levels for DNA repair genes as well as for p53 were elevated and the ones for related sirtuin deacetylases affected (SIRT 1, 3-7) in Sertoli cells. Under chronic Cre-mediated DNA damage conditions a strong downregulation of Sirt1 was observed, suggesting that the decrease of this important coordinator between DNA repair and metabolic signaling might induce the repression release of major transcription factors regulating metabolic and cytokine-mediated stress pathways. Indeed, caspase-3 was activated and increased germ cell apoptosis was observed, suggesting paracrine effects. In conclusion, the observed wide stress-induced effects and metabolic alterations suggest that it is essential to use the correct control animals (Cre/Wt) with matched Cre expression levels to differentiate between Cre-mediated and specific gene-knock out-mediated effects.	[Xiao, Yu; Karnati, Srikanth; Qian, Guofeng; Nenicu, Anca; Fan, Wei; Lueers, Georg H.; Baumgart-Vogt, Eveline] Univ Giessen, Inst Anat & Cell Biol 2, Giessen, Germany; [Tchatalbachev, Svetlin; Hoeland, Anita; Hossain, Hamid] Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Guillou, Florian] Univ Francois Rabelais Tours, INRA UMR 85, CNRS UMR 6175, IFCE Physiologie Reprod & Comportements, Nouzilly, France	Justus Liebig University Giessen; Justus Liebig University Giessen; INRAE	Xiao, Y (corresponding author), Univ Giessen, Inst Anat & Cell Biol 2, Giessen, Germany.	Eveline.Baumgart-Vogt@anatomie.med.uni-giessen.de	Karnati, Srikanth/AAP-9038-2021; Baumgart-Vogt, Eveline/I-5945-2013	Karnati, Srikanth/0000-0001-9083-2916; Baumgart-Vogt, Eveline/0000-0002-8265-3763; Windhorst, Anita C/0000-0002-7357-2080	German Research Foundation (Deutsche Forschungsgemeinschaft - DFG); Clinical Research Unit [KFO 181, Ba 2465, Lu 978]; State of Hesse (Germany) LOEWE-focus group "Male Infertility during Infection and Inflammation" (MIBIE) [A4]	German Research Foundation (Deutsche Forschungsgemeinschaft - DFG)(German Research Foundation (DFG)); Clinical Research Unit; State of Hesse (Germany) LOEWE-focus group "Male Infertility during Infection and Inflammation" (MIBIE)	This study was funded by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft - DFG) Clinical Research Unit (KFO 181, project 3, Ba 2465 and Lu 978; http://www.uni-giessen.de/cms/fbz/fb11/forschung/forschergruppen/kfo_181/home, and State of Hesse (Germany) LOEWE-focus group "Male Infertility during Infection and Inflammation" (MIBIE, project A4; http://www.uni-giessen.de/cms/fbz/fb11/forschung/schwerpunkte/loewe/male_infertility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Allan CM, 2009, AM J PHYSIOL-ENDOC M, V296, pE1022, DOI 10.1152/ajpendo.90941.2008; Allan CM, 2004, ENDOCRINOLOGY, V145, P1587, DOI 10.1210/en.2003-1164; Awasthi Yogesh C., 2003, Molecular Aspects of Medicine, V24, P219; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Baes M, 2006, BBA-MOL CELL RES, V1763, P1785, DOI 10.1016/j.bbamcr.2006.08.018; Barrera G, 2008, PPAR RES, V2008, DOI 10.1155/2008/524671; Baumgart E, 2003, MICROSC RES TECHNIQ, V61, P121, DOI 10.1002/jemt.10322; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; Baumgart E, 1997, HISTOCHEM CELL BIOL, V108, P185, DOI 10.1007/s004180050160; Baur J, 2010, PATHWAYS SABIOSCIENC, V12, P12; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chaudhary P, 2010, BIOCHEMISTRY-US, V49, P6263, DOI 10.1021/bi100517x; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dastig S, 2011, HISTOCHEM CELL BIOL, V136, P413, DOI 10.1007/s00418-011-0832-0; del Rio LA, 2003, IUBMB LIFE, V55, P71, DOI 10.1080/1521654031000094694; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fahimi HD, 1996, ANN NY ACAD SCI, V804, P341, DOI 10.1111/j.1749-6632.1996.tb18627.x; Furuta Yasuhide, 2005, Birth Defects Res C Embryo Today, V75, P43, DOI 10.1002/bdrc.20036; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GOLDFISCHER S, 1973, J HISTOCHEM CYTOCHEM, V21, P972, DOI 10.1177/21.11.972; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228; Ishikawa T, 2006, ENDOCRINOLOGY, V147, P1706, DOI 10.1210/en.2005-1576; ISSEMANN I, 1991, J STEROID BIOCHEM, V40, P263, DOI 10.1016/0960-0760(91)90191-7; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JANNINI EA, 1994, BIOL REPROD, V51, P140, DOI 10.1095/biolreprod51.1.140; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Karnati S, 2008, HISTOCHEM CELL BIOL, V130, P719, DOI 10.1007/s00418-008-0462-3; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kinoshita T, 2011, BIOCHEM BIOPH RES CO, V407, P321, DOI 10.1016/j.bbrc.2011.03.013; Konrad L, 2006, APOPTOSIS, V11, P739, DOI 10.1007/s10495-006-5542-z; Konrad L, 2006, MOL REPROD DEV, V73, P1211, DOI 10.1002/mrd.20399; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Latruffe N, 2000, BIOCHEM PHARMACOL, V60, P1027, DOI 10.1016/S0006-2952(00)00416-0; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Lobe CG, 1998, BIOESSAYS, V20, P200, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;200::AID-BIES3&gt;3.0.CO;2-V; Lombard DB, 2009, AGING-US, V1, P12, DOI 10.18632/aging.100014; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luers GH, 2006, HISTOCHEM CELL BIOL, V125, P693, DOI 10.1007/s00418-005-0114-9; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MASTERS CJ, 1995, MECH AGEING DEV, V80, P69, DOI 10.1016/0047-6374(94)01563-2; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nenicu A, 2009, BIOL REPROD, V81; Nenicu A, 2007, BIOL REPROD, V77, P1060, DOI 10.1095/biolreprod.107.061242; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Ozawa Y, 2010, OPHTHALMIC RES, V44, P199, DOI 10.1159/000316484; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Purushotham A, 2009, AGING-US, V1, P669, DOI 10.18632/aging.100076; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; SAUER B, 1992, J MOL BIOL, V223, P911, DOI 10.1016/0022-2836(92)90252-F; Schlatt S, 1997, EUR J ENDOCRINOL, V137, P107, DOI 10.1530/eje.0.1370107; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Whitsett JA, 2006, AM J RESP CELL MOL, V34, P519, DOI 10.1165/rcmb.F310; Winnall WR, 2007, BIOL REPROD, V76, P759, DOI 10.1095/biolreprod.106.053124; Xavier F, 2003, MOL CELL ENDOCRINOL, V211, P115, DOI 10.1016/j.mce.2003.09.022; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zarkovic N, 1999, LIFE SCI, V65, P1901, DOI 10.1016/S0024-3205(99)00444-0; Zarkovic Neven, 2003, Molecular Aspects of Medicine, V24, P281, DOI 10.1016/S0098-2997(03)00023-2; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	91	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41097	10.1371/journal.pone.0041097	http://dx.doi.org/10.1371/journal.pone.0041097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829911	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300050
J	Violato, M; Gray, A; Papanicolas, I; Ouellet, M				Violato, Mara; Gray, Alastair; Papanicolas, Irini; Ouellet, Melissa			Resource Use and Costs Associated with Coeliac Disease before and after Diagnosis in 3,646 Cases: Results of a UK Primary Care Database Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; IRRITABLE-BOWEL-SYNDROME; CO-MORBIDITY; MORTALITY; BURDEN; SPRUE; PREVALENCE; SYMPTOMS; PATIENT; PEOPLE	Background: Despite the considerable health impact of coeliac disease (CD), reliable estimates of the impact of diagnosis on health care use and costs are lacking. Aims: To quantify the volume, type and costs, in a United Kingdom primary care setting, of healthcare resources used by individuals diagnosed with CD up to ten years before and after diagnosis, and to estimate medical costs associated with CD. Methods: A cohort of 3,646 CD cases and a parallel cohort of 32,973 matched controls, extracted from the General Practice Research Database (GPRD) over the period 1987-2005 were used i) to evaluate the impact of diagnosis on the average resource use and costs of cases; ii) to assess direct healthcare costs due to CD by comparing average resource use and costs incurred by cases vs. controls. Results: Average annual healthcare costs per patient increased by 310 pound (95% CI 299 pound, 320) pound after diagnosis. CD cases experienced higher healthcare costs than controls both before diagnosis (mean difference 91; pound 95% CI: 86 pound, 97) pound and after diagnosis (mean difference 354; pound 95% CI: 347 pound, 361) pound. These differences were driven mainly by higher test and referral costs before diagnosis, and by increased prescription costs after diagnosis. Conclusions: This study shows significant additional primary care costs associated with coeliac disease. It provides novel evidence that will assist researchers evaluating interventions in this area, and will challenge policymakers, clinicians, researchers and the public to develop strategies that maximise the health benefits of the resources associated with this disease.	[Violato, Mara; Gray, Alastair; Ouellet, Melissa] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England; [Papanicolas, Irini] London Sch Econ, LSE Hlth, Dept Social Policy, London WC2A 2AE, England	University of Oxford; University of London; London School Economics & Political Science	Violato, M (corresponding author), Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England.	mara.violato@dph.ox.ac.uk		Violato, Mara/0000-0002-0484-7706	Coeliac UK [BXGCXLT1]; National Institute for Health Research [NF-SI-0509-10206] Funding Source: researchfish	Coeliac UK; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by Coeliac UK (http://www.coeliac.org.uk/), grant number BXGCXLT1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They, however, provided valuable comments, support and encouragement throughout the duration of the study.	Armitage P., 2002, STAT METHODS MED RES; Bingley PJ, 2004, BRIT MED J, V328, P322, DOI 10.1136/bmj.328.7435.322; Byass P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022774; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ciacci C, 2003, DIGEST DIS SCI, V48, P2216, DOI 10.1023/B:DDAS.0000004530.11738.a2; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Department of Health, 2010, NAT SCHED REF COSTS; Department of Health, 2010, HOSP COMM HLTH SERV; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dorn SD, 2008, DIGEST DIS SCI, V53, P680, DOI 10.1007/s10620-007-9939-5; Fernandez A, 2010, REV ESP ENFERM DIG, V102, P466, DOI 10.4321/s1130-01082010000800002; Gray AM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-105; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green Peter H R, 2008, J Insur Med, V40, P218; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hallert C, 2002, SCAND J GASTROENTERO, V37, P39, DOI 10.1080/003655202753387338; Hallert C, 1998, SCAND J GASTROENTERO, V33, P933, DOI 10.1080/003655298750026949; Harewood GC, 2004, DIGEST DIS SCI, V49, P1808, DOI 10.1007/s10620-004-9575-2; Harewood GC, 2001, DIGEST DIS SCI, V46, P2510, DOI 10.1023/A:1012396408370; Hauser W, 2007, ALIMENT PHARM THER, V25, P569, DOI 10.1111/j.1365-2036.2006.03227.x; Hershcovici T, 2010, ALIMENT PHARM THER, V31, P901, DOI 10.1111/j.1365-2036.2010.04242.x; Hodgson C, 2001, HLTH STAT Q, P14; Hollowell J, 1997, Popul Trends, P36; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Long KH, 2010, ALIMENT PHARM THER, V32, P261, DOI 10.1111/j.1365-2036.2010.04327.x; Mearin ML, 2005, BEST PRACT RES CL GA, V19, P441, DOI 10.1016/j.bpg.2005.02.004; Mein SM, 2004, ALIMENT PHARM THER, V19, P1199, DOI 10.1111/j.1365-2036.2004.01958.x; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; National Institute for Health and Care Excellence (NICE), 2009, ET INFL AD TREATM PS; National Institute for Health and Clinical Excellence (NICE), 2009, COEL DIS REC ASS COE; NHS, 2008, NO IR PRESCR; NHS England, 2011, PRESCR COSTS; NIELSEN OH, 1985, SCAND J GASTROENTERO, V20, P13, DOI 10.3109/00365528509089626; Personal Social Services Research Unit, 2010, UN COSTS HLTH SOC CA; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Rowlands S, 2002, BRIT J GEN PRACT, V52, P658; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Scottish Government, 2011, NHS PRESCR; Spiegel BMR, 2004, GASTROENTEROLOGY, V126, P1721, DOI 10.1053/j.gastro.2004.03.012; STEVENS L, 2008, REV CANADIENNE PRATI, V69, P147; Usai P, 2007, DIGEST LIVER DIS, V39, P824, DOI 10.1016/j.dld.2007.05.017; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; Viljamaa M, 2005, ALIMENT PHARM THER, V22, P317, DOI 10.1111/j.1365-2036.2005.02574.x; Welsh Government, 2006, FREE PRESCR WAL; West J, 2003, GASTROENTEROLOGY, V125, P429, DOI 10.1016/S0016-5085(03)00891-6; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Whitaker JKH, 2009, ALIMENT PHARM THER, V29, P1131, DOI 10.1111/j.1365-2036.2009.03983.x; Yagil Y, 2005, DIGEST DIS SCI, V50, P796, DOI 10.1007/s10620-005-2576-y	51	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41308	10.1371/journal.pone.0041308	http://dx.doi.org/10.1371/journal.pone.0041308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815991	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000306507000086
J	Cizza, G; Mistry, S; Nguyen, VT; Eskandari, F; Martinez, P; Torvik, S; Reynolds, JC; Gold, PW; Sinai, N; Csako, G				Cizza, Giovanni; Mistry, Sima; Nguyen, Vi T.; Eskandari, Farideh; Martinez, Pedro; Torvik, Sara; Reynolds, James C.; Gold, Philip W.; Sinai, Ninet; Csako, Gyorgy		POWER Study Grp	Do Premenopausal Women with Major Depression Have Low Bone Mineral Density? A 36-Month Prospective Study	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR GENE; CORONARY-HEART-DISEASE; RISK-FACTOR; INSULIN-RESISTANCE; BIDIRECTIONAL ASSOCIATION; PARATHYROID-HORMONE; OSTEOPOROSIS; METAANALYSIS; SYMPTOMS; DISORDER	Background: An inverse relationship between major depressive disorder (MDD) and bone mineral density (BMD) has been suggested, but prospective evaluation in premenopausal women is lacking. Methods: Participants of this prospective study were 21 to 45 year-old premenopausal women with MDD (n = 92) and healthy controls (n = 44). We measured BMD at the anteroposterior lumbar spine, femoral neck, total hip, mid-distal radius, trochanter, and Ward's triangle, as well as serum intact parathyroid hormone (iPTH), ionized calcium, plasma adrenocorticotropic hormone (ACTH), serum cortisol, and 24-hour urinary-free cortisol levels at 0, 6, 12, 24, and 36 months. 25-hydroxyvitamin D was measured at baseline. Results: At baseline, BMD tended to be lower in women with MDD compared to controls and BMD remained stable over time in both groups. At baseline, 6, 12, and 24 months intact PTH levels were significantly higher in women with MDD vs. controls. At baseline, ionized calcium and 25-hydroxyvitamin D levels were significantly lower in women with MDD compared to controls. At baseline and 12 months, bone-specific alkaline phosphatase, a marker of bone formation, was significantly higher in women with MDD vs. controls. Plasma ACTH was also higher in women with MDD at baseline and 6 months. Serum osteocalcin, urinary N-telopeptide, serum cortisol, and urinary free cortisol levels were not different between the two groups throughout the study. Conclusion: Women with MDD tended to have lower BMD than controls over time. Larger and longer studies are necessary to extend these observations with the possibility of prophylactic therapy for osteoporosis.	[Cizza, Giovanni; Nguyen, Vi T.; Eskandari, Farideh; Torvik, Sara] Natl Inst Diabet & Digest Kidney Dis NIDDK, Sect Neuroendocrinol Obes, NIH, Bethesda, MD 20892 USA; [Mistry, Sima] Tulane Univ, Sch Med, Internal Med Pediat Residency Program, New Orleans, LA 70112 USA; [Martinez, Pedro; Gold, Philip W.] NIMH, Behav Endocrinol Branch, NIH, Bethesda, MD 20892 USA; [Reynolds, James C.; Sinai, Ninet; Csako, Gyorgy] NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Cizza, G (corresponding author), Natl Inst Diabet & Digest Kidney Dis NIDDK, Sect Neuroendocrinol Obes, NIH, Bethesda, MD 20892 USA.	cizzag@intra.niddk.nih.gov			National Institutes of Health (NIH); National Institute of Mental Health (NIMH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was fully supported by the National Institutes of Health (NIH), Intramural Research Program: National Institute of Mental Health (NIMH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Alendronate and Placebo were generously provided by Merck Research Laboratories, Rahway, NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi JD, 2001, ARTHRITIS RHEUM, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W; Adriaanse MC, 2006, DIABETOLOGIA, V49, P2874, DOI 10.1007/s00125-006-0500-4; Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Aihara M, 2007, PSYCHIAT RES-NEUROIM, V155, P245, DOI 10.1016/j.pscychresns.2006.11.002; Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Allison DB, 2009, AM J PREV MED, V36, P341, DOI 10.1016/j.amepre.2008.11.020; Amsterdam JD, 1998, PROG NEURO-PSYCHOPH, V22, P267; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Bhalla AK, 2010, BEST PRACT RES CL RH, V24, P313, DOI 10.1016/j.berh.2010.01.006; Blaine B, 2008, J HEALTH PSYCHOL, V13, P1190, DOI 10.1177/1359105308095977; Blume J, 2011, BRAIN BEHAV IMMUN, V25, P221, DOI 10.1016/j.bbi.2010.10.008; BOUXSEIN ML, 1994, CALCIFIED TISSUE INT, V54, P113, DOI 10.1007/BF00296061; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Cizza G, 2010, HORM METAB RES, V42, P467, DOI 10.1055/s-0030-1252020; Cizza G, 2001, TRENDS ENDOCRIN MET, V12, P198, DOI 10.1016/S1043-2760(01)00407-6; Cizza G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028912; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Emaus N, 2005, AM J EPIDEMIOL, V162, P633, DOI 10.1093/aje/kwi258; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Gourlay ML, 2004, ARCH INTERN MED, V164, P603, DOI 10.1001/archinte.164.6.603; HALBREICH U, 1995, PSYCHOSOM MED, V57, P485, DOI 10.1097/00006842-199509000-00011; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Kahl KG, 2006, PSYCHOSOM MED, V68, P669, DOI 10.1097/01.psy.0000237858.76880.3d; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Krishnamurthy P, 2008, HORM METAB RES, V40, P194, DOI 10.1055/s-2007-1004541; Kunugi H, 2006, NEUROPSYCHOPHARMACOL, V31, P212, DOI 10.1038/sj.npp.1300868; Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; MATKOVIC V, 1994, J CLIN INVEST, V93, P799, DOI 10.1172/JCI117034; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602; Mussolino ME, 2004, PSYCHOSOM MED, V66, P533, DOI 10.1097/01.psy.0000132873.50734.7d; Mussolino ME, 2005, PUBLIC HEALTH REP, V120, P71, DOI 10.1177/003335490512000112; Nemeroff CB, 1996, MOL PSYCHIATR, V1, P336; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Ozsoy S, 2005, TURK PSIKIYATR DERG, V16, P77; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; Petronijevic M, 2008, BONE, V42, P582, DOI 10.1016/j.bone.2007.11.010; Reginster JY, 1999, MATURITAS, V33, P133, DOI 10.1016/S0378-5122(99)00057-2; Rubinow DR, 2011, DEPRESS ANXIETY, V28, pE1, DOI 10.1002/da.20833; Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001; Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Timonen M, 2005, BMJ-BRIT MED J, V330, P17, DOI 10.1136/bmj.38313.513310.F71; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Whooley MA, 2004, J GERIATR PSYCH NEUR, V17, P88, DOI 10.1177/0891988704264537; Williams LJ, 2011, J AFFECT DISORDERS, V131, P164, DOI 10.1016/j.jad.2010.11.019; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wu Q, 2012, OSTEOPOROSIS INT, V23, P365, DOI 10.1007/s00198-011-1778-8; Yazici AE, 2005, JOINT BONE SPINE, V72, P540, DOI 10.1016/j.jbspin.2004.12.011; Yirmiya R, 2009, BIOL PSYCHIAT, V66, P423, DOI 10.1016/j.biopsych.2009.03.016; Zhao GX, 2010, BRIT J NUTR, V104, P1696, DOI 10.1017/S0007114510002588	63	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40894	10.1371/journal.pone.0040894	http://dx.doi.org/10.1371/journal.pone.0040894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848407	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200033
J	Zeng, XF; Huang, ZM; Mao, XB; Wang, JJ; Wu, GY; Qiao, SY				Zeng, Xiangfang; Huang, Zhimin; Mao, Xiangbing; Wang, Junjun; Wu, Guoyao; Qiao, Shiyan			N-Carbamylglutamate Enhances Pregnancy Outcome in Rats through Activation of the PI3K/PKB/mTOR Signaling Pathway	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; L-ARGININE SUPPLEMENTATION; AMINO-ACIDS; GENE LEADS; FACTOR LIF; EMBRYO; GROWTH; NUTRITION; TROPHOBLAST; METABOLISM	Administration of N-carbamylglutamate (NCG), an analogue of endogenous N-acetyl-glutamate (an activator of arginine synthesis) has been shown to enhance neonatal growth by increasing circulating arginine levels. However, the effect of NCG on pregnancy remains unknown. This study examined the effects of NCG on pregnancy outcome and evaluated potential mechanisms involved. Reproductive performance, embryo implantation, and concentration of amino acids in serum and uterine flushing, were determined in rats fed control or NCG supplemented diets. Ishikawa cells and JAR cells were used to examine the mechanism by which NCG affects embryo implantation. Dietary NCG supplementation increased serum levels of arginine, onithine, and proline, as well as uterine levels of arginine, glutamine, glutamate, and proline. Additionally, it stimulated LIF expression, and enhanced the activation of signal transduction and activator of transcription 3 (Stat3), protein kinase B (PKB), and 70-kDa ribosomal protein S6 kinase (S6K1) during the periimplantation period, resulting in an increase in litter size but not birth weight. In uterine Ishikawa cells, LIF expression was also enhanced by treatment with arginine and its metabolites. In trophoblast JAR cells, treatment with arginine and its metabolites enhanced Stat3, PKB, and S6K1 activation and facilitated cellular adhesion activity. These effects were abolished by pretreatment with inhibitors of phosphatidylinositol 3-kinase (wortmannin) and mammalian target of rapamycin (rapamycin). The results demonstrate that NCG supplementation enhances pregnancy outcome and have important implications for the pregnancy outcome of mammalian species.	[Zeng, Xiangfang; Huang, Zhimin; Mao, Xiangbing; Wang, Junjun; Wu, Guoyao; Qiao, Shiyan] China Agr Univ, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Wu, Guoyao] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Wu, Guoyao] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	China Agricultural University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Zeng, XF (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Beijing 100094, Peoples R China.	qiaoshy@mafic.ac.cn			National Natural Science Foundation of China [u0731002, 30525029]; Thousand-People Talent program at China Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand-People Talent program at China Agricultural University	This work was supported by grants from the National Natural Science Foundation of China (u0731002 and 30525029) and the Thousand-People Talent program at China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Andersen CB, 1998, J BIOL CHEM, V273, P18705, DOI 10.1074/jbc.273.30.18705; Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; BACHMANN C, 1982, ADV EXP MED BIOL, V153, P313; Benzies KM, 2008, CAN MED ASSOC J, V178, P183, DOI 10.1503/cmaj.071577; Berard J, 2010, ANIMAL, V4, P1680, DOI 10.1017/S1751731110000881; Chen XM, 2009, REPRODUCTION, V138, P351, DOI 10.1530/REP-09-0090; Corvinus FM, 2003, AM J REPROD IMMUNOL, V50, P316, DOI 10.1034/j.1600-0897.2003.00099.x; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dunglison GF, 1996, HUM REPROD, V11, P191; Evans J, 2009, PARLIAMENT AFF, V62, P1, DOI 10.1093/pa/gsn045; Frank JW, 2007, J NUTR, V137, P315, DOI 10.1093/jn/137.2.315; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gao HJ, 2009, BIOL REPROD, V80, P86, DOI 10.1095/biolreprod.108.071597; Geisert R., 2002, J ANIM SCI, V80, pE54, DOI [10.2527/animalsci2002.0021881200800ES10009x, DOI 10.2527/ANIMALSCI2002.0021881200800ES10009X]; Goff AK, 2002, REPROD DOMEST ANIM, V37, P133, DOI 10.1046/j.1439-0531.2002.00344.x; GRAU E, 1992, HEPATOLOGY, V15, P446, DOI 10.1002/hep.1840150315; GUFFON N, 1995, J INHERIT METAB DIS, V18, P61, DOI 10.1007/BF00711374; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Hugentobler SA, 2007, MOL REPROD DEV, V74, P445, DOI 10.1002/mrd.20607; Kamei T, 2002, MOL ENDOCRINOL, V16, P1469, DOI 10.1210/me.16.7.1469; Lassala A, 2009, J NUTR, V139, P660, DOI 10.3945/jn.108.102020; Lavranos TC, 1995, J REPROD FERTIL, V105, P331, DOI 10.1530/jrf.0.1050331; Lengyel F, 2007, STEROIDS, V72, P422, DOI 10.1016/j.steroids.2007.03.001; Martin PM, 2003, BIOL REPROD, V69, P1101, DOI 10.1095/biolreprod.103.018010; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Mateo RD, 2007, J NUTR, V137, P652, DOI 10.1093/jn/137.3.652; MEIJER AJ, 1985, EUR J BIOCHEM, V148, P189, DOI 10.1111/j.1432-1033.1985.tb08824.x; Mitchell MH, 2002, BIOL REPROD, V67, P460, DOI 10.1095/biolreprod67.2.460; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Myrskyla M, 2009, NATURE, V460, P741, DOI 10.1038/nature08230; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Nishikawa T, 2007, BIOCHEM BIOPH RES CO, V363, P978, DOI 10.1016/j.bbrc.2007.09.082; O'Connor MF, 2001, ANESTH ANALG, V93, P809, DOI 10.1097/00000539-200110000-00001; PETTERS RM, 1990, J REPROD FERTIL, V89, P269, DOI 10.1530/jrf.0.0890269; Riley JK, 2006, J BIOL CHEM, V281, P6010, DOI 10.1074/jbc.M506982200; Riley JK, 2005, DEV BIOL, V284, P377, DOI 10.1016/j.ydbio.2005.05.033; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; SCHLAFKE S, 1975, BIOL REPROD, V12, P41, DOI 10.1095/biolreprod12.1.41; Schwahn BC, 2010, EUR J PEDIATR, V169, P133, DOI 10.1007/s00431-009-1036-7; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; Ucar SK, 2009, METAB BRAIN DIS, V24, P409, DOI 10.1007/s11011-009-9155-4; Van Winkle LJ, 2001, BIOL REPROD, V64, P1, DOI 10.1095/biolreprod64.1.1; Vosatka RJ, 1998, AM J OBSTET GYNECOL, V178, P242, DOI 10.1016/S0002-9378(98)80007-0; Wu G, 2010, J ANIM SCI, V88, pE195, DOI 10.2527/jas.2009-2446; Wu GY, 2007, J NUTR, V137, p1673S, DOI 10.1093/jn/137.6.1673S; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Wu GY, 2000, J NUTR, V130, P2626, DOI 10.1093/jn/130.11.2626; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu X, 2010, AMINO ACIDS, V39, P831, DOI 10.1007/s00726-010-0538-y; Xiao XM, 2005, INT J GYNECOL OBSTET, V88, P15, DOI 10.1016/j.ijgo.2004.09.017; Xue Q, 2009, ARTERIOSCL THROM VAS, V29, P1172, DOI 10.1161/ATVBAHA.109.185918; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yue ZP, 2000, BIOL REPROD, V63, P508, DOI 10.1095/biolreprod63.2.508; Zeng XF, 2008, J NUTR, V138, P1421, DOI 10.1093/jn/138.8.1421	59	55	65	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41192	10.1371/journal.pone.0041192	http://dx.doi.org/10.1371/journal.pone.0041192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848442	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200045
J	Eilers, EJ; Talarico, G; Hansson, BS; Hilker, M; Reinecke, A				Eilers, Elisabeth J.; Talarico, Giovanni; Hansson, Bill S.; Hilker, Monika; Reinecke, Andreas			Sensing the Underground - Ultrastructure and Function of Sensory Organs in Root-Feeding Melolontha melolontha (Coleoptera: Scarabaeinae) Larvae	PLOS ONE			English	Article							TENEBRIO-MOLITOR-L; FINE-STRUCTURE; ELECTROANTENNOGRAM RESPONSES; DROSOPHILA-MELANOGASTER; BEHAVIORAL-RESPONSES; DIGITIFORM SENSILLA; OLFACTORY SENSILLA; MAXILLAR PALP; MORPHOLOGY; SCARABAEOIDEA	Introduction: Below ground orientation in insects relies mainly on olfaction and taste. The economic impact of plant root feeding scarab beetle larvae gave rise to numerous phylogenetic and ecological studies. Detailed knowledge of the sensory capacities of these larvae is nevertheless lacking. Here, we present an atlas of the sensory organs on larval head appendages of Melolontha melolontha. Our ultrastructural and electrophysiological investigations allow annotation of functions to various sensory structures. Results: Three out of 17 ascertained sensillum types have olfactory, and 7 gustatory function. These sensillum types are unevenly distributed between antennae and palps. The most prominent chemosensory organs are antennal pore plates that in total are innervated by approximately one thousand olfactory sensory neurons grouped into functional units of three-to-four. In contrast, only two olfactory sensory neurons innervate one sensillum basiconicum on each of the palps. Gustatory sensilla chaetica dominate the apices of all head appendages, while only the palps bear thermo-/hygroreceptors. Electrophysiological responses to CO2, an attractant for many root feeders, are exclusively observed in the antennae. Out of 54 relevant volatile compounds, various alcohols, acids, amines, esters, aldehydes, ketones and monoterpenes elicit responses in antennae and palps. All head appendages are characterized by distinct olfactory response profiles that are even enantiomer specific for some compounds. Conclusions: Chemosensory capacities in M. melolontha larvae are as highly developed as in many adult insects. We interpret the functional sensory units underneath the antennal pore plates as cryptic sensilla placodea and suggest that these perceive a broad range of secondary plant metabolites together with CO2. Responses to olfactory stimulation of the labial and maxillary palps indicate that typical contact chemo-sensilla have a dual gustatory and olfactory function.	[Eilers, Elisabeth J.; Hilker, Monika] Free Univ Berlin, Dept Appl Zool Anim Ecol, Berlin, Germany; [Eilers, Elisabeth J.; Talarico, Giovanni; Hansson, Bill S.; Reinecke, Andreas] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Free University of Berlin; Max Planck Society	Eilers, EJ (corresponding author), Free Univ Berlin, Dept Appl Zool Anim Ecol, Berlin, Germany.	elisabeth.eilers@agr.uni-goettingen.de	Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223	German research foundation (DFG) [P.S. RE 302311]; Max Planck Society	German research foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was financially supported by the Max Planck Society and the German research foundation (DFG, P.S. RE 302311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PJ, 1993, PHYSIOL ENTOMOL, V18, P329, DOI 10.1111/j.1365-3032.1993.tb00605.x; Alekseev M.A., 2006, ENTMOL REV, V86, P638, DOI [10.1134/S0013873806060042., DOI 10.1134/S0013873806060042]; ALTNER H, 1985, ANNU REV ENTOMOL, V30, P273, DOI 10.1146/annurev.en.30.010185.001421; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; CHU IW, 1971, Z ZELLFORSCH MIK ANA, V117, P17, DOI 10.1007/BF00331098; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; DEVITT BD, 1982, INT J INSECT MORPHOL, V11, P255, DOI 10.1016/0020-7322(82)90015-0; DOANE JF, 1978, ANN ENTOMOL SOC AM, V71, P357, DOI 10.1093/aesa/71.3.357; Dosdall LM, 2004, COLEOPTS BULL, V58, P45, DOI 10.1649/594; ENE I. -M., 1942, Zeitschrift fur Angewandte Entomologie, V29, P529; Farazmand H., 2008, Journal of Entomological Society of Iran, V27, P1; FAUCHEUX MJ, 1995, INT J INSECT MORPHOL, V24, P391, DOI 10.1016/0020-7322(95)00011-R; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Giglio A, 2008, ZOOL ANZ, V247, P209, DOI 10.1016/j.jcz.2007.12.001; Giglio A, 2003, ZOOL ANZ, V242, P277, DOI 10.1078/0044-5231-00104; Grebennikov VV, 2004, INVERTEBR SYST, V18, P321, DOI 10.1071/IS03013; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; GUSE GW, 1980, PROTOPLASMA, V103, P55, DOI 10.1007/BF01276741; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hasler T, 1986, THESIS EIDGENOSSISCH; Hill SR, 2009, CHEM SENSES, V34, P231, DOI 10.1093/chemse/bjn080; HONOMICHL K, 1981, ACTA ZOOL-STOCKHOLM, V62, P17, DOI 10.1111/j.1463-6395.1981.tb00613.x; JEPSON W. F., 1937, Bulletin of Entomological Research, V28, P149, DOI 10.1017/S0007485300038335; JERATH M. L., 1965, COLEOPT BULL, V19, P59; Johnson SN, 2006, PHYSIOL ENTOMOL, V31, P1, DOI 10.1111/j.1365-3032.2005.00487.x; Johnson SN, 2005, J CHEM ECOL, V31, P2223, DOI 10.1007/s10886-005-6355-1; KAI M, 2009, BIOL UNSERER Z, V5, P313; Keil TA, 1996, TISSUE CELL, V28, P703, DOI 10.1016/S0040-8166(96)80073-5; Keil TA, 1999, INSECT OLFACTION, V5, P47; Kim JY, 2000, ARTHROPOD STRUCT DEV, V29, P121, DOI 10.1016/S1467-8039(00)00022-0; Klingler J, 1957, MITT SCHWEIZ ENTOMOL, V30, P317; Koschier EH, 2000, J CHEM ECOL, V26, P2643, DOI 10.1023/A:1026470122171; Leal WS, 1998, ANNU REV ENTOMOL, V43, P39, DOI 10.1146/annurev.ento.43.1.39; Marion-Poll F, 2002, J INSECT PHYSIOL, V48, P467, DOI 10.1016/S0022-1910(02)00068-9; MarionPoll F, 1996, ENTOMOL EXP APPL, V80, P113, DOI 10.1007/BF00194738; MEINECKE CC, 1975, ZOOMORPHOLOGIE, V82, P1, DOI 10.1007/BF00995905; Merivee E, 2005, PHYSIOL ENTOMOL, V30, P122, DOI 10.1111/j.1365-3032.2005.00435.x; Mico E, 2003, ANN ENTOMOL SOC AM, V96, P95, DOI 10.1603/0013-8746(2003)096[0095:BANLDF]2.0.CO;2; Mico E, 2001, EUR J ENTOMOL, V98, P311, DOI 10.14411/eje.2001.054; Mitchell BK, 1999, MICROSC RES TECHNIQ, V47, P401, DOI 10.1002/(SICI)1097-0029(19991215)47:6<401::AID-JEMT4>3.0.CO;2-7; MORON MA, 1991, COLEOPTS BULL, V45, P360; OSBORNE G O, 1974, New Zealand Journal of Zoology, V1, P371; Raguso RA, 1996, J CHEM ECOL, V22, P1735, DOI 10.1007/BF02028502; RATCLIFFE B C, 1980, Coleopterists Bulletin, V34, P85; Reinecke A, 2008, BASIC APPL ECOL, V9, P568, DOI 10.1016/j.baae.2007.10.002; Renou M, 1998, INT J INSECT MORPHOL, V27, P227, DOI 10.1016/S0020-7322(98)00014-2; Romero-Lopez A, 2010, NEOTROP ENTOMOL, V39, P957, DOI 10.1590/S1519-566X2010000600018; RUMBO ER, 1988, J INSECT PHYSIOL, V34, P117, DOI 10.1016/0022-1910(88)90163-1; Ruther J, 2000, PHYSIOL ENTOMOL, V25, P172, DOI 10.1046/j.1365-3032.2000.00183.x; Schwerdtfeger F., 1939, Zeitschrift fuer Angewandte Entomologie, V26, P215; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shields VDC, 2009, ANN ENTOMOL SOC AM, V102, P1116, DOI 10.1603/008.102.0621; Smith ABT, 2006, COLEOPTS BULL, V60, P144, DOI 10.1649/0010-065X(2006)60[144:AROTFN]2.0.CO;2; Smith ABT, 2006, COLEOPTS BULL, V60, P35, DOI 10.1649/0010-065X(2006)60[35:AOOTCA]2.0.CO;2; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STADLER E, 1975, J COMP PHYSIOL, V104, P97; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Steeghs M, 2004, PLANT PHYSIOL, V135, P47, DOI 10.1104/pp.104.038703; Stelinski LL, 2003, J INSECT PHYSIOL, V49, P845, DOI 10.1016/S0022-1910(03)00136-7; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Stopfer M, 2011, NATURE, V474, P40, DOI 10.1038/474040a; SUTHERLAND O R W, 1974, New Zealand Journal of Zoology, V1, P365; Team RDC, 2009, R LANG ENV STAT COMP; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; Vermehren-Schmaedick A, 2010, GENETICS, V186, P183, DOI 10.1534/genetics.110.118166; VISSER JH, 1995, J APPL ENTOMOL, V119, P539, DOI 10.1111/j.1439-0418.1995.tb01332.x; Watts SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018463; Weissteiner SM, 2010, THESIS G AUGUST U GO; WENSLER RJ, 1972, ENTOMOL EXP APPL, V15, P155, DOI 10.1007/BF00435166; ZACHARUK RY, 1991, ANNU REV ENTOMOL, V36, P331, DOI 10.1146/annurev.en.36.010191.001555; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	75	53	59	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41357	10.1371/journal.pone.0041357	http://dx.doi.org/10.1371/journal.pone.0041357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848471	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600055
J	Jiao, P; Feng, B; Xu, HY				Jiao, Ping; Feng, Bin; Xu, Haiyan			Mapping MKP-3/FOXO1 Interaction and Evaluating the Effect on Gluconeogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FKHR; PROTEIN-KINASE-B; HEPATIC GLUCONEOGENESIS; PHOSPHOENOLPYRUVATE CARBOXYKINASE; GENE-EXPRESSION; INSULIN; ACTIVATION; OBESITY; INHIBITION; P38	Background: MAP kinase phosphatase 3 (MKP-3) is known to attenuate the ERK signaling pathway. It has been recently demonstrated that MKP-3 is also a player in promoting hepatic glucose output in obese state by interacting and activating FOXO1. Reduction of hepatic MKP-3 expression is sufficient to reduce blood glucose levels in both diet-induced and genetically obese mice. Methodology/Principal Findings: In current study, the mechanism of MKP-3/FOXO1 interaction and the effects on transcription of gluconeogenic gene and glucose output was investigated in Fao hepatoma cells by using mutated MKP-3 and FOXO1 adenoviral constructs. The results indicate that MKP-3 phosphatase activity is not required for MKP-3/FOXO1 interaction but is essential for FOXO1 nuclear translocation and MKP-3 promoted gluconeogenesis. Compared to GFP control (1 +/- 0.38), MKP-3 increased G6Pase gene expression by 242% (3.42 +/- 0.62) while inactive MKP-3 does not change G6Pase expression (0.98 +/- 0.17). The residues 200-260 of MKP-3 and the residues 360-456 of FOXO1 are essential for mediating MKP-3/FOXO1 interaction. Interestingly, ERK phosphorylation deficient but not Akt phosphorylation deficient FOXO1 mutant lost interaction with MKP-3. Furthermore, in vivo experiments showed that Akt phosphorylation resistant FOXO1 3A mutant is sufficient to rescue the hypoglycemia caused by MKP-3 knock down in the liver of lean mice (from 141 +/- 6.78 to 209 +/- 4.64 mg/dL). Conclusions/Significance: 1) Critical residues mediating MKP-3/FOXO1 interaction have been identified; 2) ERK phosphorylation deficient FOXO1 mutant is as potent as Akt phosphorylation deficient FOXO1 mutant in activating transcription of gluconeogenic genes; 3) Constitutively active FOXO1 can rescue the hypoglycemic effect caused by reduced hepatic MKP-3 expression in vivo.	[Jiao, Ping; Feng, Bin; Xu, Haiyan] Brown Univ, Rhode Isl Hosp, Hallett Ctr Diabet & Endocrinol, Alpert Med Sch, Providence, RI 02903 USA; [Jiao, Ping] Jilin Univ, Sch Pharmaceut Sci, Changchun 130023, Jilin Province, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Jilin University	Jiao, P (corresponding author), Brown Univ, Rhode Isl Hosp, Hallett Ctr Diabet & Endocrinol, Alpert Med Sch, Providence, RI 02903 USA.	hxu@lifespan.org			National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK080746]; Brown University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080746] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Brown University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK080746 awarded to HX from National Institute of Diabetes and Digestive and Kidney Diseases. PJ is a recipient of George Bray Fellowship from Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderwald C, 2002, MOL ENDOCRINOL, V16, P1612, DOI 10.1210/me.16.7.1612; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Berasi SP, 2006, J BIOL CHEM, V281, P27167, DOI 10.1074/jbc.M602416200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Gabbay RA, 1996, J BIOL CHEM, V271, P1890, DOI 10.1074/jbc.271.4.1890; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holman GD, 1997, DIABETOLOGIA, V40, P991, DOI 10.1007/s001250050780; Koo SH, 2005, NATURE; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Schmoll D, 2001, BIOCHEM J, V357, P867, DOI 10.1042/0264-6021:3570867; Sutherland C, 1998, J BIOL CHEM, V273, P3198, DOI 10.1074/jbc.273.6.3198; Theodosiou A, 2002, GENOME BIOL, V3; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu ZD, 2010, J CLIN INVEST, V120, P3901, DOI 10.1172/JCI43250; Xu H., 2005, J BIOL CHEM; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Yan L, 2012, BIOCH J; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200	40	17	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41168	10.1371/journal.pone.0041168	http://dx.doi.org/10.1371/journal.pone.0041168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848439	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600043
J	Ge, GH; Wang, SX; Han, YP; Zhang, CH; Lu, S; Huang, ZH				Ge, Guohong; Wang, Shixia; Han, Yaping; Zhang, Chunhua; Lu, Shan; Huang, Zuhu			Removing N-Terminal Sequences in Pre-S1 Domain Enhanced Antibody and B-Cell Responses by an HBV Large Surface Antigen DNA Vaccine	PLOS ONE			English	Article							LARGE ENVELOPE PROTEIN; HEPATITIS-B; T-CELL; RECOMBINANT YEAST; IMMUNE-RESPONSES; PRES1 REGION; VIRUS; IMMUNOGENICITY; RECOGNITION; PREVENTION	Although the use of recombinant B virus surface (HBsAg) protein vaccine has successfully reduced global hepatitis B infection, there are still a number of vaccine recipients who do not develop detectable antibody responses. Various novel vaccination approaches, including DNA vaccines, have been used to futrher improve the coverage of vaccine protection. Our previous studies demonstrated that HBsAg-based DNA vaccines could induce both humoral and CMI responses in experimental animal models. However, one form of the HBsAg antigen, the large S antigen (HBs-L), expressed by DNA vaccine, was not sufficiently immunogenic in eliciting antibody responses. In the current study, we produced a modified large S antigen DNA vaccine, HBs-L(T), which has a truncated N-terminal sequence in the pre-S1 region. Compared to the original HBs-L DNA vacciene, the HBs-L(T) DNA vaccine improved secretion in cultured mammalian cells and generated significantly enhanced HBsAg-specific antibody and B cell responses. Futhermore, this improved HBsL DNA vaccine, along with other HBsAg-expressing DNA vaccines, was able to maintain predominantly Th1 type antibody responses while recombinant HBsAg protein vaccines produced in either yeast or CHO cells elicited mostly Th2 type antibody response. Our data indicate that HBsAg DNA vaccines with improved immunogenicity offer a useful alternative choice to recombinant protein-based HBV vaccines, particularly for therapeutic purposes against chronic hepatitis infection where immune tolerance led to poor antibody responses to S antigens.	[Wang, Shixia; Han, Yaping; Zhang, Chunhua; Lu, Shan; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Ge, Guohong; Han, Yaping; Zhang, Chunhua; Lu, Shan; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester; Nanjing Medical University	Ge, GH (corresponding author), Third Hosp Zhenjiang City, Zhenjiang, Jiangsu, Peoples R China.	shan.lu@umassmed.edu		Lu, Shan/0000-0002-8417-7588	Jiangsu Province Key Laboratory in Infectious Diseases, China	Jiangsu Province Key Laboratory in Infectious Diseases, China	This study was supported by Jiangsu Province Key Laboratory in Infectious Diseases, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI A, 1988, LANCET, V1, P1421; ALTER HJ, 1966, BLOOD-J HEMATOL, V27, P297, DOI 10.1182/blood.V27.3.297.297; [Anonymous], 2011, JAKARTA POST; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; BRUSS V, 1991, J VIROL, V65, P3813, DOI 10.1128/JVI.65.7.3813-3820.1991; CHENG KC, 1986, J VIROL, V60, P337, DOI 10.1128/JVI.60.2.337-344.1986; CRAVEN DE, 1986, ANN INTERN MED, V105, P356, DOI 10.7326/0003-4819-105-3-356; DAVIDSON M, 1986, J INFECTION, V13, P31, DOI 10.1016/S0163-4453(86)92653-8; FERRARI C, 1989, J CLIN INVEST, V84, P1314, DOI 10.1172/JCI114299; FORTUIN M, 1994, J INFECT DIS, V169, P1374, DOI 10.1093/infdis/169.6.1374; GALLINA A, 1995, VIROLOGY, V213, P57, DOI 10.1006/viro.1995.1546; ITOH Y, 1986, P NATL ACAD SCI USA, V83, P9174, DOI 10.1073/pnas.83.23.9174; JIN Y, 1988, J EXP MED, V168, P293, DOI 10.1084/jem.168.1.293; Kim SB, 2009, EXP MOL MED, V41, P812, DOI 10.3858/emm.2009.41.11.087; KUROKI K, 1989, MOL CELL BIOL, V9, P4459, DOI 10.1128/MCB.9.10.4459; Le Duff Y, 2009, J VIROL, V83, P12443, DOI 10.1128/JVI.01594-09; Lepere-Douard C, 2009, J VIROL, V83, P11819, DOI 10.1128/JVI.01026-09; Madalinski K, 2004, MED SCI MONITOR, V10, pPI10; MAUPAS P, 1976, LANCET, V1, P1367; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; MILICH DR, 1988, IMMUNOL TODAY, V9, P380, DOI 10.1016/0167-5699(88)91239-X; NEURATH AR, 1989, VACCINE, V7, P234; OKAMOTO H, 1992, PEDIATR RES, V32, P264, DOI 10.1203/00006450-199209000-00002; Papatheodoridis GV, 2009, J HEPATOL, V51, P226, DOI 10.1016/j.jhep.2009.02.017; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Raz R, 1996, VACCINE, V14, P207, DOI 10.1016/0264-410X(95)00185-4; Rendi-Wagner P, 2006, VACCINE, V24, P2781, DOI 10.1016/j.vaccine.2006.01.007; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shen ML, 2010, VACCINE, V28, P7288, DOI 10.1016/j.vaccine.2010.08.081; Thomas HC, 1998, J VIRAL HEPATITIS, V5, P31, DOI 10.1046/j.1365-2893.1998.0050s2031.x; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Wang SX, 2008, VACCINE, V26, P2100, DOI 10.1016/j.vaccine.2008.02.033; Wang SX, 2006, J VIROL, V80, P11628, DOI 10.1128/JVI.01065-06; Wiegand J, 2010, J VIRAL HEPATITIS, V17, P631, DOI 10.1111/j.1365-2893.2009.01220.x; Wilson JN, 2000, EPIDEMIOL INFECT, V124, P295, DOI 10.1017/S0950268800003605; Xing YP, 2008, VACCINE, V26, P5145, DOI 10.1016/j.vaccine.2008.03.072; Yu X, 1991, CHINA SCI B, VB, P633; YU XM, 1991, VIROLOGY, V181, P386, DOI 10.1016/0042-6822(91)90510-I; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018	43	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41573	10.1371/journal.pone.0041573	http://dx.doi.org/10.1371/journal.pone.0041573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844502	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700115
J	Ouyang, NT; Zhu, CH; Zhou, DY; Nie, T; Go, MF; Richards, RJ; Rigas, B				Ouyang, Nengtai; Zhu, Caihua; Zhou, Dingying; Nie, Ting; Go, Mae F.; Richards, Robert J.; Rigas, Basil			MC-12, an Annexin A1-Based Peptide, Is Effective in the Treatment of Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; SODIUM-INDUCED COLITIS; PHOSPHOLIPASE A(2); COLORECTAL-CANCER; EPITHELIAL-CELLS; ACTIVATION; INHIBITION; EXPRESSION; CYTOKINES	Annexin A1 (ANXA1) inhibits NF-kappa B, a key regulator of inflammation, the common pathophysiological mechanism of inflammatory bowel diseases (IBD). MC-12, an ANXA1-based tripeptide, suppresses NF-kappa B activation. Here, we determined the efficacy of MC-12 in the control of IBD. Mice with colitis induced by dextran sodium sulfate (DSS) or 2,4,6-trinitro benzene sulfonic acid (TNBS) were treated with various doses of MC-12 administered intraperitoneally, orally or intrarectally. We determined colon length and the histological score of colitis, and assayed: in colon tissue the levels of TNF-alpha, IFN-gamma, IL-1 beta, IL-6 and IL-10 by RT-PCR; prostaglandin E-2 (PGE(2)), cytoplasmic phospholipase A(2) (cPLA(2)) and myeloperoxidase by immunoassay; and COX-2 and NF-kappa B by immunohistochemistry; and in serum the levels of various cytokines by immunoassay. In both models MC-12: reversed dose-dependently colonic inflammation; inhibited by up to 47% myeloperoxidase activity; had a minimal effect on cytoplasmic phospholipase A(2); reduced significantly the induced levels of TNF-alpha, IFN-gamma, IL-1 beta, IL-6 and IL-10, returning them to baseline. DSS and TNBS markedly activated NF-kappa B in colonic epithelial cells and MC-12 decreased this effect by 85.8% and 72.5%, respectively. MC-12 had a similar effect in cultured NCM460 normal colon epithelial cells. Finally, MC-12 suppressed the induction of COX-2 expression, the level of PGE(2) in the colon and PGE(2) metabolite in serum. In conclusion, MC-12, representing a novel class of short peptide inhibitors of NF-kappa B, has a strong effect against colitis in two preclinical models recapitulating features of human IBD. Its mechanism of action is complex and includes pronounced inhibition of NF-kappa B. MC-12 merits further development as an agent for the control of IBD.	[Ouyang, Nengtai; Zhu, Caihua; Zhou, Dingying; Nie, Ting; Richards, Robert J.; Rigas, Basil] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Go, Mae F.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs	Ouyang, NT (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	basil.rigas@stonybrookmedicine.edu			National Institutes of Health [R01CA139454, R01CA09242308]; NATIONAL CANCER INSTITUTE [R01CA139454, R01CA092423, R03CA158669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants: R01CA139454 and R01CA09242308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen L, 2005, GUT, V54, P503, DOI 10.1136/gut.2003.034165; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Barros KV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-68; Benchimol EI, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006792.pub2; Bhattacharyya S, 2009, INFLAMM BOWEL DIS, V15, P673, DOI 10.1002/ibd.20821; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; de Silva S, 2010, NAT REV GASTRO HEPAT, V7, P93, DOI 10.1038/nrgastro.2009.221; Devlin SM, 2009, GASTROENTEROL CLIN N, V38, P577, DOI 10.1016/j.gtc.2009.07.007; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fantini MC, 2008, CURR DRUG TARGETS, V9, P375, DOI 10.2174/138945008784221206; GUSTAFSONSVARD C, 1995, SCAND J GASTROENTERO, V30, P1000, DOI 10.3109/00365529509096345; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Hendel J, 1997, AM J GASTROENTEROL, V92, P1170; Herfarth H, 2000, CLIN EXP IMMUNOL, V120, P59, DOI 10.1046/j.1365-2249.2000.01184.x; Hori Y, 2007, J PATHOL, V212, P218, DOI 10.1002/path.2176; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karrasch T, 2008, INFLAMM BOWEL DIS, V14, P114, DOI 10.1002/ibd.20243; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Kim SW, 2001, J BIOL CHEM, V276, P15712, DOI 10.1074/jbc.M009905200; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Marrero JA, 2000, AM J PHYSIOL-GASTR L, V278, pG797, DOI 10.1152/ajpgi.2000.278.5.G797; Mayer L, 2010, J GASTROENTEROL, V45, P9, DOI 10.1007/s00535-009-0138-3; Moreels TG, 2004, GUT, V53, P99, DOI 10.1136/gut.53.1.99; Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Perretti M, 2003, NEWS PHYSIOL SCI, V18, P60, DOI 10.1152/nips.01424.2002; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Petersen JW, 1996, GUT, V39, P698, DOI 10.1136/gut.39.5.698; Paiotti APR, 2009, J MOL HISTOL, V40, P317, DOI 10.1007/s10735-009-9243-0; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Roncucci L, 2008, CANCER EPIDEM BIOMAR, V17, P2291, DOI 10.1158/1055-9965.EPI-08-0224; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Szigethy E, 2010, CHILD ADOL PSYCH CL, V19, P301, DOI 10.1016/j.chc.2010.01.007; Takada Y, 2010, J IMMUNOL, V184, P1014, DOI 10.4049/jimmunol.0901196; Tanaka K, 2009, EUR J PHARMACOL, V603, P120, DOI 10.1016/j.ejphar.2008.11.058; Vatn Morten H, 2009, Curr Gastroenterol Rep, V11, P481; Williams JL, 2008, CARCINOGENESIS, V29, P390, DOI 10.1093/carcin/bgm275; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204	44	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41585	10.1371/journal.pone.0041585	http://dx.doi.org/10.1371/journal.pone.0041585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844504	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700119
J	Weiner, J; Parida, SK; Maertzdorf, J; Black, GF; Repsilber, D; Telaar, A; Mohney, RP; Arndt-Sullivan, C; Ganoza, CA; Fae, KC; Walzl, G; Kaufmann, SHE				Weiner, January, III; Parida, Shreemanta K.; Maertzdorf, Jeroen; Black, Gillian F.; Repsilber, Dirk; Telaar, Anna; Mohney, Robert P.; Arndt-Sullivan, Cordelia; Ganoza, Christian A.; Fae, Kellen C.; Walzl, Gerhard; Kaufmann, Stefan H. E.			Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; ADENOSINE RECEPTORS; MASS-SPECTROMETRY; GENE-EXPRESSION; TNF-ALPHA; R-PACKAGE; BLOOD	Although tuberculosis (TB) causes more deaths than any other pathogen, most infected individuals harbor the pathogen without signs of disease. We explored the metabolome of >400 small molecules in serum of uninfected individuals, latently infected healthy individuals and patients with active TB. We identified changes in amino acid, lipid and nucleotide metabolism pathways, providing evidence for anti-inflammatory metabolomic changes in TB. Metabolic profiles indicate increased activity of indoleamine 2,3 dioxygenase 1 (IDO1), decreased phospholipase activity, increased abundance of adenosine metabolism products, as well as indicators of fibrotic lesions in active disease as compared to latent infection. Consistent with our predictions, we experimentally demonstrate TB-induced IDO1 activity. Furthermore, we demonstrate a link between metabolic profiles and cytokine signaling. Finally, we show that 20 metabolites are sufficient for robust discrimination of TB patients from healthy individuals. Our results provide specific insights into the biology of TB and pave the way for the rational development of metabolic biomarkers for TB.	[Weiner, January, III; Parida, Shreemanta K.; Maertzdorf, Jeroen; Arndt-Sullivan, Cordelia; Ganoza, Christian A.; Fae, Kellen C.; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Black, Gillian F.; Walzl, Gerhard] Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa; [Repsilber, Dirk; Telaar, Anna] Leibniz Inst Farm Anim Biol, FBN, Biomath Bioinformat Grp, Dummerstorf, Germany; [Mohney, Robert P.] Metabolon Inc, Durham, NC USA	Max Planck Society; Stellenbosch University; Forschungsinstitut fur Nutztierbiologie (FBN); Metabolon	Weiner, J (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	january.weiner@mpiib-berlin.mpg.de; Kaufmann@mpiib-berlin.mpg.de	Ganoza, Christian A/A-8875-2014; Walzl, Gerhard/N-6371-2016; Kaufmann, Stefan HE/I-5454-2014	Ganoza, Christian A/0000-0002-5891-5372; Walzl, Gerhard/0000-0003-2487-125X; Parida, Shreemanta K/0000-0003-2129-6691; Kaufmann, Stefan HE/0000-0001-9866-8268	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by a floating grant from the Max Planck Society to SHEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila MA, 1998, GASTROENTEROLOGY, V114, P364, DOI 10.1016/S0016-5085(98)70489-5; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; Chan TYK, 2000, CALCIFIED TISSUE INT, V66, P476, DOI 10.1007/s002230010095; Chang WK, 1999, CLIN EXP IMMUNOL, V117, P482, DOI 10.1046/j.1365-2249.1999.01009.x; Cohen G, 2001, KIDNEY INT, V59, pS48, DOI 10.1046/j.1523-1755.2001.59780048.x; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Dever JT, 2006, DRUG METAB DISPOS, V34, P2036, DOI 10.1124/dmd.106.012104; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Gomez G, 2003, BLOOD, V102, P4472, DOI 10.1182/blood-2002-11-3624; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HARRISON RA, 1988, COMPLEMENT INFLAMMAT, V5, P27, DOI 10.1159/000463028; HUTCHINGS A, 1994, J ETHNOPHARMACOL, V43, P89, DOI 10.1016/0378-8741(94)90008-6; Huttmann A, 2006, BASIC RES CARDIOL, V101, P78, DOI 10.1007/s00395-005-0556-1; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jin XW, 1997, J CLIN INVEST, V100, P2849, DOI 10.1172/JCI119833; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Kinscherf R, 1996, J MOL MED-JMM, V74, P393, DOI 10.1007/s001090050040; Kono H, 2000, AM J PHYSIOL-GASTR L, V278, pG467, DOI 10.1152/ajpgi.2000.278.3.G467; Laiakis EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012655; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; MEHTA D, 1990, AM REV RESPIR DIS, V142, P157, DOI 10.1164/ajrccm/142.1.157; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller A, 2009, J CELL MOL MED, V13, P1125, DOI 10.1111/j.1582-4934.2008.00542.x; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sakamoto M, 1998, NUTRITION, V14, P391, DOI 10.1016/S0899-9007(97)00473-5; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Schwenk A, 2000, Curr Opin Clin Nutr Metab Care, V3, P285, DOI 10.1097/00075197-200007000-00008; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Slupsky CM, 2009, J PROTEOME RES, V8, P5550, DOI 10.1021/pr9006427; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Suhre K, 2011, NAT GENET, V43, P565, DOI 10.1038/ng.837; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Suzuki Y, 2012, CLIN VACCINE IMMUNOL; Szeplaki G, 2004, ATHEROSCLEROSIS, V177, P383, DOI 10.1016/j.atherosclerosis.2004.07.022; Taylor LA, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-17; To LB, 1997, BLOOD, V89, P2233, DOI 10.1182/blood.V89.7.2233; Ustianowski A, 2005, J INFECTION, V50, P432, DOI 10.1016/j.jinf.2004.07.006; Wang C, 2005, ANAL CHEM, V77, P4108, DOI 10.1021/ac0481001; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Yang J, 2004, J CHROMATOGR B, V813, P59, DOI 10.1016/j.jchromb.2004.09.032; Yuan KL, 2007, J CHROMATOGR B, V850, P236, DOI 10.1016/j.jchromb.2006.11.035	74	172	179	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40221	10.1371/journal.pone.0040221	http://dx.doi.org/10.1371/journal.pone.0040221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844400	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700009
J	Wilson, DM; Boughter, JD; Lemon, CH				Wilson, David M.; Boughter, John D., Jr.; Lemon, Christian H.			Bitter Taste Stimuli Induce Differential Neural Codes in Mouse Brain	PLOS ONE			English	Article							RECEPTOR; SUCROSE; RESPONSES; DISCRIMINATION; NEURONS; SENSITIVITIES; FAMILY; CELLS; NERVE; MICE	A growing literature suggests taste stimuli commonly classified as "bitter" induce heterogeneous neural and perceptual responses. Here, the central processing of bitter stimuli was studied in mice with genetically controlled bitter taste profiles. Using these mice removed genetic heterogeneity as a factor influencing gustatory neural codes for bitter stimuli. Electrophysiological activity (spikes) was recorded from single neurons in the nucleus tractus solitarius during oral delivery of taste solutions (26 total), including concentration series of the bitter tastants quinine, denatonium benzoate, cycloheximide, and sucrose octaacetate (SOA), presented to the whole mouth for 5 s. Seventy-nine neurons were sampled; in many cases multiple cells (2 to 5) were recorded from a mouse. Results showed bitter stimuli induced variable gustatory activity. For example, although some neurons responded robustly to quinine and cycloheximide, others displayed concentration-dependent activity (p<0.05) to quinine but not cycloheximide. Differential activity to bitter stimuli was observed across multiple neurons recorded from one animal in several mice. Across all cells, quinine and denatonium induced correlated spatial responses that differed (p<0.05) from those to cycloheximide and SOA. Modeling spatiotemporal neural ensemble activity revealed responses to quinine/denatonium and cycloheximide/SOA diverged during only an early, at least 1 s wide period of the taste response. Our findings highlight how temporal features of sensory processing contribute differences among bitter taste codes and build on data suggesting heterogeneity among "bitter" stimuli, data that challenge a strict monoguesia model for the bitter quality.	[Wilson, David M.; Lemon, Christian H.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Boughter, John D., Jr.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA	Saint Louis University; University of Tennessee System; University of Tennessee Health Science Center	Wilson, DM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	clemon@slu.edu		Lemon, Christian/0000-0003-1710-508X	St. Louis University; National Institutes of Health (NIH) [DC-011579, GM-008306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011579] Funding Source: NIH RePORTER	St. Louis University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by St. Louis University seed funds and National Institutes of Health (NIH) grant DC-011579 (CHL). DMW is supported by NIH training grant GM-008306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 2001, MAMM GENOME, V12, P695, DOI 10.1007/s00335-001-2061-7; BARTOSHUK LM, 1979, SCIENCE, V205, P934, DOI 10.1126/science.472717; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; BOUGHTER JD, 1995, BEHAV GENET, V25, P233, DOI 10.1007/BF02197181; Boughter JD, 1997, PHYSIOL BEHAV, V63, P101, DOI 10.1016/S0031-9384(97)00398-3; Brasser SM, 2005, CHEM SENSES, V30, P793, DOI 10.1093/chemse/bji071; Breslin PAS, 1996, PERCEPT PSYCHOPHYS, V58, P327, DOI 10.3758/BF03206809; Brightsmith DJ, 2008, BIOTROPICA, V40, P766, DOI 10.1111/j.1744-7429.2008.00429.x; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Carstens E, 1998, J NEUROPHYSIOL, V80, P465, DOI 10.1152/jn.1998.80.2.465; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Delwiche JF, 2001, PERCEPT PSYCHOPHYS, V63, P761, DOI 10.3758/BF03194436; Di Lorenzo PM, 2009, J NEUROSCI, V29, P9227, DOI 10.1523/JNEUROSCI.5995-08.2009; Erickson RP, 2008, BEHAV BRAIN SCI, V31, P59, DOI 10.1017/S0140525X08003348; FALCO EA, 1951, BRIT J PHARM CHEMOTH, V6, P185, DOI 10.1111/j.1476-5381.1951.tb00634.x; Felizardo R, 2009, BRAIN RES, V1288, P60, DOI 10.1016/j.brainres.2009.07.002; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Frank ME, 2004, PHYSIOL BEHAV, V80, P421, DOI 10.1016/j.physbeh.2003.09.009; Geran LC, 2006, J NEUROPHYSIOL, V96, P2513, DOI 10.1152/jn.00607.2006; Geran LC, 2011, BEHAV NEUROSCI, V125, P519, DOI 10.1037/a0023934; Geran LC, 2009, J NEUROPHYSIOL, V101, P1598, DOI 10.1152/jn.91168.2008; GILL JM, 1985, CHEM SENSES, V10, P531, DOI 10.1093/chemse/10.4.531; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 2002, J NEUROSCI, V22, P7281; Glendinning JI, 2001, J EXP BIOL, V204, P3355; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hettinger TP, 2007, BEHAV BRAIN RES, V180, P4, DOI 10.1016/j.bbr.2007.02.027; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Inoue M, 2001, PHYSIOL GENOMICS, V5, P181, DOI 10.1152/physiolgenomics.2001.5.4.181; JOHNS T, 1991, AM J CLIN NUTR, V53, P448, DOI 10.1093/ajcn/53.2.448; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; KREULEN DA, 1985, MAMMAL REV, V15, P107, DOI 10.1111/j.1365-2907.1985.tb00391.x; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; LAWLESS H, 1979, CHEM SENS FLAV, V4, P249, DOI 10.1093/chemse/4.3.249; Lemon CH, 2005, J NEUROPHYSIOL, V94, P3719, DOI 10.1152/jn.00700.2005; Lemon CH, 2004, J NEUROPHYSIOL, V92, P536, DOI 10.1152/jn.00097.2004; Lemon CH, 2009, J NEUROPHYSIOL, V101, P2459, DOI 10.1152/jn.90892.2008; Lewis RJ, 1996, SAXS DANGEROUS PROPE; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Scott TR, 1999, J NEUROPHYSIOL, V81, P60, DOI 10.1152/jn.1999.81.1.60; SHINGAI T, 1985, CHEM SENSES, V10, P51, DOI 10.1093/chemse/10.1.51; Sollars SI, 1998, BEHAV NEUROSCI, V112, P991, DOI 10.1037/0735-7044.112.4.991; Spector AC, 2002, J NEUROSCI, V22, P1937, DOI 10.1523/JNEUROSCI.22-05-01937.2002; Spector AC, 1997, AM J PHYSIOL-REG I, V272, pR1210, DOI 10.1152/ajpregu.1997.272.4.R1210; St John SJ, 1998, J NEUROSCI, V18, P4353; St John SJ, 2004, CHEM SENSES, V29, P775, DOI 10.1093/chemse/bjh082; Stapleton JR, 2002, CHEM SENSES, V27, P375, DOI 10.1093/chemse/27.4.375; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Vitazkova SK, 2001, ANIM BEHAV, V61, P887, DOI 10.1006/anbe.2000.1677; WHITNEY G, 1994, PHYSIOL BEHAV, V56, P1141, DOI 10.1016/0031-9384(94)90358-1; YOKOMUKAI Y, 1993, CHEM SENSES, V18, P669, DOI 10.1093/chemse/18.6.669	72	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41597	10.1371/journal.pone.0041597	http://dx.doi.org/10.1371/journal.pone.0041597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844505	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700121
J	Han, L; Zhang, YJ; Song, JN; Liu, MS; Zhang, ZD				Han, Lei; Zhang, Yong-Jun; Song, Jiangning; Liu, Ming S.; Zhang, Ziding			Identification of Catalytic Residues Using a Novel Feature that Integrates the Microenvironment and Geometrical Location Properties of Residues	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; ACTIVE-SITES; ANTHRANILATE SYNTHASE; AMINO-ACID; PREDICTION; ENZYME; SEQUENCE; ACCURATE; NETWORK; EVOLUTIONARY	Enzymes play a fundamental role in almost all biological processes and identification of catalytic residues is a crucial step for deciphering the biological functions and understanding the underlying catalytic mechanisms. In this work, we developed a novel structural feature called MEDscore to identify catalytic residues, which integrated the microenvironment (ME) and geometrical properties of amino acid residues. Firstly, we converted a residue's ME into a series of spatially neighboring residue pairs, whose likelihood of being located in a catalytic ME was deduced from a benchmark enzyme dataset. We then calculated an ME-based score, termed as MEscore, by summing up the likelihood of all residue pairs. Secondly, we defined a parameter called Dscore to measure the relative distance of a residue to the center of the protein, provided that catalytic residues are typically located in the center of the protein structure. Finally, we defined the MEDscore feature based on an effective nonlinear integration of MEscore and Dscore. When evaluated on a well-prepared benchmark dataset using fivefold cross-validation tests, MEDscore achieved a robust performance in identifying catalytic residues with an AUC1.0 of 0.889. At a <= 10% false positive rate control, MEDscore correctly identified approximately 70% of the catalytic residues. Remarkably, MEDscore achieved a competitive performance compared with the residue conservation score (e.g. CONscore), the most informative singular feature predominantly employed to identify catalytic residues. To the best of our knowledge, MEDscore is the first singular structural feature exhibiting such an advantage. More importantly, we found that MEDscore is complementary with CONscore and a significantly improved performance can be achieved by combining CONscore with MEDscore in a linear manner. As an implementation of this work, MEDscore has been made freely accessible at http://protein.cau. edu.cn/mepi/.	[Han, Lei; Zhang, Ziding] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhang, Yong-Jun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Liu, Ming S.] CSIRO Math Informat & Stat, Clayton, Vic, Australia	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Han, L (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ming.liu@csiro.au; zidingzhang@cau.edu.cn	, zidingzhang/E-9320-2011; Liu, Ming S./A-4886-2008; Song, Jiangning/F-9787-2010	, zidingzhang/0000-0002-9296-571X; Song, Jiangning/0000-0001-8031-9086	National Key Basic Research Program of China [2009CB918802, 2012CB1141004]; National Natural Science Foundation of China [30700137]; National Health and Medical Research Council of Australia (NHMRC); Hundred Talents Program of the Chinese Academy of Sciences (CAS); Knowledge Innovative Program of CAS [KSCX2-EW-G-8]; Tianjin Municipal Science and Technology Commission [10ZCKFSY05600]; Hundred Talents Program of CAS; CSIRO-Advanced Materials TCP and Computational and Simulation Sciences-TCP	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hundred Talents Program of the Chinese Academy of Sciences (CAS); Knowledge Innovative Program of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences); Tianjin Municipal Science and Technology Commission; Hundred Talents Program of CAS(Chinese Academy of Sciences); CSIRO-Advanced Materials TCP and Computational and Simulation Sciences-TCP	This work was supported by grants from the National Key Basic Research Program of China (2009CB918802 and 2012CB1141004), the National Natural Science Foundation of China (30700137), the National Health and Medical Research Council of Australia (NHMRC), the Hundred Talents Program of the Chinese Academy of Sciences (CAS), the Knowledge Innovative Program of CAS (KSCX2-EW-G-8) and Tianjin Municipal Science and Technology Commission (10ZCKFSY05600). JS is an NHMRC Peter Doherty Fellow and the Recipient of the Hundred Talents Program of CAS. MSL thanks China Agricultural University for hosting his visits and acknowledges the support from CSIRO-Advanced Materials TCP and Computational and Simulation Sciences-TCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; BAGLEY SC, 1995, PROTEIN SCI, V4, P622; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Ben-Shimon A, 2005, J MOL BIOL, V351, P309, DOI 10.1016/j.jmb.2005.06.047; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Brylinski M, 2007, PLOS COMPUT BIOL, V3, P909, DOI 10.1371/journal.pcbi.0030094; Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Chien TY, 2008, NUCLEIC ACIDS RES, V36, pW291, DOI 10.1093/nar/gkn324; Cilia E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-115; Cirilli M, 1998, BIOCHEMISTRY-US, V37, P16452, DOI 10.1021/bi982138o; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; David-Eden H, 2008, NUCLEIC ACIDS RES, V36, P4641, DOI 10.1093/nar/gkn433; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dou YC, 2010, AMINO ACIDS, V39, P1353, DOI 10.1007/s00726-010-0587-2; Dukka BKC, 2008, BIOINFORMATICS, V24, P2308, DOI 10.1093/bioinformatics/btn454; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Gutteridge A, 2003, J MOL BIOL, V330, P719, DOI 10.1016/S0022-2836(03)00515-1; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; Hubbard SJ., 1993, COMPUTER PROGRAM; Knochel T, 1999, P NATL ACAD SCI USA, V96, P9479, DOI 10.1073/pnas.96.17.9479; Ko JJ, 2005, PROTEINS, V59, P183, DOI 10.1002/prot.20418; Koo CW, 2000, J AM CHEM SOC, V122, P6122, DOI 10.1021/ja001193t; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Laskowski Roman A., 2003, Journal of Structural and Functional Genomics, V4, P167, DOI 10.1023/A:1026127927612; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Lengauer T, 2010, PLOS COMPUT BIOL, V6; Li GH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-439; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016932; Li YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-14; Liang MP, 2003, NUCLEIC ACIDS RES, V31, P3324, DOI 10.1093/nar/gkg553; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Morollo AA, 2001, NAT STRUCT BIOL, V8, P243, DOI 10.1038/84988; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Ota M, 2003, J MOL BIOL, V327, P1053, DOI 10.1016/S0022-2836(03)00207-9; Pande S, 2007, 2007 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P247; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; ROMERO RM, 1995, PHYTOCHEMISTRY, V39, P263, DOI 10.1016/0031-9422(95)00010-5; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sonavane S, 2010, J CHEM INF MODEL, V50, P2266, DOI 10.1021/ci1002922; Tang YR, 2008, PROTEIN ENG DES SEL, V21, P295, DOI 10.1093/protein/gzn003; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Wang K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000181; Wu S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r8; Xin FX, 2011, CURR PROTEIN PEPT SC, V12, P456, DOI 10.2174/138920311796957685; Xin FX, 2010, BIOINFORMATICS, V26, P1975, DOI 10.1093/bioinformatics/btq319; Yahalom R, 2011, PROTEINS, V79, P1952, DOI 10.1002/prot.23020; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Yao H, 2003, J MOL BIOL, V326, P255, DOI 10.1016/S0022-2836(02)01336-0; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang ZD, 2009, CURR BIOINFORM, V4, P197, DOI 10.2174/157489309789071110; ZVELEBIL MJJM, 1988, PROTEIN ENG, V2, P127, DOI 10.1093/protein/2.2.127	75	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41370	10.1371/journal.pone.0041370	http://dx.doi.org/10.1371/journal.pone.0041370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829945	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300084
J	Kilteni, K; Normand, JM; Sanchez-Vives, MV; Slater, M				Kilteni, Konstantina; Normand, Jean-Marie; Sanchez-Vives, Maria V.; Slater, Mel			Extending Body Space in Immersive Virtual Reality: A Very Long Arm Illusion	PLOS ONE			English	Article							RUBBER HAND ILLUSION; PERIPERSONAL SPACE; VISUAL SPACE; REPRESENTATION; OWNERSHIP; SELF; PERCEPTION; REGRESSION; OBJECTS; AGENCY	Recent studies have shown that a fake body part can be incorporated into human body representation through synchronous multisensory stimulation on the fake and corresponding real body part - the most famous example being the Rubber Hand Illusion. However, the extent to which gross asymmetries in the fake body can be assimilated remains unknown. Participants experienced, through a head-tracked stereo head-mounted display a virtual body coincident with their real body. There were 5 conditions in a between-groups experiment, with 10 participants per condition. In all conditions there was visuo-motor congruence between the real and virtual dominant arm. In an Incongruent condition (I), where the virtual arm length was equal to the real length, there was visuo-tactile incongruence. In four Congruent conditions there was visuo-tactile congruence, but the virtual arm lengths were either equal to (C1), double (C2), triple (C3) or quadruple (C4) the real ones. Questionnaire scores and defensive withdrawal movements in response to a threat showed that the overall level of ownership was high in both C1 and I, and there was no significant difference between these conditions. Additionally, participants experienced ownership over the virtual arm up to three times the length of the real one, and less strongly at four times the length. The illusion did decline, however, with the length of the virtual arm. In the C2-C4 conditions although a measure of proprioceptive drift positively correlated with virtual arm length, there was no correlation between the drift and ownership of the virtual arm, suggesting different underlying mechanisms between ownership and drift. Overall, these findings extend and enrich previous results that multisensory and sensorimotor information can reconstruct our perception of the body shape, size and symmetry even when this is not consistent with normal body proportions.	[Kilteni, Konstantina; Normand, Jean-Marie; Slater, Mel] Univ Barcelona, EVENT Lab, Fac Psicol, Barcelona, Spain; [Sanchez-Vives, Maria V.] IDIBAPS Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Slater, Mel] ICREA, Barcelona, Spain; [Slater, Mel] UCL, Dept Comp Sci, London, England	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of London; University College London	Kilteni, K (corresponding author), Univ Barcelona, EVENT Lab, Fac Psicol, Barcelona, Spain.	melslater@ub.edu	Kilteni, Konstantina/J-7754-2015; Slater, Mel/M-5210-2014; Sanchez-Vives, Maria/J-8526-2014	Kilteni, Konstantina/0000-0002-6887-6434; Slater, Mel/0000-0002-6223-0050; Sanchez-Vives, Maria/0000-0002-8437-9083; Normand, Jean-Marie/0000-0003-0557-4356	TRAVERSE Project, European Research Council [ERC 227985]; ICREA Funding Source: Custom	TRAVERSE Project, European Research Council; ICREA(ICREA)	This work was supported by TRAVERSE Project, ERC 227985, European Research Council (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gillies M, 2010, PRESENCE-VIRTUAL AUG, V19, P95, DOI 10.1162/pres.19.2.95; Gonzalez-Franco M, 2010, P IEEE VIRT REAL ANN, P111, DOI 10.1109/VR.2010.5444805; Graziano M, 2002, BRAIN REPRESENTS BOD; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P2621, DOI 10.1016/j.neuropsychologia.2005.09.011; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Haggard P., 2005, DISORDERS BODY SCHEM, P261; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Holmes N. P., 2006, HUMAN BODY PERCEPTIO, P15; IJsselsteijn WA, 2006, PRESENCE-TELEOP VIRT, V15, P455, DOI 10.1162/pres.15.4.455; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2009, CURR BIOL, V19, pR727, DOI 10.1016/j.cub.2009.07.024; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Makin TR, 2009, J NEUROSCI, V29, P11841, DOI 10.1523/JNEUROSCI.2955-09.2009; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Newport R, 2010, PERCEPTION, V39, P1296, DOI 10.1068/p6742; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Schaefer M, 2007, NEUROIMAGE, V36, P700, DOI 10.1016/j.neuroimage.2007.03.046; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Tecchia F, 2010, PRESENCE-VIRTUAL AUG, V19, P302, DOI 10.1162/PRES_a_00002; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; TSAKIRIS M, 2006, CEREB CORTEX; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Zopf R, 2010, NEUROPSYCHOLOGIA, V48, P713, DOI 10.1016/j.neuropsychologia.2009.10.028	44	237	237	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40867	10.1371/journal.pone.0040867	http://dx.doi.org/10.1371/journal.pone.0040867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981GZ	22829891	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300029
J	Kotarsky, H; Keller, M; Davoudi, M; Leveen, P; Karikoski, R; Enot, DP; Fellman, V				Kotarsky, Heike; Keller, Matthias; Davoudi, Mina; Leveen, Per; Karikoski, Riitta; Enot, David P.; Fellman, Vineta			Metabolite Profiles Reveal Energy Failure and Impaired Beta-Oxidation in Liver of Mice with Complex III Deficiency Due to a BCS1L Mutation	PLOS ONE			English	Article							CYTOCHROME BC(1) COMPLEX; FATTY-ACID OXIDATION; IRON-SULFUR PROTEIN; RESPIRATORY-CHAIN; MITOCHONDRIAL DYSFUNCTION; HEPATIC STEATOSIS; MOUSE MODEL; GENE; DISEASE; CELLS	Background & Aims: Liver is a target organ in many mitochondrial disorders, especially if the complex III assembly factor BCS1L is mutated. To reveal disease mechanism due to such mutations, we have produced a transgenic mouse model with c.232A>G mutation in Bcs1l, the causative mutation for GRACILE syndrome. The homozygous mice develop mitochondrial hepatopathy with steatosis and fibrosis after weaning. Our aim was to assess cellular mechanisms for disease onset and progression using metabolomics. Methods: With mass spectrometry we analyzed metabolite patterns in liver samples obtained from homozygotes and littermate controls of three ages. As oxidative stress might be a mechanism for mitochondrial hepatopathy, we also assessed H2O2 production and expression of antioxidants. Results: Homozygotes had a similar metabolic profile at 14 days of age as controls, with the exception of slightly decreased AMP. At 24 days, when hepatocytes display first histopathological signs, increases in succinate, fumarate and AMP were found associated with impaired glucose turnover and beta-oxidation. At end stage disease after 30 days, these changes were pronounced with decreased carbohydrates, high levels of acylcarnitines and amino acids, and elevated biogenic amines, especially putrescine. Signs of oxidative stress were present in end-stage disease. Conclusions: The findings suggest an early Krebs cycle defect with increases of its intermediates, which might play a role in disease onset. During disease progression, carbohydrate and fatty acid metabolism deteriorate leading to a starvation-like condition. The mouse model is valuable for further investigations on mechanisms in mitochondrial hepatopathy and for interventions.	[Kotarsky, Heike; Davoudi, Mina; Leveen, Per; Fellman, Vineta] Lund Univ, Dept Pediat, Lund, Sweden; [Karikoski, Riitta] Helsinki Univ Hosp Lab Diagnost, Cent Pathol Lab, Helsinki, Finland; [Keller, Matthias; Enot, David P.] Univ Hosp, Dept Pediat, Essen, Germany; [Fellman, Vineta] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Fellman, Vineta] Univ Helsinki, Helsinki, Finland; [Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland	Lund University; University of Duisburg Essen; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center	Kotarsky, H (corresponding author), Lund Univ, Dept Pediat, Lund, Sweden.	Vineta.Fellman@med.lu.se		Davoudi, Mina/0000-0002-4952-1099	Swedish Research Council [2005-6599, 2008-2898]; Lund University; A Tielman; Kock; Segerfalk; H and G Dunkers; Royal Physiographic Society in Lund, Sweden; Finnish Physicians' Society; Foundation for Pediatric Research, Finland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University; A Tielman; Kock; Segerfalk; H and G Dunkers; Royal Physiographic Society in Lund, Sweden; Finnish Physicians' Society; Foundation for Pediatric Research, Finland	The project was funded by grants to V.F. from the Swedish Research Council (2005-6599, 2008-2898), Lund University funding, and several foundations (A Tielman, Kock, Segerfalk, H and G Dunkers, Royal Physiographic Society in Lund, Sweden, and Finnish Physicians' Society and the Foundation for Pediatric Research, Finland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Benit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Diaz F, 2011, SEMIN FETAL NEONAT M, V16, P197, DOI 10.1016/j.siny.2011.05.004; Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6; Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Holm S, 1979, SCAND J STAT, V6; Jung YS, 2011, AMINO ACIDS; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Leveen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031; Moran M, 2010, HUM MUTAT, V31, P930, DOI 10.1002/humu.21294; MORRIS AAM, 1995, PEDIATR NEPHROL, V9, P407, DOI 10.1007/BF00866711; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Urban M, 2010, ANAL BIOCHEM, V406, P124, DOI 10.1016/j.ab.2010.07.002; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; Vankoningsloo S, 2005, J LIPID RES, V46, P1133, DOI 10.1194/jlr.M400464-JLR200; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Zara V, 2004, EUR J BIOCHEM, V271, P1209, DOI 10.1111/j.1432-1033.2004.04024.x	48	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41156	10.1371/journal.pone.0041156	http://dx.doi.org/10.1371/journal.pone.0041156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829922	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300061
J	Mamaghani, S; Simpson, CD; Cao, PJM; Cheung, M; Chow, S; Bandarchi, B; Schimmer, AD; Hedley, DW				Mamaghani, Shadi; Simpson, Craig D.; Cao, Pinjiang M.; Cheung, May; Chow, Sue; Bandarchi, Bizhan; Schimmer, Aaron D.; Hedley, David W.			Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis	PLOS ONE			English	Article							FACTOR-KAPPA-B; UP-REGULATION; HYDROGEN-PEROXIDE; RECEPTOR AGONISTS; WNT/BETA-CATENIN; REACTIVE OXYGEN; COLON-CANCER; TUMOR-CELL; IN-VIVO; K-RAS	Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) induces apoptosis in a variety of cancer cell lines with little or no effect on normal cells. However, its effect is limited as some cancers including pancreatic cancer show de novo resistance to TRAIL induced apoptosis. In this study we report that GSK-3 inhibition using the pharmacologic agent AR-18, enhanced TRAIL sensitivity in a range of pancreatic and prostate cancer cell lines. This sensitization was found to be caspase-dependent, and both pharmacological and genetic knock-down of GSK-3 isoforms resulted in apoptotic features as shown by cleavage of PARP and caspase-3. Elevated levels of reactive oxygen intermediates and disturbance of mitochondrial membrane potential point to a mitochondrial amplification loop for TRAIL-induced apoptosis after GSK-3 inhibition. Consistent with this, overexpression of anti-apoptotic mitochondrial targets such as Bcl-XL, Mcl-1, and Bcl-2 rescued PANC-1 and PPC-1 cells from TRAIL sensitization. However, overexpression of the caspase-8 inhibitor CrmA also inhibited the sensitizing effects of GSK-3 inhibitor, suggesting an additional role for GSK-3 that inhibits death receptor signaling. Acute treatment of mice bearing PANC-1 xenografts with a combination of AR-18 and TRAIL also resulted in a significant increase in apoptosis, as measured by caspase-3 cleavage. Sensitization to TRAIL occurred despite an increase in beta-catenin due to GSK-3 inhibition, suggesting that the approach might be effective even in cancers with dysregulated beta-catenin. These results suggest that GSK-3 inhibitors might be effectively combined with TRAIL for the treatment of pancreatic cancer.	[Mamaghani, Shadi; Cao, Pinjiang M.; Cheung, May; Chow, Sue; Hedley, David W.] Univ Hlth Network, Div Appl Mol Oncol, Toronto, ON, Canada; [Mamaghani, Shadi; Hedley, David W.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mamaghani, Shadi; Simpson, Craig D.; Cao, Pinjiang M.; Cheung, May; Chow, Sue; Bandarchi, Bizhan; Schimmer, Aaron D.; Hedley, David W.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Schimmer, Aaron D.; Hedley, David W.] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Mamaghani, S (corresponding author), Univ Hlth Network, Div Appl Mol Oncol, Toronto, ON, Canada.	david.hedley@uhn.on.ca		Schimmer, Aaron/0000-0003-4023-3899; Hedley, David/0000-0003-1323-2655	Campbell Family Institute for Cancer Research	Campbell Family Institute for Cancer Research	Funding was provided by the Campbell Family Institute for Cancer Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Beurel E, 2009, BIOCHEM PHARMACOL, V77, P54, DOI 10.1016/j.bcp.2008.09.026; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Dessimoz J, 2006, CELL CYCLE, V5, P7, DOI 10.4161/cc.5.1.2293; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hirpara JL, 2001, J BIOL CHEM, V276, P514, DOI 10.1074/jbc.M004687200; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holcom B, 2008, PANCREAS, V36, P225, DOI 10.1097/MPA.0b013e31815b3207; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Kerfoot C, 2004, J HISTOCHEM CYTOCHEM, V52, P419, DOI 10.1177/002215540405200314; Khanbolooki S, 2006, MOL CANCER THER, V5, P2251, DOI 10.1158/1535-7163.MCT-06-0075; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kwon D, 2006, YONSEI MED J, V47, P551, DOI 10.3349/ymj.2006.47.4.551; Liao XB, 2003, MOL CANCER THER, V2, P1215; Mamaghani S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-132; Masood Ashiq, 2011, Cancers (Basel), V3, P1527, DOI 10.3390/cancers3021527; Oikonomou E, 2009, INT J CANCER, V125, P2127, DOI 10.1002/ijc.24613; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Ozawa F, 2001, CANCER LETT, V163, P71, DOI 10.1016/S0304-3835(00)00660-1; Papenfuss K, 2008, J CELL MOL MED, V12, P2566, DOI 10.1111/j.1582-4934.2008.00514.x; PELLEGATA NS, 1994, CANCER RES, V54, P1556; Pham NA, 2000, CYTOMETRY, V41, P245, DOI 10.1002/1097-0320(20001201)41:4<245::AID-CYTO2>3.0.CO;2-#; Pham NA, 2004, MOL CANCER THER, V3, P1239; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Slebos RJC, 2000, CANCER EPIDEM BIOMAR, V9, P1223; Song L, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-20; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Xia T, 2002, CHINESE SCI BULL, V47, P480, DOI 10.1360/02tb9111; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	50	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41102	10.1371/journal.pone.0041102	http://dx.doi.org/10.1371/journal.pone.0041102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829912	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300051
J	Schultz, B; Otto, C; Schultz, A; Osthaus, WA; Krauss, T; Dieck, T; Sander, B; Rahe-Meyer, N; Raymondos, K				Schultz, Barbara; Otto, Christian; Schultz, Arthur; Osthaus, Wilhelm Alexander; Krauss, Terence; Dieck, Thorben; Sander, Bjoern; Rahe-Meyer, Niels; Raymondos, Konstantinos			Incidence of Epileptiform EEG Activity in Children during Mask Induction of Anaesthesia with Brief Administration of 8% Sevoflurane	PLOS ONE			English	Article							ELECTROENCEPHALOGRAM	Background: A high incidence of epileptiform activity in the electroencephalogram (EEG) was reported in children undergoing mask induction of anaesthesia with administration of high doses of sevoflurane for 5 minutes and longer. This study was performed to investigate whether reducing the time of exposure to a high inhaled sevoflurane concentration would affect the incidence of epileptiform EEG activity. It was hypothesized that no epileptiform activity would occur, when the inhaled sevoflurane concentration would be reduced from 8% to 4% immediately after the loss of consciousness. Methodology/Principal Findings: 70 children (age 7-96 months, ASA I-II, premedication with midazolam) were anaesthetized with 8% sevoflurane in 100% oxygen via face mask. Immediately after loss of consciousness, the sevoflurane concentration was reduced to 4%. EEGs were recorded continuously and were later analyzed visually with regard to epileptiform EEG patterns. Sevoflurane at a concentration of 8% was given for 1.2 +/- 0.4 min (mean +/- SD). In 14 children (20%) epileptiform EEG patterns without motor manifestations were observed (delta with spikes (DSP), rhythmic polyspikes (PSR), epileptiform discharges (PED) in 10, 10, 4 children (14%, 14%, 6%)). 38 children (54%) had slow, rhythmic delta waves with high amplitudes (DS) appearing on average before DSP. Conclusions/Significance: The hypothesis that no epileptiform potentials would occur during induction of anaesthesia with a reduction of the inspired sevoflurane concentration from 8% to 4% directly after LOC was not proved. Even if 8% sevoflurane is administered only briefly for induction of anaesthesia, epileptiform EEG activity may be observed in children despite premedication with midazolam.	[Schultz, Barbara; Otto, Christian; Schultz, Arthur; Osthaus, Wilhelm Alexander; Krauss, Terence; Dieck, Thorben; Sander, Bjoern; Rahe-Meyer, Niels; Raymondos, Konstantinos] Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, D-3000 Hannover, Germany	Hannover Medical School	Schultz, B (corresponding author), Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, D-3000 Hannover, Germany.	ab.schultz@t-online.de			German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Publication costs were covered by the Open Access Publication Program of the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1992, BRIT J ANAESTH, V68, P214, DOI 10.1093/bja/68.2.214; Akeson J, 2004, ACTA ANAESTH SCAND, V48, P405, DOI 10.1111/j.1399-6576.2004.00365.x; Baum Victor C., 1997, Anesthesia and Analgesia, V85, P313, DOI 10.1097/00000539-199708000-00013; Constant I, 2005, PEDIATR ANESTH, V15, P266, DOI 10.1111/j.1460-9592.2004.01538.x; Dubois MC, 1999, PAEDIATR ANAESTH, V9, P19, DOI 10.1046/j.1460-9592.1999.9120327.x; Haga S, 1992, Masui, V41, P1951; Holzki J, 1999, PAEDIATR ANAESTH, V9, P283, DOI 10.1046/j.1460-9592.1999.00415.x; Jaaskelainen SK, 2003, NEUROLOGY, V61, P1073, DOI 10.1212/01.WNL.0000090565.15739.8D; Johr M, 2005, BEST PRACT RES-CLIN, V19, P501, DOI 10.1016/j.bpa.2005.01.001; Julliac B, 2007, ANESTHESIOLOGY, V106, P243, DOI 10.1097/00000542-200702000-00011; Kreuer S, 2003, ANESTHESIOLOGY, V99, P34, DOI 10.1097/00000542-200307000-00009; Kurita N, 2005, J NEUROSURG ANESTH, V17, P199, DOI 10.1097/01.ana.0000178914.36157.c8; Nieminen K, 2002, BRIT J ANAESTH, V89, P853, DOI 10.1093/bja/aef290; Schultz A, 2001, PHARM WORLD SCI, V23, P82, DOI 10.1023/A:1011276016529; Sonkajarvi E, 2009, ACTA ANAESTH SCAND, V53, P77, DOI 10.1111/j.1399-6576.2008.01725.x; Vakkuri A, 2001, ACTA ANAESTH SCAND, V45, P805, DOI 10.1034/j.1399-6576.2001.045007805.x; Vakkuri A, 2000, ACTA ANAESTH SCAND, V44, P713, DOI 10.1034/j.1399-6576.2000.440609.x; Voss LJ, 2008, ANESTH ANALG, V107, P1689, DOI 10.1213/ane.0b013e3181852595; Woodforth IJ, 1997, ANESTHESIOLOGY, V87, P1579, DOI 10.1097/00000542-199712000-00041; Yli-Hankala A, 1999, ANESTHESIOLOGY, V91, P1596, DOI 10.1097/00000542-199912000-00009	20	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40903	10.1371/journal.pone.0040903	http://dx.doi.org/10.1371/journal.pone.0040903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829896	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300034
J	Yoon, KD; Yamamoto, K; Ueda, K; Zhou, JL; Sparrow, JR				Yoon, Kee Dong; Yamamoto, Kazunori; Ueda, Keiko; Zhou, Jilin; Sparrow, Janet R.			A Novel Source of Methylglyoxal and Glyoxal in Retina: Implications for Age-Related Macular Degeneration	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; GLYCATION END-PRODUCTS; FACTOR-H POLYMORPHISM; BRUCHS MEMBRANE; LIPOFUSCIN FLUOROPHORE; ALPHA-OXOALDEHYDES; OXIDATIVE STRESS; A2E; RPE; PROTEINS	Aging of retinal pigment epithelial (RPE) cells of the eye is marked by accumulations of bisretinoid fluorophores; two of the compounds within this lipofuscin mixture are A2E and all-trans-retinal dimer. These pigments are implicated in pathological mechanisms involved in some vision-threatening disorders including age-related macular degeneration (AMD). Studies have shown that bisretinoids are photosensitive compounds that undergo photooxidation and photodegradation when irradiated with short wavelength visible light. Utilizing ultra performance liquid chromatography (UPLC) with electrospray ionization mass spectrometry (ESI-MS) we demonstrate that photodegradation of A2E and all-trans-retinal dimer generates the dicarbonyls glyoxal (GO) and methylglyoxal (MG), that are known to modify proteins by advanced glycation endproduct (AGE) formation. By extracellular trapping with aminoguanidine, we established that these oxo-aldehydes are released from irradiated A2E-containing RPE cells. Enzyme-linked immunosorbant assays (ELISA) revealed that the substrate underlying A2E-containing RPE was AGE-modified after irradiation. This AGE deposition was suppressed by prior treatment of the cells with aminoguanidine. AGE-modification causes structural and functional impairment of proteins. In chronic diseases such as diabetes and atherosclerosis, MG and GO modify proteins by non-enzymatic glycation and oxidation reactions. AGE-modified proteins are also components of drusen, the sub-RPE deposits that confer increased risk of AMD onset. These results indicate that photodegraded RPE bisretinoid is likely to be a previously unknown source of MG and GO in the eye.	[Yoon, Kee Dong; Yamamoto, Kazunori; Ueda, Keiko; Zhou, Jilin; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Sparrow, Janet R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University	Yoon, KD (corresponding author), Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA.	jrs88@columbia.edu			National Institutes of Health [EY12951, P30EY019007]; Research to Prevent Blindness to the Department of Ophthalmology; National Research Foundation of Korea [NRF-2009-352-E00060]; NATIONAL EYE INSTITUTE [R01EY012951, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness to the Department of Ophthalmology(Research to Prevent Blindness (RPB)); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health grants EY12951 (JRS) and P30EY019007; and a grant from Research to Prevent Blindness to the Department of Ophthalmology. KDY was supported in part by National Research Foundation of Korea (NRF-2009-352-E00060). KDY is currently at the Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Alderson NL, 2004, DIABETOLOGIA, V47, P1385, DOI 10.1007/s00125-004-1474-8; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Farboud B, 1999, MOL VIS, V5, pU1; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Glenn JV, 2007, FASEB J, V21, P3542, DOI 10.1096/fj.06-7896com; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grey AC, 2011, INVEST OPHTH VIS SCI, V52, P3926, DOI 10.1167/iovs.10-7020; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Handa JT, 1999, INVEST OPHTH VIS SCI, V40, P775; Howes KA, 2004, INVEST OPHTH VIS SCI, V45, P3713, DOI 10.1167/iovs.04-0404; Hussain AA, 2010, EXP EYE RES, V90, P703, DOI 10.1016/j.exer.2010.02.013; Ishibashi T, 1998, ARCH OPHTHALMOL-CHIC, V116, P1629, DOI 10.1001/archopht.116.12.1629; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; MOORE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1290; Nawa A, 2010, LIFE SCI, V86, P402, DOI 10.1016/j.lfs.2010.01.009; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Price CL, 2009, TRENDS ENDOCRIN MET, V20, P312, DOI 10.1016/j.tem.2009.03.010; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Rabbani N, 2008, ANN NY ACAD SCI, V1126, P124, DOI 10.1196/annals.1433.043; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Roy S, 2011, MOL VIS, V17, P3166; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Thornalley PJ, 2000, BIOCHEM PHARMACOL, V60, P55, DOI 10.1016/S0006-2952(00)00287-2; Wang W, 1998, PHARMACOL REV, V50, P335; Wolff DJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P73, DOI 10.1006/abbi.1996.9811; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Yamamoto K, 2011, INVEST OPHTH VIS SCI, V52, P9084, DOI 10.1167/iovs.11-8632; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	47	60	63	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41309	10.1371/journal.pone.0041309	http://dx.doi.org/10.1371/journal.pone.0041309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829938	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300077
J	Golden, CD; Rasolofoniaina, BJR; Anjaranirina, EJG; Nicolas, L; Ravaoliny, L; Kremen, C				Golden, Christopher D.; Rasolofoniaina, B. J. Rodolph; Anjaranirina, E. J. Gasta; Nicolas, Lilien; Ravaoliny, Laurent; Kremen, Claire			Rainforest Pharmacopeia in Madagascar Provides High Value for Current Local and Prospective Global Uses	PLOS ONE			English	Article							PHARMACEUTICALS; CONSERVATION; CONSUMPTION; VALUATION; DRUGS	Botanical diversity provides value to humans through carbon sequestration, air and water purification, and the provisioning of wild foods and ethnomedicines. Here we calculate the value of botanical ethnomedicines in a rainforest region of Madagascar, the Makira Protected Area, using a substitution method that combines replacement costs and choice modeling. The Makira watershed may comprise approximately 0.8% of global botanical diversity and possesses enormous value both in its ability to provision botanical ethnomedicines to local people and as a source of potentially novel pharmaceutical drugs for society as a whole. Approximately 241 locally-recognized species are used as ethnomedicines, including 113 agricultural or weed species. We equated each ethnomedicinal treatment to the monetary value of a comparable pharmaceutical treatment adjusted by personal preferences in perceived efficacy (rather than from known or assumed medicinal equivalency). The benefit value of these botanical ethnomedicines per individual is $5.40-7.90 per year when using the value of highly subsidized Malagasy pharmaceuticals and $100.60-287.40 when using the value of American pharmaceuticals. Using local pharmaceuticals as substitutes, the value per household is $30.24-44.30 per year, equivalent to 43-63% of median annual household income, demonstrating their local importance. Using the value of American pharmaceuticals, the amount is equivalent to 22-63% of the median annual health care expenditures for American adults under 45 in 2006. The potential for developing novel biomedicines from the Makira watershed's unique flora ranges in untapped benefit value from $0.3-5.7 billion for American pharmaceutical companies, non-inclusive of the importance of providing novel medicines and improved healthcare to society. This study provides evidence of the tremendous current local and prospective global value of botanical ethnomedicines and furthers arguments for the conservation of tropical forests for sustainable use.	[Golden, Christopher D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Golden, Christopher D.; Rasolofoniaina, B. J. Rodolph; Anjaranirina, E. J. Gasta; Ravaoliny, Laurent] Madagascar Hlth & Environm Res MAHERY, Maroantsetra, Madagascar; [Golden, Christopher D.; Kremen, Claire] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Nicolas, Lilien] Maroantsetra Dist Publ Hosp, Maroantsetra, Madagascar	Harvard University; University of California System; University of California Berkeley	Golden, CD (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	cgolden@fas.harvard.edu		Golden, Christopher/0000-0002-0358-4625; Golden, Christopher/0000-0002-2258-7493	National Geographic Society Conservation Trust [C135-08]; Margot Marsh Biodiversity Fund [023815]; Mohamed bin Zayed Species Conservation Fund [1025935]; National Science Foundation [1011714]	National Geographic Society Conservation Trust(National Geographic Society); Margot Marsh Biodiversity Fund; Mohamed bin Zayed Species Conservation Fund; National Science Foundation(National Science Foundation (NSF))	The authors would like to acknowledge financial support by the National Geographic Society Conservation Trust #C135-08, the Margot Marsh Biodiversity Fund # 023815, the Mohamed bin Zayed Species Conservation Fund # 1025935 and the National Science Foundation doctoral dissertation improvement grant # 1011714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, ANNU REV ENV RESOUR, V36, P373, DOI 10.1146/annurev-environ-042009-094508; [Anonymous], R D PROD NEEDS ASS Q; Assessment M. E., 2005, EC HUM WELL BEING SY; Blumenthal M., 1998, COMPLETE GERMAN COMM; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Colwell RK, 2013, ESTIMATES STAT ESTIM; Creer DD, 2006, THORAX, V61, P75, DOI 10.1136/thx.2004.027441; Dobbs F, 1996, BRIT J GEN PRACT, V46, P461; Eriksson U, 2001, BMJ-BRIT MED J, V322, P579, DOI 10.1136/bmj.322.7286.579; Ferraro PJ, 2012, REV ENV ECON POLICY, V6, P20, DOI 10.1093/reep/rer019; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; Godoy R, 2000, NATURE, V406, P62, DOI 10.1038/35017647; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Kremer M, 2002, J ECON PERSPECT, V16, P67, DOI 10.1257/089533002320950984; Longo LP, 2000, AM FAM PHYSICIAN, V61, P2121; MENDELSOHN R, 1995, ECON BOT, V49, P223, DOI 10.1007/BF02862929; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEUMANN AK, 1982, SOC SCI MED, V16, P1817, DOI 10.1016/0277-9536(82)90442-7; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pagiola S, 2004, 101 WORLD BANK; Pattanayak SK, 2001, LAND ECON, V77, P595, DOI 10.2307/3146943; Rasoanaivo P, 2003, TRADITIONAL MED PROG; Reid W. V., 1993, Biodiversity prospecting: using genetic resources for sustainable development., P1; Schatz G, 2011, PARTING FRIENDS; Schippmann U, 2002, IMPACT CULTIVATION G; Shyamsundar P, 1996, J ENVIRON ECON MANAG, V31, P129, DOI 10.1006/jeem.1996.0036; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230	29	14	14	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41221	10.1371/journal.pone.0041221	http://dx.doi.org/10.1371/journal.pone.0041221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848447	Green Published, gold			2022-12-27	WOS:000306950200047
J	Schwarz, N; Drouot, L; Nicke, A; Fliegert, R; Boyer, O; Guse, AH; Haag, F; Adriouch, S; Koch-Nolte, F				Schwarz, Nicole; Drouot, Laurent; Nicke, Annette; Fliegert, Ralf; Boyer, Olivier; Guse, Andreas H.; Haag, Friedrich; Adriouch, Sahil; Koch-Nolte, Friedrich			Alternative Splicing of the N-Terminal Cytosolic and Transmembrane Domains of P2X7 Controls Gating of the Ion Channel by ADP-Ribosylation	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; T-CELLS; MURINE MACROPHAGES; ATP; RECEPTOR; P2X(7); RIBOSYLTRANSFERASE; EXPRESSION; ACTIVATION; PROTEINS	P2X7 is a homotrimeric ion channel with two transmembrane domains and a large extracellular ATP-binding domain. It plays a key role in the response of immune cells to danger signals released from cells at sites of inflammation. Gating of murine P2X7 can be induced by the soluble ligand ATP, as well as by NAD(+)-dependent ADP-ribosylation of arginine 125, a posttranslational protein modification catalyzed by the toxin-related ecto-enzymes ART2.1 and ART2.2. R125 is located at the edge of the ligand-binding crevice. Recently, an alternative splice variant of P2X7, designated P2X7(k), was discovered that differs from the previously described variant P2X7(a) in the N-terminal 42 amino acid residues composing the first cytosolic domain and most of the Tm1 domain. Here we compare the two splice variants of murine P2X7 with respect to their sensitivities to gating by ADP-ribosylation in transfected HEK cells. Our results show that the P2X7(k) variant is sensitive to activation by ADP-ribosylation whereas the P2X7(a) variant is insensitive, despite higher cell surface expression levels. Interestingly, a single point mutation (R276K) renders the P2X7(a) variant sensitive to activation by ADP-ribosylation. Residue 276 is located at the interface of neighboring subunits approximately halfway between the ADP-ribosylation site and the transmembrane domains. Moreover, we show that naive and regulatory T cells preferentially express the more sensitive P2X7(k) variant, while macrophages preferentially express the P2X7(a) variant. Our results indicate that differential splicing of alternative exons encoding the N-terminal cytosolic and transmembrane domains of P2X7 control the sensitivity of different immune cells to extracellular NAD(+) and ATP.	[Schwarz, Nicole; Haag, Friedrich; Koch-Nolte, Friedrich] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Drouot, Laurent; Boyer, Olivier; Adriouch, Sahil] Univ Rouen, Inst Res & Innovat Biomed, INSERM, U905, Normandy, France; [Nicke, Annette] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Fliegert, Ralf; Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Signal Transduct, Calcium Signaling Grp, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schwarz, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	nolte@uke.de	Boyer, Olivier/N-6552-2013; ADRIOUCH, Sahil/G-8999-2012	Boyer, Olivier/0000-0002-7591-307X; ADRIOUCH, Sahil/0000-0002-0265-7773; Koch-Nolte, Friedrich/0000-0003-1730-6674; Nicke, Annette/0000-0001-6798-505X	Deutsche Forschungsgemeinschaft [310/8-1, PAK362, Gu 310/13-1, NI 592/4-2, 592/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partially funded by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) to FH and FKN (No310/8-1, PAK362), RF and AHG (Gu 310/13-1, PAK362), and AN (NI 592/4-2 and 5-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adriouch S, 2005, CELL IMMUNOL, V236, P72, DOI 10.1016/j.cellimm.2005.08.011; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Bannas P, 2005, BLOOD, V105, P3663, DOI 10.1182/blood-2004-08-3325; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Haag F, 2007, PURINERG SIGNAL, V3, P71, DOI 10.1007/s11302-006-9038-7; Hara N, 1999, EUR J BIOCHEM, V259, P289, DOI 10.1046/j.1432-1327.1999.00039.x; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hong S, 2007, J IMMUNOL, V179, P6215, DOI 10.4049/jimmunol.179.9.6215; Hong SY, 2009, J IMMUNOL, V183, P578, DOI 10.4049/jimmunol.0900120; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kanaitsuka T, 1997, J IMMUNOL, V159, P2741; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Koch-Nolte F, 1999, VERSUCHSTIERKUNDE MI, P71; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; KochNolte F, 1996, J BIOL CHEM, V271, P7686, DOI 10.1074/jbc.271.13.7686; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Moller S, 2007, PURINERG SIGNAL, V3, P359, DOI 10.1007/s11302-007-9084-9; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Scheuplein F, 2003, ANN NY ACAD SCI, V1010, P296, DOI 10.1196/annals.1299.051; Scheuplein F, 2009, J IMMUNOL, V182, P2898, DOI 10.4049/jimmunol.0801711; Schwarz N, 2009, PURINERG SIGNAL, V5, P139, DOI 10.1007/s11302-009-9135-5; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Taylor SRJ, 2009, J LEUKOCYTE BIOL, V85, P978, DOI 10.1189/jlb.0408251; Young MT, 2006, BRIT J PHARMACOL, V149, P261, DOI 10.1038/sj.bjp.0706880; Zeiser R, 2011, J MOL MED, V89, P833, DOI 10.1007/s00109-011-0767-x	33	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41269	10.1371/journal.pone.0041269	http://dx.doi.org/10.1371/journal.pone.0041269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848454	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200052
J	Zampieri, S; Cattarossi, S; Ramirez, AMO; Rosano, C; Lourenco, CM; Passon, N; Moroni, I; Uziel, G; Pettinari, A; Stanzial, F; de Kremer, RD; Azar, NB; Hazan, F; Filocamo, M; Bembi, B; Dardis, A				Zampieri, Stefania; Cattarossi, Silvia; Oller Ramirez, Ana Maria; Rosano, Camillo; Lourenco, Charles Marques; Passon, Nadia; Moroni, Isabella; Uziel, Graziella; Pettinari, Antonella; Stanzial, Franco; Dodelson de Kremer, Raquel; Beatriz Azar, Nydia; Hazan, Filiz; Filocamo, Mirella; Bembi, Bruno; Dardis, Andrea			Sequence and Copy Number Analyses of HEXB Gene in Patients Affected by Sandhoff Disease: Functional Characterization of 9 Novel Sequence Variants	PLOS ONE			English	Article							COMPOUND HETEROZYGOSITY; MUTATION NOMENCLATURE; GM2 GANGLIOSIDOSIS; GAUCHER-DISEASE; DELETION; DNA; ALLELES	Sandhoff disease (SD) is a lysosomal disorder caused by mutations in the HEXB gene. To date, 43 mutations of HEXB have been described, including 3 large deletions. Here, we have characterized 14 unrelated SD patients and developed a Multiplex Ligation-dependent Probe Amplification (MLPA) assay to investigate the presence of large HEXB deletions. Overall, we identified 16 alleles, 9 of which were novel, including 4 sequence variation leading to aminoacid changes [c.626C>T (p.T209I), c.634C>A (p.H212N), c.926G>T (p.C309F), c.1451G>A (p.G484E)] 3 intronic mutations (c.1082+5G>A, c.1242+1G>A, c.1169+5G>A), 1 nonsense mutation c.146C>A (p.S49X) and 1 small in-frame deletion c.1260_1265delAGTTGA (p.V421_E422del). Using the new MLPA assay, 2 previously described deletions were identified. In vitro expression studies showed that proteins bearing aminoacid changes p.T209I and p.G484E presented a very low or absent activity, while proteins bearing the p.H212N and p.C309F changes retained a significant residual activity. The detrimental effect of the 3 novel intronic mutations on the HEXB mRNA processing was demonstrated using a minigene assay. Unprecedentedly, minigene studies revealed the presence of a novel alternative spliced HEXB mRNA variant also present in normal cells. In conclusion, we provided new insights into the molecular basis of SD and validated an MLPA assay for detecting large HEXB deletions.	[Zampieri, Stefania; Cattarossi, Silvia; Bembi, Bruno; Dardis, Andrea] Univ Hosp Santa Maria della Misericordia, Reg Coordinator Ctr Rare Dis, Udine, Italy; [Oller Ramirez, Ana Maria; Dodelson de Kremer, Raquel; Beatriz Azar, Nydia] Univ Cordoba, CEMECO, Ctr Estudio Metabolopatias Congenitas, Cordoba, Argentina; [Rosano, Camillo] Ist Nazl Ric Canc, Patol Mol Integrata AOU IRCSS San Martino IST, I-16132 Genoa, Italy; [Lourenco, Charles Marques] Univ Sao Paulo, Clin Hosp Ribeirao Preto, Med Genet Serv, Sao Paulo, Brazil; [Passon, Nadia] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Moroni, Isabella; Uziel, Graziella] Fdn Ist Neurol Besta, Dept Child Neurol, Milan, Italy; [Pettinari, Antonella] Osped Riuniti Ancona, Clin Pediat, Med Genet Lab, Ancona, Italy; [Stanzial, Franco] Azienda Sanit Alto Adige, Ctr Prov Coordinamento Rete Malattie Rare, Serv Consulenza Genet, Bolzano, Italy; [Hazan, Filiz] Fac Med, Dept Genet, Izmir, Turkey; [Filocamo, Mirella] Ist Giannina Gaslini, Lab Diagnosi Prepostnatale Malattie Met, UOSD, Genoa, Italy	Hospital Santa Maria della Misericordia; National University of Cordoba; University of Genoa; IRCCS AOU San Martino IST; Universidade de Sao Paulo; University of Udine; IRCCS Istituto Neurologico Besta; University of Genoa; IRCCS Istituto Giannina Gaslini	Zampieri, S (corresponding author), Univ Hosp Santa Maria della Misericordia, Reg Coordinator Ctr Rare Dis, Udine, Italy.	dardis.andrea@aoud.sanita.fvg.it	Dardis, Andrea/AAB-9900-2022; Moroni, Isabella/AAL-1336-2021; Filocamo, Mirella/AAG-3948-2021; Rosano, Camillo/AAA-9954-2021; Lourenço, Charles M/O-2731-2013; Rosano, Camillo/D-5386-2011; Zampieri, Stefania/AAC-2314-2022	Moroni, Isabella/0000-0002-3322-1681; Filocamo, Mirella/0000-0001-5505-8507; Rosano, Camillo/0000-0003-2949-9215; Rosano, Camillo/0000-0003-2949-9215; zampieri, stefania/0000-0003-3921-8405	Italian Health Ministry [RF3107]; Telethon Genetic Biobank Network [GTB07001]; Italian Health Department	Italian Health Ministry(Ministry of Health, Italy); Telethon Genetic Biobank Network(Fondazione Telethon); Italian Health Department	This work was supported by a grant from the Italian Health Ministry "Svillupo e utilizzo dei percorsi assistenziali diagnostico-terapeutici per malattie rare'' (RF3107); a Telethon Genetic Biobank Network (Project No. GTB07001) and the Italian Health Department "Finanziamento Ricerca Corrente (contributo per la ricerca intramurale).'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biegstraaten M, 2011, BLOOD CELL MOL DIS, V46, P39, DOI 10.1016/j.bcmd.2010.10.007; BOLHUIS PA, 1992, HUM GENET, V90, P328; den Dunnen JT, 2003, HUM MUTAT, V22, P181, DOI 10.1002/humu.10262; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filocamo M, 2004, EPILEPSIA, V45, P1154, DOI 10.1111/j.0013-9580.2004.15904.x; GEIGER B, 1977, AM J HUM GENET, V29, P508; Gieselmann V, 2005, ACTA PAEDIATR, V94, P80, DOI 10.1080/08035320510028210; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gravel R, 2001, METABOLIC MOL BASIS, V8, P3827; IKONNE JU, 1975, AM J HUM GENET, V27, P639; Kaya N, 2011, AM J MED GENET A, V155A, P1281, DOI 10.1002/ajmg.a.33932; KLEIMAN FE, 1994, HUM GENET, V94, P279, DOI 10.1007/BF00208283; Kowarz L, 2005, HUM MUTAT, V26, P271, DOI 10.1002/humu.20217; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; MCINNES B, 1992, BIOCHIM BIOPHYS ACTA, V1138, P315, DOI 10.1016/0925-4439(92)90009-C; Montfort M, 2004, HUM MUTAT, V23, P567, DOI 10.1002/humu.20043; NEOTE K, 1990, J CLIN INVEST, V86, P1524, DOI 10.1172/JCI114871; Neote K, 1988, HUM GENET, V90, P328; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sandhoff K, 2001, METABOLIC MOL BASES, V3, P3371; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Yoshizawa T, 2002, J NEUROL SCI, V195, P129, DOI 10.1016/S0022-510X(02)00007-2; Zampieri S, 2009, NEUROGENETICS, V10, P49, DOI 10.1007/s10048-008-0145-1; ZHANG ZX, 1995, HUM MOL GENET, V4, P777, DOI 10.1093/hmg/4.4.777	27	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41516	10.1371/journal.pone.0041516	http://dx.doi.org/10.1371/journal.pone.0041516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848519	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200068
J	Cao, DC; Li, JW; Huang, ZY; Baskin, CC; Baskin, JM; Hao, P; Zhou, WL; Li, JQ				Cao, Dechang; Li, Jingwen; Huang, Zhenying; Baskin, Carol C.; Baskin, Jerry M.; Hao, Peng; Zhou, Weilei; Li, Junqing			Reproductive Characteristics of a Populus euphratica Population and Prospects for Its Restoration in China	PLOS ONE			English	Article							RIPARIAN COTTONWOODS; TAKLAMAKAN DESERT; INNER-MONGOLIA; HEIHE RIVER; NW CHINA; VEGETATION; GROWTH; VULNERABILITY; CAVITATION; MANAGEMENT	Populus euphratica is a dominant tree in riparian ecosystems in arid areas of northwest China, but it fails to regenerate in these systems. This study evaluates causes for the failure of sexual and asexual regeneration of this species in the wild. P. euphratica disperses as many as 85743 seeds/m(2) during summer, and the seeds germinate to 92.0% in distilled water and to 60.8% on silt. However, very few seeds (3.6%) can germinate on unflooded soil. The seed-rain season is prolonged by temporal variability in seed dispersal among individuals, which ensures that seedling emergence can occur during favorable conditions (i.e., floods and rainfall). As a result of water shortage and river channeling due to water usage and altered river flows, there are no safe sites on river banks for seed germination, which has led to the failure of P. euphratica to regenerate from seed. Root suckers of P. euphratica were present in 86% of the forest gaps investigated. However, extensive grazing has destroyed many of them and thus has reduced this form of regeneration. This research suggests that human activities are resulting in the failure of P. euphratica to regenerate. Changes in land management such as reduced use of concrete canals in Populus forests and/or reduced sheep grazing in these areas may promote their regeneration.	[Cao, Dechang; Li, Jingwen; Hao, Peng; Zhou, Weilei; Li, Junqing] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Cao, Dechang; Huang, Zhenying] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Cao, Dechang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Baskin, Carol C.; Baskin, Jerry M.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Kentucky; University of Kentucky	Li, JW (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	lijingwen@bjfu.edu.cn; zhenying@ibcas.ac.cn	Cao, Dechang/X-3232-2019	Cao, Dechang/0000-0002-0397-4316	National Natural Science Foundation of China [31070553, 30570332]; 11th Five-Year Plan of the National Scientific and Technological Support Projects [2008BADB0B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 11th Five-Year Plan of the National Scientific and Technological Support Projects	This work was financially supported by National Natural Science Foundation of China (No. 31070553, 30570332) and the 11th Five-Year Plan of the National Scientific and Technological Support Projects (2008BADB0B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T., 2009, ICCS J MODERN CHINES, V1, P35; Akiyama T, 2007, B GLACIOLOGICAL RES, V24, P87; Beschta RL, 2005, ECOLOGY, V86, P391, DOI 10.1890/04-0964; Bruelheide H, 2003, PHYTOCOENOLOGIA, V33, P801, DOI 10.1127/0340-269X/2003/0033-0801; Chen Y, 2005, PHYS CHEM EARTH, V30, P408, DOI 10.1016/j.pce.2005.06.019; Chen YP, 2006, PHOTOSYNTHETICA, V44, P622, DOI 10.1007/s11099-006-0081-y; [高润宏 Gao Runhong], 2005, [生态学报, Acta Ecologica Sinica], V25, P1019; Gries D, 2003, PLANT CELL ENVIRON, V26, P725, DOI 10.1046/j.1365-3040.2003.01009.x; Guilloy-Froget H, 2002, WETLANDS, V22, P478, DOI 10.1672/0277-5212(2002)022[0478:DGASOP]2.0.CO;2; Hukin D, 2005, J EXP BOT, V56, P2003, DOI 10.1093/jxb/eri198; Ji F., 2001, ACTA PHYTOECOLOGICA, V25, P17; Kurschner H, 2004, PHYTOCOENOLOGIA, V34, P169, DOI 10.1127/0340-269X/2004/0034-0169; Liu PX, 2007, J INTEGR PLANT BIOL, V49, P150, DOI 10.1111/j.1744-7909.2007.00425.x; Lytle DA, 2004, ECOLOGY, V85, P2493, DOI 10.1890/04-0282; Ma HC, 1997, FOREST ECOL MANAG, V93, P55, DOI 10.1016/S0378-1127(96)03943-6; Merritt DM, 2000, REGUL RIVER, V16, P543, DOI 10.1002/1099-1646(200011/12)16:6&lt;543::AID-RRR590&gt;3.0.CO;2-N; Monda Y, 2008, LANDSC ECOL ENG, V4, P115, DOI 10.1007/s11355-008-0050-7; Ruger N, 2005, ECOL MODEL, V184, P313, DOI 10.1016/j.ecolmodel.2004.10.010; Samuelson GM, 2004, J BIOGEOGR, V31, P435, DOI 10.1111/j.0305-0270.2003.01052.x; Scott ML, 1997, ECOL APPL, V7, P677, DOI 10.1890/1051-0761(1997)007[0677:FDOCEA]2.0.CO;2; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; TYREE MT, 1994, TREE PHYSIOL, V14, P455, DOI 10.1093/treephys/14.5.455; Wang Genxu, 2005, Journal of Geographical Sciences, V15, P405, DOI 10.1360/gs050403; Westermann J, 2008, J INTEGR PLANT BIOL, V50, P536, DOI 10.1111/j.1744-7909.2007.00626.x; Xu W., 1988, POPLARS; Xu ZM, 2003, ECOL ECON, V44, P345, DOI 10.1016/S0921-8009(02)00280-X; Yang XP, 2006, GEOGR RES-AUST, V44, P146, DOI 10.1111/j.1745-5871.2006.00378.x; Zhang YB, 2005, SCI TECHNOLOGY ENG, V5, P467; Zhao WZ, 2007, SCI CHINA SER D, V50, P121, DOI 10.1007/s11430-007-2035-z; [赵文智 Zhao Wenzhi], 2005, [生态学报, Acta Ecologica Sinica], V25, P1987	30	23	35	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e39121	10.1371/journal.pone.0039121	http://dx.doi.org/10.1371/journal.pone.0039121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848351	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600001
J	Chen, HJ; Palmer, JS; Thiagarajan, RD; Dinger, ME; Lesieur, E; Chiu, HS; Schulz, A; Spiller, C; Grimmond, SM; Little, MH; Koopman, P; Wilhelm, D				Chen, Huijun; Palmer, James S.; Thiagarajan, Rathi D.; Dinger, Marcel E.; Lesieur, Emmanuelle; Chiu, Hansheng; Schulz, Alexandra; Spiller, Cassy; Grimmond, Sean M.; Little, Melissa H.; Koopman, Peter; Wilhelm, Dagmar			Identification of Novel Markers of Mouse Fetal Ovary Development	PLOS ONE			English	Article							LONG NONCODING RNAS; MAMMALIAN SEX DETERMINATION; TRANSCRIPTION FACTOR FOXL2; X-CHROMOSOME INACTIVATION; DOUBLESEX-RELATED GENES; GERM-CELLS; TESTIS DEVELOPMENT; BETA-CATENIN; DETERMINATION REVEALS; EMBRYONIC GONAD	In contrast to the developing testis, molecular pathways driving fetal ovarian development have been difficult to characterise. To date no single master regulator of ovarian development has been identified that would be considered the female equivalent of Sry. Using a genomic approach we identified a number of novel protein-coding as well as non-coding genes that were detectable at higher levels in the ovary compared to testis during early mouse gonad development. We were able to cluster these ovarian genes into different temporal expression categories. Of note, Lrrc34 and AK015184 were detected in XX but not XY germ cells before the onset of sex-specific germ cell differentiation marked by entry into meiosis in an ovary and mitotic arrest in a testis. We also defined distinct spatial expression domains of somatic cell genes in the developing ovary. Our data expands the set of markers of early mouse ovary differentiation and identifies a classification of early ovarian genes, thus providing additional avenues with which to dissect this process.	[Chen, Huijun; Palmer, James S.; Thiagarajan, Rathi D.; Dinger, Marcel E.; Lesieur, Emmanuelle; Chiu, Hansheng; Schulz, Alexandra; Spiller, Cassy; Grimmond, Sean M.; Little, Melissa H.; Koopman, Peter; Wilhelm, Dagmar] Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia	University of Queensland	Wilhelm, D (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia.	d.wilhelm@imb.uq.edu.au	Koopman, Peter A/C-9416-2009; Grimmond, Sean M/J-5304-2016; Dinger, Marcel/N-1398-2019; Grimmond, Sean/K-3246-2019; Spiller, Cassy/C-2779-2013; Wilhelm, Dagmar/B-6915-2009; Little, Melissa H/A-6170-2010	Koopman, Peter A/0000-0001-6939-0914; Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Spiller, Cassy/0000-0002-1343-8269; Wilhelm, Dagmar/0000-0002-7757-4075; Little, Melissa H/0000-0003-0380-2263; Dinger, Marcel/0000-0003-4423-934X	NIDDK, National Institute of Health, United States of America [DK070136]; Australian Research Council (ARC) [DP0879913]; National Health and Medical Research Council of Australia (NHMRC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070136] Funding Source: NIH RePORTER	NIDDK, National Institute of Health, United States of America; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the NIDDK, National Institute of Health, United States of America, (http://www2.niddk.nih.gov/, DK070136), Australian Research Council (ARC, http://www.arc.gov.au/) (DP0879913) and National Health and Medical Research Council of Australia (NHMRC; http://www.nhmrc.gov.au/455902). DW and MED are CDA Fellows of the NHMRC (519737). ML is a Principal Research Fellow of the NHMRC. PK is an ARC Federation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Arango NA, 2006, DEV DYNAM, V235, P2613, DOI 10.1002/dvdy.20907; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bono H, 2003, GENOME RES, V13, P1318, DOI 10.1101/gr.1075103; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Bowles J, 2000, AUSTR BIOCH, V31, P4; Bowles J, 2010, REPRODUCTION, V139, P943, DOI 10.1530/REP-10-0075; Bradford ST, 2007, SEX DEV, V1, P305, DOI 10.1159/000108933; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Cheng A, 2005, CELL CYCLE, V4, P155, DOI 10.4161/cc.4.1.1347; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Combes AN, 2009, DEV DYNAM, V238, P1033, DOI 10.1002/dvdy.21925; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; Coveney D, 2008, GENE EXPR PATTERNS, V8, P529, DOI 10.1016/j.gep.2008.05.006; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Di Carlo A, 2000, DEV BIOL, V226, P209, DOI 10.1006/dbio.2000.9861; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hu J, 1999, ENDOCRINOLOGY, V140, P3416, DOI 10.1210/en.140.8.3416; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jimenez R, 2010, SEX DEV, V3, P291, DOI 10.1159/000280584; Jorgensen JS, 2005, GENE EXPR PATTERNS, V5, P756, DOI 10.1016/j.modgep.2005.04.011; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Kim SS, 2003, GENE EXPR PATTERNS, V3, P77, DOI 10.1016/S1567-133X(02)00071-6; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Liu CF, 2010, CURR TOP DEV BIOL, V90, P263, DOI 10.1016/S0070-2153(10)90007-0; Luense LJ, 2009, TRENDS ENDOCRIN MET, V20, P265, DOI 10.1016/j.tem.2009.05.001; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Magoffin DA, 2005, INT J BIOCHEM CELL B, V37, P1344, DOI 10.1016/j.biocel.2005.01.016; MAGOFFIN DA, 1994, BIOL REPROD, V51, P766, DOI 10.1095/biolreprod51.4.766; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Orisaka M, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-9; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Ottolenghi C, 2002, GENOMICS, V79, P333, DOI 10.1006/geno.2002.6711; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Polanco JC, 2010, HUM MOL GENET, V19, P506, DOI 10.1093/hmg/ddp520; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Rolland AD, 2011, BIOL REPROD, V84, P790, DOI 10.1095/biolreprod.110.088443; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Takabayashi S, 2009, EXP BIOL MED, V234, P994, DOI 10.3181/0808-RM-244; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Veith AM, 2006, GENOMICS, V88, P185, DOI 10.1016/j.ygeno.2006.01.003; Wainwright EN, 2010, CURR TOP DEV BIOL, V90, P231, DOI 10.1016/S0070-2153(10)90006-9; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7	84	36	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41683	10.1371/journal.pone.0041683	http://dx.doi.org/10.1371/journal.pone.0041683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844512	Green Published, gold			2022-12-27	WOS:000309240600039
J	Tiira, K; Hakosalo, O; Kareinen, L; Thomas, A; Hielm-Bjorkman, A; Escriou, C; Arnold, P; Lohi, H				Tiira, Katriina; Hakosalo, Osmo; Kareinen, Lauri; Thomas, Anne; Hielm-Bjorkman, Anna; Escriou, Catherine; Arnold, Paul; Lohi, Hannes			Environmental Effects on Compulsive Tail Chasing in Dogs	PLOS ONE			English	Article							PERSONALITY-TRAITS; SLEEP DISORDER; ANIMAL-MODELS; BEHAVIOR; TEMPERAMENT; VALIDATION; RECEPTOR; QUESTIONNAIRE; CLOMIPRAMINE; AGGRESSION	Obsessive Compulsive Disorder (OCD) is a neuropsychiatric disorder observed both in humans and animals. Examples of Canine Compulsive Disorder (CD) include excessive tail chasing (TC), light/shadow chasing and flank sucking. We performed a questionnaire survey to investigate the characteristics of compulsive (TC) and its possible associations with environmental correlates and personality in a pet population of 368 dogs from four dog breeds. We observed an early onset of TC at 36 months of age and a large variation in TC frequency in all breeds, with an overrepresentation of milder cases. Almost half of the TC dogs showed lowered responsiveness during bouts and displayed also other types of compulsions more often than the controls. Interestingly, dogs that received dietary supplements, especially vitamins and minerals, expressed less TC compared to dogs that did not receive any supplements. Neutered females had less TC, suggesting an influence of ovarian hormones on TC. Tail chasers were shyer and had separated earlier from their mothers than the controls. Finally, our genetic study did not find an association between TC and CDH2, a locus previously associated with the canine flank sucking compulsion. In conclusion, the early- onset and the variable nature of the repetitive behaviour, which is affected by environmental factors such as micronutrients, neutering and maternal care, share several similar components between canine and human compulsions and supports canine TC as a model for human OCD.	[Tiira, Katriina; Hakosalo, Osmo; Kareinen, Lauri; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland; [Tiira, Katriina; Hakosalo, Osmo; Kareinen, Lauri; Lohi, Hannes] Folkhalsan Res Ctr, Helsinki, Finland; [Thomas, Anne] Anim Genet Lab, Lyon, France; [Hielm-Bjorkman, Anna] Univ Helsinki, Dept Equine & Small Anim Med, Helsinki, Finland; [Escriou, Catherine] Natl Vet Sch Lyon, Lyon, France; [Arnold, Paul] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada	University of Helsinki; Folkhalsan Research Center; University of Helsinki; VetAgro Sup; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011; Tiira, Katriina/U-4035-2018	Lohi, Hannes/0000-0003-1087-5532; Hielm-Bjorkman, Anna/0000-0003-1343-3473; Kareinen, Lauri/0000-0003-2525-7817; Tiira, Katriina/0000-0002-2253-8755	ERCStG [HL 260997]; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; University of Helsinki Research Funds, Folkhalsan Research Center; Finnish Cultural Foundation	ERCStG; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Funds, Folkhalsan Research Center; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the ERCStG (HL 260997; http://erc.europa.eu/starting-grants), the Jane and Aatos Erkko Foundation (http://www.jaes.fi/en/), the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), the University of Helsinki Research Funds, Folkhalsan Research Center (http://www.folkhalsan.fi/en/startsida/About-Folkhalsan/), and the Finnish Cultural Foundation (KT) (http://www.skr.fi/default.asp?docId = 12256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuso-Mateos JL., 2006, GLOBAL BURDEN OBSESS; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P377; Burn CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026553; Bush WW, 2004, J AM ANIM HOSP ASSOC, V40, P495, DOI 10.5326/0400495; CARNEY MWP, 1995, CNS DRUGS, V3, P279, DOI 10.2165/00023210-199503040-00005; Cheyne SM, 2006, PRIMATES, V47, P322, DOI 10.1007/s10329-006-0190-z; Coles ME, 2006, J ANXIETY DISORD, V20, P1118, DOI 10.1016/j.janxdis.2006.03.003; Dakshinamurti K, 1995, VITAMIN B6 ITS ROLE, P99; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Dodman NH, 1996, J AM VET MED ASSOC, V208, P688; Fernandez-Guasti A, 2006, PSYCHONEUROENDOCRINO, V31, P924, DOI 10.1016/j.psyneuen.2006.05.003; Fernando ABP, 2011, ANNU REV CLIN PSYCHO, V7, P39, DOI 10.1146/annurev-clinpsy-032210-104454; Flaisher-Grinberg S, 2009, HORM BEHAV, V55, P356, DOI 10.1016/j.yhbeh.2008.10.002; Franklin ME, 2011, ANNU REV CLIN PSYCHO, V7, P229, DOI 10.1146/annurev-clinpsy-032210-104533; Friedlander L, 2006, CLIN PSYCHOL REV, V26, P32, DOI 10.1016/j.cpr.2005.06.010; Fuchs T, 2005, APPL ANIM BEHAV SCI, V94, P287, DOI 10.1016/j.applanim.2005.02.016; Gagnon DR, 2008, J TRAUMA STRESS, V21, P448, DOI 10.1002/jts.20359; Gargaro BA, 2011, NEUROSCI BIOBEHAV R, V35, P1081, DOI 10.1016/j.neubiorev.2010.11.002; George D, 2003, SPSS WINDOWS STEP ST; Grisham JR, 2008, EUR ARCH PSY CLIN N, V258, P107, DOI 10.1007/s00406-007-0789-0; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Jones MA, 2010, APPL ANIM BEHAV SCI, V123, P63, DOI 10.1016/j.applanim.2009.12.013; Kaplan BJ, 2002, J CHILD ADOL PSYCHOP, V12, P205, DOI 10.1089/104454602760386897; Kaplan PW, 2011, EPILEPSY BEHAV, V22, P428, DOI 10.1016/j.yebeh.2011.07.029; Katerberg H, 2010, BEHAV GENET, V40, P505, DOI 10.1007/s10519-010-9339-z; Konno A, 2011, BIOL LETTERS, V7, P658, DOI 10.1098/rsbl.2011.0087; Kurup RK, 2002, INT J NEUROSCI, V112, P797, DOI 10.1080/00207450290025824; Latham NR, 2008, APPL ANIM BEHAV SCI, V110, P84, DOI 10.1016/j.applanim.2007.03.026; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Liinamo AE, 2007, APPL ANIM BEHAV SCI, V104, P95, DOI 10.1016/j.applanim.2006.04.025; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Luescher AU, 2003, VET CLIN N AM-SMALL, V33, P253, DOI 10.1016/S0195-5616(02)00100-6; Man J., 2004, Current Neuropharmacology, V2, P169, DOI 10.2174/1570159043476792; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Moon-Fanelli AA, 1998, J AM VET MED ASSOC, V212, P1252; Moon-Fanelli AA, 2007, JAVMA-J AM VET MED A, V231, P907, DOI 10.2460/javma.231.6.907; Moon-Fanelli AA, 2011, JAVMA-J AM VET MED A, V238, P883, DOI 10.2460/javma.238.7.883; National Research Council (U.S.). Ad Hoc Committee on Dog and Cat Nutrition, 2006, NUTR REQ DOGS CATS, P398; Nicolini H, 2009, PSYCHIAT RES, V170, P7, DOI 10.1016/j.psychres.2008.10.011; Overall KL, 2006, J VET BEHAV, V1, P1, DOI 10.1016/j.jveb.2006.04.008; Overall KL, 2002, J AM VET MED ASSOC, V221, P1445, DOI 10.2460/javma.2002.221.1445; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; RAPOPORT JL, 1992, ARCH GEN PSYCHIAT, V49, P517; Richter MA, 2003, DEPRESS ANXIETY, V18, P118, DOI 10.1002/da.10126; Rucklidge JJ, 2009, J ANXIETY DISORD, V23, P836, DOI 10.1016/j.janxdis.2009.02.012; Sallander MH, 2001, PREV VET MED, V50, P35, DOI 10.1016/S0167-5877(01)00217-3; Schneider BM, 2009, J VET BEHAV, V4, P118, DOI 10.1016/j.jveb.2008.10.008; Schonecker B, 2009, APPL ANIM BEHAV SCI, V121, P55, DOI 10.1016/j.applanim.2009.08.003; Seksel K, 2001, AUST VET J, V79, P252, DOI 10.1111/j.1751-0813.2001.tb11976.x; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Skarupski KA, 2010, AM J CLIN NUTR, V92, P330, DOI 10.3945/ajcn.2010.29413; Spady TC, 2008, AM J HUM GENET, V82, P10, DOI 10.1016/j.ajhg.2007.12.001; Stein DJ, 2002, LANCET, V360, P397, DOI 10.1016/S0140-6736(02)09620-4; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Takeuchi T, 1997, BEHAV RES THER, V35, P445, DOI 10.1016/S0005-7967(96)00123-4; Uchida Y, 1997, AM J VET RES, V58, P808; Uguz F, 2007, COMPR PSYCHIAT, V48, P558, DOI 10.1016/j.comppsych.2007.05.010; van Grootheest DS, 2005, TWIN RES HUM GENET, V8, P450, DOI 10.1375/183242705774310060; Vas J, 2007, APPL ANIM BEHAV SCI, V103, P105, DOI 10.1016/j.applanim.2006.03.017; Vermeire S, 2012, PSYCHIAT RES-NEUROIM, V201, P78, DOI 10.1016/j.pscychresns.2011.06.006; Vermeire S, 2009, BRAIN IMAGING BEHAV, V3, P342, DOI 10.1007/s11682-009-9076-1; Vulink NCC, 2006, INT CLIN PSYCHOPHARM, V21, P171, DOI 10.1097/01.yic.0000199454.62423.99; Walitza S, 2010, EUR CHILD ADOLES PSY, V19, P227, DOI 10.1007/s00787-010-0087-7; Wang Huei-Shyong, 2007, Chang Gung Med J, V30, P396; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wu K, 2011, PHARM BIOCH BEHAV, V100, P726	69	40	40	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41684	10.1371/journal.pone.0041684	http://dx.doi.org/10.1371/journal.pone.0041684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844513	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600040
J	Barber, MN; Risis, S; Yang, C; Meikle, PJ; Staples, M; Febbraio, MA; Bruce, CR				Barber, Melissa N.; Risis, Steve; Yang, Christine; Meikle, Peter J.; Staples, Margaret; Febbraio, Mark A.; Bruce, Clinton R.			Plasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes	PLOS ONE			English	Article							FATTY-ACID; INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATION; METABOLISM; HEALTHY; GLUCOSE	Background: Obesity and type 2 diabetes (T2DM) are associated with increased circulating free fatty acids and triacylglycerols. However, very little is known about specific molecular lipid species associated with these diseases. In order to gain further insight into this, we performed plasma lipidomic analysis in a rodent model of obesity and insulin resistance as well as in lean, obese and obese individuals with T2DM. Methodology/Principal Findings: Lipidomic analysis using liquid chromatography coupled to mass spectrometry revealed marked changes in the plasma of 12 week high fat fed mice. Although a number of triacylglycerol and diacylglycerol species were elevated along with of a number of sphingolipids, a particularly interesting finding was the high fat diet (HFD)-induced reduction in lysophosphatidylcholine (LPC) levels. As liver, skeletal muscle and adipose tissue play an important role in metabolism, we next determined whether the HFD altered LPCs in these tissues. In contrast to our findings in plasma, only very modest changes in tissue LPCs were noted. To determine when the change in plasma LPCs occurred in response to the HFD, mice were studied after 1, 3 and 6 weeks of HFD. The HFD caused rapid alterations in plasma LPCs with most changes occurring within the first week. Consistent with our rodent model, data from our small human cohort showed a reduction in a number of LPC species in obese and obese individuals with T2DM. Interestingly, no differences were found between the obese otherwise healthy individuals and the obese T2DM patients. Conclusion: Irrespective of species, our lipidomic profiling revealed a generalized decrease in circulating LPC species in states of obesity. Moreover, our data indicate that diet and adiposity, rather than insulin resistance or diabetes per se, play an important role in altering the plasma LPC profile.	[Barber, Melissa N.] Baker IDI Heart & Diabet Inst, Biobank, Melbourne, Vic, Australia; [Risis, Steve; Yang, Christine; Febbraio, Mark A.; Bruce, Clinton R.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Metabol Lab, Melbourne, Vic, Australia; [Staples, Margaret] Monash Univ, Dept Epidemiol, Melbourne, Vic 3004, Australia; [Bruce, Clinton R.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Monash University; Monash University	Barber, MN (corresponding author), Baker IDI Heart & Diabet Inst, Biobank, Melbourne, Vic, Australia.	clinton.bruce@monash.edu	Febbraio, Mark/AAE-9632-2019; Bruce, Melissa/AAY-2063-2020; Meikle, Peter J/B-4023-2009	Febbraio, Mark/0000-0002-9296-4418; Bruce, Clinton/0000-0002-0515-3343; Meikle, Peter/0000-0002-2593-4665	Diabetes Australia Research Trust; ANZ Trustees Program; National Health and Medical Research Council of Australia (NHMRC) [526608]; Operational Infrastructure Support Program of the Victorian Government, Australia; National Health and Medical Research Council of Australia	Diabetes Australia Research Trust; ANZ Trustees Program; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program of the Victorian Government, Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Diabetes Australia Research Trust, the ANZ Trustees Program, the National Health and Medical Research Council of Australia (NHMRC Project Grant No. 526608) and the Operational Infrastructure Support Program of the Victorian Government, Australia. C. R. B. is supported by a Career Development Award, P.J.M. and M. A. F. by Research Fellowships from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285; BERNSTEIN RM, 1978, DIABETOLOGIA, V14, P249, DOI 10.1007/BF01219424; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Kus V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027126; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Meikle PJ, 2008, BIOCHEM J, V411, P71, DOI 10.1042/BJ20071043; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; RABINI RA, 1994, DIABETES, V43, P915, DOI 10.2337/diabetes.43.7.915; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Smyth I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000192; Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Xing FY, 2009, J CELL MOL MED, V13, P1136, DOI 10.1111/j.1582-4934.2008.00394.x; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3; Yea K, 2009, J BIOL CHEM, V284, P33833, DOI 10.1074/jbc.M109.024869; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	29	228	233	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41456	10.1371/journal.pone.0041456	http://dx.doi.org/10.1371/journal.pone.0041456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848500	Green Published, gold			2022-12-27	WOS:000306806600068
J	Davis, AK; Chi, J; Bradley, C; Altizer, S				Davis, Andrew K.; Chi, Jean; Bradley, Catherine; Altizer, Sonia			The Redder the Better: Wing Color Predicts Flight Performance in Monarch Butterflies	PLOS ONE			English	Article							COLIAS BUTTERFLIES; MELANIN PATTERN; MATING SUCCESS; FEMALE CHOICE; LEPIDOPTERA; POPULATIONS; SEX; PIGMENTATION; DIVERGENCE; MORPHOLOGY	The distinctive orange and black wings of monarchs (Danaus plexippus) have long been known to advertise their bitter taste and toxicity to potential predators. Recent work also showed that both the orange and black coloration of this species can vary in response to individual-level and environmental factors. Here we examine the relationship between wing color and flight performance in captive-reared monarchs using a tethered flight mill apparatus to quantify butterfly flight speed, duration and distance. In three different experiments (totaling 121 individuals) we used image analysis to measure body size and four wing traits among newly-emerged butterflies prior to flight trials: wing area, aspect ratio (length/width), melanism, and orange hue. Results showed that monarchs with darker orange (approaching red) wings flew longer distances than those with lighter orange wings in analyses that controlled for sex and other morphometric traits. This finding is consistent with past work showing that among wild monarchs, those sampled during the fall migration are darker in hue (redder) than non-migratory monarchs. Together, these results suggest that pigment deposition onto wing scales during metamorphosis could be linked with traits that influence flight, such as thorax muscle size, energy storage or metabolism. Our results reinforce an association between wing color and flight performance in insects that is suggested by past studies of wing melansim and seasonal polyphenism, and provide an important starting point for work focused on mechanistic links between insect movement and color.	[Davis, Andrew K.; Chi, Jean; Bradley, Catherine; Altizer, Sonia] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Davis, AK (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	akdavis@uga.edu						Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Altizer S, 2010, EVOLUTION, V64, P1018, DOI 10.1111/j.1558-5646.2010.00946.x; Berwaerts K, 2008, EVOLUTION, V62, P2525, DOI 10.1111/j.1558-5646.2008.00456.x; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; BROWER LP, 1974, NATURE, V249, P280, DOI 10.1038/249280b0; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Davis AK, 2005, J THERM BIOL, V30, P410, DOI 10.1016/j.jtherbio.2005.04.003; Davis AK, 2009, PSYCHE 2009, V2009, DOI [10.1155/2009/705780, DOI 10.1155/2009/705780]; Davis AK, 2007, ANN ENTOMOL SOC AM, V100, P339, DOI 10.1603/0013-8746(2007)100[339:WCPFMS]2.0.CO;2; Ellers J, 2004, BIOL J LINN SOC, V82, P79, DOI 10.1111/j.1095-8312.2004.00319.x; Ellers J, 2002, EVOLUTION, V56, P836, DOI 10.1111/j.0014-3820.2002.tb01394.x; Fric Z, 2002, EVOL ECOL RES, V4, P1017; GUPPY CS, 1986, OECOLOGIA, V70, P205, DOI 10.1007/BF00379241; Janssen JM, 2001, EVOL DEV, V3, P415, DOI 10.1046/j.1525-142X.2001.01046.x; Kemp DJ, 2008, EVOLUTION, V62, P2346, DOI 10.1111/j.1558-5646.2008.00461.x; KINGSOLVER JG, 1995, EVOLUTION, V49, P932, DOI [10.2307/2410415, 10.1111/j.1558-5646.1995.tb02328.x]; Marden JH, 2004, ANIM BEHAV, V68, P857, DOI 10.1016/j.anbehav.2003.09.019; Morehouse NI, 2010, AM NAT, V176, P768, DOI 10.1086/657043; Morehouse NI, 2010, OIKOS, V119, P636, DOI 10.1111/j.1600-0706.2009.17866.x; *STATS INC, 2003, STAT VERS 6 1; Stavenga DG, 2004, P ROY SOC B-BIOL SCI, V271, P1577, DOI 10.1098/rspb.2004.2781; Van Dyck H, 2002, J EVOLUTION BIOL, V15, P216, DOI 10.1046/j.1420-9101.2002.00384.x; Vandewoestijne S, 2011, ECOGRAPHY, V34, P876, DOI 10.1111/j.1600-0587.2010.06458.x; VanDyck H, 1997, ANIM BEHAV, V53, P39, DOI 10.1006/anbe.1996.0276; WIERNASZ DC, 1989, EVOLUTION, V43, P1672, DOI 10.1111/j.1558-5646.1989.tb02617.x; Wijnen B, 2007, J INSECT PHYSIOL, V53, P1206, DOI 10.1016/j.jinsphys.2007.06.016; Wilts BD, 2011, J COMP PHYSIOL A, V197, P693, DOI 10.1007/s00359-011-0632-y	28	34	36	4	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41323	10.1371/journal.pone.0041323	http://dx.doi.org/10.1371/journal.pone.0041323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848463	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600051
J	Qi, XL; Constantinidis, C				Qi, Xue-Lian; Constantinidis, Christos			Variability of Prefrontal Neuronal Discharges before and after Training in a Working Memory Task	PLOS ONE			English	Article							CORTICAL-NEURONS; SINGLE NEURONS; ATTENTION; NOISE; CELLS; RELIABILITY; PERFORM; CORTEX; MOTOR; CAT	Variability of neural discharges can be revealing about the computations and network properties of neuronal populations during the performance of cognitive tasks. We sought to quantify neuronal variability in the prefrontal cortex of naive monkeys that were only required to fixate, and to examine how this measure was altered by learning and execution of a working memory task. We therefore performed analysis of a large database of recordings in the same animals, using the same stimuli, before and after training. Our results indicate that the Fano Factor, a measure of variability, differs across neurons depending on their functional properties both before and after learning. Fano Factor generally decreased after learning the task. Variability was modulated by task events and displayed lowest values during the stimulus presentation. Nonetheless, the decrease in variability after training was present even prior to the presentation of any stimuli, in the fixation period. The greatest decreases were observed comparing populations of neurons that exhibited elevated firing rate during the trial events. Our results offer insights on how properties of the prefrontal network are affected by performance of a cognitive task.	[Qi, Xue-Lian; Constantinidis, Christos] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center	Qi, XL (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27109 USA.	cconstan@wfubmc.edu	Constantinidis, Christos/ABB-5760-2021	Constantinidis, Christos/0000-0001-7441-022X	National Eye Institute of the National Institutes of Health [R01 EY017077]; NATIONAL EYE INSTITUTE [R01EY017077] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported in this paper was supported by the National Eye Institute of the National Institutes of Health under award number R01 EY017077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hussar C, 2010, P NATL ACAD SCI USA, V107, P21842, DOI 10.1073/pnas.1009956107; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Lee D, 1998, J NEUROSCI, V18, P1161; Maynard EM, 1999, J NEUROSCI, V19, P8083; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Meyer T, 2005, J NEUROSCI METH, V142, P27, DOI 10.1016/j.jneumeth.2004.07.009; Meyer T, 2011, J NEUROSCI, V31, P6266, DOI 10.1523/JNEUROSCI.6798-10.2011; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Oram MW, 2011, J NEUROPHYSIOL, V105, P942, DOI 10.1152/jn.00711.2009; Qi XL, 2012, J NEUROSCI, V32, P6161, DOI 10.1523/JNEUROSCI.6365-11.2012; Qi XL, 2011, CEREB CORTEX, V21, P2722, DOI 10.1093/cercor/bhr058; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SOFTKY WR, 1993, J NEUROSCI, V13, P334; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Vigneswaran G, 2011, J NEUROSCI, V31, P14235, DOI 10.1523/JNEUROSCI.3142-11.2011; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002	30	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41053	10.1371/journal.pone.0041053	http://dx.doi.org/10.1371/journal.pone.0041053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848426	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600035
J	Byrne, RD; Applebee, C; Poccia, DL; Larijani, B				Byrne, Richard D.; Applebee, Christopher; Poccia, Dominic L.; Larijani, Banafshe			Dynamics of PLC gamma and Src Family Kinase 1 Interactions during Nuclear Envelope Formation Revealed by FRET-FLIM	PLOS ONE			English	Article							PHOSPHOLIPASE C-GAMMA; CA2+ RELEASE; IN-VITRO; TYROSINE KINASE; SPERM CHROMATIN; EGG; ACTIVATION; BINDING; FUSION; PHOSPHORYLATION	The nuclear envelope (NE) breaks down and reforms during each mitotic cycle. A similar process happens to the sperm NE following fertilisation. The formation of the NE in both these circumstances involves endoplasmic reticulum membranes enveloping the chromatin, but PLC gamma-dependent membrane fusion events are also essential. Here we demonstrate the activation of PLC gamma by a Src family kinase (SFK1) during NE assembly. We show by time-resolved FRET for the first time the direct in vivo interaction and temporal regulation of PLC gamma and SFK1 in sea urchins. As a prerequisite for protein activation, there is a rapid phosphorylation of PLC gamma on its Y783 residue in response to GTP in vitro. This phosphorylation is dependent upon SFK activity; thus Y783 phosphorylation and NE assembly are susceptible to SFK inhibition. Y783 phosphorylation is also observed on the surface of the male pronucleus (MPN) in vivo during NE formation. Together the corroborative in vivo and in vitro data demonstrate the phosphorylation and activation of PLC gamma by SFK1 during NE assembly. We discuss the potential generality of such a mechanism.	[Byrne, Richard D.; Applebee, Christopher; Larijani, Banafshe] London Res Inst, Canc Res UK, Cell Biophys Lab, London, England; [Poccia, Dominic L.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Cancer Research UK; Amherst College	Byrne, RD (corresponding author), London Res Inst, Canc Res UK, Cell Biophys Lab, London, England.	richard.byrne@cancer.org.uk; banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015	Larijani, Banafshe/0000-0003-4735-1169	Cancer Research UK; Amherst College Faculty Research Award of the H. Axel Schupf '57 Fund for Intellectual Life; Royal Society [GA3335]	Cancer Research UK(Cancer Research UK); Amherst College Faculty Research Award of the H. Axel Schupf '57 Fund for Intellectual Life; Royal Society(Royal Society of London)	The project was funded by Cancer Research UK core funding to London Research Institute (RDB, CA & BL), an Amherst College Faculty Research Award of the H. Axel Schupf '57 Fund for Intellectual Life (DLP), and Royal Society travel grant no. GA3335 (BL & DLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcor Damien, 2009, V462, P307, DOI 10.1007/978-1-60327-115-8_21; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; ARKINSTALL S, 1995, MOL CELL BIOL, V15, P1431; Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; Byrne RD, 2005, BIOCHEM J, V387, P393, DOI 10.1042/BJ20040947; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; Byrne RD, 2009, CLIN LIPIDOL, V4, P103, DOI 10.2217/17584299.4.1.103; Byrne RD, 2009, ADV ENZYME REGUL, V49, P148, DOI 10.1016/j.advenzreg.2008.12.010; Byrne Richard D., 2008, V464, P207; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; CAMERON LA, 1994, DEV BIOL, V162, P568, DOI 10.1006/dbio.1994.1110; COLLAS P, 1995, DEV BIOL, V169, P123, DOI 10.1006/dbio.1995.1132; Collas P, 1996, J CELL SCI, V109, P1275; COLLAS P, 1995, MOL REPROD DEV, V42, P106, DOI 10.1002/mrd.1080420114; Collas P, 1996, J CELL BIOL, V135, P1715, DOI 10.1083/jcb.135.6.1715; Collas P, 1996, EUR J CELL BIOL, V71, P22; Conner S, 1998, DEV BIOL, V203, P334, DOI 10.1006/dbio.1998.9057; Conner SD, 2000, FASEB J, V14, P1559, DOI 10.1096/fj.14.11.1559; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; Dumas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012208; Foltz KR, 2004, METHOD CELL BIOL, V74, P39; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Giusti AF, 2003, DEV BIOL, V256, P367, DOI 10.1016/S0012-1606(03)00043-5; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Imschenetzky M, 2003, GENE, V322, P33, DOI 10.1016/j.gene.2003.08.024; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Khare S, 1997, J CLIN INVEST, V99, P1831, DOI 10.1172/JCI119350; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Larijani B, 2001, BIOCHEM J, V356, P495, DOI 10.1042/0264-6021:3560495; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; LIAO F, 1993, BIOCHEM BIOPH RES CO, V191, P1028, DOI 10.1006/bbrc.1993.1320; LONGO FJ, 1968, J CELL BIOL, V39, P339, DOI 10.1083/jcb.39.2.339; LONGO FJ, 1976, DEV BIOL, V49, P347, DOI 10.1016/0012-1606(76)90180-9; LONGO FJ, 1973, BIOL REPROD, V9, P149, DOI 10.1093/biolreprod/9.2.149; LONGO FJ, 1981, DEV BIOL, V84, P173, DOI 10.1016/0012-1606(81)90381-X; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; O'Neill FJ, 2004, J CELL SCI, V117, P6227, DOI 10.1242/jcs.01547; OKADA M, 1991, J BIOL CHEM, V266, P24249; Poccia D, 1997, DEV GROWTH DIFFER, V39, P541; Poccia D, 1996, CURR TOP DEV BIOL, V34, P25, DOI 10.1016/S0070-2153(08)60708-5; POCCIA DL, 1992, TRENDS BIOCHEM SCI, V17, P223, DOI 10.1016/0968-0004(92)90382-J; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Runft LL, 2004, DEV BIOL, V269, P220, DOI 10.1016/j.ydbio.2004.01.031; Sharma D, 2006, DEV BIOL, V295, P604, DOI 10.1016/j.ydbio.2006.03.041; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stricker SA, 2010, INT J DEV BIOL, V54, P787, DOI 10.1387/ijdb.092918ss; Townley IK, 2006, SEMIN CELL DEV BIOL, V17, P293, DOI 10.1016/j.semcdb.2006.02.006; Townley IK, 2009, DEV BIOL, V327, P465, DOI 10.1016/j.ydbio.2008.12.032; Voronina E, 2004, J CELL SCI, V117, P5995, DOI 10.1242/jcs.01518; Wilson EB, 1925, SCIENCE, V61, P184, DOI 10.1126/science.61.1572.184	57	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40669	10.1371/journal.pone.0040669	http://dx.doi.org/10.1371/journal.pone.0040669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848394	Green Submitted, gold, Green Published			2022-12-27	WOS:000306751300008
J	Chen, H; Untiveros, GM; McKee, LAK; Perez, J; Li, J; Antin, PB; Konhilas, JP				Chen, Hao; Untiveros, Gustavo M.; McKee, Laurel A. K.; Perez, Jessica; Li, Jing; Antin, Parker B.; Konhilas, John P.			Micro-RNA-195 and-451 Regulate the LKB1/AMPK Signaling Axis by Targeting MO25	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIAC-HYPERTROPHY; MOUSE MODEL; GENE-EXPRESSION; HEART-DISEASE; MICRORNAS; LKB1; METABOLISM; ENERGETICS; SIGNATURE	Background: Recently, MicroRNAs (miR) and AMP-kinase (AMPK) have emerged as prominent players in the development of cardiac hypertrophy and heart failure. We hypothesized that components of the adenosine monophosphate-activated kinase (AMPK) pathway are targeted by miRs and alter AMPK signaling during pathological cardiac stress. Methodology/Principal Findings: Using a mouse model of hypertrophic cardiomyopathy (HCM), we demonstrated early elevation of miR-195 and miR-451 in HCM hearts, which targets MO25, a central component of the MO25/STRAD/LKB1 complex that acts as an upstream kinase for AMPK. We show functional targeting of MO25 by miR-195 and -451. Further in vitro interrogation of MO25 as a functional target validated this hypothesis where over-expression of miR-195 in C2C12 cells knocked down MO25 expression levels and downstream AMPK signaling (phosphorylation of Acetyl CoA carboxylase [ACC] and AMPK activity assay), similar to MO25 knockdown in C2C12 cells by siRNA. Parallel changes were measured in 60 day R403Q HCM male hearts that were rescued by short-term administration of AICAR, an AMPK agonist. Conclusions/Significance: Elevated miR-195 targets the LKB1/AMPK signaling axis in HCM progression and implicates a functional role in HCM disease progression. MiR-195 may serve as potential therapeutics or therapeutic targets for heart disease.	[Chen, Hao; McKee, Laurel A. K.; Perez, Jessica; Konhilas, John P.] Univ Arizona, Dept Physiol, Tucson, AZ 85719 USA; [Untiveros, Gustavo M.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Antin, Parker B.] Univ Arizona, Dept Cellular & Mol Med, Mol Cardiovasc Res Program, Tucson, AZ USA; [Antin, Parker B.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA; [Li, Jing] Steele Childrens Res Ctr, Dept Pediat, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Chen, H (corresponding author), Univ Arizona, Dept Physiol, Tucson, AZ 85719 USA.	konhilas@arizona.edu		Antin, Parker/0000-0001-9066-7412; Konhilas, John/0000-0002-3579-087X	NIH [HL 098256, K01 AR052840, K02 HL105799, HD064559]; Interdisciplinary Training Grant in Cardiovascular Sciences [HL007249]; AHA WSA Postdoctoral Fellowship [11POST7900010]; Sarver Heart Center at the University of Arizona; Steven M. Gootter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064559] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098256, T32HL007249, K02HL105799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Training Grant in Cardiovascular Sciences; AHA WSA Postdoctoral Fellowship; Sarver Heart Center at the University of Arizona; Steven M. Gootter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant (HL 098256), by a National and Mentored Research Science Development Award (K01 AR052840) and Independent Scientist Award (K02 HL105799) from the NIH awarded to JPK and the Interdisciplinary Training Grant in Cardiovascular Sciences (HL007249), and by AHA WSA Postdoctoral Fellowship (11POST7900010) awarded to CH. Also, support was provided by NIH grant (HD064559) awarded to PBA. Support was received from the Sarver Heart Center at the University of Arizona and from the Steven M. Gootter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 1998, J AM COLL NUTR, V17, P548, DOI 10.1080/07315724.1998.10718802; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Bell GW, 2004, DEV DYNAM, V229, P677, DOI 10.1002/dvdy.10503; Bostjancic E, 2009, DIS MARKERS, V27, P255, DOI 10.3233/DMA-2009-0671; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Degens H, 2006, BASIC RES CARDIOL, V101, P17, DOI 10.1007/s00395-005-0549-0; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dyck JRB, 2006, CIRCULATION, V114, P1721, DOI 10.1161/CIRCULATIONAHA.106.642009; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Glazov Evgeny A, 2006, RNA Biol, V3, P36; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; Hammond SM, 2006, CANCER CHEMOTH PHARM, V58, pS63, DOI 10.1007/s00280-006-0318-2; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Kalsi KK, 1999, EUR J CLIN INVEST, V29, P469, DOI 10.1046/j.1365-2362.1999.00468.x; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lucas DT, 2003, AM J PHYSIOL-HEART C, V284, pH575, DOI 10.1152/ajpheart.00619.2002; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; Olsson MC, 2004, CIRC RES, V94, P201, DOI 10.1161/01.RES.0000111521.40760.18; Olsson MC, 2001, AM J PHYSIOL-HEART C, V280, pH1136, DOI 10.1152/ajpheart.2001.280.3.H1136; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940; Stauffer BL, 2006, J CLIN INVEST, V116, P209, DOI 10.1172/JCI24676; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vikstrom KL, 1996, MOL MED, V2, P556, DOI 10.1007/BF03401640; Vikstrom KL, 1998, CIRC RES, V82, P773, DOI 10.1161/01.RES.82.7.773; Watson PA, 2007, AM J PHYSIOL-HEART C, V293, pH246, DOI 10.1152/ajpheart.00734.2006; Williamson DL, 2006, AM J PHYSIOL-ENDOC M, V291, pE80, DOI 10.1152/ajpendo.00566.2005; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066; Woods SC, 2003, EXP BIOL MED, V228, P1175; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang CX, 2011, CLIN EXP PHARMACOL P, V38, P55, DOI 10.1111/j.1440-1681.2010.05461.x; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	52	43	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41574	10.1371/journal.pone.0041574	http://dx.doi.org/10.1371/journal.pone.0041574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844503	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700116
J	Goncalves, L; Subtil, A; de Oliveira, MR; do Rosario, V; Lee, PW; Shaio, MF				Goncalves, Luzia; Subtil, Ana; Rosario de Oliveira, M.; do Rosario, Virgilio; Lee, Pei-Wen; Shaio, Men-Fang			Bayesian Latent Class Models in Malaria Diagnosis	PLOS ONE			English	Article							LABORATORY COMPARATIVE-EVALUATION; PLASMODIUM-FALCIPARUM MALARIA; MONTE-CARLO METHODS; TOME-AND-PRINCIPE; CONDITIONAL DEPENDENCE; CONFIDENCE-INTERVALS; BINOMIAL PROPORTION; FIELD-EVALUATION; TESTS; ACCURACY	Aims: The main focus of this study is to illustrate the importance of the statistical analysis in the evaluation of the accuracy of malaria diagnostic tests, without admitting a reference test, exploring a dataset (n = 3317) collected in Sao Tome and Principe. Methods: Bayesian Latent Class Models (without and with constraints) are used to estimate the malaria infection prevalence, together with sensitivities, specificities, and predictive values of three diagnostic tests (RDT, Microscopy and PCR), in four subpopulations simultaneously based on a stratified analysis by age groups (<5, >= 5 years old) and fever status (febrile, afebrile). Results: In the afebrile individuals with at least five years old, the posterior mean of the malaria infection prevalence is 3.2% with a highest posterior density interval of [2.3-4.1]. The other three subpopulations (febrile >= 5 years, afebrile or febrile children less than 5 years) present a higher prevalence around 10.3% [8.8-11.7]. In afebrile children under-five years old, the sensitivity of microscopy is 50.5% [37.7-63.2]. In children under-five, the estimated sensitivities/specificities of RDT are 95.4% [90.3-99.5]/93.8% [91.6-96.0] - afebrile - and 94.1% [87.5-99.4]/97.5% [95.5-99.3] - febrile. In individuals with at least five years old are 96.0% [91.5-99.7]/98.7% [98.1-99.2] - afebrile - and 97.9% [95.3-99.8]/97.7% [96.6-98.6] - febrile. The PCR yields the most reliable results in four subpopulations. Conclusions: The utility of this RDT in the field seems to be relevant. However, in all subpopulations, data provide enough evidence to suggest caution with the positive predictive values of the RDT. Microscopy has poor sensitivity compared to the other tests, particularly, in the afebrile children less than 5 years. This type of findings reveals the danger of statistical analysis based on microscopy as a reference test. Bayesian Latent Class Models provide a powerful tool to evaluate malaria diagnostic tests, taking into account different groups of interest.	[Goncalves, Luzia] Univ Nova Lisboa, Inst Higiene & Med Trop, CEAUL, P-1200 Lisbon, Portugal; [Goncalves, Luzia] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Saude Publ Int & Bioestat, P-1200 Lisbon, Portugal; [Subtil, Ana; Rosario de Oliveira, M.] Univ Tecn Lisboa, Inst Super Tecn, CEMAT, P-1096 Lisbon, Portugal; [Subtil, Ana; Rosario de Oliveira, M.] Univ Tecn Lisboa, Inst Super Tecn, Dept Matemat, P-1096 Lisbon, Portugal; [do Rosario, Virgilio] Univ Nova Lisboa, Inst Higiene & Med Trop, CMDT LA, P-1200 Lisbon, Portugal; [do Rosario, Virgilio] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol Med, P-1200 Lisbon, Portugal; [Lee, Pei-Wen] HungKuang Univ, Inst Biomed Nutr, Taichung, Taiwan; [Shaio, Men-Fang] Natl Yang Ming Univ, Dept Trop Med, Taipei 112, Taiwan	Universidade de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Hungkuang University; National Yang Ming Chiao Tung University	Goncalves, L (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, CEAUL, P-1200 Lisbon, Portugal.	luziag@ihmt.unl.pt	Oliveira, M. Rosário/G-9130-2014; Gonçalves, Luzia/J-6649-2012; Subtil, Ana/G-7470-2019	Oliveira, M. Rosário/0000-0002-5234-3713; Gonçalves, Luzia/0000-0002-9710-1945; Oliveira Martins, Maria do Rosario/0000-0002-7941-0285; Subtil, Ana/0000-0002-1079-9624	STP malaria control programme; International Cooperation and Development Fund of Taiwan; RIDES/Malaria CPLP; Fundacao Nacional para a Ciencia e Tecnologia (FCT), Portugal [PTDC/SAU-ESA/81240/2006, PEst-OE/MAT/UI0006/2011]; FCT [SFRH/BD/69793/2010]	STP malaria control programme; International Cooperation and Development Fund of Taiwan; RIDES/Malaria CPLP; Fundacao Nacional para a Ciencia e Tecnologia (FCT), Portugal; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by STP malaria control programme financed by the International Cooperation and Development Fund of Taiwan and RIDES/Malaria CPLP. Statistical research was partially sponsored by national funds through the Fundacao Nacional para a Ciencia e Tecnologia (FCT), Portugal, under the projects PTDC/SAU-ESA/81240/2006 and PEst-OE/MAT/UI0006/2011. A. Subtil has an FCT PhD grant SFRH/BD/69793/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2004, BIOMETRICS, V60, P427, DOI 10.1111/j.0006-341X.2004.00187.x; Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Altman DG., 2000, STAT CONFIDENCE CONF; Batwala V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-349; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Bendezu J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-154; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Bernatsky S, 2005, STAT MED, V24, P2365, DOI 10.1002/sim.2116; Bronsvoort B, 2006, BMC VET RES, P2; Brown LD, 2002, ANN STAT, V30, P160; Canavate C, 2011, AM J TROP MED HYG, V84, P102, DOI 10.4269/ajtmh.2011.10-0229; Celeux G, 2000, J AM STAT ASSOC, V95, P957, DOI 10.2307/2669477; Chinkhumba J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-209; Cho SJ, 2010, J EDUC BEHAV STAT, V35, P336, DOI 10.3102/1076998609353111; Christensen R, 1997, LOG LINEAR MODELS LO; Coleman RE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-121; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; Dayton C.Mitchell., 2002, APPL LATENT CLASS AN, P213, DOI DOI 10.1017/CBO9780511499531.009; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Dendukuri N, 2009, STAT MED, V28, P441, DOI 10.1002/sim.3470; Dias JG, 2006, STUD CLASS DATA ANAL, P91, DOI 10.1007/3-540-34416-0_11; Dohoo IR, 2008, PREV VET MED, V86, P260, DOI 10.1016/j.prevetmed.2008.02.012; Drewe JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011196; ESPELAND MA, 1989, BIOMETRICS, V45, P587, DOI 10.2307/2531499; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Formann AK, 2003, BIOMETRICS, V59, P189, DOI 10.1111/1541-0420.00023; Gardner IA, 2010, ZOONOSES PUBLIC HLTH, V57, P82, DOI 10.1111/j.1863-2378.2009.01281.x; Garrett ES, 2000, BIOMETRICS, V56, P1055, DOI 10.1111/j.0006-341X.2000.01055.x; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Ghosh J, 2011, BIOMETRICS, V67, P917, DOI 10.1111/j.1541-0420.2010.01502.x; Gustafson P, 2005, STAT SCI, V20, P111, DOI 10.1214/088342305000000098; Gustafson P, 2009, J AM STAT ASSOC, V104, P1682, DOI 10.1198/jasa.2009.tm08603; Hadgu A, 1998, J R STAT SOC C-APPL, V47, P603, DOI 10.1111/1467-9876.00131; HAGENAARS JA, 1988, SOCIOL METHOD RES, V16, P379, DOI 10.1177/0049124188016003002; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; Jones G, 2010, BIOMETRICS, V66, P855, DOI 10.1111/j.1541-0420.2009.01330.x; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-264; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Machado C, 2009, J APPL STAT, V36, P871, DOI 10.1080/02664760802520769; Martinez EZ, 2008, CANCER INFORM, V6, P33; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Mendes JM, 2007, ENVIRONMETRICS, V18, P27, DOI 10.1002/env.800; Mens P, 2007, TROP MED INT HEALTH, V12, P238, DOI 10.1111/j.1365-3165.2006.01779.x; Menten J, 2008, STAT MED, V27, P4469, DOI 10.1002/sim.3317; Moonasar D, 2009, SAMJ S AFR MED J, V99, P810; Neelon B, 2011, BIOMETRICS, V67, P280, DOI 10.1111/j.1541-0420.2010.01439.x; Nerette P, 2008, PREV VET MED, V85, P207, DOI 10.1016/j.prevetmed.2008.01.011; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ngasala B, 2010, THESIS KAROLINSKA I; Nielsen LR, 2004, J VET DIAGN INVEST, V16, P212, DOI 10.1177/104063870401600306; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Pinto J, 2000, ACTA TROP, V76, P185, DOI 10.1016/S0001-706X(00)00100-5; Pires AM, 2008, REVSTAT-STAT J, V6, P165; Portero JL, 2010, MALARIA RES TREATMEN; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Sepulveda R, 2008, STAT MED, V27, P1855, DOI 10.1002/sim.3194; Sergeant E.S.G., 2018, EPITOOLS EPIDEMIOLOG; Singh N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-191; Smith BJ, 2007, J STAT SOFTW, V21, P1; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Sperrin M, 2010, STAT COMPUT, V20, P357, DOI 10.1007/s11222-009-9129-8; Speybroeck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016705; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stauffer WM, 2009, CLIN INFECT DIS, V49, P908, DOI 10.1086/605436; Stephens M, 2000, ANN STAT, V28, P40, DOI 10.1214/aos/1016120364; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; Subtil A, 2012, STAT PROBABIL LETT, V82, P1407, DOI 10.1016/j.spl.2012.03.030; Team. RDC, 2007, R LANG ENV STAT COMP; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Toft N, 2007, PREV VET MED, V79, P244, DOI 10.1016/j.prevetmed.2007.01.003; UNICEF, 2007, INERT1989 ROC; Weber MF, 2009, PREV VET MED, V92, P256, DOI 10.1016/j.prevetmed.2009.08.017; WHO, 2010, INERT1989 ROC; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	79	30	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40633	10.1371/journal.pone.0040633	http://dx.doi.org/10.1371/journal.pone.0040633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844405	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700014
J	Mattiazzi, M; Sun, YD; Wolinski, H; Bavdek, A; Petan, T; Anderluh, G; Kohlwein, SD; Drubin, DG; Krizaj, I; Petrovic, U				Mattiazzi, Mojca; Sun, Yidi; Wolinski, Heimo; Bavdek, Andrej; Petan, Toni; Anderluh, Gregor; Kohlwein, Sepp D.; Drubin, David G.; Krizaj, Igor; Petrovic, Uros			A Neurotoxic Phospholipase A(2) Impairs Yeast Amphiphysin Activity and Reduces Endocytosis	PLOS ONE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; BAR DOMAIN PROTEINS; SACCHAROMYCES-CEREVISIAE; BETA-BUNGAROTOXIN; CLATHRIN; ACTIN; DYNAMIN; AMMODYTOXIN; 14-3-3-PROTEINS; BINDING	Background: Presynaptically neurotoxic phospholipases A(2) inhibit synaptic vesicle recycling through endocytosis. Principal Findings: Here we provide insight into the action of a presynaptically neurotoxic phospholipase A(2) ammodytoxin A (AtxA) on clathrin-dependent endocytosis in budding yeast. AtxA caused changes in the dynamics of vesicle formation and scission from the plasma membrane in a phospholipase activity dependent manner. Our data, based on synthetic dosage lethality screen and the analysis of the dynamics of sites of endocytosis, indicate that AtxA impairs the activity of amphiphysin. Conclusions: We identified amphiphysin and endocytosis as the target of AtxA intracellular activity. We propose that AtxA reduces endocytosis following a mechanism of action which includes both a specific protein-protein interaction and enzymatic activity, and which is applicable to yeast and mammalian cells. Knowing how neurotoxic phospholipases A(2) work can open new ways to regulate endocytosis.	[Mattiazzi, Mojca; Petan, Toni; Krizaj, Igor; Petrovic, Uros] Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia; [Sun, Yidi; Drubin, David G.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wolinski, Heimo; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, Graz, Austria; [Bavdek, Andrej; Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of California System; University of California Berkeley; University of Graz; University of Ljubljana	Mattiazzi, M (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.	uros.petrovic@ijs.si	Anderluh, Gregor/C-6905-2014; Petan, Toni/AAN-4453-2020; Petan, Toni/ABA-2506-2021	Anderluh, Gregor/0000-0002-9916-8465; Petan, Toni/0000-0003-1223-2397; Mattiazzi Usaj, Mojca/0000-0002-7389-8478; Wolinski, Heimo/0000-0002-1583-6092; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Sun, Yidi/0000-0002-2157-1983; Petrovic, Uros/0000-0002-9743-9145	Slovenian Research Agency [P1-0207, Z1-4468, J1-6507]; Osterreichische Akademische Austauschdienst OAW [Sl13/2009]; Austrian Science Funds, FWF (Project LIPOTOX); Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Osterreichische Akademische Austauschdienst OAW; Austrian Science Funds, FWF (Project LIPOTOX); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been funded by grants P1-0207, Z1-4468, and J1-6507 from the Slovenian Research Agency to UP, IK, GA, and MM, the Osterreichische Akademische Austauschdienst OAW (project WTZ Slovenia Sl13/2009) to UP and SDK, and the Austrian Science Funds, FWF (Project LIPOTOX) to SDK and HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2004, ANAL BIOCHEM, V328, P233, DOI 10.1016/j.ab.2004.01.018; ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; Anderluh G, 2005, ANAL BIOCHEM, V344, P43, DOI 10.1016/j.ab.2005.06.013; Augustine GJ, 2006, BIOCHEM SOC T, V34, P68, DOI 10.1042/BST0340068; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bayburt T, 1997, BIOCHEMISTRY-US, V36, P3216, DOI 10.1021/bi961659d; Bazaa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010124; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Conibear E, 2010, CURR OPIN CELL BIOL, V22, P513, DOI 10.1016/j.ceb.2010.05.009; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DAVID C, 1994, FEBS LETT, V351, P73, DOI 10.1016/0014-5793(94)00826-4; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Delom F, 2006, PROTEOMICS, V6, P3029, DOI 10.1002/pmic.200500762; Dixon RW, 1999, AM J PATHOL, V154, P447, DOI 10.1016/S0002-9440(10)65291-1; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grandbois M, 1998, BIOPHYS J, V74, P2398, DOI 10.1016/S0006-3495(98)77948-2; Harris JB, 2000, EXP NEUROL, V161, P517, DOI 10.1006/exnr.1999.7275; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kini RM, 1997, VENOM PHOSPHOLIPASE, pxii; KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; LEE CY, 1984, ARCH INT PHARMACOD T, V268, P313; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Logonder U, 2009, EXP NEUROL, V219, P591, DOI 10.1016/j.expneurol.2009.07.017; Logonder U, 2008, J NEUROPATH EXP NEUR, V67, P1011, DOI 10.1097/NEN.0b013e318188c2d7; Lombardi R, 2001, J BIOL CHEM, V276, P6016, DOI 10.1074/jbc.M008735200; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Mattiazzi M, 2010, MOL GENET GENOMICS, V283, P519, DOI 10.1007/s00438-010-0533-8; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Montecucco C, 2000, TRENDS BIOCHEM SCI, V25, P266, DOI 10.1016/S0968-0004(00)01556-5; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; Neco P, 2003, J NEUROCHEM, V85, P329, DOI 10.1046/j.1471-4159.2003.01682.x; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Petan T, 2005, BIOCHEMISTRY-US, V44, P12535, DOI 10.1021/bi051024r; Petan T, 2007, BIOCHEMISTRY-US, V46, P12795, DOI 10.1021/bi701304e; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Petrovic U, 2005, BIOCHEM J, V391, P383, DOI 10.1042/BJ20050417; Petrovic U, 2004, BIOCHEM BIOPH RES CO, V324, P981, DOI 10.1016/j.bbrc.2004.09.144; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Prasarnpun S, 2004, NEUROPHARMACOLOGY, V47, P304, DOI 10.1016/j.neuropharm.2004.04.012; Praznikar ZJ, 2008, BBA-MOL CELL RES, V1783, P1129, DOI 10.1016/j.bbamcr.2008.01.011; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Pungercar J, 2011, ACTA CHIM SLOV, V58, P660; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Sribar J, 2005, BIOCHEM BIOPH RES CO, V329, P733, DOI 10.1016/j.bbrc.2005.02.036; Sribar J, 2003, FEBS LETT, V553, P309, DOI 10.1016/S0014-5793(03)01035-4; Sribar J, 2003, BIOCHEM BIOPH RES CO, V302, P691, DOI 10.1016/S0006-291X(03)00228-6; Sribar J, 2001, J BIOL CHEM, V276, P12493, DOI 10.1074/jbc.C100048200; Tabor S., 2001, CURR PROTOC MOL BIOL; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; VANHEUSDEN GPH, 1992, FEBS LETT, V302, P145, DOI 10.1016/0014-5793(92)80426-H; WALTSCHEWA L, 1991, YEAST, V7, P211, DOI 10.1002/yea.320070303; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; WILSCHUT JC, 1978, BIOCHIM BIOPHYS ACTA, V508, P185, DOI 10.1016/0005-2736(78)90324-3; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	85	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40931	10.1371/journal.pone.0040931	http://dx.doi.org/10.1371/journal.pone.0040931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844417	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700024
J	Reifenberg, K; Cheng, F; Orning, C; Crain, J; Kupper, I; Wiese, E; Protschka, M; Blessing, M; Lackner, KJ; Torzewski, M				Reifenberg, Kurt; Cheng, Fei; Orning, Carolin; Crain, Jeanine; Kuepper, Ines; Wiese, Elena; Protschka, Martina; Blessing, Manfred; Lackner, Karl J.; Torzewski, Michael			Overexpression of TGF-beta 1 in Macrophages Reduces and Stabilizes Atherosclerotic Plaques in ApoE-Deficient Mice	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; LATENT TGF-BETA; E KNOCKOUT MICE; T-CELLS; ACCELERATES ATHEROSCLEROSIS; RECEPTOR EXPRESSION; LESION DEVELOPMENT; GENE-EXPRESSION; IMAGE-ANALYSIS	Although macrophages represent the hallmark of both human and murine atherosclerotic lesions and have been shown to express TGF-beta 1 (transforming growth factor beta 1) and its receptors, it has so far not been experimentally addressed whether the pleiotropic cytokine TGF-beta 1 may influence atherogenesis by a macrophage specific mechanism. We developed transgenic mice with macrophage specific TGF-beta 1 overexpression, crossed the transgenics to the atherosclerotic ApoE (apolipoprotein E) knock-out strain and quantitatively analyzed both atherosclerotic lesion development and composition of the resulting double mutants. Compared with control ApoE(-/-) mice, animals with macrophage specific TGF-beta 1 overexpression developed significantly less atherosclerosis after 24 weeks on the WTD (Western type diet) as indicated by aortic plaque area en face (p<0.05). Reduced atherosclerotic lesion development was associated with significantly less macrophages (p<0.05 after both 8 and 24 weeks on the WTD), significantly more smooth muscle cells (SMCs; p<0.01 after 24 weeks on the WTD), significantly more collagen (p<0.01 and p<0.05 after 16 and 24 weeks on the WTD, respectively) without significant differences of inner aortic arch intima thickness or the number of total macrophages in the mice pointing to a plaque stabilizing effect of macrophage-specific TGF-beta 1 overexpression. Our data shows that macrophage specific TGF-beta 1 overexpression reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice.	[Reifenberg, Kurt; Crain, Jeanine; Kuepper, Ines; Wiese, Elena] Johannes Gutenberg Univ Mainz, Cent Lab Anim Facil, Univ Med Ctr, Mainz, Germany; [Cheng, Fei; Orning, Carolin; Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Inst Clin Chem & Lab Med, Univ Med Ctr, Mainz, Germany; [Protschka, Martina; Blessing, Manfred] Univ Leipzig, Ctr Biotechnol & Biomed, Fac Vet, Leipzig, Germany; [Torzewski, Michael] Robert Bosch Krankenhaus, Dept Lab Med, Stuttgart, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Leipzig University; Bosch; Robert Bosch Krankenhaus	Reifenberg, K (corresponding author), Johannes Gutenberg Univ Mainz, Cent Lab Anim Facil, Univ Med Ctr, Mainz, Germany.	michael.torzewski@rbk.de			Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine	Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine	The project was supported by the Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bobik A, 1999, CIRCULATION, V99, P2883, DOI 10.1161/01.CIR.99.22.2883; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Bot PT, 2011, ATHEROSCLEROSIS, V218, P33, DOI 10.1016/j.atherosclerosis.2011.05.017; BRAND T, 1993, J BIOL CHEM, V268, P11500; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; Frutkin AD, 2009, ARTERIOSCL THROM VAS, V29, P1251, DOI 10.1161/ATVBAHA.109.186593; FYFE AI, 1994, J CLIN INVEST, V94, P2516, DOI 10.1172/JCI117622; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Gojova A, 2003, BLOOD, V102, P4052, DOI 10.1182/blood-2003-05-1729; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; Gratchev A, 2008, J IMMUNOL, V180, P6553, DOI 10.4049/jimmunol.180.10.6553; HANSSON J, 1989, J BIOL CHEM, V264, P21788; HORVAI A, 1995, P NATL ACAD SCI USA, V92, P5391, DOI 10.1073/pnas.92.12.5391; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Lehr HA, 2001, CIRCULATION, V104, P914, DOI 10.1161/hc3401.093153; Li DY, 2006, BIOCHEM BIOPH RES CO, V344, P701, DOI 10.1016/j.bbrc.2006.04.010; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Maeda N, 2011, ARTERIOSCL THROM VAS, V31, P1957, DOI 10.1161/ATVBAHA.110.220574; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McCaffrey TA, 2000, CYTOKINE GROWTH F R, V11, P103, DOI 10.1016/S1359-6101(99)00034-9; MCCARTNEYFRANCIS NL, 1994, J LEUKOCYTE BIOL, V55, P401, DOI 10.1002/jlb.55.3.401; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; NUNES I, 1995, J IMMUNOL, V155, P1450; OWENS GK, 1988, J CELL BIOL, V107, P771, DOI 10.1083/jcb.107.2.771; Petkov PM, 2004, GENOMICS, V83, P902, DOI 10.1016/j.ygeno.2003.11.007; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84; SHARPLES K, 1987, DNA-J MOLEC CELL BIO, V6, P239, DOI 10.1089/dna.1987.6.239; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Song L, 2001, J CLIN INVEST, V108, P251, DOI 10.1172/JCI11380; Tashiro H, 2002, CORONARY ARTERY DIS, V13, P139, DOI 10.1097/00019501-200205000-00001; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Wilson K, 2001, ARTERIOSCL THROM VAS, V21, P1809, DOI 10.1161/hq1101.097805; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2005, CIRC RES, V96, P427, DOI 10.1161/01.RES.0000156889.22364.f1	48	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40990	10.1371/journal.pone.0040990	http://dx.doi.org/10.1371/journal.pone.0040990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829904	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300042
J	Murdoch, B; DelConte, C; Garcia-Castro, MI				Murdoch, Barbara; DelConte, Casey; Garcia-Castro, Martin I.			Pax7 Lineage Contributions to the Mammalian Neural Crest	PLOS ONE			English	Article							GENE REGULATORY NETWORK; ADULT SATELLITE CELLS; STEM-CELLS; EMBRYONIC ORIGIN; SKELETAL-MUSCLE; MOUSE EMBRYO; MUTANT MICE; INNER-EAR; EXPRESSION; DERIVATIVES	Background: Neural crest cells are vertebrate-specific multipotent cells that contribute to a variety of tissues including the peripheral nervous system, melanocytes, and craniofacial bones and cartilage. Abnormal development of the neural crest is associated with several human maladies including cleft/lip palate, aggressive cancers such as melanoma and neuroblastoma, and rare syndromes, like Waardenburg syndrome, a complex disorder involving hearing loss and pigment defects. We previously identified the transcription factor Pax7 as an early marker, and required component for neural crest development in chick embryos. In mammals, Pax7 is also thought to play a role in neural crest development, yet the precise contribution of Pax7 progenitors to the neural crest lineage has not been determined. Methodology/Principal Findings: Here we use Cre/loxP technology in double transgenic mice to fate map the Pax7 lineage in neural crest derivates. We find that Pax7 descendants contribute to multiple tissues including the cranial, cardiac and trunk neural crest, which in the cranial cartilage form a distinct regional pattern. The Pax7 lineage, like the Pax3 lineage, is additionally detected in some non-neural crest tissues, including a subset of the epithelial cells in specific organs. Conclusions/Significance: These results demonstrate a previously unappreciated widespread distribution of Pax7 descendants within and beyond the neural crest. They shed light regarding the regionally distinct phenotypes observed in Pax3 and Pax7 mutants, and provide a unique perspective into the potential roles of Pax7 during disease and development.	[Murdoch, Barbara] Eastern Connecticut State Univ, Dept Biol, Willimantic, CT 06226 USA; [Murdoch, Barbara; DelConte, Casey; Garcia-Castro, Martin I.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	Connecticut State University System; Eastern Connecticut State University; Yale University	Murdoch, B (corresponding author), Eastern Connecticut State Univ, Dept Biol, Willimantic, CT 06226 USA.	martin.garcia-castro@yale.edu		Garcia-Castro, Martin I./0000-0001-5128-0004	National Institutes of Health [RO1 DE017914]; CT Innovations [09SCAYALE45]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CT Innovations; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by National Institutes of Health RO1 DE017914 (MIGC) and CT Innovations 09SCAYALE45 (MIGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Basch Martin L, 2004, Birth Defects Res C Embryo Today, V72, P109, DOI 10.1002/bdrc.20015; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Buckiova D, 2004, NEUROREPORT, V15, P2001, DOI 10.1097/00001756-200409150-00002; Chai Y, 2000, DEVELOPMENT, V127, P1671; Clewes O, 2011, STEM CELL REV REP, P1; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Freyer L, 2011, DEVELOPMENT, V138, P5403, DOI 10.1242/dev.069849; Hosoyama Tohru, 2010, Genes Cancer, V1, P388; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Jinno H, 2010, STEM CELLS, V28, P2027, DOI 10.1002/stem.525; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kapur RP, 2000, DEV BIOL, V227, P146, DOI 10.1006/dbio.2000.9886; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; LaMantia AS, 2000, NEURON, V28, P411, DOI 10.1016/S0896-6273(00)00121-5; Lang D, 2003, GENOMICS, V82, P553, DOI 10.1016/S0888-7543(03)00178-2; Lang D, 2000, J CLIN INVEST, V106, P963, DOI 10.1172/JCI10828; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mansouri A, 1996, DEVELOPMENT, V122, P831; Murdoch B, 2008, J NEUROSCI, V28, P4271, DOI 10.1523/JNEUROSCI.5566-07.2008; Murdoch B, 2010, J NEUROSCI, V30, P9523, DOI 10.1523/JNEUROSCI.0867-10.2010; Nagoshi N, 2009, J CELL BIOCHEM, V107, P1046, DOI 10.1002/jcb.22213; NODEN DM, 1975, DEV BIOL, V42, P106, DOI 10.1016/0012-1606(75)90318-8; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; Otto A, 2006, ANAT EMBRYOL, V211, P293, DOI 10.1007/s00429-006-0083-3; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Sakai D, 2005, CELLS TISSUES ORGANS, V179, P24, DOI 10.1159/000084506; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; SERBEDZIJA GN, 1991, DEVELOPMENT, V111, P857; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Ziman MR, 1997, INT J BIOCHEM CELL B, V29, P1029, DOI 10.1016/S1357-2725(97)00023-X	54	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41089	10.1371/journal.pone.0041089	http://dx.doi.org/10.1371/journal.pone.0041089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848431	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200041
J	Yu, HL; Chien, LC; Yang, CH				Yu, Hwa-Lung; Chien, Lung-Chang; Yang, Chiang-Hsing			Asian Dust Storm Elevates Children's Respiratory Health Risks: A Spatiotemporal Analysis of Children's Clinic Visits across Taipei (Taiwan)	PLOS ONE			English	Article							LONG-RANGE TRANSPORT; AIR-POLLUTION; SAND DUST; HOSPITAL ADMISSIONS; EVENTS; PARTICLES; MORTALITY; EXPOSURE; INFLAMMATION; DISEASES	Concerns have been raised about the adverse impact of Asian dust storms (ADS) on human health; however, few studies have examined the effect of these events on children's health. Using databases from the Taiwan National Health Insurance and Taiwan Environmental Protection Agency, this study investigates the documented daily visits of children to respiratory clinics during and after ADS that occurred from 1997 to 2007 among 12 districts across Taipei City by applying a Bayesian structural additive regressive model controlled for spatial and temporal patterns. This study finds that the significantly impact of elevated children's respiratory clinic visits happened after ADS. Five of the seven lagged days had increasing percentages of relative rate, which was consecutively elevated from a 2-day to a 5-day lag by 0.63%similar to 2.19% for preschool children (i.e., 0 similar to 6 years of age) and 0.72%similar to 3.17% for school children (i.e., 7 similar to 14 years of age). The spatial pattern of clinic visits indicated that geographical heterogeneity was possibly associated with the clinic's location and accessibility. Moreover, day-of-week effects were elevated on Monday, Friday, and Saturday. We concluded that ADS may significantly increase the risks of respiratory diseases consecutively in the week after exposure, especially in school children.	[Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Chien, Lung-Chang] Washington Univ, Sch Med, Dept Internal Med, Div Hlth Behav Res, St Louis, MO 63110 USA; [Yang, Chiang-Hsing] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	National Taiwan University; Washington University (WUSTL); National Taipei University of Nursing & Health Science (NTUNHS)	Yu, HL (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	yangch@ntunhs.edu.tw		Yu, Hwa Lung/0000-0001-9558-2100	National Science Council of Taiwan [NSC 100-2410-H-227-004, NSC 100-2628-E-002-005]; Environmental Protection Department of the New Taipei City Government in Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Environmental Protection Department of the New Taipei City Government in Taiwan	This research was partially supported by funds from the National Science Council of Taiwan (NSC 100-2410-H-227-004) and (NSC 100-2628-E-002-005), and a research fund from the Environmental Protection Department of the New Taipei City Government in Taiwan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Basu R, 2005, EPIDEMIOLOGY, V16, P58, DOI 10.1097/01.ede.0000147117.88386.fe; Bell ML, 2008, OCCUP ENVIRON MED, V65, P104, DOI 10.1136/oem.2006.031500; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Beyea J, 1999, ENVIRON HEALTH PERSP, V107, P181; Bogaert P, 2009, ATMOS ENVIRON, V43, P2471, DOI 10.1016/j.atmosenv.2009.01.049; Brezger A, 2005, J STAT SOFTW, V14, P1; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; Chan CC, 2008, ENVIRON RES, V106, P393, DOI 10.1016/j.envres.2007.09.006; Chang SC, 2007, ENVIRON MONIT ASSESS, V132, P297, DOI 10.1007/s10661-006-9534-9; Chen SJ, 2004, ATMOS ENVIRON, V38, P5925, DOI 10.1016/j.atmosenv.2004.07.006; Chen YS, 2005, J TOXICOL ENV HEAL A, V68, P1457, DOI 10.1080/15287390590967388; Chen YS, 2004, ENVIRON RES, V95, P151, DOI 10.1016/j.envres.2003.08.008; Cheng MT, 2005, CHEMOSPHERE, V61, P1439, DOI 10.1016/j.chemosphere.2005.04.120; Chien LC, 2012, ENV HLTH PE IN PRESS; Chiu HF, 2008, INHAL TOXICOL, V20, P777, DOI 10.1080/08958370802005308 ; Choi JC, 2001, J GEOPHYS RES-ATMOS, V106, P18067, DOI 10.1029/2001JD900090; Chou CCK, 2004, TERR ATMOS OCEAN SCI, V15, P881, DOI 10.3319/TAO.2004.15.5.881(ADSE); Dominici F, 2003, ENVIRON HEALTH PERSP, V111, P39, DOI 10.1289/ehp.5181; Dominici F, 2002, J AM STAT ASSOC, V97, P100, DOI 10.1198/016214502753479266; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Fromont A, 2010, BRAIN, V133, P1889, DOI 10.1093/brain/awq134; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; He M, 2012, TOXICOL APPL PHARM, V258, P237, DOI 10.1016/j.taap.2011.11.003; He M, 2010, INHAL TOXICOL, V22, P1012, DOI 10.3109/08958378.2010.510151; Hong YC, 2010, SCI TOTAL ENVIRON, V408, P754, DOI 10.1016/j.scitotenv.2009.11.015; Hsu RN, 2003, THESIS FOOYIN U KAOH; Hsu SC, 2004, TERR ATMOS OCEAN SCI, V15, P925, DOI 10.3319/TAO.2004.15.5.925(ADSE); Ichinose T, 2008, ARCH ENVIRON CON TOX, V55, P348, DOI 10.1007/s00244-007-9128-8; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI [10.1080/08958370801935133, 10.1080/08958370801935133 ]; Janssens HM, 2003, CHEST, V123, P2083, DOI 10.1378/chest.123.6.2083; Kindermann R., 1980, MARKOV RANDOM FIELDS, DOI [10.1090/conm/001, DOI 10.1090/CONM/001]; Kishikawa RT, 2012, J ALLERGY CLIN IMMUN, V129, pAB59, DOI 10.1016/j.jaci.2011.12.717; Lee EC, 2008, EPIDEMIOLOGY, V19, pS145; Ma CJ, 2001, ATMOS ENVIRON, V35, P2707, DOI 10.1016/S1352-2310(00)00410-6; Meng ZQ, 2007, ATMOS ENVIRON, V41, P7048, DOI 10.1016/j.atmosenv.2007.05.006; Middleton N, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-39; Nee JB, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008476; SAS, 2009, SAS ONLINEDOC; Schwartz J, 2004, PEDIATRICS, V113, P1037; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; TWEPA, 2011, AS DUST STORM MON NE; Xuan Jie, 1999, Atmospheric Environment, V33, P1767, DOI 10.1016/S1352-2310(98)00339-2; Yanagisawa R, 2007, EXP BIOL MED, V232, P1109, DOI 10.3181/0612-RM-311; Yang CY, 2009, J TOXICOL ENV HEAL A, V72, P324, DOI 10.1080/15287390802529880; Yang CY, 2005, ENVIRON RES, V99, P79, DOI 10.1016/j.envres.2004.12.009; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Yu HL, 2010, ATMOS ENVIRON, V44, P3053, DOI 10.1016/j.atmosenv.2010.04.030; Yu HL, 2009, ENVIRON HEALTH PERSP, V117, P537, DOI 10.1289/ehp.0800089; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Zhou M, 1996, ATMOS RES, V40, P19, DOI 10.1016/0169-8095(95)00023-2	54	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41317	10.1371/journal.pone.0041317	http://dx.doi.org/10.1371/journal.pone.0041317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848461	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200055
J	Zakikhany, K; Allen, DJ; Brown, D; Iturriza-Gomara, M				Zakikhany, Katherina; Allen, David J.; Brown, David; Iturriza-Gomara, Miren			Molecular Evolution of GII-4 Norovirus Strains	PLOS ONE			English	Article							GASTROENTERITIS OUTBREAKS; HOST SUSCEPTIBILITY; NORWALK VIRUS; VARIANT; INFECTION; DISEASE	Background: Human Noroviruses (NoV) are the major cause of acute nonbacterial gastroenteritis and the leading cause of outbreaks of gastroenteritis worldwide. Genotype II-4 (GII-4) NoV has been shown to spread rapidly and is the most commonly detected strain worldwide, particularly in association with outbreaks. Previously, we have shown that circulating GII-4 NoV strains exist as populations of selectively neutral variants, and that the emergence of epidemic GII-4 NoV strains correlated with mutations in at least two key sites (Sites A and B) within the P2 domain of the surface exposed major capsid protein (VP1). Methodology: We developed a rapid pyrosequencing method for screening of the two Sites A and B and a homology based modelling system was used to predict the effects of amino acid substitutions at these sites on the antigenic properties of the virus (defined as surface motif types). Principle Finding/Conclusion: Here, we describe the characterisation of amino acid diversity at Sites A and B for 1062 GII-4 NoV strains from clinical specimen associated with outbreak of gastroenteritis (2000-2011) and 250 GII-4 NoV sequences from Genbank. Our data identified a high diversity of different Site A and B site combinations at amino acid level and amino acid diversity was higher at Site B than Site A. Site A motifs could be grouped into 3 clusters based on similar surface motif types. We predict that Site A is a major epitope on the virus surface, responsible for defining the antigenic profile, and a more subtle role for Site B, maintaining minor antigenic variation within the virus population.	[Zakikhany, Katherina; Allen, David J.; Brown, David; Iturriza-Gomara, Miren] Hlth Protect Agcy Microbiol Serv, Virus Reference Dept, London, England; [Zakikhany, Katherina] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden	European Centre for Disease Prevention & Control	Allen, DJ (corresponding author), Hlth Protect Agcy Microbiol Serv, Virus Reference Dept, London, England.	david.james.allen@hpa.org.uk	Gomara, Miren Iturriza/B-4351-2013	Gomara, Miren Iturriza/0000-0001-5816-6423; Allen, David/0000-0002-1194-0415				Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Allen DJ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-150; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; JOHNSON PC, 1990, J INFECT DIS, V161, P18, DOI 10.1093/infdis/161.1.18; KOOPMAN JS, 1982, AM J EPIDEMIOL, V115, P173, DOI 10.1093/oxfordjournals.aje.a113288; Kroneman A, 2004, EUROSURVEILLANCE, V8; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Matsui SM, 2000, J INFECT DIS, V181, pS331, DOI 10.1086/315587; Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2008, J INFECT DIS, V198, P940, DOI 10.1086/589810; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Wingfield T, 2010, J CLIN VIROL, V49, P219, DOI 10.1016/j.jcv.2010.07.025; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	31	40	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41625	10.1371/journal.pone.0041625	http://dx.doi.org/10.1371/journal.pone.0041625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844506	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600035
J	Canale, CI; Huchard, E; Perret, M; Henry, PY				Canale, Cindy I.; Huchard, Elise; Perret, Martine; Henry, Pierre-Yves			Reproductive Resilience to Food Shortage in a Small Heterothermic Primate	PLOS ONE			English	Article							LEMURS MICROCEBUS-MURINUS; LESSER MOUSE LEMUR; LONG-EARED BATS; CLIMATE-CHANGE; SOLITARY PRIMATE; METABOLIC-RATE; TORPOR USE; ENERGY ALLOCATION; MATE CHOICE; GUINEA-PIG	The massive energetic costs entailed by reproduction in most mammalian females may increase the vulnerability of reproductive success to food shortage. Unexpected events of unfavorable climatic conditions are expected to rise in frequency and intensity as climate changes. The extent to which physiological flexibility allows organisms to maintain reproductive output constant despite energetic bottlenecks has been poorly investigated. In mammals, reproductive resilience is predicted to be maximal during early stages of reproduction, due to the moderate energetic costs of ovulation and gestation relative to lactation. We experimentally tested the consequences of chronic-moderate and short-acute food shortages on the reproductive output of a small seasonally breeding primate, the grey mouse lemur (Microcebus murinus) under thermo-neutral conditions. These two food treatments were respectively designed to simulate the energetic constraints imposed by a lean year (40% caloric restriction over eight months) or by a sudden, severe climatic event occurring shortly before reproduction (80% caloric restriction over a month). Grey mouse lemurs evolved under the harsh, unpredictable climate of the dry forest of Madagascar and should thus display great potential for physiological adjustments to energetic bottlenecks. We assessed the resilience of the early stages of reproduction (mating success, fertility, and gestation) to these contrasted food treatments, and on the later stages (lactation and offspring growth) in response to the chronic food shortage only. Food deprived mouse lemurs managed to maintain constant most reproductive parameters, including oestrus timing, estrogenization level at oestrus, mating success, litter size, and litter mass as well as their overall number of surviving offspring at weaning. However, offspring growth was delayed in food restricted mothers. These results suggest that heterothermic, fattening-prone mammals display important reproductive resilience to energetic bottlenecks. More generally, species living in variable and unpredictable habitats may have evolved a flexible reproductive physiology that helps buffer environmental fluctuations.	[Canale, Cindy I.; Perret, Martine; Henry, Pierre-Yves] Museum Natl Hist Nat, Dept Ecol & Gest Biodivers, UMR CNRS MNHN 7179, Brunoy, France; [Huchard, Elise] German Primate Ctr GmbH DPZ, Behav Ecol & Sociobiol Unit, Gottingen, Germany; [Huchard, Elise] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Deutsches Primatenzentrum (DPZ); University of Gottingen	Canale, CI (corresponding author), Museum Natl Hist Nat, Dept Ecol & Gest Biodivers, UMR CNRS MNHN 7179, Brunoy, France.	henry@mnhn.fr	Huchard, Elise/G-9072-2011; Henry, Pierre-Yves/G-3139-2013	Huchard, Elise/0000-0002-6944-449X; Henry, Pierre-Yves/0000-0003-2255-7347	UMR [7179]; Diversite du Vivant [ED392]; Universite Pierre et Marie Curie; Deutsches Forschungsgemeinschaft (DFG) [HU 1820/1-1]	UMR; Diversite du Vivant; Universite Pierre et Marie Curie; Deutsches Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was funded by UMR 7179 and a fellowship from ED392 (Diversite du Vivant), Universite Pierre et Marie Curie, to CIC. EH was funded by a Deutsches Forschungsgemeinschaft (DFG) research grant (number HU 1820/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASSEN HP, 1990, OIKOS, V59, P107, DOI 10.2307/3545129; Andres M, 2003, FOLIA PRIMATOL, V74, P355, DOI 10.1159/000073319; AUDET D, 1988, PHYSIOL ZOOL, V61, P197, DOI 10.1086/physzool.61.3.30161232; Aujard F, 1998, J COMP PHYSIOL B, V168, P540, DOI 10.1007/s003600050175; Bauer B, 2009, GEN COMP ENDOCR, V161, P384, DOI 10.1016/j.ygcen.2009.02.003; Bazhan NM, 1996, J MAMMAL, V77, P1078, DOI 10.2307/1382788; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; BRONSON FH, 1988, AM J PHYSIOL, V254, pR616, DOI 10.1152/ajpregu.1988.254.4.R616; Canale CI, 2010, THESIS U P M CURIE P; Canale CI, 2012, NATURWISSENSCHAFTEN, V99, P159, DOI 10.1007/s00114-011-0872-2; Canale CI, 2011, FUNCT ECOL, V25, P557, DOI 10.1111/j.1365-2435.2010.01815.x; Canale CI, 2011, J EXP BIOL, V214, P551, DOI 10.1242/jeb.046987; Canale CI, 2010, CLIM RES, V43, P135, DOI 10.3354/cr00897; Carey C, 2009, PHILOS T R SOC B, V364, P3321, DOI 10.1098/rstb.2009.0182; Carney EW, 2004, TOXICOL SCI, V82, P237, DOI 10.1093/toxsci/kfh249; CLUTTONBROCK TH, 1989, NATURE, V337, P260, DOI 10.1038/337260a0; Coppack T, 2004, ADV ECOL RES, V35, P131, DOI 10.1016/S0065-2504(04)35007-5; Criscuolo F, 2008, P ROY SOC B-BIOL SCI, V275, P1565, DOI 10.1098/rspb.2008.0148; Dammhahn M, 2008, INT J PRIMATOL, V29, P1567, DOI 10.1007/s10764-008-9312-3; Daniel S, 2010, PHYSIOL BIOCHEM ZOOL, V83, P142, DOI 10.1086/647926; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; DRENT RH, 1980, ARDEA, V68, P225; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Duverge PL, 2000, ECOGRAPHY, V23, P32, DOI 10.1034/j.1600-0587.2000.230104.x; Eberle M, 2004, BEHAV ECOL SOCIOBIOL, V57, P77, DOI 10.1007/s00265-004-0826-1; Eberle M, 2006, BEHAV ECOL SOCIOBIOL, V60, P582, DOI 10.1007/s00265-006-0203-3; Elwood Robert, 1992, P299; Fietz J, 2009, J COMP PHYSIOL B, V179, P829, DOI 10.1007/s00360-009-0364-2; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Geiser F, 2008, COMP BIOCHEM PHYS A, V150, P176, DOI 10.1016/j.cbpa.2007.02.041; Geiser Fritz, 1996, P81; Genin F, 2000, PHYSIOL BEHAV, V71, P315, DOI 10.1016/S0031-9384(00)00335-8; Genin F, 2003, COMP BIOCHEM PHYS B, V136, P71, DOI 10.1016/S1096-4959(03)00172-6; Gill CJ, 1997, PHYSIOL BEHAV, V61, P387, DOI 10.1016/S0031-9384(96)00449-0; Giroud S, 2008, AM J PHYSIOL-REG I, V294, pR1958, DOI 10.1152/ajpregu.00794.2007; Giroud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008823; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Gomez D, 2012, AM J PHYS ANTHROPOL, V147, P370, DOI 10.1002/ajpa.21653; HAMILTON GD, 1985, BIOL REPROD, V32, P773, DOI 10.1095/biolreprod32.4.773; HAMMOND KA, 1992, PHYSIOL ZOOL, V65, P952, DOI 10.1086/physzool.65.5.30158552; HELDMAIER G, 1992, J COMP PHYSIOL B, V162, P696, DOI 10.1007/BF00301619; Hoying KM, 1998, J ZOOL, V245, P15, DOI 10.1111/j.1469-7998.1998.tb00067.x; Huchard E, 2012, P ROY SOC B-BIOL SCI, V279, P1371, DOI 10.1098/rspb.2011.1326; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Ingram JC, 2005, PHILOS T R SOC A, V363, P55, DOI 10.1098/rsta.2004.1476; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Kappeler PM, 2012, MOL ECOL, V21, P685, DOI 10.1111/j.1365-294X.2011.05255.x; Kauffman AS, 2010, PHYSIOL BEHAV, V99, P100, DOI 10.1016/j.physbeh.2009.10.017; Kenagy G.J., 1987, Symposia of the Zoological Society of London, P259; Kraus C, 2008, P ROY SOC B-BIOL SCI, V275, P1635, DOI 10.1098/rspb.2008.0200; Kunkele J, 2000, J ZOOL, V250, P533, DOI 10.1017/S095283690000409X; Lahann P, 2006, INT J PRIMATOL, V27, P983, DOI 10.1007/s10764-006-9055-y; Laurien-Kehnen C, 2004, ANIM BEHAV, V68, P303, DOI 10.1016/j.anbehav.2003.11.012; Liang H, 2006, PHYSIOL BEHAV, V87, P607, DOI 10.1016/j.physbeh.2005.12.006; Loudon ASI, 1987, REPROD ENERGETICS MA; Maestripieri D., 2011, MATERNAL EFFECTS MAM; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; Moreno J, 2011, CURR ZOOL, V57, P375, DOI 10.1093/czoolo/57.3.375; Munn AJ, 2010, NATURWISSENSCHAFTEN, V97, P601, DOI 10.1007/s00114-010-0670-2; Pearce-Higgins JW, 2010, GLOBAL CHANGE BIOL, V16, P12, DOI 10.1111/j.1365-2486.2009.01883.x; Perret M, 2001, INT J PRIMATOL, V22, P5, DOI 10.1023/A:1026457813626; PERRET M, 1992, FOLIA PRIMATOL, V59, P1; Perret M, 1997, APPL ANIM BEHAV SCI, V51, P275, DOI 10.1016/S0168-1591(96)01110-0; Perret M, 1998, J MAMMAL, V79, P1093, DOI 10.2307/1383001; Perret Martine, 2000, Primatologie, V3, P45; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2018, R LANG ENV STAT COMP; Racey P.A., 1987, Symposia of the Zoological Society of London, P107; RACEY PA, 1981, J REPROD FERTIL, V61, P123; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; Rogowitz GL, 1996, AM ZOOL, V36, P197; Saether BE, 2004, AM NAT, V164, P793, DOI 10.1086/425371; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schmid J, 1999, J MAMMAL, V80, P749, DOI 10.2307/1383244; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stearns S.C., 1992, pi; Temple JL, 2002, AM J PHYSIOL-REG I, V282, pR782, DOI 10.1152/ajpregu.00383.2001; Thompson Steven D., 1992, P213; Turbill C, 2006, J COMP PHYSIOL B, V176, P165, DOI 10.1007/s00360-005-0038-7; Valencak TG, 2009, J EXP BIOL, V212, P231, DOI 10.1242/jeb.022640; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; WADE GN, 1992, NEUROSCI BIOBEHAV R, V16, P235, DOI 10.1016/S0149-7634(05)80183-6; Wade GN, 1996, AM J PHYSIOL-ENDOC M, V270, pE1, DOI 10.1152/ajpendo.1996.270.1.E1; Westman W, 2002, J MAMMAL, V83, P81, DOI 10.1644/1545-1542(2002)083<0081:DTOTDM>2.0.CO;2; Wilde CJ, 1999, J EXP ZOOL, V284, P35, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;35::AID-JEZ6&gt;3.0.CO;2-Z; Williams G. C., 1966, P307; Wingfield JC, 2011, CURR ZOOL, V57, P363, DOI 10.1093/czoolo/57.3.363; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Zenuto RR, 2002, PHYSIOL BIOCHEM ZOOL, V75, P469, DOI 10.1086/344739; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844; Zuur Alain F., 2009, P1	96	15	16	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41477	10.1371/journal.pone.0041477	http://dx.doi.org/10.1371/journal.pone.0041477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848507	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000306806600072
J	Nawaz, S; Allen, DJ; Aladin, F; Gallimore, C; Iturriza-Gomara, M				Nawaz, Sameena; Allen, David J.; Aladin, Farah; Gallimore, Christopher; Iturriza-Gomara, Miren			Human Bocaviruses Are Not Significantly Associated with Gastroenteritis: Results of Retesting Archive DNA from a Case Control Study in the UK	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; INTESTINAL DISEASE; EPIDEMIOLOGIC PROFILE; FREQUENT DETECTION; FECAL SAMPLES; CHILDREN; PARVOVIRUS; PREVALENCE; ROTAVIRUS; PATHOGENS	Gastroenteritis is a common illness causing considerable morbidity and mortality worldwide. Despite improvements in detection methods, a significant diagnostic gap still remains. Human bocavirus (HBoV)s, which are associated with respiratory infections, have also frequently been detected in stool samples in cases of gastroenteritis, and a tentative association between HBoVs, and in particular type-2 HBoVs, and gastroenteritis has previously been made. The aim of this study was to determine the role of HBoVs in gastroenteritis, using archived DNA samples from the case-control Infectious Intestinal Disease Study (IID). DNA extracted from stool samples from 2,256 cases and 2,124 controls were tested for the presence of HBoV DNA. All samples were screened in a real time PCR pan-HBoV assay, and positive samples were then tested in genotype 1 to 3-specific assays. HBoV was detected in 7.4% but no significantly different prevalence was observed between cases and controls. In the genotype-specific assays 106 of the 324 HBoV-positive samples were genotyped, with HBoV-1 predominantly found in controls whilst HBoV-2 was more frequently associated with cases of gastroenteritis (p < 0.01). A significant proportion of HBoV positives could not be typed using the type specific assays, 67% of the total positives, and this was most likely due to low viral loads being present in the samples. However, the distribution of the untyped HBoV strains was no different between cases and controls. In conclusion, HBoVs, including HBoV-2 do not appear to be a significant cause of gastroenteritis in the UK population.	[Nawaz, Sameena; Allen, David J.; Aladin, Farah; Gallimore, Christopher; Iturriza-Gomara, Miren] Hlth Protect Agcy, Virus Reference Dept, London, England	Health Protection Agency	Nawaz, S (corresponding author), Hlth Protect Agcy, Virus Reference Dept, London, England.	M.Iturriza-Gomara@liverpool.ac.uk	Gomara, Miren Iturriza/B-4351-2013	Gomara, Miren Iturriza/0000-0001-5816-6423; Allen, David/0000-0002-1194-0415				Agency FS, 2000, REP STUD INF INT DIS; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Amar CFL, 2005, DIAGN MOL PATHOL, V14, P90, DOI 10.1097/01.pas.0000162752.61155.d1; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arnold JC, 2006, CLIN INFECT DIS, V43, P283, DOI 10.1086/505399; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; Brieu N, 2008, PEDIATR INFECT DIS J, V27, P969, DOI 10.1097/INF.0b013e31817acfaa; CARMICHAEL LE, 1994, J VET DIAGN INVEST, V6, P165, DOI 10.1177/104063879400600206; Carnpanini G, 2007, J CLIN VIROL, V39, P119, DOI 10.1016/j.jcv.2007.03.009; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chieochansin T, 2007, VIRUS RES, V129, P54, DOI 10.1016/j.virusres.2007.04.022; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; DURHAM PJK, 1985, RES VET SCI, V38, P234, DOI 10.1016/S0034-5288(18)31832-0; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Han TH, 2009, ARCH VIROL, V154, P1923, DOI 10.1007/s00705-009-0533-3; Han TH, 2009, EMERG INFECT DIS, V15, P1698, DOI 10.3201/eid1510.090337; Jacques J, 2008, J CLIN VIROL, V43, P142, DOI 10.1016/j.jcv.2008.05.010; Jin Y, 2011, J CLIN VIROL, V52, P251, DOI 10.1016/j.jcv.2011.07.012; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kang G, 2004, J MED VIROL, V73, P118, DOI 10.1002/jmv.20053; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Naghipour M, 2007, J MED VIROL, V79, P539, DOI 10.1002/jmv.20815; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Phillips G, 2009, J CLIN VIROL, V44, P242, DOI 10.1016/j.jcv.2008.12.001; Qu XW, 2007, EMERG INFECT DIS, V13, P165; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Smuts H, 2006, EMERG INFECT DIS, V12, P1457, DOI 10.3201/eid1209.051616; Tompkins D S, 1999, Commun Dis Public Health, V2, P108; Weissbrich B, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-109	38	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41346	10.1371/journal.pone.0041346	http://dx.doi.org/10.1371/journal.pone.0041346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848470	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000306751300032
J	Wang, YY; Sacchetti, A; van Dijk, MR; van der Zee, M; van der Horst, PH; Joosten, R; Burger, CW; Grootegoed, JA; Blok, LJ; Fodde, R				Wang, Yongyi; Sacchetti, Andrea; van Dijk, Matthijs R.; van der Zee, Marten; van der Horst, Paul H.; Joosten, Rosalie; Burger, Curt W.; Grootegoed, J. Anton; Blok, Leen J.; Fodde, Riccardo			Identification of Quiescent, Stem-Like Cells in the Distal Female Reproductive Tract	PLOS ONE			English	Article							FALLOPIAN-TUBE; EXPRESSION; ORIGIN; POPULATIONS; CARCINOMA; REVEALS; MARKER; SYSTEM	In fertile women, the endometrium undergoes regular cycles of tissue build-up and regression. It is likely that uterine stem cells are involved in this remarkable turn over. The main goal of our current investigations was to identify slow-cycling (quiescent) endometrial stem cells by means of a pulse-chase approach to selectively earmark, prospectively isolate, and characterize label-retaining cells (LRCs). To this aim, transgenic mice expressing histone2B-GFP (H2B-GFP) in a Tet-inducible fashion were administered doxycycline (pulse) which was thereafter withdrawn from the drinking water (chase). Over time, dividing cells progressively loose GFP signal whereas infrequently dividing cells retain H2B-GFP expression. We evaluated H2B-GFP retaining cells at different chase time points and identified long-term (LT; >12weeks) LRCs. The LT-LRCs are negative for estrogen receptor-alpha and express low levels of progesterone receptors. LRCs sorted by FACS are able to form spheroids capable of self-renewal and differentiation. Upon serum stimulation spheroid cells are induced to differentiate and form glandular structures which express markers of mature Mullerian epithelial cells. Overall, the results indicate that quiescent cells located in the distal oviduct have stem-like properties and can differentiate into distinct cell lineages specific of endometrium, proximal and distal oviduct. Future lineage-tracing studies will elucidate the role played by these cells in homeostasis, tissue injury and cancer of the female reproductive tract in the mouse and eventually in man.	[Wang, Yongyi; van Dijk, Matthijs R.; van der Zee, Marten; van der Horst, Paul H.; Burger, Curt W.; Blok, Leen J.] Erasmus MC, Josephine Nefkens Inst, Dept Obstet & Gynecol, Rotterdam, Netherlands; [Wang, Yongyi; Sacchetti, Andrea; Joosten, Rosalie; Fodde, Riccardo] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [Grootegoed, J. Anton] Erasmus MC, Dept Reprod & Dev, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wang, YY (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Obstet & Gynecol, Rotterdam, Netherlands.	l.blok@erasmusmc.nl; r.fodde@erasmusmc.nl	Sacchetti, Andrea/H-8763-2019; Fodde, Riccardo/AAW-9394-2021	Fodde, Riccardo/0000-0001-9839-4324				Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Halttunen M, 2000, BBA-PROTEIN STRUCT M, V1482, P149, DOI 10.1016/S0167-4838(00)00158-8; Hirst JE, 2009, INT J GYNECOL CANCER, V19, P826, DOI 10.1111/IGC.0b013e3181a1b5dc; JACOBS I, 1989, HUM REPROD, V4, P1; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Katsantoni EZ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-108; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Okada Akinobu, 2005, Journal of Toxicological Sciences, V30, P75, DOI 10.2131/jts.30.75; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; Rabban JT, 2009, AM J SURG PATHOL, V33, P111, DOI 10.1097/PAS.0b013e31817d74a7; Schulz MM, 2010, J FORENSIC SCI, V55, P492, DOI 10.1111/j.1556-4029.2009.01071.x; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Tong GX, 2007, MODERN PATHOL, V20, P856, DOI 10.1038/modpathol.3800827; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	39	49	51	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40691	10.1371/journal.pone.0040691	http://dx.doi.org/10.1371/journal.pone.0040691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848396	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300010
J	Bender, S; Rellum, T; Freitag, C; Resch, F; Rietschel, M; Treutlein, J; Jennen-Steinmetz, C; Brandeis, D; Banaschewski, T; Laucht, M				Bender, Stephan; Rellum, Thomas; Freitag, Christine; Resch, Franz; Rietschel, Marcella; Treutlein, Jens; Jennen-Steinmetz, Christine; Brandeis, Daniel; Banaschewski, Tobias; Laucht, Manfred			Time-Resolved Influences of Functional DAT1 and COMT Variants on Visual Perception and Post-Processing	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; DOPAMINE TRANSPORTER GENE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CATECHOL-O-METHYLTRANSFERASE; NUCLEUS RETICULARIS THALAMI; SLOW CORTICAL POTENTIALS; WORKING-MEMORY; PREFRONTAL CORTEX; MOTOR PREPARATION; TERM-MEMORY	Background: Dopamine plays an important role in orienting and the regulation of selective attention to relevant stimulus characteristics. Thus, we examined the influences of functional variants related to dopamine inactivation in the dopamine transporter (DAT1) and catechol-O-methyltransferase genes (COMT) on the time-course of visual processing in a contingent negative variation (CNV) task. Methods: 64-channel EEG recordings were obtained from 195 healthy adolescents of a community-based sample during a continuous performance task (A-X version). Early and late CNV as well as preceding visual evoked potential components were assessed. Results: Significant additive main effects of DAT1 and COMT on the occipito-temporal early CNV were observed. In addition, there was a trend towards an interaction between the two polymorphisms. Source analysis showed early CNV generators in the ventral visual stream and in frontal regions. There was a strong negative correlation between occipito-temporal visual post-processing and the frontal early CNV component. The early CNV time interval 500-1000 ms after the visual cue was specifically affected while the preceding visual perception stages were not influenced. Conclusions: Late visual potentials allow the genomic imaging of dopamine inactivation effects on visual post-processing. The same specific time-interval has been found to be affected by DAT1 and COMT during motor post-processing but not motor preparation. We propose the hypothesis that similar dopaminergic mechanisms modulate working memory encoding in both the visual and motor and perhaps other systems.	[Bender, Stephan] Tech Univ Dresden, Child & Adolescent Psychiat Dept, Sect Clin Neurophysiol & Multimodal Neuroimaging, D-01062 Dresden, Germany; [Bender, Stephan; Freitag, Christine] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Bender, Stephan; Resch, Franz] Univ Heidelberg Hosp, Dept Child & Adolescent Psychiat & Psychotherapy, Heidelberg, Germany; [Rellum, Thomas; Brandeis, Daniel; Banaschewski, Tobias; Laucht, Manfred] Univ Heidelberg, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Heidelbert, Germany; [Rietschel, Marcella; Treutlein, Jens] Univ Heidelberg, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Heidelberg, Germany; [Jennen-Steinmetz, Christine] Univ Heidelberg, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Biostat, Heidelberg, Germany; [Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Laucht, Manfred] Univ Potsdam, Div Clin Psychol, Dept Psychol, Potsdam, Germany	Technische Universitat Dresden; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Potsdam	Bender, S (corresponding author), Tech Univ Dresden, Child & Adolescent Psychiat Dept, Sect Clin Neurophysiol & Multimodal Neuroimaging, D-01062 Dresden, Germany.	Stephan.Bender@uniklinik-dresden.de	Bender, Stephan/AAT-1266-2021; Banaschewski, Tobias/ABE-5985-2020	Banaschewski, Tobias/0000-0003-4595-1144; Freitag, Christine Margarete/0000-0001-9676-4782	Deutsche Forschungsgemeinschaft (DFG); Ministry of Science and Investigation, Baden-Wurttemberg, Germany; Medical Faculty of the Goethe University, Frankfurt, Germany [7601002]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Science and Investigation, Baden-Wurttemberg, Germany; Medical Faculty of the Goethe University, Frankfurt, Germany	This study was supported by multiple grants from the Deutsche Forschungsgemeinschaft (DFG), the Ministry of Science and Investigation, Baden-Wurttemberg, Germany, and a grant by the Medical Faculty of the Goethe University, Frankfurt, Germany (7601002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; Bender S, 2008, CLIN NEUROPHYSIOL, V119, P587, DOI 10.1016/j.clinph.2007.11.008; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; Bender S, 2004, COGNITIVE BRAIN RES, V21, P49, DOI 10.1016/j.cogbrainres.2004.05.004; Bender S, 2004, CLIN NEUROPHYSIOL, V115, P1836, DOI 10.1016/j.clinph.2004.03.023; Bender S, PLOS ONE IN PRESS; Bender S, 2007, NEUROIMAGE, V38, P367, DOI 10.1016/j.neuroimage.2007.07.044; Bender S, 2007, PAIN, V127, P221, DOI 10.1016/j.pain.2006.08.017; Bender S, 2006, NEUROIMAGE, V32, P333, DOI 10.1016/j.neuroimage.2006.03.009; Bender S, 2010, CLIN NEUROPHYSIOL, V121, P2044, DOI 10.1016/j.clinph.2010.05.008; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Brandeis D, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00018; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; BRUNIA CHM, 1993, PSYCHOPHYSIOLOGY, V30, P327, DOI 10.1111/j.1469-8986.1993.tb02054.x; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Durston S, 2008, J AM ACAD CHILD PSY, V47, P61, DOI 10.1097/chi.0b013e31815a5f17; Franke B, 2008, AM J MED GENET B, V147B, P1576, DOI 10.1002/ajmg.b.30861; Franke B, 2010, NEUROPSYCHOPHARMACOL, V35, P656, DOI 10.1038/npp.2009.170; GAILLARD AWK, 1976, BIOL PSYCHOL, V4, P139, DOI 10.1016/0301-0511(76)90013-2; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; Hahn T, 2011, HUM BRAIN MAPP, V32, P1557, DOI 10.1002/hbm.21127; Hellwig S, 2008, INT J PSYCHOPHYSIOL, V69, P41, DOI 10.1016/j.ijpsycho.2008.02.011; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Koychev I, 2010, NEUROPSYCHOLOGIA, V48, P2205, DOI 10.1016/j.neuropsychologia.2010.04.014; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Laucht M, 1997, J CHILD PSYCHOL PSYC, V38, P843, DOI 10.1111/j.1469-7610.1997.tb01602.x; Laucht M, 2007, ARCH GEN PSYCHIAT, V64, P585, DOI 10.1001/archpsyc.64.5.585; Linssen AMW, 2011, PSYCHOPHARMACOLOGY, V218, P533, DOI 10.1007/s00213-011-2345-x; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Luthringer R, 1999, NEUROPSYCHOBIOLOGY, V39, P49, DOI 10.1159/000026560; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Mishra J, 2012, NEUROIMAGE, V59, P1968, DOI 10.1016/j.neuroimage.2011.09.028; NIGHTINGALE S, 1986, J NEUROL NEUROSUR PS, V49, P1280, DOI 10.1136/jnnp.49.11.1280; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owesson-White CA, 2012, J NEUROCHEM, V121, P252, DOI 10.1111/j.1471-4159.2012.07677.x; Rockstroh B., 1989, SLOW CORTICAL POTENT; ROHRBAUGH JW, 1980, SCIENCE, V208, P1165, DOI 10.1126/science.7375925; Ruchkin DS, 1997, COGNITIVE BRAIN RES, V6, P95, DOI 10.1016/S0926-6410(97)00021-9; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; SANO A, 1993, HUM GENET, V91, P405; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack S R, 1998, Adv Pharmacol, V42, P171; Shumay E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022754; Singhal A, 2006, INT J NEUROSCI, V116, P1457, DOI 10.1080/00207450500514342; Siniatchkin M, 2000, CEPHALALGIA, V20, P881, DOI 10.1046/j.1468-2982.2000.00132.x; SKINNER JE, 1976, ELECTROEN CLIN NEURO, V40, P288, DOI 10.1016/0013-4694(76)90152-8; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; SQUIRES K C, 1977, Electroencephalography and Clinical Neurophysiology, V42, P1, DOI 10.1016/0013-4694(77)90146-8; van Leeuwen TH, 1998, BEHAV BRAIN RES, V94, P97, DOI 10.1016/S0166-4328(97)00173-3; Vandenbergh DJ, 2000, MOL PSYCHIATR, V5, P283, DOI 10.1038/sj.mp.4000701; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; YINGLING CD, 1976, ELECTROEN CLIN NEURO, V41, P476, DOI 10.1016/0013-4694(76)90059-6	55	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41552	10.1371/journal.pone.0041552	http://dx.doi.org/10.1371/journal.pone.0041552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844499	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000306687700110
J	Chu, CL; Yu, YL; Kung, YC; Liao, PY; Liu, KJ; Tseng, YT; Lin, YC; Hsieh, SSY; Chong, PCS; Yang, CY				Chu, Ching-Liang; Yu, Yen-Ling; Kung, Yueh-Chen; Liao, Pei-Yu; Liu, Ko-Jiunn; Tseng, Yen-Tzu; Lin, Yuan-Chuen; Hsieh, Steve Shih-Yang; Chong, Pele Choi-Sing; Yang, Chiou-Ying			The Immunomodulatory Activity of Meningococcal Lipoprotein Ag473 Depends on the Conformation Made up of the Lipid and Protein Moieties	PLOS ONE			English	Article							DENDRITIC CELL ACTIVATION; TOLL-LIKE RECEPTORS; NEISSERIA-MENINGITIDIS; IMMUNE-RESPONSE; PATTERN-RECOGNITION; IN-VIVO; VACCINE; IDENTIFICATION; LIPOPEPTIDES; INDUCTION	We have previously demonstrated that the meningococcal antigen Ag473 in the presence of Freund's adjuvant can elicit protective immune responses in mouse challenge model. In this study, we evaluated the structural requirement for the immunological activity and the possible signaling pathway of recombinant Ag473 antigen produced in E. coli. We found that lipidated Ag473 (L-Ag473) possesses an intrinsic adjuvant activity that could be attributed to its ability to activate dendritic cells and promote their maturation. In addition, we found that L-Ag473 can activate human monocytes and promote maturation of human monocyte-derived dendritic cells. These results provide an indirect support that L-Ag473 may also be immunogenic in human. Interestingly, the observed activity is dependent on the overall conformation of L-Ag473 because heating and proteinase K treatment can diminish and abolish the activity. Furthermore, our data suggest a species-differential TLR recognition of L-Ag473. Overall, these data suggest a new paradigm for the ligand-TLR interaction in addition to demonstrating the self-adjuvanting activity of the vaccine candidate L-Ag473.	[Chu, Ching-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Yu, Yen-Ling; Kung, Yueh-Chen; Hsieh, Steve Shih-Yang; Chong, Pele Choi-Sing; Yang, Chiou-Ying] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Miaoli, Taiwan; [Liao, Pei-Yu; Tseng, Yen-Tzu; Lin, Yuan-Chuen; Yang, Chiou-Ying] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Liu, Ko-Jiunn] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Liu, Ko-Jiunn] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; National Chung Hsing University; National Health Research Institutes - Taiwan; Taipei Medical University	Chu, CL (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	cyyang@dragon.nchu.edu.tw	Chong, Pele/E-3855-2010; Liu, Ko-Jiunn/D-2098-2010	Chu, Ching-Liang/0000-0002-8463-526X; Yang, Chiou-Ying/0000-0001-7130-1781	National Health Research Institutes, Taiwan [NHRI-EX96-9613BI]; NTUCM [100R311001]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); NTUCM	This research was supported by grant NHRI-EX96-9613BI from National Health Research Institutes, Taiwan, to CYY, and grant 100R311001 of NTUCM to CLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Bobie J, 2003, VACCINE, V21, P605, DOI 10.1016/S0264-410X(02)00566-2; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Buckwalter MR, 2009, CURR BIOL, V19, pR355, DOI 10.1016/j.cub.2009.03.012; Cavaillon JM, 2011, LANCET INFECT DIS, V11, P426, DOI 10.1016/S1473-3099(11)70131-1; Chang GC, 2005, CANCER-AM CANCER SOC, V103, P763, DOI 10.1002/cncr.20843; Chen HW, 2009, VACCINE, V27, P1400, DOI 10.1016/j.vaccine.2008.12.043; Dietrich G, 2003, J BACTERIOL, V185, P155, DOI 10.1128/JB.185.1.155-164.2003; Duesberg U, 2002, IMMUNOL LETT, V84, P89, DOI 10.1016/S0165-2478(02)00178-5; Ganapamo F, 2003, EUR J IMMUNOL, V33, P1934, DOI 10.1002/eji.200323655; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hsu CA, 2008, PROTEOMICS, V8, P2115, DOI 10.1002/pmic.200700574; Huang RY, 2010, J IMMUNOL, V184, P6815, DOI 10.4049/jimmunol.0903991; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kimmel SR, 2005, AM FAM PHYSICIAN, V72, P2049; Kurz S, 2003, VACCINE, V21, P768, DOI 10.1016/S0264-410X(02)00596-0; Leng CH, 2010, MOL IMMUNOL, V47, P2015, DOI 10.1016/j.molimm.2010.04.012; Lin CC, 2011, CANCER IMMUNOL IMMUN, V60, P1019, DOI 10.1007/s00262-011-1016-4; Lin MK, 2011, IMMUNOBIOLOGY, V216, P1103, DOI 10.1016/j.imbio.2011.05.002; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Revets H, 2005, J IMMUNOL, V174, P1097, DOI 10.4049/jimmunol.174.2.1097; Schromm AB, 2007, J BIOL CHEM, V282, P11030, DOI 10.1074/jbc.M700287200; Sung JWC, 2010, VACCINE, V28, P8175, DOI 10.1016/j.vaccine.2010.09.091; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yang XL, 2008, MICROBES INFECT, V10, P1300, DOI 10.1016/j.micinf.2008.07.029; Yu YL, 2009, EUR J IMMUNOL, V39, P2482, DOI 10.1002/eji.200839039; Zhang HW, 1998, INFECT IMMUN, V66, P5196, DOI 10.1128/IAI.66.11.5196-5201.1998	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40873	10.1371/journal.pone.0040873	http://dx.doi.org/10.1371/journal.pone.0040873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844415	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700021
J	Donges, US; Kersting, A; Suslow, T				Donges, Uta-Susan; Kersting, Anette; Suslow, Thomas			Women's Greater Ability to Perceive Happy Facial Emotion Automatically: Gender Differences in Affective Priming	PLOS ONE			English	Article							SEX-DIFFERENCES; EXPRESSIONS; PERCEPTION; AWARENESS; EMPATHY; RECOGNITION; JUDGMENTS; ADULTS	There is evidence that women are better in recognizing their own and others' emotions. The female advantage in emotion recognition becomes even more apparent under conditions of rapid stimulus presentation. Affective priming paradigms have been developed to examine empirically whether facial emotion stimuli presented outside of conscious awareness color our impressions. It was observed that masked emotional facial expression has an affect congruent influence on subsequent judgments of neutral stimuli. The aim of the present study was to examine the effect of gender on affective priming based on negative and positive facial expression. In our priming experiment sad, happy, neutral, or no facial expression was briefly presented (for 33 ms) and masked by neutral faces which had to be evaluated. 81 young healthy volunteers (53 women) participated in the study. Subjects had no subjective awareness of emotional primes. Women did not differ from men with regard to age, education, intelligence, trait anxiety, or depressivity. In the whole sample, happy but not sad facial expression elicited valence congruent affective priming. Between-group analyses revealed that women manifested greater affective priming due to happy faces than men. Women seem to have a greater ability to perceive and respond to positive facial emotion at an automatic processing level compared to men. High perceptual sensitivity to minimal social-affective signals may contribute to women's advantage in understanding other persons' emotional states.	[Donges, Uta-Susan; Kersting, Anette; Suslow, Thomas] Univ Leipzig, Dept Psychosomat Med, Leipzig, Germany; [Suslow, Thomas] Univ Munster, Dept Psychiat, Munster, Germany	Leipzig University; University of Munster	Donges, US (corresponding author), Univ Leipzig, Dept Psychosomat Med, Leipzig, Germany.	uta-susan.donges@medizin.uni-leipzig.de		Suslow, Thomas/0000-0003-4560-0555				BARGH J A, 1989, P3; Bargh J.A., 1994, HDB SOCIAL COGNITION, P1; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barrett LF, 2000, PERS SOC PSYCHOL B, V26, P1027, DOI 10.1177/01461672002611001; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1996, MOTIV EMOTION, V20, P149, DOI 10.1007/BF02253869; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; DOHERTY RW, 1995, PSYCHOL WOMEN QUART, V19, P355, DOI 10.1111/j.1471-6402.1995.tb00080.x; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Ekman P., 1982, EMOTION HUMAN FACE; ERWIN RJ, 1992, PSYCHIAT RES, V42, P231, DOI 10.1016/0165-1781(92)90115-J; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Gohier B, 2013, EUR PSYCHIAT, V28, P74, DOI 10.1016/j.eurpsy.2011.06.007; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Hautzinger M., 1995, BECK DEPRESSIONS INV; Heberlein AS, 2007, SOC NEUROSCI-UK, P31; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; Lane RD, 1998, COMPR PSYCHIAT, V39, P377, DOI 10.1016/S0010-440X(98)90051-7; Laux L., 1981, STATE TRAIT ANGSTINV; Lazarus R. S, 1994, EMOTION ADAPTATION; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; MERIKLE PM, 1992, AM PSYCHOL, V47, P792, DOI 10.1037/0003-066X.47.6.792; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; MURPHY ST, 1995, J PERS SOC PSYCHOL, V69, P589, DOI 10.1037/0022-3514.69.4.589; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Niedenthal PM, 2002, J PERS SOC PSYCHOL, V82, P419, DOI 10.1037//0022-3514.82.3.419; NIEDENTHAL PM, 1990, J EXP SOC PSYCHOL, V26, P505, DOI 10.1016/0022-1031(90)90053-O; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Rotteveel M, 2001, EMOTION, V1, P348, DOI 10.1037//1528-3542.1.4.348; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Sweeny TD, 2009, CONSCIOUS COGN, V18, P929, DOI 10.1016/j.concog.2009.07.011; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Winkielman P, 1997, COGNITION EMOTION, V11, P433, DOI 10.1080/026999397379872; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	37	107	111	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41745	10.1371/journal.pone.0041745	http://dx.doi.org/10.1371/journal.pone.0041745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844519	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700146
J	Gonzalez-Castro, A; Yang, S; Nogales, M; Carlo, TA				Gonzalez-Castro, Aaron; Yang, Suann; Nogales, Manuel; Carlo, Tomas A.			What Determines the Temporal Changes of Species Degree and Strength in an Oceanic Island Plant-Disperser Network?	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; COEVOLUTIONARY NETWORKS; POLLINATION NETWORKS; FRUGIVOROUS BIRDS; DIGESTIVE-SYSTEM; ABUNDANCE; SPECIALIZATION; DYNAMICS; BIODIVERSITY; PREFERENCES	Network models of frugivory and seed dispersal are usually static. To date, most studies on mutualistic networks assert that interaction properties such as species' degree (k) and strength (s) are strongly influenced by species abundances. We evaluated how species' degree and strength change as a function of temporal variation not only in species abundance, but also in species persistence (i.e., phenology length). In a two-year study, we collected community-wide data on seed dispersal by birds and examined the seasonal dynamics of the above-mentioned interaction properties. Our analyses revealed that species abundance is an important predictor for plant strength within a given sub-network. However, our analyses also reveal that species' degree can often be best explained by the length of fruiting phenology (for plants degree) or by the number of fruiting species (for dispersers degree), which are factors that can be decoupled from the relative abundance of the species participating in the network. Moreover, our results suggest that generalist dispersers (when total study period is considered) act as temporal generalists, with degree constrained by the number of plant species displaying fruits in each span. Along with species identity, our findings underscore the need for a temporal perspective, given that seasonality is an inherent property of many mutualistic networks.	[Gonzalez-Castro, Aaron; Nogales, Manuel] CSIC, Inst Prod Nat & Agrobiol, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Canary Islands, Spain; [Yang, Suann; Carlo, Tomas A.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gonzalez-Castro, A (corresponding author), CSIC, Inst Prod Nat & Agrobiol, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Canary Islands, Spain.	aarongonzalezcastro@gmail.com	González-Castro, Aarón/K-3290-2016; Nogales, Manuel/I-9831-2014	González-Castro, Aarón/0000-0002-5311-1017; Nogales, Manuel/0000-0002-5327-3104; Yang, Suann/0000-0001-7985-3011; Carlo, Tomas/0000-0002-2092-0053	Spanish National Research Council; National Science Foundation; Spanish Ministry of Science and Education [CGL2007-61165/BOS, GGL2010-18759/BOS]; European Union; Biology Department; Eberly College of Science at Penn State University	Spanish National Research Council; National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Science and Education(Spanish Government); European Union(European Commission); Biology Department; Eberly College of Science at Penn State University	A. Gonzalez-Castro benefited from a JAE-PRE fellowship from the Spanish National Research Council (http://www.csic.es). S. Yang was funded by the National Science Foundation under a grant awarded in 2008 (http://www.nsf.gov). This work was financed by the Spanish Ministry of Science and Education project (CGL2007-61165/BOS) and is also framed within project GGL2010-18759/BOS, supported by Fondo Europeo de Desarrollo Regional funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are especially grateful to Benito Perez, Daniel Gonzalez, Yurena Gavilan, Leandro de Leon, Beatriz Rumeu, David Padilla and Juan Carlos Illera for their help during fieldwork. Jofre Carnicer, Ruben Heleno and two anonymous referees read an early draft of this manuscript, making useful comments and suggestions. The Biology Department and the Eberly College of Science at Penn State University provided support to T. A. Carlo, S. Yang, and A. Gonzalez-Castro during the Spring and Summer of 2011.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Bates D., 2011, IME4 LINEAR MIXED EF; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Carlo TA, 2003, OECOLOGIA, V134, P119, DOI 10.1007/s00442-002-1087-1; Carlo TA, 2011, ACTA OECOL, V37, P619, DOI 10.1016/j.actao.2011.08.001; Carnicer J, 2009, ECOLOGY, V90, P1958, DOI 10.1890/07-1939.1; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Gonzalez-Castro A, 2012, J BIOGEOGR, V39, P1938, DOI 10.1111/j.1365-2699.2012.02693.x; HERRERA CM, 1995, ANNU REV ECOL SYST, V26, P705, DOI 10.1146/annurev.es.26.110195.003421; HOWE HF, 1977, AM NAT, V111, P817, DOI 10.1086/283216; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano P., 1985, Ardeola, V32, P69; JORDANO P, 1987, IBIS, V129, P175, DOI 10.1111/j.1474-919X.1987.tb03199.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; KARASOV WH, 1990, PHYSIOL ZOOL, V63, P1248, DOI 10.1086/physzool.63.6.30152643; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; Martin A., 2001, AVES ARCHIPIELAGO CA; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; PINHEIRO J, 2009, R PACKAGE VERSION 3, P1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rezende EL, 2007, OIKOS, V116, P1919, DOI 10.1111/j.2007.0030-1299.16029.x; Mello MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017395; Schleuning M, 2011, ECOLOGY, V92, P26, DOI 10.1890/09-1842.1; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; TYRVAINEN H, 1975, Ornis Fennica, V52, P23; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; WILLSON MF, 1990, CONDOR, V92, P545, DOI 10.2307/1368671	41	26	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41385	10.1371/journal.pone.0041385	http://dx.doi.org/10.1371/journal.pone.0041385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844470	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700081
J	Volkmann, K; Pfander, C; Burstroem, C; Ahras, M; Goulding, D; Rayner, JC; Frischknecht, F; Billker, O; Brochet, M				Volkmann, Katrin; Pfander, Claudia; Burstroem, Charlotte; Ahras, Malika; Goulding, David; Rayner, Julian C.; Frischknecht, Friedrich; Billker, Oliver; Brochet, Mathieu			The Alveolin IMC1h Is Required for Normal Ookinete and Sporozoite Motility Behaviour and Host Colonisation in Plasmodium berghei	PLOS ONE			English	Article							MALARIA PARASITE; PROTEINS; FAMILY; TRANSMISSION; INFECTIVITY; MOSQUITO; LIVER; CYCLE	Alveolins, or inner membrane complex (IMC) proteins, are components of the subpellicular network that forms a structural part of the pellicle of malaria parasites. In Plasmodium berghei, deletions of three alveolins, IMC1a, b, and h, each resulted in reduced mechanical strength and gliding velocity of ookinetes or sporozoites. Using time lapse imaging, we show here that deletion of IMC1h (PBANKA_143660) also has an impact on the directionality and motility behaviour of both ookinetes and sporozoites. Despite their marked motility defects, sporozoites lacking IMC1h were able to invade mosquito salivary glands, allowing us to investigate the role of IMC1h in colonisation of the mammalian host. We show that IMC1h is essential for sporozoites to progress through the dermis in vivo but does not play a significant role in hepatoma cell transmigration and invasion in vitro. Colocalisation of IMC1h with the residual IMC in liver stages was detected up to 30 hours after infection and parasites lacking IMC1h showed developmental defects in vitro and a delayed onset of blood stage infection in vivo. Together, these results suggest that IMC1h is involved in maintaining the cellular architecture which supports normal motility behaviour, access of the sporozoites to the blood stream, and further colonisation of the mammalian host.	[Volkmann, Katrin; Pfander, Claudia; Burstroem, Charlotte; Ahras, Malika; Goulding, David; Rayner, Julian C.; Billker, Oliver; Brochet, Mathieu] Wellcome Trust Sanger Inst, Hinxton, England; [Frischknecht, Friedrich] Heidelberg Univ, Sch Med, Inst Hyg, Dept Parasitol, Heidelberg, Germany	Wellcome Trust Sanger Institute; Ruprecht Karls University Heidelberg	Volkmann, K (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	ob4@sanger.ac.uk; mb13@sanger.ac.uk	Brochet, Mathieu/B-3413-2018	Brochet, Mathieu/0000-0003-3911-5537; Pfander, Claudia/0000-0002-9574-9553; Frischknecht, Friedrich/0000-0002-8332-6668; Rayner, Julian/0000-0002-9835-1014; Billker, Oliver/0000-0003-1716-168X	Wellcome Trust [WT089085/Z/09/Z]; Medical Research Council [G0501670]; EVIMalaR European Networks of Excellence [242095]; EMBO long term fellowship [ALTF 45-2009]; Marie Curie Grant [PIEF-GA-2009-253899]; MRC [G0501670] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EVIMalaR European Networks of Excellence; EMBO long term fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Grant(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work received support from the Wellcome Trust (WT089085/Z/09/Z), the Medical Research Council (grant number G0501670) and the EVIMalaR European Networks of Excellence (No. 242095). MB is supported by an EMBO long term fellowship (ALTF 45-2009) and a Marie Curie Grant (PIEF-GA-2009-253899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Bano N, 2007, INT J PARASITOL, V37, P1329, DOI 10.1016/j.ijpara.2007.04.005; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gomes-Santos CSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029408; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hegge Stephan, 2009, Biotechnology Journal, V4, P903, DOI 10.1002/biot.200900007; Hellmann JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002080; Janse CJ, 2006, NAT PROTOC, V1, P614, DOI 10.1038/nprot.2006.88; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Montagna G, 2011, J BIOL CHEM, V2, DOI [10.1074/jbc.M1111.302109, DOI 10.1074/JBC.M1111.302109]; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Rayavara K, 2009, MOL BIOCHEM PARASIT, V167, P135, DOI 10.1016/j.molbiopara.2009.05.006; Tewari R, 2005, MOL MICROBIOL, V58, P1253, DOI 10.1111/j.1365-2958.2005.04793.x; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; Tremp AZ, 2011, J BIOL CHEM, V286, P5383, DOI 10.1074/jbc.M110.187195; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x	33	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41409	10.1371/journal.pone.0041409	http://dx.doi.org/10.1371/journal.pone.0041409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844474	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700086
J	Hsu, WY				Hsu, Wei-Yen			Registration Accuracy and Quality of Real-Life Images	PLOS ONE			English	Article							NONRIGID REGISTRATION	Background: A common registration problem for the application of consumer device is to align all the acquired image sequences into a complete scene. Image alignment requires a registration algorithm that will compensate as much as possible for geometric variability among images. However, images captured views from a real scene usually produce different distortions. Some are derived from the optic characteristics of image sensors, and others are caused by the specific scenes and objects. Methodology/Principal Findings: An image registration algorithm considering the perspective projection is proposed for the application of consumer devices in this study. It exploits a multiresolution wavelet-based method to extract significant features. An analytic differential approach is then proposed to achieve fast convergence of point matching. Finally, the registration accuracy is further refined to obtain subpixel precision by a feature-based modified Levenberg-Marquardt method. Due to its feature-based and nonlinear characteristic, it converges considerably faster than most other methods. In addition, vignette compensation and color difference adjustment are also performed to further improve the quality of registration results. Conclusions/Significance: The performance of the proposed method is evaluated by testing the synthetic and real images acquired by a hand-held digital still camera and in comparison with two registration techniques in terms of the squared sum of intensity differences (SSD) and correlation coefficient (CC). The results indicate that the proposed method is promising in registration accuracy and quality, which are statistically significantly better than other two approaches.	Natl Chung Cheng Univ, Dept Informat Management, Minhsiung Township, Chiayi County, Taiwan	National Chung Cheng University	Hsu, WY (corresponding author), Natl Chung Cheng Univ, Dept Informat Management, Minhsiung Township, Chiayi County, Taiwan.	shenswy@gmail.com			National Science Council, Taiwan [NSC101-2320-B-038-001, NSC101-2221-E-038-004]; Taipei Medical University, Taiwan [TMU100-AE1-B12]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University, Taiwan	This research was supported by grants from NSC101-2320-B-038-001 and NSC101-2221-E-038-004, National Science Council, Taiwan and from TMU100-AE1-B12, Taipei Medical University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022835; Caskey CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027372; CHEN QS, 1994, IEEE T PATTERN ANAL, V16, P1156; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Eichorst JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004082; Foroughi P, 2006, MED IMAGE ANAL, V10, P713, DOI 10.1016/j.media.2006.06.008; Heeger DJ, 1996, PSYCH; Holden M, 2008, IEEE T MED IMAGING, V27, P111, DOI 10.1109/TMI.2007.904691; Hsu WY, 2008, J MICROSC-OXFORD, V231, P408, DOI 10.1111/j.1365-2818.2008.02052.x; Hsu WY, 2012, INT J NEURAL SYST, V22, P51, DOI 10.1142/S0129065712002979; Hsu WY, 2011, INT J NEURAL SYST, V21, P335, DOI 10.1142/S0129065711002870; Hsu WY, 2011, MICROSC RES TECHNIQ, V74, P523, DOI 10.1002/jemt.20942; Hsu WY, 2009, J NEUROSCI METH, V176, P310, DOI 10.1016/j.jneumeth.2008.09.014; Magara F, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0014094; Mamitsuka H, 2005, ARTIF INTELL MED, V35, P9, DOI 10.1016/j.artmed.2005.01.007; Mann S, 1997, IEEE T IMAGE PROCESS, V6, P1281, DOI 10.1109/83.623191; Rohlfing T, 2003, IEEE T MED IMAGING, V22, P730, DOI 10.1109/TMI.2003.814791; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Sighoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018415; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Xu DJ, 2007, INT J PATTERN RECOGN, V21, P573, DOI 10.1142/S0218001407005508; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	22	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40558	10.1371/journal.pone.0040558	http://dx.doi.org/10.1371/journal.pone.0040558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829876	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300014
J	Kadarusman; Hubert, N; Hadiaty, RK; Sudaro; Paradis, E; Pouyaud, L				Kadarusman; Hubert, Nicolas; Hadiaty, Renny Kurnia; Sudaro; Paradis, Emmanuel; Pouyaud, Laurent			Cryptic Diversity in Indo-Australian Rainbowfishes Revealed by DNA Barcoding: Implications for Conservation in a Biodiversity Hotspot Candidate	PLOS ONE			English	Article							FISHES; IDENTIFICATIONS; COMMUNITIES; PATTERNS	The rainbowfishes of the family Melanotaeniidae represent one of the largest radiations of freshwater fishes from the Indo-Australian archipelago. A total of 75 nominal species have been described, among which several have become very popular among tropical fish hobbyists because of their tendency to form large schools of colourful individuals. Facing habitat loss and competition or predation by introduced species, this group has become a priority in the conservation of ornamental fishes in Indonesia. In this context, several expeditions have been conducted between 2007 and 2010 in Indonesian Papua with the aim to initiate a large-scale survey of the genetic resources in this group. We assessed the diversity of the Papua rainbowfishes with DNA barcoding. We sequenced the mitochondrial COI gene for 350 specimens belonging to 53 nominal species throughout the Indo-Australian archipelago. Unexpected levels of cryptic diversity and endemism were detected since additional cryptic lineages were detected in several watersheds from the Vogelkop and the Lengguru massif. DNA barcoding supports the presence of nearly 30 evolutionary lineages among the 15 nominal species sampled in the Vogelkop and all these lineages are endemic to a single lake or watershed. This result highlights that the diversity of the family has been largely underestimated and urges for the identification of conservation priorities in Papua.	[Kadarusman] Minist Marine Affairs & Fisheries, Akad Perikanan Sorong, Sorong, West Papua, Indonesia; [Kadarusman; Hubert, Nicolas; Paradis, Emmanuel; Pouyaud, Laurent] Inst Rech Dev, ISE M UR226, Montpellier, France; [Hadiaty, Renny Kurnia] Indonesian Inst Sci, Museum Zoologicum Bogoriense, Cibinong, West Java, Indonesia; [Sudaro] Minist Marine Affairs & Fisheries, Inst Res & Dev Ornamental Fish Culture, Depok, West Java, Indonesia	Ministry of Marine Affairs and Fisheries; Institut de Recherche pour le Developpement (IRD); Bogor Zoology Museum; Indonesian Institute of Sciences; Ministry of Marine Affairs and Fisheries	Kadarusman (corresponding author), Minist Marine Affairs & Fisheries, Akad Perikanan Sorong, Sorong, West Papua, Indonesia.	nicolas.hubert@ird.fr		Laurent, Pouyaud/0000-0003-4415-9198; Hubert, Nicolas/0000-0001-9248-3377	french Fondation de la Recherche pour la Biodiversite; COLAS Company in Indonesia; Veolia Environment Foundation	french Fondation de la Recherche pour la Biodiversite; COLAS Company in Indonesia; Veolia Environment Foundation	Funding was provided by the french Fondation de la Recherche pour la Biodiversite, the COLAS Company in Indonesia, and the Veolia Environment Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Allen GR, 1982, RAINBOWFISHES AUSTR; Allen GR, 1995, RAINBOWFISHES NATURE; Allen GR, 2006, ECOLOGY PAPUA, P637; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Bailly V, 2009, LITHOS, V113, P306, DOI 10.1016/j.lithos.2009.08.013; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Burnett JB, 2006, ECOLOGY PAPUA, P1230; Clements R, 2008, BIOL CONSERV, V141, P2751, DOI 10.1016/j.biocon.2008.08.011; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Dennis C, 2004, NATURE, V430, P396, DOI 10.1038/430396a; Eastman JM, 2011, BIOINFORMATICS, V27, P2437, DOI 10.1093/bioinformatics/btr403; Fraser S, 2006, ECOLOGY INDONESIA, P1199; Frodin DG, 2006, ECOLOGY INDONESIA, P14; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Hardman M, 2006, MOL PHYLOGENET EVOL, V40, P410, DOI 10.1016/j.ympev.2006.03.011; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Kiew R, 1991, STATE NATURE CONSERV, P42; Marshall AJ, 2006, ECOLOGY PAPUA; McAlpine J R, 2001, Asia Pac Viewp, V42, P209, DOI 10.1111/1467-8373.00145; McGuigan K, 2000, MAR FRESHWATER RES, V51, P713, DOI 10.1071/MF99159; Mertens B, 2002, SPATIAL ANAL RAPID A; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Polhemus DA, 2006, ECOLOGY PAPUA; Polhemus DA, 2004, FRESHWATER BIOTAS NE; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Read CI, 2006, MOL PHYLOGENET EVOL, V38, P808, DOI 10.1016/j.ympev.2005.08.001; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Schilthuizen M, 2005, CONSERV BIOL, V19, P949; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Sriwattanarothai N, 2010, J FISH BIOL, V77, P414, DOI 10.1111/j.1095-8649.2010.02715.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tappin AR, 2011, RAINBOWFISHES THEIR; Villeneuve M, 2010, GONDWANA RES, V18, P420, DOI 10.1016/j.gr.2009.12.011; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; ZHU DQ, 1994, MOL BIOL EVOL, V11, P672	45	28	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40627	10.1371/journal.pone.0040627	http://dx.doi.org/10.1371/journal.pone.0040627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829879	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300017
J	Ritz, N; Strach, M; Yau, C; Dutta, B; Tebruegge, M; Connell, TG; Hanekom, WA; Britton, WJ; Robins-Browne, R; Curtis, N				Ritz, Nicole; Strach, Madeleine; Yau, Carmen; Dutta, Binita; Tebruegge, Marc; Connell, Tom G.; Hanekom, Willem A.; Britton, Warwick J.; Robins-Browne, Roy; Curtis, Nigel			A Comparative Analysis of Polyfunctional T Cells and Secreted Cytokines Induced by Bacille Calmette-Guerin Immunisation in Children and Adults	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; IMMUNE-RESPONSES; BCG VACCINATION; IFN-GAMMA; PUBLISHED LITERATURE; DENDRITIC CELLS; PROTECTION; CORRELATE; NEWBORNS; INFANTS	BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protective efficacy of BCG against TB is better for children than for adults. One potential explanation is that BCG induces a better protective immune response in children. Twenty six children and adults were immunised with BCG. The proportion of Th1-cytokine-producing mycobacterial-specific T cells, and the concentrations of secreted cytokines, were measured before and 10 weeks after BCG immunisation. A significant increase in the proportion of mycobacterial-specific cytokine-producing T cells was observed in both age groups. After BCG immunisation, children and adults had comparable proportions of mycobacterial-specific polyfunctional CD4 T cells when measured relative to the total number of CD4 T cells. However, relative to the subset of Th1-cytokine-producing CD4 T cells, the proportion of polyfunctional cells was greater in children. Concentrations of secreted cytokines were comparable in children and adults. These findings suggest that the mycobacterial-specific cell-mediated immune response induced by BCG immunisation in children and adults is similar. The implication of a shift to a more polyfunctional immune response within the Th1-cytokine-producing CD4 T cells in children is uncertain as this aspect of the immune response has not been assessed as a potential correlate of protection against TB.	[Ritz, Nicole; Strach, Madeleine; Yau, Carmen; Tebruegge, Marc; Connell, Tom G.; Robins-Browne, Roy; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Ritz, Nicole; Strach, Madeleine; Yau, Carmen; Dutta, Binita; Tebruegge, Marc; Connell, Tom G.; Robins-Browne, Roy; Curtis, Nigel] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Ritz, Nicole; Tebruegge, Marc; Connell, Tom G.; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Dept Gen Med, Parkville, Vic, Australia; [Hanekom, Willem A.] Univ Cape Town, S African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Hanekom, Willem A.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Britton, Warwick J.] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Camperdown, NSW, Australia; [Robins-Browne, Roy] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Britton, Warwick J.] Univ Sydney, Dept Med, Camperdown, NSW, Australia	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Cape Town; University of Cape Town; University of Sydney; Centenary Institute; University of Melbourne; University of Sydney	Ritz, N (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	nicole.ritz@rch.org.au	Ritz, Nicole/G-2924-2015; Ritz, Nicole/L-1452-2019; Curtis, Nigel/B-3491-2012; Robinsbrowne, Roy/ABF-8434-2020; Strach, Madeleine/AAP-1125-2021	Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Curtis, Nigel/0000-0003-3446-4594; Robinsbrowne, Roy/0000-0001-9179-7884; Strach, Madeleine/0000-0002-5516-2619; Britton, Warwick/0000-0001-6721-9646; Hanekom, Willem/0000-0003-3070-6154	European Society for Paediatric Infectious Diseases; University of Melbourne; Murdoch Children's Research Institute, Parkville, Australia; Royal Children's Hospital Melbourne, Parkville, Australia; National Institute for Health Research [CL-2011-26-004] Funding Source: researchfish	European Society for Paediatric Infectious Diseases; University of Melbourne(University of Melbourne); Murdoch Children's Research Institute, Parkville, Australia; Royal Children's Hospital Melbourne, Parkville, Australia; National Institute for Health Research(National Institute for Health Research (NIHR))	NR and MT were supported by Fellowship awards from the European Society for Paediatric Infectious Diseases and scholarships from The University of Melbourne. This work was supported by a grant from the Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Britton WJ, 1998, INFECT IMMUN, V66, P2122, DOI 10.1128/IAI.66.5.2122-2127.1998; Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Demangel C, 2000, IMMUNOL CELL BIOL, V78, P318, DOI 10.1046/j.1440-1711.2000.00935.x; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Finan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003485; Fjallbrant H, 2007, SCAND J INFECT DIS, V39, P792, DOI 10.1080/00365540701367777; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hartel C, 2005, CLIN EXP IMMUNOL, V142, P446, DOI 10.1111/j.1365-2249.2005.02928.x; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Hoft DF, 1999, J LAB CLIN MED, V134, P244, DOI 10.1016/S0022-2143(99)90204-4; Hussey GD, 2002, IMMUNOLOGY, V105, P314, DOI 10.1046/j.1365-2567.2002.01366.x; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Marchant A, 1999, J IMMUNOL, V163, P2249; Mazzola TN, 2007, VACCINE, V25, P6313, DOI 10.1016/j.vaccine.2007.06.039; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; O'Garra AB, 2008, CELL BIOL, V2, P185; Ota MOC, 2006, J TROP PEDIATRICS, V52, P136, DOI 10.1093/tropej/fmi087; Ravn P, 1997, J IMMUNOL, V158, P1949; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Smith SM, 1999, INFECT IMMUN, V67, P5223, DOI 10.1128/IAI.67.10.5223-5230.1999; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tchilian EZ, 2009, INFECT IMMUN, V77, P622, DOI 10.1128/IAI.00685-08; Thurnher M, 1997, INT J CANCER, V70, P128; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Vekemans J, 2004, INFECT IMMUN, V72, P381, DOI 10.1128/IAI.72.1.381-388.2004; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731	44	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e37535	10.1371/journal.pone.0037535	http://dx.doi.org/10.1371/journal.pone.0037535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829867	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000306956300005
J	Tonkin, JA; Rees, P; Brown, MR; Errington, RJ; Smith, PJ; Chappell, SC; Summers, HD				Tonkin, James A.; Rees, Paul; Brown, Martyn R.; Errington, Rachel J.; Smith, Paul J.; Chappell, Sally C.; Summers, Huw D.			Automated Cell Identification and Tracking Using Nanoparticle Moving-Light-Displays	PLOS ONE			English	Article							PARTICLE TRACKING; MICROSCOPY; DIVISIONS	An automated technique for the identification, tracking and analysis of biological cells is presented. It is based on the use of nanoparticles, enclosed within intra-cellular vesicles, to produce clusters of discrete, point-like fluorescent, light sources within the cells. Computational analysis of these light ensembles in successive time frames of a movie sequence, using k-means clustering and particle tracking algorithms, provides robust and automated discrimination of live cells and their motion and a quantitative measure of their proliferation. This approach is a cytometric version of the moving light display technique which is widely used for analyzing the biological motion of humans and animals. We use the endocytosis of CdTe/ZnS, core-shell quantum dots to produce the light displays within an A549, epithelial, lung cancer cell line, using time-lapse imaging with frame acquisition every 5 minutes over a 40 hour time period. The nanoparticle moving light displays provide simultaneous collection of cell motility data, resolution of mitotic traversal dynamics and identification of familial relationships allowing construction of multi-parameter lineage trees.	[Tonkin, James A.; Rees, Paul; Brown, Martyn R.; Summers, Huw D.] Swansea Univ, Ctr Nanohlth, Swansea, W Glam, Wales; [Errington, Rachel J.; Smith, Paul J.; Chappell, Sally C.] Cardiff Univ, Sch Med, Heath Pk Cardiff, Wales	Swansea University; Cardiff University	Tonkin, JA (corresponding author), Swansea Univ, Ctr Nanohlth, Singleton Pk, Swansea, W Glam, Wales.	H.D.Summers@swansea.ac.uk	Summers, Huw/Y-7676-2019; Brown, Rowan/AAH-1984-2019	Brown, Rowan/0000-0003-3628-2524; Rees, Paul/0000-0002-7715-6914; Summers, Huw/0000-0002-0898-5612; Chapell, Sally/0000-0003-2712-2617	Engineering And Physical Sciences Research Council, U.K. [EP/F040954/1]; BBSRC [BB/E012574/1] Funding Source: UKRI; EPSRC [EP/F040954/1, EP/H008683/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012574/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F040954/1, EP/H008683/1] Funding Source: researchfish	Engineering And Physical Sciences Research Council, U.K.(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Grant Sponsor - Engineering And Physical Sciences Research Council, U.K. Grant Number: EP/F040954/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatz M, 2006, CYTOM PART A, V69A, P652, DOI 10.1002/cyto.a.20289; Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; Boland MV, 1998, CYTOMETRY, V33, P366; Brown MR, 2010, CYTOM PART A, V77A, P925, DOI 10.1002/cyto.a.20936; Cedras C, 1994, P IEEE C COMP VIS PA, P21; Cheng G, 2006, BIOPHYS J, V90, P713, DOI 10.1529/biophysj.105.063701; Dufour A, 2005, IEEE T IMAGE PROCESS, V14, P1396, DOI 10.1109/TIP.2005.852790; Gao YX, 2009, OPT EXPRESS, V17, P4685, DOI 10.1364/OE.17.004685; Genovesio A, 2006, IEEE T IMAGE PROCESS, V15, P1062, DOI 10.1109/TIP.2006.872323; Graves TG, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-1; Guerra-filho G. B., 2005, RITA, V12, P61; HOFFMAN DD, 1982, BIOL CYBERN, V42, P195; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lee S, 2006, METHOD ENZYMOL, V414, P468, DOI 10.1016/S0076-6879(06)14025-2; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Padfield D, 2009, MED IMAGE ANAL, V13, P143, DOI 10.1016/j.media.2008.06.018; Singhvi A, 2009, TRENDS CELL BIOL, V19, P1, DOI 10.1016/j.tcb.2008.10.004; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Summers HD, 2011, NAT NANOTECHNOL, V6, P170, DOI [10.1038/nnano.2010.277, 10.1038/NNANO.2010.277]; Swedlow JR, 2003, SCIENCE, V300, P100, DOI 10.1126/science.1082602; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640	25	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40835	10.1371/journal.pone.0040835	http://dx.doi.org/10.1371/journal.pone.0040835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829889	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300027
J	Torikoshi, K; Abe, H; Matsubara, T; Hirano, T; Ohshima, T; Murakami, T; Araki, M; Mima, A; Iehara, N; Fukatsu, A; Kita, T; Arai, H; Doi, T				Torikoshi, Kazuo; Abe, Hideharu; Matsubara, Takeshi; Hirano, Takahiro; Ohshima, Takayuki; Murakami, Taichi; Araki, Makoto; Mima, Akira; Iehara, Noriyuki; Fukatsu, Atsushi; Kita, Toru; Arai, Hidenori; Doi, Toshio			Protein Inhibitor of Activated STAT, PIASy Regulates alpha-Smooth Muscle Actin Expression by Interacting with E12 in Mesangial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LOOP-HELIX PROTEINS; TRANSCRIPTIONAL ACTIVITY; IN-VIVO; PROLIFERATIVE GLOMERULONEPHRITIS; DEPENDENT TRANSCRIPTION; DIABETIC-NEPHROPATHY; SUMO-1 MODIFICATION; FACTOR ANTAGONIZES; NUCLEAR-BODIES	Phenotypic transformation of mesangial cells (MCs) is implicated in the development of glomerular disease; however, the mechanisms underlying their altered genetic program is still unclear. alpha-smooth muscle actin (alpha-SMA) is known to be a crucial marker for phenotypic transformation of MCs. Recently, E-boxes and the class I basic helix-loop-helix proteins, such as E12 have been shown to regulate alpha-SMA expression. Therefore, we tried to identify a novel E12 binding protein in MCs and to examine its role in glomerulonephritis. We found that PIASy, one of the protein inhibitors of activated STAT family protein, interacted with E12 by yeast two-hybrid screens and coimmunopreciptation assays. Overexpression of E12 significantly enhanced the alpha-SMA promoter activity, and the increase was blocked by co-transfection of PIASy, but not by a PIASy RING mutant. In vivo sumoylation assays revealed that PIASy was a SUMO E3 ligase for E12. Furthermore, transforming growth factor-beta (TGF-beta) treatment induced expression of both PIASy and E12, consistent with alpha-SMA expression. Moreover, reduced expression of PIASy protein by siRNA specific for PIASy resulted in increased TGF-beta-mediated alpha-SMA expression. In vivo, PIASy and E12 were dramatically upregulated along with alpha-SMA and TGF-beta in the proliferative phase of Thy1 glomerulonephritis. Furthermore, an association between PIASy and E12 proteins was observed at day 6 by IP-western blotting, but not at day 0. These results suggest that TGF-beta up-regulates PIASy expression in MCs to down-regulate alpha-SMA gene transcription by the interaction with E12.	[Torikoshi, Kazuo; Matsubara, Takeshi; Araki, Makoto; Mima, Akira; Iehara, Noriyuki; Fukatsu, Atsushi] Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan; [Abe, Hideharu; Hirano, Takahiro; Murakami, Taichi; Doi, Toshio] Univ Tokushima, Dept Nephrol, Hlth Biosci Inst, Grad Sch Med, Tokushima 770, Japan; [Ohshima, Takayuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa, Japan; [Kita, Toru] Gen Hosp, Kobe City Med Ctr, Kobe, Hyogo, Japan; [Arai, Hidenori] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan	Kyoto University; Tokushima University; Tokushima Bunri University; Kobe City Medical Center General Hospital; Kyoto University	Torikoshi, K (corresponding author), Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan.	mtake@kuhp.kyoto-u.ac.jp	FUKATSU, ATSUSHI/R-7941-2019; Arai, Hidenori/P-9816-2017	Arai, Hidenori/0000-0002-9000-6849; Araki, Makoto/0000-0003-0854-4064; OHSHIMA, Takayuki/0000-0002-1501-6430	Takeda Science Foundation;  [21790808];  [21591033]; Grants-in-Aid for Scientific Research [22390169] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Young Scientists (B) (21790808), Grants-in-Aid for Scientific Research (21591033), and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; ALPERS CE, 1992, KIDNEY INT, V41, P1134, DOI 10.1038/ki.1992.173; Conlon Thomas M., 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-11; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; Gerhardinger C, 2009, DIABETES, V58, P1659, DOI 10.2337/db08-1008; Huggins GS, 1999, J BIOL CHEM, V274, P28690, DOI 10.1074/jbc.274.40.28690; Imoto S, 2003, J BIOL CHEM, V278, P34253, DOI 10.1074/jbc.M304961200; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kawai-Kowase K, 2004, ARTERIOSCL THROM VAS, V24, P1384, DOI 10.1161/01.ATV.0000136548.17816.07; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; LEDENT V, 2002, GENOME BIOL, V3; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nelson V, 2001, APOPTOSIS, V6, P221, DOI 10.1023/A:1011392811628; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Nishida T, 2007, BIOCHEM J, V405, P481, DOI 10.1042/BJ20070026; Nishida T, 2007, BIOCHEM BIOPH RES CO, V360, P226, DOI 10.1016/j.bbrc.2007.06.037; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Pippin JW, 1997, J CLIN INVEST, V100, P2512, DOI 10.1172/JCI119793; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Slattery C, 2006, FEBS LETT, V580, P4021, DOI 10.1016/j.febslet.2006.06.039; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; STRIKER LJ, 1989, SEMIN NEPHROL, V9, P318; Sumi E, 2007, AM J PATHOL, V170, P1854, DOI 10.2353/ajpath.2007.060899; Watanabe M, 2011, BBA-PROTEINS PROTEOM, V1814, P900, DOI 10.1016/j.bbapap.2011.04.006; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200; Ziswiler R, 1998, J AM SOC NEPHROL, V9, P2055	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41186	10.1371/journal.pone.0041186	http://dx.doi.org/10.1371/journal.pone.0041186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829926	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300065
J	Zhang, W; O'Brien, N; Forrest, JI; Salters, KA; Patterson, TL; Montaner, JSG; Hogg, RS; Lima, VD				Zhang, Wendy; O'Brien, Nadia; Forrest, Jamie I.; Salters, Kate A.; Patterson, Thomas L.; Montaner, Julio S. G.; Hogg, Robert S.; Lima, Viviane D.			Validating a Shortened Depression Scale (10 Item CES-D) among HIV-Positive People in British Columbia, Canada	PLOS ONE			English	Article							CD4 CELL COUNT; VIRAL LOAD; SHORT-FORM; SYMPTOMS; ASSOCIATION; INFECTION; MORTALITY; DECLINE; ADULT; WOMEN	Objective: To establish the reliability and validity of a shortened (10-item) depression scale used among HIV-positive patients enrolled in the Drug Treatment Program in British Columbia, Canada. Methods: The 10-item CES-D (Center for Epidemiologic Studies Depression Scale) was examined among 563 participants who initiated antiretroviral therapy (ART) between August 1, 1996 and June 30, 2002. Internal consistency of the scale was measured by Cronbach's alpha. Using the original CES-D 20 as primary criteria, comparisons were made using the Kappa statistic. Predictive accuracy of CES-D 10 was assessed by calculating sensitivity, specificity, positive predictive values and negative predictive values. Factor analysis was also performed to determine if the CES-D 10 contained the same factors of positive and negative affect found in the original development of the CES-D. Results: The correlation between the original and the shortened scale is very high (Spearman correlation coefficient = 0.97 (P < 0.001). Internal consistency reliability coefficients of the CES-D 10 were satisfactory (Cronbach alpha = 0.88). The CES-D 10 showed comparable accuracy to the original CES-D 20 in classifying participants with depressive symptoms (Kappa = 0.82, P < 0.001). Sensitivity of CES-D 10 was 91%; specificity was 92%; and positive predictive value was 92%. Factor analysis demonstrates that CES-D 10 contains the same underlying factors of positive and negative affect found in the original development of the CES-D 20. Conclusion: The 10-item CES-D is a comparable tool to measure depressive symptoms among HIV-positive research participants.	[Zhang, Wendy; O'Brien, Nadia; Forrest, Jamie I.; Salters, Kate A.; Montaner, Julio S. G.; Hogg, Robert S.; Lima, Viviane D.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Patterson, Thomas L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Montaner, Julio S. G.; Lima, Viviane D.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of California System; University of California San Diego; University of British Columbia; Simon Fraser University	Zhang, W (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	vlima@cfenet.ubc.ca	Montaner, Julio/K-7621-2012	Hogg, Robert/0000-0003-3463-5488	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; National Institutes of Health; Canadian Institutes of Health Research National Health Research Development Program; Health Canada; GlaxoSmithKline; Merck Laboratory; Frosst Laboratory; Abbott; Biolytical; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck; ViiV Healthcare; Ministry of Health Services; Ministry of Healthy Living and Sport; Province of British Columbia; Canadian Institutes of Health Research (CIHR); National Institute of Drug Abuse, at the U.S. National Institutes of Health [1DP1DA026182-01]; International AIDS Society; United Nations AIDS Program; World Health Organization; National Institute on Drug Abuse; National Institutes of Health Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); Bill & Melinda Gates Foundation; French National Agency for Research on AIDS & Viral Hepatitis (ANRS); Public Health Agency of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research National Health Research Development Program(Canadian Institutes of Health Research (CIHR)); Health Canada; GlaxoSmithKline(GlaxoSmithKline); Merck Laboratory(Merck & Company); Frosst Laboratory; Abbott(Abbott Laboratories); Biolytical; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); ViiV Healthcare; Ministry of Health Services; Ministry of Healthy Living and Sport; Province of British Columbia; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Drug Abuse, at the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health Research-Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); French National Agency for Research on AIDS & Viral Hepatitis (ANRS); Public Health Agency of Canada	This work was supported by the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research through Fellowship Awards to Dr. Lima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts to report: Dr. Robert Hogg has held grant funding from the National Institutes of Health, Canadian Institutes of Health Research National Health Research Development Program, Health Canada, GlaxoSmithKline and Merck Frosst Laboratories. Dr. Julio S.G. Montaner has received grants from Abbott, Biolytical, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. He is also supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); and through an Avant-Garde Award (No. 1DP1DA026182-01) from the National Institute of Drug Abuse, at the U.S. National Institutes of Health. He has also received support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institute on Drug Abuse, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), Bill & Melinda Gates Foundation, French National Agency for Research on AIDS & Viral Hepatitis (ANRS), Public Health Agency of Canada. He has academic partnerships with the University of British Columbia, Simon Fraser University, Providence Health Care and Vancouver Coastal Health. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boey KW, 1999, INT J GERIATR PSYCH, V14, P608, DOI 10.1002/(SICI)1099-1166(199908)14:8<608::AID-GPS991>3.0.CO;2-Z; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Evans DL, 2002, AM J PSYCHIAT, V159, P1752, DOI 10.1176/appi.ajp.159.10.1752; Golub ET, 2004, J URBAN HEALTH, V81, P278, DOI 10.1093/jurban/jth114; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hartzell JD, 2007, JAIDS-J ACQ IMM DEF, V44, P411, DOI 10.1097/QAI.0b013e31802f83a6; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Mayne TJ, 1996, ARCH INTERN MED, V156, P2233, DOI 10.1001/archinte.156.19.2233; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; Penzak SR, 2000, AM J HEALTH-SYST PH, V57, P376, DOI 10.1093/ajhp/57.4.376; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Wilcox H, 1998, ADOLESCENCE, V33, P565	21	262	262	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40793	10.1371/journal.pone.0040793	http://dx.doi.org/10.1371/journal.pone.0040793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981GZ	22829885	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300023
J	Shafique, K; Mirza, SS; Mughal, MK; Arain, ZI; Khan, NA; Tareen, MF; Ahmad, I				Shafique, Kashif; Mirza, Saira Saeed; Mughal, Muhammad Kashif; Arain, Zain Islam; Khan, Naveed Ahmed; Tareen, Muhammad Farooq; Ahmad, Ishtiaque			Water-Pipe Smoking and Metabolic Syndrome: A Population-Based Study	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; CIGARETTE-SMOKING; ATTITUDES; NICOTINE; EXPOSURE; BELIEFS; TOBACCO; SYRIA; RISK	Water-pipe (WP) smoking has significantly increased in the last decade worldwide. Compelling evidence suggests that the toxicants in WP smoke are similar to that of cigarette smoke. The WP smoking in a single session could have acute harmful health effects even worse than cigarette smoking. However, there is no evidence as such on long term WP smoking and its impact on chronic health conditions particularly cardiovascular and metabolic conditions. Therefore, we conducted this study to investigate the relationship between WP smoking and metabolic syndrome (MetS). This was a cross-sectional study carried out in Punjab province of Pakistan using the baseline data of a population-based study - Urban Rural Chronic Diseases Study (URCDS). Information was collected by trained nurses regarding the socio-demographic profile, lifestyle factors including WP smoking, current and past illnesses. A blood sample was obtained for measurement of complete blood count, lipid profile and fasting glucose level. MetS was ascertained by using the International Diabetic Federation's criteria. We carried out multiple logistic regressions to investigate the association between WP smoking and MetS. Final sample included 2,032 individuals - of those 325 (16.0%) were current WP smokers. Age adjusted-prevalence of MetS was significantly higher among current WP smokers (33.1%) compared with non-smokers (14.8%). Water-pipe smokers were three times more likely to have MetS (OR 3.21, 95% CI 2.38-4.33) compared with non-smokers after adjustment for age, sex and social class. WP smokers were significantly more likely to have hypertriglyceridemia (OR 1.63, 95% CI 1.25-2.10), hyperglycaemia (OR 1.82, 95% CI 1.37-2.41), Hypertension (OR 1.95, 95% CI 1.51-2.51) and abdominal obesity (OR 1.93, 95% CI 1.52-2.45). However, there were no significant differences in HDL level between WP smokers and non-smokers. This study suggests that WP smoking has a significant positive (harmful) relationship with MetS and its components.	[Shafique, Kashif; Mirza, Saira Saeed; Mughal, Muhammad Kashif] Dow Univ Hlth Sci, Inst Basic Med Sci, Karachi, Pakistan; [Arain, Zain Islam] Isra Med Univ Hosp, Dept Med, Hyderabad, Pakistan; [Khan, Naveed Ahmed] Civil Hosp Karachi, Dept Surg, Karachi, Pakistan; [Tareen, Muhammad Farooq] Govt Pakistan, Dept Hlth, Faisalabad, Pakistan; [Ahmad, Ishtiaque] Afra Gen Hosp, Faisalabad, Pakistan	Dow University of Health Sciences; Dow University of Health Sciences	Shafique, K (corresponding author), Dow Univ Hlth Sci, Inst Basic Med Sci, Karachi, Pakistan.	k.shafique@duhs.edu.pk	Khan, Naveed/AAM-2892-2021; Mughal, M. Kashif/O-1018-2019	Khan, Naveed/0000-0001-7667-8553; Mughal, M. Kashif/0000-0002-1321-0619; Shafique, Kashif/0000-0001-7151-5122				Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Daher N, 2010, ATMOS ENVIRON, V44, P8, DOI 10.1016/j.atmosenv.2009.10.004; Dzien A, 2004, DIABETES OBES METAB, V6, P127, DOI 10.1111/j.1462-8902.2004.00324.x; Eissenberg T, 2009, AM J PREV MED, V37, P518, DOI 10.1016/j.amepre.2009.07.014; Hakim F, 2011, CHEST, V139, P775, DOI 10.1378/chest.10-1833; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Jacob P, 2011, CANCER EPIDEM BIOMAR, V20, P2345, DOI 10.1158/1055-9965.EPI-11-0545; Jawaid A, 2008, INT J TUBERC LUNG D, V12, P1077; Kong C, 2001, ATHEROSCLEROSIS, V156, P373, DOI 10.1016/S0021-9150(00)00664-X; Maziak W, 2004, ANN EPIDEMIOL, V14, P646, DOI 10.1016/j.annepidem.2003.11.003; Maziak W, 2004, PREV MED, V39, P330, DOI 10.1016/j.ypmed.2004.01.024; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Raad D, 2011, CHEST, V139, P764, DOI 10.1378/chest.10-0991; Rohleder N, 2006, INT J PSYCHOPHYSIOL, V59, P236, DOI 10.1016/j.ijpsycho.2005.10.012; Roskin J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-10; Shafagoj YA, 2002, INT J CLIN PHARM TH, V40, P249; Shaikh R B, 2008, J Prev Med Hyg, V49, P101; Smith JR, 2011, AM J PUBLIC HEALTH, V101, P1876, DOI 10.2105/AJPH.2011.300196; Tareen MF, 2011, RURAL REMOTE HEALTH, V11; World Health Organization (WHO), 2011, AS PAC PERSP RED OB; Zhu YX, 2011, BIOMED ENVIRON SCI, V24, P475, DOI 10.3967/0895-3988.2011.05.004	21	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39734	10.1371/journal.pone.0039734	http://dx.doi.org/10.1371/journal.pone.0039734			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848361	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200013
J	Shingate, P; Sowdhamini, R				Shingate, Prashant; Sowdhamini, R.			Analysis of Domain-Swapped Oligomers Reveals Local Sequence Preferences and Structural Imprints at the Linker Regions and Swapped Interfaces	PLOS ONE			English	Article							HIV-INACTIVATING PROTEIN; CRYSTAL-STRUCTURE; CYANOVIRIN-N; 3D; EVOLUTION; SERVER; BETA-B2-CRYSTALLIN; CONSERVATION; DIMERIZATION; PREDICTION	Background: 3D domain swapping is an oligomerization process in which structural elements get exchanged between subunits. This mechanism grasped interest of many researchers due to its association with neurodegenerative diseases like Alzheimer's disease, spongiform encephalopathy etc. Despite the biomedical relevance, very little is known about understanding this mechanism. The quest for ruling principles behind this curious phenomenon that could enable early prediction provided an impetus for our bioinformatics studies. Methodology: A novel method, HIDE, has been developed to find non-domain-swapped homologues and to identify hinge from domain-swapped oligomers. Non-domain-swapped homologues were identified from the protein structural databank for majority of the domain-swapped entries and hinge boundaries could be recognised automatically by means of successive superposition techniques. Different sequence and structural features in domain-swapped proteins and related proteins have also been analysed. Conclusions: The HIDE algorithm was able to identify hinge region in 83% cases. Sequence and structural analyses of hinge and interfaces reveal amino acid preferences and specific conformations of residues at hinge regions, while comparing the domain-swapped and non-domain-swapped states. Interactions differ significantly between regular dimeric interfaces and interface formed at the site of domain-swapped examples. Such preferences of residues, conformations and interactions could be of predictive value.	[Shingate, Prashant; Sowdhamini, R.] Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Shingate, P (corresponding author), Natl Ctr Biol Sci, UAS GKVK Campus, Bangalore, Karnataka, India.	mini@ncbs.res.in	Shingate, Prashant/ABC-1411-2020					Alva V, 2008, PROTEIN PEPTIDE LETT, V15, P33; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chirgadze DY, 2004, STRUCTURE, V12, P1489, DOI 10.1016/j.str.2004.06.011; Chu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013361; Hadjithomas M, 2011, P NATL ACAD SCI USA, V108, P13462, DOI 10.1073/pnas.1108649108; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang K, 1999, STRUCT FOLD DES, V7, P539, DOI 10.1016/S0969-2126(99)80070-7; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Nagradova NK, 2002, BIOCHEMISTRY-MOSCOW+, V67, P839, DOI 10.1023/A:1019958402194; O'Neill JW, 2001, STRUCTURE, V9, P1017, DOI 10.1016/S0969-2126(01)00667-0; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Pintar A, 2002, BIOINFORMATICS, V18, P980, DOI 10.1093/bioinformatics/18.7.980; RAMAKRISHNAN C, 1988, COLLECT CZECH CHEM C, V53, P2801, DOI 10.1135/cccc19882801; Ramoni R, 2002, BIOCHEM J, V365, P739, DOI 10.1042/BJ20011631; Shameer K, 2011, DATABASE         APR, V2011, P1; Shameer K, 2011, PROTEIN PEPTIDE LETT, V18, P1010, DOI 10.2174/092986611796378729; Smith MA, 2007, PROTEIN SCI, V16, P615, DOI 10.1110/ps.062659107; SRINIVASAN N, 1991, MOL CONFORMATION BIO, P59; TRINKL S, 1994, PROTEIN SCI, V3, P1392, DOI 10.1002/pro.5560030905; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	35	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39305	10.1371/journal.pone.0039305	http://dx.doi.org/10.1371/journal.pone.0039305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848353	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200009
J	Sharron, M; Hoptay, CE; Wiles, AA; Garvin, LM; Geha, M; Benton, AS; Nagaraju, K; Freishtat, RJ				Sharron, Matthew; Hoptay, Claire E.; Wiles, Andrew A.; Garvin, Lindsay M.; Geha, Mayya; Benton, Angela S.; Nagaraju, Kanneboyina; Freishtat, Robert J.			Platelets Induce Apoptosis during Sepsis in a Contact-Dependent Manner That Is Inhibited by GPIIb/IIIa Blockade	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; GRANZYME-B; SEPTIC SHOCK; ESCHERICHIA-COLI; ANTIPLATELET DRUGS; MURINE MODEL; FAILURE; SURVIVAL; EPIDEMIOLOGY; INVOLVEMENT	Purpose: End-organ apoptosis is well-described in progressive sepsis and Multiple Organ Dysfunction Syndrome (MODS), especially where platelets accumulate (e.g. spleen and lung). We previously reported an acute sepsis-induced cytotoxic platelet phenotype expressing serine protease granzyme B. We now aim to define the site(s) of and mechanism(s) by which platelet granzyme B induces end-organ apoptosis in sepsis. Methods: End-organ apoptosis in murine sepsis (i.e. polymicrobial peritonitis) was analyzed by immunohistochemistry. Platelet cytotoxicity was measured by flow cytometry following 90 minute ex vivo co-incubation with healthy murine splenocytes. Sepsis progression was measured via validated preclinical murine sepsis score. Measurements and Main Results: There was evident apoptosis in spleen, lung, and kidney sections from septic wild type mice. In contrast, there was a lack of TUNEL staining in spleens and lungs from septic granzyme B null mice and these mice survived longer following induction of sepsis than wild type mice. In co-incubation experiments, physical separation of septic platelets from splenocytes by a semi-permeable membrane reduced splenocyte apoptosis to a rate indistinguishable from negative controls. Chemical separation by the platelet GPIIb/IIIa receptor inhibitor eptifibatide decreased apoptosis by 66.6 +/- 10.6% (p = 0.008). Mice treated with eptifibatide in vivo survived longer following induction of sepsis than vehicle control mice. Conclusions: In sepsis, platelet granzyme B-mediated apoptosis occurs in spleen and lung, and absence of granzyme B slows sepsis progression. This process proceeds in a contact-dependent manner that is inhibited ex vivo and in vivo by the platelet GPIIb/ IIIa receptor inhibitor eptifibatide. The GPIIb/ IIIa inhibitors and other classes of anti-platelet drugs may be protective in sepsis.	[Sharron, Matthew; Geha, Mayya; Nagaraju, Kanneboyina; Freishtat, Robert J.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Sharron, Matthew] Childrens Natl Med Ctr, Div Crit Care Med, Washington, DC 20010 USA; [Sharron, Matthew; Nagaraju, Kanneboyina; Freishtat, Robert J.] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA; [Hoptay, Claire E.; Wiles, Andrew A.; Garvin, Lindsay M.; Benton, Angela S.; Nagaraju, Kanneboyina; Freishtat, Robert J.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Hoptay, Claire E.; Garvin, Lindsay M.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Freishtat, Robert J.] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA	George Washington University; Children's National Health System; George Washington University; Children's National Health System; George Washington University; Children's National Health System	Freishtat, RJ (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.	rfreishtat@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021	Freishtat, Robert/0000-0002-7411-2342	NIH National Center for Advancing Translational Sciences [UL1RR031988 /UL1TR000075]; National Institutes of Health, Bethesda, Maryland, USA [K23RR020069]; George Washington University School of Medicine and Health Sciences; Children's National Medical Center, Washington, DC, USA; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR020069, UL1RR031988] Funding Source: NIH RePORTER	NIH National Center for Advancing Translational Sciences; National Institutes of Health, Bethesda, Maryland, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); George Washington University School of Medicine and Health Sciences; Children's National Medical Center, Washington, DC, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by Award Number UL1RR031988 /UL1TR000075 from the NIH National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. Additional funding support was provided by grants K23RR020069 (RJF) from the National Institutes of Health, Bethesda, Maryland, USA and institutional grants from George Washington University School of Medicine and Health Sciences (MS) and Children's National Medical Center (MS, RJF), Washington, DC, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Azevedo L. C. P., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P159; Bougaki M, 2010, SHOCK, V34, P281, DOI 10.1097/SHK.0b013e3181cdc327; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Chung CS, 2010, SHOCK, V34, P150, DOI 10.1097/SHK.0b013e3181cf70fb; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Dmowski WP, 2001, HUM REPROD, V16, P1802, DOI 10.1093/humrep/16.9.1802; DRAKE TA, 1993, AM J PATHOL, V142, P1458; Erlich JM, 2011, CHEST, V139, P289, DOI 10.1378/chest.10-0891; Freishtat RJ, 2009, AM J RESP CRIT CARE, V179, P467, DOI 10.1164/rccm.200807-1085OC; Gambim MH, 2007, CRIT CARE, V11, DOI 10.1186/cc6133; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hamiovigtz-Friedman A, 1997, J EXP MED, V186, P1831; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inoue S, 2010, J IMMUNOL, V184, P1401, DOI 10.4049/jimmunol.0902307; Janiszewski M, 2004, CRIT CARE MED, V32, P818, DOI 10.1097/01.CCM.0000114829.17746.19; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; KNAUS WA, 1989, CRIT CARE CLIN, V5, P221; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lipcsey M, 2005, PLATELETS, V16, P408, DOI 10.1080/09537100500163168; Mutunga M, 2001, AM J RESP CRIT CARE, V163, P195, DOI 10.1164/ajrccm.163.1.9912036; Phillips DR, 1997, AM J CARDIOL, V80, pB11, DOI 10.1016/S0002-9149(97)00572-9; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; PHILLIPS DR, 1988, BLOOD, V71, P831; Pu Q, 2001, CRIT CARE MED, V29, P1181, DOI 10.1097/00003246-200106000-00019; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; SCHNEIDER RC, 1980, AM REV RESPIR DIS, V122, P445; Seidel M, 2009, J THROMB HAEMOST, V7, P1030, DOI 10.1111/j.1538-7836.2009.03352.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shibazaki M, 1999, INFECT IMMUN, V67, P5186, DOI 10.1128/IAI.67.10.5186-5191.1999; Shibazaki M, 1996, INFECT IMMUN, V64, P5290, DOI 10.1128/IAI.64.12.5290-5294.1996; SIGURDSSON GH, 1992, CRIT CARE MED, V20, P458, DOI 10.1097/00003246-199204000-00005; Taylor FB, 1997, BLOOD, V89, P4078, DOI 10.1182/blood.V89.11.4078; Trapani JA, 1998, J BIOL CHEM, V273, P27934, DOI 10.1074/jbc.273.43.27934; Vollmar B, 2003, MICROCIRCULATION, V10, P143, DOI 10.1038/sj.mn.7800179; Waterhouse NJ, 2006, IMMUNOL CELL BIOL, V84, P72, DOI 10.1111/j.1440-1711.2005.01416.x; Waterhouse NJ, 2006, CELL DEATH DIFFER, V13, P607, DOI 10.1038/sj.cdd.4401772; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; WILKINSON JD, 1986, CRIT CARE MED, V14, P271, DOI 10.1097/00003246-198604000-00002; WILKINSON JD, 1987, J PEDIATR-US, V111, P324, DOI 10.1016/S0022-3476(87)80448-1; Winning J, 2010, CRIT CARE MED, V38, P32, DOI 10.1097/CCM.0b013e3181b4275c; Winning J, 2009, PLATELETS, V20, P50, DOI 10.1080/09537100802503368; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998; Zhou M, 2004, ANN SURG, V240, P321, DOI 10.1097/01.sla.0000133253.45591.5b	51	47	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41549	10.1371/journal.pone.0041549	http://dx.doi.org/10.1371/journal.pone.0041549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844498	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600034
J	Carranza, F; Falcon, CR; Nunez, N; Knubel, C; Correa, SG; Bianco, I; Maccioni, M; Fretes, R; Triquell, MF; Motran, CC; Cervi, L				Carranza, Franco; Roberto Falcon, Cristian; Nunez, Nicolas; Knubel, Carolina; Graciela Correa, Silvia; Bianco, Ismael; Maccioni, Mariana; Fretes, Ricardo; Fernanda Triquell, Maria; Cristina Motran, Claudia; Cervi, Laura			Helminth Antigens Enable CpG-Activated Dendritic Cells to Inhibit the Symptoms of Collagen-induced Arthritis through Foxp3+Regulatory T Cells	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE TOLERANCE; TH1 RESPONSES; MOUSE MODEL; SUPPRESSION; MECHANISMS; INDUCTION; IMMUNOMODULATION; GENERATION	Dendritic cells (DC) have the potential to control the outcome of autoimmunity by modulating the immune response. In this study, we tested the ability of Fasciola hepatica total extract (TE) to induce tolerogenic properties in CpG-ODN (CpG) maturated DC, to then evaluate the therapeutic potential of these cells to diminish the inflammatory response in collagen induced arthritis (CIA). DBA/1J mice were injected with TE plus CpG treated DC (T/C-DC) pulsed with bovine collagen II (CII) between two immunizations with CII and clinical scores CIA were determined. The levels of CII-specific IgG2 and IgG1 in sera, the histological analyses in the joints, the cytokine profile in the draining lymph node (DLN) cells and in the joints, and the number, and functionality of CD4+CD25+Foxp3+ T cells (Treg) were evaluated. Vaccination of mice with CII pulsed T/C-DC diminished the severity and incidence of CIA symptoms and the production of the inflammatory cytokine, while induced the production of anti-inflammatory cytokines. The therapeutic effect was mediated by Treg cells, since the adoptive transfer of CD4+CD25+ T cells, inhibited the inflammatory symptoms in CIA. The in vitro blockage of TGF-beta in cultures of DLN cells plus CII pulsed T/C-DC inhibited the expansion of Treg cells. Vaccination with CII pulsed T/C-DC seems to be a very efficient approach to diminish exacerbated immune response in CIA, by inducing the development of Treg cells, and it is therefore an interesting candidate for a cell-based therapy for rheumatoid arthritis (RA).	[Carranza, Franco; Roberto Falcon, Cristian; Nunez, Nicolas; Knubel, Carolina; Graciela Correa, Silvia; Maccioni, Mariana; Cristina Motran, Claudia; Cervi, Laura] Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, RA-5000 Cordoba, Argentina; [Bianco, Ismael] Consejo Nacl Invest Cient & Tecn, Agencia Cordoba Ciencia, Ctr Excelencia Prod & Proc Prov Cordoba CEPROCOR, Cordoba, Argentina; [Fretes, Ricardo; Fernanda Triquell, Maria] Univ Nacl Cordoba, Fac Ciencias Med, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Carranza, F (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, RA-5000 Cordoba, Argentina.	lcervi@fcq.unc.edu.ar	Motran, Claudia/U-9106-2019	Motran, Claudia/0000-0002-8088-3901	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET); Agencia de Promocion Cientifica y Tecnologica [PICT 2005-32027]	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) and Agencia de Promocion Cientifica y Tecnologica (PICT 2005-32027). FC, CRF, NN, CK and MFT are PhD fellows of CONICET, LC, SGC, IB, MM and CCM are members of the Scientific Career of Consejo Nacional de Investigaciones Cientificas de Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2004, SEMIN IMMUNOL, V16, P127, DOI 10.1016/j.smim.2003.12.008; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Bianco ID, 2000, FEBS LETT, V466, P292, DOI 10.1016/S0014-5793(00)01089-9; Brady MT, 1999, INFECT IMMUN, V67, P5372, DOI 10.1128/IAI.67.10.5372-5378.1999; Breedveld FC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3093; Campbell IK, 2009, ARTHRITIS RHEUM-US, V60, P1683, DOI 10.1002/art.24501; Cervi L, 1996, VET PARASITOL, V61, P97, DOI 10.1016/0304-4017(95)00816-0; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Falcon C, 2010, VET IMMUNOL IMMUNOP, V137, P36, DOI 10.1016/j.vetimm.2010.04.007; Falcon CR, 2012, J INFECT DIS, V205, P506, DOI 10.1093/infdis/jir606; Fallarino F, 2011, CURR MED CHEM, V18, P2215, DOI 0929-8673/11 $58.00+.00; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Gonzalez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007009; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; Harry RA, 2010, ANN RHEUM DIS, V69, P2042, DOI 10.1136/ard.2009.126383; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Khan S, 2009, NAT REV RHEUMATOL, V5, P566, DOI 10.1038/nrrheum.2009.185; Kudo Y, 2000, BBA-MOL BASIS DIS, V1500, P119, DOI 10.1016/S0925-4439(99)00096-4; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; MAIZELS R, 2007, NOVART FDN SYMP, V281, P204; Maizels Rick, 2007, Novartis Found Symp, V281, P192; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2361; Popov I, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2031; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; SEKI N, 1988, J IMMUNOL, V140, P1477; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Sidhu M, 2009, CLIN EXP IMMUNOL, V157, P350, DOI 10.1111/j.1365-2249.2009.03968.x; Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x; Stoop JN, 2011, ANN RHEUM DIS, V70, P1526, DOI 10.1136/ard.2011.151654; Thomson AW, 2008, ANN RHEUM DIS, V67, P90, DOI 10.1136/ard.2008.099176; van Duivenvoorde LM, 2007, J IMMUNOL, V179, P1506, DOI 10.4049/jimmunol.179.3.1506; van Duivenvoorde LM, 2004, ARTHRITIS RHEUM-US, V50, P3354, DOI 10.1002/art.20513; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803	44	46	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40356	10.1371/journal.pone.0040356	http://dx.doi.org/10.1371/journal.pone.0040356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848374	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600015
J	Ohana, O; Portner, H; Martin, KAC				Ohana, Ora; Portner, Hanspeter; Martin, Kevan A. C.			Fast Recruitment of Recurrent Inhibition in the Cat Visual Cortex	PLOS ONE			English	Article							THALAMOCORTICAL FEEDFORWARD INHIBITION; FAST-SPIKING INTERNEURONS; RECEPTIVE-FIELD STRUCTURE; SPINY STELLATE NEURONS; LAYER 4 NEURONS; STRIATE CORTEX; SYNAPTIC CONNECTIONS; GABA(A) RECEPTORS; IN-VITRO; ORIENTATION SELECTIVITY	Neurons of the same column in L4 of the cat visual cortex are likely to share the same sensory input from the same region of the visual field. Using visually-guided patch clamp recordings we investigated the biophysical properties of the synapses of neighboring layer 4 neurons. We recorded synaptic connections between all types of excitatory and inhibitory neurons in L4. The E-E, E-I, and I-E connections had moderate CVs and failure rates. However, E-I connections had larger amplitudes, faster rise-times, and shorter latencies. Identification of the sites of putative synaptic contacts together with compartmental simulations on 3D reconstructed cells, suggested that E-I synapses tended to be located on proximal dendritic branches, which would explain their larger EPSP amplitudes and faster kinetics. Excitatory and inhibitory synapses were located at the same distance on distal dendrites of excitatory neurons. We hypothesize that this co-localization and the fast recruitment of local inhibition provides an efficient means of modulating excitation in a precisely timed way.	[Ohana, Ora] Univ Med Ctr Hamburg Eppendorf, ZMNH, Ctr Mol Neurobiol, Inst Mol & Cellular Cognit, Hamburg, Germany; [Portner, Hanspeter] Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland; [Martin, Kevan A. C.] Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; ETH Zurich; ETH Zurich; University of Zurich	Ohana, O (corresponding author), Univ Med Ctr Hamburg Eppendorf, ZMNH, Ctr Mol Neurobiol, Inst Mol & Cellular Cognit, Hamburg, Germany.	ora.ohana@zmnh.uni-hamburg.de			EU research grant ['SECO' FP7-216593]; ETH grant [2-73246-08]; DFG [SFB 936]	EU research grant; ETH grant; DFG(German Research Foundation (DFG))	This work was supported by a EU research grant ('SECO' FP7-216593) and by a ETH grant (2-73246-08) to KACM. OO was supported by a DFG, SFB 936 Multi-Site Communication in the Brain, project B4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 1997, J COMP NEUROL, V380, P230; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Ali AB, 2007, J PHYSIOL-LONDON, V580, P149, DOI 10.1113/jphysiol.2006.124214; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; Angulo MC, 1997, J NEUROSCI, V17, P6685; Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Ayaz A, 2009, J NEUROPHYSIOL, V101, P958, DOI 10.1152/jn.90547.2008; Banitt Y, 2007, J NEUROSCI, V27, P10230, DOI 10.1523/JNEUROSCI.1640-07.2007; Bannister NJ, 2002, PHILOS T R SOC B, V357, P1793, DOI 10.1098/rstb.2002.1160; BAUMFALK U, 1988, BRAIN RES, V463, P398, DOI 10.1016/0006-8993(88)90418-0; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Carnevale NT, 2006, NEURON BOOK; Chitwood RA, 1999, J PHYSIOL-LONDON, V515, P743, DOI 10.1111/j.1469-7793.1999.743ab.x; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; da Costa NM, 2009, J NEUROSCI, V29, P13919, DOI 10.1523/JNEUROSCI.2785-09.2009; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Douglas RJ, 1989, NEURAL COMPUT, V1, P480, DOI 10.1162/neco.1989.1.4.480; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1997, J NEUROSCI, V17, P7220; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GU Q, 1993, J COMP NEUROL, V333, P94, DOI 10.1002/cne.903330108; GutierrezIgarza K, 1996, VISUAL NEUROSCI, V13, P61, DOI 10.1017/S0952523800007136; Hines ML, 2004, NEUROCOMPUTING, V58, P1117, DOI 10.1016/j.neucom.2004.01.175; IWAKIRI M, 1993, DEV BRAIN RES, V74, P89, DOI 10.1016/0165-3806(93)90087-Q; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; KISVARDAY ZF, 1985, J COMP NEUROL, V241, P111, DOI 10.1002/cne.902410202; KISVARDAY ZF, 1986, EXP BRAIN RES, V62, P89; Li G, 2008, NEUROSCIENCE, V155, P914, DOI 10.1016/j.neuroscience.2008.06.032; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; Mainen ZF, 1996, J NEUROPHYSIOL, V76, P1904, DOI 10.1152/jn.1996.76.3.1904; MARTIN KAC, 1983, EXP BRAIN RES, V50, P193; MARTIN KAC, 1988, Q J EXP PHYSIOL CMS, V73, P637, DOI 10.1113/expphysiol.1988.sp003190; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Murthy A, 1999, J NEUROPHYSIOL, V81, P1212, DOI 10.1152/jn.1999.81.3.1212; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Petersen CCH, 2000, J NEUROSCI, V20, P7579; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rall W, 1998, METHODS NEURONAL MOD, P27; Saez I, 2009, J NEUROSCI, V29, P4930, DOI 10.1523/JNEUROSCI.0046-09.2009; SEGEV I, 1995, J COMPUT NEUROSCI, V2, P117, DOI 10.1007/BF00961883; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SUAREZ H, 1995, J NEUROSCI, V15, P6700; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Szentagothai J, 1973, HDB SENSORY PHYSL, P269; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Troyer TW, 1998, J NEUROSCI, V18, P5908; van Elburg RAJ, 2009, NEURAL COMPUT, V21, P1913, DOI 10.1162/neco.2009.07-08-815; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; VIDYASAGAR TR, 1994, EXP BRAIN RES, V98, P31; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	75	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40601	10.1371/journal.pone.0040601	http://dx.doi.org/10.1371/journal.pone.0040601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848386	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000306806600022
J	Hanberry, BB; Dey, DC; He, HS				Hanberry, Brice B.; Dey, Dan C.; He, Hong S.			Regime Shifts and Weakened Environmental Gradients in Open Oak and Pine Ecosystems	PLOS ONE			English	Article							EASTERN REDCEDAR; COMMUNITY COMPOSITION; FOREST COMPOSITION; FIRE; VEGETATION; MISSOURI; DYNAMICS; PRODUCTIVITY; DISTURBANCE; REGRESSION	Fire suppression allows tree species that are intolerant of fire stress to increase their distribution, potentially resulting in disruption of historical species-environmental relationships. To measure changes between historical General Land Office surveys (1815 to 1850) and current USDA Forest Inventory and Assessment surveys (2004 to 2008), we compared composition, distribution, and site factors of 21 tree species or species groups in the Missouri Ozarks. We used 24 environmental variables and random forests as a classification method to model distributions. Eastern redcedar, elms, maples, and other fire-sensitive species have increased in dominance in oak forests, with concurrent reductions by oak species; specific changes varied by ecological subsection. Ordinations displayed loss of separation between formerly distinctive oak and fire-sensitive tree species groups. Distribution maps showed decreased presence of disturbance-dependent oak and pine species and increased presence of fire-sensitive species that generally expanded from subsections protected from fire along rivers to upland areas, except for eastern redcedar, which expanded into these subsections. Large scale differences in spatial gradients between past and present communities paralleled reduced influence of local topographic gradients in the varied relief of the Missouri Ozarks, as fire-sensitive species have moved to higher, drier, and sunnier sites away from riverine corridors. Due to changes in land use, landscapes in the Missouri Ozarks, eastern United States, and world-wide are changing from open oak and pine-dominated ecosystems to novel oak-mixed species forests, although at fine scales, forests are becoming more diverse in tree species today. Fire suppression weakened the influence by environmental gradients over species dominance, allowing succession from disturbance-dependent oaks to an alternative state of fire-sensitive species. Current and future research and conservation that rely on historical relationships and ecological principles based on disturbance across the landscape will need to incorporate modern interactions among species for resources into management plans and projections.	[Hanberry, Brice B.; He, Hong S.] Univ Missouri, Dept Forestry, Columbia, MO 65211 USA; [Dey, Dan C.] Univ Missouri, USDA Forest Serv, No Res Stn, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia	Hanberry, BB (corresponding author), Univ Missouri, Dept Forestry, Columbia, MO 65211 USA.	hanberryb@missouri.edu		Hanberry, Brice/0000-0001-8657-9540; He, Hong S./0000-0002-3983-2512	National Fire Plan of the USDA Forest Service, Northern Research Station	National Fire Plan of the USDA Forest Service, Northern Research Station	Funding was provided by the National Fire Plan of the USDA Forest Service, Northern Research Station. However, the work was completed without any contact with the sponsoring agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1995, CAN J FOREST RES, V25, P659, DOI 10.1139/x95-073; Abrams MD, 2003, BIOSCIENCE, V53, P927, DOI 10.1641/0006-3568(2003)053[0927:WHATWO]2.0.CO;2; ABRAMS MD, 1992, BIOSCIENCE, V42, P346, DOI 10.2307/1311781; Abrams MD, 1998, BIOSCIENCE, V48, P355, DOI 10.2307/1313374; ADAMS DE, 1980, AM J BOT, V67, P381, DOI 10.2307/2442348; Amatangelo KL, 2011, DIVERS DISTRIB, V17, P201, DOI 10.1111/j.1472-4642.2010.00730.x; Batek MJ, 1999, J BIOGEOGR, V26, P397, DOI 10.1046/j.1365-2699.1999.00292.x; BEERS TW, 1966, J FOREST, V64, P691; Blewett TJ, 1986, PRAIRIE PAST PRESENT, P122; BOURDO EA, 1956, ECOLOGY, V37, P754, DOI 10.2307/1933067; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggs JM, 2002, AM MIDL NAT, V147, P287, DOI 10.1674/0003-0031(2002)147[0287:EOWPIT]2.0.CO;2; Bruhn JN, 2000, FOREST PATHOL, V30, P43, DOI 10.1046/j.1439-0329.2000.00185.x; Burns RM, 1990, USDA FOR SER AGR HDB, V654; Chapman CH, 1983, INDIANS ARCHAEOLOGY; COTTAM G, 1949, ECOLOGY, V30, P271, DOI 10.2307/1932609; Cowell CM, 2007, J TORREY BOT SOC, V134, P215, DOI 10.3159/1095-5674(2007)134[215:SHADOA]2.0.CO;2; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DeSantis RD, 2010, J VEG SCI, V21, P606, DOI 10.1111/j.1654-1103.2010.01168.x; Dey DC, 2005, FOREST ECOL MANAG, V217, P37, DOI 10.1016/j.foreco.2005.05.002; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; ENGLE DM, 1995, INT J WILDLAND FIRE, V5, P135, DOI 10.1071/WF9950135; Fei SL, 2007, FOREST SCI, V53, P473; Fletcher PW, 1957, U MISSOURI COLL AGR, P625; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fuller TL, 1998, ECOSYSTEMS, V1, P76; GRIMM EC, 1984, ECOL MONOGR, V54, P291, DOI 10.2307/1942499; Guyette RP, 2006, FOREST ECOL MANAG, V234, P293, DOI 10.1016/j.foreco.2006.07.016; Guyette RP, 2004, FOREST ECOL MANAG, V198, P183, DOI 10.1016/j.foreco.2004.04.016; Guyette RP, 2002, ECOSYSTEMS, V5, P472, DOI 10.1007/s10021-002-0115-7; HOLTHUIJZEN AMA, 1987, CAN J BOT, V65, P1092, DOI 10.1139/b87-152; Iverson LR, 1997, LANDSCAPE ECOL, V12, P331, DOI 10.1023/A:1007989813501; JF Stritzke, 1990, E REDCEDAR ITS CONTR; Kabrick JM, 2008, FOREST ECOL MANAG, V255, P1409, DOI 10.1016/j.foreco.2007.10.054; Kabrick JM, 2008, FOREST ECOL MANAG, V255, P3051, DOI 10.1016/j.foreco.2007.09.068; KUCERA CL, 1957, ECOLOGY, V38, P285, DOI 10.2307/1931687; Lemieux CJ, 2005, CAN GEOGR-GEOGR CAN, V49, P384, DOI 10.1111/j.0008-3658.2005.00103.x; Liming FG, 1946, 106 USDA CENT STAT F; LORIMER CG, 1984, FOREST SCI, V30, P3; Nelson JC, 1997, AM MIDL NAT, V137, P79, DOI 10.2307/2426757; Nigh T.A., 2002, ATLAS MISSOURI ECORE; NIGH TA, 1985, AM MIDL NAT, V114, P235, DOI 10.2307/2425599; Norris MD, 2001, CAN J BOT, V79, P214, DOI 10.1139/cjb-79-2-214; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; Ozier TB, 2006, AM MIDL NAT, V155, P253, DOI 10.1674/0003-0031(2006)155[253:CCASCI]2.0.CO;2; PALLARDY SG, 1988, AM MIDL NAT, V120, P380, DOI 10.2307/2426010; Pallardy SG, 1995, NE197 USDA FOR SERV, P551; Raeker G, 2011, USDA FOR SERV RESOUR; Rentch JS, 2003, FOREST ECOL MANAG, V184, P285, DOI 10.1016/S0378-1127(03)00155-5; Ridgeway G., 1999, COMPUT SCI STAT, P172; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schmidt Thomas L., 1995, Northern Journal of Applied Forestry, V12, P180; SCHMIDT TL, 1993, J RANGE MANAGE, V46, P448, DOI 10.2307/4002665; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; South DB, 2003, J FOREST, V101, P30; Stambaugh MC, 2007, SHORTLEAF PINE RESTO, P59; Stambaugh MC, 2008, FOREST ECOL MANAG, V254, P463, DOI 10.1016/j.foreco.2007.08.029; Stambaugh MC, 2009, TREE-RING RES, V65, P147, DOI 10.3959/2008-14.1; Surrette SB, 2008, SOUTHEAST NAT, V7, P27, DOI 10.1656/1528-7092(2008)7[27:CAHCAS]2.0.CO;2; Umbanhowar CE, 2006, QUATERNARY RES, V66, P53, DOI 10.1016/j.yqres.2006.03.005; WARE S, 1992, AM MIDL NAT, V128, P40, DOI 10.2307/2426411; White C.A., 1983, HIST RECTANGULAR SUR	64	33	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41337	10.1371/journal.pone.0041337	http://dx.doi.org/10.1371/journal.pone.0041337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848467	Green Published, gold			2022-12-27	WOS:000306751300031
J	Bernstein, J; Gray, CF				Bernstein, Joseph; Gray, Chancellor F.			Content Factor: A Measure of a Journal's Contribution to Knowledge	PLOS ONE			English	Article							AFFORDABLE HEALTH-CARE	Impact Factor, the pre-eminent performance metric for medical journals, has been criticized for failing to capture the true impact of articles; for favoring methodology papers; for being unduly influenced by statistical outliers; and for examining a period of time too short to capture an article's long-term importance. Also, in the era of search engines, where readers need not skim through journals to find information, Impact Factor's emphasis on citation efficiency may be misplaced. A better metric would consider the total number of citations to all papers published by the journal (not just the recent ones), and would not be decremented by the total number of papers published. We propose a metric embodying these principles, "Content Factor", and examine its performance among leading medical and orthopaedic surgery journals. To remedy Impact Factor's emphasis on recent citations, Content Factor considers the total number of citations, regardless of the year in which the cited paper was published. To correct for Impact Factor's emphasis on efficiency, no denominator is employed. Content Factor is thus the total number of citations in a given year to all of the papers previously published in the journal. We found that Content Factor and Impact Factor are poorly correlated. We further surveyed 75 experienced orthopaedic authors and measured their perceptions of the "importance" of various orthopaedic surgery journals. The correlation between the importance score and the Impact Factor was only 0.08; the correlation between the importance score and Content Factor was 0.56. Accordingly, Content Factor better reflects a journal's "importance". In sum, while Content Factor cannot be defended as the lone metric of merit, to the extent that performance data informs journal evaluations, Content Factor-an easily obtained and intuitively appealing metric of the journal's knowledge contribution, not subject to gaming-can be a useful adjunct.	[Bernstein, Joseph] Vet Hosp, Dept Orthoped Surg, Philadelphia, PA USA; [Bernstein, Joseph; Gray, Chancellor F.] Univ Penn, Sch Med, Dept Orthoped Surg, Philadelphia, PA 19104 USA	University of Pennsylvania	Bernstein, J (corresponding author), Vet Hosp, Dept Orthoped Surg, Philadelphia, PA USA.	Joseph.Bernstein@uphs.upenn.edu						American Academy of Orthopaedic Surgeons, 2011, OKU 10 ORTHOPAEDIC K; [Anonymous], 2005, NATURE, V435, P1003, DOI 10.1038/4351003a; [Anonymous], 2006, PLOS MED, V3, P707, DOI 10.1371/journal.pmed.0030291; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; McCain JS, 2008, JAMA-J AM MED ASSOC, V300, P1925, DOI 10.1001/jama.2008.514; Obama B, 2008, JAMA-J AM MED ASSOC, V300, P1927, DOI 10.1001/jama.2008.515; WARREN JR, 1983, LANCET, V1, P1273	7	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41554	10.1371/journal.pone.0041554	http://dx.doi.org/10.1371/journal.pone.0041554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844500	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700111
J	Harren, K; Schumacher, J; Tudzynski, B				Harren, Karin; Schumacher, Julia; Tudzynski, Bettina			The Ca2+/Calcineurin-Dependent Signaling Pathway in the Gray Mold Botrytis cinerea: The Role of Calcipressin in Modulating Calcineurin Activity	PLOS ONE			English	Article							REGULATE GENE-EXPRESSION; ALPHA SUBUNIT BCG1; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-FUMIGATUS; HYPHAL ELONGATION; BINDING-PROTEIN; VIRULENCE; GROWTH	In the gray mold fungus Botrytis cinerea the G alpha subunit Bcg1 of a heterotrimeric G protein is an upstream activator of the Ca2+/calmodulin-dependent phosphatase calcineurin. In this study we focused on the functional characterization of the catalytic subunit of calcineurin (BcCnA) and its putative regulator calcipressin (BcRcn1). We deleted the genes encoding both proteins to examine their role concerning growth, differentiation and virulence. The Delta bccnA mutant shows a severe growth defect, does not produce conidia and is avirulent, while the loss of BcRcn1 caused retardation of hyphal growth and delayed infection of host plants, but had no impact on conidiation and sclerotia formation. Expression of several calcineurin-dependent genes and bccnA itself is positively affected by BcRcn1. Complementation of the Delta bcrcn1 mutant with a GFP-BcRcn1 fusion construct revealed that BcRcn1 is localized in the cytoplasm and accumulates around the nuclei. Furthermore, we showed that BcCnA physically interacts with BcRcn1 and the regulatory subunit of calcineurin, BcCnB. We investigated the impact of several protein domains characteristic for modulation and activation of BcCnA via BcRcn1, such as the phosphorylation sites and the calcineurin-docking site, by physical interaction studies between BcCnA and wild-type and mutated copies of BcRcn1. Based on the observed phenotypes we conclude that BcRcn1 acts as a positive modulator of BcCnA and the Ca2+/calcineurin-mediated signal transduction in B. cinerea, and that both proteins regulate fungal development and virulence.	[Harren, Karin; Schumacher, Julia; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Plants, Munster, Germany	University of Munster	Harren, K (corresponding author), Univ Munster, Inst Biol & Biotechnol Plants, Munster, Germany.	tudzynsb@uni-muenster.de	Schumacher, Julia/B-9142-2019	Schumacher, Julia/0000-0001-9120-9675	Deutsche Forschungsgemeinschaft (DFG) [TU101/10-6]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding was provided by Deutsche Forschungsgemeinschaft (DFG) grant TU101/10-6. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; Bader T, 2006, INFECT IMMUN, V74, P4366, DOI 10.1128/IAI.00142-06; Bastidas RJ, 2008, CURR OPIN INVEST DR, V9, P856; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Egan JD, 2009, MOL PLANT MICROBE IN, V22, P1293, DOI 10.1094/MPMI-22-10-1293; Fox DS, 2005, EUKARYOT CELL, V4, P1526, DOI 10.1128/EC.4.9.1526-1538.2005; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gioti A, 2006, J MOL BIOL, V358, P372, DOI 10.1016/j.jmb.2006.01.076; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Gronover CS, 2004, MOL PLANT MICROBE IN, V17, P537, DOI 10.1094/MPMI.2004.17.5.537; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hilioti Z, 2003, BIOCHEM BIOPH RES CO, V311, P1089, DOI 10.1016/S0006-291X(03)01515-8; Juvvadi PR, 2003, ARCH MICROBIOL, V179, P416, DOI 10.1007/s00203-003-0546-3; Juvvadi PR, 2008, EUKARYOT CELL, V7, P1606, DOI 10.1128/EC.00200-08; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; KANGATHARALINGAM N, 1984, CURR MICROBIOL, V10, P99, DOI 10.1007/BF01575767; Kawai M, 2001, CURR GENET, V39, P166; KAWAMURA A, 1995, J BIOL CHEM, V270, P15463, DOI 10.1074/jbc.270.26.15463; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Leroch M, 2011, APPL ENVIRON MICROB, V77, P2887, DOI 10.1128/AEM.02644-10; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Pinchai N, 2009, EUKARYOT CELL, V8, P511, DOI 10.1128/EC.00336-08; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Reedy J. L., 2010, Fungal Genetics and Biology, V47, P107, DOI 10.1016/j.fgb.2009.09.002; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Rolke Y, 2004, MOL PLANT PATHOL, V5, P17, DOI 10.1111/j.1364-3703.2004.00201.x; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher J, 2008, MOL PLANT MICROBE IN, V21, P1443, DOI 10.1094/MPMI-21-11-1443; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Schumacher J, 2008, MOL MICROBIOL, V67, P1027, DOI 10.1111/j.1365-2958.2008.06105.x; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Soriani FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-12; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Viaud M, 2003, MOL MICROBIOL, V50, P1451, DOI 10.1046/j.1365-2958.2003.03798.x; Wang HL, 2007, IUBMB LIFE, V59, P388, DOI 10.1080/15216540701370721; Wang HL, 2008, BIOCHEMISTRY-US, V47, P4461, DOI 10.1021/bi702539e; Wiesenberger G, 2007, EUKARYOT CELL, V6, P592, DOI 10.1128/EC.00382-06; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	71	31	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41761	10.1371/journal.pone.0041761	http://dx.doi.org/10.1371/journal.pone.0041761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844520	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700147
J	Lee, AWS; Hengstler, H; Schwald, K; Berriel-Diaz, M; Loreth, D; Kirsch, M; Kretz, O; Haas, CA; de Angelis, MH; Herzig, S; Brummendorf, T; Klingenspor, M; Rathjen, FG; Rozman, J; Nicholson, G; Cox, RD; Schafer, MKE				Lee, Angela W. S.; Hengstler, Heidi; Schwald, Kathrin; Berriel-Diaz, Mauricio; Loreth, Desiree; Kirsch, Matthias; Kretz, Oliver; Haas, Carola A.; de Angelis, Martin Hrabe; Herzig, Stephan; Bruemmendorf, Thomas; Klingenspor, Martin; Rathjen, Fritz G.; Rozman, Jan; Nicholson, George; Cox, Roger D.; Schaefer, Michael K. E.			Functional Inactivation of the Genome-Wide Association Study Obesity Gene Neuronal Growth Regulator 1 in Mice Causes a Body Mass Phenotype	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; INCREASED ENERGY-EXPENDITURE; EPITHELIAL OVARIAN-CANCER; NEURITE OUTGROWTH; IGLON FAMILY; HETEROPHILIC INTERACTIONS; TUMOR-SUPPRESSOR; NERVOUS-SYSTEM; DEFICIENT MICE; RAT-BRAIN	To date, genome-wide association studies (GWAS) have identified at least 32 novel loci for obesity and body mass-related traits. However, the causal genetic variant and molecular mechanisms of specific susceptibility genes in relation to obesity are yet to be fully confirmed and characterised. Here, we examined whether the candidate gene NEGR1 encoding the neuronal growth regulator 1, also termed neurotractin or Kilon, accounts for the obesity association. To characterise the function of NEGR1 for body weight control in vivo, we generated two novel mutant mouse lines, including a constitutive NEGR1-deficient mouse line as well as an ENU-mutagenised line carrying a loss-of-function mutation (Negr1-I87N) and performed metabolic phenotypic analyses. Ablation of NEGR1 results in a small but steady reduction of body mass in both mutant lines, accompanied with a small reduction in body length in the Negr1-I87N mutants. Magnetic resonance scanning reveals that the reduction of body mass in Negr1-I87N mice is due to a reduced proportion of lean mass. Negr1-I87N mutants display reduced food intake and physical activity while normalised energy expenditure remains unchanged. Expression analyses confirmed the brain-specific distribution of NEGR1 including strong expression in the hypothalamus. In vitro assays show that NEGR1 promotes cell-cell adhesion and neurite growth of hypothalamic neurons. Our results indicate a role of NEGR1 in the control of body weight and food intake. This study provides evidence that supports the link of the GWAS candidate gene NEGR1 with body weight control.	[Lee, Angela W. S.; Nicholson, George; Cox, Roger D.] MRC Mammalian Genet Unit, Harwell, Oxon, England; [Hengstler, Heidi; Schwald, Kathrin; Loreth, Desiree; Kirsch, Matthias; Kretz, Oliver; Schaefer, Michael K. E.] Univ Freiburg, Ctr Neurosci, Inst Anat & Cell Biol, D-79106 Freiburg, Germany; [Loreth, Desiree] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Berriel-Diaz, Mauricio; Herzig, Stephan] Ctr Mol Biol ZMBH, German Canc Res Ctr DKFZ, Joint Div Mol Metab Control, Heidelberg, Germany; [Berriel-Diaz, Mauricio; Herzig, Stephan] Univ Heidelberg Hosp, Heidelberg, Germany; [Haas, Carola A.] Univ Clin Freiburg, Neuroctr, Expt Epilepsy Grp, Freiburg, Germany; [de Angelis, Martin Hrabe; Rozman, Jan] Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Bruemmendorf, Thomas; Rathjen, Fritz G.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Klingenspor, Martin; Rozman, Jan] Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Klingenspor, Martin; Rozman, Jan] Tech Univ Munich, Res Ctr Nutr & Food Sci, ZIEL, Freising Weihenstephan, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany; [Nicholson, George] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	MRC Harwell; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Technical University of Munich; Technical University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Oxford	Lee, AWS (corresponding author), MRC Mammalian Genet Unit, Harwell, Oxon, England.	angela.lee@well.ox.ac.uk; r.cox@har.mrc.ac.uk; michael.schaefer@unimedizin-mainz.de	de Angelis, Martin Hrabe/F-5531-2012; Diaz, Mauricio Berriel/AAF-8285-2021; Rozman, Jan/A-2540-2010; Klingenspor, Martin/D-6930-2011; Kirsch, Matthias/G-7227-2015; Klingenspor, Martin/K-5033-2019	de Angelis, Martin Hrabe/0000-0002-7898-2353; Rozman, Jan/0000-0002-8035-8904; Klingenspor, Martin/0000-0002-4502-6664; Kirsch, Matthias/0000-0002-2090-8556; Kretz, Oliver/0000-0003-1152-5956; Herzig, Stephan/0000-0003-3950-3652; Nicholson, George/0000-0001-9588-6075; Cox, Roger/0000-0001-7170-5014; Berriel Diaz, Mauricio/0000-0003-4670-919X; Lee, Angela/0000-0002-7591-825X	UK Medical Research Council (MRC Mammalian Genetics Unit); Wellcome Trust [081219]; Bundesministerium fur Bildung und Forschung [01GS0869, 01GS0850]; Muller-Fahnenberg-Stiftung (Medizinische Fakultat Freiburg); Deutsche Forschungsgemeinschaft [BR1217/3-1]; UK Medical Research Council; Medical Research Council [MC_U142661184] Funding Source: researchfish; MRC [MC_U142661184] Funding Source: UKRI	UK Medical Research Council (MRC Mammalian Genetics Unit)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Muller-Fahnenberg-Stiftung (Medizinische Fakultat Freiburg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by UK Medical Research Council (MRC Mammalian Genetics Unit) and the Wellcome Trust (081219). Grants from the Bundesministerium fur Bildung und Forschung to M Klingenspor (01GS0869), to MHA (01GS0850) and to the German Center for Diabetes Research (DZD e.V.), from the Muller-Fahnenberg-Stiftung (Medizinische Fakultat Freiburg) to MS and from the Deutsche Forschungsgemeinschaft to TB (BR1217/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the UK Medical Research Council and the Wellcome Trust for funding. We thank the staff of the Mary Lyon Centre, MRC Harwell, FESA, GEMS cores and the Center for Neurosciences (University of Freiburg) as well as Ann-Elisabeth Schwarz and Brigitte Herrmann from the German Mouse Clinic for excellent technical support. We are grateful to Carmen Birchmeier, Max-Delbruck-Center for Molecular Medicine, Berlin, Germany, for providing the pTV0 vector and to Daniela-Nebenius Oosthuizen (Biocenter Basel) for blastocyst injection and chimera generation, and Susanne Huber for help with in situ hybridisation. Part of this research is in partial fulfilment of the requirements for the degree of Dr. med. (HH; KS) and Dr. rer. nat. (DL) at the University of Freiburg.	Akeel M, 2011, BRAIN RES, V1374, P27, DOI 10.1016/j.brainres.2010.12.028; Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Catania EH, 2008, BEHAV BRAIN RES, V188, P380, DOI 10.1016/j.bbr.2007.11.022; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Edwards D, 1995, INTRO GRAPHICAL MODE; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Gil OD, 1998, J NEUROSCI, V18, P9312; Gil OD, 2002, J NEUROBIOL, V51, P190, DOI 10.1002/neu.10050; Guijarro C, 2006, J NEUROCHEM, V97, P747, DOI 10.1111/j.1471-4159.2006.03728.x; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hashimoto T, 2008, BRAIN RES, V1224, P1, DOI 10.1016/j.brainres.2008.05.069; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Hester JM, 2011, INT J OBES LOND; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Hough TA, 2002, MAMM GENOME, V13, P595, DOI 10.1007/s00335-002-2188-1; Innos J, 2011, BEHAV BRAIN RES, V217, P21, DOI 10.1016/j.bbr.2010.09.019; Kilpelaeinen TO, 2011, AM J CLIN NUTR, V93, P851, DOI 10.3945/ajcn.110.000828; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lauritzen SL, 2004, GRAPHICAL MODELS; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; Lodge AP, 2000, MOL BRAIN RES, V82, P84, DOI 10.1016/S0169-328X(00)00184-4; Lodge AP, 2001, MOL CELL NEUROSCI, V17, P746, DOI 10.1006/mcne.2001.0964; Marg A, 1999, J CELL BIOL, V145, P865, DOI 10.1083/jcb.145.4.865; Marx M, 2012, NEUROGENETICS, V13, P49, DOI 10.1007/s10048-011-0307-4; Miyata S, 2003, NEUROSCIENCE, V117, P645, DOI 10.1016/S0306-4522(02)00873-4; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Ntougkos E, 2005, CLIN CANCER RES, V11, P5764, DOI 10.1158/1078-0432.CCR-04-2388; Pimenta AF, 2004, GENOMICS, V83, P790, DOI 10.1016/j.ygeno.2003.11.013; Pinheiro J, 2001, MIXED EFFECTS MODELS; Qiu SF, 2010, BIOL PSYCHIAT, V68, P197, DOI 10.1016/j.biopsych.2010.02.013; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed JE, 2007, NEUROPATH APPL NEURO, V33, P77, DOI 10.1111/j.1365-2990.2006.00786.x; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Schaefer MKE, 2007, J NEUROSCI, V27, P8779, DOI 10.1523/JNEUROSCI.1599-07.2007; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Schafer M, 2005, MOL CELL NEUROSCI, V29, P580, DOI 10.1016/j.mcn.2005.04.010; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sellar GC, 2003, NAT GENET, V34, P337, DOI 10.1038/ng1183; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sugimoto C, 2010, J NEUROCHEM, V112, P818, DOI 10.1111/j.1471-4159.2009.06513.x; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Walley AJ, 2011, INT J OBES LOND; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	56	45	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41537	10.1371/journal.pone.0041537	http://dx.doi.org/10.1371/journal.pone.0041537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844493	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000306687700105
J	van Ballegooijen, W; Riper, H; Donker, T; Abello, KM; Marks, I; Cuijpers, P				van Ballegooijen, Wouter; Riper, Heleen; Donker, Tara; Abello, Katherina Martin; Marks, Isaac; Cuijpers, Pim			Single-Item Screening for Agoraphobic Symptoms: Validation of a Web-Based Audiovisual Screening Instrument	PLOS ONE			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; RANDOMIZED CONTROLLED-TRIAL; ANXIETY DISORDERS; PANIC DISORDER; MOBILITY INVENTORY; LABOR MIGRANTS; MENTAL-HEALTH; SELF-HELP; INTERNET; DEPRESSION	The advent of web-based treatments for anxiety disorders creates a need for quick and valid online screening instruments, suitable for a range of social groups. This study validates a single-item multimedia screening instrument for agoraphobia, part of the Visual Screener for Common Mental Disorders (VS-CMD), and compares it with the text-based agoraphobia items of the PDSS-SR. The study concerned 85 subjects in an RCT of the effects of web-based therapy for panic symptoms. The VS-CMD item and items 4 and 5 of the PDSS-SR were validated by comparing scores to the outcomes of the CIDI diagnostic interview. Screening for agoraphobia was found moderately valid for both the multimedia item (sensitivity. 81, specificity. 66, AUC.734) and the text-based items (AUC.607-.697). Single-item multimedia screening for anxiety disorders should be further developed and tested in the general population and in patient, illiterate and immigrant samples.	[van Ballegooijen, Wouter; Riper, Heleen; Donker, Tara; Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [van Ballegooijen, Wouter; Riper, Heleen; Donker, Tara; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst, Amsterdam, Netherlands; [van Ballegooijen, Wouter; Abello, Katherina Martin] Trimbos Inst, Innovat Ctr Mental Hlth & Technol I COM, Utrecht, Netherlands; [van Ballegooijen, Wouter] Community Mental Hlth Ctr GGZ, InGeest, Dept Prevent Prezens, Amsterdam, Netherlands; [Riper, Heleen] Community Mental Hlth Ctr GGZ, InGeest, Dept Res, Amsterdam, Netherlands; [Riper, Heleen] Leuphana Univ, Luneburg, Germany; [Marks, Isaac] Kings Coll London, Inst Psychiat, London, England	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Trimbos Institute; Leuphana University Luneburg; University of London; King's College London	van Ballegooijen, W (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	w.van.ballegooijen@vu.nl	Cuijpers, Pim/G-1703-2013	van Ballegooijen, Wouter/0000-0002-9189-6695; Cuijpers, Pim/0000-0001-5497-2743; Donker, Tara/0000-0002-7470-8234	Dutch ministry of Health, Welfare and Sport, as part of 'Mental Vitality'	Dutch ministry of Health, Welfare and Sport, as part of 'Mental Vitality'	The development of the Visual Screener for Common Mental Disorders was funded by the Dutch ministry of Health, Welfare and Sport, as part of 'Mental Vitality.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The validation research was conducted without external funds.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1997, COMP INT DIAGN INT C; Austin DW, 2006, INT J TEST, V6, P25, DOI 10.1207/s15327574ijt0601_2; Buchanan T, 2002, PROF PSYCHOL-RES PR, V33, P148, DOI 10.1037//0735-7028.33.2.148; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Chambless DL, 2011, BEHAV THER, V42, P689, DOI 10.1016/j.beth.2011.03.001; CHAMBLESS DL, 1985, BEHAV RES THER, V23, P35, DOI 10.1016/0005-7967(85)90140-8; Chochinov HM, 1997, AM J PSYCHIAT, V154, P674; Cuijpers P, 2008, EUR CHILD ADOLES PSY, V17, P32, DOI 10.1007/s00787-007-0631-2; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; de Jager J, 2003, PDSS SR; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Donker T, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1134; Farvolden P, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.3.e23; Furukawa TA, 2006, BRIT J PSYCHIAT, V188, P305, DOI 10.1192/bjp.188.4.305; Furukawa TA, 2009, DEPRESS ANXIETY, V26, P922, DOI 10.1002/da.20532; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Hoyer J, 2002, J ANXIETY DISORD, V16, P113, DOI 10.1016/S0887-6185(01)00094-9; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Lin CC, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-12; Marks IM, 2004, PSYCHOL MED, V34, P9, DOI 10.1017/S003329170300878X; MARKS IM, 1979, BEHAV RES THER, V17, P263, DOI 10.1016/0005-7967(79)90041-X; Mayer R. E., 2005, CAMBRIDGE HDB MULTIM, V41, P31; Meulenbeek P, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-67; NICE, 2004, CLIN GUID; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riper H, 2009, VISUAL SCREENER COMM; Riper H, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1713; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Roness A, 2005, ACTA PSYCHIAT SCAND, V111, P51, DOI 10.1111/j.1600-0447.2004.00433.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smits CHM, 2005, INT J GERIATR PSYCH, V20, P436, DOI 10.1002/gps.1303; Smits N, 2007, INT J METH PSYCH RES, V16, P219, DOI 10.1002/mpr.230; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Sorbi MJ, 2009, PSYCHOL GEZONDH, V37, P191, DOI 10.1007/BF03080400; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Spijker J, 2004, INT J GERIATR PSYCH, V19, P538, DOI 10.1002/gps.1122; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TERSMITTEN M, 1998, COMPOSITE INT DIAGNO; Thorndike FP, 2009, COMPUT HUM BEHAV, V25, P393, DOI 10.1016/j.chb.2008.05.006; van Ballegooijen W, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-75; Whitehead L, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1593; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Wuyek LA, 2011, CLIN PSYCHOL PSYCHOT, V18, P234, DOI 10.1002/cpp.703	49	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e38480	10.1371/journal.pone.0038480	http://dx.doi.org/10.1371/journal.pone.0038480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844391	Green Published, gold			2022-12-27	WOS:000306687700003
J	Wang, B; Lindley, LE; Fernandez-Vega, V; Rieger, ME; Sims, AH; Briegel, KJ				Wang, Bin; Lindley, Linsey E.; Fernandez-Vega, Virneliz; Rieger, Megan E.; Sims, Andrew H.; Briegel, Karoline J.			The T Box Transcription Factor TBX2 Promotes Epithelial-Mesenchymal Transition and Invasion of Normal and Malignant Breast Epithelial Cells	PLOS ONE			English	Article							ULNAR-MAMMARY SYNDROME; E-CADHERIN EXPRESSION; GENE-EXPRESSION; TUMOR-METASTASIS; CANCER SUBTYPES; FACTOR SNAIL; CLAUDIN-LOW; STEM-CELLS; SENESCENCE; REPRESSES	The T box transcription factor TBX2, a master regulator of organogenesis, is aberrantly amplified in aggressive human epithelial cancers. While it has been shown that overexpression of TBX2 can bypass senescence, a failsafe mechanism against cancer, its potential role in tumor invasion has remained obscure. Here we demonstrate that TBX2 is a strong cell-autonomous inducer of the epithelial-mesenchymal transition (EMT), a latent morphogenetic program that is key to tumor progression from noninvasive to invasive malignant states. Ectopic expression of TBX2 in normal HC11 and MCF10A mammary epithelial cells was sufficient to induce morphological, molecular, and behavioral changes characteristic of EMT. These changes included loss of epithelial adhesion and polarity gene (E-cadherin, beta-catenin, ZO1) expression, and abnormal gain of mesenchymal markers (N-cadherin, Vimentin), as well as increased cell motility and invasion. Conversely, abrogation of endogenous TBX2 overexpression in the malignant human breast carcinoma cell lines MDA-MB-435 and MDA-MB-157 led to a restitution of epithelial characteristics with reciprocal loss of mesenchymal markers. Importantly, TBX2 inhibition abolished tumor cell invasion and the capacity to form lung metastases in a Xenograft mouse model. Meta-analysis of gene expression in over one thousand primary human breast tumors further showed that high TBX2 expression was significantly associated with reduced metastasis-free survival in patients, and with tumor subtypes enriched in EMT gene signatures, consistent with a role of TBX2 in oncogenic EMT. ChIP analysis and cell-based reporter assays further revealed that TBX2 directly represses transcription of E-cadherin, a tumor suppressor gene, whose loss is crucial for malignant tumor progression. Collectively, our results uncover an unanticipated link between TBX2 deregulation in cancer and the acquisition of EMT and invasive features of epithelial tumor cells.	[Wang, Bin; Lindley, Linsey E.; Fernandez-Vega, Virneliz; Rieger, Megan E.; Briegel, Karoline J.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Biochem & Mol Biol,Braman Family Breast Canc, Miami, FL 33136 USA; [Sims, Andrew H.] Edinburgh Canc Res Ctr, Breakthrough Res Unit, Appl Bioinformat Canc Res Grp, Edinburgh, Midlothian, Scotland	University of Miami; University of Edinburgh	Wang, B (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Biochem & Mol Biol,Braman Family Breast Canc, Miami, FL 33136 USA.	kbriegel@med.miami.edu	wang, bin/C-3163-2013; Sims, Andrew/E-4819-2012	Sims, Andrew/0000-0001-9082-3665	Flight Attendant Medical Research Institute/FAMRI [CIA_072080]; Bankhead Coley Cancer Research Program - Florida State Department of Health [08-BB-03]; Braman Family Breast Cancer Institute, UM Sylvester Cancer Center; DOD [W81XWH-08-1-0253]; Breakthrough Breast Cancer	Flight Attendant Medical Research Institute/FAMRI; Bankhead Coley Cancer Research Program - Florida State Department of Health; Braman Family Breast Cancer Institute, UM Sylvester Cancer Center; DOD(United States Department of Defense); Breakthrough Breast Cancer	This work was supported by grants from the Flight Attendant Medical Research Institute/FAMRI (CIA_072080), the Bankhead Coley Cancer Research Program - Florida State Department of Health (08-BB-03), and the Braman Family Breast Cancer Institute, UM Sylvester Cancer Center to KJB; a DOD predoctoral fellowship (W81XWH-08-1-0253) to MER; and from Breakthrough Breast Cancer to AHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Andersen CL, 2002, AM J PATHOL, V161, P73, DOI 10.1016/S0002-9440(10)64158-2; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Barlund M, 2000, CANCER RES, V60, P5340; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Briegel KJ, 2006, IUBMB LIFE, V58, P123, DOI 10.1080/15216540600686870; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen JR, 2001, MOL CELL ENDOCRINOL, V177, P43, DOI 10.1016/S0303-7207(01)00456-7; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Cho GS, 2011, DEVELOPMENT, V138, P465, DOI 10.1242/dev.061234; Christoffels VM, 2004, DEV DYNAM, V229, P763, DOI 10.1002/dvdy.10487; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Davis E, 2008, ONCOGENE, V27, P976, DOI 10.1038/sj.onc.1210701; Dimova I, 2009, TUMORI, V95, P357; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Fisher B, 2004, LANCET, V364, P858, DOI 10.1016/S0140-6736(04)16981-X; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Ismail A, 2009, CANCER LETT, V278, P230, DOI 10.1016/j.canlet.2009.01.006; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; Kelemen LE, 2009, CANCER EPIDEM BIOMAR, V18, P1864, DOI 10.1158/1055-9965.EPI-08-0486; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lindley LE, 2010, BIOCHEM BIOPH RES CO, V399, P659, DOI 10.1016/j.bbrc.2010.07.138; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Liu WK, 2010, ONKOLOGIE, V33, P241, DOI 10.1159/000305098; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Mani SA, 2007, P NATL ACAD SCI US; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manning L, 2006, DEV CELL, V11, P873, DOI 10.1016/j.devcel.2006.09.021; Martin N, 2012, EMBO J, V31, P95, DOI 10.1038/emboj.2011.370; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Paxton C, 2002, GENE, V283, P117, DOI 10.1016/S0378-1119(01)00878-2; Peres J, 2011, GENES CANC, V1, P272; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Redmond KL, 2010, ONCOGENE, V29, P3252, DOI 10.1038/onc.2010.84; Ribeiro I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000398; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Sinclair CS, 2002, CANCER RES, V62, P3587; Song D, 2009, ASIAN PAC J CANCER P, V10, P119; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Taneja P, 2010, CLIN MED INSIGHTS-ON, V4, P15; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trujillo KA, 2011, INT J CANCER, V129, P1310, DOI 10.1002/ijc.25788; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vance KW, 2010, MOL BIOL CELL, V21, P2770, DOI 10.1091/mbc.E09-12-1029; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vormer TL, 2008, MOL CELL BIOL, V28, P7263, DOI 10.1128/MCB.00313-08; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu M, 2009, GENE DEV, V23, P1737, DOI 10.1101/gad.1809309	92	46	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41355	10.1371/journal.pone.0041355	http://dx.doi.org/10.1371/journal.pone.0041355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844464	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700076
J	Gehrmann, M; Stangl, S; Kirschner, A; Foulds, GA; Sievert, W; Doss, BT; Walch, A; Pockley, AG; Multhoff, G				Gehrmann, Mathias; Stangl, Stefan; Kirschner, Andreas; Foulds, Gemma A.; Sievert, Wolfgang; Doss, Brigitte T.; Walch, Axel; Pockley, Alan G.; Multhoff, Gabriele			Immunotherapeutic Targeting of Membrane Hsp70-Expressing Tumors Using Recombinant Human Granzyme B	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BOUND HEAT-SHOCK-PROTEIN-70 HSP70; HEAT-SHOCK PROTEINS; CYTOTOXIC LYMPHOCYTES; CANCER; APOPTOSIS; EXPRESSION; BINDING; SURFACE; LOCALIZATION	Background: We have previously reported that human recombinant granzyme B (grB) mediates apoptosis in membrane heat shock protein 70 (Hsp70)-positive tumor cells in a perforin-independent manner. Methodology/Principal Findings: Optical imaging of uptake kinetics revealed co-localization of grB with recycling endosomes (Rab9/11) as early as 5 min after internalization, with late endosomes (Rab7) after 30 min, and the lysosomal compartment (LAMP1/2) after 60 to 120 min. Active caspase-3-mediated apoptosis was induced in mouse CT26 monolayer cells and 3D tumor spheroids, but not in normal mouse endothelial cells. Granzyme B selectively reduced the proportion of membrane Hsp70-positive cells in CT26 tumor spheroids. Consecutive i.v. injections of recombinant human grB into mice bearing membrane Hsp70-positive CT26 tumors resulted in significant tumor suppression, and a detailed inspection of normal mouse organs revealed that the administration of anti-tumoral concentrations of grB elicited no clinicopathological changes. Conclusions/Significance: These findings support the future clinical evaluation of human grB as a potential adjuvant therapeutic agent, especially for treating immunosuppressed patients that bear membrane Hsp70-positive tumors.	[Gehrmann, Mathias; Stangl, Stefan; Kirschner, Andreas; Foulds, Gemma A.; Sievert, Wolfgang; Doss, Brigitte T.; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany; [Gehrmann, Mathias; Stangl, Stefan; Kirschner, Andreas; Foulds, Gemma A.; Sievert, Wolfgang; Doss, Brigitte T.; Multhoff, Gabriele] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Clin Cooperat Grp CCG Innate Immun Tumor Biol, Munich, Germany; [Foulds, Gemma A.; Pockley, Alan G.] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Walch, Axel] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Inst Pathol, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Sheffield; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gehrmann, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Walch, Axel/B-4554-2012; Multhoff, Gabriele/AAW-9796-2021; Pockley, Alan G/I-4704-2015; Doß, Brigitte Tina Maria/AAF-1448-2021	Walch, Axel/0000-0001-5578-4023; Multhoff, Gabriele/0000-0002-2616-3137; Pockley, Alan G/0000-0001-9593-6431; Foulds, Gemma/0000-0002-2053-7580	Deutsche Forschungsgemeinschaft (DFG) [SFB824]; DFG [INST95/980-1 FUGG]; DFG-Cluster of Excellence: Munich Advanced Photonics (MAP); Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM [01EZ0826]; m4 Cluster of Excellence [01EX1021C]; Kompetenzverbund Strahlenforschung [03NUK007E]; European Union (EU CARDIORISK, FP7) [211403]; multimmune GmbH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DFG-Cluster of Excellence: Munich Advanced Photonics (MAP)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM(Federal Ministry of Education & Research (BMBF)); m4 Cluster of Excellence; Kompetenzverbund Strahlenforschung; European Union (EU CARDIORISK, FP7); multimmune GmbH	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB824, (DFG) INST95/980-1 FUGG, DFG-Cluster of Excellence: Munich Advanced Photonics (MAP), Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM (01EZ0826), m4 Cluster of Excellence (01EX1021C), Kompetenzverbund Strahlenforschung (03NUK007E), the European Union (EU CARDIORISK, FP7-211403) and multimmune GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Gabriele Multhoff and Alan Graham Pockley serve as Academic Editors of PLoS ONE. This study was partly funded by multimmune GmbH. The membrane Hsp70 phenotype on viable tumor and metastatic cells of patients was determined by flow cytometry using FITC-conjugated cmHsp70.1 mAb (multimmune GmbH, Germany). There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Balkow S, 2001, J VIROL, V75, P8781, DOI 10.1128/JVI.75.18.8781-8791.2001; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Botzler C, 1996, CANCER IMMUNOL IMMUN, V43, P226, DOI 10.1007/s002620050326; Botzler C, 1998, CELL STRESS CHAPERON, V3, P6, DOI 10.1379/1466-1268(1998)003<0006:DOELEO>2.3.CO;2; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Chavez-Galan L, 2009, CELL MOL IMMUNOL, V6, P15, DOI 10.1038/cmi.2009.3; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cullen SP, 2010, CELL DEATH DIFFER, V17, P616, DOI 10.1038/cdd.2009.206; DERTINGER H, 1984, RECENT RESULTS CANC, V95, P67; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gehrmann M, 2004, CLIN CANCER RES, V10, P3354, DOI 10.1158/1078-0432.CCR-03-0382; Gehrmann M, 2005, CELL DEATH DIFFER, V12, P38, DOI 10.1038/sj.cdd.4401510; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Gehrmann M, 2011, J IMMUNOL METHODS, V371, P8, DOI 10.1016/j.jim.2011.06.007; Gehrmann M, 2002, BIOL CHEM, V383, P1715, DOI 10.1515/BC.2002.192; Giesubel U, 2006, BIOCHEM J, V394, P563, DOI 10.1042/BJ20050687; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Krause SW, 2004, CLIN CANCER RES, V10, P3699, DOI 10.1158/1078-0432.CCR-03-0683; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liu YY, 2006, NEOPLASIA, V8, P125, DOI 10.1593/neo.05556; Liu YY, 2003, MOL CANCER THER, V2, P1341; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; Milani V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-50; Multhoff G, 1997, J IMMUNOL, V158, P4341; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Pfister K, 2007, CANCER-AM CANCER SOC, V110, P926, DOI 10.1002/cncr.22864; Rerole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16; Schilling D, 2009, FASEB J, V23, P2467, DOI 10.1096/fj.08-125229; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Stangl S, 2011, J CELL MOL MED, V15, P874, DOI 10.1111/j.1582-4934.2010.01067.x; Stangl S, 2011, P NATL ACAD SCI USA, V108, P733, DOI 10.1073/pnas.1016065108; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Trapani JA, 1996, J BIOL CHEM, V271, P4127; WANG M, 1995, J IMMUNOL, V154, P4685; Xia ZN, 1998, BIOCHEM BIOPH RES CO, V243, P384, DOI 10.1006/bbrc.1998.8102	41	24	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41341	10.1371/journal.pone.0041341	http://dx.doi.org/10.1371/journal.pone.0041341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829941	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300080
J	Yvert, T; He, ZH; Santiago, C; Hu, Y; Li, YC; Gomez-Gallego, F; Fiuza-Luces, C; Verde, Z; Muniesa, CA; Olivan, J; Santalla, A; Ruiz, JR; Lucia, A				Yvert, Thomas; He, Zi-Hong; Santiago, Catalina; Hu, Yang; Li, Yan-Chun; Gomez-Gallego, Felix; Fiuza-Luces, Carmen; Verde, Zoraida; Muniesa, Carlos A.; Olivan, Jesus; Santalla, Alfredo; Ruiz, Jonatan R.; Lucia, Alejandro			Acyl Coenzyme A Synthetase Long-Chain 1 (ACSL1) Gene Polymorphism (rs6552828) and Elite Endurance Athletic Status: A Replication Study	PLOS ONE			English	Article							FATTY-ACIDS; ASSOCIATION ANALYSIS; EXPRESSION; ENZYMES; PROTEIN; PPAR	The aim of this study was to determine the association between the rs6552828 polymorphism in acyl coenzyme A synthetase (ACSL1) and elite endurance athletic status. We studied 82 Caucasian (Spanish) World/Olympic-class endurance male athletes, and a group of sex and ethnically matched healthy young adults (controls, n = 197). The analyses were replicated in a cohort of a different ethnic origin (Chinese of the Han ethnic group), composed of elite endurance athletes (runners) [cases, n = 241 (128 male)] and healthy sedentary adults [controls, n = 504 (267 male)]. In the Spanish cohort, genotype (P = 0.591) and minor allele (A) frequencies were similar in cases and controls (P = 0.978). In the Chinese cohort, genotype (P = 0.973) and minor allele (G) frequencies were comparable in female endurance athletes and sedentary controls (P = 0.881), whereas in males the frequency of the G allele was higher in endurance athletes (0.40) compared with their controls (0.32, P = 0.040). The odds ratio (95% CI) for an elite endurance Chinese athlete to carry the G allele compared with ethnically matched controls was 1.381 (1.015-1.880) (P-value = 0.04). Our findings suggest that the ACSL1 gene polymorphism rs6552828 is not associated with elite endurance athletic status in Caucasians, yet a marginal association seems to exist for the Chinese (Han) male population.	[Yvert, Thomas; Santiago, Catalina; Gomez-Gallego, Felix; Fiuza-Luces, Carmen; Verde, Zoraida; Lucia, Alejandro] European Univ Madrid, Dept Biomed, Madrid, Spain; [He, Zi-Hong] China Inst Sport Sci, Ctr Biol, Beijing, Peoples R China; [Hu, Yang; Li, Yan-Chun] Beijing Sports Univ, Sci & Res Ctr, Beijing, Peoples R China; [Muniesa, Carlos A.; Olivan, Jesus] European Univ Madrid, Fac Sports Sci, Madrid, Spain; [Santalla, Alfredo] Pabo de Olavide Univ, Fac Sports Sci, Seville, Spain; [Ruiz, Jonatan R.] Univ Granada, Dept Phys Educ & Sport, Sch Sport Sci, Granada, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Dept Biosci & Nutr, Novum, Unit Prevent Nutr, Stockholm, Sweden	European University of Madrid; China Institute of Sport Science; Beijing Sport University; European University of Madrid; Universidad Pablo de Olavide; University of Granada; Karolinska Institutet	Yvert, T (corresponding author), European Univ Madrid, Dept Biomed, Madrid, Spain.	alejandro.lucia@uem.es	Gomez-Gallego, Felix/H-6925-2013; li, yan/GTI-4638-2022; Lucia, Alejandro/M-2759-2014; Santiago, Catalina/K-6803-2014; Santiago, Catalina/P-8177-2019; VERDE, ZORAIDA/A-9914-2012; RUIZ, JONATAN R/M-1338-2015; Gomez-Gallego, Felix/AAD-9617-2020	Gomez-Gallego, Felix/0000-0002-1968-1761; Lucia, Alejandro/0000-0002-3025-2060; Santiago, Catalina/0000-0003-3852-8217; Santiago, Catalina/0000-0003-3852-8217; VERDE, ZORAIDA/0000-0002-9260-7672; RUIZ, JONATAN R/0000-0002-7548-7138; Yvert, Thomas/0000-0002-9451-9799; Lucia, Alejandro/0000-0002-5565-0997; Santalla Hernandez, Alfredo/0000-0001-9418-0564; Fiuza-Luces, Carmen/0000-0001-8131-7007	Consejo Superior de Deportes [UPR12]; Spanish Ministry of Science and Innovation [RYC-2010-05957]; Fondo de Investigaciones Sanitarias [PS09/00194]; China Institute of Sport Science [2011-03]; Ministry of Science and Technology of the People's Republic of China [2003BA904B04]	Consejo Superior de Deportes; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); China Institute of Sport Science; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The present study was funded by the Consejo Superior de Deportes (grant #UPR12) Spanish Ministry of Science and Innovation (RYC-2010-05957) and Fondo de Investigaciones Sanitarias (ref. # PS09/00194), and grants from China Institute of Sport Science (Grant code: 2011-03) and grants from Ministry of Science and Technology of the People's Republic of China (Grant code: 2003BA904B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Daniels J, 1979, OXYGEN POWER, P5; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; He ZH, 2011, MED SCI SPORT EXER, V43, P1433, DOI 10.1249/MSS.0b013e31820e7f38; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Phillips CM, 2010, J LIPID RES, V51, P1793, DOI 10.1194/jlr.M003046; Sasabe T, 2007, NEUROSCI LETT, V412, P139, DOI 10.1016/j.neulet.2006.10.064; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schoonjans K, 1996, J LIPID RES, V37, P907	21	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41268	10.1371/journal.pone.0041268	http://dx.doi.org/10.1371/journal.pone.0041268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829935	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300074
J	Bates, M; O'Grady, J; Mwaba, P; Chilukutu, L; Mzyece, J; Cheelo, B; Chilufya, M; Mukonda, L; Mumba, M; Tembo, J; Chomba, M; Kapata, N; Rachow, A; Clowes, P; Maeurer, M; Hoelscher, M; Zumla, A				Bates, Matthew; O'Grady, Justin; Mwaba, Peter; Chilukutu, Lophina; Mzyece, Judith; Cheelo, Busiku; Chilufya, Moses; Mukonda, Lukundo; Mumba, Maxwell; Tembo, John; Chomba, Mumba; Kapata, Nathan; Rachow, Andrea; Clowes, Petra; Maeurer, Markus; Hoelscher, Michael; Zumla, Alimuddin			Evaluation of the Burden of Unsuspected Pulmonary Tuberculosis and Co-Morbidity with Non-Communicable Diseases in Sputum Producing Adult Inpatients	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV-INFECTED PATIENTS; SUBCLINICAL TUBERCULOSIS; TB; COUNTRIES; CULTURE	Background: A high burden of tuberculosis (TB) occurs in sub-Saharan African countries and many cases of active TB and drug-resistant TB remain undiagnosed. Tertiary care hospitals provide an opportunity to study TB co-morbidity with non-communicable and other communicable diseases (NCDs/CDs). We evaluated the burden of undiagnosed pulmonary TB and multi-drug resistant TB in adult inpatients, regardless of their primary admission diagnosis, in a tertiary referral centre. Methodology/Principal Findings: In this prospective study, newly admitted adult inpatients able to produce sputum at the University Teaching Hospital, Lusaka, Zambia, were screened for pulmonary TB using fluorescent smear microscopy and automated liquid culture. The burden of pulmonary TB, unsuspected TB, TB co-morbidity with NCDs and CDs was determined. Sputum was analysed from 900 inpatients (70.6% HIV infected) 277 (30.8%) non-TB suspects, 286 (31.8%) TB suspects and 337 (37.4%) were already receiving TB treatment. 202/900 (22.4%) of patients had culture confirmed TB. TB co-morbidity was detected in 20/275 (7.3%) NCD patients, significantly associated with diabetes (P = 0.006, OR 6.571, 95% CI: 1.706-25.3). 27/202 (13.4%) TB cases were unsuspected. There were 18 confirmed cases of MDR-TB, 5 of which were unsuspected. Conclusions/Significance: A large burden of unsuspected pulmonary TB co-morbidity exists in inpatients with NCDs and other CDs. Pro-active sputum screening of all inpatients in tertiary referral centres in high TB endemic countries is recommended. The scale of the problem of undiagnosed MDR-TB in inpatients requires further study.	[Bates, Matthew; O'Grady, Justin; Zumla, Alimuddin] UCL, Dept Infect, Div Infect & Immun, London, England; [Bates, Matthew; O'Grady, Justin; Mwaba, Peter; Chilukutu, Lophina; Mzyece, Judith; Cheelo, Busiku; Chilufya, Moses; Mukonda, Lukundo; Mumba, Maxwell; Tembo, John; Chomba, Mumba; Kapata, Nathan; Zumla, Alimuddin] Univ Zambia, Lusaka, Zambia; [Bates, Matthew; O'Grady, Justin; Mwaba, Peter; Chilukutu, Lophina; Mzyece, Judith; Cheelo, Busiku; Chilufya, Moses; Mukonda, Lukundo; Mumba, Maxwell; Tembo, John; Chomba, Mumba; Kapata, Nathan; Zumla, Alimuddin] Univ Teaching Hosp, Univ Coll London Med Sch UNZA UCLMS Res & Trainin, Lusaka, Zambia; [Kapata, Nathan] Minist Hlth, Natl TB Control Programme, Lusaka, Zambia; [Rachow, Andrea; Clowes, Petra; Hoelscher, Michael] MMRP, Mbeya, Tanzania; [Maeurer, Markus] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden; [Hoelscher, Michael] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany	University of London; University College London; University of Zambia; University of Zambia; Karolinska Institutet; University of Munich	Bates, M (corresponding author), UCL, Dept Infect, Div Infect & Immun, London, England.	a.zumla@ucl.ac.uk	Kapata, Nathan/AAW-2469-2020; O'Grady, Justin/I-2982-2012; Mwaba, Peter/V-6017-2019; Hoelscher, Michael/D-3436-2012; ZUMLA, Alimuddin/ABA-8208-2020	O'Grady, Justin/0000-0001-5412-7152; ZUMLA, Alimuddin/0000-0002-5111-5735; Maeurer, Markus/0000-0002-8436-8077; Kapata, Nathan/0000-0002-3877-8809; Bates, Matthew/0000-0003-0464-1529	European Union; European and Developing Countries Clinical Trials Partnership (EDCTP); UK Medical Research Council (MRC); UBS Optimus Foundation; University College London Hospitals Comprehensive Biomedical Research Centre (UCLH-CBRC); UCL Hospitals National Health Service (NHS) Foundation Trust	European Union(European Commission); European and Developing Countries Clinical Trials Partnership (EDCTP); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UBS Optimus Foundation; University College London Hospitals Comprehensive Biomedical Research Centre (UCLH-CBRC); UCL Hospitals National Health Service (NHS) Foundation Trust	AZ, MH, JOG and MB acknowledge support from the European Union and the European and Developing Countries Clinical Trials Partnership (EDCTP). AZ is supported by the UK Medical Research Council (MRC), UBS Optimus Foundation, University College London Hospitals Comprehensive Biomedical Research Centre (UCLH-CBRC) and the UCL Hospitals National Health Service (NHS) Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2011, J INFECT DIS, V204, pS1179, DOI 10.1093/infdis/jir451; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Cohn DL, 2005, CLIN INFECT DIS, V40, P1508, DOI 10.1086/429835; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Harries AD, 2006, TROP DOCT, V36, P65, DOI 10.1258/004947506776593459; Kapata N, 2012, TROP MED INT HLTH; Kapata N, 2011, TROP MED INT HEALTH, V16, P1404, DOI 10.1111/j.1365-3156.2011.02849.x; Lauritsen JM, 2008, COMPREHENSIVE TOOL V; Lawn SD, 2011, AIDS, V25, P2190, DOI 10.1097/QAD.0b013e32834cda4e; Lins Nancy E, 2010, Glob Health Promot, V17, P27, DOI 10.1177/1757975910363927; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Migliori GB, 2010, TROP MED INT HEALTH, V15, P1052, DOI 10.1111/j.1365-3156.2010.02581.x; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Swaminathan S, 2004, INT J TUBERC LUNG D, V8, P896; The National TB and Leprosy Control Programme, 2007, TUB TB HIV MAN; WHO, 2011, WHO GLOBAL TUBERCULO; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9	26	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40774	10.1371/journal.pone.0040774	http://dx.doi.org/10.1371/journal.pone.0040774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848401	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000306950200031
J	Han, SW; Cha, Y; Paquet, A; Huang, WD; Weidler, J; Lie, Y; Sherwood, T; Bates, M; Haddad, M; Park, IH; Oh, DY; Lee, KS; Im, SA; Bang, YJ; Ro, J; Kim, TY				Han, Sae-Won; Cha, Yongjun; Paquet, Agnes; Huang, Weidong; Weidler, Jodi; Lie, Yolanda; Sherwood, Thomas; Bates, Michael; Haddad, Mojgan; Park, In Hae; Oh, Do-Youn; Lee, Keun Seok; Im, Seock-Ah; Bang, Yung-Jue; Ro, Jungsil; Kim, Tae-You			Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; ERBB RECEPTORS; TRASTUZUMAB; EFFICACY; THERAPY; PROTEIN; QUANTITATION; ONCOGENE; ANTIBODY	Background: Lapatinib plus capecitabine is an effective treatment option for trastuzumab-refractory HER2-positive metastatic breast cancer. We have investigated the correlation between quantitative measures of HER2, p95HER2, and HER3 and treatment outcomes using lapatinib and capecitabine. Methods: Total HER2 (H2T), p95HER2 (p95), and total HER3 (H3T) expression were quantified in formalin-fixed paraffinembedded samples using the VeraTag assays. Patients received lapatinib and capecitabine treatment following trastuzumab failure according to the Lapatinib Expanded Access Program. The association between the protein expression levels and clinical outcomes was analyzed. Results: A total of 52 patients were evaluable. H2T level was significantly higher in responders (median 93.49 in partial response, 47.66 in stable disease, and 17.27 in progressive disease; p = 0.020). Longer time-to-progression (TTP) was observed in patients with high H2T [p = 0.018, median 5.2 months in high (> 14.95) vs. 1.8 in low (< 14.95)] and high H3T [p = 0.017, median 5.0 months in high (> 0.605) vs. 2.2 in low (< 0.605)]. Patients having both high H2T and high H3T had significantly longer TTP [adjusted hazard ratio (HR) 0.38 (95% CI 0.20-0.73), p = 0.004] and overall survival [adjusted HR 0.46 (95% CI 0.24-0.89), p = 0.020]. No significant association between p95 and response or survival was observed. Conclusions: These data suggest a correlation between high HER2 and high HER3 expression and treatment outcome, while no significant difference was observed between clinical outcome and p95 expression level in this cohort of HER2-positive, trastuzumab-refractory metastatic breast cancer patients treated with lapatinib and capecitabine.	[Han, Sae-Won; Cha, Yongjun; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Paquet, Agnes; Huang, Weidong; Weidler, Jodi; Lie, Yolanda; Sherwood, Thomas; Bates, Michael; Haddad, Mojgan] Monogram Biosci Inc, San Francisco, CA USA; [Park, In Hae; Lee, Keun Seok; Ro, Jungsil] Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea; [Kim, Tae-You] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); National Cancer Center - Korea (NCC); Seoul National University (SNU)	Han, SW (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	jungsro@ncc.re.kr; kimty@snu.ac.kr	Bang, Yung Jue/J-2759-2012; Im, Seock-Ah/J-5620-2012	Bang, Yung Jue/0000-0001-6000-4597; 	Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A091081]; Cancer Research Institute, Seoul National University	Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Cancer Research Institute, Seoul National University	This study was supported by grants from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A091081) and from Cancer Research Institute, Seoul National University (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Arribas J, 2011, CANCER RES, V71, P1515, DOI 10.1158/0008-5472.CAN-10-3795; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Goodman LJ, 2009, ASCO M, P1021; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Huang WD, 2010, AM J CLIN PATHOL, V134, P303, DOI 10.1309/AJCP3BZY4YAFNTRG; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Larson JS, 2010, PATHOLOG RES INT; Lipton A, 2010, CANCER-AM CANCER SOC, V116, P5168, DOI 10.1002/cncr.25430; Menendez JA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1773; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Motoyama AB, 2002, CANCER RES, V62, P3151; Naidu R, 1998, BRIT J CANCER, V78, P1385, DOI 10.1038/bjc.1998.689; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Scaltriti M, 2010, CLIN CANCER RES, V16, P2688, DOI 10.1158/1078-0432.CCR-09-3407; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith BL, 2004, BRIT J CANCER, V91, P1190, DOI 10.1038/sj.bjc.6602090; Sperinde J, 2010, CLIN CANCER RES, V16, P4226, DOI 10.1158/1078-0432.CCR-10-0410; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xia WL, 2004, ONCOGENE, V23, P646, DOI 10.1038/sj.onc.1207166	29	20	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39943	10.1371/journal.pone.0039943	http://dx.doi.org/10.1371/journal.pone.0039943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848366	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200015
J	Li, XQ; Zhu, YH; Zhang, HF; Yue, Y; Cai, ZX; Lu, QP; Zhang, L; Weng, XG; Zhang, FJ; Zhou, D; Yang, JC; Wang, JF				Li, Xiao-Qiong; Zhu, Yao-Hong; Zhang, Hong-Fu; Yue, Yuan; Cai, Zheng-Xing; Lu, Qing-Ping; Zhang, Lu; Weng, Xiao-Gang; Zhang, Fan-Jian; Zhou, Dong; Yang, Jin-Cai; Wang, Jiu-Feng			Risks Associated with High-Dose Lactobacillus rhamnosus in an Escherichia coli Model of Piglet Diarrhoea: Intestinal Microbiota and Immune Imbalances	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-2; EPITHELIAL-CELLS; FUNCTIONAL-CHARACTERIZATION; ANTIMICROBIAL ACTIVITY; POSTWEANING DIARRHEA; DIAMINOPIMELIC ACID; MOLECULAR-CLONING; EXPRESSION; GG	Probiotic could be a promising alternative to antibiotics for the prevention of enteric infections; however, further information on the dose effects is required. In this study, weanling piglets were orally administered low-or high-dose Lactobacillus rhamnosus ACTT 7469 (10(10) CFU/d or 10(12) CFU/d) for 1 week before F4 (K88)-positive Escherichia coli challenge. The compositions of faecal and gastrointestinal microbiota were recorded; gene expression in the intestines was assessed by real-time PCR; serum tumour necrosis factor-alpha (TNF-alpha) concentrations and intestinal Toll-like receptor 4 (TLR4) were detected by ELISA and immunohistochemistry, respectively. Unexpectedly, high-dose administration increased the incidence of diarrhoea before F4(+)ETEC challenge, despite the fact that both doses ameliorated F4(+)ETEC-induced diarrhoea with increased Lactobacillus and Bifidobacterium counts accompanied by reduced coliform shedding in faeces. Interestingly, L. rhamnosus administration reduced Lactobacillus and Bifidobacterium counts in the colonic contents, and the high-dose piglets also had lower Lactobacillius and Bacteroides counts in the ileal contents. An increase in the concentration of serum TNF-alpha induced by F4(+)ETEC was observed, but the increase was delayed by L. rhamnosus. In piglets exposed to F4(+)ETEC, jejunal TLR4 expression increased at the mRNA and protein levels, while jejunal interleukin (IL)-8 and ileal porcine beta-defensins 2 (pBD2) mRNA expression increased; however, these increases were attenuated by administration of L. rhamnosus. Notably, expression of jejunal TLR2, ileal TLR9, Nod-like receptor NOD1 and TNF-alpha mRNA was upregulated in the low-dose piglets after F4(+)ETEC challenge, but not in the high-dose piglets. These findings indicate that pretreatment with a low dose of L. rhamnosus might be more effective than a high dose at ameliorating diarrhoea. There is a risk that high-dose L. rhamnosus pretreatment may negate the preventative effects, thus decreasing the prophylactic benefits against potential enteric pathogens. Our data suggest a safe threshold for preventative use of probiotics in clinical practice.	[Li, Xiao-Qiong; Zhu, Yao-Hong; Yue, Yuan; Cai, Zheng-Xing; Weng, Xiao-Gang; Zhang, Fan-Jian; Zhou, Dong; Yang, Jin-Cai; Wang, Jiu-Feng] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Zhang, Hong-Fu; Lu, Qing-Ping] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Zhang, Lu] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Aarhus University	Li, XQ (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	Jiufeng_wang@hotmail.com			Program for New Century Excellent Talents in University (China) [NCET-10-0791]; Special Fund for Agro-Scientific Research in the Public Interest (China) [201003060-07]; State Key Laboratory of Animal Nutrition (China) [2004DA125184F1017]	Program for New Century Excellent Talents in University (China)(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-Scientific Research in the Public Interest (China); State Key Laboratory of Animal Nutrition (China)	This project was supported by grants from the Program for New Century Excellent Talents in University (China) (Project No. NCET-10-0791) and the Special Fund for Agro-Scientific Research in the Public Interest (China) (Project No. 201003060-07), and the State Key Laboratory of Animal Nutrition (China) (Project No. 2004DA125184F1017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2009, J CLIN GASTROENTEROL, V43, P208, DOI 10.1097/MCG.0b013e31815a5780; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; Casini L, 2007, LIVEST SCI, V108, P226, DOI 10.1016/j.livsci.2007.01.072; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; COCONNIER MH, 1993, J DIARRHOEAL DIS RES, V11, P235; Collado MC, 2007, CURR MICROBIOL, V55, P260, DOI 10.1007/s00284-007-0144-8; Collado-Romero M, 2010, VET RES, V41, DOI 10.1051/vetres/2009072; Cutler SA, 2007, ANTIMICROB AGENTS CH, V51, P3830, DOI 10.1128/AAC.00360-07; Daudelin JF, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-69; Devriendt B, 2010, DEV COMP IMMUNOL, V34, P1175, DOI 10.1016/j.dci.2010.06.009; Duvigneau JC, 2005, J IMMUNOL METHODS, V306, P16, DOI 10.1016/j.jim.2005.06.021; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Franklin MA, 2002, J ANIM SCI, V80, P2904; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghadimi D, 2010, INFLAMM BOWEL DIS, V16, P410, DOI 10.1002/ibd.21057; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Hermes RG, 2011, COMP IMMUNOL MICROB, V34, P479, DOI 10.1016/j.cimid.2011.08.006; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Llopis M, 2009, INFLAMM BOWEL DIS, V15, P275, DOI 10.1002/ibd.20736; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Meurens F, 2009, MOL IMMUNOL, V46, P927, DOI 10.1016/j.molimm.2008.09.036; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salazar-Lindo Eduardo, 2004, BMC Pediatr, V4, P18, DOI 10.1186/1471-2431-4-18; Saleh M, 2011, IMMUNOL REV, V243, P235, DOI 10.1111/j.1600-065X.2011.01045.x; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Shu Q, 2001, J PEDIATR GASTR NUTR, V33, P171, DOI 10.1097/00005176-200108000-00014; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tohno M, 2008, MOL IMMUNOL, V45, P1807, DOI 10.1016/j.molimm.2007.09.029; Tohno M, 2008, MOL IMMUNOL, V45, P194, DOI 10.1016/j.molimm.2007.04.019; Tohno M, 2006, VET RES, V37, P791, DOI 10.1051/vetres:2006036; Toki S, 2009, INT ARCH ALLERGY IMM, V148, P45, DOI 10.1159/000151505; Trevisi P, 2011, ANIMAL, V5, P1354, DOI 10.1017/S1751731111000462; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Veldhuizen EJA, 2007, MOL IMMUNOL, V44, P276, DOI 10.1016/j.molimm.2006.03.005; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wolvers D, 2010, J NUTR, V140, p698S, DOI 10.3945/jn.109.113753; Zhang L, 2010, VET MICROBIOL, V141, P142, DOI 10.1016/j.vetmic.2009.09.003; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752; Zhu YH, 2007, VET RES, V38, P871, DOI 10.1051/vetres:2007035	64	83	99	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40666	10.1371/journal.pone.0040666	http://dx.doi.org/10.1371/journal.pone.0040666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848393	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200027
J	Montolio, FGJ; Wesselink, C; Jansonius, NM				Montolio, Francisco G. Junoy; Wesselink, Christiaan; Jansonius, Nomdo M.			Persistence, Spatial Distribution and Implications for Progression Detection of Blind Parts of the Visual Field in Glaucoma: A Clinical Cohort Study	PLOS ONE			English	Article							STANDARD AUTOMATED PERIMETRY; SITA STANDARD; THRESHOLD PERIMETRY; SUSPECT GLAUCOMA; FULL-THRESHOLD; SPECIFICITY; SENSITIVITY; MANIFEST; VARIABILITY; STRATEGIES	Background: Visual field testing is an essential part of glaucoma care. It is hampered by variability related to the disease itself, response errors and fatigue. In glaucoma, blind parts of the visual field contribute to the diagnosis but - once established - not to progression detection; they only increase testing time. The aims of this study were to describe the persistence and spatial distribution of blind test locations in standard automated perimetry in glaucoma and to explore how the omission of presumed blind test locations would affect progression detection. Methodology/Principal Findings: Data from 221 eyes of 221 patients from a cohort study with the Humphrey Field Analyzer with 30-2 grid were used. Patients were stratified according to baseline mean deviation (MD) in six strata of 5 dB width each. For one, two, three and four consecutive <0 dB sensitivities in the same test location in a series of baseline tests, the median probabilities to observe <0 dB again in the concerning test location in a follow-up test were 76, 86, 88 and 90%, respectively. For <10 dB, the probabilities were 88, 95, 97 and 98%, respectively. Median (interquartile range) percentages of test locations with three consecutive <0 dB sensitivities were 0(0-0), 0(0-2), 4(0-9), 17(8-27), 27(20-40) and 60(50-70)% for the six MD strata. Similar percentages were found for a subset of test locations within 10 degree eccentricity (P>0.1 for all strata). Omitting test locations with three consecutive <0 dB sensitivities at baseline did not affect the performance of the MD-based Nonparametric Progression Analysis progression detection algorithm. Conclusions/Significance: Test locations that have been shown to be reproducibly blind tend to display a reasonable blindness persistence and do no longer contribute to progression detection. There is no clinically useful universal MD cut-off value beyond which testing can be limited to 10 degree eccentricity.	[Montolio, Francisco G. Junoy; Wesselink, Christiaan; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Jansonius, Nomdo M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC	Montolio, FGJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	n.m.jansonius@umcg.nl		Junoy Montolio, Francisco/0000-0002-6773-766X; Jansonius, Nomdo/0000-0002-6495-6568	University Medical Center Groningen; foundation 'Stichting Nederlands Oogheelkundig Onderzoek'	University Medical Center Groningen; foundation 'Stichting Nederlands Oogheelkundig Onderzoek'	This research was supported by the University Medical Center Groningen and the foundation 'Stichting Nederlands Oogheelkundig Onderzoek', all in the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P184; Bengtsson B, 1998, ACTA OPHTHALMOL SCAN, V76, P431, DOI 10.1034/j.1600-0420.1998.760408.x; Bengtsson B, 1998, ACTA OPHTHALMOL SCAN, V76, P268, DOI 10.1034/j.1600-0420.1998.760303.x; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P368; Budenz DL, 2002, OPHTHALMOLOGY, V109, P1052, DOI 10.1016/S0161-6420(02)01047-3; CHAUHAN BC, 1993, INVEST OPHTH VIS SCI, V34, P3534; Pierre PDP, 2006, ACTA OPHTHALMOL SCAN, V84, P345, DOI 10.1111/j.1600-0420.2005.00639.x; Delgado MF, 2002, OPHTHALMOLOGY, V109, P2362, DOI 10.1016/S0161-6420(02)01726-8; FANKHAUSER F, 1977, SURV OPHTHALMOL, V22, P131, DOI 10.1016/0039-6257(77)90094-7; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P940, DOI 10.1167/iovs.10-5803; HUDSON C, 1994, INVEST OPHTH VIS SCI, V35, P268; Jansonius NM, 2005, GRAEF ARCH CLIN EXP, V243, P433, DOI 10.1007/s00417-004-1065-x; Leske MC, 1999, OPHTHALMOLOGY, V106, P2144, DOI 10.1016/S0161-6420(99)90497-9; Schiefer U, 2009, INVEST OPHTH VIS SCI, V50, P488, DOI 10.1167/iovs.08-2229; Schiefer U, 2010, INVEST OPHTH VIS SCI, V51, P5685, DOI 10.1167/iovs.09-5067; Swanson WH, 2011, INVEST OPHTH VIS SCI, V52, P764, DOI 10.1167/iovs.10-6158; Turpin A, 2007, INVEST OPHTH VIS SCI, V48, P1627, DOI 10.1167/iovs.06-1074; Wall M, 2004, J NEURO-OPHTHALMOL, V24, P46, DOI 10.1097/00041327-200403000-00011; Wall M, 1997, INVEST OPHTH VIS SCI, V38, P426; Wall M, 2009, INVEST OPHTH VIS SCI, V50, P974, DOI 10.1167/iovs.08-1789; Wall M, 2010, ARCH OPHTHALMOL-CHIC, V128, P570, DOI 10.1001/archophthalmol.2010.71; WEBER J, 1989, INT OPHTHALMOL, V13, P47, DOI 10.1007/BF02028637; Wesselink C, 2011, J GLAUCOMA; Wesselink C, 2009, ARCH OPHTHALMOL-CHIC, V127, P270, DOI 10.1001/archophthalmol.2008.585; Westcott MC, 1997, BRIT J OPHTHALMOL, V81, P452, DOI 10.1136/bjo.81.6.452	27	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41211	10.1371/journal.pone.0041211	http://dx.doi.org/10.1371/journal.pone.0041211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848446	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200046
J	Konig, K; Kohler, D; Granja, T; Jennewein, C; Tran, N; Mirakaj, V; Krohnert, F; Rosenberger, P				Koenig, Klemens; Koehler, David; Granja, Tiago; Jennewein, Carla; Nguyen Tran; Mirakaj, Valbona; Kroehnert, Friedemann; Rosenberger, Peter			The Uncoordinated-5 Homolog B Receptor Affects Hepatic Ischemia Reperfusion Injury	PLOS ONE			English	Article							INHIBITS LEUKOCYTE MIGRATION; RAT-LIVER; INFLAMMATION; MECHANISMS; GUIDANCE; NEUTROPHILS; CHEMOTAXIS; PROTECTS; SYSTEM	Recent evidence has demonstrated additional roles for the neuronal guidance protein receptor UNC5B outside the nervous system. Given the fact that ischemia reperfusion injury (IRI) of the liver is a common source of liver dysfunction and the role of UNC5B during an acute inflammatory response we investigated the role of UNC5B on acute hepatic IRI. We report here that UNC5B(+/-) mice display reduced hepatic IRI and neutrophil (PMN) infiltration compared to WT controls. This correlated with serum levels of lactate dehydrogenase (LDH), aspartate-(AST) and alanine-(ALT) aminotransferase, the presence of PMN within ischemic hepatic tissue, and serum levels of inflammatory cytokines. Moreover, injection of an anti-UNC5B antibody resulted in a significant reduction of hepatic IR injury. This was associated with reduced parameters of liver injury (LDH, ALT, AST) and accumulation of PMN within the injured hepatic tissue. In conclusion our studies demonstrate a significant role for UNC5B in the development of hepatic IRI and identified UNC5B as a potential drug target to prevent liver dysfunction in the future.	[Koenig, Klemens; Koehler, David; Granja, Tiago; Mirakaj, Valbona; Kroehnert, Friedemann; Rosenberger, Peter] Univ Tubingen, Dept Anaesthesiol & Intens Care Med, Tubingen Univ Hosp, Tubingen, Germany; [Koenig, Klemens; Granja, Tiago; Jennewein, Carla; Nguyen Tran] Goethe Univ Frankfurt, Clin Anaesthesiol Intens Care Med & Pain Therapy, Univ Hosp Frankfurt Main, Frankfurt, Germany; [Mirakaj, Valbona] Harvard Univ, Brigham & Womens Hosp, Dept Anaesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury,Med Sch, Boston, MA 02115 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Konig, K (corresponding author), Univ Tubingen, Dept Anaesthesiol & Intens Care Med, Tubingen Univ Hosp, Tubingen, Germany.	peter.rosenberger@med.uni-tuebingen.de	Granja, Tiago/O-2597-2019; Jennewein, Carla/C-2199-2013	Granja, Tiago/0000-0002-8137-1449; Mirakaj, Valbona/0000-0002-6907-6455	Deutsche Forschungsgemeinschaft (DFG) [RO 3671/4-1, DFG-RO 3671/5-1]; ESA	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ESA(European Space Agency)	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG)-RO 3671/4-1 and grant DFG-RO 3671/5-1 to P. R. and in part by the ESA Research Grant Programme to K.K.	Aherne CM, 2011, GUT; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Hart ML, 2008, AM J PHYSIOL-GASTR L, V294, pG1431, DOI 10.1152/ajpgi.00083.2008; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; JAESCHKE H, 1993, HEPATOLOGY, V17, P915, DOI 10.1016/0270-9139(93)90169-N; JAESCHKE H, 1990, FASEB J, V4, P3355, DOI 10.1096/fasebj.4.15.2253850; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mirakaj V, 2010, J IMMUNOL; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Rao Y, 2002, GENE DEV, V16, P2973, DOI 10.1101/gad.1005802; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	26	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41085	10.1371/journal.pone.0041085	http://dx.doi.org/10.1371/journal.pone.0041085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848430	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600038
J	Yagi, T; Kosakai, A; Ito, D; Okada, Y; Akamatsu, W; Nihei, Y; Nabetani, A; Ishikawa, F; Arai, Y; Hirose, N; Okano, H; Suzuki, N				Yagi, Takuya; Kosakai, Arifumi; Ito, Daisuke; Okada, Yohei; Akamatsu, Wado; Nihei, Yoshihiro; Nabetani, Akira; Ishikawa, Fuyuki; Arai, Yasumichi; Hirose, Nobuyoshi; Okano, Hideyuki; Suzuki, Norihiro			Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; HUMAN LONGEVITY; ASSOCIATION; ALLELE; LOCUS; APOE	Induced pluripotent stem cell (iPSC) technology can be used to model human disorders, create cell-based models of human diseases, including neurodegenerative diseases, and in establishing therapeutic strategies. To detect subtle cellular abnormalities associated with common late-onset disease in iPSCs, valid control iPSCs derived from healthy donors free of serious late-onset diseases are necessary. Here, we report the generation of iPSCs from fibroblasts obtained immediately postmortem from centenarian donors (106- and 109-years-old) who were extremely healthy until an advanced age. The iPSCs were generated using a conventional method involving OCT4, SOX2, KLF4, and c-MYC, and then differentiated into neuronal cells using a neurosphere method. The expression of molecules that play critical roles in late-onset neurodegenerative diseases by neurons differentiated from the centenarian-iPSCs was compared to that of neurons differentiated from iPSCs derived from familial Alzheimer's disease and familial Parkinson's disease (PARK4: triplication of the a synuclein gene) patients. The results indicated that our series of iPSCs would be useful in neurodegeneration research. The iPSCs we describe, which were derived from donors with exceptional longevity who were presumed to have no serious disease risk factors, would be useful in longevity research and as valid super-controls for use in studies of various late-onset diseases.	[Yagi, Takuya; Kosakai, Arifumi; Ito, Daisuke; Nihei, Yoshihiro; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Okada, Yohei; Akamatsu, Wado; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Tokyo, Japan; [Nabetani, Akira; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Lab Cell Cycle Regulat, Kyoto, Japan; [Arai, Yasumichi; Hirose, Nobuyoshi] Keio Univ, Sch Med, Dept Internal Med, Div Geriatr Med, Tokyo, Japan	Keio University; Keio University; Keio University; Kyoto University; Keio University	Yagi, T (corresponding author), Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan.	d-ito@jk9.so-net.ne.jp	Okada, Yohei/L-1662-2013; Ishikawa, Fuyuki/AAU-4056-2021; Ito, Daisuke/M-3608-2013; Sander-Effron, Samuel/AAX-2231-2020; Akamatsu, Wado/L-1214-2013; Okano, Hideyuki/I-7584-2019; Ito, Daisuke/GXF-1648-2022; Resource Center, NINDS Human Genetics/AGF-2474-2022; Suzuki, Norihiro/J-5125-2013	Ishikawa, Fuyuki/0000-0002-5580-2305; Ito, Daisuke/0000-0002-4740-1675; Suzuki, Norihiro/0000-0002-0399-6590	Eisai Co. Ltd; Ministry of Education, Culture, Sports, Science and Technology of Japan	Eisai Co. Ltd(Eisai Co Ltd); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	T.Y. is a research fellow of the Japan Society for the Promotion of Science. This work was supported by grants from Eisai Co. Ltd (to D.I. and N.S.) and a grant to H.O. from the Project for the Realization of Regenerative Medicine at the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT GENET, V43, P1041, DOI 10.1038/ng.996; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Ewbank DC, 2002, GENET EPIDEMIOL, V22, P146, DOI 10.1002/gepi.0164; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Israel M. A., 2012, NATURE; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Koch P, 2011, NATURE; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Sebastiani P., 2010, SCIENCE, V2010; Sebastiani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008210; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Yagi T, 2011, HUM MOL GENET; Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029	31	63	68	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41572	10.1371/journal.pone.0041572	http://dx.doi.org/10.1371/journal.pone.0041572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848530	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600086
J	Latinus, M; Belin, P				Latinus, Marianne; Belin, Pascal			Perceptual Auditory Aftereffects on Voice Identity Using Brief Vowel Stimuli	PLOS ONE			English	Article							ADAPTATION	Humans can identify individuals from their voice, suggesting the existence of a perceptual representation of voice identity. We used perceptual aftereffects - shifts in perceived stimulus quality after brief exposure to a repeated adaptor stimulus to - further investigate the representation of voice identity in two experiments. Healthy adult listeners were familiarized with several voices until they reached a recognition criterion. They were then tested on identification tasks that used vowel stimuli generated by morphing between the different identities, presented either in isolation (baseline) or following short exposure to different types of voice adaptors (adaptation). Experiment 1 showed that adaptation to a given voice induced categorization shifts away from that adaptor's identity even when the adaptors consisted of vowels different from the probe stimuli. Moreover, original voices and caricatures resulted in comparable aftereffects, ruling out an explanation of identity aftereffects in terms of adaptation to low-level features. In Experiment 2, we show that adaptors with a disrupted configuration, i.e., altered fundamental frequency or formant frequencies, failed to produce perceptual aftereffects showing the importance of the preserved configuration of these acoustical cues in the representation of voices. These two experiments indicate a high-level, dynamic representation of voice identity based on the combination of several lower-level acoustical features into a specific voice configuration.	[Latinus, Marianne; Belin, Pascal] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Belin, Pascal] Univ Montreal, Int Labs Brain Mus & Sound BRAMS, Quebec City, PQ, Canada; [Belin, Pascal] McGill Univ, Quebec City, PQ, Canada; [Latinus, Marianne] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Glasgow; Universite de Montreal; McGill University; Indiana University System; Indiana University Bloomington	Latinus, M (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	mlatinus@gmail.com	Latinus, Marianne/A-8173-2011; Belin, Pascal/C-6247-2009	Latinus, Marianne/0000-0002-4406-2962; Belin, Pascal/0000-0002-7578-6365	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBE0039581]; Economic and Social Research Council/Medical Research Council [RES-060-25-0010]	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council/Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC))	This work was supported by UK Biotechnology and Biological Sciences Research Council grant (BBSRC, BBE0039581, http://www.bbsrc.ac.uk/) and a Economic and Social Research Council (http://www.esrc.ac.uk/)/Medical Research Council grant (http://www.mrc.ac.uk/index.htm) (RES-060-25-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 1976, ADAPTING PROPERTY DE, P55; Baumann O, 2010, PSYCHOL RES-PSYCH FO, V74, P110, DOI 10.1007/s00426-008-0185-z; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2006, PHILOS T R SOC B, V361, P2091, DOI 10.1098/rstb.2006.1933; BENSON PJ, 1994, PERCEPTION, V23, P75, DOI 10.1068/p230075; Blanz V, 2000, PERCEPTION, V29, P885, DOI 10.1068/p2851; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Charest I, 2012, CEREB CORTEX; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Ghazanfar AA, 2008, CURR BIOL, V18, pR457, DOI 10.1016/j.cub.2008.03.030; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Holt LL, 2006, J ACOUST SOC AM, V120, P2801, DOI 10.1121/1.2354071; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; Kawahara H, 1999, SPEECH COMMUN, V27, P187, DOI 10.1016/S0167-6393(98)00085-5; Kreiman J., 1997, TALKER VARIABILITY S, P85; Latinus M, 2011, CEREB CORTEX, V21, P2820, DOI 10.1093/cercor/bhr077; Latinus M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00175; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Mullennix JW, 1995, J ACOUST SOC AM, V98, P3080, DOI 10.1121/1.413832; PAPCUN G, 1989, J ACOUST SOC AM, V85, P913, DOI 10.1121/1.397564; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; SAMUEL AG, 1986, COGNITIVE PSYCHOL, V18, P452, DOI 10.1016/0010-0285(86)90007-1; Schweinberger SR, 2008, CURR BIOL, V18, P684, DOI 10.1016/j.cub.2008.04.015; Schweinberger SR, 2011, BRIT J PSYCHOL, V102, P748, DOI 10.1111/j.2044-8295.2011.02048.x; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Yamashita JA, 2005, J EXP PSYCHOL HUMAN, V31, P420, DOI 10.1037/0096-1523.31.3.420; Zaske R, 2010, HEARING RES, V268, P38, DOI 10.1016/j.heares.2010.04.011; Zaske R, 2011, HEAR RES	34	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41384	10.1371/journal.pone.0041384	http://dx.doi.org/10.1371/journal.pone.0041384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844469	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306687700080
J	Reynolds, AC; Dorrian, J; Liu, PY; Van Dongen, HPA; Wittert, GA; Harmer, LJ; Banks, S				Reynolds, Amy C.; Dorrian, Jillian; Liu, Peter Y.; Van Dongen, Hans P. A.; Wittert, Gary A.; Harmer, Lee J.; Banks, Siobhan			Impact of Five Nights of Sleep Restriction on Glucose Metabolism, Leptin and Testosterone in Young Adult Men	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; INSULIN-RESISTANCE; RISK-FACTOR; GHRELIN LEVELS; SINGLE NIGHT; DURATION; CORTISOL; ASSOCIATION; DEPRIVATION; QUALITY	Background: Sleep restriction is associated with development of metabolic ill-health, and hormonal mechanisms may underlie these effects. The aim of this study was to determine the impact of short term sleep restriction on male health, particularly glucose metabolism, by examining adrenocorticotropic hormone (ACTH), cortisol, glucose, insulin, triglycerides, leptin, testosterone, and sex hormone binding globulin (SHBG). Methodology/Principal Findings: N = 14 healthy men (aged 27.4 +/- 3.8, BMI 23.5 +/- 2.9) underwent a laboratory-based sleep restriction protocol consisting of 2 baseline nights of 10 h time in bed (TIB) (B1, B2; 22:00-08:00), followed by 5 nights of 4 h TIB (SR1-SR5; 04:00-08:00) and a recovery night of 10 h TIB (R1; 22:00-08:00). Subjects were allowed to move freely inside the laboratory; no strenuous activity was permitted during the study. Food intake was controlled, with subjects consuming an average 2000 kcal/day. Blood was sampled through an indwelling catheter on B1 and SR5, at 09:00 (fasting) and then every 2 hours from 10:00-20:00. On SR5 relative to B1, glucose (F-1,F-168 = 25.3, p<0.001) and insulin (F-1,F-168 = 12.2, p<0.001) were increased, triglycerides (F-1,F-168 = 7.5, p = 0.007) fell and there was no significant change in fasting homeostatic model assessment (HOMA) determined insulin resistance (F-1,F-168 = 1.3, p = 0.18). Also, cortisol (F-1,F-168 = 10.2, p = 0.002) and leptin (F-1,F-168 = 10.7, p = 0.001) increased, sex hormone binding globulin (F-1,F-167 = 12.1, p<0.001) fell and there were no significant changes in ACTH (F-1,F-168 = 0.3, p = 0.59) or total testosterone (F-1,F-168 = 2.8, p = 0.089). Conclusions/Significance: Sleep restriction impaired glucose, but improved lipid metabolism. This was associated with an increase in afternoon cortisol, without significant changes in ACTH, suggesting enhanced adrenal reactivity. Increased cortisol and reduced sex hormone binding globulin (SHBG) are both consistent with development of insulin resistance, although hepatic insulin resistance calculated from fasting HOMA did not change significantly. Short term sleep curtailment leads to changes in glucose metabolism and adrenal reactivity, which when experienced repeatedly may increase the risk for type 2 diabetes.	[Reynolds, Amy C.; Dorrian, Jillian; Banks, Siobhan] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia; [Liu, Peter Y.] Harbor Univ Los Angeles Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA USA; [Van Dongen, Hans P. A.] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA; [Wittert, Gary A.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Harmer, Lee J.] Repatriat Gen Hosp, Adelaide Inst Sleep Hlth, Daw Pk, SA, Australia	University of South Australia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Washington State University; University of Adelaide; Flinders University South Australia	Reynolds, AC (corresponding author), Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia.	Siobhan.Banks@unisa.edu.au	Dorrian, Jillian/K-6496-2019; Van Dongen, Hans P. A./GPW-9160-2022; wittert, gary/AAE-2398-2019; Reynolds, Amy/Y-8497-2019; Dorrian, Jillian/C-1339-2010; Banks, Siobhan/L-2149-2013	Van Dongen, Hans P. A./0000-0002-4678-2971; Reynolds, Amy/0000-0001-9534-8699; Dorrian, Jillian/0000-0002-6485-1643; Banks, Siobhan/0000-0002-7489-0929	University of South Australia; Sleep and Performance Research Center of Washington State University, Spokane; Bayer Schering; ResMed; Itamar Medical Ltd; Phillips Respironics	University of South Australia; Sleep and Performance Research Center of Washington State University, Spokane; Bayer Schering(Bayer AG); ResMed; Itamar Medical Ltd; Phillips Respironics	Research was supported by a University of South Australia Women in Science Grant, and through a collaboration with the Sleep and Performance Research Center of Washington State University, Spokane. Hans P. A. Van Dongen from the Sleep and Performance Research Center was involved in study design, decision to publish and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts to declare: Peter Y. Liu has received funding or in-kind support from Bayer Schering and from Phillips Respironics for investigator initiated trials. Hans P. A. Van Dongen has consulted for Pulsar Informatics and FedEx Corporation. Gary A. Wittert has received research support from ResMed, Itamar Medical Ltd, Bayer Schering, and is a member of the Androgen Advisory Board of Eli Lilly Australia Pty Ltd. All other authors have no conflicts of interest. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online on the guide for authors.	AKERSTEDT T, 1980, SLEEP, V3, P23, DOI 10.1093/sleep/3.1.23; Akin Fulya, 2008, Indian J Med Sci, V62, P407; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x; Balkau B, 1999, DIABETIC MED, V16, P442; Ban HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018455; BIRKELAND KI, 1993, J CLIN ENDOCR METAB, V76, P275, DOI 10.1210/jc.76.2.275; Bjorvatn B, 2007, J SLEEP RES, V16, P66, DOI 10.1111/j.1365-2869.2007.00569.x; Bode BW, 1999, DIABETES RES CLIN PR, V46, P183, DOI 10.1016/S0168-8227(99)00113-8; Brand JS, 2011, INT J EPIDEMIOL, V40, P189, DOI 10.1093/ije/dyq158; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chaput JP, 2007, DIABETOLOGIA, V50, P2298, DOI 10.1007/s00125-007-0786-x; CORTESGALLEGOS V, 1983, ARCH ANDROLOGY, V10, P33, DOI 10.3109/01485018308990167; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430; DRAY F, 1965, CR HEBD ACAD SCI, V261, P573; Einhorn Daniel, 2003, Endocr Pract, V9, P237; Gale JE, 2011, J BIOL RHYTHM, V26, P423, DOI 10.1177/0748730411416341; GONZALEZSANTOS MR, 1989, ARCH ANDROLOGY, V22, P203, DOI 10.3109/01485018908986773; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hammond GL, 2012, CURR OPIN ENDOCRINOL, V19, P183, DOI 10.1097/MED.0b013e328353732f; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; Hayes AL, 2011, SLEEP, V34, P147, DOI 10.1093/sleep/34.2.147; Jennings JR, 2007, SLEEP, V30, P219, DOI 10.1093/sleep/30.2.219; Joshi D, 2010, CLIN ENDOCRINOL, V72, P232, DOI 10.1111/j.1365-2265.2009.03641.x; Katabami T, 2010, ENDOCR J, V57, P533, DOI 10.1507/endocrj.K10E-018; Kaufman FR, 2001, DIABETES CARE, V24, P2030, DOI 10.2337/diacare.24.12.2030; Keenan D Barry, 2009, J Diabetes Sci Technol, V3, P1207; Kerkhofs M, 2007, MATURITAS, V56, P212, DOI 10.1016/j.maturitas.2006.07.007; Kern W, 1996, J GERONTOL A-BIOL, V51, pM3, DOI 10.1093/gerona/51A.1.M3; Khani S, 2001, CLIN SCI, V101, P739, DOI 10.1042/cs1010739; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Lakshman KM, 2010, OSTEOPOROSIS IN MEN: THE EFFECTS OF GENDER ON SKELETAL HEALTH, 2ND EDITION, P691, DOI 10.1016/B978-0-12-374602-3.00056-0; Leproult R, 2011, JAMA-J AM MED ASSOC, V305, P2173, DOI 10.1001/jama.2011.710; Li CY, 2010, DIABETES CARE, V33, P1618, DOI 10.2337/dc09-1788; LINDSTEDT G, 1991, DIABETES, V40, P123, DOI 10.2337/diabetes.40.1.123; Luboshitzky R, 1999, J ANDROL, V20, P731; Magee CA, 2010, OBESITY, V18, P420, DOI 10.1038/oby.2009.373; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Matsuda M, 2010, NUTR METAB CARDIOVAS, V20, P79, DOI 10.1016/j.numecd.2009.07.007; Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; Mullington JM, 2003, J NEUROENDOCRINOL, V15, P851, DOI 10.1046/j.1365-2826.2003.01069.x; Nedeltcheva AV, 2010, ANN INTERN MED, V153, P435, DOI 10.7326/0003-4819-153-7-201010050-00006; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Nedeltcheva AV, 2009, AM J CLIN NUTR, V89, P126, DOI 10.3945/ajcn.2008.26574; NESTLER JE, 1993, J CLIN ENDOCR METAB, V76, P273, DOI 10.1210/jc.76.2.273; O'Keefe JH, 2008, J AM COLL CARDIOL, V51, P249, DOI 10.1016/j.jacc.2007.10.016; Omisade A, 2010, PHYSIOL BEHAV, V99, P651, DOI 10.1016/j.physbeh.2010.01.028; Penev P, 2003, ANN ENDOCRINOL-PARIS, V64, P157; Penev PD, 2007, SLEEP, V30, P427, DOI 10.1093/sleep/30.4.427; Penev PD, 2011, SLEEP, V34, P131, DOI 10.1093/sleep/34.2.131; Perry JRB, 2010, HUM MOL GENET, V19, P535, DOI 10.1093/hmg/ddp522; PREZIOSI P, 1993, J CLIN ENDOCR METAB, V76, P283, DOI 10.1210/jcem.76.2.8432770; RESKO JA, 1966, J CLIN ENDOCR METAB, V26, P573, DOI 10.1210/jcem-26-5-573; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Schmid SM, 2008, J SLEEP RES, V17, P331, DOI 10.1111/j.1365-2869.2008.00662.x; Schmid SM, 2011, SLEEP, V34, P371, DOI 10.1093/sleep/34.3.371; Schmid SM, 2009, J CLIN ENDOCR METAB, V94, P5169, DOI 10.1210/jc.2009-0969; Schmid SM, 2009, AM J CLIN NUTR, V90, P1476, DOI 10.3945/ajcn.2009.27984; SEIDELL JC, 1990, METABOLISM, V39, P897, DOI 10.1016/0026-0495(90)90297-P; Sherif K, 1998, METABOLISM, V47, P70, DOI 10.1016/S0026-0495(98)90195-0; Simpson NS, 2010, BIOL RES NURS, V12, P47, DOI 10.1177/1099800410366301; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Tasali E, 2009, PROG CARDIOVASC DIS, V51, P381, DOI 10.1016/j.pcad.2008.10.002; van Leeuwen WMA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/108641; Vgontzas AN, 2008, SLEEP, V31, P1203; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Wang C, 2011, DIABETES CARE, V34, P1669, DOI 10.2337/dc10-2339; WHO, 1999, DEFINITION CLASSIF 1; Wu HJ, 2008, BRAIN RES BULL, V77, P241, DOI 10.1016/j.brainresbull.2008.07.013; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Zitzmann M, 2009, NAT REV ENDOCRINOL, V5, P673, DOI 10.1038/nrendo.2009.212	82	145	149	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41218	10.1371/journal.pone.0041218	http://dx.doi.org/10.1371/journal.pone.0041218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844441	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000306687700055
J	Smith, DW; Gardiner, BS; Dunstan, C				Smith, David W.; Gardiner, Bruce S.; Dunstan, Colin			Bone Balance within a Cortical BMU: Local Controls of Bone Resorption and Formation	PLOS ONE			English	Article							MULTICELLULAR UNIT; METABOLIC-CONTROL; HOMEOSTASIS; OSTEOPOROSIS; OSTEOBLAST; SYSTEMS; CELLS; INSIGHTS; BEHAVIOR	Maintaining bone volume during bone turnover by a BMU is known as bone balance. Balance is required to maintain structural integrity of the bone and is often dysregulated in disease. Consequently, understanding how a BMU controls bone balance is of considerable interest. This paper develops a methodology for identifying potential balance controls within a single cortical BMU. The theoretical framework developed offers the possibility of a directed search for biological processes compatible with the constraints of balance control. We first derive general control constraint equations and then introduce constitutive equations to identify potential control processes that link key variables that describe the state of the BMU. The paper describes specific local bone volume balance controls that may be associated with bone resorption and bone formation. Because bone resorption and formation both involve averaging over time, short-term fluctuations in the environment are removed, leaving the control systems to manage deviations in longer-term trends back towards their desired values. The length of time for averaging is much greater for bone formation than for bone resorption, which enables more filtering of variability in the bone formation environment. Remarkably, the duration for averaging of bone formation may also grow to control deviations in long-term trends of bone formation. Providing there is sufficient bone formation capacity by osteoblasts, this leads to an extraordinarily robust control mechanism that is independent of either osteoblast number or the cellular osteoid formation rate. A complex picture begins to emerge for the control of bone volume. Different control relationships may achieve the same objective, and the 'integration of information' occurring within a BMU may be interpreted as different sets of BMU control systems coming to the fore as different information is supplied to the BMU, which in turn leads to different observable BMU behaviors.	[Smith, David W.; Gardiner, Bruce S.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia; [Dunstan, Colin] Univ Sydney, Sch Aeronaut Mech & Mechatron Engn, Sydney, NSW 2006, Australia	University of Western Australia; University of Sydney	Smith, DW (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	david.smith@uwa.edu.au	Dunstan, Colin/G-6214-2013; Smith, David W/H-5856-2014; Gardiner, Bruce/C-8593-2012	Dunstan, Colin/0000-0001-7586-4071; Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908				BARON R, 2003, ANATOMY BIOL BONE MA; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brogan WL., 1990, MODERN CONTROL THEOR; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; CARTER DR, 1981, ACTA ORTHOP SCAND, V52, P481, DOI 10.3109/17453678108992136; Cooper DML, 2006, ANAT REC PART A, V288A, P806, DOI 10.1002/ar.a.20344; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Doyle J., 1990, FEEDBACK CONTROL THE; Edwards Claire M, 2008, Int J Med Sci, V5, P263; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Engin F, 2010, BONE, V46, P274, DOI 10.1016/j.bone.2009.05.027; ERIKSEN EF, 1986, BONE, V7, P213, DOI 10.1016/8756-3282(86)90020-7; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664; Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heinrich R, 1986, REGULATION CELL SYST; Helfrich MH, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P385, DOI 10.1016/B978-0-12-373884-4.00039-2; Heuett WJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-44; JAWORSKI ZFG, 1980, J ANAT, V131, P91; Karsdal MA, 2005, AM J PATHOL, V166, P467, DOI 10.1016/S0002-9440(10)62269-9; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Khalil H., 2003, NONLINEAR SYSTEMS; Komarova S V, 2003, J THEOR BIOL, V229, P293; Lanyon L.E., 2009, IBMS BONEKEY, V6, P218, DOI [10.1138/20090382, DOI 10.1138/20090382]; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Lerner UH, 2006, J DENT RES, V85, P584, DOI 10.1177/154405910608500703; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANSON JD, 1965, J ANAT, V99, P539; Martin RB, 2007, BONE, V40, P1574, DOI 10.1016/j.bone.2007.02.023; Martin RB, 2000, BONE, V26, P1, DOI 10.1016/S8756-3282(99)00241-0; Martin RB, 1998, SKELETAL TISSUE MECH; Metz LN, 2003, BONE, V33, P753, DOI 10.1016/S8756-3282(03)00245-X; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; PARFITT AM, 1976, METABOLISM, V25, P909, DOI 10.1016/0026-0495(76)90124-4; Parfitt M, 1987, J BONE MINER RES, V2, P595; Parfitt MA, 1983, PHYSL CLIN SIGNIFICA; Parfitt MA, 1994, J CELL BIOCHEM, V55, P273; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Pivonka P, 2010, J THEOR BIOL, V262, P306, DOI 10.1016/j.jtbi.2009.09.021; Reeve J, 1987, J BONE MINERAL RES, V2; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Ryser MD, 2009, J BONE MINER RES, V24, P860, DOI 10.1359/JBMR.081229; SAURO HM, 1987, EUR J BIOCHEM, V165, P215, DOI 10.1111/j.1432-1033.1987.tb11214.x; SAVAGEAU MA, 1987, MATH BIOSCI, V86, P147, DOI 10.1016/0025-5564(87)90008-3; St-Arnaud R, 2008, ARCH BIOCHEM BIOPHYS, V473, P225, DOI 10.1016/j.abb.2008.03.038; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yue H, 2006, MOL BIOSYST, V2, P640, DOI 10.1039/b609442b; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	55	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40268	10.1371/journal.pone.0040268	http://dx.doi.org/10.1371/journal.pone.0040268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844401	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700010
J	Jiang, LL; Lin, JJ; Han, HY; Dong, H; Zhao, QP; Zhu, SH; Huang, B				Jiang, Lianlian; Lin, Jiaojiao; Han, Hongyu; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Huang, Bing			Identification and Characterization of Eimeria tenella Apical Membrane Antigen-1 (AMA1)	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; TOXOPLASMA-GONDII; HOST-CELL; INVASION; COCCIDIOSIS; INFECTION; PARASITES; PURIFICATION; MEROZOITES; EXPRESSION	Apical membrane antigen-1 (AMA1) is a micronemal protein of apicomplexan parasites that appears to be essential during the invasion of host cells. In this study, a full-length cDNA of AMA1 was identified from Eimeria tenella (Et) using expressed sequence tag and the rapid amplification of cDNA ends technique. EtAMA1 had an open reading frame of 1608 bp encoding a protein of 535 amino acids. Quantitative real-time PCR analysis revealed that EtAMA1 was expressed at higher levels in sporozoites than in the other developmental stages (unsporulated oocysts, sporulated oocysts and second-generation merozoites). The ectodomain sequence was expressed as recombinant EtAMA1 (rEtAMA1) and rabbit polyclonal antibodies raised against the rEtAMA1 recognized a 58-kDa native parasite protein by Western Blotting and had a potent inhibitory effect on parasite invasion, decreasing it by approximately 70%. Immunofluorescence analysis and immunohistochemistry analysis showed EtAMA1 might play an important role in sporozoite invasion and development.	[Jiang, Lianlian; Lin, Jiaojiao; Han, Hongyu; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Huang, Bing] Chinese Acad Agr Sci, Key Lab Anim Parasitol, Minist Agr, Shanghai Vet Res Inst, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Jiang, LL (corresponding author), Chinese Acad Agr Sci, Key Lab Anim Parasitol, Minist Agr, Shanghai Vet Res Inst, Shanghai, Peoples R China.	hb@shvri.ac.cn			Shanghai Science Foundation of China [09ZR1438700]; National Nonprofit Institute Research Grant of CATAS-ITBB [2010JB02]	Shanghai Science Foundation of China; National Nonprofit Institute Research Grant of CATAS-ITBB	This work was supported by the Shanghai Science Foundation of China (Grant No. 09ZR1438700) and by the National Nonprofit Institute Research Grant of CATAS-ITBB (Grant No. 2010JB02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Allen PC, 2002, CLIN MICROBIOL REV, V15, P58, DOI 10.1128/CMR.15.1.58-65.2002; Belli SL, 2005, PROTEOMICS, V5, P918, DOI 10.1002/pmic.200401161; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Blake DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001279; Curtidor H, 2011, GENE, V474, P22, DOI 10.1016/j.gene.2010.12.005; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; Daszak P, 1999, PARASITOL TODAY, V15, P67, DOI 10.1016/S0169-4758(98)01379-9; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Han HY, 2010, J PARASITOL, V96, P95, DOI 10.1645/GE-2221.1; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Innes EA, 2006, PARASITOLOGY, V133, pS145, DOI 10.1017/S0031182006001855; Jahn D, 2009, PARASITOL RES, V105, P655, DOI 10.1007/s00436-009-1437-6; Jiang Lian-lian, 2011, Zhongguo Shouyi Kexue, V41, P551; Jiang LL, 2012, PARASITOL RES, V110, P865, DOI 10.1007/s00436-011-2568-0; Kimbita EN, 2001, VET PARASITOL, V102, P35, DOI 10.1016/S0304-4017(01)00522-2; Klotz C, 2005, EXP PARASITOL, V111, P14, DOI 10.1016/j.exppara.2005.04.005; Lal K, 2009, PROTEOMICS, V9, P4566, DOI 10.1002/pmic.200900305; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; Morris GM, 2007, PARASITOL RES, V101, P583, DOI 10.1007/s00436-007-0516-9; Ng ST, 2002, EXP PARASITOL, V101, P168, DOI 10.1016/S0014-4894(02)00109-1; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Sasai K, 2008, J PARASITOL, V94, P1432, DOI 10.1645/GE-1558.1; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Shirley MW, 2004, TRENDS PARASITOL, V20, P199, DOI 10.1016/j.pt.2004.02.005; Tabares E, 2004, MOL BIOCHEM PARASIT, V135, P123, DOI 10.1016/j.molbiopara.2004.01.013; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Tomley F, 1997, METHODS, V13, P171, DOI 10.1006/meth.1997.0509; Tonukari NJ, 2010, INT J BIOTECH MOL BI, V1, P36; Tyler JS, 2011, TRENDS PARASITOL, V27, P410, DOI 10.1016/j.pt.2011.04.002; Vermeulen A, 2001, VET PARASITOL, V100, P13, DOI 10.1016/S0304-4017(01)00479-4; Williams RB, 2006, VET PARASITOL, V135, P1, DOI 10.1016/j.vetpar.2005.10.012; Williams RB, 1998, INT J PARASITOL, V28, P1089, DOI 10.1016/S0020-7519(98)00066-6; WILSON PA, 1961, J PROTOZOOL, V8, P410, DOI 10.1111/j.1550-7408.1961.tb01236.x; XIE MQ, 1990, PARASITOL RES, V76, P566, DOI 10.1007/BF00932562; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005	43	55	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41115	10.1371/journal.pone.0041115	http://dx.doi.org/10.1371/journal.pone.0041115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829917	gold, Green Submitted, Green Published			2022-12-27	WOS:000306956300056
J	Xu, X; Xi, L; Zeng, J; Yao, QH				Xu, Xin; Xi, Lei; Zeng, Jie; Yao, Qinhong			A Functional+61G/A Polymorphism in Epidermal Growth Factor Is Associated with Glioma Risk among Asians	PLOS ONE			English	Article							EGF GENE; +61 G/A; CANCER; METAANALYSIS; LOCI	Background: Epidermal growth factor (EGF), a potent mitogenic protein, plays an important role in the development of cancers, including glioma. Previous studies showed that the EGF +61G/A polymorphism (rs4444903) may lead to an alteration in EGF production and/or activity, which can result in individual susceptibility to glioma. However, published data regarding the association between the +61G/A polymorphism and glioma risk was contradictory. Objective: The aim of this study was to perform a meta-analysis of eligible studies to derive precise estimation of the association of EGF +61G/A with glioma risk. Methods: We performed a pooled analysis of seven published studies that included 1,613 glioma cases and 2,267 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association. The pooled ORs were performed for codominant model, dominant model, and recessive model, respectively. Results: Overall, no significant associations between the EGF +61G/A polymorphism and glioma cancer risk were found for AA versus GG (OR = 0.95, 95% CI = 0.62-1.45), GA versus GG (OR = 0.94, 95% CI = 0.72-1.22), AA/GA versus GG (OR = 0.93, 95% CI = 0.70-1.23), and AA versus GA/GG (OR = 1.04, 95% CI = 0.77-1.39). However, in the stratified analysis by ethnicity, the EGF +61G/A polymorphism had a higher risk of glioma development among Asians, but a lower risk among Caucasians. Conclusions: Taken together, the results suggest that the EGF +61G/A polymorphism may contribute to the susceptibility of glioma in different ethnic groups.	[Xu, Xin; Xi, Lei; Zeng, Jie; Yao, Qinhong] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Wuxi, Peoples R China	Southeast University - China	Xu, X (corresponding author), Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Wuxi, Peoples R China.	drqhyao@163.com						Bao G, 2010, J INT MED RES, V38, P1645, DOI 10.1177/147323001003800509; Bhowmick DA, 2004, CANCER RES, V64, P1220, DOI 10.1158/0008-5472.CAN-03-3137; Bondy ML, 2001, J NATL CANCER I, V93, P1553, DOI 10.1093/jnci/93.20.1553; Costa BM, 2007, CLIN CANCER RES, V13, P2621, DOI 10.1158/1078-0432.CCR-06-2606; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fenstermaker RA, 2000, ONCOGENE, V19, P4542, DOI 10.1038/sj.onc.1203802; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; LAURENCE DJR, 1990, TUMOR BIOL, V11, P229, DOI 10.1159/000217659; Liu XQ, 2009, INT J BIOL MARKER, V24, P77, DOI 10.1177/172460080902400203; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mullhaupt B, 2000, GENE, V250, P191, DOI 10.1016/S0378-1119(00)00178-5; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Normanno N, 2001, FRONT BIOSCI-LANDMRK, V6, pD685, DOI 10.2741/Normano; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Pinto GR, 2009, INT J BIOL MARKER, V24, P277, DOI 10.1177/172460080902400410; Ramos-Corpas D, 2006, PRENATAL DIAG, V26, P1124, DOI 10.1002/pd.1568; Sauter G, 1996, AM J PATHOL, V148, P1047; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Vauleon E, 2007, CANCER GENET CYTOGEN, V172, P33, DOI 10.1016/j.cancergencyto.2006.07.013; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-221; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Xu W, 2010, MED ONCOL, V27, P1389, DOI 10.1007/s12032-009-9392-8; Zhang YM, 2010, CANCER EPIDEMIOL, V34, P150, DOI 10.1016/j.canep.2010.02.004	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41470	10.1371/journal.pone.0041470	http://dx.doi.org/10.1371/journal.pone.0041470			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829952	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300092
J	Beck, R; Dejeans, N; Glorieux, C; Creton, M; Delaive, E; Dieu, M; Raes, M; Leveque, P; Gallez, B; Depuydt, M; Collet, JF; Calderon, PB; Verrax, J				Beck, Raphael; Dejeans, Nicolas; Glorieux, Christophe; Creton, Melanie; Delaive, Edouard; Dieu, Marc; Raes, Martine; Leveque, Philippe; Gallez, Bernard; Depuydt, Matthieu; Collet, Jean-Francois; Calderon, Pedro Buc; Verrax, Julien			Hsp90 Is Cleaved by Reactive Oxygen Species at a Highly Conserved N-Terminal Amino Acid Motif	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; ATP-BINDING; LEADS; DEGRADATION; INHIBITION; MECHANISMS; CHAPERONE; COMPLEX; CELLS	Hsp90 is an essential chaperone that is necessary for the folding, stability and activity of numerous proteins. In this study, we demonstrate that free radicals formed during oxidative stress conditions can cleave Hsp90. This cleavage occurs through a Fenton reaction which requires the presence of redox-active iron. As a result of the cleavage, we observed a disruption of the chaperoning function of Hsp90 and the degradation of its client proteins, for example, Bcr-Abl, RIP, c-Raf, NEMO and hTert. Formation of Hsp90 protein radicals on exposure to oxidative stress was confirmed by immuno-spin trapping. Using a proteomic analysis, we determined that the cleavage occurs in a conserved motif of the N-terminal nucleotide binding site, between Ile-126 and Gly-127 in Hsp90 beta, and between Ile-131 and Gly-132 in Hsp90 alpha. Given the importance of Hsp90 in diverse biological functions, these findings shed new light on how oxidative stress can affect cellular homeostasis.	[Beck, Raphael; Dejeans, Nicolas; Glorieux, Christophe; Creton, Melanie; Leveque, Philippe; Gallez, Bernard; Calderon, Pedro Buc; Verrax, Julien] UCL, Louvain Drug Res Inst, Brussels, Belgium; [Delaive, Edouard; Dieu, Marc; Raes, Martine] FUNDP Univ Namur, URBC NARILIS, Namur, Belgium; [Depuydt, Matthieu; Collet, Jean-Francois] UCL, de Duve Inst, Brussels, Belgium; [Calderon, Pedro Buc] Arturo Prat Univ, Dept Ciencias Quim & Farmaceut, Iquique, Chile	Universite Catholique Louvain; University of Namur; Universite Catholique Louvain; Universidad Arturo Prat	Beck, R (corresponding author), UCL, Louvain Drug Res Inst, Brussels, Belgium.	julien.verrax@uclouvain.be		Collet, Jean-Francois/0000-0001-8069-7036; Beck, Raphael/0000-0002-5368-3808; Depuydt, Matthieu/0000-0002-4069-3521; Dieu, Marc/0000-0002-3902-542X	Belgian Fonds National de la Recherche Scientifique (FNRS) [3.4594.04]; Fonds Speciaux de Recherche (FSR) of the University of Louvain; FNRS; FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture); FNRS-Televie	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherche (FSR) of the University of Louvain; FNRS(Fonds de la Recherche Scientifique - FNRS); FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS); FNRS-Televie(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Belgian Fonds National de la Recherche Scientifique (FNRS) (3.4594.04) and by the Fonds Speciaux de Recherche (FSR) of the University of Louvain. The mass spectrometry facility of the Unite de Recherche en Biologie Cellulaire (URBC, University of Namur) is supported by the FNRS. R. Beck is an FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) recipient. N. Dejeans is an FNRS-Televie Postdoctoral Researcher. C. Glorieux is an FNRS-Televie recipient. J. Verrax is a Scientific Research Worker of the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck R, 2011, INVEST NEW DRUG, V29, P891, DOI 10.1007/s10637-010-9441-3; Beck R, 2009, BIOCHEM PHARMACOL, V77, P375, DOI 10.1016/j.bcp.2008.10.019; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BURTON K, 1959, BIOCHEM J, V71, P388, DOI 10.1042/bj0710388; Clark CB, 2009, FREE RADICAL BIO MED, V47, P1440, DOI 10.1016/j.freeradbiomed.2009.08.012; Dikalov S, 2002, J BIOL CHEM, V277, P25480, DOI 10.1074/jbc.M203271200; ESTERBAUER H, 1982, BIOCHEM J, V208, P129, DOI 10.1042/bj2080129; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Gomez-Mejiba SE, 2009, FREE RADICAL BIO MED, V46, P853, DOI 10.1016/j.freeradbiomed.2008.12.020; GOUCHER CR, 1964, J BIOL CHEM, V239, P2251; GUTTERIDGE JMC, 1987, BIOCHEM J, V243, P709, DOI 10.1042/bj2430709; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; OHKUMA S, 1986, J CELL BIOL, V102, P959, DOI 10.1083/jcb.102.3.959; Panopoulos A, 2005, J BIOL CHEM, V280, P2912, DOI 10.1074/jbc.M409524200; Pantano C, 2003, J BIOL CHEM, V278, P44091, DOI 10.1074/jbc.M308487200; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; SAMUNI A, 1983, EUR J BIOCHEM, V137, P119, DOI 10.1111/j.1432-1033.1983.tb07804.x; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Shen SC, 2008, TOXICOL APPL PHARM, V229, P239, DOI 10.1016/j.taap.2008.01.018; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Verrax F, 2005, FREE RADICAL RES, V39, P649, DOI 10.1080/10715760500097906; Verrax J, 2009, CURR MED CHEM, V16, P1821, DOI 10.2174/092986709788186057; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Ye XD, 2011, FREE RADICAL RES, V45, P1289, DOI 10.3109/10715762.2011.616199	36	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40795	10.1371/journal.pone.0040795	http://dx.doi.org/10.1371/journal.pone.0040795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848402	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200032
J	Bouadma, L; Barbier, F; Biard, L; Esposito-Farese, M; Le Corre, B; Macrez, A; Salomon, L; Bonnal, C; Zanker, C; Najem, C; Mourvillier, B; Lucet, JC; Regnier, B; Wolff, M; Tubach, F				Bouadma, Lila; Barbier, Francois; Biard, Lucie; Esposito-Farese, Marina; Le Corre, Bertrand; Macrez, Annick; Salomon, Laurence; Bonnal, Christine; Zanker, Caroline; Najem, Christophe; Mourvillier, Bruno; Lucet, Jean Christophe; Regnier, Bernard; Wolff, Michel; Tubach, Florence		INFLUENCE-A Study Grp	Personal Decision-Making Criteria Related to Seasonal and Pandemic A(H1N1) Influenza-Vaccination Acceptance among French Healthcare Workers	PLOS ONE			English	Article								Background: Influenza-vaccination rates among healthcare workers (HCW) remain low worldwide, even during the 2009 A(H1N1) pandemic. In France, this vaccination is free but administered on a voluntary basis. We investigated the factors influencing HCW influenza vaccination. Methods: In June-July 2010, HCW from wards of five French hospitals completed a cross-sectional survey. A multifaceted campaign aimed at improving vaccination coverage in this hospital group was conducted before and during the 2009 pandemic. Using an anonymous self-administered questionnaire, we assessed the relationships between seasonal (SIV) and pandemic (PIV) influenza vaccinations, and sociodemographic and professional characteristics, previous and current vaccination statuses, and 33 statements investigating 10 sociocognitive domains. The sociocognitive domains describing HCWs' SIV and PIV profiles were analyzed using the classification-and-regression-tree method. Results: Of the HCWs responding to our survey, 1480 were paramedical and 401 were medical with 2009 vaccination rates of 30% and 58% for SIV and 21% and 71% for PIV, respectively (p < 0.0001 for both SIV and PIV vaccinations). Older age, prior SIV, working in emergency departments or intensive care units, being a medical HCW and the hospital they worked in were associated with both vaccinations; while work shift was associated only with PIV. Sociocognitive domains associated with both vaccinations were self-perception of benefits and health motivation for all HCW. For medical HCW, being a role model was an additional domain associated with SIV and PIV. Conclusions: Both vaccination rates remained low. Vaccination mainly depended on self-determined factors and for medical HCW, being a role model.	[Bouadma, Lila; Biard, Lucie; Esposito-Farese, Marina; Tubach, Florence] Hop Univ Paris Nord Val Seine, Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, Paris, France; [Barbier, Francois; Wolff, Michel] Univ Paris Diderot, EA 3964, Paris, France; [Le Corre, Bertrand; Macrez, Annick] Hop Univ Paris Nord Val Seine, Hop Bichat Claude Bernard, AP HP, Direct Qualite & Gest Risques, Paris, France; [Salomon, Laurence] Hop Univ Paris Nord Val Seine, Hop Bichat Claude Bernard, AP HP, Dept Sante Publ, Paris, France; [Bonnal, Christine; Lucet, Jean Christophe] Hop Univ Paris Nord Val Seine, Hop Bretonneau, AP HP, Unite Hyg & Lutte Infect Nosocomiale, Paris, France; [Zanker, Caroline] Hop Univ Paris Nord Val Seine, Hop Beaujon, AP HP, Clichy, France; [Najem, Christophe] Hop Univ Paris Nord Val Seine, Hop Charles Richet, Serv Pharm Hyg, Villiers Le Bel, France; [Lucet, Jean Christophe; Regnier, Bernard; Wolff, Michel; Tubach, Florence] Univ Paris Diderot Sorbonne, Paris, France; [Tubach, Florence] Inst Natl Sante & Rech Med, CIE 801, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Adelaide-Hautval - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bouadma, L (corresponding author), Hop Univ Paris Nord Val Seine, Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, Paris, France.	lila.bouadma@bch.aphp.fr	Biard, Lucie/AAE-8265-2022	Biard, Lucie/0000-0003-0660-1264; MOURVILLIER, BRUNO/0000-0001-5227-1468; Christine, Bonnal/0000-0003-3030-5318	French Ministry of Health [PHRC AOM 10118]; Departement a la Recherche Clinique et au Developpement de l'Assistance Publique-Hopitaux de Paris	French Ministry of Health; Departement a la Recherche Clinique et au Developpement de l'Assistance Publique-Hopitaux de Paris	This work was supported by a research grant from the French Ministry of Health (PHRC AOM 10118) and sponsored by the Departement a la Recherche Clinique et au Developpement de l'Assistance Publique-Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], WHO REC PAND H1N1 20; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; Brehm J.W., 1966, THEORY PSYCHOL REACT; Breiman L., 1983, CLASSIFICATION REGRE, DOI 10.2307/2530946; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Caban-Martinez AJ, 2010, PREV MED, V50, P210, DOI 10.1016/j.ypmed.2010.01.001; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Centers for Disease Control and Prevention, 2010, JAMA-J AM MED ASSOC, V303, P2242; Conner M, 1995, PREDICTING HLTH BEHA, P1; Dash GP, 2004, AM J INFECT CONTROL, V32, P123, DOI 10.1016/j.ajic.2004.03.001; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Green MS, 2000, ISRAEL MED ASSOC J, V2, P912; HHS-CDC NEWS, 2006, ANN PHARMACOTHER, V40, P587; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Lankford MG, 2003, EMERG INFECT DIS, V9, P217; Maltezou HC, 2011, VACCINE, V29, P6664, DOI 10.1016/j.vaccine.2011.06.098; Mereckiene J, 2008, EURO SURVEILL, V13; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011292; Pearson Michele L., 2006, Morbidity and Mortality Weekly Report, V55, P1; Pittet D, 2004, J HOSP INFECT, V58, P1, DOI 10.1016/j.jhin.2004.06.002; Polgreen PM, 2008, INFECT CONT HOSP EP, V29, P675, DOI 10.1086/588590; Rotter J.B., 1954, SOCIAL LEARNING CLIN; Salgado CD, 2002, LANCET INFECT DIS, V2, P145, DOI 10.1016/S1473-3099(02)00221-9; Sherertz RJ, 2000, ANN INTERN MED, V132, P641, DOI 10.7326/0003-4819-132-8-200004180-00007; Stern DT, 2006, NEW ENGL J MED, V355, P1794, DOI 10.1056/NEJMra054783; Stewart AM, 2009, NEW ENGL J MED, V361, P2015, DOI 10.1056/NEJMp0910151; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Therneau T.M., 2012, R PORT B RIPLEY RPAR; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; World Health Organization, 2009, WORLD NOW START 2009	34	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e38646	10.1371/journal.pone.0038646	http://dx.doi.org/10.1371/journal.pone.0038646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848342	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200004
J	Hara, S; Isoda, R; Tahvanainen, T; Hashidoko, Y				Hara, Shintaro; Isoda, Reika; Tahvanainen, Teemu; Hashidoko, Yasuyuki			Trace Amounts of Furan-2-Carboxylic Acids Determine the Quality of Solid Agar Plates for Bacterial Culture	PLOS ONE			English	Article							ESCHERICHIA-COLI; SWARMING MOTILITY; CULTIVATION; TYPHIMURIUM; SURFACE; CELLS; LAKE	Background: Many investigators have recognised that a significant proportion of environmental bacteria exist in a viable but non-culturable state on agar plates, and some researchers have also noticed that some of such bacteria clearly recover their growth on matrices other than agar. However, the reason why agar is unsuitable for the growth of some bacteria has not been addressed. Methodology/Principal Findings: According to the guide of a bioassay for swarming inhibition, we identified 5-hydroxymethylfuran- 2-carboxylic acid (5-HMFA) and furan-2-carboxylic acid (FA) as factors that inhibit bacterial swarming and likely inhibit extracellular polysaccharide production on agar. The furan-2-carboxylic acids 5-HMFA and FA effectively inhibited the swarming and swimming of several environmental bacteria at concentrations of 1.8 and 2.3 mu g L-1 (13 and 21 nmol L-1), respectively, which are equivalent to the concentrations of these compounds in 0.3% agar. On Luria-Bertani (LB) plates containing 1.0% agar that had been previously washed with MeOH, a mixture of 5-HMFA and FA in amounts equivalent to their original concentrations in the unwashed agar repressed the swarming of Escherichia coli K12 strain W3110, a representative swarming bacterium. Conclusions/Significance: Agar that contains trace amounts of 5-HMFA and FA inhibits the proliferation of some slow-growing or difficult-to-culture bacteria on the plates, but it is useful for single colony isolation due to the ease of identification of swarmable bacteria as the non-swarmed colonies.	[Hara, Shintaro; Isoda, Reika; Hashidoko, Yasuyuki] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Hara, Shintaro; Isoda, Reika; Hashidoko, Yasuyuki] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan; [Tahvanainen, Teemu] Univ Eastern Finland, Dept Biol, Joensuu, Finland	Hokkaido University; Hokkaido University; University of Eastern Finland	Hara, S (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	yasu-h@abs.agr.hokudai.ac.jp	Hashidoko, Yasuyuki/A-5189-2012; Hara, Shintaro/ABA-9843-2020	Tahvanainen, Teemu/0000-0002-7856-299X	JSPS [20248033, 20255002]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid from JSPS (20248033 and 20255002 to YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Assante G, 2009, FOREST PATHOL, V39, P289, DOI 10.1111/j.1439-0329.2008.00582.x; Atkinson S, 2006, J BACTERIOL, V188, P1451, DOI 10.1128/JB.188.4.1451-1461.2006; Barcina Isabel, 2009, Reviews in Environmental Science and Bio/Technology, V8, P245, DOI 10.1007/s11157-009-9159-x; Bauer WD, 2001, AUST J PLANT PHYSIOL, V28, P913; Berg HC, 2005, CURR BIOL, V15, pR599, DOI 10.1016/j.cub.2005.07.042; Bridson EY, 2005, SCI LAB DIAGNOSIS, P129; Burgmann H, 2005, ENVIRON MICROBIOL, V7, P1711, DOI 10.1111/j.1462-2920.2005.00818.x; Cabrera GM, 2002, PHYTOCHEMISTRY, V61, P189, DOI 10.1016/S0031-9422(02)00221-2; Day JM, 1995, SOIL BIOL BIOCHEM, V8, P45; Hara S, 2009, APPL ENVIRON MICROB, V75, P2811, DOI 10.1128/AEM.02660-08; HARRIS JE, 1985, APPL ENVIRON MICROB, V50, P1107, DOI 10.1128/AEM.50.4.1107-1109.1985; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Klemke C, 2004, J NAT PROD, V67, P1058, DOI 10.1021/np034061x; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; LENZ P, 1987, TOXICOLOGY, V45, P185, DOI 10.1016/0300-483X(87)90104-1; Lindum PW, 1998, J BACTERIOL, V180, P6384; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moreau C, 2004, TOP CATAL, V27, P11, DOI 10.1023/B:TOCA.0000013537.13540.0e; Muchova M, 2009, WATER SCI TECHNOL, V60, P965, DOI 10.2166/wst.2009.443; MUNEKATA M, 1981, AGR BIOL CHEM TOKYO, V45, P2149, DOI 10.1080/00021369.1981.10864851; Muratore G, 2006, J AGR FOOD CHEM, V54, P860, DOI 10.1021/jf051786t; Niu C, 2005, J MICROBIOL METH, V62, P129, DOI 10.1016/j.mimet.2005.01.013; Oliver J.D., 1993, STARVATION BACTERIA, P239; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Pinto D, 2011, J APPL MICROBIOL, V110, P1601, DOI 10.1111/j.1365-2672.2011.05016.x; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Suzuki SI, 2000, CAN J MICROBIOL, V46, P708, DOI 10.1139/cjm-46-8-708; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Tamaki H, 2011, INT J SYST EVOL MICR, V61, P1442, DOI 10.1099/ijs.0.025643-0; Tamaki H, 2009, ENVIRON MICROBIOL, V11, P1827, DOI 10.1111/j.1462-2920.2009.01907.x; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Tokuyama T, 1989, B JAPAN SOC MICROBIO, V4, P101; Zhang RJ, 2010, P NATL ACAD SCI USA, V107, P288, DOI 10.1073/pnas.0912804107; Zinder SH, 2005, BERGEYS MANUAL SYSTE, P101	37	14	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41142	10.1371/journal.pone.0041142	http://dx.doi.org/10.1371/journal.pone.0041142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848437	gold, Green Published			2022-12-27	WOS:000306950200043
J	Johnson, DC; Chasela, C; Maliwichi, M; Mwafongo, A; Akinkuotu, A; Moses, A; Jamieson, DJ; Kourtis, AP; King, CC; van der Horst, C; Hosseinipour, MC				Johnson, Derek C.; Chasela, Charles; Maliwichi, Madalitso; Mwafongo, Albert; Akinkuotu, Adesola; Moses, Agness; Jamieson, Denise J.; Kourtis, Athena P.; King, Caroline C.; van der Horst, Charlie; Hosseinipour, Mina C.			Tenofovir Use and Renal Insufficiency among Pregnant and General Adult Population of HIV-infected, ART-Naive Individuals in Lilongwe, Malawi	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FOLLOW-UP; DISEASE; PREVALENCE; HEMODYNAMICS; TRANSMISSION; NEPHROPATHY; OUTPATIENT; IMPAIRMENT; TOXICITY	Background: The Malawian government recently changed its prevention of mother-to-child transmission (PMTCT) regimen and plans to change its first-line antiretroviral therapy (ART) regimen to Tenofovir(TDF)/Lamivudine/Efavirenz as a fixed-dose combination tablet. Implementation could be challenging if baseline creatinine clearance (CrCl) screening were required to assess renal function prior to TDF therapy. Our goal is to determine predictors of CrCl<50 ml/min among HIV-infected, ART-naive individuals. Methodology: Data on HIV-infected, ART-naive adults screened for enrollment into 5 HIV clinical trials in Lilongwe, Malawi were combined for a pooled analysis of predictors for CrCl<50 ml/min. CrCl was derived from the Cockroft-Gault equation. Multivariable logistic regression modeled the association of age, body mass index (BMI), hemoglobin, CD4 cell count <350 cells/mm(3), gender, and pregnancy with CrCl<50 ml/min. Results: The analysis included 3508 patients with values for creatinine clearance. Most subjects were female (90.6%) with a median age of 26 years (IQR 22-29). The median CD4 cell count was 444 (IQR 298.0-561.0), and 85.2% percent of women in our study were pregnant. Few patients had CrCl<50 ml/min (n = 38, 1.1%). A BMI less than 18.5 in non-pregnant females (OR = 8.87, 95% CI = 2.45-32.09)) was associated with CrCl<50 ml/min. Hemoglobin level higher than 10 g/dL in males (OR = 0.69, 95% CI = 0.56-0.86) and non-pregnant females (OR = 0.21, 95% CI = 0.04-0.97) was protective against CrCl<50 ml/min. Discussion: Our findings indicate few patients would be excluded from a TDF-based antiretroviral regimen, suggesting baseline creatinine clearance assessment may not be necessary for implementation. However, in ART settings individuals with low BMI or anemia could potentially be at increased risk for lower CrCl.	[Johnson, Derek C.; Chasela, Charles; Maliwichi, Madalitso; Mwafongo, Albert; Akinkuotu, Adesola; Moses, Agness; van der Horst, Charlie; Hosseinipour, Mina C.] Univ N Carolina Project Malawi, Lilongwe, Malawi; [Jamieson, Denise J.; Kourtis, Athena P.; King, Caroline C.] US Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Johnson, DC (corresponding author), Univ N Carolina Project Malawi, Lilongwe, Malawi.	Frg1@uab.edu		Kourtis, Athena/0000-0003-1585-1310; Jamieson, Denise/0000-0003-2597-1201	Fogarty International Clinical Research Scholars and Fellows (FICRS-F) Program	Fogarty International Clinical Research Scholars and Fellows (FICRS-F) Program	The Fogarty International Clinical Research Scholars and Fellows (FICRS-F) Program funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2001, J NEPHROL, V14, P377; Abeysena C, 2010, AUST NZ J OBSTET GYN, V50, P423, DOI 10.1111/j.1479-828X.2010.01220.x; Alper AB, 2007, AM J PERINAT, V24, P569, DOI 10.1055/s-2007-986697; [Anonymous], 2005, SUMM COUNTR PROF HIV; [Anonymous], 2011, ALTR PACK INS; BURDEN RP, 1979, NEPHRON, V24, P183, DOI 10.1159/000181713; Cavkaytar S, 2007, ACTA OBSTET GYN SCAN, V86, P648, DOI 10.1080/00016340601185384; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DAVISON JM, 1980, KIDNEY INT, V18, P152, DOI 10.1038/ki.1980.124; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Emem CP, 2008, NEPHROL DIAL TRANSPL, V23, P741, DOI 10.1093/ndt/gfm836; Go Malawi, 2009, MAL HIV AIDS MON EV; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Horwood C, 2010, TROP MED INT HLTH; Jones R, 2004, JAIDS-J ACQ IMM DEF, V37, P1489, DOI 10.1097/01.qai.0000138983.45235.02; Labarga P, 2010, AIDS, V24, P777, DOI 10.1097/QAD.0b013e3283322895; Landman Roland, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P379, DOI 10.1177/1545109709344352; Laradi A, 1998, J AM SOC NEPHROL, V9, P2327; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Nowicki M., 1994, International Urology and Nephrology, V26, P691, DOI 10.1007/BF02767726; Pilsczek F H, 2008, J Ayub Med Coll Abbottabad, V20, P3; Robert C, 2003, RANDOMIZED TRIAL EVA; Struik GM, 2011, INT J STD AIDS, V22, P457, DOI 10.1258/ijsa.2011.010521; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; UNAIDS, 2010, MAL HIV AIDS MON EV; United States Agency for International Development. (USAID), 2021, MAL EARL WARN ETH RO; Veille JC, 1998, J MATERN-FETAL INVES, V8, P6; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223; World Health Organization, 2021, ANT DRUGS TREAT PREG; Young B, 2009, AIDS PATIENT CARE ST, V23, P589, DOI 10.1089/apc.2008.0232	34	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41011	10.1371/journal.pone.0041011	http://dx.doi.org/10.1371/journal.pone.0041011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848422	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200038
J	Kijas, JW; Miller, JE; Hadfield, T; McCulloch, R; Garcia-Gamez, E; Neto, LRP; Cockett, N				Kijas, James W.; Miller, James E.; Hadfield, Tracy; McCulloch, Russell; Garcia-Gamez, Elsa; Neto, Laercio R. Porto; Cockett, Noelle			Tracking the Emergence of a New Breed Using 49,034 SNP in Sheep	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COAST NATIVE SHEEP; HAEMONCHUS-CONTORTUS; GENETIC DIVERSITY; DOMESTIC SHEEP; SUFFOLK; SUSCEPTIBILITY; CONSERVATION; SELECTION; REVEALS	Domestic animals are unique in that they have been organised into managed populations called breeds. The strength of genetic divergence between breeds may vary dependent on the age of the breed, the scenario under which it emerged and the strength of reproductive isolation it has from other breeds. In this study, we investigated the Gulf Coast Native breed of sheep to determine if it contains lines of animals that are sufficiently divergent to be considered separate breeds. Allele sharing and principal component analysis (PCA) using nearly 50,000 SNP loci revealed a clear genetic division that corresponded with membership of either the Florida or Louisiana Native lines. Subsequent analysis aimed to determine if the strength of the divergence exceeded that found between recognised breed pairs. Genotypes from 14 breeds sampled from Europe and Asia were used to obtain estimates of pair-wise population divergence measured as F-ST. The divergence separating the Florida and Louisiana Native (F-ST = 6.2%) was approximately 50% higher than the average divergence separating breeds developed within the same region of Europe (F-ST = 4.2%). This strongly indicated that the two Gulf Coast Native lines are sufficiently different to be considered separate breeds. PCA using small SNP sets successfully distinguished between the Florida and Louisiana Native animals, suggesting that allele frequency differences have accumulated across the genome. This is consistent with a population history involving geographic separation and genetic drift. Suggestive evidence was detected for divergence at the poll locus on sheep chromosome 10; however drift at neutral markers has been the largest contributor to the genetic separation observed. These results document the emergence of populations that can be considered separate breeds, with practical consequences for bio-conservation priorities, animal registration and the establishment of separate breed societies.	[Kijas, James W.; McCulloch, Russell; Garcia-Gamez, Elsa; Neto, Laercio R. Porto] Commonwealth Sci & Ind Res Org, Div Livestock Ind, Brisbane, Qld, Australia; [Miller, James E.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Miller, James E.] Louisiana State Univ, Dept Vet Sci, Baton Rouge, LA 70803 USA; [Hadfield, Tracy; Cockett, Noelle] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Garcia-Gamez, Elsa] Univ Leon, Dept Anim Prod, E-24071 Leon, Spain; [Neto, Laercio R. Porto] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Utah System of Higher Education; Utah State University; Universidad de Leon; University of Queensland	Kijas, JW (corresponding author), Commonwealth Sci & Ind Res Org, Div Livestock Ind, Brisbane, Qld, Australia.	James.Kijas@csiro.au	Kijas, James W/A-4656-2011; Fortes, Marina R S/G-2302-2012; Porto-Neto, Laercio R/D-2594-2012	Kijas, James W/0000-0002-1417-8278; Fortes, Marina R S/0000-0002-7254-1960; Porto-Neto, Laercio R/0000-0002-3536-8265	Agriculture and Food Research Initiative Competitive from the USDA National Institute for Food and Agriculture [2009-03923]; Spanish Ministry of Scienc [AGL2009-07000]; Spanish Ministry of Education [AP2008-01410]	Agriculture and Food Research Initiative Competitive from the USDA National Institute for Food and Agriculture; Spanish Ministry of Scienc; Spanish Ministry of Education(Spanish Government)	This work was supported by Agriculture and Food Research Initiative Competitive grant no. 2009-03923 from the USDA National Institute for Food and Agriculture. Elsa Garcia-Gamez was supported by the Spanish Ministry of Science (project AGL2009-07000) and Spanish Ministry of Education (AP2008-01410, FPU programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahirathan M, 1996, VET PARASITOL, V65, P259, DOI 10.1016/S0304-4017(96)00969-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dalvit C, 2009, J ANIM SCI, V87, P3837, DOI 10.2527/jas.2008-1682; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Menotti-Raymond M, 2008, GENOMICS, V91, P1, DOI 10.1016/j.ygeno.2007.08.008; Miller JE, 2006, VET PARASITOL, V140, P83, DOI 10.1016/j.vetpar.2006.02.043; Miller JE, 1998, VET PARASITOL, V74, P55, DOI 10.1016/S0304-4017(97)00094-0; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Paiva SR, 2011, TROP ANIM HEALTH PRO, V43, P1449, DOI 10.1007/s11250-011-9873-6; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pedrosa S, 2007, GENET SEL EVOL, V39, P91, DOI 10.1051/gse:2006034; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scherf B.D, 2000, WORLD WATCH LIST DOM; Shakya KP, 2011, VET PARASITOL, V181, P239, DOI 10.1016/j.vetpar.2011.03.051; Solovieff N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-108; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tapio M, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-76; Toro MA, 2005, PHILOS T R SOC B, V360, P1367, DOI 10.1098/rstb.2005.1680; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	25	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41508	10.1371/journal.pone.0041508	http://dx.doi.org/10.1371/journal.pone.0041508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848516	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200067
J	Kuzawa, CW; Eisenberg, DTA				Kuzawa, Christopher W.; Eisenberg, Dan T. A.			Intergenerational Predictors of Birth Weight in the Philippines: Correlations with Mother's and Father's Birth Weight and Test of Maternal Constraint	PLOS ONE			English	Article							MONKEY MACACA-MULATTA; DEVELOPMENTAL ORIGINS; PATERNAL CONTRIBUTION; FETAL-GROWTH; HEIGHT; TRANSMISSION; MORTALITY; HEALTH; RISK	Background: Birth weight (BW) predicts many health outcomes, but the relative contributions of genes and environmental factors to BW remain uncertain. Some studies report stronger mother-offspring than father-offspring BW correlations, with attenuated father-offspring BW correlations when the mother is stunted. These findings have been interpreted as evidence that maternal genetic or environmental factors play an important role in determining birth size, with small maternal size constraining paternal genetic contributions to offspring BW. Here we evaluate mother-offspring and father-offspring birth weight (BW) associations and evaluate whether maternal stunting constrains genetic contributions to offspring birth size. Methods/Principal Findings: Data include BW of offspring (n = 1,101) born to female members (n = 382) and spouses of male members (n = 275) of a birth cohort (born 1983-84) in Metropolitan Cebu, Philippines. Regression was used to relate parental and offspring BW adjusting for confounders. Resampling testing was used to evaluate whether false paternity could explain any evidence for excess matrilineal inheritance. In a pooled model adjusting for maternal height and confounders, parental BW was a borderline-significantly stronger predictor of offspring BW in mothers compared to fathers (sex of parent interaction p = 0.068). In separate multivariate models, each kg in mother's and father's BW predicted a 271 +/- 53 g (p < 0.00001) and 132 +/- 55 g (p = 0.017) increase in offspring BW, respectively. Resampling statistics suggested that false paternity rates of >25% and likely 50% would be needed to explain these differences. There was no interaction between maternal stature and maternal BW (interaction p = 0.520) or paternal BW (p = 0.545). Conclusions/Significance: Each kg change in mother's BW predicted twice the change in offspring BW as predicted by a change in father's BW, consistent with an intergenerational maternal effect on offspring BW. Evidence for excess matrilineal BW heritability at all levels of maternal stature points to indirect genetic, mitochondrial, or epigenetic maternal contributions to offspring fetal growth.	[Kuzawa, Christopher W.; Eisenberg, Dan T. A.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Kuzawa, Christopher W.; Eisenberg, Dan T. A.] Northwestern Univ, Cells Soc 2, Inst Policy Res, Evanston, IL USA; [Eisenberg, Dan T. A.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	Northwestern University; Northwestern University; University of Washington; University of Washington Seattle	Kuzawa, CW (corresponding author), Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA.	kuzawa@northwestern.edu	Eisenberg, Dan T.A./D-7691-2011	Eisenberg, Dan T.A./0000-0003-0812-1862	National Science Foundation [BCS-0746320]; National Institutes of Health [RR20649, ES10126, 7-2004-E]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the National Science Foundation [BCS-0746320] and the National Institutes of Health [RR20649, ES10126; project 7-2004-E]. DTAE was supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Agnihotri B, 2008, INDIAN J PEDIATR, V75, P111, DOI 10.1007/s12098-008-0066-x; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Aubel J, 2012, MATERN CHILD NUTR, V8, P19, DOI 10.1111/j.1740-8709.2011.00333.x; Baird J, 2001, DIABETOLOGIA, V44, P33, DOI 10.1007/s001250051577; Barker D. J. P., 1994, MOTHERS BABIES DIS L; Bedri N M, 1995, Ahfad J, V12, P74; Brewer G, 2009, EVOL PSYCHOL-US, V7, P477; Coutinho R, 1997, AM J EPIDEMIOL, V146, P804; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Gray PB, 2010, WHOS DAD FATHERBOOD; Ha JC, 2002, AM J PRIMATOL, V56, P207, DOI 10.1002/ajp.1075; Henrich J, 2010, P ROY SOC B-BIOL SCI, V277, P3715, DOI 10.1098/rspb.2010.1191; Hypponen E, 2004, BJOG-INT J OBSTET GY, V111, P377, DOI 10.1111/j.1471-0528.2004.00089.x; Jaquet D, 2005, BJOG-INT J OBSTET GY, V112, P153, DOI 10.1111/j.1471-0528.2004.00313.x; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Klebanoff MA, 1998, AM J OBSTET GYNECOL, V178, P1022, DOI 10.1016/S0002-9378(98)70542-3; Kuzawa CW, 2011, EPIGENOMICS-UK, V3, P221, DOI [10.2217/EPI.11.11, 10.2217/epi.11.11]; Kuzawa CW, 2009, ANNU REV ANTHROPOL, V38, P131, DOI 10.1146/annurev-anthro-091908-164350; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; Kuzawa CW, ANN HUM BIO IN PRESS; Leon DA, 2008, INT J EPIDEMIOL, V37, P255, DOI 10.1093/ije/dyn034; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Magnus P, 2001, J EPIDEMIOL COMMUN H, V55, P873, DOI 10.1136/jech.55.12.873; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McDade TW, 2010, P ROY SOC B-BIOL SCI, V277, P1129, DOI 10.1098/rspb.2009.1795; MORRISON J, 1991, AUST NZ J OBSTET GYN, V31, P114, DOI 10.1111/j.1479-828X.1991.tb01795.x; OUNSTED M, 1986, ANN HUM BIOL, V13, P143, DOI 10.1080/03014468600008281; Palloni A, 2006, DEMOGRAPHY, V43, P587, DOI 10.1353/dem.2006.0036; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Price KC, 1999, OBSTET GYNECOL, V94, P128, DOI 10.1016/S0029-7844(99)00269-0; Price KC, 2000, HUM REPROD, V15, P452, DOI 10.1093/humrep/15.2.452; Scheib JE, 2001, PERS RELATIONSHIP, V8, P371, DOI 10.1111/j.1475-6811.2001.tb00046.x; Smith EA, 2011, CURR ANTHROPOL, V52, P579, DOI 10.1086/660846; Smith GD, 2007, AM J EPIDEMIOL, V166, P160, DOI 10.1093/aje/kwm054; Thayer ZM, 2012, AM J HUM BIOL, V24, P1, DOI 10.1002/ajhb.21226; Veena SR, 2004, PAEDIATR PERINAT EP, V18, P361, DOI 10.1111/j.1365-3016.2004.00579.x; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; VLIETINCK R, 1989, BEHAV GENET, V19, P151, DOI 10.1007/BF01065890; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029; Whitfield J B, 2001, Twin Res, V4, P365, DOI 10.1375/twin.4.5.365	47	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40905	10.1371/journal.pone.0040905	http://dx.doi.org/10.1371/journal.pone.0040905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848409	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200034
J	Thomas, XV; de Bruijne, J; Sullivan, JC; Kieffer, TL; Ho, CKY; Rebers, SP; de Vries, M; Reesink, HW; Weegink, CJ; Molenkamp, R; Schinkel, J				Thomas, Xiomara V.; de Bruijne, Joep; Sullivan, James C.; Kieffer, Tara L.; Ho, Cynthia K. Y.; Rebers, Sjoerd P.; de Vries, Michel; Reesink, Hendrik W.; Weegink, Christine J.; Molenkamp, Richard; Schinkel, Janke			Evaluation of Persistence of Resistant Variants with Ultra-Deep Pyrosequencing in Chronic Hepatitis C Patients Treated with Telaprevir	PLOS ONE			English	Article							PROTEASE INHIBITORS; ANTIVIRAL AGENTS; VIRUS; VX-950; REPLICATION; BOCEPREVIR; MUTATIONS; INFERENCE; HISTORY	Background & Aims: Telaprevir, a hepatitis C virus NS3/4A protease inhibitor has significantly improved sustained viral response rates when given in combination with pegylated interferon alfa-2a and ribavirin, compared with current standard of care in hepatitis C virus genotype 1 infected patients. In patients with a failed sustained response, the emergence of drug-resistant variants during treatment has been reported. It is unclear to what extent these variants persist in untreated patients. The aim of this study was to assess using ultra-deep pyrosequencing, whether after 4 years follow-up, the frequency of resistant variants is increased compared to pre-treatment frequencies following 14 days of telaprevir treatment. Methods: Fifteen patients from 2 previous telaprevir phase 1 clinical studies (VX04-950-101 and VX05-950-103) were included. These patients all received telaprevir monotherapy for 14 days, and 2 patients subsequently received standard of care. Variants at previously well-characterized NS3 protease positions V36, T54, R155 and A156 were assessed at baseline and after a follow-up of 4 +/- 1.2 years by ultra-deep pyrosequencing. The prevalence of resistant variants at follow-up was compared to baseline. Results: Resistance associated mutations were detectable at low frequency at baseline. In general, prevalence of resistance mutations at follow-up was not increased compared to baseline. Only one patient had a small, but statistically significant, increase in the number of V36M and T54S variants 4 years after telaprevir-dosing. Conclusion: In patients treated for 14 days with telaprevir monotherapy, ultra-deep pyrosequencing indicates that long-term persistence of resistant variants is rare.	[Thomas, Xiomara V.; Ho, Cynthia K. Y.; Rebers, Sjoerd P.; Molenkamp, Richard; Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Sect Clin Virol, NL-1105 AZ Amsterdam, Netherlands; [de Bruijne, Joep; Reesink, Hendrik W.; Weegink, Christine J.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Sullivan, James C.; Kieffer, Tara L.] Vertex Pharmaceut Inc, Cambridge, MA USA; [de Vries, Michel] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Sect Human Retro Virol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vertex Pharmaceuticals; University of Amsterdam; Academic Medical Center Amsterdam	Thomas, XV (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Sect Clin Virol, NL-1105 AZ Amsterdam, Netherlands.	x.v.thomas@amc.uva.nl	Schinkel, Janke/I-3099-2012	Schinkel, Janke/0000-0002-1112-0644	Merck Co	Merck Co(Merck & Company)	The authors have read the journal's policy and have the following conflicts: HR serves as advisor for Roche Molecular Diagnostics, Anadys, Merck, Arrows, and Gilead, consults for PRA-International, Tibotec, GlaxoSmithKline, Chiron Novartis, and Roche Therapeutics, and receives grant/research support from Merck & Co. TK and J. Sullivan are employees and stock owners of Vertex Pharmaceuticals Incorporated. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have nothing to disclose.	[Anonymous], 2011, HEP C; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Forestier N, 2007, HEPATOLOGY, V46, P640, DOI 10.1002/hep.21774; Foster GR, 2004, SEMIN LIVER DIS, V24, P97, DOI 10.1055/s-2004-832934; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Li Kelvin, 2010, BMC Res Notes, V3, P199, DOI 10.1186/1756-0500-3-199; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; McHutchison JG, 2006, J HEPATOL, V44, P411, DOI 10.1016/j.jhep.2005.12.001; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Nei M., 2000, MOL EVOLUTION PHYLOG; Pawlotsky JM, 2004, HEPATOLOGY, V39, P554, DOI 10.1002/hep.20065; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Pybus OG, 2000, GENETICS, V155, P1429; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terrault NA, 2006, LIVER TRANSPLANT, V12, P1192, DOI 10.1002/lt.20865; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	33	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41191	10.1371/journal.pone.0041191	http://dx.doi.org/10.1371/journal.pone.0041191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848441	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200044
J	Lin, IF; Kashino, M				Lin, I-Fan; Kashino, Makio			Perceptual Grouping over Time within and across Auditory and Tactile Modalities	PLOS ONE			English	Article							RHYTHMIC MASKING RELEASE; STREAM SEGREGATION; ORGANIZATION; REPRESENTATION; SEPARATION; CORTEX; STIMULATION; INTEGRATION; NEURONS; VISION	In auditory scene analysis, population separation and temporal coherence have been proposed to explain how auditory features are grouped together and streamed over time. The present study investigated whether these two theories can be applied to tactile streaming and whether temporal coherence theory can be applied to crossmodal streaming. The results show that synchrony detection between two tones/taps at different frequencies/locations became difficult when one of the tones/taps was embedded in a perceptual stream. While the taps applied to the same location were streamed over time, the taps applied to different locations were not. This observation suggests that tactile stream formation can be explained by population-separation theory. On the other hand, temporally coherent auditory stimuli at different frequencies were streamed over time, but temporally coherent tactile stimuli applied to different locations were not. When there was withinmodality streaming, temporally coherent auditory stimuli and tactile stimuli were not streamed over time, either. This observation suggests the limitation of temporal coherence theory when it is applied to perceptual grouping over time.	[Lin, I-Fan; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Morinosato, Wakamiya, Japan	Nippon Telegraph & Telephone Corporation	Lin, IF (corresponding author), NTT Corp, NTT Commun Sci Labs, Morinosato, Wakamiya, Japan.	lin.ifan@lab.ntt.co.jp	Lin, Ifan/HHM-7112-2022		Nippon Telegraph and Telephone Corporation	Nippon Telegraph and Telephone Corporation	This work was supported by Nippon Telegraph and Telephone Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast TL, 2002, J ACOUST SOC AM, V112, P2086, DOI 10.1121/1.1510141; BERNSTEIN LE, 1991, J ACOUST SOC AM, V90, P2971, DOI 10.1121/1.401771; Best V, 2005, J ACOUST SOC AM, V118, P3766, DOI 10.1121/1.2130949; Bregman A.S., 1990, AUDITORY SCENE ANAL; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; DYKES RW, 1981, NEUROSCIENCE, V6, P1687, DOI 10.1016/0306-4522(81)90235-9; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Friedman RM, 2008, J NEUROPHYSIOL, V100, P3185, DOI 10.1152/jn.90278.2008; GARDNER EP, 1972, J NEUROPHYSIOL, V35, P954, DOI 10.1152/jn.1972.35.6.954; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Gutschalk A, 2007, J NEUROSCI, V27, P13074, DOI 10.1523/JNEUROSCI.2299-07.2007; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P539, DOI 10.1113/jphysiol.1978.sp012518; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; Kanold PO, 2001, J NEUROSCI, V21, P7848, DOI 10.1523/JNEUROSCI.21-19-07848.2001; Keetels M, 2007, EXP BRAIN RES, V180, P449, DOI 10.1007/s00221-007-0881-8; Kitagawa N, 2009, J EXP PSYCHOL HUMAN, V35, P1784, DOI 10.1037/a0016891; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LASKIN SE, 1979, J NEUROPHYSIOL, V42, P1048, DOI 10.1152/jn.1979.42.4.1048; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Micheyl C, 2010, J EXP PSYCHOL HUMAN, V36, P1029, DOI 10.1037/a0017601; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; Roseboom W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018309; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; SHERRICK CE, 1964, AM J PSYCHOL, V77, P42, DOI 10.2307/1419270; Shore SE, 2000, J COMP NEUROL, V419, P271, DOI 10.1002/(SICI)1096-9861(20000410)419:3<271::AID-CNE1>3.0.CO;2-M; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; SPARKS DW, 1978, J ACOUST SOC AM, V63, P246, DOI 10.1121/1.381720; Turgeon M, 2005, J EXP PSYCHOL HUMAN, V31, P939, DOI 10.1037/0096-1523.31.5.939; Turgeon M, 2002, J ACOUST SOC AM, V111, P1819, DOI 10.1121/1.1453450; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vliegen J, 1999, J ACOUST SOC AM, V105, P339, DOI 10.1121/1.424503; VONBEKESY G, 1958, J ACOUST SOC AM, V30, P399; WARREN RM, 1984, PSYCHOL BULL, V96, P371, DOI 10.1037/0033-2909.96.2.371; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; Yau JM, 2009, CURR BIOL, V19, P561, DOI 10.1016/j.cub.2009.02.013; YOUNG ED, 1995, J NEUROPHYSIOL, V73, P743, DOI 10.1152/jn.1995.73.2.743	43	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41661	10.1371/journal.pone.0041661	http://dx.doi.org/10.1371/journal.pone.0041661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	012MO	22844509	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600038
J	Xu, QP; van Wezel, GP; Chiu, HJ; Jaroszewski, L; Klock, HE; Knuth, MW; Miller, MD; Lesley, SA; Godzik, A; Elsliger, MA; Deacon, AM; Wilson, IA				Xu, Qingping; van Wezel, Gilles P.; Chiu, Hsiu-Ju; Jaroszewski, Lukasz; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Lesley, Scott A.; Godzik, Adam; Elsliger, Marc-Andre; Deacon, Ashley M.; Wilson, Ian A.			Structure of an MmyB-Like Regulator from C-aurantiacus, Member of a New Transcription Factor Family Linked to Antibiotic Metabolism in Actinomycetes	PLOS ONE			English	Article							REPRESSOR-OPERATOR COMPLEX; CRYSTAL-STRUCTURE; STREPTOMYCES-COELICOLOR; SECONDARY METABOLISM; GENE-CLUSTER; A-FACTOR; PROTEIN; DNA; MECHANISM; BIOSYNTHESIS	Actinomycetes are important bacterial sources of antibiotics and other secondary metabolites. Many antibiotic gene clusters are controlled by pathway-specific activators that act in response to growth conditions. Here we present the crystal structure of an MmyB-like transcription regulator MltR (PDB code 3pxp) (Caur_2278) from Chloroflexus aurantiacus, in complex with a fatty acid (myristic acid). MltR is a distant homolog of the methylenomycin activator MmyB and consists of an Xre-type N-terminal DNA-binding domain and a C-terminal ligand-binding module that is related to the Per-Arnt-Sim (PAS) domain. This structure has enabled identification of a new family of bacterial transcription factors that are distributed predominantly in actinomycetes. Bioinformatics analysis of MltR and other characterized family members suggest that they are likely associated with antibiotic and fatty acid metabolism in actinomycetes. Streptomyces coelicolor SCO4944 is a candidate as an ancestral member of the family. Its ortholog in S. griseus, SGR_6891, is induced by A-factor, a gamma-butyrolactone that controls antibiotic production and development, and is adjacent to the A-factor synthase gen, afsA. The location of mltR/mmyB homologs, in particular those adjacent to less well-studied antibiotic-related genes, makes them interesting genetic markers for identifying new antibiotic genes. A model for signal-triggered DNA-binding by MltR is proposed.	[Xu, Qingping; Chiu, Hsiu-Ju; Jaroszewski, Lukasz; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Lesley, Scott A.; Godzik, Adam; Elsliger, Marc-Andre; Deacon, Ashley M.; Wilson, Ian A.] Joint Ctr Struct Genom, La Jolla, CA USA; [Xu, Qingping; Chiu, Hsiu-Ju; Miller, Mitchell D.; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [van Wezel, Gilles P.] Leiden Univ, Gorlaeus Labs, Dept Biol, NL-2300 RA Leiden, Netherlands; [Jaroszewski, Lukasz; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Jaroszewski, Lukasz; Godzik, Adam] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, La Jolla, CA USA; [Klock, Heath E.; Knuth, Mark W.; Lesley, Scott A.] Novartis Res Fdn, Prot Sci Dept, Genom Inst, San Diego, CA USA; [Lesley, Scott A.; Elsliger, Marc-Andre; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Leiden University; Leiden University - Excl LUMC; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Novartis; Scripps Research Institute	Wilson, IA (corresponding author), Joint Ctr Struct Genom, La Jolla, CA USA.	wilson@scripps.edu	van Wezel, Gilles/ABC-7854-2021; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	van Wezel, Gilles/0000-0003-0341-1561; Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Miller, Mitchell/0000-0003-1626-4943; Elsliger, Marc Andre/0000-0002-1989-7626	DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; Netherlands Applied Research Council (STW); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, U54GM074898, P41GM103393] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Netherlands Applied Research Council (STW); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209). GPvW was supported by a VICI grant from the Netherlands Applied Research Council (STW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2009, BUSTER; Chater KF, 2008, J MICROBIOL, V46, P1, DOI 10.1007/s12275-007-0233-1; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Corre C, 2008, P NATL ACAD SCI USA, V105, P17510, DOI 10.1073/pnas.0805530105; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cundliffe E, 2006, J IND MICROBIOL BIOT, V33, P500, DOI 10.1007/s10295-006-0083-6; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Genick UK, 1998, NATURE, V392, P206, DOI 10.1038/32462; Hara H, 2009, MICROBIOL-SGM, V155, P2197, DOI 10.1099/mic.0.027862-0; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horinouchi S, 2002, FRONT BIOSCI-LANDMRK, V7, pD2045, DOI 10.2741/horinouc; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Lopez P, 2010, GENE, V461, P5, DOI 10.1016/j.gene.2010.03.016; MCDONNELL GE, 1994, J BACTERIOL, V176, P5831, DOI 10.1128/JB.176.18.5831-5834.1994; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; McLuskey K, 2005, P NATL ACAD SCI USA, V102, P14221, DOI 10.1073/pnas.0504314102; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Notredame C., 2010, CURR PROTOC BIOINFOR; O'Rourke S, 2004, MICROBIOL AUST, V25, P2; O'Rourke S, 2009, MOL MICROBIOL, V71, P763, DOI 10.1111/j.1365-2958.2008.06560.x; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x; Russo S, 2009, J BIOL CHEM, V284, P5208, DOI 10.1074/jbc.M806591200; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833	52	11	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41359	10.1371/journal.pone.0041359	http://dx.doi.org/10.1371/journal.pone.0041359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844465	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600023
J	Dobelis, P; Staley, KJ; Cooper, DC				Dobelis, Peter; Staley, Kevin J.; Cooper, Donald C.			Lack of Modulation of Nicotinic Acetylcholine Alpha-7 Receptor Currents by Kynurenic Acid in Adult Hippocampal Interneurons	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; SYNAPTIC-TRANSMISSION; POTENTIAL ROLE; ACH RECEPTORS; MOUSE-BRAIN; NEURONS; CHANNELS; SUBTYPES	Kynurenic acid (KYNA), a classical ionotropic glutamate receptor antagonist is also purported to block the alpha 7-subtype nicotinic acetylcholine receptor (alpha 7* nAChR). Although many published studies cite this potential effect, few have studied it directly. In this study, the alpha 7*-selective agonist, choline, was pressure-applied to interneurons in hippocampal subregions, CA1 stratum radiatum and hilus of acute brain hippocampal slices from adolescent to adult mice and adolescent rats. Stable alpha 7* mediated whole-cell currents were measured using voltage-clamp at physiological temperatures. The effects of bath applied KYNA on spontaneous glutamatergic excitatory postsynaptic potentials (sEPSC) as well as choline-evoked alpha 7* currents were determined. In mouse hilar interneurons, KYNA totally blocked sEPSC whole-cell currents in a rapid and reversible manner, but had no effect on choline-evoked alpha 7* whole-cell currents. To determine if this lack of KYNA effect on alpha 7* function was due to regional and/or species differences in alpha 7* nAChRs, the effects of KYNA on choline-evoked alpha 7* whole-cell currents in mouse and rat stratum radiatum interneurons were tested. KYNA had no effect on either mouse or rat stratum radiatum interneuron choline-evoked alpha 7* whole-cell currents. Finally, to test whether the lack of effect of KYNA was due to unlikely slow kinetics of KYNA interactions with alpha 7* nAChRs, recordings of alpha 7*-mediated currents were made from slices that were prepared and stored in the presence of 1 mM KYNA (>90 minutes exposure). Under these conditions, KYNA had no measurable effect on alpha 7* nAChR function. The results show that despite KYNA-mediated blockade of glutamatergic sEPSCs, two types of hippocampal interneurons that express choline-evoked alpha 7* nAChR currents fail to show any degree of modulation by KYNA. Our results indicate that under our experimental conditions, which produced complete KYNA-mediated blockade of sEPSCs, claims of KYNA effects on choline-evoked alpha 7* nAChR function should be made with caution.	[Dobelis, Peter; Cooper, Donald C.] Univ Colorado, Ctr Neurosci, Inst Behav Genet, Dept Neurosci, Boulder, CO 80309 USA; [Staley, Kevin J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts General Hospital	Dobelis, P (corresponding author), Univ Colorado, Ctr Neurosci, Inst Behav Genet, Dept Neurosci, Boulder, CO 80309 USA.	dcooper@Colorado.edu			American Epilepsy Foundation/Milken Family Foundation; NIH [R21 DA026918]; National Institute on Drug Abuse [R01-DA24040]; NIDA K award [K-01DA017750]; NINDS [R01 NS034700]; Colorado Tobacco Research Program [1F-059]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA017750, R01DA024040, R21DA026918] Funding Source: NIH RePORTER	American Epilepsy Foundation/Milken Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA K award; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Colorado Tobacco Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded and supported by the American Epilepsy Foundation/Milken Family Foundation Fellowship (PD), R21 DA026918 NIH (J. Stitzel), National Institute on Drug Abuse grant R01-DA24040 (DCC), NIDA K award K-01DA017750 (DCC), NINDS R01 NS034700 (KJS), and the Colorado Tobacco Research Program (1F-059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Alkondon M, 1998, BRAIN RES, V810, P257, DOI 10.1016/S0006-8993(98)00880-4; Alkondon M, 2003, J NEUROPHYSIOL, V90, P1613, DOI 10.1152/jn.00214.2003; Alkondon M, 2004, J NEUROSCI, V24, P4635, DOI 10.1523/JNEUROSCI.5631-03.2004; Alkondon M, 2011, BIOCHEM PHARMACOL, V82, P842, DOI 10.1016/j.bcp.2011.06.004; Alkondon M, 2011, J PHARMACOL EXP THER, V337, P572, DOI 10.1124/jpet.110.177386; Arnaiz-Cot JJ, 2008, EUR J NEUROSCI, V27, P1097, DOI 10.1111/j.1460-9568.2008.06077.x; Banerjee J, 2012, J PHARM EXP THER; Buhler AV, 2002, J NEUROPHYSIOL, V87, P548, DOI 10.1152/jn.00316.2001; Buhler AV, 2001, NEUROSCIENCE, V106, P55, DOI 10.1016/S0306-4522(01)00257-3; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; El-Hajj RA, 2007, LIFE SCI, V81, P1317, DOI 10.1016/j.lfs.2007.08.039; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 2003, J NEUROPHYSIOL, V89, P3018, DOI 10.1152/jn.01036.2002; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Girod R, 1999, ANN NY ACAD SCI, V868, P578, DOI 10.1111/j.1749-6632.1999.tb11331.x; Guo JA, 2008, J PHARMACOL EXP THER, V324, P342, DOI 10.1124/jpet.107.127266; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Lukas RJ, 1999, PHARMACOL REV, V51, P397; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Mok MHS, 2009, NEUROPHARMACOLOGY, V57, P242, DOI 10.1016/j.neuropharm.2009.06.003; Moroni F, 2012, J NEURAL TRANSM, V119, P133, DOI 10.1007/s00702-011-0763-x; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Scharfman HE, 1999, NEUROSCI LETT, V274, P111, DOI 10.1016/S0304-3940(99)00690-4; Scharfman HE, 2000, AMINO ACIDS, V19, P283, DOI 10.1007/s007260070060; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Stokes C, 2004, MOL PHARMACOL, V66, P14, DOI 10.1124/mol.66.1.14; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Stone TW, 2012, FEBS J; Sudweeks SN, 2000, J PHYSIOL-LONDON, V527, P515, DOI 10.1111/j.1469-7793.2000.00515.x; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; Wu J, 2011, BIOCHEM PHARMACOL, V82, P800, DOI 10.1016/j.bcp.2011.07.067; Yu CR, 1998, J PHYSIOL-LONDON, V509, P667, DOI 10.1111/j.1469-7793.1998.667bm.x	43	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41108	10.1371/journal.pone.0041108	http://dx.doi.org/10.1371/journal.pone.0041108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848433	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600040
J	Hughes, MF; Saarela, O; Stritzke, J; Kee, F; Silander, K; Klopp, N; Kontto, J; Karvanen, J; Willenborg, C; Salomaa, V; Virtamo, J; Amouyel, P; Arveiler, D; Ferrieres, J; Wiklund, PG; Baumert, J; Thorand, B; Diemert, P; Tregouet, DA; Hengstenberg, C; Peters, A; Evans, A; Koenig, W; Erdmann, J; Samani, NJ; Kuulasmaa, K; Schunkert, H				Hughes, Maria F.; Saarela, Olli; Stritzke, Jan; Kee, Frank; Silander, Kaisa; Klopp, Norman; Kontto, Jukka; Karvanen, Juha; Willenborg, Christina; Salomaa, Veikko; Virtamo, Jarmo; Amouyel, Phillippe; Arveiler, Dominique; Ferrieres, Jean; Wiklund, Per-Gunner; Baumert, Jens; Thorand, Barbara; Diemert, Patrick; Tregouet, David-Alexandre; Hengstenberg, Christian; Peters, Annette; Evans, Alun; Koenig, Wolfgang; Erdmann, Jeanette; Samani, Nilesh J.; Kuulasmaa, Kari; Schunkert, Heribert			Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts	PLOS ONE			English	Article							HEART-DISEASE; CARDIOVASCULAR-DISEASE; ASSOCIATION; SUSCEPTIBILITY; SCORE; VALIDATION; LOCUS; MODEL	Background: More accurate coronary heart disease (CHD) prediction, specifically in middle-aged men, is needed to reduce the burden of disease more effectively. We hypothesised that a multilocus genetic risk score could refine CHD prediction beyond classic risk scores and obtain more precise risk estimates using a prospective cohort design. Methods: Using data from nine prospective European cohorts, including 26,221 men, we selected in a case-cohort setting 4,818 healthy men at baseline, and used Cox proportional hazards models to examine associations between CHD and risk scores based on genetic variants representing 13 genomic regions. Over follow-up (range: 5-18 years), 1,736 incident CHD events occurred. Genetic risk scores were validated in men with at least 10 years of follow-up (632 cases, 1361 non-cases). Genetic risk score 1 (GRS1) combined 11 SNPs and two haplotypes, with effect estimates from previous genome-wide association studies. GRS2 combined 11 SNPs plus 4 SNPs from the haplotypes with coefficients estimated from these prospective cohorts using 10-fold cross-validation. Scores were added to a model adjusted for classic risk factors comprising the Framingham risk score and 10-year risks were derived. Results: Both scores improved net reclassification (NRI) over the Framingham score (7.5%, p = 0.017 for GRS1, 6.5%, p = 0.044 for GRS2) but GRS2 also improved discrimination (c-index improvement 1.11%, p = 0.048). Subgroup analysis on men aged 50-59 (436 cases, 603 non-cases) improved net reclassification for GRS1 (13.8%) and GRS2 (12.5%). Net reclassification improvement remained significant for both scores when family history of CHD was added to the baseline model for this male subgroup improving prediction of early onset CHD events. Conclusions: Genetic risk scores add precision to risk estimates for CHD and improve prediction beyond classic risk factors, particularly for middle aged men.	[Hughes, Maria F.; Kee, Frank; Evans, Alun] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Saarela, Olli; Silander, Kaisa; Kontto, Jukka; Karvanen, Juha; Salomaa, Veikko; Virtamo, Jarmo; Kuulasmaa, Kari] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Stritzke, Jan; Willenborg, Christina; Diemert, Patrick; Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, D-23538 Lubeck, Germany; [Silander, Kaisa] Univ Helsinki, FIMM, Inst Mol Med Finland, Helsinki, Finland; [Klopp, Norman; Baumert, Jens; Thorand, Barbara; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Munich, Germany; [Amouyel, Phillippe] INSERM, U744, F-59045 Lille, France; [Arveiler, Dominique] Univ Strasbourg, Dept Epidemiol & Publ Hlth, EA3430, Strasbourg, France; [Ferrieres, Jean] Toulouse Univ, Sch Med, INSERM, U558, Toulouse, France; [Wiklund, Per-Gunner] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Tregouet, David-Alexandre] Univ Paris 06, INSERM, UMRS937, Paris, France; [Hengstenberg, Christian] Univ Regensburg, Dept Internal Med & Cardiol, Regensburg, Germany; [Koenig, Wolfgang] Univ Ulm, Dept Internal Med Cardiol 2, Ulm, Germany; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Gen Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England	Queens University Belfast; Finland National Institute for Health & Welfare; University of Lubeck; University of Helsinki; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); Umea University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Regensburg; Ulm University; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Hughes, MF (corresponding author), Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland.	maria.hughes@qub.ac.uk	Tregouet, David-Alexandre/E-3961-2016; Willenborg, Christina/D-2668-2012; Thorand, Barbara/B-5349-2014; Peters, Annette/A-6117-2011; Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014; Hengstenberg, Christian/U-5485-2019; Trégouët, David-Alexandre/P-9210-2019; Ferrieres, Jean/S-7993-2016	Willenborg, Christina/0000-0001-5217-6882; Thorand, Barbara/0000-0002-8416-6440; Peters, Annette/0000-0001-6645-0985; Erdmann, Jeanette/0000-0002-4486-6231; Trégouët, David-Alexandre/0000-0001-9084-7800; Hughes, Maria/0000-0002-2364-7152; Koenig, Wolfgang/0000-0002-2064-9603; Ferrieres, Jean/0000-0001-6144-1297; Karvanen, Juha/0000-0001-5530-769X; Kontto, Jukka/0000-0003-3899-9852; Kuulasmaa, Kari/0000-0003-2165-1411; Amouyel, Philippe/0000-0001-9088-234X; Stritzke, Jan/0000-0003-3143-7005	European Community [QLG2-CT-2002-01254, LSHM -CT-2006-037593, 201413, HEALTH-F4-2007-201413]; German Federal Ministry of Education and Research (BMBF), German National Genome Research Network [NGFN-2, NGFN-plus, 01GS0423]; bi-national BMBF/ANR funded project CADomics [01KU0908A]; British Heart Foundation; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; Medical Research Council [MC_CF023241] Funding Source: researchfish	European Community(European Commission); German Federal Ministry of Education and Research (BMBF), German National Genome Research Network(Federal Ministry of Education & Research (BMBF)); bi-national BMBF/ANR funded project CADomics(French National Research Agency (ANR)); British Heart Foundation(British Heart Foundation); Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Community's Fifth, Sixth, and Seventh Framework Programmes (GenomEUtwin (QLG2-CT-2002-01254), Cardiogenics (LSHM -CT-2006-037593); ENGAGE (201413), and HEALTH-F4-2007-201413), by the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus; 01GS0423), as well as the bi-national BMBF/ANR funded project CADomics (01KU0908A). NJS holds a chair supported by the British Heart Foundation. His research is supported by the Leicester NIHR Biomedical Research Unit in Cardiovascular Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Davies RW, 2010, CIRCULATION CARDIO G, V3, P463; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Evans A, 2005, INT J EPIDEMIOL, V34, P21, DOI 10.1093/ije/dyh327; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janssens ACJW, 2011, ANN INTERN MED, V154, P421, DOI 10.7326/0003-4819-154-6-201103150-00008; Karvanen J, 2009, GENET EPIDEMIOL, V33, P237, DOI 10.1002/gepi.20374; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kulathinal S, 2005, DESCRIPTION MORGAM C; Kulathinal Sangita, 2007, Epidemiol Perspect Innov, V4, P15; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Niemela M., 2007, DESCRIPTION QUALITY; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Qi L, 2011, J AM COLL CARDIOL, V58, P2675, DOI 10.1016/j.jacc.2011.08.054; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Vaarhorst AAM, 2012, CIRC-CARDIOVASC GENE, V5, P202, DOI 10.1161/CIRCGENETICS.111.960708	33	72	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40922	10.1371/journal.pone.0040922	http://dx.doi.org/10.1371/journal.pone.0040922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848412	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600029
J	Yan, XH; Magnasco, MO				Yan, Xiao-Hu; Magnasco, Marcelo O.			Input-Dependent Wave Attenuation in a Critically-Balanced Model of Cortex	PLOS ONE			English	Article							VISUAL-CORTEX; NEURONAL AVALANCHES; SPATIAL SUMMATION; OSCILLATIONS; HEARING; NETWORK	A number of studies have suggested that many properties of brain activity can be understood in terms of critical systems. However it is still not known how the long-range susceptibilities characteristic of criticality arise in the living brain from its local connectivity structures. Here we prove that a dynamically critically-poised model of cortex acquires an infinitely-long ranged susceptibility in the absence of input. When an input is presented, the susceptibility attenuates exponentially as a function of distance, with an increasing spatial attenuation constant (i.e., decreasing range) the larger the input. This is in direct agreement with recent results that show that waves of local field potential activity evoked by single spikes in primary visual cortex of cat and macaque attenuate with a characteristic length that also increases with decreasing contrast of the visual stimulus. A susceptibility that changes spatial range with input strength can be thought to implement an input-dependent spatial integration: when the input is large, no additional evidence is needed in addition to the local input; when the input is weak, evidence needs to be integrated over a larger spatial domain to achieve a decision. Such input-strength-dependent strategies have been demonstrated in visual processing. Our results suggest that input-strength dependent spatial integration may be a natural feature of a critically-balanced cortical network.	[Yan, Xiao-Hu; Magnasco, Marcelo O.] Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA	Rockefeller University	Yan, XH (corresponding author), Rockefeller Univ, Phys Math Lab, 1230 York Ave, New York, NY 10021 USA.	magnasco@rockefeller.edu			National Science Foundation (NSF) [EF-0928723]; Federal Republic of Germany (FRG); Direct For Biological Sciences [0928723] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Federal Republic of Germany (FRG); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the National Science Foundation (NSF) under grant EF-0928723. XHY acknowledges the support of a Studienstiftung-Rockefeller cooperative fellowship from the Federal Republic of Germany (FRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby W.R., 1948, ELECTRON ENG, V20, P379; Atick J, 1990, NEURAL COMPUT, V2.3, P308, DOI [10.1162/neco.1990.2.3.308, DOI 10.1162/NECO.1990.2.3.308]; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bienenstock E, 1999, ADV COMPLEX SYST, V1.4, P361; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; da Silva L, 1998, PHYS LETT A, V242, P343, DOI 10.1016/S0375-9601(98)00232-1; Duke T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.158101; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Fraiman D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061922; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; GUCKENHEIMER J, 1997, NONLINEAR OSCILLATIO; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Magnasco MO, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258102; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Moreau L, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.020901; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Pikulin VP, 2012, EQUATIONS MATH PHY A; Rieke F., 1999, SPIKES; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Seung HS, 1998, NEURAL NETWORKS, V11, P1253, DOI 10.1016/S0893-6080(98)00064-1	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41419	10.1371/journal.pone.0041419	http://dx.doi.org/10.1371/journal.pone.0041419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848489	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600065
J	MacKenzie, BR; Mariani, P				MacKenzie, Brian R.; Mariani, Patrizio			Spawning of Bluefin Tuna in the Black Sea: Historical Evidence, Environmental Constraints and Population Plasticity	PLOS ONE			English	Article							COD GADUS-MORHUA; SPRAT SPRATTUS-SPRATTUS; THUNNUS-THYNNUS L.; VERTICAL-DISTRIBUTION; ATLANTIC COD; EGG BUOYANCY; PLEURONECTES-PLATESSA; STOCK FLUCTUATIONS; FERTILIZED-EGGS; FISH EGGS	The lucrative and highly migratory Atlantic bluefin tuna, Thunnus thynnus (Linnaeus 1758; Scombridae), used to be distributed widely throughout the north Atlantic Ocean, Mediterranean Sea and Black Sea. Its migrations have supported sustainable fisheries and impacted local cultures since antiquity, but its biogeographic range has contracted since the 1950s. Most recently, the species disappeared from the Black Sea in the late 1980s and has not yet recovered. Reasons for the Black Sea disappearance, and the species-wide range contraction, are unclear. However bluefin tuna formerly foraged and possibly spawned in the Black Sea. Loss of a locally-reproducing population would represent a decline in population richness, and an increase in species vulnerability to perturbations such as exploitation and environmental change. Here we identify the main genetic and phenotypic adaptations that the population must have (had) in order to reproduce successfully in the specific hydrographic (estuarine) conditions of the Black Sea. By comparing hydrographic conditions in spawning areas of the three species of bluefin tunas, and applying a mechanistic model of egg buoyancy and sinking rate, we show that reproduction in the Black Sea must have required specific adaptations of egg buoyancy, fertilisation and development for reproductive success. Such adaptations by local populations of marine fish species spawning in estuarine areas are common as is evident from a meta-analysis of egg buoyancy data from 16 species of fish. We conclude that these adaptations would have been necessary for successful local reproduction by bluefin tuna in the Black Sea, and that a locally-adapted reproducing population may have disappeared. Recovery of bluefin tuna in the Black Sea, either for spawning or foraging, will occur fastest if any remaining locally adapted individuals are allowed to survive, and by conservation and recovery of depleted Mediterranean populations which could through time re-establish local Black Sea spawning and foraging.	[MacKenzie, Brian R.] Tech Univ Denmark, Natl Inst Aquat Resources DTU Aqua, Ctr Macroecol Evolut & Climate, Charlottenlund, Denmark; [Mariani, Patrizio] Tech Univ Denmark, Natl Inst Aquat Resources DTU Aqua, Ctr Ocean Life, Charlottenlund, Denmark	Technical University of Denmark; Technical University of Denmark	MacKenzie, BR (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources DTU Aqua, Ctr Macroecol Evolut & Climate, Charlottenlund, Denmark.	brm@aqua.dtu.dk	Mariani, Patrizio/AAP-2007-2021; MacKenzie, Brian R./T-9379-2019	Mariani, Patrizio/0000-0002-8015-1583; MacKenzie, Brian R./0000-0002-4798-0363	Census of Marine Life-History of Marine Animal Populations (CoML-HMAP); Danish National Research Foundation (Dansk Grundforskningsfond); EU [287844]; Census of Marine Life-History of Marine Animal Populations (Sloan Foundation); Villum Fonden [00007178] Funding Source: researchfish	Census of Marine Life-History of Marine Animal Populations (CoML-HMAP); Danish National Research Foundation (Dansk Grundforskningsfond)(Danmarks Grundforskningsfond); EU(European Commission); Census of Marine Life-History of Marine Animal Populations (Sloan Foundation); Villum Fonden(Villum Fonden)	The authors thank the Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation), the Danish National Research Foundation (Dansk Grundforskningsfond), and the EU project "Towards COast to COast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential" (COCONET, EU FP7 No. 287844) for support including publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlandsvik B, 2001, FISH RES, V50, P59, DOI 10.1016/S0165-7836(00)00242-3; Akyuz EF, 1957, GEN FISH COUN MEDIT, V4, P93; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; ANDERSON JT, 1994, ICES MAR SC, V198, P654; Aristotle, 1910, WORKS ARISTOTLE, VIV; Arkhipov A., 2009, J ICHTHYOL, V49, P228; Arkhipov A.G., 2011, J ICHTHYOL, V51, P98, DOI [10.1134/S0032945211010024, DOI 10.1134/S0032945211010024]; Bakun A, 2003, FISH OCEANOGR, V12, P458, DOI 10.1046/j.1365-2419.2003.00258.x; Bakun A., 1996, OCEAN PROCESSES MARI; Begg GA, 2002, MAR ECOL PROG SER, V229, P245, DOI 10.3354/meps229245; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bradbury IR, 2000, CAN J FISH AQUAT SCI, V57, P1761, DOI 10.1139/cjfas-57-9-1761; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Burchard H, 2001, J PHYS OCEANOGR, V31, P1943, DOI 10.1175/1520-0485(2001)031<1943:CAOFSM>2.0.CO;2; Burchard H, 2006, J MARINE SYST, V61, P180, DOI 10.1016/j.jmarsys.2005.04.011; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Cavallaro G., 1991, COL VOL SCI PAP ICCA, V35, P502; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Coombs SH, 2004, MAR BIOL, V145, P959, DOI 10.1007/s00227-004-1389-4; COOMBS SH, 1985, J MAR BIOL ASSOC UK, V65, P461, DOI 10.1017/S0025315400050542; COOMBS SH, 1990, J CONSEIL, V47, P133; Coombs SH, 1981, 1981G84 ICES CM; Coombs Stephen, 1997, Acta Adriatica, V38, P33; Corten A, 2002, REV FISH BIOL FISHER, V11, P339; CRAIK JCA, 1987, J MAR BIOL ASSOC UK, V67, P169, DOI 10.1017/S0025315400026436; Cury Phillipe, 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V50, P239; De Metrio G, 2010, J APPL ICHTHYOL, V26, P596, DOI 10.1111/j.1439-0426.2010.01475.x; Dekhnik TV, 1950, AZCHERNIRO T, V14, P151; Drinkwater KF, 2010, ICES COOP RES REP, P1; Farley JH, 1998, FISH B-NOAA, V96, P223; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Goarant A, 2007, MAR BIOL, V151, P1907, DOI 10.1007/s00227-007-0624-1; Gordina AD, 1996, MAR FRESHWATER RES, V47, P315, DOI 10.1071/MF9960315; Gordina AD, 2001, ESTUAR COAST SHELF S, V52, P1, DOI 10.1006/ecss.2000.0662; Gordina AD, 1993, J ICHTHYOL, P33; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; HAIDER A, 1989, POWDER TECHNOL, V58, P63, DOI 10.1016/0032-5910(89)80008-7; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; ICCAT, 2010, REP 2010 ATL BLUEF T, P1; IOC SCOR and IAPSO, 2010, INTERGOVERNMENTAL OC, V56, DOI DOI 10.0RG/TE0S-10_MANUAL.PDF; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Isari S, 2011, J MAR BIOL ASSOC UK, V91, P51, DOI 10.1017/S0025315410000123; Johannesson K, 2011, AMBIO, V40, P179, DOI 10.1007/s13280-010-0129-x; JOHNSTON CE, 1988, CAN J ZOOL, V66, P737, DOI 10.1139/z88-109; Kandler R, 1965, INT COUNC EXPLOR SEA, P1; Kara AB, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004569; Karakulak F.S., 2009, COLLECTIVE VOLUME SC, V63, P153; Karakulak FS, 2004, FISH RES, V68, P361, DOI 10.1016/j.fishres.2004.02.007; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Kimura S, 2010, PROG OCEANOGR, V86, P39, DOI 10.1016/j.pocean.2010.04.018; Kitagawa T, 2010, J EXP MAR BIOL ECOL, V393, P23, DOI 10.1016/j.jembe.2010.06.016; KJESBU OS, 1992, J FISH BIOL, V41, P581, DOI 10.1111/j.1095-8649.1992.tb02685.x; Kucera CJ, 2002, J EXP MAR BIOL ECOL, V272, P147, DOI 10.1016/S0022-0981(02)00081-3; LAPRISE R, 1995, MAR ECOL PROG SER, V122, P73, DOI 10.3354/meps122073; Limborg MT, 2009, MAR ECOL PROG SER, V379, P213, DOI 10.3354/meps07889; Loaning S., 1972, Fiskeridirektoratets Skr (Havundersok), V16, P77; Locarnini RA, 2009, WORLD OCEAN ATLAS DA; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Makarchouk A., 1998, CMR11 ICES, V11, P1; Mantzouni I, 2010, ICES J MAR SCI, V67, P833, DOI 10.1093/icesjms/fsp291; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Masuma S, 2008, 034 WORLD S STUD STO, P1; Masuma Shukei, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V63, P207; Mather F.J., 1995, NMFSSEFSC370 NOAA; McDougall T.J., 2011, GETTING STARTED TEOS, V127, P1; Muhling BA, 2011, B MAR SCI, V87, P687, DOI 10.5343/bms.2010.1101; Muhling BA, 2011, ICES J MAR SCI, V68, P1051, DOI 10.1093/icesjms/fsr008; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; NIERMANN U, 1994, ICES J MAR SCI, V51, P395, DOI 10.1006/jmsc.1994.1041; NISSLING A, 1991, MAR BIOL, V111, P33, DOI 10.1007/BF01986342; Nissling A, 1996, J FISH BIOL, V48, P217; Nissling A, 1997, MAR ECOL PROG SER, V152, P261, DOI 10.3354/meps152261; Nissling A, 2003, J FISH BIOL, V63, P280, DOI 10.1046/j.1095-8649.2003.00139.x; NISSLING A, 1994, MAR ECOL PROG SER, V110, P67, DOI 10.3354/meps110067; Nissling A, 2002, ICES J MAR SCI, V59, P93, DOI 10.1006/jmsc.2001.1134; NISSLING A, 1991, MAR BIOL, V111, P29, DOI 10.1007/BF01986341; NISSLING A, 1994, J FISH BIOL, V45, P435, DOI 10.1111/j.1095-8649.1994.tb01326.x; Ogata A., 1961, US GEOLOGICAL SURVEY, P1; Ospina-Alvarez A, 2012, FISH RES, V117, P86, DOI 10.1016/j.fishres.2011.01.030; Ouellet P, 1997, CAN J FISH AQUAT SCI, V54, P211, DOI 10.1139/cjfas-54-1-211; Oven L. S, 1959, P KARADAG BIOLOGICAL, P13; PAGE FH, 1989, CAN J FISH AQUAT SCI, V46, P55; Pepin P, 2007, ICES J MAR SCI, V64, P18, DOI 10.1093/icesjms/fsl016; Petereit C, 2009, SCI MAR, V73, P59, DOI 10.3989/scimar.2009.73s1059; Petitgas P, 2010, ICES J MAR SCI, V67, P1841, DOI 10.1093/icesjms/fsq082; Philippart CJM, 2011, J EXP MAR BIOL ECOL, V400, P52, DOI 10.1016/j.jembe.2011.02.023; Piccinetti C, 1993, ICCAT COLL VOL SCI P, V40, P186; Piccinetti C, 1996, SCRS9657 ICCAT, P207; Piccinetti-Manfrin G, 1994, SCRS9496 ICCAT, P316; Potoschi A., 1994, BIOL MARINA MEDITERR, V1, P119; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; RICKER WE, 1958, J FISH RES BOARD CAN, V15, P991, DOI 10.1139/f58-054; RODI W, 1987, J GEOPHYS RES-OCEANS, V92, P5305, DOI 10.1029/JC092iC05p05305; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Ruzzante DE, 1998, MOL ECOL, V7, P1663, DOI 10.1046/j.1365-294x.1998.00497.x; Sakamoto W, 2005, NIPPON SUISAN GAKK, V71, P80, DOI 10.2331/suisan.71.80; Satilmis HH, 2003, ACTA OECOL, V24, pS275, DOI 10.1016/S1146-609X(03)00022-5; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SELFDOTT, 2009, 2 SELFDOTT PROJ, P1; Sinclair M, 1988, MARINE POPULATIONS E; Snelgrove PVR, 2008, CAN J FISH AQUAT SCI, V65, P159, DOI 10.1139/F07-148; SOLEMDAL P, 1973, OIKOS, P268; Solemdal P., 1967, Sarsia, VNo. 29, P431; Solemdal P., 1971, VIE MILIEU SUPPL, V22, P409; Stenevik EK, 2008, ICES J MAR SCI, V65, P1198, DOI 10.1093/icesjms/fsn101; SUNDBY S, 1983, DEEP-SEA RES, V30, P645, DOI 10.1016/0198-0149(83)90042-0; Tanaka Y, 2006, MAR ECOL PROG SER, V319, P225, DOI 10.3354/meps319225; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Thorsen A, 1996, J FISH BIOL, V48, P457, DOI 10.1111/j.1095-8649.1996.tb01440.x; Tibshirani R., 1995, GEN ADDITIVE MODELS; Vassilopoulou V, 2008, MEDITERR MAR SCI, V9, P21, DOI 10.12681/mms.141; Vinohradov KO, 1948, DOIPOVIDI AKAD NAUK, V1, P18; VODIANITSKII V. A., 1954, TRUDY VSESOIUSNOVO N I INST [MORSKOVO] RYBNOVO KHOZIAISTVA I OKEANOGRAFII, V28, P240; Vodyanitsky V., 1936, T SEVASTOPOL BIOI ST, V5, P3; WARE DM, 1985, CAN J FISH AQUAT SCI, V42, P577, DOI 10.1139/f85-075; WESTIN L, 1991, MAR BIOL, V108, P5, DOI 10.1007/BF01313465; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108; Zaitsev Y., 2003, WORKSH FARM MAN CONS, V13, P118; Zaitsev Y., 2008, INTRO BLACK SEA ECOL; Zaitsev Y. P., 1971, MARINE NEUSTONOLOGY; Zaitsev Y.P., 1997, MARINE BIOL DIVERSIT; ZAITSEV Yu. P., 1959, NAUK ZAP ODES K BIOL ST AKAD NAUK UKRAIN R, V1, P77	127	24	24	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e39998	10.1371/journal.pone.0039998	http://dx.doi.org/10.1371/journal.pone.0039998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848367	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300006
J	Burmolle, M; Norman, A; Sorensen, SJ; Hansen, LH				Burmolle, Mette; Norman, Anders; Sorensen, Soren J.; Hansen, Lars Hestbjerg			Sequencing of IncX-Plasmids Suggests Ubiquity of Mobile Forms of a Biofilm-Promoting Gene Cassette Recruited from Klebsiella pneumoniae	PLOS ONE			English	Article							RESISTANT HEMAGGLUTINATING FIMBRIAE; ESCHERICHIA-COLI; BACTERIAL PLASMIDS; TYPE-3 FIMBRIAE; CONFERRING RESISTANCE; MULTIDRUG EFFLUX; IDENTIFICATION; REPLICATION; PROTEIN; EXPRESSION	Plasmids are a highly effective means with which genetic traits that influence human health, such as virulence and antibiotic resistance, are disseminated through bacterial populations. The IncX-family is a hitherto sparsely populated group of plasmids that are able to thrive within Enterobacteriaceae. In this study, a replicon-centric screening method was used to locate strains from wastewater sludge containing plasmids belonging to the IncX-family. A transposon aided plasmid capture method was then employed to transport IncX-plasmids from their original hosts (and co-hosted plasmids) into a laboratory strain (Escherichia coli Genehogs (R)) for further study. The nucleotide sequences of the three newly isolated IncX-plasmids (pLN126_33, pMO17_54, pMO440_54) and the hitherto un-sequenced type-plasmid R485 revealed a remarkable occurrence of whole or partial gene cassettes that promote biofilm-formation in Klebsiella pneumonia or E. coli, in all four instances. Two of the plasmids (R485 and pLN126_33) were shown to directly induce biofilm formation in a crystal violet retention assay in E. coli. Sequence comparison revealed that all plasmid-borne forms of the type 3 fimbriae encoding gene cassette mrkABCDF were variations of a composite transposon Tn6011 first described in the E. coli IncX plasmid pOLA52. In conclusion, IncX-plasmids isolated from Enterobacteriaceae over almost 40 years and on three different continents have all been shown to carry a type 3 fimbriae gene cassette mrkABCDF stemming from pathogenic K. pneumoniae. Apart from contributing general knowledge about IncX-plasmids, this study also suggests an apparent ubiquity of a mobile form of an important virulence factor and is an illuminating example of the recruitment, evolution and dissemination of genetic traits through plasmid-mediated horizontal gene transfer.	[Burmolle, Mette; Norman, Anders; Sorensen, Soren J.; Hansen, Lars Hestbjerg] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Burmolle, M (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	burmolle@bio.ku.dk	Sørensen, Søren J/J-5015-2014; Norman, Anders/E-2515-2011; Burmølle, Mette/L-8002-2014; Sørensen, Søren Johannes/N-2120-2019	Sørensen, Søren J/0000-0001-6227-9906; Norman, Anders/0000-0002-1282-394X; Burmølle, Mette/0000-0003-1870-632X; Sørensen, Søren Johannes/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524	Faculty of Science - University of Copenhagen; Lundbeck Foundation [R44-2009-4384] Funding Source: researchfish	Faculty of Science - University of Copenhagen; Lundbeck Foundation(Lundbeckfonden)	This work was funded by a Ph.D. fellowship grant awarded to AN by the Faculty of Science - University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahl MI, 2007, APPL ENVIRON MICROB, V73, P341, DOI 10.1128/AEM.01971-06; Bergstrom CT, 2000, GENETICS, V155, P1505; BRADLEY DE, 1978, PLASMID, V1, P376, DOI 10.1016/0147-619X(78)90053-7; BRADLEY DE, 1982, PLASMID, V7, P95, DOI 10.1016/0147-619X(82)90031-2; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; Burmolle M, 2007, MICROB ECOL, V54, P352, DOI 10.1007/s00248-007-9222-5; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALES BA, 1986, J MED MICROBIOL, V22, P297, DOI 10.1099/00222615-22-4-297; HALES BA, 1986, J GEN MICROBIOL, V132, P2243; Hansen LH, 2007, J ANTIMICROB CHEMOTH, V60, P145, DOI 10.1093/jac/dkm167; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; Hayes F, 1998, J BACTERIOL, V180, P6415; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; HEDGES RW, 1973, J GEN MICROBIOL, V77, P249, DOI 10.1099/00221287-77-2-249; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HOCHMANNOVA J, 1982, J GEN MICROBIOL, V128, P529; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Johnson JG, 2011, J BACTERIOL, V193, P3453, DOI 10.1128/JB.00286-11; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; JONES C, 1992, J GEN MICROBIOL, V138, P189, DOI 10.1099/00221287-138-1-189; JONES CS, 1993, J GEN MICROBIOL, V139, P735, DOI 10.1099/00221287-139-4-735; KAUR P, 1992, PLASMID, V27, P29, DOI 10.1016/0147-619X(92)90004-T; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lili LN, 2007, GENETICS, V177, P399, DOI 10.1534/genetics.107.077420; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Madsen JS, 2012, FEMS IMMUNOL MED MIC; MUKHOPADHYAY P, 1986, J BIOL CHEM, V261, P9534; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ong CLY, 2008, J BACTERIOL, V190, P1054, DOI 10.1128/JB.01523-07; Ong CLY, 2009, APPL ENVIRON MICROB, V75, P6783, DOI 10.1128/AEM.00974-09; Singh Pushpendra, 2006, J Commun Dis, V38, P288; Smajs D, 2008, PLASMID, V59, P1, DOI 10.1016/j.plasmid.2007.08.002; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	46	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41259	10.1371/journal.pone.0041259	http://dx.doi.org/10.1371/journal.pone.0041259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844447	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700060
J	Inukai, S; de Lencastre, A; Turner, M; Slack, F				Inukai, Sachi; de Lencastre, Alexandre; Turner, Michael; Slack, Frank			Novel MicroRNAs Differentially Expressed during Aging in the Mouse Brain	PLOS ONE			English	Article							GENE-EXPRESSION; LIFE-SPAN; RNA; NEURODEGENERATION; OVEREXPRESSION; MECHANISMS; DISEASE; TARGETS; BIOMART; TOOLS	MicroRNAs (miRNAs) are endogenous small RNA molecules that regulate gene expression post-transcriptionally. Work in Caenorhabditis elegans has shown that specific miRNAs function in lifespan regulation and in a variety of age-associated pathways, but the roles of miRNAs in the aging of vertebrates are not well understood. We examined the expression of small RNAs in whole brains of young and old mice by deep sequencing and report here on the expression of 558 known miRNAs and identification of 41 novel miRNAs. Of these miRNAs, 75 known and 18 novel miRNAs exhibit greater than 2.0-fold expression changes. The majority of expressed miRNAs in our study decline in relative abundance in the aged brain, in agreement with trends observed in other miRNA studies in aging tissues and organisms. Target prediction analysis suggests that many of our novel aging-associated miRNAs target genes in the insulin signaling pathway, a central node of aging-associated genetic networks. These novel miRNAs may thereby regulate aging-related functions in the brain. Since many mouse miRNAs are conserved in humans, the aging-affected brain miRNAs we report here may represent novel regulatory genes that also function during aging in the human brain.	[Inukai, Sachi; de Lencastre, Alexandre; Turner, Michael; Slack, Frank] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Inukai, S (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	frank.slack@yale.edu		Slack, Frank/0000-0001-8263-0409; de Lencastre, Alexandre/0000-0002-3951-8515; Inukai, Sachi/0000-0002-6404-1384	National Research Service Award Postdoctoral Fellowship from the National Institutes of Health (NIH) [1F32AG030851]; Ellison Medical Foundation; NIH [AG033921]; NATIONAL INSTITUTE ON AGING [F32AG030851, R01AG033921] Funding Source: NIH RePORTER	National Research Service Award Postdoctoral Fellowship from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A.d.L. was supported by a National Research Service Award Postdoctoral Fellowship from the National Institutes of Health (NIH; 1F32AG030851). This work was also supported by grants from the Ellison Medical Foundation and the NIH (AG033921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefian E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr214; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blalock EM, 2003, J NEUROSCI, V23, P3807; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kato M, 2011, RNA, V17, P1804, DOI 10.1261/rna.2714411; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee ST, 2006, MECH AGEING DEV, V127, P432, DOI 10.1016/j.mad.2006.01.022; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Ling KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-176; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	57	100	107	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40028	10.1371/journal.pone.0040028	http://dx.doi.org/10.1371/journal.pone.0040028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844398	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700007
J	Niu, Q; Wang, W; Li, Y; Ruden, DM; Wang, FH; Li, Y; Wang, FY; Song, JY; Zheng, K				Niu, Qi; Wang, Wei; Li, Yong; Ruden, Douglas M.; Wang, Fenghua; Li, Yue; Wang, Fangying; Song, Jingying; Zheng, Kun			Low Molecular Weight Heparin Ablates Lung Cancer Cisplatin-Resistance by Inducing Proteasome-Mediated ABCG2 Protein Degradation	PLOS ONE			English	Article							STEM-CELLS; SURVIVAL; IDENTIFICATION; CHEMOTHERAPY; COMBINATION; TRIAL	Cancer side population (SP) cells, which are often referred to as cancer stem cells, are thought to be responsible for lung cancer chemotherapy resistance, and currently no drug can specifically target these cells. We hypothesize low-molecular-weight heparin (LMWH) may affect the biological properties of SP cells and could be used to clinically target these cells. To test this, SP cells were isolated from cisplatin (DDP)-resistant lung adenocarcinoma A549/DDP cells by flow cytometric sorting. Compared to non-SP cells, SP cells formed increased numbers of colonies in vitro, and had a 1000-fold increase in tumorigenicity in vivo. Proliferation and apoptosis assays demonstrated LMWH had no significant effect on lung SP cell proliferation or apoptosis. However, LMWH reduced lung SP cell colony formation ability and protein expression of the multidrug transporter, ABCG2, by FACS and western blot analyses without affecting its mRNA levels by RT-PCR. Consistently, immunohistochemistry stainings of ABCG2 in LMWH-treated tumor tissues were significantly reduced compared with those in controls. Further, we found proteasomal inhibitor MG132, but not lysosomal inhibitors leupeptin and pepstatin A, could restore ABCG2 protein levels in LMWH-treated SP cells. These suggest LMWH ablates lung SP cell chemoresistance by proteasome-mediated reduction of ABCG2 protein levels without affecting its mRNA levels. We also determined LMWH combined with cisplatin could overcome cisplatin-resistance and induced lung SP cells apoptosis both in vitro and in vivo. This study provides an experimental basis for using a combination of LMWH, which targets lung SP cells, with chemotherapy to improve lung cancer survival.	[Niu, Qi; Wang, Wei; Li, Yong; Wang, Fangying; Zheng, Kun] 309 PLA Hosp, Dept Med Oncol, Beijing, Peoples R China; [Ruden, Douglas M.] CS Mott Ctr Human Hlth & Dev, Dept Obstet & Gynecol, Inst Environm Hlth Sci, Detroit, MI USA; [Wang, Fenghua; Song, Jingying] 309 PLA Hosp, Dept Pathol, Beijing, Peoples R China; [Li, Yue] Beijing Ctr Phys & Chem Anal, Beijing, Peoples R China		Niu, Q (corresponding author), 309 PLA Hosp, Dept Med Oncol, Beijing, Peoples R China.	qi_niu@hotmail.com	Ruden, Douglas/A-5008-2016; Ruden, Douglas/ABE-1418-2021	Ruden, Douglas/0000-0002-0070-437X; Li, Yong/0000-0002-8910-9787	Scientific Research Foundation for the Returned Overseas Chinese Scholars, China State Education Ministry [2007-1108]; National Institutes of Health [ES012933]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021983, R01ES012933] Funding Source: NIH RePORTER	Scientific Research Foundation for the Returned Overseas Chinese Scholars, China State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, China State Education Ministry (No. 2007-1108) to QN and National Institutes of Health grant ES012933 to DMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-4; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Altinbas M, 2004, J THROMB HAEMOST, V2, P1266, DOI 10.1111/j.1538-7836.2004.00871.x; Angelini A, 2007, ANTICANCER RES, V27, P351; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chatzinikolaou G, 2010, CELL PROLIFERAT, V43, P9, DOI 10.1111/j.1365-2184.2009.00649.x; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hettiarachchi RJK, 1999, THROMB HAEMOSTASIS, V82, P947, DOI 10.1055/s-0037-1615937; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Icli F, 2007, J SURG ONCOL, V95, P507, DOI 10.1002/jso.20728; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Klerk CPW, 2005, J CLIN ONCOL, V23, P2130, DOI 10.1200/JCO.2005.03.134; Lazo-Langner A, 2007, J THROMB HAEMOST, V5, P729, DOI 10.1111/j.1538-7836.2007.02427.x; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Maia RC, 1996, CANCER LETT, V106, P101, DOI 10.1016/0304-3835(96)04309-1; Mitrovska S, 2009, BRATISL MED J, V110, P45; Niers TMH, 2007, CRIT REV ONCOL HEMAT, V61, P195, DOI 10.1016/j.critrevonc.2006.07.007; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Phillips PG, 2011, ANTICANCER RES, V31, P411; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Thodiyil P, 2002, CANCER TREAT REV, V28, P151, DOI 10.1016/S0305-7372(02)00040-3; van Doormaal FF, 2011, J CLIN ONCOL, V29, P2071, DOI 10.1200/JCO.2010.31.9293; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3	35	30	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41035	10.1371/journal.pone.0041035	http://dx.doi.org/10.1371/journal.pone.0041035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844424	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700035
J	Qi, Y; Noble, DWA; Fu, JZ; Whiting, MJ				Qi, Yin; Noble, Daniel W. A.; Fu, Jinzhong; Whiting, Martin J.			Spatial and Social Organization in a Burrow-Dwelling Lizard (Phrynocephalus vlangalii) from China	PLOS ONE			English	Article							EGERNIA-SAXATILIS SCINCIDAE; HOME-RANGE SIZE; PARENTAL CARE; FEMALE AGGRESSION; GENETIC-MARKERS; MATING SYSTEMS; MATERNAL-CARE; EVOLUTION; PRZEWALSKII; PATERNITY	Shared ecological resources such as burrow complexes can set the stage for social groupings and the evolution of more complex social behavior such as parental care. Paternity testing is increasingly revealing cases of kin-based groupings, and lizards may be a good system to inform on the early evolution of sociality. We examined spatial and social organization in the lizard Phrynocephalus vlangalii from China and tested genetic relatedness (based on eight microsatellite DNA loci) between offspring and parents that shared burrow complexes. Adult males and females had similar spatial patterns: they overlapped most with members of the opposite sex and least with their own sex. Males in better body condition overlapped with more females, and both sexes showed high site fidelity. Most lizards used a single burrow, but some individuals used two or three burrows. While high site fidelity is consistent with sociality in lizards, juveniles did not preferentially share burrows with parents, and we documented only a few cases of parent-offspring associations through burrow sharing. We suggest that P. vlangalii conforms to a classical polygynous mating system in which the burrow forms the core of the male's territory and may be offered as an important resource for females, but this remains to be determined.	[Qi, Yin; Fu, Jinzhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Noble, Daniel W. A.; Whiting, Martin J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Noble, Daniel W. A.; Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Macquarie University; University of Guelph	Qi, Y (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	qiyin@cib.ac.cn	Noble, Daniel/H-6214-2013; Whiting, Martin J./E-2999-2010	Noble, Daniel/0000-0001-9460-8743; Whiting, Martin J./0000-0002-4662-0227	Chinese Academy of Sciences [Y1C2021]; West Light Foundation of The Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences); West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Knowledge Innovation Program of The Chinese Academy of Sciences to JF (Y1C2021) and the West Light Foundation of The Chinese Academy of Sciences to YQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Aragon P, 2001, CAN J ZOOL, V79, P1965, DOI 10.1139/cjz-79-11-1965; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; Chapple DG, 2006, ETHOLOGY, V112, P247, DOI 10.1111/j.1439-0310.2006.01153.x; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Davis AR, 2011, P ROY SOC B-BIOL SCI, V278, P1507, DOI 10.1098/rspb.2010.1703; Earley Ryan L., 2010, P285; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Hibbitts TJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P1169, DOI 10.1007/s00265-006-0330-x; Huang WS, 2006, ANIM BEHAV, V72, P791, DOI 10.1016/j.anbehav.2005.12.011; Huang WS, 2011, FUNCT ECOL, V25, P1125, DOI 10.1111/j.1365-2435.2011.01855.x; Lourdais O, 2007, J COMP PHYSIOL B, V177, P569, DOI 10.1007/s00360-007-0155-6; Masters C., 2003, Australian Zoologist, V32, P377; McAlpin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019041; McCoy JK, 2003, LIZARD SOCIAL BEHAV; Morrison SF, 2002, MOL ECOL, V11, P535, DOI 10.1046/j.0962-1083.2002.01450.x; O'Connor D, 2003, MOL ECOL, V12, P743, DOI 10.1046/j.1365-294X.2003.01777.x; O'Connor DE, 2004, ANIM BEHAV, V68, P1361, DOI 10.1016/j.anbehav.2004.02.014; Qi Y, 2011, ASIAN HERPETOL RES, V2, P110, DOI 10.3724/SP.J.1245.2011.00110; Qi Y, 2011, J ETHOL, V29, P381, DOI 10.1007/s10164-010-0252-y; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reaney LT, 2003, ETHOL ECOL EVOL, V15, P205; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; Shine R., 1988, BIOL REPTILIA, P275; Sinn DL, 2008, ANIM BEHAV, V76, P1249, DOI 10.1016/j.anbehav.2008.06.009; Smith GR, 1995, ACTA OECOL, V16, P413; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Stamps J. A., 1983, LIZARD ECOLOGY STUDI; Stamps J. A., 1977, BIOL REPTILIA ECOL A, V7, P149; Stapley J, 2005, BEHAV ECOL, V16, P514, DOI 10.1093/beheco/ari019; Urquhart J, 2005, MOL ECOL NOTES, V5, P928, DOI 10.1111/j.1471-8286.2005.01119.x; VITT LJ, 1989, J HERPETOL, V23, P29, DOI 10.2307/1564312; While GM, 2009, P ROY SOC B-BIOL SCI, V276, P2021, DOI 10.1098/rspb.2008.1926; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Wu Pengfei, 2005, Shengtaixue Zazhi, V24, P1241; Zhan AB, 2009, MOL ECOL RESOUR, V9, P535, DOI 10.1111/j.1755-0998.2008.02248.x; ZHAO KT, 1999, FAUNA SINICA REPTILI, P153	41	22	22	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41130	10.1371/journal.pone.0041130	http://dx.doi.org/10.1371/journal.pone.0041130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844434	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700047
J	van Lutterveld, R; Hillebrand, A; Diederen, KMJ; Daalman, K; Kahn, RS; Stam, CJ; Sommer, IEC				van Lutterveld, Remko; Hillebrand, Arjan; Diederen, Kelly M. J.; Daalman, Kirstin; Kahn, Rene S.; Stam, Cornelis J.; Sommer, Iris E. C.			Oscillatory Cortical Network Involved in Auditory Verbal Hallucinations in Schizophrenia	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; TASK-RELATED CHANGES; TIME-COURSE; ACTIVATION; CORTEX; BRAIN; SYNCHRONIZATION; INHIBITION; MEMORY; GAMMA	Background: Auditory verbal hallucinations (AVH), a prominent symptom of schizophrenia, are often highly distressing for patients. Better understanding of the pathogenesis of hallucinations could increase therapeutic options. Magnetoencephalography (MEG) provides direct measures of neuronal activity and has an excellent temporal resolution, offering a unique opportunity to study AVH pathophysiology. Methods: Twelve patients (10 paranoid schizophrenia, 2 psychosis not otherwise specified) indicated the presence of AVH by button-press while lying in a MEG scanner. As a control condition, patients performed a self-paced button-press task. AVH-state and non-AVH state were contrasted in a region-of-interest (ROI) approach. In addition, the two seconds before AVH onset were contrasted with the two seconds after AVH onset to elucidate a possible triggering mechanism. Results: AVH correlated with a decrease in beta-band power in the left temporal cortex. A decrease in alpha-band power was observed in the right inferior frontal gyrus. AVH onset was related to a decrease in theta-band power in the right hippocampus. Conclusions: These results suggest that AVH are triggered by a short aberration in the theta band in a memory-related structure, followed by activity in language areas accompanying the experience of AVH itself.	[van Lutterveld, Remko; Diederen, Kelly M. J.; Daalman, Kirstin; Kahn, Rene S.; Sommer, Iris E. C.] Univ Med Ctr, Dept Psychiat, Utrecht, Netherlands; [van Lutterveld, Remko; Diederen, Kelly M. J.; Daalman, Kirstin; Kahn, Rene S.; Sommer, Iris E. C.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [Hillebrand, Arjan; Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Lutterveld, R (corresponding author), Univ Med Ctr, Dept Psychiat, Utrecht, Netherlands.	R.vanlutterveld@umcutrecht.nl	sommer, iris E/D-1190-2014	sommer, iris E/0000-0002-2682-5313; Sommer, Iris/0000-0001-5597-3262; Diederen, Kelly/0000-0002-9619-6583; Hillebrand, Arjan/0000-0002-8508-3532; Stam, Cornelis/0000-0001-9163-7274	Dutch Science Organization (Nederlandse Wetenschappelijke Organisatie NWO) [916.56.172]	Dutch Science Organization (Nederlandse Wetenschappelijke Organisatie NWO)	This work was supported by the Dutch Science Organization (Nederlandse Wetenschappelijke Organisatie NWO), Operating Grant: 916.56.172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Badcock Johanna C, 2005, Cogn Neuropsychiatry, V10, P125, DOI 10.1080/13546800344000363; Badcock JC, 2010, SCHIZOPHRENIA BULL, V36, P576, DOI 10.1093/schbul/sbn128; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Behrendt RP, 2010, NEUROSCI BIOBEHAV R, V34, P1121, DOI 10.1016/j.neubiorev.2009.12.009; Binder M, 2006, RADIOLOGY, V238, P256, DOI 10.1148/radiol.2381041622; Centorrino F, 2002, AM J PSYCHIAT, V159, P109, DOI 10.1176/appi.ajp.159.1.109; Cheung P, 1997, SCHIZOPHR RES, V26, P181, DOI 10.1016/S0920-9964(97)00049-2; Copolov DL, 2003, PSYCHIAT RES-NEUROIM, V122, P139, DOI 10.1016/S0925-4927(02)00121-X; Cornwell BR, 2010, AM J PSYCHIAT, V167, P836, DOI 10.1176/appi.ajp.2009.09050614; Daalman K, 2011, J CLIN PSYCHIAT, V72, P320, DOI 10.4088/JCP.09m05797yel; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hanlon FM, 2011, NEUROIMAGE; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hoffman RE, 2008, BRIT J PSYCHIAT, V193, P424, DOI 10.1192/bjp.bp.107.040501; Hoffman RE, 2011, BRIT J PSYCHIAT, V198, P277, DOI 10.1192/bjp.bp.110.086835; Hoffman RE, 2003, ARCH GEN PSYCHIAT, V60, P49, DOI 10.1001/archpsyc.60.1.49; Ishii R, 2000, NEUROREPORT, V11, P3283, DOI 10.1097/00001756-200009280-00047; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kisley MA, 2006, CLIN NEUROPHYSIOL, V117, P2549, DOI 10.1016/j.clinph.2006.08.003; Lenartowicz A, 2011, J COGNITIVE NEUROSCI, V23, P3388, DOI 10.1162/jocn_a_00031; Lennox BR, 1999, LANCET, V353, P644, DOI 10.1016/S0140-6736(98)05923-6; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; MCGUIRE PK, 1993, LANCET, V342, P703, DOI 10.1016/0140-6736(93)91707-S; Nayani TH, 1996, PSYCHOL MED, V26, P177, DOI 10.1017/S003329170003381X; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Quraan MA, 2011, HUM BRAIN MAPP, V32, P812, DOI 10.1002/hbm.21068; Reulbach U, 2007, NEUROPSYCHOBIOLOGY, V55, P89, DOI 10.1159/000103907; Riggs L, 2009, NEUROIMAGE, V45, P627, DOI 10.1016/j.neuroimage.2008.11.018; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Ropohl A, 2004, NEUROREPORT, V15, P523, DOI 10.1097/00001756-200403010-00028; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Schipul SE, 2012, CEREB CORTEX, V22, P937, DOI 10.1093/cercor/bhr162; Shergill SS, 2004, BRIT J PSYCHIAT, V185, P516, DOI 10.1192/bjp.185.6.516; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Slade P, 2002, SENSORY DECEPTION SC; Sommer IEC, 2008, BRAIN, V131, P3169, DOI 10.1093/brain/awn251; Sritharan A, 2005, PSYCHIAT RES, V136, P189, DOI 10.1016/j.psychres.2005.05.010; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; van de Ven VG, 2005, NEUROIMAGE, V27, P644, DOI 10.1016/j.neuroimage.2005.04.041; van Lutterveld R., 2011, FRONT PSYCHIATRY, V2, P1; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Vrba J, 1999, RECENT ADV BIOMAGN, P93; Waters Flavie A V, 2006, Cogn Neuropsychiatry, V11, P65, DOI 10.1080/13546800444000191; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027	56	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41149	10.1371/journal.pone.0041149	http://dx.doi.org/10.1371/journal.pone.0041149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844436	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700049
J	Winhofer, Y; Kiefer, FW; Handisurya, A; Klein, K; Schneider, B; Marculescu, R; Wagner, OF; Pacini, G; Luger, A; Stulnig, TM; Kautzky-Willer, A; Tura, A				Winhofer, Yvonne; Kiefer, Florian W.; Handisurya, Ammon; Klein, Katharina; Schneider, Barbara; Marculescu, Rodrig; Wagner, Oswald F.; Pacini, Giovanni; Luger, Anton; Stulnig, Thomas M.; Kautzky-Willer, Alexandra; Tura, Andrea			CTX (Crosslaps) Rather than Osteopontin Is Associated with Disturbed Glucose Metabolism in Gestational Diabetes	PLOS ONE			English	Article							ENERGY-METABOLISM; POSTMENOPAUSAL WOMEN; BONE TURNOVER; INSULIN; MODEL; MICE; EXPRESSION; STEATOSIS; PREGNANCY; ESTROGEN	Objective: Reciprocal interaction between bone and glucose metabolism might play a pivotal role in the development of type 2 diabetes. We recently demonstrated that osteocalcin is increased in women with gestational diabetes (GDM) compared to healthy pregnant women and related to enhanced insulin secretion. Here, we aimed to investigate the role of the bone resorption marker CTX and osteopontin (OPN), a key molecule in subclinical inflammation underlying insulin resistance, in gestational diabetes. Methods: Insulin sensitivity and secretion (derived from OGTT) as well as CTX and osteopontin were investigated in 26 GDM and 52 women with normal glucose tolerance during pregnancy [CON] between 24th and 28th gestational weeks; 24 women also underwent postpartum examination. Results: CTX was significantly higher in GDM compared to CON (0.44 +/- 0.20 vs. 0.28 +/- 0.12 ng/ml, p<.0001) and positively correlated with osteocalcin (R = 0.64, p<.0001) and parameters of insulin secretion. Osteopontin plasma concentrations were decreased in GDM compared to CON (28.81 +/- 22.12 vs. 37.68 +/- 19.63 ng/ml, p = 0.04), and did not show any relation to insulin secretion or sensitivity, but were significantly correlated with CRP (R = 0.3, p<0.007) and liver enzymes. Twelve weeks after delivery CTX and OPN were increased compared to pregnancy (both p,. 0001) and did not differ between GDM and CON. Conclusion: Our findings support the idea of a tight regulation between bone and glucose metabolism, and suggest, that less curbed CTX during pregnancy might be involved in osteocalcin-mediated amelioration of insulin secretion in GDM. On the other hand, osteopontin was unrelated to insulin resistance in GDM, but associated with inflammatory markers and liver enzymes in all women.	[Winhofer, Yvonne; Kiefer, Florian W.; Luger, Anton; Stulnig, Thomas M.; Kautzky-Willer, Alexandra] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria; [Handisurya, Ammon] Med Univ Vienna, Div Nephrol, Dept Internal Med 3, Vienna, Austria; [Pacini, Giovanni; Tura, Andrea] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy; [Klein, Katharina] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Schneider, Barbara] Med Univ Vienna, Sect Med Stat, CeMSIIS, Vienna, Austria; [Marculescu, Rodrig] Gen Hosp Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; [Stulnig, Thomas M.] Med Univ Vienna, Christian Doppler Lab Cardio Metab Immunotherapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Winhofer, Y (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria.	alexandra.kautzky-willer@meduniwien.ac.at	Marculescu, Rodrig/B-6474-2016	Marculescu, Rodrig/0000-0003-1772-6695; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Kiefer, Florian/0000-0003-2191-025X; Stulnig, Thomas/0000-0003-3300-6161; Winhofer, Yvonne/0000-0002-0555-9044	Austrian National Bank [13244, 12735]; "Fond des Burgermeisters der Stadt Wien" [09063]; Austrian Science Fund as part of the PhD program Cell Communication in Health and Disease [W1205-B09]; European Community [201608]	Austrian National Bank; "Fond des Burgermeisters der Stadt Wien"; Austrian Science Fund as part of the PhD program Cell Communication in Health and Disease; European Community(European Commission)	This work was supported by The Austrian National Bank, grant-no: 13244, and the "Fond des Burgermeisters der Stadt Wien", no: 09063 (all to AK); and the Austrian Science Fund as part of the PhD program Cell Communication in Health and Disease (W1205-B09), by the Austrian National Bank (project no. 12735), as well as the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant no. 201608 (all to TMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2004, ACTA OBSTET GYN SCAN, V83, P1049, DOI 10.1111/j.0001-6349.2004.00428.x; Banerjee A, 2009, TOXICOL PATHOL, V37, P492, DOI 10.1177/0192623309335633; Bautista DS, 1996, CLIN BIOCHEM, V29, P231, DOI 10.1016/0009-9120(96)84728-A; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Carpenter MW, 2007, DIABETES CARE, V30, pS246, DOI 10.2337/dc07-s224; Christgau S, 1998, CLIN CHEM, V44, P2290; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; Ferron M, 2012, BONE, V50, P568, DOI 10.1016/j.bone.2011.04.017; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; GOLDSTEIN DE, 1986, CLIN CHEM, V32, pB64; Hwang YC, 2012, OSTEOPOROSIS INT, V23, P1337, DOI 10.1007/s00198-011-1679-x; Isoda K, 2003, CIRCULATION, V107, P679, DOI 10.1161/01.CIR.0000055739.13639.D7; Kanazawa I, 2011, BONE, V48, P720, DOI 10.1016/j.bone.2010.12.020; KATTERMANN R, 1984, J CLIN CHEM CLIN BIO, V22, P245; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Lee N. K., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P351; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leen LLS, 2008, ARTERIOSCL THROM VAS, V28, P2131, DOI 10.1161/ATVBAHA.108.167965; Majima T, 2008, ENDOCR J, V55, P143, DOI 10.1507/endocrj.K07E-004; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; Seibel M J, 1998, Ther Umsch, V55, P676; Stenczer B, 2010, CLIN CHEM LAB MED, V48, P181, DOI 10.1515/CCLM.2010.042; Tanko LB, 2003, BONE, V32, P8, DOI 10.1016/S8756-3282(02)00918-3; Tura A, 2001, AM J PHYSIOL-ENDOC M, V281, pE966, DOI 10.1152/ajpendo.2001.281.5.E966; Viccica G, 2007, J Endocrinol Invest, V30, P8; Winhofer Y, 2010, DIABETES CARE, V33, P139, DOI 10.2337/dc09-1237; Xu GW, 2005, J RHEUMATOL, V32, P410	29	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40947	10.1371/journal.pone.0040947	http://dx.doi.org/10.1371/journal.pone.0040947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844418	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700026
J	Alessandri, C; Sforza, S; Palazzo, P; Lambertini, F; Paolella, S; Zennaro, D; Rafaiani, C; Ferrara, R; Bernardi, ML; Santoro, M; Zuzzi, S; Giangrieco, I; Dossena, A; Mari, A				Alessandri, Claudia; Sforza, Stefano; Palazzo, Paola; Lambertini, Francesca; Paolella, Sara; Zennaro, Danila; Rafaiani, Chiara; Ferrara, Rosetta; Bernardi, Maria Livia; Santoro, Mario; Zuzzi, Sara; Giangrieco, Ivana; Dossena, Arnaldo; Mari, Adriano			Tolerability of a Fully Maturated Cheese in Cow's Milk Allergic Children: Biochemical, Immunochemical, and Clinical Aspects	PLOS ONE			English	Article							BOVINE BETA-LACTOGLOBULIN; PARMIGIANO-REGGIANO CHEESE; GRANA-PADANO; BAKED MILK; HUMAN IGE; MICROARRAY; DIAGNOSIS; PROTEINS; SYSTEM; ALLERGENICITY	Background: From patients' reports and our preliminary observations, a fully maturated cheese (Parmigiano-Reggiano; PR) seems to be well tolerated by a subset of cow's milk (CM) allergic patients. Objective and Methods: To biochemically and immunologically characterize PR samples at different maturation stage and to verify PR tolerability in CM allergic children. Seventy patients, with suspected CM allergy, were enrolled. IgE to CM, alpha-lactalbumin (ALA), beta-lactoglobulin (BLG) and caseins (CAS) were tested using ImmunoCAP, ISAC103 and skin prick test. Patients underwent a double-blind, placebo-controlled food challenge with CM, and an open food challenge with 36 months-maturated PR. Extracts obtained from PR samples were biochemically analyzed in order to determine protein and peptide contents. Pepsin and trypsin-chymotrypsin-pepsin simulated digestions were applied to PR extracts. Each PR extract was investigated by IgE Single Point Highest Inhibition Achievable assay (SPHIAa). The efficiency analysis was carried out using CM and PR oral challenges as gold standards. Results: The IgE binding to milk allergens was 100% inhibited by almost all PR preparations; the only difference was for CAS, mainly alpha(S1)-CAS. Sixteen patients sensitized to CM tolerated both CM and PR; 29 patients tolerated PR only; 21 patients, reacted to both CM and PR, whereas 4 patients reactive to CM refused to ingest PR. ROC analysis showed that the absence of IgE to BLG measured by ISAC could be a good marker of PR tolerance. The SPHIAa using digested PR preparations showed a marked effect on IgE binding to CAS and almost none on ALA and BLG. Conclusions: 58% of patients clinically reactive to CM tolerated fully maturated PR. The preliminary digestion of CAS induced by PR maturation process, facilitating a further loss of allergenic reactivity during gut digestion, might explain the tolerance. This hypothesis seems to work when no IgE sensitization to ISAC BLG is detected.	[Alessandri, Claudia; Palazzo, Paola; Zennaro, Danila; Rafaiani, Chiara; Ferrara, Rosetta; Bernardi, Maria Livia; Santoro, Mario; Zuzzi, Sara; Giangrieco, Ivana; Mari, Adriano] IDI IRCCS, Ctr Mol Allergol, Rome, Italy; [Sforza, Stefano; Lambertini, Francesca; Paolella, Sara; Dossena, Arnaldo] Univ Parma, Dept Organ & Ind Chem, I-43100 Parma, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Parma	Alessandri, C (corresponding author), IDI IRCCS, Ctr Mol Allergol, Rome, Italy.	adriano.mari@idi.it	Alessandri, Claudia/ABG-7848-2021; Santoro, Mario/GVU-5164-2022; Sforza, Stefano/AAE-9579-2019	Alessandri, Claudia/0000-0003-2466-6870; Santoro, Mario/0000-0001-6626-9430; Lambertini, Francesca/0000-0002-4024-3598; Sforza, Stefano/0000-0001-5559-3411	Centro Ricerche Produzioni Animali S.p.a; Italian Ministry of Health	Centro Ricerche Produzioni Animali S.p.a; Italian Ministry of Health(Ministry of Health, Italy)	This study has been funded by Centro Ricerche Produzioni Animali S.p.a. (www.crpa.it) and by the Italian Ministry of Health, Current Research Program 2008-2010. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri C, 2012, CLIN EXP ALLERGY, V42, P441, DOI 10.1111/j.1365-2222.2011.03915.x; Allen KJ, 2009, J PAEDIATR CHILD H, V45, P481, DOI 10.1111/j.1440-1754.2009.01546.x; Bernard H, 1998, INT ARCH ALLERGY IMM, V115, P235, DOI 10.1159/000023906; Bernardi ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027856; Bindslev-Jensen C, 2004, ALLERGY, V59, P690, DOI 10.1111/j.1398-9995.2004.00466.x; Bonomi F, 2003, J DAIRY RES, V70, P51, DOI 10.1017/S0022029902005678; Bossios Apostolos, 2011, Clin Transl Allergy, V1, P6, DOI 10.1186/2045-7022-1-6; Bu GH, 2010, J SCI FOOD AGR, V90, P2015, DOI 10.1002/jsfa.4046; Cerecedo I, 2008, J ALLERGY CLIN IMMUN, V122, P589, DOI 10.1016/j.jaci.2008.06.040; CHIANCONE E, 1995, J INVEST ALLERG CLIN, V5, P228; Ehn BM, 2005, J AGR FOOD CHEM, V53, P3743, DOI 10.1021/jf048121w; Fiocchi A, 2011, CURR OPIN ALLERGY CL, V11, P216, DOI 10.1097/ACI.0b013e32834694ef; Fiocchi A, 2010, J ALLERGY CLIN IMMUN, V126, P1119, DOI 10.1016/j.jaci.2010.10.011; HILL DJ, 1993, CLIN EXP ALLERGY, V23, P124, DOI 10.1111/j.1365-2222.1993.tb00307.x; Hochwallner H, 2010, CLIN EXP ALLERGY, V40, P1809, DOI 10.1111/j.1365-2222.2010.03602.x; Kim JS, 2011, J ALLERGY CLIN IMMUN, V128, P125, DOI 10.1016/j.jaci.2011.04.036; Konstantinou GN, 2012, IMMUNOL ALLERGY CLIN, V32, P151, DOI 10.1016/j.iac.2011.11.003; Maier I, 2006, J CHROMATOGR B, V841, P160, DOI 10.1016/j.jchromb.2006.06.040; Malacarne M, 2006, J DAIRY RES, V73, P171, DOI 10.1017/S0022029905001688; Mari A, 2010, CURR ALLERGY ASTHM R, V10, P357, DOI 10.1007/s11882-010-0132-0; Nowak-Wegrzyn A, 2008, J ALLERGY CLIN IMMUN, V122, P342, DOI 10.1016/j.jaci.2008.05.043; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Pescuma M, 2009, J AGR FOOD CHEM, V57, P5571, DOI 10.1021/jf9006505; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P981, DOI 10.1016/S0091-6749(99)70167-3; SAVILAHTI E, 1992, J PEDIATR-US, V121, pS12, DOI 10.1016/S0022-3476(05)81401-5; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Schulmeister U, 2009, J IMMUNOL, V182, P7019, DOI 10.4049/jimmunol.0712366; Selo I, 1999, CLIN EXP ALLERGY, V29, P1055, DOI 10.1046/j.1365-2222.1999.00612.x; Sforza S, 2004, EUR J MASS SPECTROM, V10, P421, DOI 10.1255/ejms.603; Sforza S, 2003, J AGR FOOD CHEM, V51, P2130, DOI 10.1021/jf025866y; Sforza S, 2009, INT DAIRY J, V19, P582, DOI 10.1016/j.idairyj.2009.04.009; Wal JM, 2004, ANN ALLERG ASTHMA IM, V93, pS2, DOI 10.1016/S1081-1206(10)61726-7; Wal JM, 2001, ALLERGY, V56, P35, DOI 10.1111/j.1398-9995.2001.00911.x	33	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40945	10.1371/journal.pone.0040945	http://dx.doi.org/10.1371/journal.pone.0040945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829901	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300039
J	Eickhoff, R; Lorbeer, RA; Scheiblich, H; Heisterkamp, A; Meyer, H; Stern, M; Bicker, G				Eickhoff, Rene; Lorbeer, Raoul-Amadeus; Scheiblich, Hannah; Heisterkamp, Alexander; Meyer, Heiko; Stern, Michael; Bicker, Gerd			Scanning Laser Optical Tomography Resolves Structural Plasticity during Regeneration in an Insect Brain	PLOS ONE			English	Article							PROJECTION TOMOGRAPHY; AXONAL REGENERATION; GENE-EXPRESSION; MUSHROOM BODIES; TYMPANAL NERVE; DESERT LOCUST; ANTENNAL LOBE; MICROSCOPY; NEURONS; ZEBRAFISH	Background: Optical Projection Tomography (OPT) is a microscopic technique that generates three dimensional images from whole mount samples the size of which exceeds the maximum focal depth of confocal laser scanning microscopes. As an advancement of conventional emission-OPT, Scanning Laser Optical Tomography (SLOTy) allows simultaneous detection of fluorescence and absorbance with high sensitivity. In the present study, we employ SLOTy in a paradigm of brain plasticity in an insect model system. Methodology: We visualize and quantify volumetric changes in sensory information procession centers in the adult locust, Locusta migratoria. Olfactory receptor neurons, which project from the antenna into the brain, are axotomized by crushing the antennal nerve or ablating the entire antenna. We follow the resulting degeneration and regeneration in the olfactory centers (antennal lobes and mushroom bodies) by measuring their size in reconstructed SLOTy images with respect to the untreated control side. Within three weeks post treatment antennal lobes with ablated antennae lose as much as 60% of their initial volume. In contrast, antennal lobes with crushed antennal nerves initially shrink as well, but regain size back to normal within three weeks. The combined application of transmission-and fluorescence projections of Neurobiotin labeled axotomized fibers confirms that recovery of normal size is restored by regenerated afferents. Remarkably, SLOTy images reveal that degeneration of olfactory receptor axons has a trans-synaptic effect on second order brain centers and leads to size reduction of the mushroom body calyx. Conclusions: This study demonstrates that SLOTy is a suitable method for rapid screening of volumetric plasticity in insect brains and suggests its application also to vertebrate preparations.	[Eickhoff, Rene; Scheiblich, Hannah; Stern, Michael; Bicker, Gerd] Univ Vet Med Hannover, Div Cell Biol, Hannover, Germany; [Lorbeer, Raoul-Amadeus; Heisterkamp, Alexander; Meyer, Heiko] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Heisterkamp, Alexander] Univ Jena, Inst Appl Opt, Jena, Germany; [Meyer, Heiko] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Friedrich Schiller University of Jena; Leibniz University Hannover	Eickhoff, R (corresponding author), Univ Vet Med Hannover, Div Cell Biol, Hannover, Germany.	gerd.bicker@tiho-hannover.de	Heisterkamp, Alexander/V-5376-2017; Stern, Michael/E-7980-2011; Scheiblich, Hannah/ABC-3883-2021	Heisterkamp, Alexander/0000-0001-8770-0859; Stern, Michael/0000-0002-5088-5439	Deutsche Forschungsgemeinschaft (DFG); excellence cluster REBIRTH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); excellence cluster REBIRTH	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG) and the excellence cluster REBIRTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton S, 1996, J COMP NEUROL, V370, P85; Ayaz D, 2008, J NEUROSCI, V28, P6010, DOI 10.1523/JNEUROSCI.0101-08.2008; DeMicco A, 2010, TOXICOL SCI, V113, P177, DOI 10.1093/toxsci/kfp258; Eickhoff R, 2012, J COMP NEUROL, V520, P2021, DOI 10.1002/cne.23026; El Jundi B, 2009, J COMP NEUROL, V517, P210, DOI 10.1002/cne.22150; ERNST KD, 1977, CELL TISSUE RES, V176, P285, DOI 10.1007/BF00221789; Groh Claudia, 2010, Front Biosci (Schol Ed), V2, P268; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jacobs K, 1999, CELL TISSUE RES, V298, P167, DOI 10.1007/s004419900056; Kerwin J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-27; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Kruger S, 2011, J COMP PHYSIOL A, V197, P181, DOI 10.1007/s00359-010-0598-1; Kurylas AE, 2008, CELL TISSUE RES, V333, P125, DOI 10.1007/s00441-008-0620-x; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LAKESHARLAN R, 1995, J COMP PHYSIOL A, V176, P797, DOI 10.1007/BF00192627; LAURENT G, 1994, J NEUROSCI, V14, P2993; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Lorbeer RA, 2011, OPT EXPRESS, V19, P5419, DOI 10.1364/OE.19.005419; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Ott SR, 2008, J NEUROSCI METH, V172, P220, DOI 10.1016/j.jneumeth.2008.04.031; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; Patschke A, 2004, DEV BRAIN RES, V150, P73, DOI 10.1016/j.devbrainres.2004.02.006; Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007; Sharpe J, 2004, ANNU REV BIOMED ENG, V6, P209, DOI 10.1146/annurev.bioeng.6.040803.140210; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SPIRA ME, 1987, J EXP BIOL, V132, P111; Sprecher SG, 2007, GENE EXPR PATTERNS, V7, P584, DOI 10.1016/j.modgep.2007.01.004; Stern M, 1997, J NEUROBIOL, V33, P439; Stern M, 2008, DEV NEUROBIOL, V68, P295, DOI 10.1002/dneu.20585; Stern M, 2012, J COMP NEUROL, V520, P679, DOI 10.1002/cne.22770; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7; Trowe T, 1996, DEVELOPMENT, V123, P439; Vinegoni C, 2009, OPT EXPRESS, V17, P22320, DOI 10.1364/OE.17.022320; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0	41	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41236	10.1371/journal.pone.0041236	http://dx.doi.org/10.1371/journal.pone.0041236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829931	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300070
J	Greene, CM; Soto, D				Greene, Ciara M.; Soto, David			Neural Repetition Effects in the Medial Temporal Lobe Complex are Modulated by Previous Encoding Experience	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; HIGH-RESOLUTION FMRI; EVENT-RELATED FMRI; RECOGNITION MEMORY; PREFRONTAL CORTEX; EPISODIC MEMORY; BRAIN IMAGES; SUPPRESSION; RETRIEVAL; FAMILIARITY	It remains an intriguing question why the medial temporal lobe (MTL) can display either attenuation or enhancement of neural activity following repetition of previously studied items. To isolate the role of encoding experience itself, we assessed neural repetition effects in the absence of any ongoing task demand or intentional orientation to retrieve. Experiment 1 showed that the hippocampus and surrounding MTL regions displayed neural repetition suppression (RS) upon repetition of past items that were merely attended during an earlier study phase but this was not the case following re-occurrence of items that had been encoded into working memory (WM). In this latter case a trend toward neural repetition enhancement (RE) was observed, though this was highly variable across individuals. Interestingly, participants with a higher degree of neural RE in the MTL complex displayed higher memory sensitivity in a later, surprise recognition test. Experiment 2 showed that massive exposure at encoding effected a change in the neural architecture supporting incidental repetition effects, with regions of the posterior parietal and ventral-frontal cortex in addition to the hippocampus displaying neural RE, while no neural RS was observed. The nature of encoding experience therefore modulates the expression of neural repetition effects in the MTL and the neocortex in the absence of memory goals.	[Greene, Ciara M.; Soto, David] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Fac Med, London, England	Imperial College London	Greene, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Fac Med, London, England.	c.greene@imperial.ac.uk; d.soto@imperial.ac.uk	Soto, David/R-3711-2019	Soto, David/0000-0003-0205-7513; Greene, Ciara/0000-0002-8833-9046	Medical Research Council (UK) [89631]; MRC [G0802212] Funding Source: UKRI; Medical Research Council [G0802212] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK, 89631, www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Brozinsky CJ, 2005, HIPPOCAMPUS, V15, P557, DOI 10.1002/hipo.20087; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Ciaramelli E, 2010, J NEUROSCI, V30, P4943, DOI 10.1523/JNEUROSCI.1209-09.2010; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Dorfel D, 2009, EUR J NEUROSCI, V30, P1947, DOI 10.1111/j.1460-9568.2009.06973.x; Dudukovic NM, 2011, J COGNITIVE NEUROSCI, V23, P670, DOI 10.1162/jocn.2010.21509; Elman JA, 2011, NEUROIMAGE, V56, P345, DOI 10.1016/j.neuroimage.2011.02.017; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gonsalves BD, 2005, NEURON, V47, P751, DOI 10.1016/j.neuron.2005.07.013; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Guerin SA, 2011, NEUROIMAGE, V55, P801, DOI 10.1016/j.neuroimage.2010.11.066; Harris A, 2007, CEREB CORTEX, V17, P63, DOI 10.1093/cercor/bhj124; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson JD, 2008, HIPPOCAMPUS, V18, P975, DOI 10.1002/hipo.20456; Kirwan CB, 2009, P NATL ACAD SCI USA, V106, P14617, DOI 10.1073/pnas.0907624106; Korsnes MS, 2008, NEUROPSYCHOLOGIA, V46, P1454, DOI 10.1016/j.neuropsychologia.2007.12.028; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Lacy JW, 2011, LEARN MEMORY, V18, P15, DOI [10.1101/lm.1971110, 10.1101/lm.1971111]; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Mandzia JL, 2004, HUM BRAIN MAPP, V21, P1, DOI 10.1002/hbm.10140; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Montaldi D, 2006, HIPPOCAMPUS, V16, P504, DOI 10.1002/hipo.20178; Nolde SF, 1998, TRENDS COGN SCI, V2, P399, DOI 10.1016/S1364-6613(98)01233-9; Norman KA, 2010, HIPPOCAMPUS, V20, P1217, DOI 10.1002/hipo.20855; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Raposo A, 2006, NEUROPSYCHOLOGIA, V44, P2284, DOI 10.1016/j.neuropsychologia.2006.05.017; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Soto D, 2007, P NATL ACAD SCI USA, V104, P17186, DOI 10.1073/pnas.0703706104; Stark CEL, 2003, J NEUROSCI, V23, P6748; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Suzuki M, 2011, J COGNITIVE NEUROSCI, V23, P1522, DOI 10.1162/jocn.2010.21535; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Trenner MU, 2004, COGNITIVE BRAIN RES, V21, P388, DOI 10.1016/j.cogbrainres.2004.06.017; Trepel C, 1998, CEREB CORTEX, V8, P719, DOI 10.1093/cercor/8.8.719; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vilberg KL, 2007, NEUROPSYCHOLOGIA, V45, P2216, DOI 10.1016/j.neuropsychologia.2007.02.027; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wais PE, 2010, J COGNITIVE NEUROSCI, V22, P109, DOI 10.1162/jocn.2009.21190; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wixted JT, 2011, TRENDS COGN SCI, V15, P210, DOI 10.1016/j.tics.2011.03.005; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	66	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40870	10.1371/journal.pone.0040870	http://dx.doi.org/10.1371/journal.pone.0040870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829892	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300030
J	Kramer, DB; Baker, M; Ransford, B; Molina-Markham, A; Stewart, Q; Fu, K; Reynolds, MR				Kramer, Daniel B.; Baker, Matthew; Ransford, Benjamin; Molina-Markham, Andres; Stewart, Quinn; Fu, Kevin; Reynolds, Matthew R.			Security and Privacy Qualities of Medical Devices: An Analysis of FDA Postmarket Surveillance	PLOS ONE			English	Article							DEFIBRILLATORS; RECALLS	Background: Medical devices increasingly depend on computing functions such as wireless communication and Internet connectivity for software-based control of therapies and network-based transmission of patients' stored medical information. These computing capabilities introduce security and privacy risks, yet little is known about the prevalence of such risks within the clinical setting. Methods: We used three comprehensive, publicly available databases maintained by the Food and Drug Administration (FDA) to evaluate recalls and adverse events related to security and privacy risks of medical devices. Results: Review of weekly enforcement reports identified 1,845 recalls; 605 (32.8%) of these included computers, 35 (1.9%) stored patient data, and 31 (1.7%) were capable of wireless communication. Searches of databases specific to recalls and adverse events identified only one event with a specific connection to security or privacy. Software-related recalls were relatively common, and most (81.8%) mentioned the possibility of upgrades, though only half of these provided specific instructions for the update mechanism. Conclusions: Our review of recalls and adverse events from federal government databases reveals sharp inconsistencies with databases at individual providers with respect to security and privacy risks. Recalls related to software may increase security risks because of unprotected update and correction mechanisms. To detect signals of security and privacy problems that adversely affect public health, federal postmarket surveillance strategies should rethink how to effectively and efficiently collect data on security and privacy problems in devices that increasingly depend on computing systems susceptible to malware.	[Kramer, Daniel B.; Baker, Matthew; Reynolds, Matthew R.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA; [Ransford, Benjamin; Molina-Markham, Andres; Stewart, Quinn; Fu, Kevin] Univ Massachusetts, Dept Comp Sci, Amherst, MA 01003 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst	Kramer, DB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA.	dkramer@bidmc.harvard.edu	Baker, Matthew/AAB-4537-2021	Baker, Matthew/0000-0002-0002-1907	Health and Human Services (HHS) [90TR0003/01]; National Science Foundation [CNS-0831244]	Health and Human Services (HHS); National Science Foundation(National Science Foundation (NSF))	This work was sponsored by Health and Human Services (HHS) Grant Number 90TR0003/01. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also supported by National Science Foundation award CNS-0831244. Any opinions, findings, and conclusions or recommendations expressed in these materials are those of the authors and do not necessarily reflect the views of NSF.	Curfman GD, 2011, N ENGL J MED; Fu K., 2011, PUBLIC HLTH EFFECTIV; Halperin D, 2008, P IEEE S SECUR PRIV, P129, DOI 10.1109/SP.2008.31; Hanna S., 2011, P 2 USENIX WORKSH HL; Hauser RG, 2007, HEART RHYTHM, V4, P892, DOI 10.1016/j.hrthm.2007.03.041; Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918; Magrabi F, 2012, J AM MED INFORM ASSN, V19, P45, DOI 10.1136/amiajnl-2011-000369; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Maisel WH, 2010, NEW ENGL J MED, V362, P1164, DOI 10.1056/NEJMp1000745; Shah JS, 2006, JAMA-J AM MED ASSOC, V296, P655, DOI 10.1001/jama.296.6.655; Sherrill Lynette, 2012, PARTING FRIENDS; Zuckerman DM, 2011, ARCH INTERN MED, V171, P1006, DOI 10.1001/archinternmed.2011.30	12	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40200	10.1371/journal.pone.0040200	http://dx.doi.org/10.1371/journal.pone.0040200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829874	Green Published, gold			2022-12-27	WOS:000306956300012
J	Luhtala, N; Parker, R				Luhtala, Natalie; Parker, Roy			Structure-Function Analysis of Rny1 in tRNA Cleavage and Growth Inhibition	PLOS ONE			English	Article							GLYCOPROTEIN E-RNS; SWINE-FEVER VIRUS; RIBOSOMAL-RNA; SELF-INCOMPATIBILITY; CYSTIC LEUKOENCEPHALOPATHY; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; NICOTIANA-ALATA; T2 RIBONUCLEASE; S-RNASE	T2 ribonucleases are conserved nucleases that affect a variety of processes in eukaryotic cells including the regulation of self-incompatibility by S-RNases in plants, modulation of host immune cell responses by viral and schistosome T2 enzymes, and neurological development and tumor progression in humans. These roles for RNaseT2's can be due to catalytic or catalytic-independent functions of the molecule. Despite this broad importance, the features of RNaseT2 proteins that modulate catalytic and catalytic-independent functions are poorly understood. Herein, we analyze the features of Rny1 in Saccharomyces cerevisiae to determine the requirements for cleaving tRNA in vivo and for inhibiting cellular growth in a catalytic-independent manner. We demonstrate that catalytic-independent inhibition of growth is a combinatorial property of the protein and is affected by a fungal-specific C-terminal extension, the conserved catalytic core, and the presence of a signal peptide. Catalytic functions of Rny1 are independent of the C-terminal extension, are affected by many mutations in the catalytic core, and also require a signal peptide. Biochemical flotation assays reveal that in rny1 Delta cells, some tRNA molecules associate with membranes suggesting that cleavage of tRNAs by Rny1 can involve either tRNA association with, or uptake into, membrane compartments.	[Luhtala, Natalie] Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA; [Parker, Roy] Univ Arizona, Howard Hughes Med Inst, Tucson, AZ USA; [Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona; University of Arizona	Luhtala, N (corresponding author), Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu			National Institutes of Health [R37 GM45443, T32 CA09213]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA009213, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided as follows: National Institutes of Health [R37 GM45443 to R. P.], http://www.nih.gov/; National Institutes of Health [T32 CA09213 to N.L.], http://www.nih.gov/ and the Howard Hughes Medical Institute to R. P., http://www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquati F, 2005, INT J ONCOL, V26, P1159; Acquati F, P NATL ACAD SCI US, V108, P1104; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; Bruschke CJM, 1997, J VIROL, V71, P6692, DOI 10.1128/JVI.71.9.6692-6696.1997; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Cabrera M, 2008, METHOD ENZYMOL, V451, P177, DOI 10.1016/S0076-6879(08)03213-8; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; de Leeuw M, 2007, ACTA CRYSTALLOGR F, V63, P716, DOI 10.1107/S1744309107034483; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; GRAY JE, 1991, PLANT CELL, V3, P271, DOI 10.1105/tpc.3.3.271; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398; Hillwig MS, 2011, P NATL ACAD SCI USA, V108, P1093, DOI 10.1073/pnas.1009809108; Hulst MM, 1998, J VIROL, V72, P151, DOI 10.1128/JVI.72.1.151-157.1998; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kobayashi H, 2003, BIOSCI BIOTECH BIOCH, V67, P2307, DOI 10.1271/bbb.67.2307; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kurihara H, 1996, J MOL BIOL, V255, P310, DOI 10.1006/jmbi.1996.0025; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; McCubbin AG, 1997, PLANT CELL, V9, P85, DOI 10.2307/3870373; Meyers G, 1999, J VIROL, V73, P10224, DOI 10.1128/JVI.73.12.10224-10235.1999; Murfett J, 1996, PLANT CELL, V8, P943, DOI 10.1105/tpc.8.6.943; Rodriguez SM, 2008, PROTEIN SCI, V17, P681, DOI 10.1110/ps.073420708; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Vidalino L, 2012, BIOL CELL, V104, P13, DOI 10.1111/boc.201100092; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767	37	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41111	10.1371/journal.pone.0041111	http://dx.doi.org/10.1371/journal.pone.0041111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829915	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300054
J	Mehta, SD; Green, SJ; Maclean, I; Hu, H; Bailey, RC; Gillevet, PM; Spear, GT				Mehta, Supriya D.; Green, Stefan J.; Maclean, Ian; Hu, Hong; Bailey, Robert C.; Gillevet, Patrick M.; Spear, Greg T.			Microbial Diversity of Genital Ulcer Disease in Men Enrolled in a Randomized Trial of Male Circumcision in Kisumu, Kenya	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; VAGINAL MICROBIOTA; HIV PREVENTION; YOUNG MEN; SCHISTOSOMIASIS; ETIOLOGY; WOMEN; ASSOCIATION; ACQUISITION; MANAGEMENT	Background: Medical male circumcision (MMC) reduces the risk of genital ulcer disease (GUD) in men by 50%. In Ugandan and Kenyan trials, a sexually transmissible agent was not identified in 50-60% of GUD specimens by polymerase chain reaction (PCR) assay. We sought to better define the etiology of GUD in men participating in the Kenyan trial and examine how MMC affects GUD etiology. Methods: We defined GUD of unknown etiology as negative for HSV (type 1 and type 2), T. pallidum, and H. ducreyi by PCR, and negative for HSV-2 and T. pallidum by serology. We identified bacterial microbiota in a subset of 59 GUD specimens using multitag pyrosequencing of the 16S rRNA gene, and compared results by unknown vs. STI-associated etiology. Statistical analysis employed Bray-Curtis similarity measure of bacterial community by etiology, hierarchical clustering and logistic regression. Results: In 59 GUD specimens from 59 men, 23 (39%) had unknown etiology. Bacterial diversity was greater in GUD of unknown than STI etiology (p = 0.01). Fusobacteria (Fusobacterium spp. and Sneathia spp.) were more commonly detected in men with GUD of unknown etiology [adjusted OR = 5.67; 95% CI: 1.63-19.8] as were Oxobacter spp. and Anaerovorax spp. [adjusted OR = 3.12; 95% CI: 0.83-11.7]. Sequences from these four anaerobic bacterial taxa were more often detected in uncircumcised men than circumcised men (p, 0.05). Conclusions: Anaerobic are more common in genital ulcers of uncircumcised men. The specific anaerobic bacteria associated with GUD of unknown etiology have cytotoxic properties that can exacerbate epithelial disruptions leading to ulcer-like appearance. MMC may reduce GUD through a reduction in these anaerobic bacteria.	[Mehta, Supriya D.; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL 60607 USA; [Green, Stefan J.] Univ Illinois, Sch Med, Res Resources Ctr, DNA Serv, Chicago, IL USA; [Hu, Hong] Univ Illinois, Dept Bioinformat, Chicago, IL USA; [Maclean, Ian] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Gillevet, Patrick M.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Spear, Greg T.] Rush Univ, Dept Immunol & Microbiol, Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Manitoba; George Mason University; Rush University	Mehta, SD (corresponding author), Univ Illinois, Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL 60607 USA.	Supriyad@uic.edu		Green, Stefan/0000-0003-2781-359X; Mehta, Supriya/0000-0002-7926-2489	Chicago Developmental Center for AIDS Research; National Institute of Allergy and Infectious Diseases (NIAID) [AI50440]; Division of AIDS, National Institutes of Health; Canadian Institutes of Health Research [HCT 44180]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050440] Funding Source: NIH RePORTER	Chicago Developmental Center for AIDS Research; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of AIDS, National Institutes of Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This analysis was supported by a pilot grant award from the Chicago Developmental Center for AIDS Research. The clinical trial in which the data were collected was supported by grant number AI50440 from the National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS, National Institutes of Health; and by grant number HCT 44180 from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HJ, 2003, SEX TRANSM DIS, V30, P114, DOI 10.1097/00007435-200302000-00004; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Behets FMT, 1999, J INFECT DIS, V180, P1382, DOI 10.1086/315005; Brook I, 2004, J ORAL MAXIL SURG, V62, P1545, DOI 10.1016/j.joms.2003.12.043; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Enwonwu CO, 1999, AM J TROP MED HYG, V60, P223, DOI 10.4269/ajtmh.1999.60.223; FELDMEIER H, 1995, TROP GEOGR MED, V47, pS2; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000187; Halvorsen JA, 2006, ACTA DERM-VENEREOL, V86, P439, DOI 10.2340/00015555-0140; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Mallon E, 2000, ARCH DERMATOL, V136, P350, DOI 10.1001/archderm.136.3.350; Mehta SD, 2012, AIDS IN PRESS; Mehta SD, 2010, J UROLOGY, V184, P203, DOI 10.1016/j.juro.2010.03.015; Moodley P, 2003, SEX TRANSM DIS, V30, P241, DOI 10.1097/00007435-200303000-00013; NAHER H, 1992, J INVEST DERMATOL, V98, P791, DOI 10.1111/1523-1747.ep12499958; Nelson DE, 2011, PLOS ONE, V5; OFARRELL N, 1992, GENITOURIN MED, V68, P245; Opisa S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-226; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Paz-Bailey G, 2010, CLIN INFECT DIS, V50, P1060, DOI 10.1086/651115; PLUMMER FA, 1985, SEX TRANSM DIS, V12, P193, DOI 10.1097/00007435-198510000-00005; Poggensee G, 2000, J INFECT DIS, V181, P1210, DOI 10.1086/315345; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Swai B, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-134; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wilson Michael, 1995, Science Progress, V78, P19; Wolrath H, 2001, J CLIN MICROBIOL, V39, P4026, DOI 10.1128/JCM.39.11.4026-4031.2001	38	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e38991	10.1371/journal.pone.0038991	http://dx.doi.org/10.1371/journal.pone.0038991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848346	Green Published, gold			2022-12-27	WOS:000306950200007
J	Yu, JH; Oh, MH; Park, JU; Myers, AC; Dong, C; Zhu, Z; Zheng, T				Yu, Jinho; Oh, Min Hee; Park, Ju-Un; Myers, Allen C.; Dong, Chen; Zhu, Zhou; Zheng, Tao			Epicutaneous Exposure to Staphylococcal Superantigen Enterotoxin B Enhances Allergic Lung Inflammation via an IL-17A Dependent Mechanism	PLOS ONE			English	Article							HOUSE-DUST MITE; ATOPIC-DERMATITIS; T-CELLS; NEUTROPHIL RECRUITMENT; AIRWAY INFLAMMATION; FILAGGRIN MUTATIONS; MURINE MODEL; TH17 CELLS; FOLLOW-UP; IN-VIVO	Atopic dermatitis (AD) is the initial step of the atopic march: the progression from AD to allergic rhinitis and asthma. There is a close association between skin barrier abnormalities and the development of AD and the atopic march. One of cardinal features of AD is that the lesional skin of the majority of AD patients is chronically colonized with Staphylococcus aureus with half isolates producing superantigen enterotoxin B (SEB). Although diverse roles of SEB in the pathogenesis and severity of AD have been recognized, whether SEB contributes to the dermal inflammation that drives lung inflammation and airway hyperresponsiveness (AHR) has not been examined. Here we show a novel role of S. aureus superantigen SEB in augmenting allergen ovalbumin (Ova) induced atopic march through an IL-17A dependent mechanism. When mice epicutaneously (EC) sensitized with allergen Ova, addition of topical SEB led to not only augmented systemic Th2 responses but also a markedly exaggerated systemic Th17/IL-17 immune environment. The ability of SEB in enhancing Th17/IL-17 was mediated through stimulating lymphocytes in spleen and draining lymph nodes to promote IL-6 production. Epicutaneous sensitization of mice with a combination of Ova and SEB significantly enhanced Ova-induced AHR and granulocytic lung inflammation than Ova allergen alone. When IL-17A was deleted genetically, the effects of SEB on augmenting lung inflammation and AHR were markedly diminished. These findings suggest that chronic heavy colonization of enterotoxin producing S. aureus in the skin of patients with atopic dermatitis may have an important role in the development of atopic march via an IL-17A dependent mechanism.	[Yu, Jinho; Oh, Min Hee; Park, Ju-Un; Myers, Allen C.; Zhu, Zhou; Zheng, Tao] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Dong, Chen] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Dept Immunol, Houston, TX 77030 USA	Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center	Yu, JH (corresponding author), Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	tzheng@jhmi.edu	Yu, Jinho/P-4293-2014; dong, chen/B-3181-2009	Yu, Jinho/0000-0002-1226-8077; dong, chen/0000-0002-0084-9130; Oh, Min-Hee/0000-0003-1581-4288	NIH [R01AI075025, P01HL107151, R01HL079349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079349, P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01AI075025 to TZ; P01HL107151 and R01HL079349 to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Breuer K, 2001, ALLERGY, V56, P1034, DOI 10.1034/j.1398-9995.2001.00146.x; Bright JJ, 1999, J LEUKOCYTE BIOL, V65, P665, DOI 10.1002/jlb.65.5.665; Brown SJ, 2008, J ALLERGY CLIN IMMUN, V121, P940, DOI 10.1016/j.jaci.2008.01.013; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Bunikowski R, 2000, J ALLERGY CLIN IMMUN, V105, P814, DOI 10.1067/mai.2000.105528; Burgess JA, 2008, J ALLERGY CLIN IMMUN, V122, P280, DOI 10.1016/j.jaci.2008.05.018; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Eyerich K, 2009, J ALLERGY CLIN IMMUN, V123, P59, DOI 10.1016/j.jaci.2008.10.031; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Fujiwara M, 2007, J ALLERGY CLIN IMMUN, V119, P662, DOI 10.1016/j.jaci.2006.12.643; Gould Hannah J, 2007, Chem Immunol Allergy, V93, P106, DOI 10.1159/000100861; Gustafsson PM, 2000, RESP MED, V94, P466, DOI 10.1053/rmed.1999.0763; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; He R, 2009, J ALLERGY CLIN IMMUN, V124, P761, DOI 10.1016/j.jaci.2009.07.040; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Ivanov S, 2007, AM J RESP CELL MOL, V36, P442, DOI 10.1165/rcmb.2006-0020OC; Kawaguchi Mio, 2009, Inflammation & Allergy Drug Targets, V8, P383; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Laan M, 2008, RECENT PATENTS INFLA, V2, P82, DOI 10.2174/187221308784543683; Langer K, 2007, EXP DERMATOL, V16, P124, DOI 10.1111/j.1600-0625.2006.00523.x; LEUNG DYM, 1995, J INVEST DERMATOL, V105, pS37, DOI 10.1111/1523-1747.ep12315250; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mandron M, 2006, J ALLERGY CLIN IMMUN, V117, P1141, DOI 10.1016/j.jaci.2005.12.1360; Nomura I, 1999, J ALLERGY CLIN IMMUN, V104, P441, DOI 10.1016/S0091-6749(99)70390-8; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Ohshima Y, 2002, ANN ALLERG ASTHMA IM, V89, P265, DOI 10.1016/S1081-1206(10)61953-9; Ou LS, 2004, J ALLERGY CLIN IMMUN, V113, P756, DOI 10.1016/j.jaci.2004.01.772; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Ricci G, 2006, J AM ACAD DERMATOL, V55, P765, DOI 10.1016/j.jaad.2006.04.064; Savinko T, 2005, J IMMUNOL, V175, P8320, DOI 10.4049/jimmunol.175.12.8320; Schlievert PM, 2008, CLIN INFECT DIS, V46, P1562, DOI 10.1086/586746; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Simpson EL, 2006, MED CLIN N AM, V90, P149, DOI 10.1016/j.mcna.2005.09.002; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Spergel JM, 2005, CURR OPIN ALLERGY CL, V5, P17, DOI 10.1097/00130832-200502000-00005; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Spergel JM, 2010, IMMUNOL ALLERGY CLIN, V30, P269, DOI 10.1016/j.iac.2010.06.003; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Toda M, 2003, J ALLERGY CLIN IMMUN, V111, P875, DOI 10.1067/mai.2003.1414; Tomi NS, 2005, J AM ACAD DERMATOL, V53, P67, DOI 10.1016/j.jaad.2005.02.034; Travers JB, 2009, J ALLERGY CLIN IMMUN, V125, p[146, e141]; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; WILLIAMS REA, 1990, BRIT J DERMATOL, V123, P493; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu Z, 2011, SCI REP-UK, V1, DOI 10.1038/srep00023; Zollner TM, 2000, CLIN EXP ALLERGY, V30, P994	59	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39032	10.1371/journal.pone.0039032	http://dx.doi.org/10.1371/journal.pone.0039032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848348	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200008
J	Abend, M; Pfeiffer, RM; Ruf, C; Hatch, M; Bogdanova, TI; Tronko, MD; Riecke, A; Hartmann, J; Meineke, V; Boukheris, H; Sigurdson, AJ; Mabuchi, K; Brenner, AV				Abend, Michael; Pfeiffer, Ruth M.; Ruf, Christian; Hatch, Maureen; Bogdanova, Tetiana I.; Tronko, Mykola D.; Riecke, Armin; Hartmann, Julia; Meineke, Viktor; Boukheris, Houda; Sigurdson, Alice J.; Mabuchi, Kiyohiko; Brenner, Alina V.			Iodine-131 Dose Dependent Gene Expression in Thyroid Cancers and Corresponding Normal Tissues Following the Chernobyl Accident	PLOS ONE			English	Article							POST-CHERNOBYL; IONIZING-RADIATION; EPIGENETIC MECHANISMS; PAPILLARY CARCINOMAS; GAMMA-IRRADIATION; IN-VITRO; EXPOSURE; CELLS; UKRAINE; REARRANGEMENTS	The strong and consistent relationship between irradiation at a young age and subsequent thyroid cancer provides an excellent model for studying radiation carcinogenesis in humans. We thus evaluated differential gene expression in thyroid tissue in relation to iodine-131 (I-131) doses received from the Chernobyl accident. Sixty three of 104 papillary thyroid cancers diagnosed between 1998 and 2008 in the Ukrainian-American cohort with individual I-131 thyroid dose estimates had paired RNA specimens from fresh frozen tumor (T) and normal (N) tissue provided by the Chernobyl Tissue Bank and satisfied quality control criteria. We first hybridized 32 randomly allocated RNA specimen pairs (T/N) on 64 whole genome microarrays (Agilent, 4x44 K). Associations of differential gene expression (log(2)(T/N)) with dose were assessed using Kruskall-Wallis and trend tests in linear mixed regression models. While none of the genes withstood correction for the false discovery rate, we selected 75 genes with a priori evidence or P kruskall/P trend <0.0005 for validation by qRT-PCR on the remaining 31 RNA specimen pairs (T/N). The qRT-PCR data were analyzed using linear mixed regression models that included radiation dose as a categorical or ordinal variable. Eleven of 75 qRT-PCR assayed genes (ACVR2A, AJAP1, CA12, CDK12, FAM38A, GALNT7, LMO3, MTA1, SLC19A1, SLC43A3, ZNF493) were confirmed to have a statistically significant differential dose-expression relationship. Our study is among the first to provide direct human data on long term differential gene expression in relation to individual I-131 doses and to identify a set of genes potentially important in radiation carcinogenesis.	[Abend, Michael; Ruf, Christian; Riecke, Armin; Hartmann, Julia; Meineke, Viktor] Bundeswehr Inst Radiobiol, Munich, Germany; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; [Hatch, Maureen; Sigurdson, Alice J.; Mabuchi, Kiyohiko; Brenner, Alina V.] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; [Bogdanova, Tetiana I.; Tronko, Mykola D.] Inst Endocrinol & Metab, Kiev, Ukraine; [Boukheris, Houda] NOVA Res Co, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Academy of Medical Sciences of Ukraine; V. P. Komissarenko Institute of Endocrinology & Metabolism of the National Academy of Medical Science of Ukraine	Abend, M (corresponding author), Bundeswehr Inst Radiobiol, Munich, Germany.	michaelabend@bundeswehr.org	Tronko, Mykola/AAQ-3327-2021	Tronko, Mykola/0000-0001-7421-0981; Bogdanova, Tetiana/0000-0001-5119-0236	German Ministry of Defense; Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010132] Funding Source: NIH RePORTER	German Ministry of Defense; Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was primarily supported by the German Ministry of Defense. Additional funds were contributed by the Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese J, 2007, EXP HEMATOL, V35, P47, DOI 10.1016/j.exphem.2007.01.012; [Anonymous], SAS 9 1 3; Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boltze C, 2009, ONCOL REP, V22, P459, DOI 10.3892/or_00000457; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510; Caudill CM, 2005, J CLIN ENDOCR METAB, V90, P2364, DOI 10.1210/jc.2004-1811; Davis S, 2004, RADIAT RES, V162, P241, DOI 10.1667/RR3233; Detours V, 2007, BRIT J CANCER, V97, P818, DOI 10.1038/sj.bjc.6603938; Detours V, 2005, BRIT J CANCER, V92, P1545, DOI 10.1038/sj.bjc.6602521; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Goldberg Z, 2004, INT J RADIAT ONCOL, V58, P567, DOI 10.1016/j.ijrobp.2003.09.033; Goldberg Z, 2006, CLIN CANCER RES, V12, P3723, DOI 10.1158/1078-0432.CCR-05-2625; Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262; Hess J, 2011, P NATL ACAD SCI USA, V108, P9595, DOI 10.1073/pnas.1017137108; Jeggo PA, 2009, HEALTH PHYS, V97, P416, DOI 10.1097/HP.0b013e3181aff9c8; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kang HM, 2006, CANCER GENET CYTOGEN, V166, P27, DOI 10.1016/j.cancergencyto.2005.08.002; Likhtarev I, 2006, RADIAT RES, V166, P271, DOI 10.1667/RR3545.1; Likhtarev I, 2003, RADIAT PROT DOSIM, V105, P601, DOI 10.1093/oxfordjournals.rpd.a006310; Likhtarov I, 2005, RADIAT RES, V163, P125, DOI 10.1667/RR3291; Maenhaut C, 2011, CLIN ONCOL-UK, V23, P282, DOI 10.1016/j.clon.2011.01.509; Nikiforov YE, 1997, CANCER RES, V57, P1690; Ortiz-Estevez M, 2011, GENOMICS, V97, P86, DOI 10.1016/j.ygeno.2010.10.008; Ory C, 2011, ENDOCR-RELAT CANCER, V18, P193, DOI 10.1677/ERC-10-0205; Port M, 2007, RADIAT RES, V168, P639, DOI 10.1667/RR0968.1; Port M, 2005, J CLIN ONCOL, V23, P58, DOI 10.1200/JCO.2005.11.076; Powell N, 2005, J PATHOL, V205, P558, DOI 10.1002/path.1736; Romm H, 2004, CYTOGENET GENOME RES, V104, P162, DOI 10.1159/000077482; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Ron E, 2007, HEALTH PHYS, V93, P502, DOI 10.1097/01.HP.0000279018.93081.29; Seidl C, 2007, MOL CANCER THER, V6, P2346, DOI 10.1158/1535-7163.MCT-07-0132; Sioud M, 2011, METHODS MOL BIOL, V703, P173, DOI 10.1007/978-1-59745-248-9_12; Smida J, 1999, INT J CANCER, V80, P32, DOI 10.1002/(SICI)1097-0215(19990105)80:1<32::AID-IJC7>3.3.CO;2-C; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Stezhko VA, 2004, RADIAT RES, V161, P481, DOI 10.1667/3148; Thomas GA, 2011, CLIN ONCOL-UK, V23, P276, DOI 10.1016/j.clon.2011.01.503; Thomas GA, 1999, J CLIN ENDOCR METAB, V84, P4232, DOI 10.1210/jc.84.11.4232; Torres-Roca JF, 2005, CANCER RES, V65, P7169, DOI 10.1158/0008-5472.CAN-05-0656; Tronko MD, 2006, JNCI-J NATL CANCER I, V98, P897, DOI 10.1093/jnci/djj244; Williams D, 2008, Oncogene, V27 Suppl 2, pS9, DOI 10.1038/onc.2009.349; Wyrobek AJ, 2011, MUTAT RES-GEN TOX EN, V722, P119, DOI 10.1016/j.mrgentox.2011.03.002; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967	45	43	47	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39103	10.1371/journal.pone.0039103	http://dx.doi.org/10.1371/journal.pone.0039103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848350	Green Submitted, gold, Green Published			2022-12-27	WOS:000306806600004
J	Aguilar, D; Oliva, B; Buslje, CM				Aguilar, Daniel; Oliva, Baldo; Marino Buslje, Cristina			Mapping the Mutual Information Network of Enzymatic Families in the Protein Structure to Unveil Functional Features	PLOS ONE			English	Article							SMALL-WORLD; RESIDUES; PHYLOGENY; IMPROVES; SITES	Amino acids committed to a particular function correlate tightly along evolution and tend to form clusters in the 3D structure of the protein. Consequently, a protein can be seen as a network of co-evolving clusters of residues. The goal of this work is two-fold: first, we have combined mutual information and structural data to describe the amino acid networks within a protein and their interactions. Second, we have investigated how this information can be used to improve methods of prediction of functional residues by reducing the search space. As a main result, we found that clusters of co-evolving residues related to the catalytic site of an enzyme have distinguishable topological properties in the network. We also observed that these clusters usually evolve independently, which could be related to a fail-safe mechanism. Finally, we discovered a significant enrichment of functional residues (e. g. metal binding, susceptibility to detrimental mutations) in the clusters, which could be the foundation of new prediction tools.	[Aguilar, Daniel; Oliva, Baldo] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Struct Bioinformat Grp, Barcelona, Spain; [Marino Buslje, Cristina] Fdn Inst Leloir, Bioinformat Unit, Buenos Aires, DF, Argentina	Pompeu Fabra University; Leloir Institute	Aguilar, D (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Struct Bioinformat Grp, Barcelona Biomed Res Pk, Barcelona, Spain.	daniel.aguilar@upf.edu	Oliva, Baldomero/A-2690-2009; Marino-Buslje, Cristina/J-7438-2019; Gasull, Martina/J-4076-2019	Oliva, Baldomero/0000-0003-0702-0250; Marino-Buslje, Cristina/0000-0002-6564-1920; Aguilar, Daniel/0000-0001-7520-4508	Spanish Ministry of Science and Innovation; Argentine Ministry of Science [AR2009-0015]; European Regional Development Fund [BIO2008-0205]; Consejo Nacional de Investigaciones Cientificas y Tecnicas	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Argentine Ministry of Science; European Regional Development Fund(European Commission); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Spanish Ministry of Science and Innovation and the Argentine Ministry of Science AR2009-0015. BO and DA acknowledge support from the European Regional Development Fund BIO2008-0205. CMB acknowledges support from Consejo Nacional de Investigaciones Cientificas y Tecnicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; [Anonymous], 2010, R LANG ENV STAT COMP; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Bleicher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027786; Brohee S, 2008, NAT PROTOC, V3, P1616, DOI 10.1038/nprot.2008.100; Chakrabarti S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008591; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Hagberg A, 2008, P 7 PYTH SCI C SCIPY, P6; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hamacher K, 2008, GENE, V422, P30, DOI 10.1016/j.gene.2008.06.007; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Knaggs MH, 2007, BIOPHYS J, V92, P2062, DOI 10.1529/biophysj.106.081950; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Kuipers RKP, 2009, PROTEINS, V76, P608, DOI 10.1002/prot.22374; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Maritz J.S., 1981, DISTRIBUTION FREE ST; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Shackelford G, 2007, PROTEINS, V69, P159, DOI 10.1002/prot.21791; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Van Dongen S., 2000, THESIS; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Venner E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014286; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weil P, 2009, COMPUT BIOL CHEM, V33, P440, DOI 10.1016/j.compbiolchem.2009.10.003; White RA, 2007, METHOD ENZYMOL, V422, P75, DOI 10.1016/S0076-6879(06)22004-4; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	40	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41430	10.1371/journal.pone.0041430	http://dx.doi.org/10.1371/journal.pone.0041430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848494	Green Published, gold			2022-12-27	WOS:000306806600067
J	Hjalten, J; Stenbacka, F; Pettersson, RB; Gibb, H; Johansson, T; Danell, K; Ball, JP; Hilszczanski, J				Hjalten, Joakim; Stenbacka, Fredrik; Pettersson, Roger B.; Gibb, Heloise; Johansson, Therese; Danell, Kjell; Ball, John P.; Hilszczanski, Jacek			Micro and Macro-Habitat Associations in Saproxylic Beetles: Implications for Biodiversity Management	PLOS ONE			English	Article							BOREAL FOREST BIODIVERSITY; SOUTHEASTERN UNITED-STATES; COARSE WOODY DEBRIS; PICEA-ABIES FOREST; SPECIES RICHNESS; SWEDISH FORESTS; DEAD WOOD; FUNCTIONAL-GROUPS; SOUTHERN FINLAND; HIGH STUMPS	Restoration of habitats is critically important in preventing full realization of the extinction debt owed as a result of anthropogenic habitat destruction. Although much emphasis has been placed on macrohabitats, suitable microhabitats are also vital for the survival of most species. The aim of this large-scale field experiment was to evaluate the relative importance of manipulated microhabitats, i.e., dead wood substrates of spruce (snags, and logs that were burned, inoculated with wood fungi or shaded) and macrohabitats, i.e., stand types (clear-cuts, mature managed forests, and forest reserves) for species richness, abundance and assemblage composition of all saproxylic and red-listed saproxylic beetles. Beetles were collected in emergence traps in 30 forest stands in 2001, 2003, 2004 and 2006. More individuals emerged from snags and untreated logs than from burned and shaded logs, but species richness did not differ among substrates. Assemblage composition differed among substrates for both all saproxylics and red-listed saproxylic species, mainly attributed to different assemblage composition on snags. This suggests that the practise of leaving snags for conservation purposes should be complemented with log supplementation. Clear-cuts supported fewer species and different assemblages from mature managed forests and reserves. Neither abundance, nor species richness or assemblage composition differed between reserves and mature managed forests. This suggests that managed stands subjected to selective cutting, not clear-felling, maintain sufficient old growth characteristics and continuity to maintain more or less intact assemblages of saproxylic beetles. Thus, alternative management methods, e. g., continuity forestry should be considered for some of these stands to maintain continuity and conservation values. Furthermore, the significantly higher estimated abundance per ha of red-listed beetles in reserves underlines the importance of reserves for maintaining viable populations of rare red-listed species and as source areas for saproxylic species in boreal forest landscapes.	[Hjalten, Joakim; Stenbacka, Fredrik; Pettersson, Roger B.; Gibb, Heloise; Johansson, Therese; Danell, Kjell; Ball, John P.; Hilszczanski, Jacek] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences	Hjalten, J (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	joakim.hjalten@slu.se	Gibb, Heloise/B-8338-2013; Ball, John P/D-2409-2011	Johansson, Therese/0000-0002-5864-2669; Hilszczanski, Jacek/0000-0002-4731-0044; Gibb, Heloise/0000-0001-7194-0620; Hjalten, Joakim/0000-0002-8279-6633	Swedish University of Agricultural Sciences; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Centre of Environmental Research, Umea; Kempe Foundation	Swedish University of Agricultural Sciences; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Centre of Environmental Research, Umea; Kempe Foundation	The study was financed by the Swedish University of Agricultural Sciences (grant to KD and Stig Larsson), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, the Centre of Environmental Research, Umea and the Kempe Foundation (grants to J. Hjalten). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Alinvi O, 2007, J INSECT CONSERV, V11, P99, DOI 10.1007/s10841-006-9012-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON MJ, 2003, NPMANOVA FORTRAN COM; Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Basset Y, 2008, INSECT CONSERV DIVER, V1, P55, DOI 10.1111/j.1752-4598.2007.00011.x; Berg A, 1995, CONSERV BIOL, V9, P1629, DOI 10.1046/j.1523-1739.1995.09061629.x; BERG A, 1994, CONSERV BIOL, V8, P718, DOI 10.1046/j.1523-1739.1994.08030718.x; Boulanger Y, 2007, ENVIRON ENTOMOL, V36, P128, DOI 10.1603/0046-225X-36.1.128; Boulanger Y, 2010, FOREST ECOL MANAG, V260, P1114, DOI 10.1016/j.foreco.2010.06.027; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dahlberg A, 2004, VEDLEVANDE ARTERS KR; Davies ZG, 2008, BIODIVERS CONSERV, V17, P209, DOI 10.1007/s10531-007-9242-y; Djupstrom L, 2010, THESIS SWEDISH U AGR; Ebeling F, 1978, NORDSVENSKA SKOGSTYP; Ekbom B, 2006, FOREST ECOL MANAG, V221, P2, DOI 10.1016/j.foreco.2005.10.038; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Fossestol KO, 2009, SCAND J FOREST RES, V24, P403, DOI 10.1080/02827580903143871; Franc N, 2007, CAN J FOREST RES, V37, P2494, DOI 10.1139/X07-096; Gardenfors U, 2010, RODLISTADE ARTER SVE; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Gibb H, 2006, ECOGRAPHY, V29, P191, DOI 10.1111/j.2006.0906-7590.04372.x; Gilbertson RL., 1993, EUROPEAN POLYPORES 1; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Gustafsson L, 2004, BASIC APPL ECOL, V5, P123, DOI 10.1078/1439-1791-00223; Gustafsson L, 2002, CONSERV BIOL, V16, P377, DOI 10.1046/j.1523-1739.2002.00398.x; Hagvar Sigmund, 1997, Fauna Norvegica Series B, V44, P95; Hammond HE, 2001, CAN J FOREST RES, V31, P1175, DOI 10.1139/cjfr-31-7-1175; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Hedgren PO, 2004, FOREST ECOL MANAG, V203, P241, DOI 10.1016/j.foreco.2004.07.055; Hjalten J, 2007, BASIC APPL ECOL, V8, P364, DOI 10.1016/j.baae.2006.08.003; Johannesson H, 1999, FOREST ECOL MANAG, V115, P203, DOI 10.1016/S0378-1127(98)00399-5; Johansson T, 2007, FOREST ECOL MANAG, V242, P518, DOI 10.1016/j.foreco.2007.01.064; Johansson T, 2007, FOREST ECOL MANAG, V242, P496, DOI 10.1016/j.foreco.2007.01.062; Johnson EA, 1998, J VEG SCI, V9, P603, DOI 10.2307/3237276; Jonsell M, 2005, SCAND J FOREST RES, V20, P54, DOI 10.1080/02827580510008211; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jonsson BG, 2000, J VEG SCI, V11, P51, DOI 10.2307/3236775; Kaila L, 1997, BIODIVERS CONSERV, V6, P1, DOI 10.1023/A:1018399401248; Komonen A, 2004, ENTOMOL FENNICA, V15, P102; Larsson S, 2001, SCAND J FOREST RES, P5, DOI 10.1080/028275801300090528; Lawrence J.F., 1995, P779; LEKANDER B, 1977, Acta Entomologica Fennica, V32, P1; Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; Martikainen P, 2003, BIODIVERS CONSERV, V12, P1815, DOI 10.1023/A:1024132829581; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McGeoch MA, 2007, DIVERS DISTRIB, V13, P418, DOI 10.1111/j.1472-4642.2007.00350.x; Niklasson M, 2000, ECOLOGY, V81, P1484, DOI 10.1890/0012-9658(2000)081[1484:NASOFL]2.0.CO;2; Okland B, 1996, EUR J ENTOMOL, V93, P195; OLSSON J, 2008, THESIS UMEA U UMEA; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Penttila R, 2004, BIOL CONSERV, V117, P271, DOI 10.1016/j.biocon.2003.12.007; QUADE D, 1979, J AM STAT ASSOC, V74, P680, DOI 10.2307/2286991; Ranius T, 2006, POPUL ECOL, V48, P177, DOI 10.1007/s10144-006-0262-3; Saint-Germain M, 2007, ECOGRAPHY, V30, P737, DOI 10.1111/j.2007.0906-7590.05080.x; Schiegg K, 2001, FOREST ECOL MANAG, V149, P295, DOI 10.1016/S0378-1127(00)00563-6; Schigel DS, 2011, ANN ZOOL FENN, V48, P319, DOI 10.5735/086.048.0601; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Silfverberg Hans, 2004, Sahlbergia, V9, P1; SODERSTROM L, 1988, NORD J BOT, V8, P89, DOI 10.1111/j.1756-1051.1988.tb01709.x; Southwood TRE., 1978, ECOLOGICAL METHODS P; Speight M.C., 1989, SAPROXYLIC INVERTEBR; Stenbacka F, 2010, ECOL APPL, V20, P2310, DOI 10.1890/09-0815.1; Stenbacka F, 2010, INSECT CONSERV DIVER, V3, P114, DOI 10.1111/j.1752-4598.2010.00082.x; Sverdrup-Thygeson A, 2002, BIOL CONSERV, V108, P377, DOI 10.1016/S0006-3207(02)00142-8; Tikkanen OP, 2006, ANN ZOOL FENN, V43, P373; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Ulyshen MD, 2011, J INSECT CONSERV, V15, P539, DOI 10.1007/s10841-010-9348-5; Ulyshen MD, 2010, INSECT CONSERV DIVER, V3, P247, DOI 10.1111/j.1752-4598.2010.00095.x; Ulyshen MD, 2009, FOREST ECOL MANAG, V257, P653, DOI 10.1016/j.foreco.2008.09.047; Wikars LO, 2002, J INSECT CONSERV, V6, P1, DOI 10.1023/A:1015734630309; Wikars LO, 2005, CAN ENTOMOL, V137, P304, DOI 10.4039/N04-104; WIKARS LO, 1997, THESIS U UPPSALA UPP; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; ZACKRISSON O, 1977, OIKOS, V29, P22, DOI 10.2307/3543289; Zar J. H., 1996, BIOSTATISTICAL ANAL	80	40	40	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41100	10.1371/journal.pone.0041100	http://dx.doi.org/10.1371/journal.pone.0041100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848432	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600039
J	Kramer, K; Schaudien, D; Eisel, ULM; Herzog, S; Richt, JA; Baumgartner, W; Herden, C				Kramer, Katharina; Schaudien, Dirk; Eisel, Ulrich L. M.; Herzog, Sibylle; Richt, Juergen A.; Baumgaertner, Wolfgang; Herden, Christiane			TNF-Overexpression in Borna Disease Virus-Infected Mouse Brains Triggers Inflammatory Reaction and Epileptic Seizures	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR-ALPHA; NEUROLOGICAL DISORDER; MESSENGER-RNAS; EXPRESSION; CYTOKINES; MICE; ACTIVATION; RECEPTORS	Proinflammatory state of the brain increases the risk for seizure development. Neonatal Borna disease virus (BDV)-infection of mice with neuronal overexpression of tumor necrosis factor-alpha (TNF) was used to investigate the complex relationship between enhanced cytokine levels, neurotropic virus infection and reaction pattern of brain cells focusing on its role for seizure induction. Viral antigen and glial markers were visualized by immunohistochemistry. Different levels of TNF in the CNS were provided by the use of heterozygous and homozygous TNF overexpressing mice. Transgenic TNF, total TNF (native and transgenic), TNF-receptor (TNFR1, TNFR2), IL-1 and N-methyl-D-aspartate (NMDA)-receptor subunit 2B (NR2B) mRNA values were measured by real time RT-PCR. BDV-infection of TNF-transgenic mice resulted in non-purulent meningoencephalitis accompanied by epileptic seizures with a higher frequency in homozygous animals. This correlated with lower weight gain, stronger degree and progression of encephalitis and early, strong microglia activation in the TNF-transgenic mice, most obviously in homozygous animals. Activation of astroglia could be more intense and associated with an unusual hypertrophy in the transgenic mice. BDV-antigen distribution and infectivity in the CNS was comparable in TNF-transgenic and wild-type animals. Transgenic TNF mRNA-expression was restricted to forebrain regions as the transgene construct comprised the promoter of NMDA-receptor subunit2B and induced up-regulation of native TNF mRNA. Total TNF mRNA levels did not increase significantly after BDV-infection in the brain of transgenic mice but TNFR1, TNFR2 and IL-1 mRNA values, mainly in the TNF overexpressing brain areas. NR2B mRNA levels were not influenced by transgene expression or BDV-infection. Neuronal TNF-overexpression combined with BDV-infection leads to cytokine up-regulation, CNS inflammation and glial cell activation and confirmed the presensitizing effect of elevated cytokine levels for the development of spontaneous epileptic seizures when exposed to additional infectious noxi.	[Kramer, Katharina; Schaudien, Dirk; Baumgaertner, Wolfgang; Herden, Christiane] Univ Vet Med, Dept Pathol, Hannover, Germany; [Eisel, Ulrich L. M.] Univ Groningen, Dept Mol Neurobiol, Groningen, Netherlands; [Herzog, Sibylle] Univ Giessen, Inst Virol, D-6300 Giessen, Germany; [Richt, Juergen A.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	University of Veterinary Medicine Hannover, Foundation; University of Groningen; Justus Liebig University Giessen; Kansas State University	Kramer, K (corresponding author), Univ Vet Med, Dept Pathol, Hannover, Germany.	christiane.herden@vetmed.uni-giessen.de	Richt, Juergen/AAL-3632-2020	Eisel, Ulrich/0000-0003-4178-0384; Kramer, Katharina/0000-0002-8325-6030; Herden, Christiane/0000-0003-1858-2267	Hersenstichting, Nederland; Internationale Alzheimer Stichting; European Union FP6 programm NeuroproMiSe [LSHM-CT-2005-018637]; Graduate School of the Center of Systems Neuroscience (ZSN), Hannover	Hersenstichting, Nederland; Internationale Alzheimer Stichting; European Union FP6 programm NeuroproMiSe; Graduate School of the Center of Systems Neuroscience (ZSN), Hannover	U.E. was supported by Hersenstichting, Nederland, the Internationale Alzheimer Stichting and by the European Union FP6 programm NeuroproMiSe, LSHM-CT-2005-018637. Katharina Kramer was supported by a scholarship of the Graduate School of the Center of Systems Neuroscience (ZSN), Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarli JA, 2000, ARCH NEUROL-CHICAGO, V57, P1689, DOI 10.1001/archneur.57.12.1689; Akassoglou K, 1997, J IMMUNOL, V158, P438; Balosso S, 2005, ANN NEUROL, V57, P804, DOI 10.1002/ana.20480; Balosso S, 2009, NEUROSCIENCE, V161, P293, DOI 10.1016/j.neuroscience.2009.03.005; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Brachthauser L, 2011, NEUROIMMUNOMODULAT, V18, P365; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Dietz DM, 2003, PHYSIOL BEHAV, V80, P359, DOI 10.1016/j.physbeh.2003.08.011; Dietzschold B, 2001, CURR TOP MICROBIOL, V253, P145; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Durrwald R, 2007, REV MED VIROL, V17, P181, DOI 10.1002/rmv.530; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Faber M, 2005, J VIROL, V79, P15405, DOI 10.1128/JVI.79.24.15405-15416.2005; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Freude S, 2002, J VIROL, V76, P12223, DOI 10.1128/JVI.76.23.12223-12232.2002; Friedman A, 2011, EPILEPSIA, V52, P33, DOI 10.1111/j.1528-1167.2011.03034.x; Galic MA, 2009, NEUROBIOL DIS, V36, P343, DOI 10.1016/j.nbd.2009.07.025; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Getts DR, 2008, J NEUROCHEM, V104, P1167, DOI 10.1111/j.1471-4159.2007.05171.x; Glaser CA, 2008, NEUROCRIT CARE, V9, P74, DOI 10.1007/s12028-007-9042-y; Hallensleben W, 1998, J VIROL, V72, P4379, DOI 10.1128/JVI.72.5.4379-4386.1998; Hausmann J, 2004, VIRAL IMMUNOL, V17, P79, DOI 10.1089/088282404322875476; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Herden C, 2005, NEUROPATH APPL NEURO, V31, P512, DOI 10.1111/j.1365-2990.2005.00668.x; Herden C, 2000, BRAIN PATHOL, V10, P39; HERZOG S, 1980, MED MICROBIOL IMMUN, V168, P153, DOI 10.1007/BF02122849; Herzog S, 2010, J CLIN MICROBIOL, V48, P2282, DOI 10.1128/JCM.00145-10; Hofer M, 2004, AM J PATHOL, V165, P949, DOI 10.1016/S0002-9440(10)63356-1; Houzen H, 1997, J NEUROSCI RES, V50, P990, DOI 10.1002/(SICI)1097-4547(19971215)50:6<990::AID-JNR9>3.3.CO;2-8; Jankowsky JL, 2001, PROG NEUROBIOL, V63, P125, DOI 10.1016/S0301-0082(00)00022-8; Kamperschroer C, 2002, J IMMUNOL, V169, P340, DOI 10.4049/jimmunol.169.1.340; Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Lehrmann E, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01489.x; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Libbey JE, 2011, J VIROL, V85, P6913, DOI 10.1128/JVI.00458-11; Liebert UG, 2001, CURR TOP MICROBIOL, V253, P35; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Matullo CM, 2010, J VIROL, V84, P312, DOI 10.1128/JVI.00727-09; Misra UK, 2008, AM J MED, V121, P618, DOI 10.1016/j.amjmed.2008.02.012; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; Nijholt IM, 2011, ADV EXP MED BIOL, V691, P567, DOI 10.1007/978-1-4419-6612-4_59; Ovanesov MV, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-50; Owens T, 2001, NAT MED, V7, P161, DOI 10.1038/84603; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Probert L, 2001, GLIA, V36, P212, DOI 10.1002/glia.1110; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Richt JA, 2007, EQUINE INFECT DIS, P201; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Rutigliano JA, 2004, J IMMUNOL, V173, P3408, DOI 10.4049/jimmunol.173.5.3408; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Savin C, 2009, J R SOC INTERFACE, V6, P655, DOI 10.1098/rsif.2008.0387; Schaudien D, 2007, DIAGN MOL PATHOL, V16, P153, DOI 10.1097/PDM.0b013e31803c558a; Schwemmle M, 2004, MOL DIVERS, V8, P247, DOI 10.1023/B:MODI.0000036244.57859.76; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; SHANKAR V, 1992, J VIROL, V66, P992, DOI 10.1128/JVI.66.2.992-998.1992; Shirato K, 2006, VIRUS RES, V121, P11, DOI 10.1016/j.virusres.2006.03.010; Solbrig MV, 2006, NEUROBIOL DIS, V23, P612, DOI 10.1016/j.nbd.2006.05.014; Solbrig MV, 2006, BRAIN, V129, P642, DOI 10.1093/brain/awl008; Staeheli P, 2000, J GEN VIROL, V81, P2123, DOI 10.1099/0022-1317-81-9-2123; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stitz L, 2002, FRONT BIOSCI, V7, pD541, DOI 10.2741/stitz; Theodore WH, 2008, EPILEPSIA, V49, P1828, DOI 10.1111/j.1528-1167.2008.01699.x; Titeux M, 2002, MOL BRAIN RES, V109, P119, DOI 10.1016/S0169-328X(02)00547-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandevelde Marc, 2001, VETERINARMEDIZINISCH; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2011, BIOMARK MED, V5, P607, DOI [10.2217/BMM.11.61, 10.2217/bmm.11.61]; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011	73	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41476	10.1371/journal.pone.0041476	http://dx.doi.org/10.1371/journal.pone.0041476			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848506	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600071
J	Mook-Kanamori, DO; van Beijsterveldt, CEM; Steegers, EAP; Aulchenko, YS; Raat, H; Hofman, A; Eilers, PH; Boomsma, DI; Jaddoe, VWV				Mook-Kanamori, Dennis O.; van Beijsterveldt, Catharina E. M.; Steegers, Eric A. P.; Aulchenko, Yurii S.; Raat, Hein; Hofman, Albert; Eilers, Paul H.; Boomsma, Dorret I.; Jaddoe, Vincent W. V.			Heritability Estimates of Body Size in Fetal Life and Early Childhood	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; YOUNG MALE TWINS; BIRTH-WEIGHT; GENERATION-R; ENVIRONMENTAL-FACTORS; RELATIVE WEIGHT; FEMUR LENGTH; 8 COUNTRIES; HEIGHT; GROWTH	Background: The objective was to estimate the heritability for height and weight during fetal life and early childhood in two independent studies, one including parent and singleton offsprings and one of mono- and dizygotic twins. Methods: This study was embedded in the Generation R Study (n = 3407, singletons) and the Netherlands Twin Register (n = 33694, twins). For the heritability estimates in Generation R, regression models as proposed by Galton were used. In the Twin Register we used genetic structural equation modelling. Parental height and weight were measured and fetal growth characteristics (femur length and estimated fetal weight) were measured by ultrasounds in 2nd and 3rd trimester (Generation R only). Height and weight were assessed at multiple time-points from birth to 36 months in both studies. Results: Heritability estimates for length increased from 2nd to 3rd trimester from 13% to 28%. At birth, heritability estimates for length in singletons and twins were both 26% and 27%, respectively, and at 36 months, the estimates for height were 63% and 72%, respectively. Heritability estimates for fetal weight increased from 2nd to 3rd trimester from 17% to 27%. For birth weight, heritability estimates were 26% in singletons and 29% in twins. At 36 months, the estimate for twins was 71% and higher than for singletons (42%). Conclusions: Heritability estimates for height and weight increase from second trimester to infancy. This increase in heritability is observed in singletons and twins. Longer follow-up studies are needed to examine how the heritability develops in later childhood and puberty.	[Mook-Kanamori, Dennis O.; Jaddoe, Vincent W. V.] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.; Aulchenko, Yurii S.; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.] Weil Cornell Med Coll Qatar, Doha, Qatar; [van Beijsterveldt, Catharina E. M.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; [Raat, Hein] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Eilers, Paul H.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Mook-Kanamori, DO (corresponding author), Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands.	v.jaddoe@erasmusmc.nl	Boomsma, Dorret I/AAX-4470-2020; Aulchenko, Yurii/M-8270-2013	Aulchenko, Yurii/0000-0002-7899-1575; van Beijsterveldt, Toos/0000-0002-6617-4201	Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); Netherlands Organization for Health Research [ZonMw 90700303]; Twin-family database for behavior genetics and genomics studies [NWO 480-04-004]; European Research Council [ERC-230374]; Spinozapremie [NWO/SPI 56-464-14192]; Neuroscience Campus Amsterdam (NCA); EMGO+ institution	Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research(Netherlands Organization for Health Research and Development); Twin-family database for behavior genetics and genomics studies; European Research Council(European Research Council (ERC)European Commission); Spinozapremie; Neuroscience Campus Amsterdam (NCA); EMGO+ institution	The first phase of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw). Vincent Jaddoe also acknowledges the personal funding by the Netherlands Organization for Health Research (ZonMw 90700303). The Netherlands Twin Register was supported by the Twin-family database for behavior genetics and genomics studies (NWO 480-04-004); the European Research Council (Genetics of Mental Illness: A lifespan approach to the genetics of childhood and adult neuropsychiatric disorders and comorbid conditions, ERC-230374); Spinozapremie (NWO/SPI 56-464-14192); Neuroscience Campus Amsterdam (NCA) and the EMGO+ institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, EUR J HUM GENET, V17, P1070, DOI 10.1038/ejhg.2009.5; Ay L, 2009, BJOG-INT J OBSTET GY, V116, P953, DOI 10.1111/j.1471-0528.2009.02143.x; Bartels M, 2007, TWIN RES HUM GENET, V10, P3, DOI 10.1375/twin.10.1.3; Beardsall K, 2009, J CLIN ENDOCR METAB, V94, P3708, DOI 10.1210/jc.2009-0757; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Cole TJ, 2000, ANN HUM BIOL, V27, P401, DOI 10.1080/03014460050044874; Estourgie-van Burk GF, 2006, TWIN RES HUM GENET, V9, P646, DOI 10.1375/twin.9.5.646; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Galton F., 1886, J ANTHR I, V15, P246, DOI 10.2307%2F2841583; Gielen M, 2008, BEHAV GENET, V38, P44, DOI 10.1007/s10519-007-9170-3; HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115; HADLOCK FP, 1984, J ULTRAS MED, V3, P1; Hur YM, 2005, TWIN RES HUM GENET, V8, P638, DOI 10.1375/183242705774860169; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P801, DOI 10.1007/s10654-008-9309-4; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Neale M. C., 1999, MX STAT MODELING; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Ordonana JR, 2007, TWIN RES HUM GENET, V10, P749, DOI 10.1375/twin.10.5.749; Ounsted M, 2008, INT J EPIDEMIOL, V37, P245, DOI 10.1093/ije/dyn008; PHILLIPS DIW, 1993, LANCET, V341, P1008, DOI 10.1016/0140-6736(93)91086-2; Rietveld M J, 2000, Twin Res, V3, P134, DOI 10.1375/136905200320565409; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2007, INT J OBESITY, V31, P615, DOI 10.1038/sj.ijo.0803577; Silventoinen K, 2008, PEDIATRICS, V121, pE885, DOI 10.1542/peds.2007-1615; Silventoinen K, 2007, TWIN RES HUM GENET, V10, P354, DOI 10.1375/twin.10.2.354; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Tabano S, 2010, EPIGENETICS-US, V5, P313, DOI 10.4161/epi.5.4.11637; van Baal C G, 1998, Twin Res, V1, P123, DOI 10.1375/twin.1.3.123; van Dommelen P, 2004, TWIN RES, V7, P607, DOI 10.1375/1369052042663805; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Yang WJ, 2007, EPIDEMIOL REV, V29, P49, DOI 10.1093/epirev/mxm004	38	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39901	10.1371/journal.pone.0039901	http://dx.doi.org/10.1371/journal.pone.0039901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848364	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600011
J	Vermehren, J; Schlosser, B; Domke, D; Elanjimattom, S; Muller, C; Hintereder, G; Hensel-Wiegel, K; Tauber, R; Berger, A; Haas, N; Walcher, F; Mockel, M; Lehmann, R; Zeuzem, S; Sarrazin, C; Berg, T				Vermehren, Johannes; Schlosser, Beate; Domke, Diana; Elanjimattom, Sandra; Mueller, Christian; Hintereder, Gudrun; Hensel-Wiegel, Karin; Tauber, Rudolf; Berger, Annemarie; Haas, Norbert; Walcher, Felix; Moeckel, Martin; Lehmann, Ralf; Zeuzem, Stefan; Sarrazin, Christoph; Berg, Thomas			High Prevalence of Anti-HCV Antibodies in Two Metropolitan Emergency Departments in Germany: A Prospective Screening Analysis of 28,809 Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENOTYPE 1 INFECTION; AMINOTRANSFERASE LEVELS; VIRAL-HEPATITIS; PLUS RIBAVIRIN; BLOOD-DONORS; POPULATION; IMMUNOASSAYS; BOCEPREVIR; TELAPREVIR	Background and Aims: The prevalence of hepatitis C virus (HCV) antibodies in Germany has been estimated to be in the range of 0.4-0.63%. Screening for HCV is recommended in patients with elevated ALT levels or significant risk factors for HCV transmission only. However, 15-30% of patients report no risk factors and ALT levels can be normal in up to 20-30% of patients with chronic HCV infection. The aim of this study was to assess the HCV seroprevalence in patients visiting two tertiary care emergency departments in Berlin and Frankfurt, respectively. Methods: Between May 2008 and March 2010, a total of 28,809 consecutive patients were screened for the presence of anti-HCV antibodies. Anti-HCV positive sera were subsequently tested for HCV-RNA. Results: The overall HCV seroprevalence was 2.6% (95% CI: 2.4-2.8; 2.4% in Berlin and 3.5% in Frankfurt). HCV-RNA was detectable in 68% of anti-HCV positive cases. Thus, the prevalence of chronic HCV infection in the overall study population was 1.6% (95% CI 1.5-1.8). The most commonly reported risk factor was former/current injection drug use (IDU; 31.2%) and those with IDU as the main risk factor were significantly younger than patients without IDU (p<0.001) and the male-to-female ratio was 72% (121 vs. 46 patients; p<0.001). Finally, 18.8% of contacted HCV-RNA positive patients had not been diagnosed previously. Conclusions: The HCV seroprevalence was more than four times higher compared to current estimates and almost one fifth of contacted HCV-RNA positive patients had not been diagnosed previously.	[Vermehren, Johannes; Elanjimattom, Sandra; Zeuzem, Stefan; Sarrazin, Christoph] Klinikum JW Goethe Univ, Med Klin 1, Frankfurt, Germany; [Schlosser, Beate; Domke, Diana] Charite, Med Klin MS Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Mueller, Christian; Hensel-Wiegel, Karin; Tauber, Rudolf] Charite, Inst Lab Med Klin Chem & Pathobiochem, D-13353 Berlin, Germany; [Hintereder, Gudrun] Klinikum JW Goethe Univ, Zent Lab, Frankfurt, Germany; [Berger, Annemarie] Klinikum JW Goethe Univ, Inst Med Virol, Frankfurt, Germany; [Haas, Norbert] Charite, Klin Unfall & Wiederherstellungschirurg, D-13353 Berlin, Germany; [Walcher, Felix] Klinikum JW Goethe Univ, Klin Unfall Hand & Wiederherstellungschirurg, Frankfurt, Germany; [Moeckel, Martin] Charite, Med Klin MS Kardiol & Arbeitsbereich Notfallmed R, D-13353 Berlin, Germany; [Lehmann, Ralf] Klinikum JW Goethe Univ, Med Klin 3, Frankfurt, Germany; [Berg, Thomas] Univ Klinikum Leipzig, Klin & Poliklin Gastroenterol & Rheumatol, Sekt Hepatol, Leipzig, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Leipzig University	Vermehren, J (corresponding author), Klinikum JW Goethe Univ, Med Klin 1, Frankfurt, Germany.	Johannes.Vermehren@kgu.de	Mockel, Martin/AAC-2600-2019; Zeuzem, Stefan/AAE-7435-2019	Mockel, Martin/0000-0002-7691-3709; Berg, Thomas/0000-0003-0003-6241	German Competence Network for Viral Hepatitis (Hep-Net); German Ministry of Education and Research (BMBF) [01 KI 0437, 10.1.3, 10.1, 01KI0787]; Roche; Abbott	German Competence Network for Viral Hepatitis (Hep-Net); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Roche(Roche Holding); Abbott(Abbott Laboratories)	The Elecsys anti-HCV kits were kindly provided by Roche Pharma Ltd., Grenzach-Wyhlen, Germany. This work was supported by the German Competence Network for Viral Hepatitis (Hep-Net), funded by the German Ministry of Education and Research (BMBF, grant no. 01 KI 0437, project no. 10.1.3 and core project no. 10.1 Genetic host factors in viral hepatitis and Genetic Epidemiology Group in viral hepatitis), and by the BMBF Project: Host and viral determinants for susceptibility and resistance to hepatitis C virus infection (grant no. 01KI0787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Stefan Zeuzem has served as a speaker, a consultant and an advisory board member for Roche and Abbott. Christoph Sarrazin has served as a speaker, a consultant and an advisory board member, and has received research funding from Roche and Abbott. Thomas Berg has served as a speaker, a consultant and an advisory board member, and has received research funding from Roche. This does not alter the authors' adherence to all the PloS One policies on sharing data and materials.	Alborino F, 2011, MED MICROBIOL IMMUN, V200, P77, DOI 10.1007/s00430-010-0171-0; Bacon BR, 2002, HEPATOLOGY, V36, pS179, DOI 10.1053/jhep.2002.36386; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; CASPARI G, 1995, INFUSIONSTHERAPIE, V22, P208; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; DANTA M, 2007, 17 INT AIDS C MEX CI, V21, P983; Delarocque-Astagneau E, 2010, J VIRAL HEPATITIS, V17, P435, DOI 10.1111/j.1365-2893.2009.01196.x; European Center for Disease Prevention and Control, 2010, HEP B C EU NEIGHB PR; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; HOOFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575, DOI 10.1056/NEJM198612183152503; Huppe D, 2008, Z GASTROENTEROL, V46, P34, DOI 10.1055/s-2007-963691; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; KELEN GD, 1992, NEW ENGL J MED, V326, P1399, DOI 10.1056/NEJM199205213262105; Kim S, 2008, J CLIN MICROBIOL, V46, P3919, DOI 10.1128/JCM.01603-08; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; Palitzsch KD, 1999, EUR J GASTROEN HEPAT, V11, P1215, DOI 10.1097/00042737-199911000-00005; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Robert-Koch-Institut, 2011, EPIDEMIOLOGISCHES B, V29, P261; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Russmann S, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-5; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Shatin D, 2004, AM J MANAG CARE, V10, P250; Thierfelder W, 2001, EUR J EPIDEMIOL, V17, P429, DOI 10.1023/A:1013792013184; VANDELAAR TJW, 2010, 17 INT AIDS C MEX CI, V24, P1799, DOI DOI 10.1097/QAD.0B013E32833C11A5; Wiegand J, 2009, J VIRAL HEPATITIS, V16, P743, DOI 10.1111/j.1365-2893.2009.01132.x; World Health Organization, 2009, VIRAL HEPATITIS; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	33	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41206	10.1371/journal.pone.0041206	http://dx.doi.org/10.1371/journal.pone.0041206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848445	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600045
J	Weimar, CHE; Kavelaars, A; Brosens, JJ; Gellersen, B; de Vreeden-Elbertse, JMT; Heijnen, CJ; Macklon, NS				Weimar, Charlotte H. E.; Kavelaars, Annemieke; Brosens, Jan J.; Gellersen, Birgit; de Vreeden-Elbertse, Johanna M. T.; Heijnen, Cobi J.; Macklon, Nick S.			Endometrial Stromal Cells of Women with Recurrent Miscarriage Fail to Discriminate between High-and Low-Quality Human Embryos	PLOS ONE			English	Article							DEVELOPMENT IN-VITRO; PREGNANCY LOSS; IMPLANTATION; METABOLISM; ANEUPLOIDY; MOSAICISM; SELECTION; TURNOVER; IVF	Background: The aetiology of recurrent miscarriage (RM) remains largely unexplained. Women with RM have a shorter time to pregnancy interval than normally fertile women, which may be due to more frequent implantation of non-viable embryos. We hypothesized that human endometrial stromal cells (H-EnSCs) of women with RM discriminate less effectively between high-and low-quality human embryos and migrate more readily towards trophoblast spheroids than H-EnSCs of normally fertile women. Methodology/Principal Findings: Monolayers of decidualized H-EnSCs were generated from endometrial biopsies of 6 women with RM and 6 fertile controls. Cell-free migration zones were created and the effect of the presence of a high-quality (day 5 blastocyst, n = 13), a low-quality (day 5 blastocyst with three pronuclei or underdeveloped embryo, n = 12) or AC-1M88 trophoblast cell line spheroid on H-ESC migratory activity was analyzed after 18 hours. In the absence of a spheroid or embryo, migration of H-EnSCs from fertile or RM women was similar. In the presence of a low-quality embryo in the zone, the migration of H-EnSCs of control women was inhibited compared to the basal migration in the absence of an embryo (P<0.05) and compared to the migration in the presence of high-quality embryo (p<0.01). Interestingly, the migratory response H-EnSCs of women with RM did not differ between high-and low-quality embryos. Furthermore, in the presence of a spheroid their migration was enhanced compared to the H-EnSCs of controls (p<0.001). Conclusions: H-EnSCs of fertile women discriminate between high-and low-quality embryos whereas H-EnSCs of women with RM fail to do so. H-EnSCs of RM women have a higher migratory response to trophoblast spheroids. Future studies will focus on the mechanisms by which low-quality embryos inhibit the migration of H-EnSCs and how this is deregulated in women with RM.	[Weimar, Charlotte H. E.; Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis NIDOD, Utrecht, Netherlands; [Brosens, Jan J.] Univ Warwick, Warwick Med Sch, Div Reprod Hlth, Warwick, England; [Gellersen, Birgit] Endokrinologikum Hamburg, Hamburg, Germany; [de Vreeden-Elbertse, Johanna M. T.; Macklon, Nick S.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynaecol, Utrecht, Netherlands; [Macklon, Nick S.] Univ Southampton, Fac Med, Princess Anne Hosp, Southampton SO9 5NH, Hants, England	Utrecht University; Utrecht University Medical Center; University of Warwick; Utrecht University; Utrecht University Medical Center; University of Southampton	Weimar, CHE (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis NIDOD, Utrecht, Netherlands.	c.heijnen@umcutrecht.nl		Brosens, Jan/0000-0003-0116-9329	Foundation "De Drie Lichten" in the Netherlands [38/10]	Foundation "De Drie Lichten" in the Netherlands	This project has been supported by the Foundation "De Drie Lichten" in the Netherlands ( project number 38/10). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin JD, 1996, AM J REPROD IMMUNOL, V35, P261; Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Bielanska M, 2002, HUM REPROD, V17, P413, DOI 10.1093/humrep/17.2.413; Carp H, 2001, FERTIL STERIL, V75, P678, DOI 10.1016/S0015-0282(00)01801-X; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gellersen B, 2010, HUM REPROD, V25, P862, DOI 10.1093/humrep/dep468; Gonzalez M, 2011, MOL HUM REPROD, V17, P421, DOI 10.1093/molehr/gar015; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Lakovschek IC, 2011, AM J MED GENET A, V155A, P2626, DOI 10.1002/ajmg.a.34284; Leese HJ, 2007, HUM REPROD, V22, P3047, DOI 10.1093/humrep/dem253; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Musters AM, 2011, FERTIL STERIL, V95, P2153, DOI 10.1016/j.fertnstert.2010.12.022; Picton HM, 2010, MOL HUM REPROD, V16, P557, DOI 10.1093/molehr/gaq040; Popovici RM, 2006, ENDOCRINOLOGY, V147, P5662, DOI 10.1210/en.2006-0916; Quenby S, 2002, HUM REPROD, V17, P1959, DOI 10.1093/humrep/17.8.1959; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Stokes PJ, 2007, HUM REPROD, V22, P829, DOI 10.1093/humrep/del447; Teklenburg G, 2010, MOL HUM REPROD, V16, P886, DOI 10.1093/molehr/gaq079; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304	28	100	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41424	10.1371/journal.pone.0041424	http://dx.doi.org/10.1371/journal.pone.0041424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848492	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306806600066
J	Achanta, S; Kumar, AMV; Nagaraja, SB; Jaju, J; Shamrao, SRM; Uppaluri, R; Tekumalla, RR; Gupta, D; Kumar, A; Satyanarayana, S; Dewan, PK				Achanta, Shanta; Kumar, Ajay M. V.; Nagaraja, Sharath Burugina; Jaju, Jyoti; Shamrao, Srinivas Rao Motta; Uppaluri, Ramakrishna; Tekumalla, Rama Rao; Gupta, Devesh; Kumar, Ashok; Satyanarayana, Srinath; Dewan, Puneet K.			Feasibility and Effectiveness of Provider Initiated HIV Testing and Counseling of TB Suspects in Vizianagaram District, South India	PLOS ONE			English	Article								Background: Though internationally recommended, provider initiated HIV testing and counseling (PITC) of persons suspected of tuberculosis (TB) is not a policy in India; HIV seroprevalence among TB suspects has never been reported. The current policy of PITC for diagnosed TB cases may limit opportunities of early HIV diagnosis and treatment. We determined HIV seroprevalence among persons suspected of TB and assessed feasibility and effectiveness of PITC implementation at this earlier stage in the TB diagnostic pathway. Methods: All adults examined for diagnostic sputum microscopy (TB suspects) in Vizianagaram district (population 2.5 million), in November-December 2010, were offered voluntary HIV counseling and testing (VCT) and assessed for TB diagnosis. Results: Of 2918 eligible TB suspects, 2465(85%) consented to VCT. Among these, 246(10%) were HIV-positive. Of the 246, 84(34%) were newly diagnosed as HIV (HIV status not known previously). To detect a new case of HIV infection, the number needed to screen (NNS) was 26 among 'TB suspects', comparable to that among 'TB patients'. Among suspects aged 25-54 years, not diagnosed as TB, the NNS was 17. Conclusion: The seroprevalence of HIV among 'TB suspects' was as high as that among 'TB patients'. Implementation of PITC among TB suspects was feasible and effective, detecting a large number of new HIV cases with minimal additional workload on staff of HIV testing centre. HIV testing of TB suspects aged 25-54 years demonstrated higher yield for a given effort, and should be considered by policy makers at least in settings with high HIV prevalence.	[Achanta, Shanta; Kumar, Ajay M. V.; Nagaraja, Sharath Burugina; Jaju, Jyoti; Dewan, Puneet K.] Off World Hlth Org WHO Representat India, New Delhi, India; [Kumar, Ajay M. V.; Nagaraja, Sharath Burugina; Gupta, Devesh; Kumar, Ashok] Govt India, Cent TB Div, Directorate Gen Hlth Serv, Minist Hlth & Family Welf, New Delhi, India; [Shamrao, Srinivas Rao Motta] Directorate Hlth Serv, State TB Cell, Hyderabad, Andhra Pradesh, India; [Uppaluri, Ramakrishna] Andhra Pradesh State AIDS Prevent & Control Soc, Directorate Hlth Serv, Hyderabad, Andhra Pradesh, India; [Tekumalla, Rama Rao] Dist TB Ctr, Directorate Hlth Serv, Vizianagaram, Andhra Pradesh, India; [Satyanarayana, Srinath] SE Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India	World Health Organization	Achanta, S (corresponding author), Off World Hlth Org WHO Representat India, New Delhi, India.	AchantaS@rntcp.org	Nagaraja, Sharath Burugina/ABD-7238-2021; Nagaraja, Sharath Burugina/ABD-7748-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Satyanarayana, Srinath/0000-0002-5420-2551; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Union from Global Fund Round 9 India TB Project funds; WHO-India from USAID funds	Union from Global Fund Round 9 India TB Project funds; WHO-India from USAID funds(United States Agency for International Development (USAID)World Health Organization)	Funding support was provided in part by the Union from Global Fund Round 9 India TB Project funds and the rest by WHO-India from USAID funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei A A, 2006, West Afr J Med, V25, P38; Bishnu B, 2011, INT J TUBERC LUNG D, V15, pS214; Central TB Division, 2005, TEHCHN OP GUID TUB C; Central TB Division, 2011, TB IND 2011 REV NAT; Deribew A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018614; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; EpiData Association, EPIDATA ASS EPIDATA; Munthali L, 2006, INT J TUBERC LUNG D, V10, P199; Naik B, 2011, J ACQUIRED IMMUNE DE; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization, 2010, HIV EST IND 2009; National AIDS Control Organization and Central TB Division, 2009, MIN NAT TECHN WORK G; National AIDS Control Organization and Central TB Division, 2009, NAT FRAM JOINT HIV T; National AIDS Control Organization ICMR-National Institute of Medical Statistics, 2018, HIV EST 2017 TECHN R; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; WHO, 2004, INT POL COLL TB HIV; WHO, 2010, GLOB TUB CONTR 2010	19	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41378	10.1371/journal.pone.0041378	http://dx.doi.org/10.1371/journal.pone.0041378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844467	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700078
J	Bersini, H; Klatzmann, D; Six, A; Thomas-Vaslin, V				Bersini, Hugues; Klatzmann, David; Six, Adrien; Thomas-Vaslin, Veronique			State-Transition Diagrams for Biologists	PLOS ONE			English	Article								It is clearly in the tradition of biologists to conceptualize the dynamical evolution of biological systems in terms of state-transitions of biological objects. This paper is mainly concerned with (but obviously not limited too) the immunological branch of biology and shows how the adoption of UML (Unified Modeling Language) state-transition diagrams can ease the modeling, the understanding, the coding, the manipulation or the documentation of population-based immune software model generally defined as a set of ordinary differential equations (ODE), describing the evolution in time of populations of various biological objects. Moreover, that same UML adoption naturally entails a far from negligible representational economy since one graphical item of the diagram might have to be repeated in various places of the mathematical model. First, the main graphical elements of the UML state-transition diagram and how they can be mapped onto a corresponding ODE mathematical model are presented. Then, two already published immune models of thymocyte behavior and time evolution in the thymus, the first one originally conceived as an ODE population-based model whereas the second one as an agent-based one, are refactored and expressed in a state-transition form so as to make them much easier to understand and their respective code easier to access, to modify and run. As an illustrative proof, for any immunologist, it should be possible to understand faithfully enough what the two software models are supposed to reproduce and how they execute with no need to plunge into the Java or Fortran lines.	[Bersini, Hugues] Univ Libre Bruxelles, Brussels, Belgium; [Klatzmann, David; Six, Adrien; Thomas-Vaslin, Veronique] Univ Paris 06, Paris, France	Universite Libre de Bruxelles; UDICE-French Research Universities; Sorbonne Universite	Bersini, H (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	bersini@ulb.ac.be	Thomas-Vaslin, Véronique/I-7726-2019	Thomas-Vaslin, Véronique/0000-0001-7521-8635; Klatzmann, David/0000-0002-0054-3422; Six, Adrien/0000-0001-5898-555X	UniversitA(C) Libre de Bruxelles; Universite Paris 6; Universite Pierre et Marie Curie; Centre National de la Recherche Scientifique	UniversitA(C) Libre de Bruxelles; Universite Paris 6; Universite Pierre et Marie Curie; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	The sources of funding are UniversitA (c) Libre de Bruxelles and Universite Paris 6. This work was supported by Universite Pierre et Marie Curie (Emergence-UPMC programme), and Centre National de la Recherche Scientifique (PHC Tournesol programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bersini H, 2009, LECT NOTES COMPUT SC, V5666, P27, DOI 10.1007/978-3-642-03246-2_8; Bianca C., 2012, INT MATH FORUM, V7, P109; Biancuzzi F., 2009, MASTERMINDS PROGRAMM; Efroni S, 2007, PLOS COMPUT BIOL, V3, P127, DOI 10.1371/journal.pcbi.0030013; Fowler M., 2004, UML DISTILLED BRIEF, Vthird; Freeman E., 2004, HEAD 1 DESIGN PATTER; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Harel D, 2008, ELECTRON NOTES THEOR, V194, P119, DOI 10.1016/j.entcs.2007.12.009; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Janeway C., 2004, IMMUNOBIOLOGY; Larman C., 2004, APPL UML PATTERNS IN; Lavelle C., 2008, THEORETICAL BIOL INS, V1, P13; McEwan C, 2011, P COSMOS ECAL 2011 C; Pappalardo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026523; PENIT C, 1995, J IMMUNOL, V154, P5103; PENIT C, 1988, J IMMUNOL, V140, P3315; Pennisi M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S13; Rong L, 2009, PLOS COMPUTATIONAL B, P5; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Souza-e-Silva H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008233; Swerdlin N, 2008, P IEEE, V96, P1421, DOI 10.1109/JPROC.2008.925435; Thomas-Vaslin V, 2008, J IMMUNOL, V180, P2240, DOI 10.4049/jimmunol.180.4.2240; Wasowski A, 2004, ACM SIGPLAN NOTICES, V39, P257, DOI 10.1145/998300.997200	23	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41165	10.1371/journal.pone.0041165	http://dx.doi.org/10.1371/journal.pone.0041165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844438	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700051
J	Ferro, F; Spelat, R; D'Aurizio, F; Puppato, E; Pandolfi, M; Beltrami, AP; Cesselli, D; Falini, G; Beltrami, CA; Curcio, F				Ferro, Federico; Spelat, Renza; D'Aurizio, Federica; Puppato, Elisa; Pandolfi, Maura; Beltrami, Antonio Paolo; Cesselli, Daniela; Falini, Giuseppe; Beltrami, Carlo Alberto; Curcio, Francesco			Dental Pulp Stem Cells Differentiation Reveals New Insights in Oct4A Dynamics	PLOS ONE			English	Article							PROTEIN-KINASE CK2; IN-VITRO; ADIPOSE-TISSUE; DNA-BINDING; NUCLEAR EXPORT; SELF-RENEWAL; EXPRESSION; PLURIPOTENCY; MOUSE; POPULATION	Although the role played by the core transcription factor network, which includes c-Myc, Klf4, Nanog, and Oct4, in the maintenance of embryonic stem cell (ES) pluripotency and in the reprogramming of adult cells is well established, its persistence and function in adult stem cells are still debated. To verify its persistence and clarify the role played by these molecules in adult stem cell function, we investigated the expression pattern of embryonic and adult stem cell markers in undifferentiated and fully differentiated dental pulp stem cells (DPSC). A particular attention was devoted to the expression pattern and intracellular localization of the stemness-associated isoform A of Oct4 (Oct4A). Our data demonstrate that: Oct4, Nanog, Klf4 and c-Myc are expressed in adult stem cells and, with the exception of c-Myc, they are significantly down-regulated following differentiation. Cell differentiation was also associated with a significant reduction in the fraction of DPSC expressing the stem cell markers CD10, CD29 and CD117. Moreover, a nuclear to cytoplasm shuttling of Oct4A was identified in differentiated cells, which was associated with Oct4A phosphorylation. The present study would highlight the importance of the post-translational modifications in DPSC stemness maintenance, by which stem cells balance self-renewal versus differentiation. Understanding and controlling these mechanisms may be of great importance for stemness maintenance and stem cells clinical use, as well as for cancer research.	[Ferro, Federico; Spelat, Renza; Pandolfi, Maura; Beltrami, Antonio Paolo; Cesselli, Daniela; Beltrami, Carlo Alberto; Curcio, Francesco] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [D'Aurizio, Federica; Curcio, Francesco] Univ Udine, Teaching Hosp, Dept Lab Med, I-33100 Udine, Italy; [Puppato, Elisa; Pandolfi, Maura; Beltrami, Antonio Paolo; Cesselli, Daniela; Beltrami, Carlo Alberto] Regenerat Med Ctr CIME, Udine, Italy; [Falini, Giuseppe] Univ Bologna, Dept Chem G Ciamican, Bologna, Italy	University of Udine; University of Udine; University of Bologna	Ferro, F (corresponding author), Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.	ferro.federico@libero.it	Pandolfi, Margareth/H-7616-2016; Ferro, Federico/GPK-8383-2022; Curcio, Francesco/K-4669-2014; Spelat, Renza/AAZ-2980-2021; Beltrami, Antonio/C-5291-2008; d'aurizio, federica/AAC-7832-2022; CESSELLI, DANIELA/C-7052-2008	Spelat, Renza/0000-0001-5794-8976; Beltrami, Antonio/0000-0002-0679-2710; d'aurizio, federica/0000-0003-2311-859X; Ferro, Federico/0000-0002-6023-8227; CURCIO, Francesco/0000-0002-9070-4807; Cesselli, Daniela/0000-0002-0562-7852	A.S.I. Italian Space Agency	A.S.I. Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This work was supported by A.S.I. Italian Space Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Beltrami AP, 2009, PHARMACOL THERAPEUT, V124, P23, DOI 10.1016/j.pharmthera.2009.06.003; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cohen SL, 1997, ANAL BIOCHEM, V247, P257, DOI 10.1006/abio.1997.2072; CURCIO F, 1994, P NATL ACAD SCI USA, V91, P9004, DOI 10.1073/pnas.91.19.9004; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2000.1391; Ferro F, 2010, TISSUE ENG PT A, V16, P3657, DOI 10.1089/ten.TEA.2009.0750; Ferro F, 2011, AM J PATHOL, V178, P2299, DOI 10.1016/j.ajpath.2011.01.055; Gallagher MF, 2009, J OVARIAN RES, V16, P2; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gonzalez R, 2007, BIOCHEM BIOPH RES CO, V362, P491, DOI 10.1016/j.bbrc.2007.08.033; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hu B, 2005, ARCH ORAL BIOL, V50, P131, DOI 10.1016/j.archoralbio.2004.09.007; Huang AHC, 2008, J ORAL PATHOL MED, V37, P571, DOI 10.1111/j.1600-0714.2008.00654.x; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Leor J, 1996, CIRCULATION, V94, P332; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Matoba R, 2006, PLOS ONE, V20, P1; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400; Panasyuk G, 2006, J BIOL CHEM, V281, P31188, DOI 10.1074/jbc.M602618200; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; PRUITT SC, 1994, DEVELOPMENT, V120, P37; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Scaggiante B, 1998, EUR J BIOCHEM, V252, P207, DOI 10.1046/j.1432-1327.1998.2520207.x; Sengupta R, 2009, FEBS LETT, V583, P3525, DOI 10.1016/j.febslet.2009.10.016; Seybold J, 2005, BLOOD, V105, P3569, DOI 10.1182/blood-2004-07-2729; Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3; Soen Y, 2005, MOL SYST BIOL, V2, P1; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Tweddle DA, 2001, CANCER RES, V61, P8; von Knethen A, 2010, J CELL SCI, V123, P192, DOI 10.1242/jcs.055475; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wernig M, 2007, CELL STEM CELL, V2, P2; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young HE, 2004, CELL BIOCHEM BIOPHYS, V40, P1, DOI 10.1385/CBB:40:1:1; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	67	38	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41774	10.1371/journal.pone.0041774	http://dx.doi.org/10.1371/journal.pone.0041774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844522	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700149
J	Gueroult, M; Boittin, O; Mauffret, O; Etchebest, C; Hartmann, B				Gueroult, Marc; Boittin, Olivier; Mauffret, Oliver; Etchebest, Catherine; Hartmann, Brigitte			Mg2+ in the Major Groove Modulates B-DNA Structure and Dynamics	PLOS ONE			English	Article							T-C-G; METAL-ION BINDING; MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; CRYSTAL-STRUCTURES; ATOMIC-RESOLUTION; CATION INTERACTIONS; NUCLEOSOME CORE; MINOR GROOVES; FORCE-FIELD	This study investigates the effect of Mg2+ bound to the DNA major groove on DNA structure and dynamics. The analysis of a comprehensive dataset of B-DNA crystallographic structures shows that divalent cations are preferentially located in the DNA major groove where they interact with successive bases of (A/G)pG and the phosphate group of 5'-CpA or TpG. Based on this knowledge, molecular dynamics simulations were carried out on a DNA oligomer without or with Mg2+ close to an ApG step. These simulations showed that the hydrated Mg2+ forms a stable intra-strand cross-link between the two purines in solution. ApG generates an electrostatic potential in the major groove that is particularly attractive for cations; its intrinsic conformation is well-adapted to the formation of water-mediated hydrogen bonds with Mg2+. The binding of Mg2+ modulates the behavior of the 5'-neighboring step by increasing the BII (epsilon-zeta > 0 degrees) population of its phosphate group. Additional electrostatic interactions between the 5'-phosphate group and Mg2+ strengthen both the DNA-cation binding and the BII character of the 5'-step. Cation binding in the major groove may therefore locally influence the DNA conformational landscape, suggesting a possible avenue for better understanding how strong DNA distortions can be stabilized in protein-DNA complexes.	[Gueroult, Marc; Boittin, Olivier; Etchebest, Catherine; Hartmann, Brigitte] Univ Paris Diderot, INSERM, Inst Natl Transfus Sanguine, UMR 665, Paris, France; [Gueroult, Marc] CNRS, Inst Biol Phys Chim, Lab Biochim Theor, UPR 9080, Paris, France; [Mauffret, Oliver; Hartmann, Brigitte] CNRS ENS Cachan, Lab Biol & Pharmacol Appl, UMR 8113, Cachan, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Gueroult, M (corresponding author), Univ Paris Diderot, INSERM, Inst Natl Transfus Sanguine, UMR 665, Paris, France.	bhartman@ens-cachan.fr	etchebest, catherine/O-2485-2019	etchebest, catherine/0000-0002-5871-2372; Gueroult, Marc/0000-0003-1036-7490	Institut National de la Transfusion Sanguine, 6 rue Alexandre Cabanel, Paris, France	Institut National de la Transfusion Sanguine, 6 rue Alexandre Cabanel, Paris, France	Funding was provided by the Institut National de la Transfusion Sanguine, 6 rue Alexandre Cabanel, 75015 Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Ghanem J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1061; Abrescia NGA, 1999, NUCLEIC ACIDS RES, V27, P1593, DOI 10.1093/nar/27.7.1593; Ahmad R, 2003, BIOPHYS J, V84, P2460, DOI 10.1016/S0006-3495(03)75050-4; Auffinger P, 2000, J MOL BIOL, V300, P1113, DOI 10.1006/jmbi.2000.3894; Auffinger P, 2011, METAL IONS LIFE SCI, V9, P1, DOI 10.1039/978184973251200001; Bai Y, 2007, J AM CHEM SOC, V129, P14981, DOI 10.1021/ja075020g; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRUKNER I, 1994, J MOL BIOL, V236, P26, DOI 10.1006/jmbi.1994.1115; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chiu TK, 2000, J MOL BIOL, V301, P915, DOI 10.1006/jmbi.2000.4012; Chiu TK, 1999, J MOL BIOL, V292, P589, DOI 10.1006/jmbi.1999.3075; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; Djuranovic D, 2004, BIOPOLYMERS, V73, P356, DOI 10.1002/bip.10528; Djuranovic D, 2003, J BIOMOL STRUCT DYN, V20, P771, DOI 10.1080/07391102.2003.10506894; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Egli M, 2002, CHEM BIOL, V9, P277, DOI 10.1016/S1074-5521(02)00116-3; Froystein N, 1993, ACTA CHEM SCAND, V47, P49; FROYSTEIN NA, 1991, ACTA CHEM SCAND, V45, P219, DOI 10.3891/acta.chem.scand.45-0219; GRZESKOWIAK K, 1991, J BIOL CHEM, V266, P8861; GRZESKOWIAK K, 1993, BIOCHEMISTRY-US, V32, P8923, DOI 10.1021/bi00085a025; Han WH, 1997, P NATL ACAD SCI USA, V94, P10565, DOI 10.1073/pnas.94.20.10565; HARTMANN B, 1993, NUCLEIC ACIDS RES, V21, P561, DOI 10.1093/nar/21.3.561; Heddi B, 2008, J MOL BIOL, V382, P956, DOI 10.1016/j.jmb.2008.07.047; Heddi B, 2007, J MOL BIOL, V368, P1403, DOI 10.1016/j.jmb.2007.03.010; Heddi B, 2006, J AM CHEM SOC, V128, P9170, DOI 10.1021/ja061686j; Heddi B, 2010, NUCLEIC ACIDS RES, V38, P1034, DOI 10.1093/nar/gkp962; Hud NV, 1999, J MOL BIOL, V285, P233, DOI 10.1006/jmbi.1998.2327; Hud NV, 1999, J MOL BIOL, V286, P651, DOI 10.1006/jmbi.1998.2513; Hud NV, 2001, CURR OPIN STRUC BIOL, V11, P293, DOI 10.1016/S0959-440X(00)00205-0; Jerkovic B, 2001, BIOCHEMISTRY-US, V40, P9406, DOI 10.1021/bi010853j; Joli F, 2006, NUCLEIC ACIDS RES, V34, P5740, DOI 10.1093/nar/gkl617; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kielkopf CL, 2000, J MOL BIOL, V296, P787, DOI 10.1006/jmbi.1999.3478; Lankas F, 2010, NUCLEIC ACIDS RES, V38, P3414, DOI 10.1093/nar/gkq001; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Liu J, 1999, J BIOL CHEM, V274, P24749, DOI 10.1074/jbc.274.35.24749; Mack DR, 2001, J MOL BIOL, V312, P1037, DOI 10.1006/jmbi.2001.4994; Millonig H, 2009, J INORG BIOCHEM, V103, P876, DOI 10.1016/j.jinorgbio.2009.03.004; Minasov G, 1999, J MOL BIOL, V291, P83, DOI 10.1006/jmbi.1999.2934; Moldrheim E, 1998, INORG CHIM ACTA, V273, P41, DOI 10.1016/S0020-1693(97)06010-6; Oguey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015931; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Ponomarev SY, 2004, P NATL ACAD SCI USA, V101, P14771, DOI 10.1073/pnas.0406435101; PULLMAN A, 1981, Q REV BIOPHYS, V14, P289, DOI 10.1017/S0033583500002341; QUINTANA JR, 1992, J MOL BIOL, V225, P379, DOI 10.1016/0022-2836(92)90928-D; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Soler-Lopez M, 2000, J BIOL CHEM, V275, P23034, DOI 10.1074/jbc.M002119200; Srinivasan A R, 2009, Biophys Rev, V1, P13, DOI 10.1007/s12551-008-0003-2; STEINKOPF S, 1994, ACTA CHEM SCAND, V48, P388, DOI 10.3891/acta.chem.scand.48-0388; Subirana JA, 2003, ANNU REV BIOPH BIOM, V32, P27, DOI 10.1146/annurev.biophys.32.110601.141726; Tereshko V, 1999, J AM CHEM SOC, V121, P470, DOI 10.1021/ja9832919; van Dam L, 2000, J MOL BIOL, V304, P541, DOI 10.1006/jmbi.2000.4194; Varnai P, 2004, NUCLEIC ACIDS RES, V32, P4269, DOI 10.1093/nar/gkh765; Varnai P, 2010, NUCLEIC ACIDS RES, V38, P4163, DOI 10.1093/nar/gkq150; Winger RH, 1999, J BIOMOL STRUCT DYN, V17, P223, DOI 10.1080/07391102.1999.10508355; Wu B, 2010, J MOL BIOL, V398, P633, DOI 10.1016/j.jmb.2010.03.038; Young MA, 1998, J MOL BIOL, V281, P675, DOI 10.1006/jmbi.1998.1962	62	30	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41704	10.1371/journal.pone.0041704	http://dx.doi.org/10.1371/journal.pone.0041704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844516	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700142
J	Ignatowicz, L; Mazurek, J; Leepiyasakulchai, C; Skold, M; Hinkula, J; Kallenius, G; Pawlowski, A				Ignatowicz, Lech; Mazurek, Jolanta; Leepiyasakulchai, Chaniya; Skold, Markus; Hinkula, Jorma; Kallenius, Gunilla; Pawlowski, Andrzej			Mycobacterium tuberculosis Infection Interferes with HIV Vaccination in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNE-RESPONSES; HETEROLOGOUS INFECTIONS; NIGERIAN CHILDREN; MUTATION-RATE; MUCOSAL; MALARIA; DNA; SUPPRESSION; VACCINES	Tuberculosis (TB) has emerged as the most prominent bacterial disease found in human immunodeficiency virus (HIV)-positive individuals worldwide. Due to high prevalence of asymptomatic Mycobacterium tuberculosis (Mtb) infections, the future HIV vaccine in areas highly endemic for TB will often be administrated to individuals with an ongoing Mtb infection. The impact of concurrent Mtb infection on the immunogenicity of a HIV vaccine candidate, MultiHIV DNA/protein, was investigated in mice. We found that, depending on the vaccination route, mice infected with Mtb before the administration of the HIV vaccine showed impairment in both the magnitude and the quality of antibody and T cell responses to the vaccine components p24Gag and gp160Env. Mice infected with Mtb prior to intranasal HIV vaccination exhibited reduced p24Gag-specific serum IgG and IgA, and suppressed gp160Env-specific serum IgG as compared to respective titers in uninfected HIV-vaccinated controls. Importantly, in Mtb-infected mice that were HIV-vaccinated by the intramuscular route the virus neutralizing activity in serum was significantly decreased, relative to uninfected counterparts. In addition mice concurrently infected with Mtb had fewer p24Gag-specific IFN-gamma-expressing T cells and multifunctional T cells in their spleens. These results suggest that Mtb infection might interfere with the outcome of prospective HIV vaccination in humans.	[Ignatowicz, Lech; Mazurek, Jolanta; Leepiyasakulchai, Chaniya; Skold, Markus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hinkula, Jorma] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Kallenius, Gunilla; Pawlowski, Andrzej] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Linkoping University; Karolinska Institutet	Ignatowicz, L (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	andrzej.pawlowski@ki.se	Hinkula, Jorma/P-6849-2018; Källenius, Gunilla/AGZ-3956-2022	Mazurek, Jolanta/0000-0001-5023-0398; Hinkula, Jorma/0000-0003-1908-5609; Pawlowski, Andrzej/0000-0003-4555-6048	European Commission [MEST-CT-2005-020872]; Swedish Research Council [K2007-58X-13027, K2007-57X-20360-01-4]; Swedish International Development Agency; Royal Thai Government	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Agency; Royal Thai Government	This work was supported by the European Commission grant MEST-CT-2005-020872 (http://ec.europa.eu/research/mariecurieactions/) to JM, LI and AP, the Swedish Research Council grant No. K2007-58X-13027 (http://www.vr.se/) to GK, the Swedish International Development Agency (SIDA/Sarec; http://www.sida.se/) grant to JH, a scholarship from the Royal Thai Government to CL and by the Swedish Research Council grant No. K2007-57X-20360-01-4 (http://www.vr.se/) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura Y, 1999, BIOL CHEM, V380, P375, DOI 10.1515/BC.1999.049; Balmelli C, 2002, J VIROL, V76, P12596, DOI 10.1128/JVI.76.24.12596-12602.2002; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Belyakov IM, 2012, CURR TOP MICROBIOL, V354, P157, DOI 10.1007/82_2010_119; BRADLEYMOORE AM, 1985, ANN TROP MED PARASIT, V79, P563, DOI 10.1080/00034983.1985.11811963; Brave A, 2008, VACCINE, V26, P5957, DOI 10.1016/j.vaccine.2008.08.060; Burgers WA, 2009, J GEN VIROL, V90, P468, DOI 10.1099/vir.0.004614-0; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Cingolani A, 2012, CLIN INFECT DIS, V54, P853, DOI 10.1093/cid/cir900; Cooper PJ, 2001, INFECT IMMUN, V69, P1574, DOI 10.1128/IAI.69.3.1574-1580.2001; CUNNINGHAM J, 2006, DIAGNOSTICS TUBERCUL; Cunnington AJ, 2010, EXPERT REV VACCINES, V9, P409, DOI [10.1586/erv.10.16, 10.1586/ERV.10.16]; Dauby N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000571; Devito C, 2004, J IMMUNOL, V173, P7078, DOI 10.4049/jimmunol.173.11.7078; Devito C, 2000, J IMMUNOL METHODS, V238, P69, DOI 10.1016/S0022-1759(00)00141-1; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; DUBOS R, 1957, J EXP MED, V106, P703, DOI 10.1084/jem.106.5.703; Elias D, 2005, CLIN EXP IMMUNOL, V139, P398, DOI 10.1111/j.1365-2249.2004.02719.x; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Gizurarson S, 1998, J PHARM SCI, V87; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P340, DOI 10.1016/0035-9203(80)90095-4; Hamasur B, 2003, VACCINE, V21, P4081, DOI 10.1016/S0264-410X(03)00274-3; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Haynes BF, 2010, CURR OPIN HIV AIDS, V5, P362, DOI 10.1097/COH.0b013e32833d2e90; Hinkula J, 2006, VACCINE, V24, P4494, DOI 10.1016/j.vaccine.2005.08.015; Hu GZ, 2010, CELL MOL IMMUNOL, V7, P414, DOI 10.1038/cmi.2010.39; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Leepiyasakulchai C, 2012, INFECT IMMUN, V80, P1128, DOI 10.1128/IAI.05552-11; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lundholm P, 1999, VACCINE, V17, P2036, DOI 10.1016/S0264-410X(98)00404-6; Marin ND, 2010, TUBERCULOSIS, V90, P252, DOI 10.1016/j.tube.2010.05.003; Masopust D, 2009, J INTERN MED, V265, P125, DOI 10.1111/j.1365-2796.2008.02054.x; McGREGOR IAN A., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P364, DOI 10.1016/0035-9203(62)90005-6; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Nookala S, 2004, INFECT IMMUN, V72, P2598, DOI 10.1128/IAI.72.5.2598-2604.2004; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Perrin H, 2010, CURR OPIN HIV AIDS, V5, P368, DOI 10.1097/COH.0b013e32833d2cc0; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Sartono E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010328; SCHAEDLER RW, 1957, J EXP MED, V106, P719, DOI 10.1084/jem.106.5.719; Sherman DR, 2011, NAT GENET, V43, P400, DOI 10.1038/ng.815; Slifka MK, 2003, J CLIN INVEST, V111, P805, DOI 10.1172/JCI200313603; Subbramanian RA, 2002, J CLIN MICROBIOL, V40, P2141, DOI 10.1128/JCM.40.6.2141-2146.2002; Talbot HK, 2012, HUM VACCIN IMMUNOTHE, V8; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Tomaras GD, 2010, CURR OPIN HIV AIDS, V5, P421, DOI 10.1097/COH.0b013e32833d2d45; *UNAIDS, AIDS EP UPD NOV 2009; Urban JF, 2007, VET PARASITOL, V148, P14, DOI 10.1016/j.vetpar.2007.05.006; Usen S, 2000, PEDIATR INFECT DIS J, V19, P444, DOI 10.1097/00006454-200005000-00010; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; WHITTLE HC, 1973, ARCH DIS CHILD, V48, P753, DOI 10.1136/adc.48.10.753; WILLIAMSON WA, 1978, LANCET, V1, P1328; World Health Organization, 2009, GLOB TUB CONTR SHORT, pvi	67	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41205	10.1371/journal.pone.0041205	http://dx.doi.org/10.1371/journal.pone.0041205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22848444	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700053
J	Shimizu, K; Kawakami, S; Hayashi, K; Kinoshita, H; Kuwahara, K; Nakao, K; Hashida, M; Konishi, S				Shimizu, Kazunori; Kawakami, Shigeru; Hayashi, Kouji; Kinoshita, Hideyuki; Kuwahara, Koichiro; Nakao, Kazuwa; Hashida, Mitsuru; Konishi, Satoshi			In vivo Site-Specific Transfection of Naked Plasmid DNA and siRNAs in Mice by Using a Tissue Suction Device	PLOS ONE			English	Article							PRESSURE-MEDIATED TRANSFECTION; GENE DELIVERY; LIVER; INJECTION; EXPRESSION; THERAPY; PIG	We have developed an in vivo transfection method for naked plasmid DNA (pDNA) and siRNA in mice by using a tissue suction device. The target tissue was suctioned by a device made of polydimethylsiloxane (PDMS) following the intravenous injection of naked pDNA or siRNA. Transfection of pDNA encoding luciferase was achieved by the suction of the kidney, liver, spleen, and heart, but not the duodenum, skeletal muscle, or stomach. Luciferase expression was specifically observed at the suctioned region of the tissue, and the highest luciferase expression was detected at the surface of the tissue (0.12 +/- 0.03 ng/mg protein in mice liver). Luciferase expression levels in the whole liver increased linearly with an increase in the number of times the liver was suctioned. Transfection of siRNA targeting glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene significantly suppressed the expression of GAPDH mRNA in the liver. Histological analysis shows that severe damage was not observed in the suctioned livers. Since the suction device can be mounted onto the head of the endoscope, this method is a minimally invasive. These results indicate that the in vivo transfection method developed in this study will be a viable approach for biological research and therapies using nucleic acids.	[Shimizu, Kazunori; Hashida, Mitsuru; Konishi, Satoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Inst Innovat NanoBio Drug Discovery & Dev, Kyoto, Japan; [Shimizu, Kazunori; Konishi, Satoshi] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Kusatsu, Shiga, Japan; [Kawakami, Shigeru; Hayashi, Kouji; Hashida, Mitsuru] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Kyoto, Japan; [Kinoshita, Hideyuki; Kuwahara, Koichiro; Nakao, Kazuwa] Kyoto Univ Grad, Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Hashida, Mitsuru] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Konishi, Satoshi] Ritsumeikan Univ, Dept Micro Syst Technol, Kusatsu, Shiga, Japan	Kyoto University; Ritsumeikan University; Kyoto University; Kyoto University; Kyoto University; Ritsumeikan University	Shimizu, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Inst Innovat NanoBio Drug Discovery & Dev, Kyoto, Japan.	kshimizu@pharm.kyoto-u.ac.jp; konishi@se.ritsumei.ac.jp	Kuwahara, Koichiro/AFK-1723-2022; Shimizu, Kazunori/B-7553-2008; Kawakami, Shigeru/R-1460-2019	Kuwahara, Koichiro/0000-0003-2670-7170; Shimizu, Kazunori/0000-0002-9713-7016; hashida, mitsuru/0000-0001-7383-8080	Japan Science and Technology Agency [AS221Z01400F]; Showa Hokokai Foundation; Ritsumeikan University; Grants-in-Aid for Scientific Research [24591095, 21229013] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Showa Hokokai Foundation; Ritsumeikan University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (AS221Z01400F), Ritsumeikan Global Innovation Research Organisation project in Ritsumeikan University, and Showa Hokokai Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alino SF, 2010, J GENE MED, V12, P920, DOI 10.1002/jgm.1510; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ayuni EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014467; Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Kawakami S, 2000, PHARMACEUT RES, V17, P306, DOI 10.1023/A:1007501122611; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim A, 2004, BIOMATERIALS, V25, P305, DOI 10.1016/S0142-9612(03)00534-9; Kwon SM, 2008, J CONTROL RELEASE, V128, P89, DOI 10.1016/j.jconrel.2008.02.004; Lin CM, 2012, ARCH DERMATOL RES, V304, P139, DOI 10.1007/s00403-011-1181-5; Liu F, 2004, MOL THER, V9, P452, DOI 10.1016/j.ymthe.2003.12.003; Liu F, 2002, HEPATOLOGY, V35, P1314, DOI 10.1053/jhep.2002.33467; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Marshall WG, 2010, GENE THER, V17, P419, DOI 10.1038/gt.2009.153; Miao CH, 2001, MOL THER, V3, P947, DOI 10.1006/mthe.2001.0333; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; Mukai H, 2008, BIOCHEM BIOPH RES CO, V372, P383, DOI 10.1016/j.bbrc.2008.04.097; Mukai H, 2010, BIOL PHARM BULL, V33, P1627, DOI 10.1248/bpb.33.1627; Mukai H, 2009, HUM GENE THER, V20, P1157, DOI 10.1089/hum.2008.213; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Rastogi S, 2011, AM J PHYSIOL-HEART C, V300, pH1501, DOI 10.1152/ajpheart.00636.2010; Shimizu K, 2012, J CONTROL RELEASE, V159, P85, DOI 10.1016/j.jconrel.2011.12.033; Shimizu K, 2011, J BIOSCI BIOENG, V112, P508, DOI 10.1016/j.jbiosc.2011.07.015; Takemoto H, 2010, BIOMATERIALS, V31, P8097, DOI 10.1016/j.biomaterials.2010.07.015; Tani, 2009, J JAPAN SOC COMPUTER, V11, P59, DOI DOI 10.5759/JSCAS.11.59; Un K, 2010, HUM GENE THER, V21, P65, DOI 10.1089/hum.2009.106	27	20	20	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41319	10.1371/journal.pone.0041319	http://dx.doi.org/10.1371/journal.pone.0041319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844458	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700070
J	Wu, XY; Ellmann, S; Rubin, E; Gil, M; Jin, K; Han, LF; Chen, HX; Kwon, EM; Guo, JH; Ha, HC; Sukumar, S				Wu, Xinyan; Ellmann, Stephan; Rubin, Ethel; Gil, Minchan; Jin, Kideok; Han, Liangfeng; Chen, Hexin; Kwon, Erika M.; Guo, Jianhui; Ha, Hyo Chol; Sukumar, Saraswati			ADP Ribosylation by PARP-1 Suppresses HOXB7 Transcriptional Activity	PLOS ONE			English	Article							HOMEODOMAIN-CONTAINING PROTEIN; COOPERATIVE DNA-BINDING; POLY(ADP-RIBOSE) POLYMERASE; GENE-EXPRESSION; BREAST-CANCER; B-MYB; IDENTIFICATION; CELLS; COACTIVATOR; ACTIVATION	Interactions with cofactors regulate transcriptional activity and also help HOX proteins to achieve the specificity required for transcriptional regulation of target genes. In this study, we describe a novel protein/protein interaction of HOXB7 with poly (ADP-ribose) polymerase-1 (PARP-1) that involves the homeodomain of HOXB7 and the first zinc finger domain of PARP-1. Upon binding to PARP-1, HOXB7 undergoes poly(ADP-ribosyl)altion resulting in a reduction of its transcriptional activity. Since aspartic acid and glutamic acid residues are acceptors of the ADP ribose moiety transferred by PARP-1, deletion of the evolutionarily conserved C-terminal Glu-rich tail of HOXB7 dramatically attenuates ADP-ribosylation of HOXB7 by PARP-1. Further, a mutant of HOXB7 without the Glu-rich tail loses the ability to be negatively regulated by PARP-1 and becomes transcriptionally more active in luciferase reporter assays. Since the homeodomain is highly conserved among HOX proteins, five other HOX proteins were tested. All six showed interaction with, and were poly(ADP-ribosyl)ated by PARP-1. However, among them, this modification altered the DNA binding activity of only HOXA7 and HOXB7. In summary, this study identifies a new interacting partner of HOX proteins. More importantly, this study reveals a novel mechanism whereby polyADP-ribosylation regulates transcriptional activities of HOX proteins such as HOXB7 and HOXA7.	[Wu, Xinyan; Ellmann, Stephan; Rubin, Ethel; Jin, Kideok; Han, Liangfeng; Chen, Hexin; Kwon, Erika M.; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Gil, Minchan; Guo, Jianhui; Ha, Hyo Chol] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA	Johns Hopkins University; Georgetown University	Wu, XY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	xinyan@jhmi.edu; saras@jhmi.edu	Gil, Minchan/R-1280-2019; chen, hexin/F-1714-2011; Guo, Jianhui/AAJ-6220-2020; Ellmann, Stephan/P-3824-2016	Ellmann, Stephan/0000-0003-2737-5526	Breast Cancer SPORE: NIH [P50CA88843, DOD-COE W81XWH-04-1-0595]; NIH [AI64706, ES015210];  [DOD-DAMD-17-02-1-0429]; NATIONAL CANCER INSTITUTE [P50CA088843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015210] Funding Source: NIH RePORTER	Breast Cancer SPORE: NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for this work was provided by DOD-DAMD-17-02-1-0429 postdoctoral fellowship (X.W.), the Breast Cancer SPORE: NIH P50CA88843 and DOD-COE W81XWH-04-1-0595 (S.S.), NIH AI64706 and ES015210 (H.C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chariot A, 1999, ONCOGENE, V18, P4007, DOI 10.1038/sj.onc.1202776; Chariot A, 1999, J BIOL CHEM, V274, P5318, DOI 10.1074/jbc.274.9.5318; Chen HX, 2005, J BIOL CHEM, V280, P19373, DOI 10.1074/jbc.M413528200; Chen HX, 2003, CANCER BIOL THER, V2, P524, DOI 10.4161/cbt.2.5.525; Chen HX, 2004, MOL CELL BIOL, V24, P924, DOI 10.1128/MCB.24.2.924-935.2004; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Elser M, 2008, MOL CANCER RES, V6, P282, DOI 10.1158/1541-7786.MCR-07-0377; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Iwasaki M, 2005, BLOOD, V105, P784, DOI 10.1182/blood-2004-04-1508; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; Li XL, 2006, EXP CELL RES, V312, P854, DOI 10.1016/j.yexcr.2005.12.002; Li YM, 2006, MOL CELL ENDOCRINOL, V257-8, P35, DOI 10.1016/j.mce.2006.06.008; Lu QA, 1997, ONCOGENE, V14, P75, DOI 10.1038/sj.onc.1200799; LU QA, 1995, MOL CELL BIOL, V15, P3786; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Santilli G, 2001, ONCOGENE, V20, P8167, DOI 10.1038/sj.onc.1204943; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yaron Y, 2001, J IMMUNOL, V166, P5058, DOI 10.4049/jimmunol.166.8.5058; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200	45	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40644	10.1371/journal.pone.0040644	http://dx.doi.org/10.1371/journal.pone.0040644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844406	Green Published, gold			2022-12-27	WOS:000306687700015
J	Clawson, GA; Kimchi, E; Patrick, SD; Xin, P; Harouaka, R; Zheng, SY; Berg, A; Schell, T; Staveley-O'Carroll, KF; Neves, RI; Mosca, PJ; Thiboutot, D				Clawson, Gary A.; Kimchi, Eric; Patrick, Susan D.; Xin, Ping; Harouaka, Ramdane; Zheng, Siyang; Berg, Arthur; Schell, Todd; Staveley-O'Carroll, Kevin F.; Neves, Rogerio I.; Mosca, Paul J.; Thiboutot, Diane			Circulating Tumor Cells in Melanoma Patients	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; POLYMERASE CHAIN-REACTION; MESSENGER-RNA; MOLECULAR-DETECTION; MALIGNANT-MELANOMA; PROGNOSTIC VALUE; FUSION HYBRIDS; BREAST; EXPRESSION; MARKER	Circulating tumor cells (CTCs) are of recognized importance for diagnosis and prognosis of cancer patients. With melanoma, most studies do not show any clear relationship between CTC levels and stage of disease. Here, CTCs were enriched (similar to 400X) from blood of melanoma patients using a simple centrifugation device (OncoQuick), and 4 melanocyte target RNAs (TYR, MLANA, MITF, and MIF) were quantified using QPCR. Approximately one-third of melanoma patients had elevated MIF and MLANA transcripts (p<0.0001 and p<0.001, respectively) compared with healthy controls. In contrast, healthy controls had uniformly higher levels of TYR and MITF than melanoma patients (p<0.0001). There was a marked shift of leukocytes into the CTC-enriched fractions (a 430% increase in RNA recovery, p<0.001), and no relationship between CTC levels and stage of disease was found. CTCs were captured on microfabricated filters and cultured. Captured melanoma CTCs were large cells, and consisted of 2 subpopulations, based on immunoreactivity. One subpopulation (similar to 50%) stained for both pan-cytokeratin (KRT) markers and the common leukocyte marker CD-45, whereas the second subpopulation stained for only KRT. Since similar cells are described in many cancers, we also examined blood from colorectal and pancreatic cancer patients. We observed analogous results, with most captured CTCs staining for both CD-45/KRT markers (and for the monocyte differentiation marker CD-14). Our results suggest that immature melanocyte-related cells (expressing TYR and MITF RNA) may circulate in healthy controls, although they are not readily detectable without considerable enrichment. Further, as early-stage melanomas develop, immature melanocyte migration into the blood is somehow curtailed, whereas a significant proportion of patients develop elevated CTC levels (based on MIF and MLANA RNAs). The nature of the captured CTCs is consistent with literature describing leukocyte/macrophage-tumor cell fusion hybrids, and their role in metastatic progression.	[Clawson, Gary A.; Patrick, Susan D.; Xin, Ping] Penn State Univ, Gittlen Canc Res Fdn, Hershey, PA USA; [Clawson, Gary A.; Patrick, Susan D.; Xin, Ping] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA; [Clawson, Gary A.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Kimchi, Eric; Staveley-O'Carroll, Kevin F.] Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Hershey, PA 17033 USA; [Harouaka, Ramdane; Zheng, Siyang] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA; [Berg, Arthur] Penn State Univ, Milton S Hershey Med Ctr, Div Biostat, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Schell, Todd] Penn State Univ, Milton S Hershey Med Ctr, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Neves, Rogerio I.] Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Div Plast Surg, Hershey, PA 17033 USA; [Mosca, Paul J.] Duke Univ, Dept Surg, Durham, NC USA; [Thiboutot, Diane] Penn State Univ, Milton S Hershey Med Ctr, Dept Dermatol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Clawson, GA (corresponding author), Penn State Univ, Gittlen Canc Res Fdn, Hershey, PA USA.	Gac4@psu.edu	Zheng, Si-Yang/N-5826-2016; Zheng, sy/GRS-3136-2022; Neves, Rogerio Izar/AAV-5842-2020; Schell, Todd/AAC-7261-2021	Zheng, Si-Yang/0000-0002-0616-030X; Neves, Rogerio Izar/0000-0003-4866-5215; Berg, Arthur/0000-0002-4097-7348; Schell, Todd/0000-0002-6788-6518; Harouaka, Ramdane/0000-0002-1425-3960	National Institutes of Health/National Cancer Institute [CA137595]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R21CA137595] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded in part by National Institutes of Health/National Cancer Institute (www.nih.gov) grant CA137595 and with funds from the Pennsylvania Department of Health (www.health.state.pa.us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chakraborty AK, 2000, CANCER RES, V60, P2512; Chen N, 2009, MELANOMA RES, V19, P87, DOI 10.1097/CMR.0b013e3283252feb; Curry BJ, 1999, J CLIN ONCOL, V17, P2562, DOI 10.1200/JCO.1999.17.8.2562; Danila DC, 2011, CLIN CANCER RES, V17, P3903, DOI 10.1158/1078-0432.CCR-10-2650; De Giorgi V, 2010, J INVEST DERMATOL, V130, P2440, DOI 10.1038/jid.2010.141; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Erin N, 2009, INT J CANCER, V124, P1503, DOI 10.1002/ijc.24131; Fusi A, 2010, BR J DERMATOL; Garbe C, 2003, CANCER-AM CANCER SOC, V97, P1737, DOI 10.1002/cncr.11250; GATTER KC, 1985, J CLIN PATHOL, V38, P1353, DOI 10.1136/jcp.38.12.1353; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Ireland A, 2011, CLIN EXP METASTAS, V28, P327, DOI 10.1007/s10585-010-9368-2; Itakura E, 2011, AM J SURG PATHOL, V35, P1657, DOI 10.1097/PAS.0b013e3182322cf7; Kitago M, 2009, CLIN CHEM, V55, P757, DOI 10.1373/clinchem.2008.116467; Klingenstein A, 2011, MELANOMA RES, V21, P352, DOI 10.1097/CMR.0b013e328347105e; Kluk MJ, 2004, AM J DERMATOPATH, V26, P504, DOI 10.1097/00000372-200412000-00011; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Koyanagi K, 2005, J CLIN ONCOL, V23, P8057, DOI 10.1200/JCO.2005.02.0958; Lagoudianakis EE, 2009, J SURG RES, V155, P183, DOI 10.1016/j.jss.2007.10.013; Lee H, 2008, AM J CLIN PATHOL, V129, P772, DOI 10.1309/GFCLLRH8A68XKMJN; Lee J, 2010, AFR J BIOTECHNOL, V9, P5975; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Lu B, 2009, P 13 INT C MIN SYST, V13, P588; Lugini L, 2003, LAB INVEST, V83, P1555, DOI 10.1097/01.LAB.0000098425.03006.42; Mocellin S, 2004, INT J CANCER, V111, P741, DOI 10.1002/ijc.20347; Mocellin S, 2006, CLIN CANCER RES, V12, P4605, DOI 10.1158/1078-0432.CCR-06-0823; Obermayr E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-666; Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182; Pan WH, 2004, MOL THER, V9, P596, DOI 10.1016/j.ymthe.2003.12.013; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Pawelek JM, 2000, MELANOMA RES, V10, P507, DOI 10.1097/00008390-200012000-00001; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Pinzani P, 2011, CLIN CHIM ACTA, V412, P2141, DOI 10.1016/j.cca.2011.07.027; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rupani R, 2004, PIGM CELL RES, V17, P281, DOI 10.1111/j.1600-0749.2004.00148.x; Sable MS, 2011, INT J PROTEOMICS, V2011; Samija I, 2010, MELANOMA RES, V20, P293, DOI 10.1097/CMR.0b013e32833906b6; Sing T, 2009, ROCR VISUALIZING PER; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025224; Sioss JA, 2012, NANOMED-NANOTECHNOL, V8, P1017, DOI 10.1016/j.nano.2011.11.009; Sodi SA, 1998, PIGM CELL RES, V11, P299, DOI 10.1111/j.1600-0749.1998.tb00739.x; Steen S, 2008, P BAYL U MED CENT, V21, P127; Team R. D. C, 2011, R LANG ENV STAT COMP; Tsao H, 2001, ARCH DERMATOL, V137, P325; Xi L, 2007, CLIN CHEM, V53, P1206, DOI 10.1373/clinchem.2006.081828; Yang LY, 2009, BIOTECHNOL BIOENG, V102, P521, DOI 10.1002/bit.22066; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135; Yasasever V, 2007, CANCER INVEST, V25, P715, DOI 10.1080/07357900701560695	53	60	61	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41052	10.1371/journal.pone.0041052	http://dx.doi.org/10.1371/journal.pone.0041052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829910	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300048
J	Guo, LJ; Fu, YJ; Wang, YP; Lu, YH; Wei, YW; Tang, QH; Fan, PH; Liu, JB; Zhang, L; Zhang, FY; Huang, LP; Liu, D; Li, SB; Wu, HL; Liu, CM				Guo, Longjun; Fu, Yujie; Wang, Yiping; Lu, Yuehua; Wei, Yanwu; Tang, Qinghai; Fan, Peihu; Liu, Jianbo; Zhang, Long; Zhang, Feiyan; Huang, Liping; Liu, Dan; Li, Shengbin; Wu, Hongli; Liu, Changming			A Porcine Circovirus Type 2 (PCV2) Mutant with 234 Amino Acids in Capsid Protein Showed More Virulence In Vivo, Compared with Classical PCV2a/b Strain	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; WASTING SYNDROME PMWS; GENETIC-CHARACTERIZATION; LEUKOCYTE SUBPOPULATIONS; PERIPHERAL-BLOOD; INFECTION; GENOTYPES; PIGS; CONSTRUCTION; REPLICATION	Background: Porcine circovirus type 2 (PCV2) is considered to be the primary causative agent of postweaning multisystemic wasting syndrome (PMWS), which has become a serious economic problem for the swine industry worldwide. The major genotypes, PCV2a and PCV2b, are highly prevalent in the pig population and are present worldwide. However, another newly emerging PCV2b genotype mutant, which has a mutation in its ORF2-encoded capsid protein, has been sporadically present in China, as well as in other countries. It is therefore important to determine the relative virulence of the newly emerging PCV2b genotype mutant, compared with the existing PCV2a and PCV2b genotypes, and to investigate whether the newly emerging mutant virus induces more severe illness. Methodology/Principal Findings: Twenty healthy, 30-day-old, commercial piglets served as controls or were challenged with PCV2a, PCV2b and the newly emerging mutant virus. A series of indexes representing different parameters were adopted to evaluate virulence, including clinical signs, serological detection, viral load and distribution, changes in immune cell subsets in the peripheral blood, and evaluation of pathological lesions. The newly emerging PCV2 mutant demonstrated more severe signs compatible with PMWS, characterized by wasting, coughing, dyspnea, diarrhea, rough hair-coat and depression. Moreover, the pathological lesions and viremia, as well as the viral loads in lymph nodes, tonsils and spleen, were significantly more severe (P<0.05) for piglets challenged with the newly emerging mutant compared with those in the groups challenged with PCV2a and PCV2b. In addition, a significantly lower average daily weight gain (P<0.05) was recorded in the group challenged with the newly emerging PCV2 mutant than in the groups challenged with the prevailing PCV2a and PCV2b. Conclusions: This is believed to be the first report to confirm the enhanced virulence of the newly emerging PCV2 mutant in vivo.	[Guo, Longjun; Fu, Yujie; Wang, Yiping; Lu, Yuehua; Wei, Yanwu; Tang, Qinghai; Fan, Peihu; Liu, Jianbo; Zhang, Long; Zhang, Feiyan; Huang, Liping; Liu, Dan; Li, Shengbin; Wu, Hongli; Liu, Changming] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Swine Infect Dis, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Guo, LJ (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Swine Infect Dis, Harbin, Peoples R China.	lcm@hvri.ac.cn	Wang, Yiping/AAN-8548-2021	Wang, Yiping/0000-0002-3178-3752	National Science Foundation (China) [30871859]; State Key Laboratory of Veterinary Biotechnology (China) [NKLVBP200807]; Transformation Foundation Project of the Agricultural Scientific and Technological Achievements of China [2010GB23260563]	National Science Foundation (China)(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Biotechnology (China); Transformation Foundation Project of the Agricultural Scientific and Technological Achievements of China	This work was supported by grants from the National Science Foundation (China; 30871859) and the State Key Laboratory of Veterinary Biotechnology (China; NKLVBP200807), and the Transformation Foundation Project of the Agricultural Scientific and Technological Achievements of China (2010GB23260563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN GM, 1994, VET IMMUNOL IMMUNOP, V43, P357, DOI 10.1016/0165-2427(94)90157-0; Cheung AK, 2007, ARCH VIROL, V152, P1035, DOI 10.1007/s00705-006-0909-6; Choi KS, 2008, RES VET SCI, V84, P497, DOI 10.1016/j.rvsc.2007.05.017; Dupont K, 2008, VET MICROBIOL, V128, P56, DOI 10.1016/j.vetmic.2007.09.016; Fenaux M, 2004, J VIROL, V78, P13440, DOI 10.1128/JVI.78.24.13440-13446.2004; Fenaux M, 2003, J VIROL, V77, P11232, DOI 10.1128/JVI.77.20.11232-11243.2003; Finsterbusch T, 2009, VIRUS RES, V143, P177, DOI 10.1016/j.virusres.2009.02.009; Grau-Roma L, 2008, VET MICROBIOL, V128, P23, DOI 10.1016/j.vetmic.2007.09.007; Guo LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-291; Guo LJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-273; Harding JCS, 2010, VET MICROBIOL, V145, P209, DOI 10.1016/j.vetmic.2010.03.026; Harding JCS, 1997, SWINE HEALTH PROD, V5, P201; Huang LP, 2011, VIRUS RES, V161, P115, DOI 10.1016/j.virusres.2011.05.015; Jantafong T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-88; Knell S, 2005, VET MICROBIOL, V109, P169, DOI 10.1016/j.vetmic.2005.06.004; Kyriakis SC, 2002, J VET MED B, V49, P317, DOI 10.1046/j.1439-0450.2002.00574.x; Lager KM, 2007, VET REC, V161, P428, DOI 10.1136/vr.161.12.428; Li WL, 2010, VIRUS GENES, V40, P244, DOI 10.1007/s11262-009-0438-y; Liu CM, 2004, J VET MED SCI, V66, P237, DOI 10.1292/jvms.66.237; Lohse L, 2004, VIRAL IMMUNOL, V17, P594, DOI 10.1089/vim.2004.17.594; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Nielsen J, 2003, VET IMMUNOL IMMUNOP, V93, P135, DOI 10.1016/S0165-2427(03)00068-0; Nielsen J, 2003, VET IMMUNOL IMMUNOP, V92, P97, DOI 10.1016/S0165-2427(03)00031-X; Olvera A, 2007, VIROLOGY, V357, P175, DOI 10.1016/j.virol.2006.07.047; Opriessnig T, 2008, J GEN VIROL, V89, P2482, DOI 10.1099/vir.0.2008/001081-0; Opriessnig T, 2006, J GEN VIROL, V87, P2923, DOI 10.1099/vir.0.82099-0; Rosell C, 1999, J COMP PATHOL, V120, P59, DOI 10.1053/jcpa.1998.0258; Segales J, 2008, VET REC, V162, P867, DOI 10.1136/vr.162.26.867; Segales J, 2002, VET QUART, V24, P109, DOI 10.1080/01652176.2002.9695132; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; Shi KC, 2008, VET MICROBIOL, V129, P367, DOI 10.1016/j.vetmic.2007.11.020; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Todd D., 2005, VIRUS TAXONOMY, P327; Trible BR, 2012, VIRUS RES, V164, P68, DOI 10.1016/j.virusres.2011.11.018; Wang F, 2009, VIRUS RES, V145, P151, DOI 10.1016/j.virusres.2009.05.015; Wen LB, 2005, VET MICROBIOL, V110, P141, DOI 10.1016/j.vetmic.2005.07.003	38	86	96	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41463	10.1371/journal.pone.0041463	http://dx.doi.org/10.1371/journal.pone.0041463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829951	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300091
J	Lindhoud, S; van den Berg, WAM; van den Heuvel, RHH; Heck, AJR; van Mierlo, CPM; van Berkel, WJH				Lindhoud, Simon; van den Berg, Willy A. M.; van den Heuvel, Robert H. H.; Heck, Albert J. R.; van Mierlo, Carlo P. M.; van Berkel, Willem J. H.			Cofactor Binding Protects Flavodoxin against Oxidative Stress	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; PARA-HYDROXYBENZOATE HYDROXYLASE; CYSTEINE SULFINIC ACID; BETA PARALLEL PROTEIN; AZOTOBACTER-VINELANDII; SULFENIC ACID; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; ENZYME CATALYSIS; SULFONIC-ACID	In organisms, various protective mechanisms against oxidative damaging of proteins exist. Here, we show that cofactor binding is among these mechanisms, because flavin mononucleotide (FMN) protects Azotobacter vinelandii flavodoxin against hydrogen peroxide-induced oxidation. We identify an oxidation sensitive cysteine residue in a functionally important loop close to the cofactor, i.e., Cys69. Oxidative stress causes dimerization of apoflavodoxin (i.e., flavodoxin without cofactor), and leads to consecutive formation of sulfinate and sulfonate states of Cys69. Use of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-CI) reveals that Cys69 modification to a sulfenic acid is a transient intermediate during oxidation. Dithiothreitol converts sulfenic acid and disulfide into thiols, whereas the sulfinate and sulfonate forms of Cys69 are irreversible with respect to this reagent. A variable fraction of Cys69 in freshly isolated flavodoxin is in the sulfenic acid state, but neither oxidation to sulfinic and sulfonic acid nor formation of intermolecular disulfides is observed under oxidising conditions. Furthermore, flavodoxin does not react appreciably with NBD-Cl. Besides its primary role as redoxactive moiety, binding of flavin leads to considerably improved stability against protein unfolding and to strong protection against irreversible oxidation and other covalent thiol modifications. Thus, cofactors can protect proteins against oxidation and modification.	[Lindhoud, Simon; van den Berg, Willy A. M.; van Mierlo, Carlo P. M.; van Berkel, Willem J. H.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands; [van den Heuvel, Robert H. H.; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [van den Heuvel, Robert H. H.; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University	Lindhoud, S (corresponding author), Wageningen Univ, Biochem Lab, Wageningen, Netherlands.	willem.vanberkel@wur.nl	vanMierlo, Carlo p/B-4491-2016; van Berkel, Willem J.H./O-2431-2014; Heck, Albert/D-7098-2011	vanMierlo, Carlo p/0000-0002-5358-8392; van Berkel, Willem J.H./0000-0002-6551-2782; Heck, Albert/0000-0002-2405-4404	Netherlands Organisation for Scientific Research [700.56.002]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organisation for Scientific Research (http://www.nwo.nl), grant number: 700.56.002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; ALLISON WS, 1976, ACCOUNTS CHEM RES, V9, P293, DOI 10.1021/ar50104a003; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BANERJEE SK, 1992, ARCH BIOCHEM BIOPHYS, V295, P84, DOI 10.1016/0003-9861(92)90491-E; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENEMANN JR, 1969, P NATL ACAD SCI USA, V64, P1079, DOI 10.1073/pnas.64.3.1079; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200; Chang YC, 2010, PROTEOMICS, V10, P2961, DOI 10.1002/pmic.200900850; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Chiappetta G, 2010, METHOD ENZYMOL, V473, P199, DOI 10.1016/S0076-6879(10)73010-X; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Creighton TE, 1993, PROTEINS STUCTURES M; Davis DA, 2002, METHOD ENZYMOL, V348, P249, DOI 10.1016/S0076-6879(02)48643-0; De Luca A, 2010, P NATL ACAD SCI USA, V107, P18628, DOI 10.1073/pnas.1010171107; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; ESCHRICH K, 1990, FEBS LETT, V277, P197, DOI 10.1016/0014-5793(90)80843-8; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Hamann M, 2002, METHOD ENZYMOL, V348, P146, DOI 10.1016/S0076-6879(02)48634-X; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Hochgrafe F, 2005, MOL MICROBIOL, V58, P409, DOI 10.1111/j.1365-2958.2005.04845.x; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Leferink NGH, 2009, PLANT PHYSIOL, V150, P596, DOI 10.1104/pp.109.136929; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; LITTLE C, 1969, EUR J BIOCHEM, V10, P533, DOI 10.1111/j.1432-1033.1969.tb00721.x; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Nabuurs SM, 2009, J AM CHEM SOC, V131, P2739, DOI 10.1021/ja8089476; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Peelen S, 1996, J BIOMOL NMR, V7, P315; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Poole LB, 2002, METHOD ENZYMOL, V348, P122, DOI 10.1016/S0076-6879(02)48632-6; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Slavica A, 2005, APPL ENVIRON MICROB, V71, P8061, DOI 10.1128/AEM.71.12.8061-8068.2005; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Steensma E, 1998, PROTEIN SCI, V7, P306; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; TANAKA M, 1977, BIOCHEMISTRY-US, V16, P3525, DOI 10.1021/bi00635a005; van Mierlo CPM, 2000, J BIOTECHNOL, V79, P281, DOI 10.1016/S0168-1656(00)00244-3; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; VANBERKEL WJH, 1987, EUR J BIOCHEM, V167, P35; Wang Y, 2012, ANTIOXID REDOX SIGN, V16, P649, DOI 10.1089/ars.2011.4313; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wolfova J, 2009, BBA-PROTEINS PROTEOM, V1794, P1288, DOI 10.1016/j.bbapap.2009.08.001; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; YOCH DC, 1975, ARCH BIOCHEM BIOPHYS, V170, P326, DOI 10.1016/0003-9861(75)90124-1	56	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41363	10.1371/journal.pone.0041363	http://dx.doi.org/10.1371/journal.pone.0041363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829943	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300082
J	Grant, CL; Caromile, LA; Durrani, K; Rahman, MM; Claffey, KP; Fong, GH; Shapiro, LH				Grant, Christina L.; Caromile, Leslie A.; Durrani, Khayyam; Rahman, M. Mamunur; Claffey, Kevin P.; Fong, Guo-Hua; Shapiro, Linda H.			Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization	PLOS ONE			English	Article							GLUTAMATE-CARBOXYPEPTIDASE-II; FOCAL ADHESION KINASE; ENDOTHELIAL GROWTH-FACTOR; PATHOLOGICAL ANGIOGENESIS; INTRAVITREAL BEVACIZUMAB; MACULAR DEGENERATION; FOLATE HYDROLASE; CELL-ADHESION; RETINOPATHY; PREMATURITY	Background: Aberrant growth of blood vessels in the eye forms the basis of many incapacitating diseases and currently the majority of patients respond to anti-angiogenic therapies based on blocking the principal angiogenic growth factor, vascular endothelial growth factor (VEGF). While highly successful, new therapeutic targets are critical for the increasing number of individuals susceptible to retina-related pathologies in our increasingly aging population. Prostate specific membrane antigen (PSMA) is a cell surface peptidase that is absent on normal tissue vasculature but is highly expressed on the neovasculature of most solid tumors, where we have previously shown to regulate angiogenic endothelial cell invasion. Because pathologic angiogenic responses are often triggered by distinct signals, we sought to determine if PSMA also contributes to the pathologic angiogenesis provoked by hypoxia of the retina, which underlies many debilitating retinopathies. Methodology/Principal Findings: Using a mouse model of oxygen-induced retinopathy, we found that while developmental angiogenesis is normal in PSMA null mice, hypoxic challenge resulted in decreased retinal vascular pathology when compared to wild type mice as assessed by avascular area and numbers of vascular tufts/glomeruli. The vessels formed in the PSMA null mice were more organized and highly perfused, suggesting a more 'normal' phenotype. Importantly, the decrease in angiogenesis was not due to an impaired hypoxic response as levels of pro-angiogenic factors are comparable; indicating that PSMA regulation of angiogenesis is independent of VEGF. Furthermore, both systemic and intravitreal administration of a PSMA inhibitor in wild type mice undergoing OIR mimicked the PSMA null phenotype resulting in improved retinal vasculature. Conclusions/Significance: Our data indicate that PSMA plays a VEGF-independent role in retinal angiogenesis and that the lack of or inhibition of PSMA may represent a novel therapeutic strategy for treatment of angiogenesis-based ocular diseases.	[Grant, Christina L.; Caromile, Leslie A.; Durrani, Khayyam; Rahman, M. Mamunur; Claffey, Kevin P.; Fong, Guo-Hua; Shapiro, Linda H.] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT USA	University of Connecticut	Grant, CL (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT USA.	lshapiro@neuron.uchc.edu	Caromile, Leslie A/Q-2980-2016	Caromile, Leslie A/0000-0003-2193-5190	Prostate Cancer Foundation; Department of Defense Prostate Cancer Program [PC073976]	Prostate Cancer Foundation; Department of Defense Prostate Cancer Program(United States Department of Defense)	This work was supported by the Prostate Cancer Foundation and the Department of Defense Prostate Cancer Program #PC073976 to LHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2008, METHOD ENZYMOL, V444, P115, DOI 10.1016/S0076-6879(08)02806-1; Arsham Sheybani M, 2010, REV OPHTHAMOLOGY, V17, P52; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carter RE, 1996, P NATL ACAD SCI USA, V93, P749, DOI 10.1073/pnas.93.2.749; Chang SS, 1999, CANCER RES, V59, P3192; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; da Silva RG, 2010, AM J PATHOL, V177, P1534, DOI 10.2353/ajpath.2010.100043; David E, 2009, OCULAR DIS MECH MANA, P536; Dhoot DS, 2012, EXPERT OPIN BIOL TH, V12, P371, DOI 10.1517/14712598.2012.660523; Duncan GS, 1999, J IMMUNOL, V162, P3022; Ellsbury DL, 2010, CLIN PERINATOL, V37, P203, DOI 10.1016/j.clp.2010.01.012; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Fuxe J, 2011, AM J PATHOL, V178, P2897, DOI 10.1016/j.ajpath.2011.02.008; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heston WDW, 1997, UROLOGY, V49, P104, DOI 10.1016/S0090-4295(97)00177-5; Hussain N, 2008, EXPERT REV OPHTHALMO, V3, P43, DOI 10.1586/17469899.3.1.43; Hynes RO, 1999, TRENDS BIOCHEM SCI, V24, pM33, DOI 10.1016/S0968-0004(99)01479-6; ISRAELI RS, 1993, CANCER RES, V53, P227; Jefferies AL, 2010, PAED CHILD HEALT-CAN, V15, P667, DOI 10.1093/pch/15.10.667; Kahook MY, 2009, OPHTHAL SURG LAS IM, V40, P293, DOI 10.3928/15428877-20090430-12; Kamisasanuki T, 2011, BIOCHEM BIOPH RES CO, V413, P128, DOI 10.1016/j.bbrc.2011.08.068; Kornberg LJ, 2004, INVEST OPHTH VIS SCI, V45, P4463, DOI 10.1167/iovs.03-1201; Lapidus RG, 2000, PROSTATE, V45, P350, DOI 10.1002/1097-0045(20001201)45:4<350::AID-PROS10>3.0.CO;2-U; Liu H, 1997, CANCER RES, V57, P3629; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Murphy GP, 1998, CANCER-AM CANCER SOC, V83, P2259, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2259::AID-CNCR5>3.0.CO;2-T; Nguyen QD, OPHTHALMOLOGY; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rizzo MT, 2004, CARDIOVASC RES, V64, P377, DOI 10.1016/j.cardiores.2004.09.011; Rojas C, 2002, ANAL BIOCHEM, V310, P50, DOI 10.1016/S0003-2697(02)00286-5; Rojas C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-27; Sabet-Peyman EJ, 2009, OPHTHAL SURG LAS IM, V40, P316, DOI 10.3928/15428877-20090430-17; SAHAGUN G, 1989, AM J PATHOL, V134, P1227; Sivakumar B, 2004, JAMA-J AM MED ASSOC, V292, P972, DOI 10.1001/jama.292.8.972; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stupack DG, 2003, ONCOGENE, V22, P9022, DOI 10.1038/sj.onc.1207110; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; van der Post JP, 2005, BRIT J CLIN PHARMACO, V60, P128, DOI 10.1111/j.1365-2125.2005.02396.x; Wilkinson-Berka JL, 2006, INVEST OPHTH VIS SCI, V47, P1600, DOI 10.1167/iovs.05-1314; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903	51	25	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41285	10.1371/journal.pone.0041285	http://dx.doi.org/10.1371/journal.pone.0041285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815987	gold, Green Submitted, Green Published			2022-12-27	WOS:000306548900106
J	Hu, ZQ; Wang, ZQ; Xu, SZ				Hu, Zhiqiu; Wang, Zhiquan; Xu, Shizhong			An Infinitesimal Model for Quantitative Trait Genomic Value Prediction	PLOS ONE			English	Article							FEED-EFFICIENCY; SELECTION; LOCI; GROWTH; POLYMORPHISM; ASSOCIATION; SHRINKAGE; FRAMEWORK; BEHAVIOR; GENE	We developed a marker based infinitesimal model for quantitative trait analysis. In contrast to the classical infinitesimal model, we now have new information about the segregation of every individual locus of the entire genome. Under this new model, we propose that the genetic effect of an individual locus is a function of the genome location (a continuous quantity). The overall genetic value of an individual is the weighted integral of the genetic effect function along the genome. Numerical integration is performed to find the integral, which requires partitioning the entire genome into a finite number of bins. Each bin may contain many markers. The integral is approximated by the weighted sum of all the bin effects. We now turn the problem of marker analysis into bin analysis so that the model dimension has decreased from a virtual infinity to a finite number of bins. This new approach can efficiently handle virtually unlimited number of markers without marker selection. The marker based infinitesimal model requires high linkage disequilibrium of all markers within a bin. For populations with low or no linkage disequilibrium, we develop an adaptive infinitesimal model. Both the original and the adaptive models are tested using simulated data as well as beef cattle data. The simulated data analysis shows that there is always an optimal number of bins at which the predictability of the bin model is much greater than the original marker analysis. Result of the beef cattle data analysis indicates that the bin model can increase the predictability from 10% (multiple marker analysis) to 33% (multiple bin analysis). The marker based infinitesimal model paves a way towards the solution of genetic mapping and genomic selection using the whole genome sequence data.	[Hu, Zhiqiu; Xu, Shizhong] Univ Calif Reverside, Dept Bot & Plant Sci, Reverside, CA USA; [Wang, Zhiquan] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta	Hu, ZQ (corresponding author), Univ Calif Reverside, Dept Bot & Plant Sci, Reverside, CA USA.	Shizhong.Xu@ucr.edu		Hu, Zhiqiu/0000-0001-5600-4236	United States Department of Agriculture National Institute of Food and Agriculture Grant [2007-02784]; Alberta Ingenuity Bio Solution Grant [RES0008133]; Alberta Livestock and Meat Agency/Alberta Agricultural Research Institute Grant [G550000127]	United States Department of Agriculture National Institute of Food and Agriculture Grant; Alberta Ingenuity Bio Solution Grant; Alberta Livestock and Meat Agency/Alberta Agricultural Research Institute Grant	The project was supported by the United States Department of Agriculture National Institute of Food and Agriculture Grant 2007-02784 to Dr. Xu, The Alberta Ingenuity Bio Solution Grant RES0008133 to Dr. Wang and The Alberta Livestock and Meat Agency/Alberta Agricultural Research Institute Grant G550000127 to Dr. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DM, 1971, TECHNOMETRICS, V13, P469, DOI 10.2307/1267161; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Axenovich TI, 1996, GENET EPIDEMIOL, V13, P271; Bayes M, 2012, MOLECULAR ANALYSIS AND GENOME DISCOVERY, 2ND EDITION, P1; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Che Xiaohong, 2010, Int J Plant Genomics, V2010, P893206, DOI 10.1155/2010/893206; Falconer D. S., 1996, INTRO QUANTITATIVE G; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; Jiang X, 2010, GENET EPIDEMIOL, V34, P575, DOI 10.1002/gepi.20514; Kao CH, 1999, GENETICS, V152, P1203; LANDER ES, 1989, GENETICS, V121, P185; Mather K, 1941, J GENET, V41, P159, DOI 10.1007/BF02983019; Meuwissen THE, 2001, GENETICS, V157, P1819; MORTON NE, 1974, AM J HUM GENET, V26, P489; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Nkrumah JD, 2007, J ANIM SCI, V85, P2382, DOI 10.2527/jas.2006-657; Nkrumah JD, 2004, CAN J ANIM SCI, V84, P211, DOI 10.4141/A03-033; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Satagopan JM, 1996, GENETICS, V144, P805; Sen S, 2001, GENETICS, V159, P371; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Sillanpaa MJ, 1998, GENETICS, V148, P1373; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wang H, 2005, GENETICS, V170, P465, DOI 10.1534/genetics.104.039354; Whittaker J, 2000, ANN HUM GENET, V63, P366; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Xu SZ, 2010, GENET RES, V92, P423, DOI 10.1017/S0016672310000583; Xu SZ, 2003, GENETICS, V163, P789; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yi NJ, 2004, GENETICS, V167, P967, DOI 10.1534/genetics.104.026286; ZENG ZB, 1994, GENETICS, V136, P1457	44	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41336	10.1371/journal.pone.0041336	http://dx.doi.org/10.1371/journal.pone.0041336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815992	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900110
J	Lau, KS; Zhang, TH; Kendall, KR; Lauffenburger, D; Gray, NS; Haigis, KM				Lau, Ken S.; Zhang, Tinghu; Kendall, Krystle R.; Lauffenburger, Douglas; Gray, Nathanael S.; Haigis, Kevin M.			BAY61-3606 Affects the Viability of Colon Cancer Cells in a Genotype-Directed Manner	PLOS ONE			English	Article							SYNTHETIC LETHAL INTERACTION; GERMINAL CENTER KINASE; COLORECTAL-CANCER; K-RAS; MEDIATES RESISTANCE; AZD6244 ARRY-142886; PATHWAY ACTIVATION; RNA INTERFERENCE; IN-VIVO; INHIBITOR	Background: K-RAS mutation poses a particularly difficult problem for cancer therapy. Activating mutations in K-RAS are common in cancers of the lung, pancreas, and colon and are associated with poor response to therapy. As such, targeted therapies that abrogate K-RAS-induced oncogenicity would be of tremendous value. Methods: We searched for small molecule kinase inhibitors that preferentially affect the growth of colorectal cancer cells expressing mutant K-RAS. The mechanism of action of one inhibitor was explored using chemical and genetic approaches. Results: We identified BAY61-3606 as an inhibitor of proliferation in colorectal cancer cells expressing mutant forms of K-RAS, but not in isogenic cells expressing wild-type K-RAS. In addition to its anti-proliferative effects in mutant cells, BAY61-3606 exhibited a distinct biological property in wild-type cells in that it conferred sensitivity to inhibition of RAF. In this context, BAY61-3606 acted by inhibiting MAP4K2 (GCK), which normally activates NFkb signaling in wild-type cells in response to inhibition of RAF. As a result of MAP4K2 inhibition, wild-type cells became sensitive to AZ-628, a RAF inhibitor, when also treated with BAY61-3606. Conclusions: These studies indicate that BAY61-3606 exerts distinct biological activities in different genetic contexts.	[Lau, Ken S.; Kendall, Krystle R.; Haigis, Kevin M.] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA USA; [Lau, Ken S.; Kendall, Krystle R.; Haigis, Kevin M.] Massachusetts Gen Hosp, Ctr Syst Biol, Charlestown, MA USA; [Lau, Ken S.; Lauffenburger, Douglas] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lau, Ken S.; Lauffenburger, Douglas] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Zhang, Tinghu; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Lau, KS (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA USA.	khaigis@partners.org	Lau, Ken/I-7958-2019	Lau, Ken/0000-0001-8438-0319	National Cancer Institute [K01-CA118425, P30-CA006516]; American Cancer Society [MGO-114877]; Merlino Family Endowment Fund; NATIONAL CANCER INSTITUTE [P30CA006516, K01CA118425] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Merlino Family Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (K01-CA118425 and P30-CA006516) and the American Cancer Society (MGO-114877) and a donation from the Merlino Family Endowment Fund. KSL is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmanno K, 2009, INT J CANCER, V125, P2332, DOI 10.1002/ijc.24604; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Ivanov VN, 2000, ONCOGENE, V19, P933, DOI 10.1038/sj.onc.1203415; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lau KS, 2009, MOL CELLS; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Lyne PD, 2009, BIOORG MED CHEM LETT, V19, P1026, DOI 10.1016/j.bmcl.2008.10.053; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang YL, 2005, NEOPLASIA, V7, P336, DOI 10.1593/neo.04532; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zhao YC, 2010, J BIOL CHEM, V285, P25213, DOI 10.1074/jbc.M110.123067; Zhong J, 2009, P NATL ACAD SCI USA, V106, P4372, DOI 10.1073/pnas.0812642106	39	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41343	10.1371/journal.pone.0041343	http://dx.doi.org/10.1371/journal.pone.0041343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815993	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900111
J	Feuerstein, P; Puard, V; Chevalier, C; Teusan, R; Cadoret, V; Guerif, F; Houlgatte, R; Royere, D				Feuerstein, Prisca; Puard, Vincent; Chevalier, Catherine; Teusan, Raluca; Cadoret, Veronique; Guerif, Fabrice; Houlgatte, Remi; Royere, Dominique			Genomic Assessment of Human Cumulus Cell Marker Genes as Predictors of Oocyte Developmental Competence: Impact of Various Experimental Factors	PLOS ONE			English	Article							PREGNANCY PREDICTORS; EXPRESSION PROFILES; HUMAN IVF; EMBRYO; IDENTIFICATION; FERTILIZATION; TRANSCRIPTOME; METABOLOMICS; BIOMARKERS; MORPHOLOGY	Background: Single embryo transfer (SET) is the most successful way to reduce the frequency of multiple pregnancies following in vitro fertilisation. However, selecting the embryo for SET with the highest chances of pregnancy remains a difficult challenge since morphological and kinetics criteria provide poor prediction of both developmental and implantation ability. Partly through the expression of specific genes, the oocyte-cumulus interaction helps the oocyte to acquire its developmental competence. Our aim was therefore to identify at the level of cumulus cells (CCs) genes related to oocyte developmental competence. Methodology/Principal Findings: 197 individual CCs were collected from 106 patients undergoing an intra-cytoplasmic sperm injection procedure. Gene expression of CCs was studied using microarray according to the nuclear maturity of the oocyte (immature vs. mature oocyte) and to the developmental competence of the oocyte (ability to reach the blastocyst stage after fertilisation). Microarray study was followed by a meta-analysis of the behaviour of these genes in other datasets available in Gene Expression Omnibus which showed the consistency of this list of genes. Finally, 8 genes were selected according to oocyte developmental competence from the 308 differentially expressed genes (p, 0.0001) for further validation by quantitative PCR (qPCR). Three of these 8 selected genes were validated as potential biomarkers (PLIN2, RGS2 and ANG). Experimental factors such as inter-patient and qPCR series variability were then assessed using the Generalised Linear Mixed Model procedure, and only the expression level of RGS2 was confirmed to be related to oocyte developmental competence. The link between biomarkers and pregnancy was finally evaluated and level of RGS2 expression was also correlated with clinical pregnancy. Conclusion/Significance: RGS2, known as a regulator of G protein signalling, was the only gene among our 8 selected candidates biomarkers of oocyte competence to cover many factors of variability, including inter-patient factors and experimental conditions.	[Feuerstein, Prisca; Puard, Vincent; Cadoret, Veronique; Guerif, Fabrice; Royere, Dominique] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Feuerstein, Prisca; Puard, Vincent; Cadoret, Veronique; Guerif, Fabrice; Royere, Dominique] CNRS, UMR6175, Nouzilly, France; [Feuerstein, Prisca; Puard, Vincent; Guerif, Fabrice; Royere, Dominique] Univ Tours, Tours, France; [Cadoret, Veronique; Guerif, Fabrice; Royere, Dominique] CHRU Tours, Reprod Biol Lab, Tours, France; [Chevalier, Catherine; Teusan, Raluca; Houlgatte, Remi] Univ Nantes, Plateforme Puces ADN Nantes, Inst Rech Therapeut, Nantes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours; CHU Tours; Nantes Universite	Feuerstein, P (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	royere@med.univ-tours.fr	Houlgatte, Remi/P-3020-2017; chevalier, catherine/L-4803-2015; TEUSAN, Raluca/D-4069-2015	TEUSAN, Raluca/0000-0002-1428-5719; Puard, Vincent/0000-0003-4634-7627; cadoret, veronique/0000-0002-5260-0812	Institut National de la Sante et de la Recherche Medicale (Reseau de Recherche Reproduction Humaine-AMP [4REO3H]; Institut National de la Recherche Agronomique (INRA); INRA/Ferring SA fellowship; INRA/Merck Serono fellowship	Institut National de la Sante et de la Recherche Medicale (Reseau de Recherche Reproduction Humaine-AMP; Institut National de la Recherche Agronomique (INRA); INRA/Ferring SA fellowship; INRA/Merck Serono fellowship	This study was supported by a grant from the Institut National de la Sante et de la Recherche Medicale (Reseau de Recherche Reproduction Humaine-AMP', contrat No. 4REO3H) and the Institut National de la Recherche Agronomique (INRA). P.F. is supported by an INRA/Ferring SA fellowship. V.P. is supported by an INRA/Merck Serono fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens T, 2010, HUM REPROD; Anderson RA, 2009, REPRODUCTION, V138, P629, DOI 10.1530/REP-09-0144; Assidi M, 2011, J ASSIST REPROD GEN, V28, P173, DOI 10.1007/s10815-010-9491-7; Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Bergh C, 2005, HUM REPROD, V20, P323, DOI 10.1093/humrep/deh744; Botros L, 2008, MOL HUM REPROD, V14, P679, DOI 10.1093/molehr/gan066; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Canipari R, 2000, HUM REPROD UPDATE, V6, P279, DOI 10.1093/humupd/6.3.279; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fauser BC, 2010, HUM REPROD UPDATE, V17, P829; Ferrari S, 2010, J ASSIST REPROD GEN, V27, P429, DOI 10.1007/s10815-010-9428-1; Feuerstein P, 2007, HUM REPROD, V22, P3069, DOI 10.1093/humrep/dem336; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gebhardt KM, 2011, FERTIL STERIL, V96, P47, DOI 10.1016/j.fertnstert.2011.04.033; Gilbert I, 2010, MOL HUM REPROD, V16, P601, DOI 10.1093/molehr/gaq038; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Guerif F, 2007, HUM REPROD, V22, P1973, DOI 10.1093/humrep/dem100; Guerif F, 2003, THERIOGENOLOGY, V60, P1457, DOI 10.1016/S0093-691X(03)00130-4; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Hamel M, 2010, MOL HUM REPROD, V16, P548, DOI 10.1093/molehr/gaq051; Hamel M, 2010, MOL HUM REPROD, V16, P87, DOI 10.1093/molehr/gap079; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Huang ZW, 2010, MOL HUM REPROD, V16, P715, DOI 10.1093/molehr/gaq031; Jones GM, 2008, HUM REPROD, V23, P1748, DOI 10.1093/humrep/den123; Katz-Jaffe MG, 2009, MOL HUM REPROD, V15, P271, DOI 10.1093/molehr/gap012; Katz-Jaffe MG, 2006, FERTIL STERIL, V85, P101, DOI 10.1016/j.fertnstert.2005.09.011; Koks S, 2010, MOL HUM REPROD, V16, P229, DOI 10.1093/molehr/gap103; Land J. A., 2003, Human Reproduction (Oxford), V18, P455, DOI 10.1093/humrep/deg081; Li Q, 2008, MOL HUM REPROD; Milki AA, 2002, FERTIL STERIL, V78, P1244, DOI 10.1016/S0015-0282(02)04273-5; O'Shea LC, 2012, SYST BIOL REPROD MED, V0, P1; Ouandaogo ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027179; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Rijnders PM, 1998, HUM REPROD, V13, P2869, DOI 10.1093/humrep/13.10.2869; Royere D, 2009, GYNECOL OBSTET FERTI, V37, P917, DOI 10.1016/j.gyobfe.2009.09.016; Scott L, 2008, REPROD BIOMED ONLINE, V17, P461, DOI 10.1016/S1472-6483(10)60232-5; Singh R, 2007, THERIOGENOLOGY, V68, pS56, DOI 10.1016/j.theriogenology.2007.04.007; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Ujioka T, 2000, BIOL REPROD, V63, P1513, DOI 10.1095/biolreprod63.5.1513; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wang X, 2007, EMBO J, V26, P2768, DOI 10.1038/sj.emboj.7601701; Wu YL, 2008, CHINESE J PHYSIOL, V51, P282; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	52	62	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40449	10.1371/journal.pone.0040449	http://dx.doi.org/10.1371/journal.pone.0040449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848380	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200021
J	Kissner, TL; Ruthel, G; Alam, S; Mann, E; Ajami, D; Rebek, M; Larkin, E; Fernandez, S; Ulrich, RG; Ping, S; Waugh, DS; Rebek, J; Saikh, KU				Kissner, Teri L.; Ruthel, Gordon; Alam, Shahabuddin; Mann, Enrique; Ajami, Dariush; Rebek, Mitra; Larkin, Eileen; Fernandez, Stefan; Ulrich, Robert G.; Ping, Sun; Waugh, David S.; Rebek, Julius, Jr.; Saikh, Kamal U.			Therapeutic Inhibition of Pro-Inflammatory Signaling and Toxicity to Staphylococcal Enterotoxin B by a Synthetic Dimeric BB-Loop Mimetic of MyD88	PLOS ONE			English	Article							MHC CLASS-II; INNATE IMMUNE-RESPONSES; CRYSTAL-STRUCTURE; HUMAN-DISEASE; MOLECULES; CYTOKINE; SHOCK; ENDOTOXIN; DOMAIN; MICE	Staphylococcal enterotoxin B (SEB) exposure triggers an exaggerated pro-inflammatory cytokine response that often leads to toxic shock syndrome (TSS) associated with organ failure and death. MyD88 mediates pro-inflammatory cytokine signaling induced by SEB exposure and MyD88(-/-) mice are resistant to SEB intoxication, suggesting that MyD88 may be a potential target for therapeutic intervention. We targeted the BB loop region of the Toll/IL-1 receptor (TIR) domain of MyD88 to develop small-molecule therapeutics. Here, we report that a synthetic compound (EM-163), mimic to dimeric form of BB-loop of MyD88 attenuated tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, interleukin (IL)-1 beta, IL-2 and IL-6 production in human primary cells, whether administered pre- or post-SEB exposure. Results from a direct binding assay, and from MyD88 co-transfection/co-immunoprecipitation experiments, suggest that EM-163 inhibits TIR-TIR domain interaction. Additional results indicate that EM-163 prevents MyD88 from mediating downstream signaling. In an NF-kBdriven reporter assay of lipopolysaccharide-stimulated MyD88 signaling, EM-163 demonstrated a dose-dependent inhibition of reporter activity as well as TNF-alpha and IL-1 beta production. Importantly, administration of EM-163 pre- or post exposure to a lethal dose of SEB abrogated pro-inflammatory cytokine responses and protected mice from toxic shock-induced death. Taken together, our results suggest that EM-163 exhibits a potential for therapeutic use against SEB intoxication.	[Kissner, Teri L.; Ruthel, Gordon; Alam, Shahabuddin; Larkin, Eileen; Fernandez, Stefan; Ulrich, Robert G.; Saikh, Kamal U.] USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD USA; [Mann, Enrique; Ajami, Dariush; Rebek, Mitra] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Ping, Sun; Waugh, David S.; Rebek, Julius, Jr.] NCI, Macromol Crystallog Lab, Frederick, MD 21701 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kissner, TL (corresponding author), USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD USA.	kamal.saikh@amedd.army.mil	Ruthel, Gordon/GYU-9133-2022; Ajami, Dariush/A-1312-2014; Mann, Enrique/K-6594-2014	Mann, Enrique/0000-0002-2050-4295; Ruthel, Gordon/0000-0001-9193-5589	Defense Threat Reduction Agency (DTRA) [CBM.THRTOX.03.10.RD.006]; NATIONAL CANCER INSTITUTE [ZIABC010780] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Defense Threat Reduction Agency (DTRA; WWW.jpras.us) grant CBM.THRTOX.03.10.RD.006 to Kamal U. Saikh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Al-Daccak R, 2004, CURR OPIN IMMUNOL, V16, P108, DOI 10.1016/j.coi.2003.11.006; Azuma K, 2004, INT J INFECT DIS, V8, P292, DOI 10.1016/j.ijid.2003.12.005; Basith S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023989; Beno DWA, 2001, AM J PHYSIOL-GASTR L, V280, pG866, DOI 10.1152/ajpgi.2001.280.5.G866; Blank C, 1997, EUR J IMMUNOL, V27, P825, DOI 10.1002/eji.1830270405; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; Frei R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008808; Gabhann JN, 2011, CELL RES, V21, P998, DOI 10.1038/cr.2011.88; Hassan GS, 2011, NAT IMMUNOL, V12, P375, DOI 10.1038/ni.2023; Hopkins PA, 2005, BLOOD, V105, P3655, DOI 10.1182/blood-2004-07-2523; Kissner TL, 2011, INNATE IMMUN-LONDON, V17, P451, DOI 10.1177/1753425910374092; Kissner TL, 2011, J BIOL CHEM, V286, P31385, DOI 10.1074/jbc.M110.204982; Kissner TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015985; Kissner TL, 2010, IMMUNOLOGY, V130, P516, DOI 10.1111/j.1365-2567.2010.03249.x; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Piani A, 2000, EUR J IMMUNOL, V30, P3140, DOI 10.1002/1521-4141(200011)30:11<3140::AID-IMMU3140>3.0.CO;2-O; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; SCHOLL P, 1989, P NATL ACAD SCI USA, V86, P4210, DOI 10.1073/pnas.86.11.4210; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Ulrich RG, 1995, TRENDS MICROBIOL, V3, P463, DOI 10.1016/S0966-842X(00)89011-3; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	34	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40773	10.1371/journal.pone.0040773	http://dx.doi.org/10.1371/journal.pone.0040773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848400	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200030
J	Luzuriaga, AL; Sanchez, AM; Maestre, FT; Escudero, A				Luzuriaga, Arantzazu L.; Sanchez, Ana M.; Maestre, Fernando T.; Escudero, Adrian			Assemblage of a Semi-Arid Annual Plant Community: Abiotic and Biotic Filters Act Hierarchically	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; NULL MODEL ANALYSIS; SPECIES COOCCURRENCE; SHRUB INTERACTIONS; SPATIAL-PATTERNS; DESERT ANNUALS; SOIL LICHENS; SEED BANK; FACILITATION; COMPETITION	The study of species coexistence and community assembly has been a hot topic in ecology for decades. Disentangling the hierarchical role of abiotic and biotic filters is crucial to understand community assembly processes. The most critical environmental factor in semi-arid environments is known to be water availability, and perennials are usually described as nurses that create milder local conditions and expand the niche range of several species. We aimed to broaden this view by jointly evaluating how biological soil crusts (BSCs), water availability, perennial species (presence/absence of Stipa tenacissima) and plant-plant interactions shape a semi-arid annual plant community. The presence and cover of annual species was monitored during three years of contrasting climate. Water stress acted as the primary filter determining the species pool available for plant community assembly. Stipa and BSCs acted as secondary filters by modulating the effects of water availability. At extremely harsh environmental conditions, Stipa exerted a negative effect on the annual plant community, while at more benign conditions it increased annual community richness. Biological soil crusts exerted a contradictory effect depending on climate and on the presence of Stipa, favoring annuals in the most adverse conditions but showing repulsion at higher water availability conditions. Finally, interactions among co-occurring annuals shaped species richness and diversity of the final annual plant assembly. This study sheds light on the processes determining the assembly of annual communities and highlights the importance of Biological Soil Crusts and of interactions among annual plants on the final outcome of the species assembly.	[Luzuriaga, Arantzazu L.; Sanchez, Ana M.; Maestre, Fernando T.; Escudero, Adrian] Rey Juan Carlos Univ, Dept Biol & Geol, Madrid, Spain	Universidad Rey Juan Carlos	Luzuriaga, AL (corresponding author), Rey Juan Carlos Univ, Dept Biol & Geol, Madrid, Spain.	arantzazu.lopezdeluzuriaga@urjc.es	Escudero, Adrián/H-5046-2015; Luzuriaga, Arantzazu L./ABB-6536-2020; Luzuriaga, Aran/A-3734-2009; Maestre, Fernando T./A-6825-2008	Escudero, Adrián/0000-0002-1427-5465; Luzuriaga, Aran/0000-0001-5023-7813; Maestre, Fernando T./0000-0002-7434-4856; Sanchez, Ana M./0000-0002-6220-3001	ANUALES [CCG08-URJC/AMB-3530]; REMEDINAL2 [P2009/AMB-1783]; ISLAS [CGL2009-13190-C03-01]; INTERCAMBIO [BIOCOM 06/105]; Comunidad de Madrid and Universidad Rey Juan Carlos, CM; Spanish Ministerio de Ciencia e Innovacion; Fundacion BBVA; European Research Council under the European Community [242658 (BIOCOM)]	ANUALES; REMEDINAL2; ISLAS; INTERCAMBIO; Comunidad de Madrid and Universidad Rey Juan Carlos, CM; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion BBVA(BBVA Foundation); European Research Council under the European Community(European Research Council (ERC))	Funders: ANUALES (CCG08-URJC/AMB-3530), REMEDINAL2 (P2009/AMB-1783), ISLAS (CGL2009-13190-C03-01), INTERCAMBIO (BIOCOM 06/105), funded by the Comunidad de Madrid and Universidad Rey Juan Carlos, CM, the Spanish Ministerio de Ciencia e Innovacion and the Fundacion BBVA, respectively. FTM acknowledges support from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 242658 (BIOCOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RW, 1990, VEGETATION EROSION, P385; Armas C, 2011, ACTA OECOL, V37, P284, DOI 10.1016/j.actao.2011.02.013; Belnap J., 2003, BIOL SOIL CRUSTS STR, DOI 10.1007/978-3-642-56475-8_21; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bowker MA, 2010, J ECOL, V98, P551, DOI 10.1111/j.1365-2745.2010.01647.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; BYCROFT CM, 1993, NEW ZEAL J ECOL, V17, P95; Caballero I, 2008, OIKOS, V117, P1788, DOI 10.1111/j.1600-0706.2008.17138.x; Callaway R. M., 2007, POSITIVE INTERACTION; Castillo-Monroy AP, 2011, ECOSYSTEMS, V14, P835, DOI 10.1007/s10021-011-9449-3; Castillo-Monroy AP, 2010, PLANT SOIL, V333, P21, DOI 10.1007/s11104-009-0276-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cortina J, 2005, NATO SCI S SS IV EAR, V55, P85; Cortina J, 2010, PLANT SOIL, V334, P311, DOI 10.1007/s11104-010-0384-4; Dullinger S, 2007, J ECOL, V95, P1284, DOI 10.1111/j.1365-2745.2007.01288.x; DUTILLEUL P, 1993, ECOLOGY, V74, P1646, DOI 10.2307/1939923; Eldridge DJ, 2011, AUSTRAL ECOL, V36, P367, DOI 10.1111/j.1442-9993.2010.02159.x; Escudero A, 2007, J ARID ENVIRON, V70, P18, DOI 10.1016/j.jaridenv.2006.12.019; Facelli JM, 2002, AUSTRAL ECOL, V27, P422, DOI 10.1046/j.1442-9993.2002.01196.x; Fayle TM, 2010, ECOL MODEL, V221, P2237, DOI 10.1016/j.ecolmodel.2010.06.013; FRANCO AC, 1989, J ECOL, V77, P870, DOI 10.2307/2260991; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gotelli NJ, 1996, NULL MODELS ECOLOGY; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Grime J. P., 2001, PLANT STRATEGIES VEG; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holzapfel C, 1999, ECOLOGY, V80, P1747, DOI 10.2307/176564; Holzapfel C, 2006, BASIC APPL ECOL, V7, P268, DOI 10.1016/j.baae.2005.08.003; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; KADMON R, 1990, OECOLOGIA, V83, P139, DOI 10.1007/BF00324645; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Laird RA, 2008, ECOLOGY, V89, P237, DOI 10.1890/07-0117.1; Laird RA, 2006, AM NAT, V168, P182, DOI 10.1086/506259; Luzuriaga AL, 2008, J VEG SCI, V19, P445, DOI 10.3170/2008-8-18385; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Maestre FT, 2008, J VEG SCI, V19, P261, DOI 10.3170/2007-8-18366; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2004, ECOGRAPHY, V27, P776, DOI 10.1111/j.0906-7590.2004.03990.x; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Maestre FT, 2003, LICHENOLOGIST, V35, P71, DOI 10.1006/lich.2002.0425; Maestre FT, 2002, SOIL BIOL BIOCHEM, V34, P895, DOI 10.1016/S0038-0717(02)00021-4; Maestre FT, 2002, PLANT SOIL, V241, P279, DOI 10.1023/A:1016172308462; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; Maltez-Mouro S, 2010, ACTA OECOL, V36, P80, DOI 10.1016/j.actao.2009.10.003; McCluney KE, 2012, BIOL REV, V87, P563, DOI 10.1111/j.1469-185X.2011.00209.x; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Miranda JD, 2011, J ARID ENVIRON, V75, P1302, DOI 10.1016/j.jaridenv.2011.04.022; Moro MJ, 1997, ECOGRAPHY, V20, P175, DOI 10.1111/j.1600-0587.1997.tb00360.x; Myers JA, 2011, ECOLOGY, V92, P676, DOI 10.1890/10-1001.1; Olano JM, 2012, ANN BOT-LONDON, V109, P299, DOI 10.1093/aob/mcr260; PAKE CE, 1995, ECOLOGY, V76, P246, DOI 10.2307/1940646; PANTASTICOCALDAS M, 1993, ECOLOGY, V74, P2192, DOI 10.2307/1939573; Perry JN, 2002, ECOSCIENCE, V9, P133, DOI 10.1080/11956860.2002.11682699; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Perry JN, 1998, ECOLOGY, V79, P1008, DOI 10.1890/0012-9658(1998)079[1008:MOSPFC]2.0.CO;2; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Quevedo-Robledo L, 2010, J ARID ENVIRON, V74, P167, DOI 10.1016/j.jaridenv.2009.08.002; Rajaniemi TK, 2009, J VEG SCI, V20, P836, DOI 10.1111/j.1654-1103.2009.01086.x; Rivas-Arancibia SP, 2006, J ARID ENVIRON, V67, P416, DOI 10.1016/j.jaridenv.2006.03.005; Soil Survey Staff, 1994, KEYS SOIL TAX; Soliveres S, 2011, PERSPECT PLANT ECOL, V13, P247, DOI 10.1016/j.ppees.2011.06.001; Stokes CJ, 2010, ECOLOGY, V91, P1152, DOI 10.1890/08-1105.1; Stoll P., 2000, GEOMETRY ECOLOGICAL, P11, DOI DOI 10.1017/CBO9780511525537.003; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Tay T, 2004, Z NATURFORSCH C, V59, P384; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; TIELBORGER K, 1995, ECOSCIENCE, V2, P141, DOI 10.1080/11956860.1995.11682278; TILMAN D, 1988; Treberg MA, 2010, J VEG SCI, V21, P761, DOI 10.1111/j.1654-1103.2010.01182.x; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; WEIHER E, 1995, OIKOS, V73, P323, DOI 10.2307/3545956; Weiher E, 1999, ECOLOGICAL ASSEMBLY, P130, DOI DOI 10.1017/CBO9780511542237.006; Winder L, 2001, ECOL LETT, V4, P568, DOI 10.1046/j.1461-0248.2001.00269.x; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	77	70	73	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41270	10.1371/journal.pone.0041270	http://dx.doi.org/10.1371/journal.pone.0041270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848455	gold, Green Published			2022-12-27	WOS:000306950200053
J	Rogne, P; Ozdowy, P; Richter, C; Saxena, K; Schwalbe, H; Kuhn, LT				Rogne, Per; Ozdowy, Przemyslaw; Richter, Christian; Saxena, Krishna; Schwalbe, Harald; Kuhn, Lars T.			Atomic-Level Structure Characterization of an Ultrafast Folding Mini-Protein Denatured State	PLOS ONE			English	Article							TRP-CAGE MINIPROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; NMR RELAXATION MEASUREMENTS; ACID-UNFOLDED STATE; BACKBONE DYNAMICS; RANDOM COIL; HYDROPHOBIC COLLAPSE; RESIDUAL STRUCTURE; HETERONUCLEAR NMR; EARLY EVENTS	Atomic-level analyses of non-native protein ensembles constitute an important aspect of protein folding studies to reach a more complete understanding of how proteins attain their native form exhibiting biological activity. Previously, formation of hydrophobic clusters in the 6 M urea-denatured state of an ultrafast folding mini-protein known as TC5b from both photo-CIDNP NOE transfer studies and FCS measurements was observed. Here, we elucidate the structural properties of this mini-protein denatured in 6 M urea performing N-15 NMR relaxation studies together with a thorough NOE analysis. Even though our results demonstrate that no elements of secondary structure persist in the denatured state, the heterogeneous distribution of R-2 rate constants together with observing pronounced heteronuclear NOEs along the peptide backbone reveals specific regions of urea-denatured TC5b exhibiting a high degree of structural rigidity more frequently observed for native proteins. The data are complemented with studies on two TC5b point mutants to verify the importance of hydrophobic interactions for fast folding. Our results corroborate earlier findings of a hydrophobic cluster present in urea-denatured TC5b comprising both native and non-native contacts underscoring their importance for ultra rapid folding. The data assist in finding ways of interpreting the effects of pre-existing native and/or non-native interactions on the ultrafast folding of proteins; a fact, which might have to be considered when defining the starting conditions for molecular dynamics simulation studies of protein folding.	[Rogne, Per; Ozdowy, Przemyslaw; Kuhn, Lars T.] European Neurosci Inst Gottingen, Gottingen, Germany; [Rogne, Per; Ozdowy, Przemyslaw; Kuhn, Lars T.] DFG Res Ctr Mol Physiol Brain CMPB, EXC Microscopy Nanometer Range 171, Gottingen, Germany; [Richter, Christian; Saxena, Krishna; Schwalbe, Harald] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany; [Richter, Christian; Saxena, Krishna; Schwalbe, Harald] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Frankfurt, Germany	German Research Foundation (DFG); Goethe University Frankfurt; Goethe University Frankfurt	Rogne, P (corresponding author), European Neurosci Inst Gottingen, Gottingen, Germany.	lars.kuhn@gwdg.de	Kuhn, Lars Thorsten/J-5451-2015; Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Kuhn, Lars Thorsten/0000-0002-3701-580X; Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909; Rogne, Per/0000-0002-3687-9200	Biotechnology and Biological Sciences Research Council (BBSRC); German National Academic Foundation; DFG [EXC 115, EXC 171]; European Union through the European Commission [RII-026145]; Gottingen University Medical School; Max Planck Society	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German National Academic Foundation; DFG(German Research Foundation (DFG)); European Union through the European Commission; Gottingen University Medical School; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was carried out with support from the Biotechnology and Biological Sciences Research Council (BBSRC) to LTK, the German National Academic Foundation (LTK), the DFG (EXC 115 to HS; EXC 171 to LTK), and the European Union through the Sixth Framework Programme (FP 6) 'EU-NMR' (Contract No. RII-026145) of the European Commission. The European Neuroscience Institute Gottingen (ENI-G) is jointly funded by the Gottingen University Medical School and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; ARCUS VL, 1995, J MOL BIOL, V254, P305, DOI 10.1006/jmbi.1995.0618; Barua B, 2008, PROTEIN ENG DES SEL, V21, P171, DOI 10.1093/protein/gzm082; Bunagan MR, 2006, J PHYS CHEM B, V110, P3759, DOI 10.1021/jp055288z; Chowdhury S, 2004, J PHYS CHEM B, V108, P13855, DOI 10.1021/jp0478920; Chowdhury S, 2003, J MOL BIOL, V327, P711, DOI 10.1016/S0022-2836(03)00177-3; Copps J, 2007, BIOPOLYMERS, V88, P427, DOI 10.1002/bip.20709; Culik RM, 2011, ANGEW CHEM INT EDIT, V50, P10884, DOI 10.1002/anie.201104085; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dennis CA, 1998, BIOCHEM J, V333, P183, DOI 10.1042/bj3330183; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Ding F, 2005, BIOPHYS J, V88, P147, DOI 10.1529/biophysj.104.046375; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyer RB, 2007, CURR OPIN STRUC BIOL, V17, P38, DOI 10.1016/j.sbi.2007.01.001; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Farrow NA, 1997, BIOCHEMISTRY-US, V36, P2390, DOI 10.1021/bi962548h; Felitsky DJ, 2008, P NATL ACAD SCI USA, V105, P6278, DOI 10.1073/pnas.0710641105; Fernandez A, 2003, FEBS LETT, V536, P187, DOI 10.1016/S0014-5793(03)00056-5; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; FERSHT AR, 1995, CURR OPIN STRUC BIOL, V5, P79, DOI 10.1016/0959-440X(95)80012-P; Heyda J, 2011, J PHYS CHEM B, V115, P8910, DOI 10.1021/jp200790h; Hills RD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000827; Hudaky P, 2008, BIOCHEMISTRY-US, V47, P1007, DOI 10.1021/bi701371x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KARPLUS M, 1976, NATURE, V260, P404, DOI 10.1038/260404a0; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Le Duff CS, 2006, J MOL BIOL, V364, P824, DOI 10.1016/j.jmb.2006.09.037; LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; McCammon JA, 1996, P NATL ACAD SCI USA, V93, P11426, DOI 10.1073/pnas.93.21.11426; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102; PALMER AG, 1992, J AM CHEM SOC, V114, P9059, DOI 10.1021/ja00049a043; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Paschek D, 2008, P NATL ACAD SCI USA, V105, P17754, DOI 10.1073/pnas.0804775105; Peng JW, 1995, BIOCHEMISTRY-US, V34, P16733, DOI 10.1021/bi00051a023; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; PTITSYN OB, 1995, TRENDS BIOCHEM SCI, V20, P376, DOI 10.1016/S0968-0004(00)89081-7; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Rovo P, 2011, J PEPT SCI, V17, P610, DOI 10.1002/psc.1377; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q; Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Smith LJ, 1996, FOLD DES, V1, pR95, DOI 10.1016/S1359-0278(96)00046-6; Snow CD, 2002, J AM CHEM SOC, V124, P14548, DOI 10.1021/ja028604l; STONE MJ, 1993, BIOCHEMISTRY-US, V32, P426, DOI 10.1021/bi00053a007; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Tozawa K, 2005, BIOCHEMISTRY-US, V44, P11496, DOI 10.1021/bi0503596; Uversky VN, 2002, FEBS LETT, V515, P79, DOI 10.1016/S0014-5793(02)02441-9; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Williams DV, 2011, BIOCHEMISTRY-US, V50, P1143, DOI 10.1021/bi101555y; Wirmer J, 2006, J BIOMOL NMR, V35, P175, DOI 10.1007/s10858-006-9026-9; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Wu XM, 2011, COMPUT THEOR CHEM, V973, P1, DOI 10.1016/j.comptc.2011.06.018; Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595; Yao J, 2001, BIOCHEMISTRY-US, V40, P3561, DOI 10.1021/bi002776i; Zhan LX, 2007, PROTEINS, V66, P436, DOI 10.1002/prot.21157; Zhang XC, 2005, BIOCHEMISTRY-US, V44, P8117, DOI 10.1021/bi0501939; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	80	15	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41301	10.1371/journal.pone.0041301	http://dx.doi.org/10.1371/journal.pone.0041301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848459	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200054
J	Tang, Y; Gao, HJ; Zou, W; Kurths, J				Tang, Yang; Gao, Huijun; Zou, Wei; Kurths, Juergen			Identifying Controlling Nodes in Neuronal Networks in Different Scales	PLOS ONE			English	Article							CONNECTIVITY; SYNCHRONIZATION; ORGANIZATION; EVOLUTION; CLUSTERS; HUBS	Recent studies have detected hubs in neuronal networks using degree, betweenness centrality, motif and synchronization and revealed the importance of hubs in their structural and functional roles. In addition, the analysis of complex networks in different scales are widely used in physics community. This can provide detailed insights into the intrinsic properties of networks. In this study, we focus on the identification of controlling regions in cortical networks of cats' brain in microscopic, mesoscopic and macroscopic scales, based on single-objective evolutionary computation methods. The problem is investigated by considering two measures of controllability separately. The impact of the number of driver nodes on controllability is revealed and the properties of controlling nodes are shown in a statistical way. Our results show that the statistical properties of the controlling nodes display a concave or convex shape with an increase of the allowed number of controlling nodes, revealing a transition in choosing driver nodes from the areas with a large degree to the areas with a low degree. Interestingly, the community Auditory in cats' brain, which has sparse connections with other communities, plays an important role in controlling the neuronal networks.	[Tang, Yang; Gao, Huijun; Kurths, Juergen] Harbin Inst Technol, Res Inst Intelligent Control & Syst, Harbin 150006, Peoples R China; [Tang, Yang; Zou, Wei; Kurths, Juergen] Humboldt Univ, Inst Phys, D-10099 Berlin, Germany; [Tang, Yang; Zou, Wei] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Zou, Wei] Huazhong Univ Sci & Technol, Sch Math & Stat, Wuhan 430074, Peoples R China; [Kurths, Juergen] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen, Scotland	Harbin Institute of Technology; Humboldt University of Berlin; Potsdam Institut fur Klimafolgenforschung; Huazhong University of Science & Technology; University of Aberdeen	Tang, Y (corresponding author), Harbin Inst Technol, Res Inst Intelligent Control & Syst, Harbin 150006, Peoples R China.	tangtany@gmail.com; juergen.kurths@pik-potsdam.de	zou, wei/D-4391-2013; Gao, Huijun/B-6853-2013		973 Project [2009CB320600]; National Natural Science Foundation of China [60825303, 60834003, 61021002, 11171125]; Key Laboratory of Integrated Automation for the Process Industry (Northeastern University); Fundamental Research Funds for the Central Universities of China [2011QN161]; SUMO (EU); German Research Foundation (DFG); Alexander von Humboldt Foundation of Germany	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Integrated Automation for the Process Industry (Northeastern University)(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); SUMO (EU)(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Alexander von Humboldt Foundation of Germany(Alexander von Humboldt Foundation)	This research is supported by 973 Project (2009CB320600), the National Natural Science Foundation of China (60825303, 60834003, 61021002, 11171125) and the Key Laboratory of Integrated Automation for the Process Industry (Northeastern University), the Fundamental Research Funds for the Central Universities of China (2011QN161), SUMO (EU), grants of the German Research Foundation (DFG) in the Research Group FOR 868 Computational Modeling of Behavioral, Cognitive, and Neural Dynamics and in the IRTG 1740 (DFG) and the Alexander von Humboldt Foundation of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Brest J, 2006, IEEE T EVOLUT COMPUT, V10, P646, DOI 10.1109/TEVC.2006.872133; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Donetti L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.188701; Egerstedt M, 2011, NATURE, V473, P158, DOI 10.1038/473158a; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gao J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092002; Gomez S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016114; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3532801; Gomez-Gardenes J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.128701; Gomez-Gardenes J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012313; Granell C, 2011, CHAOS, V21, DOI 10.1063/1.3560932; Gutierrez R, 2008, SCI REPORTS, V2, P396; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lu JQ, 2009, IEEE T NEURAL NETWOR, V20, P1617, DOI 10.1109/TNN.2009.2027810; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Pecora LM, 1998, PHYS REV LETT, V80, P2109, DOI 10.1103/PhysRevLett.80.2109; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Ravoori B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.034102; Reichardt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021282; Ren W, 2008, COMMUN CONTROL ENG, P3; Restrepo JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094102; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; SCANNELL JW, 1993, CURR BIOL, V3, P191, DOI 10.1016/0960-9822(93)90331-H; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Schinkel S, 2011, J NEUROSCI METH, V197, P333, DOI 10.1016/j.jneumeth.2011.02.018; Son SW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.228702; Sorrentino F, 2007, CHAOS, V17, DOI 10.1063/1.2743098; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sun XJ, 2011, CHAOS, V21, DOI 10.1063/1.3559136; Tang Y, 2012, IEEE T IND INFORM, V8, P828, DOI 10.1109/TII.2012.2187911; Tang Y, 2011, CHAOS, V21, DOI 10.1063/1.3595701; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Volman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020572; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang XF, 2002, IEEE T CIRCUITS-I, V49, P54, DOI 10.1109/81.974874; Wang XF, 2002, PHYSICA A, V310, P521, DOI 10.1016/S0378-4371(02)00772-0; Wang Y, 2011, IEEE T EVOLUT COMPUT, V15, P55, DOI 10.1109/TEVC.2010.2087271; Zamora-Lopez Gorka, 2010, Front Neuroinform, V4, P1, DOI 10.3389/neuro.11.001.2010; Zemanova L, 2006, PHYSICA D, V224, P202, DOI 10.1016/j.physd.2006.09.008; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613; Zhang WB, 2011, CHAOS, V21, DOI 10.1063/1.3671609; Zhou CS, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/178; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103; Zhou CS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.034101; Zou W, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046206; Zou W, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.065204	56	47	48	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41375	10.1371/journal.pone.0041375	http://dx.doi.org/10.1371/journal.pone.0041375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848475	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200058
J	Wibrand, K; Pai, B; Siripornmongcolchai, T; Bittins, M; Berentsen, B; Ofte, ML; Weigel, A; Skaftnesmo, KO; Bramham, CR				Wibrand, Karin; Pai, Balagopal; Siripornmongcolchai, Taweeporn; Bittins, Margarethe; Berentsen, Birgitte; Ofte, May Lillian; Weigel, Arwed; Skaftnesmo, Kai Ove; Bramham, Clive R.			MicroRNA Regulation of the Synaptic Plasticity-Related Gene Arc	PLOS ONE			English	Article							CYTOSKELETON-ASSOCIATED PROTEIN; MESSENGER-RNA TRANSLATION; GYRUS IN-VIVO; NEUROTROPHIC FACTOR; RECEPTOR ACTIVATION; AMPA RECEPTORS; FEEDBACK LOOP; ARC/ARG3.1; EXPRESSION; BRAIN	Expression of activity-regulated cytoskeleton associated protein (Arc) is crucial for diverse types of experience-dependent synaptic plasticity and long-term memory in mammals. However, the mechanisms governing Arc-specific translation are little understood. Here, we asked whether Arc translation is regulated by microRNAs. Bioinformatic analysis predicted numerous candidate miRNA binding sites within the Arc 3'-untranslated region (UTR). Transfection of the corresponding microRNAs in human embryonic kidney cells inhibited expression of an Arc 3'UTR luciferase reporter from between 10 to 70% across 16 microRNAs tested. Point mutation and deletion of the microRNA-binding seed-region for miR-34a, miR-326, and miR-19a partially or fully rescued reporter expression. In addition, expression of specific microRNA pairs synergistically modulated Arc reporter expression. In primary rat hippocampal neuronal cultures, ectopic expression of miR-34a, miR-193a, or miR-326, downregulated endogenous Arc protein expression in response to BDNF treatment. Conversely, treatment of neurons with cell-penetrating, peptide nucleic acid (PNA) inhibitors of miR-326 enhanced Arc mRNA expression. BDNF dramatically upregulated neuronal expression of Arc mRNA and miR-132, a known BDNF-induced miRNA, without affecting expression of Arc-targeting miRNAs. Developmentally, miR-132 was upregulated at day 10 in vitro whereas Arc-targeting miRNAs were downregulated. In the adult brain, LTP induction in the dentate gyrus triggered massive upregulation of Arc and upregulation of miR-132 without affecting levels of mature Arc-targeting miRNAs. Turning to examine miRNA localization, qPCR analysis of dentate gyrus synaptoneurosome and total lysates fractions demonstrated synaptic enrichment relative to small nucleolar RNA. In conclusion, we find that Arc is regulated by multiple miRNAs and modulated by specific miRNA pairs in vitro. Furthermore, we show that, in contrast to miR-132, steady state levels of Arc-targeting miRNAs do not change in response to activity-dependent expression of Arc in hippocampal neurons in vitro or during LTP in vivo.	[Wibrand, Karin; Pai, Balagopal; Siripornmongcolchai, Taweeporn; Bittins, Margarethe; Berentsen, Birgitte; Ofte, May Lillian; Weigel, Arwed; Skaftnesmo, Kai Ove; Bramham, Clive R.] Univ Bergen, Dept Biomed, Bergen, Norway; [Wibrand, Karin; Pai, Balagopal; Siripornmongcolchai, Taweeporn; Bittins, Margarethe; Berentsen, Birgitte; Ofte, May Lillian; Weigel, Arwed; Skaftnesmo, Kai Ove; Bramham, Clive R.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway	University of Bergen; University of Bergen	Bramham, CR (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	clive.bramham@biomed.uib.no	Skaftnesmo, kai ove/AAF-6071-2021; Pai, Balagopal/AAY-8292-2020; Berentsen, Birgitte/AAK-9028-2021; Berentsen, Birgitte/AAG-9398-2020; Bramham, Clive/Q-1854-2018	Pai, Balagopal/0000-0003-3196-055X; Berentsen, Birgitte/0000-0003-3574-7078; Berentsen, Birgitte/0000-0003-3574-7078; Bramham, Clive/0000-0001-5958-7115	Research Council of Norway [186115, 204861, 199355]; Poland-Norway Financial Mechanism, ERASysBio+ Project [122]; University of Bergen	Research Council of Norway(Research Council of Norway); Poland-Norway Financial Mechanism, ERASysBio+ Project; University of Bergen	Supported by The Research Council of Norway (Grants 186115, 204861, and 199355), the Poland-Norway Financial Mechanism, ERASysBio+ Project 122, and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2011, P NATL ACAD SCI USA, V108, P21093, DOI 10.1073/pnas.1112061109; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Alder J, 2003, J NEUROSCI, V23, P10800; ALME MN, 2007, NEURAL PLAST, P26496; Ashraf SI, 2006, CURR OPIN NEUROBIOL, V16, P535, DOI 10.1016/j.conb.2006.08.007; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Czerniawski J, 2011, J NEUROSCI, V31, P11200, DOI 10.1523/JNEUROSCI.2211-11.2011; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiore R, 2009, EMBO J; Fiore R, 2011, EMBO J, V30, P4116, DOI 10.1038/emboj.2011.356; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Haramati S, 2011, J NEUROSCI, V31, P14191, DOI 10.1523/JNEUROSCI.1673-11.2011; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Junker A, 2011, FEBS LETT, V585, P3738, DOI 10.1016/j.febslet.2011.03.052; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Kosik KS, 2009, NAT REV NEUROSCI, V10, P754, DOI 10.1038/nrn2713; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lugli G, 2008, NEUROCHEMISTRY; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Moonat S, 2011, ADDICT BIOL, V16, P238, DOI 10.1111/j.1369-1600.2010.00275.x; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Oh SY, 2010, OLIGONUCLEOTIDES, V20, P225, DOI 10.1089/oli.2010.0238; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Raju CS, 2011, MOL BIOL CELL, V22, P1864, DOI 10.1091/mbc.E10-11-0904; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Shin CY, 2004, J NEUROSCI, V24, P9425, DOI 10.1523/JNEUROSCI.2457-04.2004; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Smalheiser NR, 2008, NEUROSCI RES, V62, P236, DOI 10.1016/j.neures.2008.08.010; Soule J, 2012, J BIOL CHEM, V287, P22354, DOI 10.1074/jbc.M112.376491; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Tognini P, 2011, NAT NEUROSCI, V14, P1237, DOI 10.1038/nn.2920; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vo NK, 2010, CURR OPIN NEUROBIOL, V20, P457, DOI 10.1016/j.conb.2010.04.002; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	75	68	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41688	10.1371/journal.pone.0041688	http://dx.doi.org/10.1371/journal.pone.0041688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844515	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600042
J	Ariza, M; Garolera, M; Jurado, MA; Garcia-Garcia, I; Hernan, I; Sanchez-Garre, C; Vernet-Vernet, M; Sender-Palacios, MJ; Marques-Iturria, I; Pueyo, R; Segura, B; Narberhaus, A				Ariza, Mar; Garolera, Maite; Angeles Jurado, Maria; Garcia-Garcia, Isabel; Hernan, Imma; Sanchez-Garre, Consuelo; Vernet-Vernet, Maria; Jose Sender-Palacios, Maria; Marques-Iturria, Idoia; Pueyo, Roser; Segura, Barbara; Narberhaus, Ana			Dopamine Genes (DRD2/ANKK1-TaqA1 and DRD4-7R) and Executive Function: Their Interaction with Obesity	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; D-4 RECEPTOR GENE; BODY-MASS INDEX; 7-REPEAT ALLELE; MOLECULAR-GENETICS; D2 RECEPTOR; COGNITIVE PERFORMANCE; ORBITOFRONTAL CORTEX; INHIBITORY CONTROL; A(1) ALLELE	Obesity is a multifactorial disease caused by the interaction between genotype and environment, and it is considered to be a type of addictive alteration. The A1 allele of the DRD2/ANKK1-TaqIA gene has been associated with addictive disorders, with obesity and with the performance in executive functions. The 7 repeat allele of the DRD4 gene has likewise been associated with the performance in executive functions, as well as with addictive behaviors and impulsivity. Participants were included in the obesity group (N = 42) if their body mass index (BMI) was equal to or above 30, and in the lean group (N = 42) if their BMI was below 25. The DRD2/ANKK1-TaqIA and DRD4 VNTR polymorphisms were obtained. All subjects underwent neuropsychological assessment. Eating behavior traits were evaluated. The 'DRD2/ANKK1-TaqIA A1-allele status' had a significant effect on almost all the executive variables, but no significant 'DRD4 7R-allele status' effects were observed for any of the executive variables analyzed. There was a significant 'group' x 'DRD2/ANKK1-TaqIA A1-allele status' interaction effect on LN and 'group' x 'DRD4 7R-allele status' interaction effect on TMT B-A score. Being obese and a carrier of the A1 allele of DRD2/ANKK1-TaqIA or the 7R allele of DRD4 VNTR polymorphisms could confer a weakness as regards the performance of executive functions.	[Ariza, Mar; Angeles Jurado, Maria; Garcia-Garcia, Isabel; Marques-Iturria, Idoia; Pueyo, Roser; Segura, Barbara; Narberhaus, Ana] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Ariza, Mar; Angeles Jurado, Maria; Pueyo, Roser; Narberhaus, Ana] Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Ariza, Mar; Garolera, Maite; Angeles Jurado, Maria; Pueyo, Roser; Segura, Barbara; Narberhaus, Ana] Grp Recerca Consolidat Neuropsicol SGR0941, Barcelona, Spain; [Garolera, Maite] Hosp Terrassa Consorci Sanitari Terrassa, Neuropsychol Unit, Terrassa, Spain; [Hernan, Imma] Hosp Terrassa Consorci Sanitari Terrassa, Mol Genet Unit, Terrassa, Spain; [Sanchez-Garre, Consuelo] Hosp Terrassa Consorci Sanitari Terrassa, Dept Pediat, Pediat Endocrinol Unit, Terrassa, Spain; [Vernet-Vernet, Maria; Jose Sender-Palacios, Maria] Consorci Sanitari Terrassa, CAP Terrassa Nord, Terrassa, Spain	University of Barcelona; University of Barcelona	Ariza, M (corresponding author), Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain.	MGarolera@cst.cat	Garcia-Garcia, Isabel/J-8085-2019; Ariza, Mar/F-2754-2019; Segura, Barbara/B-9038-2017; Garolera, Maite/A-3109-2015; Garolera, Maite/D-7811-2012; JURADO, MARIA ANGELES/E-1745-2011; Pueyo, Roser/G-3433-2011	Garcia-Garcia, Isabel/0000-0002-5873-2664; Segura, Barbara/0000-0002-9673-5479; Garolera, Maite/0000-0001-7443-8249; Garolera, Maite/0000-0001-7443-8249; JURADO, MARIA ANGELES/0000-0002-9403-1670; Pueyo, Roser/0000-0002-8230-8409; Ariza, Mar/0000-0003-1020-6945	Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya (AGAUR) [2009SGR941]; Ministerio de Ciencia e Innovacion [PSI2008-05803-C02-01/PSIC, PSI2008-05803-C02-02/PSIC]; Generalitat de Catalunya [FI-2009]	Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya (AGAUR); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grant 2009SGR941 from the Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya (AGAUR), by grants PSI2008-05803-C02-01/PSIC to Maria Angeles Jurado (PhD) and PSI2008-05803-C02-02/PSIC to Maite Garolera (PhD) (both from the Ministerio de Ciencia e Innovacion), and by grant FI-2009 from the Generalitat de Catalunya to Isabel Garcia-Garcia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], 1999, WISCONSIN CARD SORTI; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Banegas JR, 2003, EUR J CLIN NUTR, V57, P201, DOI 10.1038/sj.ejcn.1601538; Bartres-Faz D, 2002, NEUROREPORT, V13, P1121, DOI 10.1097/00001756-200207020-00010; Benton AL., 1983, MULTILINGUAL APHASIA; BERMAN SM, 1995, BEHAV GENET, V25, P45, DOI 10.1007/BF02197241; Blum K, 1996, PHARMACOGENETICS, V6, P297, DOI 10.1097/00008571-199608000-00003; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Bombin I, 2008, AM J MED GENET B, V147B, P873, DOI 10.1002/ajmg.b.30710; Braw Y, 2011, J AFFECT DISORDERS, V129, P342, DOI 10.1016/j.jad.2010.07.032; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Cohen J.E., 1988, STAT POWER ANAL BEHA; COMINGS DE, 1993, BIOCHEM MED METAB B, V50, P176, DOI 10.1006/bmmb.1993.1059; Comings DE, 1999, AM J MED GENET, V88, P358, DOI 10.1002/(SICI)1096-8628(19990820)88:4<358::AID-AJMG13>3.0.CO;2-G; Congdon E, 2008, AM J MED GENET B, V147B, P27, DOI 10.1002/ajmg.b.30557; Crowe SF, 2000, ASSESSMENT, V7, P113, DOI 10.1177/107319110000700202; Cserjesi R, 2009, APPETITE, V52, P535, DOI 10.1016/j.appet.2009.01.003; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Eisenberg DTA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-2; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; First MB., 1996, STRUCTURED CLIN INTE; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Froehlich TE, 2007, BIOL PSYCHIAT, V62, P243, DOI 10.1016/j.biopsych.2006.09.039; Golden CJ, 1995, STROOP TEST COLORES; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gustafson D, 2004, NEUROLOGY, V63, P1876, DOI 10.1212/01.WNL.0000141850.47773.5F; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; HENDERSON M, 1987, BRIT J PSYCHIAT, V150, P18, DOI 10.1192/bjp.150.1.18; Ito H, 1999, NEUROIMAGE, V9, P235, DOI 10.1006/nimg.1998.0401; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Langley K, 2004, AM J PSYCHIAT, V161, P133, DOI 10.1176/appi.ajp.161.1.133; Levitan RD, 2004, BIOL PSYCHIAT, V56, P665, DOI 10.1016/j.biopsych.2004.08.013; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; LIDOW MS, 1989, P NATL ACAD SCI USA, V86, P6412, DOI 10.1073/pnas.86.16.6412; Lokken KL, 2010, AM SURGEON, V76, P55; Manor I, 2002, MOL PSYCHIATR, V7, P790, DOI 10.1038/sj.mp.4001078; Markett S, 2011, COGN AFFECT BEHAV NE, V11, P644, DOI 10.3758/s13415-011-0058-6; MeadorWoodruff JH, 1997, ARCH GEN PSYCHIAT, V54, P1089; MEADORWOODRUFF JH, 1994, NEUROPSYCHOPHARMACOL, V10, P239, DOI 10.1038/npp.1994.27; MeadorWoodruff JH, 1996, NEUROPSYCHOPHARMACOL, V15, P17, DOI 10.1016/0893-133X(95)00150-C; Meyer JH, 2006, AM J PSYCHIAT, V163, P1594, DOI 10.1176/appi.ajp.163.9.1594; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Noble EP, 1997, AM J MED GENET, V74, P162; NOBLE EP, 1994, INT J EAT DISORDER, V15, P205, DOI 10.1002/1098-108X(199404)15:3&lt;205::AID-EAT2260150303&gt;3.0.CO;2-P; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reuter M, 2005, BEHAV BRAIN RES, V164, P93, DOI 10.1016/j.bbr.2005.06.002; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Ritchie T, 1996, BRAIN RES, V718, P193, DOI 10.1016/0006-8993(96)00068-6; Rodriguez-Jimenez R, 2006, EUR PSYCHIAT, V21, P66, DOI 10.1016/j.eurpsy.2005.05.010; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Small DM, 2007, ANN NY ACAD SCI, V1121, P136, DOI 10.1196/annals.1401.002; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Smith A, 2005, TEST SIMBOLOS DIGITO; Spitz MR, 2000, NUTR RES, V20, P371, DOI 10.1016/S0271-5317(00)00130-5; Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swanson J, 2000, P NATL ACAD SCI USA, V97, P4754, DOI 10.1073/pnas.080070897; Szekely A, 2011, GENES BRAIN BEHAV, V10, P129, DOI 10.1111/j.1601-183X.2010.00645.x; Theisen FM, 2003, J NEURAL TRANSM, V110, P111, DOI 10.1007/s00702-002-0792-6; Tsai SJ, 2002, NEUROPSYCHOBIOLOGY, V45, P128, DOI 10.1159/000054951; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Volkow ND, 2007, AM J PSYCHIAT, V164, P708, DOI 10.1176/appi.ajp.164.5.708; Waldman ID, 2005, BIOL PSYCHIAT, V57, P1347, DOI 10.1016/j.biopsych.2005.03.002; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wechsler D, 1999, WAIS; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; Young JW, 2011, BEHAV BRAIN RES, V222, P183, DOI 10.1016/j.bbr.2011.03.054; Young RM, 2004, ADDICT BEHAV, V29, P1275, DOI 10.1016/j.addbeh.2004.06.012; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	82	52	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41482	10.1371/journal.pone.0041482	http://dx.doi.org/10.1371/journal.pone.0041482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848508	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600073
J	Moreno, E				Moreno, Eduardo			Design and Construction of "Synthetic Species"	PLOS ONE			English	Article							REGULATORY EVOLUTION; MORPHOLOGICAL EVOLUTION; TYROSINE KINASE; DROSOPHILA EYE; CELL; GENE; PROTEIN; EXPRESSION; ENCODES; BIOLOGY	Synthetic biology is an area of biological research that combines science and engineering. Here, I merge the principles of synthetic biology and regulatory evolution to create a new species with a minimal set of known elements. Using preexisting transgenes and recessive mutations of Drosophila melanogaster, a transgenic population arises with small eyes and a different venation pattern that fulfils the criteria of a new species according to Mayr's Biological Species Concept. The population described here is the first transgenic organism that cannot hybridize with the original wild type population but remains fertile when crossed with other identical transgenic animals. I therefore propose the term "synthetic species" to distinguish it from "natural species", not only because it has been created by genetic manipulation, but also because it may never be able to survive outside the laboratory environment. The use of genetic engineering to design artificial species barriers could help us understand natural speciation and may have practical applications. For instance, the transition from transgenic organisms towards synthetic species could constitute a safety mechanism to avoid the hybridization of genetically modified animals with wild type populations, preserving biodiversity.	Univ Bern, Inst Cell Biol, Bern, Switzerland	University of Bern	Moreno, E (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	emoreno@izb.unibe.ch		moreno, eduardo/0000-0001-5040-452X				Barbash DA, 2010, GENETICS, V186, P1, DOI 10.1534/genetics.110.121459; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Coyne J.A., 2004, SPECIATION; Darwin C, 1859, ORIGIN SPECIES MEANS; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Greig D, 2009, HEREDITY, V102, P39, DOI 10.1038/hdy.2008.73; Karim FD, 1998, DEVELOPMENT, V125, P1; Kling J, 2009, NAT BIOTECHNOL, V27, P302, DOI 10.1038/nbt0409-302; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lutes AA, 2011, P NATL ACAD SCI USA, V108, P302; Marris E, 2010, NATURE, V467, P259, DOI 10.1038/467259a; Mayrose I, 2011, SCIENCE, V333, P1257, DOI 10.1126/science.1207205; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Ortiz-Barrientos D, 2009, ANN NY ACAD SCI, V1168, P156, DOI 10.1111/j.1749-6632.2009.04919.x; Pardo R, 2009, EMBO REP, V10, P1069, DOI 10.1038/embor.2009.208; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rhiner C, 2010, DEV CELL, V18, P985, DOI 10.1016/j.devcel.2010.05.010; RICE WR, 1988, AM NAT, V131, P911, DOI 10.1086/284831; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768	30	16	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39054	10.1371/journal.pone.0039054	http://dx.doi.org/10.1371/journal.pone.0039054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848349	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600003
J	Voormolen, EHJ; Woerdeman, PA; van Stralen, M; Noordmans, HJ; Viergever, MA; Regli, L; van der Sprenkel, JWB				Voormolen, Eduard H. J.; Woerdeman, Peter A.; van Stralen, Marijn; Noordmans, Herke Jan; Viergever, Max A.; Regli, Luca; van der Sprenkel, Jan Willem Berkelbach			Validation of Exposure Visualization and Audible Distance Emission for Navigated Temporal Bone Drilling in Phantoms	PLOS ONE			English	Article							LATERAL SUBOCCIPITAL APPROACH; IMAGE-GUIDED SURGERY; SKULL BASE	Background: A neuronavigation interface with extended function as compared with current systems was developed to aid during temporal bone surgery. The interface, named EVADE, updates the prior anatomical image and visualizes the bone drilling process virtually in real-time without need for intra-operative imaging. Furthermore, EVADE continuously calculates the distance from the drill tip to segmented temporal bone critical structures (e. g. the sigmoid sinus and facial nerve) and produces audiovisual warnings if the surgeon drills in too close vicinity. The aim of this study was to evaluate the accuracy and surgical utility of EVADE in physical phantoms. Methodology/Principal Findings: We performed 228 measurements assessing the position accuracy of tracking a navigated drill in the operating theatre. A mean target registration error of 1.33 +/- 0.61 mm with a maximum error of 3.04 mm was found. Five neurosurgeons each drilled two temporal bone phantoms, once using EVADE, and once using a standard neuronavigation interface. While using standard neuronavigation the surgeons damaged three modeled temporal bone critical structures. No structure was hit by surgeons utilizing EVADE. Surgeons felt better orientated and thought they had improved tumor exposure with EVADE. Furthermore, we compared the distances between surface meshes of the virtual drill cavities created by EVADE to actual drill cavities: average maximum errors of 2.54 +/- 0.49 mm and -2.70 +/- 0.48 mm were found. Conclusions/Significance: These results demonstrate that EVADE gives accurate feedback which reduces risks of harming modeled critical structures compared to a standard neuronavigation interface during temporal bone phantom drilling.	[Voormolen, Eduard H. J.; Woerdeman, Peter A.; Regli, Luca; van der Sprenkel, Jan Willem Berkelbach] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands; [Voormolen, Eduard H. J.; van Stralen, Marijn; Viergever, Max A.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Noordmans, Herke Jan] Univ Med Ctr Utrecht, Dept Med Technol & Clin Phys, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Voormolen, EHJ (corresponding author), Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands.	e.h.j.voormolen@umcutrecht.nl	van Stralen, Marijn/A-8552-2011; Viergever, Max A/J-1215-2014; Noordmans, Herke Jan/AAN-8366-2020	van Stralen, Marijn/0000-0002-3051-5000; Noordmans, Herke Jan/0000-0002-9913-4556	University Medical Center Utrecht, Utrecht, The Netherlands	University Medical Center Utrecht, Utrecht, The Netherlands(Netherlands Government)	This study was funded by a personal grant, named the 'Alexandre Suerman MD/PhD grant' obtained by the principal author (EHV) from the University Medical Center Utrecht, Utrecht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gharabaghi A, 2008, NEUROSURGERY, V63, P24, DOI [10.1227/01.neu.0000317370.15265.8b, 10.1227/01.NEU.0000249233.12860.EC]; Gharabaghi A, 2008, NEUROSURGERY, V63, P18, DOI [10.1227/01.NEU.0000297024.52502.BB, 10.1227/01.neu.0000317369.07641.9c]; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kral F, 2011, ARCH OTOLARYNGOL, V137, P144, DOI 10.1001/archoto.2010.249; Miller RS, 2006, OTOLARYNG HEAD NECK, V134, P778, DOI 10.1016/j.otohns.2005.12.015; Nemec SF, 2007, EUR J RADIOL, V62, P192, DOI 10.1016/j.ejrad.2006.11.029; Pillai P, 2008, NEUROSURGERY, V63, P326, DOI 10.1227/01.NEU.0000316429.19314.67; Pillai P, 2009, NEUROSURGERY, V65, P53, DOI 10.1227/01.NEU.0000343521.88537.16; Staecker H, 2001, SKULL BASE-INTERD AP, V11, P245, DOI 10.1055/s-2001-18631; Sure U, 2000, SURG NEUROL, V53, P563, DOI 10.1016/S0090-3019(00)00243-3; Van Havenbergh T, 2003, ACTA NEUROCHIR, V145, P737, DOI 10.1007/s00701-003-0054-x; Voormolen EH, 2011, P SPIE; Voormolen EH, 2011, NEUROSURGER IN PRESS; Woerdeman PA, 2009, NEUROSURGERY, V64, pS170, DOI 10.1227/01.NEU.0000335791.85615.38; Woerdeman PA, 2009, J NEUROSURG, V110, P257, DOI 10.3171/2008.3.17431; Wurm J, 2008, INT J MED ROBOT COMP, V4, P202, DOI 10.1002/rcs.197	16	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41262	10.1371/journal.pone.0041262	http://dx.doi.org/10.1371/journal.pone.0041262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848452	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000306806600047
J	Zhang, ML; Su, SC; Bhatnagar, RK; Hassett, DJ; Lu, LJ				Zhang, Minlu; Su, Shengchang; Bhatnagar, Raj K.; Hassett, Daniel J.; Lu, Long J.			Prediction and Analysis of the Protein Interactome in Pseudomonas aeruginosa to Enable Network-Based Drug Target Selection	PLOS ONE			English	Article							ESSENTIAL GENES; DATABASE; TOOL; COMPLEXES; GENOMES; ATLAS; PFAM	Pseudomonas aeruginosa (PA) is a ubiquitous opportunistic pathogen that is capable of causing highly problematic, chronic infections in cystic fibrosis and chronic obstructive pulmonary disease patients. With the increased prevalence of multi-drug resistant PA, the conventional 'one gene, one drug, one disease'' paradigm is losing effectiveness. Network pharmacology, on the other hand, may hold the promise of discovering new drug targets to treat a variety of PA infections. However, given the urgent need for novel drug target discovery, a PA protein-protein interaction (PPI) network of high accuracy and coverage, has not yet been constructed. In this study, we predicted a genome-scale PPI network of PA by integrating various genomic features of PA proteins/genes by a machine learning-based approach. A total of 54,107 interactions covering 4,181 proteins in PA were predicted. A high-confidence network combining predicted high-confidence interactions, a reference set and verified interactions that consist of 3,343 proteins and 19,416 potential interactions was further assembled and analyzed. The predicted interactome network from this study is the first large-scale PPI network in PA with significant coverage and high accuracy. Subsequent analysis, including validations based on existing small-scale PPI data and the network structure comparison with other model organisms, shows the validity of the predicted PPI network. Potential drug targets were identified and prioritized based on their essentiality and topological importance in the high-confidence network. Host-pathogen protein interactions between human and PA were further extracted and analyzed. In addition, case studies were performed on protein interactions regarding anti-sigma factor MucA, negative periplasmic alginate regulator MucB, and the transcriptional regulator RhlR. A web server to access the predicted PPI dataset is available at http://research.cchmc.org/PPIdatabase/.	[Zhang, Minlu; Lu, Long J.] Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH USA; [Zhang, Minlu; Lu, Long J.] Univ Cincinnati, Sch Comp Sci & Informat, Cincinnati, OH USA; [Su, Shengchang; Hassett, Daniel J.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Bhatnagar, Raj K.] Univ Cincinnati, Sch Elect & Comp Syst, Cincinnati, OH USA; [Lu, Long J.] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Zhang, ML (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH USA.	long.lu@cchmc.org	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022		Cincinnati Children's Hospital Medical Center (CCHMC) Trustee Grant; Midwest Center for Emerging Infectious Diseases (MI-CEID); University Research Council (URC), University of Cincinnati	Cincinnati Children's Hospital Medical Center (CCHMC) Trustee Grant; Midwest Center for Emerging Infectious Diseases (MI-CEID); University Research Council (URC), University of Cincinnati	This research was supported by a Cincinnati Children's Hospital Medical Center (CCHMC) Trustee Grant and a grant from the Midwest Center for Emerging Infectious Diseases (MI-CEID) awarded to LJL, and a 2010-11 Graduate Student Research Fellowship from University Research Council (URC), University of Cincinnati awarded to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ATTNEAVE F, 1980, CC/SOC BEHAV SCI, P10; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Deng MH, 2002, GENOME RES, V12, P1540, DOI 10.1101/gr.153002; Driscoll T, 2009, NUCLEIC ACIDS RES, V37, pD647, DOI 10.1093/nar/gkn799; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Florez AF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-484; Foundation CF, 2009, CYST FIBR FDN PAT RE; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goll J, 2008, BIOINFORMATICS, V24, P1743, DOI 10.1093/bioinformatics/btn285; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huang S, 2002, DRUG DISCOV TODAY, V7, pS163, DOI 10.1016/S1359-6446(02)02463-7; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lee CYK, 2007, CHEST, V131, P796, DOI 10.1378/chest.06-1524; Liu H, 1995, PROC INT C TOOLS ART, P388, DOI 10.1109/TAI.1995.479783; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Lu LJ, 2007, TRENDS BIOCHEM SCI, V32, P320, DOI 10.1016/j.tibs.2007.06.003; Lu LJ, 2005, DATA ANALYSIS AND VISUALIZATION IN GENOMICS AND PROTEOMICS, P61, DOI 10.1002/0470094419.ch5; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; McDowall MD, 2009, NUCLEIC ACIDS RES, V37, pD651, DOI 10.1093/nar/gkn870; Park DU, 2005, BIOINFORMATICS, V21, P3234, DOI 10.1093/bioinformatics/bti512; Park SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S18; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Retief J D, 2000, Methods Mol Biol, V132, P243; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shannon CE, 1997, M D COMPUT, V14, P306; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Sprinzak E, 2003, J MOL BIOL, V327, P919, DOI 10.1016/S0022-2836(03)00239-0; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suthram S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-360; Szklarczyk D, 2010, NUCL ACIDS RES; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vicens Q, 2002, CHEM BIOL, V9, P747, DOI 10.1016/S1074-5521(02)00153-9; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xia Y, 2006, J MOL BIOL, V357, P339, DOI 10.1016/j.jmb.2005.12.067; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zhang M, 2010, KNOWLEDGE BASED BIOI, P253; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	72	26	33	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41202	10.1371/journal.pone.0041202	http://dx.doi.org/10.1371/journal.pone.0041202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848443	Green Submitted, gold, Green Published			2022-12-27	WOS:000306751300026
J	Hamanaka, Y; Kinoshita, M; Homberg, U; Arikawa, K				Hamanaka, Yoshitaka; Kinoshita, Michiyo; Homberg, Uwe; Arikawa, Kentaro			Immunocytochemical Localization of Amines and GABA in the Optic Lobe of the Butterfly, Papilio xuthus	PLOS ONE			English	Article							SEROTONIN-IMMUNOREACTIVE NEURONS; OCTOPAMINE-LIKE IMMUNOREACTIVITY; VISUAL-SYSTEM; DROSOPHILA-MELANOGASTER; NERVOUS-SYSTEM; SUBESOPHAGEAL GANGLION; SYNAPTIC ORGANIZATION; DETECTION PATHWAY; TANGENTIAL CELLS; MOTION DETECTION	Butterflies have sophisticated color vision. While the spectral organization of the compound eye has been well characterized in the Japanese yellow swallowtail butterfly, Papilio xuthus, neural mechanisms underlying its color vision are largely unexplored. Towards a better understanding of signal processing in the visual system of P. xuthus, we used immunocytochemical techniques to analyze the distribution of transmitter candidates, namely, histamine, serotonin, tyramine and gamma-aminobutyric acid (GABA). Photoreceptor terminals in the lamina and medulla exhibited histamine immunoreactivity as demonstrated in other insects. The anti-histamine antiserum also labeled a few large medulla neurons. Medulla intrinsic neurons and centrifugal neurons projecting to the lamina showed serotonin immunoreactivity. Tyramine immunostaining was detected in a subset of large monopolar cells (LMCs) in the lamina, transmedullary neurons projecting to the lobula plate, and cell bodies surrounding the first optic chiasma. An anti-GABA antiserum labeled a subset of LMCs and populations of columnar and tangential neurons surrounding the medulla. Each of the four antisera also labeled a few centrifugal neurons that innervate the lobula complex from the central brain, suggesting that they have neuromodulatory roles. A distinctive feature we found in this study is the possibility that tyramine and GABA act as transmitters in LMCs of P. xuthus, which has not been reported in any other insects so far.	[Hamanaka, Yoshitaka; Kinoshita, Michiyo; Arikawa, Kentaro] Grad Univ Adv Studies, Lab Neuroethol, Hayama, Kanagawa, Japan; [Homberg, Uwe] Univ Marburg, Dept Biol, Marburg, Germany	Graduate University for Advanced Studies - Japan; Philipps University Marburg	Hamanaka, Y (corresponding author), Grad Univ Adv Studies, Lab Neuroethol, Hayama, Kanagawa, Japan.	arikawa@soken.ac.jp	Homberg, Uwe/AFH-8214-2022	Homberg, Uwe/0000-0002-8229-7236; Kinoshita, Michiyo/0000-0002-5818-9622; Arikawa, Kentaro/0000-0002-4365-0762	Japanese Society for Promotion of Science (JSPS) [21247009]; Kazato research foundation; Canon Foundation in Europe	Japanese Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kazato research foundation(Kazato Research Foundation); Canon Foundation in Europe(Canon Foundation)	Japanese Society for Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (A) No. 21247009 to Kentaro Arikawa/Kazato research foundation grant to Yoshitaka Hamanaka Canon Foundation in Europe grant to Michiyo Kinoshita. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BICKER G, 1988, J NEUROSCI, V8, P2108; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brotz TM, 1996, J NEUROPHYSIOL, V76, P1786, DOI 10.1152/jn.1996.76.3.1786; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; CAMPOSOR.JA, 1973, BRAIN RES, V59, P119, DOI 10.1016/0006-8993(73)90255-2; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V338, P1189, DOI 10.1016/j.bbrc.2005.10.058; Chen B, 1999, J COMP PHYSIOL A, V185, P393, DOI 10.1007/s003590050400; Dahdal D, 2010, NEURON, V68, P964, DOI 10.1016/j.neuron.2010.11.017; DATUM KH, 1986, J COMP PHYSIOL A, V159, P241, DOI 10.1007/BF00612306; Elphick MR, 1996, J EXP BIOL, V199, P2395; Fabian-Fine R, 1999, J NEUROSCI, V19, P298, DOI 10.1523/JNEUROSCI.19-01-00298.1999; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FULLER H, 1989, CELL TISSUE RES, V255, P225; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Hamanaka Y, 2007, CELL TISSUE RES, V329, P581, DOI 10.1007/s00441-007-0433-3; HARDIE RC, 1987, J COMP PHYSIOL A, V161, P201, DOI 10.1007/BF00615241; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Harzsch S, 1999, J NEUROSCI, V19, P3472; Heinze S, 2012, J COMP NEUROL, V520, P1599, DOI 10.1002/cne.23054; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; HEVERS W, 1995, NEURON, V14, P845, DOI 10.1016/0896-6273(95)90228-7; Homberg U, 2004, CELL TISSUE RES, V318, P439, DOI 10.1007/s00441-004-0913-7; Homberg U, 2003, CHRONOBIOL INT, V20, P577, DOI 10.1081/CBI-120022412; Homberg U, 2002, MICROSC RES TECHNIQ, V56, P189, DOI 10.1002/jemt.10024; HOMBERG U, 1989, J COMP NEUROL, V288, P243, DOI 10.1002/cne.902880204; HOMBERG U, 1987, CELL TISSUE RES, V248, P1, DOI 10.1007/BF01239957; Homberg U., 1994, PROG ZOOL, V40, P1; ICHIKAWA T, 1994, NEUROSCI LETT, V172, P115, DOI 10.1016/0304-3940(94)90675-0; ICHIKAWA T, 1994, J EXP BIOL, V195, P361; ICHIKAWA T, 1994, J COMP NEUROL, V340, P185, DOI 10.1002/cne.903400205; Kinoshita M, 1999, J EXP BIOL, V202, P95; Kinoshita M, 2000, J EXP BIOL, V203, P3521; Kinoshita M, 2008, J EXP BIOL, V211, P3504, DOI 10.1242/jeb.017848; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Kononenko NL, 2009, J COMP NEUROL, V512, P433, DOI 10.1002/cne.21911; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; Lange AB, 2009, GEN COMP ENDOCR, V162, P18, DOI 10.1016/j.ygcen.2008.05.021; Leitinger G, 1999, BRAIN RES, V823, P11, DOI 10.1016/S0006-8993(98)01339-0; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MEYER EP, 1986, HISTOCHEMISTRY, V84, P207, DOI 10.1007/BF00495784; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; NASSEL DR, 1991, PROG NEUROBIOL, V37, P179, DOI 10.1016/0301-0082(91)90027-X; Nassel DR, 1999, MICROSC RES TECHNIQ, V44, P121, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<121::AID-JEMT6>3.0.CO;2-F; NASSEL DR, 1988, PROG NEUROBIOL, V30, P1, DOI 10.1016/0301-0082(88)90002-0; NASSEL DR, 1985, J COMP NEUROL, V232, P190, DOI 10.1002/cne.902320205; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Pyza E, 1996, J COMP PHYSIOL A, V178, P33, DOI 10.1007/BF00189588; Raghu SV, 2007, J COMP NEUROL, V502, P598, DOI 10.1002/cne.21319; Raghu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019472; Raghu SV, 2011, J COMP NEUROL, V519, P162, DOI 10.1002/cne.22512; RIBI WA, 1987, CELL TISSUE RES, V247, P393; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; Sattelle D.B., 1990, Advances in Insect Physiology, V22, P1, DOI 10.1016/S0065-2806(08)60005-3; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Sdhof TC, 1989, SCIENCE, V245, P1474; Seidel C, 1997, BRAIN RES, V769, P273, DOI 10.1016/S0006-8993(97)00716-6; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; STERN M, 1995, J COMP PHYSIOL A, V177, P611, DOI 10.1007/BF00207190; Stern M, 1999, MICROSC RES TECHNIQ, V45, P135, DOI 10.1002/(SICI)1097-0029(19990501)45:3<135::AID-JEMT1>3.0.CO;2-G; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; STRAUSFELD NJ, 1970, PHILOS T R SOC B, V258, P135, DOI 10.1098/rstb.1970.0033; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; STRAUSFELD NJ, 1970, PHILOS T R SOC B, V258, P81, DOI 10.1098/rstb.1970.0032; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Takemura SY, 2006, J COMP NEUROL, V494, P663, DOI 10.1002/cne.20830; Takemura SY, 2005, J COMP NEUROL, V483, P341, DOI 10.1002/cne.20446; Takeuchi Y, 2006, J EXP BIOL, V209, P2873, DOI 10.1242/jeb.02311; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0	84	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41109	10.1371/journal.pone.0041109	http://dx.doi.org/10.1371/journal.pone.0041109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844431	Green Published, gold			2022-12-27	WOS:000306687700044
J	Hooton, H; Angquist, L; Holst, C; Hager, J; Rousseau, F; Hansen, RD; Tjonneland, A; Roswall, N; van der A, DL; Overvad, K; Jakobsen, MU; Boeing, H; Meidtner, K; Palli, D; Masala, G; Bouatia-Naji, N; Saris, WHM; Feskens, EJM; Wareham, NJ; Vimaleswaran, KS; Langin, D; Loos, RJF; Sorensen, TIA; Clement, K				Hooton, Henri; Aengquist, Lars; Holst, Claus; Hager, Jorg; Rousseau, Francis; Hansen, Rikke D.; Tjonneland, Anne; Roswall, Nina; van der A, Daphne L.; Overvad, Kim; Jakobsen, Marianne Uhre; Boeing, Heiner; Meidtner, Karina; Palli, Domenico; Masala, Giovanna; Bouatia-Naji, Nabila; Saris, Wim H. M.; Feskens, Edith J. M.; Wareham, Nicolas J.; Vimaleswaran, Karani S.; Langin, Dominique; Loos, Ruth J. F.; Sorensen, Thorkild I. A.; Clement, Karine			Dietary Factors Impact on the Association between CTSS Variants and Obesity Related Traits	PLOS ONE			English	Article							CATHEPSIN-S; WEIGHT-LOSS; FAT INTAKE; ADIPOSE-TISSUE; GLYCEMIC INDEX; FLIP-FLOP; WOMEN; PROTEIN; CANCER; GENE	Background/Aims: Cathepsin S, a protein coded by the CTSS gene, is implicated in adipose tissue biology-this protein enhances adipose tissue development. Our hypothesis is that common variants in CTSS play a role in body weight regulation and in the development of obesity and that these effects are influenced by dietary factors-increased by high protein, glycemic index and energy diets. Methods: Four tag SNPs (rs7511673, rs11576175, rs10888390 and rs1136774) were selected to capture all common variation in the CTSS region. Association between these four SNPs and several adiposity measurements (BMI, waist circumference, waist for given BMI and being a weight gainer-experiencing the greatest degree of unexplained annual weight gain during follow-up or not) given, where applicable, both as baseline values and gain during the study period (6-8 years) were tested in 11,091 European individuals (linear or logistic regression models). We also examined the interaction between the CTSS variants and dietary factors-energy density, protein content (in grams or in % of total energy intake) and glycemic index-on these four adiposity phenotypes. Results: We found several associations between CTSS polymorphisms and anthropometric traits including baseline BMI (rs11576175 (SNP N degrees 2), p = 0.02, beta = -0.2446), and waist change over time (rs7511673 (SNP N degrees 1), p = 0.01, beta = -0.0433 and rs10888390 (SNP N degrees 3), p = 0.04, beta = -0.0342). In interaction with the percentage of proteins contained in the diet, rs11576175 (SNP N degrees 2) was also associated with the risk of being a weight gainer (p(interaction) = 0.01, OR = 1.0526)-the risk of being a weight gainer increased with the percentage of proteins contained in the diet. Conclusion: CTSS variants seem to be nominally associated to obesity related traits and this association may be modified by dietary protein intake.	[Hooton, Henri; Clement, Karine] INSERM, U872, Paris, France; [Hooton, Henri; Clement, Karine] Univ Paris 06, Ctr Rech Cordeliers, U872, Paris, France; [Hooton, Henri; Bouatia-Naji, Nabila; Clement, Karine] Univ Paris 05, Paris, France; [Aengquist, Lars; Holst, Claus; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Hager, Jorg] CNG, Paris, France; [Rousseau, Francis] INTEGRAGEN, Paris, France; [Hansen, Rikke D.; Tjonneland, Anne; Roswall, Nina] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [van der A, Daphne L.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Overvad, Kim; Jakobsen, Marianne Uhre] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Boeing, Heiner; Meidtner, Karina] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Palli, Domenico; Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Bouatia-Naji, Nabila; Wareham, Nicolas J.; Vimaleswaran, Karani S.; Loos, Ruth J. F.] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Bouatia-Naji, Nabila] INSERM, U970, Paris Cardiovasc Res Ctr, Paris, France; [Saris, Wim H. M.] Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Human Biol, Maastricht, Netherlands; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Vimaleswaran, Karani S.] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Vimaleswaran, Karani S.] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Langin, Dominique] Inst Metab & Cardiovasc Dis, INSERM, U1048, Obes Res Lab,Team 4, Toulouse, France; [Langin, Dominique] Univ Toulouse 3, U1048, Univ Toulouse, F-31062 Toulouse, France; [Langin, Dominique] Toulouse Univ Hosp, Dept Clin Biochem, Toulouse, France; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Clement, Karine] Hop La Pitie Salpetriere, AP HP, Dept Nutr, Paris, France; [Clement, Karine] Ctr Rech Nutr Humaine Ile France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Danish Cancer Society; Netherlands National Institute for Public Health & the Environment; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Maastricht University; Wageningen University & Research; University of London; University College London; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Novo Nordisk Foundation; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hooton, H (corresponding author), INSERM, U872, Paris, France.	henri.hooton@upmc.fr	Clément, karine/R-1120-2017; Loos, Ruth J F/Q-2862-2016; Feskens, Edith/ABI-1446-2020; Roswall, Nina/AAJ-6700-2020; Bouatia-Naji, Nabila/AGF-1400-2022; Masala, Giovanna/AAC-5474-2022; BOUATIA-NAJI, NABILA/D-5863-2013; Jakobsen, Marianne Uhre/I-8550-2018; Loos, Ruth/GON-5877-2022	Loos, Ruth J F/0000-0002-8532-5087; Feskens, Edith/0000-0001-5819-2488; Roswall, Nina/0000-0003-3071-1658; Bouatia-Naji, Nabila/0000-0001-5424-2134; Masala, Giovanna/0000-0002-5758-9069; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Meidtner, Karina/0000-0001-5810-4062; Karani, Vimal/0000-0002-8485-8930; Angquist, Lars/0000-0002-9516-4424; Tjonneland, Anne/0000-0003-4385-2097; tumino, rosario/0000-0003-2666-414X; PALLI, Domenico/0000-0002-5558-2437; Langin, Dominique/0000-0002-2669-7825; Overvad, Kim/0000-0001-6429-7921	European grant DIOGENES; European grant GENDINOB; Region Ile de France (CODDIM); Fondation pour la recherche medicale/Danone; l'Agence Nationale de la Recherche (Programme OBCAT); Medical Research Council [MC_U106179471] Funding Source: researchfish	European grant DIOGENES; European grant GENDINOB; Region Ile de France (CODDIM)(Region Ile-de-France); Fondation pour la recherche medicale/Danone(Danone Nutricia); l'Agence Nationale de la Recherche (Programme OBCAT)(French National Research Agency (ANR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by two European grants: the DIOGENES grant and the GENDINOB grant. Work on Cathepsins in Nutriomique laboratory is supported by Region Ile de France (CODDIM), Fondation pour la recherche medicale/Danone and l'Agence Nationale de la Recherche (Programme OBCAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders simply provided the funds for the study.	Astrup A, 2000, INT J OBESITY, V24, P1545, DOI 10.1038/sj.ijo.0801453; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Brehm BJ, 2005, J CLIN ENDOCR METAB, V90, P1475, DOI 10.1210/jc.2004-1540; Carmichael HE, 1998, J AM DIET ASSOC, V98, P35, DOI 10.1016/S0002-8223(98)00011-X; Clarke GM, 2010, GENET EPIDEMIOL, V34, P266, DOI 10.1002/gepi.20458; Dolley G, 2008, INT J OBESITY, V32, P669, DOI 10.1038/sj.ijo.0803773; Du H, 2009, INT J OBESITY, V33, P1280, DOI 10.1038/ijo.2009.163; Du HD, 2006, ACTA CARDIOL, V61, P383, DOI 10.2143/AC.61.4.2017298; Du HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017436; Fontanesi L, 2010, MEAT SCI, V85, P331, DOI 10.1016/j.meatsci.2010.01.023; Forouhi NG, 2009, AM J CLIN NUTR, V90, P1632, DOI 10.3945/ajcn.2009.27828; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gelb BD, 1997, GENOMICS, V41, P258, DOI 10.1006/geno.1997.4631; Halkjaer J, 2010, INT J OBES LOND; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hasselbalch AL, 2008, OBESITY, V16, P2723, DOI 10.1038/oby.2008.440; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hooton H, 2011, OBESITY FACTS, V4, P131, DOI 10.1159/000327797; Jeor STS, 2001, CIRCULATION, V104, P1869, DOI 10.1161/hc4001.096152; Katunuma N, 2000, BIOCHEM BIOPH RES CO, V272, P151, DOI 10.1006/bbrc.2000.2738; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Lafarge JC, 2010, BIOCHIMIE, V92, P1580, DOI 10.1016/j.biochi.2010.04.011; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu Y-J, 2010, OBESITY SILVER SPRIN; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moonesinghe R, 2010, EUR J HUM GENET, V18, P485, DOI 10.1038/ejhg.2009.209; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Naukkarinen J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000976; Oarada M, 2010, BIOSCI BIOTECH BIOCH, V74, P620, DOI 10.1271/bbb.90829; Pirozzo S, 2003, Obes Rev, V4, P83, DOI 10.1046/j.1467-789X.2003.00099.x; Pirozzo S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003640; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2006, INT J CANCER, V118, P2832, DOI 10.1002/ijc.21730; Rock CL, 2001, CANCER-AM CANCER SOC, V91, P25, DOI 10.1002/1097-0142(20010101)91:1&lt;25::AID-CNCR4&gt;3.0.CO;2-G; Rood JA, 1997, GENOMICS, V41, P169, DOI 10.1006/geno.1997.4614; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Saris WHM, 2005, OBES REV, V6, P175, DOI 10.1111/j.1467-789x.2005.00200.x; SHEPPARD L, 1991, AM J CLIN NUTR, V54, P821, DOI 10.1093/ajcn/54.5.821; Sherwood NE, 2000, INT J OBESITY, V24, P395, DOI 10.1038/sj.ijo.0801169; SHI GP, 1994, J BIOL CHEM, V269, P11530; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spielmann N, 2008, CLIN GENET, V74, P155, DOI 10.1111/j.1399-0004.2008.01043.x; Taleb S, 2006, J CLIN ENDOCR METAB, V91, P1042, DOI 10.1210/jc.2005-1601; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vimaleswaran KS, 2012, OBESITY, V20, P1669, DOI 10.1038/oby.2012.49; Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P14, DOI 10.1038/sj.ijo.0800538; Westerterp-Plantenga MS, 2003, CURR OPIN CLIN NUTR, V6, P635, DOI 10.1097/00075197-200311000-00005; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x; Willett WC, 2002, AM J MED, V113, P47, DOI 10.1016/S0002-9343(01)00992-5; Yang M, 2008, ARTERIOSCL THROM VAS, V28, P2202, DOI 10.1161/ATVBAHA.108.172320; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001	61	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40394	10.1371/journal.pone.0040394	http://dx.doi.org/10.1371/journal.pone.0040394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844403	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000306687700012
J	Steinmann, C; Fedorov, DG; Jensen, JH				Steinmann, Casper; Fedorov, Dmitri G.; Jensen, Jan H.			The Effective Fragment Molecular Orbital Method for Fragments Connected by Covalent Bonds	PLOS ONE			English	Article							POTENTIAL METHOD; QUANTUM-CHEMISTRY; LARGE SYSTEMS; FORCE-FIELD; ACCURATE; CAPS; FRACTIONATION; FORMULATION; PRINCIPLES; PREDICTION	We extend the effective fragment molecular orbital method (EFMO) into treating fragments connected by covalent bonds. The accuracy of EFMO is compared to FMO and conventional ab initio electronic structure methods for polypeptides including proteins. Errors in energy for RHF and MP2 are within 2 kcal/mol for neutral polypeptides and 6 kcal/mol for charged polypeptides similar to FMO but obtained two to five times faster. For proteins, the errors are also within a few kcal/mol of the FMO results. We developed both the RHF and MP2 gradient for EFMO. Compared to ab initio, the EFMO optimized structures had an RMSD of 0.40 and 0.44 A for RHF and MP2, respectively.	[Steinmann, Casper; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Fedorov, Dmitri G.] Natl Inst Adv Ind Sci & Technol, NRI, Tsukuba, Ibaraki, Japan	University of Copenhagen; National Institute of Advanced Industrial Science & Technology (AIST)	Steinmann, C (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	steinmann@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; Svendsen, Casper/T-6775-2018	Jensen, Jan Halborg/0000-0002-1465-1010; Svendsen, Casper/0000-0002-5638-1346	Danish research Council; insilico rational engineering of novel enzymes (IRENE) [10502564]; Next Generation Super Computing Project Nanoscience Program (MEXT, Japan); Computational Materials Science Initiative	Danish research Council(Det Frie Forskningsrad (DFF)); insilico rational engineering of novel enzymes (IRENE); Next Generation Super Computing Project Nanoscience Program (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Computational Materials Science Initiative	This work was funded by a Schou Fellowship to JHJ from the Danish research Council. CS was sponsored by the insilico rational engineering of novel enzymes (IRENE). URL: http://cordis.europa.eu/search/index.cfm?fuseaction = proj.document&PJ_RCN = 10502564. DF is sponsored by Next Generation Super Computing Project Nanoscience Program (MEXT, Japan) and the Computational Materials Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovic I, 2005, MOL PHYS, V103, P379, DOI 10.1080/00268970512331317246; [Anonymous], 2011, OPEN BABEL PACKAGE V; Beran GJO, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3121323; Dahlke EE, 2007, J CHEM THEORY COMPUT, V3, P46, DOI 10.1021/ct600253j; Day PN, 1996, J CHEM PHYS, V105, P1968, DOI 10.1063/1.472045; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; EDMISTON C, 1963, REV MOD PHYS, V35, P457, DOI 10.1103/RevModPhys.35.457; Fedorov DG, 2004, J CHEM PHYS, V121, P2483, DOI 10.1063/1.1769362; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; Fedorov DG, 2004, J COMPUT CHEM, V25, P872, DOI 10.1002/jcc.20018; Fedorov DG, 2005, J PHYS CHEM A, V109, P2638, DOI 10.1021/jp047186z; Fedorov DG, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2007588; Fedorov DG, 2008, J PHYS CHEM A, V112, P11808, DOI 10.1021/jp805435n; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Fedorov DG, 2007, J PHYS CHEM A, V111, P2722, DOI 10.1021/jp0671042; Fedorov DG, 2007, J COMPUT CHEM, V28, P1476, DOI 10.1002/jcc.20645; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Fedorov DG, 2011, J PHYS CHEM LETT, V2, P282, DOI 10.1021/jz1016894; Fedorov DG, 2009, CHEM PHYS LETT, V477, P169, DOI 10.1016/j.cplett.2009.06.072; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Ghosh D, 2010, J PHYS CHEM A, V114, P12739, DOI 10.1021/jp107557p; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Gordon MS, 2009, J PHYS CHEM B, V113, P9646, DOI 10.1021/jp811519x; GORDON MS, 1982, J AM CHEM SOC, V104, P2797, DOI 10.1021/ja00374a017; Gordon MS, 2001, J PHYS CHEM A, V105, P293, DOI 10.1021/jp002747h; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Ishimura K, 2006, J COMPUT CHEM, V27, P407, DOI 10.1002/jcc.20348; Jacobson LD, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3560026; James J. P, 2008, MOPAC2009 STEWART CO; Jensen JH, 2005, J PHYS CHEM A, V109, P6634, DOI 10.1021/jp051922x; Jiang N, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2178796; Kairys V, 2000, J PHYS CHEM A, V104, P6656, DOI 10.1021/jp000887l; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Mazanetz MP, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-2; Minikis RM, 2001, J PHYS CHEM A, V105, P3829, DOI 10.1021/jp0032659; Molina PA, 2003, J COMPUT CHEM, V24, P1971, DOI 10.1002/jcc.10333; Nagata T, 2011, CHALL ADV COMPUT CHE, V13, P17, DOI 10.1007/978-90-481-2853-2_2; Nagata T, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3611020; Nagata T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3568010; Nagata T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3517110; Nagata T, 2010, CHEM PHYS LETT, V492, P302, DOI 10.1016/j.cplett.2010.04.043; Nagata T, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3156313; Nakano T, 2000, CHEM PHYS LETT, V318, P614, DOI 10.1016/S0009-2614(00)00070-1; Nakano T, 2002, CHEM PHYS LETT, V351, P475, DOI 10.1016/S0009-2614(01)01416-6; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohno K, 2011, CURR MED CHEM, V18, P220, DOI 10.2174/092986711794088335; Sawada T, 2010, J AM CHEM SOC, V132, P16862, DOI 10.1021/ja105051e; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sebetci A, 2010, J CHEM THEORY COMPUT, V6, P155, DOI 10.1021/ct900545v; Soderhjelm P, 2009, J PHYS CHEM B, V113, P11085, DOI 10.1021/jp810551h; Soderhjelm P, 2009, J PHYS CHEM A, V113, P617, DOI 10.1021/jp8073514; Steinmann C, 2010, J PHYS CHEM A, V114, P8705, DOI 10.1021/jp101498m; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; STONE AJ, 1981, CHEM PHYS LETT, V83, P233, DOI 10.1016/0009-2614(81)85452-8; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Xie WS, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2936122; Xie WS, 2007, J CHEM THEORY COMPUT, V3, P1890, DOI 10.1021/ct700167b; Zhang DW, 2003, J COMPUT CHEM, V24, P1846, DOI 10.1002/jcc.10346; Zhang DW, 2003, J CHEM PHYS, V119, P3599, DOI 10.1063/1.1591727	60	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41117	10.1371/journal.pone.0041117	http://dx.doi.org/10.1371/journal.pone.0041117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844433	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700046
J	Zhang, YB; Li, X; Zhang, F; Wang, DM; Yu, J				Zhang, Yong-Biao; Li, Xin; Zhang, Feng; Wang, Duen-Mei; Yu, Jun			A Preliminary Study of Copy Number Variation in Tibetans	PLOS ONE			English	Article							HUMAN GENOME; NATURAL-SELECTION; MALE-INFERTILITY; HUMAN-DISEASE; Y-CHROMOSOME; GENE; POPULATION; VARIANTS; DIFFERENTIATION; EXPRESSION	Genetic features of Tibetans have been broadly investigated, but the properties of copy number variation (CNV) have not been well examined. To get a preliminary view of CNV in Tibetans, we scanned 29 Tibetan genomes with the Illumina Human-1 M high-resolution genotyping microarray and identified 139 putative copy number variable regions (CNVRs), consisting of 70 deletions, 61 duplications, and 8 multi-allelic loci. Thirty-four of the 139 CNVRs showed differential allele frequencies versus other East-Asian populations, with P values < 0.0001. These results indicated a distinct pattern of CNVR allele frequency distribution in Tibetans. The Tibetan CNVRs are enriched for genes in the disease class of human reproduction (such as genes from the DAZ, BPY2, CDY, and HLA-DQ and -DR gene clusters) and biological process categories of "response to DNA damage stimulus" and "DNA repair" (such as RAD51, RAD52, and MRE11A). These genes are related to the adaptive traits of high infant birth weight and darker skin tone of Tibetans, and may be attributed to recent local adaptation. Our results provide a different view of genetic diversity in Tibetans and new insights into their high-altitude adaptation.	[Zhang, Yong-Biao; Li, Xin; Zhang, Feng; Wang, Duen-Mei; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhang, YB (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	zhangf@big.ac.cn			Knowledge Innovation Program of the Chinese Academy of Sciences	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroviita P, 2004, EUR J IMMUNOGENET, V31, P21, DOI 10.1111/j.1365-2370.2004.00434.x; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Beall CA, 2007, RESP PHYSIOL NEUROBI, V158, P161, DOI 10.1016/j.resp.2007.05.013; Buroker NE, 2010, CLIN CHIM ACTA, V411, P1466, DOI 10.1016/j.cca.2010.05.043; Chen W, 2011, NEPHROL DIAL TRANSPL, V26, P1592, DOI 10.1093/ndt/gfq608; Chen XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012185; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gayden T, 2009, J HUM GENET, V54, P216, DOI 10.1038/jhg.2009.14; Halper-Stromberg E, 2011, BIOINFORMATICS, V27, P1052, DOI 10.1093/bioinformatics/btr106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kang LL, 2010, J HUM GENET, V55, P270, DOI 10.1038/jhg.2010.21; Kruse C, 2004, HUM REPROD, V19, P1215, DOI 10.1093/humrep/deh200; Li J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007958; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Lin CH, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-92; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Ouzhu B, 1998, J TIBET U, V24, P5; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Roll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013750; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thompson PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023543; Tse JYM, 2003, BIOL REPROD, V69, P746, DOI 10.1095/biolreprod.103.015792; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564; Zasloff M, 2005, J INVEST DERMATOL, V125, pXVI, DOI 10.1111/j.0022-202X.2005.23924.x; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang Y, 2010, J HUM GENET; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	46	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41768	10.1371/journal.pone.0041768	http://dx.doi.org/10.1371/journal.pone.0041768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844521	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700148
J	Fu, SJ; Peng, ZG; Cao, ZD; Peng, JL; He, XK; Xu, DD; Zhang, AJ				Fu, Shi-Jian; Peng, Zuogang; Cao, Zhen-Dong; Peng, Jiang-Lan; He, Xiao-Ke; Xu, Dandan; Zhang, An-Jie			Habitat-Specific Locomotor Variation among Chinese Hook Snout Carp (Opsariichthys bidens) along a River	PLOS ONE			English	Article							SWIMMING PERFORMANCE; GENETIC-DIVERGENCE; CYPRINUS-CARPIO; FISH; MORPHOLOGY; LAKE; TEMPERATURE; EXERCISE	The Wujiang River is a tributary of the upper Yangtze River that shows great variations in its flow regime and habitat condition. Dams have been built along the Wujiang River and have altered the habitats profoundly enough that they may give rise to reproductive isolation. To test whether the swimming performance and morphology of the Chinese hook snout carp (Opsariichthys bidens), varied among habitats and whether the possible differences had a genetic basis, we measured the steady and unsteady swimming performance, external body shape and genetic distance among fish collected from both the main and tributary streams of the upper, middle and lower reaches along the river. We also measured the routine energy expenditure (RMR), maximum metabolic rate (MMR), cost of transport (COT) and calculated the optimal swimming speed. The steady swimming capacity, RMR, MMR and optimal swimming speed were all higher and the COT was lower in the upper reach or tributary streams compared with the lower reach or main stream. However, unsteady swimming performance showed no variation among collecting sites. Flow regimes as suggested by river slope and water velocity were positively correlated with steady swimming performance but not with unsteady swimming performance. Predation stress were significantly related with body morphology and hence energy cost during swimming but not U-crit value. The fish from only one population (Hao-Kou) showed relatively high genetic differentiation compared with the other populations. Fish from the upper reach or tributary streams exhibited improved steady swimming performance through improved respiratory capacity and lower energy expenditure during swimming at the cost of higher maintenance metabolism. There was no correlation between the steady and unsteady swimming performance at either the population or the individual levels. These results suggest that a trade-off between steady and unsteady swimming does not occur in O. bidens.	[Fu, Shi-Jian; Cao, Zhen-Dong; Peng, Jiang-Lan; He, Xiao-Ke; Zhang, An-Jie] Chongqing Normal Univ, Chongqing Key Lab Anim Biol, Lab Evolutionary Physiol & Behav, Chongqing, Peoples R China; [Peng, Zuogang; Xu, Dandan] Southwest Univ, Sch Life Sci, Key Lab Freshwater Fish Reprod & Dev MOE, Chongqing, Peoples R China	Chongqing Normal University; Southwest University - China	Fu, SJ (corresponding author), Chongqing Normal Univ, Chongqing Key Lab Anim Biol, Lab Evolutionary Physiol & Behav, Chongqing, Peoples R China.	shijianfu9@126.com	Fu, Shi-Jian/R-8084-2019; Peng, Zuogang/D-4448-2011	Fu, Shi-Jian/0000-0001-7665-9037; Peng, Zuogang/0000-0001-8810-2025	National Science Foundation of China [NSFC 31172096]; Natural Science Foundation Project of Chongqing [CSTC2010BB1089]; Project of Chongqing Science & Technology Commission [2010CA1010]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing); Project of Chongqing Science & Technology Commission	This study was funded by grants from the National Science Foundation of China (NSFC 31172096), the Natural Science Foundation Project of Chongqing (CSTC2010BB1089) and the Project of Chongqing Science & Technology Commission (No. CSTC, 2010CA1010) granted to SJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake R.W., 1983, FISH LOCOMOTION; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Fu SJ, 2011, J EXP BIOL, V214, P2080, DOI 10.1242/jeb.053132; Fu SJ, 2009, J EXP BIOL, V212, P2296, DOI 10.1242/jeb.027102; He Xiao-ke, 2011, Shengtaixue Zazhi, V30, P2523; Hendry AP, 2011, J EVOLUTION BIOL, V24, P23, DOI 10.1111/j.1420-9101.2010.02155.x; Kieffer JD, 2010, COMP BIOCHEM PHYS A, V156, P163, DOI 10.1016/j.cbpa.2010.02.009; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; Langerhans RB, 2006, PREDATION ORGANISMS, P177; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law TC, 1996, J EXP BIOL, V199, P2595; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; McGuigan K, 2003, EVOLUTION, V57, P104; Nelson JA, 2003, CAN J FISH AQUAT SCI, V60, P301, DOI 10.1139/F03-023; Oufiero CE, 2011, ECOLOGY, V92, P170, DOI 10.1890/09-1912.1; Pang X, 2011, COMP BIOCHEM PHYS A, V159, P253, DOI 10.1016/j.cbpa.2011.03.013; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Reidy SP, 2000, J EXP BIOL, V203, P347; Rouleau S, 2010, FUNCT ECOL, V24, P310, DOI 10.1111/j.1365-2435.2009.01636.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Varian A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012950; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Webb P.W., 1985, P110; Webster MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021060; Xiao WH, 2001, MOL PHYLOGENET EVOL, V18, P163, DOI 10.1006/mpev.2000.0879; Yan GJ, 2012, J THERM BIOL, V37, P424, DOI 10.1016/j.jtherbio.2012.04.006	34	19	27	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40791	10.1371/journal.pone.0040791	http://dx.doi.org/10.1371/journal.pone.0040791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829884	Green Submitted, gold, Green Published			2022-12-27	WOS:000306956300022
J	Guo, HJ; Sun, YC; Ren, Q; Zhu-Salzman, K; Kang, L; Wang, CZ; Li, CY; Ge, F				Guo, Huijuan; Sun, Yucheng; Ren, Qin; Zhu-Salzman, Keyan; Kang, Le; Wang, Chenzhu; Li, Chuanyou; Ge, Feng			Elevated CO2 Reduces the Resistance and Tolerance of Tomato Plants to Helicoverpa armigera by Suppressing the JA Signaling Pathway	PLOS ONE			English	Article							SEASON SQUARE ABSCISSION; TRANSGENIC BT COTTON; JASMONIC ACID; ARABIDOPSIS-THALIANA; POLYPHENOL OXIDASE; HERBIVORE DAMAGE; CARBON TRANSPORT; RAPID CHANGES; AVAILABILITY; IMPACTS	Both resistance and tolerance, which are two strategies that plants use to limit biotic stress, are affected by the abiotic environment including atmospheric CO2 levels. We tested the hypothesis that elevated CO2 would reduce resistance (i.e., the ability to prevent damage) but enhance tolerance (i.e., the ability to regrow and compensate for damage after the damage has occurred) of tomato plants to the cotton bollworm, Helicoverpa armigera. The results showed that elevated CO2 reduced resistance by decreasing the jasmonic acid (JA) level and activities of lipoxygenase, proteinase inhibitors, and polyphenol oxidase in wild-type (WT) plants infested with H. armigera. Consequently, the activities of total protease, trypsin-like enzymes, and weak and active alkaline trypsin-like enzymes increased in the midgut of H. armigera when fed on WT plants grown under elevated CO2. Unexpectedly, the tolerance of the WT to H. armigera (in terms of photosynthetic rate, activity of sucrose phosphate synthases, flower number, and plant biomass and height) was also reduced by elevated CO2. Under ambient CO2, the expression of resistance and tolerance to H. armigera was much greater in wild type than in spr2 (a JA-deficient genotype) plants, but elevated CO2 reduced these differences of the resistance and tolerance between WT and spr2 plants. The results suggest that the JA signaling pathway contributes to both plant resistance and tolerance to herbivorous insects and that by suppressing the JA signaling pathway, elevated CO2 will simultaneously reduce the resistance and tolerance of tomato plants.	[Guo, Huijuan; Sun, Yucheng; Kang, Le; Wang, Chenzhu; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China; [Guo, Huijuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Ren, Qin] Jining Normal Coll, Jining, Inner Mongolia, Peoples R China; [Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Li, Chuanyou] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Guo, HJ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China.	gef@ioz.ac.cn	Kang, Le/ABD-1116-2022; Li, Chuanyou/ABF-4143-2020	Kang, Le/0000-0003-4262-2329; Sun, Yucheng/0000-0003-2353-0218	National Nature Science Fund of China [30921063, 31030012]; Innovation Program of Beijing Institutes of Life Science, CAS [2010-Biols-CAS-0102]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Beijing Institutes of Life Science, CAS	This project was supported by the National Nature Science Fund of China (No. 30921063; No. 31030012) and the Innovation Program of Beijing Institutes of Life Science, CAS (2010-Biols-CAS-0102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2004, AGR FOREST METEOROL, V122, P85, DOI 10.1016/j.agrformet.2003.09.002; Babst BA, 2005, NEW PHYTOL, V167, P63, DOI 10.1111/j.1469-8137.2005.01388.x; Babst BA, 2008, ENTOMOL EXP APPL, V128, P117, DOI 10.1111/j.1570-7458.2008.00698.x; Bailey JK, 2010, BIOL INVASIONS, V12, P337, DOI 10.1007/s10530-009-9630-1; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Bezemer TM, 2000, BIOCHEM SYST ECOL, V28, P839, DOI 10.1016/S0305-1978(99)00130-1; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Bidart-Bouzat MG, 2004, ECOL LETT, V7, P837, DOI 10.1111/j.1461-0248.2004.00648.x; Bidart-Bouzat MG, 2004, ECOLOGY, V85, P297, DOI 10.1890/03-3062; BLACKWOOD CE, 1965, ANAL BIOCHEM, V12, P128, DOI 10.1016/0003-2697(65)90150-8; Chen F. J, 2004, ENTOMOL KNOWLEDGE, V41, P279; Chen FJ, 2007, ENTOMOL EXP APPL, V124, P27, DOI 10.1111/j.1570-7458.2007.00563.x; Chen FJ, 2004, J APPL ENTOMOL, V128, P723, DOI 10.1111/j.1439-0418.2004.00921.x; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Couture JJ, 2010, CHEMOECOLOGY, V20, P277, DOI 10.1007/s00049-010-0058-y; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; Fornoni J, 2003, EVOL ECOL RES, V5, P1049; Ge Feng, 2003, Yingyong Shengtai Xuebao, V14, P241; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Halitschke R, 2004, J PLANT GROWTH REGUL, V23, P238, DOI 10.1007/s00344-004-0037-z; Hartley SE, 2000, GLOBAL CHANGE BIOL, V6, P497, DOI 10.1046/j.1365-2486.2000.00333.x; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Karowe DN, 2011, J CHEM ECOL, V37, P1332, DOI 10.1007/s10886-011-0044-z; Katjiua MLJ, 2006, J CHEM ECOL, V32, P1431, DOI 10.1007/s10886-006-9060-9; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; Li CR, 2002, PLANT CELL ENVIRON, V25, P369, DOI 10.1046/j.0016-8025.2001.00818.x; Li CY, 2003, PLANT CELL, V15, P1646, DOI 10.1105/tpc.012237; MAHANTA PK, 1993, J AGR FOOD CHEM, V41, P272, DOI 10.1021/jf00026a026; Marshall CB, 2008, PLANT ECOL, V196, P1, DOI 10.1007/s11258-007-9331-8; Matros A, 2006, PLANT CELL ENVIRON, V29, P126, DOI 10.1111/j.1365-3040.2005.01406.x; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Ren Q, 2010, WEED SCI, V58, P252, DOI 10.1614/WS-D-09-00002.1; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; STOUT MJ, 1994, J CHEM ECOL, V20, P2575, DOI 10.1007/BF02036193; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Sun YC, 2010, PLANT CELL ENVIRON, V33, P729, DOI 10.1111/j.1365-3040.2009.02098.x; Tegelberg R, 2008, ENVIRON EXP BOT, V62, P308, DOI 10.1016/j.envexpbot.2007.10.003; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Vigue LM, 2010, AGR FOREST ENTOMOL, V12, P267, DOI 10.1111/j.1461-9563.2010.00475.x; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wu G, 2007, FIELD CROP RES, V102, P239, DOI 10.1016/j.fcr.2007.03.007; Wu G, 2007, AGRON J, V99, P791, DOI 10.2134/agronj2006.0138; Yin J, 2010, ENTOMOL EXP APPL, V136, P12, DOI 10.1111/j.1570-7458.2010.00998.x; Yin J, 2009, AGR ECOSYST ENVIRON, V132, P267, DOI 10.1016/j.agee.2009.04.010; Zavala JA, 2008, P NATL ACAD SCI USA, V105, P10631, DOI 10.1073/pnas.0805247105; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x; Zavala JA, 2009, OECOLOGIA, V161, P35, DOI 10.1007/s00442-009-1360-7	52	39	41	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41426	10.1371/journal.pone.0041426	http://dx.doi.org/10.1371/journal.pone.0041426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829948	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300088
J	Ho-Pun-Cheung, A; Bazin, H; Gaborit, N; Larbouret, C; Garnero, P; Assenat, E; Castan, F; Bascoul-Mollevi, C; Ramos, J; Ychou, M; Pelegrin, A; Mathis, G; Lopez-Crapez, E				Ho-Pun-Cheung, Alexandre; Bazin, Herve; Gaborit, Nadege; Larbouret, Christel; Garnero, Patrick; Assenat, Eric; Castan, Florence; Bascoul-Mollevi, Caroline; Ramos, Jeanne; Ychou, Marc; Pelegrin, Andre; Mathis, Gerard; Lopez-Crapez, Evelyne			Quantification of HER Expression and Dimerization in Patients' Tumor Samples Using Time-Resolved Forster Resonance Energy Transfer	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; PHASE-II; ADJUVANT CHEMOTHERAPY; 1ST-LINE TREATMENT; TRASTUZUMAB; RECEPTOR; HER2; EFFICACY; SAFETY	Following the development of targeted therapies against EGFR and HER2, two members of the human epidermal receptor (HER) family of receptor tyrosine kinases, much interest has been focused on their expression in tumors. However, knowing the expression levels of individual receptors may not be sufficient to predict drug response. Here, we describe the development of antibody-based time-resolved Forster resonance energy transfer (TR-FRET) assays for the comprehensive analysis not only of EGFR and HER2 expression in tumor cryosections, but also of their activation through quantification of HER homo-or heterodimers. First, EGFR and HER2 expression levels were quantified in 18 breast tumors and the results were compared with those obtained by using reference methods. The EGFR number per cell determined by TR-FRET was significantly correlated with EGFR mRNA copy number (P < 0.0001). Moreover, our method detected HER2 overexpression with 100% specificity and sensibility, as confirmed by the standard IHC, FISH and qPCR analyses. EGFR and HER2 dimerization was then assessed, using as controls xenograft tumors from cell lines with known dimer expression profiles. Our results show that quantification of HER dimerization provides information about receptor activation that cannot be obtained by quantification of single receptors. Quantifying HER expression and dimerization by TR-FRET assays might help identifying novel clinical markers for optimizing patients' treatment in oncology.	[Ho-Pun-Cheung, Alexandre; Lopez-Crapez, Evelyne] CRLC Val dAurelle Paul Lamarque, Translat Res Unit, Montpellier, France; [Bazin, Herve; Garnero, Patrick; Mathis, Gerard] Cisbio Bioassays, Res Dept, Codolet, France; [Gaborit, Nadege; Larbouret, Christel; Ychou, Marc; Pelegrin, Andre] Univ Montpellier I, CRLC Val dAurelle Paul Lamarque, IRCM, INSERM,U896, Montpellier, France; [Assenat, Eric; Ychou, Marc] CRLC Val dAurelle Paul Lamarque, Dept Med & Digest Oncol, Montpellier, France; [Castan, Florence; Bascoul-Mollevi, Caroline] CRLC Val dAurelle Paul Lamarque, Dept Biostat, Montpellier, France; [Ramos, Jeanne] CHU Montpellier, Dept Pathol, Montpellier, France	UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; CHU de Montpellier	Ho-Pun-Cheung, A (corresponding author), CRLC Val dAurelle Paul Lamarque, Translat Res Unit, Montpellier, France.	evelyne.crapez@montpellier.unicancer.fr	Mollevi, Caroline/AAA-6839-2019; Pèlegrin, André/J-3167-2016; Gaborit, Nadège A/O-7825-2017	Mollevi, Caroline/0000-0003-4827-3684; Ychou, Marc/0000-0001-7378-9469; Crapez, evelyne/0000-0002-8261-3470; Pelegrin, Andre/0000-0001-9254-2648	Agence Nationale de la Recherche (ANR) [ANR-07-RIB]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This study was supported by a grant from the Agence Nationale de la Recherche (ANR), program "Recherche & Innovation en Biotechnologie" ANR-07-RIB (http://www.agence-nationale-recherche.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Andresen BT, 2010, METHOD ENZYMOL, V484, P631, DOI [10.1016/S0076-6879(10)84031-5, 10.1016/B978-0-12-381298-8.00031-9]; Baselga J, 1999, SEMIN ONCOL, V26, P78; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; CHAZIN VR, 1992, ONCOGENE, V7, P1859; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Desmedt C, 2009, DIAGN MOL PATHOL, V18, P22, DOI 10.1097/PDM.0b013e31818ebc69; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Gaborit N, 2011, J BIOL CHEM, V286, P11337, DOI 10.1074/jbc.M111.223503; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; Ho-Pun-Cheung A, 2011, INT J CANCER, V128, P2938, DOI 10.1002/ijc.25639; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Jensen KHR, 2010, J BIOMOL SCREEN, V15, P1071, DOI 10.1177/1087057110376834; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Johannessen LE, 2001, BIOCHEM J, V356, P87, DOI 10.1042/0264-6021:3560087; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Perez EA, 2006, J CLIN ONCOL, V24, P3032, DOI 10.1200/JCO.2005.03.4744; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spears M, 2011, BREAST CANC IN PRESS; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	30	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e37065	10.1371/journal.pone.0037065	http://dx.doi.org/10.1371/journal.pone.0037065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829865	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300003
J	Morales-Botello, ML; Aguilar, J; Foffani, G				Morales-Botello, M. L.; Aguilar, J.; Foffani, G.			Imaging the Spatio-Temporal Dynamics of Supragranular Activity in the Rat Somatosensory Cortex in Response to Stimulation of the Paws	PLOS ONE			English	Article							SPINAL-CORD-INJURY; SENSORY-MOTOR CORTEX; BARREL CORTEX; RECEPTIVE-FIELDS; FUNCTIONAL-ORGANIZATION; IN-VIVO; CORTICAL REPRESENTATION; ADULT-RATS; LAYER 2/3; VOLTAGE	We employed voltage-sensitive dye (VSD) imaging to investigate the spatio-temporal dynamics of the responses of the supragranular somatosensory cortex to stimulation of the four paws in urethane-anesthetized rats. We obtained the following main results. (1) Stimulation of the contralateral forepaw evoked VSD responses with greater amplitude and smaller latency than stimulation of the contralateral hindpaw, and ipsilateral VSD responses had a lower amplitude and greater latency than contralateral responses. (2) While the contralateral stimulation initially activated only one focus, the ipsilateral stimulation initially activated two foci: one focus was typically medial to the focus activated by contralateral stimulation and was stereotaxically localized in the motor cortex; the other focus was typically posterior to the focus activated by contralateral stimulation and was stereotaxically localized in the somatosensory cortex. (3) Forepaw and hindpaw somatosensory stimuli activated large areas of the sensorimotor cortex, well beyond the forepaw and hindpaw somatosensory areas of classical somatotopic maps, and forepaw stimuli activated larger cortical areas with greater activation velocity than hindpaw stimuli. (4) Stimulation of the forepaw and hindpaw evoked different cortical activation dynamics: forepaw responses displayed a clear medial directionality, whereas hindpaw responses were much more uniform in all directions. In conclusion, this work offers a complete spatio-temporal map of the supragranular VSD cortical activation in response to stimulation of the paws, showing important somatotopic differences between contralateral and ipsilateral maps as well as differences in the spatio-temporal activation dynamics in response to forepaw and hindpaw stimuli.	[Morales-Botello, M. L.; Aguilar, J.; Foffani, G.] Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Spain; [Foffani, G.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Hospital Nacional de Paraplejicos; Drexel University	Morales-Botello, ML (corresponding author), Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Spain.	guglielmo.foffani@drexel.edu	Aguilar, Juan/Q-2206-2015; Morales Botello, Maria de la Luz/O-8755-2015; Foffani, Guglielmo/ABD-5897-2020; Aguilar, Juan/N-3850-2019	Aguilar, Juan/0000-0002-8070-3923; Morales Botello, Maria de la Luz/0000-0002-5347-8388; Aguilar, Juan/0000-0002-8070-3923; Foffani, Guglielmo/0000-0001-7289-6668	FISCAM (Gobierno de Castilla-La Mancha) [MOV-2008_JI/9]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (Spain) [PI08/1852 PI11/02451]; FEDER (Fondo Europeo de Desarrollo Regional)	FISCAM (Gobierno de Castilla-La Mancha); Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This work was supported by FISCAM (Gobierno de Castilla-La Mancha) MOV-2008_JI/9 and Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III PI08/1852 PI11/02451 (Spain), co-funded by FEDER (Fondo Europeo de Desarrollo Regional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2008, EUR J NEUROSCI, V27, P378, DOI 10.1111/j.1460-9568.2008.06025.x; Aguilar JR, 2005, J NEUROSCI, V25, P10990, DOI 10.1523/JNEUROSCI.3229-05.2005; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1988, EXP BRAIN RES, V70, P155; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Bermejo PE, 2003, J COMP NEUROL, V463, P419, DOI 10.1002/cne.10747; BERNARDO KL, 1990, J COMP NEUROL, V291, P231, DOI 10.1002/cne.902910207; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; BURSTEIN R, 1990, BRAIN RES, V511, P329, DOI 10.1016/0006-8993(90)90179-F; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Chakraibarti S, 2006, J COMP NEUROL, V498, P624, DOI 10.1002/cne.21052; CHAPIN JK, 1987, J COMP NEUROL, V263, P326, DOI 10.1002/cne.902630303; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Chemla S, 2010, NEUROIMAGE, V53, P420, DOI 10.1016/j.neuroimage.2010.06.026; Civillico EF, 2006, J NEUROPHYSIOL, V96, P336, DOI 10.1152/jn.00128.2006; CLARKE KA, 1995, PHYSIOL BEHAV, V58, P415, DOI 10.1016/0031-9384(95)00072-Q; Cliffer KD, 1998, MUSCLE NERVE, V21, P1405, DOI 10.1002/(SICI)1097-4598(199811)21:11<1405::AID-MUS7>3.3.CO;2-D; COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968; Colechio EM, 2009, BRAIN STRUCT FUNCT, V213, P423, DOI 10.1007/s00429-009-0215-7; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; DAWSON DR, 1987, J COMP NEUROL, V256, P246, DOI 10.1002/cne.902560205; Derdikman D, 2003, J NEUROSCI, V23, P3100; Devonshire IM, 2010, EUR J NEUROSCI, V32, P786, DOI 10.1111/j.1460-9568.2010.07322.x; DONOGHUE JP, 1979, J COMP NEUROL, V183, P647, DOI 10.1002/cne.901830312; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; ERZURUMLU RS, 1980, NEUROSCIENCE, V5, P1891, DOI 10.1016/0306-4522(80)90037-8; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Foffani G, 2009, J NEUROSCI, V29, P5964, DOI 10.1523/JNEUROSCI.4416-08.2009; Foffani G, 2008, J NEUROPHYSIOL, V100, P268, DOI 10.1152/jn.01015.2007; Francis JT, 2008, J NEUROPHYSIOL, V99, P2291, DOI 10.1152/jn.01206.2007; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; GOCHIN PM, 1992, P NATL ACAD SCI USA, V89, P8381, DOI 10.1073/pnas.89.17.8381; Goloshevsky AG, 2011, NEUROIMAGE, V57, P526, DOI 10.1016/j.neuroimage.2011.04.002; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Higley MJ, 2007, J NEUROPHYSIOL, V97, P647, DOI 10.1152/jn.00777.2006; JAIN N, 1995, J NEUROPHYSIOL, V73, P1537, DOI 10.1152/jn.1995.73.4.1537; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Laaris N, 2000, J NEUROSCI, V20, P1529; Lam YW, 2010, CEREB CORTEX, V20, P13, DOI 10.1093/cercor/bhp077; Lee KH, 2011, J NEUROTRAUM, V28, P797, DOI 10.1089/neu.2010.1492; Lilja J, 2006, J NEUROSCI, V26, P6330, DOI 10.1523/JNEUROSCI.0626-06.2006; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MANZONI T, 1980, EXP BRAIN RES, V39, P1; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Rocco-Donovan M, 2011, SOMATOSENS MOT RES, V28, P63, DOI 10.3109/08990220.2011.606660; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Sigler A, 2009, P NATL ACAD SCI USA, V106, P11759, DOI 10.1073/pnas.0812695106; Tsytsarev V, 2010, NEUROIMAGE, V53, P233, DOI 10.1016/j.neuroimage.2010.06.022; Tutunculer B, 2006, CEREB CORTEX, V16, P791, DOI 10.1093/cercor/bhj023; Urban J, 2002, EUR J NEUROSCI, V16, P1772, DOI 10.1046/j.1460-9568.2002.02225.x; Usunoff KG, 1999, ANAT EMBRYOL, V200, P265, DOI 10.1007/s004290050278; Weng JC, 2011, NEUROIMAGE, V54, P1122, DOI 10.1016/j.neuroimage.2010.08.046; Whishaw IQ, 2010, BEHAV BRAIN RES, V206, P21, DOI 10.1016/j.bbr.2009.08.030; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; WOOLF CJ, 1982, BRAIN RES, V242, P77, DOI 10.1016/0006-8993(82)90497-8; Wree A, 2005, ANAT EMBRYOL, V210, P155, DOI 10.1007/s00429-005-0012-x; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011; Yu X, 2010, NEUROIMAGE, V49, P1667, DOI 10.1016/j.neuroimage.2009.09.021	83	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40174	10.1371/journal.pone.0040174	http://dx.doi.org/10.1371/journal.pone.0040174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829873	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300011
J	Nicolaides, C; Cueto-Felgueroso, L; Gonzalez, MC; Juanes, R				Nicolaides, Christos; Cueto-Felgueroso, Luis; Gonzalez, Marta C.; Juanes, Ruben			A Metric of Influential Spreading during Contagion Dynamics through the Air Transportation Network	PLOS ONE			English	Article							CENTRALITY	The spread of infectious diseases at the global scale is mediated by long-range human travel. Our ability to predict the impact of an outbreak on human health requires understanding the spatiotemporal signature of early-time spreading from a specific location. Here, we show that network topology, geography, traffic structure and individual mobility patterns are all essential for accurate predictions of disease spreading. Specifically, we study contagion dynamics through the air transportation network by means of a stochastic agent-tracking model that accounts for the spatial distribution of airports, detailed air traffic and the correlated nature of mobility patterns and waiting-time distributions of individual agents. From the simulation results and the empirical air-travel data, we formulate a metric of influential spreading-the geographic spreading centrality-which accounts for spatial organization and the hierarchical structure of the network traffic, and provides an accurate measure of the early-time spreading power of individual nodes.	[Nicolaides, Christos; Cueto-Felgueroso, Luis; Gonzalez, Marta C.; Juanes, Ruben] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Gonzalez, Marta C.] MIT, Engn Sci Div, Cambridge, MA 02139 USA; [Juanes, Ruben] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Nicolaides, C (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	juanes@mit.edu	Juanes, Ruben/F-8004-2011; Cueto-Felgueroso, Luis/F-8809-2014; Nicolaides, Christos/O-5991-2017; Gonzalez, Marta C./E-9456-2011	Cueto-Felgueroso, Luis/0000-0001-5303-0236; Nicolaides, Christos/0000-0002-1485-2736; Gonzalez, Marta C./0000-0002-8482-0318	Vergottis Graduate Fellowship; NEC Corporation Fund; Solomon Buchsbaum Research Fund; U.S. Department of Energy [DE-SC0003907]; ARCO Chair in Energy Studies	Vergottis Graduate Fellowship; NEC Corporation Fund; Solomon Buchsbaum Research Fund; U.S. Department of Energy(United States Department of Energy (DOE)); ARCO Chair in Energy Studies	This work was supported by a Vergottis Graduate Fellowship, awards from the NEC Corporation Fund and the Solomon Buchsbaum Research Fund, the U.S. Department of Energy Award No. DE-SC0003907, and the ARCO Chair in Energy Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barnhart C, 2011, MODELING PASSENGER T; Barrat A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/05/P05003; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Castellano C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218701; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gomez S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38009; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062; Meloni S, 2009, P NATL ACAD SCI USA, V106, P16897, DOI 10.1073/pnas.0907121106; Nicolaides C, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.055101; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Youn H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.128701	33	43	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40961	10.1371/journal.pone.0040961	http://dx.doi.org/10.1371/journal.pone.0040961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829902	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300040
J	Zurek, B; Schoultz, I; Neerincx, A; Napolitano, LM; Birkner, K; Bennek, E; Sellge, G; Lerm, M; Meroni, G; Soderholm, JD; Kufer, TA				Zurek, Birte; Schoultz, Ida; Neerincx, Andreas; Napolitano, Luisa M.; Birkner, Katharina; Bennek, Eveline; Sellge, Gernot; Lerm, Maria; Meroni, Germana; Soderholm, Johan D.; Kufer, Thomas A.			TRIM27 Negatively Regulates NOD2 by Ubiquitination and Proteasomal Degradation	PLOS ONE			English	Article							RET FINGER PROTEIN; INTESTINAL EPITHELIAL-CELLS; CLASS-II TRANSACTIVATOR; KAPPA-B ACTIVATION; TRIPARTITE-MOTIF; GENE-EXPRESSION; FAMILY-MEMBER; INNATE; MHC; INTERACTS	NOD2, the nucleotide-binding domain and leucine-rich repeat containing gene family (NLR) member 2 is involved in mediating antimicrobial responses. Dysfunctional NOD2 activity can lead to severe inflammatory disorders, but the regulation of NOD2 is still poorly understood. Recently, proteins of the tripartite motif (TRIM) protein family have emerged as regulators of innate immune responses by acting as E3 ubiquitin ligases. We identified TRIM27 as a new specific binding partner for NOD2. We show that NOD2 physically interacts with TRIM27 via the nucleotide-binding domain, and that NOD2 activation enhances this interaction. Dependent on functional TRIM27, ectopically expressed NOD2 is ubiquitinated with K48-linked ubiquitin chains followed by proteasomal degradation. Accordingly, TRIM27 affects NOD2-mediated pro-inflammatory responses. NOD2 mutations are linked to susceptibility to Crohn's disease. We found that TRIM27 expression is increased in Crohn's disease patients, underscoring a physiological role of TRIM27 in regulating NOD2 signaling. In HeLa cells, TRIM27 is partially localized in the nucleus. We revealed that ectopically expressed NOD2 can shuttle to the nucleus in a Walker A dependent manner, suggesting that NOD2 and TRIM27 might functionally cooperate in the nucleus. We conclude that TRIM27 negatively regulates NOD2-mediated signaling by degradation of NOD2 and suggest that TRIM27 could be a new target for therapeutic intervention in NOD2-associated diseases.	[Zurek, Birte; Neerincx, Andreas; Birkner, Katharina; Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Schoultz, Ida; Lerm, Maria; Soderholm, Johan D.] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Schoultz, Ida; Lerm, Maria; Soderholm, Johan D.] Linkoping Univ Hosp, Dept Surg, S-58185 Linkoping, Sweden; [Napolitano, Luisa M.] Telethon Inst Genet & Med, Naples, Italy; [Bennek, Eveline; Sellge, Gernot] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Napolitano, Luisa M.; Meroni, Germana] Cluster Biomed CBM, Trieste, Italy	University of Cologne; Linkoping University; Linkoping University; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); RWTH Aachen University; RWTH Aachen University Hospital	Zurek, B (corresponding author), Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany.	thomas.kufer@uk-koeln.de	Napolitano, Luisa Maria Rosaria/S-4088-2016; Kufer, Thomas A/I-5146-2015; Lerm, Maria/AAM-8705-2020; Lerm, Maria/AAA-1780-2020	Napolitano, Luisa Maria Rosaria/0000-0001-9214-7269; Kufer, Thomas A/0000-0003-4563-0412; Lerm, Maria/0000-0002-5092-9892; Zurek, PhD, Birte/0000-0002-8200-7542; Schoultz, Ida/0000-0002-8391-1576	German Research Foundation (DFG) [SFB670-NG01]; Swedish Society of Medicine; Regional Research Council of South-East Sweden (FORSS); Swedish Research Council division of Medicine; Gustav V 90th anniversary foundation; Italian Telethon Foundation; DFG [SE 1122/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); Swedish Society of Medicine; Regional Research Council of South-East Sweden (FORSS); Swedish Research Council division of Medicine; Gustav V 90th anniversary foundation; Italian Telethon Foundation(Fondazione Telethon); DFG(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG), grant SFB670-NG01 to TAK and grants from the Swedish Society of Medicine, the Regional Research Council of South-East Sweden (FORSS) and the Swedish Research Council division of Medicine and Gustav V 90th anniversary foundation to ML and JDS. GM is partly funded by the Italian Telethon Foundation. EB and GS acknowledge funding from the DFG, grant SE 1122/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 1997, CELL, V90, P797; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Bernot A, 1997, NAT GENET, V17, P25; Bielig H, 2009, MOL IMMUNOL, V46, P2647, DOI 10.1016/j.molimm.2009.04.022; Bloor AJC, 2005, ONCOGENE, V24, P6729, DOI 10.1038/sj.onc.1208828; Borzutzky A, 2009, CLIN IMMUNOL; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Cao TY, 1998, J CELL SCI, V111, P1319; Cao TY, 1997, J CELL SCI, V110, P1563; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dho SH, 2003, J BIOL CHEM, V278, P31902, DOI 10.1074/jbc.M304062200; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Hasegawa N, 1996, BIOCHEM BIOPH RES CO, V225, P627, DOI 10.1006/bbrc.1996.1221; Henry J, 1997, IMMUNOGENETICS, V46, P383, DOI 10.1007/s002510050292; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Ishii T, 2003, J IMMUNOL, V170, P3653, DOI 10.4049/jimmunol.170.7.3653; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Lecat A, 2010, BIOCHEM PHARMACOL, V80, P2021, DOI 10.1016/j.bcp.2010.07.016; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu J, 2008, MOL PLANT, V1, P411, DOI 10.1093/mp/ssn010; Liu YD, 2003, PLANT J, V34, P149, DOI 10.1046/j.1365-313X.2003.01709.x; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Magalhaes JG, 2011, CURR OPIN IMMUNOL, V23, P29, DOI 10.1016/j.coi.2010.12.003; Matsuura T, 2005, EXP CELL RES, V308, P65, DOI 10.1016/j.yexcr.2005.04.022; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Nakayama EE, 2010, REV MED VIROL, V20, P77, DOI 10.1002/rmv.637; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Neerincx A, 2012, J IMMUNOL, V188, P4940, DOI 10.4049/jimmunol.1103136; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh HM, 2005, CELL IMMUNOL, V237, P37, DOI 10.1016/j.cellimm.2005.09.006; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Patel CA, 2005, BIOCHEM BIOPH RES CO, V330, P333, DOI 10.1016/j.bbrc.2005.02.162; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; RASBAND W, 2007, IMAGEJ; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Shimono Y, 2000, J BIOL CHEM, V275, P39411, DOI 10.1074/jbc.M006585200; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Tameling WIL, 2007, PLANT CELL, V19, P1682, DOI 10.1105/tpc.107.050880; Tezel G, 1999, PATHOL INT, V49, P881, DOI 10.1046/j.1440-1827.1999.00957.x; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Toniato E, 2002, J BIOL CHEM, V277, P37315, DOI 10.1074/jbc.M205900200; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Yamamoto-Furusho JK, 2006, J BIOL CHEM, V281, P36060, DOI 10.1074/jbc.M602383200; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zika E, 2005, CURR OPIN IMMUNOL, V17, P58, DOI 10.1016/j.coi.2004.11.008; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	88	79	83	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41255	10.1371/journal.pone.0041255	http://dx.doi.org/10.1371/journal.pone.0041255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829933	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300072
J	Wald, DS; Morris, JK; Wald, NJ				Wald, David S.; Morris, Joan K.; Wald, Nicholas J.			Randomized Polypill Crossover Trial in People Aged 50 and Over	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PREVENTION	Background: A Polypill is proposed for the primary prevention of cardiovascular disease in people judged to be at risk on account of their age alone. Its efficacy in reducing cholesterol and blood pressure is uncertain. Methods: We conducted a randomized double-blind placebo-controlled crossover trial of a Polypill among individuals aged 50+ without a history of cardiovascular disease and compared the reductions with those predicted from published estimates of the effects of the individual drugs. Participants took the Polypill (amlodipine 2.5 mg, losartan 25 mg, hydrochlorothiazide 12.5 mg and simvastatin 40 mg) each evening for 12 weeks and a placebo each evening for 12 weeks in random sequence. The mean within-person differences in blood pressure and low density lipoprotein (LDL) cholesterol at the end of each 12 week period were determined. Results: 84 out of 86 participants completed both treatment periods. The mean systolic blood pressure was reduced by 17.9 mmHg (95% CI, 15.7-20.1) on the Polypill, diastolic blood pressure by 9.8 mmHg (8.1-11.5), and LDL cholesterol by 1.4 mmol/L (1.2-1.6), reductions of 12%, 11%, and 39% respectively. The results were almost identical to those predicted; 18.4 mmHg, 9.7 mmHg, and 1.4 mmol/L respectively. Conclusion: The Polypill resulted in the predicted reductions in blood pressure and LDL cholesterol. Long term reductions of this magnitude would have a substantial effect in preventing heart attacks and strokes.	[Wald, David S.; Morris, Joan K.; Wald, Nicholas J.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Wald, DS (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England.	d.s.wald@qmul.ac.uk	Wald, Nicholas/AAY-2814-2021; Morris, Joan/AAT-9211-2020; Wald, Nicholas/AAY-8924-2021	Morris, Joan/0000-0002-7164-612X; 	London Charity	London Charity	Cipla provided the Polypill and placebo to the specification of the trial investigators and Barts and the London Charity provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cholesterol Treatment Trialists' (CTT) Collaborators, 2012, LANCET; Cilla DD, 1996, J CLIN PHARMACOL, V36, P604, DOI 10.1002/j.1552-4604.1996.tb04224.x; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Mulatero P, 2002, HYPERTENSION, V40, P897, DOI 10.1161/01.HYP.0000038478.59760.41; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; The Indian Polycap Study (TIPS), 2009, LANCET, V373; van Gils PF, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000363; Wald DS, 2011, J EVAL CLIN PRACT, DOI [10.1111/j.1365-2753.2011.01637, DOI 10.1111/J.1365-2753.2011.01637]; Wald NJ, 2011, LANCET, V377, P1649, DOI 10.1016/S0140-6736(11)60665-X; Wald N, 2009, LANCET, V374, P781, DOI 10.1016/S0140-6736(09)61584-1; Wald NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018742; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wald NJ, 2000, UK Patents, Patent No. [GB0100548, 0100548]; Wald NJ, 2000, United Kingdom, Patents, Patent No. [GB008791 and GB0100548, 008791]	21	96	101	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41297	10.1371/journal.pone.0041297	http://dx.doi.org/10.1371/journal.pone.0041297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815989	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900108
J	Yan, DS; Dong, XD; Chen, XY; Yao, SS; Wang, LH; Wang, J; Wang, C; Hu, DN; Qu, J; Tu, LL				Yan, Dongsheng; Dong, Xiang Da; Chen, Xiaoyan; Yao, Shasha; Wang, Lihua; Wang, Jiao; Wang, Chao; Hu, Dan-Ning; Qu, Jia; Tu, LiLi			Role of MicroRNA-182 in Posterior Uveal Melanoma: Regulation of Tumor Development through MITF, BCL2 and Cyclin D2	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MALIGNANT-MELANOMA; C-MET; PROGNOSTIC MARKER; LINEAGE SURVIVAL; MASTER REGULATOR; GENE-EXPRESSION; METASTASIS; PROLIFERATION; MELANOCYTES	MicroRNAs (miRNAs) are endogenous small non-coding RNAs that play central roles in diverse pathological processes. In this study, we investigated the effect of microRNA-182 (miR-182) on the development of posterior uveal melanomas. Initially, we demonstrated that miR-182 expression was dependent on p53 induction in uveal melanoma cells. Interestingly, transient transfection of miR-182 into cultured uveal melanoma cells led to a significant decrease in cell growth, migration, and invasiveness. Cells transfected with miR-182 demonstrated cell cycle G1 arrest and increased apoptotic activity. Using bioinformatics, we identified three potential targets of miR-182, namely MITF, BCL2 and cyclin D2. miR-182 was shown to have activity on mRNA expression by targeting the 3' untranslated region of MITF, BCL2 and cyclin D2. Subsequent Western blot analysis confirmed the downregulation of MITF, BCL2 and cyclin D2 protein expression. The expression of oncogene c-Met and its downstream Akt and ERK1/2 pathways was also downregulated by miR-182. Concordant with the findings that miR-182 was decreased in uveal melanoma tissue samples, overexpression of miR-182 also suppressed the in vivo growth of uveal melanoma cells. Our results demonstrated that miR-182, a p53 dependent miRNA, suppressed the expression of MITF, BCL2, cyclin D2 and functioned as a potent tumor suppressor in uveal melanoma cells.	[Yan, Dongsheng; Chen, Xiaoyan; Yao, Shasha; Wang, Lihua; Wang, Jiao; Wang, Chao; Qu, Jia; Tu, LiLi] Wenzhou Med Coll, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Yao, Shasha; Wang, Lihua; Wang, Jiao; Wang, Chao; Hu, Dan-Ning; Qu, Jia; Tu, LiLi] Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Yao, Shasha; Wang, Lihua; Wang, Jiao; Wang, Chao; Hu, Dan-Ning; Qu, Jia; Tu, LiLi] Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Dong, Xiang Da] Columbia Univ, Stamford Hosp, Dept Surg, Stamford, CT USA; [Hu, Dan-Ning] New York Med Coll, New York Eye & Ear Infirm, Tissue Culture Ctr, New York, NY USA	Wenzhou Medical University; Columbia University; Stamford Hospital; New York Eye & Ear Infirmary of Mount Sinai; New York Medical College	Yan, DS (corresponding author), Wenzhou Med Coll, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	dnaprotein@yahoo.com.cn; tulili@mail.eye.ac.cn	Yan, Dongsheng/B-1861-2018	Yan, Dongsheng/0000-0003-0551-2219; wang, chao/0000-0002-8592-3781	National Natural Science Foundation of China [81071682]; Zhejiang Provincial Natural Science Foundation of China [Y2080853]; Program for New Century Excellent Talents in University [NCET-06-0538]; 973 Projects from the Ministry of Science and Technology of China [2011CB504605, 2012CB22303]; Major Program of Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College [YNZD201002]; Science Foundation of Wenzhou Medical College [QTJ11020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 973 Projects from the Ministry of Science and Technology of China; Major Program of Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College; Science Foundation of Wenzhou Medical College	This work was supported, in part, by the National Natural Science Foundation of China Grant 81071682, Zhejiang Provincial Natural Science Foundation of China Grant Y2080853, Program for New Century Excellent Talents in University (NCET-06-0538), 973 Projects (2011CB504605 & 2012CB22303) from the Ministry of Science and Technology of China, Major Program of Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College YNZD201002 and Science Foundation of Wenzhou Medical College QTJ11020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bakalian S, 2008, CLIN CANCER RES, V14, P951, DOI 10.1158/1078-0432.CCR-06-2630; Bastian BC, 1998, CANCER RES, V58, P2170; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen X, 2010, INVEST OPHTH VIS SCI, V52, P1193; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Henriquez F, 2007, INVEST OPHTH VIS SCI, V48, P4897, DOI 10.1167/iovs.07-0440; Hoefig KP, 2010, METHODS MOL BIOL, V667, P47, DOI 10.1007/978-1-60761-811-9_4; Hurst EA, 2003, ARCH DERMATOL, V139, P1067, DOI 10.1001/archderm.139.8.1067; Kincaid, 1998, Cancer Control, V5, P299; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lekmine F, 2007, BIOCHEM BIOPH RES CO, V354, P830, DOI 10.1016/j.bbrc.2007.01.075; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malaponte G, 2006, CANCER BIOL THER, V5, P225, DOI 10.4161/cbt.5.2.2429; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Mouriaux F, 2003, EXP EYE RES, V76, P653, DOI 10.1016/S0014-4835(03)00082-4; NAITO S, 1986, CANCER RES, V46, P4109; Otsuka T, 1998, CANCER RES, V58, P5157; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Salti GI, 2000, CANCER RES, V60, P5012; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selzer E, 2002, CANCER RES, V62, P2098; SOULIERES D, 1991, INT J CANCER, V49, P498, DOI 10.1002/ijc.2910490404; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681	43	97	105	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40967	10.1371/journal.pone.0040967	http://dx.doi.org/10.1371/journal.pone.0040967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848417	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200035
J	Collard, M; Ruttle, A; Buchanan, B; O'Brien, MJ				Collard, Mark; Ruttle, April; Buchanan, Briggs; O'Brien, Michael J.			Risk of Resource Failure and Toolkit Variation in Small-Scale Farmers and Herders	PLOS ONE			English	Article							TECHNOLOGY; COMPLEXITY; EVOLUTION	Recent work suggests that global variation in toolkit structure among hunter-gatherers is driven by risk of resource failure such that as risk of resource failure increases, toolkits become more diverse and complex. Here we report a study in which we investigated whether the toolkits of small-scale farmers and herders are influenced by risk of resource failure in the same way. In the study, we applied simple linear and multiple regression analysis to data from 45 small-scale food-producing groups to test the risk hypothesis. Our results were not consistent with the hypothesis; none of the risk variables we examined had a significant impact on toolkit diversity or on toolkit complexity. It appears, therefore, that the drivers of toolkit structure differ between hunter-gatherers and small-scale food-producers.	[Collard, Mark; Ruttle, April; Buchanan, Briggs] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada; [Collard, Mark; Ruttle, April; Buchanan, Briggs] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Buchanan, Briggs; O'Brien, Michael J.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA	Simon Fraser University; Simon Fraser University; University of Missouri System; University of Missouri Columbia	Collard, M (corresponding author), Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada.	mcollard@sfu.ca		Collard, Mark/0000-0002-2725-4989; Buchanan, Briggs/0000-0002-5684-9615	Canada Research Chairs Program; Social Sciences and Humanities Research Council (SSHRC); Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Simon Fraser University (SFU); University of Missouri; SFU; Joseph-Armand Bombardier CGS Master's Scholarship from SSHRC	Canada Research Chairs Program(Canada Research Chairs); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University (SFU); University of Missouri; SFU; Joseph-Armand Bombardier CGS Master's Scholarship from SSHRC	MC is supported by the Canada Research Chairs Program, the Social Sciences and Humanities Research Council (SSHRC), the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and Simon Fraser University (SFU). BB is supported by the University of Missouri and SFU. AR's work on the study was supported by a Joseph-Armand Bombardier CGS Master's Scholarship from SSHRC, and by SFU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY HP, 1960, GEOGR ANN, V42, P1, DOI DOI 10.2307/520173; Bannayan M, 2011, INT J BIOMETEOROL, V55, P387, DOI 10.1007/s00484-010-0348-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Benyshek DC, 2006, AM J PHYS ANTHROPOL, V131, P120, DOI 10.1002/ajpa.20334; Boserup Ester, 1981, POPULATION TECHNOLOG; Bowles S, 2011, P NATL ACAD SCI USA, V108, P4760, DOI 10.1073/pnas.1010733108; Collard M., 2005, CAN J ARCHAEOL J CAN, V29, P1; Collard M, 2011, PHILOS T R SOC B, V366, P1129, DOI 10.1098/rstb.2010.0366; Dierig DA, 2006, IND CROP PROD, V24, P17, DOI 10.1016/j.indcrop.2005.10.004; Dike MC, 1997, INT J PEST MANAGE, V43, P191, DOI 10.1080/096708797228663; Dirks Robert, 1993, CROSS-CULT RES, V27, P28, DOI DOI 10.1177/106939719302700103; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; LOW BS, 1990, RISK UNCERTAINTY TRI, P229; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; National Oceanic and Atmospheric Administration, 1991, HIST CLIM SER; Osborn Alan J, 1999, FOLSOM LITHIC TECHNO, P188; Oswalt W. H., 1973, HABITAT TECHNOLOGY E; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Read D, 2008, AM ANTIQUITY, V73, P599, DOI 10.2307/25470520; SHOTT M, 1986, J ANTHROPOL RES, V42, P15, DOI 10.1086/jar.42.1.3630378; Sokal RR, 1995, BIOMETRY; Torrence R, 2001, BIOSOCIAL S, V13, P73; Torrence R., 1989, TIME ENERGY STONE TO, P57; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107; White Leslie H., 1959, EVOLUTION CULTURE DE; Wilken G.C., 1987, GOOD FARMERS TRADITI	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40975	10.1371/journal.pone.0040975	http://dx.doi.org/10.1371/journal.pone.0040975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844421	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600013
J	Joachim, SC; Gramlich, OW; Laspas, P; Schmid, H; Beck, S; von Pein, HD; Dick, HB; Pfeiffer, N; Grus, FH				Joachim, Stephanie C.; Gramlich, Oliver W.; Laspas, Panagiotis; Schmid, Heiko; Beck, Sabine; von Pein, Harald D.; Dick, H. Burkhard; Pfeiffer, Norbert; Grus, Franz H.			Retinal Ganglion Cell Loss Is Accompanied by Antibody Depositions and Increased Levels of Microglia after Immunization with Retinal Antigens	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEAT-SHOCK PROTEINS; OPTIC-NERVE HEAD; ELEVATED INTRAOCULAR-PRESSURE; EXPERIMENTAL RAT MODEL; GLAUCOMA PATIENTS; MULTIPLE-SCLEROSIS; DIFFERENTIAL EXPRESSION; AUTOREACTIVE ANTIBODIES; MACULAR DEGENERATION	Background: Antibodies against retinal and optic nerve antigens are detectable in glaucoma patients. Recent studies using a model of experimental autoimmune glaucoma demonstrated that immunization with certain ocular antigens causes an immun-mediated retinal ganglion cell loss in rats. Methodology/Principal Findings: Rats immunized with a retinal ganglion cell layer homogenate (RGA) had a reduced retinal ganglion cell density on retinal flatmounts (p = 0.007) and a lower number of Brn3(+) retinal ganglion cells (p = 0.0001) after six weeks. The autoreactive antibody development against retina and optic nerve was examined throughout the study. The levels of autoreactive antibodies continuously increased up to 6 weeks (retina: p = 0.004; optic nerve: p = 0.000003). Additionally, antibody deposits were detected in the retina (p = 0.02). After 6 weeks a reactive gliosis (GFAP density: RGA: 174.7 +/- 41.9; CO: 137.6 +/- 36.8, p = 0.0006; %GFAP(+) area: RGA: 8.5 +/- 3.4; CO: 5.9 +/- 3.6, p = 0.006) as well as elevated level of Iba1(+) microglia cells (p = 0.003) was observed in retinas of RGA animals. Conclusions/Significance: Our findings suggest that these antibodies play a substantial role in mechanisms leading to retinal ganglion cell death. This seems to lead to glia cell activation as well as the invasion of microglia, which might be associated with debris clearance.	[Joachim, Stephanie C.; Schmid, Heiko; Dick, H. Burkhard] Ruhr Univ Bochum, Hosp Eye, Expt Eye Res Inst, Bochum, Germany; [Gramlich, Oliver W.; Laspas, Panagiotis; Beck, Sabine; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [von Pein, Harald D.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuropathol, Mainz, Germany	Ruhr University Bochum; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Joachim, SC (corresponding author), Ruhr Univ Bochum, Hosp Eye, Expt Eye Res Inst, Univ Str 150, Bochum, Germany.	stephanie.joachim@rub.de	Pfeiffer, Norbert/AAO-7586-2020; Dick, Burkhard/AAI-7504-2020; Joachim, Stephanie/AAV-5980-2021	Gramlich, Oliver W/0000-0001-6948-0522	German Research Foundation [JO 886/1-1]; Gertrud Kusen Foundation; Herbert Funke Foundation	German Research Foundation(German Research Foundation (DFG)); Gertrud Kusen Foundation; Herbert Funke Foundation	This work was supported by the German Research Foundation (grant JO 886/1-1), the Gertrud Kusen Foundation, and the Herbert Funke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badie B, 2001, J NEUROIMMUNOL, V120, P19, DOI 10.1016/S0165-5728(01)00361-7; Bjorkqvist M, 2009, NEURON, V64, P21, DOI 10.1016/j.neuron.2009.09.034; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boehm N., 2011, INVEST OPHTHALMOL VI; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Gellrich MM, 1996, GRAEF ARCH CLIN EXP, V234, P315, DOI 10.1007/BF00220707; Gramlich OW, 2010, INVEST OPHTH VIS SCI, V51; Gramlich OW, 2011, ARVO M, V52, P2928; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Grus FH, 2006, INVEST OPHTH VIS SCI, V47, P968, DOI 10.1167/iovs.05-0685; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Harrer MD, 2009, EXP NEUROL, V216, P431, DOI 10.1016/j.expneurol.2008.12.027; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Howlett DR, 2011, EXP BRAIN RES, V214, P185, DOI 10.1007/s00221-011-2819-4; Huizinga R, 2008, TRENDS IMMUNOL, V29, P54, DOI 10.1016/j.it.2007.11.002; Husain D, 2005, ARCH OPHTHALMOL-CHIC, V123, P509, DOI 10.1001/archopht.123.4.509; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Joachim SC, 2005, GRAEF ARCH CLIN EXP, V243, P817, DOI 10.1007/s00417-004-1094-5; Joachim SC, 2003, EUR J OPHTHALMOL, V13, P752, DOI 10.1177/1120672103013009-1003; Joachim SC, 2008, GRAEF ARCH CLIN EXP, V246, P573, DOI 10.1007/s00417-007-0737-8; Joachim SC, 2009, INVEST OPHTH VIS SCI, V50, P4734, DOI 10.1167/iovs.08-3144; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Lam TT, 2003, INVEST OPHTH VIS SCI, V44, P638, DOI 10.1167/iovs.02-0255; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Laspas P, 2011, INVEST OPHTH VIS SCI, V52, P8835, DOI 10.1167/iovs.10-6889; Lim MJ, 2006, NEUROPATH APPL NEURO, V32, P469, DOI 10.1111/j.1365-2990.2006.00738.x; Lim MJ, 2007, NEUROBIOL DIS, V25, P239, DOI 10.1016/j.nbd.2006.09.005; Maruyama I, 2002, TOHOKU J EXP MED, V197, P125, DOI 10.1620/tjem.197.125; Moore S, 1996, PROG NEUROBIOL, V48, P441, DOI 10.1016/0301-0082(95)00051-8; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Palagina G, 2009, P NATL ACAD SCI USA, V106, P8743, DOI 10.1073/pnas.0900068106; Park CK, 2009, EXP BRAIN RES, V197, P101, DOI 10.1007/s00221-009-1896-0; Patel N, 2005, IMMUNOLOGY, V115, P422, DOI 10.1111/j.1365-2567.2005.02173.x; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Qu J, 2010, EXP EYE RES; Reichelt J, 2008, CURR EYE RES, V33, P253, DOI 10.1080/02713680701871157; Ross RJ, 2008, EXP EYE RES, V86, P675, DOI 10.1016/j.exer.2008.01.014; Rudehill S, 2006, ACTA NEUROCHIR, V148, P199, DOI 10.1007/s00701-005-0673-5; Sakurai T, 2011, J NEUROIMMUNOL, V233, P175, DOI 10.1016/j.jneuroim.2010.11.003; SHIOSAKA S, 1984, J NEUROSCI METH, V10, P229, DOI 10.1016/0165-0270(84)90059-1; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; Simon P, 1998, J NEUROSCI METH, V83, P113, DOI 10.1016/S0165-0270(98)00060-0; Smith AW, 2011, INVEST OPHTH VIS SCI, V52, P4935, DOI 10.1167/iovs.10-7027; SUTTER A, 1991, PATHOBIOLOGY, V59, P254; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Tezel G, 2003, INVEST OPHTH VIS SCI, V44, P3025, DOI 10.1167/iovs.02-1136; Tezel G, 2000, J NEUROSCI, V20, P3552, DOI 10.1523/JNEUROSCI.20-10-03552.2000; Tezel Gulgun, 2004, Curr Opin Ophthalmol, V15, P80, DOI 10.1097/00055735-200404000-00003; ULVESTAD E, 1994, J NEUROPATH EXP NEUR, V53, P27, DOI 10.1097/00005072-199401000-00004; Vidal L, 2010, BRAIN RES BULL, V82, P18, DOI 10.1016/j.brainresbull.2010.02.011; Vilaplana J, 1999, J NEUROSCI METH, V88, P181, DOI 10.1016/S0165-0270(99)00016-3; Vyshkina T, 2008, LAB INVEST, V88, P796, DOI 10.1038/labinvest.2008.53; Wang L, 2002, INVEST OPHTH VIS SCI, V43, P1088; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wax MB, 2001, OPHTHALMOLOGY, V108, P296, DOI 10.1016/S0161-6420(00)00525-X; Wekerle H, 2008, ANN RHEUM DIS, V67, P56, DOI 10.1136/ard.2008.098020; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Ziehn MO, 2010, LAB INVEST, V90, P774, DOI 10.1038/labinvest.2010.6	63	58	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40616	10.1371/journal.pone.0040616	http://dx.doi.org/10.1371/journal.pone.0040616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848388	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600007
J	Siddique, S; Sobczak, M; Tenhaken, R; Grundler, FMW; Bohlmann, H				Siddique, Shahid; Sobczak, Miroslaw; Tenhaken, Raimund; Grundler, Florian M. W.; Bohlmann, Holger			Cell Wall Ingrowths in Nematode Induced Syncytia Require UGD2 and UGD3	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; ARABIDOPSIS-THALIANA; HETERODERA-SCHACHTII; MATRIX POLYSACCHARIDES; GENE FAMILY; ROOTS; RESPONSES; BIOSYNTHESIS; HOST; TRANSCRIPTOME	The cyst nematode Heterodera schachtii infects roots of Arabidopsis plants and establishes feeding sites called syncytia, which are the only nutrient source for nematodes. Development of syncytia is accompanied by changes in cell wall structures including the development of cell wall ingrowths. UDP- glucuronic acid is a precursor of several cell wall polysaccharides and can be produced by UDP-glucose dehydrogenase through oxidation of UDP-glucose. Four genes in Arabidopsis encode this enzyme. Promoter::GUS analysis revealed that UGD2 and UGD3 were expressed in syncytia as early as 1 dpi while expression of UGD1 and UGD4 could only be detected starting at 2 dpi. Infection assays showed no differences between Delta ugd1 and Delta ugd4 single mutants and wild type plants concerning numbers of males and females and the size of syncytia and cysts. On single mutants of Delta ugd2 and Delta ugd3, however, less and smaller females, and smaller syncytia formed compared to wild type plants. The double mutant Delta Delta ugd23 had a stronger effect than the single mutants. These data indicate that UGD2 and UGD3 but not UGD1 and UGD4 are important for syncytium development. We therefore studied the ultrastructure of syncytia in the Delta Delta ugd23 double mutant. Syncytia contained an electron translucent cytoplasm with degenerated cellular organelles and numerous small vacuoles instead of the dense cytoplasm as in syncytia developing in wild type roots. Typical cell wall ingrowths were missing in the Delta Delta ugd23 double mutant. Therefore we conclude that UGD2 and UGD3 are needed for the production of cell wall ingrowths in syncytia and that their lack leads to a reduced host suitability for H. schachtii resulting in smaller syncytia, lower number of developing nematodes, and smaller females.	[Siddique, Shahid; Grundler, Florian M. W.; Bohlmann, Holger] Univ Nat Resources & Life Sci, Div Plant Protect, Dept Crop Sci, Vienna, Austria; [Sobczak, Miroslaw] Warsaw Univ Life Sci SGGW, Dept Bot, Warsaw, Poland; [Tenhaken, Raimund] Salzburg Univ, Div Plant Physiol, A-5020 Salzburg, Austria	University of Natural Resources & Life Sciences, Vienna; Warsaw University of Life Sciences; Salzburg University	Bohlmann, H (corresponding author), Univ Nat Resources & Life Sci, Div Plant Protect, Dept Crop Sci, Vienna, Austria.	holger.bohlmann@boku.ac.at	Grundler, Florian MW/I-6508-2012; Tenhaken, Raimund/O-6556-2019	Tenhaken, Raimund/0000-0002-6764-4826; Sobczak, Miroslaw/0000-0002-4660-6935; Grundler, Florian M.W./0000-0001-8101-0558; Siddique, Shahid/0000-0001-7503-4318	Austrian Science Fund (FWF) [P16296-B06, P20471-B11]; Polish Ministry of Science and Higher Education [116/N-COST/2008]; Higher Education Commission of Pakistan (HEC); Austrian Science Fund (FWF) [P 20471] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Higher Education Commission of Pakistan (HEC)(Higher Education Commission of Pakistan); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by grants P16296-B06 and P20471-B11 of the Austrian Science Fund (FWF, www.fwf.ac.at) and by grant 116/N-COST/2008 of the Polish Ministry of Science and Higher Education (www.nauka.gov.pl). Shahid Siddique was supported by Higher Education Commission of Pakistan (HEC, www.hec.gov.pk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriunas FA, 2012, J EXP BOT, V63, P3617, DOI 10.1093/jxb/ers029; BETKA M, 1991, PHYTOPATHOLOGY, V81, P75, DOI 10.1094/Phyto-81-75; BOCKENHOFF A, 1994, PARASITOLOGY, V109, P249, DOI 10.1017/S003118200007637X; Cai DG, 1997, SCIENCE, V275, P832, DOI 10.1126/science.275.5301.832; Edwards J, 2010, PLANT J, V63, P651, DOI 10.1111/j.1365-313X.2010.04269.x; Endres S, 2011, PLANTA, V234, P157, DOI 10.1007/s00425-011-1394-z; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; Golinowski W, 1996, PROTOPLASMA, V194, P103, DOI 10.1007/BF01273172; Grundler FMW, 1998, EUR J PLANT PATHOL, V104, P545, DOI 10.1023/A:1008692022279; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Hussey RS, 1998, PHYSIOLOGY AND BIOCHEMISTRY OF FREE-LIVING AND PLANT-PARASITIC NEMATODES, P213; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; JONES MGK, 1972, J CELL SCI, V10, P789; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; Ju rgensen K, 2001, UNTERSUCHUNGEN ZUM A; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Klinghammer M, 2007, J EXP BOT, V58, P3609, DOI 10.1093/jxb/erm209; LITTRELL RH, 1966, PHYTOPATHOLOGY, V56, P540; Muller J., 1981, Revue de Nematologie, V4, P227; Offler CE, 2003, ANNU REV PLANT BIOL, V54, P431, DOI 10.1146/annurev.arplant.54.031902.134812; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Reboul R, 2011, J BIOL CHEM, V286, P39982, DOI 10.1074/jbc.M111.255695; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Siddique S, 2009, NEW PHYTOL, V184, P457, DOI 10.1111/j.1469-8137.2009.02981.x; SIJMONS PC, 1991, PLANT J, V1, P245, DOI 10.1111/j.1365-313X.1991.00245.x; Sobczak M, 1997, EUR J PLANT PATHOL, V103, P113, DOI 10.1023/A:1008609409465; Sobczak M, 1996, INVESTIGATIONS STRUC; Sobczak M, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P395, DOI 10.1007/978-94-007-0434-3_19; Szakasits D, 2009, PLANT J, V57, P771, DOI 10.1111/j.1365-313X.2008.03727.x; Thiel J, 2008, PLANT PHYSIOL, V148, P1436, DOI 10.1104/pp.108.127001; TRUDGILL DL, 1967, NEMATOLOGICA, V13, P263, DOI 10.1163/187529267X00120; Urwin PE, 1997, PARASITOLOGY, V114, P605; Wieczorek K, 2008, PLANT J, V53, P336, DOI 10.1111/j.1365-313X.2007.03340.x; Wieczorek K, 2006, PLANT J, V48, P98, DOI 10.1111/j.1365-313X.2006.02856.x; WYSS U, 1992, NETH J PLANT PATHOL, V98, P165, DOI 10.1007/BF01974483; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129	37	33	39	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41515	10.1371/journal.pone.0041515	http://dx.doi.org/10.1371/journal.pone.0041515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848518	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600032
J	Zhu, ML; Shi, TY; Hu, HC; He, J; Wang, MY; Jin, L; Yang, YJ; Wang, JC; Sun, MH; Chen, H; Zhao, KL; Zhang, Z; Chen, HQ; Xiang, JQ; Wei, QY				Zhu, Mei-Ling; Shi, Ting-Yan; Hu, Hai-Chuan; He, Jing; Wang, Mengyun; Jin, Li; Yang, Ya-Jun; Wang, Jiu-Cun; Sun, Meng-Hong; Chen, Huan; Zhao, Kuai-Le; Zhang, Zhen; Chen, Hai-Quan; Xiang, Jia-Qing; Wei, Qing-Yi			Polymorphisms in the ERCC5 Gene and Risk of Esophageal Squamous Cell Carcinoma (ESCC) in Eastern Chinese Populations	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; GENOME-WIDE ASSOCIATION; DNA-REPAIR; LUNG-CANCER; MOLECULAR-BASIS; BREAST-CANCER; XPG GENE; SUSCEPTIBILITY; EXPRESSION; RECRUITMENT	Background: Excision repair cross complementing group 5(ERCC5 or XPG) plays an important role in regulating DNA excision repair; its functional single nucleotide polymorphisms (SNPs) may alter DNA repair capacity and thus contribute to cancer risk. Methodology/Principal Findings: In a hospital-based case-control study of 1115 esophageal squamous cell carcinoma (ESCC) cases and 1117 cancer-free controls, we genotyped three potentially functional SNPs of ERCC5 (SNPs, rs2296147T>C, rs2094258C>T and rs873601G>A) and estimated crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for their associations with risk of ESCC using unconditional logistic regression models. We also calculated false-positive report probabilities (FPRPs) for significant findings. We found that compared with the TT genotype, ERCC5 rs2296147 C variant genotypes were associated with a significantly lower ESCC risk (CT: adjusted OR = 0.76, 95% CI = 0.63-0.93, CT/CC: adjusted OR = 0.80, 95% CI = 0.67-0.96); however, this risk was not observed for the other two SNPs (rs2094258C>T and rs873601 G>A), nor in further stratification and haplotype analysis. Conclusions/Significances: These findings suggested that ERCC5 polymorphisms may contribute to risk of ESCC in Eastern Chinese populations, but the effect was weak and needs further validation by larger population-based case-control studies.	[Zhu, Mei-Ling; Shi, Ting-Yan; Hu, Hai-Chuan; He, Jing; Wang, Mengyun; Sun, Meng-Hong; Chen, Huan; Zhao, Kuai-Le; Zhang, Zhen; Chen, Hai-Quan; Xiang, Jia-Qing] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Mei-Ling; Shi, Ting-Yan; He, Jing; Wang, Mengyun] Fudan Univ, Dept Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Zhu, Mei-Ling; Shi, Ting-Yan; He, Jing; Wang, Mengyun; Jin, Li; Yang, Ya-Jun; Wei, Qing-Yi] Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Hu, Hai-Chuan; Chen, Hai-Quan; Xiang, Jia-Qing] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Sun, Meng-Hong; Chen, Huan] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Zhao, Kuai-Le; Zhang, Zhen] Fudan Univ, Dept Radiotherapy, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Xiang, JQ (corresponding author), Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	j.q.xiang@hotmail.com; weiqingyi@yahoo.com	He, Jing/M-5774-2015; Jin, Li/C-1468-2009; Hu, Haichuan/U-7131-2017; Wang, Jiucun/J-8744-2012; Jin, Li/M-5063-2019; Hu, Haichuan/O-7726-2018	He, Jing/0000-0002-1954-2892; Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620; Hu, Haichuan/0000-0003-3436-290X	Chinese Recruitment Program of Global Experts at Fudan University; Ministry of Health [201002007]	Chinese Recruitment Program of Global Experts at Fudan University; Ministry of Health	This study was supported by funding from the Chinese Recruitment Program of Global Experts at Fudan University and a grant from the Ministry of Health (grant number 201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bartolucci R, 2009, CLIN LUNG CANCER, V10, P47, DOI 10.3816/CLC.2009.n.007; Blankenburg S, 2005, EUR J HUM GENET, V13, P253, DOI 10.1038/sj.ejhg.5201296; Blomquist TM, 2010, CARCINOGENESIS, V31, P1242, DOI 10.1093/carcin/bgq057; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang JS, 2008, INT J CANCER, V123, P2095, DOI 10.1002/ijc.23801; Chang-Claude J, 1997, INT J EPIDEMIOL, V26, P1159, DOI 10.1093/ije/26.6.1159; Cheng L, 2002, CANCER-AM CANCER SOC, V94, P393, DOI 10.1002/cncr.10231; Cheng L, 2000, CARCINOGENESIS, V21, P1527, DOI 10.1093/carcin/21.8.1527; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Doherty JA, 2011, CANCER EPIDEM BIOMAR, V20, P1873, DOI 10.1158/1055-9965.EPI-11-0119; Emmert S, 2002, J INVEST DERMATOL, V118, P972, DOI 10.1046/j.1523-1747.2002.01782.x; Garcia-Closas M, 2006, CANCER EPIDEM BIOMAR, V15, P536, DOI 10.1158/1055-9965.EPI-05-0749; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hanawalt PC, 2001, MUTAT RES-DNA REPAIR, V485, P3, DOI 10.1016/S0921-8777(00)00071-9; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Koeppel F, 2004, CLIN CANCER RES, V10, P5604, DOI 10.1158/1078-0432.CCR-04-0442; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; Kumar R, 2003, INT J CANCER, V103, P671, DOI 10.1002/ijc.10870; Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672; Li XY, 2007, GENOMICS, V90, P474, DOI 10.1016/j.ygeno.2007.06.006; Lomonaco SL, 2009, DNA CELL BIOL, V28, P285, DOI 10.1089/dna.2008.0815; Ma HX, 2012, PHARMACOGENET GENOM, V22, P50, DOI 10.1097/FPC.0b013e32834e3cf6; Mechanic LE, 2006, CARCINOGENESIS, V27, P1377, DOI 10.1093/carcin/bgi330; Mohrenweiser H, 2007, MUTAT RES-FUND MOL M, V616, P221, DOI 10.1016/j.mrfmmm.2006.11.008; Nouspikel TP, 2006, MOL CELL BIOL, V26, P8722, DOI 10.1128/MCB.01263-06; Pan J, 2009, CARCINOGENESIS, V30, P785, DOI 10.1093/carcin/bgp058; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; Povey JE, 2007, CARCINOGENESIS, V28, P1087, DOI 10.1093/carcin/bgl257; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Riancho JA, 2012, REUMATOL CLIN, V8, P56, DOI 10.1016/j.reuma.2011.07.005; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Sanyal S, 2004, CARCINOGENESIS, V25, P729, DOI 10.1093/carcin/bgh058; Scharer OD, 2008, DNA REPAIR, V7, P339, DOI 10.1016/j.dnarep.2007.10.007; SCHERLY D, 1993, NATURE, V363, P182, DOI 10.1038/363182a0; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Shen J, 2006, CANCER EPIDEM BIOMAR, V15, P1614, DOI 10.1158/1055-9965.EPI-06-0218; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Xing DY, 2003, ONCOL REP, V10, P1615; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	51	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41500	10.1371/journal.pone.0041500	http://dx.doi.org/10.1371/journal.pone.0041500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848513	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600030
J	Lambert-Niclot, S; Flandre, P; Valantin, MA; Soulie, C; Fourati, S; Wirden, M; Sayon, S; Pakianather, S; Bocket, L; Masquelier, B; Dos Santos, G; Katlama, C; Calvez, V; Marcelin, AG				Lambert-Niclot, Sidonie; Flandre, Philippe; Valantin, Marc-Antoine; Soulie, Cathia; Fourati, Slim; Wirden, Marc; Sayon, Sophie; Pakianather, Sophie; Bocket, Laurence; Masquelier, Bernard; Dos Santos, Georges; Katlama, Christine; Calvez, Vincent; Marcelin, Anne-Genevieve			Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI-ANRS136 Trial over 96 Weeks	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; LOPINAVIR/RITONAVIR MONOTHERAPY; RNA; EFFICACY; VIREMIA; PLASMA; IMPACT; CELLS; PCR	Background: A higher proportion of intermittent viremia (to have a HIV-1 RNA viral load>50 copies/mL not confirmed) was reported in the boosted protease inhibitor monotherapy arm in some studies including MONOI trial, and that could have an impact on the replenishment of the HIV-1 DNA reservoirs. The HIV-1 DNA level is an interesting marker which reflects the size of cellular HIV reservoir. Our objectives were to study the impact of 96 weeks of Darunavir/ritonavir monotherapy versus a triple standard combination on the HIV-1 blood reservoir and factors associated with HIV-1 plasma DNA at baseline in MONOI trial sub-study. Methodology/Principal Findings: This sub-study is focused on 160 patients (79 patients in monotherapy arm and 81 in tritherapy arm) for whom blood cells were available both at baseline and at week 96 (W96). Baseline HIV-1 plasma DNA was associated with CD4 nadir, pre therapeutic HIV-1 RNA viral load and baseline HIV-1 RNA measured by ultrasensitive assay. A similar median delta HIV-DNA was observed between D0 and W96 in both arms; 0.35 log copies/10(6) leucocytes in monotherapy arm versus 0.51 log copies/10(6) leucocytes in tritherapy arm. Conclusion/Significance: Despite a higher proportion of intermittent viremia in monotherapy arm, a similar evolution of cellular HIV-1 DNA level was observed between mono and triple therapy arm.	[Lambert-Niclot, Sidonie; Flandre, Philippe; Valantin, Marc-Antoine; Soulie, Cathia; Fourati, Slim; Wirden, Marc; Sayon, Sophie; Katlama, Christine; Calvez, Vincent; Marcelin, Anne-Genevieve] Hop La Pitie Salpetriere, AP HP, INSERM, U943, Paris, France; [Lambert-Niclot, Sidonie; Flandre, Philippe; Valantin, Marc-Antoine; Soulie, Cathia; Fourati, Slim; Wirden, Marc; Sayon, Sophie; Katlama, Christine; Calvez, Vincent; Marcelin, Anne-Genevieve] Univ Paris 06, Paris, France; [Bocket, Laurence] CHRU, Lille, France; [Masquelier, Bernard] Pellegrin Hosp, AP HP, Bordeaux, France; [Dos Santos, Georges] Ctr Hosp, Fort De France, Martinique, France; [Dos Santos, Georges] Univ Fort de France, Fort De France, Martinique, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); CHU Bordeaux; CHU Martinique	Lambert-Niclot, S (corresponding author), Hop La Pitie Salpetriere, AP HP, INSERM, U943, Paris, France.	sidonie.lambert@psl.aphp.fr	Fourati, Slim/B-2756-2016; SOULIE, CATHIA/AIF-3965-2022; Marcelin, Anne-Genevieve/D-8272-2014; Flandre, Philippe/N-6314-2017	Marcelin, Anne-Genevieve/0000-0003-4808-8999; Flandre, Philippe/0000-0002-2612-3522	Agence Nationale de Recherches sur le SIDA (ANRS); European Community [223131]; ARVD (Association de Recherche en Virologie et Dermatologie)	Agence Nationale de Recherches sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); European Community(European Commission); ARVD (Association de Recherche en Virologie et Dermatologie)	This work was supported by the Agence Nationale de Recherches sur le SIDA (ANRS), the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" - [grant agreement no 223131] and ARVD (Association de Recherche en Virologie et Dermatologie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Avettand-Fenoel V, 2010, J ANTIMICROB CHEMOTH, V65, P1005, DOI 10.1093/jac/dkq084; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Burgard M, 2000, AIDS RES HUM RETROV, V16, P1939, DOI 10.1089/088922200750054666; BURGARD M, 2009, 17 INT AIDS C MEX CI, V23, P2165, DOI DOI 10.1097/QAD.0B013E32833032D4; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; EACS European AIDS Clinical Society, 2011, CLIN MAN TREATM HIV; HATZAKIS AE, 2004, 17 INT AIDS C MEX CI, V18, P2261; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hoen B, 2007, CLIN INFECT DIS, V45, P381, DOI 10.1086/519428; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Meynard JL, 2010, J ANTIMICROB CHEMOTH; Morand-Doubert L, 2005, JAIDS-J ACQ IMM DEF, V38, P268; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Pulido F, 2008, AIDS, V22, P1696, DOI 10.1097/QAD.0b013e32830a98ac; Valantin MA, 2012, J ANTIMICROB CHEMOTH, V67, P691, DOI 10.1093/jac/dkr504; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005	19	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41390	10.1371/journal.pone.0041390	http://dx.doi.org/10.1371/journal.pone.0041390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848481	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600060
J	Tsai, KC; Jian, JW; Yang, EW; Hsu, PC; Peng, HP; Chen, CT; Chen, JB; Chang, JY; Hsu, WL; Yang, AS				Tsai, Keng-Chang; Jian, Jhih-Wei; Yang, Ei-Wen; Hsu, Po-Chiang; Peng, Hung-Pin; Chen, Ching-Tai; Chen, Jun-Bo; Chang, Jeng-Yih; Hsu, Wen-Lian; Yang, An-Suei			Prediction of Carbohydrate Binding Sites on Protein Surfaces with 3-Dimensional Probability Density Distributions of Interacting Atoms	PLOS ONE			English	Article							FEATURES	Non-covalent protein-carbohydrate interactions mediate molecular targeting in many biological processes. Prediction of non-covalent carbohydrate binding sites on protein surfaces not only provides insights into the functions of the query proteins; information on key carbohydrate-binding residues could suggest site-directed mutagenesis experiments, design therapeutics targeting carbohydrate-binding proteins, and provide guidance in engineering protein-carbohydrate interactions. In this work, we show that non-covalent carbohydrate binding sites on protein surfaces can be predicted with relatively high accuracy when the query protein structures are known. The prediction capabilities were based on a novel encoding scheme of the three-dimensional probability density maps describing the distributions of 36 non-covalent interacting atom types around protein surfaces. One machine learning model was trained for each of the 30 protein atom types. The machine learning algorithms predicted tentative carbohydrate binding sites on query proteins by recognizing the characteristic interacting atom distribution patterns specific for carbohydrate binding sites from known protein structures. The prediction results for all protein atom types were integrated into surface patches as tentative carbohydrate binding sites based on normalized prediction confidence level. The prediction capabilities of the predictors were benchmarked by a 10-fold cross validation on 497 non-redundant proteins with known carbohydrate binding sites. The predictors were further tested on an independent test set with 108 proteins. The residue-based Matthews correlation coefficient (MCC) for the independent test was 0.45, with prediction precision and sensitivity (or recall) of 0.45 and 0.49 respectively. In addition, 111 unbound carbohydrate-binding protein structures for which the structures were determined in the absence of the carbohydrate ligands were predicted with the trained predictors. The overall prediction MCC was 0.49. Independent tests on anti-carbohydrate antibodies showed that the carbohydrate antigen binding sites were predicted with comparable accuracy. These results demonstrate that the predictors are among the best in carbohydrate binding site predictions to date.	[Tsai, Keng-Chang; Jian, Jhih-Wei; Yang, Ei-Wen; Hsu, Po-Chiang; Peng, Hung-Pin; Chen, Ching-Tai; Chen, Jun-Bo; Chang, Jeng-Yih; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Jian, Jhih-Wei; Peng, Hung-Pin; Chen, Ching-Tai] Acad Sinica, Inst Informat Sci, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan; [Jian, Jhih-Wei; Peng, Hung-Pin] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Ching-Tai] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chen, Jun-Bo] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Tsing Hua University	Tsai, KC (corresponding author), Natl Res Inst Chinese Med, Taipei, Taiwan.	yangas@gate.sinica.edu.tw	Hsu, Wen-Lian/ABB-2851-2020	Hsu, Wen-Lian/0000-0001-7061-3513; Yang, An-Suei/0000-0002-4699-873X; Tsai, Keng-Chang/0000-0001-8277-9174	National Health Research Institutes [NHRI-EX98-9802EI]; National Science Council [NSC 99-2311-B-001-014-MY3]; Genomics Research Center at Academia Sinica [AS-100-TP2-B01]; NRPB program, NSC [NSC 100-2325-B-001-009, 100IDP006-3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Genomics Research Center at Academia Sinica(Academia Sinica - Taiwan); NRPB program, NSC	This work was supported by National Health Research Institutes [NHRI-EX98-9802EI to A-S.Y.], National Science Council [NSC 99-2311-B-001-014-MY3 to A-S.Y.], Genomics Research Center at Academia Sinica [AS-100-TP2-B01 to A-S.Y.], and NRPB program, NSC. [NSC 100-2325-B-001-009; 100IDP006-3 to A-S.Y.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen CT, 2008, BIOINFORMATICS, V24, P2691, DOI 10.1093/bioinformatics/btn538; Kulharia M, 2009, J MOL GRAPH MODEL, V28, P297, DOI 10.1016/j.jmgm.2009.08.009; Laskowski RA, 1996, J MOL BIOL, V259, P175, DOI 10.1006/jmbi.1996.0311; Lebrilla CB, 2009, MOL BIOSYST, V5, P17, DOI 10.1039/b811781k; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; Manning CD, 2007, INTRO INFORM RETRIEV; McConkey BJ, 2003, P NATL ACAD SCI USA, V100, P3215, DOI 10.1073/pnas.0535768100; Nassif H, 2009, PROTEINS, V77, P121, DOI 10.1002/prot.22424; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; Riedmiller M., 1994, RPROP DESCRIPTION IM; Shionyu-Mitsuyama C, 2003, PROTEIN ENG, V16, P467, DOI 10.1093/protein/gzg065; Taroni C, 2000, PROTEIN ENG, V13, P89, DOI 10.1093/protein/13.2.89; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; Varki A, 2009, ESSENTIALS GLYCOBIOL; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Yu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033340	23	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40846	10.1371/journal.pone.0040846	http://dx.doi.org/10.1371/journal.pone.0040846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848404	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600025
J	Araki, Y; Hamafuji, T; Noguchi, C; Shimizu, N				Araki, Yoshio; Hamafuji, Tetsuro; Noguchi, Chiemi; Shimizu, Noriaki			Efficient Recombinant Production in Mammalian Cells Using a Novel IR/MAR Gene Amplification Method	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; REPLICATION INITIATION REGION; DNA-REPLICATION; EXPRESSION; LINES; HETEROCHROMATIN; TRANSCRIPTION; METHYLATION; MODULATION; PLASMIDS	We previously found that plasmids bearing a mammalian replication initiation region (IR) and a nuclear matrix attachment region (MAR) efficiently initiate gene amplification and spontaneously increase their copy numbers in animal cells. In this study, this novel method was applied to the establishment of cells with high recombinant antibody production. The level of recombinant antibody expression was tightly correlated with the efficiency of plasmid amplification and the cytogenetic appearance of the amplified genes, and was strongly dependent on cell type. By using a widely used cell line for industrial protein production, CHO DG44, clones expressing very high levels of antibody were easily obtained. High-producer clones stably expressed the antibody over several months without eliciting changes in both the protein expression level and the cytogenetic appearance of the amplified genes. The integrity and reactivity of the protein produced by this method was fine. In serum-free suspension culture, the specific protein production rate in high-density cultures was 29.4 pg/cell/day. In conclusion, the IR/MAR gene amplification method is a novel and efficient platform for recombinant antibody production in mammalian cells, which rapidly and easily enables the establishment of stable high-producer cell clone.	[Araki, Yoshio; Noguchi, Chiemi; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan; [Hamafuji, Tetsuro] Transgenic Inc, Chuo Ku, Kobe, Hyogo, Japan	Hiroshima University	Araki, Y (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan.	shimizu@hiroshima-u.ac.jp			Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a "Practical Application Research" from Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Antoniou M, 2003, GENOMICS, V82, P269, DOI 10.1016/S0888-7543(03)00107-1; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Dorai H, 2012, BIOTECHNOL BIOENG, V109, P1016, DOI 10.1002/bit.24367; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Huang YM, 2010, BIOTECHNOL PROGR, V26, P1400, DOI 10.1002/btpr.436; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Jun SC, 2005, APPL MICROBIOL BIOT, V69, P162, DOI 10.1007/s00253-005-1972-8; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; Kim M., 2011, BIOTECHNOL BIOENG; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Okamoto A, 2011, MUTAGENESIS; Ortega JM, 1998, J CELL SCI, V111, P3663; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2004, J CELL SCI, V117, P5303, DOI 10.1242/jcs.01414; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; Wang F, 2012, GENE, V500, P59, DOI 10.1016/j.gene.2012.03.049; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yang YS, 2010, J BIOTECHNOL, V147, P180, DOI 10.1016/j.jbiotec.2010.04.004; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Zahn-Zabal M, 2001, J BIOTECHNOL, V87, P29, DOI 10.1016/S0168-1656(00)00423-5	36	29	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41787	10.1371/journal.pone.0041787	http://dx.doi.org/10.1371/journal.pone.0041787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844523	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700150
J	Kodaka, F; Takahashi, H; Yamada, M; Takano, H; Nakayama, K; Ito, H; Suhara, T				Kodaka, Fumitoshi; Takahashi, Hidehiko; Yamada, Makiko; Takano, Harumasa; Nakayama, Kazuhiko; Ito, Hiroshi; Suhara, Tetsuya			Effect of Cooperation Level of Group on Punishment for Non-Cooperators: A Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							PREFRONTAL CORTEX DAMAGE; DECISION-MAKING; NEURAL BASIS; ULTIMATUM GAME; FAIRNESS	Sometimes we punish non-cooperators in our society. Such behavior could be derived from aversive emotion for inequity (inequity aversion) to make non-cooperators cooperative. Thus, punishing behavior derived from inequity is believed to be important for maintaining our society. Meanwhile, our daily experiences suggest that the degree of cooperation by the members of society (cooperation level of the group) could change the punishing behavior for non-cooperators even if the inequity were equal. Such effect of the cooperation level of the group cannot be explained by simple inequity aversion. Although punishment-related brain regions have been reported in previous functional magnetic resonance imaging (fMRI) study, little is known about such regions affected by the cooperation level of the group. In the present fMRI study, we investigated the effect of the cooperation level of the group on the punishing behavior for non-cooperators and its related brain activations by a paradigm in which the degree of the cooperative state varied from low to high. Punishment-related activations were observed in brain regions such as the anterior insula, dorsolateral prefrontal cortex (DLPFC), and anterior cingulate cortex (ACC). The quantity of punishment in a high cooperation context was greater than in a low cooperation context, and activation in the right DLPFC and ACC in a high cooperation context showed greater activity than in a low cooperation context. This indicates that the cooperation level of the group, as well as aversive emotion for inequity, is the important factor of punishing behavior.	[Kodaka, Fumitoshi; Takahashi, Hidehiko; Yamada, Makiko; Takano, Harumasa; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Clin Neuroimaging Team,Inage Ku, Chiba 260, Japan; [Kodaka, Fumitoshi; Nakayama, Kazuhiko] Jikei Univ, Sch Med, Dept Psychiat, Minato Ku, Tokyo, Japan; [Takahashi, Hidehiko] Kyoto Univ, Grad Sch Med, Dept Psychiat, Sakyo Ku, Kyoto, Japan; [Takahashi, Hidehiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Ito, Hiroshi] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Biophys Team,Inage Ku, Chiba 260, Japan	National Institutes for Quantum Science & Technology; Jikei University; Kyoto University; Japan Science & Technology Agency (JST); National Institutes for Quantum Science & Technology	Kodaka, F (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Clin Neuroimaging Team,Inage Ku, Chiba 260, Japan.	hidehiko@kuhp.kyoto-u.ac.jp		Takahashi, Hidehiko/0000-0002-5102-1982	Ministry of Education, Culture, Sports, Science and Technology of Japan [23120009]; Takeda Science Foundation; Casio Science Foundation;  [23680045]; Grants-in-Aid for Scientific Research [24791251] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Casio Science Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by a Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making (23120009), and a consignment expense for the Molecular Imaging Program on "Research Base for PET Diagnosis" from Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Young Scientist A (23680045), a research grant from Takeda Science Foundation, and a research grant from Casio Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fiddick L, 2005, NEUROIMAGE, V28, P778, DOI 10.1016/j.neuroimage.2005.05.033; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MILLER BL, 1993, DEMENTIA, V4, P204, DOI 10.1159/000107324; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Perry RJ, 2001, NEUROCASE, V7, P145, DOI 10.1076/neur.7.2.145.16267; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schelling T, 1978, MICROMOTIVES MACROBE; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; SKOTKO V, 1974, J CONFLICT RESOLUT, V18, P707, DOI 10.1177/002200277401800411; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936	22	3	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41338	10.1371/journal.pone.0041338	http://dx.doi.org/10.1371/journal.pone.0041338			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844462	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700074
J	Kodandaramaiah, U; Weingartner, E; Janz, N; Leski, M; Slove, J; Warren, A; Nylin, S				Kodandaramaiah, Ullasa; Weingartner, Elisabet; Janz, Niklas; Leski, Michael; Slove, Jessica; Warren, Andrew; Nylin, Soren			Investigating Concordance among Genetic Data, Subspecies Circumscriptions and Hostplant Use in the Nymphalid Butterfly Polygonia faunus	PLOS ONE			English	Article							HOST-PLANT SPECIALIZATION; POPULATION-STRUCTURE; ALPINE BUTTERFLIES; MITOCHONDRIAL-DNA; WOLBACHIA; DIVERSITY; DIFFERENTIATION; PHYLOGEOGRAPHY; EVOLUTIONARY; BIOGEOGRAPHY	Subspecies are commonly used taxonomic units to formally describe intraspecific geographic variation in morphological traits. However, the concept of subspecies is not clearly defined, and there is little agreement about what they represent in terms of evolutionary units, and whether they can be used as reliably useful units in conservation, evolutionary theory and taxonomy. We here investigate whether the morphologically well-characterized subspecies in the North American butterfly Polygonia faunus are supported by genetic data from mitochondrial sequences and eight microsatellite loci. We also investigate the phylogeographic structure of P. faunus and test whether similarities in host-plant use among populations are related to genetic similarity. Neither the nuclear nor the mitochondrial data corroborated subspecies groupings. We found three well defined genetic clusters corresponding to California, Arizona and (New Mexico+Colorado). There was little structuring among the remaining populations, probably due to gene flow across populations. We found no support for the hypothesis that similarities in host use are related to genetic proximity. The results indicate that the species underwent a recent rapid expansion, probably from two glacial refugia in western North America. The mitochondrial haplotype network indicates at least two independent expansion phases into eastern North America. Our results clearly demonstrate that subspecies in P. faunus do not conform to the structuring of genetic variation. More studies on insects and other invertebrates are needed to better understand the scope of this phenomenon. The results of this study will be crucial in designing further experiments to understand the evolution of hostplant utilization in this species.	[Kodandaramaiah, Ullasa; Weingartner, Elisabet; Janz, Niklas; Slove, Jessica; Nylin, Soren] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Warren, Andrew] Univ Florida, Florida Museum Nat Hist, McGuire Ctr Lepidoptera & Biodivers, Gainesville, FL 32611 USA	Stockholm University; State University System of Florida; University of Florida	Kodandaramaiah, U (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	uk214@cam.ac.uk	Nylin, Soren/B-7375-2008; Janz, Niklas/B-1756-2010	Nylin, Soren/0000-0003-4195-8920; Janz, Niklas/0000-0002-6379-7905; Kodandaramaiah, Ullasa/0000-0002-1564-1738	Swedish Research Council [621-2011-5636]; Strategic research programme EkoKlim at Stockholm University; Stockholm University Faculty of Science; ERC	Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic research programme EkoKlim at Stockholm University; Stockholm University Faculty of Science; ERC(European Research Council (ERC)European Commission)	This study was funded by a grant to SN from the Swedish Research Council (# 621-2011-5636) and grants to NJ and SN from the Strategic research programme EkoKlim at Stockholm University as well as a grant from the Stockholm University Faculty of Science to NJ. UK was partially funded by the ERC grant EMARES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRITTEN HB, 1992, CAN J ZOOL, V70, P539, DOI 10.1139/z92-081; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DeChaine EG, 2005, J BIOGEOGR, V32, P1943, DOI 10.1111/j.1365-2699.2005.01356.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Frost Darrel R., 1992, Herpetological Review, V23, P46; Goudet J, 1996, GENETICS, V144, P1933; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Janz N, 1998, P ROY SOC B-BIOL SCI, V265, P1675, DOI 10.1098/rspb.1998.0487; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Joyce DA, 2009, BIOL J LINN SOC, V97, P314, DOI 10.1111/j.1095-8312.2009.01213.x; Kodandaramaiah U, 2011, J EVOLUTION BIOL, V24, P2173, DOI 10.1111/j.1420-9101.2011.02352.x; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Nei M., 1987, MOL EVOLUTIONARY GEN; Nice CC, 2001, ANN ENTOMOL SOC AM, V94, P257, DOI 10.1603/0013-8746(2001)094[0257:PGEORG]2.0.CO;2; Noonan GR, 1999, J BIOGEOGR, V26, P1147, DOI 10.1046/j.1365-2699.1999.00362.x; Nygren GH, 2006, J EVOLUTION BIOL, V19, P1882, DOI 10.1111/j.1420-9101.2006.01174.x; Nylin S, 2009, EVOL ECOL, V23, P137, DOI 10.1007/s10682-007-9205-5; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Patten MA, 2002, AUK, V119, P26, DOI 10.1642/0004-8038(2002)119[0026:DVMDOS]2.0.CO;2; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reiss RA, 1999, J BIOGEOGR, V26, P785, DOI 10.1046/j.1365-2699.1999.00321.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SCOTT JA, 1986, BUTTERFLIES N AM; SLATKIN M, 1991, GENETICS, V129, P555; Slove J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016057; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STANCELAND E. M., 2011, INTERACTIVE LISTING; TEMPLETON AR, 1992, GENETICS, V132, P619; Warren AD, LEPIDOPTERA N AM, V6, P408; Weingartner E, 2006, J EVOLUTION BIOL, V19, P483, DOI 10.1111/j.1420-9101.2005.01009.x; Weingartner E, 2006, SYST ENTOMOL, V31, P621, DOI 10.1111/j.1365-3113.2006.00333.x; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; West-Eberhard Mary Jane, 2003, pi; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2010, J AVIAN BIOL, V41, P1, DOI 10.1111/j.1600-048X.2009.04903.x	47	13	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41058	10.1371/journal.pone.0041058	http://dx.doi.org/10.1371/journal.pone.0041058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844425	gold, Green Submitted, Green Published			2022-12-27	WOS:000306687700039
J	Zheng, YB; Zhang, XH; Huang, ZL; Lin, CS; Lai, J; Gu, YR; Lin, BL; Xie, DY; Xie, SB; Peng, L; Gao, ZL				Zheng, Yu-Bao; Zhang, Xiao-Hong; Huang, Zhan-Lian; Lin, Chao-Shuang; Lai, Jing; Gu, Yu-Rong; Lin, Bin-Liang; Xie, Dong-Ying; Xie, Shi-Bin; Peng, Liang; Gao, Zhi-Liang			Amniotic-Fluid-Derived Mesenchymal Stem Cells Overexpressing Interleukin-1 Receptor Antagonist Improve Fulminant Hepatic Failure	PLOS ONE			English	Article							GROWTH-FACTOR; UP-REGULATION; BONE-MARROW; DIFFERENTIATION; REGENERATION; INVOLVEMENT; VECTORS; IL-1RA; INJURY; LINES	Uncontrolled hepatic immunoactivation is regarded as the primary pathological mechanism of fulminant hepatic failure (FHF). The major acute-phase mediators associated with FHF, including IL-1 beta, IL-6, and TNF-alpha, impair the regeneration of liver cells and stem cell grafts. Amniotic-fluid-derived mesenchymal stem cells (AF-MSCs) have the capacity, under specific conditions, to differentiate into hepatocytes. Interleukin-1-receptor antagonist (IL-1Ra) plays an anti-inflammatory and antiapoptotic role in acute and chronic inflammation, and has been used in many experimental and clinical applications. In the present study, we implanted IL-1Ra-expressing AF-MSCs into injured liver via the portal vein, using D-galactosamine-induced FHF in a rat model. IL-1Ra expression, hepatic injury, liver regeneration, cytokines (IL-1 beta, IL-6), and animal survival were assessed after cell transplantation. Our results showed that AF-MSCs over-expressing IL-1Ra prevented liver failure and reduced mortality in rats with FHF. These animals also exhibited improved liver function and increased survival rates after injection with these cells. Using green fluorescent protein as a marker, we demonstrated that the engrafted cells and their progeny were incorporated into injured livers and produced albumin. This study suggests that AF-MSCs genetically modified to over-express IL-1Ra can be implanted into the injured liver to provide a novel therapeutic approach to the treatment of FHF.	[Zheng, Yu-Bao; Zhang, Xiao-Hong; Huang, Zhan-Lian; Lin, Chao-Shuang; Lai, Jing; Gu, Yu-Rong; Lin, Bin-Liang; Xie, Dong-Ying; Xie, Shi-Bin; Peng, Liang; Gao, Zhi-Liang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Yu-Bao; Gao, Zhi-Liang] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zheng, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	zhilianggao@21cn.com	gu, yu/GSD-4507-2022		Natural Science Fund of Guangdong province [10451008901004818]; National Natural Science Foundation of China [30971356]; National Grand Program on Key Infectious Disease(AIDS and viral hepatitis), China [2012ZX10002007-002]	Natural Science Fund of Guangdong province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease(AIDS and viral hepatitis), China	This study was financially supported by grants from the Natural Science Fund of Guangdong province (No. 10451008901004818), the National Natural Science Foundation of China (No. 30971356), the National Grand Program on Key Infectious Disease(AIDS and viral hepatitis), China, No. 2012ZX10002007-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge V, 2012, HEPATOLOGY, V56, P1063, DOI 10.1002/hep.25716; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Baranova A, 2011, DIGESTION, V83, P32, DOI 10.1159/000314592; Chen JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019964; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Dinarello Charles A, 2000, NEW ENGL J MED, V343, P732; Farmer DG, 2009, ANN SURG, V250, P484, DOI 10.1097/SLA.0b013e3181b480ad; Grisafi D, 2008, STEM CELLS DEV, V17, P953, DOI 10.1089/scd.2007.0188; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685; Leifeld L, 2003, J PATHOL, V199, P335, DOI 10.1002/path.1298; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Park JK, 2005, J BIOSCI BIOENG, V99, P311, DOI 10.1263/jbb.99.311; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Sgroi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025442; Shito M, 2001, DIGEST DIS SCI, V46, P1700, DOI 10.1023/A:1010653504568; Siegel N, 2007, STEM CELL REV, V3, P256, DOI 10.1007/s12015-007-9003-z; Stuart WD, 2011, HEPATOLOGY, V53, P1618, DOI 10.1002/hep.24239; Sun CC, 2006, STEM CELLS, V24, P2130, DOI 10.1634/stemcells.2005-0590; Tron K, 2005, LAB INVEST, V85, P376, DOI 10.1038/labinvest.3700228; Xi JF, 2007, PROG BIOCHEM BIOPHYS, V34, P207; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Yumoto E, 2002, J GASTROEN HEPATOL, V17, P285, DOI 10.1046/j.1440-1746.2002.02690.x; Zheng YB, 2008, CELL BIOL INT, V32, P1439, DOI 10.1016/j.cellbi.2008.08.015; Zhu RZ, 2010, WORLD J GASTROENTERO, V16, P2771, DOI 10.3748/wjg.v16.i22.2771	26	35	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41392	10.1371/journal.pone.0041392	http://dx.doi.org/10.1371/journal.pone.0041392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844472	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700083
J	Arias, MA; Van Roey, GA; Tregoning, JS; Moutaftsi, M; Coler, RN; Windish, HP; Reed, SG; Carter, D; Shattock, RJ				Arias, Mauricio A.; Van Roey, Griet A.; Tregoning, John S.; Moutaftsi, Magdalini; Coler, Rhea N.; Windish, Hillarie P.; Reed, Steven G.; Carter, Darrick; Shattock, Robin J.			Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140	PLOS ONE			English	Article							ANTIBODY-RESPONSES; HIV-1 INFECTION; VACCINE; IMMUNITY; CHITOSAN; NASAL; TH17; EFFICACY; DELIVERY; MPL	Successful vaccine development against HIV will likely require the induction of strong, long-lasting humoral and cellular immune responses in both the systemic and mucosal compartments. Based on the known immunological linkage between the upper-respiratory and urogenital tracts, we explored the potential of nasal adjuvants to boost immunization for the induction of vaginal and systemic immune responses to gp140. Mice were immunized intranasally with HIV gp140 together with micellar and emulsion formulations of a synthetic TLR4 agonist, Glucopyranosyl Lipid Adjuvant (GLA) and responses were compared to R848, a TLR7/8 agonist, or chitosan, a non TLR adjuvant. GLA and chitosan but not R848 greatly enhanced serum immunoglobulin levels when compared to antigen alone. Both GLA and chitosan induced high IgG and IgA titers in nasal and vaginal lavage and feces. The high IgA and IgG titers in vaginal lavage were associated with high numbers of gp140-specific antibody secreting cells in the genital tract. Whilst both GLA and chitosan induced T cell responses to immunization, GLA induced a stronger Th17 response and chitosan induced a more Th2 skewed response. Our results show that GLA is a highly potent intranasal adjuvant greatly enhancing humoral and cellular immune responses, both systemically and mucosally.	[Arias, Mauricio A.; Van Roey, Griet A.; Tregoning, John S.; Shattock, Robin J.] St Georges Univ London, Ctr Infect & Immun, London, England; [Tregoning, John S.; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, London, England; [Moutaftsi, Magdalini; Coler, Rhea N.; Windish, Hillarie P.; Reed, Steven G.; Carter, Darrick] IDRI, Seattle, WA USA	St Georges University London; Imperial College London	Arias, MA (corresponding author), St Georges Univ London, Ctr Infect & Immun, London, England.	r.shattock@imperial.ac.uk	Carter, Darrick/N-3304-2016	Carter, Darrick/0000-0001-5901-3402; Tregoning, John/0000-0001-8093-8741	Bill and Melinda Gates Foundation; Wellcome Trust through the Grand Challenges in Global Health initiative; EC [LSHP-CT-2006-037611]; Dormeur Investment Service Ltd.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust through the Grand Challenges in Global Health initiative(Wellcome Trust); EC(European CommissionEuropean Commission Joint Research Centre); Dormeur Investment Service Ltd.	This work was funded by a grant to St George's, University of London, from the Bill and Melinda Gates Foundation and the Wellcome Trust, through the Grand Challenges in Global Health initiative. Griet A. Van Roey was funded on a studentship supported by the FP-6-funded EUROPRISE, EC grant LSHP-CT-2006-037611. The authors are indebted to Dormeur Investment Service Ltd., for funding of equipment used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Arias MA, 2011, VACCINE, V29, P1258, DOI 10.1016/j.vaccine.2010.11.084; Baldrick P, 2002, REGUL TOXICOL PHARM, V35, P398, DOI 10.1006/rtph.2002.1541; Baldwin SL, 2012, J IMMUNOL; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Brewer JM, 1998, J IMMUNOL, V161, P4000; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; Cranage MP, 2011, VACCINE, V29, P1421, DOI 10.1016/j.vaccine.2010.12.034; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; DiTommaso A, 1996, INFECT IMMUN, V64, P974, DOI 10.1128/IAI.64.3.974-979.1996; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Guglani L, 2010, CURR OPIN HIV AIDS, V5, P120, DOI 10.1097/COH.0b013e328335c2f6; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Johnson DA, 1999, BIOORG MED CHEM LETT, V9, P2273, DOI 10.1016/S0960-894X(99)00374-1; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kemp TJ, 2008, VACCINE, V26, P3608, DOI 10.1016/j.vaccine.2008.04.074; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Koff WC, 2012, VACCINE, V30, P4310, DOI 10.1016/j.vaccine.2011.11.014; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lin YY, 2010, SEMIN IMMUNOPATHOL, V32, P79, DOI 10.1007/s00281-009-0191-2; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Nabel GJ, 2011, PHILOS T R SOC B, V366, P2759, DOI 10.1098/rstb.2011.0096; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pantel A, 2012, EUR J IMMUNOL, V42, P101, DOI 10.1002/eji.201141855; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rudin A, 1999, INFECT IMMUN, V67, P2884, DOI 10.1128/IAI.67.6.2884-2890.1999; Schneider LP, 2012, VACCINE, V30, P4216, DOI 10.1016/j.vaccine.2012.04.051; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sui ZW, 2010, VACCINE, V28, P7690, DOI 10.1016/j.vaccine.2010.09.019; TAKAYAMA K, 1984, REV INFECT DIS, V6, P439; van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5; Van Roey GA, 2012, EUR J IMMUNOL, V42, P353, DOI 10.1002/eji.201141787; Vila A, 2004, EUR J PHARM BIOPHARM, V57, P123, DOI 10.1016/j.ejpb.2003.09.006; Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008; Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034	50	72	91	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41144	10.1371/journal.pone.0041144	http://dx.doi.org/10.1371/journal.pone.0041144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829921	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300060
J	Jokela, J; Oftedal, L; Herfindal, L; Permi, P; Wahlsten, M; Doskeland, SO; Sivonen, K				Jokela, Jouni; Oftedal, Linn; Herfindal, Lars; Permi, Perttu; Wahlsten, Matti; Doskeland, Stein Ove; Sivonen, Kaarina			Anabaenolysins, Novel Cytolytic Lipopeptides from Benthic Anabaena Cyanobacteria	PLOS ONE			English	Article							BALTIC SEA; SECONDARY METABOLITES; MARINE CYANOBACTERIA; MICROCYSTIN-LR; GENUS ANABAENA; CELL-LINE; APOPTOSIS; STRAINS; PROLIFERATION; INHIBITORS	Two novel cyclic lipopeptides, anabaenolysin A and anabaenolysin B, were isolated from two benthic cyanobacterial strains of the genus Anabaena. This novel class of cyanobacterial lipopeptides has a general structure of a small peptide ring consisting of four amino acids from which two are proteinogenic and two unusual; glycine(1), glycine(2), 2-(3-amino-5-oxytetrahydrofuran-2-yl)-2-hydroxyacetic acid(3) and a long unsaturated C-18 beta-amino acid(4) with a conjugated triene structure. They are distinguished by the presence of a conjugated dienic structure in the C18 beta-amino acid present in anabaenolysin A but not in anabaenolysin B. Conjugated triene structure generates a typical UV spectrum for anabaenolysins for easy recognition. Anabaenolysin A constituted up to 400 ppm of the cyanobacterial dry weight. We found evidence of thirteen variants of anabaenolysins in one cyanobacterial strain. This suggests that the anabaenolysins are an important class of secondary metabolites in benthic Anabaena cyanobacteria. Both anabaenolysin A and B had cytolytic activity on a number of mammalian cell lines.	[Jokela, Jouni; Wahlsten, Matti; Sivonen, Kaarina] Univ Helsinki, Div Microbiol, Dept Food & Environm Sci, Helsinki, Finland; [Oftedal, Linn; Herfindal, Lars; Doskeland, Stein Ove] Univ Bergen, Dept Biomed, Bergen, Norway; [Herfindal, Lars] Haukeland Hosp, Translat Signaling Grp, N-5021 Bergen, Norway; [Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland	University of Helsinki; University of Bergen; University of Bergen; Haukeland University Hospital; University of Helsinki	Jokela, J (corresponding author), Univ Helsinki, Div Microbiol, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi		Wahlsten, Matti/0000-0002-4107-1695; Sivonen, Kaarina/0000-0002-2904-0458; Herfindal, Lars/0000-0003-0353-3614; Oftedal, Linn/0000-0003-1793-4013; Jokela, Jouni/0000-0001-5096-3575; Doskeland, Stein Ove/0000-0002-4009-4756	Academy of Finland [214457, 118637]; Norwegian Research Council [157338, 138694/432]; Western Norway Regional Health Authority	Academy of Finland(Academy of Finland); Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority	This research was supported by the Academy of Finland (grants 214457 and 118637 to KS), the Norwegian Research Council (157338 and 138694/432) and the Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO T, 1993, J CHEM ECOL, V19, P119, DOI 10.1007/BF00987477; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; Degenkolb T, 2008, CHEM BIODIVERS, V5, P693, DOI 10.1002/cbdv.200890066; Dobson G, 1998, J AM OIL CHEM SOC, V75, P137, DOI 10.1007/s11746-998-0024-9; Gademann K, 2008, CURR ORG CHEM, V12, P326, DOI 10.2174/138527208783743750; Golakoti T, 2001, J NAT PROD, V64, P54, DOI 10.1021/np000316k; Halinen K, 2008, FEMS MICROBIOL ECOL, V64, P199, DOI 10.1111/j.1574-6941.2008.00461.x; Herfindal L, 2005, TOXICON, V46, P252, DOI 10.1016/j.toxicon.2005.04.005; ITOH J, 1982, AGR BIOL CHEM TOKYO, V46, P2659, DOI 10.1080/00021369.1982.10865491; Jokela J, 2010, CHEMBIOCHEM, V11, P1594, DOI 10.1002/cbic.201000179; Jourdan E, 2009, MOL PLANT MICROBE IN, V22, P456, DOI 10.1094/MPMI-22-4-0456; Kaya K, 2002, J NAT PROD, V65, P920, DOI 10.1021/np010660x; LACAZE N, 1983, LEUKEMIA RES, V7, P145, DOI 10.1016/0145-2126(83)90005-X; LANOTTE M, 1991, BLOOD, V77, P1080; Leikoski N, 2010, APPL ENVIRON MICROB, V76, P701, DOI 10.1128/AEM.01061-09; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Martin J, 2001, J MASS SPECTROM, V36, P1294; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; McDermott CM, 1998, TOXICON, V36, P1981, DOI 10.1016/S0041-0101(98)00128-7; MELLGREN G, 1995, J CELL PHYSIOL, V163, P232, DOI 10.1002/jcp.1041630203; Mitchell L, 1994, BIOCHEMISTRY-US, V33, P15223; Neuhof T, 2005, J NAT PROD, V68, P695, DOI 10.1021/np049671r; Nunnery JK, 2010, CURR OPIN BIOTECH, V21, P787, DOI 10.1016/j.copbio.2010.09.019; Oftedal L, 2010, MAR DRUGS, V8, P2659, DOI 10.3390/md8102659; Sano T, 2005, PHYTOCHEMISTRY, V66, P543, DOI 10.1016/j.phytochem.2005.01.001; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shiono Y, 2007, J ANTIBIOT, V60, P309, DOI 10.1038/ja.2007.39; Sivonen Kaarina, 2008, P159; Surakka A, 2005, ENVIRON TOXICOL, V20, P285, DOI 10.1002/tox.20119; Taniguchi M, 2010, J NAT PROD, V73, P393, DOI 10.1021/np900428h; Zheng JK, 2010, J NAT PROD, V73, P1133, DOI 10.1021/np100198h	32	24	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41222	10.1371/journal.pone.0041222	http://dx.doi.org/10.1371/journal.pone.0041222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829929	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300068
J	Wu, SQ; Wu, FQ; Hong, RT; He, J				Wu, Shunquan; Wu, Fuquan; Hong, Rongtao; He, Jia			Incidence Analyses and Space-Time Cluster Detection of Hepatitis C in Fujian Province of China from 2006 to 2010	PLOS ONE			English	Article							VIRUS-INFECTION; UNSAFE INJECTIONS; SURVEILLANCE DATA; DEVELOPING-WORLD; UNITED-STATES; RISK-FACTORS; SYSTEM; EPIDEMIOLOGY; TRANSMISSION; PREVALENCE	Background: There is limited epidemiologic information about the incidence of hepatitis C in China, and few studies have applied space-time scan statistic to detect clusters of hepatitis C and made adjustment for temporal trend and relative risk of regions. Methodology and Principal Findings: We analyzed the temporal changes and characteristics of incidence of hepatitis C in Fujian Province from 2006 through 2010. The discrete Poisson model of space-time scan statistic was chosen for cluster detection. Data on new cases of hepatitis C were obtained from the Center for Disease Control and Prevention of Fujian Province. Between 2006 and 2010, there was an annualized increase in the incidence of hepatitis C of 23.0 percent, from 928 cases (2.63 per 100,000 persons) to 2,180 cases (6.01 per 100,000 persons). The incidence among women increased more rapidly. The cumulative incidence showed that people who were over 60 years had the highest risk to suffer hepatitis C (52.51 per 100,000 persons), and women had lower risk compared to men (OR = 0.69). Putian had the highest cumulative incidence among all the regions (86.95 per 100,000 persons). The most likely cluster was identified in Putian during March to August in 2009 without adjustment, but it shifted to three contiguous cities with a two-month duration after adjustment for temporal trend and relative risk of regions. Conclusions/Significance: The incidence of hepatitis C is increasing in Fujian Province, and women are at a more rapid pace. The space-time scan statistic is useful as a screening tool for clusters of hepatitis C, with adjustment for temporal trend and relative risk of regions recommended.	[Wu, Shunquan; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Wu, Fuquan] Second Mil Med Univ, Int Cooperat Lab Signal Transduct, Eastern Hepatobiliary Surg Inst, Shanghai, Peoples R China; [Hong, Rongtao] Fujian Ctr Dis Control & Prevet, Fuzhou, Fujian Province, Peoples R China	Naval Medical University; Naval Medical University	Wu, SQ (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com		He, Jia/0000-0002-2338-9501	National Natural Science Foundation of China [81072388]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [81072388]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2003, INT J EPIDEMIOL, V32, P725, DOI 10.1093/ije/dyg266; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; Dockerty JD, 1999, J EPIDEMIOL COMMUN H, V53, P154, DOI 10.1136/jech.53.3.154; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; Hagan H, 2002, J URBAN HEALTH, V79, P579, DOI 10.1093/jurban/79.4.579; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Jones RC, 2006, PUBLIC HEALTH REP, V121, P133, DOI 10.1177/003335490612100206; Kane A, 1999, B WORLD HEALTH ORGAN, V77, P801; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 1999, J NATL I PUBLIC HLTH, V48, P94; Kulldorff M, 2022, SATSCAN USER GUIDE V; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Liang HG, 2004, INT J MED INFORM, V73, P675, DOI 10.1016/j.ijmedinf.2004.05.010; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; NOBRE FF, 1994, INT J EPIDEMIOL, V23, P408, DOI 10.1093/ije/23.2.408; Orland JR, 2001, HEPATOLOGY, V33, P321, DOI 10.1053/jhep.2001.22112; Perz JF, 2006, J HEPATOL, V44, P441, DOI 10.1016/j.jhep.2005.12.007; Prati D, 1997, HEPATOLOGY, V25, P702, DOI 10.1002/hep.510250335; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; Robotin MC, 2004, J GASTROEN HEPATOL, V19, P283, DOI 10.1111/j.1440-1746.2003.03270.x; Sheehan T Joseph, 2005, Int J Health Geogr, V4, P15, DOI 10.1186/1476-072X-4-15; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Sowmyanarayanan TV, 2008, INDIAN J MED RES, V128, P32; Spada E, 2001, DIGEST LIVER DIS, V33, P778, DOI 10.1016/S1590-8658(01)80695-2; Sy Theodore, 2006, Int J Med Sci, V3, P41; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3	32	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40872	10.1371/journal.pone.0040872	http://dx.doi.org/10.1371/journal.pone.0040872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829893	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300031
J	Chiappini, N; Seubert, A; Telford, JL; Grandi, G; Serruto, D; Margarit, I; Janulczyk, R				Chiappini, Nico; Seubert, Anja; Telford, John L.; Grandi, Guido; Serruto, Davide; Margarit, Immaculada; Janulczyk, Robert			Streptococcus pyogenes SpyCEP Influences Host-Pathogen Interactions during Infection in a Murine Air Pouch Model	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; CHEMOKINE DEGRADATION; BACTERIAL CLEARANCE; REGULATORY SYSTEM; INVASIVE DISEASE; PROTEASE SPYCEP; EXPRESSION; SURFACE; SEPSIS; GENE	Streptococcus pyogenes is a major human pathogen worldwide, responsible for both local and systemic infections. These bacteria express the subtilisin-like protease SpyCEP which cleaves human IL-8 and related chemokines. We show that localization of SpyCEP is growth-phase and strain dependent. Significant shedding was observed only in a strain naturally overexpressing SpyCEP, and shedding was not dependent on SpyCEP autoproteolytic activity. Surface-bound SpyCEP in two different strains was capable of cleaving IL-8. To investigate SpyCEP action in vivo, we adapted the mouse air pouch model of infection for parallel quantification of bacterial growth, host immune cell recruitment and chemokine levels in situ. In response to infection, the predominant cells recruited were neutrophils, monocytes and eosinophils. Concomitantly, the chemokines KC, LIX, and MIP-2 in situ were drastically increased in mice infected with the SpyCEP knockout strain, and growth of this mutant strain was reduced compared to the wild type. SpyCEP has been described as a potential vaccine candidate against S. pyogenes, and we showed that surface-associated SpyCEP was recognized by specific antibodies. In vitro, such antibodies also counteracted the inhibitory effects of SpyCEP on chemokine mediated PMN recruitment. Thus, alpha-SpyCEP antibodies may benefit the host both directly by enabling opsonophagocytosis, and indirectly, by neutralizing an important virulence factor. The animal model we employed shows promise for broad application in the study of bacterial pathogenesis.	[Chiappini, Nico; Seubert, Anja; Telford, John L.; Grandi, Guido; Serruto, Davide; Margarit, Immaculada; Janulczyk, Robert] Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy	Novartis	Chiappini, N (corresponding author), Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy.	Robert.Janulczyk@Novartis.com	Telford, John Laird/ABG-8144-2020	Grandi, Guido/0000-0001-9724-2185; Seubert, Anja/0000-0003-3321-9140	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was supported by internal funding from Novartis Vaccines and Diagnostics, whose role, through the employment of Nico Chiappini, Anja Seubert, John L. Telford, Guido Grandi, Davide Serruto, Immaculada Margarit and Robert Janulczyk, involved conceiving, designing and performing the experiments and analyzing the data.	Bensi G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015693; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CHEN CC, 1990, J BIOL CHEM, V265, P3161; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Delano DL, 2005, INFLAMMATION, V29, P1, DOI 10.1007/s10753-006-8962-6; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Fritzer A, 2010, INFECT IMMUN, V78, P4051, DOI 10.1128/IAI.00295-10; Fritzer A, 2009, BIOCHEM J, V422, P533, DOI 10.1042/BJ20090278; Garcia AF, 2010, MICROBIOL-SGM, V156, P3085, DOI 10.1099/mic.0.042614-0; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Kaur SJ, 2010, J BIOL CHEM, V285, P27798, DOI 10.1074/jbc.M109.098053; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; NickersonNutter CL, 1996, ARTHRITIS RHEUM, V39, P515, DOI 10.1002/art.1780390320; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Sjolinder H, 2008, INFECT IMMUN, V76, P3959, DOI 10.1128/IAI.00128-08; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Turner CE, 2009, VACCINE, V27, P4923, DOI 10.1016/j.vaccine.2009.06.042; Turner CE, 2009, J INFECT DIS, V200, P555, DOI 10.1086/603541; Yamamoto Y, 1998, LIFE SCI, V62, P1767, DOI 10.1016/S0024-3205(98)00138-6; Zingaretti C, 2010, FASEB J, V24, P2839, DOI 10.1096/fj.09-145631; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	37	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40411	10.1371/journal.pone.0040411	http://dx.doi.org/10.1371/journal.pone.0040411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848376	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200018
J	Karim, Z; Adnan, R; Ansari, MS				Karim, Zoheb; Adnan, Rohana; Ansari, Mohd Saquib			Low Concentration of Silver Nanoparticles Not Only Enhances the Activity of Horseradish Peroxidase but Alter the Structure Also	PLOS ONE			English	Article							CIRCULAR-DICHROISM; QUANTUM DOTS; GOLD NANOPARTICLES; IMMOBILIZATION; PROTEIN; DENATURATION; CONFORMATION; ABSORPTION; STABILITY; REMOVAL	Chemical synthesis of Ag-NPs was carried out using reduction method. The reduction mechanistic approach of silver ions was found to be a basic clue for the formation of the Ag-NPs. The nanoparticles were characterized by UV-vis, FT-IR and TEM analysis. We had designed some experiments in support of our hypothesis, "low concentrations of novel nanoparticles (silver and gold) increases the activity of plant peroxidases and alter their structure also'', we had used Ag-NPs and HRP as models. The immobilization/interaction experiment had demonstrated the specific concentration range of the Ag-NPs and within this range, an increase in HRP activity was reported. At 0.08 mM concentration of Ag-NPs, 50% increase in the activity yield was found. The U. V-vis spectra had demonstrated the increase in the absorbance of HRP within the reported concentration range (0.06-0.12 mM). Above and below this concentration range there was a decrease in the activity of HRP. The results that we had found from the fluorescence spectra were also in favor of our hypothesis. There was a maximum increase in ellipticity and alpha-helix contents in the presence of 0.08 mM concentration of Ag-NPs, demonstrated by circular dichroism (CD) spectra. Finally, incubation of a plant peroxidase, HRP with Ag-NPs, within the reported concentration range not only enhances the activity but also alter the structure.	[Karim, Zoheb; Adnan, Rohana] Univ Sains Malaysia, Sch Chem Sci, George Town, Malaysia; [Ansari, Mohd Saquib] Univ Delhi, Shaheed Rajguru Coll Appl Sci Woman, Sch Biomed Sci, Delhi 110007, India	Universiti Sains Malaysia; University of Delhi	Karim, Z (corresponding author), Univ Sains Malaysia, Sch Chem Sci, George Town, Malaysia.	zoheb.karim@gmail.com; r_adnan@usm.my	Karim, Zoheb/O-1567-2016; Adnan, Rohana/E-5342-2012	Karim, Zoheb/0000-0002-4196-8419; Adnan, Rohana/0000-0002-7628-7656	University sains Malaysia	University sains Malaysia(Universiti Sains Malaysia)	University sains Malaysia is a funding source but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, NANOTECHNOLOGY; [Anonymous], 1996, CIRCULAR DICHROISM C; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai WB, 2006, NANO LETT, V6, P669, DOI 10.1021/nl052405t; Cai WB, 2007, NANOSCALE RES LETT, V2, P265, DOI 10.1007/s11671-007-9061-9; Cai WB, 2007, SMALL, V3, P1840, DOI 10.1002/smll.200700351; Carvalho ASL, 2003, ARCH BIOCHEM BIOPHYS, V415, P257, DOI 10.1016/S0003-9861(03)00275-3; Chattopadhyay K, 2000, BIOCHEMISTRY-US, V39, P263, DOI 10.1021/bi990729o; Chen X, 2010, ACS NANO, V4, P6387, DOI 10.1021/nn1016605; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Duran Nelson, 2005, J Nanobiotechnology, V3, P8, DOI 10.1186/1477-3155-3-8; Gao JQ, 2010, SPECTROCHIM ACTA A, V77, P895, DOI 10.1016/j.saa.2010.08.065; Greenfield NJ, 1999, TRAC-TREND ANAL CHEM, V18, P236, DOI 10.1016/S0165-9936(98)00112-5; Grodzinski P, 2006, EXPERT REV MOL DIAGN, V6, P307, DOI 10.1586/14737159.6.3.307; Guzman M. G., 2009, INT J CHEM BIOL ENG, V2, P3; Ho SY, 1997, J FOOD ENG, V31, P69, DOI 10.1016/S0260-8774(96)00052-0; Hu DH, 2008, SPECTROCHIM ACTA A, V69, P830, DOI 10.1016/j.saa.2007.05.036; Huang XH, 2007, NANOMEDICINE-UK, V2, P681, DOI 10.2217/17435889.2.5.681; Hungerford G, 2006, BIOPHYS CHEM, V120, P81, DOI 10.1016/j.bpc.2005.10.009; Iseult L, 2008, NATURE NANOTECHNOL, V4, P546; Ishikawa H, 1996, J AGR FOOD CHEM, V44, P2646, DOI 10.1021/jf9602075; Ispas C, 2009, ANAL BIOANAL CHEM, V393, P543, DOI 10.1007/s00216-008-2250-2; Jiang L, 2003, CHEM PHYS LETT, V380, P29, DOI 10.1016/j.cplett.2003.08.087; Kamal JKA, 2001, BIOCHEM BIOPH RES CO, V289, P427, DOI 10.1006/bbrc.2001.6018; Karim Z, 2012, INT BIODETER BIODEGR, V72, P10, DOI 10.1016/j.ibiod.2012.04.008; Karim Z, 2011, J SCI IND RES INDIA, V70, P352; Karim Z, 2010, FOOD CHEM TOXICOL, V48, P3385, DOI 10.1016/j.fct.2010.09.009; Karim Z, 2009, J MOL CATAL B-ENZYM, V59, P185, DOI 10.1016/j.molcatb.2009.02.012; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Milsom EV, 2007, J ELECTROANAL CHEM, V610, P28, DOI 10.1016/j.jelechem.2007.06.021; Mizuki T, 2010, BIOCHEM BIOPH RES CO, V393, P779, DOI 10.1016/j.bbrc.2010.02.081; Mukherjee P, 2001, ANGEW CHEM INT EDIT, V40, P3585, DOI 10.1002/1521-3773(20011001)40:19<3585::AID-ANIE3585>3.0.CO;2-K; MYER YP, 1968, J BIOL CHEM, V243, P2115; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Neng-Qin J, 2005, FILMS ANAL LETT, V38, P1237; Park JW, 2004, SEMIN ONCOL, V31, P196, DOI 10.1053/j.seminoncol.2004.08.009; Pascoal AM, 2010, FOOD BIOPROD PROCESS, V12, P34; Phadtare S, 2004, BIOTECHNOL BIOENG, V85, P629, DOI 10.1002/bit.10856; Rocha S, 2012, BIOCHEM BIOPH RES CO, V420, P136, DOI 10.1016/j.bbrc.2012.02.129; Senapati S, 2005, SMALL, V1, P517, DOI 10.1002/smll.200400053; Senapati S., 2005, THESIS U PUNE; Tang JL, 2002, CHEM PHYS LIPIDS, V120, P119, DOI 10.1016/S0009-3084(02)00109-3; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Veitch NC, 2009, PHYTOCHEMISTRY, V65, P249; Wang P, 2001, BIOTECHNOL BIOENG, V74, P249, DOI 10.1002/bit.1114; Wu ZC, 2009, INT J MOL SCI, V10, P4198, DOI 10.3390/ijms10104198; Yamamoto S, 2004, ANAL SCI, V20, P1347, DOI 10.2116/analsci.20.1347; Zamorano LS, 2004, THERMOCHIM ACTA, V417, P67, DOI 10.1016/j.tca.2004.01.018; Zhang JR, 2004, J SOLID STATE CHEM, V177, P1425, DOI 10.1016/j.jssc.2003.11.024; Zou GL, 2007, MATER RES BULL, V42, P1153, DOI 10.1016/j.materresbull.2006.09.008	50	28	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41422	10.1371/journal.pone.0041422	http://dx.doi.org/10.1371/journal.pone.0041422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848490	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200062
J	Zuurbier, CJ; Jong, WMC; Eerbeek, O; Koeman, A; Pulskens, WP; Butter, LM; Leemans, JC; Hollmann, MW				Zuurbier, Coert J.; Jong, Willeke M. C.; Eerbeek, Otto; Koeman, Anneke; Pulskens, Wilco P.; Butter, Loes M.; Leemans, Jaklien C.; Hollmann, Markus W.			Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling	PLOS ONE			English	Article							INFLAMMASOME-INDEPENDENT ROLE; MECHANISMS; INJURY; INTERLEUKIN-6; HYPOXIA; DISEASE	Objective: Recent studies indicate that the innate immune system is not only triggered by exogenous pathogens and pollutants, but also by endogenous danger signals released during ischemia and necrosis. As triggers for the innate immune NLRP3 inflammasome protein complex appear to overlap with those for cardiac ischemia-reperfusion (I/R) and ischemic preconditioning (IPC), we explored the possibility that the NLRP3 inflammasome is involved in IPC and acute I/R injury of the heart. Principal Findings: Baseline cardiac performance and acute I/R injury were investigated in isolated, Langendorff-perfused hearts from wild-type (WT), ASC(-/-) and NLRP3(-/-) mice. Deletion of NLRP3 inflammasome components ASC(-/-) or NLRP3(-)/(-) did not affect baseline performance. The deletions exacerbated I/R-induced mechanical dysfunction, but were without effect on I/R-induced cell death. When subjected to IPC, WT and ASC(-/-) hearts were protected against I/R injury (improved function and less cell death). However, IPC did not protect NLRP3(-/-) hearts against I/R injury. NLRP3(-/-) hearts had significantly decreased cardiac IL-6 levels with a trend towards lower IL-1 beta levels at end reperfusion, suggesting abrogation of IPC through diminished IL-6 and/or IL-1 beta signaling. Subsequent experiments showed that neutralising IL-6 using an antibody against IL-6 abrogated IPC in WT hearts. However, inhibition of the IL-1 receptor with the IL-1 receptor inhibitor Anakinra (100 mg/L) did not abrogate IPC in WT hearts. Analysis of survival kinases after IPC demonstrated decreased STAT3 expression in NLRP3(-/-) hearts when compared to WT hearts. Conclusions: The data suggest that the innate immune NLRP3 protein, in an NLRP3-inflammasome-independentfashion, is an integral component of IPC in the isolated heart, possibly through an IL-6/STAT3 dependent mechanism.	[Zuurbier, Coert J.; Jong, Willeke M. C.; Koeman, Anneke; Hollmann, Markus W.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Eerbeek, Otto] Univ Amsterdam, Acad Med Ctr, Dept Physiol, NL-1105 AZ Amsterdam, Netherlands; [Pulskens, Wilco P.; Butter, Loes M.; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Zuurbier, CJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.zuurbier@amc.uva.nl	Pulskens, Wilco/P-6023-2015; Leemans, Jaklien/AAM-4958-2020	Pulskens, Wilco/0000-0001-9697-3189; 	Academic Medical Center, Amsterdam	Academic Medical Center, Amsterdam	The Academic Medical Center, Amsterdam, supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Belosjorow S, 1999, AM J PHYSIOL-HEART C, V277, pH2470, DOI 10.1152/ajpheart.1999.277.6.H2470; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Dawn B, 2004, CARDIOVASC RES, V64, P61, DOI 10.1016/j.cardiores.2004.05.011; Dong JW, 2010, AM J PHYSIOL-HEART C, V298, pH1079, DOI 10.1152/ajpheart.00306.2009; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gurel E, 2009, J APPL PHYSIOL, V106, P1909, DOI 10.1152/japplphysiol.90537.2008; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Kanno S, 2000, CIRCULATION, V101, P2742, DOI 10.1161/01.CIR.101.23.2742; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Netea MG, 2000, EUR J IMMUNOL, V30, P3057, DOI 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P; Oba T, 2010, CIRCULATION, V122; Peart J, 2003, CARDIOVASC RES, V58, P589, DOI 10.1016/S0008-6363(03)00259-1; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Smeele KMA, 2011, CIRC RES, V108, P1165, DOI 10.1161/CIRCRESAHA.111.244962; Smith RM, 2002, CARDIOVASC RES, V55, P553, DOI 10.1016/S0008-6363(02)00283-3; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Teoh N, 2006, J HEPATOL, V45, P20, DOI 10.1016/j.jhep.2006.01.039; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou WW, 2010, PEDIATR CARDIOL, V31, P22, DOI 10.1007/s00246-009-9536-9	41	60	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40643	10.1371/journal.pone.0040643	http://dx.doi.org/10.1371/journal.pone.0040643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848390	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200024
J	Chua, GL; Tang, XY; Patra, AT; Tan, SM; Bhattacharjya, S				Chua, Geok-Lin; Tang, Xiao-Yan; Patra, Alok Tanala; Tan, Suet-Mien; Bhattacharjya, Surajit			Structure and Binding Interface of the Cytosolic Tails of alpha X beta 2 Integrin	PLOS ONE			English	Article							SUBUNIT CYTOPLASMIC DOMAINS; NMR ANALYSIS; ALPHA-IIB-BETA-3; TRANSMEMBRANE; PROTEIN; ACTIVATION; IDENTIFICATION; MECHANISM; MONOCYTES; MIGRATION	Background: Integrins are signal transducer proteins involved in a number of vital physiological processes including cell adhesion, proliferation and migration. Integrin molecules are hetero-dimers composed of two distinct subunits, alpha and beta. In humans, 18 alpha and 8 beta subunits are combined into 24 different integrin molecules. Each of the subunit comprises a large extracellular domain, a single pass transmembrane segment and a cytosolic tail (CT). The CTs of integrins are vital for bidirectional signal transduction and in maintaining the resting state of the receptors. A large number of intracellular proteins have been found to interact with the CTs of integrins linking integrins to the cytoskeleton. Methodology/Principal Findings: In this work, we have investigated structure and interactions of CTs of the leukocyte specific integrin alpha X beta 2. We determined the atomic resolution structure of a myristoylated CT of alpha X in perdeuterated dodecylphosphocholine (DPC) by NMR spectroscopy. Our results reveal that the 35-residue long CT of alpha X adopts an alpha-helical conformation for residues F4-N17 at the N-terminal region. The remaining residues located at the C-terminal segment of alpha X delineate a long loop of irregular conformations. A segment of the loop maintains packing interactions with the helical structure by an extended non-polar surface of the alpha X CT. Interactions between alpha X and beta 2 CTs are demonstrated by N-15-H-1 HSQC NMR experiments. We find that residues constituting the polar face of the helical conformation of alpha X are involved in interactions with the N-terminal residues of beta 2 CT. A docked structure of the CT complex indicates that a network of polar and/or salt-bridge interactions may sustain the heteromeric interactions. Conclusions/Significance: The current study provides important insights into the conservation of interactions and structures among different CTs of integrins.	[Chua, Geok-Lin; Tang, Xiao-Yan; Patra, Alok Tanala; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	smtan@ntu.edu.sg; surajit@ntu.edu.sg	PATRA, ALOK/HCH-9797-2022; Tan, Suet/A-2224-2011	PATRA, ALOK/0000-0001-6983-911X; Tan, Suet-Mien/0000-0003-2371-8739	A*Star Biomedical Research Council, Singapore [08/1/22/19/556]; Singapore Ministry of Education [2010-T2-2-014]	A*Star Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education(Ministry of Education, Singapore)	This work is supported by grants 08/1/22/19/556 from A*Star Biomedical Research Council, Singapore [SB and SM] and Singapore Ministry of Education grant 2010-T2-2-014 [SM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Bernard E, 2009, ACS CHEM BIOL, V4, P457, DOI 10.1021/cb8002623; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; Chua GL, 2011, J BIOL CHEM, V286, P43842, DOI 10.1074/jbc.M111.280164; Geng X, 2005, IMMUNOLOGY, V115, P347, DOI 10.1111/j.1365-2567.2005.02175.x; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goddard TD, GRAPHICAL NMR ASSIGN; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; KEIZER GD, 1987, EUR J IMMUNOL, V17, P1317, DOI 10.1002/eji.1830170915; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Tang RH, 2006, FEBS LETT, V580, P4435, DOI 10.1016/j.febslet.2006.06.099; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41924	10.1371/journal.pone.0041924	http://dx.doi.org/10.1371/journal.pone.0041924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844534	Green Published, gold			2022-12-27	WOS:000309240600057
J	Janardan, N; Harijan, RK; Wierenga, RK; Murthy, MRN				Janardan, Neelanjana; Harijan, Rajesh K.; Wierenga, Rikkert K.; Murthy, Mathur R. N.			Crystal Structure of a Monomeric Thiolase-Like Protein Type 1 (TLP1) from Mycobacterium smegmatis	PLOS ONE			English	Article							X-RAY-DIFFRACTION; BIOSYNTHETIC THIOLASE; STEROL CARRIER; COA; SUPERFAMILY; MITOCHONDRIAL; TUBERCULOSIS; COENZYME; INSIGHTS; ENZYMES	An analysis of the Mycobacterium smegmatis genome suggests that it codes for several thiolases and thiolase-like proteins. Thiolases are an important family of enzymes that are involved in fatty acid metabolism. They occur as either dimers or tetramers. Thiolases catalyze the Claisen condensation of two acetyl-Coenzyme A molecules in the synthetic direction and the thiolytic cleavage of 3-ketoacyl-Coenzyme A molecules in the degradative direction. Some of the M. smegmatis genes have been annotated as thiolases of the poorly characterized SCP2-thiolase subfamily. The mammalian SCP2-thiolase consists of an N-terminal thiolase domain followed by an additional C-terminal domain called sterol carrier protein-2 or SCP2. The M. smegmatis protein selected in the present study, referred to here as the thiolase-like protein type 1 (MsTLP1), has been biochemically and structurally characterized. Unlike classical thiolases, MsTLP1 is a monomer in solution. Its structure has been determined at 2.7 angstrom resolution by the single wavelength anomalous dispersion method. The structure of the protomer confirms that the N-terminal domain has the thiolase fold. An extra C-terminal domain is indeed observed. Interestingly, it consists of six beta-strands forming an anti-parallel beta-barrel which is completely different from the expected SCP2-fold. Detailed sequence and structural comparisons with thiolases show that the residues known to be essential for catalysis are not conserved in MsTLP1. Consistent with this observation, activity measurements show that MsTLP1 does not catalyze the thiolase reaction. This is the first structural report of a monomeric thiolase-like protein from any organism. These studies show that MsTLP1 belongs to a new group of thiolase related proteins of unknown function.	[Harijan, Rajesh K.; Wierenga, Rikkert K.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Janardan, Neelanjana; Murthy, Mathur R. N.] Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland	Indian Institute of Science (IISC) - Bangalore; Finland National Institute for Health & Welfare; University of Oulu	Wierenga, RK (corresponding author), Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland.	rik.wierenga@oulu.fi; mrn@mbu.iisc.ernet.in	Harijan, Rajesh K./AAY-3277-2021	Janardan, Neelanjana/0000-0001-6028-1279; Harijan, Rajesh/0000-0003-1503-5057	Department of Science and Technology (DST); Department of Biotechnology (DBT), Government of India; BM 14 beam line, ESRF, Grenoble, France; Council for Scientific and Industrial Research (CSIR), Government of India; Academy of Finland Indo-Finnish Grant [BT/FINNISH/27/MRNM/2009]	Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); BM 14 beam line, ESRF, Grenoble, France; Council for Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Academy of Finland Indo-Finnish Grant(Academy of Finland)	The intensity data were collected using the X-ray Facility for Structural Biology at the Molecular Biophysics Unit, Indian Institute of Science, supported by the Department of Science and Technology (DST) and the Department of Biotechnology (DBT), Government of India and at the BM 14 beam line, ESRF, Grenoble, France. We acknowledge the award of Shyama Prasad Mukherji Fellowship by the Council for Scientific and Industrial Research (CSIR), Government of India to NJ. We thank Prof. D. Chatterji for the gift of M. smegmatis genomic DNA. We thank Anju Paul for technical assistance and Dr. Piotr Prus for helping with the Biacore measurements.; Department of Biotechnology, Government of India and Academy of Finland Indo-Finnish Grant Grant number: BT/FINNISH/27/MRNM/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Choinowski T, 2000, BIOCHEMISTRY-US, V39, P1897, DOI 10.1021/bi992742e; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cole ST, 2011, CURR OPIN MICROBIOL, V14, P570, DOI 10.1016/j.mib.2011.07.022; Delarbre L, 2001, J MOL BIOL, V308, P1063, DOI 10.1006/jmbi.2001.4636; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Haapalainen AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/bi6026192; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; Janardan N, 2011, ACTA CRYSTALLOGR F, V67, P817, DOI 10.1107/S1744309111019324; Jiang CG, 2008, MOL PHYLOGENET EVOL, V49, P691, DOI 10.1016/j.ympev.2008.09.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kursula P, 2005, J MOL BIOL, V347, P189, DOI 10.1016/j.jmb.2005.01.018; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATHIEU M, 1994, STRUCTURE, V2, P797, DOI 10.1016/S0969-2126(94)00081-6; Mazet M, 2011, INT J PARASITOL, V41, P1273, DOI 10.1016/j.ijpara.2011.07.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merilainen G, 2009, BIOCHEMISTRY-US, V48, P11011, DOI 10.1021/bi901069h; Merilainen G, 2008, FEBS J, V275, P6136, DOI 10.1111/j.1742-4658.2008.06737.x; Modis Y, 1999, STRUCTURE, V7, P1279, DOI 10.1016/S0969-2126(00)80061-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SEEDORF U, 1994, J BIOL CHEM, V269, P21277; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; WILLIAMS SF, 1992, J BIOL CHEM, V267, P16041	37	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41894	10.1371/journal.pone.0041894	http://dx.doi.org/10.1371/journal.pone.0041894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844533	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000309240600055
J	Barbosa-da-Silva, S; Fraulob-Aquino, JC; Lopes, JR; Mandarim-de-Lacerda, CA; Aguila, MB				Barbosa-da-Silva, Sandra; Fraulob-Aquino, Julio C.; Lopes, Jessica R.; Mandarim-de-Lacerda, Carlos A.; Aguila, Marcia B.			Weight Cycling Enhances Adipose Tissue Inflammatory Responses in Male Mice	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; NECROSIS-FACTOR-ALPHA; HIGH-FAT DIETS; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; GENE-EXPRESSION; OBESE MICE; CALORIC RESTRICTION; METABOLIC SYNDROME; ABDOMINAL OBESITY	Background: Obesity is associated with low-grade chronic inflammation attributed to dysregulated production, release of cytokines and adipokines and to dysregulated glucose-insulin homeostasis and dyslipidemia. Nutritional interventions such as dieting are often accompanied by repeated bouts of weight loss and regain, a phenomenon known as weight cycling (WC). Methods: In this work we studied the effects of WC on the feed efficiency, blood lipids, carbohydrate metabolism, adiposity and inflammatory markers in C57BL/6 male mice that WC two or three consecutive times by alternation of a high-fat (HF) diet with standard chow (SC). Results: The body mass (BM) grew up in each cycle of HF feeding, and decreased after each cycle of SC feeding. The alterations observed in the animals feeding HF diet in the oral glucose tolerance test, in blood lipids, and in serum and adipose tissue expression of adipokines were not recuperated after WC. Moreover, the longer the HF feeding was (two, four and six months), more severe the adiposity was. After three consecutive WC, less marked was the BM reduction during SC feeding, while more severe was the BM increase during HF feeding. Conclusion: In conclusion, the results of the present study showed that both the HF diet and WC are relevant to BM evolution and fat pad remodeling in mice, with repercussion in blood lipids, homeostasis of glucose-insulin and adipokine levels. The simple reduction of the BM during a WC is not able to recover the high levels of adipokines in the serum and adipose tissue as well as the pro-inflammatory cytokines enhanced during a cycle of HF diet. These findings are significant because a milieu with altered adipokines in association with WC potentially aggravates the chronic inflammation attributed to dysregulated production and release of adipokines in mice.	[Barbosa-da-Silva, Sandra; Fraulob-Aquino, Julio C.; Lopes, Jessica R.; Mandarim-de-Lacerda, Carlos A.; Aguila, Marcia B.] Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Barbosa-da-Silva, S (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	mbaguila@uerj.br	Mandarim-de-Lacerda, Carlos A/F-7125-2012; Aguila, Marcia/P-2349-2019; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia Barbosa/ABF-6505-2020; AQUINO, JULIO CESAR FRAULOB/ABG-8977-2020	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Aguila, Marcia Barbosa/0000-0003-3994-4589; 	CNPq (National Council for Science and Technology); Faperj (Rio de Janeiro Foundation for Research)	CNPq (National Council for Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj (Rio de Janeiro Foundation for Research)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This research was supported by CNPq (National Council for Science and Technology) and Faperj (Rio de Janeiro Foundation for Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Altintas MM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-198; Astrup A, 1999, AM J CLIN NUTR, V69, P1117; Azuma K, 2003, OBES RES, V11, P997, DOI 10.1038/oby.2003.137; BLACKBURN GL, 1989, AM J CLIN NUTR, V49, P1105, DOI 10.1093/ajcn/49.5.1105; Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x; Catta-Preta M, 2012, NUTRITION, V28, P212, DOI 10.1016/j.nut.2011.05.011; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Delbue S, 2007, J NEUROVIROL, V13, P73, DOI 10.1080/13550280601094563; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Field AE, 2009, ARCH INTERN MED, V169, P881, DOI 10.1001/archinternmed.2009.67; FLATT JP, 1987, AM J CLIN NUTR, V45, P296, DOI 10.1093/ajcn/45.1.296; Flint AJ, 2010, OBESITY, V18, P377, DOI 10.1038/oby.2009.223; Forbes GB, 2000, ANN NY ACAD SCI, V904, P359; Fumeron F, 2004, DIABETES, V53, P1150, DOI 10.2337/diabetes.53.4.1150; Giesen K, 2003, BIOCHEM BIOPH RES CO, V304, P812, DOI 10.1016/S0006-291X(03)00664-8; Gruson E, 2010, HEART, V96, P136, DOI 10.1136/hrt.2009.171447; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Heitmann BL, 2002, AM J CLIN NUTR, V75, P840, DOI 10.1093/ajcn/75.5.840; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; JOLICOEUR P, 1986, BIOMETRICS, V42, P785, DOI 10.2307/2530693; Kochan Z, 2006, J PHYSIOL PHARMACOL, V57, P115; Korkeila M, 1999, AM J CLIN NUTR, V70, P965; Kshatriya S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/270624; Lee IS, 2010, ENDOCR J, V57, P39, DOI 10.1507/endocrj.K09E-046; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Moreno-Navarrete JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-27; Marques CMM, 2010, BRAZ J MED BIOL RES, V43, P467, DOI 10.1590/S0100-879X2010007500030; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Morin CL, 1997, ENDOCRINOLOGY, V138, P4665, DOI 10.1210/en.138.11.4665; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Ohman Miina K, 2009, Recent Pat Cardiovasc Drug Discov, V4, P164; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; OLEFSKY JM, 1974, AM J MED, V57, P551, DOI 10.1016/0002-9343(74)90006-0; Peake PW, 2005, EUR J ENDOCRINOL, V153, P409, DOI 10.1530/eje.1.01978; Qi QB, 2008, EUR J ENDOCRINOL, V159, P585, DOI 10.1530/EJE-08-0427; REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; ROZEN R, 1994, AM J CLIN NUTR, V59, P560, DOI 10.1093/ajcn/59.3.560; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Shi HF, 2007, AM J PHYSIOL-ENDOC M, V293, pE316, DOI 10.1152/ajpendo.00710.2006; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Smith J, 2006, CLIN SCI, V110, P1; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Strohacker K, 2010, Front Biosci (Elite Ed), V2, P98, DOI 10.2741/e70; Strychar I, 2009, J AM DIET ASSOC, V109, P718, DOI 10.1016/j.jada.2008.12.026; Taing KY, 2011, OBESITY SILVER SPRIN; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Tsochatzis E, 2006, AM J GASTROENTEROL, V101, P2629, DOI 10.1111/j.1572-0241.2006.00848.x; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Valsamakis G, 2004, METABOLISM, V53, P430, DOI 10.1016/j.metabol.2003.11.022; Xydakis AM, 2004, J CLIN ENDOCR METAB, V89, P2697, DOI 10.1210/jc.2003-031826; Zhang YY, 2002, AM J PHYSIOL-REG I, V282, pR226, DOI 10.1152/ajpregu.00392.2001; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	63	73	74	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39837	10.1371/journal.pone.0039837	http://dx.doi.org/10.1371/journal.pone.0039837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848362	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600010
J	Horn, F; Correa, AMR; Barbieri, NL; Glodde, S; Weyrauch, KD; Kaspers, B; Driemeier, D; Ewers, C; Wieler, LH				Horn, Fabiana; Ribeiro Correa, Andre Mendes; Barbieri, Nicolle Lima; Glodde, Susanne; Weyrauch, Karl Dietrich; Kaspers, Bernd; Driemeier, David; Ewers, Christa; Wieler, Lothar H.			Infections with Avian Pathogenic and Fecal Escherichia coli Strains Display Similar Lung Histopathology and Macrophage Apoptosis	PLOS ONE			English	Article							VIRULENCE FACTORS; CHICKEN; IDENTIFICATION; SYSTEM; EXPRESSION; CELLS; MODEL; IBEA	The purpose of this study was to compare histopathological changes in the lungs of chickens infected with avian pathogenic (APEC) and avian fecal (A(fecal)) Escherichia coli strains, and to analyze how the interaction of the bacteria with avian macrophages relates to the outcome of the infection. Chickens were infected intratracheally with three APEC strains, MT78, IMT5155, and UEL17, and one non-pathogenic A(fecal) strain, IMT5104. The pathogenicity of the strains was assessed by isolating bacteria from lungs, kidneys, and spleens at 24 h post-infection (p.i.). Lungs were examined for histopathological changes at 12, 18, and 24 h p.i. Serial lung sections were stained with hematoxylin and eosin (HE), terminal deoxynucleotidyl dUTP nick end labeling (TUNEL) for detection of apoptotic cells, and an anti-O2 antibody for detection of MT78 and IMT5155. UEL17 and IMT5104 did not cause systemic infections and the extents of lung colonization were two orders of magnitude lower than for the septicemic strains MT78 and IMT5155, yet all four strains caused the same extent of inflammation in the lungs. The inflammation was localized; there were some congested areas next to unaffected areas. Only the inflamed regions became labeled with anti-O2 antibody. TUNEL labeling revealed the presence of apoptotic cells at 12 h p.i in the inflamed regions only, and before any necrotic foci could be seen. The TUNEL-positive cells were very likely dying heterophils, as evidenced by the purulent inflammation. Some of the dying cells observed in avian lungs in situ may also be macrophages, since all four avian E. coli induced caspase 3/7 activation in monolayers of HD11 avian macrophages. In summary, both pathogenic and non-pathogenic fecal strains of avian E. coli produce focal infections in the avian lung, and these are accompanied by inflammation and cell death in the infected areas.	[Horn, Fabiana; Barbieri, Nicolle Lima] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil; [Horn, Fabiana; Glodde, Susanne; Ewers, Christa; Wieler, Lothar H.] Free Univ Berlin, Inst Microbiol & Epizoot, Berlin, Germany; [Ribeiro Correa, Andre Mendes; Driemeier, David] Univ Fed Rio Grande do Sul, Setor Patol Vet, Porto Alegre, RS, Brazil; [Weyrauch, Karl Dietrich] Free Univ Berlin, Inst Vet Anat, Berlin, Germany; [Kaspers, Bernd] Univ Munich, Fac Vet Med, Munich, Germany; [Ewers, Christa] Univ Giessen, Inst Hyg & Infect Dis Animals, Giessen, Germany	Universidade Federal do Rio Grande do Sul; Free University of Berlin; Universidade Federal do Rio Grande do Sul; Free University of Berlin; University of Munich; Justus Liebig University Giessen	Horn, F (corresponding author), Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil.	fabiana.horn@ufrgs.br	Horn, Fabiana/K-9637-2013; Barbieri, Nicolle Lima/L-6477-2013; Barbieri, Nicolle/AAB-3223-2020; Ewers, Christa/AAL-9186-2020; Driemeier, David/H-3461-2012; Lima Barbieri, Nicolle/L-6477-2013	Barbieri, Nicolle Lima/0000-0002-8223-6580; Driemeier, David/0000-0003-3766-0654; Ewers, Christa/0000-0001-6167-1340; Lima Barbieri, Nicolle/0000-0001-8641-7592; Wieler, Lothar H./0000-0003-4365-3717	CNPq (Brazil) [MAPA 57864/2008-5]; FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Brazil); Indo-German Research Training Group - Internationales Graduiertenkolleg - Functional Molecular Infection Epidemiology [GRK1673]; National Genome Research Network in the framework of the FUGATO E. coli chick project; Federal Ministry of Education and Research (Germany); CAPES (Ministry of Education, Brazil) [BEX2204/04-5]	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Brazil)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Indo-German Research Training Group - Internationales Graduiertenkolleg - Functional Molecular Infection Epidemiology; National Genome Research Network in the framework of the FUGATO E. coli chick project; Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); CAPES (Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was partially supported by CNPq (MAPA 57864/2008-5, Brazil), FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Brazil), by the Indo-German Research Training Group - Internationales Graduiertenkolleg (GRK1673) - Functional Molecular Infection Epidemiology, and by the National Genome Research Network in the framework of the FUGATO E. coli chick project funded by the Federal Ministry of Education and Research (Germany). FH was the recipient of a CAPES (Ministry of Education, Brazil, grant number BEX2204/04-5) sponsorship during her stay at the Institute of Microbiology and Epizootics, Freie Universitat Berlin, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007796; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Bastiani M, 2005, FEMS MICROBIOL LETT, V253, P133, DOI 10.1016/j.femsle.2005.09.024; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Caza M, 2011, MOL MICROBIOL, V80, P266, DOI 10.1111/j.1365-2958.2011.07570.x; Chouikha I, 2008, MICROBES INFECT, V10, P432, DOI 10.1016/j.micinf.2008.01.002; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Ciraci C, 2011, DEV COMP IMMUNOL, V35, P392, DOI 10.1016/j.dci.2010.11.012; Dai J, 2010, BMC MICROBIOLOGY, P10; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; DHO M, 1982, AVIAN DIS, V26, P787, DOI 10.2307/1589865; Dho-Moulin M, 1999, VET RES, V30, P299; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Dwars RM, 2009, VET IMMUNOL IMMUNOP, V127, P65, DOI 10.1016/j.vetimm.2008.09.019; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; He HQ, 2011, CYTOKINE, V53, P363, DOI 10.1016/j.cyto.2010.12.009; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Li GW, 2011, INFECT IMMUN, V79, P1951, DOI 10.1128/IAI.01230-10; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; Maina JN, 2006, BIOL REV, V81, P545, DOI 10.1017/S1464793106007111; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Matter LB, 2011, VET MICROBIOL, V148, P51, DOI 10.1016/j.vetmic.2010.08.006; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Pourbakhsh SA, 1997, VET MICROBIOL, V58, P195, DOI 10.1016/S0378-1135(97)00163-6; Pourbakhsh SA, 1997, AVIAN DIS, V41, P221, DOI 10.2307/1592463; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Tyler CD, 2008, AVIAN DIS, V52, P23, DOI 10.1637/8026-053107-Reg; VIDOTTO MC, 1990, AVIAN DIS, V34, P531, DOI 10.2307/1591241	31	37	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41031	10.1371/journal.pone.0041031	http://dx.doi.org/10.1371/journal.pone.0041031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848424	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600034
J	Gong, B; Kielar, C; Morton, AJ				Gong, Belvin; Kielar, Catherine; Morton, A. Jennifer			Temporal Separation of Aggregation and Ubiquitination during Early Inclusion Formation in Transgenic Mice Carrying the Huntington's Disease Mutation	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE TRACTS; MUTANT HUNTINGTIN; MOUSE MODEL; R6/2 MOUSE; CELL-DEATH; NEUROLOGICAL PHENOTYPE; MEDIATED TRANSCRIPTION; PROTEIN AGGREGATION; CORTICAL-NEURONS	Abnormal insoluble ubiqitinated protein aggregates are found in the brains of Huntington's disease (HD) patients and in mice transgenic for the HTT mutation. Here, we describe the earliest stages of visible NII formation in brains of R6/2 mice killed between 2 and 6 weeks of age. We found that huntingtin-positive aggregates formed rapidly (within 24-48 hours) in a spatiotemporal manner similar to that we described previously for ubiquitinated inclusions. However, in most neurons, aggregates are not ubiquitinated when they first form. It has always been assumed that mutant huntingtin is recognised as 'foreign' and consequently ubiquitinated and targeted for degradation by the ubiquitin-proteasome system pathway. Our data, however, suggest that aggregation and ubiquitination are separate processes, and that mutant huntingtin fragment is not recognized as 'abnormal' by the ubiquitin-proteasome system before aggregation. Rather, mutant Htt appears to aggregate before it is ubiquitinated, and then either aggregated huntingtin is ubiquitinated or ubiquitinated proteins are recruited into aggregates. Our findings have significant implications for the role of the ubiquitin-proteasome system in the formation of aggregates, as they suggest that this system is not involved until after the first aggregates form.	[Gong, Belvin; Kielar, Catherine; Morton, A. Jennifer] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Gong, Belvin] Univ Calif Davis, UC Davis NIH NeuroMab Facil, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of Cambridge; University of California System; University of California Davis	Gong, B (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	ajm41@cam.ac.uk	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346	Merck, Sharp and Dohme, Incorporated; Cambridge Overseas Trust; CHDI Foundation; Wellcome Trust; Merck, Sharp and Dohme	Merck, Sharp and Dohme, Incorporated; Cambridge Overseas Trust; CHDI Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Merck, Sharp and Dohme(Merck & Company)	This work was supported by by Merck, Sharp and Dohme, Incorporated (PhD studentship to BG), the Cambridge Overseas Trust (BG), CHDI Foundation (CK and AJM) and the Wellcome Trust (AJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Merck, Sharp and Dohme. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; [Anonymous], ADV NEUROL; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bhide PG, 1996, J NEUROSCI, V16, P5523; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Cajavec Branka, 2005, Genome Inform, V16, P262; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cepeda C, 2003, J NEUROSCI, V23, P961; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Cummings DM, 2009, J NEUROSCI, V29, P10371, DOI 10.1523/JNEUROSCI.1592-09.2009; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Durr A, 1999, J MED GENET, V36, P172; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Fusco FR, 1999, J NEUROSCI, V19, P1189; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gibson HE, 2005, EUR J NEUROSCI, V22, P1701, DOI 10.1111/j.1460-9568.2005.04349.x; Gil JM, 2009, BRAIN RES REV, V59, P410, DOI 10.1016/j.brainresrev.2008.12.001; Gong B, 2008, BRAIN RES BULL, V75, P146, DOI 10.1016/j.brainresbull.2007.08.005; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Kung VWS, 2007, NEUROSCIENCE, V146, P1571, DOI 10.1016/j.neuroscience.2007.03.036; Laccone F, 1999, NEUROLOGY, V53, P801, DOI 10.1212/WNL.53.4.801; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lione LA, 1999, J NEUROSCI, V19, P10428; Maat-Schieman M, 2007, BRAIN PATHOL, V17, P31, DOI 10.1111/j.1750-3639.2006.00040.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Menalled LB, 2002, J NEUROSCI, V22, P8266; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Morton AJ, 2000, J NEUROCYTOL, V29, P679, DOI 10.1023/A:1010887421592; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; MYERS RH, 1989, AM J HUM GENET, V45, P615; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Rankin J, 2003, BIOCHEM J, V15, P15; Rubinsztein DC, 1999, J MED GENET, V36, P265; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Senut MC, 2000, J NEUROSCI, V20, P219, DOI 10.1523/JNEUROSCI.20-01-00219.2000; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Southwell AL, 2010, REV NEUROSCIENCE, V21, P273; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Wanderer J, 2007, HISTOCHEM CELL BIOL, V127, P473, DOI 10.1007/s00418-007-0272-z; Wetzel R, 2006, NAT CHEM BIOL, V2, P297, DOI 10.1038/nchembio0606-297; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yamada M, 2008, ACTA NEUROPATHOL, V115, P71, DOI 10.1007/s00401-007-0287-5; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013; Zuchner T, 2008, CELL DEATH DIFFER, V15, P435, DOI 10.1038/sj.cdd.4402261	76	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41450	10.1371/journal.pone.0041450	http://dx.doi.org/10.1371/journal.pone.0041450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848498	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300041
J	Lahtinen, AM; Noseworthy, PA; Havulinna, AS; Jula, A; Karhunen, PJ; Kettunen, J; Perola, M; Kontula, K; Newton-Cheh, C; Salomaa, V				Lahtinen, Annukka M.; Noseworthy, Peter A.; Havulinna, Aki S.; Jula, Antti; Karhunen, Pekka J.; Kettunen, Johannes; Perola, Markus; Kontula, Kimmo; Newton-Cheh, Christopher; Salomaa, Veikko			Common Genetic Variants Associated with Sudden Cardiac Death: The FinSCDgen Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LONG QT SYNDROME; MIDDLE-AGED MEN; INTERVAL DURATION; RISK-FACTORS; ARTERY-DISEASE; CHANNEL GENE; POPULATION; MUTATIONS; ARRHYTHMIAS	Background: Sudden cardiac death (SCD) accounts for up to half of cardiac mortality. The risk of SCD is heritable but the underlying genetic variants are largely unknown. We investigated whether common genetic variants predisposing to arrhythmia or related electrocardiographic phenotypes, including QT-interval prolongation, are associated with increased risk of SCD. Methodology/Principal Findings: We studied the association between 28 candidate SNPs and SCD in a meta-analysis of four population cohorts (FINRISK 1992, 1997, 2002 and Health 2000, n = 27,629) and two forensic autopsy series (The Helsinki Sudden Death Study and The Tampere Autopsy Study, n = 694). We also studied the association between established cardiovascular risk factors and SCD. Causes of death were reviewed using registry-based health and autopsy data. Cox regression and logistic regression models were adjusted for age, sex, and geographic region. The total number of SCDs was 716. Two novel SNPs were associated with SCD: SCN5A rs41312391 (relative risk [RR] 1.27 per minor T allele, 95% CI 1.11-1.45, P = 3.4x10(-4)) and rs2200733 in 4q25 (RR 1.28 per minor T allele, 95% CI 1.11-1.48, P = 7.9x10(-4)). We also replicated the associations for 9p21 (rs2383207, RR 1.13 per G allele, 95% CI 1.01-1.26, P = 0.036), as well as for male sex, systolic blood pressure, diabetes, cigarette smoking, low physical activity, coronary heart disease, and digoxin use (P < 0.05). Conclusions/Significance: Two novel genetic variants, one in the cardiac sodium channel gene SCN5A and another at 4q25 previously associated with atrial fibrillation, are associated with SCD.	[Lahtinen, Annukka M.; Kontula, Kimmo] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Lahtinen, Annukka M.; Kontula, Kimmo] Univ Helsinki, Dept Med, Helsinki, Finland; [Noseworthy, Peter A.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Noseworthy, Peter A.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Noseworthy, Peter A.; Newton-Cheh, Christopher] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Havulinna, Aki S.; Perola, Markus; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Jula, Antti] Natl Inst Hlth & Welf, Turku, Finland; [Karhunen, Pekka J.] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Karhunen, Pekka J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kettunen, Johannes; Perola, Markus] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland	University of Helsinki; University of Helsinki; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Tampere University; Tampere University Hospital; Tampere University; University of Helsinki	Lahtinen, AM (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki, Finland.	cnewtoncheh@chgr.mgh.harvard.edu; veikko.salomaa@thl.fi	Tuiskula, Annukka/ABF-6377-2020; Havulinna, Aki/AAM-4769-2021	Tuiskula, Annukka/0000-0002-6538-635X; 	Finnish Cultural Foundation; Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology; Burroughs Wellcome Fund travel grant; Finnish Academy SALVE program "Pubgensense" [10404]; Wellcome Trust; Academy of Finland [129494]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; United States National Institutes of Health [HL080025, HL098283]; Doris Duke Charitable Foundation; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098283, K23HL080025] Funding Source: NIH RePORTER	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology; Burroughs Wellcome Fund travel grant(Burroughs Wellcome Fund); Finnish Academy SALVE program "Pubgensense"; Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Finnish Cultural Foundation (to A. M. L.); the Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology (to P.A.N.); a Burroughs Wellcome Fund travel grant (to P.A.N.); Finnish Academy SALVE program "Pubgensense" (#10404 to M.P.); the Wellcome Trust, the Academy of Finland (to K.K. and #129494 to V.S.); the Finnish Foundation for Cardiovascular Research (to K.K. and V.S.); the Sigrid Juselius Foundation (to K.K. and V.S.); the United States National Institutes of Health (HL080025, HL098283 to C.N.-C.); the Doris Duke Charitable Foundation (to C.N.-C.); and the Burroughs Wellcome Fund (to C.N.-C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabag AS, 2010, NAT REV CARDIOL, V7, P216, DOI 10.1038/nrcardio.2010.3; Adams KF, 2005, J AM COLL CARDIOL, V46, P497, DOI 10.1016/j.jacc.2005.02.091; [Anonymous], 2010, R LANG ENV STAT COMP; Antzelevitch C, 2002, CURR OPIN CARDIOL, V17, P43, DOI 10.1097/00001573-200201000-00007; Aydin A, 2005, J MOL MED, V83, P159, DOI 10.1007/s00109-004-0595-3; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Chugh SS, 2009, CIRCULATION, V119, P663, DOI 10.1161/CIRCULATIONAHA.108.797035; CURB JD, 1995, CIRCULATION, V91, P2591, DOI 10.1161/01.CIR.91.10.2591; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Franco D, 2003, TRENDS CARDIOVAS MED, V13, P157, DOI 10.1016/S1050-1738(03)00039-2; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Gouas L, 2007, EUR J HUM GENET, V15, P974, DOI 10.1038/sj.ejhg.5201866; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Heistaro S, 2008, KTL B, P26; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; KANNEL WB, 1988, AM HEART J, V115, P869, DOI 10.1016/0002-8703(88)90891-5; KANNEL WB, 1985, J AM COLL CARDIOL, V5, pB141, DOI 10.1016/S0735-1097(85)80545-3; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Ni H, 2009, AM HEART J, V157, P46, DOI 10.1016/j.ahj.2008.08.016; Noseworthy PA, 2011, CIRC-CARDIOVASC GENE, V4, P305, DOI 10.1161/CIRCGENETICS.110.959049; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Pedersen OD, 2006, EUR HEART J, V27, P290, DOI 10.1093/eurheartj/ehi629; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Tyynela P, 2009, ANN MED, V41, P57, DOI 10.1080/07853890802258753; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WANNAMETHEE G, 1995, CIRCULATION, V91, P1749, DOI 10.1161/01.CIR.91.6.1749	42	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41675	10.1371/journal.pone.0041675	http://dx.doi.org/10.1371/journal.pone.0041675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844511	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700139
J	Lundquist, D; Gemmell, NJ; Wursig, B				Lundquist, David; Gemmell, Neil J.; Wuersig, Bernd			Behavioural Responses of Dusky Dolphin Groups (Lagenorhynchus obscurus) to Tour Vessels off Kaikoura, New Zealand	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; WHALE-WATCHING BOATS; TURSIOPS-TRUNCATUS; STENELLA-LONGIROSTRIS; SARASOTA BAY; ORCINUS-ORCA; PATTERNS; SWIMMERS; NOISE; DISTURBANCE	Background: Commercial viewing and swimming with dusky dolphins (Lagenorhynchus obscurus) near Kaikoura, New Zealand began in the late 1980s and researchers have previously described changes in vocalisation, aerial behaviour, and group spacing in the presence of vessels. This study was conducted to assess the current effects that tourism has on the activity budget of dusky dolphins to provide wildlife managers with information for current decision-making and facilitate development of quantitative criteria for management of this industry in the future. Methodology/Principal Findings: First-order time discrete Markov chain models were used to assess changes in the behavioural state of dusky dolphin pods targeted by tour vessels. Log-linear analysis was conducted on behavioural state transitions to determine whether the likelihood of dolphins moving from one behavioural state to another changed based on natural and anthropogenic factors. The best-fitting model determined by Akaike Information Criteria values included season, time of day, and vessel presence within 300 m. Interactions with vessels reduced the proportion of time dolphins spent resting in spring and summer and increased time spent milling in all seasons except autumn. Dolphins spent more time socialising in spring and summer, when conception occurs and calves are born, and the proportion of time spent resting was highest in summer. Resting decreased and traveling increased in the afternoon. Conclusions/Significance: Responses to tour vessel traffic are similar to those described for dusky dolphins elsewhere. Disturbance linked to vessels may interrupt social interactions, carry energetic costs, or otherwise affect individual fitness. Research is needed to determine if increased milling is a result of acoustic masking of communication due to vessel noise, and to establish levels at which changes to behavioural budgets of dusky dolphins are likely to cause long-term harm. Threshold values from these studies would allow managers to set appropriate operational conditions based on quantifiable criteria.	[Lundquist, David; Gemmell, Neil J.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Wuersig, Bernd] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	University of Otago; Texas A&M University System	Lundquist, D (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	lundquistdave@hotmail.com	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637	New Zealand Department of Conservation; National Geographic Society Committee for Research and Exploration [8341-07]; University of Otago Postgraduate Scholarship; UC-Santa Cruz MHIRT stipend	New Zealand Department of Conservation; National Geographic Society Committee for Research and Exploration(National Geographic Society); University of Otago Postgraduate Scholarship; UC-Santa Cruz MHIRT stipend	Funding for this work was provided by the New Zealand Department of Conservation (http://www.doc.govt.nz) and the National Geographic Society Committee for Research and Exploration (Grant number 8341-07, http://www.nationalgeographic.com/explorers/grants-programs/cre/). DL was supported by a University of Otago Postgraduate Scholarship and UC-Santa Cruz MHIRT stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Gutierrez A, 2000, MAR MAMMAL SCI, V16, P287, DOI 10.1111/j.1748-7692.2000.tb00925.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2003, THESIS TEXAS AM U; Au WWL, 2000, MAR ENVIRON RES, V49, P469, DOI 10.1016/S0141-1136(99)00086-0; Barr K, 1999, DEP CONSERVATION CON, V229; Barr K, 1997, IMPACTS MARINE TOURI; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L., 2005, LINKING SHORT LONG T; Bejder L, 2004, MARINE MAMMALS FISHE, P229; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; BLANE JM, 1994, ENVIRON CONSERV, V21, P267, DOI 10.1017/S0376892900033282; Brown NC, 2000, DUSKY DOLPHIN LAGENO; Buckstaff KC, 2004, MAR MAMMAL SCI, V20, P709, DOI 10.1111/j.1748-7692.2004.tb01189.x; Burgess WC, 1998, DEEP-SEA RES PT II, V45, P1327, DOI 10.1016/S0967-0645(98)00032-0; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Childerhouse S, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P245, DOI 10.1016/B978-0-12-373723-6.00012-6; Cipriano FW, 1992, BEHAV OCCURRENCE PAT; Cisneros-Montemayor AM, 2010, MAR POLICY, V34, P1273, DOI 10.1016/j.marpol.2010.05.005; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Courbis S, 2009, MAR MAMMAL SCI, V25, P430, DOI 10.1111/j.1748-7692.2008.00254.x; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dans SL, 2008, MAR ECOL PROG SER, V369, P287, DOI 10.3354/meps07629; Duprey NMT, 2008, OCEAN COAST MANAGE, V51, P632, DOI 10.1016/j.ocecoaman.2008.06.013; Duprey NM, 2007, DUSKY DOLPHIN LAGENO; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Foster KR, 2000, SCIENCE, V288, P979, DOI 10.1126/science.288.5468.979; Gordon J, 1992, DEP CONSERVATION SCI, V52; Hanson Mark T., 1993, Aquatic Mammals, V19, P127; Higham JES, 2008, ENVIRON CONSERV, V35, P294, DOI 10.1017/S0376892908005249; Hoyt E, 2007, BLUEPR DOLPH WHAL WA; International Whaling Commission (IWC), 1996, REP SCI COMM IWC; Jahoda M, 2003, MAR MAMMAL SCI, V19, P96, DOI 10.1111/j.1748-7692.2003.tb01095.x; Janik VM, 1996, MAR MAMMAL SCI, V12, P597, DOI 10.1111/j.1748-7692.1996.tb00073.x; Kruse S., 1991, P149; Lusseau D., 2006, Tourism in Marine Environments, V3, P173, DOI 10.3727/154427306779435184; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Mann J, 2000, CETACEAN SOCIETIES, P45; Markov AA, 1906, B SOC PHYS MATH KAZA, V2, P155; Markowitz T. M., 2009, TOURISM EFFECTS DUSK; Markowitz TM, 2004, SOCIAL ORG NZ DUSKY; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; O'Connor S., 2009, WHALE WATCHING WORLD; Richardson WJ, 1995, MARINE MAMMALS NOISE, P387; Richter CF, 2003, SCI CONSERVATION, V219; Rolland RM, 2005, GEN COMP ENDOCR, V142, P308, DOI 10.1016/j.ygcen.2005.02.002; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Scarpaci Carol, 2000, Journal of Cetacean Research and Management, V2, P183; Scheidat Meike, 2004, Journal of Cetacean Research and Management, V6, P63; Shane S.H., 1990, P245; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Speakman JR, 1997, DOUBLY LABELLED WATE; Srinivasan M, 2009, PREDATOR INFLUENCES; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Timmel Gregory, 2008, Aquatic Mammals, V34, P402, DOI 10.1578/AM.34.4.2008.402; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Wursig B, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P1; Wursig B., 1997, Report of the International Whaling Commission, V47, P715; Wursig B, 2007, DUSKY DOLPHINS LAGEN; Yin S, 1999, MOVEMENT PATTERNS BE	69	36	38	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41969	10.1371/journal.pone.0041969	http://dx.doi.org/10.1371/journal.pone.0041969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844536	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700163
J	Palmigiano, A; Pastor, J; de Sola, RG; Ortega, GJ				Palmigiano, Agostina; Pastor, Jesus; Garcia de Sola, Rafael; Ortega, Guillermo J.			Stability of Synchronization Clusters and Seizurability in Temporal Lobe Epilepsy	PLOS ONE			English	Article							NEURAL-NETWORKS; COMPLEX NETWORKS; DYNAMICS; HUBS	Purpose: Identification of critical areas in presurgical evaluations of patients with temporal lobe epilepsy is the most important step prior to resection. According to the "epileptic focus model", localization of seizure onset zones is the main task to be accomplished. Nevertheless, a significant minority of epileptic patients continue to experience seizures after surgery (even when the focus is correctly located), an observation that is difficult to explain under this approach. However, if attention is shifted from a specific cortical location toward the network properties themselves, then the epileptic network model does allow us to explain unsuccessful surgical outcomes. Methods: The intraoperative electrocorticography records of 20 patients with temporal lobe epilepsy were analyzed in search of interictal synchronization clusters. Synchronization was analyzed, and the stability of highly synchronized areas was quantified. Surrogate data were constructed and used to statistically validate the results. Our results show the existence of highly localized and stable synchronization areas in both the lateral and the mesial areas of the temporal lobe ipsilateral to the clinical seizures. Synchronization areas seem to play a central role in the capacity of the epileptic network to generate clinical seizures. Resection of stable synchronization areas is associated with elimination of seizures; nonresection of synchronization clusters is associated with the persistence of seizures after surgery. Discussion: We suggest that synchronization clusters and their stability play a central role in the epileptic network, favoring seizure onset and propagation. We further speculate that the stability distribution of these synchronization areas would differentiate normal from pathologic cases.	[Palmigiano, Agostina] Univ Buenos Aires, Dept Phys, Buenos Aires, DF, Argentina; [Pastor, Jesus; Garcia de Sola, Rafael; Ortega, Guillermo J.] Inst Invest Sanitaria Hosp Princesa, Madrid, Spain	University of Buenos Aires	Palmigiano, A (corresponding author), Univ Buenos Aires, Dept Phys, Buenos Aires, DF, Argentina.	gjortega.hlpr@salud.madrid.org	Pastor, Jesus/AAH-9238-2020	Pastor, Jesus/0000-0001-6870-8409; G. Sola, Rafael/0000-0002-0063-9301	Instituto de Salud Carlos III [PS09/02116, PI10/00160]; PIP, CONICET [11420100100261]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); PIP, CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Instituto de Salud Carlos III (projects PS09/02116 and PI10/00160) and PIP 11420100100261 CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Andrzejak RG, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046203; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Bancaud J., 1965, STEREOELECTROENCEPHA; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2001, CLIN NEUROPHYSIOL, V112, P1746, DOI 10.1016/S1388-2457(01)00591-0; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bertram EH, 1998, EPILEPSY RES, V32, P194, DOI 10.1016/S0920-1211(98)00051-5; Binder DK, 2008, TXB EPILEPSY SURG, P1083; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Dauwels J, 2009, IEEE ENG MED BIO, P2180, DOI 10.1109/IEMBS.2009.5332447; de la Prida LM, 2002, NEUROREPORT, V13, P1421, DOI 10.1097/00001756-200208070-00015; Dichter MA, 1997, EPILEPSIA, V38, pS2, DOI 10.1111/j.1528-1157.1997.tb05200.x; EFRON B, 1979, SIAM REV, V21, P460, DOI 10.1137/1021092; Engel J, 1993, SURG TREATMENT EPILE, P609; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Feinstein A, 2002, PRINCIPLES MED STAT; FERRER I, 1994, J NEUROL SCI, V123, P18, DOI 10.1016/0022-510X(94)90198-8; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Milton GJ, 2007, HDB BRAIN CONNECTIVI; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Netoff TI, 2002, J NEUROSCI, V22, P7297; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Ortega GJ, 2011, CLIN NEUROPHYSIOL, V122, P1106, DOI 10.1016/j.clinph.2010.11.001; Ortega GJ, 2008, NEUROSCI LETT, V447, P129, DOI 10.1016/j.neulet.2008.09.080; Palmigiano A, 2012, REV NEUROLO IN PRESS; Pastor J, 2005, REV NEUROLOGIA, V41, P709, DOI 10.33588/rn.4112.2005477; Pastor J, 2012, EPILEPSY HISTOLOGICA; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pereira T, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036201; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Rosow C, 2001, Anesthesiol Clin North Am, V19, P947; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; SPENCER DD, 1984, NEUROSURGERY, V15, P667, DOI 10.1227/00006123-198411000-00005; Spencer DD, 1995, OPERATIVE NEUROSURGI, P1305; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Tang J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055101; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Towle VL, 1999, J CLIN NEUROPHYSIOL, V16, P528, DOI 10.1097/00004691-199911000-00005; van Dellen E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008081; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhou CS, 2006, CHAOS, V16, DOI 10.1063/1.2150381	53	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41799	10.1371/journal.pone.0041799	http://dx.doi.org/10.1371/journal.pone.0041799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844524	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700151
J	Shi, MG; Beauchamp, RD; Zhang, B				Shi, Mingguang; Beauchamp, R. Daniel; Zhang, Bing			A Network-Based Gene Expression Signature Informs Prognosis and Treatment for Colorectal Cancer Patients	PLOS ONE			English	Article							II COLON-CANCER; BREAST-CANCER; RECURRENCE; CHEMOTHERAPY; METASTASIS; PREDICTION; PROFILES; MARKERS; BENEFIT	Background: Several studies have reported gene expression signatures that predict recurrence risk in stage II and III colorectal cancer (CRC) patients with minimal gene membership overlap and undefined biological relevance. The goal of this study was to investigate biological themes underlying these signatures, to infer genes of potential mechanistic importance to the CRC recurrence phenotype and to test whether accurate prognostic models can be developed using mechanistically important genes. Methods and Findings: We investigated eight published CRC gene expression signatures and found no functional convergence in Gene Ontology enrichment analysis. Using a random walk-based approach, we integrated these signatures and publicly available somatic mutation data on a protein-protein interaction network and inferred 487 genes that were plausible candidate molecular underpinnings for the CRC recurrence phenotype. We named the list of 487 genes a NEM signature because it integrated information from Network, Expression, and Mutation. The signature showed significant enrichment in four biological processes closely related to cancer pathophysiology and provided good coverage of known oncogenes, tumor suppressors, and CRC-related signaling pathways. A NEM signature-based Survival Support Vector Machine prognostic model was trained using a microarray gene expression dataset and tested on an independent dataset. The model-based scores showed a 75.7% concordance with the real survival data and separated patients into two groups with significantly different relapse-free survival (p = 0.002). Similar results were obtained with reversed training and testing datasets (p = 0.007). Furthermore, adjuvant chemotherapy was significantly associated with prolonged survival of the high-risk patients (p = 0.006), but not beneficial to the low-risk patients (p = 0.491). Conclusions: The NEM signature not only reflects CRC biology but also informs patient prognosis and treatment response. Thus, the network-based data integration method provides a convergence between biological relevance and clinical usefulness in gene signature development.	[Shi, Mingguang; Zhang, Bing] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Beauchamp, R. Daniel; Zhang, Bing] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Beauchamp, R. Daniel] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA; [Beauchamp, R. Daniel] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Beauchamp, R. Daniel; Zhang, Bing] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Shi, MG (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	bing.zhang@vanderbilt.edu		Beauchamp, Robert Daniel/0000-0002-8446-4114	NIH [GM088822, CA069457, DK052334]; Vanderbilt Ingram Cancer Center [CA068485]; GI Cancer SPORE [CA095103]; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA069457, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center; GI Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (http://www.nih.gov/) grants GM088822, CA069457, DK052334, and support from the Vanderbilt Ingram Cancer Center Support Grant CA068485 and the GI Cancer SPORE Grant CA095103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2007, ONCOL REP, V17, P1089; Barrier A, 2007, ONCOGENE, V26, P2642, DOI 10.1038/sj.onc.1210060; Barrier A, 2006, J CLIN ONCOL, V24, P4685, DOI 10.1200/JCO.2005.05.0229; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Chen JL, 2011, J AM MED INFORM ASSN, V18, P392, DOI 10.1136/amiajnl-2011-000178; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Drier Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017795; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Evers L, 2008, BIOINFORMATICS, V24, P1632, DOI 10.1093/bioinformatics/btn253; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kopetz S, 2009, CLIN CANCER RES, V15, P7451, DOI 10.1158/1078-0432.CCR-09-2523; Li J, 2010, HUM MUTAT, V31, P219, DOI 10.1002/humu.21176; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Oh S. C., 2011, GUT; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Ransohoff DF, 2004, GASTROENTEROLOGY, V127, P1028, DOI 10.1053/j.gastro.2004.08.030; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Shen RL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-28; SHIKE M, 1990, B WORLD HEALTH ORGAN, V68, P377; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Van Belle V, 2011, BIOINFORMATICS, V27, P87, DOI 10.1093/bioinformatics/btq617; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2011, MOL BIOSYST, V7, P2118, DOI 10.1039/c1mb05014a	41	42	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41292	10.1371/journal.pone.0041292	http://dx.doi.org/10.1371/journal.pone.0041292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844451	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700063
J	Rouzaud-Laborde, C; Hanoun, N; Baysal, I; Rech, JS; Mias, C; Calise, D; Sicard, P; Frugier, C; Seguelas, MH; Parini, A; Pizzinat, N				Rouzaud-Laborde, Charlotte; Hanoun, Naima; Baysal, Ipek; Rech, Jean-Simon; Mias, Celine; Calise, Denis; Sicard, Pierre; Frugier, Celine; Seguelas, Marie-Helene; Parini, Angelo; Pizzinat, Nathalie			Role of Endothelial AADC in Cardiac Synthesis of Serotonin and Nitrates Accumulation	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; CARDIOVASCULAR-SYSTEM; CORONARY ARTERIOLES; REPERFUSION INJURY; MEDIATED DILATION; SMOOTH-MUSCLE; CELLS; 5-HYDROXYTRYPTAMINE; HEART; ACTIVATION	Serotonin (5-HT) regulates different cardiac functions by acting directly on cardiomyocytes, fibroblasts and endothelial cells. Today, it is widely accepted that activated platelets represent a major source of 5-HT. In contrast, a supposed production of 5-HT in the heart is still controversial. To address this issue, we investigated the expression and localization of 5-HT synthesizing enzyme tryptophan hydroxylase (TPH) and L-aromatic amino acid decarboxylase (AADC) in the heart. We also evaluated their involvement in cardiac production of 5-HT. TPH1 was weakly expressed in mouse and rat heart and appeared restricted to mast cells. Degranulation of mast cells by compound 48/80 did not modify 5-HT cardiac content in mice. Western blots and immunolabelling experiments showed an abundant expression of AADC in the mouse and rat heart and its co-localization with endothelial cells. Incubation of cardiac homogenate with the AADC substrate (5-hydroxy-L-tryptophan) 5-HTP or intraperitoneal injection of 5-HTP in mice significantly increased cardiac 5-HT. These effects were prevented by the AADC inhibitor benserazide. Finally, 5-HTP administration in mice increased phosphorylation of aortic nitric oxide synthase 3 at Ser (1177) as well as accumulation of nitrates in cardiac tissue. This suggests that the increase in 5-HT production by AADC leads to activation of endothelial and cardiac nitric oxide pathway. These data show that endothelial AADC plays an important role in cardiac synthesis of 5-HT and possibly in 5-HT-dependent regulation of nitric oxide generation.	[Rouzaud-Laborde, Charlotte; Baysal, Ipek; Rech, Jean-Simon; Mias, Celine; Calise, Denis; Sicard, Pierre; Frugier, Celine; Seguelas, Marie-Helene; Parini, Angelo; Pizzinat, Nathalie] Inst Natl Sante & Rech Med, Inst Malad Metab & Cardiovasc Rangueil, Toulouse, France; [Rouzaud-Laborde, Charlotte; Baysal, Ipek; Rech, Jean-Simon; Mias, Celine; Calise, Denis; Sicard, Pierre; Frugier, Celine; Seguelas, Marie-Helene; Parini, Angelo; Pizzinat, Nathalie] Univ Toulouse 3, Inst Med Mol Rangueil, F-31062 Toulouse, France; [Rouzaud-Laborde, Charlotte; Parini, Angelo] Ctr Hosp Univ Toulouse, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Rouzaud-Laborde, C (corresponding author), Inst Natl Sante & Rech Med, Inst Malad Metab & Cardiovasc Rangueil, Toulouse, France.	nathalie.pizzinat@inserm.fr	Sicard, Pierre/N-7310-2018; hanoun, naima NH/M-6408-2014; Baysal, Ipek/I-8429-2013	Sicard, Pierre/0000-0001-5837-3916; Baysal, Ipek/0000-0002-9607-4199; Parini, Angelo/0000-0002-9848-8838; FRUGIER, Celine/0000-0003-2889-9188; Mias, Celine/0000-0001-8055-8255	region Midi Pyrenees	region Midi Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur)	The authors would like to thank region Midi Pyrenees for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 2009, NEOPLASIA, V11, P408, DOI 10.1593/neo.81630; Bouchard JF, 2000, CARDIOVASC RES, V45, P418, DOI 10.1016/S0008-6363(99)00343-0; COCKS TM, 1992, BRIT J PHARMACOL, V107, P591, DOI 10.1111/j.1476-5381.1992.tb12788.x; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; DeFily DV, 1996, AM J PHYSIOL-HEART C, V270, pH2094, DOI 10.1152/ajpheart.1996.270.6.H2094; dePablo ALL, 1996, J NEUROCHEM, V67, P2060; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Ellwood AJ, 1996, BRIT J PHARMACOL, V119, P721, DOI 10.1111/j.1476-5381.1996.tb15732.x; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; HOUSTON DS, 1988, J PHARMACOL EXP THER, V244, P1; Ishida Tatsuro, 1998, Kobe Journal of Medical Sciences, V44, P51; Izikki M, 2007, AM J PHYSIOL-LUNG C, V293, pL1045, DOI 10.1152/ajplung.00082.2007; Kaumann AJ, 2006, PHARMACOL THERAPEUT, V111, P674, DOI 10.1016/j.pharmthera.2005.12.004; Manjarrez-Gutierrez G, 2009, CIR CIR, V77, P395; MARCUS ML, 1990, CIRCULATION, V82, P1, DOI 10.1161/01.CIR.82.1.1; Mekontso-Dessap A, 2006, CIRCULATION, V113, P81, DOI 10.1161/CIRCULATIONAHA.105.554667; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Ni W, 2008, BRIT J PHARMACOL, V154, P663, DOI 10.1038/bjp.2008.111; Nomura T, 1996, BRAIN RES, V735, P314, DOI 10.1016/0006-8993(96)00790-1; Qamirani E, 2005, ARTERIOSCL THROM VAS, V25, P995, DOI 10.1161/01.ATV.0000159890.10526.1e; SOLE MJ, 1979, CIRC RES, V45, P629, DOI 10.1161/01.RES.45.5.629; Takano S, 2004, J CARDIOVASC PHARM T, V9, P43, DOI 10.1177/107424840400900i107; Tiefenbacher CP, 1996, CIRCULATION, V94, P1423, DOI 10.1161/01.CIR.94.6.1423; Villalon CM, 2007, N-S ARCH PHARMACOL, V376, P45, DOI 10.1007/s00210-007-0179-1; Villeneuve C, 2009, AM J PHYSIOL-HEART C, V297, pH821, DOI 10.1152/ajpheart.00345.2009; Wang W, 2011, MICROCIRCULATION, V18, P36, DOI 10.1111/j.1549-8719.2010.00066.x; Watts SW, 2009, AM J PHYSIOL-REG I, V296, pR252, DOI 10.1152/ajpregu.90676.2008; Wei JF, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-21; Yabanoglu S, 2009, J MOL CELL CARDIOL, V46, P518, DOI 10.1016/j.yjmcc.2008.12.019; Zhang CH, 2001, FASEB J, V15, P1264, DOI 10.1096/fj.00-0681fje	31	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e34893	10.1371/journal.pone.0034893	http://dx.doi.org/10.1371/journal.pone.0034893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829864	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300002
J	Dorman, SR; Harvey, ES; Newman, SJ				Dorman, Stacey R.; Harvey, Euan S.; Newman, Stephen J.			Bait Effects in Sampling Coral Reef Fish Assemblages with Stereo-BRUVs	PLOS ONE			English	Article							HOUTMAN ABROLHOS ISLANDS; UNDERWATER VIDEO STATIONS; MARINE PROTECTED AREAS; SPATIAL VARIABILITY; HOOKING LOCATION; RELATIVE DENSITY; TEMPERATE; ABUNDANCE; HABITAT; COMMUNITY	Baited underwater video techniques are increasingly being utilised for assessing and monitoring demersal fishes because they are: 1) non extractive, 2) can be used to sample across multiple habitats and depths, 3) are cost effective, 4) sample a broader range of species than many other techniques, 5) and with greater statistical power. However, an examination of the literature demonstrates that a range of different bait types are being used. The use of different types of bait can create an additional source of variability in sampling programs. Coral reef fish assemblages at the Houtman Abrolhos Islands, Western Australia, were sampled using baited remote underwater stereo-video systems. One-hour stereo-video recordings were collected for four different bait treatments (pilchards, cat food, falafel mix and no bait (control)) from sites inside and outside a targeted fishery closure (TFC). In total, 5209 individuals from 132 fish species belonging to 41 families were recorded. There were significant differences in the fish assemblage structure and composition between baited and non-baited treatments (P<0.001), while no difference was observed with species richness. Samples baited with cat food and pilchards contained similar ingredients and were found to record similar components of the fish assemblage. There were no significant differences in the fish assemblages in areas open or closed to fishing, regardless of the bait used. Investigation of five targeted species indicated that the response to different types of bait was species-specific. For example, the relative abundance of Pagrus auratus was found to increase in areas protected from fishing, but only in samples baited with pilchards and cat food. The results indicate that the use of bait in conjunction with stereo-BRUVs is advantageous. On balance, the use of pilchards as a standardised bait for stereo-BRUVs deployments is justified for use along the mid-west coast of Western Australia.	[Dorman, Stacey R.; Harvey, Euan S.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Dorman, Stacey R.; Harvey, Euan S.] Univ Western Australia, UWA Oceans Inst M470, Perth, WA 6009, Australia; [Dorman, Stacey R.; Newman, Stephen J.] Govt Western Australia, Dept Fisheries, Western Australian Fisheries & Marine Res Labs, Perth, WA, Australia	University of Western Australia; University of Western Australia; Western Australian Fisheries & Marine Research Laboratories	Dorman, SR (corresponding author), Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia.	euan.harvey@uwa.edu.au	Harvey, Euan/B-2896-2011; Newman, Stephen/C-4507-2016	Harvey, Euan/0000-0002-9069-4581; Newman, Stephen/0000-0002-5324-5568	Department of Fisheries, Government of Western Australia; University of Western Australia	Department of Fisheries, Government of Western Australia; University of Western Australia	This research was funded by The Department of Fisheries, Government of Western Australia and a University of Western Australia Honour grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos J, 2009, FISH RES, V97, P270, DOI 10.1016/j.fishres.2009.03.003; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1987, DEV MORE EFFICIENT T; Archdale MV, 2008, FISH RES, V91, P291, DOI 10.1016/j.fishres.2007.12.005; Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Bailey DM, 2002, MAR BIOL, V141, P831, DOI 10.1007/s00227-002-0891-9; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Broadhurst MK, 2001, FISH RES, V53, P169, DOI 10.1016/S0165-7836(00)00297-6; Brooks EJ, 2001, ENDANGERED SPECIES R, V13, P231; Burdwick D, 2008, STATE CORAL REEF ECO; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2006, AUSTR SOC FISH BIOL, VVol. 1, P101, DOI DOI 10.1007/978-1-62703-724-2_1; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Charbonnel E, 2002, ICES J MAR SCI, V59, pS208, DOI 10.1006/jmsc.2002.1263; Chatfield BS, 2010, J BIOGEOGR, V37, P593, DOI 10.1111/j.1365-2699.2009.02246.x; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collins MA, 2002, ICES J MAR SCI, V59, P370, DOI 10.1006/jmsc.2001.1167; Cowx IG, 2004, FISHERIES MANAG ECOL, V11, P145, DOI 10.1111/j.1365-2400.2004.00411.x; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Gaughan DJ, 2001, REV FISH BIOL FISHER, V11, P113, DOI 10.1023/A:1015255900836; Grixti D, 2007, FISH RES, V84, P338, DOI 10.1016/j.fishres.2006.11.039; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Hasson KW, 2006, DIS AQUAT ORGAN, V71, P91, DOI 10.3354/dao071091; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; HOLBROOK SJ, 1994, AM ZOOL, V34, P463; Jaureguizar AJ, 2003, ESTUAR COAST SHELF S, V56, P921, DOI 10.1016/S0272-7714(02)00288-3; Jones JB, 1997, RISK ANAL PRACTICE I; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Langlois T., 2006, FISH NEWSL S PAC COM, P53; Lowry M, 2006, FISH RES, V78, P266, DOI 10.1016/j.fishres.2005.11.014; MacRae PSD, 2006, CAN J FISH AQUAT SCI, V63, P558, DOI 10.1139/f05-240; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Mclean DL, 2011, J EXP MAR BIOL ECOL, V406, P71, DOI 10.1016/j.jembe.2011.06.009; McLean DL, 2010, MAR ECOL PROG SER, V418, P189, DOI 10.3354/meps08834; MEFFE GK, 1988, AM MIDL NAT, V120, P225, DOI 10.2307/2425994; Monk J, 2011, CONT SHELF RES, V31, pS17, DOI 10.1016/j.csr.2010.02.012; Moore CH, 2011, ECOGRAPHY, V34, P425, DOI 10.1111/j.1600-0587.2010.06436.x; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; Moranta J, 2006, ESTUAR COAST SHELF S, V68, P579, DOI 10.1016/j.ecss.2006.03.008; MUNRO JL, 1974, J CONSEIL, V35, P337; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Nardi K, 2004, ENVIRON CONSERV, V31, P160, DOI 10.1017/S0376892904001274; NEWMAN SJ, 1990, THESIS J COOK U N QU; Newman SJ, 2011, REV FISH SCI, V19, P74, DOI 10.1080/10641262.2010.543961; Pearce A., 2011, MARINE HEAT WAVE W A; Priede IG, 1996, J FISH BIOL, V49, P207, DOI 10.1111/j.1095-8649.1996.tb06077.x; Pusey BJ, 2000, ECOL FRESHW FISH, V9, P30, DOI 10.1034/j.1600-0633.2000.90105.x; RSPCA, 2011, CAT FOOD MAD SAF; Saila SB, 2002, N AM J FISH MANAGE, V22, P602, DOI 10.1577/1548-8675(2002)022<0602:DLTBIT>2.0.CO;2; SAINTE-MARIE B, 1987, MAR BIOL, V94, P431, DOI 10.1007/BF00428250; SeaGIS, 2011, CAM CAL BUNDL ADJ; SeaGIS, 2011, 3 DIM STER MEAS VIS; SHEAVES MJ, 1995, B MAR SCI, V56, P475; Smith PA, 2002, FISHERIES MANAG ECOL, V9, P261, DOI 10.1046/j.1365-2400.2002.00311.x; Spencer ML, 2005, ESTUAR COAST SHELF S, V64, P497, DOI 10.1016/j.ecss.2005.03.012; Stewart BD, 2000, MAR ECOL PROG SER, V197, P259, DOI 10.3354/meps197259; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Stoner AW, 2008, J EXP MAR BIOL ECOL, V354, P202, DOI 10.1016/j.jembe.2007.11.008; Stoner AW, 2006, FISH RES, V81, P202, DOI 10.1016/j.fishres.2006.07.005; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Watson D. L., 2009, Journal of the Royal Society of Western Australia, V92, P147; Watson D.L, 2006, THESIS U W AUSTR; Watson DL, 2007, MAR BIOL, V152, P1197, DOI 10.1007/s00227-007-0767-0; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2009, MAR ECOL PROG SER, V384, P241, DOI 10.3354/meps08009; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Westerberg H, 2011, FISH RES, V110, P459, DOI 10.1016/j.fishres.2011.06.002; WHITELAW AW, 1991, AUST J MAR FRESH RES, V42, P369; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wraith J. A., 2007, ASSESSING REEF FISH; Zar JH, 1999, BIOSTATISTICAL ANAL	83	83	84	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41538	10.1371/journal.pone.0041538	http://dx.doi.org/10.1371/journal.pone.0041538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848522	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200069
J	Hu, GL; Huang, K; Yu, JH; Gopalakrishna-Pillai, S; Kong, J; Xu, H; Liu, ZS; Zhang, KS; Xu, J; Luo, YP; Li, SG; Sun, YE; Iverson, LE; Xue, ZG; Fan, GP				Hu, Ganlu; Huang, Kevin; Yu, Juehua; Gopalakrishna-Pillai, Sailesh; Kong, Jun; Xu, He; Liu, Zhenshan; Zhang, Kunshan; Xu, Jun; Luo, Yuping; Li, Siguang; Sun, Yi E.; Iverson, Linda E.; Xue, Zhigang; Fan, Guoping			Identification of miRNA Signatures during the Differentiation of hESCs into Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MICRORNA EXPRESSION; MACULAR DEGENERATION; MOLECULAR SIGNATURE; GENE-EXPRESSION; VISUAL FUNCTION; DICER; RPE; IMPACT	Retinal pigment epithelium (RPE) cells can be obtained through in vitro differentiation of both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). We have previously identified 87 signature genes relevant to RPE cell differentiation and function through transcriptome analysis of both human ESC- and iPSC-derived RPE as well as normal fetal RPE. Here, we profile miRNA expression through small RNA-seq in human ESCs and their RPE derivatives. Much like conclusions drawn from our previous transcriptome analysis, we find that the overall miRNA landscape in RPE is distinct from ESCs and other differentiated somatic tissues. We also profile miRNA expression during intermediate stages of RPE differentiation and identified unique subsets of miRNAs that are gradually up- or down-regulated, suggesting that dynamic regulation of these miRNAs is associated with the RPE differentiation process. Indeed, the down-regulation of a subset of miRNAs during RPE differentiation is associated with up- regulation of RPE-specific genes, such as RPE65, which is exclusively expressed in RPE. We conclude that miRNA signatures can be used to classify different degrees of in vitro differentiation of RPE from human pluripotent stem cells. We suggest that RPE-specific miRNAs likely contribute to the functional maturation of RPE in vitro, similar to the regulation of RPE-specific mRNA expression.	[Hu, Ganlu; Sun, Yi E.; Xue, Zhigang] Tongji Univ, Translat Ctr Stem Cell Res, Tongji Hosp, Sch Med, Shanghai 200092, Peoples R China; [Hu, Ganlu; Liu, Zhenshan; Zhang, Kunshan; Xu, Jun; Luo, Yuping; Li, Siguang; Sun, Yi E.; Xue, Zhigang; Fan, Guoping] Tongji Univ, Stem Cell Res Ctr, Dept Regenerat Med, Sch Med, Shanghai 200092, Peoples R China; [Huang, Kevin; Kong, Jun; Xu, He; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Gopalakrishna-Pillai, Sailesh; Iverson, Linda E.] Beckman Res Inst City Hope, Duarte, CA USA	Tongji University; Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; Beckman Research Institute of City of Hope	Hu, GL (corresponding author), Tongji Univ, Translat Ctr Stem Cell Res, Tongji Hosp, Sch Med, Shanghai 200092, Peoples R China.	Xuezhigang75@gmail.com; GFan@mednet.ucla.edu	Yu, Juehua/G-4596-2013	Fan, Guoping/0000-0001-5235-6410	Ministry of Science and Technology in China [2011CB965102, 2011CB966204, 2012CB966300]; International Science & Technology Cooperation Program of China, National Institutes of Health Grants [2011DFB30010]; California Institute for Regenerative Medicine [P01GM081621, R21NS072924, RC1-0111, TR1-272]; California Institute of Regenerative Medicine Training Grant [TG2-01169]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691, R21NS072924] Funding Source: NIH RePORTER	Ministry of Science and Technology in China(Ministry of Science and Technology, China); International Science & Technology Cooperation Program of China, National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); California Institute of Regenerative Medicine Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by 2011CB965102, 2011CB966204 and 2012CB966300 grants from the Ministry of Science and Technology in China, 2011DFB30010 from the International Science & Technology Cooperation Program of China, National Institutes of Health Grants P01GM081621 and R21NS072924, and RC1-0111 and TR1-272 from the California Institute for Regenerative Medicine. Kevin Huang and Juehua Yu are supported by a California Institute of Regenerative Medicine Training Grant (TG2-01169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Chung EJ, 2011, BIOCHEM BIOPH RES CO, V415, P367, DOI 10.1016/j.bbrc.2011.10.074; da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Gopalakrishna-Pillai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020663; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haruta Masathoshi, 2005, Semin Ophthalmol, V20, P17, DOI 10.1080/08820530590921846; Hirasawa M, 2011, MOL VIS, V17, P1222; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kokkinaki M, 2011, STEM CELLS, V29, P825, DOI 10.1002/stem.635; Kuipers H, 2010, J IMMUNOL, V185, P400, DOI 10.4049/jimmunol.0903912; Kutty RK, 2010, MOL VIS, V16, P1475; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856	34	34	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e37224	10.1371/journal.pone.0037224	http://dx.doi.org/10.1371/journal.pone.0037224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848339	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950200001
J	Lau, FH; Xia, F; Kaplan, A; Cerrato, F; Greene, AK; Taghinia, A; Cowan, CA; Labow, BI				Lau, Frank H.; Xia, Fang; Kaplan, Adam; Cerrato, Felecia; Greene, Arin K.; Taghinia, Amir; Cowan, Chad A.; Labow, Brian I.			Expression Analysis of Macrodactyly Identifies Pleiotrophin Upregulation	PLOS ONE			English	Article							GROWTH-FACTOR; DIVERSE FUNCTIONS; GENE-EXPRESSION; BREAST-CANCER; PROTEIN; BRAIN; CELLS	Macrodactyly is a rare family of congenital disorders characterized by the diffuse enlargement of 1 or more digits. Multiple tissue types within the affected digits are involved, but skeletal patterning and gross morphological features are preserved. Not all tissues are equally involved and there is marked heterogeneity with respect to clinical phenotype. The molecular mechanisms responsible for these growth disturbances offer unique insight into normal limb growth and development, in general. To date, no genes or loci have been implicated in the development of macrodactyly. In this study, we performed the first transcriptional profiling of macrodactyly tissue. We found that pleiotrophin (PTN) was significantly overexpressed across all our macrodactyly samples. The mitogenic functions of PTN correlate closely with the clinical characteristics of macrodactyly. PTN thus represents a promising target for further investigation into the etiology of overgrowth phenotypes.	[Lau, Frank H.; Xia, Fang; Kaplan, Adam; Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Lau, Frank H.; Xia, Fang; Kaplan, Adam; Cowan, Chad A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Cerrato, Felecia; Greene, Arin K.; Taghinia, Amir; Labow, Brian I.] Childrens Hosp Boston, Dept Plast & Oral Surg, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital	Lau, FH (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	Brian.labow@childrens.harvard.edu						Akinci M, 2004, J HAND SURG-AM, V29A, P1010, DOI 10.1016/j.jhsa.2004.07.004; APPENZELLER O, 1974, NEUROLOGY, V24, P767, DOI 10.1212/WNL.24.8.767; Azizan A, 2000, MATRIX BIOL, V19, P521, DOI 10.1016/S0945-053X(00)00110-4; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Ben-Bassat M, 1966, J Bone Joint Surg Br, V48, P359; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; FANG WJ, 1992, J BIOL CHEM, V267, P25889; Gu DY, 2007, FEBS LETT, V581, P382, DOI 10.1016/j.febslet.2006.12.043; Imai S, 2009, BONE, V44, P785, DOI 10.1016/j.bone.2009.01.004; Kretschmer P J, 1991, Growth Factors, V5, P99, DOI 10.3109/08977199109000275; Li G, 2006, J BIOL CHEM, V281, P10663, DOI 10.1074/jbc.M512509200; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; McCombe D, MACRODACTYLY GREENS; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; Moore BH, J BONE JOINT SURG AM, V24, P617; Orr B, 2011, PROSTATE, V71, P305, DOI 10.1002/pros.21244; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Plaisier CL, 2009, ARTERIOSCL THROM VAS, V29, P147, DOI 10.1161/ATVBAHA.108.178533; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Relf M, 1997, CANCER RES, V57, P963; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; Upton J, PLASTIC SURG, V8, P20; Upton J, 2006, PLASTIC SURG, V8, P277; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; WIEDEMANN HR, 1983, EUR J PEDIATR, V140, P5, DOI 10.1007/BF00661895; Zhang N, 2006, BIOCHEM BIOPH RES CO, V343, P653, DOI 10.1016/j.bbrc.2006.03.006	32	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40423	10.1371/journal.pone.0040423	http://dx.doi.org/10.1371/journal.pone.0040423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848377	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200019
J	Latif, AA; Putterill, JF; de Klerk, DG; Pienaar, R; Mans, BJ				Latif, Abdalla A.; Putterill, John F.; de Klerk, Daniel G.; Pienaar, Ronel; Mans, Ben J.			Nuttalliella namaqua (Ixodoidea: Nuttalliellidae): First Description of the Male, Immature Stages and Re-Description of the Female	PLOS ONE			English	Article							TICKS; ACARI; MORPHOLOGY; IXODIDAE; REDESCRIPTION; ARGASIDAE	Nuttalliella namaqua is the only species of the enigmatic third tick family. Females possess features of hard and soft ticks and have been designated as the "missing link'' between the main tick families. Its position at the base of the tick tree suggests that some of the features unique to hard and soft ticks were present in the ancestral tick lineage. Larvae, nymphae and males have not been described to date and questions regarding their biological affinities to the main tick families remain unclear. The current study addressed these questions via the description of larvae, nymphae and males and resolved issues pertaining to female morphology. Field collected as well as laboratory-engorged females laid eggs and viable larvae subsequently hatched. The larvae possess morphological structures not present in subsequent stages: namely, a sclerotized scutum, pores on the dorsal surface of legs and a dentate anal plate. The last two characters are not present in ixodids and argasids. N. namaqua larvae and nymphae show a similar morphology to females: a unique hypostomal structure i.e., bluntly rounded apically in nymphae and females and ball-like in the larvae. A re-description of some structures in female N. namaqua has resolved differences in the original descriptions, namely that N. namaqua have 4 palpal segments as found in ixodids and argasids and posthypostomal setae. The male was discovered for the first time and described. Characteristic male features include: a pseudoscutum over most of the dorsum, an outgrowth on the chelicerae forming a unique rod-like structure similar to a spematodactyl in mites and medial extension of palpal segment 2 forming a large ventral crib for segment 4. All life stages possess some features found in hard and soft ticks and its status as the "missing link'' between the tick families remains.	[Latif, Abdalla A.; Putterill, John F.; de Klerk, Daniel G.; Pienaar, Ronel; Mans, Ben J.] Onderstepoort Vet Inst, Agr Res Council, Parasites Vectors & Vector Borne Dis Programme, Onderstepoort, South Africa; [Latif, Abdalla A.; Mans, Ben J.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa	Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria	Latif, AA (corresponding author), Onderstepoort Vet Inst, Agr Res Council, Parasites Vectors & Vector Borne Dis Programme, Onderstepoort, South Africa.	latifa@arc.agric.za	Pienaar, Ronel/T-6705-2018; Mans, Ben J./M-2427-2017	Pienaar, Ronel/0000-0002-9096-0237; Mans, Ben J./0000-0002-0177-0029; Latif, Abdalla/0000-0003-3138-3975	Joy Liebenberg Trust [21/19/JT02]; South African National Research Foundation	Joy Liebenberg Trust; South African National Research Foundation(National Research Foundation - South Africa)	This project was funded by the Joy Liebenberg Trust (21/19/JT02) allocated to BM, a South African National Research Foundation grant allocated to AL (NRF-Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashov YS., 1972, MISCELLANEOUS PUBLIC, V8, P268; BEDFORD G. A. H., 1931, PARASITOLOGY, V23, P230, DOI 10.1017/S0031182000013573; Coons Lewis B., 1999, P267; CORWIN D, 1979, J MED ENTOMOL, V16, P352, DOI 10.1093/jmedent/16.4.352; ELSHOURA SM, 1984, J PARASITOL, V70, P114; ELSHOURA SM, 1990, ACAROLOGIA, V31, P349; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; HOOGSTRAAL H, 1985, ADV PARASIT, V24, P135, DOI 10.1016/S0065-308X(08)60563-1; Horak IG, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i1.405; KEIRANS JE, 1976, ANN ENTOMOL SOC AM, V69, P926, DOI 10.1093/aesa/69.5.926; Klompen JSH, 1997, SYST PARASITOL, V38, P1, DOI 10.1023/A:1005815925466; Mans BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023675; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; OLIVER JH, 1989, ANNU REV ECOL SYST, V20, P397, DOI 10.1146/annurev.es.20.110189.002145; ROSHDY MA, 1983, Z PARASITENKD, V69, P817, DOI 10.1007/BF00927431; Sonenshine DE, 1991, BIOL TICKS, V1; Walter D, 1999, MITES ECOLOGY EVOLUT, P57	17	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41651	10.1371/journal.pone.0041651	http://dx.doi.org/10.1371/journal.pone.0041651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844508	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600037
J	Cheke, LG; Loissel, E; Clayton, NS				Cheke, Lucy G.; Loissel, Elsa; Clayton, Nicola S.			How Do Children Solve Aesop's Fable?	PLOS ONE			English	Article							OVER-IMITATION; CAUSAL; COVARIATION; CONTIGUITY; KNOWLEDGE	Studies on members of the crow family using the "Aesop's Fable" paradigm have revealed remarkable abilities in these birds, and suggested a mechanism by which associative learning and folk physics may interact when learning new problems. In the present study, children between 4 and 10 years of age were tested on the same tasks as the birds. Overall the performance of the children between 5-7-years was similar to that of the birds, while children from 8-years were able to succeed in all tasks from the first trial. However the pattern of performance across tasks suggested that different learning mechanisms might be being employed by children than by adult birds. Specifically, it is possible that in children, unlike corvids, performance is not affected by counter-intuitive mechanism cues.	[Cheke, Lucy G.; Loissel, Elsa; Clayton, Nicola S.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Cheke, LG (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	nsc22@cam.ac.uk		Loissel, Elsa/0000-0002-1272-7448; Cheke, Lucy/0000-0001-5588-7575; Clayton, Nicola/0000-0003-1835-423X				Baraff-Bonawitz E, 2010, COGNITION, V115, P104; Beck SR, 2011, COGNITION, V119, P301, DOI 10.1016/j.cognition.2011.01.003; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; BULLOCK M, 1984, BRIT J DEV PSYCHOL, V2, P139, DOI 10.1111/j.2044-835X.1984.tb00777.x; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; Hanus D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019555; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Jaswal VK, 2010, COGNITIVE PSYCHOL, V61, P248, DOI 10.1016/j.cogpsych.2010.06.002; KOSLOWSKI B, 1989, CHILD DEV, V60, P1316, DOI 10.2307/1130923; McGuigan N, 2011, BRIT J PSYCHOL, V102, P1, DOI 10.1348/000712610X493115; MENDELSON R, 1976, J EXP CHILD PSYCHOL, V22, P408, DOI 10.1016/0022-0965(76)90104-1; Piaget J., 1974, UNDERSTANDING CAUSAL; Piaget J, 1955, CHILDS CONSTRUCTION, Vxiii; Piaget J, 1930, CHILDS CONCEPTION PH; ROSE SA, 1974, CHILD DEV, V45, P499, DOI 10.2307/1127977; Schlottmann A, 2001, CURR DIR PSYCHOL SCI, V10, P111, DOI 10.1111/1467-8721.00128; Schlottmann A, 1999, DEV PSYCHOL, V35, P303, DOI 10.1037/0012-1649.35.1.303; SHULTZ TR, 1975, CHILD DEV, V46, P394; SIEGLER RS, 1975, J EXP CHILD PSYCHOL, V20, P512, DOI 10.1016/0022-0965(75)90123-X; SIEGLER RS, 1974, DEV PSYCHOL, V10, P574, DOI 10.1037/h0036594; Sobel DM, 2006, DEV PSYCHOL, V42, P1103, DOI 10.1037/0012-1649.42.6.1103; Taylor AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026887; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Wu R, 2011, DEV PSYCHOL, V47, P1220, DOI 10.1037/a0024023	26	25	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40574	10.1371/journal.pone.0040574	http://dx.doi.org/10.1371/journal.pone.0040574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979GX	22848384	gold, Green Published			2022-12-27	WOS:000306806600020
J	Esser, PR; Wolfle, U; Durr, C; von Loewenich, FD; Schempp, CM; Freudenberg, MA; Jakob, T; Martin, SF				Esser, Philipp R.; Woelfle, Ute; Duerr, Christoph; von Loewenich, Friederike D.; Schempp, Christoph M.; Freudenberg, Marina A.; Jakob, Thilo; Martin, Stefan F.			Contact Sensitizers Induce Skin Inflammation via ROS Production and Hyaluronic Acid Degradation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; ADAPTIVE IMMUNE-RESPONSES; LYMPH-NODE DATA; REACTIVE OXYGEN; DENDRITIC CELLS; DANGER SIGNAL; T-CELLS; LUNG INJURY; INNATE; HYPERSENSITIVITY	Background: Allergic contact dermatitis (ACD) represents a severe health problem with increasing worldwide prevalence. It is a T cell-mediated skin disease induced by protein-reactive organic and inorganic chemicals. A key feature of contact allergens is their ability to trigger an innate immune response that leads to skin inflammation. Previous evidence from the mouse contact hypersensitivity (CHS) model suggests a role for endogenous activators of innate immune signaling. Here, we analyzed the role of contact sensitizer induced ROS production and concomitant changes in hyaluronic acid metabolism on CHS responses. Methodology/Principal Findings: We analyzed in vitro and in vivo ROS production using fluorescent ROS detection reagents. HA fragmentation was determined by gel electrophoresis. The influence of blocking ROS production and HA degradation by antioxidants, hyaluronidase-inhibitor or p38 MAPK inhibitor was analyzed in the murine CHS model. Here, we demonstrate that organic contact sensitizers induce production of reactive oxygen species (ROS) and a concomitant breakdown of the extracellular matrix (ECM) component hyaluronic acid (HA) to pro-inflammatory low molecular weight fragments in the skin. Importantly, inhibition of either ROS-mediated or enzymatic HA breakdown prevents sensitization as well as elicitation of CHS. Conclusions/Significance: These data identify an indirect mechanism of contact sensitizer induced innate inflammatory signaling involving the breakdown of the ECM and generation of endogenous danger signals. Our findings suggest a beneficial role for anti-oxidants and hyaluronidase inhibitors in prevention and treatment of ACD.	[Esser, Philipp R.; Jakob, Thilo; Martin, Stefan F.] Univ Freiburg, Med Ctr, Allergy Res Grp, Freiburg, Germany; [Woelfle, Ute; Schempp, Christoph M.] Univ Freiburg, Med Ctr, Competence Ctr Skintegral, Dept Dermatol, Freiburg, Germany; [Duerr, Christoph] Univ Freiburg, Med Ctr, Dept Haematol & Oncol, Freiburg, Germany; [von Loewenich, Friederike D.] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany; [Freudenberg, Marina A.] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society	Esser, PR (corresponding author), Univ Freiburg, Med Ctr, Allergy Res Grp, Freiburg, Germany.	philipp.esser@uniklinik-freiburg.de; stefan.martin@uniklinik-freiburg.de	Wölfle, Ute/AAG-6972-2021; Jakob, Thilo/J-1621-2012; Loewenich, Friederike/AAL-1587-2020; Esser, Philipp/F-6849-2011	Wölfle, Ute/0000-0003-0093-560X; Esser, Philipp/0000-0002-7379-9699; Freudenberg, Marina Alexandra/0000-0001-5894-1805	European Commission [LSHB-CT-2005-018681]; German Federal Ministry of Economics and Technology [KF2556501SK0]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi))	This work was supported in part by a grant of the European Commission as part of the project "Novel Testing Strategies for In Vitro Assessment of Allergens (Sens-it-iv)", LSHB-CT-2005-018681 (Dr. Martin) and by a grant from the German Federal Ministry of Economics and Technology, grant no. KF2556501SK0 (Dr. Schempp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Campo GM, 2010, INNATE IMMUN-LONDON, V16, P48, DOI 10.1177/1753425909340419; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; Casetti F, 2009, J PHOTOCH PHOTOBIO B, V96, P260, DOI 10.1016/j.jphotobiol.2009.07.003; DELMAGE JM, 1986, ANN CLIN LAB SCI, V16, P303; Eberlein M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-20; Freudenberg MA, 2009, GIORN ITAL DERMAT V, V144, P173; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; GUNTENHONER MW, 1992, MATRIX, V12, P388, DOI 10.1016/S0934-8832(11)80035-1; Jeong E, 2011, YONSEI MED J, V52, P379, DOI [10.3349/ymj.2011.52.3.379, 10.3349/ymj.2011.52.3.429]; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Docampo MJ, 2011, VET DERMATOL, V22, P535, DOI 10.1111/j.1365-3164.2011.00986.x; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038; Kimber I, 2002, CONTACT DERMATITIS, V46, P1, DOI 10.1034/j.1600-0536.2002.460101.x; Klekotka PA, 2010, J INVEST DERMATOL, V130, P184, DOI 10.1038/jid.2009.242; Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z; Kwangmin N, 2007, J INVEST DERMATOL, V127, P1930, DOI 10.1038/sj.jid.5700802; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lembo A, 2003, INFECT IMMUN, V71, P6058, DOI 10.1128/IAI.71.10.6058-6062.2003; Lin WQ, 1997, J HISTOCHEM CYTOCHEM, V45, P1157, DOI 10.1177/002215549704500813; Liu AQ, 2005, BLOOD, V105, P1606, DOI 10.1182/blood-2004-06-2406; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Martin SF, 2004, J IMMUNOL, V173, P3178, DOI 10.4049/jimmunol.173.5.3178; Martin SF, 2004, INT ARCH ALLERGY IMM, V134, P186, DOI 10.1159/000078765; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9; Martin SF, 2010, CELL MOL LIFE SCI, V67, P4171, DOI 10.1007/s00018-010-0495-3; Mehrotra P, 2005, TOXICOL MECH METHOD, V15, P343, DOI 10.1080/15376520500191490; Mizuashi M, 2005, J INVEST DERMATOL, V124, P579, DOI 10.1111/j.0022-202X.2005.23624.x; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Nusgens BV, 2010, ANN DERMATOL VENER, V137, pS3, DOI 10.1016/S0151-9638(10)70002-8; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Powell JD, 2005, IMMUNOL RES, V31, P207, DOI 10.1385/IR:31:3:207; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P131; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Woelfle U, 2010, PHYTOTHER RES, V24, P1033, DOI 10.1002/ptr.3069; Wolfle U, 2011, FREE RADICAL BIO MED, V50, P1081, DOI 10.1016/j.freeradbiomed.2011.01.027; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Yamazaki K, 2003, ARTHRITIS RHEUM, V48, P3151, DOI 10.1002/art.11305; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	64	129	133	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41340	10.1371/journal.pone.0041340	http://dx.doi.org/10.1371/journal.pone.0041340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848468	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600054
J	Zhong, L; Gerges, NZ				Zhong, Ling; Gerges, Nashaat Z.			Neurogranin Targets Calmodulin and Lowers the Threshold for the Induction of Long-Term Potentiation	PLOS ONE			English	Article							HYPOTHYROIDISM-INDUCED IMPAIRMENT; KINASE-C SUBSTRATE; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITIES; MESSENGER-RNA; PROTEIN; PHOSPHORYLATION; MEMORY; TRANSLOCATION; EXPRESSION	Calcium entry and the subsequent activation of CaMKII trigger synaptic plasticity in many brain regions. The induction of long-term potentiation (LTP) in the CA1 region of the hippocampus requires a relatively high amount of calcium-calmodulin. This requirement is usually explained, based on in vitro and theoretical studies, by the low affinity of CaMKII for calmodulin. An untested hypothesis, however, is that calmodulin is not randomly distributed within the spine and its targeting within the spine regulates LTP. We have previously shown that overexpression of neurogranin enhances synaptic strength in a calmodulin-dependent manner. Here, using post-embedding immunogold labeling, we show that calmodulin is not randomly distributed, but spatially organized in the spine. Moreover, neurogranin regulates calmodulin distribution such that its overexpression concentrates calmodulin closer to the plasma membrane, where a high level of CaMKII immunogold labeling is also found. Interestingly, the targeting of calmodulin by neurogranin results in lowering the threshold for LTP induction. These findings highlight the significance of calmodulin targeting within the spine in synaptic plasticity.	[Zhong, Ling; Gerges, Nashaat Z.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Zhong, L (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	ngerges@mcw.edu			Alzheimer's Association; United States National Institute on Aging [AG032320]; NATIONAL INSTITUTE ON AGING [R01AG032320] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); United States National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Alzheimer's Association and the United States National Institute on Aging (AG032320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKON DL, 1990, FASEB J, V4, P1567, DOI 10.1096/fasebj.4.6.2108074; Alzoubi KH, 2006, HIPPOCAMPUS, V16, P861, DOI 10.1002/hipo.20217; Alzoubi KH, 2005, EXP NEUROL, V195, P330, DOI 10.1016/j.expneurol.2005.05.007; BAUDIER J, 1991, J BIOL CHEM, V266, P229; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; CACERES A, 1983, NEUROSCIENCE, V10, P449, DOI 10.1016/0306-4522(83)90145-8; CARLIN RK, 1981, J CELL BIOL, V89, P449, DOI 10.1083/jcb.89.3.449; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Coldren CD, 2009, NEUROGENETICS, V10, P89, DOI 10.1007/s10048-008-0157-x; Craske H, 1999, P NATL ACAD SCI USA, V96, P4426, DOI 10.1073/pnas.96.8.4426; d'Alcantara P, 2003, EUR J NEUROSCI, V17, P2521, DOI 10.1046/j.1460-9568.2003.02693.x; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dominguez-Gonzalez I, 2007, BIOCHEM J, V404, P31, DOI 10.1042/BJ20061483; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; George AJ, 2010, NEUROTOX RES, V17, P360, DOI 10.1007/s12640-009-9112-3; Gerendasy D, 1999, J NEUROSCI RES, V58, P107, DOI 10.1002/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Grab D J, 1980, Ann N Y Acad Sci, V356, P55, DOI 10.1111/j.1749-6632.1980.tb29599.x; GRAB DJ, 1979, J BIOL CHEM, V254, P8690; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Kaleka KS, 2012, JOVE-J VIS EXP, DOI 10.3791/3502; Krazem A, 2003, BEHAV BRAIN RES, V147, P17, DOI 10.1016/S0166-4328(03)00113-X; Krazem A, 2003, NEUROSCI LETT, V338, P62, DOI 10.1016/S0304-3940(02)01337-X; Krucker T, 2002, J NEUROSCI, V22, P5525; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Malinow R, 1999, INTRO GREEN FLUORESC; MARTZEN MR, 1995, J NEUROCHEM, V64, P92; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; NeunerJehle M, 1996, BRAIN RES, V733, P149, DOI 10.1016/0006-8993(96)00786-X; O'Connell DJ, 2010, MOL CELL PROTEOMICS, V9, P1118, DOI 10.1074/mcp.M900324-MCP200; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Pohlack ST, 2011, MOL PSYCHIATR, V16, P1072, DOI 10.1038/mp.2011.66; Prichard L, 1999, J BIOL CHEM, V274, P7689, DOI 10.1074/jbc.274.12.7689; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Ruano D, 2008, J PSYCHIATR RES, V42, P125, DOI 10.1016/j.jpsychires.2006.10.008; Shen YC, 2012, SCHIZOPHR RES; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; WATSON JB, 1992, P NATL ACAD SCI USA, V89, P8581, DOI 10.1073/pnas.89.18.8581; Zhabotinsky AM, 2006, J NEUROSCI, V26, P7337, DOI 10.1523/JNEUROSCI.0729-06.2006; Zhong L, 2011, EUR J NEUROSCI, V33, P244, DOI 10.1111/j.1460-9568.2010.07506.x; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236	55	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41275	10.1371/journal.pone.0041275	http://dx.doi.org/10.1371/journal.pone.0041275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848456	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600048
J	Barchiesi, G; Wache, S; Cattaneo, L				Barchiesi, Guido; Wache, Susan; Cattaneo, Luigi			The Frames of Reference of the Motor-Visual Aftereffect	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; USE-DEPENDENT PLASTICITY; MIRROR NEURON SYSTEM; SEMANTIC SATIATION; REPRESENTATION; TRANSFORMATION; MECHANISMS; SIMULATION; MOVEMENTS	Repeatedly performing similar motor acts produces short-term adaptive changes in the agent's motor system. One striking use-dependent effect is the motor-to-visual aftereffect (MVA), a short-lasting negative bias in the conceptual categorization of visually-presented training-related motor behavior. The MVA is considered the behavioral counterpart of the adaptation of visuomotor neurons that code for congruent executed and observed motor acts. Here we characterize which features of the motor training generate the MVA, along 3 main dimensions: a) the relative role of motor acts vs. the semantics of the task-set; b) the role of muscular-specific vs. goal-specific training and c) the spatial frame of reference with respect to the whole body. Participants were asked to repeatedly push or pull some small objects in a bowl as we varied different components of adapting actions across three experiments. The results show that a) the semantic value of the instructions given to the participant have no role in generating the MVA, which depends only on the motor meaning of the training act; b) both intrinsic body movements and extrinsic action goals contribute simultaneously to the genesis of the MVA and c) changes in the relative position of the acting hand compared to the observed hand, when they do not involve changes to the movement performed or to the action meaning, do not have an effect on the MVA. In these series of experiments we confirm that recent motor experiences produce measurable changes in how humans see each others' actions. The MVA is an exquisite motor effect generated by two distinct motor sub-systems, one operating in an intrinsic, muscular specific, frame of reference and the other operating in an extrinsic motor space.	[Barchiesi, Guido; Wache, Susan; Cattaneo, Luigi] Univ Trent, CIMeC, Ctr Mind Brain Sci, Trento, Italy	University of Trento	Barchiesi, G (corresponding author), Univ Trent, CIMeC, Ctr Mind Brain Sci, Trento, Italy.	luigi.cattaneo@unitn.it	Barchiesi, Guido/K-3857-2015	Barchiesi, Guido/0000-0002-8936-4171; Cattaneo, Luigi/0000-0001-8905-7529	Fondazione Cassa di Risparmio di Trento e Rovereto; Provincia Autonoma di Trento	Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro); Provincia Autonoma di Trento(Autonomous Province of Trento)	The present work has been realized thanks to the financial support of the Fondazione Cassa di Risparmio di Trento e Rovereto and of the Provincia Autonoma di Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P415, DOI 10.1016/j.neuropsychologia.2008.09.012; Arevalo AL, 2012, CORTEX, V48, P242, DOI 10.1016/j.cortex.2010.06.001; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Balota DA, 1997, MEM COGNITION, V25, P190, DOI 10.3758/BF03201112; Black SR, 2001, AM J PSYCHOL, V114, P493, DOI 10.2307/1423607; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Cantarero G, 2011, J COGNITIVE NEUROSCI, V23, P3757, DOI 10.1162/jocn_a_00051; Cattaneo L, 2011, SOC COGN AFFECT NEUR, V6, P301, DOI 10.1093/scan/nsq099; Cattaneo L, 2009, J NEUROSCI, V29, P11134, DOI 10.1523/JNEUROSCI.2605-09.2009; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Glenberg AM, 2008, CURR BIOL, V18, pR290, DOI 10.1016/j.cub.2008.02.036; Glenberg AM, 2010, FRONT HUM NEUROSCI, V4, DOI [10.3389/fnhum.2010.00204, 10.3389/fnhum.2010.00206]; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kounios J, 2000, MEM COGNITION, V28, P1366, DOI 10.3758/BF03211837; Kurata K, 2002, J NEUROPHYSIOL, V88, P3118, DOI 10.1152/jn.00070.2002; Kurata K, 2007, J NEUROPHYSIOL, V98, P2008, DOI 10.1152/jn.00149.2007; Negri GAL, 2007, COGN NEUROPSYCHOL, V24, P795, DOI 10.1080/02643290701707412; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; Pobric G, 2006, CURR BIOL, V16, P524, DOI 10.1016/j.cub.2006.01.033; Sato M, 2011, CORTEX, V47, P1001, DOI 10.1016/j.cortex.2011.03.009; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; SMITH LC, 1984, MEM COGNITION, V12, P483, DOI 10.3758/BF03198310; Stefan K, 2008, EUR J NEUROSCI, V27, P730, DOI 10.1111/j.1460-9568.2008.06035.x; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; World Medical Association, 2008, WORLD MED J, V54, P122	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40892	10.1371/journal.pone.0040892	http://dx.doi.org/10.1371/journal.pone.0040892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22848406	Green Published, gold			2022-12-27	WOS:000306687700022
J	de Jong, HJI; Saldi, SRF; Klungel, OH; Vandebriel, RJ; Souverein, PC; Meyboom, RHB; Passier, JLM; van Loveren, H; Tervaert, JWC				de Jong, Hilda J. I.; Saldi, Siti R. F.; Klungel, Olaf H.; Vandebriel, Rob J.; Souverein, Patrick C.; Meyboom, Ronald H. B.; Passier, J. L. M. (Anneke); van Loveren, Henk; Tervaert, Jan Willem Cohen			Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach	PLOS ONE			English	Article							VITAMIN-D; MYOPATHY; MYALGIAS	Objective: To assess whether there is an association between statin use and the occurrence of polymyalgia rheumatic (PMR) in the spontaneous reporting database of the World Health Organisation (WHO). Methods: We conducted a case/non-case study based on individual case safety reports (ICSR) in the WHO global ICSR database (VigiBase). Case reports containing the adverse event term polymyalgia rheumatica (WHOART or MedDRA Preferred Term) were defined as cases. Non-cases were all case reports containing other adverse event terms. Each case was matched to five non-cases by age, gender, and time of reporting. Case reports regarding a statin as suspected or concomitant drug were identified using the Anatomical Therapeutic Chemical (ATC) classification. Multivariate logistic regression was used to calculate reporting odds ratios (RORs) with 95% confidence intervals (CI). Results: We identified 327 reports of PMR as cases and 1635 reports of other ADRs as non-cases. Among cases, statins were more frequently reported as suspected agent (29.4%) compared to non-cases (2.9%). After adjustment for several covariates, statins were significantly associated with reports of PMR (ROR 14.21; 95% CI 9.89-20.85). Conclusion: The results of this study lends support to previous anecdotal case reports in the literature suggesting that the use of a statin may be associated with the occurrence of PMR. Further studies are needed to study the strength of the association in more detail and to elucidate the underlying mechanism.	[de Jong, Hilda J. I.; Vandebriel, Rob J.; van Loveren, Henk] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [de Jong, Hilda J. I.; van Loveren, Henk] Maastricht Univ, Med Ctr, Dept Toxicogen, Maastricht, Netherlands; [de Jong, Hilda J. I.; Saldi, Siti R. F.; Klungel, Olaf H.; Souverein, Patrick C.; Meyboom, Ronald H. B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol,Fac Sci, Utrecht, Netherlands; [Meyboom, Ronald H. B.] World Hlth Org Collaborating Ctr Int Drug Monitor, Uppsala Monitoring Ctr, Uppsala, Sweden; [Passier, J. L. M. (Anneke)] Netherlands Pharmacovigilance Ctr Lareb, Shertogenbosch, Netherlands; [Tervaert, Jan Willem Cohen] Maastricht Univ, Med Ctr, Dept Internal Med, Div Clin & Expt Immunol, Maastricht, Netherlands	Netherlands National Institute for Public Health & the Environment; Maastricht University; Utrecht University; World Health Organization; Maastricht University	de Jong, HJI (corresponding author), Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands.	jw.cohentervaert@maastrichtuniversity.nl	tervaert, jan willem cohen/AAB-1111-2019; Vandebriel, Rob/P-6769-2019	Vandebriel, Rob/0000-0001-9140-952X; Passier, Anneke/0000-0001-5594-6360; Souverein, Patrick/0000-0002-7452-0477; Saldi, Siti Rizny Fitriana/0000-0002-5960-5616; de Jong, Hilda/0000-0002-4112-7572	National Institute for Public Health and the Environment [S340040]; GlaxoSmithKline; Novo Nordisk; Dutch Medicines Evaluation Board	National Institute for Public Health and the Environment; GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Dutch Medicines Evaluation Board	Funding for this study was obtained from the National Institute for Public Health and the Environment (project S340040). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, employing authors HJI de Jong, SRF Saldi, OH Klungel, PC Souverein and RHB Meyboom has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, private-public funded Top Institute Pharma (www.tipharma.nl and includes co-funding from universities, government and industry) and the Dutch Medicines Evaluation Board. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahmed W, 2009, TRANSL RES, V153, P11, DOI 10.1016/j.trsl.2008.11.002; Arnaud C, 2005, TRENDS CARDIOVAS MED, V15, P202, DOI 10.1016/j.tcm.2005.07.002; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bell DSH, 2010, SOUTH MED J, V103, P690, DOI 10.1097/SMJ.0b013e3181e21088; Christopher-Stine L, 2010, ARTHRITIS RHEUM-US, V62, P2757, DOI 10.1002/art.27572; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; de Jong HJI, 2012, ANN RHEUM DIS, V71, P648, DOI 10.1136/ard.2011.155622; de Jong HJI, 2011, SEMIN ARTHRITIS RHEU, V41, P373, DOI 10.1016/j.semarthrit.2011.06.002; Dedeoglu F, 2009, CURR OPIN RHEUMATOL, V21, P547, DOI 10.1097/BOR.0b013e32832f13db; Duell PB, 2008, CIRCULATION, V118, pS470; Goeb V, 2004, CLIN RHEUMATOL, V23, P179, DOI 10.1007/s10067-003-0772-8; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Grable-Esposito P, 2010, MUSCLE NERVE, V41, P185, DOI 10.1002/mus.21486; GREENLAND S, 1985, AM J EPIDEMIOL, V122, P495, DOI 10.1093/oxfordjournals.aje.a114131; Gupta A, 2011, ATHEROSCLEROSIS, V215, P23, DOI 10.1016/j.atherosclerosis.2010.11.039; Haroon Muhammad, 2008, Clin Rheumatol, V27 Suppl 2, pS75, DOI 10.1007/s10067-008-1020-z; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Kay Jonathan, 2006, N Engl J Med, V354, P623; Lee P, 2009, CLIN ENDOCRINOL, V71, P154, DOI 10.1111/j.1365-2265.2008.03448.x; Lindquist M, 2008, DRUG INF J, V42, P409, DOI 10.1177/009286150804200501; LUMLEY C E, 1986, Pharmaceutical Medicine (London), V1, P205; Martin RM, 1998, BRIT MED J, V317, P119, DOI 10.1136/bmj.317.7151.119; Noel B, 2007, J EUR ACAD DERMATOL, V21, P17, DOI 10.1111/j.1468-3083.2006.01838.x; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rudski L, 1998, MEDICINE, V77, P378, DOI 10.1097/00005792-199811000-00002; SALVARANI C, 1995, ARTHRITIS RHEUM, V38, P369, DOI 10.1002/art.1780380311; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Samanta A., 2002, Rheumatology (Oxford), V41, P1455, DOI 10.1093/rheumatology/41.12.1455; Sen D, 2010, INT J RHEUM DIS, V13, pe29, DOI 10.1111/j.1756-185X.2010.01481.x; Smeeth L, 2006, ANN RHEUM DIS, V65, P1093, DOI 10.1136/ard.2005.046912; Smolders J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015235; *WHO COLL CTR DRUG, 1999, GUID ATC CLASS DDD A; Wilson AM, 2004, BRIT J CLIN PHARMACO, V57, P127, DOI 10.1046/j.1365-2125.2003.01968.x	36	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41289	10.1371/journal.pone.0041289	http://dx.doi.org/10.1371/journal.pone.0041289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844450	gold, Green Published			2022-12-27	WOS:000306687700062
J	Lerner, I; Bentin, S; Shriki, O				Lerner, Itamar; Bentin, Shlomo; Shriki, Oren			Excessive Attractor Instability Accounts for Semantic Priming in Schizophrenia	PLOS ONE			English	Article							WORKING-MEMORY DYSFUNCTION; WORD PRONUNCIATION; NEURAL-NETWORKS; MODEL; ACTIVATION; DOPAMINE; THOUGHT; NEURONS; TIME; IMPAIRMENT	One of the most pervasive findings in studies of schizophrenics with thought disorders is their peculiar pattern of semantic priming, which presumably reflects abnormal associative processes in the semantic system of these patients. Semantic priming is manifested by faster and more accurate recognition of a word-target when preceded by a semantically related prime, relative to an unrelated prime condition. Compared to control, semantic priming in schizophrenics is characterized by reduced priming effects at long prime-target Stimulus Onset Asynchrony (SOA) and, sometimes, augmented priming at short SOA. In addition, unlike controls, schizophrenics consistently show indirect (mediated) priming (such as from the prime 'wedding' to the target 'finger', mediated by 'ring'). In a previous study, we developed a novel attractor neural network model with synaptic adaptation mechanisms that could account for semantic priming patterns in healthy individuals. Here, we examine the consequences of introducing attractor instability to this network, which is hypothesized to arise from dysfunctional synaptic transmission known to occur in schizophrenia. In two simulated experiments, we demonstrate how such instability speeds up the network's dynamics and, consequently, produces the full spectrum of priming effects previously reported in patients. The model also explains the inconsistency of augmented priming results at short SOAs using directly related pairs relative to the consistency of indirect priming. Further, we discuss how the same mechanism could account for other symptoms of the disease, such as derailment ('loose associations') or the commonly seen difficulty of patients in utilizing context. Finally, we show how the model can statistically implement the overly-broad wave of spreading activation previously presumed to characterize thought-disorders in schizophrenia.	[Lerner, Itamar; Bentin, Shlomo] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91905 Jerusalem, Israel; [Bentin, Shlomo] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Shriki, Oren] NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lerner, I (corresponding author), Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91905 Jerusalem, Israel.	itamar.lerner@gmail.com; oren70@gmail.com	Shriki, Oren/R-8638-2019	Shriki, Oren/0000-0003-1129-4799	Intramural Research Program of the National Institute of Mental Health	Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Oren Shriki was supported in part by the Intramural Research Program of the National Institute of Mental Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Akrami A, 2012, BRAIN RES, V1434, P4, DOI 10.1016/j.brainres.2011.07.030; ANDREASEN NC, 1979, ARCH GEN PSYCHIAT, V36, P1315, DOI 10.1001/archpsyc.1979.01780120045006; Barch DM, 1996, J ABNORM PSYCHOL, V105, P592, DOI 10.1037/0021-843X.105.4.592; Bibitchkov D, 2002, NETWORK-COMP NEURAL, V13, P115, DOI 10.1088/0954-898X/13/1/304; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bogen IL, 2009, NEUROCHEM INT, V55, P13, DOI 10.1016/j.neuint.2009.02.006; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Carter CS, 1998, AM J PSYCHIAT, V155, P1285, DOI 10.1176/ajp.155.9.1285; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Conklin HM, 2000, AM J PSYCHIAT, V157, P275, DOI 10.1176/appi.ajp.157.2.275; Durstewitz D, 2009, NEURAL NETWORKS, V22, P1189, DOI 10.1016/j.neunet.2009.07.016; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; FLEMING K, 1995, PSYCHIAT RES, V56, P155, DOI 10.1016/0165-1781(95)02589-3; Geva AB, 2000, J INT NEUROPSYCH SOC, V6, P608, DOI 10.1017/S1355617700655108; HERRMANN M, 1993, BIOL CYBERN, V68, P455, DOI 10.1007/BF00198778; Hoff AL, 1996, SCHIZOPHR RES, V20, P21, DOI 10.1016/0920-9964(95)00065-8; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kern RS, 1998, BIOL PSYCHIAT, V44, P726, DOI 10.1016/S0006-3223(98)00088-2; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; KWAPIL TR, 1990, J ABNORM PSYCHOL, V99, P215, DOI 10.1037/0021-843X.99.3.215; Lavigne F, 2008, NEUROPSYCHOLOGIA, V46, P3074, DOI 10.1016/j.neuropsychologia.2008.06.019; Lecardeur L, 2008, BRIT J PSYCHIAT, V193, P82, DOI 10.1192/bjp.193.1.82; Lerner I, 2012, COGN SCI IN PRESS; Lerner I, 2010, COGNITION IN FLUX, P1112; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; Minzenberg Michael J, 2003, Cogn Neuropsychiatry, V8, P107, DOI 10.1080/135468000247; Minzenberg MJ, 2002, J INT NEUROPSYCH SOC, V8, P699, DOI 10.1017/S1355617702801357; Moreno-Bote R, 2005, NEUROCOMPUTING, V65, P441, DOI 10.1016/j.neucom.2004.10.016; Moritz S, 2003, SCHIZOPHR RES, V59, P181, DOI 10.1016/S0920-9964(01)00337-1; Moritz S, 2001, SCHIZOPHR RES, V48, P301, DOI 10.1016/S0920-9964(00)00057-8; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; OBER BA, 1995, NEUROPSYCHOLOGY, V9, P220, DOI 10.1037/0894-4105.9.2.220; Pomarol-Clotet E, 2008, BRIT J PSYCHIAT, V192, P92, DOI 10.1192/bjp.bp.106.032102; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Rossell SL, 2007, CURR PSYCHIATRY REV, V3, P137, DOI 10.2174/157340007780599050; Russo E, 2012, ARXIV12031067V1; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Siekmeier PJ, 2002, BRIT J PSYCHIAT, V180, P345, DOI 10.1192/bjp.180.4.345; SPITZER M, 1993, BIOL PSYCHIAT, V34, P864, DOI 10.1016/0006-3223(93)90054-H; Spitzer M, 1997, SCHIZOPHRENIA BULL, V23, P29, DOI 10.1093/schbul/23.1.29; Treves A, 2005, COGN NEUROPSYCHOL, V22, P276, DOI 10.1080/02643290442000329; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P259, DOI 10.1142/S0217984990000325; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; VINOGRADOV S, 1992, SCHIZOPHR RES, V8, P171, DOI 10.1016/0920-9964(92)90033-2; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025435	54	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40663	10.1371/journal.pone.0040663	http://dx.doi.org/10.1371/journal.pone.0040663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844407	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700016
J	List, J; Albers, J; Kurten, J; Schwindt, A; Wilbers, E; Floel, A				List, Jonathan; Albers, Johannes; Kuerten, Julia; Schwindt, Arne; Wilbers, Eike; Floeel, Agnes			Reperfusion Does Not Improve Impaired Rapid-Onset Cortical Plasticity in Patients with Severe Stenosis of the Internal Carotid Artery	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PAIRED-ASSOCIATIVE STIMULATION; MOTOR CORTEX; COGNITIVE PERFORMANCE; CEREBRAL-ISCHEMIA; ENDARTERECTOMY; INDUCTION; STROKE; REVASCULARIZATION; DYSFUNCTION	Background: Severe stenosis of the internal carotid artery (ICA) has been associated with impaired cognition in patients, but its effect on rapid-onset cortical plasticity is not known. Carotid endarterectomy (CEA) in patients with severe ICA stenosis reduces stroke risk, but the impact on cognition or physiology of the respective hemisphere remains controversial. Methods/Results: 16 patients with severe stenosis of the ICA and 16 age and sex matched controls were included. Rapid-onset cortical plasticity was assessed using the paired-associative stimulation (PAS) protocol. PAS models long-term synaptic potentiation in human motor cortex, combining repetitive stimulation of the peripheral ulnar nerve with transcranial magnetic stimulation of the contralateral motor cortex. Cognitive status was assessed with a neuropsychological test battery. In patients, verbal learning and rapid-onset cortical plasticity were significantly reduced as compared to controls. Identical follow-up tests in 9 of the 16 patients six months after CEA revealed no improvement of cognitive parameters or cortical plasticity. Conclusions: Decreased rapid-onset cortical plasticity in patients with severe stenosis of the ICA was not improved by reperfusion. Thus, other strategies known to increase plasticity should be tested for their potential to improve cortical plasticity and subsequently cognition in these patients.	[List, Jonathan; Floeel, Agnes] Charite, Dept Neurol, D-13353 Berlin, Germany; [List, Jonathan; Albers, Johannes; Kuerten, Julia; Wilbers, Eike] Univ Hosp Munster, Dept Neurol, Munster, Germany; [Schwindt, Arne] Univ Hosp Munster, Dept Vasc Surg, Munster, Germany; [List, Jonathan; Floeel, Agnes] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Floeel, Agnes] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	List, J (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	agnes.floeel@charite.de	Floel, Agnes/A-9426-2017		Deutsche Forschungsgemeinschaft [Fl 379-4/2, Fl 379-8/1, DFG-Exc 257]; Else-Kroner Fresenius Stiftung [2009-141]; Interdisciplinary Center of Clinical Research Munster [Floe3/004/08]; Bundesministerium fur Bildung und Forschung [FKZ 0315673A, 01EO0801]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroner Fresenius Stiftung; Interdisciplinary Center of Clinical Research Munster; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Fl 379-4/2, Fl 379-8/1; and DFG-Exc 257), the Else-Kroner Fresenius Stiftung (2009-141), the Interdisciplinary Center of Clinical Research Munster (Floe3/004/08) and the Bundesministerium fur Bildung und Forschung (FKZ 0315673A and 01EO0801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon-Peretz J, 2003, EUR J NEUROL, V10, P525, DOI 10.1046/j.1468-1331.2003.00633.x; [Anonymous], 2010, R LANG ENV STAT COMP; Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; Battaglia F, 2008, NEUROBIOL AGING, V29, P1272, DOI 10.1016/j.neurobiolaging.2007.02.025; Battaglia F, 2007, BIOL PSYCHIAT, V62, P1405, DOI 10.1016/j.biopsych.2007.02.027; Bejot Y, 2011, STROKE, V42, P607, DOI 10.1161/STROKEAHA.110.595553; Bonati LH, 2010, LANCET NEUROL, V9, P353, DOI 10.1016/S1474-4422(10)70057-0; Castel-Lacanal E, 2009, NEUROREHAB NEURAL RE, V23, P366, DOI 10.1177/1545968308322841; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; Conde V, 2012, NEUROIMAGE, V60, P864, DOI 10.1016/j.neuroimage.2012.01.052; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Enzinger C, 2010, CEREBROVASC DIS, V30, P540, DOI 10.1159/000319025; Fearn SJ, 2003, EUR J VASC ENDOVASC, V26, P529, DOI 10.1016/S1078-5884(03)00384-8; Florian J, 2007, EUR J NEUROSCI, V25, P3461, DOI 10.1111/j.1460-9568.2007.05603.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frantseva MV, 2008, CEREB CORTEX, V18, P990, DOI 10.1093/cercor/bhm151; Ghogawala Z, 2008, NEUROSURGERY, V62, P385, DOI 10.1227/01.neu.0000316005.88517.60; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Hautzinger M, 1994, BECK DEPRESSIONS INV; Heyer EJ, 2006, NEUROSURGERY, V58, P474, DOI 10.1227/01.NEU.0000197123.09972.EA; Heyer EJ, 1998, STROKE, V29, P1110, DOI 10.1161/01.STR.29.6.1110; Incalzi RA, 1997, J CLIN EXP NEUROPSYC, V19, P785, DOI 10.1080/01688639708403760; Kang JS, 2011, CEREB CORTEX, V21, P1203, DOI 10.1093/cercor/bhq204; Khan ZU, 2011, BEHAV BRAIN RES; Landgraff NC, 2010, J NEUROL, V257, P982, DOI 10.1007/s00415-009-5449-z; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li S, 2010, NEUROSCIENCE, V165, P654, DOI 10.1016/j.neuroscience.2009.10.053; List J, 2012, HUM BRAIN MAPP; List J, 2011, CEREB CORTEX, V21, P2774, DOI 10.1093/cercor/bhr071; Mathiesen EB, 2004, NEUROLOGY, V62, P695, DOI 10.1212/01.WNL.0000113759.80877.1F; Matsubara S, 2009, J NEUROSURG, V111, P28, DOI 10.3171/2008.09.17663; Mori K, 1998, BRAIN RES, V795, P221, DOI 10.1016/S0006-8993(98)00295-9; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; NORRIS JW, 1992, STROKE, V23, P483, DOI 10.1161/01.STR.23.4.483; Nurk E, 2009, J NUTR, V139, P120, DOI 10.3945/jn.108.095182; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Romero JR, 2009, STROKE, V40, P1590, DOI 10.1161/STROKEAHA.108.535245; Sale MV, 2008, J NEUROSCI, V28, P8285, DOI 10.1523/JNEUROSCI.1963-08.2008; Silvestrini M, 2009, NEUROLOGY, V72, P1062, DOI 10.1212/01.wnl.0000345015.35520.52; Spencer JPE, 2009, ARCH BIOCHEM BIOPHYS, V492, P1, DOI 10.1016/j.abb.2009.10.003; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Tecchio F, 2008, CLIN NEUROPHYSIOL, V119, P675, DOI 10.1016/j.clinph.2007.10.023; Thirugnanasambandam N, 2011, NEUROPSYCHOPHARMACOL, V36, P879, DOI 10.1038/npp.2010.227; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Wasser K, 2011, J VASC SURG, V53, P61, DOI 10.1016/j.jvs.2010.07.061; Weise D, 2006, BRAIN, V129, P2709, DOI 10.1093/brain/awl221; Witt K, 2007, J NEUROL, V254, P1524, DOI 10.1007/s00415-007-0576-x; Witte AV, 2012, J NEUROSCI, V32, P4553, DOI 10.1523/JNEUROSCI.6010-11.2012; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Xu B, 2010, EUR J PHARMACOL, V627, P99, DOI 10.1016/j.ejphar.2009.10.038; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004; Zuccala G, 2001, NEUROLOGY, V57, P1986, DOI 10.1212/WNL.57.11.1986	56	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41004	10.1371/journal.pone.0041004	http://dx.doi.org/10.1371/journal.pone.0041004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844423	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700034
J	Thayil, SM; Ho, YC; Bollinger, RC; Blankson, JN; Siliciano, RF; Karakousis, PC; Page, KR				Thayil, Seema M.; Ho, Ya-Chi; Bollinger, Robert C.; Blankson, Joel N.; Siliciano, Robert F.; Karakousis, Petros C.; Page, Kathleen R.			Mycobacterium tuberculosis Complex Enhances Susceptibility of CD4 T Cells to HIV through a TLR2-Mediated Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE ACTIVATION; DENDRITIC CELLS; INFECTED PATIENTS; HOST FACTORS; DISEASE; EXPRESSION; RESPONSES; TLR2	Among HIV-infected individuals, co-infection with Mycobacterium tuberculosis is associated with faster progression to AIDS. We investigated the hypothesis that M. bovis BCG and M. tuberculosis (Mtb complex) could enhance susceptibility of CD4+ cells to HIV infection. Peripheral blood mononuclear cells (PBMCs) collected from healthy donors were stimulated with M. bovis BCG, M. tuberculosis CDC1551 and M. smegmatis MC(2)155, and stimulated CD4+ cells were infected with R5- and X4-tropic single replication-competent pseudovirus. CD4+ cells stimulated with Mtb complex showed enhanced infection with R5- and X4-tropic HIV, compared to unstimulated cells or cells stimulated with M. smegmatis (p<0.01). Treatment with TLR2 siRNA reversed the increased susceptibility of CD4+ cells with R5- and X4-tropic virus induced by Mtb complex. These findings suggest that TB infection and/or BCG vaccination may be a risk factor for HIV acquisition.	[Thayil, Seema M.; Ho, Ya-Chi; Bollinger, Robert C.; Blankson, Joel N.; Siliciano, Robert F.; Karakousis, Petros C.; Page, Kathleen R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Thayil, SM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	petros@jhmi.edu	Karakousis, Petros Constantine/AAR-7899-2020	Thayil, SEEMA/0000-0002-3111-6861; Bollinger, Robert/0000-0002-6798-6834; Ho, Ya-Chi/0000-0002-7046-0147	National Institutes of Health [K23HD056957, R01AI083125]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD056957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants K23HD056957 to KRP and R01AI083125 to PCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Bafica A, 2004, J IMMUNOL, V172, P7229, DOI 10.4049/jimmunol.172.12.7229; Bafica A, 2003, J IMMUNOL, V171, P1123, DOI 10.4049/jimmunol.171.3.1123; Barnabas RV, 2011, AIDS, V25, P1559, DOI 10.1097/QAD.0b013e3283491e3e; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bosinger SE, 2011, CURR OPIN HIV AIDS, V6, P411, DOI 10.1097/COH.0b013e3283499cf6; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Chang JS, 2006, J IMMUNOL, V176, P3010, DOI 10.4049/jimmunol.176.5.3010; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Croix DA, 2000, AIDS RES HUM RETROV, V16, P1895, DOI 10.1089/08892220050195856; Ding J, 2012, J IMMUNOL, V188, P992, DOI 10.4049/jimmunol.1102098; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; Equils O, 2003, J IMMUNOL, V170, P5159, DOI 10.4049/jimmunol.170.10.5159; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gonzalez OA, 2010, CLIN VACCINE IMMUNOL, V17, P1417, DOI 10.1128/CVI.00009-10; Hanekom WA, 2005, ANN NY ACAD SCI, V1062, P69, DOI 10.1196/annals.1358.010; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hernandez JC, 2011, AIDS RES HUM RETROV, V27, P1099, DOI [10.1089/aid.2010.0302, 10.1089/AID.2010.0302]; Huang D, 2007, J INFECT DIS, V195, P55, DOI 10.1086/509895; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kalinkovich A, 2001, CLIN IMMUNOL, V100, P107, DOI 10.1006/clim.2001.5040; Kaul R, 2011, AM J REPROD IMMUNOL, V65, P317, DOI 10.1111/j.1600-0897.2010.00962.x; Koesters SA, 2004, J CLIN IMMUNOL, V24, P702, DOI 10.1007/s10875-004-6238-1; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Ogawa Y, 2009, BLOOD, V113, P5157, DOI 10.1182/blood-2008-10-185728; Page KR, 2006, CELL MICROBIOL, V8, P185, DOI 10.1111/j.1462-5822.2005.00653.x; Pancino G, 2010, J INFECT DIS, V202, pS345, DOI 10.1086/655973; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Schreiber HA, 2011, J CLIN INVEST, V121, P3902, DOI 10.1172/JCI45113; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sundstrom JB, 2004, J IMMUNOL, V172, P4391, DOI 10.4049/jimmunol.172.7.4391; Tan DBA, 2011, AIDS, V25, P1455, DOI 10.1097/QAD.0b013e328348fb18; Thibault S, 2007, J IMMUNOL, V179, P4357, DOI 10.4049/jimmunol.179.7.4357; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; van den Biggelaar AHJ, 2009, J ALLERGY CLIN IMMUN, V124, P544, DOI 10.1016/j.jaci.2009.03.040; Walson JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub3; WHO, 2011, TB DAT 2011; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	46	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41093	10.1371/journal.pone.0041093	http://dx.doi.org/10.1371/journal.pone.0041093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844428	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700042
J	Liu, LL; Zhang, CZ; Cai, MY; Fu, J; Chen, GG; Yun, JP				Liu, Lili; Zhang, Chris Zhiyi; Cai, Muyan; Fu, Jia; Chen, George Gong; Yun, Jingping			Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis	PLOS ONE			English	Article							EXPRESSION; PLK4; SAK; AREAS; MICE	Polo-like kinase 4 (PLK4), belonging to serine/threonine kinase family, is critical for centriole replication and cell cycle progression. PLK4 has been proposed as a tumor suppressor in hepatocellular carcinoma (HCC). However, its expression and significance in HCC have not been well studied. In the present study, we found that PLK4 was markedly downregulated in both HCC cell lines and fresh cancer tissues, using quantitative real-time-PCR and western blot. Immunohistochemistry data also revealed that decreased expression of PLK4 was present in 72.4% (178/246) of HCC tissues, compared with the corresponding adjacent nontumorous tissues. Furthermore, PLK4 expression significantly correlated with clinicopathological parameters, including clinical stage (P = 0.034), serum alpha-fetoprotein (AFP) (P = 0.019) and tumor size (P = 0.032). Moreover, HCC patients with low PLK4 expression survived shorter than those with high PLK4 expression, as indicated by overall survival (P = 0.002) and disease-free survival (P = 0.012) assessed by the Kaplan-Meier method. In addition, multivariate analysis suggested PLK4 as an independent predictor of overall survival (HR, 0.556; 95%CI, 0.37-20.822; P = 0.003) and disease-free survival (HR, 0.547; 95%CI, 0.382-0.783; P = 0.001). Collectively, our study demonstrated that PLK4 was remarkably downregulated in HCC and could be served as a potential prognostic marker for patients with this deadly disease.	[Liu, Lili; Zhang, Chris Zhiyi; Cai, Muyan; Fu, Jia; Yun, Jingping] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Lili; Zhang, Chris Zhiyi; Cai, Muyan; Fu, Jia; Yun, Jingping] Sun Yat Sen Univ, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, George Gong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital	Liu, LL (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	yunjp@sysucc.org.cn	Liu, Lili/HHC-6357-2022; Chen, George Gong/I-2757-2016; Zhang, Chris Zhiyi/F-9862-2013		National Natural Science Foundation of China [81172345, 30973506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81172345 and No. 30973506). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban KC, 2004, J SURG ONCOL, V86, P157, DOI 10.1002/jso.20051; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Eckerdt F, 2011, CURR BIOL, V21, P428, DOI 10.1016/j.cub.2011.01.072; Feo F, 2006, BBA-REV CANCER, V1765, P126, DOI 10.1016/j.bbcan.2005.08.007; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Fode C, 1996, MOL CELL BIOL, V16, P4665; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kwon Oh Sang, 2010, Korean J Hepatol, V16, P308, DOI 10.3350/kjhep.2010.16.3.308; Liu L, 2010, LEUKEMIA LYMPHOMA, V51, P1079, DOI 10.3109/10428191003706939; Macmillan JC, 2001, ANN SURG ONCOL, V8, P729, DOI 10.1245/aso.2001.8.9.729; Marwoto Wirasmi, 2000, Kobe Journal of Medical Sciences, V46, P217; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Pellegrino R, 2010, HEPATOLOGY, V51, P857, DOI 10.1002/hep.23467; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; SUNKEL CE, 1988, J CELL SCI, V89, P25; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tanenbaum ME, 2007, NAT CELL BIOL, V9, P1127, DOI 10.1038/ncb1007-1127; Ward A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-71; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; YAMADA H, 1985, HISTOCHEMISTRY, V83, P285, DOI 10.1007/BF00684372; Zhou L, 2011, EJSO-EUR J SURG ONC, V37, P521, DOI 10.1016/j.ejso.2011.03.137; Zimling ZG, 2012, J THORAC ONCOL, V7, P249, DOI 10.1097/JTO.0b013e318233d6a9	32	36	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41293	10.1371/journal.pone.0041293	http://dx.doi.org/10.1371/journal.pone.0041293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829937	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300076
J	Maughan-Brown, B; Venkataramani, AS				Maughan-Brown, Brendan; Venkataramani, Atheendar S.			Learning That Circumcision Is Protective against HIV: Risk Compensation among Men and Women in Cape Town, South Africa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PREVENTION; INFECTION; KENYA; BEHAVIOR; KISUMU; UGANDA; RAKAI	Objectives: We examined whether knowledge of the HIV-protective benefits of male circumcision (MC) led to risk compensating behavior in a traditionally circumcising population in South Africa. We extend the current literature by examining risk compensation among women, which has hitherto been unexplored. Methods: We used data on Xhosa men and women from the 2009 Cape Area Panel Study. Respondents were asked if they had heard that MC reduces a man's risk of contracting HIV, about their perceived risk of contracting HIV, and condom use. For each gender group we assessed whether risk perception and condom use differed by knowledge of the protective benefits of MC using bivariate and then multivariate models controlling for demographic characteristics, HIV knowledge/beliefs, and previous sexual behaviors. In a further check for confounding, we used data from the 2005 wave to assess whether individuals who would eventually become informed about the protective benefits of circumcision were already different in terms of HIV risk perception and condom use. Results: 34% of men (n = 453) and 27% of women (n = 690) had heard that circumcision reduces a man's risk of HIV infection. Informed men perceived slightly higher risk of contracting HIV and were more likely to use condoms at last sex (p < 0.10). Informed women perceived lower HIV risk (p < 0.05), were less likely to use condoms both at last sex (p < 0.10) and more generally (p < 0.01), and more likely to forego condoms with partners of positive or unknown serostatus (p < 0.01). The results were robust to covariate adjustment, excluding people living with HIV, and accounting for risk perceptions and condom use in 2005. Conclusions: We find evidence consistent with risk compensation among women but not men. Further attention should be paid to the role of new information regarding MC, and drivers of HIV risk more broadly, in modulating sexual behavior among women.	[Maughan-Brown, Brendan] Univ Cape Town, So Africa Labour & Dev Res Unit, ZA-7925 Cape Town, South Africa; [Venkataramani, Atheendar S.] Massachusetts Gen Hosp, MGH Charlestown HealthCare Ctr, Dept Med, Charlestown, MA USA	University of Cape Town; Harvard University; Massachusetts General Hospital	Maughan-Brown, B (corresponding author), Univ Cape Town, So Africa Labour & Dev Res Unit, ZA-7925 Cape Town, South Africa.	avenkataramani@partners.org	Maughan-Brown, Brendan/AAH-4254-2019		United States National Institute for Child Health and Human Development; Andrew W. Mellon Foundation; National Institute on Aging; Health Economics & HIV/AIDS Research Division (HEARD) at the University of KwaZulu-Natal; European Union; NRF Research Chair in Poverty and Inequality Research; University Research Committee at the University of Cape Town	United States National Institute for Child Health and Human Development; Andrew W. Mellon Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Health Economics & HIV/AIDS Research Division (HEARD) at the University of KwaZulu-Natal; European Union(European Commission); NRF Research Chair in Poverty and Inequality Research; University Research Committee at the University of Cape Town	Funding for the Cape Area Panel Study was provided by the United States National Institute for Child Health and Human Development, the Andrew W. Mellon Foundation, the National Institute on Aging, the Health Economics & HIV/AIDS Research Division (HEARD) at the University of KwaZulu-Natal, and the European Union. Brendan Maughan-Brown is grateful for funding from the NRF Research Chair in Poverty and Inequality Research and the University Research Committee at the University of Cape Town for his Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA 2008 HIV AIDS P; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dupas P, 2011, AM ECON J-APPL ECON, V3, P1, DOI 10.1257/app.3.1.1; Eaton LA, 2011, INT J STD AIDS, V22, P674, DOI 10.1258/ijsa.2011.011006; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Godlonton S, 2011, 313 BUR RES EC AN DE; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grebe E, 2011, AIDS BEHAV, DOI [10.1007/s10461-10011-19958-10462, DOI 10.1007/S10461-10011-19958-10462]; Green LW, 2010, AM J PREV MED, V39, P479, DOI 10.1016/j.amepre.2010.07.010; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Maughan-Brown B, 2011, JAIDS-J ACQ IMM DEF, V58, P499, DOI 10.1097/QAI.0b013e31823584c1; Mishra V., 2009, LEVELS SPREAD HIV SE; Rain-Taljaard RC, 2003, AIDS CARE, V15, P315, DOI 10.1080/0954012031000105379; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Vincent L, 2008, CULT HEALTH SEX, V10, P431, DOI 10.1080/13691050701861447; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; World Health Organization Joint United Nations Programme on HIV/AIDS, 2011, JOINT STRAT ACT FRAM	21	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40753	10.1371/journal.pone.0040753	http://dx.doi.org/10.1371/journal.pone.0040753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981GZ	22829883	Green Published, gold			2022-12-27	WOS:000306956300021
J	Zoccolella, S; Tortorella, C; Iaffaldano, P; Direnzo, V; D'Onghia, M; Luciannatelli, E; Paolicelli, D; Livrea, P; Trojano, M				Zoccolella, Stefano; Tortorella, Carla; Iaffaldano, Pietro; Direnzo, Vita; D'Onghia, Mariangela; Luciannatelli, Elena; Paolicelli, Damiano; Livrea, Paolo; Trojano, Maria			Low Serum Urate Levels Are Associated to Female Gender in Multiple Sclerosis Patients	PLOS ONE			English	Article							URIC-ACID LEVELS; CEREBROSPINAL-FLUID; NITRIC-OXIDE; BLOOD; DISEASE; PEROXYNITRITE; PATHOGENESIS; RELAPSES; LIPIDS	Backgroudn: Urate is a natural antioxidant and may prevent CNS tissue damage and the clinical manifestations of experimental autoimmune encephalitis. Results from clinical studies are conflicting and the contribution of urate to the pathogenesis of Multiple Sclerosis ( MS) remains uncertain. Objective: To evaluate serum urate levels in MS patients and their relationships with clinical, demographic and MRI variables. Methods: Levels of non-fasting serum uric acid and creatinine were determined by an automated enzymatic assay and glomerular filtration rate was assessed in 245 MS patients, in 252 age/sex-matched neurological controls (NC) and in 59 Healthy controls (HC). Results: Median serum urate levels did not differ between MS patients (3.8 mg/dL), HC (4.0 mg/dl) and NC (4.0 mg/dL). Serum urate levels were lower in females than in males in all groups (p = < 0.0001). In female-MS, serum urate levels (3.2 mg/dL) were lower compared to those in female HC (3.8; p = 0.01) and NC (3.5 mg/dL; p = 0.02), whereas in male-MS they(4.8 mg/dL) did not differ from those in male HC (4.5 mg/dl) and NC (4.8 mg/dL). Urate concentrations trended to be lower in Clinically isolated syndromes suggestive of MS (3.7 mg/dL) and in relapsing MS (3.7 mg/dL), compared to patients with progressive MS (4.4 mg/dL; p = 0.06), and in patients with an annual relapse rate (ARR) > 2 (3.3 mg/dL) than in those with an ARR <= 2: 3.9 mg/dL; p = 0.05). Significant lower serum urate levels were found in females than in males in all clinical MS subtypes (p < 0.01), separately evaluated. Female sex (beta: -0.53; p < 0.00001) was the most significant determinant of serum urate concentrations in MS patients on multivariate regression analysis. Conclusions: Our findings suggest that low urate levels could be of significance in predominantly inflammatory phases of MS even at the early stage and mainly in females.	[Zoccolella, Stefano; Tortorella, Carla; Iaffaldano, Pietro; Direnzo, Vita; D'Onghia, Mariangela; Luciannatelli, Elena; Paolicelli, Damiano; Livrea, Paolo; Trojano, Maria] Univ Bari, Dept Neurosci & Organs Senses, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Zoccolella, S (corresponding author), Univ Bari, Dept Neurosci & Organs Senses, Bari, Italy.	mtrojano@neurol.unibait	Iaffaldano, Pietro/AFE-8061-2022; Tortorella, Carla/J-2557-2012; zoccolella, stefano/AAA-2515-2020	Iaffaldano, Pietro/0000-0003-2308-1731; Tortorella, Carla/0000-0001-9037-7300; Livrea, Paolo/0000-0001-7410-3860; Trojano, Maria/0000-0002-6329-8946	Serono Foundation; Merck Serono; Biogen; Novartis	Serono Foundation; Merck Serono(Merck & Company); Biogen(Biogen); Novartis(Novartis)	Dr Tortorella has received honoraria for speaking from Biogen, Sanofi-Aventis, and Novartis. Dr Paolicelli reports a research Grant from Serono Foundation and received speaking honoraria from Biogen Idech and Novartis. Prof Maria Trojano received honoraria for consultancy or speaking from Biogen, Sanofi-Aventis, Merck Serono and Bayer-Schering and research grants from Merck Serono, Biogen and Novartis. We confirm that none of the above research grants were used for this particular study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ames BN, 1988, P NATL ACAD SCI USA, V78, P6858; Amorini AM, 2009, CLIN BIOCHEM, V42, P1001, DOI 10.1016/j.clinbiochem.2009.03.020; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Becker BF, 2004, NUCLEOS NUCLEOT NUCL, V23, P1201, DOI 10.1081/NCN-200027469; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Drulovic J, 2001, J NEUROL, V248, P121, DOI 10.1007/s004150170246; Dujmovic I, 2009, CLIN CHEM LAB MED, V47, P848, DOI 10.1515/CCLM.2009.192; Gasteyger C, 2006, OBES SURG, V16, P243, DOI 10.1381/096089206776116381; Gonsette RE, 2010, MULT SCLER J, V16, P455, DOI 10.1177/1352458509360547; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; Guerrero AL, 2008, EUR J NEUROL, V15, P394, DOI 10.1111/j.1468-1331.2008.02087.x; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; Kanabrocki EL, 2008, CLIN TER, V159, P35; Karg E, 1999, J NEUROL, V246, P533, DOI 10.1007/s004150050399; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Liu B, 2012, NEUROL RES, V34, P163, DOI 10.1179/1743132811Y.0000000074; Massa J, 2009, J NEUROL, V256, P1643, DOI 10.1007/s00415-009-5170-y; Miller E, 2012, CLIN BIOCHEM, V45, P26, DOI 10.1016/j.clinbiochem.2011.09.021; Moore GRW, 2010, CAN J NEUROL SCI, V37, pS5; Mostert JP, 2005, J NEUROL SCI, V231, P41, DOI 10.1016/j.jns.2004.12.008; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Peng FH, 2008, MULT SCLER, V14, P188, DOI 10.1177/1352458507082143; Peng FH, 2012, NEUROIMMUNOMODULAT, V19, P43, DOI 10.1159/000327727; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramsaransing GSM, 2005, EUR J NEUROL, V12, P514, DOI 10.1111/j.1468-1331.2005.01009.x; Rentzos M, 2006, CLIN NEUROL NEUROSUR, V108, P527, DOI 10.1016/j.clineuro.2005.08.004; Salemi G, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-19; Sotgiu S, 2002, NEUROL SCI, V23, P183, DOI 10.1007/s100720200059; Spitsin S, 2001, MULT SCLER, V7, P165, DOI 10.1191/135245801678438384; Tavazzi B, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/167156; Toncev G, 2002, EUR J NEUROL, V9, P221, DOI 10.1046/j.1468-1331.2002.00384.x; van der Veen RC, 1999, J NEUROIMMUNOL, V95, P1, DOI 10.1016/S0165-5728(98)00239-2; Zamani A, 2008, CLIN NEUROL NEUROSUR, V110, P642, DOI 10.1016/j.clineuro.2008.03.002	37	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40608	10.1371/journal.pone.0040608	http://dx.doi.org/10.1371/journal.pone.0040608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848387	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950200022
J	Ghosh, A; Chattopadhyay, S; Chawla-Sarkar, M; Nandy, P; Nandy, A				Ghosh, Ambarnil; Chattopadhyay, Shiladitya; Chawla-Sarkar, Mamta; Nandy, Papiya; Nandy, Ashesh			In Silico Study of Rotavirus VP7 Surface Accessible Conserved Regions for Antiviral Drug/Vaccine Design	PLOS ONE			English	Article							T-CELL EPITOPE; GRAPHICAL REPRESENTATION; PROTECTIVE IMMUNITY; PROTEIN SEQUENCES; VIRAL-PROTEINS; QSAR MODEL; PREDICTION; BIOMARKERS; INFLUENZA; PEPTIDE	Background: Rotaviral diarrhoea kills about half a million children annually in developing countries and accounts for one third of diarrhea related hospitalizations. Drugs and vaccines against the rotavirus are handicapped, as in all viral diseases, by the rapid mutational changes that take place in the DNA and protein sequences rendering most of these ineffective. As of now only two vaccines are licensed and approved by the WHO (World Health Organization), but display reduced efficiencies in the underdeveloped countries where the disease is more prevalent. We approached this issue by trying to identify regions of surface exposed conserved segments on the surface glycoproteins of the virion, which may then be targeted by specific peptide vaccines. We had developed a bioinformatics protocol for these kinds of problems with reference to the influenza neuraminidase protein, which we have refined and expanded to analyze the rotavirus issue. Results: Our analysis of 433 VP7 (Viral Protein 7 from rotavirus) surface protein sequences across 17 subtypes encompassing mammalian hosts using a 20D Graphical Representation and Numerical Characterization method, identified four possible highly conserved peptide segments. Solvent accessibility prediction servers were used to identify that these are predominantly surface situated. These regions analyzed through selected epitope prediction servers for their epitopic properties towards possible T-cell and B-cell activation showed good results as epitopic candidates (only dry lab confirmation). Conclusions: The main reasons for the development of alternative vaccine strategies for the rotavirus are the failure of current vaccines and high production costs that inhibit their application in developing countries. We expect that it would be possible to use the protein surface exposed regions identified in our study as targets for peptide vaccines and drug designs for stable immunity against divergent strains of the rotavirus. Though this study is fully dependent on computational prediction algorithms, it provides a platform for wet lab experiments.	[Nandy, Ashesh] Ctr Interdisciplinary Res & Educ, Kolkata, W Bengal, India; [Ghosh, Ambarnil; Nandy, Papiya] Jadavpur Univ, Dept Phys, Kolkata, W Bengal, India; [Chattopadhyay, Shiladitya; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India	Jadavpur University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Nandy, A (corresponding author), Ctr Interdisciplinary Res & Educ, Kolkata, W Bengal, India.	anandy43@yahoo.com		Ghosh, Ambarnil/0000-0002-1400-0963				Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Aguiar-Pulido V, 2012, MOL BIOSYST, V8, P1716, DOI 10.1039/c2mb25039j; Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020; Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P3173, DOI 10.1073/pnas.1113342109; Blutt SE, 2004, J VIROL, V78, P6974, DOI 10.1128/JVI.78.13.6974-6981.2004; Buesa J, 1999, VIROLOGY, V257, P424, DOI 10.1006/viro.1999.9646; Cantor JR, 2011, P NATL ACAD SCI USA, V108, P1272, DOI 10.1073/pnas.1014739108; Chakladar A, 1998, INTERVIROLOGY, V41, P127, DOI 10.1159/000024924; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; Choi AH, 2002, VACCINE, V20, P3310, DOI 10.1016/S0264-410X(02)00315-8; Cruz-Monteagudo M, 2008, BIOORGAN MED CHEM, V16, P9684, DOI 10.1016/j.bmc.2008.10.004; Dea-Ayuela MA, 2008, BIOORGAN MED CHEM, V16, P7770, DOI 10.1016/j.bmc.2008.07.023; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; FDA, 2010, UPD ROT VACC; FRANCO MA, 1993, J GEN VIROL, V74, P2579, DOI 10.1099/0022-1317-74-12-2579; Ghosh A, 2011, 7 AS BIOPH ASS ABA S, P88; Ghosh A, 2011, ADV PROTEIN CHEM STR, V83, P1, DOI 10.1016/B978-0-12-381262-9.00001-X; Ghosh A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-6; Ghosh A, 2009, J CHEM INF MODEL, V49, P2627, DOI 10.1021/ci9001662; Gonzalez-Diaz H, 2005, BIOPOLYMERS, V77, P296, DOI 10.1002/bip.20234; Gonzalez-Diaz H, 2009, J THEOR BIOL, V261, P136, DOI 10.1016/j.jtbi.2009.07.029; Gonzalez-Diaz H, 2011, MOL BIOSYST, V7, P1938, DOI 10.1039/c1mb05069a; Graff JW, 2007, J GEN VIROL, V88, P613, DOI 10.1099/vir.0.82255-0; Gu Y, 2008, EXP PARASITOL, V118, P66, DOI 10.1016/j.exppara.2007.06.014; Gultyaev AP, 2010, INT REV IMMUNOL, V29, P533, DOI 10.3109/08830185.2010.507828; HART CA, 2003, ANTIGENIC VARIATION, P84; JIANG V, 2010, HUM VACCIN, V6; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JUTILA MA, 1992, J EXP MED, V175, P1565, DOI 10.1084/jem.175.6.1565; Li ZL, 2009, J VIROL, V83, P1754, DOI 10.1128/JVI.01855-08; Ludert JE, 2002, J VIROL, V76, P6643, DOI 10.1128/JVI.76.13.6643-6651.2002; Lynch M, 2001, CLIN INFECT DIS, V33, P932, DOI 10.1086/322650; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mukherjee A, 2010, INFECT GENET EVOL, V10, P311, DOI 10.1016/j.meegid.2010.01.002; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Nandy Ashesh, 2009, In Silico Biology, V9, P77, DOI 10.3233/ISB-2009-0389; Novic M, 2008, SAR QSAR ENVIRON RES, V19, P317, DOI 10.1080/10629360802085066; Perez-Bello A, 2009, J THEOR BIOL, V256, P458, DOI 10.1016/j.jtbi.2008.09.035; Rahman M, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-24; Randic M, 2003, J CHEM INF COMP SCI, V43, P532, DOI 10.1021/ci020051a; Randic M, 2009, SAR QSAR ENVIRON RES, V20, P415, DOI 10.1080/10629360903278685; Randic M, 2007, J MOL GRAPH MODEL, V26, P290, DOI 10.1016/j.jmgm.2006.12.006; Randic M, 2011, CHEM REV, V111, P790, DOI 10.1021/cr800198j; RUGGERI FM, 1991, J VIROL, V65, P2211, DOI 10.1128/JVI.65.5.2211-2219.1991; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009432; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Velazquez RF, 1996, NEW ENGL J MED, V335, P1022; Vilar S, 2008, J COMPUT CHEM, V29, P2613, DOI 10.1002/jcc.21016; Vilar S, 2009, J THEOR BIOL, V261, P449, DOI 10.1016/j.jtbi.2009.07.031; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Ward Richard L, 2008, Ther Clin Risk Manag, V4, P49; Widdowson MA, 2005, CURR OPIN GASTROEN, V21, P26; Zupan J, 2005, J CHEM INF MODEL, V45, P309, DOI 10.1021/ci040104j; 2008, MMWR MORB MORTAL WKL, V57, P1255	61	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40749	10.1371/journal.pone.0040749	http://dx.doi.org/10.1371/journal.pone.0040749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844409	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600008
J	Pingault, JB; Falissard, B; Cote, S; Berthoz, S				Pingault, Jean-Baptiste; Falissard, Bruno; Cote, Sylvana; Berthoz, Sylvie			A New Approach of Personality and Psychiatric Disorders: A Short Version of the Affective Neuroscience Personality Scales	PLOS ONE			English	Article							BIPOLAR SPECTRUM ILLNESS; EMOTIONAL ENDOPHENOTYPES; GENDER-DIFFERENCES; VALIDATION; CRITERIA; DEFENSE; TRAITS; MODELS	Background: The Affective Neuroscience Personality Scales (ANPS) is an instrument designed to assess endophenotypes related to activity in the core emotional systems that have emerged from affective neuroscience research. It operationalizes six emotional endophenotypes with empirical evidence derived from ethology, neural analyses and pharmacology: PLAYFULNESS/joy, SEEKING/interest, CARING/nurturance, ANGER/rage, FEAR/anxiety, and SADNESS/separation distress. We aimed to provide a short version of this questionnaire (ANPS-S). Methodology/Principal Findings: We used a sample of 830 young French adults which was randomly split into two subsamples. The first subsample was used to select the items for the short scales. The second subsample and an additional sample of 431 Canadian adults served to evaluate the psychometric properties of the short instrument. The ANPS-S was similar to the long version regarding intercorrelations between the scales and gender differences. The ANPS-S had satisfactory psychometric properties, including factorial structure, unidimensionality of all scales, and internal consistency. The scores from the short version were highly correlated with the scores from the long version. Conclusions/Significance: The short ANPS proves to be a promising instrument to assess endophenotypes for psychiatrically relevant science.	[Pingault, Jean-Baptiste; Cote, Sylvana] Univ Montreal, Hop St Justine, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ H3T 1C5, Canada; [Pingault, Jean-Baptiste; Falissard, Bruno; Cote, Sylvana] Univ Montreal, Int Lab Child & Adolescent Mental Hlth Dev, Montreal, PQ, Canada; [Pingault, Jean-Baptiste; Falissard, Bruno; Cote, Sylvana] Univ Paris Descartes & Paris Sud, INSERM U669, Paris, France; [Berthoz, Sylvie] Inst Mutualiste Mt Souris, Dept Psychiat Adolescents & Young Adults, Paris, France	Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Pingault, JB (corresponding author), Univ Montreal, Hop St Justine, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ H3T 1C5, Canada.	jean-baptiste.pingault@umontreal.ca	Côté, Sylvana M./T-4600-2019; Berthoz Landron, Sylvie/M-4517-2018	Côté, Sylvana M./0000-0001-7944-0647; Pingault, Jean-Baptiste/0000-0003-2557-4716; Berthoz, Sylvie/0000-0002-6862-2362	European Union research funding NEST program [FP6-2005-NEST-Path Imp 043403]; Canadian Institutes for Health Research [MOP 79420]; Canadian Council on Learning; Canadian Psychiatric Research Foundation (CPRF); Government of Canada Post-doctoral Research Fellowships (PDRF); Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec [16031]; Fondation pour la Recherche en Psychiatrie et Sante Mentale FRPsySM)	European Union research funding NEST program; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Council on Learning; Canadian Psychiatric Research Foundation (CPRF); Government of Canada Post-doctoral Research Fellowships (PDRF); Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec; Fondation pour la Recherche en Psychiatrie et Sante Mentale FRPsySM)	The research on the French sample was supported by the European Union research funding NEST program (FP6-2005-NEST-Path Imp 043403) and the Fondation pour la Recherche en Psychiatrie et Sante Mentale FRPsySM). The research on the Canadian sample was made possible by grants to Sylvana M Cote from the Canadian Institutes for Health Research (#MOP 79420), from the Canadian Council on Learning and from the Canadian Psychiatric Research Foundation (2005-2006 CPRF). Dr Pingault received a Government of Canada Post-doctoral Research Fellowships (PDRF) and a post-doctoral fellowship from the Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec (#16031) attributed to Dr. S. M. Cote . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2011, SPAN J PSYCHOL, V14, P926, DOI 10.5209/rev_SJOP.2011.v14.n2.38; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; Berthoz S, 2011, DETERMINATION EMOTIO; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P761; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Davis KL, 2011, NEUROSCI BIOBEHAV R, V35, P1946, DOI 10.1016/j.neubiorev.2011.04.004; Davis KL., 2003, NEUROPSYCHOANALYSIS, V5, P57, DOI [DOI 10.1080/15294145.2003.10773410, 10.1080/15294145.2003.10773410]; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; Eibl Eibesfeldt I., 1975, ETHOLOGY BIOL BEHAV; Falissard B., 2005, COMPRENDRE UTILISER, P384; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Kline RB., 2004, PRINCIPLES PRACTICE, V2nd; Lance CE, 2006, ORGAN RES METHODS, V9, P202, DOI 10.1177/1094428105284919; Leibenluft E., 1999, GENDER DIFFERENCES M; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; McNaughton N, 2011, PERS INDIV DIFFER, V50, P898, DOI 10.1016/j.paid.2010.07.011; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Montag C, 2011, BIOL PSYCHIAT, V69, P601, DOI 10.1016/j.biopsych.2010.10.026; Nunnally J., 1978, PSYCHOMETRIC THEORY; Pahlavan F, 2008, EUR REV APPL PSYCHOL, V58, P155, DOI 10.1016/j.erap.2007.08.004; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J., 2011, ARCHAEOLOGY MIND NEU; Panksepp J, 2006, PROG NEURO-PSYCHOPH, V30, P774, DOI 10.1016/j.pnpbp.2006.01.004; Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391; Pingault JB, 2012, PSYCHOL ASSESSMENT, V24, P375, DOI 10.1037/a0025692; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reuter M, 2005, EUR J PERSONALITY, V19, P83, DOI 10.1002/per.534; Reuter M, 2009, BEHAV BRAIN RES, V202, P179, DOI 10.1016/j.bbr.2009.03.032; Rouquette A, 2011, INT J METH PSYCH RES, V20, P235, DOI 10.1002/mpr.352; Savitz J, 2008, GENES BRAIN BEHAV, V7, P869, DOI 10.1111/j.1601-183X.2008.00426.x; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Savitz J, 2008, J PSYCHIATR RES, V42, P920, DOI 10.1016/j.jpsychires.2007.10.011; Savitz J, 2008, J AFFECT DISORDERS, V109, P305, DOI 10.1016/j.jad.2007.12.006; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012	40	28	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41489	10.1371/journal.pone.0041489	http://dx.doi.org/10.1371/journal.pone.0041489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	012MO	22848510	Green Published, gold			2022-12-27	WOS:000309240600029
J	Tetard-Jones, C; Kertesz, MA; Preziosi, RF				Tetard-Jones, Catherine; Kertesz, Michael A.; Preziosi, Richard F.			Identification of Plant Quantitative Trait Loci Modulating a Rhizobacteria-Aphid Indirect Effect	PLOS ONE			English	Article							ECO-EVOLUTIONARY DYNAMICS; HOST-PLANT; ECOLOGICAL COMMUNITIES; SYSTEMIC RESISTANCE; EMERGING SYNTHESIS; MYCORRHIZAL FUNGI; BROWN PLANTHOPPER; GENETIC-VARIATION; CEREAL APHIDS; PERFORMANCE	Plants simultaneously interact with a plethora of species both belowground and aboveground, which can result in indirect effects mediated by plants. Studies incorporating plant genetic variation indicate that indirect effects mediated by plants may be a significant factor influencing the ecology and evolution of species within a community. Here, we present findings of a Quantitative Trait Locus (QTL) mapping study, where we mapped a rhizobacteria-aphid indirect effect onto the barley genome. We measured the size of aphid populations on barley when the barley rhizosphere either was or was not supplemented with a rhizobacterial species. Using a QTL mapping subset, we located five regions of the barley genome associated with the rhizobacteria-aphid indirect effect. Rhizobacterial supplementation led to an increase in aphid population size (mapped to three barley QTL), or a decrease in aphid population size (mapped to two barley QTL). One QTL associated with plant resistance to aphids was affected by a significant QTL-by-environment interaction, because it was not expressed when rhizobacteria was supplemented. Our results indicated that rhizobacterial supplementation of barley roots led to either increased or reduced aphid population size depending on plant genotype at five barley QTL. This indicates that the direction of a rhizobacteria-aphid indirect effect could influence the selection pressure on plants, when considering species that affect plant fitness. Further research may build on the findings presented here, to identify genes within QTL regions that are involved in the indirect interaction.	[Tetard-Jones, Catherine; Kertesz, Michael A.; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Tetard-Jones, C (corresponding author), Newcastle Univ, Mol Agr Grp, Nafferton Ecol Farming Grp, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Catherine.tetard-jones@ncl.ac.uk	Tétard-Jones, Catherine/H-5509-2019; KERTESZ, Michael/Q-7642-2019; Preziosi, Richard F/A-8626-2010; Tétard-Jones, Catherine/G-2961-2011; Kertesz, Michael/A-6720-2011	Tétard-Jones, Catherine/0000-0001-7121-2236; KERTESZ, Michael/0000-0003-2112-4451; Preziosi, Richard F/0000-0003-0468-6655; Tétard-Jones, Catherine/0000-0001-7121-2236; Kertesz, Michael/0000-0003-2112-4451	NERC Environmental Genomics grant; NERC doctoral studentship; Natural Environment Research Council [NER/T/S/2002/00188] Funding Source: researchfish	NERC Environmental Genomics grant; NERC doctoral studentship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by a NERC Environmental Genomics grant and a NERC doctoral studentship to CT-J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SN, 1998, THEOR APPL GENET, V97, P1370, DOI 10.1007/s001220051031; Astles PA, 2005, P ROY SOC B-BIOL SCI, V272, P2577, DOI 10.1098/rspb.2005.3174; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bailey JK, 2009, NEW PHYTOL, V184, P746, DOI 10.1111/j.1469-8137.2009.03081.x; BASTEN CJ, 2002, QTL CARTOGRAPHER; Bennett AE, 2006, AM NAT, V167, P141, DOI 10.1086/499379; BONIERBALE MW, 1994, THEOR APPL GENET, V87, P973, DOI 10.1007/BF00225792; Bonkowski M, 2001, OIKOS, V95, P441, DOI 10.1034/j.1600-0706.2001.950309.x; Bonte D, 2010, PLOS ONE, V5, P9; Broadway RM, 1997, J INSECT PHYSIOL, V43, P855, DOI 10.1016/S0022-1910(97)00028-0; Castro AM, 2004, PLANT BREEDING, V123, P361, DOI 10.1111/j.1439-0523.2004.00995.x; Chen L, 2006, GENETICS, V173, P2371, DOI 10.1534/genetics.105.052506; Cronin JT, 2001, OECOLOGIA, V127, P87, DOI 10.1007/s004420000561; Dodd IC, 2010, ANN APPL BIOL, V157, P361, DOI 10.1111/j.1744-7348.2010.00439.x; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Fuentes-Contreras E, 2002, ECOSCIENCE, V9, P37, DOI 10.1080/11956860.2002.11682688; GAGNE S, 1993, SOIL BIOL BIOCHEM, V25, P269, DOI 10.1016/0038-0717(93)90038-D; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Goellner K, 2008, EUR J PLANT PATHOL, V121, P233, DOI 10.1007/s10658-007-9251-4; Hale BK, 2003, ECOL ENTOMOL, V28, P666, DOI 10.1111/j.1365-2311.2003.00563.x; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Jensen CJ, 1976, BARL GEN 3 P 3 INT B, P316; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Lawson HA, 2010, J LIPID RES, V51, P2976, DOI 10.1194/jlr.M006957; Li AiLi, 2006, Agricultural Sciences in China, V5, P241, DOI 10.1016/S1671-2927(06)60045-X; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Miller TE, 1996, ECOLOGY, V77, P1329, DOI 10.2307/2265530; Moharramipour S, 1997, THEOR APPL GENET, V94, P592, DOI 10.1007/s001220050455; Pate J, 1998, OECOLOGIA, V117, P301, DOI 10.1007/s004420050663; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Poveda K, 2005, OIKOS, V108, P503, DOI 10.1111/j.0030-1299.2005.13664.x; Smith KP, 1999, P NATL ACAD SCI USA, V96, P4786, DOI 10.1073/pnas.96.9.4786; Snoeren TAL, 2007, J ECOL, V95, P17, DOI 10.1111/j.1365-2745.2006.01183.x; Soler R, 2007, OIKOS, V116, P367, DOI 10.1111/j.0030-1299.2007.15501.x; Soundararajan RP, 2004, CROP SCI, V44, P2214, DOI 10.2135/cropsci2004.2214; Steffenson BJ, 1996, THEOR APPL GENET, V92, P552, DOI 10.1007/BF00224557; Stout MJ, 2002, ARCH INSECT BIOCHEM, V51, P222, DOI 10.1002/arch.10066; Strauss SY, 2005, NEW PHYTOL, V165, P81, DOI 10.1111/j.1469-8137.2004.01228.x; Tetard-Jones C, 2011, PHILOS T R SOC B, V366, P1368, DOI 10.1098/rstb.2010.0356; Tetard-Jones C, 2007, AM NAT, V170, P492, DOI 10.1086/520115; Underwood N, 2000, ECOLOGY, V81, P1565, DOI 10.1890/0012-9658(2000)081[1565:TEOHPG]2.0.CO;2; Utsumi S, 2011, POPUL ECOL, V53, P23, DOI 10.1007/s10144-010-0253-2; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; van Loon JJA, 2000, ENTOMOL EXP APPL, V97, P219, DOI 10.1046/j.1570-7458.2000.00733.x; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wooley SC, 2007, ECOL ENTOMOL, V32, P428, DOI 10.1111/j.1365-2311.2007.00883.x; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Wurst S, 2004, NEW PHYTOL, V163, P169, DOI 10.1111/j.1469-8137.2004.01106.x; Zhong SB, 2003, PHYTOPATHOLOGY, V93, P604, DOI 10.1094/PHYTO.2003.93.5.604; Zytynska SE, 2010, ECOLOGY, V91, P1563, DOI 10.1890/09-2070.1	59	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41524	10.1371/journal.pone.0041524	http://dx.doi.org/10.1371/journal.pone.0041524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844487	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600033
J	Zhang, MQ; Jiang, M; Bi, Y; Zhu, H; Zhou, ZM; Sha, JH				Zhang, Mianqiu; Jiang, Min; Bi, Ye; Zhu, Hui; Zhou, Zuomin; Sha, Jiahao			Autophagy and Apoptosis Act as Partners to Induce Germ Cell Death after Heat Stress in Mice	PLOS ONE			English	Article							TRANSIENT SCROTAL HYPERTHERMIA; MOLECULAR-MECHANISMS; SINGLE EXPOSURE; TESTIS; RAT; SPERMATOGENESIS; SUBFERTILITY; TESTOSTERONE; YEAST; EPIDIDYMIDES	Testicular heating suppresses spermatogenesis which is marked by germ cell loss via apoptotic pathways. Recently, it is reported that autophagy also can be induced by heat treatment in somatic cells. In this study, the status of autophagy in germ cells after heat treatment, as well as the partnership between autophagy and apoptosis in these cells was investigated. The results demonstrated that besides initiating apoptotic pathways, heat also induced autophagic pathways in germ cells. Exposure of germ cells to hyperthermia resulted in several specific features of the autophagic process, including autophagosome formation and the conversion of LC3-I to LC3-II. Furthermore, the ubiquitin-like protein conjugation system was implicated as being likely responsible for heat-induced autophagy in germ cells since all genes involving this system were found to be expressed in the testes. In addition, the upstream protein in this system, Atg7 (Autophagy-related gene 7), was found to be expressed in all types of spermatogenic cells, and its expression level was positively correlated with the level of autophagy in germ cells. As a result, Atg7 was selected as the investigative target to further analyze the role of autophagy in heat-induced germ cell death. It was shown that down expression of Atg7 protein resulted in the notable decrease in the level of autophagy in heat-treated germ cells, and this down-regulation of autophagy caused by Atg7 knockdown further reduced the apoptotic rate of germ cells. These results suggest that autophagy plays a positive role in the process of germ cell apoptosis after heat treatment. In conclusion, this study demonstrates that heat triggers autophagy and apoptosis in germ cells. These two mechanisms might act as partners, not antagonist, to induce cell death and lead to eventual destruction of spermatogenesis.	[Zhang, Mianqiu; Jiang, Min; Bi, Ye; Zhu, Hui; Zhou, Zuomin; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhang, MQ (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	njzhuhui@njmu.edu.cn	Bi, Ye/A-6272-2017	Jiang, Min/0000-0002-7005-937X	973 program [2011CB944304]	973 program(National Basic Research Program of China)	This study was supported by grants from 973 program (grant no.: 2011CB944304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon MA, 2005, REPROD TOXICOL, V20, P127, DOI 10.1016/j.reprotox.2004.11.016; Armstrong DJ, 2002, INT J BIOCHEM CELL B, V34, P588, DOI 10.1016/S1357-2725(01)00157-1; BARTH AD, 1994, CAN VET J, V35, P93; BLACKSHAW AW, 1978, AUST J BIOL SCI, V31, P53, DOI 10.1071/BI9780053; CHILVERS C, 1986, J PEDIATR SURG, V21, P691, DOI 10.1016/S0022-3468(86)80389-X; COLLINS P, 1969, PROC R SOC SER B-BIO, V172, P17, DOI 10.1098/rspb.1969.0009; Coto-Montes A, 2012, MOL CELL ENDOCRINOL; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006; Guo XJ, 2011, PROTEOMICS, V11, P298, DOI 10.1002/pmic.200900726; Guo XJ, 2010, J PROTEOME RES, V9, P1246, DOI 10.1021/pr900735k; Hikim APS, 1997, BIOL REPROD, V57, P1193, DOI 10.1095/biolreprod57.5.1193; Hikim APS, 1999, REV REPROD, V4, P38; Jannes P, 1998, HUM REPROD, V13, P372, DOI 10.1093/humrep/13.2.372; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2006, J CLIN ENDOCR METAB, V91, P539, DOI 10.1210/jc.2005-1808; MIEUSSET R, 1994, INT J ANDROL, V17, P186, DOI 10.1111/j.1365-2605.1994.tb01241.x; MIEUSSET R, 1992, J REPROD FERTIL, V94, P337, DOI 10.1530/jrf.0.0940337; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Richburg JH, 2002, TOXICOL LETT, V135, P167, DOI 10.1016/S0378-4274(02)00254-0; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Sciarretta S, 2012, AUTOPHAGY, V8, P1252, DOI 10.4161/auto.20670; Song BS, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097949; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; WAITES GMH, 1973, J REPROD FERTIL, V34, P41; Wang C, 2007, J CLIN ENDOCR METAB, V92, P3292, DOI 10.1210/jc.2007-0367; Woolveridge L, 1999, BIOL REPROD, V60, P461, DOI 10.1095/biolreprod60.2.461; Yin YZ, 1997, J ANDROL, V18, P159; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhu H, 2010, PROTEOMICS, V10, P3480, DOI 10.1002/pmic.201000281	42	119	122	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41412	10.1371/journal.pone.0041412	http://dx.doi.org/10.1371/journal.pone.0041412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848486	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600063
J	Cobiac, LJ; Magnus, A; Lim, S; Barendregt, JJ; Carter, R; Vos, T				Cobiac, Linda J.; Magnus, Anne; Lim, Stephen; Barendregt, Jan J.; Carter, Rob; Vos, Theo			Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease?	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; MELBOURNE STROKE INCIDENCE; BLOOD-PRESSURE; RISK-FACTORS; HEALTH; AUSTRALIA; METAANALYSIS; STATINS; CHOLESTEROL; REDUCTION	Background: Despite many decades of declining mortality rates in the Western world, cardiovascular disease remains the leading cause of death worldwide. In this research we evaluate the optimal mix of lifestyle, pharmaceutical and population-wide interventions for primary prevention of cardiovascular disease. Methods and Findings: In a discrete time Markov model we simulate the ischaemic heart disease and stroke outcomes and cost impacts of intervention over the lifetime of all Australian men and women, aged 35 to 84 years, who have never experienced a heart disease or stroke event. Best value for money is achieved by mandating moderate limits on salt in the manufacture of bread, margarine and cereal. A combination of diuretic, calcium channel blocker, ACE inhibitor and low-cost statin, for everyone with at least 5% five-year risk of cardiovascular disease, is also cost-effective, but lifestyle interventions aiming to change risky dietary and exercise behaviours are extremely poor value for money and have little population health benefit. Conclusions: There is huge potential for improving efficiency in cardiovascular disease prevention in Australia. A tougher approach from Government to mandating limits on salt in processed foods and reducing excessive statin prices, and a shift away from lifestyle counselling to more efficient absolute risk-based prescription of preventive drugs, could cut health care costs while improving population health.	[Cobiac, Linda J.; Barendregt, Jan J.; Vos, Theo] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Magnus, Anne; Carter, Rob] Deakin Univ, Deakin Hlth Econ Strateg Res Ctr Populat Hlth, Burwood, Vic, Australia; [Lim, Stephen] Inst Hlth Metr & Evaluat, Seattle, WA USA	University of Queensland; Deakin University; Institute for Health Metrics & Evaluation	Cobiac, LJ (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	l.cobiac@uq.edu.au	Barendregt, Jan J/F-6895-2010	Carter, Rob/0000-0002-1586-5619	National Health and Medical Research Council [351558]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a grant from the National Health and Medical Research Council (Project ID no. 351558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2009, CONS PRIC IND AUSTR; ABS, 1995, NAT NUTR SURV FOODS; AIHW, 2006, HLTH EXP AUSTR; AIHW, 2009, HLTH EXP AUSTR 2007; AIHW, AIHW NAT HOSP MORB D; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baltussen RM., 2003, MAKING CHOICES HLTH; Barnett H, 2010, BMJ-BRIT MED J, V340, pc1805; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Begg S, 2008, AUST HEALTH REV, V32, P148, DOI 10.1071/AH080148; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Beilby J, 2005, GEN PRACTICE AUSTR 2, P128; Britt H, 2009, GEN PRACTICE ACTIVIT; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Brunner EJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub3; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Chen JT, 2005, PHARMACOTHERAPY, V25, P171, DOI 10.1592/phco.25.2.171.56942; Clarke PM, 2010, MED J AUSTRALIA, V192, P633, DOI 10.5694/j.1326-5377.2010.tb03661.x; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Caterina R, 2010, J AM COLL CARDIOL, V55, P198, DOI 10.1016/j.jacc.2009.07.062; Department of Health, 2008, EC MOD VASC CHECKS; Department of Health, 2008, PUTT PREV 1 VASC CHE; Department of Health and Ageing, 2005, GEN PRACT AUSTR 2004; Department of Veterens' Affairs, 2008, EX PHYS SCHED FEES; Department of Veterens' Affairs, 2008, DIET SCHED FEES; Dewey HM, 2001, STROKE, V32, P2409, DOI 10.1161/hs1001.097222; Dunstan D, 2001, DIABESITY ASS DISORD; Ebrahim S, 2006, COCHRANE DATABASE SY; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Food Standards Australia New Zealand, 2010, AUSTR NZ FOOD STAND; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Gold MR, 1996, COST EFFECTIVENESS H; Ha DA, 2010, HLTH POLICY PLANNING; Heeley EL, 2010, MED J AUSTRALIA, V192, P254, DOI 10.5694/j.1326-5377.2010.tb03502.x; Kidd J, 2006, NAT REV DRUG DISCOV, V5, P813, DOI 10.1038/nrd2156; KPMG Health Education and Community Services Group, 2002, COST WEIGHT SUTD; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; Lim S, 2005, THESIS MONASH U MELB; MBS, 2008, MED BEN SCHED; McElduff P, 2000, WHO MONICA STUDY AUS; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; Moon JC, 2006, BMJ-BRIT MED J, V332, P1344, DOI 10.1136/bmj.332.7554.1344; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; National Vascular Disease Prevention Alliance, 2009, GUID ASS ABS CARD DI; NHS Prescription Services, 2010, NHS EL DRUG TAR DEC; OECD, 2009, PURCH POW PAR PPPS O; PBS, 2008, PHARM BEN SCHED; Pennant M, 2010, AM J EPIDEMIOL, V172, P501, DOI 10.1093/aje/kwq171; PHARMAC, 2010, PHARM SCHED; Ronckers ET, 2006, BMC PUBLIC HEALTH, V6; Rubinstein A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-627; Senes S, 2007, MED CARDIOVASCULAR H; Simons LA, 2000, BRIT MED J, V321, P1084, DOI 10.1136/bmj.321.7268.1084; Simons LA, 2008, MED J AUSTRALIA, V188, P224, DOI 10.5694/j.1326-5377.2008.tb01589.x; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Thrift AG, 2000, STROKE, V31, P2087, DOI 10.1161/01.STR.31.9.2087; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Veerman L., 2010, ASSESSING COST EFFEC; Wells S, 2008, EUR J CARDIOV PREV R, V15, P173, DOI 10.1097/HJR.0b013e3282f13af4; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; WHO, 2009, TABL COSTS PRIC US W; World Health Organization, 2008, GLOB BURD DIS 2004 U; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	73	59	59	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41842	10.1371/journal.pone.0041842	http://dx.doi.org/10.1371/journal.pone.0041842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844529	Green Published, gold			2022-12-27	WOS:000306687700157
J	Luntamo, M; Rantala, AM; Meshnick, SR; Cheung, YB; Kulmala, T; Maleta, K; Ashorn, P				Luntamo, Mari; Rantala, Anne-Maria; Meshnick, Steven R.; Cheung, Yin Bun; Kulmala, Teija; Maleta, Kenneth; Ashorn, Per			The Effect of Monthly Sulfadoxine-Pyrimethamine, Alone or with Azithromycin, on PCR-Diagnosed Malaria at Delivery: A Randomized Controlled Trial	PLOS ONE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; PREGNANCY-ASSOCIATED MALARIA; PLASMODIUM-FALCIPARUM; WOMEN; RESISTANCE; THERAPY; BURDEN; INFECTIONS; PREVALENCE; EFFICACY	Background: New regimens for intermittent preventive treatment in pregnancy (IPTp) against malaria are needed as the effectiveness of the standard two-dose sulfadoxine-pyrimethamine (SP) regimen is under threat. Previous trials have shown that IPTp with monthly SP benefits HIV-positive primi-and secundigravidae, but there is no conclusive evidence of the possible benefits of this regimen to HIV-negative women, or to a population comprising of both HIV-positive and -negative women of different gravidities. Methods: This study analyzed 484 samples collected at delivery as part of a randomized, partially placebo controlled clinical trial, conducted in rural Malawi between 2003 and 2007. The study included pregnant women regardless of their gravidity or HIV-infection status. The participants received SP twice (controls), monthly SP, or monthly SP and two doses of azithromycin (AZI-SP). The main outcome was the prevalence of peripheral Plasmodium falciparum malaria at delivery diagnosed with a real-time polymerase chain reaction (PCR) assay. Findings: Overall prevalence of PCR-diagnosed peripheral P. falciparum malaria at delivery was 10.5%. Compared with the controls, participants in the monthly SP group had a risk ratio (95% CI) of 0.33 (0.17 to 0.64, P<0.001) and those in the AZI-SP group 0.23 (0.11 to 0.48, P<0.001) for malaria at delivery. When only HIV-negative participants were analyzed, the corresponding figures were 0.26 (0.12 to 0.57, P<0.001) for women in the monthly SP group, and 0.24 (0.11 to 0.53, P<0.001) for those in the AZI-SP group. Conclusions: Our results suggest that increasing the frequency of SP administration during pregnancy improves the efficacy against malaria at delivery among HIV-negative women, as well as a population consisting of both HIV-positive and negative pregnant women of all gravidities, in a setting of relatively low but holoendemic malaria transmission, frequent use of bed nets and high SP resistance.	[Luntamo, Mari; Rantala, Anne-Maria; Kulmala, Teija; Ashorn, Per] Univ Tampere, Dept Int Hlth, Sch Med, FIN-33101 Tampere, Finland; [Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Cheung, Yin Bun] Singapore Clin Res Inst, Singapore, Singapore; [Cheung, Yin Bun] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Maleta, Kenneth] Univ Malawi, Coll Med, Blantyre, Malawi; [Ashorn, Per] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Tampere University; University of North Carolina; University of North Carolina Chapel Hill; Singapore Clinical Research Institute; National University of Singapore; University of Malawi; Tampere University; Tampere University Hospital	Luntamo, M (corresponding author), Univ Tampere, Dept Int Hlth, Sch Med, FIN-33101 Tampere, Finland.	mari.luntamo@gmail.com	Maleta, Ken M/J-2821-2016	Maleta, Ken M/0000-0002-2536-3938; Ashorn, Per/0000-0003-2311-2593	Academy of Finland [79787, 207010]; Foundation for Pediatric Research in Finland; Medical Research Fund of Tampere University Hospital; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Foundation for Pediatric Research in Finland; Medical Research Fund of Tampere University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by grants from the Academy of Finland (grants 79787 and 207010), the Foundation for Pediatric Research in Finland, the Medical Research Fund of Tampere University Hospital, and the Sigrid Juselius Foundation. Azithromycin and its placebo were provided free of charge by Pfizer Inc (New York). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; Ashwood-Smith Hannah, 2002, Malawi Med J, V14, P8; Bertin G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-196; Chico RM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-255; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Gill CJ, 2007, J INFECT DIS, V196, P1577, DOI 10.1086/522137; Hamer DH, 2007, J INFECT DIS, V196, P1585, DOI 10.1086/522142; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Kalilani L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001166; Kulmala T, 2001, Afr J Reprod Health, V5, P99, DOI 10.2307/3583328; Luntamo M, 2010, AM J TROP MED HYG, V83, P1212, DOI 10.4269/ajtmh.2010.10-0264; Maiga OM, 2011, CLIN INFECT DIS, V53, P215, DOI 10.1093/cid/cir374; Mayor A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-9; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x; Mockenhaupt FP, 2008, J INFECT DIS, V198, P1545, DOI 10.1086/592455; Ouma PO, 2007, TROP MED INT HEALTH, V12, P953, DOI 10.1111/j.1365-3156.2007.01876.x; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; *PFIZ INC, ZITHR PROD INF; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Sangare LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015066; Sridaran S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-247; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Taylor SM, 2012, CLIN INFECT DIS, V55, P42, DOI 10.1093/cid/cis301; Taylor SM, 2012, INFECT GENET EVOL, V12, P282, DOI 10.1016/j.meegid.2011.11.006; ter Kuile FO, 2007, J INFECT DIS, V196, P1574, DOI 10.1086/522233; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; WHO, 2011, WORLD MALARIA REPORT 2011, P1	33	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41123	10.1371/journal.pone.0041123	http://dx.doi.org/10.1371/journal.pone.0041123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829919	gold, Green Submitted, Green Published			2022-12-27	WOS:000306956300058
J	Mahvi, AH; Roodbari, AA; Nodehi, RN; Nasseri, S; Dehghani, MH; Alimohammadi, M				Mahvi, Amir Hossein; Roodbari, Ali Akbar; Nodehi, Ramin Nabizadeh; Nasseri, Simin; Dehghani, Mohammad Hadil; Alimohammadi, Mahmood			RETRACTED: Improvement of Landfill Leachate Biodegradability with Ultrasonic Process (Retracted article. See vol. 9, e96133, 2014)	PLOS ONE			English	Article; Retracted Publication							AEROBIC BIOLOGICAL TREATMENT; ADVANCED OXIDATION PROCESSES; HEAVY-METALS; WASTE; ADSORPTION; FENTON; REDUCTION; TOXICITY; REMOVAL; REACTOR	Landfills leachates are known to contain recalcitrant and/or non-biodegradable organic substances and biological processes are not efficient in these cases. A promising alternative to complete oxidation of biorecalcitrant leachate is the use of ultrasonic process as pre-treatment to convert initially biorecalcitrant compounds to more readily biodegradable intermediates. The objectives of this study are to investigate the effect of ultrasonic process on biodegradability improvement. After the optimization by factorial design, the ultrasonic were applied in the treatment of raw leachates using a batch wise mode. For this, different scenarios were tested with regard to power intensities of 70 and 110 W, frequencies of 30, 45 and 60 KHz, reaction times of 30, 60, 90 and 120 minutes and pH of 3, 7 and 10. For determining the effects of catalysts on sonication efficiencies, 5 mg/l of TiO2 and ZnO have been also used. Results showed that when applied as relatively brief pre-treatment systems, the sonocatalysis processes induce several modifications of the matrix, which results in significant enhancement of its biodegradability. For this reason, the integrated chemical-biological systems proposed here represent a suitable solution for the treatment of landfill leachate samples.	[Mahvi, Amir Hossein; Roodbari, Ali Akbar; Nodehi, Ramin Nabizadeh; Nasseri, Simin; Dehghani, Mohammad Hadil; Alimohammadi, Mahmood] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran; [Mahvi, Amir Hossein] Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran; [Mahvi, Amir Hossein] Univ Tehran Med Sci, Inst Environm Res, Ctr Solid Waste Res, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Mahvi, AH (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran.	ahmahvi@yahoo.com	Alimohammadi, Mahmood/M-1286-2017; Roudbari, AliAkbar/L-8684-2017	Alimohammadi, Mahmood/0000-0003-0850-154X; Roudbari, AliAkbar/0000-0002-9672-3646; nasseri, simin/0000-0003-4498-5617; nabizadeh, ramin/0000-0002-6798-7474; dehghani, mohammad hadi/0000-0001-7516-8885				Anglada A, 2011, WATER RES, V45, P828, DOI 10.1016/j.watres.2010.09.017; Atmaca E, 2009, J HAZARD MATER, V163, P109, DOI 10.1016/j.jhazmat.2008.06.067; Aziz HA, 2011, DESALINATION, V276, P278, DOI 10.1016/j.desal.2011.03.063; Bae BU, 1999, WATER RES, V33, P2669, DOI 10.1016/S0043-1354(98)00488-6; Bashir MJK, 2010, J HAZARD MATER, V182, P115, DOI 10.1016/j.jhazmat.2010.06.005; Ben Yahmed A, 2009, DESALINATION, V246, P378, DOI 10.1016/j.desal.2008.04.054; Bidhendi ME, 2010, INT J ENVIRON SCI TE, V7, P545, DOI 10.1007/BF03326163; Bila DM, 2005, J HAZARD MATER, V117, P235, DOI 10.1016/j.jhazmat.2004.09.022; Chen CC, 2010, INT J ENVIRON SCI TE, V7, P447, DOI 10.1007/BF03326154; Chianese A, 1999, WATER RES, V33, P647, DOI 10.1016/S0043-1354(98)00240-1; CHIANG LC, 1995, WATER RES, V29, P671, DOI 10.1016/0043-1354(94)00146-X; Cortez S, 2011, J ENVIRON MANAGE, V92, P749, DOI 10.1016/j.jenvman.2010.10.035; de Morais JL, 2005, J HAZARD MATER, V123, P181, DOI 10.1016/j.jhazmat.2005.03.041; Dehghani Mohammad Hadi, 2007, Journal of Zhejiang University-Science B, V8, P493, DOI 10.1631/jzus.2007.B0493; Guo JS, 2010, J HAZARD MATER, V178, P699, DOI 10.1016/j.jhazmat.2010.01.144; Kargi F, 2004, ENZYME MICROB TECH, V34, P422, DOI 10.1016/j.enzmictec.2003.11.016; Kargi F, 2003, PROCESS BIOCHEM, V38, P1413, DOI 10.1016/S0032-9592(03)00030-X; Kurniawan TA, 2009, WATER RES, V43, P4079, DOI 10.1016/j.watres.2009.06.060; Leao S., 2004, Computers, Environment and Urban Systems, V28, P353, DOI 10.1016/S0198-9715(03)00043-7; Li HJ, 2010, J ENVIRON SCI-CHINA, V22, P1116, DOI 10.1016/S1001-0742(09)60226-6; Lim PE, 2010, CHEM ENG J, V159, P123, DOI 10.1016/j.cej.2010.02.064; Lim YN, 2009, CHEM ENG J, V146, P86, DOI 10.1016/j.cej.2008.05.020; Mahini A. Salman, 2006, International Journal of Environmental Science and Technology, V3, P435, DOI 10.1007/BF03325953; Mahvi AH, 2009, IRAN J ENVIRON HEALT, V6, P233; Mahvi AH, 2009, IRAN J PUBLIC HEALTH, V38, P1; Ogundiran OO, 2008, INT J ENVIRON SCI TE, V5, P243, DOI 10.1007/BF03326018; Pattnaik S, 2010, RESOUR CONSERV RECY, V54, P512, DOI 10.1016/j.resconrec.2009.10.008; Pi KW, 2009, PROCESS SAF ENVIRON, V87, P191, DOI 10.1016/j.psep.2009.01.002; Pilli S, 2011, ULTRASON SONOCHEM, V18, P1, DOI 10.1016/j.ultsonch.2010.02.014; ROBINSON HD, 1983, WATER RES, V17, P1537, DOI 10.1016/0043-1354(83)90010-6; Schoeman JJ, 2008, DESALINATION, V224, P178, DOI 10.1016/j.desal.2007.02.090; SCHUK WW, 1986, WASTE MANAGE RES, V4, P265, DOI 10.1177/0734242X8600400133; Scullion J, 2007, WATER RES, V41, P4129, DOI 10.1016/j.watres.2007.05.043; Sun YJ, 2010, ULTRASON SONOCHEM, V17, P654, DOI 10.1016/j.ultsonch.2009.12.005; Suthar S, 2008, INT J ENVIRON SCI TE, V5, P99, DOI 10.1007/BF03326002; Vilar VJP, 2011, WATER RES, V45, P2647, DOI 10.1016/j.watres.2011.02.019	36	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e27571	10.1371/journal.pone.0027571	http://dx.doi.org/10.1371/journal.pone.0027571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829863	Green Published, gold			2022-12-27	WOS:000306956300001
J	Mendes, LF; Pirraco, RP; Szymczyk, W; Frias, AM; Santos, TC; Reis, RL; Marques, AP				Mendes, Luis F.; Pirraco, Rogerio P.; Szymczyk, Wojciech; Frias, Ana M.; Santos, Tircia C.; Reis, Rui L.; Marques, Alexandra P.			Perivascular-Like Cells Contribute to the Stability of the Vascular Network of Osteogenic Tissue Formed from Cell Sheet-Based Constructs	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; MESENCHYMAL STROMAL CELLS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; STEM-CELLS; MATRIX-METALLOPROTEINASE; CULTURE SURFACES; BLOOD-VESSELS; TGF-BETA; IN-VIVO	In recent years several studies have been supporting the existence of a close relationship in terms of function and progeny between Mesenchymal Stem Cells (MSCs) and Pericytes. This concept has opened new perspectives for the application of MSCs in Tissue Engineering (TE), with special interest for the pre-vascularization of cell dense constructs. In this work, cell sheet technology was used to create a scaffold-free construct composed of osteogenic, endothelial and perivascular-like (CD146(+)) cells for improved in vivo vessel formation, maturation and stability. The CD146 pericyte-associated phenotype was induced from human bone marrow mesenchymal stem cells (hBMSCs) by the supplementation of standard culture medium with TGF-beta 1. Co-cultured cell sheets were obtained by culturing perivascular-like (CD146(+)) cells and human umbilical vein endothelial cells (HUVECs) on an hBMSCs monolayer maintained in osteogenic medium for 7 days. The perivascular-like (CD146(+)) cells and the HUVECs migrated and organized over the collagen-rich osteogenic cell sheet, suggesting the existence of cross-talk involving the co-cultured cell types. Furthermore the presence of that particular ECM produced by the osteoblastic cells was shown to be the key regulator for the singular observed organization. The osteogenic and angiogenic character of the proposed constructs was assessed in vivo. Immunohistochemistry analysis of the explants revealed the integration of HUVECs with the host vasculature as well as the osteogenic potential of the created construct, by the expression of osteocalcin. Additionally, the analysis of the diameter of human CD146 positive blood vessels showed a higher mean vessel diameter for the co-cultured cell sheet condition, reinforcing the advantage of the proposed model regarding blood vessels maturation and stability and for the in vitro pre-vascularization of TE constructs.	[Mendes, Luis F.; Pirraco, Rogerio P.; Szymczyk, Wojciech; Frias, Ana M.; Santos, Tircia C.; Reis, Rui L.; Marques, Alexandra P.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal; [Mendes, Luis F.; Pirraco, Rogerio P.; Szymczyk, Wojciech; Frias, Ana M.; Santos, Tircia C.; Reis, Rui L.; Marques, Alexandra P.] Univ Minho, ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal	Universidade do Minho; Universidade do Minho	Mendes, LF (corresponding author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal.	apmarques@dep.uminho.pt	Santos, Tircia/I-5595-2013; Marques, AP/H-7865-2019; Reis, Rui L./A-8938-2008; Marques, Alexandra P/B-1238-2012; Pirraco, Rogerio/O-8122-2015	Santos, Tircia/0000-0002-5365-4863; Marques, AP/0000-0002-3222-0310; Reis, Rui L./0000-0002-4295-6129; Marques, Alexandra P/0000-0002-3222-0310; Pirraco, Rogerio/0000-0001-5521-950X; Freitas Mendes, Luis Filipe/0000-0002-4170-8617	Fundacao para a Ciencia e a Tecnologia project Skingineering [PTDC/SAU-OSM/099422/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-OSM/099422/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia project Skingineering; Fundação para a Ciência e a Tecnologia	Funding provided by Fundacao para a Ciencia e a Tecnologia project Skingineering (PTDC/SAU-OSM/099422/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Amselgruber WM, 1999, ANAT HISTOL EMBRYOL, V28, P157, DOI 10.1046/j.1439-0264.1999.00195.x; Anfosso F, 2001, J BIOL CHEM, V276, P1564, DOI 10.1074/jbc.M007065200; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Bu PC, 2007, BBA-MOL CELL RES, V1773, P513, DOI 10.1016/j.bbamcr.2007.01.009; Caplan AI, 2011, J ORTHOPAEDIC RES; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Dohle E, 2011, EUR CELLS MATER, V21, P144, DOI 10.22203/eCM.v021a12; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; ENGERMAN RL, 1967, LAB INVEST, V17, P738; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018; Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342; Hirschi K K, 1997, EXS, V79, P419; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Kano K, 2008, HEPATOL RES, V38, P1140, DOI 10.1111/j.1872-034X.2008.00371.x; Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193; Kirkpatrick CJ, 2011, ADV DRUG DE IN PRESS; Kobayashi J, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014111; Krizmanich WJ, 1997, EXP MOL PATHOL, V64, P157, DOI 10.1006/exmp.1997.2217; Kushida A, 2005, Eur Cell Mater, V10, P23; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; Lafleur MA, 2001, BIOCHEM BIOPH RES CO, V282, P463, DOI 10.1006/bbrc.2001.4596; Lennon D. P., 2006, MESENCHYMAL STEM CEL, P23; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016767; Li XY, 2008, WOUND REPAIR REGEN, V16, P346, DOI 10.1111/j.1524-475X.2008.00374.x; NEHLS V, 1992, CELL TISSUE RES, V270, P469, DOI 10.1007/BF00645048; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Obokata H, 2011, NAT PROTOC, V6, P1053, DOI 10.1038/nprot.2011.356; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Ouhtit A, 2009, BBA-REV CANCER, V1795, P130, DOI 10.1016/j.bbcan.2009.01.002; Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535; Pirraco RP, 2011, TISSUE ENG PT A, V17, P1507, DOI [10.1089/ten.TEA.2010.0470, 10.1089/ten.tea.2010.0470]; Pirraco RP, 2011, TERMIS EU 2011 TISS; Pries AR, 2005, HYPERTENSION, V46, P725, DOI 10.1161/01.HYP.0000184428.16429.be; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Sekiya S, 2010, MICROVASC RES, V80, P549, DOI 10.1016/j.mvr.2010.08.001; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Shepherd BR, 2009, TISSUE ENG PT A, V15, P165, DOI 10.1089/ten.tea.2008.0010; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Takakura N, 2011, J THROMB HAEMOST, V9, P144, DOI 10.1111/j.1538-7836.2011.04275.x; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107; Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002; Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032; Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001; von Tell D, 2006, EXP CELL RES, V312, P623, DOI 10.1016/j.yexcr.2005.10.019; Williams C, 2011, BIOMATERIALS, V32, P5625, DOI 10.1016/j.biomaterials.2011.04.050; Williams C, 2011, BIOMATERIALS, V32, P410, DOI 10.1016/j.biomaterials.2010.08.105; Wolfe Margaret, 2008, V449, P3, DOI 10.1007/978-1-60327-169-1_1; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Zimmerlin L, 2011, CYTOMETRY A	74	43	46	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41051	10.1371/journal.pone.0041051	http://dx.doi.org/10.1371/journal.pone.0041051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829909	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300047
J	Perrin, S; Cremer, J; Roll, P; Faucher, O; Menard, A; Reynes, J; Dellamonica, P; Naqvi, A; Micallef, J; Jouve, E; Tamalet, C; Solas, C; Pissier, C; Arnoux, I; Nicolino-Brunet, C; Espinosa, L; Levy, N; Kaspi, E; Robaglia-Schlupp, A; Poizot-Martin, I; Cau, P				Perrin, Sophie; Cremer, Jonathan; Roll, Patrice; Faucher, Olivia; Menard, Amelie; Reynes, Jacques; Dellamonica, Pierre; Naqvi, Alissa; Micallef, Joelle; Jouve, Elisabeth; Tamalet, Catherine; Solas, Caroline; Pissier, Christel; Arnoux, Isabelle; Nicolino-Brunet, Corine; Espinosa, Leon; Levy, Nicolas; Kaspi, Elise; Robaglia-Schlupp, Andree; Poizot-Martin, Isabelle; Cau, Pierre			HIV-1 Infection and First Line ART Induced Differential Responses in Mitochondria from Blood Lymphocytes and Monocytes: The ANRS EP45 "Aging" Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; MONONUCLEAR-CELLS; OXIDATIVE STRESS; INDUCED APOPTOSIS; REDOX REGULATION; DENDRITIC CELLS; COMPLEX-I; TOXICITY; MECHANISMS	Background: The ANRS EP45 "Aging" study investigates the cellular mechanisms involved in the accelerated aging of HIV-1 infected and treated patients. The data reported focus on mitochondria, organelles known to be involved in cell senescence. Methods: 49 HIV-1 infected patients untreated with antiretroviral therapy, together with 49 seronegative age-and sex-matched control subjects and 81 HIV-1 infected and treated patients, were recruited by 3 AIDS centres (Marseille, Montpellier, Nice; France; http://clinicaltrials.gov/, NCT01038999). In more than 88% of treated patients, the viral load was <40 copies/ml and the CD4+ cell count was >500/mm(3). ROS (reactive oxygen species) production and Delta Psi m (inner membrane potential) were measured by flow cytometry in blood lymphocytes and monocytes (functional parameters). Three mitochondrial network quantitative morphological parameters were computed using confocal microscopy and image analysis. Three PBMC mitochondrial proteins (porin and subunits 2 and 4 of cytochrome C oxidase encoded by mtDNA or nuclear DNA, respectively) were analysed by western blotting. Results: Quantitative changes in PBMC mitochondrial proteins were not induced by either HIV-1 infection or ART. Discriminant analysis integrating functional (ROS production and Delta Psi m) or morphological (network volume density, fragmentation and branching) parameters revealed HIV-1 infection and ART differential effects according to cell type. First line ART tended to rescue lymphocytemitochondrial parameters altered by viral infection, but induced slight changes in monocytes. No statistical difference was found between the effects of three ART regimens on mitochondrial parameters. Correlations between functional parameters and viral load confirmed the damaging effects of HIV-1 in lymphocyte mitochondria. Conclusions: In patients considered to be clinically stable, mitochondria exhibited functional and morphological modifications in PBMCs resulting from either direct or indirect effects of HIV-1 infection (lymphocytes), or from first line ART (monocytes). Together with other tissue impairments, these changes may contribute to global aging.	[Perrin, Sophie; Cremer, Jonathan; Roll, Patrice; Levy, Nicolas; Kaspi, Elise; Robaglia-Schlupp, Andree; Cau, Pierre] Aix Marseille Univ, INSERM, UMR 910, Marseille, France; [Perrin, Sophie; Cremer, Jonathan; Roll, Patrice; Kaspi, Elise; Robaglia-Schlupp, Andree; Cau, Pierre] CHU Timone, AP HM, Lab Biol Cellulaire, Marseille, France; [Faucher, Olivia; Menard, Amelie; Poizot-Martin, Isabelle] CHU St Marguerite, AP HM, Serv Immunohematol Clin, Marseille, France; [Reynes, Jacques] CHRU Gui de Chauliac, Dept Maladies Infect & Trop, Montpellier, France; [Dellamonica, Pierre; Naqvi, Alissa] CHU Archet 1, Serv Infectiol, Nice, France; [Micallef, Joelle; Jouve, Elisabeth] CHU Timone, AP HM, CIC, UPCET, Marseille, France; [Tamalet, Catherine] CHU Timone, AP HM, Federat Microbiol Clin, Marseille, France; [Tamalet, Catherine] Aix Marseille Univ, CNRS, UMR 6236, URMITE,IRD, Marseille, France; [Solas, Caroline; Pissier, Christel] CHU Timone, AP HM, Lab Pharmacocinet & Toxicol, Marseille, France; [Solas, Caroline; Pissier, Christel] Aix Marseille Univ, InsermUMR, U911, Marseille, France; [Arnoux, Isabelle] CHU Timone, AP HM, Hematol Lab, Marseille, France; [Nicolino-Brunet, Corine] CHU Concept, AP HM, Hematol Lab, Marseille, France; [Levy, Nicolas] CHU Timone, AP HM, Lab Genet Mol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Perrin, S (corresponding author), Aix Marseille Univ, INSERM, UMR 910, Marseille, France.	pierre.cau@univ-amu.fr	Kaspi, Elise/I-4936-2016; LEVY, Nicolas/J-1632-2014; Jouve, Elisabeth/GSN-9120-2022; Joëlle, Micallef/P-6977-2016; ROLL, Patrice/GLS-4467-2022; ROLL, Patrice/I-4355-2016; Espinosa, Leon/V-8410-2017; Cau, Pierre/M-3541-2016	Kaspi, Elise/0000-0003-0458-5109; LEVY, Nicolas/0000-0001-5171-6365; Jouve, Elisabeth/0000-0002-4873-6522; ROLL, Patrice/0000-0002-0045-5641; ROLL, Patrice/0000-0002-0045-5641; Perrin, Sophie/0000-0003-4950-283X	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [ANRS EP45]; ANRS [ANRS EP45]; Sidaction [B/22-2-02032, A/19-3-01487]; ADEREM (Biological and medical research supportive association for Marseille hospital centres); GlaxoSmithKline; Boehringen Mannheim	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; ADEREM (Biological and medical research supportive association for Marseille hospital centres); GlaxoSmithKline(GlaxoSmithKline); Boehringen Mannheim	This work was supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS, http://www.anrs.fr/) [ANRS EP45 "Aging" to PC]. SP was a recipient of a 3-year Ph.D. grant from ANRS [ANRS EP45 "Aging" to PC] and a fourth additional Ph.D. year from Sidaction (http://www.sidaction.org/) grant [B/22-2-02032 to SP]. SP received a 3-month transition grant from ADEREM (Biological and medical research supportive association for Marseille hospital centres, http://aderem.fr/index.htm). JC was a recipient of a grant from Sidaction [A/19-3-01487 to PC]. PC was a recipient of grants from GlaxoSmithKline and from Boehringen Mannheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Alexaki A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000215; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Caron M, 2004, AIDS, V18, P2127, DOI 10.1097/00002030-200411050-00004; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Ciccosanti F, 2010, ANTIVIR THER, V15, P377, DOI 10.3851/IMP1530; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Cossarizza A, 2003, ANTIVIR THER, V8, P315; Cossarizza A, 1998, PURDUE CYTOMETRY, V4; Cote HCF, 2007, CURR OPIN HIV AIDS, V2, P253, DOI 10.1097/COH.0b013e3281df3410; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Curran A, 2011, EXPERT OPIN DRUG SAF, V10, P389, DOI 10.1517/14740338.2011.542145; Danaher RJ, 2010, AIDS, V24, P2578, DOI 10.1097/QAD.0b013e32833f4022; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Einsiedel L, 2010, MITOCHONDRION, V10, P534, DOI 10.1016/j.mito.2010.05.010; Elbim C, 1999, J VIROL, V73, P4561, DOI 10.1128/JVI.73.6.4561-4566.1999; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Garrabou G, 2011, AIDS, V25, P165, DOI 10.1097/QAD.0b013e3283423219; Gavegnano Christina, 2009, Antiviral Chemistry & Chemotherapy, V20, P63, DOI 10.3851/IMP1374; Gerschenson M, 2009, J ANTIMICROB CHEMOTH, V63, P1244, DOI 10.1093/jac/dkp100; Groener JB, 2011, AIDS RES HUM RETROV, V27, P969, DOI 10.1089/aid.2010.0348; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Huberty C., 2006, APPL MANOVA DISCRIMI; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Jolly C, 2007, TRENDS IMMUNOL, V28, P474, DOI 10.1016/j.it.2007.08.008; Jones SP, 2005, JAIDS-J ACQ IMM DEF, V40, P565, DOI 10.1097/01.qai.0000187443.30838.3e; Kadiu I, 2009, CELL IMMUNOL, V258, P44, DOI 10.1016/j.cellimm.2009.03.012; Karamchand L, 2008, JAIDS-J ACQ IMM DEF, V48, P381, DOI 10.1097/QAI.0b013e3181799662; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klatt NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003862; Koczor CA, 2010, EXPERT OPIN DRUG MET, V6, P1493, DOI 10.1517/17425255.2010.526602; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu X, 2010, EXPERT OPIN DRUG SAF, V9, P743, DOI 10.1517/14740331003767395; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Lopez S, 2006, AIDS RES HUM RETROV, V22, P33, DOI 10.1089/aid.2006.22.33; Lugli E, 2005, CYTOM PART A, V68A, P28, DOI 10.1002/cyto.a.20188; Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012; Maagaard A, 2009, J ANTIMICROB CHEMOTH, V64, P901, DOI 10.1093/jac/dkp316; Maggiolo F, 2010, ANTIVIR THER, V15, P51, DOI 10.3851/IMP1483; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; Mandas A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/749575; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Martin AM, 2007, AIDS, V21, P1233, DOI 10.1097/QAD.0b013e3280119579; McComsey GA, 2008, HIV CLIN TRIALS, V9, P126, DOI 10.1310/hct0902-126; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Montaner JSG, 2003, JAIDS-J ACQ IMM DEF, V34, pS85, DOI 10.1097/00126334-200309011-00013; Morse CG, 2012, J INFECT DIS, V205, P1778, DOI 10.1093/infdis/jis101; Mukhopadhyay A, 2002, MITOCHONDRION, V1, P511, DOI 10.1016/S1567-7249(02)00042-9; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nakamura H, 2002, ANTIOXID REDOX SIGN, V4, P455, DOI 10.1089/15230860260196245; Narayanan A, 2011, EXPERT OPIN BIOL TH, V11, P17, DOI 10.1517/14712598.2011.540564; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Onafuwa-Nuga A, 2010, CELL RES, V20, P1185, DOI 10.1038/cr.2010.140; Pajonk F, 2002, CANCER RES, V62, P5230; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Petrovas C, 2007, BLOOD, V109, P2505, DOI 10.1182/blood-2006-05-021626; Piccinini M, 2002, AIDS, V16, P693, DOI 10.1097/00002030-200203290-00004; Pinti M, 2006, BBA-BIOENERGETICS, V1757, P700, DOI 10.1016/j.bbabio.2006.05.001; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stehbens WE, 2004, EXP MOL PATHOL, V77, P121, DOI 10.1016/j.yexmp.2004.04.007; Sternfeld T, 2009, HIV MED, V10, P512, DOI 10.1111/j.1468-1293.2009.00723.x; Sternfeld T, 2007, ANTIVIR THER, V12, P769; Sun GH, 2011, TRENDS PHARMACOL SCI, V32, P675, DOI 10.1016/j.tips.2011.07.003; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vidal F, 2006, ANTIMICROB AGENTS CH, V50, P3824, DOI 10.1128/AAC.00437-06; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; Wei Yau-Huei, 2009, Chang Gung Med J, V32, P113; WHITELAW DM, 1972, CELL TISSUE KINET, V5, P311, DOI 10.1111/j.1365-2184.1972.tb00369.x; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Zhao C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.69; Zhao CQ, 2009, J PROTEOME RES, V8, P4028, DOI 10.1021/pr900364p	97	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41129	10.1371/journal.pone.0041129	http://dx.doi.org/10.1371/journal.pone.0041129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829920	Green Published, gold			2022-12-27	WOS:000306956300059
J	Saw, S; Kale, SL; Arora, N				Saw, Sanjay; Kale, Sagar Laxman; Arora, Naveen			Serine Protease Inhibitor Attenuates Ovalbumin Induced Inflammation in Mouse Model of Allergic Airway Disease	PLOS ONE			English	Article							MAST-CELL TRYPTASE; DUST-MITE ALLERGEN; MAJOR ALLERGEN; EPICOCCUM-PURPURASCENS; PROTEOLYTIC ACTIVITY; NAFAMOSTAT MESILATE; HISTAMINE-RELEASE; CHYMASE INHIBITOR; MURINE MODEL; ACTIVATION	Background: Serine proteases promote inflammation and tissue remodeling by activating proteinase-activated receptors, urokinase, metalloproteinases and angiotensin. In the present study, 4-(2-Aminoethyl) benzenesulfonyl fluoride (AEBSF) a serine protease inhibitor was evaluated for prophylactic and therapeutic treatment in mouse model of airway allergy. Methods: BALB/c mice were sensitized by i.p route and challenged with ovalbumin. They were treated i.n. with 2, 10 and 50 mu g of AEBSF, one hour before or after challenge and euthanized to collect BALF (bronchoalveolar lavage fluid), blood and lungs. Proteolytic activity, total cell/eosinophil/neutrophil count eosinophil peroxidase activity (EPO), IL-4, IL-5, IL-10, IL-13, cysteinyl leukotrienes and 8-isoprostane were determined in BALF and immunoglobulins were measured in serum. H&E and PAS stained lung sections were examined for cellular infiltration and airway inflammation. Results: Mice exposed to ovalbumin and treated with PBS showed increased cellular infiltration in lungs and higher serum IgE, IgG1 and IgG2a levels as compared to sham mice. Treatment with AEBSF reduced total cells/eosinophil/neutrophil infiltration. Both prophylactic and therapeutic AEBSF treatment of 10 or 50 mg reduced serum IgE and IgG1 significantly (p<0.05) than control. AEBSF treatment reduced the proteolytic activity in BALF. IL-4 IL-5 and IL-13 levels decreased significantly (p<0.05) after AEBSF treatment while IL-10 levels increased significantly (p<0.05) in BALF. Airway inflammation and goblet cell hyperplasia reduced as demonstrated by lung histopathology, EPO activity and cysteinyl leukotrienes in BALF after treatment. AEBSF treatment also suppressed oxidative stress in terms of 8-isoprostane in BALF. Among the treatment doses, 10 or 50 mg of AEBSF were most effective in reducing the inflammatory parameters. Conclusions: Prophylactic and therapeutic treatment with serine protease inhibitor attenuates the airway inflammation in mouse model of airway allergy and have potential for adjunct therapy.	[Saw, Sanjay; Kale, Sagar Laxman; Arora, Naveen] Inst Genom & Integrat Biol, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Saw, S (corresponding author), Inst Genom & Integrat Biol, Delhi Univ Campus, Delhi, India.	naveen@igib.res.in	Kale, Sagar/I-7107-2019	Saw, Sanjay/0000-0002-8973-3731	Council for Scientific and Industrial Reasearch (CSIR)	Council for Scientific and Industrial Reasearch (CSIR)	The work covered in this manuscript was funded by the Council for Scientific and Industrial Reasearch (CSIR). The URL for the funder's website is "http://rdpp.csir.res.in/csir_acsir/Home.aspx". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLDIN G, 1979, H-S Z PHYSIOL CHEM, V360, P651, DOI 10.1515/bchm2.1979.360.1.651; Bisht V, 2004, FEMS IMMUNOL MED MIC, V42, P205, DOI 10.1016/j.femsim.2004.05.003; Chen CL, 2006, J ALLERGY CLIN IMMUN, V118, P105, DOI 10.1016/j.jaci.2006.02.047; Conseil V, 1999, ANTIMICROB AGENTS CH, V43, P1358, DOI 10.1128/AAC.43.6.1358; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Goel C, 2012, CLIN EXP ALLERGY, V42, P412, DOI 10.1111/j.1365-2222.2011.03937.x; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Gupta R, 2004, ALLERGY, V59, P421, DOI 10.1046/j.1398-9995.2003.00378.x; He S, 1998, J PHARMACOL EXP THER, V286, P289; He SH, 2001, EUR J PHARMACOL, V412, P223, DOI 10.1016/S0014-2999(01)00734-8; He SH, 1997, EUR J PHARMACOL, V328, P89, DOI 10.1016/S0014-2999(97)83033-6; HERBERT CA, 1995, AM J RESP CELL MOL, V12, P369, DOI 10.1165/ajrcmb.12.4.7695916; Hewitt CRA, 1998, ALLERGY, V53, P60, DOI 10.1111/j.1398-9995.1998.tb05000.x; Holla LI, 2009, INT ARCH ALLERGY IMM, V148, P73, DOI 10.1159/000151508; Imada T, 2002, JPN J PHARMACOL, V90, P214, DOI 10.1254/jjp.90.214; Inoue KI, 2005, CHEST, V128, P1069, DOI 10.1378/chest.128.2.1069; Ishizaki M, 2008, J PHARMACOL SCI, V108, P355, DOI 10.1254/jphs.08162FP; Kauffman HF, 2003, CURR ALLERGY ASTHM R, V3, P101, DOI 10.1007/s11882-003-0021-x; Kawikova I, 1996, AM J RESP CRIT CARE, V153, P590, DOI 10.1164/ajrccm.153.2.8564103; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Krishna MT, 2001, J ALLERGY CLIN IMMUN, V107, P1039, DOI 10.1067/mai.2001.115631; Kukreja N, 2008, CLIN EXP IMMUNOL, V154, P162, DOI 10.1111/j.1365-2249.2008.03762.x; Liu YC, 1998, BRIT J PHARMACOL, V124, P563, DOI 10.1038/sj.bjp.0701886; Megyeri P, 1995, IMMUNOLOGY, V86, P629; Megyeri P, 1999, EUR J PHARMACOL, V374, P207, DOI 10.1016/S0014-2999(99)00224-1; Mehta AK, 2007, EUR RESPIR J, V30, P662, DOI 10.1183/09031936.00019307; Nadeem Ahmed, 2008, Ther Adv Respir Dis, V2, P215, DOI 10.1177/1753465808094971; Nakamura Y, 1998, THORAX, V53, P835, DOI 10.1136/thx.53.10.835; Oh SW, 2002, J IMMUNOL, V168, P1992, DOI 10.4049/jimmunol.168.4.1992; Post S, 2011, THORAX; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Saito K, 2004, ANN ALLERG ASTHMA IM, V93, P594, DOI 10.1016/S1081-1206(10)61269-0; Sano C, 2000, CLIN EXP IMMUNOL, V121, P77, DOI 10.1046/j.1365-2249.2000.01269.x; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Shen HD, 1999, CLIN EXP ALLERGY, V29, P642, DOI 10.1046/j.1365-2222.1999.00509.x; Shen HD, 2007, CURR ALLERGY ASTHM R, V7, P351, DOI 10.1007/s11882-007-0053-8; Simpson JL, 2005, AM J RESP CRIT CARE, V172, P559, DOI 10.1164/rccm.200503-369OC; Sudha VT, 2008, ALLERGY, V63, P768, DOI 10.1111/j.1398-9995.2007.01602.x; Sudha VT, 2009, EUR J CLIN INVEST, V39, P507, DOI 10.1111/j.1365-2362.2009.02112.x; Tomimori Y, 2002, BIOCHEM PHARMACOL, V64, P1187, DOI 10.1016/S0006-2952(02)01265-0; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P775; Tripathi P, 2009, J CLIN IMMUNOL, V29, P292, DOI 10.1007/s10875-008-9261-9; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Watanabe N, 2002, INT ARCH ALLERGY IMM, V128, P229, DOI 10.1159/000064256; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; Wijayanti N, 2005, J BIOL CHEM, V280, P21820, DOI 10.1074/jbc.M502943200; Zarnowski R, 2007, DIAGN MICR INFEC DIS, V59, P39, DOI 10.1016/j.diagmicrobio.2007.03.020	48	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41107	10.1371/journal.pone.0041107	http://dx.doi.org/10.1371/journal.pone.0041107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829914	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300053
J	Shizu, R; Shindo, S; Yoshida, T; Numazawa, S				Shizu, Ryota; Shindo, Sawako; Yoshida, Takemi; Numazawa, Satoshi			MicroRNA-122 Down-Regulation Is Involved in Phenobarbital-Mediated Activation of the Constitutive Androstane Receptor	PLOS ONE			English	Article							NUCLEAR RECEPTOR; PROTEIN-KINASE; ACTIVE/ANDROSTANE RECEPTOR; TUMOR PROMOTION; RAT HEPATOCYTES; LIVER; EXPRESSION; CAR; INDUCTION; MIR-122	Constitutive androstane receptor (CAR) is a nuclear receptor that regulates the transcription of target genes, including CYP2B and 3A. Phenobarbital activates CAR, at least in part, in an AMP-activated protein kinase (AMPK)-dependent manner. However, the precise mechanisms underlying phenobarbital activation of AMPK are still unclear. In the present study, it was demonstrated that phenobarbital administration to mice decreases hepatic miR-122, a liver-enriched microRNA involved in both hepatic differentiation and function. The time-course change in the phenobarbital-mediated down-regulation of miR-122 was inversely correlated with AMPK activation. Phenobarbital decreased primary miR-122 to approximately 25% of the basal level as early as 1 h and suppressed transactivity of mir-122 promoter in HuH-7 cells, suggesting that the down-regulation occurred at the transcriptional level. AMPK activation by metformin or 5-aminoimidazole-4-carboxamide 1-beta-D-ribonucleoside had no evident effect on miR-122 levels. An inhibitory RNA specific for miR-122 increased activated AMPK and CAR-mediated trancactivation of the phenobarbital-responsive enhancer module in HepG2 cells. Conversely, the reporter activity induced by the ectopic CAR was almost completely suppressed by co-transfection with the miR-122 mimic RNA. GFP-tagged CAR was expressed in the cytoplasm in addition to the nucleus in the majority of HuH-7 cells in which miR-122 was highly expressed. Co-transfection of the mimic or the inhibitor RNA for miR-122 further increased or decreased, respectively, the number of cells that expressed GFP-CAR in the cytoplasm. Taken together, these results suggest that phenobarbital-mediated down-regulation of miR-122 is an early and important event in the AMPK-dependent CAR activation and transactivation of its target genes.	[Shizu, Ryota; Shindo, Sawako; Yoshida, Takemi; Numazawa, Satoshi] Showa Univ, Sch Pharm, Dept Biochem Toxicol, Tokyo, Japan	Showa University	Shizu, R (corresponding author), Showa Univ, Sch Pharm, Dept Biochem Toxicol, Tokyo, Japan.	numazawa@pharm.showa-u.ac.jp	Numazawa, Satoshi/E-4618-2010; Shizu, Ryota/ACP-9957-2022	Numazawa, Satoshi/0000-0002-4818-1061; Shizu, Ryota/0000-0002-0465-5077	Ministry of Education, Culture, Sports, Science, and Technology of Japan [S1001011];  [22590143]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by a Grant-in-Aid for Scientific Research C [22590143 to S.N.] and by Private University High Technology Research Center Project matching fund subsidy [S1001011] from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Bell AW, 2006, HEPATOLOGY, V44, P186, DOI 10.1002/hep.21234; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Halappanavar S, 2011, TOXICOLOGY, V285, P133, DOI 10.1016/j.tox.2011.04.011; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Joannard F, 2006, TOXICOL LETT, V161, P61, DOI 10.1016/j.toxlet.2005.08.006; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Kodama S, 2006, DRUG METAB REV, V38, P75, DOI 10.1080/03602530600569851; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Osabe M, 2011, J BIOL CHEM, V286, P35763, DOI 10.1074/jbc.M111.284596; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238; Tamasi V, 2009, MOL PHARMACEUT, V6, P1573, DOI 10.1021/mp9001552; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Whysner J, 1996, PHARMACOL THERAPEUT, V71, P153, DOI 10.1016/0163-7258(96)00067-8; Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yokoi T, 2011, TOXICOL SCI, V123, P1, DOI 10.1093/toxsci/kfr168; Yoshioka W, 2011, TOXICOL SCI, V122, P457, DOI 10.1093/toxsci/kfr130; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	37	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41291	10.1371/journal.pone.0041291	http://dx.doi.org/10.1371/journal.pone.0041291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815988	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900107
J	Jin, H; Wang, B; Gao, Q; Chao, JQ; Wang, SY; Tian, L; Liu, P				Jin, Hui; Wang, Bei; Gao, Qian; Chao, Jianqian; Wang, Siyuan; Tian, Lin; Liu, Pei			Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China	PLOS ONE			English	Article							GENERAL-POPULATION; HEALTH STATES; US; EUROQOL; DISEASE; SCORES; JAPAN	Background: The SF-6D and EQ-5D are widely used generic index measures as health-related quality of life. We assessed within-subject agreement between SF-6D and EQ-5D utilities with different preference weights, and their validities in measuring Chinese rural residents, before and after standardization scores. Methodology/Principal Findings: Rural residents over 18 years old were interviewed using EQ-5D and SF-6D in Jiangsu Province, China. EQ-5D utility-scoring algorithms were used from three conversion tables from the United Kingdom, Japan, and the United States. Validities, Sensitivity and agreement between instruments were computed and compared. Factors affecting utility difference were explored with multiple liner regression models. Scores with standardization intervals of 0-1 in the two instruments were analyzed by the use of the above methods again. In 929 respondents, relative efficiency statistic and receiver operating characteristic curves analysis showed SF-6D to be the more efficient, followed by the EQ-5D model in Japan weights. Bland-Altman plot analysis showed paired SF-6D/EQ-5D in UK weights had better agreement. Though some risk factors were found, multiple liner regression demonstrated most coefficients were weaker than 0.2, and all R 2 values were less than 0.06. Standardization did not significantly influence these results except scores' value. Conclusions/Significance: SF-6D and next EQ-5D in Japan weights could be used for Chinese rural residents. Further research with larger sample size of population is needed to establish and determine the feasibility of standardization score.	[Jin, Hui; Wang, Bei; Gao, Qian; Wang, Siyuan; Liu, Pei] Southeast Univ, Dept Epidemiol & Hlth Stat, Nanjing, Peoples R China; [Jin, Hui; Wang, Bei; Gao, Qian; Liu, Pei] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Peoples R China; [Chao, Jianqian; Tian, Lin] Southeast Univ, Dept Med Insurance, Nanjing, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Liu, P (corresponding author), Southeast Univ, Dept Epidemiol & Hlth Stat, Nanjing, Peoples R China.	liupeiseu@126.com	Jin, Hui/GXG-2296-2022; JIN, HUI/AAA-8732-2019		National Science and Technology Major Project of China [2009ZX10004-904]	National Science and Technology Major Project of China	This work was supported in part by National Science and Technology Major Project of China (2009ZX10004-904. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 2010, PHARMACOECONOMICS, V28, P477, DOI 10.2165/11533010-000000000-00000; Badia X, 2001, MED DECIS MAKING, V21, P7, DOI 10.1177/0272989X0102100102; Barton GR, 2008, HEALTH ECON, V17, P815, DOI 10.1002/hec.1298; Bharmal M, 2006, VALUE HEALTH, V9, P262, DOI 10.1111/j.1524-4733.2006.00108.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Cunillera O, 2010, QUAL LIFE RES, V19, P853, DOI 10.1007/s11136-010-9639-z; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Grieve R, 2009, EUR J HEALTH ECON, V10, P15, DOI 10.1007/s10198-008-0097-2; Huang IC, 2008, HEALTH SERV RES, V43, P327, DOI 10.1111/j.1475-6773.2007.00745.x; Janssen MF, 2008, VALUE HEALTH, V11, P275, DOI 10.1111/j.1524-4733.2007.00230.x; Kontodimopoulos N, 2009, QUAL LIFE RES, V18, P87, DOI 10.1007/s11136-008-9420-8; McCrone P, 2009, J MENT HEALTH POLICY, V12, P27; McGhee S M, 2011, Hong Kong Med J, V17 Suppl 6, P17; Sakthong P, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-71; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Zhang XH, 2009, VALUE HEALTH, V12, pS106, DOI 10.1111/j.1524-4733.2009.00640.x; Zhao FL, 2010, VALUE HEALTH, V13, P649, DOI 10.1111/j.1524-4733.2010.00728.x	20	11	11	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41550	10.1371/journal.pone.0041550	http://dx.doi.org/10.1371/journal.pone.0041550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848526	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200070
J	Nagel, S; Ehrentraut, S; Tomasch, J; Lienenklaus, S; Schneider, B; Geffers, R; Meyer, C; Kaufmann, M; Drexler, HG; MacLeod, RAF				Nagel, Stefan; Ehrentraut, Stefan; Tomasch, Juergen; Lienenklaus, Stefan; Schneider, Bjoern; Geffers, Robert; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.			Transcriptional Activation of Prostate Specific Homeobox Gene NKX3-1 in Subsets of T-Cell Lymphoblastic Leukemia (T-ALL)	PLOS ONE			English	Article							EXPRESSION SIGNATURES; MULTIPLE MECHANISMS; PROTEINS; LINES; PROMOTES; TAL1; DIFFERENTIATION; JUXTAPOSITION; PROLIFERATION; REGULATORS	Homeobox genes encode transcription factors impacting key developmental processes including embryogenesis, organogenesis, and cell differentiation. Reflecting their tight transcriptional control, homeobox genes are often embedded in large non-coding, cis-regulatory regions, containing tissue specific elements. In T-cell acute lymphoblastic leukemia (T-ALL) homeobox genes are frequently deregulated by chromosomal aberrations, notably translocations adding T-cell specific activatory elements. NKX3-1 is a prostate specific homeobox gene activated in T-ALL patients expressing oncogenic TAL1 or displaying immature T-cell characteristics. After investigating regulation of NKX3-1 in primary cells and cell lines, we report its ectopic expression in T-ALL cells independent of chromosomal rearrangements. Using siRNAs and expression profiling, we exploited NKX3-1 positive T-ALL cell lines as tools to investigate aberrant activatory mechanisms. Our data confirmed NKX3-1 activation by TAL1/GATA3/LMO and identified LYL1 as an alternative activator in immature T-ALL cells devoid of GATA3. Moreover, we showed that NKX3-1 is directly activated by early T-cell homeodomain factor MSX2. These activators were regulated by MLL and/or by IL7-, BMP4- and IGF2-signalling. Finally, we demonstrated homeobox gene SIX6 as a direct leukemic target of NKX3-1 in T-ALL. In conclusion, we identified three major mechanisms of NKX3-1 regulation in T-ALL cell lines which are represented by activators TAL1, LYL1 and MSX2, corresponding to particular T-ALL subtypes described in patients. These results may contribute to the understanding of leukemic transcriptional networks underlying disturbed T-cell differentiation in T-ALL.	[Nagel, Stefan; Ehrentraut, Stefan; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, Braunschweig, Germany; [Schneider, Bjoern] Univ Rostock, Inst Pathol, Rostock, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Helmholtz Association; Helmholtz-Center for Infection Research; University of Rostock	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de	Lienenklaus, Stefan/HIK-0899-2022	Tomasch, Jurgen/0000-0002-3914-2781; Lienenklaus, Stefan/0000-0003-4790-3445				BEGUEKIRN C, 1994, INT J DEV BIOL, V38, P405; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Casolaro V, 2000, J BIOL CHEM, V275, P36605, DOI 10.1074/jbc.M007086200; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; Chen S, 2011, LEUKEMIA, V25, P1632, DOI 10.1038/leu.2011.119; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Ferrando AA, 2004, BLOOD, V103, P1909, DOI 10.1182/blood-2003-07-2577; Ferrando AA, 2003, BLOOD, V102, P262, DOI 10.1182/blood-2002-10-3221; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Finetti F, 2011, TRENDS IMMUNOL, V32, P139, DOI 10.1016/j.it.2011.02.001; Graux C, 2006, LEUKEMIA, V20, P1496, DOI 10.1038/sj.leu.2404302; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; Homminga I, 2012, LEUKEMIA, V26, P572, DOI 10.1038/leu.2011.330; Kecha O, 2000, ENDOCRINOLOGY, V141, P1209, DOI 10.1210/en.141.3.1209; KEES UR, 1987, LEUKEMIA RES, V11, P489, DOI 10.1016/0145-2126(87)90082-8; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Lee SH, 2009, BIOCHEM BIOPH RES CO, V381, P214, DOI 10.1016/j.bbrc.2009.02.026; Li X, 2002, SCIENCE, V297, P1180; Licona-Limon P, 2007, IMMUNOL LETT, V109, P1, DOI 10.1016/j.imlet.2006.12.010; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; Nagel S, 2003, CANCER RES, V63, P5329; Nagel S, 2011, LEUKEMIA LYMPHOMA, V52, P1348, DOI 10.3109/10428194.2011.566391; Nagel S, 2011, LEUKEMIA LYMPHOMA, V52, P290, DOI 10.3109/10428194.2010.537003; Nagel S, 2010, LEUKEMIA RES, V34, P521, DOI 10.1016/j.leukres.2009.06.020; Nagel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-371; Nakamura TY, 2011, CIRC RES, V109, P512, DOI 10.1161/CIRCRESAHA.111.248864; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Porter BO, 2000, SEMIN IMMUNOL, V12, P465, DOI 10.1006/smim.2000.0264; Prins GS, 2008, DIFFERENTIATION, V76, P641, DOI 10.1111/j.1432-0436.2008.00277.x; Rice KL, 2008, LEUKEMIA RES, V32, P873, DOI 10.1016/j.leukres.2007.11.001; Riz I, 2009, BIOCHEM BIOPH RES CO, V380, P361, DOI 10.1016/j.bbrc.2009.01.099; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Ryan DP, 2008, PROTEINS, V70, P1461, DOI 10.1002/prot.21638; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418	53	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40747	10.1371/journal.pone.0040747	http://dx.doi.org/10.1371/journal.pone.0040747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848398	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200029
J	Wu, Y; Wang, JX; Xu, T; Liu, JR; Yu, WQ; Lou, Q; Zhu, T; He, NA; Ben, HJ; Hu, J; Gotz, F; Qu, D				Wu, Yang; Wang, Jiaxue; Xu, Tao; Liu, Jingran; Yu, Wenqi; Lou, Qiang; Zhu, Tao; He, Nianan; Ben, Haijing; Hu, Jian; Goetz, Friedrich; Qu, Di			The Two-Component Signal Transduction System ArlRS Regulates Staphylococcus epidermidis Biofilm Formation in an ica-Dependent Manner	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI; ESCHERICHIA-COLI BIOFILMS; IN-VIVO; PROTEOLYTIC ACTIVITY; GENE-EXPRESSION; MAJOR ROLE; AUREUS; SARA; VIRULENCE	Due to its ability to form biofilms on medical devices, Staphylococcus epidermidis has emerged as a major pathogen of nosocomial infections. In this study, we investigated the role of the two-component signal transduction system ArlRS in regulating S. epidermidis biofilm formation. An ArlRS-deficient mutant, WW06, was constructed using S. epidermidis strain 1457 as a parental strain. Although the growth curve of WW06 was similar to that of SE1457, the mutant strain was unable to form biofilms in vitro. In a rabbit subcutaneous infection model, sterile disks made of polymeric materials were implanted subcutaneously followed with inoculation of WW06 or SE1457. The viable bacteria cells of WW06 recovered from biofilms on the embedded disks were much lower than that of SE1457. Complementation of arlRS genes expression from plasmid in WW06 restored biofilm-forming phenotype both in vivo and in vitro. WW06 maintained the ability to undergo initial attachment. Transcription levels of several genes involved in biofilm formation, including icaADBC, sigB, and sarA, were decreased in WW06, compared to SE1457; and icaR expression was increased in WW06, detected by real-time reverse-transcription PCR. The biofilm-forming phenotype was restored by overexpressing icaADBC in WW06 but not by overexpressing sigB, indicating that ArlRS regulates biofilm formation through the regulation of icaADBC. Gel shift assay showed that ArlR can bind to the promoter region of the ica operon. In conclusion, ArlRS regulates S. epidermidis biofilm formation in an ica-dependent manner, distinct from its role in S. aureus.	[Wu, Yang; Wang, Jiaxue; Xu, Tao; Liu, Jingran; Lou, Qiang; Zhu, Tao; Ben, Haijing; Hu, Jian; Qu, Di] Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wu, Yang; Wang, Jiaxue; Xu, Tao; Liu, Jingran; Lou, Qiang; Zhu, Tao; Ben, Haijing; Hu, Jian; Qu, Di] Fudan Univ, Inst Med Microbiol, Shanghai Med Coll, Minist Publ Hlth, Shanghai 200433, Peoples R China; [Wu, Yang; Wang, Jiaxue; Xu, Tao; Liu, Jingran; Lou, Qiang; Zhu, Tao; Ben, Haijing; Hu, Jian; Qu, Di] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yu, Wenqi; Goetz, Friedrich] Univ Tubingen, Tubingen, Germany; [He, Nianan] Fudan Univ, Zhongshan Hosp, Dept Ultrasound, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Eberhard Karls University of Tubingen; Fudan University	Wu, Y (corresponding author), Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	dqu@shmu.edu.cn	Qu, Di/AAO-4590-2020		National Science and Technology Major Project of China [2012ZX09301002-005, 2012ZX10003008-010]; National Natural Science Foundation of China [81101214, 30800036, J0730860]; Scientific Technology Development Foundation of Shanghai [10410700600, 09DZ1908602]; Program of Ministry of Science and Technology of China [2010DFA32100]; Specialized Research Fund for the Doctoral Program of Higher Education [20100071120049]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Development Foundation of Shanghai; Program of Ministry of Science and Technology of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Science and Technology Major Project of China [2012ZX09301002-005, 2012ZX10003008-010; http://www. nmp.gov.cn], the National Natural Science Foundation of China [81101214, 30800036, J0730860; http://www. nsfc.gov.cn/Portal0/default106.htm], the Scientific Technology Development Foundation of Shanghai [10410700600, 09DZ1908602;http:// www.stcsm.gov.cn], the Program of Ministry of Science and Technology of China [2010DFA32100;http://www. nmp.gov.cn], and the Specialized Research Fund for the Doctoral Program of Higher Education [20100071120049; http://www.cutech.edu.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Carmen JC, 2004, J BIOMATER APPL, V18, P237, DOI 10.1177/0885328204040540; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176; Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Lou Q, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-146; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rediske AM, 1999, ANTIMICROB AGENTS CH, V43, P1211, DOI 10.1128/AAC.43.5.1211; Rediske AM, 2000, ANTIMICROB AGENTS CH, V44, P771, DOI 10.1128/AAC.44.3.771-772.2000; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun ZP, 2009, J MICROBES INFECT, V4, P92; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005; Trotonda MP, 2005, J BACTERIOL, V187, P5790, DOI 10.1128/JB.187.16.5790-5798.2005; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x; Zhu T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-287; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	50	31	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40041	10.1371/journal.pone.0040041	http://dx.doi.org/10.1371/journal.pone.0040041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848368	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200016
J	Lin, XB; Dieleman, LA; Ketabi, A; Bibova, I; Sawyer, MB; Xue, HY; Field, CJ; Baracos, VE; Ganzle, MG				Lin, Xiaoxi B.; Dieleman, Levinus A.; Ketabi, Ali; Bibova, Ilona; Sawyer, Michael B.; Xue, Hongyu; Field, Catherine J.; Baracos, Vickie E.; Gaenzle, Michael G.			Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats	PLOS ONE			English	Article							BETA-GLUCURONIDASE; PARENTERAL GLUTAMINE; HYDROCHLORIDE CPT-11; ANTITUMOR EFFICACY; COLORECTAL-CANCER; FECAL MICROFLORA; DIARRHEA; TOXICITY; INHIBITION; MODULATION	Intestinal microbiota mediate toxicity of irinotecan (CPT-11) cancer therapies and cause systemic infection after CPT-11-induced loss of barrier function. The intestinal microbiota and their functions are thus potential targets for treatment to mitigate CPT-11 toxicity. However, microbiota changes during CPT-11 therapy remain poorly described. This study analysed changes in intestinal microbiota induced by CPT-11 chemotherapy. Qualitative and quantitative taxonomic analyses, and functional analyses were combined to characterize intestinal microbiota during CPT-11-based chemotherapy, and in presence or absence of oral glutamine, a treatment known to reduce CPT-11 toxicity. In the first set of experiments tumour-bearing rats received a dose-intensive CPT-11 regimen (125 mg kg(-1)x3 days), with or without oral glutamine bolus (0.75 g kg(-1)). In a subsequent more clinically-oriented chemotherapy regimen, rats received two cycles of CPT-11 (50 mg kg(-1)) followed by 5-flurouracil (50 mg kg(-1)). The analysis of fecal samples over time demonstrated that tumours changed the composition of intestinal microbiota, increasing the abundance of clostrridial clusters I, XI, and Enterobacteriaceae. CPT-11 chemotherapy increased cecal Clostridium cluster XI and Enterobacteriaceae, particularly after the dose-intensive therapy. Glutamine treatment prevented the reduced abundance of major bacterial groups after CPT-11 administration; i.e. total bacteria, Clostridium cluster VI, and the Bacteroides-group. Virulence factor/toxin genes of pathogenic Escherichia coli and Clostridium difficile were not detected in the cecal microbiota. In conclusion, both colon cancer implantation and CPT-11-based chemotherapies disrupted the intestinal microbiota. Oral glutamine partially mitigated CPT-11 toxicity and induced temporary changes of the intestinal microbiota.	[Lin, Xiaoxi B.; Ketabi, Ali; Bibova, Ilona; Field, Catherine J.; Gaenzle, Michael G.] Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada; [Dieleman, Levinus A.] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Sawyer, Michael B.; Xue, Hongyu; Baracos, Vickie E.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Ganzle, MG (corresponding author), Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada.	mgaenzle@ualberta.ca	Bibova, Ilona/J-8051-2014; Gänzle, Michael/F-1432-2017; Xue, Hongyu/E-4201-2013; Dieleman, Levinus/AAT-8198-2021	Gänzle, Michael/0000-0003-0972-928X; Baracos, Vickie/0000-0002-9609-1001; Field, Catherine/0000-0001-7285-4767; Dieleman, Levinus/0000-0001-7852-2122; Bibova, Ilona/0000-0002-0839-8434	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; AFNS PhD Entrance Scholarship; Canada Research Chairs Program; Crohn's and Colitis Foundation of Canada (CCFC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); AFNS PhD Entrance Scholarship; Canada Research Chairs Program(Canada Research Chairs); Crohn's and Colitis Foundation of Canada (CCFC)	The Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council are acknowledged for funding. X.X.B. Lin acknowledges support by the AFNS PhD Entrance Scholarship; M.G. Ganzle acknowledges the Canada Research Chairs Program for funding. L.A. Dieleman was supported by the Crohn's and Colitis Foundation of Canada (CCFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold Renee J Goldberg, 2005, J Support Oncol, V3, P227; Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Dawson LF, 2009, INFECT GENET EVOL, V9, P1410, DOI 10.1016/j.meegid.2009.06.005; Decker-Baumann C, 1999, EUR J CANCER, V35, P202, DOI 10.1016/S0959-8049(98)00389-X; Dorofeyev AE, 2009, DIGEST DIS, V27, P502, DOI 10.1159/000233289; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Faber J, 2009, ONCOL REP, V22, P1403, DOI 10.3892/or_00000581; Franks AH, 2008, APPL ENVIRON MICROB, V64, P3336; Goodhand JR, 2011, ALIMENT PHARM THER, V33, P428, DOI 10.1111/j.1365-2036.2010.04548.x; GUPTA E, 1994, CANCER RES, V54, P3723; Hautmann MG, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-89; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; IKUNO N, 1995, J NATL CANCER I, V87, P1876, DOI 10.1093/jnci/87.24.1876; Janda JM, 2008, PRACTICAL HDB MICROB, P217; Jermy A, 2010, NAT REV MICROBIOL, V8, P838, DOI 10.1038/nrmicro2479; Koleva PT, 2012, BRIT J NUTR, V108, P1633, DOI 10.1017/S0007114511007203; Kurita A, 2011, CANCER CHEMOTH PHARM, V67, P201, DOI 10.1007/s00280-010-1310-4; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Lv ML, 2011, FRONT BIOSCI-LANDMRK, V16, P2515, DOI 10.2741/3869; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Manhart N, 2001, ANN SURG, V234, P92, DOI 10.1097/00000658-200107000-00014; Marteau P, 2011, DIGEST DIS, V29, P166, DOI 10.1159/000323879; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Picazo JJ, 2005, INT J ANTIMICROB AG, V26, pS120, DOI 10.1016/j.ijantimicag.2005.07.010; Reeds PJ, 2001, J NUTR, V131, p2505S, DOI 10.1093/jn/131.9.2505S; Rothenberg ML, 2001, ONCOLOGIST, V6, P66, DOI 10.1634/theoncologist.6-1-66; Schloerb PR, 1999, JPEN-PARENTER ENTER, V23, P117, DOI 10.1177/0148607199023003117; Sinh P, 2011, GASTROENTER IN PRESS; Sparreboom A, 1998, CLIN CANCER RES, V4, P2747; Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940; Stringer AM, 2009, CURR DRUG METAB, V10, P79, DOI 10.2174/138920009787048419; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Takasuna K, 1996, CANCER RES, V56, P3752; Takasuna K, 1998, CANCER CHEMOTH PHARM, V42, P280, DOI 10.1007/s002800050818; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Trifan OC, 2002, CANCER RES, V62, P5778; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wiegand PN, 2012, J HOSP INFECT; Xue HY, 2008, J NUTR, V138, P740, DOI 10.1093/jn/138.4.740; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P74, DOI 10.1177/0148607110377338; Yang XX, 2006, J PHARMACOL EXP THER, V319, P82, DOI 10.1124/jpet.106.103606; Zwielehner JC, 2010, THESIS U WIEN	48	95	107	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e39764	10.1371/journal.pone.0039764	http://dx.doi.org/10.1371/journal.pone.0039764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844397	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600004
J	Xu, ZQ; Shen, FX; Li, XG; Wu, Y; Chen, Q; Jie, X; Yao, MS				Xu, Zhenqiang; Shen, Fangxia; Li, Xiaoguang; Wu, Yan; Chen, Qi; Jie, Xu; Yao, Maosheng			Molecular and Microscopic Analysis of Bacteria and Viruses in Exhaled Breath Collected Using a Simple Impaction and Condensing Method	PLOS ONE			English	Article							INFLUENZA; AIR; TRANSMISSION; OUTBREAK; PROGRESS; DISEASE; CANCER; PH	Exhaled breath condensate (EBC) is increasingly being used as a non-invasive method for disease diagnosis and environmental exposure assessment. By using hydrophobic surface, ice, and droplet scavenging, a simple impaction and condensing based collection method is reported here. Human subjects were recruited to exhale toward the device for 1, 2, 3, and 4 min. The exhaled breath quickly formed into tiny droplets on the hydrophobic surface, which were subsequently scavenged into a 10 mu L rolling deionized water droplet. The collected EBC was further analyzed using culturing, DNA stain, Scanning Electron Microscope (SEM), polymerase chain reaction (PCR) and colorimetry (VITEK 2) for bacteria and viruses. Experimental data revealed that bacteria and viruses in EBC can be rapidly collected using the method developed here, with an observed efficiency of 100 mu L EBC within 1 min. Culturing, DNA stain, SEM, and qPCR methods all detected high bacterial concentrations up to 7000 CFU/m(3) in exhaled breath, including both viable and dead cells of various types. Sphingomonas paucimobilis and Kocuria variants were found dominant in EBC samples using VITEK 2 system. SEM images revealed that most bacteria in exhaled breath are detected in the size range of 0.5-1.0 mu m, which is able to enable them to remain airborne for a longer time, thus presenting a risk for airborne transmission of potential diseases. Using qPCR, influenza A H3N2 viruses were also detected in one EBC sample. Different from other devices restricted solely to condensation, the developed method can be easily achieved both by impaction and condensation in a laboratory and could impact current practice of EBC collection. Nonetheless, the reported work is a proof-of-concept demonstration, and its performance in non-invasive disease diagnosis such as bacterimia and virus infections needs to be further validated including effects of its influencing matrix.	[Xu, Zhenqiang; Shen, Fangxia; Wu, Yan; Chen, Qi; Yao, Maosheng] Peking Univ, State Key Joint Lab Environm Simulat & Pollut Con, Coll Environm Sci & Engn, Beijing 100871, Peoples R China; [Li, Xiaoguang; Jie, Xu] Peking Univ, Hosp 3, Dept Infect Dis, Beijing 100871, Peoples R China	Peking University; Peking University	Xu, ZQ (corresponding author), Peking Univ, State Key Joint Lab Environm Simulat & Pollut Con, Coll Environm Sci & Engn, Beijing 100871, Peoples R China.	yao@pku.edu.cn	Shen, Fangxia/F-3718-2018; Chen, QH/GXH-3158-2022; Shen, Fangxia/I-5774-2016; shen, fangxia/HGA-6200-2022	Shen, Fangxia/0000-0003-4166-4615; shen, fangxia/0000-0003-4166-4615	National Science Foundation of China [21077005, 20877004]; National High Technology Research and Development Program of China [2008AA062503]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the National Science Foundation of China (Grants 21077005 and 20877004), and National High Technology Research and Development Program of China (Grant 2008AA062503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ICRP PUBL; [Anonymous], 2008, WORLD HLTH STAT 2008; Baker MG, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2424; Basaglia G, 2002, J CLIN MICROBIOL, V40, P311, DOI 10.1128/JCM.40.1.311-313.2002; Bodini A, 2005, PEDIATR PULM, V40, P494, DOI 10.1002/ppul.20336; Carpagnano GE, 2002, INT J BIOL MARKER, V17, P141, DOI 10.1177/172460080201700211; Chambers ST, 2011, MED MYCOL, V49, pS54, DOI 10.3109/13693786.2010.508187; Christensen LS, 2011, J VIROL METHODS, V177, P44, DOI 10.1016/j.jviromet.2011.06.011; Conrad DH, 2008, J GEN INTERN MED, V23, P78, DOI 10.1007/s11606-007-0411-1; COUCH RB, 1969, AM REV RESPIR DIS, V99, P24; Czebe K, 2008, RESP MED, V102, P720, DOI 10.1016/j.rmed.2007.12.013; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Dweik RA, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/030201; Dweik RA, 2008, J BREATH RES, V2, DOI 10.1088/1752-7163/2/3/030301; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Fabian P, 2009, J ENVIRON MONITOR, V11, P314, DOI 10.1039/b813520g; Fiegel J, 2006, DRUG DISCOV TODAY, V11, P51, DOI 10.1016/S1359-6446(05)03687-1; Gessner C, 2004, LUNG CANCER, V43, P215, DOI 10.1016/j.lungcan.2003.08.034; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Houk V N, 1980, Ann N Y Acad Sci, V353, P10, DOI 10.1111/j.1749-6632.1980.tb18901.x; Houspie L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-98; Hunt J, 2011, CHEST, V139, P5, DOI 10.1378/chest.10-1150; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Kilic A, 2007, JPN J INFECT DIS, V60, P394; Knight V., 1973, AIRB TRANSM AIRB INF; Kostikas K, 2011, RESP MED, V105, P526, DOI 10.1016/j.rmed.2010.10.015; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Liu J, 2007, EUR RESPIR J, V30, P807, DOI 10.1183/09031936.00080207; LOOSLI CG, 1970, ARCH ENVIRON HEALTH, V21, P332, DOI 10.1080/00039896.1970.10667248; Majic Z, 2009, PROMET-ZAGREB, V21, P425; Montuschi Paolo, 2007, Ther Adv Respir Dis, V1, P5, DOI 10.1177/1753465807082373; Muscatello G, 2009, J CLIN MICROBIOL, V47, P734, DOI 10.1128/JCM.01395-08; Papaioannou AI, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-67; Papineni RS, 1996, J AEROSOL MED, V10, P105, DOI 10.1089/jam.1997.10.105; Pelclova D, 2007, IND HEALTH, V45, P766, DOI 10.2486/indhealth.45.766; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Rosias PPR, 2010, PEDIAT ALLERG IMM-UK, V21, pE235, DOI 10.1111/j.1399-3038.2009.00909.x; St George K, 2010, J VIROL METHODS, V163, P144, DOI 10.1016/j.jviromet.2009.08.019; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Teng Y, 2011, CHEST, V140, P108, DOI 10.1378/chest.10-2816; Vereb H, 2011, ENVIRON SCI TECHNOL, V45, P8167, DOI [10.1021/es202041J, 10.1021/es202041j]; Xu ZQ, 2011, AEROSOL SCI TECH, V45, P1337, DOI 10.1080/02786826.2011.593591; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Yu X, 2002, MODERN AEROBIOLOGIA, P248; Zakharkina T, 2011, RESPIROLOGY, V16, P932, DOI 10.1111/j.1440-1843.2011.01977.x	47	33	34	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41137	10.1371/journal.pone.0041137	http://dx.doi.org/10.1371/journal.pone.0041137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848436	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600041
J	Zoephel, J; Reiher, W; Rexer, KH; Kahnt, J; Wegener, C				Zoephel, Judith; Reiher, Wencke; Rexer, Karl-Heinz; Kahnt, Joerg; Wegener, Christian			Peptidomics of the Agriculturally Damaging Larval Stage of the Cabbage Root Fly Delia radicum (Diptera: Anthomyiidae)	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOWFLY CALLIPHORA-VOMITORIA; DROSOPHILA-MELANOGASTER; MASS-SPECTROMETRY; FEEDING-BEHAVIOR; FRUIT-FLY; FUNCTIONAL-CHARACTERIZATION; IMMUNOREACTIVE NEURONS; NEOBELLIERIA-BULLATA; ADULT DROSOPHILA	The larvae of the cabbage root fly induce serious damage to cultivated crops of the family Brassicaceae. We here report the biochemical characterisation of neuropeptides from the central nervous system and neurohemal organs, as well as regulatory peptides from enteroendocrine midgut cells of the cabbage maggot. By LC-MALDI-TOF/TOF and chemical labelling with 4-sulfophenyl isothiocyanate, 38 peptides could be identified, representing major insect peptide families: allatostatin A, allatostatin C, FMRFamide-like peptides, kinin, CAPA peptides, pyrokinins, sNPF, myosuppressin, corazonin, SIFamide, sulfakinins, tachykinins, NPLP1-peptides, adipokinetic hormone and CCHamide 1. We also report a new peptide (Yamide) which appears to be homolog to an amidated eclosion hormone-associated peptide in several Drosophila species. Immunocytochemical characterisation of the distribution of several classes of peptide-immunoreactive neurons and enteroendocrine cells shows a very similar but not identical peptide distribution to Drosophila. Since peptides regulate many vital physiological and behavioural processes such as moulting or feeding, our data may initiate the pharmacological testing and development of new specific peptide-based protection methods against the cabbage root fly and its larva.	[Zoephel, Judith; Kahnt, Joerg] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Zoephel, Judith; Reiher, Wencke; Rexer, Karl-Heinz; Wegener, Christian] Univ Marburg, Dept Biol, Marburg, Germany; [Reiher, Wencke; Wegener, Christian] Univ Wurzburg, Theodor Boveri Inst, Bioctr, Wurzburg, Germany	Max Planck Society; Philipps University Marburg; University of Wurzburg	Zoephel, J (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	christian.wegener@uni-wuerzburg.de		Wegener, Christian/0000-0003-4481-3567; Rexer, Karl-Heinz/0000-0002-5513-6576	Deutsche Forschungsgemeinschaft [WE 2652/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (WE 2652/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Audsley N, 2011, PEPTIDES, V32, P434, DOI 10.1016/j.peptides.2010.08.028; Bader R, 2007, J COMP NEUROL, V502, P848, DOI 10.1002/cne.21342; Baggerman G, 2005, J MASS SPECTROM, V40, P250, DOI 10.1002/jms.744; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; DUVE H, 1994, CELL TISSUE RES, V276, P367, DOI 10.1007/BF00306122; DUVE H, 1995, EUR J BIOCHEM, V232, P633, DOI 10.1111/j.1432-1033.1995.tb20854.x; DUVE H, 1988, CELL TISSUE RES, V253, P583; Eckert M, 2002, J COMP NEUROL, V452, P264, DOI 10.1002/cne.10382; Erichsen E., 2005, Gesunde Pflanzen, V57, P149, DOI 10.1007/s10343-005-0081-z; Finch S, 2000, CROP PROT, V19, P817, DOI 10.1016/S0261-2194(00)00109-5; FINCH S, 1989, ANNU REV ENTOMOL, V34, P117, DOI 10.1146/annurev.en.34.010189.001001; Fitches E, 2002, INSECT BIOCHEM MOLEC, V32, P1653, DOI 10.1016/S0965-1748(02)00105-4; Gade G, 2003, PEST MANAG SCI, V59, P1063, DOI 10.1002/ps.755; Gade G, 1997, PROG CH ORG NAT PROD, V71, P1; Gevaert K, 2001, ELECTROPHORESIS, V22, P1645, DOI 10.1002/1522-2683(200105)22:9<1645::AID-ELPS1645>3.0.CO;2-Z; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Inosaki A, 2010, COMP BIOCHEM PHYS A, V155, P190, DOI 10.1016/j.cbpa.2009.10.036; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Konig S, 2005, RAPID COMMUN MASS SP, V19, P3021, DOI 10.1002/rcm.2167; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Leon IR, 2007, J MASS SPECTROM, V42, P1363, DOI 10.1002/jms.1324; LUNDQUIST CT, 1994, J COMP NEUROL, V341, P225, DOI 10.1002/cne.903410208; LUNDQUIST CT, 1994, PEPTIDES, V15, P761, DOI 10.1016/0196-9781(94)90027-2; MARDER E, 1987, J COMP NEUROL, V259, P150, DOI 10.1002/cne.902590111; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Muska F., 2008, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V60, P252; Nachman RJ, 2005, PEPTIDES, V26, P2151, DOI 10.1016/j.peptides.2005.04.024; Nachman RJ, 2011, PEPTIDES, V32, P587, DOI 10.1016/j.peptides.2010.09.013; NASSEL DR, 1988, J COMP NEUROL, V267, P343, DOI 10.1002/cne.902670305; O'Brien MA, 1998, J EXP BIOL, V201, P193; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Pollock VP, 2004, J EXP BIOL, V207, P4135, DOI 10.1242/jeb.01255; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Predel R, 2004, J COMP NEUROL, V474, P379, DOI 10.1002/cne.20145; Predel R, 2003, PEPTIDES, V24, P1487, DOI 10.1016/j.peptides.2003.06.009; Predel R, 2001, PEPTIDES, V22, P199, DOI 10.1016/S0196-9781(00)00383-1; Predel Reinhard, 2006, P127; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Pyza E, 2003, MICROSC RES TECHNIQ, V62, P103, DOI 10.1002/jemt.10365; Radford JHC, 2004, J EXP BIOL, V207, P4573, DOI 10.1242/jeb.01317; Rahman MM, 2009, GEN COMP ENDOCR, V162, P52, DOI 10.1016/j.ygcen.2008.08.006; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; Santos JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000695; Santos JG, 2006, CELL TISSUE RES, V326, P187, DOI 10.1007/s00441-006-0211-7; Scherkenbeck J, 2009, BIOORGAN MED CHEM, V17, P4071, DOI 10.1016/j.bmc.2008.12.061; SCHNEIDER LE, 1993, J COMP NEUROL, V337, P446, DOI 10.1002/cne.903370308; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; SIVASUBRAMANIAN P, 1991, COMP BIOCHEM PHYS C, V99, P507, DOI 10.1016/0742-8413(91)90278-2; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; TAGHERT PH, 1990, J NEUROSCI, V10, P1929; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Veenstra JA, 1997, J BIOL CHEM, V272, P10402, DOI 10.1074/jbc.272.16.10402; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V316, P763, DOI 10.1016/j.bbrc.2004.02.115; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V320, P334, DOI 10.1016/j.bbrc.2004.05.173; Vitzthum H, 1996, J COMP NEUROL, V369, P419, DOI 10.1002/(SICI)1096-9861(19960603)369:3&lt;419::AID-CNE7&gt;3.0.CO;2-8; Vomel M, 2007, DEV NEUROBIOL, V67, P792, DOI 10.1002/dneu.20392; Wang DX, 2004, RAPID COMMUN MASS SP, V18, P96, DOI 10.1002/rcm.1289; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Wegener C, 2010, METHODS MOL BIOL, V615, P117, DOI 10.1007/978-1-60761-535-4_9; Wegener C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r131; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Williamson M, 2001, BIOCHEM BIOPH RES CO, V281, P544, DOI 10.1006/bbrc.2001.4402; Winther AME, 2003, J COMP NEUROL, V464, P180, DOI 10.1002/cne.10790; Yoon JG, 1995, J COMP NEUROL, V363, P475, DOI 10.1002/cne.903630310; Zohren E., 1968, Zeitschrift fuer Angewandte Entomologie, V62, P139	77	31	60	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41543	10.1371/journal.pone.0041543	http://dx.doi.org/10.1371/journal.pone.0041543			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848525	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600083
J	Siegl, S; Uhlig, S				Siegl, Stephanie; Uhlig, Stefan			Using the One-Lung Method to Link p38 to Pro-Inflammatory Gene Expression during Overventilation in C57BL/6 and BALB/c Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; INBRED MOUSE STRAINS; PULMONARY INFLAMMATION; MAP KINASE; XANTHINE OXIDOREDUCTASE; IMMUNE-RESPONSE; INJURY; VENTILATION; INFECTION	Introduction: The mechanisms of ventilator-induced lung injury (VILI), including the role of MAP kinases, are frequently studied in different mouse strains. A useful model for such studies is the isolated perfused mouse lung. As a further development we present the one-lung method that permits to continue perfusion and ventilation of the right lung after removal of the left lung. This method was used to compare the effect of high pressure ventilation (HPV) on pro-inflammatory signaling events in two widely used mouse strains (C57BL/6, BALB/c) and to further define the role of p38 in VILI. Methods: Lungs were perfused and ventilated for 30 min under control conditions before they were randomized to low (8 cm H2O) or high (25 cm H2O) pressure ventilation (HPV) for 210 min, with the left lung being removed after 180 min. In the left lung we measured the phosphorylation of p38, JNK, ERK and Akt kinase, and in the right lung gene expression and protein concentrations of Il1b, Il6, Tnf, Cxcl1, Cxcl2, and Areg. Results: Lung mechanics and kinase activation were similar in both mouse strains. HPV increased all genes (except Tnf in BALB/c) and all mediators in both strains. The gene expression of mRNA for Il1b, Il6, Cxcl1 and Cxcl2 was higher in BALB/c mice. Backward regression of the kinase data at t = 180 min with the gene and protein expression data at t = 240 min suggested that p38 controls HPV-induced gene expression, but not protein production. This hypothesis was confirmed in experiments with the p38-kinase inhibitor SB203580. Conclusions: The one-lung method is useful for mechanistic studies in the lungs. While C57BL/6 show diminished pro-inflammatory responses during HPV, lung mechanics and mechanotransduction processes appear to be similar in both mouse strains. Finally, the one-lung method allowed us to link p38 to gene expression during VILI.	[Siegl, Stephanie; Uhlig, Stefan] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Fac Med, Aachen, Germany	RWTH Aachen University	Siegl, S (corresponding author), Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Fac Med, Aachen, Germany.	suhlig@ukaachen.de	Uhlig, Stefan/A-7290-2014	Uhlig, Stefan/0000-0003-2332-1280	Deutsche Forschungsgemeinschaft [TPC16, SFB542]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (TPC16 within the SFB542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; Arcaroli J, 2001, CLIN IMMUNOL, V101, P211, DOI 10.1006/clim.2001.5108; BOHN E, 1994, INFECT IMMUN, V62, P3027, DOI 10.1128/IAI.62.7.3027-3032.1994; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chen XL, 2003, SHOCK, V19, P475, DOI 10.1097/01.shk.0000055242.25446.84; DINARELLO CA, 1990, PROG CLIN BIOL RES, V349, P195; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Dombrowsky H, 2007, EUR RESPIR J, V30, P865, DOI 10.1183/09031936.00134006; Dombrowsky H, 2009, PULM PHARMACOL THER, V22, P593, DOI 10.1016/j.pupt.2009.08.005; Donahoe Michael, 2011, Pulm Circ, V1, P192, DOI 10.4103/2045-8932.83454; Fanelli V, 2010, INTENS CARE MED, V36, P1935, DOI 10.1007/s00134-010-2018-y; Fonseca-Aten M, 2005, AM J RESP CELL MOL, V32, P201, DOI 10.1165/rcmb.2004-0197OC; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Held HD, 2000, J APPL PHYSIOL, V88, P2192, DOI 10.1152/jappl.2000.88.6.2192; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Kang YJ, 2006, J BIOL CHEM, V281, P26225, DOI 10.1074/jbc.M606800200; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kitsiouli E, 2009, BBA-MOL BASIS DIS, V1792, P941, DOI 10.1016/j.bbadis.2009.06.007; Kobayashi N, 2003, KIDNEY INT, V64, P1675, DOI 10.1046/j.1523-1755.2003.00258.x; Kuebler WM, 2003, AM J RESP CRIT CARE, V168, P1391, DOI 10.1164/rccm.200304-562OC; Le A, 2008, J APPL PHYSIOL, V105, P1282, DOI 10.1152/japplphysiol.90689.2008; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Li LF, 2004, AM J RESP CRIT CARE, V169, P518, DOI 10.1164/rccm.200305-660OC; Liu S, 2008, EUR J PHARMACOL, V584, P159, DOI 10.1016/j.ejphar.2008.02.009; MCDEVITT HO, 1969, SCIENCE, V163, P1207, DOI 10.1126/science.163.3872.1207; Miyahara T, 2007, AM J PHYSIOL-LUNG C, V293, pL11, DOI 10.1152/ajplung.00279.2005; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Nick JA, 2002, J IMMUNOL, V169, P5260, DOI 10.4049/jimmunol.169.9.5260; Packiam M, 2010, INFECT IMMUN, V78, P433, DOI 10.1128/IAI.00711-09; Peng X, ACTA PHARM SIN, V31, P175; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierrakos C, 2012, EUROPEAN RESP J OFFI; Reinhard C, 2002, MAMM GENOME, V13, P429, DOI 10.1007/s00335-002-3005-6; Reiss LK, EUROPEAN J CELL BIOL; Reiss LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024527; Rocca NA, 2011, EXP LUNG RES, V37, P419, DOI 10.3109/01902148.2011.583712; Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x; ROSSIBERGMANN B, 1993, INFECT IMMUN, V61, P2266, DOI 10.1128/IAI.61.5.2266-2269.1993; Safholm J, 2011, PULM PHARMACOL THER, V24, P361, DOI 10.1016/j.pupt.2011.01.001; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Stamme C, 2002, PULM PHARMACOL THER, V15, P455, DOI 10.1006/pupt.2002.0383; Uhlig S, 2004, TRENDS PHARMACOL SCI, V25, P592, DOI 10.1016/j.tips.2004.09.002; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Uhlig U, 2011, COMPREHENSIVE PHYSL; Uhlig U, 2006, ANESTHESIOLOGY, V105, P1192, DOI 10.1097/00000542-200612000-00019; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; van Doorn NEM, 1999, INFECT IMMUN, V67, P3040, DOI 10.1128/IAI.67.6.3040-3046.1999; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; von Bethmann AN, 1998, AM J RESP CRIT CARE, V157, P263, DOI 10.1164/ajrccm.157.1.9608052; vonBethmann AN, 1996, ACP-APPL CARDIOPUL P, V6, P171; Wakeham J, 2000, INFECT IMMUN, V68, P6946, DOI 10.1128/IAI.68.12.6946-6953.2000; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Weinberg JB, 2004, VIRAL IMMUNOL, V17, P69, DOI 10.1089/088282404322875467; Wilson MR, 2007, AM J PHYSIOL-LUNG C, V293, pL60, DOI 10.1152/ajplung.00284.2006; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yong HY, 2009, EXPERT OPIN INV DRUG, V18, P1893, DOI 10.1517/13543780903321490	58	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41464	10.1371/journal.pone.0041464	http://dx.doi.org/10.1371/journal.pone.0041464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848503	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300043
J	Voss, M; Ivert, T; Pehrsson, K; Hammar, N; Alexanderson, K; Nilsson, T; Vaez, M				Voss, Margaretha; Ivert, Torbjorn; Pehrsson, Kenneth; Hammar, Niklas; Alexanderson, Kristina; Nilsson, Tage; Vaez, Marjan			Sickness Absence following Coronary Revascularisation. A National Study of Women and Men of Working Age in Sweden 1994-2006	PLOS ONE			English	Article							ARTERY-BYPASS GRAFT; GENDER-DIFFERENCES; EUROPEAN-SOCIETY; SURGERY; ANGIOPLASTY; DISEASE; REVASCULARIZATION; EMPLOYMENT; RETURN	Background: Evidence based and gender specific knowledge about sickness absence following coronary revascularisation is lacking. The objective was to investigate sickness absence after a first coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) among women and men in a national Swedish study. Materials and Methods: All patients 30-63 years of age, who underwent a first CABG (n = 22,985, 16% women) or PCI (40,891, 22% women) in Sweden between 1994 and 2006 were included. Information on sickness absence, co-morbidity, and other patient characteristics was obtained from national registers. Long-term sickness absence (LTSA) was defined as >180 and >90 sick-leave days in the first sick-leave spell following CABG and PCI, respectively. Prevalence ratio (PR) and 95% confidence interval (CI) of LTSA were calculated. Findings: LTSA followed the interventions in 41% and 36% for CABG and PCI patients, respectively. Women had more often LTSA compared with men, (CABG PR = 1.23: 95% CI 1.19-1.28 and PCI PR = 1.19; 95% CI 1.16-1.23). A history of sickness absence the year before the intervention increased the risk for LTSA after the intervention in both genders. Among women, older age, or being self employed or unemployed was associated with a lower risk for LTSA. Among men previous cardiovascular disease, diabetes and low socio-economic position increased the risk. During the observation period, there was no change in sickness absence rates among PCI patients but an increase among CABG patients adjusting for patient characteristics. Conclusion: This national study covering a 13-year period shows that long-term sickness absence following coronary revascularisation is common in Sweden, especially among women, and is associated with socio-economic position, comorbidity, and sickness absence during the year before the intervention. Gender specific scientific knowledge about use and effects of sickness absence following coronary revascularisation is warranted for the patients, the treating physicians, the healthcare sector, and the society.	[Voss, Margaretha; Alexanderson, Kristina; Vaez, Marjan] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Ivert, Torbjorn] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Pehrsson, Kenneth] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Hammar, Niklas] AstraZeneca R&D, Sodertalje, Sweden; [Hammar, Niklas] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Nilsson, Tage] Cent Hosp Karlstad, PCI Unit, Karlstad, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; Karolinska Institutet	Voss, M (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.	margaretha.voss@ki.se	Alexanderson, Kristina A/J-3429-2013	Alexanderson, Kristina/0000-0002-9313-3413	Swedish Heart and Lung Association [227/6, 128/09]; Centre for Health Care Science, Karolinska Institutet, Sweden; Swedish National Board of Health and Welfare [2008-21415, 2009-22405, SLS-100201]; Swedish Council for Working Life and Social Research [2007-0728]; Centre of Gender Related Medicine, Karolinska Institutet, Sweden	Swedish Heart and Lung Association(Swedish Heart-Lung Foundation); Centre for Health Care Science, Karolinska Institutet, Sweden; Swedish National Board of Health and Welfare; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Centre of Gender Related Medicine, Karolinska Institutet, Sweden	This work was supported by the Swedish Heart and Lung Association (grant numbers 227/6, 128/09; http://www.hjart-lung.se); the Centre for Health Care Science and Centre of Gender Related Medicine, Karolinska Institutet, Sweden (www.ki.se); the Swedish National Board of Health and Welfare (grant numbers 2008-21415, 2009-22405, SLS-100201; www.socialstyrelsen.se); and the Swedish Council for Working Life and Social Research (grant number 2007-0728; www.fas.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; [Anonymous], ANN REP SWEDEHEART 2; [Anonymous], 2007, SOC SIT EUR UN 2005; Blackledge HM, 2009, HEART, V95, P304, DOI 10.1136/hrt.2007.127928; BOUDREZ H, 1994, EUR HEART J, V15, P32, DOI 10.1093/oxfordjournals.eurheartj.a060376; Hammar N, 1997, J AM COLL CARDIOL, V29, P659, DOI 10.1016/S0735-1097(96)00531-1; Hlatky MA, 1998, ANN INTERN MED, V129, P543, DOI 10.7326/0003-4819-129-7-199810010-00006; Hooftman WE, 2005, J OCCUP ENVIRON MED, V47, P244, DOI 10.1097/01.jom.0000150387.14885.6b; Isaaz K, 2010, ARCH CARDIOVASC DIS, V103, P310, DOI 10.1016/j.acvd.2010.04.007; IVERT T, 1981, SCAND J THORAC CARD, V15, P171, DOI 10.3109/14017438109101043; Janzon M, 2002, EUR HEART J, V23, P31, DOI 10.1053/euhj.2001.2695; Labriola M, 2011, OCCUP ENVIRON MED, V68, P703, DOI 10.1136/oem.2010.060632; MARK DB, 1994, ANN INTERN MED, V120, P111, DOI 10.7326/0003-4819-120-2-199401150-00003; MCKENNA KT, 1994, AUST NZ J MED, V24, P15, DOI 10.1111/j.1445-5994.1994.tb04419.x; Messing K, 2003, AM J IND MED, V43, P618, DOI 10.1002/ajim.10225; MONPERE C, 1988, European Heart Journal, V9, P48; Norheim A, 2011, SCAND CARDIOVASC J, V45, P247, DOI 10.3109/14017431.2011.582139; Perk J, 2004, SCAND J PUBLIC HEALT, V32, P181, DOI 10.1080/14034950410021880; Romans F, 2007, TRANSITION WOMEN MEN; Sellier Philippe, 2003, Eur J Cardiovasc Prev Rehabil, V10, P469, DOI 10.1097/01.hjr.0000106837.97722.86; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Skinner JS, 1999, QJM-INT J MED, V92, P87, DOI 10.1093/qjmed/92.2.87; Soderman E, 2003, SOC SCI MED, V56, P193, DOI 10.1016/S0277-9536(02)00024-2; Stramba-Badiale M, 2006, EUR HEART J, V27, P994, DOI 10.1093/eurheartj/ehi819; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; The Swedish Social Insurance Agency, 2011, SOC INS FIG	28	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40952	10.1371/journal.pone.0040952	http://dx.doi.org/10.1371/journal.pone.0040952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848415	gold, Green Submitted, Green Published			2022-12-27	WOS:000306751300018
J	Huang, SP; Bao, BY; Hour, TC; Huang, CY; Yu, CC; Liu, CC; Lee, YC; Huang, CN; Pao, JB; Huang, CH				Huang, Shu-Pin; Bao, Bo-Ying; Hour, Tzyh-Chyuan; Huang, Chao-Yuan; Yu, Chia-Cheng; Liu, Chia-Chu; Lee, Yung-Chin; Huang, Chun-Nung; Pao, Jiunn-Bey; Huang, Chun-Hsiung			Genetic Variants in CASP3, BMP5, and IRS2 Genes May Influence Survival in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RECEPTOR SUBSTRATE-1; SUSCEPTIBILITY LOCI; INCREASED EXPRESSION; MULTIPLE LOCI; IDENTIFICATION; POLYMORPHISMS; MORTALITY	Several genome-wide association studies (GWAS) have been conducted to identify the common single nucleotide polymorphisms (SNPs) that influence the risk of prostate cancer. It was hypothesized that some prostate cancer-associated SNPs might relate to the clinical outcomes in patients treated for prostate cancer using androgen-deprivation therapy (ADT). A cohort of 601 patients who have received ADT for prostate cancer was genotyped for 29 SNPs that have been associated with prostate cancer in Cancer Genetic Markers of Susceptibility GWAS, and within the genes that have been implicated in cancer. Prognostic significance of these SNPs on the disease progression, prostate cancer-specific mortality (PCSM) and all-cause mortality (ACM) after ADT were assessed by Kaplan-Meier analysis and Cox regression model. Three SNPs, namely CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346, were found to be closely associated with the ACM (P <= 0.042), and BMP5 rs3734444 and IRS2 rs7986346 were also noted to be significantly related to the PCSM (P <= 0.032) after adjusting for the known clinicopathologic predictors. Moreover, patients carrying a greater number of unfavorable genotypes at the loci of interest had a shorter time to ACM and PCSM during ADT (P for trend <0.001). Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	[Huang, Shu-Pin; Liu, Chia-Chu; Lee, Yung-Chin; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin; Liu, Chia-Chu; Lee, Yung-Chin; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Bao, Bo-Ying] China Med Univ, Dept Pharm, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan; [Hour, Tzyh-Chyuan] Kaohsiung Med Univ, Inst Biochem, Kaohsiung, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Yu, Chia-Cheng] Kaohsiung Vet Gen Hosp, Dept Surg, Div Urol, Kaohsiung, Taiwan; [Pao, Jiunn-Bey] Taipei City Hosp, Yangming Branch, Dept Pharm, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Veterans General Hospital; Taipei City Hospital	Huang, SP (corresponding author), Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan.	shpihu@yahoo.com.tw	LIU, CHIA CHU/T-2880-2019; Bao, Bo-Ying/D-1789-2012; Bao, Bo-Ying/H-4589-2019	Bao, Bo-Ying/0000-0001-5510-6513; Bao, Bo-Ying/0000-0001-5510-6513; HUANG, CHAO-YUAN/0000-0002-9322-6062	NSC [NSC-98-2320-B-039-019-MY3, NSC-99-2314-B-037-018-MY3, NSC-100-2314-B-039-009-MY3]; China Medical University [CMU99-COL-13]	NSC(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	This work was supported by the NSC grants NSC-98-2320-B-039-019-MY3, NSC-99-2314-B-037-018-MY3, NSC-100-2314-B-039-009-MY3, and China Medical University grant CMU99-COL-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Bao BY, 2012, INT J CANCER, V130, P876, DOI 10.1002/ijc.26091; Bao BY, 2011, CLIN CANCER RES, V17, P928, DOI 10.1158/1078-0432.CCR-10-2648; BENTLEY H, 1992, BRIT J CANCER, V66, P1159, DOI 10.1038/bjc.1992.427; Bergmann U, 1996, BIOCHEM BIOPH RES CO, V220, P886, DOI 10.1006/bbrc.1996.0500; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Chang Q, 2002, CANCER RES, V62, P6035; Doak SH, 2007, CANCER GENET CYTOGEN, V176, P161, DOI 10.1016/j.cancergencyto.2007.03.011; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; HARRIS SE, 1994, PROSTATE, V24, P204, DOI 10.1002/pros.2990240406; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang CN, 2012, J INTERN MED, V271, P499, DOI 10.1111/j.1365-2796.2011.02449.x; Huang CN, 2012, ANN ONCOL, V23, P707, DOI 10.1093/annonc/mdr264; Huang SP, 2009, CANCER EPIDEM BIOMAR, V18, P3068, DOI 10.1158/1055-9965.EPI-09-0665; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Pao JB, 2013, WORLD J UROL, V31, P281, DOI 10.1007/s00345-011-0813-x; Smith MR, 2006, J CLIN ENDOCR METAB, V91, P1305, DOI 10.1210/jc.2005-2507; Stewart AJ, 2005, J CLIN ONCOL, V23, P6556, DOI 10.1200/JCO.2005.20.966; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Szabolcs M, 2009, AM J PATHOL, V174, P276, DOI 10.2353/ajpath.2009.080086; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Tanaka S, 1996, J CLIN INVEST, V98, P2100, DOI 10.1172/JCI119016; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490	39	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41219	10.1371/journal.pone.0041219	http://dx.doi.org/10.1371/journal.pone.0041219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844442	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700056
J	Mokrousov, I; Vyazovaya, A; Otten, T; Zhuravlev, V; Pavlova, E; Tarashkevich, L; Krishevich, V; Vishnevsky, B; Narvskaya, O				Mokrousov, Igor; Vyazovaya, Anna; Otten, Tatiana; Zhuravlev, Viacheslav; Pavlova, Elena; Tarashkevich, Larisa; Krishevich, Valery; Vishnevsky, Boris; Narvskaya, Olga			Mycobacterium tuberculosis Population in Northwestern Russia: An Update from Russian-EU/Latvian Border Region	PLOS ONE			English	Article							DRUG-RESISTANT; BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; GENETIC DIVERSITY; STRAINS; FAMILY; PREVALENCE; SPREAD; OBLAST	This study aimed to characterize the population structure of Mycobacterium tuberculosis in Pskov oblast in northwestern Russia, to view it in the geographical context, to compare drug resistance properties across major genetic families. Ninety M. tuberculosis strains from tuberculosis (TB) patients, permanent residents in Pskov oblast were subjected to LAM-specific IS6110-PCR and spoligotyping, followed by comparison with SITVITWEB and MIRU-VNTRplus databases. The Beijing genotype (n = 40) was found the most prevalent followed by LAM (n = 18), T (n = 13), Haarlem (n = 10), Ural (n = 5), and Manu2 (n = 1); the family status remained unknown for 3 isolates. The high rate of Beijing genotype and prevalence of LAM family are similar to those in the other Russian settings. A feature specific for M. tuberculosis population in Pskov is a relatively higher rate of Haarlem and T types. Beijing strains were further typed with 12-MIRU (followed by comparison with proprietary global database) and 3 hypervariable loci QUB-3232, VNTR-3820, VNTR-4120. The 12-MIRU typing differentiated 40 Beijing strains into 14 types (HGI = 0.82) while two largest types were M2 (223325153533) prevalent throughout former USSR and M11 (223325173533) prevalent in Russia and East Asia. The use of 3 hypervariable loci increased a discrimination of the Beijing strains (18 profiles, HGI = 0.89). Both major families Beijing and LAM had similar rate of MDR strains (62.5 and 55.6%, respectively) that was significantly higher than in other strains (21.9%; P = 0.001 and 0.03, respectively). The rpoB531 mutations were more frequently found in Beijing strains while LAM drug resistant strains mainly harbored rpoB516 and inhA -15 mutations. Taken together with a high rate of multidrug resistance among Beijing strains from new TB cases (79.3% versus 44.4% in LAM), these findings suggest the critical impact of the Beijing genotype on the current situation with MDR-TB in the Pskov region in northwestern Russia.	[Mokrousov, Igor; Vyazovaya, Anna; Narvskaya, Olga] St Petersburg Pasteur Inst, Mol Microbiol Lab, St Petersburg, Russia; [Otten, Tatiana; Vishnevsky, Boris] Res Inst Phthisiopulmonol, Microbiol Lab, St Petersburg, Russia; [Zhuravlev, Viacheslav] Res Inst Phthisiopulmonol, Lab Mol Genet Methods, St Petersburg, Russia; [Pavlova, Elena; Tarashkevich, Larisa; Krishevich, Valery] Pskov Oblast AntiTB Dispensary, Bacteriol Lab, Pskov, Russia	Saint-Petersburg Pasteur Institute; St. Petersburg State Research Institute of Phthisiopulmonology; St. Petersburg State Research Institute of Phthisiopulmonology	Mokrousov, I (corresponding author), St Petersburg Pasteur Inst, Mol Microbiol Lab, St Petersburg, Russia.	imokrousov@mail.ru	Zhuravlev, Viacheslav Y./H-1223-2017; Narvskaya, Olga/H-1770-2012; Mokrousov, Igor/Q-5941-2019; Mokrousov, Igor/J-3640-2014	Narvskaya, Olga/0000-0002-0830-5808; Mokrousov, Igor/0000-0001-5924-0576; Mokrousov, Igor/0000-0001-5924-0576; Zhuravlev, Viacheslav/0000-0001-6906-6225; Vyazovaya, Anna/0000-0001-9140-8957	Ministry of Health of Russia	Ministry of Health of Russia	This work was done as a regular work in all participating laboratories supported by the regular budget received from the Ministry of Health of Russia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev MV, 2011, EUR J CLIN MICROBIOL, V30, P181, DOI 10.1007/s10096-010-1067-z; Allix-Beguec C, 2011, 32 ESM C LUB GERM 26; [Anonymous], 2010, Tuberk Biolezni Legkih, P54; Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Dymova MA, 2011, J MED MICROBIOL, V60, P1003, DOI 10.1099/jmm.0.027995-0; Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gilman J., 1998, EPICALC 2000 VERSION; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Iwamoto T, 2007, FEMS MICROBIOL LETT, V272, P282, DOI 10.1111/j.1574-6968.2007.00777.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kovalev SY, 2005, INT J TUBERC LUNG D, V9, P746; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Lapina A I, 1970, Bull Int Union Tuberc, V43, P188; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Makinen J, 2011, EUR J CLIN MICROBIOL, V30, P1119, DOI 10.1007/s10096-011-1200-7; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Marttila HJ, 2008, INT J TUBERC LUNG D, V12, P338; Ministry of Health of Russian Federation, 2003, 109 MIN HLTH RUSS FE; Mokrousov I, 2004, EMERG INFECT DIS, V10, P1337; Mokrousov I, 2012, CAUSES CONSEQUENCES, P317; Mokrousov I, 2008, INFECT GENET EVOL, V8, P777, DOI 10.1016/j.meegid.2008.07.003; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Mokrousov I, 2009, FEMS IMMUNOL MED MIC, V55, P13, DOI 10.1111/j.1574-695X.2008.00470.x; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Narvskaia O V, 1999, Probl Tuberk, P39; Narvskaya O, 2005, TRENDS IN DNA FINGERPRINTING RESEARCH, P111; Narvskaya O, 2003, THESIS I EXPT MED ST; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Nikolayevskyy VV, 2007, CLIN MICROBIOL INFEC, V13, P129, DOI 10.1111/j.1469-0691.2006.01583.x; Norkina O. V., 2003, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P9; Ogarkov OB, 2008, MOL MED, V2, P33; Sajduda A, 2004, INT J TUBERC LUNG D, V8, P1448; Shemyakin I. G., 2002, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P30; Sinkov VV, 2010, EPIDEMIOLOGIYA INFEK, V4, P50; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; Tracevska T, 2003, INT J TUBERC LUNG D, V7, P1097; Valcheva V, 2008, INFECT GENET EVOL, V8, P657, DOI 10.1016/j.meegid.2008.06.006; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasilenko N, 2006, IMMUNOPAT ALLERGOL I, V4, P70; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Zhakipbaeva BT, 2009, THESIS ASFENDIYAROV	52	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41318	10.1371/journal.pone.0041318	http://dx.doi.org/10.1371/journal.pone.0041318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844457	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700069
J	Rafii, A; Stoeckle, E; Jean-Laurent, M; Ferron, G; Morice, P; Houvenaeghel, G; Lecuru, F; Leblanc, E; Querleu, D				Rafii, Arash; Stoeckle, Eberhard; Jean-Laurent, Mehdi; Ferron, Gwenael; Morice, Philippe; Houvenaeghel, Gilles; Lecuru, Fabrice; Leblanc, Eric; Querleu, Denis			Multi-Center Evaluation of Post-Operative Morbidity and Mortality after Optimal Cytoreductive Surgery for Advanced Ovarian Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; RECTOSIGMOID RESECTION; PROGNOSTIC-FACTOR; RISK-FACTORS; CARCINOMA; COMPLICATIONS; MANAGEMENT; TRIALS	Purpose: While optimal cytoreduction is the standard of care for advanced ovarian cancer, the related post-operative morbidity has not been clearly documented outside pioneering centers. Indeed most of the studies are monocentric with inclusions over several years inducing heterogeneity in techniques and goals of surgery. We assessed the morbidity of optimal cytoreduction surgery for advanced ovarian cancer within a short inclusion period in 6 referral centers dedicated to achieve complete cytoreduction. Patients and Methods: The 30 last optimal debulking surgeries of 6 cancer centers were included. Inclusion criteria included: stage IIIc- IV ovarian cancer and optimal surgery performed at the site of inclusion. All post-operative complications within 30 days of surgery were recorded and graded using the Memorial secondary events grading system. Student-t, Chi2 and non-parametric statistical tests were performed. Results: 180 patients were included. There was no demographic differences between the centers. 63 patients underwent surgery including intestinal resections (58 recto-sigmoid resection), 24 diaphragmatic resections, 17 splenectomies. 61 patients presented complications; One patient died post-operatively. Major (grade 3-5) complications requiring subsequent surgeries occurred in 21 patients (11.5%). 76% of patients with a major complication had undergone an ultraradical surgery (P = 0.004). Conclusion: While ultraradical surgery may result in complete resection of peritoneal disease in advanced ovarian cancer, the associated complication rate is not negligible. Patients should be carefully evaluated and the timing of their surgery optimized in order to avoid major complications.	[Rafii, Arash; Jean-Laurent, Mehdi; Ferron, Gwenael; Querleu, Denis] Inst Claudius Regaud, Toulouse, France; [Stoeckle, Eberhard] Inst Bergonie, Bordeaux, France; [Morice, Philippe] Inst Gustave Roussy, Paris, France; [Lecuru, Fabrice] Hop Europeen Georges Pompidou, Paris, France; [Houvenaeghel, Gilles] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Leblanc, Eric] Ctr Oscar Lambret, F-59020 Lille, France	UNICANCER; Institut Claudius Regaud; UNICANCER; Institut Bergonie; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Oscar Lambret	Rafii, A (corresponding author), Weill Cornell Med Coll Qatar, Dept Genet Med & Obstet & Gynecol, Education City, Ar Rayyan, Qatar.	jat2021@qatar-med.cornell.edu	Morice, Philippe/ABC-3179-2021; Rafii, Arash/E-4106-2013; Ferron, Gwenael/P-6193-2014	Ferron, Gwenael/0000-0002-8545-4700; Morice, Philippe/0000-0003-0579-9993; leblanc, eric/0000-0001-7299-0339				Aletti GD, 2011, GYNECOL ONCOL, V120, P23, DOI 10.1016/j.ygyno.2010.09.010; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Bristow RE, 2006, GYNECOL ONCOL, V103, P1070, DOI 10.1016/j.ygyno.2006.06.025; Chereau E, 2011, EJSO-EUR J SURG ONC, V37, P175, DOI 10.1016/j.ejso.2010.10.004; Chereau E, 2009, BJOG-INT J OBSTET GY, V116, P1062, DOI 10.1111/j.1471-0528.2009.02214.x; Chereau E, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.856; Chi DS, 2006, GYNECOL ONCOL, V103, P559, DOI 10.1016/j.ygyno.2006.03.051; Chi DS, 2010, GYNECOL ONCOL, V119, P38, DOI 10.1016/j.ygyno.2010.05.031; Chi DS, 2008, GYNECOL ONCOL, V111, P391, DOI 10.1016/j.ygyno.2008.07.058; Chi DS, 2009, GYNECOL ONCOL, V114, P26, DOI 10.1016/j.ygyno.2009.03.018; Chi DS, 2004, AM J OBSTET GYNECOL, V191, P1138, DOI 10.1016/j.ajog.2004.05.004; Dowdy SC, 2008, GYNECOL ONCOL, V109, P303, DOI 10.1016/j.ygyno.2008.02.012; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Gerestein CG, 2009, GYNECOL ONCOL, V114, P523, DOI 10.1016/j.ygyno.2009.03.011; Kang S, 2009, ANN SURG ONCOL, V16, P2315, DOI 10.1245/s10434-009-0558-6; Look M, 2003, INT J GYNECOL CANCER, V13, P764, DOI 10.1111/j.1525-1438.2003.13319.x; Mercado C, 2010, GYNECOL ONCOL, V117, P18, DOI 10.1016/j.ygyno.2009.12.033; Mourton SM, 2005, GYNECOL ONCOL, V99, P608, DOI 10.1016/j.ygyno.2005.07.112; OMURA GA, 1991, J CLIN ONCOL, V9, P1138, DOI 10.1200/JCO.1991.9.7.1138; Peiretti M, 2010, GYNECOL ONCOL, V119, P259, DOI 10.1016/j.ygyno.2010.07.032; Richardson DL, 2006, GYNECOL ONCOL, V103, P667, DOI 10.1016/j.ygyno.2006.05.003; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Schwartz PE, 2008, ONCOLOGY-NY, V22, P1025; Stuart GCE, 2011, INT J GYNECOL CANCER, V21, P750, DOI 10.1097/IGC.0b013e31821b2568; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806	25	54	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e39415	10.1371/journal.pone.0039415	http://dx.doi.org/10.1371/journal.pone.0039415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844394	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700005
J	Wang, ML; Hada, M; Saha, J; Sridharan, DM; Pluth, JM; Cucinotta, FA				Wang, Minli; Hada, Megumi; Saha, Janapriya; Sridharan, Deepa M.; Pluth, Janice M.; Cucinotta, Francis A.			Protons Sensitize Epithelial Cells to Mesenchymal Transition	PLOS ONE			English	Article							GROWTH; CANCER; EXPOSURE; RECEPTOR; THERAPY; TARGET; EMT	Proton radiotherapy has gained more favor among oncologists as a treatment option for localized and deep-seated tumors. In addition, protons are a major constituent of the space radiation astronauts receive during space flights. The potential for these exposures to lead to, or enhance cancer risk has not been well studied. Our objective is to study the biological effects of low energy protons on epithelial cells and its propensity to enhance transforming growth factor beta 1 (TGF beta 1)-mediated epithelial-mesenchymal transition (EMT), a process occurring during tumor progression and critical for invasion and metastasis. Non-transformed mink lung epithelial cells (Mv1Lu) and hTERT-immortalized human esophageal epithelial cells (EPC) were used in this study. EMT was identified by alterations in cell morphology, EMT-related gene expression changes determined using real-time PCR, and EMT changes in specific cellular markers detected by immunostaining and western blotting. Although TGF beta 1 treatment alone is able to induce EMT in both Mv1Lu and EPC cells, low energy protons (5 MeV) at doses as low as 0.1 Gy can enhance TGF beta 1 induced EMT. Protons alone can also induce a mild induction of EMT. SD208, a potent TGF beta Receptor 1 (TGF beta R1) kinase inhibitor, can efficiently block TGF beta 1/Smad signaling and attenuate EMT induction. We suggest a model for EMT after proton irradiation in normal and cancerous tissue based on our results that showed that low and high doses of protons can sensitize normal human epithelial cells to mesenchymal transition, more prominently in the presence of TGF beta 1, but also in the absence of TGF beta 1.	[Wang, Minli; Hada, Megumi; Saha, Janapriya] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA; [Sridharan, Deepa M.; Pluth, Janice M.] Lawrence Berkeley Natl Lab, Dept Canc & DNA Damage Responses, Berkeley, CA USA; [Cucinotta, Francis A.] NASA, Lyndon B Johnson Space Ctr, Space Radiat Program, Houston, TX 77058 USA	Universities Space Research Association (USRA); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Wang, ML (corresponding author), Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA.	francis.a.cucinotta@nasa.gov	Cucinotta, Francis/AAZ-5941-2020		National Aeronautics and Space Administration; Department of Environment	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Department of Environment	This work supported by National Aeronautics and Space Administration and Department of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andarawewa KL, 2011, INT J RADIAT ONCOL, V79, P1523, DOI 10.1016/j.ijrobp.2010.11.058; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Chen C, 2001, PLOS ONE, V6; CUCINOTTA FA, 1991, RADIAT RES, V127, P130, DOI 10.2307/3577956; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Ehrhart EJ, 1996, RADIAT RES, V145, P157, DOI 10.2307/3579170; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Harada H, 2003, MOL CANCER RES, V1, P729; Isacsson U, 1998, INT J RADIAT ONCOL, V41, P441, DOI 10.1016/S0360-3016(98)00047-9; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Kong Fengming, 1995, International Journal of Radiation Oncology Biology Physics, V32, P239, DOI 10.1016/0360-3016(95)97858-X; Lamouille S, 2011, CELLS TISSUES ORGANS, V193, P8, DOI 10.1159/000320172; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Sigurdsson V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023833; Terasawa T, 2009, ANN INTERN MED, V151, P556, DOI 10.7326/0003-4819-151-8-200910200-00145; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; von Rahden BHA, 2006, MOL CARCINOGEN, V45, P786, DOI 10.1002/mc.20259; Wang ML, 2012, J RADIAT RES, V53, P51, DOI 10.1269/jrr.11121; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Xie YF, 2009, CANCER RES, V69, P7756, DOI 10.1158/0008-5472.CAN-09-0496; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956	31	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41249	10.1371/journal.pone.0041249	http://dx.doi.org/10.1371/journal.pone.0041249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844446	gold, Green Submitted, Green Published			2022-12-27	WOS:000306687700059
J	Lautz, TB; Jie, C; Clark, S; Naiditch, JA; Jafari, N; Qiu, YY; Zheng, X; Chu, F; Madonna, MB				Lautz, Timothy B.; Jie, Chunfa; Clark, Sandra; Naiditch, Jessica A.; Jafari, Nadereh; Qiu, Yi-Yong; Zheng, Xin; Chu, Fei; Madonna, Mary Beth			The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; TUMOR-CELLS; MDR1 GENE; CANCER; APOPTOSIS; ACID; MECHANISMS; PROGRAM	Histone deacetylase (HDAC) inhibitors, especially vorinostat, are currently under investigation as potential adjuncts in the treatment of neuroblastoma. The effect of vorinostat co-treatment on the development of resistance to other chemotherapeutic agents is unknown. In the present study, we treated two human neuroblastoma cell lines [SK-N-SH and SK-N-Be(2)C] with progressively increasing doses of doxorubicin under two conditions: with and without vorinsotat co-therapy. The resultant doxorubicin-resistant (DoxR) and vorinostat-treated doxorubicin resistant (DoxR-v) cells were equally resistant to doxorubicin despite significantly lower P-glycoprotein expression in the DoxR-v cells. Whole genome analysis was performed using the Ilumina Human HT-12 v4 Expression Beadchip to identify genes with differential expression unique to the DoxR-v cells. We uncovered a number of genes whose differential expression in the DoxR-v cells might contribute to their resistant phenotype, including hypoxia inducible factor-2. Finally, we used Gene Ontology to categorize the biological functions of the differentially expressed genes unique to the DoxR-v cells and found that genes involved in cellular metabolism were especially affected.	[Lautz, Timothy B.; Naiditch, Jessica A.; Madonna, Mary Beth] Northwestern Univ, Dept Surg, Lurie Childrens Hosp, Chicago, IL 60611 USA; [Lautz, Timothy B.; Clark, Sandra; Naiditch, Jessica A.; Qiu, Yi-Yong; Zheng, Xin; Chu, Fei; Madonna, Mary Beth] Northwestern Univ, Canc Biol Program, Childrens Mem Res Ctr, Chicago, IL 60611 USA; [Jie, Chunfa; Jafari, Nadereh] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University; Northwestern University	Lautz, TB (corresponding author), Northwestern Univ, Dept Surg, Lurie Childrens Hosp, Chicago, IL 60611 USA.	fchu@childrensmemorial.org; mmadonna@childrensmemorial.org		Naiditch, Jessica/0000-0002-6340-0947; Lautz, Timothy/0000-0002-3323-6509	John W Anderson Foundation, Valparaiso, Indiana [46383-2567]; Children's Research Foundation	John W Anderson Foundation, Valparaiso, Indiana; Children's Research Foundation	Funding provided by John W Anderson Foundation, 402 Wall St # 12, Valparaiso, Indiana 46383-2567 and the Children's Research Foundation, http://www.childrensresearchfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, GENE SET ENRICHMENT; Bhatt RS, 2008, BJU INT, V102, P358, DOI 10.1111/j.1464-410X.2008.07558.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Coffey DC, 2001, CANCER RES, V61, P3591; Comerford KM, 2002, CANCER RES, V62, P3387; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fouladi M, 2010, J CLIN ONCOL, V28, P3623, DOI 10.1200/JCO.2009.25.9119; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Glick RD, 1999, CANCER RES, V59, P4392; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Haber M, 1997, EUR J CANCER, V33, P2031, DOI 10.1016/S0959-8049(97)00229-3; Huang JM, 2010, MOL CANCER THER, V9, P3289, DOI 10.1158/1535-7163.MCT-10-0562; Keenan J, 2009, PROTEOMICS, V9, P1556, DOI 10.1002/pmic.200800633; Keshelava N, 2007, JNCI-J NATL CANCER I, V99, P1107, DOI 10.1093/jnci/djm044; Keshelava N, 2009, PEDIATR BLOOD CANCER, V53, P505, DOI 10.1002/pbc.21988; Kim SH, 2007, ONCOL REP, V17, P647; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Montopoli M, 2011, CURR CANCER DRUG TAR, V11, P226, DOI 10.2174/156800911794328501; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Ozaki K, 2008, CANCER SCI, V99, P376, DOI 10.1111/j.1349-7006.2007.00669.x; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Shankar S, 2009, MOL CANCER THER, V8, P1596, DOI 10.1158/1535-7163.MCT-08-1004; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, LIMMA LINEAR MODELS; Temmink OH, 2010, MOL CANCER THER, V9, P1047, DOI 10.1158/1535-7163.MCT-09-0932; Witt O, 2009, CURR PHARM DESIGN, V15, P436, DOI 10.2174/138161209787315774; Witte I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.91; Zhao LY, 2006, CANCER RES, V66, P9445, DOI 10.1158/0008-5472.CAN-06-1713	32	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40816	10.1371/journal.pone.0040816	http://dx.doi.org/10.1371/journal.pone.0040816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829886	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300024
J	Mamun, AA; O'Callaghan, MJ; Williams, GM; Najman, JM				Mamun, Abdullah A.; O'Callaghan, Michael J.; Williams, Gail M.; Najman, Jake M.			Maternal Smoking During Pregnancy Predicts Adult Offspring Cardiovascular Risk Factors - Evidence from a Community-Based Large Birth Cohort Study	PLOS ONE			English	Article							CHILDHOOD OBESITY; BLOOD-PRESSURE; NICOTINE; WEIGHT; OVERWEIGHT; ADIPOSITY; EXPOSURE; AGE	Background: Maternal smoking during pregnancy is associated with offspring obesity. However, little is known about whether maternal smoking in pregnancy predicts other offspring cardiovascular risk factors including waist circumference (WC), waist-hip-ratio (WHR), pulse rate (PR), systolic (SBP), and diastolic blood pressure (DBP). Methods: We studied a sub-sample of 2038 (50% males) young adults who were born in Brisbane, Australia to investigate the prospective association of maternal smoking during pregnancy with young adult cardiovascular risk factors. We compared offspring mean BMI, WC, WHR, SBP, DBP and PR and the risk of being overweight and obese at 21 years by three mutually exclusive categories of maternal smoking status defined as never smoked, smoked before and/or after pregnancy but not in pregnancy or smoked during pregnancy and other times. Results: Offspring of mothers who smoked during pregnancy had greater mean BMI, WC, WHR and PR and they were at greater risk of being obese at 21 years compared to offspring of those mothers who never smoked. The mean of these risk factors among those adult offspring whose mothers stopped smoking during pregnancy, but who then smoked at other times in the child's life, were similar to those mothers who never smoked. These results were independent of a range of potential confounding factors. Conclusion: The findings of this study suggest a prospective association of maternal smoking during pregnancy and offspring obesity as well as PR in adulthood, and reinforce the need to persuade pregnant women not to smoke.	[Mamun, Abdullah A.; Williams, Gail M.; Najman, Jake M.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [O'Callaghan, Michael J.] Univ Queensland, Mater Childrens Hosp, Child Dev Serv, Brisbane, Qld 4101, Australia; [O'Callaghan, Michael J.] Univ Queensland, Mater Childrens Hosp, Child Rehabil Serv, Brisbane, Qld 4101, Australia; [O'Callaghan, Michael J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Najman, Jake M.] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland	Mamun, AA (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	mamun@sph.uq.edu.au	Williams, Gail/S-8833-2019; Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022; Najman, Jackob M./B-1527-2008	Williams, Gail/0000-0002-4822-5263; Mamun, Abdullah A/0000-0002-1535-8086; Najman, Jackob M./0000-0001-7079-2080	National Health and Medical Research Council (NHMRC) of Australia; NHMRC [519756]; National Heart Foundation of Australia [G07B3135]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	The core study was funded by the National Health and Medical Research Council (NHMRC) of Australia. AAM is supported by a Career Development Awards from the NHMRC (ID 519756). For the work in this paper AAM has a grant from the National Heart Foundation of Australia (ID G07B3135). The views expressed in the paper are those of the authors and not necessarily those of any funding body and no funding body influenced the way in which the data were analysed and presented. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2006, AM J EPIDEMIOL, V164, P317, DOI 10.1093/aje/kwj209; Bergel E, 2000, AM J EPIDEMIOL, V151, P594, DOI 10.1093/oxfordjournals.aje.a010247; Blake KV, 2000, EARLY HUM DEV, V57, P137, DOI 10.1016/S0378-3782(99)00064-X; Chen AM, 2006, INT J EPIDEMIOL, V35, P121, DOI 10.1093/ije/dyi218; Fasting MH, 2009, EARLY HUM DEV, V85, P19, DOI 10.1016/j.earlhumdev.2008.05.009; Gao YJ, 2005, OBES RES, V13, P687, DOI 10.1038/oby.2005.77; Grassi G, 2009, PROG CARDIOVASC DIS, V52, P31, DOI 10.1016/j.pcad.2009.05.007; Ino T, 2010, PEDIATR INT, V52, P94, DOI 10.1111/j.1442-200X.2009.02883.x; Kane JK, 2000, ENDOCRINOLOGY, V141, P3623, DOI 10.1210/en.141.10.3623; KEEPING JD, 1989, BRIT J OBSTET GYNAEC, V96, P289, DOI 10.1111/j.1471-0528.1989.tb02388.x; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Montgomery SM, 2002, BRIT MED J, V324, P26, DOI 10.1136/bmj.324.7328.26; MORLEY R, 1995, ARCH DIS CHILD, V72, P120, DOI 10.1136/adc.72.2.120; Nafstad P, 1997, J EPIDEMIOL COMMUN H, V51, P261, DOI 10.1136/jech.51.3.261; Najman JM, 2005, INT J EPIDEMIOL, V34, P992, DOI 10.1093/ije/dyi119; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Oken E, 2005, OBES RES, V13, P2021, DOI 10.1038/oby.2005.248; Ong KKL, 2000, BRIT MED J, V320, P1244; Power C, 2010, ATHEROSCLEROSIS, V211, P643, DOI 10.1016/j.atherosclerosis.2010.03.015; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Rustemeier K, 2002, FOOD CHEM TOXICOL, V40, P93, DOI 10.1016/S0278-6915(01)00085-0; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Suzuki K, 2009, J EPIDEMIOL, V19, P136, DOI 10.2188/jea.JE20081012; Swauger JE, 2002, REGUL TOXICOL PHARM, V35, P142, DOI 10.1006/rtph.2001.1521; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; Vanhala M, 1999, ANN MED, V31, P236, DOI 10.3109/07853899908995885; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; World Health Organization, 1997, OB PREV MAN GLOB EP	31	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41106	10.1371/journal.pone.0041106	http://dx.doi.org/10.1371/journal.pone.0041106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829913	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300052
J	Pitek, AS; O'Connell, D; Mahon, E; Monopoli, MP; Bombelli, FB; Dawson, KA				Pitek, Andrzej S.; O'Connell, David; Mahon, Eugene; Monopoli, Marco P.; Bombelli, Francesca Baldelli; Dawson, Kenneth A.			Transferrin Coated Nanoparticles: Study of the Bionano Interface in Human Plasma	PLOS ONE			English	Article							PROTEIN CORONA; GOLD NANOPARTICLES; SURFACE-PROPERTIES; CELLULAR UPTAKE; DRUG-DELIVERY; CANCER-CELLS; RECEPTOR; SIZE; NANOMATERIALS; THERAPY	It is now well established that the surface of nanoparticles (NPs) in a biological environment is immediately modified by the adsorption of biomolecules with the formation of a protein corona and it is also accepted that the protein corona, rather than the original nanoparticle surface, defines a new biological identity. Consequently, a methodology to effectively study the interaction between nanomaterials and the biological corona encountered within an organism is a key objective in nanoscience for understanding the impact of the nanoparticle-protein interactions on the biological response in vitro and in vivo. Here, we outline an integrated methodology to address the different aspects governing the formation and the function of the protein corona of polystyrene nanoparticles coated with Transferrin by different strategies. Protein-NP complexes are studied both in situ (in human plasma, full corona FC) and after washing (hard corona, HC) in terms of structural properties, composition and second-order interactions with protein microarrays. Human protein microarrays are used to effectively study NP-corona/proteins interactions addressing the growing demand to advance investigations of the extrinsic function of corona complexes. Our data highlight the importance of this methodology as an analysis to be used in advance of the application of engineered NPs in biological environments.	[Pitek, Andrzej S.; Mahon, Eugene; Monopoli, Marco P.; Bombelli, Francesca Baldelli; Dawson, Kenneth A.] Natl Univ Ireland Univ Coll Dublin, Ctr BioNano Interact, Sch Chem & Chem Biol, Dublin 4, Ireland; [Pitek, Andrzej S.; O'Connell, David; Monopoli, Marco P.; Dawson, Kenneth A.] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Bombelli, Francesca Baldelli] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England	University College Dublin; University College Dublin; University of East Anglia	Pitek, AS (corresponding author), Natl Univ Ireland Univ Coll Dublin, Ctr BioNano Interact, Sch Chem & Chem Biol, Dublin 4, Ireland.	f.baldelli-bombelli@uea.ac.uk	Che Cob, Zaihisma/GLT-0159-2022; Monopoli, Marco P./AAM-6527-2021; Monopoli, Marco P/I-7060-2018; Dawson, Kenneth A. A/L-2540-2016; Bombelli, Francesca Baldelli/M-5368-2015	Che Cob, Zaihisma/0000-0003-0875-9188; Monopoli, Marco P./0000-0002-2035-6894; Monopoli, Marco P/0000-0002-2035-6894; Dawson, Kenneth A. A/0000-0002-0568-6588; Bombelli, Francesca Baldelli/0000-0001-8138-9246; Pitek, Andrzej/0000-0002-4021-835X; Mahon, Eugene/0000-0002-5170-6332; O'Connell, David/0000-0002-6461-7750	EU FP7 Small Collaborative Project NeuroNano [NMP4-SL-2008-214547]; Environmental Protection Agency (EPA) [2008-EH-MS-5]	EU FP7 Small Collaborative Project NeuroNano; Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	Authors would like to acknowledge the INSPIRE programme - an Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013, under which this work was conducted. Additional funding from the EU FP7 Small Collaborative Project NeuroNano (NMP4-SL-2008-214547) and the Environmental Protection Agency (EPA) project (2008-EH-MS-5) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal WT, 2011, ACCOUNTS CHEM RES, V44, P1094, DOI 10.1021/ar200105p; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Barth BM, 2010, ACS NANO, V4, P1279, DOI 10.1021/nn901297q; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Casals E, 2011, SMALL, V7, P3479, DOI 10.1002/smll.201101511; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136; Choi CHJ, 2011, P NATL ACAD SCI USA, V108, P6656, DOI 10.1073/pnas.1103573108; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Dandekar P, 2010, J AEROSOL MED PULM D, V23, P343, DOI 10.1089/jamp.2009.0784; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001; Faneca H, 2004, J GENE MED, V6, P681, DOI 10.1002/jgm.550; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Jung SH, 2010, COLLOID SURFACE B, V76, P434, DOI 10.1016/j.colsurfb.2009.12.002; Kumari A, 2011, EXPERT OPIN DRUG DEL, V8, P141, DOI 10.1517/17425247.2011.547934; Lesniak A, 2010, BIOMATERIALS, V31, P9511, DOI 10.1016/j.biomaterials.2010.09.049; Li JL, 2009, CANCER LETT, V274, P319, DOI 10.1016/j.canlet.2008.09.024; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Marano F, 2011, ARCH TOXICOL, V85, P733, DOI 10.1007/s00204-010-0546-4; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; Monopoli M.P., 2011, J AM CHEM SOC; Monopoli MP, 2011, NAT NANOTECHNOL, V6, P11, DOI 10.1038/nnano.2011.267; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Rosenholm JM, 2009, ACS NANO, V3, P197, DOI 10.1021/nn800781r; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang J, 2010, J AM CHEM SOC, V132, P11306, DOI 10.1021/ja1043177; Wang M, 2010, PHARMACOL RES, V62, P90, DOI 10.1016/j.phrs.2010.03.005; Xia XR, 2011, ACS NANO, V5, P9074, DOI 10.1021/nn203303c; Yang PH, 2005, BIOCONJUGATE CHEM, V16, P494, DOI 10.1021/bc049775d; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; Zheng Y, 2010, INT J PHARMACEUT, V390, P234, DOI 10.1016/j.ijpharm.2010.02.008	40	70	70	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40685	10.1371/journal.pone.0040685	http://dx.doi.org/10.1371/journal.pone.0040685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829881	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300019
J	Vaisman, BL; Andrews, KL; Khong, SML; Wood, KC; Moore, XL; Fu, Y; Kepka-Lenhart, DM; Morris, SM; Remaley, AT; Chin-Dusting, JPF				Vaisman, Boris L.; Andrews, Karen L.; Khong, Sacha M. L.; Wood, Katherine C.; Moore, Xiao L.; Fu, Yi; Kepka-Lenhart, Diane M.; Morris, Sidney M., Jr.; Remaley, Alan T.; Chin-Dusting, Jaye P. F.			Selective Endothelial Overexpression of Arginase II Induces Endothelial Dysfunction and Hypertension and Enhances Atherosclerosis in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LOW-DENSITY-LIPOPROTEIN; VASCULAR ENDOTHELIUM; ARGININE METABOLISM; OXIDATIVE STRESS; TRANSGENIC MICE; CAROTID-ARTERY; CELLS; INHIBITION; EXPRESSION	Background: Cardiovascular disorders associated with endothelial dysfunction, such as atherosclerosis, have decreased nitric oxide (NO) bioavailability. Arginase in the vasculature can compete with eNOS for L-arginine and has been implicated in atherosclerosis. The aim of this study was to evaluate the effect of endothelial-specific elevation of arginase II expression on endothelial function and the development of atherosclerosis. Methodology/Principal Findings: Transgenic mice on a C57BL/6 background with endothelial-specific overexpression of human arginase II (hArgII) gene under the control of the Tie2 promoter were produced. The hArgII mice had elevated tissue arginase activity except in liver and in resident peritoneal macrophages, confirming endothelial specificity of the transgene. Using small-vessel myography, aorta from these mice exhibited endothelial dysfunction when compared to their non-transgenic littermate controls. The blood pressure of the hArgII mice was 17% higher than their littermate controls and, when crossed with apoE -/- mice, hArgII mice had increased aortic atherosclerotic lesions. Conclusion: We conclude that overexpression of arginase II in the endothelium is detrimental to the cardiovascular system.	[Vaisman, Boris L.; Wood, Katherine C.; Remaley, Alan T.] NHLBI, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA; [Andrews, Karen L.; Khong, Sacha M. L.; Moore, Xiao L.; Fu, Yi; Chin-Dusting, Jaye P. F.] Baker IDI Heart & Diabet Inst, Vasc Pharmacol Lab, Melbourne, Vic, Australia; [Kepka-Lenhart, Diane M.; Morris, Sidney M., Jr.] Univ Pittsburgh, Sch Med, Dept Microbiol, Pittsburgh, PA USA; [Kepka-Lenhart, Diane M.; Morris, Sidney M., Jr.] Univ Pittsburgh, Sch Med, Dept Mol Genet, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baker Heart and Diabetes Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vaisman, BL (corresponding author), NHLBI, Cardiovasc Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	karen.andrews@bakeridi.edu.au	Vaisman, Boris L/B-3453-2008; Morris, Sidney M/I-3440-2015		Intramural NHLBI; National Institutes of Health [RO1 GM57384]; National Health and Medical Research Council of Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057384] Funding Source: NIH RePORTER	Intramural NHLBI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by Intramural NHLBI (to ATR), National Institutes of Health funding (RO1 GM57384 to SMM) and a National Health and Medical Research Council of Australia program grant (to JCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anghelina M, 2005, J CELL MOL MED, V9, P113, DOI 10.1111/j.1582-4934.2005.tb00341.x; Basso F, 2006, BIOCHEM BIOPH RES CO, V351, P398, DOI 10.1016/j.bbrc.2006.10.044; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Camilletti A, 2001, AM J HYPERTENS, V14, P382, DOI 10.1016/S0895-7061(00)01297-8; CARVAJAL N, 1986, BIOCHIM BIOPHYS ACTA, V870, P181, DOI 10.1016/0167-4838(86)90219-0; CHEN GF, 1990, J PHYSIOL-LONDON, V421, P521, DOI 10.1113/jphysiol.1990.sp017959; Demougeot C, 2005, J HYPERTENS, V23, P971, DOI 10.1097/01.hjh.0000166837.78559.93; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Erdely A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015253; Gkaliagkousi E, 2009, J HYPERTENS, V27, P2310, DOI 10.1097/HJH.0b013e328330e89a; Topal JLG, 2006, J PHARMACOL EXP THER, V318, P1368, DOI 10.1124/jpet.106.103747; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; Huynh NN, 2009, BRIT J PHARMACOL, V156, P84, DOI 10.1111/j.1476-5381.2008.00036.x; Huynh NN, 2009, HYPERTENSION, V54, P294, DOI 10.1161/HYPERTENSIONAHA.108.121731; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Johnson FK, 2005, AM J PHYSL REGUL INT; Judkins CP, AM J PHYSL HEART CIR, V298, pH24; Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96; Kepka-Lenhart D, 2008, METHOD ENZYMOL, V440, P221, DOI 10.1016/S0076-6879(07)00813-0; Khong SML, 2012, BRIT J PHARMACOL, V166, P2015, DOI 10.1111/j.1476-5381.2012.01876.x; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; Kim NN, 2001, BIOCHEMISTRY-US, V40, P2678, DOI 10.1021/bi002317h; Kim SW, 2003, INT J IMPOT RES, V15, P355, DOI 10.1038/sj.ijir.3901038; Lim HK, 2007, AM J PHYSIOL-HEART C, V293, pH3317, DOI 10.1152/ajpheart.00700.2007; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Matsumoto T, 2003, J PHARMACOL EXP THER, V306, P103, DOI 10.1124/jpet.103.049163; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; Ming XF, 2004, CIRCULATION; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Ryoo S, 2006, CIRC RES, V99, P951, DOI 10.1161/01.RES.0000247034.24662.b4; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Tain YL, 2007, AM J PHYSIOL-RENAL, V292, pF1404, DOI 10.1152/ajprenal.00260.2006; Takaya T, 2007, ARTERIOSCL THROM VAS, V27, P1632, DOI 10.1161/ATVBAHA.107.142182; Tawfik HE, 2008, AM J PHYSIOL-HEART C, V295, pH1736, DOI 10.1152/ajpheart.87.2008; Teng PI, 2002, PHYSIOL GENOMICS, V11, P99, DOI 10.1152/physiolgenomics.00059.2002; Teupser D, 2006, ARTERIOSCL THROM VAS, V26, P365, DOI 10.1161/01.ATV.0000195791.83380.4c; Thuraisingham RC, 2003, KIDNEY INT, V63, pS29, DOI 10.1046/j.1523-1755.63.s84.41.x; VAISMAN BL, 1995, J BIOL CHEM, V270, P12269, DOI 10.1074/jbc.270.20.12269; Vinh A, 2008, CARDIOVASC RES, V77, P178, DOI 10.1093/cvr/cvm021; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang WZ, 2004, ANAL BIOCHEM, V326, P87, DOI 10.1016/j.ab.2003.11.006	48	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e39487	10.1371/journal.pone.0039487	http://dx.doi.org/10.1371/journal.pone.0039487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829869	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000306956300007
J	Balasubramanian, P; Lang, JC; Jatana, KR; Miller, B; Ozer, E; Old, M; Schuller, DE; Agrawal, A; Teknos, TN; Summers, TA; Lustberg, MB; Zborowski, M; Chalmers, JJ				Balasubramanian, Priya; Lang, James C.; Jatana, Kris R.; Miller, Brandon; Ozer, Enver; Old, Mathew; Schuller, David E.; Agrawal, Amit; Teknos, Theodoros N.; Summers, Thomas A., Jr.; Lustberg, Maryam B.; Zborowski, Maciej; Chalmers, Jeffrey J.			Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-PATIENTS; DEPLETION	Epithelial to mesenchymal transition (EMT) has been hypothesized as a mechanism by which cells change phenotype during carcinogenesis, as well as tumor metastasis. Whether EMT is involved in cancer metastasis has a specific, practical impact on the field of circulating tumor cells (CTCs). Since the generally accepted definition of a CTC includes the expression of epithelial surface markers, such as EpCAM, if a cancer cell loses its epithelial surface markers (which is suggested in EMT), it will not be separated and/or identified as a CTC. We have developed, and previously reported on the use of, a purely negative enrichment technology enriching for CTCs in the blood of squamous cell carcinoma of the head and neck (SCCHN). This methodology does not depend on the expression of surface epithelial markers. Using this technology, our initial data on SCCHN patient blood indicates that the presence of CTCs correlates with worse disease-free survival. Since our enrichment is not dependent on epithelial markers, we have initiated investigation of the presence of mesenchymal markers in these CTC cells to include analysis of: vimentin, epidermal growth factor receptor, N-cadherin, and CD44. With the aid of confocal microscopy, we have demonstrated not only presumed CTCs that express and/or contain: a nucleus, cytokeratins, vimentin, and either EGFR, CD44, or N-cadherin, but also cells that contain all of the aforementioned proteins except cytokeratins, suggesting that the cells have undergone the EMT process. We suggest that our negative depletion enrichment methodology provides a more objective approach in identifying and evaluating CTCs, as opposed to positive selection approaches, as it is not subjective to a selection bias and can be tailored to accommodate a variety of cytoplasmic and surface markers which can be evaluated to identify a multitude of phenotypic patterns within CTCs from individual patients, including so-called EMT as presented here.	[Balasubramanian, Priya; Miller, Brandon; Chalmers, Jeffrey J.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Lang, James C.; Jatana, Kris R.; Ozer, Enver; Old, Mathew; Schuller, David E.; Agrawal, Amit; Teknos, Theodoros N.] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Jatana, Kris R.] Nationwide Childrens Hosp, Dept Otolaryngol Head & Neck Surg, Columbus, OH USA; [Summers, Thomas A., Jr.] Walter Reed Natl Mil Med Ctr, Dept Pathol & Lab Serv, Bethesda, MD USA; [Lustberg, Maryam B.] James Canc Hosp, Dept Internal Med, Columbus, OH USA; [Lustberg, Maryam B.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Zborowski, Maciej] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Chalmers, Jeffrey J.] OSU Comprehens Canc Ctr, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Walter Reed National Military Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chalmers, JJ (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	chalmers.1@osu.edu	Ozer, Enver/E-3802-2011; Old, Matthew/J-2315-2017; Jatana, Kris/E-3309-2011; Miller, Brandon/B-7645-2013	Old, Matthew/0000-0003-1795-5877; Miller, Brandon/0000-0003-1523-9092	National Science Foundation [BES-0124897, EEC 0425626]; National Cancer Institute [R01 CA97391-01A1]; State of Ohio Third Frontier Program [ODOD 26140000:TECH 07-001]; National Cancer Institute CCC Core Grant [P30 CA16058]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA062349, R01CA097391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); State of Ohio Third Frontier Program; National Cancer Institute CCC Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the following agencies: The National Science Foundation (BES-0124897); the National Cancer Institute (R01 CA97391-01A1); the State of Ohio Third Frontier Program (ODOD 26140000:TECH 07-001); the National Cancer Institute CCC Core Grant (P30 CA16058) and National Science Foundation (EEC 0425626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America Cancer Society, 2011, CANC FACTS FIG; Balasubramanian P, 2009, MOL PHARMACEUT, V6, P1402, DOI 10.1021/mp9000519; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Gath HJ, 1999, CANCER METAST REV, V18, P109, DOI 10.1023/A:1006268621730; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Jatana KR, 2010, ARCH OTOLARYNGOL, V136, P1274, DOI 10.1001/archoto.2010.223; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Lara O, 2004, EXP HEMATOL, V32, P891, DOI 10.1016/j.exphem.2004.07.007; MCGUIRT WF, 1995, ARCH OTOLARYNGOL, V121, P278; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Tkaczuk KHR, 2008, BREAST CANCER RES TR, V111, P355, DOI 10.1007/s10549-007-9771-9; van de Stolpe A, 2011, CANCER RES, V71, P5955, DOI 10.1158/0008-5472.CAN-11-1254; Wang ZP, 2000, CANCER, V88, P2787, DOI 10.1002/1097-0142(20000615)88:12<2787::AID-CNCR18>3.0.CO;2-2; Yang LY, 2009, BIOTECHNOL BIOENG, V102, P521, DOI 10.1002/bit.22066; Yuen APW, 1997, HEAD NECK-J SCI SPEC, V19, P583, DOI 10.1002/(SICI)1097-0347(199710)19:7<583::AID-HED4>3.0.CO;2-3; Zborowski M, 2011, ANAL CHEM, V83, P8050, DOI 10.1021/ac200550d	25	90	92	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42048	10.1371/journal.pone.0042048	http://dx.doi.org/10.1371/journal.pone.0042048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844540	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600065
J	Petersen, SB; Neves-Petersen, MT; Henriksen, SB; Mortensen, RJ; Geertz-Hansen, HM				Petersen, Steffen B.; Neves-Petersen, Maria Teresa; Henriksen, Svend B.; Mortensen, Rasmus J.; Geertz-Hansen, Henrik M.			Scale-Free Behaviour of Amino Acid Pair Interactions in Folded Proteins	PLOS ONE			English	Article							POWER-LAW BEHAVIOR; INTERACTION NETWORKS; CONTACT ENERGIES; FOLDING PROBLEM; ORGANIZATION; APPROXIMATION; DUPLICATION; RESIDUES; DOMAINS; NUMBER	The protein structure is a cumulative result of interactions between amino acid residues interacting with each other through space and/or chemical bonds. Despite the large number of high resolution protein structures, the "protein structure code'' has not been fully identified. Our manuscript presents a novel approach to protein structure analysis in order to identify rules for spatial packing of amino acid pairs in proteins. We have investigated 8706 high resolution non-redundant protein chains and quantified amino acid pair interactions in terms of solvent accessibility, spatial and sequence distance, secondary structure, and sequence length. The number of pairs found in a particular environment is stored in a cell in an 8 dimensional data tensor. When plotting the cell population against the number of cells that have the same population size, a scale free organization is found. When analyzing which amino acid paired residues contributed to the cells with a population above 50, pairs of Ala, Ile, Leu and Val dominate the results. This result is statistically highly significant. We postulate that such pairs form "structural stability points'' in the protein structure. Our data shows that they are in buried alpha-helices or beta-strands, in a spatial distance of 3.8-4.3 angstrom and in a sequence distance >4 residues. We speculate that the scale free organization of the amino acid pair interactions in the 8D protein structure combined with the clear dominance of pairs of Ala, Ile, Leu and Val is important for understanding the very nature of the protein structure formation. Our observations suggest that protein structures should be considered as having a higher dimensional organization.	[Petersen, Steffen B.; Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab INL, Braga, Portugal; [Petersen, Steffen B.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Petersen, Steffen B.] SUNY Buffalo, Inst Lasers, Buffalo, NY 14260 USA; [Neves-Petersen, Maria Teresa] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Henriksen, Svend B.; Mortensen, Rasmus J.] Aalborg Univ, Dept Phys & Nanotechnol, Aalborg, Denmark; [Mortensen, Rasmus J.] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Geertz-Hansen, Henrik M.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil Fremtidsvej, Copenhagen, Denmark	International Iberian Nanotechnology Laboratory; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Aalborg University; Aalborg University; Statens Serum Institut; Novo Nordisk Foundation; Technical University of Denmark	Petersen, SB (corresponding author), Int Iberian Nanotechnol Lab INL, Braga, Portugal.	steffen.petersen.at@inl.int; teresa.petersen@inl.int	INL, Citations/K-3436-2015; Petersen, Steffen b/E-8727-2015	INL, Citations/0000-0002-3745-5100; Petersen, Steffen b/0000-0002-0739-2751; Geertz-Hansen, Henrik Marcus/0000-0003-0425-7551; Neves-Petersen, Maria Teresa/0000-0003-3178-3709	Aalborg University	Aalborg University	The authors are grateful for the support from Aalborg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral L.A.N., 1997, PNAS, P11149; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernal JD, 1939, NATURE, V143, P663, DOI 10.1038/143663a0; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Buchete NV, 2008, PROTEINS, V70, P119, DOI 10.1002/prot.21538; Caldarelli G., 2007, SCALE FREE NETWORKS; CATH, PROT STRUCT CLASS DA; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Gao J, 2008, BIOPOLYMERS, V89, P1174, DOI 10.1002/bip.21072; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Henriksen C, 2011, PLOS ONE, V6; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jha AN, 2010, PROTEIN SCI, V19, P603, DOI 10.1002/pro.339; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kim J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055101; Levinthal C., 1969, MOSSBAUER SPECTROSC, V67, P22; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Mathews B, 2010, PROTEIN FOLDING SHOR; Miyazawa S, 1999, PROTEINS, V34, P49; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; RACKOVSKY S, 1993, P NATL ACAD SCI USA, V90, P644, DOI 10.1073/pnas.90.2.644; Rzhetsky A, 2001, BIOINFORMATICS, V17, P988, DOI 10.1093/bioinformatics/17.10.988; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sawada Y, 2006, BIOPHYS J, V91, P1213, DOI 10.1529/biophysj.105.076661; Service RF, 2008, SCIENCE, V321, P784, DOI 10.1126/science.321.5890.784; Soundararajan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009391; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; TANFORD C, 1987, Biochemical Society Transactions, V15, p1S; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	54	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41322	10.1371/journal.pone.0041322	http://dx.doi.org/10.1371/journal.pone.0041322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848462	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600022
J	Tseng, CW; Kyme, PA; Arruda, A; Ramanujan, VK; Tawackoli, W; Liu, GY				Tseng, Ching Wen; Kyme, Pierre A.; Arruda, Andrea; Ramanujan, V. Krishnan; Tawackoli, Wafa; Liu, George Y.			Innate Immune Dysfunctions in Aged Mice Facilitate the Systemic Dissemination of Methicillin-Resistant S.aureus	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; STAPHYLOCOCCUS-AUREUS INFECTIONS; BONE-MARROW; INFLAMMATION; PHAGOCYTOSIS; ACTIVATION; EXPRESSION	Elderly humans show increased susceptibility to invasive staphylococcal disease after skin and soft tissue infection. However, it is not understood how host immunity changes with aging, and how that predisposes to invasive disease. In a model of severe skin infection, we showed that aged mice (16- to 20-month-old) exhibit dramatic bacterial dissemination compared with young adult mice (2-month-old). Bacterial dissemination was associated with significant reductions of CXCL1 (KC), polymorphonuclear cells (PMNs), and extracellular DNA traps (NETs) at the infection site. PMNs and primary skin fibroblasts isolated from aged mice showed decreased secretion of CXCL2 (MIP-2) and KC in response to MRSA, and in vitro analyses of mitochondrial functions revealed that the mitochondrial electron transport chain complex I plays a significant role in induction of chemokines in the cells isolated from young but not old mice. Additionally, PMNs isolated from aged mice have reduced ability to form NETs and to kill MRSA. Expression of nuclease by S. aureus led to increased bacterial systemic dissemination in young but not old mice, suggesting that defective NETs formation in elderly mice permitted nuclease and non-nuclease expressing S. aureus to disseminate equally well. Overall, these findings suggest that gross impairment of both skin barrier function and innate immunity contributes to the propensity for MRSA to disseminate in aged mice. Furthermore, the study indicates that contribution of bacterial factors to pathogenicity may vary with host age.	[Tseng, Ching Wen; Kyme, Pierre A.; Arruda, Andrea; Liu, George Y.] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Tseng, Ching Wen; Kyme, Pierre A.; Arruda, Andrea; Liu, George Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Tseng, Ching Wen; Kyme, Pierre A.; Arruda, Andrea; Liu, George Y.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Ramanujan, V. Krishnan; Tawackoli, Wafa] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Ramanujan, V. Krishnan; Tawackoli, Wafa] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Tseng, CW (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA.	tsengcw@cshs.org; george.liu@cshs.org	Ramanujan, V Krishnan/O-2831-2014		Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) [W81XWH-09-1-0644]	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work is supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) under Award No. W81XWH-09-1-0644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bianchi M, 2011, J ALLERGY CLIN IMMUN; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Demling Robert H, 2007, J Burns Wounds, V7, pe8; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; FU YK, 1994, INFECT IMMUN, V62, P1; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Genova ML, 1997, FEBS LETT, V410, P467; GOLDSTEIN E, 1978, J INFECT DIS, V138, P299, DOI 10.1093/infdis/138.3.299; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Kim SY, 2006, J BIOL CHEM, V281, P28794, DOI 10.1074/jbc.M604964200; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kriete A, 2009, EXP GERONTOL, V44, P250, DOI 10.1016/j.exger.2008.12.005; Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868; Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621; LIPSCHITZ DA, 1986, J GERONTOL, V41, P690, DOI 10.1093/geronj/41.6.690; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; NIWA Y, 1989, LIFE SCI, V44, P1655, DOI 10.1016/0024-3205(89)90482-7; Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Rittie L, 2005, METH MOLEC MED, V117, P83; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011606, 10.1371/journal.pone.0009518]; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Wagner C, 2006, CLIN EXP IMMUNOL, V143, P70, DOI 10.1111/j.1365-2249.2005.02963.x; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wenisch C, 2000, J LEUKOCYTE BIOL, V67, P40, DOI 10.1002/jlb.67.1.40; Young LM, 2008, SURG INFECT, V9, P469, DOI 10.1089/sur.2007.052; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC	38	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41454	10.1371/journal.pone.0041454	http://dx.doi.org/10.1371/journal.pone.0041454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844481	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600028
J	Viswanathan, V; Kumpatla, S; Aravindalochanan, V; Rajan, R; Chinnasamy, C; Srinivasan, R; Selvam, JM; Kapur, A				Viswanathan, Vijay; Kumpatla, Satyavani; Aravindalochanan, Vigneswari; Rajan, Rajeswari; Chinnasamy, C.; Srinivasan, Rajan; Selvam, Jerard Maria; Kapur, Anil			Prevalence of Diabetes and Pre-Diabetes and Associated Risk Factors among Tuberculosis Patients in India	PLOS ONE			English	Article							MELLITUS	Background: Diabetes mellitus (DM) is recognised as an important risk factor to tuberculosis (TB). India has high TB burden, along with rising DM prevalence. There are inadequate data on prevalence of DM and pre-diabetes among TB cases in India. Aim was to determine diabetes prevalence among a cohort of TB cases registered under Revised National Tuberculosis Control Program in selected TB units in Tamil Nadu, India, and assess pattern of diabetes management amongst known cases. Methods: 827 among the eligible patients (n = 904) underwent HbA1c and anthropometric measurements. OGTT was done for patients without previous history of DM and diagnosis was based on WHO criteria. Details of current treatment regimen of TB and DM and DM complications, if any, were recorded. A pretested questionnaire was used to collect information on sociodemographics, habitual risk factors, and type of TB. Findings: DM prevalence was 25.3% (95% CI 22.6-28.5) and that of pre-diabetes 24.5% (95% CI 20.4-27.6). Risk factors associated with DM among TB patients were age (31-35, 36-40, 41-45, 46-50, >50 years vs <30 years) [OR (95% CI) 6.75 (2.36-19.3); 10.46 (3.95-27.7); 18.63 (6.58-52.7); 11.05 (4.31-28.4); 24.7 (9.73-62.7) (p<0.001)], positive family history of DM [3.08 (1.73-5.5) (p<0.001)], sedentary occupation [1.69 (1.10-2.59) (p = 0.016)], and BMI (18.5-22.9, 23-24.9 and >= 25 kg/m(2) vs <18.5 kg/m(2)) [2.03 (1.32-3.12) (p = 0.001); 0.87 (0.31-2.43) (p = 0.78); 1.44 (0.54-3.8) (p = 0.47)]; for pre-diabetes, risk factors were age (36-40, 41-45, 46-50, >50 years vs <30 years) [2.24 (1.1-4.55) (p = 0.026); 6.96 (3.3-14.7); 3.44 (1.83-6.48); 4.3 (2.25-8.2) (p<0.001)], waist circumference [<90 vs. >= 90 cm (men), <80 vs. >= 80 cm (women)] [3.05 (1.35-6.9) (p = 0.007)], smoking [1.92 (1.12-3.28) (p = 0.017)] and monthly income (5000-10,000 INR vs <5000 INR) [0.59 (0.37-0.94) (p = 0.026)]. DM risk was higher among pulmonary TB [3.06 (1.69-5.52) (p<0.001)], especially sputum positive, than non-pulmonary TB. Interpretation: Nearly 50% of TB patients had either diabetes or pre-diabetes.	[Viswanathan, Vijay; Kumpatla, Satyavani; Aravindalochanan, Vigneswari; Rajan, Rajeswari] MV Hosp Diabetes, Madras, Tamil Nadu, India; [Viswanathan, Vijay; Kumpatla, Satyavani; Aravindalochanan, Vigneswari; Rajan, Rajeswari] WHO Collaborating Ctr Res Educ & Training Diabet, Prof M Viswanathan Diabet Res Ctr, Madras, Tamil Nadu, India; [Chinnasamy, C.] Directorate Med Serv, Dept Hlth, Madras, Tamil Nadu, India; [Srinivasan, Rajan] WHO RNTCP Tech Assistance Project, Dept Hlth, Madras, Tamil Nadu, India; [Selvam, Jerard Maria] Tamil Nadu Hlth Syst Project, Tamil Nadu State Hlth Dept, Madras, Tamil Nadu, India; [Kapur, Anil] World Diabet Fdn, Gentofte, Denmark		Viswanathan, V (corresponding author), MV Hosp Diabetes, Madras, Tamil Nadu, India.	drvijay@mvdiabetes.com	Aravindalochanan, Vigneswari/AAA-2853-2022	Aravindalochanan, Vigneswari/0000-0001-5722-8741; Srinivasan, Rajan/0000-0002-2854-3627	 [WDF08-385]		Grant NO. WDF08-385 (URL: www.worlddiabetesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; [Anonymous], 2011, INT DIAB FED ATL; Balasubramanian Rani, 2007, Indian J Tuberc, V54, P168; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Harries AD, 2012, TROP MED INT HEALTH, V15, P659; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kapur A, 2009, EUREOPEAN ENDOCRINOL, V5, P10; Meena R, 2011, EUR RESP J S55; MUGUSI F, 1990, TUBERCLE, V71, P271, DOI 10.1016/0041-3879(90)90040-F; Murray Sally, 2006, CMAJ, V174; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Shetty N, 2006, INT J TUBERC LUNG D, V10, P80; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wang PairDong, 2000, Journal of Infectious Diseases and Antimicrobial Agents, V17, P101; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, 2010, TUB WHO FACTSH 2010; World Health Organization, 2009, GLOB TUB CONTR EP ST; Zhang Q, 2009, JPN J INFECT DIS, V62, P390	25	144	149	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41367	10.1371/journal.pone.0041367	http://dx.doi.org/10.1371/journal.pone.0041367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848473	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600024
J	Gallo, V; Mackenbach, JP; Ezzati, M; Menvielle, G; Kunst, AE; Rohrmann, S; Kaaks, R; Teucher, B; Boeing, H; Bergmann, MM; Tjonneland, A; Dalton, SO; Overvad, K; Redondo, ML; Agudo, A; Daponte, A; Arriola, L; Navarro, C; Gurrea, AB; Khaw, KT; Wareham, N; Key, T; Naska, A; Trichopoulou, A; Trichopoulos, D; Masala, G; Panico, S; Contiero, P; Tumino, R; Bueno-de-Mesquita, HB; Siersema, PD; Peeters, PP; Zackrisson, S; Almquist, M; Eriksson, S; Hallmans, G; Skeie, G; Braaten, T; Lund, E; Illner, AK; Mouw, T; Riboli, E; Vineis, P				Gallo, Valentina; Mackenbach, Johan P.; Ezzati, Majid; Menvielle, Gwenn; Kunst, Anton E.; Rohrmann, Sabine; Kaaks, Rudolf; Teucher, Birgit; Boeing, Heiner; Bergmann, Manuela M.; Tjonneland, Anne; Dalton, Susanne O.; Overvad, Kim; Redondo, Maria-Luisa; Agudo, Antonio; Daponte, Antonio; Arriola, Larraitz; Navarro, Carmen; Barricante Gurrea, Aurelio; Khaw, Kay-Tee; Wareham, Nick; Key, Tim; Naska, Androniki; Trichopoulou, Antonia; Trichopoulos, Dimitrios; Masala, Giovanna; Panico, Salvatore; Contiero, Paolo; Tumino, Rosario; Bueno-de-Mesquita, H. Bas; Siersema, Peter D.; Peeters, Petra P.; Zackrisson, Sophia; Almquist, Martin; Eriksson, Sture; Hallmans, Goran; Skeie, Guri; Braaten, Tonje; Lund, Eiliv; Illner, Anne-Kathrin; Mouw, Traci; Riboli, Elio; Vineis, Paolo			Social Inequalities and Mortality in Europe - Results from a Large Multi-National Cohort	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; LUNG-CANCER; EDUCATIONAL INEQUALITIES; CARDIOVASCULAR RISK; HEALTH; WOMEN; SURVIVAL; DETERMINANTS; ASSOCIATION; POPULATIONS	Background: Socio-economic inequalities in mortality are observed at the country level in both North America and Europe. The purpose of this work is to investigate the contribution of specific risk factors to social inequalities in cause-specific mortality using a large multi-country cohort of Europeans. Methods: A total of 3,456,689 person/years follow-up of the European Prospective Investigation into Cancer and Nutrition (EPIC) was analysed. Educational level of subjects coming from 9 European countries was recorded as proxy for socioeconomic status (SES). Cox proportional hazard model's with a step-wise inclusion of explanatory variables were used to explore the association between SES and mortality; a Relative Index of Inequality (RII) was calculated as measure of relative inequality. Results: Total mortality among men with the highest education level is reduced by 43% compared to men with the lowest (HR 0.57, 95% C.I. 0.52-0.61); among women by 29% (HR 0.71, 95% C.I. 0.64-0.78). The risk reduction was attenuated by 7% in men and 3% in women by the introduction of smoking and to a lesser extent (2% in men and 3% in women) by introducing body mass index and additional explanatory variables (alcohol consumption, leisure physical activity, fruit and vegetable intake) (3% in men and 5% in women). Social inequalities were highly statistically significant for all causes of death examined in men. In women, social inequalities were less strong, but statistically significant for all causes of death except for cancer-related mortality and injuries. Discussion: In this European study, substantial social inequalities in mortality among European men and women which cannot be fully explained away by accounting for known common risk factors for chronic diseases are reported.	[Gallo, Valentina; Ezzati, Majid; Mouw, Traci; Riboli, Elio; Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Gallo, Valentina] London Sch Hyg & Trop Med, London WC1, England; [Mackenbach, Johan P.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Menvielle, Gwenn] INSERM, Villejuif, France; [Menvielle, Gwenn] Univ Versailles St Quentin, Versailles, France; [Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Rohrmann, Sabine] Univ Zurich, Inst Social & Prevent Med, Div Canc Epidemiol & Prevent, CH-8006 Zurich, Switzerland; [Kaaks, Rudolf; Teucher, Birgit] German Canc Res Ctr, Div Clin Epidemiol, D-6900 Heidelberg, Germany; [Boeing, Heiner; Bergmann, Manuela M.] Inst Human Nutr, Potsdam, Germany; [Tjonneland, Anne; Dalton, Susanne O.] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Redondo, Maria-Luisa] Hlth & Hlth Care Serv Council, Publ Hlth & Participat Directorate, Oviedo, Asturias, Spain; [Agudo, Antonio] Catalan Inst Oncol, Unit Nutr Environm & Canc, Barcelona, Spain; [Daponte, Antonio; Arriola, Larraitz; Navarro, Carmen; Barricante Gurrea, Aurelio] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Daponte, Antonio] Andalusian Sch Publ Hlth, Granada, Spain; [Navarro, Carmen] Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Navarro, Carmen] Univ Murcia, Sch Med, Dept Ciencias Sociosanitarias, Murcia, Spain; [Barricante Gurrea, Aurelio] Navarra Publ Hlth Inst, Pamplona, Spain; [Khaw, Kay-Tee] Univ Cambridge, Cambridge, England; [Wareham, Nick] MRC, Epidemiol Unit, Cambridge, England; [Key, Tim] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Naska, Androniki; Trichopoulou, Antonia] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, World Hlth Org Collaborating Ctr Food & Nutr Poli, GR-11527 Athens, Greece; [Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Masala, Giovanna] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Contiero, Paolo] Ist Nazl Tumori, Canc Registry, I-20133 Milan, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Histopathol Unit, Ragusa, Italy; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas; Siersema, Peter D.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Peeters, Petra P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Zackrisson, Sophia] Lund Univ, Dept Clin Sci Malmo, S-22100 Lund, Sweden; [Almquist, Martin] Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden; [Eriksson, Sture; Hallmans, Goran] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Skeie, Guri; Braaten, Tonje; Lund, Eiliv] Univ Tromso, Inst Samfunnsmed, Tromso, Norway; [Illner, Anne-Kathrin] Int Agcy Res Canc, Nutr & Metab Sect, Dietary Exposure Assessment Grp, F-69372 Lyon, France	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Amsterdam; Academic Medical Center Amsterdam; University of Zurich; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Danish Cancer Society; Aarhus University; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Escuela Andaluza de Salud Publica; University of Murcia; Public Health Institute of Navarra; University of Cambridge; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; University of Naples Federico II; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Lund University; Lund University; Skane University Hospital; Umea University; UiT The Arctic University of Tromso; World Health Organization; International Agency for Research on Cancer (IARC)	Gallo, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	p.vineis@imperial.ac.uk	Masala, Giovanna/AAC-5474-2022; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Almquist, Martin/H-7209-2019; Khaw, Kay-Tee/AAZ-3209-2021; Teucher, Birgit/J-6380-2015; Contiero, Paolo/F-6721-2016; Gallo, Valentina/X-1139-2018; Eriksson, Sture/AAF-8435-2021; Agudo, Antonio/J-1805-2016; Rohrmann, Sabine/D-2113-2012; Siersema, Peter/V-1636-2019; Gallo, Valentina/J-3089-2012; Menvielle, Gwenn/E-7201-2017	Masala, Giovanna/0000-0002-5758-9069; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Almquist, Martin/0000-0002-0953-1188; Contiero, Paolo/0000-0001-6760-3605; Gallo, Valentina/0000-0002-1268-8629; Eriksson, Sture/0000-0002-3098-3787; Agudo, Antonio/0000-0001-9900-5677; Rohrmann, Sabine/0000-0002-2215-1200; Lund, Eiliv/0000-0002-8071-8711; Overvad, Kim/0000-0001-6429-7921; Naska, Androniki/0000-0002-1610-1813; Arriola, Larraitz/0000-0001-8487-7181; tumino, rosario/0000-0003-2666-414X; Riboli, Elio/0000-0001-6795-6080; Kunst, Anton/0000-0002-3313-5273; Navarro, Carmen/0000-0001-8896-7483; Dalton, Susanne Oksbjerg/0000-0002-5485-2730; Panico, Salvatore/0000-0002-5498-8312; Tjonneland, Anne/0000-0003-4385-2097; Skeie, Guri/0000-0003-2476-4251	European Community (5th Framework Programme) [QLK4CT199900927]; Compagnia di San Paolo; Europe Against cancer Program of the European Commission (SANCO); ISCIII, Red de Centros RCESP [C03/09]; Deutsche Krebshilfe; Deutsches Krebsforschungszentrum; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health; Spanish Regional Government of Andalucia; Spanish Regional Government of Asturias; Spanish Regional Government of Basque Country; Spanish Regional Government of Murcia; Spanish Regional Government of Navarra; Cancer Research U.K.; Medical Research Council, United Kingdom; Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom; Greek Ministry of Health and Social Solidarity; Stavros Niacrchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer; Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against Cancer; Inserm; Mutuelle Generale l'Education National; IGR; Medical Research Council [G1000143, G0801056B, MC_U106179471, G0401527] Funding Source: researchfish	European Community (5th Framework Programme)(European Commission); Compagnia di San Paolo(Compagnia di San Paolo); Europe Against cancer Program of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); ISCIII, Red de Centros RCESP(Instituto de Salud Carlos III); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsches Krebsforschungszentrum; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Health Research Fund (FIS) of the Spanish Ministry of Health(Instituto de Salud Carlos III); Spanish Regional Government of Andalucia; Spanish Regional Government of Asturias(Principality of Asturias); Spanish Regional Government of Basque Country; Spanish Regional Government of Murcia; Spanish Regional Government of Navarra; Cancer Research U.K.(Cancer Research UK); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association, United Kingdom; British Heart Foundation(British Heart Foundation); Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom(Wellcome Trust); Greek Ministry of Health and Social Solidarity; Stavros Niacrchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Swedish Cancer; Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); French League against Cancer; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Mutuelle Generale l'Education National; IGR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research has been made possible thanks to a grant of the European Community (5th Framework Programme) to PV (grant QLK4CT199900927); and a grant of the Compagnia di San Paolo to the ISI Foundation. All authors are independent form founders. Mortality data from the Netherlands were obtained from "Statistics Netherlands". In addition we would like to thank for their financial support: Europe Against cancer Program of the European Commission (SANCO); ISCIII, Red de Centros RCESP, C03/09; Deutsche Krebshilfe; Deutsches Krebsforschungszentrum; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health; Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; Cancer Research U.K.; Medical Research Council, United Kingdom; Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom; Greek Ministry of Health and Social Solidarity; Stavros Niacrchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer; Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against Cancer, Inserm, Mutuelle Generale l'Education National and IGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baio G, 2011, INT J EPIDE IN PRESS; Becker R, 2006, B WORLD HEALTH ORGAN, V84, P297; Berglund A, 2010, THORAX, V65, P327, DOI 10.1136/thx.2009.125914; Dalton SO, 2008, EUR J CANCER, V44, P1989, DOI 10.1016/j.ejca.2008.06.023; Danaei G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000248; Din-Dzietham R, 2000, AM J EPIDEMIOL, V152, P617, DOI 10.1093/aje/152.7.617; Espelt A, 2011, EUR J PUBLI IN PRESS; GLIKSMAN MD, 1995, J EPIDEMIOL COMMUN H, V49, P10, DOI 10.1136/jech.49.1.10; Hart CL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3785; Karlamangla AS, 2010, ANN EPIDEMIOL, V20, P617, DOI 10.1016/j.annepidem.2010.05.003; Lawlor DA, 2005, CURR OPIN NEPHROL HY, V14, P259, DOI 10.1097/01.mnh.0000165893.13620.2b; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Menvielle G, 2011, AM J EPIDEMIOL, V173, P26, DOI 10.1093/aje/kwq319; Menvielle G, 2010, INT J CANCER, V126, P1928, DOI 10.1002/ijc.24924; Menvielle G, 2009, JNCI-J NATL CANCER I, V101, P321, DOI 10.1093/jnci/djn513; Montez JK, 2009, J GERONTOL B-PSYCHOL, V64, P625, DOI 10.1093/geronb/gbp013; Rehkopf DH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-383; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rostad B, 2009, SCAND J PUBLIC HEALT, V37, P401, DOI 10.1177/1403494809102777; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Sprague BL, 2011, CANCER-AM CANCER SOC, V117, P1542, DOI 10.1002/cncr.25589; Strand BH, 2007, EUR J CANCER, V43, P1200, DOI 10.1016/j.ejca.2007.01.021; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; United Nations Educational SaCOU, 2011, GEN C 36 SESS; van Lenthe FJ, 2004, EUR J PUBLIC HEALTH, V14, P63, DOI 10.1093/eurpub/14.1.63; Wagenaar KP, 2012, CANC EPIDEM IN PRESS; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Yu XQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-364	34	96	97	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39013	10.1371/journal.pone.0039013	http://dx.doi.org/10.1371/journal.pone.0039013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979GX	22848347	Green Published, gold			2022-12-27	WOS:000306806600002
J	Iacobucci, I; Iraci, N; Messina, M; Lonetti, A; Chiaretti, S; Valli, E; Ferrari, A; Papayannidis, C; Paoloni, F; Vitale, A; Storlazzi, CT; Ottaviani, E; Guadagnuolo, V; Durante, S; Vignetti, M; Soverini, S; Pane, F; Foa, R; Baccarani, M; Muschen, M; Perini, G; Martinelli, G				Iacobucci, Ilaria; Iraci, Nunzio; Messina, Monica; Lonetti, Annalisa; Chiaretti, Sabina; Valli, Emanuele; Ferrari, Anna; Papayannidis, Cristina; Paoloni, Francesca; Vitale, Antonella; Storlazzi, Clelia Tiziana; Ottaviani, Emanuela; Guadagnuolo, Viviana; Durante, Sandra; Vignetti, Marco; Soverini, Simona; Pane, Fabrizio; Foa, Robin; Baccarani, Michele; Mueschen, Markus; Perini, Giovanni; Martinelli, Giovanni			IKAROS Deletions Dictate a Unique Gene Expression Signature in Patients with Adult B-Cell Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GENOMIC MICROARRAY; FATE COMMITMENT; WORKING PARTY; SELF-RENEWAL; CHILDHOOD; IKZF1; LYMPHOCYTES; PROGNOSIS; MUTATION	Background: Deletions of IKAROS (IKZF1) frequently occur in B-cell precursor acute lymphoblastic leukemia (B-ALL) but the mechanisms by which they influence pathogenesis are unclear. To address this issue, a cohort of 144 adult B-ALL patients (106 BCR-ABL1-positive and 38 B-ALL negative for known molecular rearrangements) was screened for IKZF1 deletions by single nucleotide polymorphism (SNP) arrays; a sub-cohort of these patients (44%) was then analyzed for gene expression profiling. Principal Findings: Total or partial deletions of IKZF1 were more frequent in BCR-ABL1-positive than in BCR-ABL1-negative B-ALL cases (75% vs 58%, respectively, p = 0.04). Comparison of the gene expression signatures of patients carrying IKZF1 deletion vs those without showed a unique signature featured by down-regulation of B-cell lineage and DNA repair genes and up-regulation of genes involved in cell cycle, JAK-STAT signalling and stem cell self-renewal. Through chromatin immunoprecipitation and luciferase reporter assays we corroborated these findings both in vivo and in vitro, showing that Ikaros deleted isoforms lacked the ability to directly regulate a large group of the genes in the signature, such as IGLL1, BLK, EBF1, MSH2, BUB3, ETV6, YES1, CDKN1A (p21), CDKN2C (p18) and MCL1. Conclusions: Here we identified and validated for the first time molecular pathways specifically controlled by IKZF1, shedding light into IKZF1 role in B-ALL pathogenesis.	[Iacobucci, Ilaria; Ferrari, Anna; Papayannidis, Cristina; Ottaviani, Emanuela; Guadagnuolo, Viviana; Durante, Sandra; Soverini, Simona; Baccarani, Michele; Martinelli, Giovanni] Univ Bologna, Dept Hematol & Oncol Sci L&A Seragnoli, S Orsola Malpighi Hosp, Bologna, Italy; [Iraci, Nunzio; Valli, Emanuele; Perini, Giovanni] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Messina, Monica; Chiaretti, Sabina; Vitale, Antonella; Foa, Robin] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Lonetti, Annalisa] Univ Bologna, Cellular Signalling Lab, Dept Human Anat, Bologna, Italy; [Paoloni, Francesca; Vignetti, Marco] GIMEMA Fdn, Grp Italiano Malattie Ematol Maligne Adulto GIMEM, Rome, Italy; [Storlazzi, Clelia Tiziana] Univ Bari, Dept Genet & Microbiol, Bari, Italy; [Pane, Fabrizio] Univ Naples Federico II, CEINGE Biotecnol Avanzate, Naples, Italy; [Pane, Fabrizio] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Mueschen, Markus] Univ So Calif, Childrens Hosp Los Angeles, Leukemia Res Program, Los Angeles, CA USA	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; Sapienza University Rome; University of Bologna; Fondazione GIMEMA; Universita degli Studi di Bari Aldo Moro; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; Children's Hospital Los Angeles; University of Southern California	Iacobucci, I (corresponding author), Univ Bologna, Dept Hematol & Oncol Sci L&A Seragnoli, S Orsola Malpighi Hosp, Bologna, Italy.	giovanni.martinelli2@unibo.it	Valli, Emanuele/ABD-7213-2020; Simona, Soverini/A-3608-2016; Iraci, Nunzio/M-7451-2016; Vignetti, Marco/HHS-9990-2022; Martinelli, Giovanni/AAK-9211-2020; Ferrari, Anna/AHE-5511-2022; Lonetti, Annalisa/AAB-3647-2019; Papayannidis, Cristina/F-2141-2018	Valli, Emanuele/0000-0002-0928-8624; Simona, Soverini/0000-0002-4508-0353; Iraci, Nunzio/0000-0003-2146-9329; Martinelli, Giovanni/0000-0002-1025-4210; Ferrari, Anna/0000-0002-7022-9906; Lonetti, Annalisa/0000-0002-3944-3090; Papayannidis, Cristina/0000-0001-8705-8333; CHIARETTI, Sabina/0000-0001-8499-4492; Durante, Sandra/0000-0002-3723-8659; Vignetti, Marco/0000-0003-1278-604X; Storlazzi, Clelia Tiziana/0000-0002-1696-0028; Paoloni, Francesca/0000-0001-5527-981X; ottaviani, emanuela/0000-0002-1879-5417; Messina, Monica/0000-0003-3531-4766	AIRC IG; Fondazione Del Monte di Bologna e Ravenna; FIRB; Ateneo RFO grants; Project of integrated program (PIO); Programma di Ricerca Regione - Universita; NATIONAL CANCER INSTITUTE [R01CA157644, R01CA137060] Funding Source: NIH RePORTER	AIRC IG(Fondazione AIRC per la ricerca sul cancro); Fondazione Del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ateneo RFO grants; Project of integrated program (PIO); Programma di Ricerca Regione - Universita; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funding that we received for this study came from: AIRC IG 2010 - Grant Proposal 2010, Fondazione Del Monte di Bologna e Ravenna, FIRB 2006, Ateneo RFO grants, Project of integrated program (PIO), and Programma di Ricerca Regione - Universita 2007 - 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Beldjord K, 2011, BLOOD, V118, P263, DOI 10.1182/blood.V118.21.572.572; Bungaro S, 2009, GENE CHROMOSOME CANC, V48, P22, DOI 10.1002/gcc.20616; Copland M, 2009, FUTURE ONCOL, V5, P455, DOI 10.2217/FON.09.16; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Gleissner B, 2003, EXPERT REV MOL DIAGN, V3, P339, DOI 10.1586/14737159.3.3.339; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Iacobucci I, 2010, HAEMATOL-HEMATOL J, V95, P1683, DOI 10.3324/haematol.2009.020792; Iacobucci I, 2009, BLOOD, V114, P2159, DOI 10.1182/blood-2008-08-173963; Kano G, 2008, LEUKEMIA LYMPHOMA, V49, P965, DOI 10.1080/10428190801993462; Kawamata N, 2008, P NATL ACAD SCI USA, V105, P11921, DOI 10.1073/pnas.0711039105; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Martinelli G, 2009, J CLIN ONCOL, V27, P5202, DOI 10.1200/JCO.2008.21.6408; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Moorman AV, 2007, BLOOD, V109, P3189, DOI 10.1182/blood-2006-10-051912; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Mullighan CG, 2009, SEMIN HEMATOL, V46, P3, DOI 10.1053/j.seminhematol.2008.09.005; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Nichogiannopoulou A, 1998, SEMIN IMMUNOL, V10, P119, DOI 10.1006/smim.1998.0113; Papathanasiou P, 2009, STEM CELLS, V27, P3082, DOI 10.1002/stem.232; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Tavolaro S, 2010, LEUKEMIA RES, V34, P733, DOI 10.1016/j.leukres.2009.11.005; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Waanders E, 2011, LEUKEMIA, V25, P254, DOI 10.1038/leu.2010.275; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1	43	55	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40934	10.1371/journal.pone.0040934	http://dx.doi.org/10.1371/journal.pone.0040934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848414	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600031
J	Storey, AA; Athens, JS; Bryant, D; Carson, M; Emery, K; deFrance, S; Higham, C; Huynen, L; Intoh, M; Jones, S; Kirch, PV; Ladefoged, T; McCoy, P; Morales-Muniz, A; Quiroz, D; Reitz, E; Robins, J; Walter, R; Matisoo-Smith, E				Storey, Alice A.; Athens, J. Stephen; Bryant, David; Carson, Mike; Emery, Kitty; deFrance, Susan; Higham, Charles; Huynen, Leon; Intoh, Michiko; Jones, Sharyn; Kirch, Patrick V.; Ladefoged, Thegn; McCoy, Patrick; Morales-Muniz, Arturo; Quiroz, Daniel; Reitz, Elizabeth; Robins, Judith; Walter, Richard; Matisoo-Smith, Elizabeth			Investigating the Global Dispersal of Chickens in Prehistory Using Ancient Mitochondrial DNA Signatures	PLOS ONE			English	Article							MULTIPLE MATERNAL ORIGINS; GENETIC DIVERSITY; MTDNA SEQUENCES; GALLUS-GALLUS; CHINESE; BREEDS; ISLAND; RADIOCARBON; CALIBRATION; POLYNESIA	Data from morphology, linguistics, history, and archaeology have all been used to trace the dispersal of chickens from Asian domestication centers to their current global distribution. Each provides a unique perspective which can aid in the reconstruction of prehistory. This study expands on previous investigations by adding a temporal component from ancient DNA and, in some cases, direct dating of bones of individual chickens from a variety of sites in Europe, the Pacific, and the Americas. The results from the ancient DNA analyses of forty-eight archaeologically derived chicken bones provide support for archaeological hypotheses about the prehistoric human transport of chickens. Haplogroup E mtDNA signatures have been amplified from directly dated samples originating in Europe at 1000 B.P. and in the Pacific at 3000 B.P. indicating multiple prehistoric dispersals from a single Asian centre. These two dispersal pathways converged in the Americas where chickens were introduced both by Polynesians and later by Europeans. The results of this study also highlight the inappropriate application of the small stretch of D-loop, traditionally amplified for use in phylogenetic studies, to understanding discrete episodes of chicken translocation in the past. The results of this study lead to the proposal of four hypotheses which will require further scrutiny and rigorous future testing.	[Storey, Alice A.] Univ New England, Dept Archaeol & Palaeoanthropol, Armidale, NSW, Australia; [Athens, J. Stephen] Int Archaeol Res Inst Inc, Honolulu, HI USA; [Bryant, David] Univ Otago, Dept Math & Stat, Dunedin, New Zealand; [Carson, Mike] Univ Guam, MARC, Mangilao, GU USA; [Emery, Kitty] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [deFrance, Susan] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Higham, Charles; Walter, Richard] Univ Otago, Dept Anthropol, Dunedin, New Zealand; [Huynen, Leon] Griffith Univ, Sch Environm, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Intoh, Michiko] Natl Museum Ethnol, Osaka, Japan; [Jones, Sharyn] Univ Alabama Birmingham, Dept Anthropol, Birmingham, AL USA; [Kirch, Patrick V.] Univ Calif Berkeley, Dept Anthropol, Berkeley, CA 94720 USA; [Kirch, Patrick V.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ladefoged, Thegn; Robins, Judith] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [McCoy, Patrick] Pacific Consulting Serv Inc, Honolulu, HI USA; [Morales-Muniz, Arturo] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Quiroz, Daniel] Direcc Bibliotecas Archivos & Museos Proyecto Fon, Santiago, Chile; [Reitz, Elizabeth] Univ Georgia, Georgia Museum Nat Hist, Athens, GA 30602 USA; [Robins, Judith] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Matisoo-Smith, Elizabeth] Univ Otago, Otago Sch Med Sci, Dept Anat & Struct Biol, Dunedin, New Zealand; [Matisoo-Smith, Elizabeth] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of New England; University of Otago; University of Guam; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Otago; Griffith University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Auckland; Autonomous University of Madrid; University System of Georgia; University of Georgia; University of Auckland; University of Otago; University of Otago	Storey, AA (corresponding author), Univ New England, Dept Archaeol & Palaeoanthropol, Armidale, NSW, Australia.	astorey2@une.edu.au	Muñiz, Arturo Morales/ABG-7980-2020; Emery, Kitty/B-5850-2011; Quiroz, Daniel/R-8903-2019	Muñiz, Arturo Morales/0000-0002-9933-6836; Emery, Kitty/0000-0002-4031-1968; Quiroz, Daniel/0000-0001-7436-6142; Matisoo-Smith, Elizabeth/0000-0002-3500-8307	Japan Society for the Promotion of Science; Marsden Fund; Allan Wilson Centre for Molecular Ecology and Evolution; University of Auckland	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Allan Wilson Centre for Molecular Ecology and Evolution; University of Auckland	Excavations in Fais by MI were made possible by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. DB gratefully acknowledges support from the Marsden Fund, and the Allan Wilson Centre for Molecular Ecology and Evolution. During the course of this research AS was supported by a Postgraduate Scholarship from the University of Auckland and a Fellowship from the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison DJ, 2010, ARCHAEOL OCEAN, V45, P1; [Anonymous], 2007, PREHISTORY INDO MALA, DOI [DOI 10.26530/OAPEN_459472, 10.22459/PIMA.03.2007, DOI 10.22459/PIMA.03.2007]; Beebe W., 1938, PHEASANTS THEIR LIVE; Berlin S, 2004, P NATL ACAD SCI USA, V101, P15967, DOI 10.1073/pnas.0405126101; Bradley DG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P273; Bradley DG, 2000, ARCHAEOGENETICS DNA, P315; Brisbin IL, 2007, ANIMAL CONSERVATION, V10; Bronk Ramsey C, 2006, OXCAL PROGRAM V4 0; Brown E., 1929, POULTRY BREEDING PRO; Burney J, 1967, CHRONOLOGICAL HIST 1; Burnham GP, 1874, CHINA FOWL; Caudill D., 1975, ARAUCANA POULTERERS; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; Cool HEM, 2006, EATING AND DRINKING IN ROMAN BRITAIN, P1, DOI 10.2277/ 052100327X; Cooper A, 2000, SCIENCE, V289, P1139; Cranstone BAL, 1983, DOMODOMO, V1, P7; Crawford R. D., 1990, POULTRY BREEDING GEN, P1; Crawford R. D., 1984, EVOLUTION DOMESTICAT, P298; Dana N, 2011, ANIM GENET, V42, P125, DOI 10.1111/j.1365-2052.2010.02134.x; Dancause KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016843; Darwin Charles R, 1875, VARIATION ANIMALS PL, Vsecond; Defrance SD, 2010, INT J OSTEOARCHAEOL, V20, P508, DOI 10.1002/oa.1074; Delacour J., 1977, PHEASANTS WORLD; Dixon ES, 1850, ORNAMENTAL DOMESTIC; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Fitzpatrick SM, 2009, J ARCHAEOL SCI, V36, P214, DOI 10.1016/j.jas.2008.09.002; Fu V, 2001, ACTA GENET SINICA, P612; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Glover I., 2004, SE ASIA PREHISTORY H; Gongora J, 2008, P NATL ACAD SCI USA, V105, P10308, DOI 10.1073/pnas.0801991105; Gongora J, 2008, P NATL ACAD SCI USA, V105, pE100, DOI 10.1073/pnas.0809681105; Guan X, 2007, J HERED, DOI 10-1093/jhered/esm094; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Harumi Takashi, 2004, Animal Science Journal, V75, P503, DOI 10.1111/j.1740-0929.2004.00220.x; HATHER J, 1991, ANTIQUITY, V65, P887, DOI 10.1017/S0003598X00080613; Hehn V., 1888, WANDERINGS PLANTS AN, DOI DOI 10.1098/rspb.2010.0708; Hemming John, 1970, CONQUEST INCAS; Hernandez Carrasquilla Francisco, 1992, Archaeofauna, V1, P45; Higham Charles, 1989, ARCHAEOLOGY MAINLAND; Holland B, 2003, LECT N BIOINFORMAT, V2812, P165; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huynen L., 2003, Notornis, V50, P231; Intoh, 2008, ASIAN PERSPECT, V47, P121; Intoh M, 2004, ANTHROPOL SCI, V112, P257, DOI 10.1537/ase.040511; Intoh M, 1999, COLLOQ SEMI, P407; Johnsgard PA, 1999, PHEASANTS WORLD BIOL; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; KELLY L, 2006, LITTLE CHICKEN BOOK; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Komiyama T, 2003, GENE, V317, P195, DOI 10.1016/S0378-1119(03)00703-0; Kovacs-Nolan J, 2005, J AGR FOOD CHEM, V53, P8421, DOI 10.1021/jf050964f; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Lee YJ, 2007, ASIAN AUSTRAL J ANIM, V20, P477, DOI 10.5713/ajas.2007.477; Levesque R, 1992, HIST MICRONESIA, V1; Levesque R, 1992, HIST MICRONESIA, V2; Lind LR, 1963, ALDROVANDI CHICKENS; Liu YP, 2006, BIOCHEM GENET, V44, P18, DOI 10.1007/s10528-006-9012-7; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Liu ZG, 2004, ASIAN AUSTRAL J ANIM, V17, P903, DOI 10.5713/ajas.2004.903; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Markham C, 1967, VOYAGES PF DEQUIROS; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Matisoo-Smith E, 2009, J ISL COAST ARCHAEOL, V4, P151, DOI [DOI 10.1080/15564890903155273, 10.1080/15564890903155273]; MatisooSmith E, 1997, ELECTROPHORESIS, V18, P1534, DOI 10.1002/elps.1150180908; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McCoy P.C., 1988, ARCHAEOL OCEAN, V23, P104, DOI [10.1002/j.1834, DOI 10.1002/J.1834]; Moiseeva IG, 1996, GENETIKA+, V32, P1553; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Mwacharo JM, 2011, MOL PHYLOGENET EVOL, V58, P374, DOI 10.1016/j.ympev.2010.11.027; Newson L.A., 2009, CONQUEST PESTILENCE; Nishibori M, 2005, ANIM GENET, V36, P367, DOI 10.1111/j.1365-2052.2005.01318.x; Niu D, 2002, BIOCHEM GENET, V40, P163, DOI 10.1023/A:1015832108669; Oka T, 2007, ANIM GENET, V38, P287, DOI 10.1111/j.1365-2052.2007.01604.x; OREILLY DJW, 2007, EARLY CIVILIZATIONS; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Peters JP., 1913, J AM ORIENT SOC, V33; Petersen G, 2006, ARCHAEOL OCEAN, V41, P82, DOI 10.1002/j.1834-4453.2006.tb00611.x; Pisenti JM, 2001, AVIAN POULT BIOL REV, V12, P1; Pizzari T, 2002, HEREDITY, V88, P112, DOI 10.1038/sj.hdy.6800014; Pliny, 2009, PLINY YOUNGER COMPLE; Qu LJ, 2009, ASIAN AUSTRAL J ANIM, V22, P1085, DOI 10.5713/ajas.2009.80660; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; REINMAN FRED R, 1977, ARCHAEOLOGICAL SURVE; Reitz E.J., 1995, PUERTO REAL ARCHAEOL, P287; Revay T, 2010, ANIM GENET, V41, P548, DOI 10.1111/j.1365-2052.2010.02041.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schaffer LN, 1996, MARTIME SE ASIA 1500; Serjeantson D, 2009, CAMB MAN ARCHAEOL, P1; Simoons Frederick, 1994, EAT NOT THIS FLESH F; Storey AA, 2008, INT J OSTEOARCHAEOL, V18, P240, DOI 10.1002/oa.947; Storey A.A., 2011, POLYNESIANS AM PRECO, P139; Storey A. A., 2011, RAPA NUI J, V25, P5; Storey AA, 2007, P NATL ACAD SCI USA, V104, P10335, DOI 10.1073/pnas.0703993104; Storey AA, 2010, J ARCHAEOL SCI, V37, P2459, DOI 10.1016/j.jas.2010.05.006; Storey AA, 2008, P NATL ACAD SCI USA, V105, pE99, DOI 10.1073/pnas.0807625105; Swafford DL, 2003, PAUP PHYLOGENETIC AN; Tegetmeier WB, 1867, POULTRY BOOK COMPRIS; Townsend Peterson A., 1998, Bird Conservation International, V8, P387; Underhill AP, 1997, J WORLD PREHIST, V11, P103, DOI 10.1007/BF02221203; Varro MT, 1912, VARRO FARMING; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; WEST B, 1989, WORLD POULTRY SCI J, V45, P205, DOI 10.1079/WPS19890012; Wickler, 2004, COLONISATION MIGRATI, P28; WOODGUSH DGM, 1959, POULTRY SCI, V38, P321, DOI 10.3382/ps.0380321; Yalden D, 2010, HIST BRIT BIRDS; Yen D.E., 1974, SWEET POTATO OCEANIA; Zerega NJC, 2004, AM J BOT, V91, P760, DOI 10.3732/ajb.91.5.760; Zeuner F. E, 1963, HIST DOMESTICATED AN	113	91	92	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39171	10.1371/journal.pone.0039171	http://dx.doi.org/10.1371/journal.pone.0039171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	979GX	22848352	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600005
J	Tognon, G; Berg, C; Mehlig, K; Thelle, D; Strandhagen, E; Gustavsson, J; Rosengren, A; Lissner, L				Tognon, Gianluca; Berg, Christina; Mehlig, Kirsten; Thelle, Dag; Strandhagen, Elisabeth; Gustavsson, Jaana; Rosengren, Annika; Lissner, Lauren			Comparison of Apolipoprotein (apoB/apoA-I) and Lipoprotein (Total Cholesterol/HDL) Ratio Determinants. Focus on Obesity, Diet and Alcohol Intake	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; RISK-FACTORS; LIPID-LEVELS; 52 COUNTRIES; WOMEN; VALIDITY	The ratio between apolipoprotein B and apolipoprotein A-I (apoB/apoA-I) has been suggested to be a powerful and more accurate predictor of future cardiovascular disease risk than total cholesterol and HDL cholesterol. Since diet and lifestyle can directly influence dyslipidemia, it is of interest to identify modifiable factors that are associated with high levels of the apolipoprotein ratio and if they can have a different association with a more traditional indicator of cardiovascular risk such as total cholesterol/HDL. The relationship between obesity and dyslipidemia is established and it is of interest to determine which factors can modify this association. This study investigated the cross-sectional association of obesity, diet and lifestyle factors with apoB/apoA-I and total cholesterol/HDL respectively, in a Swedish population of 2,907 subjects (1,537 women) as part of the INTERGENE study. The apolipoprotein and lipoprotein ratios were highly correlated, particularly in women, and obesity was strongly associated with both. Additionally, age, cigarette smoking and alcohol intake were important determinants of these ratios. Alcohol was the only dietary factor that appreciably attenuated the association between obesity and each of the ratios, with a stronger attenuation in women. Other dietary intake and lifestyle-related factors such as smoking status and physical activity had a lower effect on this association. Because the apolipoprotein and lipoprotein ratios share similar diet and lifestyle determinants as well as being highly correlated, we conclude that either of these ratios may be a sufficient indicator of dyslipidemia.	[Tognon, Gianluca; Mehlig, Kirsten; Thelle, Dag; Strandhagen, Elisabeth; Lissner, Lauren] Univ Gothenburg, Dept Publ Hlth & Community Med, Publ Hlth Epidemiol Unit, Gothenburg, Sweden; [Berg, Christina] Univ Gothenburg, Dept Food & Nutr, Gothenburg, Sweden; [Thelle, Dag] Univ Oslo, Inst Basic Med Sci, Sect Biostat, Oslo, Norway; [Gustavsson, Jaana] Univ Gothenburg, Dept Publ Hlth & Community Med, Occupat & Environm Med Unit, Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Oslo; University of Gothenburg; University of Gothenburg	Tognon, G (corresponding author), Univ Gothenburg, Dept Publ Hlth & Community Med, Publ Hlth Epidemiol Unit, Gothenburg, Sweden.	gianluca.tognon@gu.se	Thelle, Dag Steinar/ABD-1867-2020; Tognon, Gianluca/ABC-3937-2021; Mehlig, Kirsten/AAT-3468-2020	Thelle, Dag Steinar/0000-0002-4417-5967; Berg, Christina/0000-0002-7953-5037; Tognon, Gianluca/0000-0001-7997-7313	Vastra Gotaland County Council; Swedish Council for Working life and Social Research; Swedish Research Council; Swedish Swedish Heart and Lung Foundation; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; FAS EpiLife center	Vastra Gotaland County Council; Swedish Council for Working life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Swedish Heart and Lung Foundation; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); FAS EpiLife center	The InterGene study was funded by grants from the Vastra Gotaland County Council, the Swedish Council for Working life and Social Research, the Swedish Research Council, the Swedish Swedish Heart and Lung Foundation and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. This work was supported by a postdoctoral fellowship from the FAS EpiLife center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Aires N, 2003, EUR J EPIDEMIOL, V18, P479, DOI 10.1023/A:1024682523710; Arsenault BJ, 2010, EUR J CLIN INVEST, V40, P1081, DOI 10.1111/j.1365-2362.2010.02357.x; Berg C, 2005, INT J OBESITY, V29, P916, DOI 10.1038/sj.ijo.0802964; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Berg CM, 2005, EUR J CARDIOV PREV R, V12, P115, DOI 10.1097/00149831-200504000-00005; Brinton EA, 2010, CURR OPIN LIPIDOL, V21, P346, DOI 10.1097/MOL.0b013e32833c1f41; Denke MA, 2005, CIRCULATION, V112, P3368, DOI 10.1161/CIRCULATIONAHA.105.588178; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Kaluza J, 2009, EUR J CLIN NUTR, V63, P451, DOI 10.1038/sj.ejcn.1602968; Kappelle PJWH, 2011, J INTERN MED, V269, P232, DOI 10.1111/j.1365-2796.2010.02323.x; Kargman DE, 1998, ATHEROSCLEROSIS, V139, P391, DOI 10.1016/S0021-9150(98)00085-9; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Mehlig K, 2008, AM J EPIDEMIOL, V167, P684, DOI 10.1093/aje/kwm366; Messerer M, 2004, J NUTR, V134, P1800, DOI 10.1093/jn/134.7.1800; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Sesso H D, 2001, Am J Cardiovasc Drugs, V1, P167, DOI 10.2165/00129784-200101030-00002; Simonsson M, 2007, J INTERN MED, V262, P537, DOI 10.1111/j.1365-2796.2007.01866.x; Sniderman AD, 2006, J INTERN MED, V259, P455, DOI 10.1111/j.1365-2796.2006.01649.x; Steinmetz J, 1997, ANN BIOL CLIN-PARIS, V55, P451; Strandhagen E, 2010, EUR J EPIDEMIOL, V25, P163, DOI 10.1007/s10654-010-9427-7; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; Volcik KA, 2008, ANN EPIDEMIOL, V18, P101, DOI 10.1016/j.annepidem.2007.07.103; Walldius G, 2006, J INTERN MED, V259, P259, DOI 10.1111/j.1365-2796.2005.01610.x; WHO, 2003, WHO TECHN REP SER, V916, P54; Willett W., 1998, NUTR EPIDEMIOL, V122, P101; Wolk A, 1998, EUR J CLIN NUTR, V52, P186, DOI 10.1038/sj.ejcn.1600538; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	36	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40878	10.1371/journal.pone.0040878	http://dx.doi.org/10.1371/journal.pone.0040878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848405	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600026
J	Weldon, WC; Zarnitsyn, VG; Esser, ES; Taherbhai, MT; Koutsonanos, DG; Vassilieva, EV; Skountzou, I; Prausnitz, MR; Compans, RW				Weldon, William C.; Zarnitsyn, Vladimir G.; Esser, E. Stein; Taherbhai, Misha T.; Koutsonanos, Dimitrios G.; Vassilieva, Elena V.; Skountzou, Ioanna; Prausnitz, Mark R.; Compans, Richard W.			Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; LANGERHANS CELLS; IMMUNE-RESPONSE; DENDRITIC CELLS; INTRADERMAL VACCINATION; SEASONAL INFLUENZA; DELIVERY-SYSTEMS; VIRUS INFECTION; YOUNG-CHILDREN; CHOLERA-TOXIN	Recent studies have demonstrated the effectiveness of vaccine delivery to the skin by vaccine-coated microneedles; however there is little information on the effects of adjuvants using this approach for vaccination. Here we investigate the use of TLR ligands as adjuvants with skin-based delivery of influenza subunit vaccine. BALB/c mice received 1 mu g of monovalent H1N1 subunit vaccine alone or with 1 mu g of imiquimod or poly(I:C) individually or in combination via coated microneedle patches inserted into the skin. Poly(I:C) adjuvanted subunit influenza vaccine induced similar antigen-specific immune responses compared to vaccine alone when delivered to the skin by microneedles. However, imiquimod-adjuvanted vaccine elicited higher levels of serum IgG2a antibodies and increased hemagglutination inhibition titers compared to vaccine alone, suggesting enhanced induction of functional antibodies. In addition, imiquimod-adjuvanted vaccine induced a robust IFN-gamma cellular response. These responses correlated with improved protection compared to influenza subunit vaccine alone, as well as reduced viral replication and production of pro-inflammatory cytokines in the lungs. The finding that microneedle delivery of imiquimod with influenza subunit vaccine induces improved immune responses compared to vaccine alone supports the use of TLR7 ligands as adjuvants for skin-based influenza vaccines.	[Weldon, William C.; Esser, E. Stein; Taherbhai, Misha T.; Koutsonanos, Dimitrios G.; Vassilieva, Elena V.; Skountzou, Ioanna; Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Weldon, William C.; Esser, E. Stein; Taherbhai, Misha T.; Koutsonanos, Dimitrios G.; Vassilieva, Elena V.; Skountzou, Ioanna; Compans, Richard W.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Zarnitsyn, Vladimir G.; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Weldon, WC (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu	Compans, Richard W/I-4087-2013; Skountzou, Ioanna/A-4454-2010	Compans, Richard W/0000-0003-2360-335X; Skountzou, Ioanna/0000-0002-6429-244X; Prausnitz, Mark/0000-0002-9076-8448	U.S. National Institutes of Health [AI074579, EB006369, EB012495]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN266200700006C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI028147, U01AI074579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012495, R01EB006369] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported in part by U.S. National Institutes of Health grants AI074579, EB006369 and EB012495. DK was supported by a fellowship from National Institutes of Health/National Institute of Allergy and Infectious Diseases HHSN266200700006C Center of Excellence for Influenza Research and Surveillance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Andrianov AK, 2009, P NATL ACAD SCI USA, V106, P18936, DOI 10.1073/pnas.0908842106; Atmar RL, 2010, EXPERT REV VACCINES, V9, P1399, DOI [10.1586/erv.10.134, 10.1586/ERV.10.134]; Bal SM, 2012, EUR J PHARM SCI, V45, P475, DOI 10.1016/j.ejps.2011.10.003; Barrett PN, 2011, LANCET INFECT DIS, V11, P496, DOI 10.1016/S1473-3099(11)70155-4; Chen DX, 2003, VACCINE, V21, P2830, DOI 10.1016/S0264-410X(03)00175-0; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Coffman R L, 1989, Semin Immunol, V1, P55; Corbett HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013460; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dormitzer PR, 2009, PLOS CURR, V1, DOI [10.1371/currents.RRN1025, DOI 10.1371/CURRENTS.RRN1025]; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; El Sahly H, 2010, EXPERT REV VACCINES, V9, P1135, DOI [10.1586/ERV.10.111, 10.1586/erv.10.111]; FLYNN PM, 1994, CHEST, V106, P1463, DOI 10.1378/chest.106.5.1463; Fragapane E, 2010, CLIN VACCINE IMMUNOL, V17, P1817, DOI 10.1128/CVI.00461-09; Fujita H, 2004, BIOCHEM BIOPH RES CO, V319, P832, DOI 10.1016/j.bbrc.2004.05.059; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Glenn GM, 1998, J IMMUNOL, V161, P3211; Grohskopf Lisa, 2011, Morbidity and Mortality Weekly Report, V60, P1128; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kim YC, 2012, CURR TOP MICROBIOL, V351, P77, DOI 10.1007/82_2011_123; Kim YC, 2010, J CONTROL RELEASE, V142, P187, DOI 10.1016/j.jconrel.2009.10.013; Kim YC, 2009, VACCINE, V27, P6932, DOI 10.1016/j.vaccine.2009.08.108; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Koutsonanos DG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00357; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Launay O, 2011, J INFECT DIS, V204, P124, DOI 10.1093/infdis/jir211; Mitsui H, 2004, J INVEST DERMATOL, V122, P95, DOI 10.1046/j.0022-202X.2003.22116.x; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Schneider-Ohrum K, 2011, VACCINE, V29, P9081, DOI 10.1016/j.vaccine.2011.09.051; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Slutter B, 2011, J CONTROL RELEASE, V154, P123, DOI 10.1016/j.jconrel.2011.02.007; Suzuki H, 2000, J INVEST DERMATOL, V114, P135, DOI 10.1046/j.1523-1747.2000.00833.x; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, P563, DOI 10.1097/INF.0b013e31819d6394; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Weldon WC, 2011, CLIN VACCINE IMMUNOL, V18, P647, DOI 10.1128/CVI.00435-10; World Health Organization, 2002, WHO MAN AN INFL DIAG	52	69	73	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41501	10.1371/journal.pone.0041501	http://dx.doi.org/10.1371/journal.pone.0041501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848514	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600076
J	Bretana, NA; Lu, CT; Chiang, CY; Su, MG; Huang, KY; Lee, TY; Weng, SL				Bretana, Neil Arvin; Lu, Cheng-Tsung; Chiang, Chiu-Yun; Su, Min-Gang; Huang, Kai-Yao; Lee, Tzong-Yi; Weng, Shun-Long			Identifying Protein Phosphorylation Sites with Kinase Substrate Specificity on Human Viruses	PLOS ONE			English	Article							MAXIMAL DEPENDENCE DECOMPOSITION; WILD-TYPE; PREDICTION; IDENTIFICATION; SEQUENCE; TRANSCRIPTION; REPLICATION; DATABASE; MOTIFS; SERVER	Viruses infect humans and progress inside the body leading to various diseases and complications. The phosphorylation of viral proteins catalyzed by host kinases plays crucial regulatory roles in enhancing replication and inhibition of normal host-cell functions. Due to its biological importance, there is a desire to identify the protein phosphorylation sites on human viruses. However, the use of mass spectrometry-based experiments is proven to be expensive and labor-intensive. Furthermore, previous studies which have identified phosphorylation sites in human viruses do not include the investigation of the responsible kinases. Thus, we are motivated to propose a new method to identify protein phosphorylation sites with its kinase substrate specificity on human viruses. The experimentally verified phosphorylation data were extracted from virPTM - a database containing 301 experimentally verified phosphorylation data on 104 human kinase-phosphorylated virus proteins. In an attempt to investigate kinase substrate specificities in viral protein phosphorylation sites, maximal dependence decomposition (MDD) is employed to cluster a large set of phosphorylation data into subgroups containing significantly conserved motifs. The experimental human phosphorylation sites are collected from Phospho. ELM, grouped according to its kinase annotation, and compared with the virus MDD clusters. This investigation identifies human kinases such as CK2, PKB, CDK, and MAPK as potential kinases for catalyzing virus protein substrates as confirmed by published literature. Profile hidden Markov model is then applied to learn a predictive model for each subgroup. A five-fold cross validation evaluation on the MDD-clustered HMMs yields an average accuracy of 84.93% for Serine, and 78.05% for Threonine. Furthermore, an independent testing data collected from UniProtKB and Phospho. ELM is used to make a comparison of predictive performance on three popular kinase-specific phosphorylation site prediction tools. In the independent testing, the high sensitivity and specificity of the proposed method demonstrate the predictive effectiveness of the identified substrate motifs and the importance of investigating potential kinases for viral protein phosphorylation sites.	[Bretana, Neil Arvin; Lu, Cheng-Tsung; Chiang, Chiu-Yun; Su, Min-Gang; Huang, Kai-Yao; Lee, Tzong-Yi] Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan; [Lee, Tzong-Yi] Yuan Ze Univ, Grad Program Biomed Informat, Chungli, Taiwan; [Weng, Shun-Long] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Weng, Shun-Long] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Weng, Shun-Long] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Weng, Shun-Long] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan	Yuan Ze University; Yuan Ze University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Bretana, NA (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan.	francis@saturn.yzu.edu.tw		Bretana, Neil Arvin/0000-0003-4743-348X	National Science Council of the Republic of China [NSC 100-2221-E-155-079]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors sincerely appreciate the National Science Council of the Republic of China for financially supporting this research under Contract Numbers of NSC 100-2221-E-155-079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1992, J BIOL CHEM, V267, P21977; Agostini I, 2002, AIDS RES HUM RETROV, V18, P283, DOI 10.1089/088922202753472856; Ammosova T, 2005, VIROLOGY, V341, P171, DOI 10.1016/j.virol.2005.06.041; Andrew J, 2009, PLOS COMPUTATIONAL B; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Benetti L, 2006, J VIROL, V80, P3341, DOI 10.1128/JVI.80.7.3341-3348.2006; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang WC, 2009, J COMPUT CHEM; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; COCHRANE AW, 1989, J VIROL, V63, P4438, DOI 10.1128/JVI.63.10.4438-4440.1989; Coito C, 2004, J VIROL, V78, P3502, DOI 10.1128/JVI.78.7.3502-3513.2004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; ECKERT EA, 1967, SCIENCE, V158, P527, DOI 10.1126/science.158.3800.527-b; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Esfandiarei M, 2004, J VIROL, V78, P4289, DOI 10.1128/JVI.78.8.4289-4298.2004; Habran L, 2005, J BIOL CHEM, V280, P29135, DOI 10.1074/jbc.M503312200; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hemonnot B, 2006, VIROLOGY, V349, P430, DOI 10.1016/j.virol.2006.02.043; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Kobe B, 2005, BBA-PROTEINS PROTEOM, V1754, P200, DOI 10.1016/j.bbapap.2005.07.036; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021849; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Lee TY, 2011, BIOINFORMATICS, V27, P1780, DOI 10.1093/bioinformatics/btr291; Lee TY, 2011, NUCLEIC ACIDS RES, V39, pD777, DOI 10.1093/nar/gkq970; LELE S, 1991, AM J PHYS ANTHROPOL, V86, P415, DOI 10.1002/ajpa.1330860307; Lu CT, 2011, J COMPUT AID MOL DES, V25, P987, DOI 10.1007/s10822-011-9477-2; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miller ML, 2009, PROTEOMICS, V9, P116, DOI 10.1002/pmic.200800285; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; NAVARRO J, 1991, J GEN VIROL, V72, P1455, DOI 10.1099/0022-1317-72-6-1455; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ritz A, 2009, BIOINFORMATICS, V25, P14, DOI 10.1093/bioinformatics/btn569; Saunders NFW, 2008, NUCLEIC ACIDS RES, V36, pW286, DOI 10.1093/nar/gkn279; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Schang LM, 2002, J VIROL, V76, P7874, DOI 10.1128/JVI.76.15.7874-7882.2002; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001099; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; St-Denis NA, 2009, MOL CELL BIOL, V29, P2068, DOI 10.1128/MCB.01563-08; STAHL J, 1974, ACTA BIOL MED GER, V33, P667; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Wang L, 2002, MOL CELL BIOCHEM, V237, P137, DOI 10.1023/A:1016555821581; Wang Q, 2009, J VIROL, V83, P3668, DOI 10.1128/JVI.02063-08; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Xue Y, 2010, CURR PROTEIN PEPT SC, V11, P485, DOI 10.2174/138920310791824138; Yang PW, 2008, J GEN VIROL, V89, P884, DOI 10.1099/vir.0.83546-0; Zell R, 2008, CURR OPIN BIOTECH, V19, P652, DOI 10.1016/j.copbio.2008.10.009; Zhou Y, 2000, J VIROL, V74, P6520, DOI 10.1128/JVI.74.14.6520-6527.2000	61	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40694	10.1371/journal.pone.0040694	http://dx.doi.org/10.1371/journal.pone.0040694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844408	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700017
J	Cohen, EB; Moore, FR; Fischer, RA				Cohen, Emily B.; Moore, Frank R.; Fischer, Richard A.			Experimental Evidence for the Interplay of Exogenous and Endogenous Factors on the Movement Ecology of a Migrating Songbird	PLOS ONE			English	Article							PASSERINE MIGRANTS; HABITAT SELECTION; REPRODUCTIVE-PERFORMANCE; FOOD AVAILABILITY; STOPOVER ECOLOGY; SPATIAL-BEHAVIOR; BIRDS; FAT; COMPETITION; POPULATION	Movement patterns during songbird migration remain poorly understood despite their expected fitness consequences in terms of survival, energetic condition and timing of migration that will carry over to subsequent phases of the annual cycle. We took an experimental approach to test hypotheses regarding the influence of habitat, energetic condition, time of season and sex on the hour-by-hour, local movement decisions of a songbird during spring stopover. To simulate arrival of nocturnal migrants at unfamiliar stopover sites, we translocated and continuously tracked migratory red-eyed vireos (Vireo olivaceus) throughout spring stopover with and without energetic reserves that were released in two replicates of three forested habitat types. Migrants moved the most upon release, during which time they selected habitat characterized by greater food abundance and higher foraging attack rates. Presumably under pressure to replenish fuel stores necessary to continue migration in a timely fashion, migrants released in poorer energetic condition moved faster and further than migrants in better condition and the same pattern was true for migrants released late in spring relative to those released earlier. However, a migrant's energetic condition had less influence on their behavior when they were in poor quality habitat. Movement did not differ between sexes. Our study illustrates the importance of quickly finding suitable habitat at each stopover site, especially for energetically constrained migrants later in the season. If an initial period prior to foraging were necessary at each stop along a migrant's journey, non-foraging periods would cumulatively result in a significant energetic and time cost to migration. However, we suggest behavior during stopover is not solely a function of underlying resource distributions but is a complex response to a combination of endogenous and exogenous factors.	[Cohen, Emily B.; Moore, Frank R.] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Fischer, Richard A.] United States Army Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA	University of Southern Mississippi; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Cohen, EB (corresponding author), Smithsonian Conservat Biol Inst, Natl Zool Pk, Migratory Bird Ctr, Washington, DC USA.	cohene@si.edu	Cohen, Emily/AAB-4246-2020	Cohen, Emily/0000-0002-4978-4278	The University of Southern Mississippi; Department of Defense Strategic Environmental Research and Development Program (SERDP) [SI-1469]	The University of Southern Mississippi; Department of Defense Strategic Environmental Research and Development Program (SERDP)	Funding for this project was provided by The University of Southern Mississippi and the Department of Defense Strategic Environmental Research and Development Program (SERDP Project SI-1469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborn DA, 1997, BEHAVIOUR, V134, P1077, DOI 10.1163/156853997X00412; Alerstam T, 2003, AVIAN MIGRATION, P253; Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; [Anonymous], 2010, R LANG ENV STAT COMP; BAIRLEIN F, 1983, ORNIS SCAND, V14, P239, DOI 10.2307/3676157; BLAKE JG, 1986, AUK, V103, P328, DOI 10.1093/auk/103.2.328; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Cerasale DJ, 2010, AUK, V127, P636, DOI 10.1525/auk.2010.09124; Champlin TB, 2009, ECOLOGY, V90, P1586, DOI 10.1890/08-1190.1; Chernetsov N, 2006, J ORNITHOL, V147, P185, DOI 10.1007/s10336-006-0064-6; Chernetsov N, 2005, ANN NY ACAD SCI, V1046, P242, DOI 10.1196/annals.1343.021; Chernetsov N, 2006, WILSON J ORNITHOL, V118, P364, DOI 10.1676/04-134.1; Cimprich DA, 2005, ANIM BEHAV, V69, P1173, DOI 10.1016/j.anbehav.2004.07.021; Cimprich DA, 2000, BIRDS N AM; Cimprich DA, 2006, AUK, V123, P1069, DOI 10.1642/0004-8038(2006)123[1069:FAPBIG]2.0.CO;2; Delingat J, 2006, ARDEA, V94, P593; Fischer RA, 2012, J FIELD ORNITHOL, V83, P61, DOI 10.1111/j.1557-9263.2011.00356.x; FRANCIS CM, 1986, AUK, V103, P548; Hatch MI, 2009, IBIS, V151, P771, DOI 10.1111/j.1474-919X.2009.00964.x; Helms CW, 1960, BIRD BANDING, V31, P1, DOI DOI 10.2307/4510793; HUTTO RL, 1985, AUK, V102, P120, DOI 10.2307/4086827; JAMES F C, 1970, Audubon Field Notes, V24, P727; Jenni L, 2003, AVIAN MIGRATION, P155; Johnson MD, 2000, J FIELD ORNITHOL, V71, P88, DOI 10.1648/0273-8570-71.1.88; Johnson MD, 2001, J ANIM ECOL, V70, P546, DOI 10.1046/j.1365-2656.2001.00522.x; Keddy PA, 2009, SOUTHEAST NAT, V8, P213, DOI 10.1656/058.008.0202; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; LINDSTROM A, 1990, ANIM BEHAV, V40, P453, DOI 10.1016/S0003-3472(05)80525-1; LINDSTROM A, 1991, ORNIS SCAND, V22, P12, DOI 10.2307/3676616; Loria DE, 1990, BEHAV ECOL, V1, P24, DOI 10.1093/beheco/1.1.24; Martin G.R., 1990, P185; Matthews SN, 2010, LANDSCAPE ECOL, V25, P955, DOI 10.1007/s10980-010-9475-0; Moore F, 2003, AVIAN MIGRATION, P281; MOORE FR, 1990, WILSON BULL, V102, P487; MOORE FR, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P345; Moore FR, 2000, STUD AVIAN BIOL-SER, P34; MOORE FR, 1991, BEHAV ECOL SOCIOBIOL, V28, P85; Moore Frank R., 1995, P121; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Mukhin A, 2008, BEHAV ECOL, V19, P716, DOI 10.1093/beheco/arn025; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; Petit DR, 2000, STUD AVIAN BIOL-SER, P15; Pyle P, 1997, IDENTIFICATION GUIDE; Rubolini D, 2004, BEHAV ECOL, V15, P592, DOI 10.1093/beheco/arh048; Schwilch R, 2001, AUK, V118, P698, DOI 10.1642/0004-8038(2001)118[0698:LIRRAS]2.0.CO;2; Seewagen CL, 2010, ACTA OECOL, V36, P484, DOI 10.1016/j.actao.2010.06.005; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Smith RJ, 2003, OECOLOGIA, V134, P325, DOI 10.1007/s00442-002-1152-9; SPINA F, 1990, J ORNITHOL, V131, P429, DOI 10.1007/BF01639819; Tietz JR, 2007, CONDOR, V109, P795, DOI 10.1650/0010-5422(2007)109[795:SEAHSO]2.0.CO;2; Wang Yong, 2005, Acta Zoologica Sinica, V51, P12; Yong W, 1998, AUK, V115, P829, DOI 10.2307/4089502; Zuur Alain F., 2009, P1	58	48	48	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41818	10.1371/journal.pone.0041818	http://dx.doi.org/10.1371/journal.pone.0041818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844528	gold, Green Submitted, Green Published			2022-12-27	WOS:000306687700155
J	Guo, YR; Tukaye, DN; Wu, WJ; Zhu, XP; Book, M; Tan, W; Jones, SP; Rokosh, G; Narumiya, S; Li, QH; Bolli, R				Guo, Yiru; Tukaye, Deepali Nivas; Wu, Wen-Jian; Zhu, Xiaoping; Book, Michael; Tan, Wei; Jones, Steven P.; Rokosh, Gregg; Narumiya, Shuh; Li, Qianhong; Bolli, Roberto			The COX-2/PGI2 Receptor Axis Plays an Obligatory Role in Mediating the Cardioprotection Conferred by the Late Phase of Ischemic Preconditioning	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; HEAT-SHOCK-PROTEIN; JAK-STAT PATHWAY; A(3) ADENOSINE RECEPTOR; CO-RELEASING MOLECULE; CONSCIOUS RABBITS; GENE-THERAPY; PROSTACYCLIN RECEPTOR; 2ND WINDOW	Background: Pharmacologic studies with cyclooxygenase-2 (COX-2) inhibitors suggest that the late phase of ischemic preconditioning (PC) is mediated by COX-2. However, nonspecific effects of COX-2 inhibitors cannot be ruled out, and the selectivity of these inhibitors for COX-2 vs. COX-1 is only relative. Furthermore, the specific prostaglandin (PG) receptors responsible for the salubrious actions of COX-2-derived prostanoids remain unclear. Objective: To determine the role of COX-2 and prostacyclin receptor (IP) in late PC by gene deletion. Methods: COX-2 knockout (KO) mice (COX-2(-/-)), prostacyclin receptor KO (IP-/-) mice, and respective wildtype (WT, COX-2(+/+) and IP+/+) mice underwent sham surgery or PC with six 4-min coronary occlusion (O)/4-min R cycles 24 h before a 30-min O/24 h R. Results: There were no significant differences in infarct size (IS) between non-preconditioned (non-PC) COX-2(+/+), COX-2(-/-), IP+/+, and IP-/- mice, indicating that neither COX-2 nor IP modulates IS in the absence of PC. When COX-2(-/-) or IP-/- mice were preconditioned, IS was not reduced, indicating that the protection of late PC was completely abrogated by deletion of either the COX-2 or the IP gene. Administration of the IP selective antagonist, RO3244794 to C57BL6/J (B6) mice 30 min prior to the 30-min O had no effect on IS. When B6 mice were preconditioned 24 h prior to the 30-min O, IS was markedly reduced; however, the protection of late PC was completely abrogated by pretreatment of RO3244794. Conclusions: This is the first study to demonstrate that targeted disruption of the COX-2 gene completely abrogates the infarct-sparing effect of late PC, and that the IP, downstream of the COX-2/prostanoid pathway, is a key mediator of the late PC. These results provide unequivocal molecular genetic evidence for an essential role of the COX-2/PGI2 receptor axis in the cardioprotection afforded by the late PC.	[Guo, Yiru; Wu, Wen-Jian; Zhu, Xiaoping; Book, Michael; Tan, Wei; Jones, Steven P.; Rokosh, Gregg; Li, Qianhong; Bolli, Roberto] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [Tukaye, Deepali Nivas] Univ Louisville, Dept Internal Med, Louisville, KY 40292 USA; [Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan	University of Louisville; University of Louisville; Kyoto University	Guo, YR (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	rbolli@louisville.edu	Li, Qianhong/AAJ-7643-2020; Guo, Yiru/L-2618-2015; Rokosh, Gregg/J-2730-2013; Jones, Steven P./D-5092-2009; Bolli, Roberto/A-6870-2010	Guo, Yiru/0000-0002-0614-9899; Jones, Steven P./0000-0001-5376-8089; Rokosh, Gregg/0000-0002-9214-2254	NIH [R01HL55757, R01HL060481, R01HL-680888, R01HL-70897, R01HL-76794, R01HL090529, P01HL78825, P20RR024489]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070897, R01HL076794, R01HL055757, P01HL078825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by NIH grants R01HL55757, R01HL060481, R01HL-680888, R01HL-70897, R01HL-76794, R01HL090529, P01HL78825, and P20RR024489. The authors have received no additional external funding for this study.	Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Baxter GF, 1997, ANN MED, V29, P345, DOI 10.3109/07853899708999359; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; Black RG, 2002, CIRC RES, V91, P165, DOI 10.1161/01.RES.0000028007.91385.EE; Bley KR, 2006, BRIT J PHARMACOL, V147, P335, DOI 10.1038/sj.bjp.0706554; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1897, DOI 10.1006/jmcc.2001.1462; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1893, DOI 10.1006/jmcc.2001.1469; Bolli R, 1996, BASIC RES CARDIOL, V91, P57; Bolli R, 1997, CIRC RES, V81, P1094; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; Camitta MGW, 2001, CIRCULATION, V104, P2453, DOI 10.1161/hc4401.098429; Dawn B, 2004, J MOL CELL CARDIOL, V37, P51, DOI 10.1016/j.yjmcc.2004.03.012; Dawn B, 2004, CARDIOVASC RES, V64, P61, DOI 10.1016/j.cardiores.2004.05.011; Emery P, 2005, LANCET, V365, P1538, DOI 10.1016/S0140-6736(05)66447-1; Flaherty MP, 2008, J MOL CELL CARDIOL, V45, P735, DOI 10.1016/j.yjmcc.2008.08.014; Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607; Gres P, 2002, CARDIOVASC RES, V55, P626, DOI 10.1016/S0008-6363(01)00505-3; Guo Y, 2005, AM J PHYSIOL-HEART C, V289, pH2251, DOI 10.1152/ajpheart.00341.2005; Guo Y, 2003, J MOL CELL CARDIOL, V35, pA47; Guo Y, 2001, CIRCULATION, V104, P60; Guo Y, 2001, J MOL CELL CARDIOL, V33, pA41, DOI 10.1016/S0022-2828(01)90163-4; Guo Y, 2001, J MOL CELL CARDIOL, V33, P825, DOI 10.1006/jmcc.2001.1338; Guo Y, 2000, BASIC RES CARDIOL, V95, P479, DOI 10.1007/s003950070024; Guo Y, 1999, P NATL ACAD SCI USA, V96, P11507, DOI 10.1073/pnas.96.20.11507; Guo Y, 2000, ISHR HDB EXPT LAB PR; Guo Y, 2000, J MOL CELL CARDIOL, V32, pA51; Guo Y, 1999, J MOL CELL CARDIOL, V31, pA11; Guo Y, 2008, J MOL CELL CARDIOL, V44, P496, DOI 10.1016/j.yjmcc.2008.01.003; Guo YR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0253-9; Guo YR, 2003, CIRCULATION, V108, P93; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Guo YR, 2002, CIRCULATION, V106, P313; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; Guo YR, 2000, CIRCULATION, V102, P121; Hausenloy DJ, 2010, CARDIOVASC DRUG THER, V24, P235, DOI 10.1007/s10557-010-6237-9; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Hong TT, 2008, AM J PHYSIOL-HEART C, V294, pH145, DOI 10.1152/ajpheart.00646.2007; Hu LF, 2008, PFLUG ARCH EUR J PHY, V455, P971, DOI 10.1007/s00424-007-0346-8; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; JOHNSON G, 1990, CIRC RES, V66, P1362, DOI 10.1161/01.RES.66.5.1362; Jones WK, 1999, J MOL CELL CARDIOL, V31, P1469, DOI 10.1006/jmcc.1999.0983; Jugdutt B I, 1980, Adv Prostaglandin Thromboxane Res, V7, P675; JUGDUTT BI, 1981, CIRC RES, V49, P685, DOI 10.1161/01.RES.49.3.685; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kerr DJ, 2007, NEW ENGL J MED, V357, P360, DOI 10.1056/NEJMoa071841; Kodani E, 2002, AM J PHYSIOL-HEART C, V283, pH1943, DOI 10.1152/ajpheart.00150.2002; Krotz F, 2005, J VASC RES, V42, P312, DOI 10.1159/000086459; LEFER AM, 1978, SCIENCE, V200, P52, DOI 10.1126/science.345441; Li QH, 2006, AM J PHYSIOL-HEART C, V290, pH584, DOI 10.1152/ajpheart.00855.2005; Li QH, 2003, CIRC RES, V92, P741, DOI 10.1161/01.RES.0000065441.72685.29; Li QH, 1998, CIRCULATION, V98, P1438, DOI 10.1161/01.CIR.98.14.1438; Li QH, 2001, CIRCULATION, V103, P1893; Li QH, 2007, CIRCULATION, V116, P1577, DOI 10.1161/CIRCULATIONAHA.107.689810; Li QH, 2011, BASIC RES CARDIOL, V106, P1367, DOI 10.1007/s00395-011-0208-6; Li QH, 2011, BASIC RES CARDIOL, V106, P1355, DOI 10.1007/s00395-011-0207-7; Li QH, 2009, CIRCULATION, V120, P1222, DOI 10.1161/CIRCULATIONAHA.108.778688; Lin H, 2002, CIRCULATION, V105, P1962, DOI 10.1161/01.CIR.0000015365.49180.05; Lo RKH, 2008, CELL SIGNAL, V20, P2095, DOI 10.1016/j.cellsig.2008.08.003; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; OVIZE M, 1992, CIRCULATION, V85, P779, DOI 10.1161/01.CIR.85.2.779; Patel HH, 2004, LIFE SCI, V75, P129, DOI 10.1016/j.lfs.2003.10.036; Przyklenk K, 2003, J AM COLL CARDIOL, V41, P1195, DOI 10.1016/S0735-1097(03)00087-1; Qian YZ, 1999, AM J PHYSIOL-HEART C, V276, pH224, DOI 10.1152/ajpheart.1999.276.1.H224; Qiu YM, 1997, CIRC RES, V80, P730, DOI 10.1161/01.RES.80.5.730; Ruan Cheng-Huai, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-23; Sato H, 2007, AM J PHYSIOL-HEART C, V293, pH2557, DOI 10.1152/ajpheart.00858.2007; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; Shinmura K, 2004, BASIC RES CARDIOL, V99, P46, DOI 10.1007/s00395-003-0436-5; Shinmura K, 2003, J AM COLL CARDIOL, V41, P1183, DOI 10.1016/S0735-1097(03)00086-X; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Shinmura K, 2002, AM J PHYSIOL-HEART C, V283, pH2534, DOI 10.1152/ajpheart.00209.2002; Shinmura K, 2002, CIRC RES, V90, P602, DOI 10.1161/01.RES.0000012202.52809.40; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; Stein AB, 2004, STROKE, V35, P2676, DOI 10.1161/01.STR.0000143220.21382.fd; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Stitham J, 2007, BRIT J PHARMACOL, V152, P513, DOI 10.1038/sj.bjp.0707413; Tanaka K, 2004, ANESTHESIOLOGY, V100, P525, DOI 10.1097/00000542-200403000-00010; Tang XL, 1997, AM J PHYSIOL-HEART C, V273, pH1651, DOI 10.1152/ajpheart.1997.273.4.H1651; Wang GW, 2008, J MOL CELL CARDIOL, V44, P1016, DOI 10.1016/j.yjmcc.2008.03.020; Wang Y, 2004, CIRC RES, V95, P84, DOI 10.1161/01.RES.0000133679.38825.a6; Wang Y, 2002, J MOL CELL CARDIOL, V34, P5, DOI 10.1006/jmcc.2001.1482; West MB, 2008, CIRCULATION, V118, P1970, DOI 10.1161/CIRCULATIONAHA.108.791533; Wilson SJ, 2007, ARTERIOSCL THROM VAS, V27, P290, DOI 10.1161/01.ATV.0000252667.53790.4e; Woodward DF, 2010, PHARMACOL REV, V63, P471; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Xuan YT, 2003, J MOL CELL CARDIOL, V35, P525, DOI 10.1016/S0022-2828(03)00076-2; Xuan YT, 2007, CIRCULATION, V116, P535, DOI 10.1161/CIRCULATIONAHA.107.689471; Yamashita N, 1998, J MOL CELL CARDIOL, V30, P1181, DOI 10.1006/jmcc.1998.0682; Yoshida KI, 1996, MOL CELL BIOCHEM, V156, P1	101	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41178	10.1371/journal.pone.0041178	http://dx.doi.org/10.1371/journal.pone.0041178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844439	Green Published, gold			2022-12-27	WOS:000306687700052
J	Hasdemir, D; Smits, GJ; Westerhuis, JA; Smilde, AK				Hasdemir, Dicle; Smits, Gertien J.; Westerhuis, Johan A.; Smilde, Age K.			Topology of Transcriptional Regulatory Networks: Testing and Improving	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; COMPONENT ANALYSIS; MICROARRAY DATA; BUDDING YEAST; GENE; EXPRESSION; PROTEIN; KINASE; SWI5	With the increasing amount and complexity of data generated in biological experiments it is becoming necessary to enhance the performance and applicability of existing statistical data analysis methods. This enhancement is needed for the hidden biological information to be better resolved and better interpreted. Towards that aim, systematic incorporation of prior information in biological data analysis has been a challenging problem for systems biology. Several methods have been proposed to integrate data from different levels of information most notably from metabolomics, transcriptomics and proteomics and thus enhance biological interpretation. However, in order not to be misled by the dominance of incorrect prior information in the analysis, being able to discriminate between competing prior information is required. In this study, we show that discrimination between topological information in competing transcriptional regulatory network models is possible solely based on experimental data. We use network topology dependent decomposition of synthetic gene expression data to introduce both local and global discriminating measures. The measures indicate how well the gene expression data can be explained under the constraints of the model network topology and how much each regulatory connection in the model refuses to be constrained. Application of the method to the cell cycle regulatory network of Saccharomyces cerevisiae leads to the prediction of novel regulatory interactions, improving the information content of the hypothesized network model.	[Hasdemir, Dicle; Smits, Gertien J.; Westerhuis, Johan A.; Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Hasdemir, Dicle; Westerhuis, Johan A.; Smilde, Age K.] Netherlands Metabol Ctr, Leiden, Netherlands	University of Amsterdam	Hasdemir, D (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	D.Hasdemir@uva.nl	Smits, Gertien J./I-4327-2014	Smits, Gertien J./0000-0002-8439-7791; Smilde, Age/0000-0002-3052-4644	Netherlands Metabolomics Centre (NMC) a part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	Netherlands Metabolomics Centre (NMC) a part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	This project was financed by the Netherlands Metabolomics Centre (NMC) which is a part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis or preparation of the manuscript. They read the manuscript and agreed to publish.	Aerne BL, 1998, MOL BIOL CELL, V9, P945, DOI 10.1091/mbc.9.4.945; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; Bean JM, 2005, GENETICS, V171, P49, DOI 10.1534/genetics.105.044560; Bouquin N, 1999, MOL BIOL CELL, V10, P3389, DOI 10.1091/mbc.10.10.3389; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Chang CQ, 2008, BIOINFORMATICS, V24, P1349, DOI 10.1093/bioinformatics/btn131; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Galbraith SJ, 2006, BIOINFORMATICS, V22, P1886, DOI 10.1093/bioinformatics/btl279; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Kramer W, 1996, MOL GEN GENET, V252, P275; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Sabatti C, 2006, BIOINFORMATICS, V22, P739, DOI 10.1093/bioinformatics/btk017; Schuster T, 1997, Recent Results Cancer Res, V143, P251; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tran LM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511; Tran LM, 2005, METAB ENG, V7, P128, DOI 10.1016/j.ymben.2004.12.001; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Westerhuis JA, 2007, J CHEMOMETR, V21, P474, DOI 10.1002/cem.1072; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yu TW, 2005, BIOINFORMATICS, V21, P4033, DOI 10.1093/bioinformatics/bti656; Zijlstra BJH, 2002, J CHEMOMETR, V16, P596, DOI 10.1002/cem.764	32	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40082	10.1371/journal.pone.0040082	http://dx.doi.org/10.1371/journal.pone.0040082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844399	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700008
J	Power, SD; Kushki, A; Chau, T				Power, Sarah D.; Kushki, Azadeh; Chau, Tom			Intersession Consistency of Single-Trial Classification of the Prefrontal Response to Mental Arithmetic and the No-Control State by NIRS	PLOS ONE			English	Article							COMMUNICATION; CORTEX	Near-infrared spectroscopy (NIRS) has been recently investigated for use in noninvasive brain-computer interface (BCI) technologies. Previous studies have demonstrated the ability to classify patterns of neural activation associated with different mental tasks (e.g., mental arithmetic) using NIRS signals. Though these studies represent an important step towards the realization of an NIRS-BCI, there is a paucity of literature regarding the consistency of these responses, and the ability to classify them on a single-trial basis, over multiple sessions. This is important when moving out of an experimental context toward a practical system, where performance must be maintained over longer periods. When considering response consistency across sessions, two questions arise: 1) can the hemodynamic response to the activation task be distinguished from a baseline (or other task) condition, consistently across sessions, and if so, 2) are the spatiotemporal characteristics of the response which best distinguish it from the baseline (or other task) condition consistent across sessions. The answers will have implications for the viability of an NIRS-BCI system, and the design strategies (especially in terms of classifier training protocols) adopted. In this study, we investigated the consistency of classification of a mental arithmetic task and a no-control condition over five experimental sessions. Mixed model linear regression on intrasession classification accuracies indicate that the task and baseline states remain differentiable across multiple sessions, with no significant decrease in accuracy (p = 0.67). Intersession analysis, however, revealed inconsistencies in spatiotemporal response characteristics. Based on these results, we investigated several different practical classifier training protocols, including scenarios in which the training and test data come from 1) different sessions, 2) the same session, and 3) a combination of both. Results indicate that when selecting optimal classifier training protocols for NIRS-BCI, a compromise between accuracy and convenience (e.g., in terms of duration/frequency of training data collection) must be considered.	[Power, Sarah D.; Chau, Tom] Univ Toronto, Insitute Biomat & Biomed Engn, Toronto, ON, Canada; [Power, Sarah D.; Kushki, Azadeh; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Power, SD (corresponding author), Univ Toronto, Insitute Biomat & Biomed Engn, Toronto, ON, Canada.	tom.chau@utoronto.ca	Chau, Tom TK/C-8426-2009; Power, Sarah/AAU-9422-2020	Chau, Tom TK/0000-0002-7486-0316; Power, Sarah/0000-0001-5132-2753	Natural Sciences and Engineering Research Council [RGPIN 227451]; Canada Research Chairs Program	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	Natural Sciences and Engineering Research Council, Grant number: RGPIN 227451 (http://www.nserc-crsng.gc.ca/Index_eng.asp) and Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind G, 2008, BIOMED TECH, V53, P36, DOI 10.1515/BMT.2008.005; Benaron DA, 2000, J CEREBR BLOOD F MET, V20, P469, DOI 10.1097/00004647-200003000-00005; Buttfield A, 2006, IEEE T NEUR SYS REH, V14, P164, DOI 10.1109/TNSRE.2006.875555; COPE M, 1991, THESIS U LONDON; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Falk TH, 2011, IEEE T NEUR SYS REH, V19, P136, DOI 10.1109/TNSRE.2010.2078516; Franceschini MA, 2000, PROCEEDINGS OF INTER-INSTITUTE WORKSHOP ON IN VIVO OPTICAL IMAGING AT THE NIH, P73; Herrmann MJ, 2003, BIOL PSYCHOL, V64, P255, DOI 10.1016/S0301-0511(03)00095-4; Leeb R., 2007, COMPUTATIONAL INTELL; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mason SG, 2006, INERT1989 ROC; Matthews F, 2008, IEEE SIGNAL PROC MAG, V25, P87, DOI 10.1109/MSP.2008.4408445; Naito M, 2007, IEICE T INF SYST, VE90D, P1028, DOI 10.1093/ietisy/e90-d.7.1028; Ogata H, 2007, P ANN INT IEEE EMBS, P4731, DOI 10.1109/IEMBS.2007.4353396; Pfurtscheller G, 2010, INT J PSYCHOPHYSIOL, V76, P186, DOI 10.1016/j.ijpsycho.2010.03.013; Power SD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066004; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Sitaram R, 2009, NEURAL NETWORKS, V22, P1320, DOI 10.1016/j.neunet.2009.05.009; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Tai K, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-39; Utsugi K, 2007, P ANN INT IEEE EMBS, P5338, DOI 10.1109/IEMBS.2007.4353547; VAUGHN R, 1977, HEADACHE, V16, P313, DOI 10.1111/j.1526-4610.1976.hed1606313.x; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Yamamoto T, 2002, PHYS MED BIOL, V47, P3429, DOI 10.1088/0031-9155/47/18/311	30	64	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e37791	10.1371/journal.pone.0037791	http://dx.doi.org/10.1371/journal.pone.0037791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844390	gold, Green Submitted, Green Published			2022-12-27	WOS:000306687700002
J	Yoshida-Amano, Y; Hachiya, A; Ohuchi, A; Kobinger, GP; Kitahara, T; Takema, Y; Fukuda, M				Yoshida-Amano, Yasuko; Hachiya, Akira; Ohuchi, Atsushi; Kobinger, Gary P.; Kitahara, Takashi; Takema, Yoshinori; Fukuda, Mitsunori			Essential Role of RAB27A in Determining Constitutive Human Skin Color	PLOS ONE			English	Article							KERATINOCYTE-MELANOCYTE INTERACTIONS; BLACK-AND-WHITE; MELANOSOME TRANSPORT; TYROSINASE ACTIVITY; MYOSIN-VA; DISTRIBUTION PATTERNS; GRISCELLI-SYNDROME; SENILE LENTIGO; GENE-TRANSFER; HUMAN HAIR	Human skin color is predominantly determined by melanin produced in melanosomes within melanocytes and subsequently distributed to keratinocytes. There are many studies that have proposed mechanisms underlying ethnic skin color variations, whereas the processes involved from melanin synthesis in melanocytes to the transfer of melanosomes to keratinocytes are common among humans. Apart from the activities in the melanogenic rate-limiting enzyme, tyrosinase, in melanocytes and the amounts and distribution patterns of melanosomes in keratinocytes, the abilities of the actin-associated factors in charge of melanosome transport within melanocytes also regulate pigmentation. Mutations in genes encoding melanosome transport-related molecules, such as MYO5A, RAB27A and SLAC-2A, have been reported to cause a human pigmentary disease known as Griscelli syndrome, which is associated with diluted skin and hair color. Thus we hypothesized that process might play a role in modulating skin color variations. To address that hypothesis, the correlations of expression of RAB27A and its specific effector, SLAC2-A, to melanogenic ability were evaluated in comparison with tyrosinase, using human melanocytes derived from 19 individuals of varying skin types. Following the finding of the highest correlation in RAB27A expression to the melanogenic ability, darkly-pigmented melanocytes with significantly higher RAB27A expression were found to transfer significantly more melanosomes to keratinocytes than lightly-pigmented melanocytes in co-culture and in human skin substitutes (HSSs) in vivo, resulting in darker skin color in concert with the difference observed in African-descent and Caucasian skins. Additionally, RAB27A knockdown by a lentivirus-derived shRNA in melanocytes concomitantly demonstrated a significantly reduced number of transferred melanosomes to keratinocytes in co-culture and a significantly diminished epidermal melanin content skin color intensity (Delta L* = 4.4) in the HSSs. These data reveal the intrinsically essential role of RAB27A in human ethnic skin color determination and provide new insights for the fundamental understanding of regulatory mechanisms underlying skin pigmentation.	[Yoshida-Amano, Yasuko; Hachiya, Akira; Ohuchi, Atsushi; Kitahara, Takashi] Kao Corp, Biol Sci Labs, Haga, Tochigi, Japan; [Kobinger, Gary P.] Univ Manitoba, Special Pathogens Program, Natl Microbiol Lab, Dept Med Microbiol,Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Takema, Yoshinori] Kao Corp, Res & Dev Global, Sumida Ku, Tokyo, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech, Sendai, Miyagi 980, Japan	KAO Corporation; Public Health Agency of Canada; University of Manitoba; KAO Corporation; Tohoku University	Yoshida-Amano, Y (corresponding author), Kao Corp, Biol Sci Labs, Haga, Tochigi, Japan.	hachiya.akira@kao.co.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Kao Corporation; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Kao Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors have read the journal's policy and have the following conflicts: Yasuko Yoshida-Amano, Akira Hachiya, Atsushi Ohuchi, Takashi Kitahara, and Yoshinori Takema are employed by Kao Corporation, who were the funders of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alaluf S, 2003, PIGM CELL RES, V16, P35, DOI 10.1034/j.1600-0749.2003.00005.x; Babiarz-Magee L, 2004, PIGM CELL RES, V17, P241, DOI 10.1111/j.1600-0749.2004.00133.x; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Byers HR, 2003, J INVEST DERMATOL, V121, P813; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Diamond J, 2005, NATURE, V435, P283, DOI 10.1038/435283a; Fitzpatrick T. B., 1975, J MED ESTHETIQUE, V2, P33, DOI DOI 10.1159/000251345; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fuller BB, 2001, EXP CELL RES, V262, P197, DOI 10.1006/excr.2000.5092; Hachiya A, 2007, GENE THER, V14, P648, DOI 10.1038/sj.gt.3302915; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; IWATA M, 1990, J INVEST DERMATOL, V95, P9, DOI 10.1111/1523-1747.ep12872677; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kawasaki A, 2008, PIGM CELL MELANOMA R, V21, P56, DOI 10.1111/j.1755-148X.2007.00420.x; KONRAD K, 1973, ARCH DERMATOL, V107, P853; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; MONTAGNA W, 1991, J AM ACAD DERMATOL, V24, P929, DOI 10.1016/0190-9622(91)70148-U; NAEYAERT JM, 1991, BRIT J DERMATOL, V125, P297, DOI 10.1111/j.1365-2133.1991.tb14161.x; Noblesse E, 2006, SKIN PHARMACOL PHYS, V19, P95, DOI 10.1159/000091976; Paine C, 2001, J INVEST DERMATOL, V116, P587, DOI 10.1046/j.1523-1747.2001.01291.x; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Passeron T, 2004, FASEB J, V18, P989, DOI 10.1096/fj.03-1240fje; POMERANTZ SH, 1975, J CLIN INVEST, V55, P1127, DOI 10.1172/JCI108014; SAEKI H, 1985, J INVEST DERMATOL, V85, P423, DOI 10.1111/1523-1747.ep12277091; Scott MC, 2002, J CELL SCI, V115, P2349; SEARLE AG, 1990, OPHTHALMIC PAED GEN, V11, P159, DOI 10.3109/13816819009020974; Seiberg M, 2000, J INVEST DERMATOL, V115, P162, DOI 10.1046/j.1523-1747.2000.00035.x; Seiberg M, 2000, EXP CELL RES, V254, P25, DOI 10.1006/excr.1999.4692; Seiberg M, 2001, PIGM CELL RES, V14, P236, DOI 10.1034/j.1600-0749.2001.140402.x; Sharlow ER, 2000, J CELL SCI, V113, P3093; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Smith DR, 2004, EXP CELL RES, V298, P521, DOI 10.1016/j.yexcr.2004.04.033; Sriwiriyanont P, 2011, J INVEST DERMATOL, V131, P320, DOI 10.1038/jid.2010.309; Sriwiriyanont P, 2009, J INVEST DERMATOL, V129, P2296, DOI 10.1038/jid.2009.33; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; SZABO G, 1969, NATURE, V222, P1082, DOI 10.1038/2221081a0; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Unver N, 2006, BRIT J DERMATOL, V155, P119, DOI 10.1111/j.1365-2133.2006.07210.x; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yoshida Y, 2007, FASEB J, V21, P2829, DOI 10.1096/fj.06-6845com	53	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41160	10.1371/journal.pone.0041160	http://dx.doi.org/10.1371/journal.pone.0041160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844437	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700050
J	Lenzen, H; Lunnemann, M; Bleich, A; Manns, MP; Seidler, U; Jorns, A				Lenzen, Henrike; Luennemann, Maria; Bleich, Andre; Manns, Michael P.; Seidler, Ursula; Joerns, Anne			Downregulation of the NHE3-Binding PDZ-Adaptor Protein PDZK1 Expression during Cytokine-Induced Inflammation in Interleukin-10-Deficient Mice	PLOS ONE			English	Article							INTESTINAL ION-TRANSPORT; TUMOR-NECROSIS-FACTOR; BOWEL-DISEASE; ULCERATIVE-COLITIS; NA+/H+ EXCHANGER; CROHNS-DISEASE; DEFICIENT MICE; KNOCKOUT MICE; NHE3; DIARRHEA	Background: Impaired salt and water absorption is an important feature in the pathogenesis of diarrhea in inflammatory bowel disease (IBD). We analyzed the expression of proinflammatory cytokines in the infiltrating immune cells and the function and expression of the Na+/H+ exchanger isoform 3 (NHE3) and its regulatory PDZ-adaptor proteins NHERF1, NHERF2, and PDZK1 in the colon of interleukin-10-deficient (IL-10(-/-)) mice. Methodology/Principal Findings: Gene and protein expression were analyzed by real-time reverse transcription polymerase chain reaction (qRT-PCR), in situ RT-PCR, and immunohistochemistry. NHE3 activity was measured fluorometrically in apical enterocytes within isolated colonic crypts. Mice developed chronic colitis characterized by a typical immune cell infiltration composed of T-lymphocytes and macrophages, with high levels of gene and protein expression of the proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha. In parallel, inducible nitric oxide synthase expression was increased while procaspase 3 expression was unaffected. Interferon-gamma expression remained low. Although acid-activated NHE3 activity was significantly decreased, the inflammatory process did not affect its gene and protein expression or its abundance and localization in the apical membrane. However, expression of the PDZ-adaptor proteins NHERF2 and PDZK1 was downregulated. NHERF1 expression was unchanged. In a comparative analysis we observed the PDZK1 downregulation also in the DSS (dextran sulphate sodium) model of colitis. Conclusions/Significance: The impairment of the absorptive function of the inflamed colon in the IL-10(-/-) mouse, in spite of unaltered NHE3 expression and localization, is accompanied by the downregulation of the NHE3-regulatory PDZ adaptors NHERF2 and PDZK1. We propose that the downregulation of PDZ-adaptor proteins may be an important factor leading to NHE3 dysfunction and diarrhea in the course of the cytokine-mediated inflammatory process in these animal models of IBD.	[Lenzen, Henrike; Luennemann, Maria; Manns, Michael P.; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Joerns, Anne] Hannover Med Sch, Inst Clin Biochem, D-3000 Hannover, Germany; [Joerns, Anne] Hannover Med Sch, Ctr Anat, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Lenzen, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany.	Lenzen.Henrike@mh-hannover.de	Seidler, Ursula/HII-8049-2022	Seidler, Ursula/0000-0002-9600-2769	Deutsche Forschungsgemeinschaft [Se460/9-5, S460/9-6, SFB621-C9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants Se460/9-5, S460/9-6 and SFB621-C9 from the Deutsche Forschungsgemeinschaft (to US). Publication charges for this article were supported by the Deutsche Forschungsgemeinschaft in the framework of the program "Open Access Publishing''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt T, 2009, DIABETOLOGIA, V52, P1381, DOI 10.1007/s00125-009-1348-1; Bachmann O, 2003, AM J PHYSIOL-GASTR L, V284, pG37, DOI 10.1152/ajpgi.00209.2002; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Broere N, 2009, PFLUG ARCH EUR J PHY, V457, P1079, DOI 10.1007/s00424-008-0579-1; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; Davidson NJ, 1998, J IMMUNOL, V161, P3143; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Gawenis LR, 2002, AM J PHYSIOL-GASTR L, V282, pG776, DOI 10.1152/ajpgi.00297.2001; Gratz R, 2002, DIGEST DIS SCI, V47, P1723, DOI 10.1023/A:1016476024293; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x; Jorns A, 2005, DIABETES, V54, P2041, DOI 10.2337/diabetes.54.7.2041; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Lohi H, 2002, AM J PHYSIOL-GASTR L, V283, pG567, DOI 10.1152/ajpgi.00356.2001; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Seidler U, 2006, ANN NY ACAD SCI, V1072, P262, DOI 10.1196/annals.1326.024; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Siddique I, 2009, SCAND J GASTROENTERO, V44, P56, DOI 10.1080/00365520802321253; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Uno S, 2007, DIABETOLOGIA, V50, P596, DOI 10.1007/s00125-006-0569-9; Yang HY, 1998, AM J PHYSIOL-GASTR L, V275, pG1445, DOI 10.1152/ajpgi.1998.275.6.G1445; Yeruva S, 2010, INFLAMM BOWEL DIS, V16, P1149, DOI 10.1002/ibd.21183; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	45	31	32	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40657	10.1371/journal.pone.0040657	http://dx.doi.org/10.1371/journal.pone.0040657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848392	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200026
J	Li, PH; Bai, XW; Cao, YM; Han, CH; Lu, ZJ; Sun, P; Yin, H; Liu, ZX				Li, Pinghua; Bai, Xingwen; Cao, Yimei; Han, Chenghao; Lu, Zengjun; Sun, Pu; Yin, Hong; Liu, Zaixin			Expression and Stability of Foreign Epitopes Introduced into 3A Nonstructural Protein of Foot-and-Mouth Disease Virus	PLOS ONE			English	Article							STABLE EXPRESSION; GENETIC STABILITY; HOST-RANGE; POLIOVIRUS; REPLICATION; VECTOR; REGION; DETERMINANTS; ASSOCIATION	Foot-and-mouth disease virus (FMDV) is an aphthovirus that belongs to the Picornaviridae family and causes one of the most important animal diseases worldwide. The capacity of other picornaviruses to express foreign antigens has been extensively reported, however, little is known about FMDV. To explore the potential of FMDV as a viral vector, an 11-amino-acid (aa) HSV epitope and an 8 aa FLAG epitope were introduced into the C-terminal different regions of 3A protein of FMDV full-length infectious cDNA clone. Recombinant viruses expressing the HSV or FLAG epitope were successfully rescued after transfection of both modified constructs. Immunofluorescence assay, Western blot and sequence analysis showed that the recombinant viruses stably maintained the foreign epitopes even after 11 serial passages in BHK-21 cells. The 3A-tagged viruses shared similar plaque phenotypes and replication kinetics to those of the parental virus. In addition, mice experimentally infected with the epitope-tagged viruses could induce tag-specific antibodies. Our results demonstrate that FMDV can be used effectively as a viral vector for the delivery of foreign tags.	[Li, Pinghua; Bai, Xingwen; Cao, Yimei; Han, Chenghao; Lu, Zengjun; Sun, Pu; Yin, Hong; Liu, Zaixin] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Li, PH (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	yinhong@caas.net.cn; liuzaixin3@hotmail.com	Yin, Hong/AAC-5784-2020; Li, Ping/GYV-4914-2022		National "863'' project [2011AA10A211]	National "863'' project(National High Technology Research and Development Program of China)	The current research was supported by National "863'' project, 2011AA10A211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDINO R, 1994, SCIENCE, V265, P1448, DOI 10.1126/science.8073288; ARNOLD GF, 1994, VIROLOGY, V198, P703, DOI 10.1006/viro.1994.1082; Beard CW, 2000, J VIROL, V74, P987, DOI 10.1128/JVI.74.2.987-991.2000; Beard MR, 2001, J VIROL, V75, P1414, DOI 10.1128/JVI.75.3.1414-1426.2001; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Benjamin B, 2011, J GEN VIROL, V92, P2906; BIENZ K, 1983, VIROLOGY, V131, P39, DOI 10.1016/0042-6822(83)90531-7; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; Bramel-Verheije MHG, 2000, VIROLOGY, V278, P380, DOI 10.1006/viro.2000.0525; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Bukreyev A, 1996, J VIROL, V70, P6634, DOI 10.1128/JVI.70.10.6634-6641.1996; Chapman NM, 2000, J VIROL, V74, P7952, DOI 10.1128/JVI.74.17.7952-7962.2000; Ehrenfeld E, 2009, J VIROL, V84, P1477; Engel-Herbert I, 2003, J VIROL METHODS, V108, P19, DOI 10.1016/S0166-0934(02)00247-1; GIRAUDO AT, 1990, VIROLOGY, V177, P780, DOI 10.1016/0042-6822(90)90549-7; Hammoumi S, 2006, ARCH VIROL, V151, P1783, DOI 10.1007/s00705-006-0746-7; Kim DS, 2010, VACCINE, V28, P1234, DOI 10.1016/j.vaccine.2009.11.017; Knowles NJ, 2001, J VIROL, V75, P1551, DOI 10.1128/JVI.75.3.1551-1556.2001; Li PH, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-57; Li SA, 2010, VIRUS GENES, V41, P406, DOI 10.1007/s11262-010-0529-9; Lu ZJ, 2007, VET MICROBIOL, V125, P157, DOI 10.1016/j.vetmic.2007.05.017; Maroudam V, 2010, INFECT GENET EVOL, V10, P703, DOI 10.1016/j.meegid.2010.03.004; MATTION NM, 1994, J VIROL, V68, P3925, DOI 10.1128/JVI.68.6.3925-3933.1994; MATTION NM, 1995, J VIROL, V69, P5132, DOI 10.1128/JVI.69.8.5132-5137.1995; Mebatsion T, 1996, P NATL ACAD SCI USA, V93, P7310, DOI 10.1073/pnas.93.14.7310; Mohapatra JK, 2008, VIRUS RES, V136, P16, DOI 10.1016/j.virusres.2008.04.010; Mueller S, 1998, J VIROL, V72, P20, DOI 10.1128/JVI.72.1.20-31.1998; Nunez JI, 2001, J VIROL, V75, P3977, DOI 10.1128/JVI.75.8.3977-3983.2001; Nunez JI, 2007, J VIROL, V81, P8497, DOI 10.1128/JVI.00340-07; O'Donnell VK, 2001, VIROLOGY, V287, P151, DOI 10.1006/viro.2001.1035; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Piccone ME, 2011, VIRUS RES, V155, P91, DOI 10.1016/j.virusres.2010.09.004; PORTER AG, 1993, J VIROL, V67, P6917, DOI 10.1128/JVI.67.12.6917-6921.1993; RIEDER E, 1993, J VIROL, V67, P5139, DOI 10.1128/JVI.67.9.5139-5145.1993; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Singh M, 1999, J VIROL, V73, P4823, DOI 10.1128/JVI.73.6.4823-4828.1999; Tan JL, 2009, J GEN VIROL, V90, P614, DOI 10.1099/vir.0.005488-0; Tang SB, 1997, J VIROL, V71, P7841, DOI 10.1128/JVI.71.10.7841-7850.1997; Teterina NL, 2011, J VIROL, V85, P4284, DOI 10.1128/JVI.02398-10; Teterina NL, 2011, VIROLOGY, V409, P1, DOI 10.1016/j.virol.2010.09.028; Towner JS, 1996, J BIOL CHEM, V271, P26810, DOI 10.1074/jbc.271.43.26810; Wegelt A, 2011, J GEN VIROL, V92, P1352, DOI 10.1099/vir.0.029330-0; Wu Lei, 2010, Chinese Veterinary Science / Zhongguo Shouyi Kexue, V40, P331; ZHANG L, 1995, J VIROL, V69, P3171, DOI 10.1128/JVI.69.5.3171-3175.1995	47	13	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41486	10.1371/journal.pone.0041486	http://dx.doi.org/10.1371/journal.pone.0041486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848509	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200066
J	Martens, MJI; Lemmens, SGT; Born, JM; Westerterp-Plantenga, MS				Martens, Mieke J. I.; Lemmens, Sofie G. T.; Born, Jurriaan M.; Westerterp-Plantenga, Margriet S.			Satiating Capacity and Post-Prandial Relationships between Appetite Parameters and Gut-Peptide Concentrations with Solid and Liquefied Carbohydrate	PLOS ONE			English	Article							PHYSICAL STATE; ENERGY-INTAKE; FOOD-INTAKE; PLASMA GHRELIN; NORMAL-WEIGHT; RELEASE; EXPENDITURE; SENSATIONS; SATIETY; LIQUID	Background: Differences in satiating capacity of liquid and solid meals are unclear. Objective: Investigating appetite parameters, physiological measurements and within-subject relationships after consumption of a single macronutrient, subject-specific carbohydrate meal in liquefied versus solid form, controlled for energy density, weight and volume. Design: In a cross-over design, ten male subjects (age = 21.1 +/- 3.9 y, BMI = 22.4 +/- 1.2 kg/m(2)) consumed a solid (CS, whole peaches +750 ml water) and liquefied carbohydrate (CL, peach blended in 500 ml water +250 ml water) lunch. Appetite profiles, insulin-, glucose- and ghrelin concentrations were measured over three hours. Post-prandial relationships between appetite and blood parameters were calculated using subject-specific regression analyses. Results: Fullness ratings were higher in the CL (85 +/- 5 mm) compared to the CS condition (73 +/- 8 mm) at 20 min (p<0.03). Glucose concentrations peaked 20 to 30 min after the start of the lunch in the CL condition, and 30 to 40 min after start of the CS condition. Correspondingly, insulin concentrations were peaked at 20-30 min in the CL condition, and at 30-40 min in the CS condition. AUC or condition x time interactions were not different comparing the CL and the CS condition. Insulin was significantly higher in the CS compared to the CL condition 40 min after the start of the lunch (p<0.05). Fullness scores were significantly related to insulin concentrations but not to glucose concentrations; desire to eat scores were significantly associated with ghrelin concentrations in both, the CL and the CS condition. The relationship between fullness scores and glucose concentrations was not statistically significant. Conclusion: Liquefied and solid carbohydrate meals do not differ in satiating capacity, supported by appetite profile and relevant blood parameters. Postprandially, fullness and desire to eat were associated with respectively insulin and ghrelin concentrations.	[Martens, Mieke J. I.; Lemmens, Sofie G. T.; Born, Jurriaan M.; Westerterp-Plantenga, Margriet S.] MUMC, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Martens, Mieke J. I.; Lemmens, Sofie G. T.; Born, Jurriaan M.; Westerterp-Plantenga, Margriet S.] Top Inst Food & Nutr, Wageningen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Top Institute Food & Nutrition	Martens, MJI (corresponding author), MUMC, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands.	mieke.martens@maastrichtuniversity.nl	Born, Jan/K-2596-2016	Born, Jan/0000-0002-1847-6248				Adam TCM, 2005, HORM METAB RES, V37, P111, DOI 10.1055/s-2005-861160; Almiron-Roig E, 2003, Obes Rev, V4, P201, DOI 10.1046/j.1467-789X.2003.00112.x; Almiron-Roig E, 2004, PHYSIOL BEHAV, V82, P671, DOI 10.1016/j.physbeh.2004.06.003; BYRNE DH, 1991, J AM SOC HORTIC SCI, V116, P1004, DOI 10.21273/JASHS.116.6.1004; Diepvens K, 2008, INT J OBESITY, V32, P510, DOI 10.1038/sj.ijo.0803758; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Erdmann J, 2007, EUR J NUTR, V46, P196, DOI 10.1007/s00394-007-0649-8; FITZSIMONS JT, 1972, PHYSIOL REV, V52, P468, DOI 10.1152/physrev.1972.52.2.468; FITZSIMONS JT, 1966, BRIT MED BULL, V22, P232, DOI 10.1093/oxfordjournals.bmb.a070479; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Flint A, 2007, BRIT J NUTR, V98, P17, DOI 10.1017/S000711450768297X; Guo Y, 2006, OBESITY, V14, P1562, DOI 10.1038/oby.2006.180; HABER GB, 1977, LANCET, V2, P679; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Himaya A, 1998, APPETITE, V30, P199, DOI 10.1006/appe.1997.0138; Joosen AMCP, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-25; KISSILEFF HR, 1985, AM J CLIN NUTR, V42, P956, DOI 10.1093/ajcn/42.5.956; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Lemmens SG, 2011, AM J CLIN NUTR, V94, P717, DOI 10.3945/ajcn.110.008631; Maffeis C, 2010, OBESITY, V18, P449, DOI 10.1038/oby.2009.271; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Martens MJI, 2011, OBESITY, V19, P522, DOI 10.1038/oby.2010.258; Martens MJI, 2011, OBESITY IN PRESS; Mattes R, 2005, PHYSIOL BEHAV, V83, P739, DOI 10.1016/j.physbeh.2004.09.021; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; Olsen NJ, 2009, OBES REV, V10, P68, DOI 10.1111/j.1467-789X.2008.00523.x; Philippaerts RM, 1999, INT J SPORTS MED, V20, P284, DOI 10.1055/s-2007-971132; Rolls BJ, 1999, AM J CLIN NUTR, V70, P448; Santangelo A, 1998, BRIT J NUTR, V80, P521, DOI 10.1017/S0007114598001615; Smeets AJ, 2008, J NUTR, V138, P698, DOI 10.1093/jn/138.4.698; TOURNIER A, 1991, APPETITE, V16, P17, DOI 10.1016/0195-6663(91)90107-4; Zijlstra N, 2008, INT J OBESITY, V32, P676, DOI 10.1038/sj.ijo.0803776; Zijlstra N, 2009, AM J CLIN NUTR, V90, P269, DOI 10.3945/ajcn.2009.27694; Zijlstra N, 2009, PHYSIOL BEHAV, V97, P68, DOI 10.1016/j.physbeh.2009.02.001	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42110	10.1371/journal.pone.0042110	http://dx.doi.org/10.1371/journal.pone.0042110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844543	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600068
J	Sepulchre, JA; Merajver, SD; Ventura, AC				Sepulchre, Jacques-Alexandre; Merajver, Sofia D.; Ventura, Alejandra C.			Retroactive Signaling in Short Signaling Pathways	PLOS ONE			English	Article							COVALENT MODIFICATION; PROTEIN; MODEL; ULTRASENSITIVITY; CASCADES	In biochemical signaling pathways without explicit feedback connections, the core signal transduction is usually described as a one-way communication, going from upstream to downstream in a feedforward chain or network of covalent modification cycles. In this paper we explore the possibility of a new type of signaling called retroactive signaling, offered by the recently demonstrated property of retroactivity in signaling cascades. The possibility of retroactive signaling is analysed in the simplest case of the stationary states of a bicyclic cascade of signaling cycles. In this case, we work out the conditions for which variables of the upstream cycle are affected by a change of the total amount of protein in the downstream cycle, or by a variation of the phosphatase deactivating the same protein. Particularly, we predict the characteristic ranges of the downstream protein, or of the downstream phosphatase, for which a retroactive effect can be observed on the upstream cycle variables. Next, we extend the possibility of retroactive signaling in short but nonlinear signaling pathways involving a few covalent modification cycles.	[Sepulchre, Jacques-Alexandre] Univ Nice Sophia Antipolis, CNRS, UMR 7335, Inst Non Lineaire Nice, Valbonne, France; [Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Ventura, Alejandra C.] Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias, Buenos Aires, DF, Argentina; [Ventura, Alejandra C.] Univ Buenos Aires, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Sepulchre, JA (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 7335, Inst Non Lineaire Nice, Valbonne, France.	jacques-alexandre.sepulchre@inln.cnrs.fr			Department of Defense Breast Cancer Research Program; Center for Computational Medicine and Bioinformatics (University of Michigan); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); Breast Cancer Research Foundation; international program of scientific collaboration [PICS 05922]	Department of Defense Breast Cancer Research Program(United States Department of Defense); Center for Computational Medicine and Bioinformatics (University of Michigan)(University of Michigan System); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Breast Cancer Research Foundation; international program of scientific collaboration	ACV is a member of the Carrera del Investigador Cientifico (CONICET) and was supported by the Department of Defense Breast Cancer Research Program, the Center for Computational Medicine and Bioinformatics (University of Michigan), and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina). SDM receives funding from the Breast Cancer Research Foundation. The international program of scientific collaboration PICS 05922 between CNRS (France) and CONICET (Argentina) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe44; Anderson J, 2011, AUTOMATICA, V47, P1165, DOI 10.1016/j.automatica.2011.03.010; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Elion EA, 2005, SCIENCE, V307, P687, DOI 10.1126/science.1109500; Feliu E, 2012, B MATH BIOL, V74, P45, DOI 10.1007/s11538-011-9658-0; Franco E, 2009, IEEE DECIS CONTR P, P4584, DOI 10.1109/CDC.2009.5400523; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Jiang P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002152; Kim Y, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.121; Kim Y, 2010, CURR BIOL, V20, P446, DOI 10.1016/j.cub.2010.01.019; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; Nelson D.L., 2004, PRINCIPLES BIOCH, V4th; Ossareh HR, 2011, BIOPHYS J, V100, P1617, DOI 10.1016/j.bpj.2011.02.014; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Soyer OS, 2009, FEBS J, V276, P3290, DOI 10.1111/j.1742-4658.2009.07054.x; Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Wynn ML, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-156; Zumsande M, 2010, J THEOR BIOL, V265, P481, DOI 10.1016/j.jtbi.2010.04.025	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40806	10.1371/journal.pone.0040806	http://dx.doi.org/10.1371/journal.pone.0040806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848403	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600010
J	Wen, CY; Yan, ZF; Yang, XL; Guan, K; Xu, CZ; Song, T; Zheng, ZR; Wang, WJ; Wang, Y; Zhao, M; Zhang, YH; Xu, T; Dou, JP; Liu, JM; Xu, QB; He, X; Wei, C; Zhong, H				Wen, Chaoyang; Yan, Zhifeng; Yang, Xiaoli; Guan, Kai; Xu, Changzhi; Song, Ting; Zheng, Zirui; Wang, Wenjun; Wang, Ying; Zhao, Man; Zhang, Yanhong; Xu, Tao; Dou, Jianping; Liu, Jingmei; Xu, Quanbin; He, Xiang; Wei, Congwen; Zhong, Hui			Identification of Tyrosine-9 of MAVS as Critical Target for Inducible Phosphorylation That Determines Activation	PLOS ONE			English	Article							NF-KAPPA-B; ADAPTER PROTEIN; INNATE IMMUNITY; UBIQUITIN; VIRUS; NEMO; RESPONSES; BINDING; CARDIF; SITES	Background: Innate immunity to viruses involves receptors such as RIG-I, which senses viral RNA and triggers an IFN-beta signaling pathway involving the outer mitochondrial membrane protein MAVS. However, the functional status of MAVS phosphorylation remains elusive. Methodology/Principal Findings: Here we demonstrate for the first time that MAVS undergoes extensive tyrosine phosphorylation upon viral infection, indicating that MAVS phosphorylation might play an important role in MAVS function. A tyrosine-scanning mutational analysis revealed that MAVS tyrosine-9 (Y9) is a phosphorylation site that is required for IFN-beta signaling. Indeed, MAVS Y9F mutation severely impaired TRAF3/TRAF6 recruitment and displayed decreased tyrosine phosphorylation in response to VSV infection compared to wild type MAVS. Functionally, MAVS Y9 phosphorylation contributed to MAVS antiviral function without interfering with its apoptosis property. Conclusions/Significance: These experiments identify a novel residue of MAVS that is crucially involved in the recruitment of TRAF3/TRAF6 and in downstream propagation of MAVS signaling.	[Liu, Jingmei; He, Xiang] Beijing Inst Dis Control & Prevent, Beijing, Peoples R China; [Wen, Chaoyang; Yan, Zhifeng; Yang, Xiaoli; Xu, Tao; Dou, Jianping] Chinese PLA Gen Hosp Sanya City, Hainan Branch, Hainan, Peoples R China; [Wen, Chaoyang; Guan, Kai; Xu, Changzhi; Song, Ting; Zheng, Zirui; Wang, Wenjun; Wang, Ying; Zhao, Man; Zhang, Yanhong; Xu, Quanbin; Wei, Congwen; Zhong, Hui] Beijing Inst Biotechnol, Beijing, Peoples R China; [Yang, Xiaoli] Gen Hosp Peoples Armed Police Hosp, Beijing, Peoples R China		He, X (corresponding author), Beijing Inst Dis Control & Prevent, Beijing, Peoples R China.	hexiang_spring@yahoo.com; wency301@vip.sina.com; towall@yahoo.com	Xu, Quanbin/K-1904-2019	Xu, Quanbin/0000-0002-2833-9773	National Science Funding Committe(NSFC) [31170029];  [2012CB518900]	National Science Funding Committe(NSFC); 	This work was supported in part by 973 grant 2012CB518900 and National Science Funding Committe(NSFC) Grant 31170029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello MD, 2007, CELL HOST MICROBE, V2, P367, DOI 10.1016/j.chom.2007.11.005; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sebban-Benin H, 2007, HUM MOL GENET, V16, P2805, DOI 10.1093/hmg/ddm237; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	27	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41687	10.1371/journal.pone.0041687	http://dx.doi.org/10.1371/journal.pone.0041687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844514	Green Submitted, gold, Green Published			2022-12-27	WOS:000309240600041
J	Ogunjimi, B; Peeters, D; Hens, N; Malfait, R; Van Tendeloo, V; Van Damme, P; Beutels, P; Smits, E				Ogunjimi, Benson; Peeters, Dieter; Hens, Niel; Malfait, Ronald; Van Tendeloo, Viggo; Van Damme, Pierre; Beutels, Philippe; Smits, Evelien			Sampling Site Matters When Counting Lymphocyte Subpopulations	PLOS ONE			English	Article							IMMUNE-RESPONSES; FLOW-CYTOMETRY; VENOUS-BLOOD; ARTERIAL; PARAMETERS; PITFALLS; ELISPOT; CELLS	Clinical and scientific work routinely relies on antecubital venipunctures for hematological, immunological or other analyses on blood. This study tested the hypothesis that antecubital veins can be considered to be a good proxy for other sampling sites. Using a hematocytometer and a flow cytometer, we analyzed the cell counts from samples coming from the radial artery, the dorsal hand veins and the antecubital veins from 18 volunteers. Most surprisingly, we identified the greatest difference not to exist between arterial and venous circulation, but between the distal (radial artery & dorsal hand veins) and proximal (antecubital veins) sampling sites. Naive T cells had a higher cell count distally compared to proximally and the reverse was true for effector memory T cells. Despite these differences there were high correlations between the different sampling sites, which partially supports our initial hypothesis. Our findings are crucial for the future design and interpretation of immunological research, and for clinical practice. Furthermore, our results suggest a role for interval lymph nodes in the trafficking of lymphocytes.	[Ogunjimi, Benson; Hens, Niel; Beutels, Philippe] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modeling Infect Dis, B-2020 Antwerp, Belgium; [Peeters, Dieter] GZA Hosp Sint Augustinus, Ctr Oncol, Translat Canc Res Unit, Antwerp, Belgium; [Peeters, Dieter] Univ Antwerp, Dept Med Oncol, B-2020 Antwerp, Belgium; [Malfait, Ronald] Univ Antwerp Hosp, Dept Lab Med, Antwerp, Belgium; [Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Van Tendeloo, Viggo; Smits, Evelien] Univ Antwerp, Vaccine & Infect Dis Inst, Lab Expt Hematol, B-2020 Antwerp, Belgium; [Van Tendeloo, Viggo; Smits, Evelien] Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, Antwerp, Belgium; [Van Damme, Pierre] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium; [Beutels, Philippe] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of Antwerp; University of Antwerp; University of Antwerp; Hasselt University; University of Antwerp; University of Antwerp; University of Antwerp; University of New South Wales Sydney	Ogunjimi, B (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modeling Infect Dis, B-2020 Antwerp, Belgium.	benson.ogunjimi@ua.ac.be	Van Tendeloo, Viggo FI/A-1233-2010; Smits, Evelien/A-3520-2014; van damme, pierre/I-4846-2013; Ogunjimi, Benson/G-2606-2011; Ogunjimi, Benson/AGK-8323-2022; Hens, Niel/M-4445-2017; Beutels, Philippe/A-1919-2010	Van Tendeloo, Viggo FI/0000-0003-3217-9917; Smits, Evelien/0000-0001-9255-3435; Ogunjimi, Benson/0000-0002-0831-2063; Hens, Niel/0000-0003-1881-0637; Beutels, Philippe/0000-0001-5034-3595; van damme, pierre/0000-0002-8642-1249; Peeters, Dieter/0000-0002-6943-2675	University of Antwerp; Research Foundation Flanders (FWO)	University of Antwerp; Research Foundation Flanders (FWO)(FWO)	The authors thank the University of Antwerp for the financial support received. B.O., D. P. and E. S. thank the Research Foundation Flanders (FWO) for the financial support they have received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blann AD, 1996, HAEMOSTASIS, V26, P72; CHRISTENSEN RD, 1979, AM J CLIN PATHOL, V72, P608; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Durila M, 2010, BLOOD COAGUL FIBRIN, V21, P770, DOI 10.1097/MBC.0b013e32834013d7; Gaisne E, 1994, Ann Chir Main Memb Super, V13, P172, DOI 10.1016/S0753-9053(94)80043-X; Lenders K, 2010, J IMMUNOL METHODS, V357, P51, DOI 10.1016/j.jim.2010.03.001; Lue APV, 2007, VET J, V173, P664, DOI 10.1016/j.tvjl.2006.03.003; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Makino A, 2007, BIORHEOLOGY, V44, P221; Matter M, 2007, J NUCL MED, V48, P1607, DOI 10.2967/jnumed.107.041707; MIYAWAKI T, 1984, CLIN EXP IMMUNOL, V55, P618; Mokken FC, 1996, ANN HEMATOL, V73, P135, DOI 10.1007/s002770050214; Ogunjimi B, 2012, HUM VACC IMMUNOTHER, V8, P499, DOI 10.4161/hv.18855; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Shah MD, 2008, PLATELETS, V19, P365, DOI 10.1080/09537100802054107; Smith JG, 2001, CLIN DIAGN LAB IMMUN, V8, P871, DOI 10.1128/CDLI.8.5.871-879.2001; Son KH, 2010, CLIN HEMORHEOL MICRO, V44, P27, DOI 10.3233/CH-2010-1248; THURLBECK SM, 1987, ARCH DIS CHILD, V62, P74, DOI 10.1136/adc.62.1.74; Weinberg A, 1998, CLIN DIAGN LAB IMMUN, V5, P804, DOI 10.1128/CDLI.5.6.804-807.1998	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41405	10.1371/journal.pone.0041405	http://dx.doi.org/10.1371/journal.pone.0041405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848485	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600062
J	Liu, AP; Yin, X; Shi, L; Li, P; Thornburg, KL; Wang, RK; Rugonyi, S				Liu, Aiping; Yin, Xin; Shi, Liang; Li, Peng; Thornburg, Kent L.; Wang, Ruikang; Rugonyi, Sandra			Biomechanics of the Chick Embryonic Heart Outflow Tract at HH18 Using 4D Optical Coherence Tomography Imaging and Computational Modeling	PLOS ONE			English	Article							BLOOD-FLOW; SECONDARY HEART; SHEAR-STRESS; STRAIN; WALL; MYOCARDIUM; PROLIFERATION; PATTERNS; VELOCITY; GROWTH	During developmental stages, biomechanical stimuli on cardiac cells modulate genetic programs, and deviations from normal stimuli can lead to cardiac defects. Therefore, it is important to characterize normal cardiac biomechanical stimuli during early developmental stages. Using the chicken embryo model of cardiac development, we focused on characterizing biomechanical stimuli on the Hamburger-Hamilton (HH) 18 chick cardiac outflow tract (OFT), the distal portion of the heart from which a large portion of defects observed in humans originate. To characterize biomechanical stimuli in the OFT, we used a combination of in vivo optical coherence tomography (OCT) imaging, physiological measurements and computational fluid dynamics (CFD) modeling. We found that, at HH18, the proximal portion of the OFT wall undergoes larger circumferential strains than its distal portion, while the distal portion of the OFT wall undergoes larger wall stresses. Maximal wall shear stresses were generally found on the surface of endocardial cushions, which are protrusions of extracellular matrix onto the OFT lumen that later during development give rise to cardiac septa and valves. The non-uniform spatial and temporal distributions of stresses and strains in the OFT walls provide biomechanical cues to cardiac cells that likely aid in the extensive differential growth and remodeling patterns observed during normal development.	[Liu, Aiping] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA; [Yin, Xin; Shi, Liang; Rugonyi, Sandra] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Li, Peng; Wang, Ruikang] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Thornburg, Kent L.] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97201 USA	University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; University of Washington; University of Washington Seattle; Oregon Health & Science University	Liu, AP (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA.	rugonyis@ohsu.edu	Rugonyi, Sandra/AAF-9269-2020; Wang, Ruikang/L-3889-2019; Li, Peng/H-7290-2017	Wang, Ruikang/0000-0001-5169-8822; Li, Peng/0000-0002-9652-2369	National Institutes of Health [HL094570]; National Science Foundation [DBI-1052688]; American Heart Association [0910093G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health HL094570 (SR), National Science Foundation DBI-1052688 (SR) and a predoctoral fellowship from American Heart Association 0910093G (AL). The content is solely the responsibility of the authors and does not necessarily represent the official views of grant giving bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartman T, 2005, DEV DYNAM, V233, P373, DOI 10.1002/dvdy.20367; Boppart SA, 2000, METH MOL B, V135, P217; Bruhn A, 2005, INT J COMPUT VISION, V61, P211, DOI 10.1023/B:VISI.0000045324.43199.43; Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684; Clark E B, 1978, Birth Defects Orig Artic Ser, V14, P431; CLARK EB, 1986, AM J PHYSIOL, V250, pH407, DOI 10.1152/ajpheart.1986.250.3.H407; COHEN LD, 1993, IEEE T PATTERN ANAL, V15, P1131, DOI 10.1109/34.244675; Damon BJ, 2009, DEV DYNAM, V238, P1535, DOI 10.1002/dvdy.21958; Dancu MB, 2004, ARTERIOSCL THROM VAS, V24, P2088, DOI 10.1161/01.ATV.0000143855.85343.0e; Filas BA, 2007, ANAT REC, V290, P1057, DOI 10.1002/ar.20575; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Garita B, 2011, AM J PHYSIOL-HEART C, V300, pH879, DOI 10.1152/ajpheart.00433.2010; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HU N, 1995, AM J PHYSIOL-HEART C, V269, pH1359, DOI 10.1152/ajpheart.1995.269.4.H1359; HU N, 1989, CIRC RES, V65, P1665, DOI 10.1161/01.RES.65.6.1665; ICARDO JM, 1989, ANAT REC, V225, P150, DOI 10.1002/ar.1092250210; Jenkins MW, 2007, OPT EXPRESS, V15, P6251, DOI 10.1364/OE.15.006251; Johnston PM, 1954, AM J PHYSIOL, V180, P361; KELLER BB, 1991, CIRC RES, V68, P226, DOI 10.1161/01.RES.68.1.226; LEATHERBURY L, 1991, PEDIATR RES, V30, P509, DOI 10.1203/00006450-199112000-00002; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; LIN IE, 1995, J BIOMECH ENG-T ASME, V117, P343, DOI 10.1115/1.2794190; Liu AP, 2011, COMPUT STRUCT, V89, P855, DOI 10.1016/j.compstruc.2011.03.003; Liu AP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3184462; Ma ZH, 2010, BIOMED OPT EXPRESS, V1, P798, DOI 10.1364/BOE.1.000798; Manner J, 2008, DEV DYNAM, V237, P953, DOI 10.1002/dvdy.21483; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; Martinsen BJ, 2005, DEV DYNAM, V233, P1217, DOI 10.1002/dvdy.20468; Miller CE, 2000, IN VITRO CELL DEV-AN, V36, P633; Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X; Oosterbaan AM, 2009, ULTRASOUND OBST GYN, V33, P638, DOI 10.1002/uog.6362; PATTEN BM, 1948, ANAT REC, V102, P299, DOI 10.1002/ar.1091020305; Pexieder T, 1970, J Fla Med Assoc, V57, P46; Poelma C, 2009, J R SOC INTERFACE; Poelmann RE, 2008, MED BIOL ENG COMPUT, V46, P479, DOI 10.1007/s11517-008-0304-4; Qayyum SR, 2001, ANAT RECORD, V264, P273, DOI 10.1002/ar.1162; Qiu YC, 2000, J VASC RES, V37, P147, DOI 10.1159/000025726; Rana MS, 2007, CIRC RES, V100, P1000, DOI 10.1161/01.RES.0000262688.14288.b8; Rothenberg Florence, 2003, Birth Defects Research, V69, P38, DOI 10.1002/bdrc.10007; Rugonyi S, 2008, PHYS MED BIOL, V53, P5077, DOI 10.1088/0031-9155/53/18/015; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; Sedmera D, 1997, ANAT RECORD, V248, P421; Sedmera D, 2011, DEV DYNAM, V240, P1322, DOI 10.1002/dvdy.22650; TABER LA, 1993, CIRC RES, V72, P455, DOI 10.1161/01.RES.72.2.455; Taber LA, 2001, J BIOMECH ENG-T ASME, V123, P528, DOI 10.1115/1.1412451; Taber LA, 2000, J ELASTICITY, V61, P165, DOI 10.1023/A:1011082712497; Van der Heiden K, 2006, DEV DYNAM, V235, P19, DOI 10.1002/dvdy.20557; Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Xu C, 2004, BIORHEOLOGY, V41, P113; YANG M, 1994, J BIOMECH ENG-T ASME, V116, P213, DOI 10.1115/1.2895722; ZHAO SM, 1995, ARTERIOSCL THROM VAS, V15, P1781, DOI 10.1161/01.ATV.15.10.1781	57	51	51	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40869	10.1371/journal.pone.0040869	http://dx.doi.org/10.1371/journal.pone.0040869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844414	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700020
J	Rabosky, ARD; Corl, A; Liwanag, HEM; Surget-Groba, Y; Sinervo, B				Rabosky, Alison R. Davis; Corl, Ammon; Liwanag, Heather E. M.; Surget-Groba, Yann; Sinervo, Barry			Direct Fitness Correlates and Thermal Consequences of Facultative Aggregation in a Desert Lizard	PLOS ONE			English	Article							CLIMATE-CHANGE; XANTUSIA-VIGILIS; SOCIAL-BEHAVIOR; LIFE-HISTORY; EVOLUTION; EUSOCIALITY; DISPERSAL; BENEFITS; RELATEDNESS; PHILOPATRY	Social aggregation is a common behavioral phenomenon thought to evolve through adaptive benefits to group living. Comparing fitness differences between aggregated and solitary individuals in nature - necessary to infer an evolutionary benefit to living in groups - has proven difficult because communally-living species tend to be obligately social and behaviorally complex. However, these differences and the mechanisms driving them are critical to understanding how solitary individuals transition to group living, as well as how and why nascent social systems change over time. Here we demonstrate that facultative aggregation in a reptile (the Desert Night Lizard, Xantusia vigilis) confers direct reproductive success and survival advantages and that thermal benefits of winter huddling disproportionately benefit small juveniles, which can favor delayed dispersal of offspring and the formation of kin groups. Using climate projection models, however, we estimate that future aggregation in night lizards could decline more than 50% due to warmer temperatures. Our results support the theory that transitions to group living arise from direct benefits to social individuals and offer a clear mechanism for the origin of kin groups through juvenile philopatry. The temperature dependence of aggregation in this and other taxa suggests that environmental variation may be a powerful but underappreciated force in the rapid transition between social and solitary behavior.	[Rabosky, Alison R. Davis; Corl, Ammon; Liwanag, Heather E. M.; Surget-Groba, Yann; Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Rabosky, Alison R. Davis] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Rabosky, Alison R. Davis] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Rabosky, Alison R. Davis] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Corl, Ammon] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Liwanag, Heather E. M.] Adelphi Univ, Dept Biol, Garden City, NY 11530 USA; [Surget-Groba, Yann] Xishuangbanna Trop Bot Garden, Ecol Evolut Grp, Mengla, Yunnan, Peoples R China	University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Uppsala University; Adelphi University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Rabosky, ARD (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	ardr@umich.edu	; Surget-Groba, Yann/K-4917-2012	Liwanag, Heather/0000-0003-3250-2542; Surget-Groba, Yann/0000-0001-7612-4892	American Museum of Natural History; American Society of Ichthyologists and Herpetologists; United States Department of Education; NSF [DBI-09060346]	American Museum of Natural History; American Society of Ichthyologists and Herpetologists; United States Department of Education(US Department of Education); NSF(National Science Foundation (NSF))	This research was funded by grants from the American Museum of Natural History, the American Society of Ichthyologists and Herpetologists, the United States Department of Education, and NSF (DBI-09060346) to ARDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; Agnarsson I, 2006, EVOLUTION, V60, P2342; Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; ARNOLD W, 1988, J COMP PHYSIOL B, V158, P151, DOI 10.1007/BF01075828; Aviles L, 2007, AM NAT, V170, P783, DOI 10.1086/521965; Berteaux D, 1996, OIKOS, V76, P330, DOI 10.2307/3546205; Cahan SH, 2002, OIKOS, V96, P206, DOI 10.1034/j.1600-0706.2002.960202.x; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Davis AR, 2012, BEHAV ECOL, V23, P18, DOI 10.1093/beheco/arr144; Davis AR, 2011, P ROY SOC B-BIOL SCI, V278, P1507, DOI 10.1098/rspb.2010.1703; Davis Alison R., 2007, Herpetological Review, V38, P402; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Eikenaar C, 2007, BEHAV ECOL, V18, P874, DOI 10.1093/beheco/arm047; Elfstrom BEO, 1999, J HERPETOL, V33, P240, DOI 10.2307/1565721; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Field J, 2010, CURR BIOL, V20, P2028, DOI 10.1016/j.cub.2010.10.020; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hatchwell BJ, 2009, PHILOS T R SOC B, V364, P3217, DOI 10.1098/rstb.2009.0109; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; HINES J E, 1989, U S Fish and Wildlife Service Fish and Wildlife Technical Report, P1; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Hunt JH, 1999, EVOLUTION, V53, P225, DOI 10.1111/j.1558-5646.1999.tb05348.x; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Jones TC, 2002, BEHAV ECOL, V13, P142, DOI 10.1093/beheco/13.1.142; KAUFMANN JS, 1989, PHYSIOL ZOOL, V62, P1047, DOI 10.1086/physzool.62.5.30156195; Krause J, 2002, LIVING GROUPS; MILLER MR, 1951, COPEIA, P114; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Okasha S, 2010, NATURE, V467, P653, DOI 10.1038/467653a; Rabosky DL, 2009, NATURE, V457, P183, DOI 10.1038/nature07435; Shah B, 2003, BEHAVIOUR, V140, P1039, DOI 10.1163/156853903322589632; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Voituron Y, 2002, J COMP PHYSIOL B, V172, P71; Wcislo WT, 1997, TRENDS ECOL EVOL, V12, P468, DOI 10.1016/S0169-5347(97)01198-1; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson E.O., 1975, P1; ZWEIFEL RICHARD G., 1966, AMER MUS NOVI TATES, V2247, P1	45	21	23	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40866	10.1371/journal.pone.0040866	http://dx.doi.org/10.1371/journal.pone.0040866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844413	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700019
J	Schulz, MA; Schmalbach, B; Brugger, P; Witt, K				Schulz, Marc-Andre; Schmalbach, Barbara; Brugger, Peter; Witt, Karsten			Analysing Humanly Generated Random Number Sequences: A Pattern-Based Approach	PLOS ONE			English	Article							PARKINSONS-DISEASE	In a random number generation task, participants are asked to generate a random sequence of numbers, most typically the digits 1 to 9. Such number sequences are not mathematically random, and both extent and type of bias allow one to characterize the brain's "internal random number generator". We assume that certain patterns and their variations will frequently occur in humanly generated random number sequences. Thus, we introduce a pattern-based analysis of random number sequences. Twenty healthy subjects randomly generated two sequences of 300 numbers each. Sequences were analysed to identify the patterns of numbers predominantly used by the subjects and to calculate the frequency of a specific pattern and its variations within the number sequence. This pattern analysis is based on the Damerau-Levenshtein distance, which counts the number of edit operations that are needed to convert one string into another. We built a model that predicts not only the next item in a humanly generated random number sequence based on the item's immediate history, but also the deployment of patterns in another sequence generated by the same subject. When a history of seven items was computed, the mean correct prediction rate rose up to 27% (with an individual maximum of 46%, chance performance of 11%). Furthermore, we assumed that when predicting one subject's sequence, predictions based on statistical information from the same subject should yield a higher success rate than predictions based on statistical information from a different subject. When provided with two sequences from the same subject and one from a different subject, an algorithm identifies the foreign sequence in up to 88% of the cases. In conclusion, the pattern-based analysis using the Levenshtein-Damarau distance is both able to predict humanly generated random number sequences and to identify person-specific information within a humanly generated random number sequence.	[Schulz, Marc-Andre] Rhein Westfal TH Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany; [Schmalbach, Barbara; Witt, Karsten] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany; [Brugger, Peter] Univ Zurich Hosp, Dept Neurol, Neuropsychol Unit, CH-8091 Zurich, Switzerland	RWTH Aachen University; University of Kiel; University of Zurich; University Zurich Hospital	Schulz, MA (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany.	k.witt@neurologie.uni-kiel.de			Felgenhauer Foundation, Germany	Felgenhauer Foundation, Germany	The study was supported by the Felgenhauer Foundation, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 1998, Q J EXP PSYCHOL-A, V51, P819, DOI 10.1080/027249898391413; Bodenmann S, 2010, SLEEP, V33, P1027, DOI 10.1093/sleep/33.8.1027; Brown RG, 1998, NEUROPSYCHOLOGIA, V36, P1355, DOI 10.1016/S0028-3932(98)00015-3; Brugger P, 1996, NEUROPSYCHOLOGIA, V34, P97, DOI 10.1016/0028-3932(95)00066-6; DAMERAU FJ, 1964, COMMUN ACM, V7, P171, DOI 10.1145/363958.363994; Daniels C, 2003, NEUROSCI LETT, V345, P25, DOI 10.1016/S0304-3940(03)00496-8; Dirnberger G, 2005, NEUROIMAGE, V25, P588, DOI 10.1016/j.neuroimage.2004.11.023; GINSBURG N, 1994, PERCEPT MOTOR SKILL, V79, P1059, DOI 10.2466/pms.1994.79.3.1059; Gottselig JM, 2006, J SLEEP RES, V15, P31, DOI 10.1111/j.1365-2869.2006.00497.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Jahanshahi M, 2000, NEUROIMAGE, V12, P713, DOI 10.1006/nimg.2000.0647; Matsukawa Y, 2006, SCAND J RHEUMATOL, V35, P295, DOI 10.1080/03009740600556027; ROSENBERG S, 1990, PSYCHOL MED, V20, P953, DOI 10.1017/S0033291700036643; Salame P, 2007, J INT NEUROPSYCH SOC, V13, P277, DOI 10.1017/S1355617707070300; Shinba T, 2000, PERCEPT MOTOR SKILL, V91, P1091, DOI 10.2466/PMS.91.7.1091-1105; Sim L H, 1993, Australas Phys Eng Sci Med, V16, P22; SPATT J, 1993, BRAIN COGNITION, V23, P231, DOI 10.1006/brcg.1993.1057; Towse JN, 1998, BRIT J PSYCHOL, V89, P77, DOI 10.1111/j.2044-8295.1998.tb02674.x; TUNE GS, 1964, PSYCHOL BULL, V61, P286, DOI 10.1037/h0048618	19	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41531	10.1371/journal.pone.0041531	http://dx.doi.org/10.1371/journal.pone.0041531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844490	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000306687700102
J	Shange, RS; Ankumah, RO; Ibekwe, AM; Zabawa, R; Dowd, SE				Shange, Raymon S.; Ankumah, Ramble O.; Ibekwe, Abasiofiok M.; Zabawa, Robert; Dowd, Scot E.			Distinct Soil Bacterial Communities Revealed under a Diversely Managed Agroecosystem	PLOS ONE			English	Article							LAND-USE CHANGE; MICROBIAL DIVERSITY; FOREST; DISTURBANCE; ECOSYSTEMS; IMPACT	Land-use change and management practices are normally enacted to manipulate environments to improve conditions that relate to production, remediation, and accommodation. However, their effect on the soil microbial community and their subsequent influence on soil function is still difficult to quantify. Recent applications of molecular techniques to soil biology, especially the use of 16S rRNA, are helping to bridge this gap. In this study, the influence of three land-use systems within a demonstration farm were evaluated with a view to further understand how these practices may impact observed soil bacterial communities. Replicate soil samples collected from the three land-use systems (grazed pine forest, cultivated crop, and grazed pasture) on a single soil type. High throughput 16S rRNA gene pyrosequencing was used to generate sequence datasets. The different land use systems showed distinction in the structure of their bacterial communities with respect to the differences detected in cluster analysis as well as diversity indices. Specific taxa, particularly Actinobacteria, Acidobacteria, and classes of Proteobacteria, showed significant shifts across the land-use strata. Families belonging to these taxa broke with notions of copio- and oligotrphy at the class level, as many of the less abundant groups of families of Actinobacteria showed a propensity for soil environments with reduced carbon/nutrient availability. Orders Actinomycetales and Solirubrobacterales showed their highest abundance in the heavily disturbed cultivated system despite the lowest soil organic carbon (SOC) values across the site. Selected soil properties ([SOC], total nitrogen [TN], soil texture, phosphodiesterase [PD], alkaline phosphatase [APA], acid phosphatase [ACP] activity, and pH) also differed significantly across land-use regimes, with SOM, PD, and pH showing variation consistent with shifts in community structure and composition. These results suggest that use of pyrosequencing along with traditional analysis of soil physiochemical properties may provide insight into the ecology of descending taxonomic groups in bacterial communities.	[Shange, Raymon S.; Ankumah, Ramble O.] Tuskegee Univ, Dept Agr & Environm Sci, Tuskegee, AL 36088 USA; [Ibekwe, Abasiofiok M.] ARS, USDA, US Salin Lab, Riverside, CA USA; [Zabawa, Robert] Tuskegee Univ, George Washington Carver Agr Expt Stn, Tuskegee, AL 36088 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA	Tuskegee University; United States Department of Agriculture (USDA); Tuskegee University	Shange, RS (corresponding author), Tuskegee Univ, Dept Agr & Environm Sci, Tuskegee, AL 36088 USA.	rshange2946@mytu.tuskegee.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Ibekwe, Abasiofiok/0000-0003-3352-759X	United States Department of Agriculture-McIntyre-Stennis Forest Service Grant [ALX-MSFSW 0219038]; United States Department of Agriculture-National Institute of Food and Agriculture Grant [ALX-SWQ 0211874]	United States Department of Agriculture-McIntyre-Stennis Forest Service Grant; United States Department of Agriculture-National Institute of Food and Agriculture Grant	The work for this publication was funded by a United States Department of Agriculture-McIntyre-Stennis Forest Service Grant (ALX-MSFSW 0219038; http://www.csrees.usda.gov/about/offices/legis/mcintirestennis.html), and a United States Department of Agriculture-National Institute of Food and Agriculture Grant (ALX-SWQ 0211874; http://www.csrees.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Acosta-Martinez V, 2006, J ENVIRON QUAL, V35, P1309, DOI 10.2134/jeq2005.0470; Acosta-Martinez V., 2010, Diversity, V2, P910; Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Brye KR, 2003, SOIL SCI SOC AM J, V67, P1405, DOI 10.2136/sssaj2003.1405; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Burke RA, 2003, J ENVIRON QUAL, V32, P198, DOI 10.2134/jeq2003.0198; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; Chong CW, 2012, POLAR BIOL, V35, P387, DOI 10.1007/s00300-011-1084-0; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dupouey JL, 2002, ECOLOGY, V83, P2978, DOI 10.1890/0012-9658(2002)083[2978:IIOPLU]2.0.CO;2; Elsgaard L, 2002, SOIL BIOL BIOCHEM, V34, P79, DOI 10.1016/S0038-0717(01)00157-2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Hart SP, 2001, J DAIRY SCI S, V84, pE170; HENDRIX PF, 1990, SUSTAINABLE AGRICULTURAL SYSTEMS, P637; Hill P, 2011, MICROB ECOL, V61, P286, DOI 10.1007/s00248-010-9752-0; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Honnay O, 2003, LANDSCAPE URBAN PLAN, V63, P241, DOI 10.1016/S0169-2046(02)00194-9; Houghton RA, 2004, GEOPHYS MONOGR SER, V153, P85, DOI 10.1029/153GM08; Ibekwe AM, 2002, FEMS MICROBIOL ECOL, V39, P183, DOI 10.1111/j.1574-6941.2002.tb00921.x; Ishak HD, 2011, SCI REP-UK, V1, DOI 10.1038/srep00204; Jacobson M.G., 2002, SMALL SCALE FOREST E, V1, P71, DOI 10.1007/s11842-002-0006-y; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; KARCHESY JJ, 1980, J AGR FOOD CHEM, V28, P222, DOI 10.1021/jf60228a061; Keller JM, 2006, SOIL SCI SOC AM J, V70, P1094, DOI 10.2136/sssaj2005.0303N; Kennedy A.C., 2006, ANN ARID ZONE, V45, P287; Kohler F, 2005, PLANT SOIL, V278, P327, DOI 10.1007/s11104-005-8809-1; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lugo AE, 1997, FOREST ECOL MANAG, V99, P9, DOI 10.1016/S0378-1127(97)00191-6; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Neher DA, 1999, AGROFOREST SYST, V45, P159, DOI 10.1023/A:1006299100678; Osborne CA, 2011, FEMS MICROBIOL ECOL, V78, P70, DOI 10.1111/j.1574-6941.2011.01105.x; Parfitt RL, 2003, BIOGEOCHEMISTRY, V66, P203, DOI 10.1023/B:BIOG.0000005324.37711.63; Parham JA, 2003, BIOL FERT SOILS, V38, P209, DOI 10.1007/s00374-003-0657-7; Patra AK, 2005, ECOL MONOGR, V75, P65, DOI 10.1890/03-0837; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Saul-Tcherkas V, 2011, MICROB ECOL, V61, P64, DOI 10.1007/s00248-010-9763-x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Selvakumar G., 2007, Indian Journal of Microbiology, V47, P267, DOI 10.1007/s12088-007-0049-z; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Torsvik V, 1998, J BIOTECHNOL, V64, P53, DOI 10.1016/S0168-1656(98)00103-5; TSIOUVARAS CN, 1989, FOREST SCI, V35, P1125; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; WARDLE DA, 1995, PLANT SOIL, V170, P35, DOI 10.1007/BF02183053	60	97	97	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40338	10.1371/journal.pone.0040338	http://dx.doi.org/10.1371/journal.pone.0040338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844402	Green Published, gold			2022-12-27	WOS:000306687700011
J	Zarate, S; Jaita, G; Ferraris, J; Eijo, G; Magri, ML; Pisera, D; Seilicovich, A				Zarate, Sandra; Jaita, Gabriela; Ferraris, Jimena; Eijo, Guadalupe; Magri, Maria L.; Pisera, Daniel; Seilicovich, Adriana			Estrogens Induce Expression of Membrane-Associated Estrogen Receptor alpha Isoforms in Lactotropes	PLOS ONE			English	Article							PLASMA-MEMBRANE; PROLACTIN-RELEASE; GENE-EXPRESSION; PITUITARY-CELLS; ER-ALPHA; ESTRADIOL; 17-BETA-ESTRADIOL; PROGESTERONE; MECHANISM; APOPTOSIS	Estrogens are key to anterior pituitary function, stimulating hormone release and controlling cell fate to achieve pituitary dynamic adaptation to changing physiological conditions. In addition to their classical mechanism of action through intracellular estrogen receptors (ERs), estrogens exert rapid actions via cell membrane-localized ERs (mERs). We previously showed that E2 exerts a rapid pro-apoptotic action in anterior pituitary cells, especially in lactotropes and somatotropes, through activation of mERs. In the present study, we examined the involvement of mER alpha in the rapid pro-apoptotic action of estradiol by TUNEL in primary cultures of anterior pituitary cells from ovariectomized rats using a cell-impermeable E2 conjugate (E2-BSA) and an ER alpha selective antagonist (MPP dihydrochloride). We studied mER alpha expression during the estrous cycle and its regulation by gonadal steroids in vivo by flow cytometry. We identified ER alpha variants in the plasma membrane of anterior pituitary cells during the estrous cycle and studied E2 regulation of these mER alpha variants in vitro by surface biotinylation and Western Blot. E2-BSA-induced apoptosis was abrogated by MPP in total anterior pituitary cells and lactotropes. In cycling rats, we detected a higher number of lactotropes and a lower number of somatotropes expressing mER alpha at proestrus than at diestrus. Acute E2 treatment increased the percentage of mER alpha-expressing lactotropes whereas it decreased the percentage of mER alpha-expressing somatotropes. We detected three mER alpha isoforms of 66, 39 and 22 kDa. Expression of mER alpha 66 and mER alpha 39 was higher at proestrus than at diestrus, and short-term E2 incubation increased expression of these two mER alpha variants. Our results indicate that the rapid apoptotic action exerted by E2 in lactotropes depends on mER alpha, probably full-length ER alpha and/or a 39 kDa ER alpha variant. Expression and activation of mER alpha variants in lactotropes could be one of the mechanisms through which E2 participates in anterior pituitary cell renewal during the estrous cycle.	[Zarate, Sandra; Jaita, Gabriela; Ferraris, Jimena; Eijo, Guadalupe; Magri, Maria L.; Pisera, Daniel; Seilicovich, Adriana] Univ Buenos Aires, Fac Med, Inst Invest Biomed, Buenos Aires, DF, Argentina	University of Buenos Aires	Zarate, S (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed, Buenos Aires, DF, Argentina.	adyseili@fmed.uba.ar		Ferraris, Jimena/0000-0001-7472-0439; JAITA, GABRIELA/0000-0002-6513-0514	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2009-53]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 0159]; Universidad de Buenos Aires [UBACyT M067, M054]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This study was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2009-53), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 0159) and Universidad de Buenos Aires (UBACyT M067 and M054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Alyea RA, 2008, J NEUROCHEM, V106, P1525, DOI 10.1111/j.1471-4159.2008.05491.x; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009; BRANN DW, 1988, BIOL REPROD, V39, P1067, DOI 10.1095/biolreprod39.5.1067; Bulayeva NN, 2005, AM J PHYSIOL-ENDOC M, V288, pE388, DOI 10.1152/ajpendo.00349.2004; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; CARONTI B, 1993, TUMOR BIOL, V14, P59, DOI 10.1159/000217826; Castrique E, 2010, J ENDOCRINOL, V205, P49, DOI 10.1677/JOE-09-0414; Childs G. V., 2002, Archives of Physiology and Biochemistry, V110, P42, DOI 10.1076/apab.110.1.42.906; Childs GV, 2000, TRENDS ENDOCRIN MET, V11, P168, DOI 10.1016/S1043-2760(00)00252-6; Childs GV, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1483; CHO BN, 1993, MOL CELL ENDOCRINOL, V93, P47, DOI 10.1016/0303-7207(93)90138-A; Christian HC, 2002, J PHYSIOL-LONDON, V539, P557, DOI 10.1113/jphysiol.2001.012947; Davis TL, 2011, BIOL REPROD, V85, P770, DOI 10.1095/biolreprod.111.091926; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Dominguez R, 2010, J NEUROSCI, V30, P12589, DOI 10.1523/JNEUROSCI.1038-10.2010; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Gabriel L, 2009, JOVE, V34, DOI 10.3791/1669; GEFFROYROISNE S, 1992, ENDOCRINOLOGY, V131, P1503, DOI 10.1210/en.131.3.1503; Gonzalez M, 2008, GEN COMP ENDOCR, V155, P857, DOI 10.1016/j.ygcen.2007.10.007; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Gutierrez S, 2008, STEROIDS, V73, P515, DOI 10.1016/j.steroids.2008.01.002; Gutierrez S, 2012, MOL CELL ENDOCRINOL, V355, P169, DOI 10.1016/j.mce.2012.02.008; Hart SA, 2007, J NEUROSCI, V27, P2102, DOI 10.1523/JNEUROSCI.5436-06.2007; Heberden C, 2006, INT J BIOCHEM CELL B, V38, P376, DOI 10.1016/j.biocel.2005.09.006; Jaita G, 2011, ENDOCRINE, V39, P21, DOI 10.1007/s12020-010-9407-4; Jeng YJ, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-61; JENSEN EV, 1962, RECENT PROG HORM RES, V18, P387; Kawashima K, 2002, ENDOCRINOLOGY, V143, P2750, DOI 10.1210/en.143.7.2750; Kim KH, 2011, MOL BIOL CELL, V22, P4415, DOI 10.1091/mbc.E11-05-0416; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; McDevitta MA, 2008, MOL CELL ENDOCRINOL, V290, P24, DOI 10.1016/j.mce.2008.04.003; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Mitchner NA, 1998, ENDOCRINOLOGY, V139, P3976, DOI 10.1210/en.139.9.3976; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Muppidi J, 2004, CURRENT PROTOCOLS IM, P452; Norfleet AM, 2000, FASEB J, V14, P157, DOI 10.1096/fasebj.14.1.157; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Piroli GG, 1996, NEUROENDOCRINOLOGY, V63, P530, DOI 10.1159/000127082; Pisera D, 2004, AM J PHYSIOL-ENDOC M, V287, pE767, DOI 10.1152/ajpendo.00052.2004; Qiu J, 2006, J NEUROSCI, V26, P5649, DOI 10.1523/JNEUROSCI.0327-06.2006; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sanchez-Cardenas C, 2010, P NATL ACAD SCI USA, V107, P21878, DOI 10.1073/pnas.1010849107; Sarkar DK, 2006, FRONT HORM RES, V35, P32, DOI 10.1159/000094307; Schaeffer M, 2011, ENDOCRINOLOGY, V152, P4789, DOI 10.1210/en.2011-1430; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Shupnik MA, 2002, J NEUROENDOCRINOL, V14, P85, DOI 10.1046/j.0007-1331.2001.00744.x; Sosa LDV, 2012, AM J PHYSIOL-ENDOC M, V302, pE1189, DOI 10.1152/ajpendo.00408.2011; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Taylor SE, 2010, CANCER LETT, V288, P133, DOI 10.1016/j.canlet.2009.06.017; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Watson CS, 2008, FASEB J, V22, P3328, DOI 10.1096/fj.08-107672; Watson CS, 2002, STEROIDS, V67, P429, DOI 10.1016/S0039-128X(01)00172-6; Yin P, 2002, NEUROENDOCRINOLOGY, V76, P272, DOI 10.1159/000066626; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zarate S, 2010, FRONT HORM RES, V38, P25, DOI 10.1159/000318491; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR130, DOI 10.1186/bcr959	66	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41299	10.1371/journal.pone.0041299	http://dx.doi.org/10.1371/journal.pone.0041299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844453	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700065
J	Zhuo, WL; Zhang, L; Zhu, B; Ling, JJ; Chen, ZT				Zhuo, Wenlei; Zhang, Liang; Zhu, Bo; Ling, Junjun; Chen, Zhengtang			Association of MDM2 SNP309 Variation with Lung Cancer Risk: Evidence from 7196 Cases and 8456 Controls	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; ACCELERATES TUMOR-FORMATION; GENETIC POLYMORPHISMS; CIGARETTE-SMOKING; 309T-GREATER-THAN-G POLYMORPHISM; P53-INDEPENDENT ROLE; DNA-DAMAGE; P53; SUSCEPTIBILITY; PROMOTER	Background: Evidence suggests that MDM2 T309G polymorphism may be a risk factor for several cancers. Increasing investigations have been conducted on the association of MDM2 T309G polymorphisms with lung cancer risk and have yielded conflicting results. Previous meta-analyses on this issue have reported inconclusive data. The aim of the present study was to derive a more precise estimation of the relationship. Methods and Findings: Updated meta-analyses examining the association between MDM2 T309G polymorphism and lung cancer risk were performed. Separate analyses on ethnicity, smoking status, histological types and gender as well as source of controls were also implemented. Eligible studies were identified for the period up to Feb 2012. Lastly, ten publications including eleven case-control studies were selected for analysis. The overall data failed to indicate a significant association between MDM2 T309G polymorphism and lung cancer risk (GG vs TT OR = 1.14; 95% CI = 0.95-1.37; dominant model: OR = 1.05; 95% CI = 0.92-1.19; recessive model: OR = 1.12; 95% CI = 0.99-1.27). In a subgroup analysis by smoking status, increased lung cancer risk was shown among never-smokers (GG vs TT: OR = 1.76; 95% CI = 1.36-2.29; dominant model: OR = 1.48; 95% CI = 1.2-21.81; recessive model: OR = 1.37; 95% CI = 1.11-1.69). In subgroup analysis by gender, elevated risk was presented among women under a recessive model (OR = 1.29; 95% CI = 1.04-1.59). In the subgroup analysis by ethnicity, histological types and source of controls, no marked associations were observed. Conclusions: Compared to the previous meta-analyses, the results of this study confirmed that MDM2 T309G polymorphism might be a risk factor for lung cancer among never-smokers. However, the data failed to suggest a marked association between the G allele of MDM2 T309G and lung cancer risk among Asians. More interestingly, subgroup analysis by gender indicated that homozygous GG alleles might raise lung cancer risk among females.	[Zhuo, Wenlei; Zhu, Bo; Chen, Zhengtang] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China; [Zhang, Liang] Third Mil Med Univ, Coll Prevent Med, Dept Environm Hyg, Chongqing, Peoples R China; [Ling, Junjun] Third Mil Med Univ, Southwest Hosp, Dept Otolaryngol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Zhuo, WL (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China.	zhuowenlei@yahoo.com.cn; cztsyd@yahoo.com						Ahn MJ, 2012, HUM GENET, V131, P365, DOI 10.1007/s00439-011-1080-z; Bai JL, 2009, J TOXICOL ENV HEAL A, V72, P677, DOI 10.1080/15287390902840930; Bogush TA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1421, DOI 10.1134/S0006297910120011; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Cai X, 2011, J CANC RES CLIN ONCO; Cao C, 2011, CHINESE MED J-PEKING, V124, P2203, DOI 10.3760/cma.j.issn.0366-6999.2011.14.022; Carlsten C, 2008, AM J EPIDEMIOL, V167, P759, DOI 10.1093/aje/kwm383; Chaar I, 2012, EUR J GASTROEN HEPAT, V24, P320, DOI 10.1097/MEG.0b013e32834bdf84; Charloux A, 1997, LUNG CANCER, V16, P133, DOI 10.1016/S0169-5002(96)00623-X; Chen B, 2010, LUNG CANCER, V70, P247, DOI 10.1016/j.lungcan.2010.03.011; Chien WP, 2010, ANN SURG ONCOL, V17, P1194, DOI 10.1245/s10434-009-0853-2; Chua HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-88; Cohen SBZ, 2007, AM J RESP CRIT CARE, V176, P113, DOI 10.1164/rccm.20011-1655PP; Cui D, 2011, LUNG CANCER, V73, P153, DOI 10.1016/j.lungcan.2010.12.012; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong HJ, 2012, INT J CANCER, V130, P2054, DOI 10.1002/ijc.26222; Dong J, 2011, MOL CARCINOGEN, V50, P433, DOI 10.1002/mc.20727; Economopoulos KP, 2010, BREAST CANCER RES TR, V120, P211, DOI 10.1007/s10549-009-0467-1; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fucic A, 2010, TOXICOL PATHOL, V38, P849, DOI 10.1177/0192623310378136; Gajjar M, 2012, CANCER CELL, V21, P25, DOI 10.1016/j.ccr.2011.11.016; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Gui XH, 2009, EUR J CANCER, V45, P2023, DOI 10.1016/j.ejca.2009.02.002; Hamard PJ, 2012, CANCER CELL, V21, P3, DOI 10.1016/j.ccr.2011.12.018; Han JY, 2008, CANCER-AM CANCER SOC, V113, P799, DOI 10.1002/cncr.23668; Heist RS, 2007, J CLIN ONCOL, V25, P2243, DOI 10.1200/JCO.2006.08.8914; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Hu ZB, 2006, INT J CANCER, V118, P1275, DOI 10.1002/ijc.21463; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jaboin JJ, 2011, UROL ONCOL-SEMIN ORI, V29, P319, DOI 10.1016/j.urolonc.2009.03.031; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jun HJ, 2007, MOL CARCINOGEN, V46, P100, DOI 10.1002/mc.20279; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li GJ, 2006, CARCINOGENESIS, V27, P2028, DOI 10.1093/carcin/bgl047; Li Y, 2011, HUM CELL, V24, P57, DOI 10.1007/s13577-011-0013-4; Li Y, 2009, LUNG CANCER, V66, P15, DOI 10.1016/j.lungcan.2008.12.009; Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872; Liu G, 2008, INT J CANCER, V122, P915, DOI 10.1002/ijc.23178; Liu GY, 2011, ARCH MED RES, V42, P149, DOI 10.1016/j.arcmed.2011.02.002; Liu J, 2011, ASIAN PAC J CANCER P, V12, P1899; Liu L, 2011, J THORAC ONCOL, V6, P1793, DOI 10.1097/JTO.0b013e3182272273; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mittelstrass K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-113; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; Park SH, 2006, LUNG CANCER, V54, P19, DOI 10.1016/j.lungcan.2006.06.008; Pauk N, 2005, LUNG CANCER, V48, P1, DOI 10.1016/j.lungcan.2004.10.009; Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pine SR, 2006, CANCER EPIDEM BIOMAR, V15, P1559, DOI 10.1158/1055-9965.EPI-06-0217; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; SATO S, 1994, CANCER RES, V54, P5652; Shi JX, 2012, CANCER DISCOV, V2, P131, DOI 10.1158/2159-8290.CD-11-0246; Steliga MA, 2011, SURG ONCOL CLIN N AM, V20, P605, DOI 10.1016/j.soc.2011.07.003; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Verma MK, 2011, J STEROID BIOCHEM, V127, P216, DOI 10.1016/j.jsbmb.2011.07.013; Wang J, 2011, INT J IMMUNOGENET, V38, P311, DOI 10.1111/j.1744-313X.2011.01014.x; Wang JJ, 2011, EUR J CANCER PREV, V20, P445, DOI 10.1097/CEJ.0b013e328345f937; Wang WC, 2012, HUM GENET; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu H, 2011, CELL CYCLE, V10, P1912, DOI 10.4161/cc.10.12.15882; Yokota J, 2010, ADV CANCER RES, V109, P51, DOI 10.1016/B978-0-12-380890-5.00002-8; Zhang XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/humu.20277	71	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41546	10.1371/journal.pone.0041546	http://dx.doi.org/10.1371/journal.pone.0041546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844496	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700108
J	Li, SY; Spooner, RA; Hampton, RY; Lord, JM; Roberts, LM				Li, Shuyu; Spooner, Robert A.; Hampton, Randolph Y.; Lord, J. Michael; Roberts, Lynne M.			Cytosolic Entry of Shiga-Like Toxin A Chain from the Yeast Endoplasmic Reticulum Requires Catalytically Active Hrd1p	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; PROTEIN DISULFIDE-ISOMERASE; RICIN A-CHAIN; O-MANNOSYLATION; CHOLERA-TOXIN; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; UBIQUITIN-LIGASE; A(1) DOMAIN; EUKARYOTIC RIBOSOMES	Background: Escherichia coli Shiga-like toxin 1 normally traffics to the endoplasmic reticulum (ER) in sensitive mammalian cells from where the catalytic A chain (SLTxA1) dislocates to the cytosol to inactivate ribosomes. Currently, no molecular details of the dislocation process are available. To investigate the mechanism of the dislocation step we expressed SLTxA1 in the ER of Saccharomyces cerevisiae. Methodology and Principal Findings: Using a combination of growth studies and biochemical tracking in yeast knock-out strains we show that SLTxA1 follows an ER-associated degradation (ERAD) pathway to enter the cytosol in a step mediated by the transmembrane Hrd1p ubiquitin ligase complex. ER-to-cytosol dislocation of the bulk population of SLTxA1 requires Cdc48p and its ubiquitin-handling co-factor Npl4p, and this population of toxin is terminally dispatched by proteasomal degradation. A small sub-population of SLTxA1 uncouples from this classical ERAD pathway and recovers catalytic activity in the cytosol. The pathway that leads to toxicity is also Hrd1p-dependent but, unlike that for the related ricin A chain toxin, SLTxA1 dislocation does require the catalytic cysteine of Hrd1p. However it does not depend on canonical ubiquitylation since toxin variants lacking endogenous lysyl residues also utilize this pathway, and furthermore there is no requirement for a number of Cdc48p co-factors. Conclusions and Significance: The fraction of SLTxA1 that disengages from the ERAD pathway thus does so upstream of Cdc48p interactions and downstream of Hrd1p interactions, in a step that possibly involves de-ubiquitylation. Mechanistically therefore, the dislocation of this toxin is quite distinct from that of conventional ERAD substrates that are normally degraded, and the toxins partially characterised to date that do not require the catalytic cysteine of the major Hrd1p component of the dislocation apparatus.	[Li, Shuyu; Spooner, Robert A.; Lord, J. Michael; Roberts, Lynne M.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Hampton, Randolph Y.] Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of Warwick; University of California System; University of California San Diego	Li, SY (corresponding author), Univ Dundee, Coll Life Sci, Dundee, Scotland.	Lynne.Roberts@warwick.ac.uk	Spooner, Robert/A-9870-2010	Spooner, Robert/0000-0001-9593-0195	Wellcome Trust [080566/Z/06/Z]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051996] Funding Source: NIH RePORTER; Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the Wellcome Trust (Program Grant number 080566/Z/06/Z) http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Aletrari MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022713; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Duriez M, 2008, J BIOL CHEM, V283, P32352, DOI 10.1074/jbc.M807178200; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; ENDO Y, 1987, J BIOL CHEM, V262, P5908; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Falguieres T, 2006, BIOL CELL, V98, P125, DOI 10.1042/BC20050001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; GARRED O, 1995, J BIOL CHEM, V270, P10817; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Goder V, 2008, FEBS LETT, V582, P1575, DOI 10.1016/j.febslet.2008.03.056; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; Menikh A, 1997, BIOCHEMISTRY-US, V36, P15865, DOI 10.1021/bi970944+; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Plemper RK, 1999, J CELL SCI, V112, P4123; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Redmann V, 2011, J BIOL CHEM, V286, P21231, DOI 10.1074/jbc.M111.234708; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Saleh MT, 1996, BIOCHEMISTRY-US, V35, P9325, DOI 10.1021/bi960177z; SANDVIG K, 1994, J CELL BIOL, V126, P53, DOI 10.1083/jcb.126.1.53; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Spooner RA, 2011, CURR TOP MICROBIOL I; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VOGEL JP, 1993, J BIOL CHEM, V268, P3040; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	81	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41119	10.1371/journal.pone.0041119	http://dx.doi.org/10.1371/journal.pone.0041119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829918	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300057
J	Pilosof, S; Dick, CW; Korine, C; Patterson, BD; Krasnov, BR				Pilosof, Shai; Dick, Carl W.; Korine, Carmi; Patterson, Bruce D.; Krasnov, Boris R.			Effects of Anthropogenic Disturbance and Climate on Patterns of Bat Fly Parasitism	PLOS ONE			English	Article							HIGH HOST-SPECIFICITY; FLIES DIPTERA; HABITAT FRAGMENTATION; NEOTROPICAL BATS; COUNT DATA; FOREST; ABUNDANCE; ECTOPARASITES; COMMUNITIES; ASSEMBLAGES	Environmental conditions, including anthropogenic disturbance, can significantly alter host and parasite communities. Yet, our current knowledge is based mainly on endoparasites, while ectoparasites remain little studied. We studied the indirect effects of anthropogenic disturbance (human population density) and climate (temperature, precipitation and elevation) on abundance of highly host-specific bat flies in four Neotropical bat species across 43 localities in Venezuela. We formulated a set of 11 a priori hypotheses that included a combination of the two effectors and host species. Statistically, each of these hypotheses was represented by a zero-inflated negative binomial mixture model, allowing us to control for excess zeros in the data. The best model was selected using Akaike's information criteria. Fly abundance was affected by anthropogenic disturbance in Artibeus planirostris, Carollia perspicillata and Pteronotus parnellii, but not Desmodus rotundus. Climate affected fly abundance in all bat species, suggesting mediation of these effects via the host or by direct effects on flies. We conclude that human disturbance may play a role in shaping bat-bat fly interactions. Different processes could determine fly abundance in the different bat species.	[Pilosof, Shai; Korine, Carmi; Krasnov, Boris R.] Ben Gurion Univ Negev, Albert Katz Int Sch Desert Studies, Swiss Inst Dryland Environm & Energy Res, Mitrani Dept Desert Ecol,Jacob Blaustein Inst Des, IL-84105 Beer Sheva, Israel; [Dick, Carl W.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Patterson, Bruce D.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA	Ben Gurion University; Western Kentucky University; Field Museum of Natural History (Chicago)	Pilosof, S (corresponding author), Ben Gurion Univ Negev, Albert Katz Int Sch Desert Studies, Swiss Inst Dryland Environm & Energy Res, Mitrani Dept Desert Ecol,Jacob Blaustein Inst Des, IL-84105 Beer Sheva, Israel.	spilosof@post.bgu.ac.il	Krasnov, Boris R./F-2234-2012; Dick, Carl/AAE-7154-2022; Patterson, Bruce D/O-5068-2019; Pilosof, Shai/AAX-8055-2020; Krasnov, Boris R./ABG-8403-2021	Krasnov, Boris R./0000-0002-0382-3331; Patterson, Bruce D/0000-0002-2249-7260; Pilosof, Shai/0000-0003-0430-5568; Krasnov, Boris R./0000-0002-0382-3331	Albert Katz International School for Desert Studies; Kreitman Fellowship for PhD students, Ben-Gurion University of the Negev	Albert Katz International School for Desert Studies; Kreitman Fellowship for PhD students, Ben-Gurion University of the Negev	SP was supported by a scholarship from the Albert Katz International School for Desert Studies and the Kreitman Fellowship for PhD students, Ben-Gurion University of the Negev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Beldomenico Pablo M, 2010, Trends Ecol Evol, V25, P21, DOI 10.1016/j.tree.2009.06.015; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Combes Claude., 2001, PARASITISM ECOLOGY E; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; Denwood MJ, 2008, PARASITOLOGY, V135, P1225, DOI 10.1017/S0031182008004708; Dick CW, 2007, ECOL ENTOMOL, V32, P446, DOI 10.1111/j.1365-2311.2007.00836.x; Dick CW, 2007, INT J PARASITOL, V37, P871, DOI 10.1016/j.ijpara.2007.02.004; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Handley C.O. Jr., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hyman G, 2000, LATIN AM POPULATION; Jackman S, 2011, PSCL CLASSES METHODS; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; King KC, 2007, PARASITOLOGY, V134, P2063, DOI 10.1017/S0031182007003277; Korallo-Vinarskaya NP, 2009, EVOL ECOL, V23, P329, DOI 10.1007/s10682-007-9229-x; Krasnov BR, 2007, OECOLOGIA, V154, P185, DOI 10.1007/s00442-007-0824-x; Krasnov BR, 2005, J BIOGEOGR, V32, P633, DOI 10.1111/j.1365-2699.2004.01206.x; Krasnov BR., 2010, BIOGEOGRAPHY HOST PA, P99; Kunz T.H., 1982, P1; Lafferty Kevin D., 2005, P113; LaVal RK, 2004, J MAMMAL, V85, P237, DOI 10.1644/BWG-016; Lebarbenchon C, 2006, ECOHEALTH, V3, P303, DOI 10.1007/s10393-006-0067-z; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Linares O., 1998, MAMIFEROS VENEZUELA; Loeys T, 2012, BRIT J MATH STAT PSY, V65, P163, DOI 10.1111/j.2044-8317.2011.02031.x; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Mbora DNM, 2009, J ANIM ECOL, V78, P210, DOI 10.1111/j.1365-2656.2008.01481.x; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Mello MAR, 2004, ACTA CHIROPTEROL, V6, P309, DOI 10.3161/001.006.0209; Merino S, 1996, ECOGRAPHY, V19, P107, DOI 10.1111/j.1600-0587.1996.tb00161.x; Munroe SEM, 2011, J PARASITOL, V97, P377, DOI 10.1645/GE-2592.1; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Patterson BD, 2008, PARASITOL RES, V103, P1091, DOI 10.1007/s00436-008-1097-y; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Patterson BD, 2009, ECOGRAPHY, V32, P481, DOI 10.1111/j.1600-0587.2008.05727.x; Poulin R, 2003, J BIOGEOGR, V30, P837, DOI 10.1046/j.1365-2699.2003.00868.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Russo D, 2010, BIODIVERS CONSERV, V19, P2501, DOI 10.1007/s10531-010-9856-3; Schulze MD, 2000, BIOTROPICA, V32, P174, DOI 10.1646/0006-3606(2000)032[0174:ACOTPB]2.0.CO;2; Stanko M, 2006, J ANIM ECOL, V75, P575, DOI 10.1111/j.1365-2656.2006.01080.x; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Taylor PD, 1996, LANDSCAPE ECOL, V11, P181, DOI 10.1007/BF02447516; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; Tinsley RC, 2011, PARASITOLOGY, V138, P1029, DOI 10.1017/S0031182011000461; Tobler W, 1997, Int J Popul Geogr, V3, P203; Valtonen ET, 2003, PARASITOLOGY, V126, pS43, DOI 10.1017/S0031182003003494; Wenzel R.L., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Willig MR, 2007, BIOTROPICA, V39, P737, DOI 10.1111/j.1744-7429.2007.00322.x; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	56	46	49	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41487	10.1371/journal.pone.0041487	http://dx.doi.org/10.1371/journal.pone.0041487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829953	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300093
J	Simoncini, D; Berenger, F; Shrestha, R; Zhang, KYJ				Simoncini, David; Berenger, Francois; Shrestha, Rojan; Zhang, Kam Y. J.			A Probabilistic Fragment-Based Protein Structure Prediction Algorithm	PLOS ONE			English	Article							MODELS; SOFTWARE; ROSETTA; SEARCH	Conformational sampling is one of the bottlenecks in fragment-based protein structure prediction approaches. They generally start with a coarse-grained optimization where mainchain atoms and centroids of side chains are considered, followed by a fine-grained optimization with an all-atom representation of proteins. It is during this coarse-grained phase that fragment-based methods sample intensely the conformational space. If the native-like region is sampled more, the accuracy of the final all-atom predictions may be improved accordingly. In this work we present EdaFold, a new method for fragment-based protein structure prediction based on an Estimation of Distribution Algorithm. Fragment-based approaches build protein models by assembling short fragments from known protein structures. Whereas the probability mass functions over the fragment libraries are uniform in the usual case, we propose an algorithm that learns from previously generated decoys and steers the search toward native-like regions. A comparison with Rosetta AbInitio protocol shows that EdaFold is able to generate models with lower energies and to enhance the percentage of near-native coarse-grained decoys on a benchmark of 20 proteins. The best coarse-grained models produced by both methods were refined into all-atom models and used in molecular replacement. All atom decoys produced out of EdaFold's decoy set reach high enough accuracy to solve the crystallographic phase problem by molecular replacement for some test proteins. EdaFold showed a higher success rate in molecular replacement when compared to Rosetta. Our study suggests that improving low resolution coarse-grained decoys allows computational methods to avoid subsequent sampling issues during all-atom refinement and to produce better all-atom models. EdaFold can be downloaded from http://www.riken.jp/zhangiru/software/.	[Simoncini, David; Berenger, Francois; Shrestha, Rojan; Zhang, Kam Y. J.] RIKEN, Zhang Initiat Res Unit, Adv Sci Inst, Wako, Saitama, Japan; [Shrestha, Rojan; Zhang, Kam Y. J.] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	RIKEN; University of Tokyo	Simoncini, D (corresponding author), RIKEN, Zhang Initiat Res Unit, Adv Sci Inst, Wako, Saitama, Japan.	kamzhang@riken.jp	Berenger, Francois/ABH-8997-2020; Simoncini, David/AAA-5204-2021; Zhang, Kam Y. J./B-3552-2012	Berenger, Francois/0000-0003-1377-944X; Simoncini, David/0000-0002-3772-5473; Zhang, Kam Y. J./0000-0002-9282-8045	Institute of Physical and Chemical Research (RIKEN)	Institute of Physical and Chemical Research (RIKEN)	This work was supported by the Initiative Research Program from The Institute of Physical and Chemical Research (RIKEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenger F, 2011, BIOINFORMATICS, V27, P939, DOI 10.1093/bioinformatics/btr072; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blum B, 2010, PROTEINS, V78, P1583, DOI 10.1002/prot.22677; Brunette TJ, 2005, BIOINFORMATICS, V21, pI66, DOI 10.1093/bioinformatics/bti1029; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; DANDEKAR T, 1992, PROTEIN ENG, V5, P637, DOI 10.1093/protein/5.7.637; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Das R, 2009, ACTA CRYSTALLOGR D, V65, P169, DOI 10.1107/S0907444908020039; Hamelryck T, 2006, PLOS COMPUT BIOL, V2, P1121, DOI 10.1371/journal.pcbi.0020131; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li SC, 2008, PROTEIN SCI, V17, P1925, DOI 10.1110/ps.036442.108; Lourenco HR, 2002, HDB METAHEURISTICS, P321, DOI DOI 10.1007/0-306-48056-5_11; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUHLENBEIN H, 1996, PARALLEL PROBLEM SOL, V4, P178, DOI DOI 10.1007/3-540-61723-X; Park Sung-Joon, 2005, Genome Inform, V16, P104; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sakae Y, 2011, J COMPUT CHEM, V32, P1353, DOI 10.1002/jcc.21716; Santana R, 2008, IEEE T EVOLUT COMPUT, V12, P418, DOI 10.1109/TEVC.2007.906095; Shmygelska A, 2009, P NATL ACAD SCI USA, V106, P1415, DOI 10.1073/pnas.0812510106; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Shrestha R, 2011, ACTA CRYSTALLOGR D, V67, P804, DOI 10.1107/S090744491102779X; Xu D, 2012, PROTEINS; Zhao F, 2008, PROTEINS, V73, P228, DOI 10.1002/prot.22057; Zhao F, 2010, BIOINFORMATICS, V26, pi310, DOI 10.1093/bioinformatics/btq193	26	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e38799	10.1371/journal.pone.0038799	http://dx.doi.org/10.1371/journal.pone.0038799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829868	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300006
J	Liu, GH; Wang, SY; Huang, WY; Zhao, GH; Wei, SJ; Song, HQ; Xu, MJ; Lin, RQ; Zhou, DH; Zhu, XQ				Liu, Guo-Hua; Wang, Shu-Yan; Huang, Wei-Yi; Zhao, Guang-Hui; Wei, Shu-Jun; Song, Hui-Qun; Xu, Min-Jun; Lin, Rui-Qing; Zhou, Dong-Hui; Zhu, Xing-Quan			The Complete Mitochondrial Genome of Galba pervia (Gastropoda: Mollusca), an Intermediate Host Snail of Fasciola spp.	PLOS ONE			English	Article							TRANSFER-RNA GENES; COMPLETE SEQUENCE; DNA-SEQUENCE; EVOLUTION; REARRANGEMENTS; ORGANIZATION; ORDER; BASOMMATOPHORA; DUPLICATION; PHYLOGENIES	Complete mitochondrial (mt) genomes and the gene rearrangements are increasingly used as molecular markers for investigating phylogenetic relationships. Contributing to the complete mt genomes of Gastropoda, especially Pulmonata, we determined the mt genome of the freshwater snail Galba pervia, which is an important intermediate host for Fasciola spp. in China. The complete mt genome of G. pervia is 13,768 bp in length. Its genome is circular, and consists of 37 genes, including 13 genes for proteins, 2 genes for rRNA, 22 genes for tRNA. The mt gene order of G. pervia showed novel arrangement (tRNA-His, tRNA-Gly and tRNA-Tyr change positions and directions) when compared with mt genomes of Pulmonata species sequenced to date, indicating divergence among different species within the Pulmonata. A total of 3655 amino acids were deduced to encode 13 protein genes. The most frequently used amino acid is Leu (15.05%), followed by Phe (11.24%), Ser (10.76%) and IIe (8.346%). Phylogenetic analyses using the concatenated amino acid sequences of the 13 protein-coding genes, with three different computational algorithms (maximum parsimony, maximum likelihood and Bayesian analysis), all revealed that the families Lymnaeidae and Planorbidae are closely related two snail families, consistent with previous classifications based on morphological and molecular studies. The complete mt genome sequence of G. pervia showed a novel gene arrangement and it represents the first sequenced high quality mt genome of the family Lymnaeidae. These novel mtDNA data provide additional genetic markers for studying the epidemiology, population genetics and phylogeographics of freshwater snails, as well as for understanding interplay between the intermediate snail hosts and the intra-mollusca stages of Fasciola spp..	[Liu, Guo-Hua; Wang, Shu-Yan; Zhao, Guang-Hui; Song, Hui-Qun; Xu, Min-Jun; Zhou, Dong-Hui; Zhu, Xing-Quan] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China; [Liu, Guo-Hua; Zhu, Xing-Quan] Hunan Agr Univ, Coll Vet Med, Changsha, Hunan, Peoples R China; [Wang, Shu-Yan; Huang, Wei-Yi] Guangxi Univ, Coll Anim Sci & Technol, Nanning 530004, Guangxi Zhuang, Peoples R China; [Zhao, Guang-Hui] NW A&F Univ, Coll Vet Med, Yangling, Shaanxi Provinc, Peoples R China; [Wei, Shu-Jun] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Lin, Rui-Qing] S China Agr Univ, Coll Vet Med, Parasitol Lab, Guangzhou, Guangdong, Peoples R China; [Zhu, Xing-Quan] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan Province, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Hunan Agricultural University; Guangxi University; Northwest A&F University - China; Beijing Academy of Agriculture & Forestry; South China Agricultural University; Yunnan Agricultural University	Zhu, XQ (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China.	xingquanzhu1@hotmail.com	Wei, Shu-Jun/C-1109-2011	Wei, Shu-Jun/0000-0001-7398-0968	Open Funds of the State Key Laboratory of Veterinary Etiological Biology; Lanzhou Veterinary Research Institute; Chinese Academy of Agricultural Sciences [SKLVEB2011KFKT011, SKLVEB2010KFKT009, SKLVEB2009KFKT008, SKLVEB2011KFKT010, SKLVEB2011KFKT004]; Program for Outstanding Scientists in Agricultural Research; Yunnan Provincial Program for Introducing High-level Scientists [2009CI125]; Special Funds for Talents in Northwest A F University [Z109021107, 2010BSJJ015]	Open Funds of the State Key Laboratory of Veterinary Etiological Biology; Lanzhou Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Program for Outstanding Scientists in Agricultural Research; Yunnan Provincial Program for Introducing High-level Scientists; Special Funds for Talents in Northwest A F University	This work was supported by the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant Nos. SKLVEB2011KFKT011, SKLVEB2010KFKT009, SKLVEB2009KFKT008, SKLVEB2011KFKT010 and SKLVEB2011KFKT004), the Program for Outstanding Scientists in Agricultural Research, the Yunnan Provincial Program for Introducing High-level Scientists (Grant No. 2009CI125) and the Special Funds for Talents in Northwest A & F University (Z109021107 and 2010BSJJ015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ai L, 2011, VET PARASITOL, V181, P329, DOI 10.1016/j.vetpar.2011.03.057; Alasaad S, 2011, VET PARASITOL, V179, P266, DOI 10.1016/j.vetpar.2011.01.059; Bandyopadhyay PK, 2006, TOXICON, V48, P29, DOI 10.1016/j.toxicon.2006.04.013; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BOTTGER C., 1955, ZOOL ANZ, V18, P253; Cai XQ, 2012, PARASITOL RES, V110, P235, DOI 10.1007/s00436-011-2477-2; CANTATORE P, 1987, NATURE, V329, P853, DOI 10.1038/329853a0; Catanese G, 2010, GENE, V452, P35, DOI 10.1016/j.gene.2009.12.004; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Dayrat B, 2001, MOL PHYLOGENET EVOL, V19, P225, DOI 10.1006/mpev.2001.0926; Dayrat B, 2011, MOL PHYLOGENET EVOL, V59, P425, DOI 10.1016/j.ympev.2011.02.014; DeJong RJ, 2004, J PARASITOL, V90, P991, DOI 10.1645/GE-284R; Dowton M, 2003, J MOL EVOL, V56, P517, DOI 10.1007/s00239-002-2420-3; Fahrein K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-386; Feldmeyer B, 2010, MOL PHYLOGENET EVOL, V57, P1329, DOI 10.1016/j.ympev.2010.09.012; Grande C, 2004, MOL BIOL EVOL, V21, P303, DOI 10.1093/molbev/msh016; Grande C, 2002, MOL BIOL EVOL, V19, P1672, DOI 10.1093/oxfordjournals.molbev.a003990; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; HOFFMANN RJ, 1992, GENETICS, V131, P397; Kaset C, 2010, EXP PARASITOL, V126, P482, DOI 10.1016/j.exppara.2010.05.021; Ki JS, 2009, GENE, V435, P13, DOI 10.1016/j.gene.2009.01.005; Klussmann-Kolb A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-57; Knudsen B, 2006, MOL PHYLOGENET EVOL, V38, P459, DOI 10.1016/j.ympev.2005.08.017; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Lei RH, 2010, GENE, V464, P44, DOI 10.1016/j.gene.2010.06.001; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Lin RQ, 2007, PARASITOL RES, V101, P813, DOI 10.1007/s00436-007-0512-0; Lin RQ, 2011, GENE, V480, P28, DOI 10.1016/j.gene.2011.03.004; Liu GH, 2011, MOL BIOL REP, V38, P2249, DOI 10.1007/s11033-010-0355-0; Liu YY, 1965, B BIOL FR BELG, V3, P8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paraense WL, 2003, MEM I OSWALDO CRUZ, V98, P767, DOI 10.1590/S0074-02762003000600010; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Rawlings TA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-440; Relf V, 2011, VET PARASITOL, V175, P287, DOI 10.1016/j.vetpar.2010.10.010; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Spithill TW, 1998, PARASITOL TODAY, V14, P224, DOI 10.1016/S0169-4758(98)01245-9; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023008; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yamazaki N, 1997, GENETICS, V145, P749; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yasuda N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-17; Zhang HYKF., 1999, CHIN J VET PARASTIOL, V1, P1	62	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42172	10.1371/journal.pone.0042172	http://dx.doi.org/10.1371/journal.pone.0042172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844544	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600069
J	O'Donnell, MA; Hase, H; Legarda, D; Ting, AT				O'Donnell, Marie Anne; Hase, Hidenori; Legarda, Diana; Ting, Adrian T.			NEMO Inhibits Programmed Necrosis in an NF kappa B-Independent Manner by Restraining RIP1	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; NONAPOPTOTIC CELL-DEATH; DOMAIN KINASE RIP; FACTOR-ALPHA; ACTIVATION; UBIQUITINATION; APOPTOSIS; TRAF2; PATHWAYS; INDUCTION	TNF can trigger two opposing responses: cell survival and cell death. TNFR1 activates caspases that orchestrate apoptosis but some cell types switch to a necrotic death when treated with caspase inhibitors. Several genes that are required to orchestrate cell death by programmed necrosis have been identified, such as the kinase RIP1, but very little is known about the inhibitory signals that keep this necrotic cell death pathway in check. We demonstrate that T cells lacking the regulatory subunit of IKK, NF kappa B essential modifier (NEMO), are hypersensitive to programmed necrosis when stimulated with TNF in the presence of caspase inhibitors. Surprisingly, this pro-survival activity of NEMO is independent of NF kappa B-mediated gene transcription. Instead, NEMO inhibits necrosis by binding to ubiquitinated RIP1 to restrain RIP1 from engaging the necrotic death pathway. In the absence of NEMO, or if ubiquitination of RIP1 is blocked, necrosis ensues when caspases are blocked. These results indicate that recruitment of NEMO to ubiquitinated RIP1 is a key step in the TNFR1 signaling pathway that determines whether RIP1 triggers a necrotic death response.	[O'Donnell, Marie Anne; Hase, Hidenori; Legarda, Diana; Ting, Adrian T.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	O'Donnell, MA (corresponding author), Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA.	marie.a.odonnell@mssm.edu; adrian.ting@mssm.edu			National Institutes of Health [AI052417]; New York Chapter of the Arthritis Foundation; Crohn's and Colitis Foundation of America; Irma T. Hirschl Career Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052417, R56AI052417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Chapter of the Arthritis Foundation; Crohn's and Colitis Foundation of America; Irma T. Hirschl Career Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI052417 and a grant from the New York Chapter of the Arthritis Foundation to A.T.T. M.A.O. is a recipient of a Research Fellowship Award from the Crohn's and Colitis Foundation of America. D.L. is a recipient of a Career Development Award from the Crohn's and Colitis Foundation of America. A.T.T. is a recipient of the Irma T. Hirschl Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026069; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fliss PM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002517; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Galluzzi L, 2009, CELL HOST MICROBE, V5, P107, DOI 10.1016/j.chom.2009.01.002; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; He KL, 2003, EUR J IMMUNOL, V33, P1917, DOI 10.1002/eji.200323650; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hur GM, 2006, J BIOL CHEM, V281, P25011, DOI 10.1074/jbc.M605577200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lee SY, 1998, J EXP MED, V188, P1381, DOI 10.1084/jem.188.7.1381; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Mahul-Mellier AL, 2012, CELL DEATH DIFFER, V19, P891, DOI 10.1038/cdd.2011.185; May MJ, 2007, J BIOL CHEM, V282, P16105, DOI 10.1074/jbc.M611115200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Natoli G, 1998, BIOCHEM PHARMACOL, V56, P915, DOI 10.1016/S0006-2952(98)00154-3; O'Donnell MA, 2011, NATURE CELL IN PRESS; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; O'Donnell MA, 2010, CELL CYCLE, V9, P1065, DOI 10.4161/cc.9.6.10982; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Waring P, 1999, CELL DEATH DIFFER, V6, P624, DOI 10.1038/sj.cdd.4400540; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	67	52	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41238	10.1371/journal.pone.0041238	http://dx.doi.org/10.1371/journal.pone.0041238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848449	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600017
J	Zhang, Y; Li, WZ; Ou, LL; Wang, WW; Delyagina, E; Lux, C; Sorg, H; Riehemann, K; Steinhoff, G; Ma, N				Zhang, Yue; Li, Wenzhong; Ou, Lailiang; Wang, Weiwei; Delyagina, Evgenya; Lux, Cornelia; Sorg, Heiko; Riehemann, Kristina; Steinhoff, Gustav; Ma, Nan			Targeted Delivery of Human VEGF Gene via Complexes of Magnetic Nanoparticle-Adenoviral Vectors Enhanced Cardiac Regeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACUTE MYOCARDIAL-INFARCTION; MESENCHYMAL STEM-CELLS; THERAPY; HEART; ARTERIOGENESIS; ANGIOPOIETIN-1; INJECTION; KINASE; SWINE	This study assessed the concept of whether delivery of magnetic nanobeads (MNBs)/adenoviral vectors (Ad)-encoded hVEGF gene (Ad(hVEGF)) could regenerate ischaemically damaged hearts in a rat acute myocardial infarction model under the control of an external magnetic field. Adenoviral vectors were conjugated to MNBs with the Sulfo-NHS-LC-Biotin linker. In vitro transduction efficacy of MNBs/Ad-encoded luciferase gene (Ad(luc)) was compared with Ad(luc) alone in human umbilical vein endothelial cells (HUVECs) under magnetic field stimulation. In vivo, in a rat acute myocardial infarction (AMI) model, MNBs/Ad(hVEGF) complexes were injected intravenously and an epicardial magnet was employed to attract the circulating MNBs/Ad(hVEGF) complexes. In vitro, compared with Ad(luc) alone, MNBs/Ad(luc) complexes had a 50-fold higher transduction efficiency under the magnetic field. In vivo, epicardial magnet effectively attracted MNBs/Ad(hVEGF) complexes and resulted in strong therapeutic gene expression in the ischemic zone of the infarcted heart. When compared to other MI-treated groups, the MI-M+/Ad(hVEGF) group significantly improved left ventricular function (p<0.05) assessed by pressure-volume loops after 4 weeks. Also the MI-M+/Ad(hVEGF) group exhibited higher capillary and arteriole density and lower collagen deposition than other MI-treated groups (p<0.05). Magnetic targeting enhances transduction efficiency and improves heart function. This novel method to improve gene therapy outcomes in AMI treatment offers the potential into clinical applications.	[Zhang, Yue; Li, Wenzhong; Ou, Lailiang; Wang, Weiwei; Delyagina, Evgenya; Lux, Cornelia; Steinhoff, Gustav; Ma, Nan] Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, Rostock, Germany; [Li, Wenzhong; Wang, Weiwei; Ma, Nan] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Teltow, Germany; [Li, Wenzhong; Wang, Weiwei; Ma, Nan] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany; [Sorg, Heiko] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; [Riehemann, Kristina] Univ Munster, Ctr Nanotechnol, Munster, Germany; [Riehemann, Kristina] Univ Munster, Inst Phys, D-4400 Munster, Germany	University of Rostock; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Hannover Medical School; University of Munster; University of Munster	Li, WZ (corresponding author), Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, Rostock, Germany.	wenzhong.li@med.uni-rostock.de	Ma, Nan/L-1282-2013; Li, Wenzhong/I-2882-2014; Steinhoff, Gustav/AAB-1848-2020; ma, nan/AAF-6968-2020	Ma, Nan/0000-0003-4006-1003; ma, nan/0000-0003-4006-1003; Sorg, Heiko/0000-0001-6827-0857	German Federal Ministry of Education and Research, BioChancePlus program [0313191]; German Helmholtz Association, Mecklenburg-Vorpommern, German Federal Ministry of Education and Research, German Research Foundation (Nachwuchsgruppe Regenerative Medizin Regulation der Stammzellmigration) [0402710]; Forderkennzeichen (Ministry of Education (Germany, Berlin) [0312138 A]; Ministry of Economy (Mecklenburg-West Pommerania, Schwerin) [V220-630-08-TFMV-F/S-035]; Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-IRSES; Reference and Translation Center for Cardiac Stem Cell Therapy;  [Sonderforschungsbereich/Transregio 37];  [B5];  [B2];  [A4]	German Federal Ministry of Education and Research, BioChancePlus program(Federal Ministry of Education & Research (BMBF)); German Helmholtz Association, Mecklenburg-Vorpommern, German Federal Ministry of Education and Research, German Research Foundation (Nachwuchsgruppe Regenerative Medizin Regulation der Stammzellmigration); Forderkennzeichen (Ministry of Education (Germany, Berlin); Ministry of Economy (Mecklenburg-West Pommerania, Schwerin); Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-IRSES; Reference and Translation Center for Cardiac Stem Cell Therapy; ; ; ; 	This work was supported by Sonderforschungsbereich/Transregio 37 (B5, B2 and A4); German Federal Ministry of Education and Research, BioChancePlus program (0313191); The German Helmholtz Association, Mecklenburg-Vorpommern, German Federal Ministry of Education and Research, German Research Foundation (Nachwuchsgruppe Regenerative Medizin Regulation der Stammzellmigration 0402710); Forderkennzeichen 0312138 A (Ministry of Education (Germany, Berlin)); V220-630-08-TFMV-F/S-035 (Ministry of Economy (Mecklenburg-West Pommerania, Schwerin)); Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-2009-IRSES); and the Reference and Translation Center for Cardiac Stem Cell Therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; [Anonymous], 2004, J ADV NURSING, V48, P542; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Crottogini A, 2003, HUM GENE THER, V14, P1307, DOI 10.1089/104303403322319390; Curato C, 2010, J IMMUNOL, V185, P6286, DOI 10.4049/jimmunol.0903681; Delyagina E, 2011, NANOMEDICINE-UK, V6, P1593, DOI [10.2217/NNM.11.143, 10.2217/nnm.11.143]; Emmrich S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-61; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Forbes ZG, 2003, IEEE T MAGN, V39, P3372, DOI 10.1109/TMAG.2003.816260; Furlani D, 2008, TRANSPL P, V40, P962, DOI 10.1016/j.transproceed.2008.03.033; Gaebel R, 2011, BIOMATERIALS, V32, P9218, DOI 10.1016/j.biomaterials.2011.08.071; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Guerrero M, 2008, J INTERV CARDIOL, V21, P242, DOI 10.1111/j.1540-8183.2008.00358.x; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Hofmann A, 2009, P NATL ACAD SCI USA, V106, P44, DOI 10.1073/pnas.0803746106; Jacquier A, 2007, RADIOLOGY, V245, P196, DOI 10.1148/radiol.2451061077; Kastrati A, 2004, J AM COLL CARDIOL, V43, P734, DOI 10.1016/j.jacc.2003.07.054; Katare R, CIRC RES, V108, P1238; Laguens R, 2002, GENE THER, V9, P1676, DOI 10.1038/sj.gt.3301844; Li WZ, 2008, J GENE MED, V10, P897, DOI 10.1002/jgm.1208; Li WZ, 2007, J MAGN MAGN MATER, V311, P336, DOI 10.1016/j.jmmm.2006.11.201; Meloni M, 2012, DIABETES, V61, P229, DOI 10.2337/db11-0763; Mykhaylyk O, 2009, J BIOMED NANOTECHNOL, V5, P692, DOI 10.1166/jbn.2009.1086; Ou LL, 2011, J CELL MOL MED, V15, P1310, DOI 10.1111/j.1582-4934.2010.01086.x; Ou Lailiang, 2010, Open Cardiovasc Med J, V4, P231, DOI 10.2174/1874192401004010231; Pandori MW, 2002, VIROLOGY, V299, P204, DOI 10.1006/viro.2002.1510; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Saeed M, 2007, RADIOLOGY, V243, P451, DOI 10.1148/radiol.2432060928; Siddiqui AJ, 2003, BIOCHEM BIOPH RES CO, V310, P1002, DOI 10.1016/j.bbrc.2003.09.111; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Tamura K, 1999, JPN CIRC J, V63, P357, DOI 10.1253/jcj.63.357; Torchilin VP, 2000, EUR J PHARM SCI, V11, pS81, DOI 10.1016/S0928-0987(00)00166-4; Wang WW, 2011, J CELL MOL MED, V15, P1989, DOI 10.1111/j.1582-4934.2010.01130.x; Wang WW, 2010, J CELL MOL MED, V14, P392, DOI 10.1111/j.1582-4934.2008.00624.x; Wang WW, 2009, INT J ARTIF ORGANS, V32, P141, DOI 10.1177/039139880903200304; Wilchek M, 1999, BIOMOL ENG, V16, P1; Yang TC, 2007, MOL THER, V15, P997, DOI 10.1038/sj.mt.6300130; Yin Ruixing, 2000, Chinese Medical Sciences Journal, V15, P205; Yin Ruixing, 2000, Chinese Medical Sciences Journal, V15, P154; Zhou L, 2005, GENE THER, V12, P196, DOI 10.1038/sj.gt.3302416	41	50	51	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e39490	10.1371/journal.pone.0039490	http://dx.doi.org/10.1371/journal.pone.0039490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844395	gold, Green Submitted, Green Published			2022-12-27	WOS:000309240600003
J	Doukakis, P; Pikitch, EK; Rothschild, A; DeSalle, R; Amato, G; Kolokotronis, SO				Doukakis, Phaedra; Pikitch, Ellen K.; Rothschild, Anna; DeSalle, Rob; Amato, George; Kolokotronis, Sergios-Orestis			Testing the Effectiveness of an International Conservation Agreement: Marketplace Forensics and CITES Caviar Trade Regulation	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ACIPENSER-BAERII; RUSSIAN STURGEON; IDENTIFICATION; POLYMORPHISM; PADDLEFISH; MANAGEMENT; ALGORITHM; FISHERIES; RECOVERY	Background: The international wildlife trade is a key threat to biodiversity. Temporal genetic marketplace monitoring can determine if wildlife trade regulation efforts such as the Convention on International Trade in Endangered Species (CITES) are succeeding. Protected under CITES effective 1997, sturgeons and paddlefishes, the producers of black caviar, are flagship CITES species. Methodology/Principal Findings: We test whether CITES has limited the amount of fraudulent black caviar reaching the marketplace. Using mitochondrial DNA-based methods, we compare mislabeling in caviar and meat purchased in the New York City area pre and post CITES listing. Our recent sampling of this market reveals a decrease in mislabeled caviar (2006-2008; 10%; n = 90) compared to pre-CITES implementation (1995-1996; 19%; n = 95). Mislabeled caviar was found only in online purchase (n = 49 online/41 retail). Conclusions/Significance: Stricter controls on importing and exporting as per CITES policies may be having a positive conservation effect by limiting the amount of fraudulent caviar reaching the marketplace. Sturgeons and paddlefishes remain a conservation priority, however, due to continued overfishing and habitat degradation. Other marine and aquatic species stand to benefit from the international trade regulation that can result from CITES listing.	[Doukakis, Phaedra] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Doukakis, Phaedra; Pikitch, Ellen K.] SUNY Stony Brook, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA; [Doukakis, Phaedra; Rothschild, Anna; DeSalle, Rob; Amato, George; Kolokotronis, Sergios-Orestis] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Kolokotronis, Sergios-Orestis] Columbia Univ, Dept Biol, Barnard Coll, New York, NY USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; American Museum of Natural History (AMNH); Columbia University	Doukakis, P (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	pdoukakis@ucsd.edu	Kolokotronis, Sergios-Orestis/A-1910-2009; Kolokotronis, Sergios-Orestis/GWM-5773-2022	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465	Alfred P. Sloan Foundation; Sackler Institute for Comparative Genomics at the American Museum of Natural History	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Sackler Institute for Comparative Genomics at the American Museum of Natural History	The authors thank the Pew Charitable Trusts, J.F. Thye, and P. R. Thye, and one anonymous contributor to the Institute for Ocean Conservation Science at Stony Brook University. Laboratory work was supported by the Alfred P. Sloan Foundation, and the Sackler Institute for Comparative Genomics at the American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CS, 2008, MOL ECOL, V17, P3985, DOI 10.1111/j.1365-294X.2008.03867.x; Bettoli PW, 2009, AM FISH S S, V66, P23; Birstein Vadim J., 2000, Conservation Genetics, V1, P81, DOI 10.1023/A:1010141906100; Birstein VJ, 1998, CONSERV BIOL, V12, P766, DOI 10.1046/j.1523-1739.1998.97081.x; Birstein VJ, 1999, J APPL ICHTHYOL, V15, P12, DOI 10.1111/j.1439-0426.1999.tb00197.x; Broad S, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P3; Bronzi P, 2011, J APPL ICHTHYOL, V27, P169, DOI 10.1111/j.1439-0426.2011.01757.x; Calix M., 2018, EUROPEAN RED LIST SA; Congiu L, 2001, MOL ECOL, V10, P2355, DOI 10.1046/j.0962-1083.2001.01368.x; DeSalle R, 1996, NATURE, V381, P197, DOI 10.1038/381197a0; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Doukakis P, 2011, MITOCHONDR DNA, V22, P15, DOI 10.3109/19401736.2010.526112; Doukakis P, 2010, CONSERV BIOL, V24, P769, DOI 10.1111/j.1523-1739.2010.01458.x; Doukakis P, 2009, CONSERV BIOL, V23, P841, DOI 10.1111/j.1523-1739.2009.01281.x; Gessner J, 2002, J APPL ICHTHYOL, V18, P665, DOI 10.1046/j.1439-0426.2002.00366.x; Ginsberg J, 2002, CONSERV BIOL, V16, P1184, DOI 10.1046/j.1523-1739.2002.16504.x; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Jenneckens I, 2000, ECOL LETT, V3, P503, DOI 10.1046/j.1461-0248.2000.00179.x; Kottelat M, 2009, ACIPENSER NUDIVENTRI; Krieger J, 2008, J APPL ICHTHYOL, V24, P36, DOI 10.1111/j.1439-0426.2008.01088.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Ludwig A, 2008, J APPL ICHTHYOL, V24, P2, DOI 10.1111/j.1439-0426.2008.01085.x; Ludwig A, 2006, EUR J WILDLIFE RES, V52, P3, DOI 10.1007/s10344-005-0006-2; Ludwig A, 2009, BIOL INVASIONS, V11, P753, DOI 10.1007/s10530-008-9289-z; Mugue NS, 2008, RUSS J GENET+, V44, P793, DOI 10.1134/S1022795408070065; Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Uscamaita MR, 2010, ORYX, V44, P83, DOI 10.1017/S0030605309990196; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Ruban GI, 2011, J APPL ICHTHYOL, V27, P470, DOI 10.1111/j.1439-0426.2011.01668.x; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Simons AM, 2001, T AM FISH SOC, V130, P359, DOI 10.1577/1548-8659(2001)130&lt;0359:POSBOM&gt;2.0.CO;2; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stokstad E, 2010, SCIENCE, V328, P26, DOI 10.1126/science.328.5974.26-a; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Timoshkina NN, 2009, RUSS J GENET+, V45, P1098, DOI 10.1134/S1022795409090117; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wuertz S, 2009, AQUACULTURE, V298, P51, DOI 10.1016/j.aquaculture.2009.09.029; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	43	41	42	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40907	10.1371/journal.pone.0040907	http://dx.doi.org/10.1371/journal.pone.0040907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848410	Green Published, gold			2022-12-27	WOS:000306806600028
J	Osterholm, C; Lu, N; Liden, A; Karlsen, TV; Gullberg, D; Reed, RK; Kusche-Gullberg, M				Osterholm, Cecilia; Lu, Ning; Liden, Asa; Karlsen, Tine V.; Gullberg, Donald; Reed, Rolf K.; Kusche-Gullberg, Marion			Fibroblast EXT1-Levels Influence Tumor Cell Proliferation and Migration in Composite Spheroids	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; HEPARAN-SULFATE; EXTRACELLULAR-MATRIX; CANCER; INTEGRIN; STROMA; PROTEOGLYCANS; SYNDECAN-1; ACTIVATION; GROWTH	Background: Stromal fibroblasts are important determinants of tumor cell behavior. They act to condition the tumor microenvironment, influence tumor growth, support tumor angiogenesis and affect tumor metastasis. Heparan sulfate proteoglycans, present both on tumor and stromal cells, interact with a large number of ligands including growth factors, their receptors, and structural components of the extracellular matrix. Being ubiquitously expressed in the tumor microenvironment heparan sulfate proteoglycans are candidates for playing central roles in tumor-stroma interactions. The objective of this work was to investigate the role of heparan sulfate expressed by stromal fibroblasts in modulating the growth of tumor cells and in controlling the interstitial fluid pressure in a 3-D model. Methodology/Principal Findings: We generated spheroids composed of fibroblasts alone, or composite spheroids, composed of fibroblasts and tumor cells. Here we show that stromal fibroblasts with a mutation in the heparan sulfate elongating enzyme Ext1 and thus a low heparan sulfate content, formed composite fibroblast/tumor cell spheroids with a significant lower interstitial fluid pressure than corresponding wild-type fibroblast/tumor cell composite spheroids. Furthermore, immunohistochemistry of composite spheroids revealed that the cells segregated, so that after 6 days in culture, the wild-type fibroblasts formed an inner core and the tumor cells an outer layer of cells. For composite spheroids containing Ext1-mutated fibroblasts this segregation was less obvious, indicating impaired cell migration. Analysis of tumor cells expressing the firefly luciferase gene revealed that the changes in tumor cell migration in mutant fibroblast/tumor cell composite spheroids coincided with a lower proliferation rate. Conclusions/Significance: This is the first demonstration that stromal Ext1-levels modulate tumor cell proliferation and affect the interstitial fluid pressure in a 3-D spheroid model. Learning how structural changes in stromal heparan sulfate influence tumor cells is essential for our understanding how non-malignant cells of the tumor microenvironment influence tumor cell progression.	[Osterholm, Cecilia; Lu, Ning; Liden, Asa; Karlsen, Tine V.; Gullberg, Donald; Reed, Rolf K.; Kusche-Gullberg, Marion] Univ Bergen, Dept Biomed, Bergen, Norway	University of Bergen	Osterholm, C (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.	marion.kusche@biomed.uib.no	Corbascio, Cecilia Österholm/ABF-2213-2020; Gullberg, Donald/H-2495-2016; Kusche-Gullberg, Marion/P-4466-2016; Reed, Rolf K./B-9422-2017	Corbascio, Cecilia Österholm/0000-0001-7506-084X; Gullberg, Donald/0000-0002-7245-4437; Kusche-Gullberg, Marion/0000-0002-5636-1695; Reed, Rolf K./0000-0002-2633-6595; Karlsen, Tine Veronica/0000-0002-1512-2479	Research Council of Norway [178497, 183258/O10]; Norwegian Cancer Society [OK01-2008-0052, PK01-2009-0435, PR-536711]; University of Bergen [710020]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); University of Bergen	This work was funded by the Research Council of Norway (Grants no. 178497 to RKR, 183258/O10 to DG), the Norwegian Cancer Society (Grants no. OK01-2008-0052 and PK01-2009-0435 to MKG, PR-536711 to DG), and the University of Bergen (Grant no. 710020 to MKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington CB, 2009, DEVELOPMENT, V136, P3143, DOI 10.1242/dev.031492; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Berg A, 1998, J APPL PHYSIOL, V85, P465, DOI 10.1152/jappl.1998.85.2.465; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; Dvorak HF, 2011, J SURG ONCOL, V103, P468, DOI 10.1002/jso.21709; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Ishikawa T, 2010, EXP CELL RES, V316, P951, DOI 10.1016/j.yexcr.2009.12.013; Ivascu A, 2007, INT J ONCOL, V31, P1403; JAIN RK, 1987, CANCER RES, V47, P3039; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kiaris H, 2004, MOL CELL BIOCHEM, V261, P117, DOI 10.1023/B:MCBI.0000028746.54447.6c; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lammerts E, 2002, INT J CANCER, V102, P453, DOI 10.1002/ijc.10722; Li JP, 2008, ANTI-CANCER AGENT ME, V8, P64, DOI 10.2174/187152008783330824; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; Nazareth MR, 2007, J IMMUNOL, V178, P5552, DOI 10.4049/jimmunol.178.9.5552; Oesterholm C, 2009, J BIOL CHEM, V284, P34935, DOI 10.1074/jbc.M109.005264; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Reed RK, 2010, CARDIOVASC RES, V87, P211, DOI 10.1093/cvr/cvq143; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Shi ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015956; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Stuhr LEB, 2003, AM J PHYSIOL-CELL PH, V285, pC1101, DOI 10.1152/ajpcell.00050.2003; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Timmins Nicholas E., 2007, V140, P141; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Vaheri A, 2009, EXP CELL RES, V315, P1633, DOI 10.1016/j.yexcr.2009.03.005; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Wang HY, 2010, J BIOL CHEM, V285, P13569, DOI 10.1074/jbc.M110.102137; WIIG H, 1981, MICROVASC RES, V21, P308, DOI 10.1016/0026-2862(81)90014-5; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200; Yang N, 2011, AM J PATHOL, V178, P325, DOI 10.1016/j.ajpath.2010.11.039; Yu WH, 2001, ANAL BIOCHEM, V293, P38, DOI 10.1006/abio.2001.5099; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	57	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41334	10.1371/journal.pone.0041334	http://dx.doi.org/10.1371/journal.pone.0041334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848466	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600053
J	Dinh, H; Rajasekaran, S; Davila, J				Dinh, Hieu; Rajasekaran, Sanguthevar; Davila, Jaime			qPMS7: A Fast Algorithm for Finding (l, d)-Motifs in DNA and Protein Sequences	PLOS ONE			English	Article							MOTIFS	Detection of rare events happening in a set of DNA/protein sequences could lead to new biological discoveries. One kind of such rare events is the presence of patterns called motifs in DNA/protein sequences. Finding motifs is a challenging problem since the general version of motif search has been proven to be intractable. Motifs discovery is an important problem in biology. For example, it is useful in the detection of transcription factor binding sites and transcriptional regulatory elements that are very crucial in understanding gene function, human disease, drug design, etc. Many versions of the motif search problem have been proposed in the literature. One such is the (l, d)-motif search (or Planted Motif Search (PMS)). A generalized version of the PMS problem, namely, Quorum Planted Motif Search (qPMS), is shown to accurately model motifs in real data. However, solving the qPMS problem is an extremely difficult task because a special case of it, the PMS Problem, is already NP-hard, which means that any algorithm solving it can be expected to take exponential time in the worse case scenario. In this paper, we propose a novel algorithm named qPMS7 that tackles the qPMS problem on real data as well as challenging instances. Experimental results show that our Algorithm qPMS7 is on an average 5 times faster than the state-of-art algorithm. The executable program of Algorithm qPMS7 is freely available on the web at http://pms.engr.uconn.edu/downloads/qPMS7.zip. Our online motif discovery tools that use Algorithm qPMS7 are freely available at http://pms.engr.uconn.edu or http://motifsearch.com.	[Dinh, Hieu; Rajasekaran, Sanguthevar] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Davila, Jaime] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA	University of Connecticut; Mayo Clinic	Dinh, H (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.	hdinh@engr.uconn.edu; rajasek@engr.uconn.edu	Davila, Jaime/AAI-2023-2019	Davila, Jaime/0000-0002-8163-6267	NSF [0829916]; NIH [R01-LM010101]; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0829916] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work has been supported in part by the following grants: NSF 0829916 and NIH R01-LM010101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bandyopadhyay S, 2012, P 2 IEEE INT C COMP, P1; Blanchette M, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P37; Blanchette M., 2001, P 5 ANN INT C COMP M, P49; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; Buhler J., 2001, P 5 ANN INT C COMP B; Chin HCL, 2005, P 3 AS PAC BIOINF C, P261; Davila J, 2007, AB BAF MU MAG KASH B; Davila J, 2007, IEEE ACM T COMPUT BI, V4, P544, DOI 10.1109/TCBB.2007.70241; Dinh H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-410; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Eskin E, 2002, BIOINFORMATICS, V18, pS354, DOI DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S354.; GALAS DJ, 1985, J MOL BIOL, V186, P117, DOI 10.1016/0022-2836(85)90262-1; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Keich U, 2002, BIOINFORMATICS, V18, P1374, DOI 10.1093/bioinformatics/18.10.1374; Kuksa PP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S1; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; Pisanti N, 2006, LECT NOTES COMPUT SC, V3887, P757, DOI 10.1007/11682462_69; Price A, 2003, BIOINFORMATICS, V19, pII149, DOI 10.1093/bioinformatics/btg1072; Rajasekaran S, 2005, J COMPUT BIOL, V12, P1117, DOI 10.1089/cmb.2005.12.1117; Rajasekaran S, 2009, FRONT BIOSCI-LANDMRK, V14, P5052, DOI 10.2741/3586; Rocke E., 1998, RECOMB 98. Proceedings of the Second Annual International Conference on Computational Molecular Biology, P228, DOI 10.1145/279069.279119; Sinha S, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P344; STADEN R, 1989, COMPUT APPL BIOSCI, V5, P293; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Tompa M, 1999, Proc Int Conf Intell Syst Mol Biol, P262; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947	28	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41425	10.1371/journal.pone.0041425	http://dx.doi.org/10.1371/journal.pone.0041425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848493	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300039
J	Funke, SA; Bartnik, D; Gluck, JM; Piorkowska, K; Wiesehan, K; Weber, U; Gulyas, B; Halldin, C; Pfeifer, A; Spenger, C; Muhs, A; Willbold, D				Funke, Susanne Aileen; Bartnik, Dirk; Glueck, Julian Marius; Piorkowska, Kasia; Wiesehan, Katja; Weber, Urs; Gulyas, Balazs; Halldin, Christer; Pfeifer, Andrea; Spenger, Christian; Muhs, Andreas; Willbold, Dieter			Development of a Small D-Enantiomeric Alzheimer's Amyloid-beta Binding Peptide Ligand for Future In Vivo Imaging Applications	PLOS ONE			English	Article							TRANSGENIC MICE; FIBRIL FORMATION; PHAGE DISPLAY; DISEASE; BRAIN; PLAQUES; AUTORADIOGRAPHY; CYTOTOXICITY; BIOSENSORS; DIAGNOSIS	Alzheimer's disease (AD) is a devastating disease affecting predominantly the aging population. One of the characteristic pathological hallmarks of AD are neuritic plaques, consisting of amyloid-beta peptide (A beta). While there has been some advancement in diagnostic classification of AD patients according to their clinical severity, no fully reliable method for pre-symptomatic diagnosis of AD is available. To enable such early diagnosis, which will allow the initiation of treatments early in the disease progress, neuroimaging tools are under development, making use of A beta-binding ligands that can visualize amyloid plaques in the living brain. Here we investigate the properties of a newly designed series of D-enantiomeric peptides which are derivatives of ACI-80, formerly called D1, which was developed to specifically bind aggregated A beta 1-42. We describe ACI-80 derivatives with increased stability and A beta binding properties, which were characterized using surface plasmon resonance and enzyme-linked immunosorbent assays. The specific interactions of the lead compounds with amyloid plaques were validated by ex vivo immunochemistry in transgenic mouse models of AD. The novel compounds showed increased binding affinity and are promising candidates for further development into in vivo imaging compounds.	[Funke, Susanne Aileen; Bartnik, Dirk; Glueck, Julian Marius; Wiesehan, Katja; Willbold, Dieter] Forschungszentrum Julich, ICS 6, D-52425 Julich, Germany; [Piorkowska, Kasia; Weber, Urs; Pfeifer, Andrea; Muhs, Andreas] Ecole Polytech Fed Lausanne, AC Immune, CH-1015 Lausanne, Switzerland; [Gulyas, Balazs; Halldin, Christer] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden; [Spenger, Christian] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Spenger, Christian] Prodema Management AG, Bronschhofen, Switzerland; [Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Ecole Polytechnique Federale de Lausanne; Karolinska Institutet; Karolinska Institutet; Heinrich Heine University Dusseldorf	Funke, SA (corresponding author), Forschungszentrum Julich, ICS 6, D-52425 Julich, Germany.	d.willbold@fz-juelich.de	Funke, Susanne/A-1460-2015; Willbold, Dieter/A-6280-2013; Gulyas, Balazs/F-9508-2015; Gluck, Julian/G-5668-2013	Willbold, Dieter/0000-0002-0065-7366; Gluck, Julian/0000-0002-2833-3988				Abraham GN, 1981, MOL CELL BIOCH, V38, P181; Bartnik D, 2010, REJUV RES, V13, P202, DOI 10.1089/rej.2009.0924; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Dlff K, 2006, ALZ DIS ASSOC DIS, V20, P202, DOI 10.1097/01.wad.0000213881.01289.d9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganguli M, 2004, J AM GERIATR SOC, V52, P1668, DOI 10.1111/j.1532-5415.2004.52459.x; Gulyas B, 2012, NEUROCHEM INT, V60, P153, DOI 10.1016/j.neuint.2011.10.010; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Jahan M, 2012, NUCL MED BIOL, V39, P315, DOI 10.1016/j.nucmedbio.2011.09.008; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MOHS RC, 1988, PSYCHOPHARMACOL BULL, V24, P627; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Nordberg A, 2008, NEUROPSYCHOLOGIA, V46, P1636, DOI 10.1016/j.neuropsychologia.2008.03.020; Nordberg A, 2007, CURR OPIN NEUROL, V20, P398, DOI 10.1097/WCO.0b013e3281a47744; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Silverman DHS, 2004, J NUCL MED, V45, P594; Svedberg MM, 2009, NEUROCHEM INT, V54, P347, DOI 10.1016/j.neuint.2008.12.016; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Visser PJ, 2005, J NEUROL NEUROSUR PS, V76, P1348, DOI 10.1136/jnnp.2004.047720; Wei GX, 2005, ANTIMICROB AGENTS CH, V49, P2336, DOI 10.1128/AAC.49.6.2336-2342.2005; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Wiesehan K, 2003, CHEMBIOCHEM, V4, P811, DOI 10.1002/cbic.200300570	34	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41457	10.1371/journal.pone.0041457	http://dx.doi.org/10.1371/journal.pone.0041457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848501	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300042
J	Kosem, A; van Wassenhove, V				Koesem, Anne; van Wassenhove, Virginie			Temporal Structure in Audiovisual Sensory Selection	PLOS ONE			English	Article							VISUAL-SEARCH; NEURONAL OSCILLATIONS; AUDITORY FLUTTER; ATTENTION; PERCEPTION; SYNCHRONY; PHASE; SOUND; TIME; SIGNALS	In natural environments, sensory information is embedded in temporally contiguous streams of events. This is typically the case when seeing and listening to a speaker or when engaged in scene analysis. In such contexts, two mechanisms are needed to single out and build a reliable representation of an event (or object): the temporal parsing of information and the selection of relevant information in the stream. It has previously been shown that rhythmic events naturally build temporal expectations that improve sensory processing at predictable points in time. Here, we asked to which extent temporal regularities can improve the detection and identification of events across sensory modalities. To do so, we used a dynamic visual conjunction search task accompanied by auditory cues synchronized or not with the color change of the target (horizontal or vertical bar). Sounds synchronized with the visual target improved search efficiency for temporal rates below 1.4 Hz but did not affect efficiency above that stimulation rate. Desynchronized auditory cues consistently impaired visual search below 3.3 Hz. Our results are interpreted in the context of the Dynamic Attending Theory: specifically, we suggest that a cognitive operation structures events in time irrespective of the sensory modality of input. Our results further support and specify recent neurophysiological findings by showing strong temporal selectivity for audiovisual integration in the auditory-driven improvement of visual search efficiency.	[Koesem, Anne; van Wassenhove, Virginie] INSERM, U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [Koesem, Anne; van Wassenhove, Virginie] CEA, DSV I2BM, NeuroSpin Ctr, Gif Sur Yvette, France; [Koesem, Anne; van Wassenhove, Virginie] Univ Paris Sud, Cognit Neuroimaging Unit, Gif Sur Yvette, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Kosem, A (corresponding author), INSERM, U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France.	Virginie.van-Wassenhove@cea.fr	Kosem, Anne/M-2344-2019; van Wassenhove, Virginie/F-4129-2010	Kosem, Anne/0000-0002-2692-9999; van Wassenhove, Virginie/0000-0002-2569-5502	Marie Curie [IRG-249222, ERC-StG-263584, ANRJCJC-1904]; Fondation Electricite De France (EDF); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)/Direction Generale des Armees (DGA) PhD fellowship	Marie Curie(European Commission); Fondation Electricite De France (EDF); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)/Direction Generale des Armees (DGA) PhD fellowship	This work was supported by Marie Curie IRG-249222, ERC-StG-263584, and ANRJCJC-1904 to VvW and Fondation Electricite De France (EDF) and Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)/Direction Generale des Armees (DGA) PhD fellowship to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsius A, 2011, EXP BRAIN RES, V213, P175, DOI 10.1007/s00221-011-2624-0; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Bates D. M., 2007, LME4 LINEAR MIXED EF; Benjamins JS, 2008, PERCEPTION, V37, P848, DOI 10.1068/p5783; Besle J, 2011, J NEUROSCI, V31, P3176, DOI 10.1523/JNEUROSCI.4518-10.2011; Blake Randolph, 2005, Behav Cogn Neurosci Rev, V4, P21, DOI 10.1177/1534582305276839; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Chen YC, 2008, PSYCHON B REV, V15, P404, DOI 10.3758/PBR.15.2.404; Chen YC, 2009, EXP BRAIN RES, V198, P209, DOI 10.1007/s00221-009-1831-4; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V54, P277, DOI 10.3758/BF03205262; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; FRENCHSTGEORGE M, 1989, PERCEPT PSYCHOPHYS, V46, P384; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2007, VISION RES, V47, P1075, DOI 10.1016/j.visres.2007.01.021; Fujisaki W, 2010, P ROY SOC B-BIOL SCI, V277, P2281, DOI 10.1098/rspb.2010.0243; Galambos R, 1981, P NATL ACAD SCI USA, V78, P2343; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; Gomez-Ramirez M, 2011, J NEUROSCI, V31, P18556, DOI 10.1523/JNEUROSCI.2164-11.2011; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Huang LQ, 2005, PERCEPT PSYCHOPHYS, V67, P150, DOI 10.3758/BF03195018; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jones MR, 2006, COGNITIVE PSYCHOL, V53, P59, DOI 10.1016/j.cogpsych.2006.01.003; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Kandil FI, 2001, EUR J NEUROSCI, V13, P2004, DOI 10.1046/j.0953-816x.2001.01573.x; KEELE SW, 1989, PSYCHOL RES-PSYCH FO, V50, P251, DOI 10.1007/BF00309261; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lee SH, 1999, SCIENCE, V284, P1165, DOI 10.1126/science.284.5417.1165; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000445; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; R Development Core Team, 2007, R LANG ENV STAT COMP; REGAN D, 1966, ELECTROEN CLIN NEURO, V20, P238, DOI 10.1016/0013-4694(66)90088-5; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Turgeon M, 2001, ANN NY ACAD SCI, V930, P375, DOI 10.1111/j.1749-6632.2001.tb05746.x; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010664; VanRullen R, 2006, J NEUROSCI, V26, P502, DOI 10.1523/JNEUROSCI.4654-05.2006; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; WELCH RB, 1986, PERCEPT PSYCHOPHYS, V39, P294, DOI 10.3758/BF03204939; Winfree A.T., 2000, GEOMETRY BIOL TIME; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zou H, 2012, J VISION, V12, DOI 10.1167/12.5.2	58	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40936	10.1371/journal.pone.0040936	http://dx.doi.org/10.1371/journal.pone.0040936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981GZ	22829899	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300037
J	Orr, BA; Haffner, MC; Nelson, WG; Yegnasubramanian, S; Eberhart, CG				Orr, Brent A.; Haffner, Michael C.; Nelson, William G.; Yegnasubramanian, Srinivasan; Eberhart, Charles G.			Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; ACTIVE DNA DEMETHYLATION; EMBRYONIC STEM-CELLS; IDH2 MUTATIONS; DIFFUSE GLIOMAS; MAMMALIAN DNA; HUMAN CANCERS; GLIOBLASTOMA; 5-METHYLCYTOSINE; DIFFERENTIATION	Epigenetic modification of DNA by cytosine methylation to produce 5-methylcytosine (5mC) has become well-recognized as an important epigenetic process in human health and disease. Recently, further modification of 5mC by the ten eleven translocated (TET) family of enzymes to produce 5-hydroxymethylcytosine (5hmC) has been described. In the present study, we used immunohistochemistry to evaluate the distribution of 5hmC in human brain during different periods of development and in a large series of gliomas (n = 225). We found that during development, 5hmC levels are high in more differentiated compartments like the fetal cortex, but low in the periventricular progenitor cell regions. In adults, we found 5hmC levels to be highest in the cortex, but present in all intrinsic cell types in the brain including stromal elements. In brain tumors, 5hmC levels were high in low grade tumors and reduced in malignant glioma, but did not exhibit any correlation with IDH1 mutation status. Additionally, we identified a significant relationship between low levels of 5hmC and reduced survival in malignant glioma. This observation was further supported by in silico analysis showing differential expression of genes involved in 5hmC homeostasis in aggressive subsets of glioblastoma. Finally, we show that several genes involved in regulating the levels of 5hmC are also prognostic in malignant glioma. These findings suggest that 5hmC regulation in malignant glioma may represent an important determinant of tumor differentiation and aggressive behavior, as well as a potential therapeutic target.	[Orr, Brent A.; Nelson, William G.; Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA; [Haffner, Michael C.; Nelson, William G.; Yegnasubramanian, Srinivasan] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Nelson, William G.] Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Orr, BA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	brentorr5@gmail.com; syegnasu@jhmi.edu		Orr, Brent/0000-0003-0997-4728	National Institutes of Health [T32CA067751, 5R01NS055089, 5R01CA070196]; Martin D. Abeloff V Scholar Award; NATIONAL CANCER INSTITUTE [R01CA070196, T32CA067751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martin D. Abeloff V Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially funded by National Institutes of Health postdoctoral fellowship (T32CA067751) to B.A.O., 5R01NS055089 to C.G.E., 5R01CA070196 and Martin D. Abeloff V Scholar Award to S.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Capper D, 2012, INT J CANCER, V131, P766, DOI 10.1002/ijc.26425; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Haffner MC, 2011, ONCOTARGET, V2, P627; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim YH, 2011, J CLIN PATHOL, V64, P850, DOI 10.1136/jclinpath-2011-200133; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kraus TF, 2012, INT J CANC IN PRESS; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Metellus P, 2011, ANN SURG ONCOL, V18, P2937, DOI 10.1245/s10434-011-1703-6; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; The WHO, 2020, CLASSIFICATION TUMOU; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	51	134	142	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41036	10.1371/journal.pone.0041036	http://dx.doi.org/10.1371/journal.pone.0041036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829908	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300046
J	Sabree, ZL; Hansen, AK; Moran, NA				Sabree, Zakee L.; Hansen, Allison K.; Moran, Nancy A.			Independent Studies Using Deep Sequencing Resolve the Same Set of Core Bacterial Species Dominating Gut Communities of Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA; MICROBIOTA; DIVERSITY; ORDERS	Starting in 2003, numerous studies using culture-independent methodologies to characterize the gut microbiota of honey bees have retrieved a consistent and distinctive set of eight bacterial species, based on near identity of the 16S rRNA gene sequences. A recent study [Mattila HR, Rios D, Walker-Sperling VE, Roeselers G, Newton ILG (2012) Characterization of the active microbiotas associated with honey bees reveals healthier and broader communities when colonies are genetically diverse. PLoS ONE 7(3): e32962], using pyrosequencing of the V1-V2 hypervariable region of the 16S rRNA gene, reported finding entirely novel bacterial species in honey bee guts, and used taxonomic assignments from these reads to predict metabolic activities based on known metabolisms of cultivable species. To better understand this discrepancy, we analyzed the Mattila et al. pyrotag dataset. In contrast to the conclusions of Mattila et al., we found that the large majority of pyrotag sequences belonged to clusters for which representative sequences were identical to sequences from previously identified core species of the bee microbiota. On average, they represent 95% of the bacteria in each worker bee in the Mattila et al. dataset, a slightly lower value than that found in other studies. Some colonies contain small proportions of other bacteria, mostly species of Enterobacteriaceae. Reanalysis of the Mattila et al. dataset also did not support a relationship between abundances of Bifidobacterium and of putative pathogens or a significant difference in gut communities between colonies from queens that were singly or multiply mated. Additionally, consistent with previous studies, the dataset supports the occurrence of considerable strain variation within core species, even within single colonies. The roles of these bacteria within bees, or the implications of the strain variation, are not yet clear.	[Sabree, Zakee L.; Hansen, Allison K.; Moran, Nancy A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Sabree, ZL (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	nancy.moran@yale.edu		Hansen, Allison/0000-0002-3066-5527	US National Science Foundation [DEB 1046153]; Yale University	US National Science Foundation(National Science Foundation (NSF)); Yale University	This work was supported by the US National Science Foundation (DEB 1046153) and by Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Dunn AK, 2005, APPL ENVIRON MICROB, V71, P8784, DOI 10.1128/AEM.71.12.8784-8794.2005; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2012, P NATL ACAD IN PRESS; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; GILLIAM M, 1976, J INVERTEBR PATHOL, V28, P275, DOI 10.1016/0022-2011(76)90137-3; Hansen AK, 2009, NORTHWEST SCI, V83, P348, DOI 10.3955/046.083.0406; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mather P. M., 1976, COMPUTATIONAL METHOD; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McCune B., 2011, PC ORD MULTIVARIATE; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Rosengaus RB, 2011, APPL ENVIRON MICROB, V77, P4303, DOI 10.1128/AEM.01886-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Volkmann M, 2010, INT J SYST EVOL MICR, V60, P2601, DOI 10.1099/ijs.0.019026-0	37	86	92	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41250	10.1371/journal.pone.0041250	http://dx.doi.org/10.1371/journal.pone.0041250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829932	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300071
J	Tarasov, AI; Semplici, F; Ravier, MA; Bellomo, EA; Pullen, TJ; Gilon, P; Sekler, I; Rizzuto, R; Rutter, GA				Tarasov, Andrei I.; Semplici, Francesca; Ravier, Magalie A.; Bellomo, Elisa A.; Pullen, Timothy J.; Gilon, Patrick; Sekler, Israel; Rizzuto, Rosario; Rutter, Guy A.			The Mitochondrial Ca2+ Uniporter MCU Is Essential for Glucose-Induced ATP Increases in Pancreatic beta-Cells	PLOS ONE			English	Article							SENSITIVE K+ CHANNEL; INSULIN-SECRETION; ESSENTIAL COMPONENT; CYTOPLASMIC CA2+; CYTOSOLIC CA2+; FATTY-ACIDS; CALCIUM; OSCILLATIONS; PROTEIN; EXOCYTOSIS	Glucose induces insulin release from pancreatic beta-cells by stimulating ATP synthesis, membrane depolarisation and Ca2+ influx. As well as activating ATP-consuming processes, cytosolic Ca2+ increases may also potentiate mitochondrial ATP synthesis. Until recently, the ability to study the role of mitochondrial Ca2+ transport in glucose-stimulated insulin secretion has been hindered by the absence of suitable approaches either to suppress Ca2+ uptake into these organelles, or to examine the impact on beta-cell excitability. Here, we have combined patch-clamp electrophysiology with simultaneous real-time imaging of compartmentalised changes in Ca2+ and ATP/ADP ratio in single primary mouse beta-cells, using recombinant targeted (Pericam or Perceval, respectively) as well as entrapped intracellular (Fura-Red), probes. Through shRNA-mediated silencing we show that the recently-identified mitochondrial Ca2+ uniporter, MCU, is required for depolarisation-induced mitochondrial Ca2+ increases, and for a sustained increase in cytosolic ATP/ADP ratio. By contrast, silencing of the mitochondrial Na+-Ca2+ exchanger NCLX affected the kinetics of glucose-induced changes in, but not steady state values of, cytosolic ATP/ADP. Exposure to gluco-lipotoxic conditions delayed both mitochondrial Ca2+ uptake and cytosolic ATP/ADP ratio increases without affecting the expression of either gene. Mitochondrial Ca2+ accumulation, mediated by MCU and modulated by NCLX, is thus required for normal glucose sensing by pancreatic beta-cells, and becomes defective in conditions mimicking the diabetic milieu.	[Tarasov, Andrei I.; Semplici, Francesca; Ravier, Magalie A.; Bellomo, Elisa A.; Pullen, Timothy J.; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol, Div Diabet Endocrinol & Metab, Dept Med, London, England; [Ravier, Magalie A.] Univ Montpellier I, Inst Genom Fonct, INSERM U661, CNRS UMR5203, Montpellier, France; [Ravier, Magalie A.] Univ Montpellier 2, Inst Genom Fonct, INSERM U661, CNRS UMR5203, Montpellier, France; [Gilon, Patrick] Catholic Univ Louvain, Fac Med, B-1200 Brussels, Belgium; [Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel; [Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, Padua, Italy	Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite Catholique Louvain; Ben Gurion University; University of Padua	Tarasov, AI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol, Div Diabet Endocrinol & Metab, Dept Med, London, England.	g.rutter@imperial.ac.uk	Ravier, Magalie/K-9911-2019; Pullen, Timothy J/H-2143-2011; Ravier, Magalie A/N-6934-2017; Tarasov, Andrei/I-6210-2012	Ravier, Magalie/0000-0001-6607-6559; Pullen, Timothy J/0000-0002-6853-5701; Ravier, Magalie A/0000-0001-6607-6559; Tarasov, Andrei/0000-0002-8883-176X; Rizzuto, Rosario/0000-0001-7044-5097; Rutter, Guy/0000-0001-6360-0343; Bellomo, Elisa/0000-0003-4823-2209	Wellcome Trust [081958/Z/07/Z]; JDRF; Telethon-Italy; Italian Ministry of Education (PRIN, FIRB); Cariparo Foundation; Royal Society; Italian Association for Cancer Research; European Research Council ("mitoCalcium"); Biotechnology and Biological Sciences Research Council [BB/J015873/1] Funding Source: researchfish; Medical Research Council [G0401641] Funding Source: researchfish; BBSRC [BB/J015873/1] Funding Source: UKRI; MRC [G0401641] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); JDRF(Juvenile Diabetes Research Foundation); Telethon-Italy(Fondazione Telethon); Italian Ministry of Education (PRIN, FIRB); Cariparo Foundation(Fondazione Cariparo); Royal Society(Royal Society of London); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); European Research Council ("mitoCalcium"); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Wellcome Trust (Programme Grant 081958/Z/07/Z to GAR, Value in People (VIP) award to TJP) and the JDRF (Postdoctoral Fellowship to AIT), Telethon-Italy, Italian Association for Cancer Research, the Italian Ministry of Education (PRIN, FIRB), the Cariparo Foundation and the European Research Council ("mitoCalcium") (for RR). PG is Research Director of the Fonds National de la Recherche Scientifique, Brussels. MAR is Charge de Recherches from INSERM, Paris. GAR is a Wellcome Trust Senior Investigator (WT098424AIA) and the holder of a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Ainscow EK, 2001, BIOCHEM J, V353, P175, DOI 10.1042/0264-6021:3530175; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Detimary P, 1998, BIOCHEM J, V333, P269, DOI 10.1042/bj3330269; Eliasson L, 1997, J PHYSIOL-LONDON, V503, P399, DOI 10.1111/j.1469-7793.1997.399bh.x; Eliasson L, 1996, SCIENCE, V271, P813, DOI 10.1126/science.271.5250.813; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Fink C, 1998, BIOPHYS J, V75, P1648, DOI 10.1016/S0006-3495(98)77607-6; Gilon P, 1999, J BIOL CHEM, V274, P20197, DOI 10.1074/jbc.274.29.20197; GILON P, 1992, J BIOL CHEM, V267, P20713; Gopel SO, 1999, J GEN PHYSIOL, V114, P759, DOI 10.1085/jgp.114.6.759; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; HORN R, 1992, METHOD ENZYMOL, V207, P149; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kohnke R, 2007, NUTR NEUROSCI, V10, P273, DOI 10.1080/10284150701745910; Lee B, 2003, DIABETES, V52, P965, DOI 10.2337/diabetes.52.4.965; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Nguyen KT, 2009, P NATL ACAD SCI USA, V106, P2007, DOI 10.1073/pnas.0810934106; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Parton LE, 2006, AM J PHYSIOL-ENDOC M, V291, pE982, DOI 10.1152/ajpendo.00067.2006; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rutter GA, 2004, DIABETOLOGIA, V47, P1861, DOI 10.1007/s00125-004-1541-1; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; RUTTER GA, 1990, INT J BIOCHEM, V22, P1081, DOI 10.1016/0020-711X(90)90105-C; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Tarasov AI, 2008, DIABETES, V57, P1595, DOI 10.2337/db07-1547; Tarasov AI, 2006, DIABETES, V55, P2446, DOI 10.2337/db06-0360; Tarasov AI, 2006, DIABETES, V55, P3075, DOI 10.2337/db06-0637; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914	49	126	130	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e39722	10.1371/journal.pone.0039722	http://dx.doi.org/10.1371/journal.pone.0039722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829870	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300008
J	Wolff, MJ; Leung, JM; Davenport, M; Poles, MA; Cho, I; Loke, P				Wolff, Martin J.; Leung, Jacqueline M.; Davenport, Michael; Poles, Michael A.; Cho, Ilseung; Loke, P'ng			T(H)17, T(H)22 and T-Reg Cells Are Enriched in the Healthy Human Cecum	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; INFLAMMATION; RESISTIN; GENE; APPENDECTOMY; PATHOGENESIS; POLYMORPHISM; MACROPHAGES; HOMEOSTASIS; EXPRESSION	There is increasing evidence that dysregulation of CD4(+) T cell populations leads to intestinal inflammation, but the regional distribution of these populations throughout the intestinal tract in healthy individuals remains unclear. Here, we show that T(H)17, T(H)22 and T-Reg cells are enriched in the healthy human cecum compared to the terminal ileum and sigmoid colon, whereas T(H)1 and T(H)2 cells do not significantly vary by location. Transcriptional profiling analysis of paired pinch biopsies from different regions of the intestine identified significant differences in the metabolic state of the terminal ileum, cecum, and sigmoid colon. An increased proportion of T(H)17 cells was positively associated with expression of resistin (RETN) and negatively associated with expression of trefoil factor 1 (TFF1). These results suggest that CD4(+) T helper cells that are important in maintaining mucosal barrier function may be enriched in the cecum as a result of metabolic differences of the surrounding microenvironment.	[Wolff, Martin J.; Poles, Michael A.; Cho, Ilseung] NYU, Sch Med, Dept Med, Div Gastroenterol, New York, NY 10003 USA; [Wolff, Martin J.; Leung, Jacqueline M.; Davenport, Michael; Loke, P'ng] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY USA; [Poles, Michael A.; Cho, Ilseung] Vet Affairs New York Harbor Healthcare Syst, Dept Med, Div Gastroenterol, New York, NY USA	New York University; New York University	Wolff, MJ (corresponding author), NYU, Sch Med, Dept Med, Div Gastroenterol, New York, NY 10003 USA.	Png.loke@nyumc.org	Loke, Png/X-2278-2019	Wolff, Martin/0000-0003-4391-2395; Leung, Jacqueline/0000-0002-1963-3380; Cho, Ilseung/0000-0002-7308-8707; Poles, Michael/0000-0002-7993-6156	New York University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093811] Funding Source: NIH RePORTER	New York University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by startup funds to Dr. P'ng Loke from the New York University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Bolin TD, 2009, AM J GASTROENTEROL, V104, P2476, DOI 10.1038/ajg.2009.388; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Cosnes J, 2002, GUT, V51, P803, DOI 10.1136/gut.51.6.803; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ehrhardt GRA, 2011, CURR TOP MICROBIOL, V350, P89, DOI 10.1007/82_2010_88; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Gardenbroek TJ, 2011, COLORECTAL DIS; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hartigan-O'Connor DJ, 2011, CURR OPIN HIV AIDS, V6, P221, DOI 10.1097/COH.0b013e32834577b3; Heitman SJ, 2009, CLIN GASTROENTEROL H, V7, P1272, DOI 10.1016/j.cgh.2009.05.032; Honda K, 2011, ANN REV IMMUNOL, V30; Hong PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025042; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Im GY, 2011, CLIN GASTROENTEROL H, V9, P1072, DOI 10.1016/j.cgh.2011.06.006; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Kyo K, 2001, J HUM GENET, V46, P5, DOI 10.1007/s100380170118; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matsushita M., 2007, Inflammopharmacology, V15, P154, DOI 10.1007/s10787-007-1563-7; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Palestrant D, 2004, ULTRASTRUCT PATHOL, V28, P23, DOI 10.1080/01913120490275196; Paski SC, 2007, AM J GASTROENTEROL, V102, P2294, DOI 10.1111/j.1572-0241.2007.01389.x; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; RIO MC, 1991, GASTROENTEROLOGY, V100, P375, DOI 10.1016/0016-5085(91)90205-Y; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Smith HF, 2009, J EVOLUTION BIOL, V22, P1984, DOI 10.1111/j.1420-9101.2009.01809.x; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Soutto M, 2011, J CLIN INVEST, V121, P1753, DOI 10.1172/JCI43922; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Swainson LA, 2010, J IMMUNOL, V184, P3639, DOI 10.4049/jimmunol.0903943; Tang X, 2009, TISSUE ANTIGENS, V74, P314, DOI 10.1111/j.1399-0039.2009.01335.x; Tiaka EK, 2011, CYTOKINE GROWTH F R, V22, P109, DOI 10.1016/j.cytogfr.2011.04.002; Trifari S, 2010, EUR J IMMUNOL, V40, P2369, DOI 10.1002/eji.201040848; Vestergaard EM, 2004, SCAND J CLIN LAB INV, V64, P146, DOI 10.1080/00365510410001176; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; Wolff D, 2010, CARIES RES, V44, P498, DOI 10.1159/000320161; Wolff MJ, 2012, TRENDS PARASITOL, V28, P187, DOI 10.1016/j.pt.2012.02.008; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	53	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41373	10.1371/journal.pone.0041373	http://dx.doi.org/10.1371/journal.pone.0041373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829946	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300085
J	Patel, AS; Lin, L; Geyer, A; Haspel, JA; An, CH; Cao, JF; Rosas, IO; Morse, D				Patel, Avignat S.; Lin, Ling; Geyer, Alexander; Haspel, Jeffrey A.; An, Chang Hyeok; Cao, Jiaofei; Rosas, Ivan O.; Morse, Danielle			Autophagy in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GROWTH-FACTOR-BETA; OXIDATIVE STRESS; EPITHELIAL-CELLS; GENE-EXPRESSION; RAPAMYCIN; HYPOXIA; DISEASE; INFLAMMATION; TARGET	Background: Autophagy is a basic cellular homeostatic process important to cell fate decisions under conditions of stress. Dysregulation of autophagy impacts numerous human diseases including cancer and chronic obstructive lung disease. This study investigates the role of autophagy in idiopathic pulmonary fibrosis. Methods: Human lung tissues from patients with IPF were analyzed for autophagy markers and modulating proteins using western blotting, confocal microscopy and transmission electron microscopy. To study the effects of TGF-beta(1) on autophagy, human lung fibroblasts were monitored by fluorescence microscopy and western blotting. In vivo experiments were done using the bleomycin-induced fibrosis mouse model. Results: Lung tissues from IPF patients demonstrate evidence of decreased autophagic activity as assessed by LC3, p62 protein expression and immunofluorescence, and numbers of autophagosomes. TGF-beta(1) inhibits autophagy in fibroblasts in vitro at least in part via activation of mTORC1; expression of TIGAR is also increased in response to TGF-beta(1). In the bleomycin model of pulmonary fibrosis, rapamycin treatment is antifibrotic, and rapamycin also decreases expression of a-smooth muscle actin and fibronectin by fibroblasts in vitro. Inhibition of key regulators of autophagy, LC3 and beclin-1, leads to the opposite effect on fibroblast expression of a-smooth muscle actin and fibronectin. Conclusion: Autophagy is not induced in pulmonary fibrosis despite activation of pathways known to promote autophagy. Impairment of autophagy by TGF-beta(1) may represent a mechanism for the promotion of fibrogenesis in IPF.	[Patel, Avignat S.; Haspel, Jeffrey A.; An, Chang Hyeok; Cao, Jiaofei; Rosas, Ivan O.; Morse, Danielle] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Patel, Avignat S.; Haspel, Jeffrey A.; An, Chang Hyeok; Cao, Jiaofei; Rosas, Ivan O.; Morse, Danielle] Harvard Univ, Sch Med, Boston, MA USA; [Lin, Ling] Penn State Univ, Dept Med, Hershey, PA USA; [Geyer, Alexander] Mt Sinai Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY USA; [Rosas, Ivan O.] Lovelace Resp Res Inst, Albuquerque, NM USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Icahn School of Medicine at Mount Sinai; Lovelace Respiratory Research Institute	Patel, AS (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	edmorse@partners.org	Haspel, J./K-3563-2019	An, Chang Hyeok/0000-0001-9145-1322; Lin, Ling/0000-0001-5527-0575	NIH [5T32HL007633-25, K23 HL087030, R01HL087122-01]; National Institutes of Health (NIH) [5T32HL007633-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL087030, R01HL087122, T32HL007633] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A.S.P. is supported by NIH Grant 5T32HL007633-25. A.G. was supported by National Institutes of Health (NIH) Grant 5T32HL007633-24. I.O.R. is supported by NIH Grant K23 HL087030. D.M. is supported by NIH Grant R01HL087122-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Chang YP, 2010, J BIOL CHEM, V285, P28715, DOI 10.1074/jbc.M110.133355; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Fu LW, 2009, EUR J CELL BIOL, V88, P215, DOI 10.1016/j.ejcb.2008.11.003; Goc A, 2011, J CELL PHYSIOL, V226, P3004, DOI 10.1002/jcp.22648; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Kliment CR, 2010, FREE RADICAL BIO MED, V49, P707, DOI 10.1016/j.freeradbiomed.2010.04.036; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Korfhagen TR, 2009, AM J RESP CELL MOL, V41, P562, DOI 10.1165/rcmb.2008-0377OC; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Lin L, 2008, AM J PATHOL, V173, P337, DOI 10.2353/ajpath.2008.070915; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Poulalhon N, 2006, J BIOL CHEM, V281, P33045, DOI 10.1074/jbc.M606366200; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Simler NR, 2002, EUR RESPIR J, V19, P1124, DOI 10.1183/09031936.02.00281602; Tulek B, 2011, CLIN INVEST MED, V34, pE341; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshizaki A, 2010, ARTHRITIS RHEUM-US, V62, P2476, DOI 10.1002/art.27498; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HY, 1996, AM J PATHOL, V148, P527; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009	53	253	275	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41394	10.1371/journal.pone.0041394	http://dx.doi.org/10.1371/journal.pone.0041394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815997	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900115
J	Saintrain, MVD; Vieira, APGF				de Lima Saintrain, Maria Vieira; Gomes Fernandes Vieira, Anya Pimentel			Application of the Community Oral Health Indicator by Non-Dental Personnel and Its Contribution to Oral Healthcare	PLOS ONE			English	Article							VALIDATION; AGREEMENT; SCALE; KAPPA	Objective: To validate the Community Oral Health Indicator- COHI by non- dental personnel. Methods: Risk assessment is an essential component in the decision-making process. Therefore, the COHI, an instrument to evaluate population oral health situation in a simple manner, was created. Community Health Agents (CHA) were trained to use the COHI (variables as number of teeth, presence of cavities, residual dental roots, oral lesions, etc.), while dentists for the COHI and DMFT. 60 individuals were examined, by CHA and DS, with these indicators in order to validate the use of COHI by non-dental personnel. Results: Dental and soft tissues problems were well spread among those individuals. People with and without soft tissue damage, as well as with and without use and/or need for prostheses were found in the sample, proving it to be a heterogeneous population for the evaluated factors and representing the real population. The results of examinations performed by dentists using the COHI and DMF-T/dmf-t presented strong agreement when comparing the two instruments. When COHI and DMFT were compared, the results showed a concordance of 0.86 for the number of present teeth, and 0.85 for the number of residual roots. Likewise, when analyzing the data comparing the use of the COHI by DS and CHA a high agreement level, specificity and sensitivity was found. Conclusion: The COHI has shown to be useful for detecting problems in oral health. Therefore, COHI may be used, after training, by non-dental personnel, contributing to the planning and organization of the community dental assistance.	[de Lima Saintrain, Maria Vieira; Gomes Fernandes Vieira, Anya Pimentel] Univ Fortaleza UNIFOR, Sch Dent, Fortaleza, Ceara, Brazil; [de Lima Saintrain, Maria Vieira; Gomes Fernandes Vieira, Anya Pimentel] Univ Fortaleza UNIFOR, Publ Hlth Master Program, Fortaleza, Ceara, Brazil; [Gomes Fernandes Vieira, Anya Pimentel] Fundacao Oswaldo Cruz, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Universidade Fortaleza; Fundacao Oswaldo Cruz	Saintrain, MVD (corresponding author), Univ Fortaleza UNIFOR, Sch Dent, Fortaleza, Ceara, Brazil.	mvlsaintrain@yahoo.com.br			Health Management CNPq-process [409392/2006-5]	Health Management CNPq-process	Funding provided by the announcement number 232,006 Health Management CNPq-process 409392/2006-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Correa-Carhuachin Violeta, 2011, Rev. gastroenterol. Perú, V31, P351; Frazao P, 2003, PUBLIC HLTH DENT PLA, P64; Gruebbel Allen 0., 1944, JOUR DENTAL RES, V23, P163, DOI 10.1177/00220345440230030201; Hugoson A, 2008, INT J PAEDIATR DENT, V18, P18, DOI 10.1111/j.1365-263X.2007.00874.x; IBICIT. Brazilian Institute of Information Science and Technology, 2004, NAT NETW MERG TRANSF; KLEIN H., 1938, Public Health Reports, V53, P751, DOI 10.2307/4582532; KLEIN H, 1937, PUBL HLTH B, V239; Lamontagne V, 2012, MED PROBL PERFORM AR, V27, P37; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Mahmood MA, 2012, J SEX MED, V9, P1883, DOI 10.1111/j.1743-6109.2012.02714.x; Milne D, 2013, PSYCHO-ONCOLOGY, V22, P940, DOI 10.1002/pon.3071; Narvai PC, 2008, ORAL HLTH BRAZIL FAR; Noorani AM, 2012, INT J SHOULDER SURG, V6, P9, DOI 10.4103/0973-6042.94307; Norman GR., 2000, BIOSTATISTICS BARE E, V2nd; Honorio RPP, 2011, REV BRAS ENFERM, V64, P882, DOI 10.1590/S0034-71672011000500013; Petersson GH, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-5; Saintrain MVL, 2007, REV BRAS PROM SAUDE, V20, P199; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Vieira APGF, 2005, J AM DENT ASSOC, V136, P895, DOI 10.14219/jada.archive.2005.0290; WHO, 1999, ORAL HLTH SURV BAS M; World Health Organization (WHO), 1991, EP SURV OR HLTH ED I	24	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39733	10.1371/journal.pone.0039733	http://dx.doi.org/10.1371/journal.pone.0039733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848360	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200012
J	Forster, AJ; Taljaard, M; Bennett, C; van Walraven, C				Forster, Alan J.; Taljaard, Monica; Bennett, Carol; van Walraven, Carl			Reliability of the Peer-Review Process for Adverse Event Rating	PLOS ONE			English	Article							PATIENTS AFTER-DISCHARGE; LATENT CLASS ANALYSIS; HOSPITALIZED-PATIENTS; HEALTH-CARE; ERRORS; RATES	Background: Adverse events are poor patient outcomes caused by medical care. Their identification requires the peer-review of poor outcomes, which may be unreliable. Combining physician ratings might improve the accuracy of adverse event classification. Objective: To evaluate the variation in peer-reviewer ratings of adverse outcomes; determine the impact of this variation on estimates of reviewer accuracy; and determine the number of reviewers who judge an adverse event occurred that is required to ensure that the true probability of an adverse event exceeded 50%, 75% or 95%. Methods: Thirty physicians rated 319 case reports giving details of poor patient outcomes following hospital discharge. They rated whether medical management caused the outcome using a six-point ordinal scale. We conducted latent class analyses to estimate the prevalence of adverse events as well as the sensitivity and specificity of each reviewer. We used this model and Bayesian calculations to determine the probability that an adverse event truly occurred to each patient as function of their number of positive ratings. Results: The overall median score on the 6-point ordinal scale was 3 (IQR 2,4) but the individual rater median score ranged from a minimum of 1 (in four reviewers) to a maximum median score of 5. The overall percentage of cases rated as an adverse event was 39.7% (3798/9570). The median kappa for all pair-wise combinations of the 30 reviewers was 0.26 (IQR 0.16, 0.42; Min = -0.07, Max = 0.62). Reviewer sensitivity and specificity for adverse event classification ranged from 0.06 to 0.93 and 0.50 to 0.98, respectively. The estimated prevalence of adverse events using a latent class model with a common sensitivity and specificity for all reviewers (0.64 and 0.83 respectively) was 47.6%. For patients to have a 95% chance of truly having an adverse event, at least 3 of 3 reviewers are required to deem the outcome an adverse event. Conclusion: Adverse event classification is unreliable. To be certain that a case truly represents an adverse event, there needs to be agreement among multiple reviewers.	[Forster, Alan J.; Taljaard, Monica; Bennett, Carol; van Walraven, Carl] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Forster, Alan J.; van Walraven, Carl] Univ Ottawa, Dept Med, Fac Med, Ottawa, ON, Canada; [Forster, Alan J.; Bennett, Carol; van Walraven, Carl] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Taljaard, Monica] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Forster, AJ (corresponding author), Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada.	aforster@ohri.ca		Bennett, Carol/0000-0002-3033-9860; Taljaard, Monica/0000-0002-3978-8961	Canadian Institutes of Health Research [FRN: 79977]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a Canadian Institutes of Health Research grant (FRN: 79977 http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Bartholemew D J, 1987, LATENT VARIABLE MODE; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BRENNAN TA, 1989, MED CARE, V27, P1148, DOI 10.1097/00005650-198912000-00006; Dunn G., 1989, DESIGN ANAL RELIABIL; Fleiss JL., 2003, STAT METHODS RATES P; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Forster AJ, 2007, J CLIN EPIDEMIOL, V60, P892, DOI 10.1016/j.jclinepi.2006.11.019; HAYWARD RA, 1993, ANN INTERN MED, V118, P550, DOI 10.7326/0003-4819-118-7-199304010-00010; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; LAST JM, 1995, DICT EPIDEMIOLOGY; Pronovost PJ, 2006, JAMA-J AM MED ASSOC, V296, P696, DOI 10.1001/jama.296.6.696; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Skrondal A., 2004, GEN LATENT VARIABLE; Thomas EJ, 2002, ANN INTERN MED, V136, P812, DOI 10.7326/0003-4819-136-11-200206040-00009; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; UEBERSAX JS, 1990, STAT MED, V9, P559, DOI 10.1002/sim.4780090509; van Walraven C, 2010, J CLIN EPIDEMIOL, V63, P1000, DOI 10.1016/j.jclinepi.2010.01.023; Vermunt JK, 1997, LEM GEN PROGRAM ANAL; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; WALTER SD, 1988, J CLIN EPIDEMIOL, V41, P923, DOI 10.1016/0895-4356(88)90110-2; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	25	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41239	10.1371/journal.pone.0041239	http://dx.doi.org/10.1371/journal.pone.0041239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844445	gold, Green Submitted, Green Published			2022-12-27	WOS:000309240600018
J	Lehtinen, J; Raki, M; Bergstrom, KA; Uutela, P; Lehtinen, K; Hiltunen, A; Pikkarainen, J; Liang, HM; Pitkanen, S; Maatta, AM; Ketola, RA; Yliperttula, M; Wirth, T; Urtti, A				Lehtinen, Julia; Raki, Mari; Bergstrom, Kim A.; Uutela, Paivi; Lehtinen, Katariina; Hiltunen, Annukka; Pikkarainen, Jere; Liang, Huamin; Pitkanen, Sari; Maatta, Ann-Marie; Ketola, Raimo A.; Yliperttula, Marjo; Wirth, Thomas; Urtti, Arto			Pre-Targeting and Direct Immunotargeting of Liposomal Drug Carriers to Ovarian Carcinoma	PLOS ONE			English	Article							AVIDIN-BIOTIN TECHNOLOGY; PRETARGETED RADIOIMMUNOTHERAPY; IN-VITRO; MONOCLONAL-ANTIBODIES; PEGYLATED LIPOSOMES; COATED LIPOSOMES; ANTITUMOR DRUGS; SOLID TUMORS; MOUSE MODEL; CANCER	Background: Epidermal growth factor receptor (EGFR) is overexpressed in many solid tumor types, such as ovarian carcinoma. Immunoliposome based drug targeting has shown promising results in drug delivery to the tumors. However, the ratio of tumor-to-normal tissue concentrations should be increased to minimize the adverse effects of cytostatic drugs. Methodology/Principal Findings: We studied the EGFR-targeted doxorubicin immunoliposomes using pre-targeting and local intraperitoneal (i.p.) administration of the liposomes. This approach was used to increase drug delivery to tumors as compared to direct intravenous (i.v.) administration of liposomes. EGFR antibodies were attached on the surface of PEG coated liposomes using biotin-neutravidin binding. Receptor mediated cellular uptake and cytotoxic efficacy of EGFR-targeted liposomes were investigated in human ovarian adenocarcinoma (SKOV-3 and SKOV3.ip1) cells. In vivo distribution of the liposomes in mice was explored using direct and pre-targeting approaches and SPECT/CT imaging. Targeted liposomes showed efficient and specific receptor-mediated binding to ovarian carcinoma cells in vitro, but the difference in cytotoxicity between targeted and non-targeted liposomes remained small. The relatively low cytotoxic efficacy is probably due to insufficient doxorubicin release from the liposomes rather than lack of target binding. Tumor uptake of targeted liposomes in vivo was comparable to that of non-targeted liposomes after both direct and pre-targeting administration. For both EGFR-targeted and non-targeted liposomes, the i.p. administration increased liposome accumulation to the tumors compared to i.v. injections. Conclusions/Significance: Intraperitoneal administration of liposomes may be a beneficial approach to treat the tumors in the abdominal cavity. The i.p. pre-targeting method warrants further studies as a potential approach in cancer therapy.	[Lehtinen, Julia; Raki, Mari; Bergstrom, Kim A.; Uutela, Paivi; Ketola, Raimo A.; Urtti, Arto] Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland; [Lehtinen, Julia; Lehtinen, Katariina; Hiltunen, Annukka; Liang, Huamin; Yliperttula, Marjo] Univ Helsinki, Div Biopharm & Pharmacokinet, Fac Pharm, Helsinki, Finland; [Pikkarainen, Jere; Maatta, Ann-Marie] Ark Therapeut, Kuopio, Finland; [Pikkarainen, Jere; Wirth, Thomas] Univ Eastern Finland, Dept Biotechnol & Mol Med, Kuopio, Finland; [Pitkanen, Sari] Univ Eastern Finland, Dept Biosci, Kuopio, Finland	University of Helsinki; University of Helsinki; University of Eastern Finland; University of Eastern Finland	Lehtinen, J (corresponding author), Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland.	julia.lehtinen@helsinki.fi	Liang, Huamin/B-9909-2011	Liang, Huamin/0000-0001-8688-7404; Viitala, Sari/0000-0002-1401-3406; Kurkipuro, Jere/0000-0002-5239-6532	Ark Therapeutics (Kuopio, Finland); Finnish Funding Agency for Technology and Innovation (Helsinki, Finland); Finnish Cultural Foundation (Helsinki, Finland); TEKES	Ark Therapeutics (Kuopio, Finland); Finnish Funding Agency for Technology and Innovation (Helsinki, Finland)(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Cultural Foundation (Helsinki, Finland)(Finnish Cultural Foundation); TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	This research was funded by Ark Therapeutics (Kuopio, Finland; www.arktherapeutics.com), TEKES, the Finnish Funding Agency for Technology and Innovation (Helsinki, Finland; www.tekes.fi) and the Finnish Cultural Foundation (Helsinki, Finland; www.skr.fi). The public funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Company funder, Ark Therapeutics, participated in study design and performed one of the animal experiments.	Axworthy DB, 2000, P NATL ACAD SCI USA, V97, P1802, DOI 10.1073/pnas.97.4.1802; Boerman OC, 2003, J NUCL MED, V44, P400; Bolotin Elijah M., 1994, Journal of Liposome Research, V4, P455, DOI 10.3109/08982109409037057; Chen LC, 2007, NUCL MED BIOL, V34, P415, DOI 10.1016/j.nucmedbio.2007.02.003; Chuang KH, 2010, MOL CANCER THER, V9, P1903, DOI 10.1158/1535-7163.MCT-09-0899; DEJONG J, 1993, TRAC-TREND ANAL CHEM, V12, P422, DOI 10.1016/0165-9936(93)80006-6; Forero A, 2004, BLOOD, V104, P227, DOI 10.1182/blood-2003-09-3284; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 1999, BIOCONJUGATE CHEM, V10, P289, DOI 10.1021/bc9801124; Goins Beth A., 2003, P319; Hamblett KJ, 2005, BIOCONJUGATE CHEM, V16, P131, DOI 10.1021/bc034049g; Harding JA, 1997, BBA-BIOMEMBRANES, V1327, P181, DOI 10.1016/S0005-2736(97)00056-4; Hsieh YJ, 2008, INT J PHARM, V350, P265, DOI 10.1016/j.ijpharm.2007.09.002; Huhtala T, 2010, NUCL MED BIOL, V37, P957, DOI 10.1016/j.nucmedbio.2010.03.001; Ishida T, 2006, INT J PHARM, V309, P94, DOI 10.1016/j.ijpharm.2005.11.010; Kirchmeier MJ, 2001, J LIPOSOME RES, V11, P15, DOI 10.1081/LPR-100103167; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Kullberg M, 2009, J DRUG TARGET, V17, P98, DOI [10.1080/10611860802471562, 10.1080/10611860802471562 ]; Lee CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-255; Lehtinen J, 2008, J CONTROL RELEASE, V131, P145, DOI 10.1016/j.jconrel.2008.07.018; Lehtinen J, 2012, EUR J PHARM SCI, V46, P121, DOI 10.1016/j.ejps.2012.02.009; Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749; Lin YY, 2009, CANCER BIOTHER RADIO, V24, P453, DOI 10.1089/cbr.2008.0572; Mamot C, 2005, CANCER RES, V65, P11631, DOI 10.1158/0008-5472.CAN-05-1093; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; Mastrobattista E, 1999, ADV DRUG DELIVER REV, V40, P103, DOI 10.1016/S0169-409X(99)00043-5; Nobs L, 2006, BIOCONJUGATE CHEM, V17, P139, DOI 10.1021/bc050137k; Noske A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-294; Paasonen L, 2007, J CONTROL RELEASE, V122, P86, DOI 10.1016/j.jconrel.2007.06.009; Pan H, 2008, J CONTROL RELEASE, V125, P228, DOI 10.1016/j.jconrel.2007.10.016; Perez-Soler R, 2004, ONCOLOGIST, V9, P58, DOI 10.1634/theoncologist.9-1-58; Phelps SLB, 2008, GYNECOL ONCOL, V109, P411, DOI 10.1016/j.ygyno.2008.02.030; Pulkkinen M, 2008, EUR J PHARM BIOPHARM, V70, P66, DOI 10.1016/j.ejpb.2008.04.018; Sadzuka Y, 1997, CANCER LETT, V111, P77, DOI 10.1016/S0304-3835(96)04513-2; Sharkey RM, 2003, CANCER RES, V63, P354; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Xiao Z, 2002, J BIOTECHNOL, V94, P171, DOI 10.1016/S0168-1656(01)00424-2; YU DH, 1993, CANCER RES, V53, P891; YUAN F, 1995, CANCER RES, V55, P3752; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zavaleta CL, 2007, INT J PHARM, V337, P316, DOI 10.1016/j.ijpharm.2007.01.010	42	41	44	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41410	10.1371/journal.pone.0041410	http://dx.doi.org/10.1371/journal.pone.0041410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844475	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600026
J	Liu, Z; Zhang, B; Liu, K; Ding, Z; Hu, X				Liu, Zhen; Zhang, Biao; Liu, Kun; Ding, Zonghui; Hu, Xun			Schisandrin B Attenuates Cancer Invasion and Metastasis Via Inhibiting Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							MEDIATED MULTIDRUG-RESISTANCE; BREAST-CANCER; P-GLYCOPROTEIN; MOUSE MODEL; CELL-LINES; TGF-BETA; PROGRESSION; APOPTOSIS; TUMORS; TWIST	Background: Metastasis is the major cause of cancer related death and targeting the process of metastasis has been proposed as a strategy to combat cancer. Therefore, to develop candidate drugs that target the process of metastasis is very important. In the preliminary studies, we found that schisandrin B (Sch B), a naturally-occurring dibenzocyclooctadiene lignan with very low toxicity, could suppress cancer metastasis. Methodology: BALB/c mice were inoculated subcutaneously or injected via tail vein with murine breast cancer 4T1 cells. Mice were divided into Sch B-treated and control groups. The primary tumor growth, local invasion, lung and bone metastasis, and survival time were monitored. Tumor biopsies were examined immuno- and histo-pathologically. The inhibitory activity of Sch B on TGF-beta induced epithelial-mesenchymal transition (EMT) of 4T1 and primary human breast cancer cells was assayed. Principal Findings: Sch B significantly suppressed the spontaneous lung and bone metastasis of 4T1 cells inoculated s.c. without significant effect on primary tumor growth and significantly extended the survival time of these mice. Sch B did not inhibit lung metastasis of 4T1 cells that were injected via tail vein. Delayed start of treatment with Sch B in mice with preexisting tumors did not reduce lung metastasis. These results suggested that Sch B acted at the step of local invasion. Histopathological evidences demonstrated that the primary tumors in Sch B group were significantly less locally invasive than control tumors. In vitro assays demonstrated that Sch B could inhibit TGF-b induced EMT of 4T1 cells and of primary human breast cancer cells. Conclusions: Sch B significantly suppresses the lung and bone metastasis of 4T1 cells via inhibiting EMT, suggesting its potential application in targeting the process of cancer metastasis.	[Liu, Zhen; Zhang, Biao; Ding, Zonghui; Hu, Xun] Zhejiang Univ, Sch Med, Affiliated Hosp 2,Canc Inst, Key Lab Canc Intervent & Prevent,China Natl Minis, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Kun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg 2, Zhanjiang, Peoples R China	Zhejiang University; Zhejiang University	Liu, Z (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2,Canc Inst, Key Lab Canc Intervent & Prevent,China Natl Minis, Hangzhou 310003, Zhejiang, Peoples R China.	huxun@zju.edu.cn	Ding, Zonghui/H-9829-2019	Ding, Zonghui/0000-0001-9291-6435; Liu, Kun/0000-0001-7608-1335; Liu, Zhen/0000-0002-8910-9664	National 863 project [2007AA02Z143]; China Natural Sciences Foundation projects [30772544, 81071802]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	National 863 project; China Natural Sciences Foundation projects; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	This work was supported by National 863 project (2007AA02Z143), China Natural Sciences Foundation projects (30772544, 81071802) and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China, to X. Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; American Cancer Society, 2012, CANC FACTS FIG 2012, P9; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Box GM, 2011, METHODS MOL BIOL, V769, P311, DOI 10.1007/978-1-61779-207-6_21; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Demaria S, 2005, CLIN CANCER RES, V11, P728; Ding W, 2010, HEPATOLOGY, V52, P945, DOI 10.1002/hep.23748; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Fong WF, 2007, PLANTA MED, V73, P212, DOI 10.1055/s-2007-967120; Giridharan VV, 2012, FREE RADICAL RES, V46, P50, DOI 10.3109/10715762.2011.638291; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hancke JL, 1999, FITOTERAPIA, V70, P451, DOI 10.1016/S0367-326X(99)00102-1; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Huang M, 2008, CANCER CHEMOTH PHARM, V62, P1015, DOI 10.1007/s00280-008-0691-0; Ip SP, 1996, BIOCHEM PHARMACOL, V52, P1687, DOI 10.1016/S0006-2952(96)00517-5; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Li L, 2006, BIOCHEM PHARMACOL, V71, P584, DOI 10.1016/j.bcp.2005.11.026; Li L, 2007, CLIN CANCER RES, V13, P6753, DOI 10.1158/1078-0432.CCR-07-1579; Li L, 2007, LIFE SCI, V80, P741, DOI 10.1016/j.lfs.2006.11.002; Lorusso G, 2012, SEMIN CANC IN PRESS; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Man SL, 2008, CLIN EXP METASTAS, V25, P855, DOI 10.1007/s10585-008-9201-3; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; Office of Animal Care and Use, 2011, GUID ENDP AN STUD PR; Ottewell PD, 2006, BREAST CANCER RES TR, V96, P101, DOI 10.1007/s10549-005-9067-x; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pan QR, 2006, CANCER CHEMOTH PHARM, V58, P99, DOI 10.1007/s00280-005-0133-1; Pan SY, 2006, EUR J PHARMACOL, V537, P200, DOI 10.1016/j.ejphar.2006.03.001; Park EJ, 2012, BIOCHEM PHARMACOL, V83, P378, DOI 10.1016/j.bcp.2011.11.002; PRICE JE, 1990, CANCER RES, V50, P717; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Pulaski BA, 2001, MOUSE 4T1 BREAST TUM; Riihimaki M, 2012, ANN ONCOL, V23, P604, DOI 10.1093/annonc/mdr160; Sabel MS, 2010, BREAST CANCER RES TR, V122, P325, DOI 10.1007/s10549-009-0570-3; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Speirs V, 1998, BRIT J CANCER, V78, P1421, DOI 10.1038/bjc.1998.702; Sun M, 2007, CANCER LETT, V246, P300, DOI 10.1016/j.canlet.2006.03.009; Wu H, 2012, J PATHOL, V227, P189, DOI 10.1002/path.3978; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	53	33	41	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40480	10.1371/journal.pone.0040480	http://dx.doi.org/10.1371/journal.pone.0040480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848381	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600017
J	Mieczkowski, J; Swiatek-Machado, K; Kaminska, B				Mieczkowski, Jakub; Swiatek-Machado, Karolina; Kaminska, Bozena			Identification of Pathway Deregulation - Gene Expression Based Analysis of Consistent Signal Transduction	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; COLORECTAL-CANCER; BREAST-CANCER; CELL CANCER; METASTASIS; SIGNATURES; TUMORIGENESIS; BIOCONDUCTOR; RECEPTOR; THERAPY	Signaling pathways belong to a complex system of communication that governs cellular processes. They represent signal transduction from an extracellular stimulus via a receptor to intracellular mediators, as well as intracellular interactions. Perturbations in signaling cascade often lead to detrimental changes in cell function and cause many diseases, including cancer. Identification of deregulated pathways may advance the understanding of complex diseases and lead to improvement of therapeutic strategies. We propose Analysis of Consistent Signal Transduction (ACST), a novel method for analysis of signaling pathways. Our method incorporates information regarding pathway topology, as well as data on the position of every gene in each pathway. To preserve gene-gene interactions we use a subject-sampling permutation model to assess the significance of pathway perturbations. We applied our approach to nine independent datasets of global gene expression profiling. The results of ACST, as well as three other methods used to analyze signaling pathways, are presented in the context of biological significance and repeatability among similar, yet independent, datasets. We demonstrate the usefulness of using information of pathway structure as well as genes' functions in the analysis of signaling pathways. We also show that ACST leads to biologically meaningful results and high repeatability.	[Mieczkowski, Jakub; Swiatek-Machado, Karolina; Kaminska, Bozena] M Nencki Inst Expt Biol, Dept Cell Biol, Lab Transcript Regulat, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Mieczkowski, J (corresponding author), M Nencki Inst Expt Biol, Dept Cell Biol, Lab Transcript Regulat, Pasteur 3, PL-02093 Warsaw, Poland.	j.mieczkowski@nencki.gov.pl	Mieczkowski, Jakub/G-7251-2019; Kaminska, Bozena/B-2915-2014; Kaminska, Bozena/H-4592-2011	Mieczkowski, Jakub/0000-0002-2091-012X; Kaminska, Bozena/0000-0002-2642-4616	Ministry of Science and Higher Education (Poland) [N N301 551340]	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland)	The study was supported by grant N N301 551340 from the Ministry of Science and Higher Education (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhopuro P, 2012, INT J CANCER, V130, P1558, DOI 10.1002/ijc.26167; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Egunsola AT, 2012, CELL IMMUNOL, V272, P220, DOI 10.1016/j.cellimm.2011.10.008; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; Esteva-Font C, 2007, MED CLIN-BARCELONA, V129, P433, DOI 10.1157/13110477; Fellenberg M, 1999, BIOINFORMATICS, V99; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Fukata M, 2010, NAT MED, V16, P639, DOI 10.1038/nm0610-639; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giacomini CP, 2005, CANCER RES, V65, P9200, DOI 10.1158/0008-5472.CAN-04-4163; Gillis J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-306; Gimm O, 2001, CANCER LETT, V163, P143, DOI 10.1016/S0304-3835(00)00697-2; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Isci S, 2011, BIOINFORMATICS, V27, P1667, DOI 10.1093/bioinformatics/btr269; Jensen MB, 2010, J STEROID BIOCHEM, V121, P376, DOI 10.1016/j.jsbmb.2010.03.069; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keller A, 2009, BIOINFORMATICS, V25, P2787, DOI 10.1093/bioinformatics/btp510; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kruhoffer M, 2005, BRIT J CANCER, V92, P2240, DOI 10.1038/sj.bjc.6602621; Larsson O, 2006, NAT BIOTECHNOL, V24, P1322, DOI 10.1038/nbt1106-1322; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Mieczkowski J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-104; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Qi J, 2008, CURR DRUG TARGETS, V9, P548, DOI 10.2174/138945008784911769; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ryan AJ, 2005, CELL TISSUE RES, V322, P53, DOI 10.1007/s00441-005-1109-5; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Santegoets LAM, 2007, INT J CANCER, V121, P759, DOI 10.1002/ijc.22769; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Team R, 2010, R LANG ENV STAT COMP; Terragni J, 2011, J BIOL CHEM, V286, P36215, DOI 10.1074/jbc.M111.246116; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yuen J, 2009, J UROLOGY, V25, P427; Zhao YS, 2008, INT J COLORECTAL DIS, V23, P875, DOI 10.1007/s00384-008-0479-z	51	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41541	10.1371/journal.pone.0041541	http://dx.doi.org/10.1371/journal.pone.0041541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848524	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600082
J	Shen, L; Kim, SH; Chen, CY				Shen, Ling; Kim, Sung-Hoon; Chen, Chang Yan			Sensitization of Human Pancreatic Cancer Cells Harboring Mutated K-ras to Apoptosis	PLOS ONE			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; PHOSPHORYLATION; ADENOCARCINOMA; ISOFORMS; EPSILON; PATHWAY; DELTA; PKC	Pancreatic cancer is a devastating human malignancy and gain of functional mutations in K-ras oncogene is observed in 75%-90% of the patients. Studies have shown that oncogenic ras is not only able to promote cell growth or survival, but also apoptosis, depending upon circumstances. Using pancreatic cancer cell lines with or without expressing mutated K-ras, we demonstrated that the inhibition of endogenous PKC activity sensitized human pancreatic cancer cells (MIA and PANC-1) expressing mutated K-ras to apoptosis, which had no apoptotic effect on BxPC-3 pancreatic cancer cells that contain a normal Ras as well as human lung epithelial BAES-2B cells. In this apoptotic process, the level of ROS was increased and PUMA was upregulated in a p73-dependent fashion in MIA and PANC-1 cells. Subsequently, caspase-3 was cleaved. A full induction of apoptosis required the activation of both ROS- and p73-mediated pathways. The data suggest that PKC is a crucial factor that copes with aberrant K-ras to maintain the homeostasis of the pancreatic cancer cells harboring mutated K-ras. However, the suppression or loss of PKC disrupts the balance and initiates an apoptotic crisis, in which ROS and p73 appear the potential, key targets.	[Shen, Ling; Chen, Chang Yan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA; [Kim, Sung-Hoon] Kyung Hee Univ, Grad Sch EW Med Sci, Lab Angiogenesis & Chemoprevent, Seoul, South Korea	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyung Hee University	Shen, L (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA.	cchen6@bidmc.harvard.edu		kim, sunghoon/0000-0002-1570-3230	internal JCRT (Joint Center for Radiation Therapy, Harvard Medical School); National Institute of Health [1RO1CA100498]; NATIONAL CANCER INSTITUTE [R01CA100498] Funding Source: NIH RePORTER	internal JCRT (Joint Center for Radiation Therapy, Harvard Medical School); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was in part supported by an internal JCRT (Joint Center for Radiation Therapy, Harvard Medical School) and National Institute of Health 1RO1CA100498 awarded to Chang Yan Chen. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agami R, 1999, NATURE, V399, P809; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Aziz MH, 2006, CANCER RES, V66, P713, DOI 10.1158/0008-5472.CAN-05-2684; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Cappel WHDTN, 2003, CLIN CANCER RES, V9, P3598; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Cohenuram M, 2007, J PANCREAS, V8, P4; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Guo JJ, 2009, J CELL BIOCHEM, V107, P76, DOI 10.1002/jcb.22102; Jansen AP, 2001, CANCER RES, V61, P808; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; KALTHOFF H, 1993, ONCOGENE, V8, P289; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Kurinna S, 2006, LEUKEMIA, V20, P1316, DOI 10.1038/sj.leu.2404248; MANECKJEE R, 1994, CELL GROWTH DIFFER, V5, P1033; McCormic F, 1993, NATURE, V363, P5; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; PASTOR MI, 1995, CANCER SURV, V22, P75; Perletti GP, 1996, ONCOGENE, V12, P847; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Roberti MP, 2011, BREAST CANCER RES TR, V130, P465, DOI 10.1007/s10549-011-1360-2; Rusanescu G, 2001, MOL CELL BIOL, V21, P2650, DOI 10.1128/MCB.21.8.2650-2658.2001; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Schutte M, 1997, CANCER RES, V57, P3126; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Shama GD, 2007, EXP EYE RES, V85, P298; Shi X, 2001, PANCREATOLOGY, V1, P517, DOI 10.1159/000055854; Skowronski EW, 1996, CELL DEATH DIFFER, V3, P171; Tomaszewska Romana, 1998, Polish Journal of Pathology, V49, P83; Zhu T, 2010, ONCOGENE, V29, P1050, DOI 10.1038/onc.2009.344; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	44	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40435	10.1371/journal.pone.0040435	http://dx.doi.org/10.1371/journal.pone.0040435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848379	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600016
J	Fuentes, F; Zimmer, D; Atienza, M; Schottenfeld, J; Penkala, I; Bale, T; Bence, KK; Arregui, CO				Fuentes, Federico; Zimmer, Derek; Atienza, Marybless; Schottenfeld, Jamie; Penkala, Ian; Bale, Tracy; Bence, Kendra K.; Arregui, Carlos O.			Protein Tyrosine Phosphatase PTP1B Is Involved in Hippocampal Synapse Formation and Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE DEVELOPMENT; BETA-CATENIN; N-CADHERIN; ENDOPLASMIC-RETICULUM; STRUCTURAL PLASTICITY; ADHESION MOLECULES; MEDIATED ADHESION; GROWTH CONES; KINASE FER	ER-bound PTP1B is expressed in hippocampal neurons, and accumulates among neurite contacts. PTP1B dephosphorylates beta-catenin in N-cadherin complexes ensuring cell-cell adhesion. Here we show that endogenous PTP1B, as well as expressed GFP-PTP1B, are present in dendritic spines of hippocampal neurons in culture. GFP-PTP1B overexpression does not affect filopodial density or length. In contrast, impairment of PTP1B function or genetic PTP1B-deficiency leads to increased filopodia-like dendritic spines and a reduction in mushroom-like spines, while spine density is unaffected. These morphological alterations are accompanied by a disorganization of pre- and post-synapses, as judged by decreased clustering of synapsin-1 and PSD-95, and suggest a dynamic synaptic phenotype. Notably, levels of beta-catenin-Tyr-654 phosphorylation increased similar to 5-fold in the hippocampus of adult PTP1B(-/-) (KO) mice compared to wild type (WT) mice and this was accompanied by a reduction in the amount of beta-catenin associated with N-cadherin. To determine whether PTP1B-deficiency alters learning and memory, we generated mice lacking PTP1B in the hippocampus and cortex (PTP1B(fl/fl)-Emx1-Cre). PTP1B(fl/fl)-Emx1-Cre mice displayed improved performance in the Barnes maze (decreased time to find and enter target hole), utilized a more efficient strategy (cued), and had better recall compared to WT controls. Our results implicate PTP1B in structural plasticity within the hippocampus, likely through modulation of N-cadherin function by ensuring dephosphorylation of beta-catenin on Tyr-654. Disruption of hippocampal PTP1B function or expression leads to elongation of dendritic filopodia and improved learning and memory, demonstrating an exciting novel role for this phosphatase.	[Fuentes, Federico; Arregui, Carlos O.] Univ San Martin, CONICET, Inst Invest Biotecnol, Buenos Aires, DF, Argentina; [Zimmer, Derek; Atienza, Marybless; Schottenfeld, Jamie; Penkala, Ian; Bale, Tracy; Bence, Kendra K.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Pennsylvania	Fuentes, F (corresponding author), Univ Buenos Aires, Fac Exact & Nat Sci, Max Planck Lab Cellular Dynam, Ciudad Univ, Buenos Aires, DF, Argentina.	kbence@vet.upenn.edu; carregui@iib.unsam.edu.ar		Arregui, Carlos/0000-0003-0704-3321; Bence, Kendra/0000-0002-5879-4726; Penkala, Ian/0000-0002-4932-2970	NIH [DK082417]; Bunge y Born-Fulbright Scholarship;  [PICT 31939];  [PICT 332]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bunge y Born-Fulbright Scholarship; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	COA: PICT 31939 AND PICT 332, http://www.agencia.mincyt.gov.ar/spip.php?article28; KKB: NIH DK082417; FF: Bunge y Born-Fulbright Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arregui C, 2000, J CELL BIOL, V149, P1263, DOI 10.1083/jcb.149.6.1263; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Bult A, 1996, J NEUROSCI, V16, P7821; Chacon PJ, 2010, MOL CELL NEUROSCI, V43, P384, DOI 10.1016/j.mcn.2010.01.005; DAILEY ME, 1989, J NEUROSCI, V9, P1897; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fuentes F, 2009, MOL BIOL CELL, V20, P1878, DOI 10.1091/mbc.E08-07-0675; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Goetze B, 2004, J NEUROBIOL, V60, P517, DOI 10.1002/neu.20073; Gorski JA, 2002, J NEUROSCI, V22, P6309; Goslin K., 1991, CULTURING NERVE CELL, P251; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Gu Jiaping, 2009, Open Neurosci J, V3, P128; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; Hilfiker S, 1999, NAT NEUROSCI, V2, P104, DOI 10.1038/5659; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horn KE, 2012, J NEUROCHEM, V122, P147, DOI 10.1111/j.1471-4159.2012.07762.x; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pathre P, 2001, J NEUROSCI RES, V63, P143, DOI 10.1002/1097-4547(20010115)63:2<143::AID-JNR1006>3.0.CO;2-1; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Rhee J, 2001, J BIOL CHEM, V276, P6640, DOI 10.1074/jbc.M007656200; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Venkitaramani DV, 2011, EUR J NEUROSCI, V33, P2288, DOI 10.1111/j.1460-9568.2011.07687.x; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Xu G, 2002, J BIOL CHEM, V277, P49989, DOI 10.1074/jbc.M206454200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	81	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41536	10.1371/journal.pone.0041536	http://dx.doi.org/10.1371/journal.pone.0041536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844492	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700104
J	Guzman-Gutierrez, E; Westermeier, F; Salomon, C; Gonzalez, M; Pardo, F; Leiva, A; Sobrevia, L				Guzman-Gutierrez, Enrique; Westermeier, Francisco; Salomon, Carlos; Gonzalez, Marcelo; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis			Insulin-Increased L-Arginine Transport Requires A(2A) Adenosine Receptors Activation in Human Umbilical Vein Endothelium	PLOS ONE			English	Article							FACTOR-KAPPA-B; NITRIC-OXIDE; DIFFERENTIAL EXPRESSION; INTERNATIONAL UNION; CELLS; INHIBITION; GLUCOSE; CLASSIFICATION; NOMENCLATURE; PHARMACOLOGY	Adenosine causes vasodilation of human placenta vasculature by increasing the transport of arginine via cationic amino acid transporters 1 (hCAT-1). This process involves the activation of A(2A) adenosine receptors (A(2A)AR) in human umbilical vein endothelial cells (HUVECs). Insulin increases hCAT-1 activity and expression in HUVECs, and A(2A)AR stimulation increases insulin sensitivity in subjects with insulin resistance. However, whether A(2A)AR plays a role in insulin-mediated increase in L-arginine transport in HUVECs is unknown. To determine this, we first assayed the kinetics of saturable L-arginine transport (1 minute, 37 degrees C) in the absence or presence of nitrobenzylthioinosine (NBTI, 10 mu mol/L, adenosine transport inhibitor) and/or adenosine receptors agonist/antagonists. We also determined hCAT-1 protein and mRNA expression levels (Western blots and quantitative PCR), and SLC7A1 (for hCAT-1) reporter promoter activity. Insulin and NBTI increased the extracellular adenosine concentration, the maximal velocity for L-arginine transport without altering the apparent K-m for L-arginine transport, hCAT-1 protein and mRNA expression levels, and SLC7A1 transcriptional activity. An A2AAR antagonist ZM-241385 blocked these effects. ZM241385 inhibited SLC7A1 reporter transcriptional activity to the same extent in cells transfected with pGL3-hCAT-1(-1606) or pGL3-hCAT-1(-650) constructs in the presence of NBTI + insulin. However, SLC7A1 reporter activity was increased by NBTI only in cells transfected with pGL3-hCAT-1(-1606), and the ZM-241385 sensitive fraction of the NBTI response was similar in the absence or in the presence of insulin. Thus, insulin modulation of hCAT-1 expression and activity requires functional A(2A)AR in HUVECs, a mechanism that may be applicable to diseases associated with fetal insulin resistance, such as gestational diabetes.	[Guzman-Gutierrez, Enrique; Westermeier, Francisco; Salomon, Carlos; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, CMPL,Div Obstet & Gynaecol,Med Res Ctr CIM, Santiago, Chile; [Gonzalez, Marcelo] Univ Concepcion, Fac Biol Sci, Dept Physiol, Vasc Physiol Lab, Concepcion, Chile	Pontificia Universidad Catolica de Chile; Universidad de Concepcion	Guzman-Gutierrez, E (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Sch Med, CMPL,Div Obstet & Gynaecol,Med Res Ctr CIM, Alameda 340, Santiago, Chile.	sobrevia@med.puc.cl	Salomon, Carlos F/L-2167-2013; Sobrevia, Luis/H-9608-2016; Westermeier, Francisco/AAL-4145-2021; Gonzalez, Marcelo/O-4416-2016; Guzman-Gutierrez, Enrique/H-3536-2016	Salomon, Carlos F/0000-0003-4474-0046; Westermeier, Francisco/0000-0002-4476-4198; Gonzalez, Marcelo/0000-0002-0521-3633; Sobrevia, Luis/0000-0001-5802-2243; Guzman-Gutierrez, Enrique/0000-0001-6589-5667	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 1120928, 11110059, 11100192]; Comision Nacional de Investigacion en Ciencia y Tecnologia [CONICYT], Chile [PIA Anillos ACT-73, AT-24100210]; CONICYT-PhD (Chile) fellowships	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion en Ciencia y Tecnologia [CONICYT], Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT-PhD (Chile) fellowships	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 1120928, 11110059, 11100192]; Comision Nacional de Investigacion en Ciencia y Tecnologia [CONICYT, PIA Anillos ACT-73, AT-24100210], Chile. FP holds a postdoctoral position (CONICYT PIA Anillos ACT-73 postdoctoral research associate at CMPL, Pontificia Universidad Catolica de Chile). EG-G, FW and CS hold CONICYT-PhD (Chile) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljada A, 2001, J CLIN ENDOCR METAB, V86, P450, DOI 10.1210/jc.86.1.450; Casanello P, 2002, CIRC RES, V91, P127, DOI 10.1161/01.RES.0000027813.55750.E7; Ciaraldi TP, 1997, J CLIN ENDOCR METAB, V82, P1421, DOI 10.1210/jc.82.5.1421; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; da Silva CG, 2006, CIRC RES, V98, pE39, DOI 10.1161/01.RES.0000215436.92414.1d; Dong YL, 2004, AM J PHYSIOL-HEART C, V286, pH230, DOI 10.1152/ajpheart.00140.2003; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Escudero C, 2008, PLACENTA, V29, P816, DOI 10.1016/j.placenta.2008.06.014; Espinoza J, 2011, AM J OBSTET GYNECOL, V205, DOI DOI 10.1016/J.AJ0G.2011.06.034; Feoktistov I, 2002, CIRC RES, V90, P531, DOI 10.1161/01.RES.0000012203.21416.14; Fredholm BB, 1998, J NEUROCHEM, V70, P1210; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gonzalez M, 2011, J CELL PHYSIOL, V226, P2916, DOI 10.1002/jcp.22635; Guo D, 2012, BRIT J PHARMACOL, V166, P1846, DOI 10.1111/j.1476-5381.2012.01897.x; Guzman-Gutierrez E, 2011, CURR VASC PHARMACOL, V9, P750, DOI 10.2174/157016111797484062; Hammermann R, 2001, AMINO ACIDS, V21, P211, DOI 10.1007/s007260170029; KENIMER JG, 1981, MOL PHARMACOL, V20, P585; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Klotz KN, 1999, N-S ARCH PHARMACOL, V360, P103, DOI 10.1007/s002109900044; Lappas M, 2011, ANTIOXID REDOX SIGN, V15, P3061, DOI 10.1089/ars.2010.3765; Leiva A, 2011, EXP DIABETES RES, DOI 10.1155/2011/349286; Linden J, 1999, MOL PHARMACOL, V56, P705; Munoz G, 2006, J CELL PHYSIOL, V209, P826, DOI 10.1002/jcp.20769; Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326; Pandolfi A, 2010, CARDIOVASC RES, V86, P9, DOI 10.1093/cvr/cvq055; Ramkumar V, 2011, CURR NEUROPHARMACOL, V9, P342, DOI 10.2174/157015911795596559; READ MA, 1993, BRIT J PHARMACOL, V110, P454, DOI 10.1111/j.1476-5381.1993.tb13832.x; SALVATORE CA, 1993, P NATL ACAD SCI USA, V90, P10365, DOI 10.1073/pnas.90.21.10365; Sands WA, 2004, MOL PHARMACOL, V66, P1147, DOI 10.1124/mol.104.001107; Srinivasan M, 2005, J AM COLL CARDIOL, V46, P42, DOI 10.1016/j.jacc.2005.03.056; Steinberg HO, 2002, DIABETOLOGIA, V45, P623, DOI 10.1007/s00125-002-0800-2; Tsai PS, 2006, ANESTHESIOLOGY, V105, P1201, DOI 10.1097/00000542-200612000-00020; Vasquez G, 2004, J PHYSIOL-LONDON, V560, P111, DOI 10.1113/jphysiol.2004.068288; Vaquez R, 2007, J CELL PHYSIOL, V212, P626, DOI 10.1002/jcp.21057; Vega JL, 2009, CARDIOVASC RES, V82, P458, DOI 10.1093/cvr/cvp045; Visigalli R, 2007, BBA-BIOMEMBRANES, V1768, P1479, DOI 10.1016/j.bbamem.2007.02.016; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Wyatt AW, 2002, FASEB J, V16, P1584, DOI 10.1096/fasebj.16.12.1584; Zhang Wan-fu, 2010, Zhonghua Shao Shang Za Zhi, V26, P175	40	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41705	10.1371/journal.pone.0041705	http://dx.doi.org/10.1371/journal.pone.0041705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844517	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700143
J	Huang, TT; Ojcius, DM; Young, JD; Wu, YH; Ko, YF; Wong, TY; Wu, CY; Lu, CC; Lai, HC				Huang, Tsung-Teng; Ojcius, David M.; Young, John D.; Wu, Yi-Hui; Ko, Yun-Fei; Wong, Tsui-Yin; Wu, Cheng-Yeu; Lu, Chia-Chen; Lai, Hsin-Chih			The Anti-Tumorigenic Mushroom Agaricus blazei Murill Enhances IL-1 beta Production and Activates the NLRP3 Inflammasome in Human Macrophages	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; NALP3 INFLAMMASOME; P2X(7) RECEPTOR; CATHEPSIN-B; BETA-GLUCAN; IN-VITRO; MICE; EXTRACT; SECRETION; RELEASE	Agaricus blazei Murill (AbM) has been reported to possess immune activity against tumors and infections through stimulation of mononuclear phagocytes. Recently, AbM extract was shown to induce the production of the pro-inflammatory cytokine, interleukin-1 beta (IL-1 beta), in human monocytes. IL-1 beta is a key pro-inflammatory cytokine produced by activated macrophages and monocytes and its secretion is strictly controlled by the inflammasome. The purpose of this study is to investigate the effect of AbM water extracts on the regulation of IL-1 beta production and activation of the NLRP3 inflammasome in human THP-1 macrophages. The NLRP3 inflammasome consists of an NLRP3 receptor, an adaptor protein called ASC, and the inflammatory protease, caspase-1. Typically, stimulation of immune cells with microbial products results in production of pro-IL-1 beta, but a second stress-related signal activates the inflammasome and caspase-1, leading to processing and secretion of IL-1 beta. Our results show that AbM enhances transcription of IL-1 beta and triggers NLRP3 inflammasome-mediated IL-1 beta secretion in human THP-1 macrophages. AbM-mediated IL-1 beta secretion was markedly reduced in macrophages deficient in NLRP3 and ASC, demonstrating that the NLRP3 inflammasome is essential for AbM-induced IL-1 beta secretion. In addition, caspase-1 was activated and involved in proteolytic cleavage and secretion of IL-1 beta in AbM-treated macrophages. AbM-mediated IL-1 beta secretion also decreased in cells treated with cathepsin B inhibitor, suggesting that AbM can induce the release of cathepsin B. Furthermore, our data show that AbM-induced inflammasome activation requires the release of ATP, binding of extracellular ATP to the purinergic receptor P2X(7), the generation of reactive oxygen species, and efflux of potassium. Taken together, these findings reveal that AbM activates the NLRP3 inflammasome via multiple mechanisms, resulting in the secretion of IL-1 beta.	[Huang, Tsung-Teng; Ojcius, David M.; Young, John D.; Wong, Tsui-Yin; Wu, Cheng-Yeu; Lai, Hsin-Chih] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Young, John D.; Wong, Tsui-Yin; Wu, Cheng-Yeu] Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Wong, Tsui-Yin; Wu, Cheng-Yeu; Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Young, John D.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Young, John D.; Ko, Yun-Fei] Mingchi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan; [Wu, Yi-Hui] Natl Cheng Kung Univ Hosp, Canc Res Ctr, Tainan 70428, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; University of California System; University of California Merced; Rockefeller University; Ming Chi University of Technology; National Cheng Kung University; National Cheng Kung University Hospital; Fu Jen Catholic University	Huang, TT (corresponding author), Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan.	hclai@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council [NSC100-2321-B-002-009]; Chang Gung Memorial Hospital [CMRPD190302]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council (NSC100-2321-B-002-009) and Chang Gung Memorial Hospital (CMRPD190302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bernardshaw S, 2006, SHOCK, V25, P420, DOI 10.1097/01.shk.0000209526.58614.92; Bernardshaw S, 2005, SCAND J IMMUNOL, V62, P393, DOI 10.1111/j.1365-3083.2005.01667.x; Bernardshaw S, 2007, APMIS, V115, P719, DOI 10.1111/j.1600-0463.2007.apm_619.x; Bernardshaw S, 2005, INFLAMMATION, V29, P147, DOI 10.1007/s10753-006-9010-2; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ebina T, 1998, BIOTHERAPY, V11, P259, DOI 10.1023/A:1008054111445; Ellertsen LK, 2006, INT IMMUNOPHARMACOL, V6, P133, DOI 10.1016/j.intimp.2005.07.007; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Firenzuoli F, 2008, EVID-BASED COMPL ALT, V5, P3, DOI 10.1093/ecam/nem007; Forland DT, 2010, CYTOKINE, V49, P245, DOI 10.1016/j.cyto.2009.09.002; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Frlan R, 2006, CURR MED CHEM, V13, P2309, DOI 10.2174/092986706777935122; Fujimiya Y, 1998, CANCER IMMUNOL IMMUN, V46, P147, DOI 10.1007/s002620050473; Fujimiya Y, 1999, ANTICANCER RES, V19, P113; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hetland G, 2008, SCAND J IMMUNOL, V68, P363, DOI 10.1111/j.1365-3083.2008.02156.x; Hetland G, 2000, FEMS IMMUNOL MED MIC, V27, P111, DOI 10.1111/j.1574-695X.2000.tb01420.x; Hetland G, 1998, SCAND J IMMUNOL, V47, P548; Hetland G, 2002, FEMS IMMUNOL MED MIC, V33, P41, DOI 10.1111/j.1574-695X.2002.tb00570.x; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; ITOH H, 1994, JPN J PHARMACOL, V66, P265, DOI 10.1254/jjp.66.265; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; KAWAGISHI H, 1989, CARBOHYD RES, V186, P267, DOI 10.1016/0008-6215(89)84040-6; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mizuno M, 1999, BIOCHEM MOL BIOL INT, V47, P707; Nakajima A, 2002, INT IMMUNOPHARMACOL, V2, P1205, DOI 10.1016/S1567-5769(02)00056-5; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Said-Sadier N, 2012, CHANG GUNG MED J, V35, P297; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Smiderle FR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-58; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sorimachi K, 2001, CELL STRUCT FUNCT, V26, P103, DOI 10.1247/csf.26.103; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Takaku T, 2001, J NUTR, V131, P1409, DOI 10.1093/jn/131.5.1409; Vancompernolle K, 1998, FEBS LETT, V438, P150, DOI 10.1016/S0014-5793(98)01275-7; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	63	15	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41383	10.1371/journal.pone.0041383	http://dx.doi.org/10.1371/journal.pone.0041383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844468	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700079
J	Kneitel, JM				Kneitel, Jamie M.			Are Trade-Offs Among Species' Ecological Interactions Scale Dependent? A Test Using Pitcher-Plant Inquiline Species	PLOS ONE			English	Article							COMMUNITY STRUCTURE; FOOD WEBS; COMPETITION; COEXISTENCE; PREDATION; DISPERSAL; DIVERSITY; TRAITS; MECHANISMS; RICHNESS	Trade-offs among species' ecological interactions is a pervasive explanation for species coexistence. The traits associated with trade-offs are typically measured to mechanistically explain species coexistence at a single spatial scale. However, species potentially interact at multiple scales and this may be reflected in the traits among coexisting species. I quantified species' ecological traits associated with the trade-offs expected at both local (competitive ability and predator tolerance) and regional (competitive ability and colonization rate) community scales. The most common species (four protozoa and a rotifer) from the middle trophic level of a pitcher plant (Sarracenia purpurea) inquiline community were used to link species traits to previously observed patterns of species diversity and abundance. Traits associated with trade-offs (competitive ability, predator tolerance, and colonization rate) and other ecological traits (size, growth rate, and carrying capacity) were measured for each of the focal species. Traits were correlated with one another with a negative relationship indicative of a trade-off. Protozoan and rotifer species exhibited a negative relationship between competitive ability and predator tolerance, indicative of coexistence at the local community scale. There was no relationship between competitive ability and colonization rate. Size, growth rate, and carrying capacity were correlated with each other and the trade-off traits: Size was related to both competitive ability and predator tolerance, but growth rate and carrying capacity were correlated with predator tolerance. When partial correlations were conducted controlling for size, growth rate and carrying capacity, the trade-offs largely disappeared. These results imply that body size is the trait that provides the basis for ecological interactions and trade-offs. Altogether, this study showed that the examination of species' traits in the context of coexistence at different scales can contribute to our understanding of the mechanisms underlying community structure.	Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA	California State University System; California State University Sacramento	Kneitel, JM (corresponding author), Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA.	kneitel@csus.edu		Kneitel, Jamie/0000-0002-7841-1198	NSF [DEB-0083617, DEB-0091776]	NSF(National Science Foundation (NSF))	This project was funded by NSF grants DEB-0083617 and DEB-0091776 to T. E. Miller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; BALCIUNAS D, 1995, ECOLOGY, V76, P1327, DOI 10.2307/1940939; Bohannan BJM, 2002, ANTON LEEUW INT J G, V81, P107, DOI 10.1023/A:1020585711378; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; Brewer JS, 1998, OIKOS, V82, P347, DOI 10.2307/3546975; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Buckley HL, 2010, GLOBAL ECOL BIOGEOGR, V19, P711, DOI 10.1111/j.1466-8238.2010.00554.x; Buckley HL, 2003, ECOL LETT, V6, P825, DOI 10.1046/j.1461-0248.2003.00504.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; Cadotte MW, 2006, AM NAT, V168, P704, DOI 10.1086/508296; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; Coomes DA, 2002, OIKOS, V96, P421, DOI 10.1034/j.1600-0706.2002.960304.x; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Gudelj I, 2010, ECOL LETT, V13, P1073, DOI 10.1111/j.1461-0248.2010.01507.x; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; HARRISON S, 1995, AM NAT, V145, P546, DOI 10.1086/285755; Harvey E, 1996, OECOLOGIA, V108, P562, DOI 10.1007/BF00333734; HEARD SB, 1994, EVOL ECOL, V8, P493, DOI 10.1007/BF01238254; HilleRisLambers R, 2003, P ROY SOC B-BIOL SCI, V270, P2591, DOI 10.1098/rspb.2003.2532; Hoekman D, 2011, OECOLOGIA, V165, P1073, DOI 10.1007/s00442-010-1802-2; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Kneitel JM, 2004, ECOLOGY, V85, P2088, DOI 10.1890/03-3172; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; KURIHARA Y, 1990, ECOLOGY, V71, P645, DOI 10.2307/1940318; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; LUCKINBILL LS, 1979, AM NAT, V113, P427, DOI 10.1086/283400; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Maguire Jr B, 1971, ANNU REV ECOL SYST, V2, P439, DOI [DOI 10.1146/ANNUREV.ES.02.110171.002255, 10.1146/annurev.es.02.110171.002255]; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; MILLER T, 1994, AM MIDL NAT, V131, P136, DOI 10.2307/2426616; Miller TE, 2002, ECOLOGY, V83, P898, DOI 10.1890/0012-9658(2002)083[0898:EOCSOI]2.0.CO;2; Miller TE, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P122; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Shurin JB, 2001, AM NAT, V158, P624, DOI 10.1086/323589; Steiner CF, 2003, OIKOS, V101, P569, DOI 10.1034/j.1600-0706.2003.12309.x; Suding KN, 2003, ECOLOGY, V84, P1; terHorst CP, 2011, J EVOLUTION BIOL, V24, P36, DOI 10.1111/j.1420-9101.2010.02140.x; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Violle C, 2010, P NATL ACAD SCI USA, V107, P12925, DOI 10.1073/pnas.1000699107; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337	55	12	12	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41809	10.1371/journal.pone.0041809	http://dx.doi.org/10.1371/journal.pone.0041809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844526	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700153
J	Lass, U; Numann, A; von Eckardstein, K; Kiwit, J; Stockhammer, F; Horaczek, JA; Veelken, J; Herold-Mende, C; Jeuken, J; von Deimling, A; Mueller, W				Lass, Ulrike; Nuemann, Astrid; von Eckardstein, Kajetan; Kiwit, Juergen; Stockhammer, Florian; Horaczek, Joern A.; Veelken, Julian; Herold-Mende, Christel; Jeuken, Judith; von Deimling, Andreas; Mueller, Wolf			Clonal Analysis in Recurrent Astrocytic, Oligoastrocytic and Oligodendroglial Tumors Implicates IDH1- Mutation as Common Tumor Initiating Event	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; GLIOMATOSIS CEREBRI; GENETIC-ANALYSIS; NERVOUS-SYSTEM; 1P; RESISTANCE; SURVIVAL; 19Q; TEMOZOLOMIDE; ASSAY	Background: To investigate the dynamics of inter- and intratumoral molecular alterations during tumor progression in recurrent gliomas. Methodology/Principal Findings: To address intertumoral heterogeneity we investigated non-microdissected tumor tissue of 106 gliomas representing 51 recurrent tumors. To address intratumoral heterogeneity a set of 16 gliomas representing 7 tumor pairs with at least one recurrence, and 4 single mixed gliomas were investigated by microdissection of distinct oligodendroglial and astrocytic tumor components. All tumors and tumor components were analyzed for allelic loss of 1p/19q (LOH 1p/19q), for TP53-mutations and for R132 mutations in the IDH1 gene. The investigation of non-microdissected tumor tissue revealed clonality in 75% (38/51). Aberrant molecular alterations upon recurrence were detected in 25% (13/51). 64% (9/14) of these were novel and associated with tumor progression. Loss of previously detected alterations was observed in 36% (5/14). One tumor pair (1/14; 7%) was significant for both. Intratumoral clonality was detected in 57% (4/7) of the microdissected tumor pairs and in 75% (3/4) of single microdissected tumors. 43% (3/7) of tumor pairs and one single tumor (25%) revealed intratumoral heterogeneity. While intratumoral heterogeneity affected both the TP53-mutational status and the LOH1p/19q status, all tumors with intratumoral heterogeneity shared the R132 IDH1-mutation as a common feature in both their microdissected components. Conclusions/Significance: The majority of recurrent gliomas are of monoclonal origin. However, the detection of divertive tumor cell clones in morphological distinct tumor components sharing IDH1-mutations as early event may provide insight into the tumorigenesis of true mixed gliomas.	[Lass, Ulrike; von Deimling, Andreas] German Canc Ctr DKFZ, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [von Deimling, Andreas; Mueller, Wolf] Univ Heidelberg Hosp, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Nuemann, Astrid] Charite, Dept Neurol, D-13353 Berlin, Germany; [Kiwit, Juergen] HELIOS Klinikum Berlin Buch, Dept Neurosurg, Berlin, Germany; [von Eckardstein, Kajetan; Stockhammer, Florian] Univ Hosp Gottingen, Dept Neurosurg, Gottingen, Germany; [Horaczek, Joern A.; Veelken, Julian] Vivantes Klinikum Neukolln, Dept Neurosurg, Berlin, Germany; [Herold-Mende, Christel] Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Jeuken, Judith] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; University of Gottingen; VIivantes Klinikum Neukolln; Ruprecht Karls University Heidelberg; Radboud University Nijmegen	Lass, U (corresponding author), German Canc Ctr DKFZ, Clin Cooperat Unit Neuropathol, Heidelberg, Germany.	wolf.mueller@med.uni-heidelberg.de	von Deimling, Andreas/F-7774-2013	von Deimling, Andreas/0000-0002-5863-540X; Stockhammer, Florian/0000-0002-0525-5956	TUMORZENTRUM, Heidelberg - Mannheim [D.10026951]	TUMORZENTRUM, Heidelberg - Mannheim	The present study was supported by the TUMORZENTRUM, Heidelberg - Mannheim, project number D.10026951. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Cahill Daniel P, 2008, Clin Neurosurg, V55, P165; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dong ZQ, 2002, HUM PATHOL, V33, P528, DOI 10.1053/hupa.2002.124784; Felsberg J, 2004, BRAIN PATHOL, V14, P121, DOI 10.1111/j.1750-3639.2004.tb00044.x; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Hartmann C, 2005, J NEUROPATH EXP NEUR, V64, P10, DOI 10.1093/jnen/64.1.10; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Kattar MM, 1997, HUM PATHOL, V28, P1166, DOI 10.1016/S0046-8177(97)90255-0; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kokubo Y, 2005, BRIT J CANCER, V92, P1711, DOI 10.1038/sj.bjc.6602559; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Kros JM, 2002, J NEUROPATH EXP NEUR, V61, P806, DOI 10.1093/jnen/61.9.806; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; LOUIS DN, 1992, AM J PATHOL, V141, P777; Martinez R, 2005, J NEURO-ONCOL, V72, P95, DOI 10.1007/s11060-004-3347-x; Martinez R, 2007, J NEURO-ONCOL, V83, P91, DOI 10.1007/s11060-006-9292-0; Mawrin C, 2005, ACTA NEUROPATHOL, V110, P527, DOI 10.1007/s00401-005-1083-8; Mawrin C, 2003, HUM PATHOL, V34, P102, DOI 10.1053/hupa.2003.1; Mueller W, 2001, BRAIN PATHOL, V11, P39; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Ohgaki H., 2009, CANC SCI; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Piechocki MP, 2007, CANCER RES, V67, P6825, DOI 10.1158/0008-5472.CAN-07-0765; Qu MQ, 2007, ACTA NEUROPATHOL, V113, P129, DOI 10.1007/s00401-006-0142-0; Sahm F, 2012, ARCH NEUROL-CHICAGO, V69, P523, DOI 10.1001/archneurol.2011.2910; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Tada M, 1996, INT J CANCER, V67, P447, DOI 10.1002/(SICI)1097-0215(19960729)67:3<447::AID-IJC22>3.0.CO;2-3; The WHO, 2020, CLASSIFICATION TUMOU; van Dijk MC, 2005, DIAGN MOL PATHOL, V14, P9, DOI 10.1097/01.pas.0000146701.98954.47; VONDEIMLING A, 1993, NEUROPATH APPL NEURO, V19, P524; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Zhu JJ, 1997, AM J PATHOL, V151, P565; Zhuang Z, 2004, NEUROLOGY, V62, P2316, DOI 10.1212/WNL.62.12.2316	41	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41298	10.1371/journal.pone.0041298	http://dx.doi.org/10.1371/journal.pone.0041298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844452	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700064
J	Miaskowski, C; Cooper, BA; Dhruva, A; Dunn, LB; Langford, DJ; Cataldo, JK; Baggott, CR; Merriman, JD; Dodd, M; Lee, K; West, C; Paul, SM; Aouizerat, BE				Miaskowski, Christine; Cooper, Bruce A.; Dhruva, Anand; Dunn, Laura B.; Langford, Dale J.; Cataldo, Janine K.; Baggott, Christina R.; Merriman, John D.; Dodd, Marylin; Lee, Kathryn; West, Claudia; Paul, Steven M.; Aouizerat, Bradley E.			Evidence of Associations between Cytokine Genes and Subjective Reports of Sleep Disturbance in Oncology Patients and Their Family Caregivers	PLOS ONE			English	Article							QUALITY-OF-LIFE; NF-KAPPA-B; PSYCHOMETRIC EVALUATION; INTERLEUKIN-6 GENE; RADIATION-THERAPY; PROSTATE-CANCER; TRAIT ANXIETY; FATIGUE; BREAST; SYMPTOMS	The purposes of this study were to identify distinct latent classes of individuals based on subjective reports of sleep disturbance; to examine differences in demographic, clinical, and symptom characteristics between the latent classes; and to evaluate for variations in pro- and anti-inflammatory cytokine genes between the latent classes. Among 167 oncology outpatients with breast, prostate, lung, or brain cancer and 85 of their FCs, growth mixture modeling (GMM) was used to identify latent classes of individuals based on General Sleep Disturbance Scale (GSDS) obtained prior to, during, and for four months following completion of radiation therapy. Single nucleotide polymorphisms (SNPs) and haplotypes in candidate cytokine genes were interrogated for differences between the two latent classes. Multiple logistic regression was used to assess the effect of phenotypic and genotypic characteristics on GSDS group membership. Two latent classes were identified: lower sleep disturbance (88.5%) and higher sleep disturbance (11.5%). Participants who were younger and had a lower Karnofsky Performance status score were more likely to be in the higher sleep disturbance class. Variation in two cytokine genes (i.e., IL6, NFKB) predicted latent class membership. Evidence was found for latent classes with distinct sleep disturbance trajectories. Unique genetic markers in cytokine genes may partially explain the interindividual heterogeneity characterizing these trajectories.	[Miaskowski, Christine; Langford, Dale J.; Cataldo, Janine K.; Baggott, Christina R.; Merriman, John D.; Dodd, Marylin; West, Claudia; Paul, Steven M.; Aouizerat, Bradley E.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Cooper, Bruce A.] Univ Calif San Francisco, Dept Community Hlth Syst, San Francisco, CA 94143 USA; [Dhruva, Anand] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dunn, Laura B.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Lee, Kathryn] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miaskowski, C (corresponding author), Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA.	chris.miaskowski@nursing.ucsf.edu	Merriman, John/AAX-4055-2021; Paul, Steve/ABE-5400-2020; Merriman, John/AAX-4054-2021	Merriman, John/0000-0002-7113-5389; Merriman, John/0000-0002-7113-5389	National Institute of Nursing Research [NR04835]; University of California San Francisco(UCSF) Academic Senate grant; National Institutes of Health (NIH) Roadmap for Medical Research Grant [KL2 RR624130]; American Cancer Society (ACS); NIH Mentored Patient-Oriented Research Career Development Award [K23 AT005340]; Department of Defense Breast Cancer Research Program Postdoctoral Fellowship; NINR fellowship [F31 NR012604]; ACS Doctoral Degree Scholarship [DSCN-10-087]; Oncology Nursing Society Doctoral Scholarship; UCSF Nursing Alumni Association Scholarship; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K23AT005340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [F31NR012604, R01NR004835] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); University of California San Francisco(UCSF) Academic Senate grant; National Institutes of Health (NIH) Roadmap for Medical Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); NIH Mentored Patient-Oriented Research Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Postdoctoral Fellowship(United States Department of Defense); NINR fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); ACS Doctoral Degree Scholarship; Oncology Nursing Society Doctoral Scholarship; UCSF Nursing Alumni Association Scholarship; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by a grant from the National Institute of Nursing Research (NR04835) and partially supported by an University of California San Francisco(UCSF) Academic Senate grant to LBD and BEA. BEA was funded through the National Institutes of Health (NIH) Roadmap for Medical Research Grant (KL2 RR624130). CM is funded by the American Cancer Society (ACS) as a Clinical Research Professor. AD is funded through NIH Mentored Patient-Oriented Research Career Development Award (K23 AT005340). DJL is supported by a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship. JDM is supported by an NINR fellowship (F31 NR012604), an ACS Doctoral Degree Scholarship (DSCN-10-087), an Oncology Nursing Society Doctoral Scholarship, and a UCSF Nursing Alumni Association Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Aouizerat BE, 2009, BIOL RES NURS, V11, P27, DOI 10.1177/1099800409333871; Beck SL, 2004, J PAIN SYMPTOM MANAG, V27, P140, DOI 10.1016/j.jpainsymman.2003.12.002; Berger AM, 2009, SUPPORT CARE CANC; Berger AM, 2008, J PAIN SYMPTOM MANAG, V36, P191, DOI 10.1016/j.jpainsymman.2007.10.008; Berger AM, 2007, J PAIN SYMPTOM MANAG, V33, P398, DOI 10.1016/j.jpainsymman.2006.09.022; Berger Ann M, 2005, Oncol Nurs Forum, V32, pE98, DOI 10.1188/05.ONF.E98-E126; Berger AM, 2009, ONCOL NURS FORUM, V36, P401, DOI 10.1188/09.ONF.E165-E177; Bieling PJ, 1998, BEHAV RES THER, V36, P777, DOI 10.1016/S0005-7967(98)00023-0; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carney S, 2011, J CLIN ONCOL, V29, P1001, DOI 10.1200/JCO.2010.30.9104; Carpenter J S, 1998, Issues Ment Health Nurs, V19, P481; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Chen ML, 2008, LUNG CANCER, V62, P391, DOI 10.1016/j.lungcan.2008.03.016; Cho MH, 2006, J CANCER EDUC, V21, pS37, DOI 10.1207/s15430154jce2101s_8; Cimprich B, 2005, PSYCHO-ONCOLOGY, V14, P70, DOI 10.1002/pon.821; CIMPRICH B, 1992, RES NURS HEALTH, V15, P199, DOI 10.1002/nur.4770150306; Cimprich B, 2011, PSYCHO-ONCOLOGY, V20, P194, DOI 10.1002/pon.1729; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Davidson JR, 2002, SOC SCI MED, V54, P1309, DOI 10.1016/S0277-9536(01)00043-0; Dhruva A, 2012, CANCER NURS, V35, P70, DOI 10.1097/NCC.0b013e3182194a25; Dunn LB, 2012, EUR J ONCOL NURS, V16, P1, DOI 10.1016/j.ejon.2011.01.003; Enders C. K., 2008, IDENTIFYING CORRECT; Fletcher BS, 2008, J CLIN ONCOL, V26, P599, DOI 10.1200/JCO.2007.12.2838; Foley KA, 2010, BEHAV SLEEP MED, V8, P90, DOI 10.1080/15402001003622842; Fortner BV, 2002, J PAIN SYMPTOM MANAG, V24, P471, DOI 10.1016/S0885-3924(02)00500-6; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garrett K, 2011, J PAIN SYMPTOM MANAG, V42, P239, DOI 10.1016/j.jpainsymman.2010.11.010; Gay Caryl L, 2004, Biol Res Nurs, V5, P311, DOI 10.1177/1099800403262142; Gibbins J, 2009, J PAIN SYMPTOM MANAG, V38, P860, DOI 10.1016/j.jpainsymman.2009.04.025; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hearson B, 2007, INT J PALLIAT NURS, V13, P495, DOI 10.12968/ijpn.2007.13.10.27493; Heffner KL, 2011, CLIN J PAIN, V27, P35, DOI 10.1097/AJP.0b013e3181eef761; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hublin C, 2011, SLEEP, V34, P957, DOI 10.5665/SLEEP.1136; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kennedy BL, 2001, PSYCHIAT QUART, V72, P263, DOI 10.1023/A:1010305200087; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Larkin EK, 2010, CTS-CLIN TRANSL SCI, V3, P337, DOI 10.1111/j.1752-8062.2010.00236.x; Lee K A, 1999, J Obstet Gynecol Neonatal Nurs, V28, P193, DOI 10.1111/j.1552-6909.1999.tb01984.x; LEE KA, 1992, SLEEP, V15, P493, DOI 10.1093/sleep/15.6.493; LEE KA, 1992, BIRTH-ISS PERINAT C, V19, P208, DOI 10.1111/j.1523-536X.1992.tb00404.x; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Magidson J, 2004, HDB QUANTITATIVE MET, P175, DOI DOI 10.4135/9781412986311.N19; Maurovich-Horvat E, 2008, Prague Med Rep, V109, P275; Miaskowski C, 1999, J PAIN SYMPTOM MANAG, V17, P320, DOI 10.1016/S0885-3924(99)00008-1; Miaskowski C, 2008, J PAIN SYMPTOM MANAG, V35, P632, DOI 10.1016/j.jpainsymman.2007.07.007; Miaskowski Christine, 2006, Oncol Nurs Forum, V33, pE79, DOI 10.1188/06.ONF.E79-E89; Miaskowski C, 2011, CANCER NURS, V34, P255, DOI 10.1097/NCC.0b013e3181f65d9b; Miaskowski C, 2010, J PAIN SYMPTOM MANAG, V40, P531, DOI 10.1016/j.jpainsymman.2009.12.006; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; Muthen B., 2010, MPLUS USERS GUIDE; Muthen B. O., 2002, BEHAVIORMETRIKA, V29, P81, DOI [DOI 10.2333/BHMK.29.81, 10.2333/bhmk.29.81]; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Osoba D, 1999, INT J CANCER, P132; Pollmacher T, 2002, BRAIN BEHAV IMMUN, V16, P525, DOI 10.1016/S0889-1591(02)00004-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pud D, 2008, J PAIN SYMPTOM MANAG, V35, P162, DOI 10.1016/j.jpainsymman.2007.03.010; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Savard J, 2009, J CLIN ONCOL, V27, P5233, DOI 10.1200/JCO.2008.21.6333; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; SHEEHAN TJ, 1995, J PERS ASSESS, V64, P507, DOI 10.1207/s15327752jpa6403_9; Spielberger C.G., 1983, MANUAL STATE ANXIETY; SPSS, 2010, IBM SPSS WIND VERS 1; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268	78	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40560	10.1371/journal.pone.0040560	http://dx.doi.org/10.1371/journal.pone.0040560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844404	Green Published, gold			2022-12-27	WOS:000306687700013
J	Brielmaier, J; Matteson, PG; Silverman, JL; Senerth, JM; Kelly, S; Genestine, M; Millonig, JH; DiCicco-Bloom, E; Crawley, JN				Brielmaier, Jennifer; Matteson, Paul G.; Silverman, Jill L.; Senerth, Julia M.; Kelly, Samantha; Genestine, Matthieu; Millonig, James H.; DiCicco-Bloom, Emanuel; Crawley, Jacqueline N.			Autism-Relevant Social Abnormalities and Cognitive Deficits in Engrailed-2 Knockout Mice	PLOS ONE			English	Article							HOMEOBOX-TRANSCRIPTION-FACTOR; SENSORIMOTOR GATING DEFICITS; INBRED MOUSE STRAINS; FORCED SWIMMING TEST; TAIL SUSPENSION TEST; MUTANT MICE; PREPULSE INHIBITION; SPECTRUM-DISORDER; BEHAVIORAL PHENOTYPES; ASPERGER-SYNDROME	ENGRAILED 2 (En2), a homeobox transcription factor, functions as a patterning gene in the early development and connectivity of rodent hindbrain and cerebellum, and regulates neurogenesis and development of monoaminergic pathways. To further understand the neurobiological functions of En2, we conducted neuroanatomical expression profiling of En2 wildtype mice. RTQPCR assays demonstrated that En2 is expressed in adult brain structures including the somatosensory cortex, hippocampus, striatum, thalamus, hypothalamus and brainstem. Human genetic studies indicate that EN2 is associated with autism. To determine the consequences of En2 mutations on mouse behaviors, including outcomes potentially relevant to autism, we conducted comprehensive phenotyping of social, communication, repetitive, and cognitive behaviors. En2 null mutants exhibited robust deficits in reciprocal social interactions as juveniles and adults, and absence of sociability in adults, replicated in two independent cohorts. Fear conditioning and water maze learning were impaired in En2 null mutants. High immobility in the forced swim test, reduced prepulse inhibition, mild motor coordination impairments and reduced grip strength were detected in En2 null mutants. No genotype differences were found on measures of ultrasonic vocalizations in social contexts, and no stereotyped or repetitive behaviors were observed. Developmental milestones, general health, olfactory abilities, exploratory locomotor activity, anxiety-like behaviors and pain responses did not differ across genotypes, indicating that the behavioral abnormalities detected in En2 null mutants were not attributable to physical or procedural confounds. Our findings provide new insight into the role of En2 in complex behaviors and suggest that disturbances in En2 signaling may contribute to neuropsychiatric disorders marked by social and cognitive deficits, including autism spectrum disorders.	[Brielmaier, Jennifer; Silverman, Jill L.; Senerth, Julia M.; Crawley, Jacqueline N.] NIMH, Lab Behav Neurosci, Bethesda, MD 20892 USA; [Matteson, Paul G.; Kelly, Samantha; Millonig, James H.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Genestine, Matthieu; Millonig, James H.; DiCicco-Bloom, Emanuel] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Brielmaier, J (corresponding author), NIMH, Lab Behav Neurosci, Bethesda, MD 20892 USA.	brielmaierjm@mail.nih.gov			National Institute of Mental Health Intramural Research Program [NIH R01 MH076624]; NJ Governor's Council for Medical Research and Treatment of Autism; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002179, R01MH076624] Funding Source: NIH RePORTER	National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NJ Governor's Council for Medical Research and Treatment of Autism; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health Intramural Research Program (JB, JLS, JMS, JNC), NIH R01 MH076624 (JHM and EDB), and the NJ Governor's Council for Medical Research and Treatment of Autism (EDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128; Alsene KM, 2011, NEUROPSYCHOPHARMACOL, V36, P1003, DOI 10.1038/npp.2010.238; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bailey KR, 2007, PHARMACOL BIOCHEM BE, V86, P8, DOI 10.1016/j.pbb.2006.11.024; Benayed R, 2005, AM J HUM GENET, V77, P851, DOI 10.1086/497705; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blakeman KH, 2003, NEUROSCIENCE, V117, P221, DOI 10.1016/S0306-4522(02)00779-0; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; Brooks SP, 2004, GENES BRAIN BEHAV, V3, P206, DOI 10.1111/j.1601-183X.2004.00072.X; Brune CW, 2008, AM J MED GENET B, V147B, P187, DOI 10.1002/ajmg.b.30585; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Calamandrei G, 1999, NEUROTOXICOL TERATOL, V21, P29, DOI 10.1016/S0892-0362(98)00035-X; Cao BJ, 2002, BRAIN RES, V937, P32, DOI 10.1016/S0006-8993(02)02461-7; Carasso BS, 1998, NEUROPHARMACOLOGY, V37, P401, DOI 10.1016/S0028-3908(98)00051-3; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Cheh MA, 2006, BRAIN RES, V1116, P166, DOI 10.1016/j.brainres.2006.07.086; Choi J, 2012, HUM MOL GENET, V21, P1566, DOI 10.1093/hmg/ddr594; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; Dawson G, 2002, DEV PSYCHOPATHOL, V14, P581, DOI 10.1017/S0954579402003103; Dawson G, 2002, CHILD DEV, V73, P345, DOI 10.1111/1467-8624.00411; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Estes A, 2011, AUTISM RES, V4, P212, DOI 10.1002/aur.193; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; Fox SR, 2012, J NEUROSCI, V32, P7832, DOI 10.1523/JNEUROSCI.5829-11.2012; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; Genestine M, 2011, SOC NEUROSCIENCE; Gerlai R, 1996, BEHAV NEUROSCI, V110, P126, DOI 10.1037/0735-7044.110.1.126; Geyer MA, 2006, NEUROTOX RES, V10, P211, DOI 10.1007/BF03033358; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; Ghaziuddin M, 1998, J INTELL DISABIL RES, V42, P43, DOI 10.1046/j.1365-2788.1998.00065.x; Ghaziuddin M, 2002, J AUTISM DEV DISORD, V32, P299, DOI 10.1023/A:1016330802348; GOLD JM, 1993, PSYCHIAT CLIN N AM, V16, P295; Hilber P, 2001, NEUROSCIENCE, V102, P615, DOI 10.1016/S0306-4522(00)00509-1; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266; Holmes A, 2001, BEHAV NEUROSCI, V115, P1129, DOI 10.1037//0735-7044.115.5.1129; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Joliot A, 1997, DEVELOPMENT, V124, P1865; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; Kanner L, 1943, NERV CHILD, V2, P217; Keefe RSE, 2007, J CLIN PSYCHIAT, V68, P8; Kesner RP, 2006, BIOL PSYCHOL, V73, P3, DOI 10.1016/j.biopsycho.2006.01.004; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Konopka G, 2012, MOL PSYCHIATR, V17, P202, DOI 10.1038/mp.2011.60; Kuemerle B, 1997, J NEUROSCI, V17, P7881; Kuemerle B, 2007, BEHAV BRAIN RES, V176, P121, DOI 10.1016/j.bbr.2006.09.009; Kuperberg G, 2000, CURR OPIN NEUROBIOL, V10, P205, DOI 10.1016/S0959-4388(00)00068-4; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; LALONDE R, 1990, BRAIN RES REV, V15, P325, DOI 10.1016/0165-0173(90)90006-A; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lin L. L., 2010, INT M AUT RES; Long JM, 2004, GENES BRAIN BEHAV, V3, P51, DOI 10.1046/j.1601-183x.2003.00045.x; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Maaswinkel H, 1996, PHYSIOL BEHAV, V60, P55, DOI 10.1016/0031-9384(95)02233-3; Maizel A, 2002, DEVELOPMENT, V129, P3545; MANSBACH RS, 1988, PSYCHOPHARMACOLOGY, V94, P507, DOI 10.1007/BF00212846; Mao R, 2009, J NEURODEV DISORD, V1, P224, DOI 10.1007/s11689-009-9025-8; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Millen KJ, 1995, DEVELOPMENT, V121, P3935; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; Miyahara M, 1997, J AUTISM DEV DISORD, V27, P595, DOI 10.1023/A:1025834211548; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nguyen P. T. H., 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018004, DOI 10.1371/JOURNAL.PONE.0018004]; Orvis GD, 2012, DEV BIOL, V367, P25, DOI 10.1016/j.ydbio.2012.04.018; Page DT, 2009, P NATL ACAD SCI USA, V106, P1989, DOI 10.1073/pnas.0804428106; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Paylor R, 2001, PHYSIOL BEHAV, V73, P781, DOI 10.1016/S0031-9384(01)00515-7; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; PETIT E, 1995, J MED GENET, V32, P269, DOI 10.1136/jmg.32.4.269; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Renard CE, 2003, FUND CLIN PHARMACOL, V17, P449, DOI 10.1046/j.1472-8206.2003.00160.x; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; Roy K, 2002, PHYSIOL BEHAV, V77, P595, DOI 10.1016/S0031-9384(02)00902-2; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Runker AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026488; Ryan BC, 2010, BEHAV BRAIN RES, V208, P178, DOI 10.1016/j.bbr.2009.11.031; Sacchetti B, 2005, NEUROSCIENTIST, V11, P217, DOI 10.1177/1073858405276428; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schmeisser M. J., 2012, NATURE; Sen B, 2010, GENES BRAIN BEHAV, V9, P248, DOI 10.1111/j.1601-183X.2009.00556.x; Serradj N, 2007, BEHAV BRAIN RES, V177, P80, DOI 10.1016/j.bbr.2006.11.001; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Sillitoe RV, 2010, J NEUROSCI, V30, P10015, DOI 10.1523/JNEUROSCI.0653-10.2010; Sillitoe RV, 2008, J NEUROSCI, V28, P12150, DOI 10.1523/JNEUROSCI.2059-08.2008; Silverman JL, 2010, NEUROSCIENCE, V171, P1197, DOI 10.1016/j.neuroscience.2010.09.059; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016; Simon HH, 2004, CELL TISSUE RES, V318, P53, DOI 10.1007/s00441-004-0973-8; Sipes TE, 1995, BEHAV PHARMACOL, V6, P839; Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Stack CM, 2008, EXP NEUROL, V211, P67, DOI 10.1016/j.expneurol.2008.01.003; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stewart ME, 2006, AUTISM, V10, P103, DOI 10.1177/1362361306062013; Storm EE, 2005, NEURON, V47, P483, DOI 10.1016/j.neuron.2005.08.004; Terranova ML, 2001, SCORING SOCIAL INTER; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Timmann D, 2010, CORTEX, V46, P845, DOI 10.1016/j.cortex.2009.06.009; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Tripathi PP, 2009, NEUROSCIENCE, V159, P842, DOI 10.1016/j.neuroscience.2009.01.007; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Vanderschuren LJMJ, 1997, NEUROSCI BIOBEHAV R, V21, P309, DOI 10.1016/S0149-7634(96)00020-6; Veenstra-VanderWeele J, 2012, P NATL ACAD SCI USA, V109, P5469, DOI 10.1073/pnas.1112345109; Vogel MW, 1996, DEV BRAIN RES, V96, P210; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Volkmar FR, 2003, LANCET, V362, P1133, DOI 10.1016/S0140-6736(03)14471-6; Wang LF, 2008, AM J MED GENET B, V147B, P434, DOI 10.1002/ajmg.b.30623; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8; WING L, 1981, J AUTISM DEV DISORD, V11, P31, DOI 10.1007/BF01531339; Winslow JT, 2000, HORM BEHAV, V37, P145, DOI 10.1006/hbeh.1999.1566; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Wrenn CC, 2004, EUR J NEUROSCI, V19, P1384, DOI 10.1111/j.1460-9568.2004.03214.x; Wylie CJ, 2010, J NEUROSCI, V30, P670, DOI 10.1523/JNEUROSCI.4656-09.2010; Yang M, 2009, CURRENT PROTOCOLS NE; Yang M, 2011, CURRENT PROTOCOLS NE, V56; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Yang M, 2011, AUTISM RES, V4, P17, DOI 10.1002/aur.163; Yang M, 2009, EUR J NEUROSCI, V29, P1663, DOI 10.1111/j.1460-9568.2009.06714.x; Yang PC, 2008, NEUROPSYCHOBIOLOGY, V57, P3, DOI 10.1159/000123115; Yang PC, 2010, NEUROPSYCHOBIOLOGY, V62, P104, DOI 10.1159/000315441; Yang W, 2001, MOL CELL BIOL, V21, P6031, DOI 10.1128/MCB.21.17.6031-6043.2001	165	115	115	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40914	10.1371/journal.pone.0040914	http://dx.doi.org/10.1371/journal.pone.0040914			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829897	Green Submitted, gold, Green Published			2022-12-27	WOS:000306956300035
J	Clarenbach, CF; Senn, O; Christ, AL; Fischler, M; Maggiorini, M; Bloch, KE				Clarenbach, Christian F.; Senn, Oliver; Christ, Andreas L.; Fischler, Manuel; Maggiorini, Marco; Bloch, Konrad E.			Lung Function and Breathing Pattern in Subjects Developing High Altitude Pulmonary Edema	PLOS ONE			English	Article							DIFFUSING-CAPACITY; VOLUME; STANDARDIZATION; CLIMBERS; GASES; BLOOD	Introduction: The purpose of the study was to comprehensively evaluate physiologic changes associated with development of high altitude pulmonary edema (HAPE). We tested whether changes in pulmonary function and breathing pattern would herald clinically overt HAPE at an early stage. Methods: In 18 mountaineers, spirometry, diffusing capacity, nitrogen washout, nocturnal ventilation and pulse oximetry were recorded at 490 m and during 3 days after rapid ascent to 4559 m. Findings were compared among subjects developing HAPE and those remaining well (controls). Results: In 8 subjects subsequently developing radiographically documented HAPE at 4559 m, median FVC declined to 82% of low altitude baseline while closing volume increased to 164% of baseline (P<0.05, both instances). In 10 controls, FVC decreased slightly (to 93% baseline, P<0.05) but significantly less than in subjects with HAPE and closing volume remained unchanged. Sniff nasal pressure was reduced in both subjects with and without subsequent HAPE. During nights at 4559 m, mean nocturnal oxygen saturation dropped to lower values while minute ventilation, the number of periodic breathing cycles and heart rate were higher (60%; 8.6 L/min; 97 cycles/h; 94 beats/min, respectively) in subjects subsequently developing HAPE than in controls (73%; 5.1 L/min; 48 cycles/h; 79 beats/min; P<0.05 vs. HAPE, all instances). Conclusion: The results comprehensively represent the pattern of physiologic alterations that precede overt HAPE. The changes in lung function are consistent with reduced lung compliance and impaired gas exchange. Pronounced nocturnal hypoxemia, ventilatory control instability and sympathetic stimulation are further signs of subsequent overt HAPE.	[Clarenbach, Christian F.; Senn, Oliver; Christ, Andreas L.; Bloch, Konrad E.] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland; [Maggiorini, Marco; Bloch, Konrad E.] Univ Zurich, Ctr Human Integrat Physiol, Zurich, Switzerland; [Fischler, Manuel; Maggiorini, Marco] Univ Zurich Hosp, Med Intens Care Unit, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Clarenbach, CF (corresponding author), Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland.	konrad.bloch@usz.ch		Maggiorini, Marco/0000-0001-8180-2117; Senn, Oliver/0000-0003-4422-7250	Lung Ligue of Zurich, Switzerland	Lung Ligue of Zurich, Switzerland	This study was supported by grants from the Lung Ligue of Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Bloch KE, 2010, AM J RESP CRIT CARE, V182, P562, DOI 10.1164/rccm.200911-1694OC; Brack T, 2007, CHEST, V132, P1463, DOI 10.1378/chest.07-0121; Cremona G, 2002, LANCET, V359, P303, DOI 10.1016/S0140-6736(02)07496-2; Deboeck G, 2005, MED SCI SPORT EXER, V37, P754, DOI 10.1249/01.MSS.0000162687.18387.97; Dehnert C, 2010, EUR RESPIR J, V35, P812, DOI 10.1183/09031936.00185808; Eichenberger U, 1996, AM J RESP CRIT CARE, V154, P1748, DOI 10.1164/ajrccm.154.6.8970365; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; JAEGER JJ, 1979, J APPL PHYSIOL, V47, P670, DOI 10.1152/jappl.1979.47.4.670; Lehmann T, 2006, J APPL PHYSIOL, V100, P690, DOI 10.1152/japplphysiol.00991.2005; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Maggiorini M, 1998, AVIAT SPACE ENVIR MD, V69, P1186; Maggiorini M, 2006, ANN INTERN MED, V145, P497, DOI 10.7326/0003-4819-145-7-200610030-00007; Mason NP, 2003, J APPL PHYSIOL, V94, P2043, DOI 10.1152/japplphysiol.00777.2002; MILES DS, 1983, RESP PHYSIOL, V52, P349, DOI 10.1016/0034-5687(83)90090-7; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; SACKNER MA, 1989, J APPL PHYSIOL, V66, P410, DOI 10.1152/jappl.1989.66.1.410; Senn O, 2006, MED SCI SPORT EXER, V38, P1565, DOI 10.1249/01.mss.0000229102.37359.af; Ulrich S, 2008, CHEST, V133, P1375, DOI 10.1378/chest.07-3035; VOCK P, 1991, CHEST, V100, P1306, DOI 10.1378/chest.100.5.1306; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WELSH CH, 1993, AM REV RESPIR DIS, V147, P1239, DOI 10.1164/ajrccm/147.5.1239	23	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41188	10.1371/journal.pone.0041188	http://dx.doi.org/10.1371/journal.pone.0041188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829927	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306956300066
J	Lei, YF; Zouani, OF; Remy, M; Ayela, C; Durrieu, MC				Lei, Yifeng; Zouani, Omar F.; Remy, Murielle; Ayela, Cedric; Durrieu, Marie-Christine			Geometrical Microfeature Cues for Directing Tubulogenesis of Endothelial Cells	PLOS ONE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; CAPILLARY LUMEN FORMATION; ANGIOGENESIS IN-VITRO; PEPTIDE SVVYGLR; TUBE FORMATION; DIFFERENTIATION; OSTEOPONTIN; MORPHOGENESIS; GROWTH; VIVO	Angiogenesis, the formation of new blood vessels by sprouting from pre-existing ones, is critical for the establishment and maintenance of complex tissues. Angiogenesis is usually triggered by soluble growth factors such as VEGF. However, geometrical cues also play an important role in this process. Here we report the induction of angiogenesis solely by SVVYGLR peptide micropatterning on polymer surfaces. SVVYGLR peptide stripes were micropatterned onto polymer surfaces by photolithography to study their effects on endothelial cell (EC) behavior. Our results showed that the EC behaviors (cell spreading, orientation and migration) were significantly more guided and regulated on narrower SVVYGLR micropatterns (10 and 50 mm) than on larger stripes (100 mm). Also, EC morphogenesis into tube formation was switched on onto the smaller patterns. We illustrated that the central lumen of tubular structures can be formed by only one-to-four cells due to geometrical constraints on the micropatterns which mediated cell-substrate adhesion and generated a correct maturation of adherens junctions. In addition, sprouting of ECs and vascular networks were also induced by geometrical cues on surfaces micropatterned with SVVYGLR peptides. These micropatterned surfaces provide opportunities for mimicking angiogenesis by peptide modification instead of exogenous growth factors. The organization of ECs into tubular structures and the induction of sprouting angiogenesis are important towards the fabrication of vascularized tissues, and this work has great potential applications in tissue engineering and tissue regeneration.	[Lei, Yifeng; Zouani, Omar F.; Remy, Murielle; Durrieu, Marie-Christine] Univ Bordeaux 2, INSERM, U1026, F-33076 Bordeaux, France; [Lei, Yifeng; Zouani, Omar F.; Durrieu, Marie-Christine] Univ Bordeaux 1, CNRS, CBMN, UMR 5248, Pessac, France; [Ayela, Cedric] Univ Bordeaux, CNRS, IMS, UMR 5218, Talence, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite de Bordeaux	Lei, YF (corresponding author), Univ Bordeaux 2, INSERM, U1026, F-33076 Bordeaux, France.	yifeng.lei@inserm.fr; omar.zouani@inserm.fr	DURRIEU, Marie-Christine/I-4358-2016; lei, yifeng/GON-4920-2022	DURRIEU, Marie-Christine/0000-0003-0583-9289; Lei, Yifeng/0000-0002-3523-6887	"Region Aquitaine"; GIS "Advanced Materials in Aquitaine" (AMA); "Agence nationale pour la Recherche" (ANR) [ANR-09-ETEC-001-01]	"Region Aquitaine"(Region Nouvelle-Aquitaine); GIS "Advanced Materials in Aquitaine" (AMA); "Agence nationale pour la Recherche" (ANR)(French National Research Agency (ANR))	The work was financially supported by the "Region Aquitaine", the GIS "Advanced Materials in Aquitaine" (AMA) (www.ama-materials.com), and the "Agence nationale pour la Recherche" (ANR) (grant number ANR-09-ETEC-001-01) (www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Bayless KJ, 2002, J CELL SCI, V115, P1123; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chollet C, 2010, COLLOID SURFACE B, V75, P107, DOI 10.1016/j.colsurfb.2009.08.024; Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033; Co CC, 2005, J AM CHEM SOC, V127, P1598, DOI 10.1021/ja044382a; Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030; Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174; Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Green PM, 2001, FEBS LETT, V503, P75, DOI 10.1016/S0014-5793(01)02690-4; Hamada Y, 2004, DENT MATER J, V23, P650, DOI 10.4012/dmj.23.650; Hamada Y, 2003, BIOCHEM BIOPH RES CO, V310, P153, DOI 10.1016/j.bbrc.2003.09.001; Hamada Y, 2007, DENT MATER J, V26, P487, DOI 10.4012/dmj.26.487; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Li HY, 2010, AM J PHYSIOL-CELL PH, V299, pC422, DOI 10.1152/ajpcell.00562.2009; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Sukmana I, 2010, BIOMATERIALS, V31, P5091, DOI 10.1016/j.biomaterials.2010.02.076; Williams DF, 2011, BIOMATERIALS, V32, P4195, DOI 10.1016/j.biomaterials.2011.02.025; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229; Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042	56	39	40	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41163	10.1371/journal.pone.0041163	http://dx.doi.org/10.1371/journal.pone.0041163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829923	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300062
J	Lekawanvijit, S; Kompa, AR; Manabe, M; Wang, BH; Langham, RG; Nishijima, F; Kelly, DJ; Krum, H				Lekawanvijit, Suree; Kompa, Andrew R.; Manabe, Minako; Wang, Bing H.; Langham, Robyn G.; Nishijima, Fuyuhiko; Kelly, Darren J.; Krum, Henry			Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; NF-KAPPA-B; STAGE RENAL-DISEASE; ORAL ADSORBENT; INTERSTITIAL FIBROSIS; ARTERIAL STIFFNESS; GENE-EXPRESSION; HEART-FAILURE; LONG-TERM; AST-120	Cardiovascular death commonly occurs in patients with chronic kidney disease. Indoxyl sulfate (IS), a uremic toxin, has been demonstrated in vitro as a contributory factor in cardiac fibrosis, a typical pathological finding in uremic cardiomyopathy. This study aimed to determine if cardiac fibrosis is reversible by lowering serum IS levels using an oral charcoal adsorbent, AST-120. Subtotal-nephrectomized (5/6-STNx) Sprague-Dawley rats were randomized to receive either AST-120 (AST-120, n = 13) or no treatment (vehicle, n = 17) for 12 weeks. Sham operated rats (n = 12) were used as controls. Early left ventricular (LV) diastolic dysfunction was demonstrated by an increase in peak velocity of atrial filling [A and A' waves] and a decrease of E/A and E'/A' ratios obtained by echocardiography. This was accompanied by a 4.5-fold increase in serum IS (p<0.001) as well as elevated tail-cuff blood pressure (p<0.001) and heart weight (p<0.001). Increased LV fibrosis (p<0.001), gene expression of pro-fibrotic (TGF-beta, CTGF) and hypertrophic (ANP, beta-MHC and alpha-skeletal muscle actin) markers, as well as TGF-beta and phosphorylated NF-kappa B protein expression were observed in STNx + vehicle rats. Treatment with AST-120 reduced serum creatinine (by 54%, p<0.05) and urine total protein (by 27%, p<0.05) vs vehicle whilst having no effect on blood pressure (AST-120 = 227 +/- 11 vs vehicle = 224 +/- 8 mmHg, ns) and heart weight. The increase in serum IS was prevented with AST-120 (by 100%, p<0.001) which was accompanied by reduced LV fibrosis (68%, p<0.01) and TGF-beta and phosphorylated NF-kappa B protein expression (back to sham levels, p<0.05) despite no significant change in LV function. In conclusion, STNx resulted in increased cardiac fibrosis and circulating IS levels. Reduction of IS with AST-120 normalizes cardiac fibrosis, in a blood pressure independent manner.	[Lekawanvijit, Suree; Kompa, Andrew R.; Wang, Bing H.; Krum, Henry] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Kompa, Andrew R.; Langham, Robyn G.; Kelly, Darren J.] Univ Melbourne, Dept Med, St Vincents Hosp, Melbourne, Vic, Australia; [Manabe, Minako; Nishijima, Fuyuhiko] Kureha Corp, Dept Pharmaceut, Tokyo, Japan; [Langham, Robyn G.] St Vincents Hosp, Dept Nephrol, Melbourne, Vic, Australia	Monash University; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne	Lekawanvijit, S (corresponding author), Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	henry.krum@monash.edu		Kompa, Andrew/0000-0003-1002-2302; Kelly, Darren/0000-0003-4850-3929	National Health and Medical Research Council [334008, 546272]; Chiang Mai University, Thailand under the Royal Patronage of Her Royal Highness Princess Galyanivadhana	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Chiang Mai University, Thailand under the Royal Patronage of Her Royal Highness Princess Galyanivadhana	This work was supported by the National Health and Medical Research Council [Program Grant #334008 and #546272]. The URL of the funder's website is http://www.nhmrc.gov.au. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the technical support of Ms Mariana Pacheco and Ms Jemma Court for the animal studies, Ms Alison Cox for assistance with the Cobas assay, Dr Yuan Zhang for assistance with cardiac fibrosis analysis. S.L. is a recipient of a scholarship from the 'Prince Doctor' Fund, Chiang Mai University, Thailand, under the Royal Patronage of Her Royal Highness Princess Galyanivadhana.	Amann K, 2000, NEPHROL DIAL TRANSPL, V15, P964, DOI 10.1093/ndt/15.7.964; Aoyama I, 2002, NEPHRON, V92, P635, DOI 10.1159/000064108; Aoyama I, 2000, AM J NEPHROL, V20, P232, DOI 10.1159/000013594; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Campbell DJ, 2011, HYPERTENSION, V57, P186, DOI 10.1161/HYPERTENSIONAHA.110.165043; Cannella G, 1997, AM J KIDNEY DIS, V30, P659, DOI 10.1016/S0272-6386(97)90490-X; Cice G, 2003, J AM COLL CARDIOL, V41, P1438, DOI 10.1016/S0735-1097(03)00241-9; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Hampl H, 2005, AM J NEPHROL, V25, P211, DOI 10.1159/000085881; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Iida Shuji, 2006, Clin Exp Nephrol, V10, P262, DOI 10.1007/s10157-006-0441-8; Iyngkaran P., 2009, HEART LUNG CIRCUL, V18, pS250, DOI [10.1016/j.hlc.2009.05.618, DOI 10.1016/J.HLC.2009.05.618]; Kelly DJ, 1998, KIDNEY INT, V54, P343, DOI 10.1046/j.1523-1755.1998.00019.x; Kikuchi K, 2010, J CHROMATOGR B, V878, P2997, DOI 10.1016/j.jchromb.2010.09.006; Kobayashi N, 2002, NEPHRON, V91, P480, DOI 10.1159/000064291; Kompa AR, 2008, J PHARMACOL EXP THER, V325, P741, DOI 10.1124/jpet.107.133546; Kompa AR, 2010, PEPTIDES, V31, P1523, DOI 10.1016/j.peptides.2010.04.026; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; Maeda K, 2009, J INT MED RES, V37, P205, DOI 10.1177/147323000903700125; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Miyazaki T, 2000, NEPHROL DIAL TRANSPL, V15, P1773, DOI 10.1093/ndt/15.11.1773; Motojima M, 2003, KIDNEY INT, V63, P1671, DOI 10.1046/j.1523-1755.2003.00906.x; Nakai K, 2011, AM J NEPHROL, V33, P218, DOI 10.1159/000324354; Nakamura T, 2004, KIDNEY BLOOD PRESS R, V27, P121, DOI 10.1159/000077536; Nitta K, 2004, HYPERTENS RES, V27, P527, DOI 10.1291/hypres.27.527; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Niwa T, 1997, KIDNEY INT, V52, pS23; NIWA T, 1994, J LAB CLIN MED, V124, P96; Niwa T, 2010, NAGOYA J MED SCI, V72, P1; Owada S, 2008, AM J NEPHROL, V28, P446, DOI 10.1159/000112823; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Shibahara H, 2010, J NEPHROL, V23, P535; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; STANFEL LA, 1986, CLIN CHEM, V32, P938; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Tamada S, 2006, J PHARMACOL SCI, V100, P17, DOI 10.1254/jphs.FMJ05003X4; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Tran L, 2010, AM J PHYSIOL-HEART C, V298, pH608, DOI 10.1152/ajpheart.00942.2009; Ueda H, 2008, RENAL FAILURE, V30, P856, DOI 10.1080/08860220802356531; United States Renal Data Systems, USRDS 2007 ANN DAT R; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vlahakos DV, 1997, J AM SOC NEPHROL, V8, P1764; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zoccali C, 2002, HYPERTENSION, V40, P41, DOI 10.1161/01.HYP.0000022063.50739.60	51	121	131	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41281	10.1371/journal.pone.0041281	http://dx.doi.org/10.1371/journal.pone.0041281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829936	gold, Green Published			2022-12-27	WOS:000306956300075
J	Olson, KL; Mandl, KD				Olson, Karen L.; Mandl, Kenneth D.			Temporal Patterns of Medications Dispensed to Children and Adolescents in a National Insured Population	PLOS ONE			English	Article							PEDIATRIC POPULATION; CLAIMS DATA; DRUG-USE; TRENDS; PRESCRIPTIONS; LIMITATIONS; ADHERENCE; NORWAY; AGE	This study aimed to comprehensively describe prevalence and temporal dispensing patterns for medications prescribed to children and adolescents in the United States. Participants were 1.6 million children (49% female) under 18 years old enrolled in a nation-wide, employer-provided insurance plan. All medication claims from 1999-2006 were reviewed retrospectively. Drugs were assigned to 16 broad therapeutic categories. Effects of trend over time, seasonality, age and gender on overall and within category prevalence were examined. Results: Mean monthly prevalence for dispensed medications was 23.5% (range 19.4-27.5), with highest rates in winter and lowest in July. The age group with the highest prevalence was one-year-old children. On average each month, 17.1% of all children were dispensed a single drug and 6.4% were dispensed two or more. Over time, prevalence for two or more drugs did not change, but the proportion of children dispensed a single drug decreased (slope -.02%, p = .001). Overall, boys had higher monthly rates than girls (average difference 0.9%, p = .002). However, differences by gender were greatest during middle childhood, especially for respiratory and central nervous system agents. Contraceptives accounted for a large proportion of dispensed medication to older teenage girls. Rates for the drugs with the highest prevalence in this study were moderately correlated (average Pearson r.66) with those from a previously published national survey. Conclusion: On average, nearly one quarter of a population of insured children in the United States was dispensed medication each month. This rate decreased somewhat over time, primarily because proportionally fewer children were dispensed a single medication. The rate for two or more drugs dispensed simultaneously remained steady.	[Olson, Karen L.; Mandl, Kenneth D.] Childrens Hosp, Informat Program, Harvard MIT Hlth Sci & Technol, Div Emergency Med, Boston, MA 02115 USA; [Olson, Karen L.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Olson, KL (corresponding author), Childrens Hosp, Informat Program, Harvard MIT Hlth Sci & Technol, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	karen.olson@childrens.harvard.edu			National Library of Medicine, National Institutes of Health [R01 LM007677]; NATIONAL LIBRARY OF MEDICINE [R01LM007677] Funding Source: NIH RePORTER	National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by R01 LM007677 from the National Library of Medicine, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers R, 2009, ARCH DIS CHILD, V94, P443, DOI 10.1136/adc.2008.144386; Berg C, 2009, NORWEGIAN PRESCRIPTI; Blix HS, 2007, J ANTIMICROB CHEMOTH, V59, P971, DOI 10.1093/jac/dkm032; Christensen L, 2010, CURR MED RES OPIN, V26, P977, DOI 10.1185/03007991003673617; Clavenna A, 2009, EUR J PEDIATR, V168, P173, DOI 10.1007/s00431-008-0725-y; Clavenna A, 2009, EUR J CLIN PHARMACOL, V65, P749, DOI 10.1007/s00228-009-0679-7; Cox ER, 2008, PEDIATRICS, V122, pE1053, DOI 10.1542/peds.2008-0214; Crystal S, 2007, MED CARE, V45, pS58, DOI 10.1097/MLR.0b013e31805371bf; Ellis Alan R, 2010, N C Med J, V71, P9; Fredheim OMS, 2010, PEDIATR ANESTH, V20, P537, DOI 10.1111/j.1460-9592.2010.03310.x; Hameen-Anttila K, 2010, PHARMACOEPIDEM DR S, V19, P400, DOI 10.1002/pds.1887; Hassanin Hanan, 2010, Hawaii Med J, V69, P17; Jain R, 2011, J AM ACAD CHILD PSY, V50, P171, DOI 10.1016/j.jaac.2010.11.005; Karlstad O, 2010, EUR J CLIN PHARMACOL, V66, P399, DOI 10.1007/s00228-009-0749-x; Karve S, 2008, MED CARE, V46, P1125, DOI 10.1097/MLR.0b013e31817924d2; Lasky T, 2009, CLIN THER, V31, P436, DOI 10.1016/j.clinthera.2009.02.003; May DE, 2010, DRUGS, V70, P15, DOI 10.2165/11530540-000000000-00000; Olfson M, 2002, J AM ACAD CHILD PSY, V41, P514, DOI 10.1097/00004583-200205000-00008; Olfson M, 2010, J AM ACAD CHILD PSY, V49, P13, DOI 10.1016/j.jaac.2009.09.003; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Pathak P, 2010, PSYCHIAT SERV, V61, P123, DOI 10.1176/ps.2010.61.2.123; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Tournier M, 2010, PSYCHIAT RES, V179, P57, DOI 10.1016/j.psychres.2010.06.007; Vernacchio L, 2009, PEDIATRICS, V124, P446, DOI 10.1542/peds.2008-2869; Waxmonsky James G, 2005, Essent Psychopharmacol, V6, P262	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40991	10.1371/journal.pone.0040991	http://dx.doi.org/10.1371/journal.pone.0040991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829905	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300043
J	Kawashima, T; Sato, T				Kawashima, Takayuki; Sato, Takao			Adaptation in Sound Localization Processing Induced by Interaural Time Difference in Amplitude Envelope at High Frequencies	PLOS ONE			English	Article							TRANSPOSED STIMULI; MODULATED TONES; AUDITORY SPACE; DELAYS; LATERALIZATION; DISCRIMINATION; PERCEPTION; NEURONS; LEVEL	Background: When a second sound follows a long first sound, its location appears to be perceived away from the first one (the localization/lateralization aftereffect). This aftereffect has often been considered to reflect an efficient neural coding of sound locations in the auditory system. To understand determinants of the localization aftereffect, the current study examined whether it is induced by an interaural temporal difference (ITD) in the amplitude envelope of high frequency transposed tones (over 2 kHz), which is known to function as a sound localization cue. Methodology/Principal Findings: In Experiment 1, participants were required to adjust the position of a pointer to the perceived location of test stimuli before and after adaptation. Test and adapter stimuli were amplitude modulated (AM) sounds presented at high frequencies and their positional differences were manipulated solely by the envelope ITD. Results showed that the adapter's ITD systematically affected the perceived position of test sounds to the directions expected from the localization/lateralization aftereffect when the adapter was presented at +/- 600 mu s ITD; a corresponding significant effect was not observed for a 0 mu s ITD adapter. In Experiment 2, the observed adapter effect was confirmed using a forced-choice task. It was also found that adaptation to the AM sounds at high frequencies did not significantly change the perceived position of pure-tone test stimuli in the low frequency region (128 and 256 Hz). Conclusions/Significance: The findings in the current study indicate that ITD in the envelope at high frequencies induces the localization aftereffect. This suggests that ITD in the high frequency region is involved in adaptive plasticity of auditory localization processing.	[Kawashima, Takayuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Tokyo, Japan; [Sato, Takao] Univ Tokyo, Grad Sch Humanities & Sociol, Dept Psychol, Tokyo, Japan	University of Tokyo; University of Tokyo	Kawashima, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Tokyo, Japan.	takayuki.kawashima@thu.ac.jp			Grants-in-Aid for Scientific Research [24650130] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BATRA R, 1993, J NEUROPHYSIOL, V70, P64, DOI 10.1152/jn.1993.70.1.64; BERNSTEIN LR, 1985, J ACOUST SOC AM, V78, P514, DOI 10.1121/1.392473; Bernstein LR, 2003, J ACOUST SOC AM, V113, P3335, DOI 10.1121/1.1570431; Bernstein LR, 2002, J ACOUST SOC AM, V112, P1026, DOI 10.1121/1.1497620; Bernstein LR, 2000, PHYSL PSYCHOPHYSICAL, P137; Blauert J, 1997, SPATIAL HEARING, P508; Carlile S, 2001, J ACOUST SOC AM, V110, P416, DOI 10.1121/1.1375843; COLBURN HS, 1976, J ACOUST SOC AM, V59, pS23, DOI 10.1121/1.2002503; Dahmen JC, 2010, NEURON, V66, P937, DOI 10.1016/j.neuron.2010.05.018; Furukawa S, 2005, J NEUROPHYSIOL, V93, P3313, DOI 10.1152/jn.01219.2004; GRANTHAM DW, 1989, PERCEPT PSYCHOPHYS, V45, P129, DOI 10.3758/BF03208047; HENNING GB, 1974, J ACOUST SOC AM, V55, P84, DOI 10.1121/1.1928135; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Kashino M, 1998, J ACOUST SOC AM, V103, P3597, DOI 10.1121/1.423064; KASHINO M, 1998, PSYCHOL PHYSL ADV HE, P322; KAY RH, 1982, PHYSIOL REV, V62, P894, DOI 10.1152/physrev.1982.62.3.894; KLUMPP RG, 1956, J ACOUST SOC AM, V28, P859, DOI 10.1121/1.1908493; MCFADDEN D, 1976, J ACOUST SOC AM, V59, P634, DOI 10.1121/1.380913; NUETZEL JM, 1981, J ACOUST SOC AM, V69, P1112, DOI 10.1121/1.385690; Phillips DP, 2005, HEARING RES, V202, P188, DOI 10.1016/j.heares.2004.11.001; THURLOW WR, 1973, J ACOUST SOC AM, V53, P1573, DOI 10.1121/1.1913505; Van Wanrooij MM, 2005, J NEUROSCI, V25, P5413, DOI 10.1523/JNEUROSCI.0850-05.2005; vandePar S, 1997, J ACOUST SOC AM, V101, P1671, DOI 10.1121/1.418151; Wojtczak M, 2003, J ACOUST SOC AM, V114, P991, DOI 10.1121/1.1593067	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41328	10.1371/journal.pone.0041328	http://dx.doi.org/10.1371/journal.pone.0041328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848464	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200056
J	Tachibana, Y; Fukushima, A; Saito, H; Yoneyama, S; Ushida, K; Yoneyama, S; Kawashima, R				Tachibana, Yoshiyuki; Fukushima, Ai; Saito, Hitomi; Yoneyama, Satoshi; Ushida, Kazuo; Yoneyama, Susumu; Kawashima, Ryuta			A New Mother-Child Play Activity Program to Decrease Parenting Stress and Improve Child Cognitive Abilities: A Cluster Randomized Controlled Trial	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; FLUID INTELLIGENCE; PREFRONTAL CORTEX; SELF-REGULATION; WORKING-MEMORY; ATTACHMENT; INTERVENTIONS; SENSITIVITY; FAMILIES; ANXIETY	Background: We propose a new play activity intervention program for mothers and children. Our interdisciplinary program integrates four fields of child-related sciences: neuroscience, preschool pedagogy, developmental psychology, and child and maternal psychiatry. To determine the effect of this intervention on child and mother psychosocial problems related to parenting stress and on the children's cognitive abilities, we performed a cluster randomized controlled trial. Methodology/Principal Findings: Participants were 238 pairs of mothers and typically developing preschool children (ages 4-6 years old) from Wakakusa kindergarten in Japan. The pairs were asked to play at home for about 10 min a day, 5 days a week for 3 months. Participants were randomly assigned to the intervention or control group by class unit. The Parenting Stress Index (PSI) (for mothers), the Goodenough Draw-a-Man intelligence test (DAM), and the new S-S intelligence test (NSSIT) (for children) PSI (for maternal psychosocial problems related to parenting stress), and the score on the DAM (for child cognitive abilities). The results of the PSI suggested that the program may reduce parenting stress. The results of the cognitive tests suggested that the program may improve the children's fluid intelligence, working memory, and processing speed. Conclusions/Significance: Our intervention program may ameliorate the children's psychosocial problems related to parenting stress and increase their cognitive abilities.	[Tachibana, Yoshiyuki] Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Div Maternal Child Psychiat, Tokyo, Japan; [Tachibana, Yoshiyuki; Kawashima, Ryuta] Tohoku Univ, Smart Aging Int Res Ctr, IDAC, Dept Appl Brain Sci, Sendai, Miyagi 980, Japan; [Fukushima, Ai; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, IDAC, Sendai, Miyagi 980, Japan; [Saito, Hitomi; Yoneyama, Satoshi; Ushida, Kazuo; Yoneyama, Susumu] Wakakusa Kindergarten, Sendai, Miyagi, Japan	National Center for Child Health & Development - Japan; Tohoku University; Tohoku University	Tachibana, Y (corresponding author), Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Div Maternal Child Psychiat, Tokyo, Japan.	tatibana@idac.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the promotion scheme "Researches for improvement of children's life style'' by the Ministry of Education, Culture, Sports, Science and Technology entitled "The research and practice of the play program for enhancing parent-child attachment and child cognitive abilities''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RR., 1995, PSYCHOL ASSESSMENT R; Abidin RR., 1983, PARENTING STRESS IND; Abidin RR, 1995, PARENTING STRESS IND, V75; Anthony LG, 2005, INFANT CHILD DEV, V14, P133, DOI 10.1002/icd.385; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Barnett DW, 2002, DESIGNING PRESCHOOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk L. E., 1995, SCAFFOLDING CHILDREN; Bierman KL, 2008, DEV PSYCHOPATHOL, V20, P821, DOI 10.1017/S0954579408000394; Blair C, 2008, DEV PSYCHOPATHOL, V20, P899, DOI 10.1017/S0954579408000436; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Booth P. B., 1999, THERAPLAY HELPING PA; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; BOWLBY J, 1977, BRIT J PSYCHIAT, V130, P201, DOI 10.1192/bjp.130.3.201; Bowlby J., 1988, SECURE BASE; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Campbell MJ, 2000, STAT METHODS MED RES, V9, P81, DOI 10.1191/096228000676246354; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colom R, 2007, J BIOSOC SCI, V39, P79, DOI 10.1017/S0021932005001173; Creasey G, 2003, PLAY CHILDREN ATTACH, P133; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deater-Deckard K., 2004, PARENTING STRESS; Dehn MJ, 2008, WORKING MEMORY ACAD; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Dudoit S., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1040; Edwards CP, 2000, CROSS-CULT RES, V34, P318, DOI 10.1177/106939710003400402; Fagan J, 1999, EARLY CHILD RES Q, V14, P243, DOI 10.1016/S0885-2006(99)00008-3; Fivush R, 2006, ATTACH HUM DEV, V8, P283, DOI 10.1080/08912960600858935; Fonagy P., 2002, AFFECT REGULATION ME; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Goodenough FL., 1926, MEASUREMENT INTELLIG; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Greenberg MT, 2006, ANN NY ACAD SCI, V1094, P139, DOI 10.1196/annals.1376.013; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Judge S, 2003, FAM RELAT, V52, P241, DOI 10.1111/j.1741-3729.2003.00241.x; Juffer F., 2008, PROMOTING POSITIVE P; Kazui M, 2005, ATTACHMENT; Kerr M, 1998, STRATEGIES MANAGING; Khatena J, 1967, GIFTED CHILD Q, V11, P227; Killip S, 2004, ANN FAM MED, V2, P204, DOI 10.1370/afm.141; Kobayashi S, 1967, P YAMAGATA U ED SCI, V5, P131; Love JM., 2002, MAKING DIFFERENCE LI, VI; LOYD BH, 1985, J PEDIATR PSYCHOL, V10, P169, DOI 10.1093/jpepsy/10.2.169; Magill-Evans J, 2006, J ADV NURS, V55, P248, DOI 10.1111/j.1365-2648.2006.03896.x; McBride BA, 1991, EARLY CHILD DEV CARE, V67, P73, DOI DOI 10.1080/0300443910670107; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monk CS, 2008, DEV PSYCHOPATHOL, V20, P1231, DOI 10.1017/S095457940800059X; MOUTON PY, 1988, J CLIN CHILD PSYCHOL, V17, P217, DOI 10.1207/s15374424jccp1703_4; Narama M., 1999, SHOUNI HOKEN KENKYU, V58, P610; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Raven J.C., 1958, GUIDE USING COLOURED; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Rohde TE, 2007, INTELLIGENCE, V35, P83, DOI 10.1016/j.intell.2006.05.004; Russ HG, 1988, EFFECTS ADOPTION PRE; Seifer R, 1995, MONOGR SOC RES CHILD, V60, P146, DOI 10.2307/1166176; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; Swanson HL, 2006, J EDUC PSYCHOL, V98, P17; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Thompson RA, 2000, CHILD DEV, V71, P145, DOI 10.1111/1467-8624.00128; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI DOI 10.3310/HTA3050; van Ijzendoorn MH, 1992, MULTIPLE CARETAKER P; Ana B, 2007, PSYCHON B REV, V14, P320, DOI 10.3758/BF03194071; Vygotsky L. S., 1978, MIND SOC DEV HIGHER, P52; Vygotsky LS, 1960, GENESIS HIGHER MENTA, P61; Warren SL, 1997, J AM ACAD CHILD PSY, V36, P637, DOI 10.1097/00004583-199705000-00014; Wechsler D, 1991, WISC 3 WECHSLER INTE; WEINER A, 1994, FAM PROCESS, V33, P441, DOI 10.1111/j.1545-5300.1994.00441.x; West BT, 2007, LINEAR MIXED MODELS, p[98, 268, 333]; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x; Yamane K, 1977, MANUAL NEW S S INTEL	80	15	15	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e38238	10.1371/journal.pone.0038238	http://dx.doi.org/10.1371/journal.pone.0038238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848340	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200002
J	Hoflehner, E; Binder, M; Hemmer, W; Mahler, V; Panzani, RC; Jarisch, R; Wiedermann, U; Duchene, M				Hoflehner, Elisabeth; Binder, Marina; Hemmer, Wolfgang; Mahler, Vera; Panzani, Raphael C.; Jarisch, Reinhart; Wiedermann, Ursula; Duchene, Michael			Thioredoxin from the Indianmeal Moth Plodia interpunctella: Cloning and Test of the Allergenic Potential in Mice	PLOS ONE			English	Article							HOUSE-DUST; CROSS-REACTIVITY; ARGININE KINASE; IGE ANTIBODIES; BAKERS ASTHMA; PAN-ALLERGEN; FAMILY; INSECTS; WHEAT; RESPONSES	Background/Objective: The Indianmeal moth Plodia interpunctella is a highly prevalent food pest in human dwellings, and has been shown to contain a number of allergens. So far, only one of these, the arginine kinase (Plo i 1) has been identified. Objective: The aim of this study was to identify further allergens and characterise these in comparison to Plo i 1. Method: A cDNA library from whole adult P. interpunctella was screened with the serum of a patient with indoor allergy and IgE to moths, and thioredoxin was identified as an IgE-binding protein. Recombinant thioredoxin was generated in E. coli, and tested together with Plo i 1 and whole moth extracts in IgE immunoblots against a large panel of indoor allergic patients' sera. BALB/c mice were immunised with recombinant thioredoxin and Plo i 1, and antibody production, mediator release from RBL cells, T-cell proliferation and cytokine production were measured. Result: For the first time a thioredoxin from an animal species was identified as allergen. About 8% of the sera from patients with IgE against moth extracts reacted with recombinant P. interpunctella thioredoxin, compared to 25% reacting with recombinant Plo i 1. In immunised BALB/c mice, the recombinant allergens both induced classical Th2-biased immune responses such as induction IgE and IgG1 antibodies, upregulation of IL-5 and IL-4 and basophil degranulation. Conclusion: Thioredoxin from moths like Plo i 1 acts like a classical Type I allergen as do the thioredoxins from wheat or corn. This clearly supports the pan-allergen nature of thioredoxin. The designation Plo i 2 is suggested for the new P. interpunctella allergen.	[Hoflehner, Elisabeth; Binder, Marina; Wiedermann, Ursula; Duchene, Michael] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Hemmer, Wolfgang; Jarisch, Reinhart] Floridsdorfer Allergiezentrum, Vienna, Austria; [Mahler, Vera] Univ Erlangen Nurnberg, Dept Dermatol, Erlangen, Germany; [Panzani, Raphael C.] Ctr Rech Allergol, Marseille, France	Medical University of Vienna; University of Erlangen Nuremberg	Duchene, M (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	michael.duchene@meduniwien.ac.at	Duchêne, Michael/G-6659-2019	Duchêne, Michael/0000-0003-1232-3600; Wiedermann, Ursula/0000-0002-1302-3223	"Jubilaumsstiftung der Osterreichischen Nationalbank'', Vienna, Austria [8643]; "Hochschuljubilaumsstiftung der Stadt Wien'', Vienna, Austria [H-1760/2006]	"Jubilaumsstiftung der Osterreichischen Nationalbank'', Vienna, Austria; "Hochschuljubilaumsstiftung der Stadt Wien'', Vienna, Austria	This study was supported by Grant 8643 from the "Jubilaumsstiftung der Osterreichischen Nationalbank'', and by Grant H-1760/2006 from the "Hochschuljubilaumsstiftung der Stadt Wien'', Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRUDA LK, 1995, INT ARCH ALLERGY IMM, V107, P295, DOI 10.1159/000237006; BALDO BA, 1988, INT ARCH ALLER A IMM, V85, P278, DOI 10.1159/000234518; Binder M, 2001, J IMMUNOL, V167, P5470, DOI 10.4049/jimmunol.167.9.5470; Buchanan BB, 1997, P NATL ACAD SCI USA, V94, P5372, DOI 10.1073/pnas.94.10.5372; Buchanan BB, 2007, J ALLERGY CLIN IMMUN, V119, P513, DOI 10.1016/j.jaci.2006.08.039; Chu KH, 2005, ADV BIOCHEM ENG BIOT, V97, P205, DOI 10.1007/b135827; Chuang CY, 2009, INHAL TOXICOL, V21, P153, DOI [10.1080/08958370802368730, 10.1080/08958370802368730 ]; del Val G, 1999, J ALLERGY CLIN IMMUN, V103, P690, DOI 10.1016/S0091-6749(99)70244-7; Fu CX, 2009, MOL CELL PROTEOMICS, V8, P1674, DOI 10.1074/mcp.M800580-MCP200; Glaser AG, 2008, ALLERGY, V63, P1617, DOI 10.1111/j.1398-9995.2008.01777.x; Hales BJ, 2007, CLIN EXP ALLERGY, V37, P1357, DOI 10.1111/j.1365-2222.2007.02786.x; Hoffman DR, 2008, CURR OPIN ALLERGY CL, V8, P338, DOI 10.1097/ACI.0b013e3283036a7d; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; Komase Y, 1997, ALLERGY, V52, P75, DOI 10.1111/j.1398-9995.1997.tb02548.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Limacher A, 2007, J IMMUNOL, V178, P389, DOI 10.4049/jimmunol.178.1.389; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sander I, 2011, ALLERGY, V66, P1208, DOI 10.1111/j.1398-9995.2011.02636.x; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Son A, 2006, CELL RES, V16, P230, DOI 10.1038/sj.cr.7310031; STEVENSON DD, 1967, J ALLERGY, V39, P274, DOI 10.1016/0021-8707(67)90091-3; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Uda K, 2006, COMP BIOCHEM PHYS D, V1, P209, DOI 10.1016/j.cbd.2005.10.007; URBACH ERIC, 1941, JOUR ALLERGY, V12, P485, DOI 10.1016/S0021-8707(41)90227-7; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; vanWijnen JH, 1997, ALLERGY, V52, P460, DOI 10.1111/j.1398-9995.1997.tb01030.x; Vaughan WT, 1928, J LAB CLIN MED, V13, P955; Weichel M, 2006, J ALLERGY CLIN IMMUN, V117, P676, DOI 10.1016/j.jaci.2005.11.040; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Wittich FW, 1940, J LANCET, P418; Yu CJ, 2003, J IMMUNOL, V170, P445, DOI 10.4049/jimmunol.170.1.445	33	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42026	10.1371/journal.pone.0042026	http://dx.doi.org/10.1371/journal.pone.0042026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844539	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600062
J	Ngui, R; Lim, YAL; Chua, KH				Ngui, Romano; Lim, Yvonne A. L.; Chua, Kek Heng			Rapid Detection and Identification of Human Hookworm Infections through High Resolution Melting (HRM) Analysis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; ANCYLOSTOMA-DUODENALE; NECATOR-AMERICANUS; ASSAY; POLYMORPHISM; DIAGNOSIS; WORLD; EGGS; GENE	Background: Hookworm infections are still endemic in low and middle income tropical countries with greater impact on the socioeconomic and public health of the bottom billion of the world's poorest people. In this study, a real-time polymerase chain reaction (PCR) coupled with high resolution melting-curve (HRM) analysis was evaluated for an accurate, rapid and sensitive tool for species identification focusing on the five human hookworm species. Methods: Real-time PCR coupled with HRM analysis targeting the second internal transcribed spacer (ITS-2) of nuclear ribosomal DNA as the genetic marker was used to identify and distinguish hookworm species in human samples. Unique and distinct characteristics of HRM patterns were produced for each of the five hookworm species. The melting curves were characterized by peaks of 79.24 +/- 0.05 degrees C and 83.00 +/- 0.04 degrees C for Necator americanus, 79.12 +/- 0.10 degrees C for Ancylostoma duodenale, 79.40 +/- 0.10 degrees C for Ancylostoma ceylanicum, 79.63 +/- 0.05 degrees C for Ancylostoma caninum and 79.70 +/- 0.14 degrees C for Ancylostoma braziliense. An evaluation of the method's sensitivity and specificity revealed that this assay was able to detect as low as 0.01 ng/mu l hookworm DNA and amplification was only recorded for hookworm positive samples. Conclusion: The HRM assay developed in this study is a rapid and straightforward method for the diagnosis, identification and discrimination of five human hookworms. This assay is simple compared to other probe-based genotyping methods as it does not require multiplexing, DNA sequencing or post-PCR processing. Therefore, this method offers a new alternative for rapid detection of human hookworm species.	[Chua, Kek Heng] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Ngui, Romano; Lim, Yvonne A. L.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chua, KH (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	khchua@um.edu.my	CHUA, KEK HENG/B-5261-2010; LIM, YVONNE AL/B-5276-2010; Ngui, Romano/H-9645-2015	CHUA, KEK HENG/0000-0002-0452-9994; LIM, YVONNE AL/0000-0003-4050-6332; Ngui, Romano/0000-0002-3520-579X	University of Malaya High Impact Research Grant (UM/MoHE HIR Grant) [E000044-20001]; University of Malaya Student Research Grant [PV024/2011B]; E-Science Grant from the Ministry of Science, Technology and Innovative (MOSTI), Malaysia	University of Malaya High Impact Research Grant (UM/MoHE HIR Grant); University of Malaya Student Research Grant; E-Science Grant from the Ministry of Science, Technology and Innovative (MOSTI), Malaysia	This study was supported by the University of Malaya High Impact Research Grant (UM/MoHE HIR Grant E000044-20001), University of Malaya Student Research Grant (PV024/2011B) and the E-Science Grant from the Ministry of Science, Technology and Innovative (MOSTI), Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 1999, ADV PARASIT, V42, P277, DOI 10.1016/S0065-308X(08)60151-7; Andriantsoanirina V, 2009, J MICROBIOL METH, V78, P165, DOI 10.1016/j.mimet.2009.05.013; Areekit Supatra, 2009, J Med Assoc Thai, V92 Suppl 3, pS24; Basuni M, 2011, AM J TROP MED HYG, V84, P338, DOI 10.4269/ajtmh.2011.10-0499; Bienz M, 2001, PARASITOL RES, V87, P1011; Brooker S, 2008, ADV PARASIT, V58, P197; Crompton DWT, 2000, PARASITOLOGY, V121, pS39, DOI 10.1017/S0031182000006454; de Gruijter JM, 2005, TROP MED INT HEALTH, V10, P574, DOI 10.1111/j.1365-3156.2005.01440.x; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Gasser RB, 1997, MOL CELL PROBE, V11, P201, DOI 10.1006/mcpr.1997.0106; GASSER RB, 1993, NUCLEIC ACIDS RES, V21, P2525, DOI 10.1093/nar/21.10.2525; Gasser RB, 1998, MOL BIOCHEM PARASIT, V92, P303, DOI 10.1016/S0166-6851(98)00008-5; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000405; Hussein EM, 2009, PARASITOL RES, V105, P1053, DOI 10.1007/s00436-009-1515-9; Jiraanankul V, 2011, AM J TROP MED HYG, V84, P594, DOI 10.4269/ajtmh.2011.10-0189; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Ng ZX, 2012, BRIT J OPHTHALMOL, V96, P289, DOI 10.1136/bjophthalmol-2011-300658; Ngui R, 2012, AM J TROP MED HYG, V86, P837, DOI 10.4269/ajtmh.2012.11-0446; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001522; Pangasa A, 2009, MOL CELL PROBE, V23, P10, DOI 10.1016/j.mcp.2008.10.003; Poulson MD, 2007, BIOTECHNIQUES, V43, P87, DOI 10.2144/000112459; Radvansky J, 2011, PARASITOL RES, V108, P201, DOI 10.1007/s00436-010-2057-x; Radvansky J, 2010, ANAL BIOCHEM, V398, P126, DOI 10.1016/j.ab.2009.11.005; Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Robinson BS, 2006, APPL ENVIRON MICROB, V72, P5857, DOI 10.1128/AEM.00113-06; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Sato M, 2010, T ROY SOC TROP MED H, V104, P617, DOI 10.1016/j.trstmh.2010.06.006; Stanley KK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni182; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153, DOI 10.1093/ajcn/65.1.153; Talmi-Frank D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000581; Teh CSJ, 2010, J APPL MICROBIOL, V108, P1940, DOI 10.1111/j.1365-2672.2009.04599.x; Thong KL, 2011, TROP BIOMED, V28, P21; Traub RJ, 2004, VET PARASITOL, V123, P245, DOI 10.1016/j.vetpar.2004.05.026; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Zhou L, 2004, TISSUE ANTIGENS, V64, P156, DOI 10.1111/j.1399-0039.2004.00248.x	41	41	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41996	10.1371/journal.pone.0041996	http://dx.doi.org/10.1371/journal.pone.0041996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844538	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600061
J	Bolhuis, JJ; Gobes, SMH; Terpstra, NJ; den Boer-Visser, AM; Zandbergen, MA				Bolhuis, Johan J.; Gobes, Sharon M. H.; Terpstra, Nienke J.; den Boer-Visser, Ardie M.; Zandbergen, Matthijs A.			Learning-Related Neuronal Activation in the Zebra Finch Song System Nucleus HVC in Response to the Bird's Own Song	PLOS ONE			English	Article							NEURAL MECHANISMS; GENE-EXPRESSION; AUTOGENOUS SONG; NMDA RECEPTORS; BRAIN; MEMORY; SELECTIVITY; PREFERENCE; EXPOSURE; REPRESENTATION	Like many other songbird species, male zebra finches learn their song from a tutor early in life. Song learning in birds has strong parallels with speech acquisition in human infants at both the behavioral and neural levels. Forebrain nuclei in the 'song system' are important for the sensorimotor acquisition and production of song, while caudomedial pallial brain regions outside the song system are thought to contain the neural substrate of tutor song memory. Here, we exposed three groups of adult zebra finch males to either tutor song, to their own song, or to novel conspecific song. Expression of the immediate early gene protein product Zenk was measured in the song system nuclei HVC, robust nucleus of the arcopallium (RA) and Area X. There were no significant differences in overall Zenk expression between the three groups. However, Zenk expression in the HVC was significantly positively correlated with the strength of song learning only in the group that was exposed to the bird's own song, not in the other two groups. These results suggest that the song system nucleus HVC may contain a neural representation of a memory of the bird's own song. Such a representation may be formed during juvenile song learning and guide the bird's vocal output.	[Bolhuis, Johan J.; Gobes, Sharon M. H.; Terpstra, Nienke J.; Zandbergen, Matthijs A.] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Bolhuis, Johan J.; Gobes, Sharon M. H.; Terpstra, Nienke J.; Zandbergen, Matthijs A.] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Bolhuis, Johan J.; Gobes, Sharon M. H.; Terpstra, Nienke J.; Zandbergen, Matthijs A.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Gobes, Sharon M. H.] Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA; [Terpstra, Nienke J.; den Boer-Visser, Ardie M.] Leiden Univ, Inst Biol, Leiden, Netherlands	Utrecht University; Utrecht University; Utrecht University; Wellesley College; Leiden University; Leiden University - Excl LUMC	Bolhuis, JJ (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	j.j.bolhuis@uu.nl		Gobes, Sharon/0000-0001-9598-7116	Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research (NWO) grants (ALW Open Competition and GW Horizon Programme) to JJB (URL: NWO.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMODT SM, 1995, J NEUROBIOL, V27, P76, DOI 10.1002/neu.480270108; Aamodt SM, 1996, NEUROBIOL LEARN MEM, V65, P91, DOI 10.1006/nlme.1996.0010; Basham ME, 1996, NEUROBIOL LEARN MEM, V66, P295, DOI 10.1006/nlme.1996.0071; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2003, ANIM BIOL, V53, P129, DOI 10.1163/157075603769700331; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BOLHUIS JJ, 2008, NEUROSCIENCE BIRDSON, P269; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Bolhuis JJ, 2010, NEUROREPORT, V21, P395, DOI 10.1097/WNR.0b013e3283385949; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Funabiki Y, 2003, J NEUROSCI, V23, P6928; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Gobes SMH, 2010, P ROY SOC B-BIOL SCI, V277, P3343, DOI 10.1098/rspb.2010.0870; Gobes SMH, 2009, J COMP NEUROL, V516, P312, DOI 10.1002/cne.22113; Gobes SMH, 2012, BIRDSONG SP IN PRESS; Gobes SMH, 2011, 2011 NEUR M PLANN; Heinrich JE, 2003, NEUROBIOL LEARN MEM, V79, P99, DOI 10.1016/S1074-7427(02)00016-3; Houx BB, 1999, ANIM BEHAV, V57, P837; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; MARGOLIASH D, 1985, P NATL ACAD SCI USA, V82, P5997, DOI 10.1073/pnas.82.17.5997; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; Marler, 2008, NEUROSCIENCE BIRDSON, P381; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Moorman S, 2012, BIRDSONG SP IN PRESS; Moorman S, 2011, BIOESSAYS, V33, P377, DOI 10.1002/bies.201000150; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; Nordeen KW, 2004, ANN NY ACAD SCI, V1016, P416, DOI 10.1196/annals.1298.018; Nottebohm F, 1999, DESIGN OF ANIMAL COMMUNICATION, P63; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Prather J.F., 2008, NEUROSCIENCE BIRDSON, P174; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Riebel K, 2002, P ROY SOC B-BIOL SCI, V269, P729, DOI 10.1098/rspb.2001.1930; Riebel K, 2000, P ROY SOC B-BIOL SCI, V267, P2553, DOI 10.1098/rspb.2000.1320; Solis MM, 2000, NEURON, V25, P109, DOI 10.1016/S0896-6273(00)80875-2; Solis MM, 2000, P NATL ACAD SCI USA, V97, P11836, DOI 10.1073/pnas.97.22.11836; Sturdy CB, 1999, J COMP PSYCHOL, V113, P204, DOI 10.1037/0735-7036.113.2.204; Sturdy CB, 1999, J COMP PSYCHOL, V113, P194, DOI 10.1037/0735-7036.113.2.194; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Theunissen FE, 2008, NEUROSCIENCE BIRDSON, P157; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; VOLMAN SF, 1993, J NEUROSCI, V13, P4737; Zann RA., 1996, ZEBRA FINCH SYNTHESI	60	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41556	10.1371/journal.pone.0041556	http://dx.doi.org/10.1371/journal.pone.0041556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848527	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600084
J	Lv, BJ; Lindholt, JS; Cheng, X; Wang, J; Shi, GP				Lv, Bing-Jie; Lindholt, Jes S.; Cheng, Xiang; Wang, Jing; Shi, Guo-Ping			Plasma Cathepsin S and Cystatin C Levels and Risk of Abdominal Aortic Aneurysm: A Randomized Population-Based Study	PLOS ONE			English	Article							SERUM-ELASTIN-PEPTIDES; MATRIX-METALLOPROTEINASE; CYSTEINE PROTEASES; DEFICIENCY; MICE; ATHEROSCLEROSIS; EXPRESSION; DEGRADATION; WALL; MATRIX-METALLOPROTEINASE-9	Background: Human abdominal aortic aneurysm (AAA) lesions contain high levels of cathepsin S (CatS), but are deficient in its inhibitor, cystatin C. Whether plasma CatS and cystatin C levels are also altered in AAA patients remains unknown. Methods and Results: Plasma samples were collected from 476 male AAA patients and 200 age-matched male controls to determine CatS and cystatin C levels by ELISA. Student's t test demonstrated higher plasma levels of total, active, and pro-CatS in AAA patients than in controls (P < 0.001). ROC curve analysis confirmed higher plasma total, active, and pro-CatS levels in AAA patients than in controls (P < 0.001). Logistic regression suggested that plasma total (odds ratio [OR] = 1.332), active (OR = 1.21), and pro-CatS (OR = 1.25) levels were independent AAA risk factors that associated positively with AAA (P < 0.001). Plasma cystatin C levels associated significantly, but negatively, with AAA (OR = 0.356, P < 0.001). Univariate correlation demonstrated that plasma total and active CatS levels correlated positively with body-mass index, diastolic blood pressure, and aortic diameter, but negatively with the lowest ankle-brachial index (ABI). Plasma cystatin C levels also correlated negatively with the lowest ABI. Multivariate linear regression showed that plasma total, active, and pro-CatS levels correlated positively with aortic diameter and negatively with the lowest ABI, whereas plasma cystatin C levels correlated negatively with aortic diameter and the lowest ABI, after adjusting for common AAA risk factors. Conclusions: Correlation of plasma CatS and cystatin C with aortic diameter and the lowest ABI suggest these serological parameters as biomarkers for human peripheral arterial diseases and AAA.	[Lv, Bing-Jie; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Cardiol, Wuhan 430074, Peoples R China; [Lv, Bing-Jie; Wang, Jing; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lv, Bing-Jie; Wang, Jing; Shi, Guo-Ping] Harvard Univ, Sch Med, Boston, MA USA; [Lindholt, Jes S.] Viborg Hosp, Dept Vasc Surg, Vasc Res Unit, Viborg, Denmark	Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Aarhus University	Lv, BJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Cardiol, Wuhan 430074, Peoples R China.	jwang38@rics.bwh.harvard.edu; gshi@rics.bwh.harvard.edu	Cheng, Xiang/K-2190-2012; Lindholt, Jes/J-2907-2014	Lindholt, Jes/0000-0001-9536-4488	mid-region of Denmark; 7th European framework programme [Health-2007-2.4.2-2, 200647]; National Institutes of Health [HL60942, HL81090, HL88547]; AHA [0840118N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060942, R01HL081090, R01HL088547] Funding Source: NIH RePORTER	mid-region of Denmark; 7th European framework programme(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by the mid-region of Denmark and the 7th European framework programme, Health-2007-2.4.2-2 agreement number 200647 (JL); by grants from the National Institutes of Health (HL60942, HL81090, HL88547) (GPS); and by an Established Investigator Award (0840118N) from the AHA (GPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussien H, 2007, AM J PATHOL, V170, P809, DOI 10.2353/ajpath.2007.060522; Abisi S, 2007, J VASC SURG, V46, P1260, DOI 10.1016/j.jvs.2007.08.015; Bergoeing MP, 2007, J VASC SURG, V45, P1217, DOI 10.1016/j.jvs.2007.01.058; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Crowther M, 2000, BRIT J SURG, V87, P1391, DOI 10.1046/j.1365-2168.2000.01554.x; Eriksson P, 2004, BRIT J SURG, V91, P86, DOI 10.1002/bjs.4364; Grondal N, 2012, EUR J VASC ENDOVASC, V43, P30, DOI 10.1016/j.ejvs.2011.09.025; Grondal N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-67; Hurks R, 2010, EUR J VASC ENDOVASC, V39, P569, DOI 10.1016/j.ejvs.2010.01.030; Joensen JB, 2008, ANGIOLOGY, V59, P296, DOI 10.1177/0003319707308198; Lindholt JS, 1997, EUR J VASC ENDOVASC, V14, P12, DOI 10.1016/S1078-5884(97)80219-5; Lindholt JS, 2001, EUR J VASC ENDOVASC, V22, P546, DOI 10.1053/ejvs.2001.1516; Lindholt JS, 2001, BRIT J SURG, V88, P1472, DOI 10.1046/j.0007-1323.2001.01911.x; Lindholt JS, 2001, EUR J VASC ENDOVASC, V21, P235, DOI 10.1053/ejvs.2001.1329; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Liu J, 2006, ATHEROSCLEROSIS, V186, P411, DOI 10.1016/j.atherosclerosis.2005.08.001; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Satta J, 1997, J VASC SURG, V25, P909, DOI 10.1016/S0741-5214(97)70222-2; Satta J, 1998, EUR J VASC ENDOVASC, V15, P313, DOI 10.1016/S1078-5884(98)80034-8; Schulte S, 2010, AM J PATHOL, V177, P456, DOI 10.2353/ajpath.2010.090381; SHI GP, 1992, J BIOL CHEM, V267, P7258; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Shiraya S, 2006, HYPERTENSION, V48, P628, DOI 10.1161/01.HYP.0000240266.26185.57; Shiraya S, 2009, ATHEROSCLEROSIS, V202, P34, DOI 10.1016/j.atherosclerosis.2008.03.020; Steinmetz EF, 2005, ANN SURG, V241, P92, DOI 10.1097/01.sla.0000150258.36236.e0; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sun JS, 2012, ARTERIOSCL THROM VAS, V32, P15, DOI 10.1161/ATVBAHA.111.235002; Sun JS, 2011, ARTERIOSCL THROM VAS, V31, P2500, DOI 10.1161/ATVBAHA.111.230201; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; Treska V, 2000, INT ANGIOL, V19, P64; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Williams IM, 1996, ANN ROY COLL SURG, V78, P501; Yamashita A, 2001, WORLD J SURG, V25, P259, DOI 10.1007/s002680020062; Zhang YL, 2009, ARTERIOSCL THROM VAS, V29, P1764, DOI 10.1161/ATVBAHA.109.192609	35	45	49	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41813	10.1371/journal.pone.0041813	http://dx.doi.org/10.1371/journal.pone.0041813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844527	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700154
J	Robertson, T; Batty, GD; Der, G; Green, MJ; McGlynn, LM; McIntyre, A; Shiels, PG; Benzeval, M				Robertson, Tony; Batty, G. David; Der, Geoff; Green, Michael J.; McGlynn, Liane M.; McIntyre, Alan; Shiels, Paul G.; Benzeval, Michaela			Is Telomere Length Socially Patterned? Evidence from the West of Scotland Twenty-07 Study	PLOS ONE			English	Article							FETUIN-A LEVELS; SOCIOECONOMIC-STATUS; PULSE PRESSURE; PATERNAL AGE; BLOOD-CELLS; OLDER MEN; ASSOCIATION; HEALTH; MORTALITY; INDICATOR	Lower socioeconomic status (SES) is strongly associated with an increased risk of morbidity and premature mortality, but it is not known if the same is true for telomere length, a marker often used to assess biological ageing. The West of Scotland Twenty-07 Study was used to investigate this and consists of three cohorts aged approximately 35 (N = 775), 55 (N = 866) and 75 years (N = 544) at the time of telomere length measurement. Four sets of measurements of SES were investigated: those collected contemporaneously with telomere length assessment, educational markers, SES in childhood and SES over the preceding twenty years. We found mixed evidence for an association between SES and telomere length. In 35-year-olds, many of the education and childhood SES measures were associated with telomere length, i.e. those in poorer circumstances had shorter telomeres, as was intergenerational social mobility, but not accumulated disadvantage. A crude estimate showed that, at the same chronological age, social renters, for example, were nine years (biologically) older than home owners. No consistent associations were apparent in those aged 55 or 75. There is evidence of an association between SES and telomere length, but only in younger adults and most strongly using education and childhood SES measures. These results may reflect that childhood is a sensitive period for telomere attrition. The cohort differences are possibly the result of survival bias suppressing the SES-telomere association; cohort effects with regard different experiences of SES; or telomere possibly being a less effective marker of biological ageing at older ages.	[Robertson, Tony; Batty, G. David; Der, Geoff; Green, Michael J.; Benzeval, Michaela] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [McGlynn, Liane M.; McIntyre, Alan; Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, MVLS, Glasgow, Lanark, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; University College London	Robertson, T (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	t.robertson@sphsu.mrc.ac.uk	Benzeval, Michaela/J-3163-2015; Batty, GD/Y-4401-2018; Robertson, Tony/L-5062-2015	Benzeval, Michaela/0000-0002-0372-2098; Batty, GD/0000-0003-1822-5753; Robertson, Tony/0000-0002-1962-5874; Shiels, Paul/0000-0002-7577-9843; Der, Geoff/0000-0002-8677-073X; Green, Michael/0000-0003-3193-2452	UK Medical Research Council (MRC) [MC_US_A540_0080]; MRC [MC_US_A540_0056]; Medical Research Council [MC_U130059823, MC_UP_A540_1021, MC_U130059821] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [MC_U130059821, MC_UP_A540_1021, MC_U130059823] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The West of Scotland Twenty-07 Study is funded by the UK Medical Research Council (MRC) (MC_US_A540_0080) and the data were originally collected by the MRC/CSO Social and Public Health Sciences Unit. T. Robertson, M. Green, G. Der and M. Benzeval are funded by the MRC (MC_US_A540_0056). G. D. Batty is a Wellcome Trust Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2007, AGING CELL, V6, P125, DOI 10.1111/j.1474-9726.2006.00258.x; Adams JM, 2004, EUR J PUBLIC HEALTH, V14, P331, DOI 10.1093/eurpub/14.3.331; Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P839, DOI 10.1136/jech.2009.088427; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Carstairs V., 1991, DEPRIVATION HLTH SCO; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan R, 2010, BRIT J NUTR, V103, P107, DOI 10.1017/S0007114509991383; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; Deroo LA, 2009, AM J EPIDEMIOL, V169, pS88; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fernandez-Egea E, 2009, SCHIZOPHRENIA BULL, V35, P437, DOI 10.1093/schbul/sbn169; Geronimus AT, 2010, HUM NATURE-INT BIOS, V21, P19, DOI 10.1007/s12110-010-9078-0; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Harris SE, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.013; Hou LF, 2009, CANCER EPIDEM BIOMAR, V18, P3103, DOI 10.1158/1055-9965.EPI-09-0347; Janicki-Deverts D, 2009, PSYCHOSOM MED, V71, P541, DOI 10.1097/PSY.0b013e31819e7526; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kuh D, 2006, AGING CELL, V5, P579, DOI 10.1111/j.1474-9726.2006.00250.x; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Lorimer K, 2010, 20078 MRCCSO SOC PUB; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.2307/3180803; Macintyre S, 1989, READINGS NEW PUBLIC, P56; Marmot M, 2010, MARMOT REV FAIR SOC; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Mather KA, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-62; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Maxwell F, 2011, CLIN CANCER RES, V17, P5573, DOI 10.1158/1078-0432.CCR-10-3271; McLoone P., 2004, CARSTAIRS SCORES SCO; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nordfjall K, 2008, SCAND J PUBLIC HEALT, V36, P744, DOI 10.1177/1403494808090634; OPCS (Office of Population Censuses and Surveys), 1980, CLASS OCC 1980; Parks CG, 2011, OCCUP ENVIRON MED, V68, P582, DOI 10.1136/oem.2010.063214; Risques RA, 2010, J AM GERIATR SOC, V58, P1289, DOI 10.1111/j.1532-5415.2010.02948.x; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Seaman S, 2011, 27 MRCCSO SOC PUBL H; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Shiels PG, 2010, J GERONTOL A-BIOL, V65, P789, DOI 10.1093/gerona/glq095; Sies H., 1991, OXIDATIVE STRESS OXI; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Walsh D., 2008, AFTERSHOCK DEINDUSTR; Woo J, 2009, AGE AGEING, V38, P553, DOI 10.1093/ageing/afp098; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006; Zheng YL, 2010, BREAST CANCER RES TR, V120, P769, DOI 10.1007/s10549-009-0440-z	60	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41805	10.1371/journal.pone.0041805	http://dx.doi.org/10.1371/journal.pone.0041805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844525	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700152
J	Tang, K; Jiao, NZ; Liu, KS; Zhang, Y; Li, SH				Tang, Kai; Jiao, Nianzhi; Liu, Keshao; Zhang, Yao; Li, Shuhui			Distribution and Functions of TonB-Dependent Transporters in Marine Bacteria and Environments: Implications for Dissolved Organic Matter Utilization	PLOS ONE			English	Article							ACETYLGLUCOSAMINE UTILIZATION PATHWAY; OUTER-MEMBRANE; CAULOBACTER-CRESCENTUS; COMPARATIVE GENOMICS; PROTEOMIC ANALYSIS; ACTIVE-TRANSPORT; PROTEIN; OCEAN; DATABASE; CARBON	Background: Bacteria play critical roles in marine nutrient cycles by incorporating and redistributing dissolved organic matter (DOM) and inorganic nutrients in the ocean. TonB-dependent transporter (TBDT) proteins allow Gram-negative bacteria to take up scarce resources from nutrient-limiting environments as well as siderophores, heme, vitamin B12, and recently identified carbohydrates. Thus, the characterization of TBDT distribution and functions is essential to better understand the contribution TBDT to DOM assimilation and its consequences on nutrient cycling in the environment. Methodology/Principal Findings: This study presents the distribution of encoded known and putative TBDT proteins in the genomes of microorganisms and from the Global Ocean Survey data. Using a Lek clustering algorithm and substrate specificities, the TBDT sequences were mainly classified into the following three groups: (1) DOM transporters; (2) Siderophores/Vitamins transporters; and (3) Heme/Hemophores/Iron(heme)-binding protein transporters. Diverse TBDTs were found in the genomes of oligotroph Citromicrobium bathyomarinum JL354 and Citromicrobium sp JLT1363 and were highly expressed in the stationary phase of bacterial growth. The results show that the Gammaproteobacteria and the Cytophaga-Flavobacterium-Bacteroides (CFB) group bacteria accounted for the majority of the TBDT gene pool in marine surface waters. Conclusions/Significance: The results of this study confirm the ecological importance of TBDTs in DOM assimilation for bacteria in marine environments owing to a wide range of substrate utilization potential in the ubiquitous Gammaproteobacteria and CFB group bacteria.	[Tang, Kai; Jiao, Nianzhi; Liu, Keshao; Zhang, Yao; Li, Shuhui] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Xiamen University	Tang, K (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	tangkai@xmu.edu.cn; jiao@xmu.edu			NSFC (Natural Science Foundation of China) [40906079]; National Basic Research Program of China [2011CB808800]; NSFC [91028001]; Public Science and Technology Research Funds Projects of Ccean [201105021]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China	NSFC (Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ccean; Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by NSFC (Natural Science Foundation of China) 40906079, National Basic Research Program of China 2011CB808800, key NSFC 91028001, Public Science and Technology Research Funds Projects of Ccean 201105021 and the Scientific Research Foundation for Returned Scholars, Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aluwihare LI, 1999, MAR ECOL PROG SER, V186, P105, DOI 10.3354/meps186105; Babbette B, 2004, J BACTERIOL, V186, P374, DOI 10.1128/JB.186.2.374-382.2004; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Biers EJ, 2007, APPL ENVIRON MICROB, V75, P2221; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boulanger A, 2010, J BACTERIOL, V192, P1487, DOI 10.1128/JB.01418-09; Chen JL, 1997, FEMS MICROBIOL LETT, V156, P61, DOI 10.1016/S0378-1097(97)00396-0; Christie-Oleza JA, 2012, ISME J, V6, P124, DOI 10.1038/ismej.2011.86; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunliffe M, 2009, ISME J, V3, P1001, DOI 10.1038/ismej.2009.69; Dafher EV, 2002, J ENVIRON MONITOR, V4, P55, DOI 10.1039/b107279j; Dai J, 2005, ANAL CHEM, V77, P5793, DOI 10.1021/ac050251w; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Eddy Sean R, 2009, Genome Inform, V23, P205; Edwards JL, 2010, GENES-BASEL, V1, P371, DOI 10.3390/genes1030371; Eisenbeis S, 2008, J BACTERIOL, V190, P5230, DOI 10.1128/JB.00194-08; Eppler T., 2001, MICROBIAL TRANSPORT, P77; Erni B, 2001, MICROBIAL TRANSPORT, P115; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; He JS, 2008, FEMS MICROBIOL LETT, V288, P221, DOI 10.1111/j.1574-6968.2008.01354.x; Hopkinson BM, 2012, ENVIRON MICROBIOL, V14, P114, DOI 10.1111/j.1462-2920.2011.02539.x; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Jiao NZ, 2011, APPL ENVIRON MICROB, V77, P7439, DOI 10.1128/AEM.05640-11; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jiao NZ, 2010, J BACTERIOL, V192, P1169, DOI 10.1128/JB.01504-09; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lim BL, 2010, MICROBES ENVIRON, V25, P67, DOI 10.1264/jsme2.ME10102; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCarthy M, 1996, MAR CHEM, V55, P281, DOI 10.1016/S0304-4203(96)00041-2; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller TR, 2010, J BACTERIOL, V192, P6101, DOI 10.1128/JB.01030-10; Milton H, 2001, MICROBIAL TRANSPORT, P1; Mirus O, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-68; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Obernosterer I., 2007, BIOGEOSCIENCES DISCU, V4, P2809, DOI [10.5194/bgd-4-2809-2007, DOI 10.5194/BGD-4-2809-2007]; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Sowell SM, 2011, ISME J, V5, P856, DOI 10.1038/ismej.2010.168; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Suzumura M, 1995, LIMNOL OCEANOGR, V40, P1254, DOI 10.4319/lo.1995.40.7.1254; Tang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011604; Tang K, 2010, CURR MICROBIOL, V60, P124, DOI 10.1007/s00284-009-9515-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Wilmes B, 2011, APPL ENVIRON MICROB, V77, P1276, DOI 10.1128/AEM.01750-10; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zheng QA, 2011, J BACTERIOL, V193, P2074, DOI 10.1128/JB.00121-11	69	75	76	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41204	10.1371/journal.pone.0041204	http://dx.doi.org/10.1371/journal.pone.0041204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829928	Green Submitted, Green Published, gold			2022-12-27	WOS:000306956300067
J	Fajardo, T; Rosas, MF; Sobrino, F; Martinez-Salas, E				Fajardo, Teodoro, Jr.; Flora Rosas, Maria; Sobrino, Francisco; Martinez-Salas, Encarnacion			Exploring IRES Region Accessibility by Interference of Foot-and-Mouth Disease Virus Infectivity	PLOS ONE			English	Article							RIBOSOME-ENTRY SITE; TRANSLATION INITIATION-FACTORS; INTERNAL INITIATION; IN-VIVO; L-PROTEASE; HETEROTYPIC INHIBITION; MORPHOLINO OLIGOMERS; FUNCTIONAL-ANALYSIS; NONCODING REGIONS; STABLE EXPRESSION	Translation initiation of picornavirus RNA is driven by an internal ribosome entry site (IRES) element located upstream of the initiator codon. RNA structure organization as well as RNA-protein interaction plays a fundamental role in internal initiation. IRES activity has been mainly analyzed in the context of reporter genes, lacking regions of the viral genome potentially affecting translation efficiency. With the aim to understand the vulnerability of the IRES and translation start region to small molecules in the context of the viral genome, we designed a set of customized RNase-resistant 2'O-methyl antisense oligoribonucleotides (2'OMe AONs) based on RNA structure data. These AONs were then used to monitor their capacity to interfere viral RNA translation, and thus, to inhibit virus yield. Foot-and-mouth disease virus (FMDV) RNA translation can be initiated at two in-frame AUG codons. We show here that a 2'OMe AON complementary to AUG2 inhibited viral multiplication more efficiently than the one that targeted AUG1. Furthermore, the response of the viral RNA to AONs targeting the IRES region denoted important differences between tissue culture cells and cell-free systems, reinforcing the need to analyze viral RNA response in living cells. Importantly, we have identified four specific motifs within the IRES element that are targets for viral inhibitors both in tissue culture cells and in cell-free systems. The identified targets define accessible regions to small molecules, which disturb either the RNA structural organization or the RNA-protein interactions needed to initiate translation in FMDV RNA.	[Fajardo, Teodoro, Jr.; Flora Rosas, Maria; Sobrino, Francisco; Martinez-Salas, Encarnacion] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Fajardo, T (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain.	emartinez@cbm.uam.es	; Martinez-Salas, Encarna/J-5733-2014	Sobrino, Francisco/0000-0003-4968-8291; Martinez-Salas, Encarna/0000-0002-8432-5587	Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-02159, CSD2009-00080, BFU2011-25437]; Fundacion Ramon Areces; MICINN [BIO2011-24351]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by grants BFU2008-02159, CSD2009-00080, BFU2011-25437 from Ministerio de Ciencia e Innovacion (MICINN) and by an Institutional Grant from Fundacion Ramon Areces. Work at FS laboratory was supported by grant BIO2011-24351 from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev DE, 2007, RNA, V13, P1366, DOI 10.1261/rna.469707; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; BELSHAM GJ, 1992, EMBO J, V11, P1105, DOI 10.1002/j.1460-2075.1992.tb05150.x; BELSHAM GJ, 1990, J VIROL, V64, P5389, DOI 10.1128/JVI.64.11.5389-5395.1990; Bigeriego P, 1999, ANTIVIR RES, V44, P133, DOI 10.1016/S0166-3542(99)00057-1; CAO XM, 1995, J VIROL, V69, P560, DOI 10.1128/JVI.69.1.560-563.1995; de los Santos T, 2006, J VIROL, V80, P1906, DOI 10.1128/JVI.80.4.1906-1914.2006; de Quinto SL, 1998, GENE, V217, P51; de Quinto SL, 1999, VIROLOGY, V255, P324, DOI 10.1006/viro.1999.9598; De Quinto SL, 2000, RNA, V6, P1380, DOI 10.1017/S1355838200000753; de Quinto SL, 2002, NUCLEIC ACIDS RES, V30, P4398, DOI 10.1093/nar/gkf569; De Quinto SL, 2001, RNA, V7, P1213, DOI 10.1017/S1355838201010433; Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005; deQuinto SL, 1997, J VIROL, V71, P4171; Fernandez N, 2011, NUCLEIC ACIDS RES, V39, P8572, DOI 10.1093/nar/gkr560; Fernandez N, 2011, VIROLOGY, V409, P251, DOI 10.1016/j.virol.2010.10.013; Fernandez-Miragall O, 2006, RNA, V12, P223, DOI 10.1261/rna.2153206; Fernandez-Miragall O, 2003, RNA, V9, P1333, DOI 10.1261/rna.5950603; Fernandez-Miragall O, 2007, J GEN VIROL, V88, P3053, DOI 10.1099/vir.0.83218-0; FORSS S, 1984, NUCLEIC ACIDS RES, V12, P6587, DOI 10.1093/nar/12.16.6587; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005; Gonzalez-Carmona MA, 2011, J HEPATOL, V55, P19, DOI 10.1016/j.jhep.2010.11.010; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; GUTIERREZ A, 1993, ANTIVIR RES, V22, P1, DOI 10.1016/0166-3542(93)90082-T; GUTIERREZ A, 1994, J VIROL, V68, P7426; Haraguchi T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1317; HOKE GD, 1991, NUCLEIC ACIDS RES, V19, P5743, DOI 10.1093/nar/19.20.5743; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; INOUE H, 1987, FEBS LETT, V215, P327, DOI 10.1016/0014-5793(87)80171-0; KING AMQ, 1980, J VIROL, V34, P627, DOI 10.1128/JVI.34.3.627-634.1980; Kinney RM, 2005, J VIROL, V79, P5116, DOI 10.1128/JVI.79.8.5116-5128.2005; Knox C, 2005, J GEN VIROL, V86, P687, DOI 10.1099/vir.0.80208-0; KUHN R, 1990, J VIROL, V64, P4625; Lawrence P, 2012, VIROLOGY, V425, P40, DOI 10.1016/j.virol.2011.12.019; Laxton C, 2011, ANTIMICROB AGENTS CH, V55, P3105, DOI 10.1128/AAC.00222-11; LUZ N, 1991, J VIROL, V65, P6486, DOI 10.1128/JVI.65.12.6486-6494.1991; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; Martinez-Salas E, 2010, PICORNAVIRUSES, P141; Martinez-Salas E, 2008, TRENDS MICROBIOL, V16, P230, DOI 10.1016/j.tim.2008.01.013; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MartinezSalas E, 1996, J VIROL, V70, P992; MARTINEZSALAS E, 1993, J VIROL, V67, P3748; Mason PW, 2002, J VIROL, V76, P9686, DOI 10.1128/JVI.76.19.9686-9694.2002; Monaghan P, 2004, J GEN VIROL, V85, P933, DOI 10.1099/vir.0.19408-0; Neuman BW, 2005, J VIROL, V79, P9665, DOI 10.1128/JVI.79.15.9665-9676.2005; O'Donnell V, 2011, VIROLOGY, V410, P142, DOI 10.1016/j.virol.2010.10.042; Pacheco A, 2008, PROTEOMICS, V8, P4782, DOI 10.1002/pmic.200800338; Pacheco A, 2009, NUCLEIC ACIDS RES, V37, P582, DOI 10.1093/nar/gkn979; Piccone ME, 2009, J VIROL, V83, P6681, DOI 10.1128/JVI.01729-08; Pilipenko EV, 2000, GENE DEV, V14, P2028; Pineiro D, 2012, NUCLEIC ACIDS RES, V40, P4942, DOI 10.1093/nar/gks172; Pulido MR, 2007, VIROLOGY, V364, P466, DOI 10.1016/j.virol.2007.03.013; Rodriguez-Pulido M, 2011, J VIROL, V85, P6492, DOI 10.1128/JVI.00599-11; Rosas MF, 2008, VIROLOGY, V380, P34, DOI 10.1016/j.virol.2008.06.040; Rosas MF, 2003, J GEN VIROL, V84, P393, DOI 10.1099/vir.0.18668-0; Saiz M, 2001, J GEN VIROL, V82, P93, DOI 10.1099/0022-1317-82-1-93; Santos TDL, 2005, VIROLOGY, V335, P222, DOI 10.1016/j.virol.2005.03.001; Serrano P, 2006, J GEN VIROL, V87, P3013, DOI 10.1099/vir.0.82059-0; Serrano P, 2009, VIROLOGY, V388, P221, DOI 10.1016/j.virol.2009.03.021; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; Stone JK, 2008, ANTIMICROB AGENTS CH, V52, P1970, DOI 10.1128/AAC.00011-08; Vagnozzi A, 2007, J VIROL, V81, P11669, DOI 10.1128/JVI.00557-07; Wakita T, 1999, J MED VIROL, V57, P217, DOI 10.1002/(SICI)1096-9071(199903)57:3<217::AID-JMV1>3.3.CO;2-O; Yu YP, 2011, NUCLEIC ACIDS RES, V39, P4851, DOI 10.1093/nar/gkr045	67	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41382	10.1371/journal.pone.0041382	http://dx.doi.org/10.1371/journal.pone.0041382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815996	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900114
J	Bejjani, A; O'Neill, J; Kim, JA; Frew, AJ; Yee, VW; Ly, R; Kitchen, C; Salamon, N; McCracken, JT; Toga, AW; Alger, JR; Levitt, JG				Bejjani, Anthony; O'Neill, Joseph; Kim, John A.; Frew, Andrew J.; Yee, Victor W.; Ly, Ronald; Kitchen, Christina; Salamon, Noriko; McCracken, James T.; Toga, Arthur W.; Alger, Jeffry R.; Levitt, Jennifer G.			Elevated Glutamatergic Compounds in Pregenual Anterior Cingulate in Pediatric Autism Spectrum Disorder Demonstrated by H-1 MRS and H-1 MRSI	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CARRIER SLC25A12 GENE; ACETYL-L-ASPARTATE; N-ACETYLASPARTYLGLUTAMATE; YOUNG-CHILDREN; WHITE-MATTER; GLUTAMATE-RECEPTOR-6 GENE; DIAGNOSTIC INTERVIEW; ASPERGER-SYNDROME; INFANTILE-AUTISM	Recent research in autism spectrum disorder (ASD) has aroused interest in anterior cingulate cortex and in the neurometabolite glutamate. We report two studies of pregenual anterior cingulate cortex (pACC) in pediatric ASD. First, we acquired in vivo single-voxel proton magnetic resonance spectroscopy (1 H MRS) in 8 children with ASD and 10 typically developing controls who were well matched for age, but with fewer males and higher IQ. In the ASD group in midline pACC, we found mean 17.7% elevation of glutamate + glutamine (Glx) (p < 0.05) and 21.2% (p < 0.001) decrement in creatine + phosphocreatine (Cr). We then performed a larger (26 subjects with ASD, 16 controls) follow-up study in samples now matched for age, gender, and IQ using proton magnetic resonance spectroscopic imaging (H-1 MRSI). Higher spatial resolution enabled bilateral pACC acquisition. Significant effects were restricted to right pACC where Glx (9.5%, p < 0.05), Cr (6.7%, p < 0.05), and N-acetyl-aspartate + N-acetyl-aspartyl-glutamate (10.2%, p < 0.01) in the ASD sample were elevated above control. These two independent studies suggest hyperglutamatergia and other neurometabolic abnormalities in pACC in ASD, with possible right-lateralization. The hyperglutamatergic state may reflect an imbalance of excitation over inhibition in the brain as proposed in recent neurodevelopmental models of ASD.	[Bejjani, Anthony; Frew, Andrew J.; Alger, Jeffry R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [O'Neill, Joseph; Yee, Victor W.; Ly, Ronald; McCracken, James T.; Levitt, Jennifer G.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci, Div Child & Adolescent Psychiat, Los Angeles, CA 90095 USA; [Kim, John A.; Toga, Arthur W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Lab Neuroimaging, Los Angeles, CA 90095 USA; [Kitchen, Christina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Salamon, Noriko] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [McCracken, James T.; Toga, Arthur W.; Alger, Jeffry R.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bejjani, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	joneill@mednet.ucla.edu	Ramirez, Christina/AAT-5088-2021	Bejjani, Anthony/0000-0003-2241-6974; Ramirez, Christina/0000-0002-8435-0416	National Institute for Neurological Diseases and Stroke [R01NS46018]; National Institute of Mental Health [KO8-MH01385]; NIH (Strickland) [P01 MH63357]; NIH Pediatric MRI Database (JGL/JMC); NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH063357, K08MH001385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046018] Funding Source: NIH RePORTER	National Institute for Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (Strickland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pediatric MRI Database (JGL/JMC); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by award R01NS46018-01 (JGL) from the National Institute for Neurological Diseases and Stroke, by award KO8-MH01385 (JGL) from the National Institute of Mental Health, by NIH award P01 MH63357 (Strickland), and by the NIH Pediatric MRI Database (JGL/JMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; Aldred S, 2003, J AUTISM DEV DISORD, V33, P93, DOI 10.1023/A:1022238706604; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; Ballaban-Gil K, 2000, MENT RETARD DEV D R, V6, P300, DOI 10.1002/1098-2779(2000)6:4<300::AID-MRDD9>3.0.CO;2-R; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Baslow MH, 2005, J MOL NEUROSCI, V26, P1, DOI 10.1385/JMN:26:1:001; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Baslow MH, 1997, J NEUROCHEM, V68, P1335; Bernardi S, 2011, BRAIN RES, V1380, P198, DOI 10.1016/j.brainres.2010.12.057; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; Blasi F, 2006, EUR J HUM GENET, V14, P123, DOI 10.1038/sj.ejhg.5201444; Bonilha L, 2008, BRAIN DEV-JPN, V30, P396, DOI 10.1016/j.braindev.2007.11.006; Brune CW, 2008, AUTISM RES, V1, P108, DOI 10.1002/aur.11; Buttenschon HN, 2009, J NEURAL TRANSM, V116, P381, DOI 10.1007/s00702-008-0142-4; CANGRO CB, 1987, J NEUROCHEM, V49, P1579, DOI 10.1111/j.1471-4159.1987.tb01030.x; Carlsson ML, 1998, J NEURAL TRANSM, V105, P525, DOI 10.1007/s007020050076; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; CASSIDY M, 1993, NEUROPEPTIDES, V24, P271, DOI 10.1016/0143-4179(93)90015-3; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Correia C, 2006, J AUTISM DEV DISORD, V36, P1137, DOI 10.1007/s10803-006-0138-6; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DeVito TJ, 2007, BIOL PSYCHIAT, V61, P465, DOI 10.1016/j.biopsych.2006.07.022; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P215, DOI 10.1093/scan/nsp017; Duncan NW, 2011, HUM BRAIN MAPP, V32, P2172, DOI 10.1002/hbm.21179; Dutta S, 2007, CELL MOL NEUROBIOL, V27, P1035, DOI 10.1007/s10571-007-9193-6; Endo T, 2007, BIOL PSYCHIAT, V62, P1030, DOI 10.1016/j.biopsych.2007.05.015; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Fatemi SH, 2008, PROG NEURO-PSYCHOPH, V32, P911, DOI 10.1016/j.pnpbp.2007.11.004; Fayed N, 2005, ACAD RADIOL, V12, P566, DOI 10.1016/j.acra.2005.01.016; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Friedman SD, 2006, ARCH GEN PSYCHIAT, V63, P786, DOI 10.1001/archpsyc.63.7.786; Fujii E, 2010, J MED INVESTIG, V57, P35, DOI 10.2152/jmi.57.35; Gabis L, 2008, J CHILD NEUROL, V23, P766, DOI 10.1177/0883073808315423; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Hancu I, 2009, ISMRM 17 SCI M EXH H; Harada M, 2011, J AUTISM DEV DISORD, V41, P447, DOI 10.1007/s10803-010-1065-0; Hardan AY, 2008, PSYCHIAT RES-NEUROIM, V163, P97, DOI 10.1016/j.pscychresns.2007.12.002; Hashimoto T, 1997, J CHILD NEUROL, V12, P91, DOI 10.1177/088307389701200204; Hashimoto T, 1998, ACTA NEUROL SCAND, V98, P8, DOI 10.1111/j.1600-0404.1998.tb07371.x; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hisaoka S, 2001, NEURORADIOLOGY, V43, P496, DOI 10.1007/s002340000520; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Jamain S, 2002, MOL PSYCHIATR, V7, P302, DOI 10.1038/sj.mp.4000979; Jiao Y, 2010, NEUROIMAGE, V50, P589, DOI 10.1016/j.neuroimage.2009.12.047; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Ke XY, 2008, NEUROREPORT, V19, P921, DOI 10.1097/WNR.0b013e328300edf3; Kleinhans NM, 2007, BRAIN RES, V1162, P85, DOI 10.1016/j.brainres.2007.04.081; Kleinhans NM, 2009, J AUTISM DEV DISORD, V39, P1079, DOI 10.1007/s10803-009-0707-6; Korkmaz B, 2006, J CHILD NEUROL, V21, P600, DOI 10.1177/08830738060210070601; Lepagnol-Bestel AM, 2008, MOL PSYCHIATR, V13, P385, DOI 10.1038/sj.mp.4002120; Levitt JG, 2003, BIOL PSYCHIAT, V54, P1355, DOI 10.1016/S0006-3223(03)00688-7; Levitt JG, MR SPECTROS IN PRESS; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 1999, AUTISM DIAGNOSTIC OB; McDougle CJ, 2005, J CLIN PSYCHIAT, V66, P9; MINSHEW NJ, 1993, BIOL PSYCHIAT, V33, P762, DOI 10.1016/0006-3223(93)90017-8; Moreno A, 2001, J NEUROCHEM, V77, P347, DOI 10.1046/j.1471-4159.2001.00282.x; MORENO H, 1992, INVEST CLIN, V33, P13; Moreno-Fuenmayor H, 1996, Invest Clin, V37, P113; Mori Kenji, 2001, No To Hattatsu, V33, P329; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; Murphy DGM, 2006, AM J PSYCHIAT, V163, P934, DOI 10.1176/appi.ajp.163.5.934; Murphy DGM, 2002, ARCH GEN PSYCHIAT, V59, P885, DOI 10.1001/archpsyc.59.10.885; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; O'Gorman RL, 2009, ISMRM 17 SCI M EXH H; O'Neill J, 2000, MAGNET RESON MED, V43, P244, DOI 10.1002/(SICI)1522-2594(200002)43:2<244::AID-MRM11>3.0.CO;2-2; O'Neill J, 2009, CINGULATE NEUROBIOLO; O'Neill J, 2006, ISMRM WORKSH QUANT S; Oblak A, 2009, AUTISM RES, V2, P205, DOI 10.1002/aur.88; Oblak AL, 2010, J NEUROCHEM, V114, P1414, DOI 10.1111/j.1471-4159.2010.06858.x; Oner O, 2007, AM J NEURORADIOL, V28, P1494, DOI 10.3174/ajnr.A0625; Page LA, 2006, AM J PSYCHIAT, V163, P2189, DOI 10.1176/appi.ajp.163.12.2189; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; PATEL TB, 1979, BIOCHEM J, V184, P163; Perich-Alsina J, 2002, REV NEUROL, V34, pS68; Petroff O A, 2000, Adv Neurol, V83, P261; Petropoulos H, 2006, NEUROLOGY, V67, P632, DOI 10.1212/01.wnl.0000229923.08213.1e; Pfund Z, 2000, J CEREBR BLOOD F MET, V20, P871, DOI 10.1097/00004647-200005000-00014; Pizzarelli R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/297153; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Rabionet R, 2006, AM J PSYCHIAT, V163, p929A; Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; ROLF LH, 1993, ACTA PSYCHIAT SCAND, V87, P312, DOI 10.1111/j.1600-0447.1993.tb03378.x; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; ROSS BD, 1991, NMR BIOMED, V4, P59, DOI 10.1002/nbm.1940040205; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rumsey JM, 2000, MENT RETARD DEV D R, V6, P171, DOI 10.1002/1098-2779(2000)6:3<171::AID-MRDD4>3.0.CO;2-N; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Seese RR, 2011, SCHIZOPHR RES, V133, P82, DOI 10.1016/j.schres.2011.07.011; Segurado R, 2005, AM J PSYCHIAT, V162, P2182, DOI 10.1176/appi.ajp.162.11.2182; Serajee FJ, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e42; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Shulman RG, 2003, CR BIOL, V326, P253, DOI 10.1016/S1631-0691(03)00071-4; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Sibson NR, 1998, DEV NEUROSCI-BASEL, V20, P321, DOI 10.1159/000017327; SIEGEL BV, 1995, SCHIZOPHR RES, V17, P85, DOI 10.1016/0920-9964(95)00033-I; Siesjo B.K., 1978, BRAIN ENERGY METABOL; Silverman JM, 2008, AM J MED GENET B, V147B, P408, DOI 10.1002/ajmg.b.30614; Simms ML, 2009, ACTA NEUROPATHOL, V118, P673, DOI 10.1007/s00401-009-0568-2; Sled JG, 1998, IEEE T MED IMAGING, V17, P653, DOI 10.1109/42.730409; Sokol DK, 2002, J CHILD NEUROL, V17, P245, DOI 10.1177/088307380201700401; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Strauss WL, 2002, AM J PSYCHIAT, V159, P755, DOI 10.1176/appi.ajp.159.5.755; Suzuki K, 2010, INT J NEUROPSYCHOPH, V13, P529, DOI 10.1017/S1461145709990952; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Turunen JA, 2008, AUTISM RES, V1, P189, DOI 10.1002/aur.25; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Vlamings PHJM, 2008, EUR J NEUROSCI, V28, P399, DOI 10.1111/j.1460-9568.2008.06336.x; Vogt B.A., 2009, CINGULATE NEUROBIOLO, P3; Walker JB, 1979, ADV ENZYMOLOGY; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1991, WISC 3 WECHSLER INTE; WILLIAMSON LC, 1988, BRAIN RES, V475, P151, DOI 10.1016/0006-8993(88)90209-0; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Zeegers M, 2007, J NEURAL TRANSM, V114, P289, DOI 10.1007/s00702-006-0501-y	125	76	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e38786	10.1371/journal.pone.0038786	http://dx.doi.org/10.1371/journal.pone.0038786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848344	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200006
J	McFarland, KN; Das, S; Sun, TT; Leyfer, D; Xia, E; Sangrey, GR; Kuhn, A; Luthi-Carter, R; Clark, TW; Sadri-Vakili, G; Cha, JHJ				McFarland, Karen N.; Das, Sudeshna; Sun, Ting Ting; Leyfer, Dmitri; Xia, Eva; Sangrey, Gavin R.; Kuhn, Alexandre; Luthi-Carter, Ruth; Clark, Timothy W.; Sadri-Vakili, Ghazaleh; Cha, Jang-Ho J.			Genome-Wide Histone Acetylation Is Altered in a Transgenic Mouse Model of Huntington's Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SODIUM-BUTYRATE; DEACETYLASE INHIBITOR; MUTANT HUNTINGTIN; TRANSCRIPTIONAL DYSREGULATION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; CELL-LINES; CHROMATIN; MICE	In Huntington's disease (HD; MIM ID # 143100), a fatal neurodegenerative disorder, transcriptional dysregulation is a key pathogenic feature. Histone modifications are altered in multiple cellular and animal models of HD suggesting a potential mechanism for the observed changes in transcriptional levels. In particular, previous work has suggested an important link between decreased histone acetylation, particularly acetylated histone H3 (AcH3; H3K9K14ac), and downregulated gene expression. However, the question remains whether changes in histone modifications correlate with transcriptional abnormalities across the entire transcriptome. Using chromatin immunoprecipitation paired with microarray hybridization (ChIP-chip), we interrogated AcH3-gene interactions genome-wide in striata of 12-week old wild-type (WT) and transgenic (TG) R6/2 mice, an HD mouse model, and correlated these interactions with gene expression levels. At the level of the individual gene, we found decreases in the number of sites occupied by AcH3 in the TG striatum. In addition, the total number of genes bound by AcH3 was decreased. Surprisingly, the loss of AcH3 binding sites occurred within the coding regions of the genes rather than at the promoter region. We also found that the presence of AcH3 at any location within a gene strongly correlated with the presence of its transcript in both WT and TG striatum. In the TG striatum, treatment with histone deacetylase (HDAC) inhibitors increased global AcH3 levels with concomitant increases in transcript levels; however, AcH3 binding at select gene loci increased only slightly. This study demonstrates that histone H3 acetylation at lysine residues 9 and 14 and active gene expression are intimately tied in the rodent brain, and that this fundamental relationship remains unchanged in an HD mouse model despite genome-wide decreases in histone H3 acetylation.	[McFarland, Karen N.; Sun, Ting Ting; Xia, Eva; Sangrey, Gavin R.; Sadri-Vakili, Ghazaleh; Cha, Jang-Ho J.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA USA; [Das, Sudeshna; Leyfer, Dmitri; Clark, Timothy W.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, MIND Informat, Cambridge, MA USA; [Kuhn, Alexandre; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	McFarland, KN (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA.	j.cha@merck.com		Clark, Timothy/0000-0003-4060-7360; Kuhn, Alexandre/0000-0003-3839-5282	Huntington's Disease Society of America Coalition for the Cure; Glendorn Foundation; National Institutes of Health (NIH) [NS38106, NS45242]; Massachusetts General Hospital Fund for Medical Discovery; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038106, P01NS045242] Funding Source: NIH RePORTER	Huntington's Disease Society of America Coalition for the Cure; Glendorn Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Fund for Medical Discovery; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Huntington's Disease Society of America Coalition for the Cure, the Glendorn Foundation, the National Institutes of Health (NIH NS38106, NS45242) and the Massachusetts General Hospital Fund for Medical Discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Braveman Melissa W., 2004, V277, P261; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gottesfeld JM, 2009, FUTUR NEUROL, V4, P775, DOI 10.2217/FNL.09.55; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kazantsev AG, 2009, CURR PHARM DESIGN, V15, P3917, DOI 10.2174/138161209789649312; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim MO, 2008, J NEUROSCI, V28, P3947, DOI 10.1523/JNEUROSCI.5667-07.2008; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Monti B, 2010, NEUROTOX RES, V17, P130, DOI 10.1007/s12640-009-9090-5; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Stack EC, 2007, HUM MOL GENET, V16, P1164, DOI 10.1093/hmg/ddm064; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; VIDALI G, 1978, P NATL ACAD SCI USA, V75, P2239, DOI 10.1073/pnas.75.5.2239; VIDALI G, 1978, BIOCHEM BIOPH RES CO, V82, P223, DOI 10.1016/0006-291X(78)90599-5; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Zadori D, 2009, PHARMACOL BIOCHEM BE, V94, P148, DOI 10.1016/j.pbb.2009.08.001; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	56	63	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41423	10.1371/journal.pone.0041423	http://dx.doi.org/10.1371/journal.pone.0041423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848491	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200063
J	Tian, XG; Su, XB; Li, X; Li, HT; Li, T; Zhou, ZC; Zhong, TH; Zhou, R				Tian, Xingui; Su, Xiaobo; Li, Xiao; Li, Haitao; Li, Ting; Zhou, Zhichao; Zhong, Tianhua; Zhou, Rong			Protection against Enterovirus 71 with Neutralizing Epitope Incorporation within Adenovirus Type 3 Hexon	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; VP1 CAPSID PROTEIN; MOUTH-DISEASE; SPECIES-B; VACCINE DESIGN; NEWBORN MICE; IDENTIFICATION; INFECTION; VECTOR; LETHAL	Enterovirus 71 (EV71) is responsible for hand, foot and mouth disease with high mortality among children. Various neutralizing B cell epitopes of EV71 have been identified as potential vaccine candidates. Capsid-incorporation of antigens into adenovirus (Ad) has been developed for a novel vaccine approach. We constructed Ad3-based EV71 vaccine vectors by incorporating a neutralizing epitope SP70 containing 15 amino acids derived from capsid protein VP1 of EV71 within the different surface-exposed domains of the capsid protein hexon of Ad3EGFP, a recombinant adenovirus type 3 (Ad3) expressing enhanced green fluorescence protein. Thermostability and growth kinetic assays suggested that the SP70 epitope incorporation into hypervariable region (HVR1, HVR2, or HVR7) of the hexon did not affect Ad fitness. The SP70 epitopes were thought to be exposed on all hexon-modified intact virion surfaces. Repeated administration of BALB/c mice with the modified Ads resulted in boosting of the anti-SP70 humoral immune response. Importantly, the modified Ads immunization of mother mice conferred protection in vivo to neonatal mice against the lethal EV71 challenge, and the modified Ads-immunized mice serum also conferred passive protection against the lethal challenge in newborn mice. Compared with the recombinant GST-fused SP70 protein immunization, immunization with the Ads containing SP70 in HVR1 or HVR2 elicited higher SP70-specific IgG titers, higher neutralization titers, and conferred more effective protection to neonatal mice. Thus, this study provides valuable information for hexon-modified Ad3 vector development as a promising EV71 vaccine candidate and as an epitope-delivering vehicle for other pathogens.	[Tian, Xingui; Li, Xiao; Li, Haitao; Li, Ting; Zhou, Zhichao; Zhong, Tianhua; Zhou, Rong] Guangzhou Med Coll, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Su, Xiaobo] Guangzhou Med Coll, Sch Basic Sci, Dept Med Genet & Cell Biol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University	Tian, XG (corresponding author), Guangzhou Med Coll, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	zhou3218@yahoo.com	Tian, Xingui/AAF-5709-2020; Tian, Xingui/AAC-3957-2021	Tian, Xingui/0000-0001-9761-6677	National Nature Science Foundation of China (NSFC) [31070150]; Nature Science Foundation of Guangdong [10151009504000006]; School of Guangzhou [10A006D]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); School of Guangzhou	This work was supported by the National Nature Science Foundation of China (NSFC, 31070150), the Nature Science Foundation of Guangdong (10151009504000006) and School of Guangzhou Research Projects (10A006D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo MT, 2009, FEMS IMMUNOL MED MIC, V55, P346, DOI 10.1111/j.1574-695X.2008.00518.x; Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; CROMPTON J, 1994, J GEN VIROL, V75, P133, DOI 10.1099/0022-1317-75-1-133; Dudek NL, 2010, CURR PHARM DESIGN, V16, P3149; Foo DGW, 2008, VIRAL IMMUNOL, V21, P215, DOI 10.1089/vim.2007.0089; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Jia CS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-47; Jones FR, 2011, VACCINE, V29, P7020, DOI 10.1016/j.vaccine.2011.07.073; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Lanzi A, 2011, VACCINE, V29, P1463, DOI 10.1016/j.vaccine.2010.12.025; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Liu JN, 2010, VACCINE, V28, P7444, DOI 10.1016/j.vaccine.2010.08.080; Matsui H, 2009, GENE THER, V16, P1050, DOI 10.1038/gt.2009.65; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Matthews QL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-98; McConnell MJ, 2006, J VIROL, V80, P5361, DOI 10.1128/JVI.00256-06; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Shiratsuchi T, 2010, J CLIN INVEST, V120, P3688, DOI 10.1172/JCI39812; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Stone D, 2007, MOL THER, V15, P2146, DOI 10.1038/sj.mt.6300319; Tian XG, 2011, VIRUS RES, V160, P214, DOI 10.1016/j.virusres.2011.06.017; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Wong KT, 2000, NEW ENGL J MED, V342, P356; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Wu HJ, 2002, J VIROL, V76, P12775, DOI 10.1128/JVI.76.24.12775-12782.2002; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Youil R, 2002, HUM GENE THER, V13, P311, DOI 10.1089/10430340252769824; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368; Yuan XH, 2009, VACCINE, V27, P5103, DOI 10.1016/j.vaccine.2009.06.041; Zhang DM, 2010, INT J INFECT DIS, V14, pE739, DOI 10.1016/j.ijid.2009.12.002; Zhang QW, 2009, VACCINE, V27, P1145, DOI 10.1016/j.vaccine.2008.12.039; Zhu YL, 2010, ENDOCRINE, V37, P430, DOI 10.1007/s12020-010-9333-5	54	26	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41381	10.1371/journal.pone.0041381	http://dx.doi.org/10.1371/journal.pone.0041381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848478	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200060
J	Yang, B; Yu, RL; Tuo, S; Tuo, CW; Liu, QZ; Zhang, N; Lu, XC; Chi, XH; Lv, SB; Cai, LL				Yang, Bo; Yu, Rui-li; Tuo, Shuai; Tuo, Chao-wei; Liu, Qiu-Zhen; Zhang, Ning; Lu, Xue-chun; Chi, Xiao-hua; Lv, Shu-bao; Cai, Li-li			Antisense Oligonucleotide against hTERT (Cantide) Inhibits Tumor Growth in an Orthotopic Primary Hepatic Lymphoma Mouse Model	PLOS ONE			English	Article							INTACT PATIENT SPECIMENS; NON-HODGKINS-LYMPHOMA; LUNG-CANCER CELLS; NUDE-MICE; METASTATIC MODELS; TELOMERASE ACTIVITY; ORGAN ENVIRONMENT; COLON-CANCER; SCID MICE; LIVER	Background: Human xenograft models, resulting from orthotopic transplantation (implantation into the anatomically correct site) of histologically intact tissue into animals, are important for investigating local tumor growth, vascular and lymphatic invasion at the primary tumor site and metastasis. Methodology/Principal Findings: We used surgical orthotopic transplantation to establish a nude mouse model of primary hepatic lymphoma (PHL), HLBL-0102. We performed orthotopic transfer of the HLBL-0102 tumor for 42 generations and characterized the tumor cells. The maintenance of PHL characteristics were supported by immunohistochemical and cytogenetic analysis. We also report the antitumor effect of Cantide, an antisense phosphorothioate oligonucleotide against hTERT, on the growth of HLBL-0102 tumors. We showed a significant, dose-dependent inhibition of tumor weight and serum LDH activity in the orthotopically transplanted animals by Cantide. Importantly, survival was prolonged in Cantide-treated HLBL-0102 tumor-bearing mice when compared to mock-treated mice. Conclusions/Significance: Our study provided the basis for the development of a clinical trial protocol to treat PHL.	[Yang, Bo; Lu, Xue-chun] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Hematol, Beijing, Peoples R China; [Yu, Rui-li] Chinese Peoples Liberat Army Gen Hosp, Inst Otorhinolaryngol, Beijing, Peoples R China; [Tuo, Shuai; Tuo, Chao-wei; Liu, Qiu-Zhen; Zhang, Ning] Hosp Chinese PLA, Dept Ultrastruct Pathol, Shenyang, Peoples R China; [Chi, Xiao-hua] Second Artillery Gen Hosp, Dept Pharm, Beijing, Peoples R China; [Lv, Shu-bao] Unit Chinese PLA, Dept Stat, Baicheng, Peoples R China; [Cai, Li-li] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Lab Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Yang, B (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Hematol, Beijing, Peoples R China.	yuruili45@163.com			China Postdoctoral Science Foundation [20080431362]; National Medical Science and Technique Foundation [96A230603]; National Natural Science Foundation of China [30772597, 81172986, 30873086]; Innovation and Nursery Foundation of Chinese PLA General Hospital [11KMM24]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Medical Science and Technique Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation and Nursery Foundation of Chinese PLA General Hospital	This study was supported by China Postdoctoral Science Foundation (Grant No. 20080431362), National Medical Science and Technique Foundation during the 9th Five-Year Plan Period (Grant No. 96A230603), National Natural Science Foundation of China (Grant No. 30772597, No. 81172986 and No. 30873086), and Innovation and Nursery Foundation of Chinese PLA General Hospital (Grant No. 11KMM24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2004, AGE AGEING, V33, P637, DOI 10.1093/ageing/afh197; Avlonitis VS, 1999, EUR J SURG, V165, P725; Du QY, 2003, WORLD J GASTROENTERO, V9, P2030, DOI 10.3748/wjg.v9.i9.2030; FIDLER IJ, 1991, CANCER METAST REV, V10, P229, DOI 10.1007/BF00050794; FIDLER IJ, 1994, CANCER METAST REV, V13, P209, DOI 10.1007/BF00689637; FU XY, 1993, ANTICANCER RES, V13, P283; FU XY, 1992, ANTICANCER RES, V12, P1395; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Gewirtz AM, 2007, J CLIN INVEST, V117, P3612, DOI 10.1172/JCI34274; Hodes R, 2001, P NATL ACAD SCI USA, V98, P7649, DOI 10.1073/pnas.151267698; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; KUBOTA T, 1994, J CELL BIOCHEM, V56, P4, DOI 10.1002/jcb.240560103; KUO TH, 1993, ANTICANCER RES, V13, P627; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Lin RX, 2005, ACTA PHARMACOL SIN, V26, P762, DOI 10.1111/j.1745-7254.2005.00762.x; MANZOTTI C, 1993, CLIN EXP METASTAS, V11, P5, DOI 10.1007/BF00880061; Marsoni S, 2004, ANN ONCOL, V15, P229, DOI 10.1093/annonc/mdh931; Memeo L, 1999, ACTA ONCOL, V38, P655; MORIKAWA K, 1988, CANCER RES, V48, P6863; Olie RA, 2000, CANCER RES, V60, P2805; Pocard M, 1996, IN VIVO, V10, P463; RYAN J, 1994, J GASTROEN HEPATOL, V9, P308, DOI 10.1111/j.1440-1746.1994.tb01731.x; RYAN J, 1988, CANCER, V61, P370, DOI 10.1002/1097-0142(19880115)61:2<370::AID-CNCR2820610228>3.0.CO;2-I; Scerpella EG, 1996, J CLIN GASTROENTEROL, V22, P51, DOI 10.1097/00004836-199601000-00015; Schweiger F, 2000, CAN J GASTROENTEROL, V14, P955, DOI 10.1155/2000/201928; SHARKEY FE, 1984, CANCER METAST REV, V3, P341, DOI 10.1007/BF00051459; Sun FX, 1996, J CANCER RES CLIN, V122, P397, DOI 10.1007/BF01212878; TALAMO TS, 1980, CANCER, V46, P336, DOI 10.1002/1097-0142(19800715)46:2<336::AID-CNCR2820460221>3.0.CO;2-1; WANG XO, 1992, INT J CANCER, V51, P992; Waters JS, 2000, J CLIN ONCOL, V18, P1812, DOI 10.1200/JCO.2000.18.9.1812; Webb A, 1997, LANCET, V349, P1137, DOI 10.1016/S0140-6736(96)11103-X; Yang Y, 2005, WORLD J GASTROENTERO, V11, P2491, DOI 10.3748/wjg.v11.i16.2491; Zangemeister-Wittke U, 2000, CLIN CANCER RES, V6, P2547; Zhang Y, 2002, CELL BIOL INT, V26, P427, DOI 10.1006/cbir.2002.0875; Ziegler A, 1997, JNCI-J NATL CANCER I, V89, P1027, DOI 10.1093/jnci/89.14.1027	35	6	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41467	10.1371/journal.pone.0041467	http://dx.doi.org/10.1371/journal.pone.0041467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848504	Green Submitted, gold, Green Published			2022-12-27	WOS:000306751300044
J	Chen, Y; Gou, XC; Ke, X; Cui, HY; Chen, Z				Chen, Yanke; Gou, Xingchun; Ke, Xia; Cui, Hongyong; Chen, Zhinan			Human Tumor Cells Induce Angiogenesis through Positive Feedback between CD147 and Insulin-Like Growth Factor-I	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INDUCER; ENDOTHELIAL-CELLS; SURFACE EXPRESSION; UP-REGULATION; CANCER CELLS; FACTOR VEGF; EMMPRIN; HAB18G/CD147; INVASION; MODELS	Tumor angiogenesis is a complex process based upon a sequence of interactions between tumor cells and endothelial cells. Previous studies have shown that CD147 was correlated with tumor angiogenesis through increasing tumor cell secretion of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). In this study, we made a three-dimensional (3D) tumor angiogenesis model using a co-culture system of human hepatocellular carcinoma cells SMMC-7721 and humanumbilical vein endothelial cells (HUVECs) in vitro. We found that CD147-expressing cancer cells could promote HUVECs to form net-like structures resembling the neo-vasculature, whereas the ability of proliferation, migration and tube formation of HUVECs was significantly decreased in tumor conditioned medium (TCM) of SMMC-7721 cells transfected with specific CD147-siRNA. Furthermore, by assaying the change of pro-angiogenic factors in TCM, we found that the inhibition of CD147 expression led to significant decrease of VEGF and insulin-like growth factor-I (IGF-I) secretion. Interestingly, we also found that IGF-I up-regulated the expression of CD147 in both tumor cells and HUVECs. These findings suggest that there is a positive feedback between CD147 and IGF-I at the tumor-endothelial interface and CD147 initiates the formation of an angiogenesis niche.	[Chen, Yanke] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Gou, Xingchun; Ke, Xia; Cui, Hongyong; Chen, Zhinan] Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China; [Chen, Yanke; Ke, Xia; Cui, Hongyong; Chen, Zhinan] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Peoples R China; [Ke, Xia; Cui, Hongyong; Chen, Zhinan] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Gou, Xingchun] Xian Med Univ, Lab Cell Biol & Translat Med, Xian, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Medical University	Chen, Y (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	yankechen@126.com; Zhinanchen@fmmu.edu.cn			National Basic Research Program of China [2009CB521704]; National Natural Science Foundation of China [81101744]; Shaanxi Provincial Education Department;  [2010JK801]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Education Department; 	This work was supported by Grant 2009CB521704 from the National Basic Research Program of China, Grant No. 81101744 from National Natural Science Foundation of China and Grant No. 2010JK801 from the Scientific Research Program Funded by Shaanxi Provincial Education Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner I, 1998, VASA-J VASCULAR DIS, V27, P201; BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Caudroy S, 2002, CLIN EXP METASTAS, V19, P697, DOI 10.1023/A:1021350718226; Chen YK, 2009, CANCER LETT, V278, P113, DOI 10.1016/j.canlet.2009.01.004; Clark D E, 1998, Angiogenesis, V2, P309, DOI 10.1023/A:1009200824934; Dai L, 2011, INT J CANC; Folkman J, 1997, EXS, V79, P1; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Han MD, 2006, DEV DYNAM, V235, P124, DOI 10.1002/dvdy.20531; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holly J, 2004, LANCET, V364, P325, DOI 10.1016/S0140-6736(04)16708-1; Horiuchi A, 2002, ANTICANCER RES, V22, P2697; Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Li RS, 2001, J CELL PHYSIOL, V186, P371, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1042>3.0.CO;2-8; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Menashi S, 2003, CANCER RES, V63, P7575; Millimaggi D, 2007, NEOPLASIA, V9, P349, DOI 10.1593/neo.07133; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Pushkarsky T, 2005, J BIOL CHEM, V280, P27866, DOI 10.1074/jbc.M503770200; Qin ZQ, 2010, CANCER RES, V70, P3884, DOI 10.1158/0008-5472.CAN-09-4663; Riethdorf S, 2006, INT J CANCER, V119, P1800, DOI 10.1002/ijc.22062; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI13374; Shi YH, 2007, PATHOLOGY, V39, P396, DOI 10.1080/00313020701444549; Shigematsu S, 1999, ENDOCR J, V46, pS59; Sun JX, 2001, CANCER RES, V61, P2276; Tang Y, 2004, MOL CANCER RES, V2, P73; Tang Y, 2006, MOL CANCER RES, V4, P371, DOI 10.1158/1541-7786.MCR-06-0042; Turner KJ, 2002, BRIT J CANCER, V86, P1276, DOI 10.1038/sj.bjc.6600215; Voigt H, 2009, CANCER INVEST, V27, P329, DOI 10.1080/07357900802392675; Wellmann S, 2001, CLIN CHEM, V47, P654; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Yang XJ, 2010, ORAL ONCOL, V46, P755, DOI 10.1016/j.oraloncology.2010.08.008; Yurchenko V, 2005, J BIOL CHEM, V280, P17013, DOI 10.1074/jbc.M412851200; Zheng HC, 2006, BRIT J CANCER, V95, P1371, DOI 10.1038/sj.bjc.6603425; Zhu W, 2008, NEUROCHEM INT, V52, P1086, DOI 10.1016/j.neuint.2007.11.005; Zigrino P, 2005, BIOCHIMIE, V87, P321, DOI 10.1016/j.biochi.2004.10.025	42	25	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40965	10.1371/journal.pone.0040965	http://dx.doi.org/10.1371/journal.pone.0040965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844419	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700029
J	Chen, Y; Sjolinder, M; Wang, X; Altenbacher, G; Hagner, M; Berglund, P; Gao, YM; Lu, T; Jonsson, AB; Sjolinder, H				Chen, Yao; Sjolinder, Mikael; Wang, Xiao; Altenbacher, Georg; Hagner, Matthias; Berglund, Pernilla; Gao, Yumin; Lu, Ting; Jonsson, Ann-Beth; Sjolinder, Hong			Thyroid Hormone Enhances Nitric Oxide-Mediated Bacterial Clearance and Promotes Survival after Meningococcal Infection	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EUTHYROID SICK SYNDROME; NEISSERIA-GONORRHOEAE; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; SEPTIC SHOCK; CELL-SURFACE; ACID DITPA; IN-VITRO; RECEPTOR	Euthyroid sick syndrome characterized by reduced levels of thyroid hormones (THs) is observed in patients with meningococcal shock. It has been found that the level of THs reflects disease severity and is predictive for mortality. The present study was conducted to investigate the impact of THs on host defense during meningococcal infection. We found that supplementation of thyroxine to mice infected with Neisseria meningitidis enhanced bacterial clearance, attenuated the inflammatory responses and promoted survival. In vitro studies with macrophages revealed that THs enhanced bacteria-cell interaction and intracellular killing of meningococci by stimulating inducible nitric oxide synthase (iNos)-mediated NO production. TH treatment did not activate expression of TH receptors in macrophages. Instead, the observed TH-directed actions were mediated through nongenomic pathways involving the protein kinases PI3K and ERK1/2 and initiated at the membrane receptor integrin alpha v beta 3. Inhibition of nongenomic TH signaling prevented iNos induction, NO production and subsequent intracellular bacterial killing by macrophages. These data demonstrate a beneficial role of THs in macrophage-mediated N. meningitidis clearance. TH replacement might be a novel option to control meningococcal septicemia.	[Chen, Yao; Sjolinder, Mikael; Wang, Xiao; Altenbacher, Georg; Hagner, Matthias; Berglund, Pernilla; Gao, Yumin; Lu, Ting; Jonsson, Ann-Beth; Sjolinder, Hong] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Stockholm University	Chen, Y (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	hong.sjolinder@gmt.su.se			Swedish Research Council [2008-2572, 2008-3367]; Swedish Society of Medicine; Magnus Bergvalls Foundation; Harald Jeanssons Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Magnus Bergvalls Foundation; Harald Jeanssons Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	This work was supported by the Swedish Research Council (Grant no. 2008-2572, 2008-3367, www.vr.se), the Swedish Society of Medicine (www.sls.se), the Magnus Bergvalls Foundation (http://www.magnbergvallsstiftelse.nu), the Harald Jeanssons Foundation (http://www.jeanssonsstiftelser.se), the Tore Nilsons Foundation (http://www.torenilsonsstiftelse.nu), and the Ake Wiberg Foundation (http://www.ake-wiberg.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abed Y, 2011, P NATL ACAD SCI USA, V108, P8224, DOI 10.1073/pnas.1017624108; Anjum MF, 2002, J BACTERIOL, V184, P2987, DOI 10.1128/JB.184.11.2987-2993.2002; Annane D., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002243.pub2, DOI 10.1002/14651858.CD002243.PUB2]; Arcos MLB, 2006, AM J PHYSIOL-CELL PH, V291, pC327, DOI 10.1152/ajpcell.00316.2005; Astier AL, 2008, IMMUNOLOGY, V124, P149, DOI 10.1111/j.1365-2567.2008.02821.x; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Carrillo-Sepulveda MA, 2010, CARDIOVASC RES, V85, P560, DOI 10.1093/cvr/cvp304; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; den Brinker M, 2005, J CLIN ENDOCR METAB, V90, P5613, DOI 10.1210/jc.2005-0888; den Brinker M, 2005, INTENS CARE MED, V31, P970, DOI 10.1007/s00134-005-2671-8; Farwell AP, 2005, DEV BRAIN RES, V154, P121, DOI 10.1016/j.devbrainres.2004.07.016; Fernandez V, 1997, NITRIC OXIDE-BIOL CH, V1, P463, DOI 10.1006/niox.1997.0149; Flamant F, 2007, MOL ENDOCRINOL, V21, P321, DOI 10.1210/me.2006-0035; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Inan M, 2003, SURG TODAY, V33, P24, DOI 10.1007/s005950300004; Jack DL, 2005, J LEUKOCYTE BIOL, V77, P328, DOI 10.1189/jlb.0604342; Johansson L, 2005, J IMMUNOL, V175, P433, DOI 10.4049/jimmunol.175.1.433; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Kallstrom H, 2001, CELL MICROBIOL, V3, P133, DOI 10.1046/j.1462-5822.2001.00095.x; Karanikas G, 2004, THYROID, V14, P488, DOI 10.1089/1050725041517002; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Kelly G S, 2000, Altern Med Rev, V5, P306; Kirchner M, 2005, MOL MICROBIOL, V56, P945, DOI 10.1111/j.1365-2958.2005.04600.x; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; KLEBANOFF SJ, 1967, J EXP MED, V126, P1063, DOI 10.1084/jem.126.6.1063; Kuzman JA, 2007, CAN J PHYSIOL PHARM, V85, P311, DOI 10.1139/Y07-011; Leonard JL, 1997, THYROID, V7, P147, DOI 10.1089/thy.1997.7.147; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; LITTLE JS, 1985, ENDOCRINOLOGY, V117, P1431, DOI 10.1210/endo-117-4-1431; Mascanfroni ID, 2010, J BIOL CHEM, V285, P9569, DOI 10.1074/jbc.M109.071241; May RC, 2001, J CELL SCI, V114, P1061; McIver B, 1997, THYROID, V7, P125, DOI 10.1089/thy.1997.7.125; Mezosi E, 2005, J ENDOCRINOL, V185, P121, DOI 10.1677/joe.1.05968; Mitchell FE, 2010, J THROID RES, V2010, DOI 10.4061/2010/726098; Mousa SA, 2006, ENDOCRINOLOGY, V147, P1602, DOI 10.1210/en.2005-1390; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; Novitzky D, 1989, Eur J Cardiothorac Surg, V3, P140, DOI 10.1016/1010-7940(89)90092-4; NOVITZKY D, 1987, TRANSPLANT P, V19, P2037; Patel DM, 2011, J CELL SCI, V124, P578, DOI 10.1242/jcs.076208; Persson BD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001122; ROTHWELL PM, 1995, CRIT CARE MED, V23, P78, DOI 10.1097/00003246-199501000-00015; Russell W, 2008, J CLIN ENDOCR METAB, V93, P2300, DOI 10.1210/jc.2007-2674; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2004, ENDOCRINOLOGY, V145, P2357, DOI 10.1210/en.2003-1696; Salman H, 2000, CRYOBIOLOGY, V41, P66, DOI 10.1006/cryo.2000.2267; Schlenker EH, 2008, AM J PHYSIOL-REG I, V294, pR1504, DOI 10.1152/ajpregu.00027.2008; SCHOENFELD PS, 1995, SOUTHERN MED J, V88, P347, DOI 10.1097/00007611-199503000-00019; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; SIEGEL E, 1964, J CLIN ENDOCR METAB, V24, P313, DOI 10.1210/jcem-24-4-313; Sjolinder H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000241; SLAG MF, 1981, JAMA-J AM MED ASSOC, V245, P43, DOI 10.1001/jama.245.1.43; Tomanek RJ, 1998, J MOL CELL CARDIOL, V30, P923, DOI 10.1006/jmcc.1998.0671; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006; Williams JM, 1998, MOL MICROBIOL, V27, P171, DOI 10.1046/j.1365-2958.1998.00670.x; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yildizdas D, 2004, J PEDIATR ENDOCR MET, V17, P1435	62	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41445	10.1371/journal.pone.0041445	http://dx.doi.org/10.1371/journal.pone.0041445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844479	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700091
J	He, YL; Zhang, CL; Gao, XF; Yao, JJ; Hu, CL; Mei, YA				He, Yan-Lin; Zhang, Chun-Lei; Gao, Xiao-Fei; Yao, Jin-Jing; Hu, Chang-Long; Mei, Yan-Ai			Cyproheptadine Enhances the I-K of Mouse Cortical Neurons through Sigma-1 Receptor-Mediated Intracellular Signal Pathway	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; POTASSIUM CHANNELS; CAMP/PROTEIN-KINASE; C-TERMINALS; KV2.1; PHOSPHORYLATION; LOCALIZATION; MODULATION; INHIBITION; SUBUNIT	Cyproheptadine (CPH) is a histamine- and serotonin-receptor antagonist, and its effects are observed recently in the modulation of multiple intracellular signals. In this study, we used cortical neurons and HEK-293 cells transfected with Kv2.1 alpha-subunit to address whether CPH modify neural voltage-gated K+ channels by a mechanism independent of its serotonergic and histaminergic properties. Our results demonstrate that intracellularly delivered CPH increased the I-K by reducing the activity of protein kinas A (PKA). Inhibition of G(i) eliminated the CPH-induced effect on both the I-K and PKA. Blocking of 5-HT-, M-, D-2-, H-1- or H-2-type GPCR receptors with relevant antagonists did not eliminate the CPH-induced effect on the I-K. Antagonists of the sigma-1 receptor, however, blocked the effect of CPH. Moreover, the inhibition of sigma-1 by siRNA knockdown significantly reduced the CPH-induced effect on the I-K. On the contrary, sigma-1 receptor agonist mimicked the effects of CPH on the induction of I-K. A ligand-receptor binding assay indicated that CPH bound to the sigma-1 receptor. Similar effect of CPH were obtained from HEK-293 cells transfected with the alpha-subunit of Kv2.1. In overall, we reveal for the first time that CPH enhances the I-K by modulating activity of PKA, and that the associated activation of the sigma-1 receptor/G(i)-protein pathway might be involved. Our findings illustrate an uncharacterized effect of CPH on neuron excitability through the I-K, which is independent of histamine H-1 and serotonin receptors.	[He, Yan-Lin] Fudan Univ, Sch Life Sci, Inst Brain Sci, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	He, YL (corresponding author), Fudan Univ, Sch Life Sci, Inst Brain Sci, Shanghai 200433, Peoples R China.	yamei@fudan.edu.cn	Hu, Changlong/AAQ-8348-2020	Hu, Changlong/0000-0002-8609-8947; Zhang, Chun-Lei/0000-0003-1296-1370; He, Yanlin/0000-0002-5471-9016	National Basic Research Program of China [2007CB512303, 2011CB503703]; Shanghai Leading Academic Discipline Project [B111]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The study was supported by a grant from the National Basic Research Program of China (2007CB512303 and 2011CB503703) and the Shanghai Leading Academic Discipline Project [B111]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Cerda O, 2011, J BIOL CHEM, V286, P28738, DOI 10.1074/jbc.M111.251942; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CLINESCHMIDT BV, 1976, ARCH INT PHARMACOD T, V223, P287; Codd EE, 2010, TOXICOL SCI, V117, P493, DOI 10.1093/toxsci/kfq200; Droogmans S, 2009, AM J PHYSIOL-HEART C, V296, pH1940, DOI 10.1152/ajpheart.01177.2008; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Goudie AJ, 2007, J PSYCHOPHARMACOL, V21, P179, DOI 10.1177/0269881107067076; GOUELI BS, 1995, ANAL BIOCHEM, V225, P10, DOI 10.1006/abio.1995.1100; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hawkins BS, 2004, TOXICOL SCI, V79, P258, DOI 10.1093/toxsci/kfh113; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; He YL, 2010, J PHARMACOL EXP THER, V332, P437, DOI 10.1124/jpet.109.159160; Holl Ralph, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P220; Jiao S, 2007, J NEUROCHEM, V100, P979, DOI 10.1111/j.1471-4159.2006.04261.x; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Klouz A, 2002, BRIT J PHARMACOL, V135, P1607, DOI 10.1038/sj.bjp.0704626; KOTAKE H, 1987, EUR J PHARMACOL, V139, P307; Levitt ES, 2011, MOL PHARMACOL, V79, P461, DOI 10.1124/mol.110.064816; Liao Z, 2007, TOXICON, V50, P135, DOI 10.1016/j.toxicon.2007.03.006; Liu LY, 2007, J NEUROCHEM, V102, P333, DOI 10.1111/j.1471-4159.2007.04669.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao XL, 2008, BLOOD, V112, P760, DOI 10.1182/blood-2008-02-142687; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Mavlyutov TA, 2012, NEUROSCIENCE, V206, P60, DOI 10.1016/j.neuroscience.2011.12.040; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Melishchuk A, 1998, BIOPHYS J, V75, P1828, DOI 10.1016/S0006-3495(98)77624-6; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; REMY DC, 1977, J MED CHEM, V20, P836, DOI 10.1021/jm00216a020; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; Rueff Laura, 2008, Rev Neurol Dis, V5, P65; Soriani O, 1999, J PHARMACOL EXP THER, V289, P321; Spangler DL, 2006, SOUTH MED J, V99, P593, DOI 10.1097/01.smj.0000221631.98056.87; Stahl SM, 2005, CNS SPECTRUMS, V10, P319, DOI 10.1017/S1092852900022641; Suh HW, 1999, NEUROPEPTIDES, V33, P121, DOI 10.1054/npep.1999.0006; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; WALKER JM, 1990, PHARMACOL REV, V42, P355; WOOLTORTON JRA, 1995, BRIT J PHARMACOL, V116, P2191, DOI 10.1111/j.1476-5381.1995.tb15053.x; Wu YJ, 2005, CURR MED CHEM, V12, P453, DOI 10.2174/0929867053363045; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41303	10.1371/journal.pone.0041303	http://dx.doi.org/10.1371/journal.pone.0041303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844454	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700067
J	Swett, R; Cisneros, GA; Feig, AL				Swett, Rebecca; Cisneros, G. Andres; Feig, Andrew L.			Conformational Analysis of Clostridium difficile Toxin B and Its Implications for Substrate Recognition	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; PARTICLE MESH EWALD; CHARGE FORCE-FIELD; STRUCTURAL DETERMINANTS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; HINGE PREDICTION; PORE FORMATION; AMINO-ACIDS; PROTEINS	Clostridium difficile (C. difficile) is an opportunistic pathogen that can cause potentially lethal hospital-acquired infections. The cellular damage that it causes is the result of two large clostridial cytotoxins: TcdA and TcdB which act by glucosylating cytosolic G-proteins, mis-regulation of which induces apoptosis. TcdB is a large flexible protein that appears to undergo significant structural rearrangement upon accommodation of its substrates: UDP-glucose and a Rho-family GTPase. To characterize the conformational space of TcdB, we applied normal mode and hinge-region analysis, followed by long-timescale unbiased molecular dynamics. In order to examine the TcdB and RhoA interaction, macromolecular docking and simulation of the TcdB/RhoA complex was performed. Generalized Masked Delaunay analysis of the simulations determined the extent of significant motions. This combination of methods elucidated a wide range of motions within TcdB that are reiterated in both the low-cost normal mode analysis and the extensive MD simulation. Of particular interest are the coupled motions between a peripheral 4-helix bundle and a small loop in the active site that must rearrange to allow RhoA entry to the catalytic site. These extensive coupled motions are indicative of TcdB using a conformational capture mechanism for substrate accommodation.	[Swett, Rebecca; Cisneros, G. Andres; Feig, Andrew L.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Wayne State University	Swett, R (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	afeig@chem.wayne.edu	Cisneros, G. Andres/H-5197-2017	Cisneros, G. Andres/0000-0001-6629-3430; Feig, Andrew/0000-0002-5783-1097	Wayne State University; Wayne State University C&IT (Computer and Information Technology group)	Wayne State University; Wayne State University C&IT (Computer and Information Technology group)	This work was supported by Wayne State University. The authors wish to acknowledge support from the Wayne State University C&IT (Computer and Information Technology group) group that oversees the TeraGrid facilities on campus and other high performance computing infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen SJ, 2010, ACS CHEM BIOL, V5, P1097, DOI 10.1021/cb100209b; [Anonymous], 2010, MATH ED VERS 8 0; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cookson B, 2007, POSTGRAD MED J, V83, P291, DOI 10.1136/pgmj.2006.056143; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawson LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025754; DEBRUNNER PG, 1982, ANNU REV PHYS CHEM, V33, P283, DOI 10.1146/annurev.pc.33.100182.001435; Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P332, DOI 10.1086/596604; Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P57, DOI 10.1086/592981; Egerer M, 2008, N-S ARCH PHARMACOL, V377, P11; Egerer M, 2007, N-S ARCH PHARMACOL, V375, P93; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Flores SC, 2008, PROTEINS, V73, P299, DOI 10.1002/prot.22060; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Giesemann T, 2006, N-S ARCH PHARMACOL, V372, P125; Grant BJ, 2010, BIOPHYS J, V99, pL87, DOI 10.1016/j.bpj.2010.10.020; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivarsson M. E., 2012, ANGEW CHEM, V124, P4098; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jank T, 2006, N-S ARCH PHARMACOL, V372, P55; Jank T, 2005, J BIOL CHEM, V280, P37833, DOI 10.1074/jbc.M506836200; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jank T, 2006, J BIOL CHEM, V281, P19527, DOI 10.1074/jbc.M600863200; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kaiser E, 2011, INFECT IMMUN, V79, P3913, DOI 10.1128/IAI.05372-11; Keating KS, 2009, PROTEIN SCI, V18, P359, DOI 10.1002/pro.38; Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Lanis JM, 2012, MOL MICROBIOL, V84, P66, DOI 10.1111/j.1365-2958.2012.08009.x; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Mathieu R, 2003, J BIOMOL NMR, V25, P83, DOI 10.1023/A:1021990314599; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McGlone SM, 2011, CLIN MICROBIOL INFEC; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Muller S, 1999, EUR J BIOCHEM, V266, P1073, DOI 10.1046/j.1432-1327.1999.00951.x; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077; Patel S, 2004, J COMPUT CHEM, V25, P1, DOI 10.1002/jcc.10355; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; PETSKO GA, 1984, ANNU REV BIOPHYS BIO, V13, P331; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Ritchie DW, 2005, J APPL CRYSTALLOGR, V38, P808, DOI 10.1107/S002188980502474X; Sapay N, 2011, J COMPUT CHEM, V32, P1400, DOI 10.1002/jcc.21726; Shen A, 2011, NAT STRUCT MOL BIOL, V18, P364, DOI 10.1038/nsmb.1990; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Wang H, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3446812; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wriggers W, 2009, J CHEM THEORY COMPUT, V5, P2595, DOI 10.1021/ct900229u	62	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41518	10.1371/journal.pone.0041518	http://dx.doi.org/10.1371/journal.pone.0041518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844485	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700097
J	Bertels, F; Merker, H; Kost, C				Bertels, Felix; Merker, Holger; Kost, Christian			Design and Characterization of Auxotrophy-Based Amino Acid Biosensors	PLOS ONE			English	Article							ESCHERICHIA-COLI; MICROBIOLOGICAL ASSAY; AVAILABLE LYSINE; BIOAVAILABILITY; QUANTIFICATION; TN7	Efficient and inexpensive methods are required for the high-throughput quantification of amino acids in physiological fluids or microbial cell cultures. Here we develop an array of Escherichia coli biosensors to sensitively quantify eleven different amino acids. By using online databases, genes involved in amino acid biosynthesis were identified that - upon deletion should render the corresponding mutant auxotrophic for one particular amino acid. This rational design strategy suggested genes involved in the biosynthesis of arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, threonine, tryptophan, and tyrosine as potential genetic targets. A detailed phenotypic characterization of the corresponding single-gene deletion mutants indeed confirmed that these strains could neither grow on a minimal medium lacking amino acids nor transform any other proteinogenic amino acid into the focal one. Site-specific integration of the egfp gene into the chromosome of each biosensor decreased the detection limit of the GFP-labeled cells by 30% relative to turbidometric measurements. Finally, using the biosensors to determine the amino acid concentration in the supernatants of two amino acid overproducing E. coli strains (i.e. DhisL and DtdcC) both turbidometrically and via GFP fluorescence emission and comparing the results to conventional HPLC measurements confirmed the utility of the developed biosensor system. Taken together, our study provides not only a genotypically and phenotypically well-characterized set of publicly available amino acid biosensors, but also demonstrates the feasibility of the rational design strategy used.	[Bertels, Felix; Merker, Holger; Kost, Christian] Max Planck Inst Chem Ecol, Res Grp Expt Ecol & Evolut, Jena, Germany	Max Planck Society	Bertels, F (corresponding author), Max Planck Inst Chem Ecol, Res Grp Expt Ecol & Evolut, Jena, Germany.	christiankost@gmail.com	Kost, Christian/N-1553-2014	Kost, Christian/0000-0002-7870-7343	Volkswagen Foundation; Jena School for Microbial Communication	Volkswagen Foundation(Volkswagen); Jena School for Microbial Communication	Funding by the Volkswagen Foundation (CK) and the Jena School for Microbial Communication (HM, CK) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLACKMOR.JA, 1972, J CLIN PATHOL, V25, P171, DOI 10.1136/jcp.25.2.171; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Chalova VI, 2007, APPL MICROBIOL BIOT, V76, P91, DOI 10.1007/s00253-007-0989-6; Chalova VI, 2008, WORLD J MICROB BIOT, V24, P353, DOI 10.1007/s11274-007-9479-3; Chalova VI, 2009, SENSORS-BASEL, V9, P7038, DOI 10.3390/s90907038; DeAngelis KM, 2005, APPL ENVIRON MICROB, V71, P8537, DOI 10.1128/AEM.71.12.8537-8547.2005; EFRON ML, 1964, NEW ENGL J MED, V270, P1378, DOI 10.1056/NEJM196406252702602; Erickson AM, 2000, J MICROBIOL METH, V40, P207, DOI 10.1016/S0167-7012(00)00121-4; Froelich CA, 2005, J RAPID METH AUT MIC, V13, P1, DOI 10.1111/j.1745-4581.2005.00001.x; FURST P, 1990, J CHROMATOGR, V499, P557, DOI 10.1016/S0021-9673(00)97000-6; GUILBAULT GG, 1974, ANAL CHIM ACTA, V69, P183, DOI 10.1016/0003-2670(74)80021-8; Hansen LH, 2001, MICROBIAL ECOL, V42, P483, DOI 10.1007/s00248-001-0025-9; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Herbert P, 2000, J FOOD SCI, V65, P1130, DOI 10.1111/j.1365-2621.2000.tb10251.x; HITCHINS AD, 1989, PLANT FOOD HUM NUTR, V39, P109, DOI 10.1007/BF01092407; KACANIKLIC V, 1994, ELECTROANAL, V6, P381, DOI 10.1002/elan.1140060505; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaspar H, 2008, J CHROMATOGR B, V870, P222, DOI 10.1016/j.jchromb.2008.06.018; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kim MI, 2010, ANAL CHEM, V82, P4072, DOI 10.1021/ac100087r; Kwan RCH, 2002, BIOTECHNOL LETT, V24, P1203, DOI 10.1023/A:1016163315804; LANZER M, 1988, P NATL ACAD SCI USA, V85, P8973, DOI 10.1073/pnas.85.23.8973; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Li X, 2003, LETT APPL MICROBIOL, V37, P458, DOI 10.1046/j.1472-765X.2003.01425.x; LICHTENSTEIN C, 1982, NATURE, V297, P601, DOI 10.1038/297601a0; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; NEWTON WA, 1965, J BACTERIOL, V89, P355, DOI 10.1128/JB.89.2.355-364.1965; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; PFEIFFER D, 1990, ELECTROANAL, V2, P517, DOI 10.1002/elan.1140020704; Seki A, 2003, SENSOR ACTUAT B-CHEM, V94, P253, DOI 10.1016/S0925-4005(03)00381-2; Simova E, 2006, INT J FOOD MICROBIOL, V107, P112, DOI 10.1016/j.ijfoodmicro.2005.08.020; STOTT JA, 1966, BRIT J NUTR, V20, P663, DOI 10.1079/BJN19660069; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Tepper N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016274; Tessaro MJ, 2012, APPL ENVIRON MICROB, V78, P604, DOI 10.1128/AEM.05261-11; TUFFNELL JM, 1985, J APPL BACTERIOL, V58, P333, DOI 10.1111/j.1365-2672.1985.tb01469.x; VANSTOCKEM M, 1987, APPL ENVIRON MICROB, V53, P410, DOI 10.1128/AEM.53.2.410-415.1987; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003; ZLATKIS A, 1960, ANAL CHEM, V32, P162, DOI 10.1021/ac60158a006	43	31	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41349	10.1371/journal.pone.0041349	http://dx.doi.org/10.1371/journal.pone.0041349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829942	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300081
J	Guo, JP; Wu, XY; Too, CL; Yin, FR; Lu, XL; He, J; Li, R; Liu, X; Murad, S; Padyukov, L; Li, ZG				Guo, Jianping; Wu, Xinyu; Too, Chun Lai; Yin, Fangrui; Lu, Xiaolan; He, Jing; Li, Ru; Liu, Xu; Murad, Shahnaz; Padyukov, Leonid; Li, Zhanguo			A Replication Study Confirms the Association of Dendritic Cell Immunoreceptor (DCIR) Polymorphisms with ACPA - Negative RA in a Large Asian Cohort	PLOS ONE			English	Article							HLA-DRB1 SHARED EPITOPE; RHEUMATOID-ARTHRITIS; RECEPTOR COMPLEX; AUTOIMMUNITY; ANTIBODIES; DISEASES; SMOKING; PTPN22; GENE	Objectives: Dendritic cell immunoreceptor (DCIR) has been implicated in development of autoimmune disorders in rodent and DCIR polymorphisms were associated with anti-citrullinated proteins antibodies (ACPA)-negative rheumatoid arthritis (RA) in Swedish Caucasians. This study was undertaken to further investigate whether DCIR polymorphisms are also risk factors for the development of RA in four Asian populations originated from China and Malaysia. Methods: We genotyped two DCIR SNPs rs2377422 and rs10840759 in Han Chinese population (1,193 cases, 1,278 controls), to assess their association with RA. Subsequently, rs2377422 was further genotyped in three independent cohorts of Malaysian-Chinese subjects (MY_Chinese, 254 cases, 206 controls), Malay subjects (MY_Malay, 515 cases, 986 controls), and Malaysian-Indian subjects (MY_Indian, 378 cases, 285 controls), to seek confirmation of association in various ethnic groups. Meta-analysis was preformed to evaluate the contribution of rs2377422 polymorphisms to the development of ACPA-negative RA in distinct ethnic groups. Finally, we carried out association analysis of rs2377422 polymorphisms with DCIR mRNA expression levels. Results: DCIR rs2377422 was found to be significantly associated with ACPA -negative RA in Han Chinese (OR 1.92, 95% CI 1.27-2.90, P = 0.0020). Meta-analysis confirms DCIR rs2377422 as a risk factor for ACPA-negative RA across distinct ethnic groups (ORoverall = 1.17, 95% CI 1.06-1.30, P = 0.003). The SNP rs2377422 polymorphism showed significant association with DCIR mRNA expression level, i.e. RA-risk CC genotype exhibit a significant increase in the expression of DCIR (P = 0.0023, Kruskal-Wallis). Conclusions: Our data provide evidence for association between DCIR rs2377422 and RA in non-Caucasian populations and confirm the influence of DCIR polymorphisms on RA susceptibility, especially on ACPA-negative RA.	[Guo, Jianping; Wu, Xinyu; He, Jing; Li, Ru; Liu, Xu; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China; [Too, Chun Lai; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Too, Chun Lai; Murad, Shahnaz] Inst Med Res, Kuala Lumpur 50588, Malaysia; [Yin, Fangrui] Baotou Med Coll, Affiliated Hosp 1, Dept Rheumatol, Baotou, Peoples R China; [Lu, Xiaolan] Xuanwu Hosp, Dept Rheumatol, Beijing, Peoples R China	Peking University; Karolinska Institutet; Kementerian Kesihatan Malaysia; Baotou Medical College; Capital Medical University	Guo, JP (corresponding author), Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China.	leonid.padyukov@ki.se; jpguo99@gmail.com	lu, xl/HDO-8340-2022; Too, Chun Lai/AAW-8967-2021; Chun-Lai, Too/AAI-1878-2020; Padyukov, Leonid/A-4890-2009	Too, Chun Lai/0000-0002-4079-8454; Padyukov, Leonid/0000-0003-2950-5670	National Basic Research Program of China (973 Program) [2010CB529100]; Program of International Science & Technology Cooperation from MOST [S2011ZR0260]; Major International Joint Research Project from NSFC [81120108020]; Doctoral Fund of Ministry of Education of China [20110001110045]; Ministry of Health (MOH), Malaysia [MRG 7/2005, JPP-IMR 08-012 (NMRR-08-820-1975)]; Swedish Medical Research Council; Swedish Combined program	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program of International Science & Technology Cooperation from MOST; Major International Joint Research Project from NSFC; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Ministry of Health (MOH), Malaysia; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Combined program	This study was financially supported by National Basic Research Program of China (973 Program) (No. 2010CB529100, http://www.973.gov.cn/ AreaAppl.aspx), Program of International Science & Technology Cooperation from MOST (No: S2011ZR0260, http://www.most.gov.cn/), Major International Joint Research Project from NSFC (No: 81120108020 http://www.nsfc.gov.cn/Portal0/default152.htm) and the Doctoral Fund of Ministry of Education of China (No: 20110001110045, http://www.cutech.edu.cn/cn/index.htm). MyEIRA study was financially supported by the Ministry of Health (MOH), Malaysia: MRG 7/2005 and JPP-IMR 08-012 (NMRR-08-820-1975), and by the Swedish Medical Research Council and the Swedish Combined program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bax M, 2011, IMMUNOGENETICS, V63, P459, DOI 10.1007/s00251-011-0528-6; Chun-Lai T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021069; Eklow C, 2008, ANN RHEUM DIS, V67, P1742, DOI 10.1136/ard.2007.076976; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Guo JP, 2009, GENES IMMUN, V10, P227, DOI 10.1038/gene.2009.4; Guo JP, 2008, ARTHRITIS RHEUM, V58, P1343, DOI 10.1002/art.23434; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Kochi Y, 2009, J AUTOIMMUN, V32, P158, DOI 10.1016/j.jaut.2009.02.020; Kokkonen H, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2214; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Ronninger M, 2008, GENES IMMUN, V9, P412, DOI 10.1038/gene.2008.32; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015	20	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41228	10.1371/journal.pone.0041228	http://dx.doi.org/10.1371/journal.pone.0041228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829930	Green Submitted, gold, Green Published			2022-12-27	WOS:000306956300069
J	Hounton, S; Newlands, D				Hounton, Sennen; Newlands, David			Applying the Net-Benefit Framework for Analyzing and Presenting Cost-Effectiveness Analysis of a Maternal and Newborn Health Intervention	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; EFFECTIVENESS ACCEPTABILITY CURVES; DEVELOPING-COUNTRIES; UNCERTAINTY; STRATEGIES; TRIAL; CARE	Background: Coverage of maternal and newborn health (MNH) interventions is often influenced by important determinants and decision makers are often concerned with equity issues. The net-benefit framework developed and applied alongside clinical trials and in pharmacoeconomics offers the potential for exploring how cost-effectiveness of MNH interventions varies at the margin by important covariates as well as for handling uncertainties around the ICER estimate. Aim: We applied the net-benefit framework to analyze cost-effectiveness of the Skilled Care Initiative and assessed relative advantages over a standard computation of incremental cost effectiveness ratios. Methods: Household and facility surveys were carried out from January to July 2006 in Ouargaye district (where the Skilled Care Initiative was implemented) and Diapaga (comparison site) district in Burkina Faso. Pregnancy-related and perinatal mortality were retrospectively assessed and data were collected on place of delivery, education, asset ownership, place, and distance to health facilities, costs borne by households for institutional delivery, and cost of standard provision of maternal care. Descriptive and regression analyses were performed. Results: There was a 30% increase in institutional births in the intervention district compared to 10% increase in comparison district, and a significant reduction of perinatal mortality rates (OR 0.75, CI 0.70-0.80) in intervention district. The incremental cost for achieving one additional institutional delivery in Ouargaye district compared to Diapaga district was estimated to be 170 international dollars and varied significantly by covariates. However, the joint probability distribution (net-benefit framework) of the effectiveness measure (institutional delivery), the cost data and covariates indicated distance to health facilities as the single most important determinant of the cost-effectiveness analysis with implications for policy making. Conclusion: The net-benefit framework, the application of which requires household-level effects and cost data, has proven more insightful (than traditional ICER) in presenting and interpreting cost-effectiveness results of the Skilled Care Initiative.	[Hounton, Sennen] Ctr MURAZ, Bobo Dioulasso, Burkina Faso; [Hounton, Sennen; Newlands, David] Univ Aberdeen, Immpact, Aberdeen AB9 1FX, Scotland	Centre Muraz; University of Aberdeen	Hounton, S (corresponding author), Ctr MURAZ, Bobo Dioulasso, Burkina Faso.	hounton_sennen@yahoo.fr			Bill & Melinda Gates Foundation; UK Department for International Development; European Commission; USAID	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Department for International Development; European Commission(European CommissionEuropean Commission Joint Research Centre); USAID(United States Agency for International Development (USAID))	This research is part of a larger maternal health research programme, Immpact (Initiative for Maternal Mortality Programme Assessment), funded by the Bill & Melinda Gates Foundation, the UK Department for International Development, the European Commission and USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gray AM, 1999, HLTH TECHNOL ASSESS, V3; Hoch JS, 2008, J HEALTH ECON, V27, P476, DOI 10.1016/j.jhealeco.2007.07.002; Hoch JS, 2007, PHARMACOECONOMICS, V25, P807, DOI 10.2165/00019053-200725100-00001; Hoch JS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-68; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Hounton S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1947; Newnlands D, 2008, TROP MED INT HEALTH, V13, P61; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Ternent L, 2010, APPL HEALTH ECON HEA, V8, P99, DOI 10.2165/11313960-000000000-00000; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0	20	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40995	10.1371/journal.pone.0040995	http://dx.doi.org/10.1371/journal.pone.0040995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981GZ	22829906	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300044
J	Li, CY; Chiang, CS; Cheng, WC; Wang, SC; Cheng, HT; Chen, CR; Shu, WY; Tsai, ML; Hseu, RS; Chang, CW; Huang, CY; Fang, SH; Hsu, IC				Li, Chia-Yang; Chiang, Chi-Shiun; Cheng, Wei-Chung; Wang, Shu-Chi; Cheng, Hung-Tsu; Chen, Chaang-Ray; Shu, Wun-Yi; Tsai, Min-Lung; Hseu, Ruey-Shyang; Chang, Cheng-Wei; Huang, Chao-Ying; Fang, Shih-Hua; Hsu, Ian C.			Gene Expression Profiling of Dendritic Cells in Different Physiological Stages under Cordyceps sinensis Treatment	PLOS ONE			English	Article							MICROARRAY DATA-ANALYSIS; TRADITIONAL CHINESE MEDICINE; SCIENTIFIC REDISCOVERY; CDNA MICROARRAYS; HERBAL MEDICINE; EXTRACTS; DESIGN; POLYSACCHARIDES; FUNDAMENTALS; INFLAMMATION	Cordyceps sinensis (CS) has been commonly used as herbal medicine and a health supplement in China for over two thousand years. Although previous studies have demonstrated that CS has benefits in immunoregulation and anti-inflammation, the precise mechanism by which CS affects immunomodulation is still unclear. In this study, we exploited duplicate sets of loop-design microarray experiments to examine two different batches of CS and analyze the effects of CS on dendritic cells (DCs), in different physiology stages: naive stage and inflammatory stage. Immature DCs were treated with CS, lipopolysaccharide (LPS), or LPS plus CS (LPS/CS) for two days, and the gene expression profiles were examined using cDNA microarrays. The results of two loop-design microarray experiments showed good intersection rates. The expression level of common genes found in both loop-design microarray experiments was consistent, and the correlation coefficients (Rs), were higher than 0.96. Through intersection analysis of microarray results, we identified 295 intersecting significantly differentially expressed (SDE) genes of the three different treatments (CS, LPS, and LPS/CS), which participated mainly in the adjustment of immune response and the regulation of cell proliferation and death. Genes regulated uniquely by CS treatment were significantly involved in the regulation of focal adhesion pathway, ECM-receptor interaction pathway, and hematopoietic cell lineage pathway. Unique LPS regulated genes were significantly involved in the regulation of Toll-like receptor signaling pathway, systemic lupus erythematosus pathway, and complement and coagulation cascades pathway. Unique LPS/CS regulated genes were significantly involved in the regulation of oxidative phosphorylation pathway. These results could provide useful information in further study of the pharmacological mechanisms of CS. This study also demonstrates that with a rigorous experimental design, the biological effects of a complex compound can be reliably studied by a complex system like cDNA microarray.	[Li, Chia-Yang; Chiang, Chi-Shiun; Cheng, Wei-Chung; Wang, Shu-Chi; Chen, Chaang-Ray; Tsai, Min-Lung; Chang, Cheng-Wei; Huang, Chao-Ying; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Li, Chia-Yang] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Cheng, Wei-Chung] Taipei Vet Gen Hosp, Div Pediat Neurosurg, Neurol Inst, Taipei, Taiwan; [Cheng, Hung-Tsu] Natl Tsing Hua Univ, Inst Nanoengineerin & Microsyst, Hsinchu, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Hseu, Ruey-Shyang] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Fang, Shih-Hua] Natl Taiwan Sport Univ, Inst Athlet, Taichung, Taiwan	National Tsing Hua University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Taipei Veterans General Hospital; National Tsing Hua University; National Tsing Hua University; National Taiwan University	Li, CY (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008; Hsiao, Wei-Hung/B-9931-2013	Chiang, Chi-Shiun/0000-0002-2581-4129; Cheng, Wei-Chung/0000-0002-1229-4857; LI, CHIA-YANG/0000-0001-5689-9850; Chen, Chaang-Ray/0000-0003-2106-8699	Committee on Chinese Medicine and Pharmacy of the Department of Health (Taiwan) [CCMP93-RD-051, CCMP-94-RD-049]	Committee on Chinese Medicine and Pharmacy of the Department of Health (Taiwan)	This study was funded by the Committee on Chinese Medicine and Pharmacy of the Department of Health (Taiwan) under contract numbers CCMP93-RD-051 and CCMP-94-RD-049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ahn SK, 2003, INT J MOL MED, V12, P231; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benoit YD, 2009, BIOL CELL, V101, P695, DOI 10.1042/BC20090060; Birerdinc A, 2010, J VIRAL HEPATITIS, V17, P730, DOI 10.1111/j.1365-2893.2009.01235.x; Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chen CR, 2012, COMPUT BIOL MED, V42, P228, DOI 10.1016/j.compbiomed.2011.11.012; Chen YJ, 1997, LIFE SCI, V60, P2349, DOI 10.1016/S0024-3205(97)00291-9; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clark TA, 2007, MOL ECOL, V16, P2613, DOI 10.1111/j.1365-294X.2007.03354.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kuo MC, 2007, APPL MICROBIOL BIOT, V75, P769, DOI 10.1007/s00253-007-0880-5; KUO YC, 1994, CANCER INVEST, V12, P611, DOI 10.3109/07357909409023046; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Leung YF, 2003, TRENDS GENET, V19, P649, DOI 10.1016/j.tig.2003.09.015; Li CY, 2009, J LEUKOCYTE BIOL, V85, P987, DOI 10.1189/jlb.0908573; Li SP, 2006, J PHARMACEUT BIOMED, V41, P1571, DOI 10.1016/j.jpba.2006.01.046; Liu WC, 2008, EXP BIOL MED, V233, P447, DOI 10.3181/0708-RM-230; Liu WC, 2006, RADIAT RES, V166, P900, DOI 10.1667/RR0670.1; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Opal SM, 2002, CRIT CARE, V6, P125; Perseghin P, 2009, TRANSFUS APHER SCI, V41, P33, DOI 10.1016/j.transci.2009.05.011; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Schuchhardt J, 2000, Nucleic Acids Res, V28, pE47, DOI 10.1093/nar/28.10.e47; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Siu KM, 2004, LIFE SCI, V76, P385, DOI 10.1016/j.lfs.2004.07.014; Tempelman RJ, 2005, VET IMMUNOL IMMUNOP, V105, P175, DOI 10.1016/j.vetimm.2005.02.002; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Tsai CH, 2001, J AGR FOOD CHEM, V49, P2137, DOI 10.1021/jf001071k; Tsai ML, 2009, RADIAT RES, V171, P716, DOI 10.1667/RR1625.1; Vinciotti V, 2005, BIOINFORMATICS, V21, P492, DOI 10.1093/bioinformatics/bti022; Yamaguchi Y, 2000, PHYTOTHER RES, V14, P647, DOI 10.1002/1099-1573(200012)14:8&lt;647::AID-PTR670&gt;3.0.CO;2-W; Zhao BT, 2001, AM J PHYSIOL-CELL PH, V281, pC1587, DOI 10.1152/ajpcell.2001.281.5.C1587; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P429, DOI 10.1089/acm.1998.4.429	49	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40824	10.1371/journal.pone.0040824	http://dx.doi.org/10.1371/journal.pone.0040824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829888	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300026
J	Zhang, Y; He, Y; Praseedom, RK; Zheng, SS; Dong, JH; Chen, H				Zhang, Ying; He, Yong; Praseedom, Raaj Kumar; Zheng, Shusen; Dong, Jiahong; Chen, Hao			Establishment of Animal Model of Dual Liver Transplantation in Rat	PLOS ONE			English	Article							GRAFTS; SIZE; INJURY; DONORS	The animal model of the whole-size and reduced-size liver transplantation in both rat and mouse has been successfully established. Because of the difficulties and complexities in microsurgical technology, the animal model of dual liver transplantation was still not established for twelve years since the first human dual liver transplantation has been made a success. There is an essential need to establish this animal model to lay a basic foundation for clinical practice. To study the physiological and histopathological changes of dual liver transplantation, "Y" type vein from the cross part between vena cava and two iliac of donor and "Y' type prosthesis were employed to recanalize portal vein and the bile duct between dual liver grafts and recipient. The dual right upper lobes about 45-50% of the recipient liver volume were taken as donor, one was orthotopically implanted at its original position, the other was rotated 180 degrees sagitally and heterotopically positioned in the left upper quadrant. Microcirculation parameters, liver function, immunohistochemistry and survival were analyzed to evaluate the function of dual liver grafts. No significant difference in the hepatic microcirculatory flow was found between two grafts in the first 90 minutes after reperfusion. Light and electronic microscope showed the liver architecture was maintained without obvious features of cellular destruction and the continuity of the endothelium was preserved. Only 3 heterotopically positioned graft appeared patchy desquamation of endothelial cell, mitochondrial swelling and hepatocytes cytoplasmic vacuolization. Immunohistochemistry revealed there is no difference in hepatocyte activity and the ability of endothelia to contract and relax after reperfusion between dual grafts. Dual grafts made a rapid amelioration of liver function after reperfusion. 7 rats survived more than 7 days with survival rate of 58.3.%. Using "Y" type vein and bile duct prosthesis, we successfully established a novel rat model of dual right upper liver lobe transplantation.	[Zhang, Ying] Chinese Peoples Liberat Army Gen Hosp, Dept Microbiol, Beijing, Peoples R China; [Zhang, Ying] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [He, Yong; Zheng, Shusen; Chen, Hao] Zhejiang Univ, Key Lab Combined Multiorgan Transplantat, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Praseedom, Raaj Kumar] Addenbrookes Hosp, Dept Gen Surg, NIHR Comprehens Biomed Campus, Cambridge, England; [Dong, Jiahong] Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China; [Chen, Hao] Zhejiang Prov Peoples Hosp, Dept Gen Surg, Hangzhou, Zhejiang, Peoples R China; [Chen, Hao] Univ Florida, Coll Med, Dept Cardiol, Gainesville, FL USA	Chinese People's Liberation Army General Hospital; State University System of Florida; University of Florida; Zhejiang University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Chinese People's Liberation Army General Hospital; Zhejiang Provincial People's Hospital; State University System of Florida; University of Florida	Zhang, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Microbiol, Beijing, Peoples R China.	chenhao.dr@gmail.com			973 project [2003CB5500]; National Nature Science Foundation of China	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by grants from the 973 project 2003CB5500, the National Nature Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boillot O, 2002, LANCET, V359, P406, DOI 10.1016/S0140-6736(02)07593-1; Broering DC, 2007, LIVER TRANSPLANT, V13, P149, DOI 10.1002/lt.21042; Dahmen U, 2008, J SURG RES, V149, P15, DOI 10.1016/j.jss.2007.09.010; Delriviere L, 1998, MICROSURG, V18, P12, DOI 10.1002/(SICI)1098-2752(1998)18:1<12::AID-MICR4>3.0.CO;2-W; Fan ST, 2000, ARCH SURG-CHICAGO, V135, P336, DOI 10.1001/archsurg.135.3.336; Fiorini RN, 2004, AM J TRANSPLANT, V4, P1567, DOI 10.1111/j.1600-6143.2004.00549.x; GOTO M, 1994, HEPATOLOGY, V19, P675, DOI 10.1002/hep.1840190319; Haddad F., 1999, OXFORD TXB CLIN HEPA, P77; Huet PM, 2004, HEPATOLOGY, V39, P1110, DOI 10.1002/hep.20157; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Kawasaki S, 1998, ANN SURG, V227, P269, DOI 10.1097/00000658-199802000-00017; Lee SG, 2001, TRANSPLANT P, V33, P3461, DOI 10.1016/S0041-1345(01)02491-5; Moon D, 2006, LIVER TRANSPLANT, V12, P1156, DOI 10.1002/lt.20814; Oldani G, 2008, J SURG RES, V149, P303, DOI 10.1016/j.jss.2007.12.779; Soejima Y, 2008, AM J TRANSPLANT, V8, P887, DOI 10.1111/j.1600-6143.2008.02153.x; Wang WT, 2006, CHIN J ORGAN TRANSPL, V27, P277	16	6	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40818	10.1371/journal.pone.0040818	http://dx.doi.org/10.1371/journal.pone.0040818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829887	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300025
J	Cronin, KR; Mangan, TP; Carew, JA				Cronin, Katherine R.; Mangan, Thomas P.; Carew, Josephine A.			Upregulation of the Coagulation Factor VII Gene during Glucose Deprivation Is Mediated by Activating Transcription Factor 4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; ASPARAGINE SYNTHETASE GENE; FACTOR PROCOAGULANT ACTIVITY; FACTOR-BINDING PROTEIN-1; AMINO-ACID LIMITATION; TISSUE FACTOR; ER STRESS; MESSENGER-RNA; C/EBP-BETA	Background: Constitutive production of blood coagulation proteins by hepatocytes is necessary for hemostasis. Stressful conditions trigger adaptive cellular responses and delay processing of most proteins, potentially affecting plasma levels of proteins secreted exclusively by hepatocytes. We examined the effect of glucose deprivation on expression of coagulation proteins by the human hepatoma cell line, HepG2. Methodology/Principal Findings: Expression of coagulation factor VII, which is required for initiation of blood coagulation, was elevated by glucose deprivation, while expression of other coagulation proteins decreased. Realtime PCR and ELISA demonstrated that the relative percentage expression +/- SD of steady-state F7 mRNA and secreted factor VII antigen were significantly increased (from 100+/-15% to 188+/-27% and 100+/-8.8% to 176.3+/-17.3% respectively, p < 0.001) at 24 hr of treatment. The integrated stress response was induced, as indicated by upregulation of transcription factor ATF4 and of additional stress-responsive genes. Small interfering RNAs directed against ATF4 potently reduced basal F7 expression, and prevented F7 upregulation by glucose deprivation. The response of the endogenous F7 gene was replicated in reporter gene assays, which further indicated that ATF4 effects were mediated via interaction with an amino acid response element in the F7 promoter. Conclusions/Significance: Our data indicated that glucose deprivation enhanced F7 expression in a mechanism reliant on prior ATF4 upregulation primarily due to increased transcription from the ATF4 gene. Of five coagulation protein genes examined, only F7 was upregulated, suggesting that its functions may be important in a systemic response to glucose deprivation stress.	[Cronin, Katherine R.; Mangan, Thomas P.; Carew, Josephine A.] VA Boston Healthcare Syst, Dept Res, W Roxbury, MA USA; [Carew, Josephine A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School	Cronin, KR (corresponding author), VA Boston Healthcare Syst, Dept Res, W Roxbury, MA USA.	josephine_carew@hms.harvard.edu			Department of Veteran's Affairs of the United States government	Department of Veteran's Affairs of the United States government	This work was funded by a Merit-1 research award (to JAC) by the Department of Veteran's Affairs of the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Arbini AA, 1997, BLOOD, V89, P176, DOI 10.1182/blood.V89.1.176.176_176_182; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boden G, 2011, OBESITY, V19, P1366, DOI 10.1038/oby.2011.71; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carew JA, 1998, BLOOD, V92, P1639, DOI 10.1182/blood.V92.5.1639.417k10_1639_1645; Carew JA, 2000, BLOOD, V96, P4370; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Connelly S, 1999, THROMB HAEMOSTASIS, V81, P234, DOI 10.1055/s-0037-1614449; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dietzen DJ, 2004, BLOOD, V103, P3038, DOI 10.1182/blood-2003-07-2399; ESTES SD, 1995, EXP CELL RES, V220, P47, DOI 10.1006/excr.1995.1290; FAIR DS, 1983, J LAB CLIN MED, V101, P372; Gombart AF, 2007, J LEUKOCYTE BIOL, V81, P1535, DOI 10.1189/jlb.0806516; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heeb MJ, 2008, EXPERT REV HEMATOL, V1, P9, DOI 10.1586/17474086.1.1.9; Hinnebusch AG, 2005, NAT STRUCT MOL BIOL, V12, P835, DOI 10.1038/nsmb1005-835; Hoffman M, 2007, J THROMB HAEMOST, V5, P1403, DOI 10.1111/j.1538-7836.2007.02576.x; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Huang CC, 2010, BIOCHEM J, V429, P215, DOI 10.1042/BJ20100286; Jackson AA, 2007, J BIOL CHEM, V282, P31156, DOI 10.1074/jbc.M704694200; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Kavlie A, 2003, THROMB HAEMOSTASIS, V90, P194, DOI 10.1160/TH02-09-0050; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Mackman N, 2006, BLOOD CELL MOL DIS, V36, P104, DOI 10.1016/j.bcmd.2005.12.008; Mackman N, 2005, ARTERIOSCL THROM VAS, V25, P2273, DOI 10.1161/01.ATV.0000183884.06371.52; Malabanan KP, 2010, J MOL MED, V88, P545, DOI 10.1007/s00109-010-0615-4; Marchand A, 2006, J BIOL CHEM, V281, P19124, DOI 10.1074/jbc.M602157200; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Moneva MH, 2002, CURR DRUG TARGETS, V3, P203, DOI 10.2174/1389450023347803; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Muth H, 2005, THROMB HAEMOSTASIS, V94, P1028, DOI 10.1160/TH05-01-0002; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; Romisch J, 1999, BLOOD COAGUL FIBRIN, V10, P471; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosen ED, 2005, THROMB HAEMOSTASIS, V94, P493, DOI 10.1160/TH05-05-0337; Rosen ED, 1997, NATURE, V390, P290, DOI 10.1038/36862; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selvaraj SR, 2012, J THROMB HAEMOST, V10, P107, DOI 10.1111/j.1538-7836.2011.04545.x; Shinagawa K, 2009, AM J PHYSIOL-LUNG C, V296, pL763, DOI 10.1152/ajplung.90638.2008; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Toomey JR, 1996, BLOOD, V88, P1583; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wolberg AS, 1999, BLOOD COAGUL FIBRIN, V10, P201, DOI 10.1097/00001721-199906000-00007; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Xu H, 2006, J PATHOL, V210, P488, DOI 10.1002/path.2073; Xu H, 2009, J PATHOL, V217, P362, DOI 10.1002/path.2454; Xu Z, 2010, MOL MED, V16, P167, DOI 10.2119/molmed.2009.00171; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zheng XW, 2011, BLOOD COAGUL FIBRIN, V22, P624, DOI 10.1097/MBC.0b013e3283497699	96	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40994	10.1371/journal.pone.0040994	http://dx.doi.org/10.1371/journal.pone.0040994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848420	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200037
J	Izumi, N; Helker, C; Ehling, M; Behrens, A; Herzog, W; Adams, RH				Izumi, Nanae; Helker, Christian; Ehling, Manuel; Behrens, Axel; Herzog, Wiebke; Adams, Ralf H.			Fbxw7 Controls Angiogenesis by Regulating Endothelial Notch Activity	PLOS ONE			English	Article							FBW7 UBIQUITIN LIGASE; TIP CELL-FORMATION; CARDIOVASCULAR DEVELOPMENT; VASCULAR DEVELOPMENT; NEGATIVE REGULATOR; ZEBRAFISH EMBRYO; TUMOR-SUPPRESSOR; PROTEIN; VEGF; DIFFERENTIATION	Notch signaling controls fundamental aspects of angiogenic blood vessel growth including the selection of sprouting tip cells, endothelial proliferation and arterial differentiation. The E3 ubiquitin ligase Fbxw7 is part of the SCF protein complex responsible for the polyubiquitination and thereby proteasomal degradation of substrates such as Notch, c-Myc and c-Jun. Here, we show that Fbxw7 is a critical regulator of angiogenesis in the mouse retina and the zebrafish embryonic trunk, which we attribute to its role in the degradation of active Notch. Growth of retinal blood vessel was impaired and the Notch ligand Dll4, which is also a Notch target, upregulated in inducible and endothelial cell-specific Fbxw7(iECKO) mutant mice. The stability of the cleaved and active Notch intracellular domain was increased after siRNA knockdown of the E3 ligase in cultured human endothelial cells. Injection of fbxw7 morpholinos interfered with the sprouting of zebrafish intersegmental vessels (ISVs). Arguing strongly that Notch and not other Fbxw7 substrates are primarily responsible for these phenotypes, the genetic inactivation of Notch pathway components reversed the impaired ISV growth in the zebrafish embryo as well as sprouting and proliferation in the mouse retina. Our findings establish that Fbxw7 is a potent positive regulator of angiogenesis that limits the activity of Notch in the endothelium of the growing vasculature.	[Izumi, Nanae; Ehling, Manuel; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany; [Izumi, Nanae; Ehling, Manuel; Adams, Ralf H.] Univ Munster, Fac Med, Munster, Germany; [Helker, Christian; Herzog, Wiebke] Univ Munster, Fac Biol, Munster, Germany; [Helker, Christian; Herzog, Wiebke] Max Planck Inst Mol Biomed, Angiogenesis Lab, Munster, Germany; [Behrens, Axel] CRUK London Res Inst, Lincolns Inn Fields Labs, Mammalian Genet Lab, London, England	Max Planck Society; University of Munster; University of Munster; Max Planck Society; Cancer Research UK	Izumi, N (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany.	ralf.adams@mpi-muenster.mpg.de	Adams, Ralf H/AAE-9274-2019	Herzog, Wiebke/0000-0002-9843-3458; Helker, Christian/0000-0003-0427-5338; Behrens, Axel/0000-0002-1557-1143	University of Muenster; State of North-Westphalia; Cancer Research UK; Max Planck Society; German Research Foundation; Cancer Research UK [15679] Funding Source: researchfish	University of Muenster; State of North-Westphalia; Cancer Research UK(Cancer Research UK); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK)	This study was funded by the University of Muenster (to RHA), the State of North-Westphalia (to CH and WH), Cancer Research UK (to AB), the Max Planck Society and the program SFB 629 of the German Research Foundation (to NI and RHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Carlson TR, 2005, P NATL ACAD SCI USA, V102, P9884, DOI 10.1073/pnas.0504391102; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kidd KR, 2003, BRIT J PHARMACOL, V140, P585, DOI 10.1038/sj.bjp.0705496; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933; Lamont Ryan E, 2006, Sci STKE, V2006, ppe39, DOI 10.1126/stke.3552006pe39; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Ny A, 2006, EXP CELL RES, V312, P684, DOI 10.1016/j.yexcr.2005.10.018; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Roman BL, 2002, DEVELOPMENT, V129, P3009; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290	42	47	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41116	10.1371/journal.pone.0041116	http://dx.doi.org/10.1371/journal.pone.0041116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848434	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200042
J	Zeeberg, BR; Kohn, KW; Kahn, A; Larionov, V; Weinstein, JN; Reinhold, W; Pommier, Y				Zeeberg, Barry R.; Kohn, Kurt W.; Kahn, Ari; Larionov, Vladimir; Weinstein, John N.; Reinhold, William; Pommier, Yves			Concordance of Gene Expression and Functional Correlation Patterns across the NCl-60 Cell Lines and the Cancer Genome Atlas Glioblastoma Samples	PLOS ONE			English	Article							TOOL	Background: The NCl-60 is a panel of 60 diverse human cancer cell lines used by the U. S. National Cancer Institute to screen compounds for anticancer activity. We recently clustered genes based on correlation of expression profiles across the NCl-60. Many of the resulting clusters were characterized by cancer-associated biological functions. The set of curated glioblastoma (GBM) gene expression data from the Cancer Genome Atlas (TCGA) initiative has recently become available. Thus, we are now able to determine which of the processes are robustly shared by both the immortalized cell lines and clinical cancers. Results: Our central observation is that some sets of highly correlated genes in the NCl-60 expression data are also highly correlated in the GBM expression data. Furthermore, a "double fishing'' strategy identified many sets of genes that show Pearson correlation >= 0.60 in both the NCl-60 and the GBM data sets relative to a given "bait'' gene. The number of such gene sets far exceeds the number expected by chance. Conclusion: Many of the gene-gene correlations found in the NCl-60 do not reflect just the conditions of cell lines in culture; rather, they reflect processes and gene networks that also function in vivo. A number of gene network correlations co-occur in the NCl-60 and GBM data sets, but there are others that occur only in NCl-60 or only in GBM. In sum, this analysis provides an additional perspective on both the utility and the limitations of the NCl-60 in furthering our understanding of cancers in vivo.	[Zeeberg, Barry R.; Kohn, Kurt W.; Larionov, Vladimir; Reinhold, William; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kahn, Ari] SRA Int Inc, Fairfax, VA USA; [Weinstein, John N.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Comp Biol & Syst Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); SRA International; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Zeeberg, BR (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	zeebergb@mail.nih.gov	zeeberg, barry/AAO-1246-2020; Reinhold, William/J-6704-2017	Weinstein, John/0000-0001-9401-6908; Reinhold, William/0000-0001-5513-9323	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Cancer Institute (UT-MD Anderson TCGA Genome Data Analysis Center) [U24CA143883]; Michael & Susan Dell Foundation; NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006192, U24CA143883] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (UT-MD Anderson TCGA Genome Data Analysis Center); Michael & Susan Dell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The work of JNW was supported in part by Grant Number U24CA143883 from the National Cancer Institute (UT-MD Anderson TCGA Genome Data Analysis Center), by a gift from the H.A. & Mary K. Chapman Foundation, and by a grant from the Michael & Susan Dell Foundation honoring Lorraine Dell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Kohn KW, 2012, PLOS ONE, V7; Reinhold WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025991; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WEINSTEIN JN, 1994, STEM CELLS, V12, P13, DOI 10.1002/stem.5530120106; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Weinstein JN, 2006, MOL CANCER THER, V5, P2601, DOI 10.1158/1535-7163.MCT-06-0640; Zeeberg BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030317; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zoppoli G, 2011, ONCOGENE, V31, P535	14	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40062	10.1371/journal.pone.0040062	http://dx.doi.org/10.1371/journal.pone.0040062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848369	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600005
J	Landry, GJ; Opiol, H; Marchant, EG; Pavlovski, I; Mear, RJ; Hamson, DK; Mistlberger, RE				Landry, Glenn J.; Opiol, Hanna; Marchant, Elliott G.; Pavlovski, Ilya; Mear, Rhiannon J.; Hamson, Dwayne K.; Mistlberger, Ralph E.			Scheduled Daily Mating Induces Circadian Anticipatory Activity Rhythms in the Male Rat	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; FEEDING SCHEDULES; GENE-EXPRESSION; SYRIAN-HAMSTERS; DRUG REWARD; DAILY MEAL; FOOD; CLOCK; ENTRAINMENT; ACCESS	Daily schedules of limited access to food, palatable high calorie snacks, water and salt can induce circadian rhythms of anticipatory locomotor activity in rats and mice. All of these stimuli are rewarding, but whether anticipation can be induced by neural correlates of reward independent of metabolic perturbations associated with manipulations of food and hydration is unclear. Three experiments were conducted to determine whether mating, a non-ingestive behavior that is potently rewarding, can induce circadian anticipatory activity rhythms in male rats provided scheduled daily access to steroid-primed estrous female rats. In Experiment 1, rats anticipated access to estrous females in the mid-light period, but also exhibited post-coital eating and running. In Experiment 2, post-coital eating and running were prevented and only a minority of rats exhibited anticipation. Rats allowed to see and smell estrous females showed no anticipation. In both experiments, all rats exhibited sustained behavioral arousal and multiple mounts and intromissions during every session, but ejaculated only every 2-3 days. In Experiment 3, the rats were given more time with individual females, late at night for 28 days, and then in the midday for 28 days. Ejaculation rates increased and anticipation was robust to night sessions and significant although weaker to day sessions. The anticipation rhythm persisted during 3 days of constant dark without mating. During anticipation of nocturnal mating, the rats exhibited a significant preference for a tube to the mating cage over a tube to a locked cage with mating cage litter. This apparent place preference was absent during anticipation of midday mating, which may reflect a daily rhythm of sexual reward. The results establish mating as a reward stimulus capable of inducing circadian rhythms of anticipatory behavior in the male rat, and reveal a critical role for ejaculation, a modulatory role for time of day, and a potential confound role for uncontrolled food intake.	[Landry, Glenn J.; Opiol, Hanna; Marchant, Elliott G.; Pavlovski, Ilya; Mear, Rhiannon J.; Hamson, Dwayne K.; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Landry, GJ (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Landry, Glenn J/L-2133-2015; Hamson, Dwayne/AAA-6914-2020	Landry, Glenn J/0000-0002-6946-3914; 	Natural Science and Engineering Research Council of Canada; PGSD scholarship; USRA	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); PGSD scholarship; USRA	This work was funded by the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), in the form of an operating grant to REM, a PGSD scholarship to GJL, and a USRA scholarship to HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1992, AM J PHYSIOL, V263, pR116, DOI 10.1152/ajpregu.1992.263.1.R116; Agmo A, 1997, BRAIN RES PROTOC, V1, P203, DOI 10.1016/S1385-299X(96)00036-0; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; ASCHOFF J, 1986, MONIT ZOOL ITAL, V20, P195; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Challet E, 2010, CELL TISSUE RES, V341, P1, DOI 10.1007/s00441-010-1001-9; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DAMSMA G, 1992, BEHAV NEUROSCI, V106, P181, DOI 10.1037/0735-7044.106.1.181; Davidson AJ, 2005, METHOD ENZYMOL, V393, P509, DOI 10.1016/S0076-6879(05)93026-7; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Davis BA, 2007, BEHAV NEUROSCI, V121, P1012, DOI 10.1037/0735-7044.121.5.1012; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; ERSKINE MS, 1980, J ENDOCRINOL, V86, P127, DOI 10.1677/joe.0.0860127; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Honma K, 2009, EUR J NEUROSCI, V30, P1707, DOI 10.1111/j.1460-9568.2009.06976.x; Hood S, 2011, NEUROSCIENCE, V186, P65, DOI 10.1016/j.neuroscience.2011.04.045; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Hsu, 2010, PLOS ONE, V5; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012903; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Iijima M, 2002, EUR J NEUROSCI, V16, P921, DOI 10.1046/j.1460-9568.2002.02140.x; Jansen HT, 2012, CHRONOBIOL INT; Kosobud AEK, 1998, NEUROSCI LETT, V250, P99, DOI 10.1016/S0304-3940(98)00439-X; KOSOBUD AEK, 1994, J NEUROSCI, V14, P7117; Lopez HH, 1999, HORM BEHAV, V36, P176, DOI 10.1006/hbeh.1999.1535; Marchant EG, 1996, PHYSIOL BEHAV, V60, P657, DOI 10.1016/S0031-9384(96)80045-X; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1991, J BIOL RHYTHM, V6, P71, DOI 10.1177/074873049100600108; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; MISTLBERGER RE, 1995, BEHAV NEUROSCI, V109, P790, DOI 10.1037/0735-7044.109.4.790; MISTLBERGER RE, 1992, J BIOL RHYTHM, V7, P149, DOI 10.1177/074873049200700206; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; Paul MJ, 2007, COLD SH Q B, V72, P615, DOI 10.1101/sqb.2007.72.042; Pecoraro N, 2002, BEHAV NEUROSCI, V116, P757, DOI 10.1037//0735-7044.116.5.757; ROSENWASSER AM, 1988, ANIM LEARN BEHAV, V16, P324, DOI 10.3758/BF03209084; Sinclair SV, 1997, BEHAV BRAIN RES, V87, P127, DOI 10.1016/S0166-4328(96)02274-7; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tenk CM, 2009, HORM BEHAV, V55, P93, DOI 10.1016/j.yhbeh.2008.08.012; TERMAN M, 1984, ANN NY ACAD SCI, V423, P470, DOI 10.1111/j.1749-6632.1984.tb23454.x; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Webb IC, 2009, J BIOL RHYTHM, V24, P465, DOI 10.1177/0748730409346657; Webb IC, 2009, EUR J NEUROSCI, V30, P1739, DOI 10.1111/j.1460-9568.2009.06966.x; WHALEN RE, 1961, J COMP PHYSIOL PSYCH, V54, P409, DOI 10.1037/h0046385	59	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40895	10.1371/journal.pone.0040895	http://dx.doi.org/10.1371/journal.pone.0040895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848408	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600027
J	Stanley, CQ; MacPherson, M; Fraser, KC; McKinnon, EA; Stutchbury, BJM				Stanley, Calandra Q.; MacPherson, Maggie; Fraser, Kevin C.; McKinnon, Emily A.; Stutchbury, Bridget J. M.			Repeat Tracking of Individual Songbirds Reveals Consistent Migration Timing but Flexibility in Route	PLOS ONE			English	Article							LONG-DISTANCE MIGRANTS; ENERGETIC CONDITION; CLIMATE-CHANGE; CONNECTIVITY; GEOLOCATOR; SCHEDULES; AUTUMN	Tracking repeat migratory journeys of individual animals is required to assess phenotypic plasticity of individual migration behaviour in space and time. We used light-level geolocators to track the long-distance journeys of migratory songbirds (wood thrush, Hylocichla mustelina), and, for the first time, repeat journeys of individuals. We compare between- and within-individual variation in migration to examine flexibility of timing and route in spring and autumn. Date of departure from wintering sites in Central America, along with sex and age factors, explained most of the variation (71%) in arrival date at North American breeding sites. Spring migration showed high within-individual repeatability in timing, but not in route. In particular, spring departure dates of individuals were highly repeatable, with a mean difference between years of just 3 days. Autumn migration timing and routes were not repeatable. Our results provide novel evidence of low phenotypic plasticity in timing of spring migration, which may limit the ability of individuals to adjust migration schedules in response to climate change.	[Stanley, Calandra Q.; MacPherson, Maggie; Fraser, Kevin C.; McKinnon, Emily A.; Stutchbury, Bridget J. M.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	Stanley, CQ (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	fraserkev@gmail.com	MacPherson, Maggie/AAQ-9801-2021	MacPherson, Maggie/0000-0002-9522-5688; McKinnon, Emily/0000-0003-3631-0644; Stanley, Calandra Q./0000-0003-1588-2248	Natural Sciences and Engineering Research Council of Canada; National Geographic Society; U.S. Fish & Wildlife Service Neotropical Migratory Bird Grant; Kenneth G. Molson Foundation; Schad Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Geographic Society(National Geographic Society); U.S. Fish & Wildlife Service Neotropical Migratory Bird Grant; Kenneth G. Molson Foundation; Schad Foundation	This work was funded by the Natural Sciences and Engineering Research Council of Canada, National Geographic Society, U.S. Fish & Wildlife Service Neotropical Migratory Bird Grant, Kenneth G. Molson Foundation, Schad Foundation and proceeds from Silence of the Songbirds (2007, Walker & Co.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Bairlein F., 2012, BIOL LETT; Battley PF, 2006, BIOL LETTERS, V2, P517, DOI 10.1098/rsbl.2006.0535; Berthold P, 1996, CONTROL BIRD MIGRATI; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Both C, 2010, CURR BIOL, V20, P243, DOI 10.1016/j.cub.2009.11.074; Brown CR, 2000, BEHAV ECOL SOCIOBIOL, V47, P339, DOI 10.1007/s002650050674; Conklin JR, 2011, BEHAV ECOL, V22, P854, DOI 10.1093/beheco/arr054; Conklin JR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1072; Fudickar AM, 2010, METHODS ECOLOGY EVOL, V3, P47; Heckscher CM, 2011, AUK, V128, P531, DOI 10.1525/auk.2011.10280; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lisovski S, 2012, METHODS ECOLOGY EVOL; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Pulido F, 2005, ANN NY ACAD SCI, V1046, P228, DOI 10.1196/annals.1343.020; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Ryder TB, 2011, AUK, V128, P448, DOI 10.1525/auk.2011.11091; Sandberg R, 1996, BEHAV ECOL SOCIOBIOL, V39, P1, DOI 10.1007/s002650050261; Schmaljohann H, 2012, BEHAV ECOLOGY SOCIOB; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2011, P ROY SOC B-BIOL SCI, V278, P131, DOI 10.1098/rspb.2010.1220; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Tottrup AP, 2008, BIOL LETTERS, V4, P685, DOI 10.1098/rsbl.2008.0290; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Zuur Alain F., 2009, P1	32	148	153	2	163	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40688	10.1371/journal.pone.0040688	http://dx.doi.org/10.1371/journal.pone.0040688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848395	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600023
J	Lynch, EA; Langille, MGI; Darling, A; Wilbanks, EG; Haltiner, C; Shao, KSY; Starr, MO; Teiling, C; Harkins, TT; Edwards, RA; Eisen, JA; Facciotti, MT				Lynch, Erin A.; Langille, Morgan G. I.; Darling, Aaron; Wilbanks, Elizabeth G.; Haltiner, Caitlin; Shao, Katie S. Y.; Starr, Michael O.; Teiling, Clotilde; Harkins, Timothy T.; Edwards, Robert A.; Eisen, Jonathan A.; Facciotti, Marc T.			Sequencing of Seven Haloarchaeal Genomes Reveals Patterns of Genomic Flux	PLOS ONE			English	Article							AUTOTROPHIC CARBON FIXATION; HALOFERAX-VOLCANII; INTERACTIVE TREE; ALIGNMENT; RNA; ARCHAEON; CYCLE; LIFE; IDENTIFICATION; TRANSCRIPTION	We report the sequencing of seven genomes from two haloarchaeal genera, Haloferax and Haloarcula. Ease of cultivation and the existence of well-developed genetic and biochemical tools for several diverse haloarchaeal species make haloarchaea a model group for the study of archaeal biology. The unique physiological properties of these organisms also make them good candidates for novel enzyme discovery for biotechnological applications. Seven genomes were sequenced to similar to 20xcoverage and assembled to an average of 50 contigs (range 5 scaffolds - 168 contigs). Comparisons of protein-coding gene compliments revealed large-scale differences in COG functional group enrichment between these genera. Analysis of genes encoding machinery for DNA metabolism reveals genera-specific expansions of the general transcription factor TATA binding protein as well as a history of extensive duplication and horizontal transfer of the proliferating cell nuclear antigen. Insights gained from this study emphasize the importance of haloarchaea for investigation of archaeal biology.	[Lynch, Erin A.; Wilbanks, Elizabeth G.; Eisen, Jonathan A.; Facciotti, Marc T.] Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA; [Langille, Morgan G. I.] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada; [Darling, Aaron; Eisen, Jonathan A.; Facciotti, Marc T.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Haltiner, Caitlin] Childrens Hosp Oakland Res Inst, Oakland, CA USA; [Haltiner, Caitlin] Univ Calif Davis, Dept Forens Sci, Davis, CA 95616 USA; [Shao, Katie S. Y.] Davis Senior High Sch, Davis, CA USA; [Teiling, Clotilde] 454 Life Sci, Branford, CT USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Harkins, Timothy T.] Life Technol, Beverly, MA USA; [Edwards, Robert A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Edwards, Robert A.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Starr, Michael O.; Facciotti, Marc T.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; Dalhousie University; University of California System; University of California Davis; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Davis; California State University System; San Diego State University; Thermo Fisher Scientific; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Lynch, EA (corresponding author), Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA.	jaeisen@ucdavis.edu; mtfacciotti@ucdavis.edu	Eisen, Jonathan A./H-2706-2019; Facciotti, Marc/AAF-9227-2020; Darling, Aaron/G-8119-2017; Edwards, Robert/Q-1691-2019	Eisen, Jonathan A./0000-0002-0159-2197; Facciotti, Marc/0000-0003-4453-3274; Edwards, Robert/0000-0001-8383-8949; Darling, Aaron/0000-0003-2397-7925; Langille, Morgan/0000-0002-6604-3009; Becker, Erin/0000-0002-6832-0233	NSF [EF0949453]; 454 Life Sciences	NSF(National Science Foundation (NSF)); 454 Life Sciences	This work was funded by NSF Grant #EF0949453 and by 454 Life Sciences. Sequencing and genome assembly for this project was provided by 454 Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEKAR W, 1992, ARCH MICROBIOL, V158, P356, DOI 10.1007/BF00245365; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson I, 2012, STAND GENOMIC SCI, V6, P31, DOI 10.4056/sigs.2505605; Anderson I, 2009, STAND GENOMIC SCI, V1, P218, DOI 10.4056/sigs.31864; [Anonymous], 2006, MACPYMOL PYMOL ENH M; Atomi H, 2011, CURRENT OPINION BIOT, V22, P1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Bonete M.J., 2008, SALINE SYSTEMS, V4; Bowers KJ, 2011, EXTREMOPHILES, V15, P119, DOI 10.1007/s00792-010-0347-y; Cabello P, 2004, MICROBIOL-SGM, V150, P3527, DOI 10.1099/mic.0.27303-0; Capes MD, 2011, PLASMID, V65, P77, DOI 10.1016/j.plasmid.2010.11.005; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Didelot X, 2009, GENOME RES, V19, P306, DOI 10.1101/gr.082263.108; Dyall-Smith ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020968; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Facciotti MT, 2006, PNAS, V104, P4630; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Legat A, 2010, APPL MICROBIOL BIOT, V87, P1119, DOI 10.1007/s00253-010-2611-6; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lobasso S, 2012, PHOTOCHEM PHOTOBIOL, V88, P690, DOI 10.1111/j.1751-1097.2012.01089.x; Lucas A, 2011, CTC PACKAGE; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Malfatti S, 2009, STAND GENOMIC SCI, V1, P150, DOI 10.4056/sigs.23264; Margesin R, 2001, EXTREMOPHILES, V5, P73, DOI 10.1007/s007920100184; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Matsumi R, 2011, RES MICROBIOL, V162, P39, DOI 10.1016/j.resmic.2010.10.003; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Nakao Y, 2011, J PHOTOCH PHOTOBIO B, V102, P45, DOI 10.1016/j.jphotobiol.2010.09.004; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Pan M, 2011, BIOCHEM SOC T, V39, P20, DOI 10.1042/BST0390020; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Roh SW, 2010, J BACTERIOL, V192, P4528, DOI 10.1128/JB.00663-10; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Saunders E, 2010, STAND GENOMIC SCI, V2, P07; Sharma AK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-79; Siddaramappa S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-165; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Tindall BJ, 2009, STAND GENOMIC SCI, V1, P270, DOI 10.4056/sigs.42644; Turkarslan S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.87; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Walter JM, 2010, CURR OPIN BIOTECH, V21, P265, DOI 10.1016/j.copbio.2010.03.007; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilm A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn174; Winter JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-55; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zhang T, 2011, GREEN CHEM, V13, P2083, DOI 10.1039/c1gc15193b; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	80	34	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41389	10.1371/journal.pone.0041389	http://dx.doi.org/10.1371/journal.pone.0041389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848480	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300035
J	Calvert, C; Thomas, SL; Ronsmans, C; Wagner, KS; Adler, AJ; Filippi, V				Calvert, Clara; Thomas, Sara L.; Ronsmans, Carine; Wagner, Karen S.; Adler, Alma J.; Filippi, Veronique			Identifying Regional Variation in the Prevalence of Postpartum Haemorrhage: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED TRIAL; BLOOD-LOSS; 3RD STAGE; MATERNAL DEATH; COMPLICATIONS; MISOPROSTOL; DELIVERY	Objective: To provide regional estimates of the prevalence of maternal haemorrhage and explore the effect of methodological differences between studies on any observed regional variation. Methods: We conducted a systematic review of the prevalence of maternal haemorrhage, defined as blood loss greater than or equal to 1) 500 ml or 2) 1000 ml in the antepartum, intrapartum or postpartum period. We obtained regional estimates of the prevalence of maternal and severe maternal haemorrhage by conducting meta-analyses and used meta-regression to explore potential sources of between-study heterogeneity. Findings: No studies reported the prevalence of antepartum haemorrhage (APH) according to our definitions. The prevalence of postpartum haemorrhage (PPH) (blood loss >= 500 ml) ranged from 7.2% in Oceania to 25.7% in Africa. The prevalence of severe PPH (blood loss >= 1000 ml) was highest in Africa at 5.1% and lowest in Asia at 1.9%. There was strong evidence of between-study heterogeneity in the prevalence of PPH and severe PPH in most regions. Meta-regression analyses suggested that region and method of measurement of blood loss influenced prevalence estimates for both PPH and severe PPH. The regional patterns changed after adjusting for the other predictors of PPH indicating that, compared with European women, Asian women have a lower prevalence of PPH. Conclusions: We found evidence that Asian women have a very low prevalence of PPH compared with women in Europe. However, more reliable estimates will only be obtained with the standardisation of the measurement of PPH so that the data from different regions are comparable.	[Calvert, Clara; Thomas, Sara L.; Ronsmans, Carine; Wagner, Karen S.; Adler, Alma J.; Filippi, Veronique] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Calvert, C (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	clara.calvert@lshtm.ac.uk			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by a grant awarded by the Bill & Melinda Gates Foundation to the U.S. fund for UNICEF to support the Child Health Epidemiology Reference Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Abu-Omar AA, 2001, SAUDI MED J, V22, P1118; Alfirevic Z, 2004, EUR J OBSTET GYN R B, V115, P28, DOI 10.1016/j.ejogrb.2003.10.036; Amelink-Verburg MP, 2008, BJOG-INT J OBSTET GY, V115, P570, DOI 10.1111/j.1471-0528.2007.01580.x; Carroli G, 2008, BEST PRACT RES CL OB, V22, P999, DOI 10.1016/j.bpobgyn.2008.08.004; Craigo S, 1994, OBSTET GYNECOLOGIC D; Davies GAL, 2005, OBSTET GYNECOL, V105, P294, DOI 10.1097/01.AOG.0000148264.20909.bb; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoj L, 2005, BMJ-BRIT MED J, V331, P723, DOI 10.1136/bmj.331.7519.723; Jackson KW, 2001, AM J OBSTET GYNECOL, V185, P873, DOI 10.1067/mob.2001.117363; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Koh E, 2009, SINGAP MED J, V50, P693; Marchant S, 2006, PAEDIATR PERINAT EP, V20, P392, DOI 10.1111/j.1365-3016.2006.00743.x; Matsubara S, 2008, J PERINAT MED, V36, P507, DOI 10.1515/JPM.2008.089; Murphy DJ, 2010, COCHRANE DATABASE SY, V7; Ng PS, 2001, HUM REPROD, V16, P31, DOI 10.1093/humrep/16.1.31; Ohkuchi A, 2003, J PERINAT MED, V31, P209, DOI 10.1515/JPM.2003.028; Prasertcharoensuk W, 2000, INT J GYNECOL OBSTET, V71, P69, DOI 10.1016/S0020-7292(00)00294-0; PRENDIVILLE WJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]; Robinson HE, 2005, OBSTET GYNECOL, V106, P1357, DOI 10.1097/01.AOG.0000188387.88032.41; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Schmidt N, 2002, ACTA OBSTET GYN SCAN, V81, P731, DOI 10.1034/j.1600-0412.2002.810808.x; Sentilhes L, 2011, ACTA OBSTET GYNECOLO; Seoane G, 1998, INT J GYNECOL OBSTET, V62, P229, DOI 10.1016/S0020-7292(98)00104-0; Stafford I, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.049; Stuart A, 1994, KENDALLS ADV THEORY; World Health Organization (WHO), 2008, PROP BIRTHS ATT SKIL	32	108	112	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41114	10.1371/journal.pone.0041114	http://dx.doi.org/10.1371/journal.pone.0041114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844432	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000306687700045
J	Daddaoua, A; Fillet, S; Fernandez, M; Udaondo, Z; Krell, T; Ramos, JL				Daddaoua, Abdelali; Fillet, Sandy; Fernandez, Matilde; Udaondo, Zulema; Krell, Tino; Ramos, Juan L.			Genes for Carbon Metabolism and the ToxA Virulence Factor in Pseudomonas aeruginosa Are Regulated through Molecular Interactions of PtxR and PtxS	PLOS ONE			English	Article							FERRIC UPTAKE REGULATOR; GLUCOSE-METABOLISM; SIGMA-FACTOR; EXOTOXIN-A; PUTIDA; PROMOTERS; REGA; EXPRESSION; PATHWAYS; QUANTIFICATION	Homologs of the transcriptional regulator PtxS are omnipresent in Pseudomonas, whereas PtxR homologues are exclusively found in human pathogenic Pseudomonas species. In all Pseudomonas sp., PtxS with 2-ketogluconate is the regulator of the gluconate degradation pathway and controls expression from its own promoter and also from the P-gad and P-kgu for the catabolic operons. There is evidence that PtxS and PtxR play a central role in the regulation of exotoxin A expression, a relevant primary virulence factor of Pseudomonas aeruginosa. We show using DNaseI-footprint analysis that in P. aeruginosa PtxR binds to the -35 region of the P-toxA promoter in front of the exotoxin A gene, whereas PtxS does not bind to this promoter. Bioinformatic and DNaseI-footprint analysis identified a PtxR binding site in the P-kgu and P-gad promoters that overlaps the -35 region, while the PtxS operator site is located 50 bp downstream from the PtxR site. In vitro, PtxS recognises PtxR with nanomolar affinity, but this interaction does not occur in the presence of 2-ketogluconate, the specific effector of PtxS. DNAaseI footprint assays of P-kgu and P-gad promoters with PtxS and PtxR showed a strong region of hyper-reactivity between both regulator binding sites, indicative of DNA distortion when both proteins are bound; however in the presence of 2-ketogluconate no protection was observed. We conclude that PtxS modulates PtxR activity in response to 2-ketogluconate by complex formation in solution in the case of the P-toxA promoter, or via the formation of a DNA loop as in the regulation of gluconate catabolic genes. Data suggest two different mechanisms of control exerted by the same regulator.	[Daddaoua, Abdelali; Fillet, Sandy; Udaondo, Zulema; Krell, Tino; Ramos, Juan L.] CSIC EEZ, Environm Protect Dept, Granada, Spain; [Fernandez, Matilde] Poligono Juncaril, Bioiliberis R&D, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Daddaoua, A (corresponding author), CSIC EEZ, Environm Protect Dept, Granada, Spain.	juanluis.ramos@eez.csic.es	Fernandez, Matilde/F-5980-2013; Krell, Tino/G-7296-2015; Daddaoua, Abdelali/D-6930-2014; Udaondo, Zulema/ABI-7810-2020	Fernandez, Matilde/0000-0002-7064-670X; Krell, Tino/0000-0002-9040-3166; Daddaoua, Abdelali/0000-0002-7348-6393; Udaondo, Zulema/0000-0003-3445-6842; Ramos, Juan L./0000-0002-8731-7435; Fernandez, Matilde/0000-0002-5832-5161	European Research Area Network (ERANET) programme Pathogenomics within the ADHERS [BIO2008-04419-E]; Fondos Europeos para El Desarrollo (FEDER) [BIO-2006-05668, BIO2010-17227, CVI-3010]	European Research Area Network (ERANET) programme Pathogenomics within the ADHERS; Fondos Europeos para El Desarrollo (FEDER)	This study was supported by the European Research Area Network (ERANET) programme Pathogenomics within the ADHERS BIO2008-04419-E/project. We also received Fondos Europeos para El Desarrollo (FEDER) grants BIO-2006-05668, BIO2010-17227 and CVI-3010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; Barton HA, 1996, MOL MICROBIOL, V21, P1001, DOI 10.1046/j.1365-2958.1996.381426.x; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Chastre J, 2002, J BACTERIOL, V192, P4357; Colmer JA, 2001, CAN J MICROBIOL, V47, P820, DOI 10.1139/cjm-47-9-820; Colmer JA, 1998, MOL GEN GENET, V258, P250, DOI 10.1007/s004380050729; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; Daddaoua A, 2010, J BACTERIOL, V192, P4357, DOI 10.1128/JB.00520-10; Daniels C, 2010, J BIOL CHEM, V285, P21372, DOI 10.1074/jbc.M110.113282; Davinic M, 2009, MICROBIOL-SGM, V155, P2265, DOI 10.1099/mic.0.028373-0; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; del Castillo T, 2007, J BACTERIOL, V189, P6602, DOI 10.1128/JB.00679-07; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; Dohar JE, 2005, LARYNGOSCOPE, V115, P1469, DOI 10.1097/01.mlg.0000172036.82897.d4; ENTNER N, 1952, J BIOL CHEM, V196, P853; FENNER C, 1975, ANAL BIOCHEM, V63, P595, DOI 10.1016/0003-2697(75)90386-3; Ferrell E, 2008, MICROBIOL-SGM, V154, P431, DOI 10.1099/mic.0.2007/011577-0; Fillet S, 2009, J BACTERIOL, V191, P1901, DOI 10.1128/JB.01504-08; FRANK DW, 1988, J BACTERIOL, V170, P4477, DOI 10.1128/jb.170.10.4477-4483.1988; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Gaines JM, 2007, MICROBIOL-SGM, V153, P4219, DOI 10.1099/mic.0.2007/011338-0; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Hamood AN, 1996, MOL MICROBIOL, V21, P97, DOI 10.1046/j.1365-2958.1996.6251337.x; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; HEDSTROM RC, 1986, INFECT IMMUN, V51, P37, DOI 10.1128/IAI.51.1.37-42.1986; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; MARQUES S, 1993, BIOCHIM BIOPHYS ACTA, V1216, P227, DOI 10.1016/0167-4781(93)90149-8; Miller J.H., 1972, EXPT MOL GENETICS; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ochsner UA, 1996, MOL MICROBIOL, V21, P1019, DOI 10.1046/j.1365-2958.1996.481425.x; Sainsbury S, 2009, NUCLEIC ACIDS RES, V37, P4545, DOI 10.1093/nar/gkp445; Sasse J, 2004, CURR PROTOC IMMUNOL, V8, P89; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; STOREY DG, 1990, MOL MICROBIOL, V4, P499, DOI 10.1111/j.1365-2958.1990.tb00616.x; Swanson BL, 2000, J BACTERIOL, V182, P4366, DOI 10.1128/JB.182.15.4366-4371.2000; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; WEST SEH, 1994, INFECT IMMUN, V62, P897, DOI 10.1128/IAI.62.3.897-903.1994	42	25	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e39390	10.1371/journal.pone.0039390	http://dx.doi.org/10.1371/journal.pone.0039390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844393	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700004
J	Guo, CJ; Yang, LS; Zhang, YF; Wu, YY; Weng, SP; Yu, XQ; He, JG				Guo, Chang-Jun; Yang, Li-Shi; Zhang, Ying-Fen; Wu, Yan-Yan; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			A Novel Viral SOCS from Infectious Spleen and Kidney Necrosis Virus: Interacts with Jak1 and Inhibits IFN-alpha Induced Stat1/3 Activation	PLOS ONE			English	Article							JANUS TYROSINE KINASE; SIGNALING PATHWAY; MOLECULAR EPIDEMIOLOGY; GENE-EXPRESSION; PROTEIN; FISH; SUPPRESSION; IDENTIFICATION; IRIDOVIRUS; BINDING	Interferon (IFN)-induced Janus kinase (Jak)/signal transducer and activator of transcription (Stat) pathway is important in controlling immune responses and is negatively response-regulated by the suppressor of cytokine signaling (SOCS) proteins. However, several viruses have developed various strategies to inhibit this pathway to circumvent the anti-viral immunity of the host. The infectious spleen and kidney necrosis virus (ISKNV) is the type species of the genus Megalocytivirus in the family Iridoviridae and a causative agent of epizootics in fish. ISKNV ORF103R encodes a predicted viral SOCS (vSOCS) with high homology to the vertebrate SOCS1, but lacks a SOCS-box domain. Interestingly, vSOCS only exists in the genus Megalocytivirus. ISKNV-vSOCS can block the IFN-alpha-induced Jak/Stat pathway in HepG2 cells. Over-expression of ISKNV-vSOCS inhibited the activities of IFN-stimulated response element (ISRE) promoter; however, the inhibitions by ISKNV-vSOCS were dose-dependent. ISKNV-vSOCS interacted with Jak1 protein and inhibited its tyrosine kinase activity in vitro. ISKNV-vSOCS also impaired the phosphorylation of Stat1 and Stat3 proteins and suppressed their activations. The point mutations (F18D, S66A, S85A, and R64K) of ISKNV-vSOCS significantly impaired the inhibition of IFN-alpha-induced ISRE-promoter activation. In conclusion, vSOCS inhibits IFN-alpha-induced Stat1/Stat3 signaling, suggesting that Megalocytivirus has developed a novel strategy to evade IFN anti-viral immunity via vSOCS protein.	[Guo, Chang-Jun; He, Jian-Guo] Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Chang-Jun; Yang, Li-Shi; Zhang, Ying-Fen; Wu, Yan-Yan; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Div Cell Biol & Biophys, Sch Biol Sci, Kansas City, MO 64110 USA	Sun Yat Sen University; Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	Guo, CJ (corresponding author), Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn	YU, XiaoQiang/GRJ-1077-2022; YU, XIAO-QIANG/AAL-1797-2021	YU, XIAO-QIANG/0000-0003-1419-9009	National Natural Science Foundation of China [U0631008, 31001123]; National Basic Research Program of China [2006CB101802]; National High Technology Research and Development Program of China (863 Program) [2006AA09Z445, 2006AA100309]; Priming Scientific Research Foundation for Junior Teachers in Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Priming Scientific Research Foundation for Junior Teachers in Sun Yat-sen University	This work was supported by the National Natural Science Foundation of China, under Grant Nos. U0631008 and 31001123; the National Basic Research Program of China, under Grant No. 2006CB101802; the National High Technology Research and Development Program of China (863 Program), under Grant Nos. 2006AA09Z445 and 2006AA100309; and the Priming Scientific Research Foundation for Junior Teachers in Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2006, VIROLOGY, V355, P213, DOI 10.1016/j.virol.2006.07.004; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Baetz A, 2008, FASEB J, V22, P4296, DOI 10.1096/fj.08-116079; Banes AK, 2004, AM J PHYSIOL-RENAL, V286, pF653, DOI 10.1152/ajprenal.00163.2003; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chinchar V.G., 2005, VIRUS TAXONOMY CLASS, P145; De Sepulveda P, 1999, EMBO J, V18, P904; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; Federici M, 2002, J IMMUNOL, V169, P434, DOI 10.4049/jimmunol.169.1.434; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Go J, 2006, MOL CELL PROBE, V20, P212, DOI 10.1016/j.mcp.2005.12.002; Guo CJ, 2009, FISH SHELLFISH IMMUN, V27, P349, DOI 10.1016/j.fsi.2009.06.001; Haan S, 2008, J IMMUNOL, V180, P998, DOI 10.4049/jimmunol.180.2.998; Harcourt BH, 1999, J VIROL, V73, P3491, DOI 10.1128/JVI.73.4.3491-3496.1999; He JG, 2001, VIROLOGY, V291, P126, DOI 10.1006/viro.2001.1208; He Jianguo, 1998, Acta Scientiarum Naturalium Universitatis Sunyatseni, V37, P74; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Hirano T, 2006, DEV CELL, V10, P542, DOI 10.1016/j.devcel.2006.04.011; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Jin HJ, 2008, MOL IMMUNOL, V45, P1258, DOI 10.1016/j.molimm.2007.09.015; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; KALVAKOLANU DVR, 1991, P NATL ACAD SCI USA, V88, P7459, DOI 10.1073/pnas.88.17.7459; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kim TJ, 2007, J FISH DIS, V30, P691, DOI 10.1111/j.1365-2761.2007.00856.x; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Li SY, 1999, ONCOGENE, V18, P5727, DOI 10.1038/sj.onc.1202960; Limnander A, 2004, MOL CELL, V15, P329, DOI 10.1016/j.molcel.2004.06.041; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Lu L, 2005, VIROLOGY, V339, P81, DOI 10.1016/j.virol.2005.05.021; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200; PAZDRAK K, 1995, J IMMUNOL, V155, P397; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sun BJ, 2007, VET IMMUNOL IMMUNOP, V116, P26, DOI 10.1016/j.vetimm.2007.01.001; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Terstegen L, 2001, J IMMUNOL, V167, P5209, DOI 10.4049/jimmunol.167.9.5209; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vidy A, 2005, J VIROL, V79, P14411, DOI 10.1128/JVI.79.22.14411-14420.2005; Wang YQ, 2007, ARCH VIROL, V152, P763, DOI 10.1007/s00705-006-0870-4; Williams T, 1996, ADV VIRUS RES, V46, P345, DOI 10.1016/S0065-3527(08)60076-7; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yeh TC, 1999, CELL MOL LIFE SCI, V55, P1523, DOI 10.1007/s000180050392; Yokota S, 2003, VIROLOGY, V306, P135, DOI 10.1016/S0042-6822(02)00026-0; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	62	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41092	10.1371/journal.pone.0041092	http://dx.doi.org/10.1371/journal.pone.0041092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844427	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700041
J	Muramatsu, D; Iwai, A; Aoki, S; Uchiyama, H; Kawata, K; Nakayama, Y; Nikawa, Y; Kusano, K; Okabe, M; Miyazaki, T				Muramatsu, Daisuke; Iwai, Atsushi; Aoki, Shiho; Uchiyama, Hirohumi; Kawata, Koji; Nakayama, Yosuke; Nikawa, Yasuhiro; Kusano, Kisato; Okabe, Mitsuyasu; Miyazaki, Tadaaki			beta-Glucan Derived from Aureobasidium pullulans Is Effective for the Prevention of Influenza in Mice	PLOS ONE			English	Article							A-VIRUS-INFECTION; COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; STRAIN BLACK YEAST; TOLL-LIKE RECEPTOR; ALVEOLAR MACROPHAGES; RIG-I; RNA VIRUSES; IMMUNE-RESPONSES; INTERFERON-ALPHA	beta-(1 -> 3)-D-glucans with beta-(1 -> 6)-glycosidic linked branches produced by mushrooms, yeast and fungi are known to be an immune activation agent, and are used in anti-cancer drugs or health-promoting foods. In this report, we demonstrate that oral administration of Aureobasidium pullulans-cultured fluid (AP-CF) enriched with the beta-(1 -> 3),(1 -> 6)-D-glucan exhibits efficacy to protect mice infected with a lethal titer of the A/Puerto Rico/8/34 (PR8; H1N1) strain of influenza virus. The survival rate of the mice significantly increased by AP-CF administration after sublethal infection of PR8 virus. The virus titer in the mouse lung homogenates was significantly decreased by AP-CF administration. No significant difference in the mRNA expression of inflammatory cytokines, and in the population of lymphocytes was observed in the lungs of mice administered with AP-CF. Interestingly, expression level for the mRNA of virus sensors, RIG-I (retinoic acid-inducible gene-I) and MDA5 (melanoma differentiation-associated protein 5) strongly increased at 5 hours after the stimulation of A. pullulans-produced purified beta-(1 -> 3),(1 -> 6)-D-glucan (AP-BG) in murine macrophage-derived RAW264.7 cells. Furthermore, the replication of PR8 virus was significantly repressed by pre-treatment of AP-BG. These findings suggest the increased expression of virus sensors is effective for the prevention of influenza by the inhibition of viral replication with the administration of AP-CF.	[Muramatsu, Daisuke; Aoki, Shiho; Nikawa, Yasuhiro] Aureo Sci Co Ltd, Sapporo, Hokkaido, Japan; [Iwai, Atsushi; Uchiyama, Hirohumi; Kawata, Koji; Nikawa, Yasuhiro; Kusano, Kisato; Okabe, Mitsuyasu] Aureo Co Ltd, Chiba, Japan; [Muramatsu, Daisuke; Iwai, Atsushi; Aoki, Shiho; Uchiyama, Hirohumi; Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Sapporo, Hokkaido, Japan; [Miyazaki, Tadaaki] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan; [Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Inst Med Genet, Res Sect Probiot Immunol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Muramatsu, D (corresponding author), Aureo Sci Co Ltd, Sapporo, Hokkaido, Japan.	miyazaki@pop.med.hokudai.ac.jp	Iwai, Atsushi/I-6469-2019	Iwai, Atsushi/0000-0002-1491-4693	Aureo Co., Ltd.; Aureo-Science Co., Ltd.; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases; Global COE Program Establishment of International Collaboration Centers for Zoonosis Control from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	Aureo Co., Ltd.; Aureo-Science Co., Ltd.; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program Establishment of International Collaboration Centers for Zoonosis Control from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was funded by by Aureo Co., Ltd., and Aureo-Science Co., Ltd. This work was supported, in part, by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases and Global COE Program Establishment of International Collaboration Centers for Zoonosis Control from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akramiene D, 2007, MEDICINA-LITHUANIA, V43, P597, DOI 10.3390/medicina43080076; Boyd M, 2006, MED J AUSTRALIA, V185, pS44; BROWN RG, 1967, ACTA CHEM SCAND, V21, P2383, DOI 10.3891/acta.chem.scand.21-2383; BROWN RG, 1967, ACTA CHEM SCAND, V21, P2379, DOI 10.3891/acta.chem.scand.21-2379; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Chaung HC, 2009, VET IMMUNOL IMMUNOP, V131, P147, DOI 10.1016/j.vetimm.2009.04.004; CHIHARA G, 1970, CANCER RES, V30, P2776; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Conti L, 2008, IMMUNOBIOLOGY, V213, P859, DOI 10.1016/j.imbio.2008.07.017; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Hamada N, 2000, BIOSCI BIOTECH BIOCH, V64, P1801, DOI 10.1271/bbb.64.1801; HASHIMOTO K, 1991, INT J IMMUNOPHARMACO, V13, P437, DOI 10.1016/0192-0561(91)90014-X; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Husser L, 2011, VIRUS RES, V159, P9, DOI 10.1016/j.virusres.2011.04.005; Ikewaki N, 2007, MICROBIOL IMMUNOL, V51, P861, DOI 10.1111/j.1348-0421.2007.tb03982.x; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; KATAOKASHIRASUGI N, 1994, BIOSCI BIOTECH BIOCH, V58, P2145, DOI 10.1271/bbb.58.2145; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Kimura Y, 2007, J PHARM PHARMACOL, V59, P1137, DOI 10.1211/jpp.59.8.0012; Kimura Y, 2007, INT IMMUNOPHARMACOL, V7, P963, DOI 10.1016/j.intimp.2007.03.003; Kimura Y, 2006, ANTICANCER RES, V26, P4131; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Liu JJ, 2009, RECENT PAT ANTI-CANC, V4, P101, DOI 10.2174/157489209788452858; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lynch JP, 2007, SEMIN RESP CRIT CARE, V28, P144, DOI 10.1055/s-2007-976487; MASHIBA H, 1979, GANN, V70, P687; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; McCaughey Conall, 2010, Ulster Med J, V79, P46; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Mok KP, 2009, J INFECT DIS, V200, P1104, DOI 10.1086/605606; Novak M., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P67; OHHASHI F, 1978, GANN, V69, P255; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Queiroz LS, 2010, INT IMMUNOPHARMACOL, V10, P34, DOI 10.1016/j.intimp.2009.09.015; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; SAKURAI T, 1992, INT J IMMUNOPHARMACO, V14, P821, DOI 10.1016/0192-0561(92)90080-5; Shimizu K, 2009, HEPATO-GASTROENTEROL, V56, P240; Sugiyama A, 2010, J VET MED SCI, V72, P755, DOI 10.1292/jvms.09-0526; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Uchiyama Hirofumi, 2012, BMC Res Notes, V5, P189, DOI 10.1186/1756-0500-5-189; Van Reeth K, 1998, J INFECT DIS, V177, P1076, DOI 10.1086/517398; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; YAMAMOTO T, 1981, Invasion and Metastasis, V1, P71; Yatawara L, 2009, KOREAN J PARASITOL, V47, P345, DOI 10.3347/kjp.2009.47.4.345; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, ADV DRUG DELIVER REV, V60, P841, DOI 10.1016/j.addr.2007.12.001; Yoon HS, 2010, J MICROBIOL BIOTECHN, V20, P438, DOI 10.4014/jmb.0905.05058; Zhou LD, 2009, INT IMMUNOPHARMACOL, V9, P455, DOI 10.1016/j.intimp.2009.01.010	60	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41399	10.1371/journal.pone.0041399	http://dx.doi.org/10.1371/journal.pone.0041399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844473	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700084
J	Ureshino, H; Murakami, Y; Watari, K; Izumi, H; Kawahara, A; Kage, M; Arao, T; Nishio, K; Yanagihara, K; Kinoshita, H; Kuwano, M; Ono, M				Ureshino, Hiroki; Murakami, Yuichi; Watari, Kosuke; Izumi, Hiroto; Kawahara, Akihiko; Kage, Masayoshi; Arao, Tokuzo; Nishio, Kazuto; Yanagihara, Kazuyoshi; Kinoshita, Hisafumi; Kuwano, Michihiko; Ono, Mayumi			N-myc Downstream Regulated Gene 1 (NDRG1) Promotes Metastasis of Human Scirrhous Gastric Cancer Cells through Epithelial Mesenchymal Transition	PLOS ONE			English	Article							PANCREATIC-CANCER; STOMACH-CANCER; TUMOR-GROWTH; EXPRESSION; PROGRESSION; SUPPRESSOR; FAMILY; ANGIOGENESIS; MICROARRAY; INHIBITOR	Our recent study demonstrated that higher expression of N-myc downregulated gene 1 (NDRG1) is closely correlated with poor prognosis in gastric cancer patients. In this study, we asked whether NDRG1 has pivotal roles in malignant progression including metastasis of gastric cancer cells. By gene expression microarray analysis expression of NDRG1 showed the higher increase among a total of 3691 up-regulated genes in a highly metastatic gastric cancer cell line (58As1) than their parental low metastatic counterpart (HSC-58). The highly metastatic cell lines showed decreased expression of E-cadherin, together with enhanced expression of vimentin and Snail. This decreased expression of E-cadherin was restored by Snail knockdown in highly metastatic cell lines. We next established stable NDRG1 knockdown cell lines (As1/Sic50 and As1/Sic54) from the highly metastatic cell line, and both of these cell lines showed enhanced expression of E-cadherin and decreased expression of vimentin and Snail. And also, E-cadherin promoter-driven luciferase activity was found to be increased by NDRG1 knockdown in the highly metastatic cell line. NDRG1 knockdown in gastric cancer cell showed suppressed invasion of cancer cells into surround tissues, suppressed metastasis to the peritoneum and decreased ascites accumulation in mice with significantly improved survival rates. This is the first study to demonstrate that NDRG1 plays its pivotal role in the malignant progression of gastric cancer through epithelial mesenchymal transition.	[Ureshino, Hiroki; Murakami, Yuichi; Watari, Kosuke; Ono, Mayumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 807, Japan; [Kawahara, Akihiko; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan; [Arao, Tokuzo; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Ureshino, Hiroki; Kinoshita, Hisafumi] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan; [Kuwano, Michihiko] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut, Lab Mol Canc Biol, Fukuoka 812, Japan	Kyushu University; University of Occupational & Environmental Health - Japan; Kurume University; Kindai University (Kinki University); National Cancer Center - Japan; Kurume University; Kyushu University	Ureshino, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan.	mono@phar.kyushu-u.ac.jp		Watari, Kosuke/0000-0003-0260-2323	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23300350] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Dr. Ono), and by the 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan (Dr. Kuwano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aomatsu K, 2012, INVEST OPHTH VIS SCI, V53, P751, DOI 10.1167/iovs.11-8222; Azuma K, 2012, J THORAC ON IN PRESS; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Chan ACO, 2003, J CLIN ONCOL, V21, P2288, DOI 10.1200/JCO.2003.08.078; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Hasegawa S, 2002, CANCER RES, V62, P7012; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Inagaki Y, 2009, DIGEST LIVER DIS, V41, P96, DOI 10.1016/j.dld.2008.04.003; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kawahara A, 2011, EXP THER MED, V2, P471, DOI 10.3892/etm.2011.222; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Masuda K, 2003, INT J CANCER, V105, P803, DOI 10.1002/ijc.11152; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Oliveira C, 2009, HUM MOL GENET, V18, P1545, DOI 10.1093/hmg/ddp046; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; Strumane K, 2004, HANDB EXP PHARM, V165, P69, DOI 10.1007/978-3-540-68170-0_4; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yanagihara K, 2006, CANCER RES, V66, P7532, DOI 10.1158/0008-5472.CAN-05-3259; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	35	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41312	10.1371/journal.pone.0041312	http://dx.doi.org/10.1371/journal.pone.0041312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844455	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700068
J	Wan, ZX; Ritchie, I; Beaudoin, MS; Castellani, L; Chan, CB; Wright, DC				Wan, Zhongxiao; Ritchie, Ian; Beaudoin, Marie-Soleil; Castellani, Laura; Chan, Catherine B.; Wright, David C.			IL-6 Indirectly Modulates the Induction of Glyceroneogenic Enzymes in Adipose Tissue during Exercise	PLOS ONE			English	Article							MUSCLE-DERIVED INTERLEUKIN-6; ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; MESSENGER-RNA; ADIPOCYTES; LIPOLYSIS; THIAZOLIDINEDIONES	Background: Glyceroneogenesis is an important step in the control of fatty acid re-esterification with PEPCK and PDK4 being identified as key enzymes in this process. We have previously shown that glyceroneogenic enzymes such as PDK4 are rapidly induced in white adipose tissue during exercise. Recent studies have suggested that IL-6 regulates adipose tissue metabolism and gene expression during exercise. Interestingly, IL-6 has been reported to directly decrease PEPCK expression. The purpose of this investigation was to determine the role of IL-6 in modulating the effects of exercise on the expression of glyceroneogenic enzymes in mouse adipose tissue. We hypothesized that the exercise-mediated induction of PDK4 and PEPCK would be greater in adipose tissue from IL-6 deficient mice compared to wild type controls. Methodology and Principle Findings: Treatment of cultured epididymal adipose tissue (eWAT) with IL-6 (150 ng/ml) increased the phosphorylation of AMPK, ACC and STAT3 and induced SOCS3 mRNA levels while decreasing PEPCK and PDK4 mRNA. AICAR decreased the expression of PDK4 and PEPCK. The activation of AMPK by IL-6 was independent of increases in lipolysis. An acute bout of treadmill running (15 meters/minute, 5% incline, 90 minutes) did not induce SOCS3 or increase phosphorylation of STAT3 in eWAT, indicating that IL-6 signalling was not activated. Exercise-induced increases in PEPCK and PDK4 mRNA expression were attenuated in eWAT from IL-6(-/-) mice in parallel with a greater relative increase in AMPK phosphorylation compared to exercised WT mice. These changes occurred independent of alterations in beta-adrenergic signalling in adipose tissue from IL-6(-/-) mice. Conclusions and Significance: Our findings question the role of IL-6 signalling in adipose tissue during exercise and suggest an indirect effect of this cytokine in the regulation of adipose tissue gene expression during exercise.	[Wan, Zhongxiao; Chan, Catherine B.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Ritchie, Ian; Beaudoin, Marie-Soleil; Castellani, Laura; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Alberta; University of Guelph	Wan, ZX (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	dcwright@uoguelph.ca	Chan, Catherine/C-1162-2011	Chan, Catherine/0000-0003-3882-0592; Wright, David/0000-0003-3867-8901	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This project was funded by a grant from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ian Ritchie was supported by a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship. Marie-Soleil Beaudoin received stipend support from an Ontario Graduate Scholarship. David C. Wright is a Canadian Diabetes Association Scholar and Tier II Canada Research Chair in Lipids, Metabolism and Health.	Brandt C, 2011, ACTA PHYSL OXF; Cadoudal T, 2007, DIABETOLOGIA, V50, P666, DOI 10.1007/s00125-006-0560-5; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Feingold KR, 2011, INNATE IMMUN; FranckhauserVogel S, 1997, J CELL BIOCHEM, V66, P386, DOI 10.1002/(SICI)1097-4644(19970901)66:3<386::AID-JCB10>3.0.CO;2-D; Fried S K, 2001, Methods Mol Biol, V155, P197; Fritsche L, 2010, DIABETOLOGIA, V53, P1732, DOI 10.1007/s00125-010-1754-4; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ji C, 2011, J BIOENERG BIOMEMBR; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Leroyer S, 2011, J LIPID RES, V52, P207, DOI 10.1194/jlr.M000869; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Nielsen NB, 2009, REGUL PEPTIDES, V155, P39, DOI 10.1016/j.regpep.2009.04.010; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen L, 2012, AM J PHYSIOL-ENDOC M, V302, pE831, DOI 10.1152/ajpendo.00339.2011; Pedersen L, 2011, J PHYSIOL-LONDON, V589, P1409, DOI 10.1113/jphysiol.2010.200733; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RESHEFF L, 1970, J BIOL CHEM, V245, P5979; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; ROGNSTAD R, 1966, P NATL ACAD SCI USA, V55, P1148, DOI 10.1073/pnas.55.5.1148; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Tchivileva IE, 2009, MOL IMMUNOL, V46, P2256, DOI 10.1016/j.molimm.2009.04.008; Thomson DM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1572, DOI 10.1152/ajpendo.00371.2007; Thonberg H, 2002, BIOCHEM J, V364, P73, DOI 10.1042/bj3640073; Wan Z, 2011, OBESITY SILVER SPRIN; Wan ZX, 2010, AM J PHYSIOL-CELL PH, V299, pC1162, DOI 10.1152/ajpcell.00188.2010; Wang T, 2003, OBES RES, V11, P880, DOI 10.1038/oby.2003.121; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang YQ, 2010, BIOCHEM CELL BIOL, V88, P853, DOI [10.1139/O10-116, 10.1139/o10-116]; Zhang J, 2011, ENDOCRINOLOGY, V152, P1829, DOI 10.1210/en.2010-0828	38	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41719	10.1371/journal.pone.0041719	http://dx.doi.org/10.1371/journal.pone.0041719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844518	gold, Green Published			2022-12-27	WOS:000306687700144
J	Gomes, CC; Diniz, MG; Orsine, LA; Duarte, AP; Fonseca-Silva, T; Conn, BI; De Marco, L; Pereira, CM; Gomez, RS				Gomes, Carolina Cavalieri; Diniz, Marina Goncalves; Orsine, Lissur Azevedo; Duarte, Alessandra Pires; Fonseca-Silva, Thiago; Conn, Brendan I.; De Marco, Luiz; Pereira, Claudia Maria; Gomez, Ricardo Santiago			Assessment of TP53 Mutations in Benign and Malignant Salivary Gland Neoplasms	PLOS ONE			English	Article							EX-PLEOMORPHIC ADENOMA; TUMOR-SUPPRESSOR GENE; PROTEIN ACCUMULATION; BCL-2 EXPRESSION; BREAST-TISSUE; P53 MUTATIONS; CANCER; CARCINOMAS; HEAD; SUSCEPTIBILITY	Despite advances in the understanding of the pathogenesis of salivary gland neoplasms (SGN), the molecular pathways associated with enhanced tumor growth and cell survival remain to be established. The aim of the present study was to investigate whether TP53 mutations are relevant to SGN pathogenesis and if they impact on p53 protein expression. The study included 18 benign and 18 malignant SGN samples. Two polymorphic microsatellite markers at the TP53 genetic locus were chosen to assess loss of heterozygosity (LOH) in the samples that had matched normal DNA. The TP53 exons 2-11 were amplified by PCR, and all of the products were sequenced. Reverse transcription-PCR of the TP53 open reading frame (ORF) was carried out in the samples that had fresh tissue available, and immunohistochemistry for the p53 protein was performed in all samples. TP53 LOH was only found in two pleomorphic adenomas. We found two missense mutations in exon 7 (one in a pleomorphic adenoma and the other in a polymorphous low grade adenocarcinoma), another in exon 8 (in a carcinoma ex pleomorphic adenoma) and a fourth missense mutation in exon 10 (in a mucoepidermoid carcinoma). In addition, a nonsense mutation was found in exon 8 of an adenoid cystic carcinoma. Several intronic and exonic SNPs were detected. Although almost all of the malignant samples were immunopositive for p53, approximately 37% of the benign samples were positive, including the sample harboring the missense mutation and one of the samples that showed LOH. The complete TP53 ORF could be amplified in all samples analyzed, including the IHC negative samples, the samples showing LOH and one sample displaying a missense mutation. In summary, our results show that TP53 mutations are not a frequent event in SGN and that p53 immunopositivity might not be associated with sequence mutations in SGN.	[Gomes, Carolina Cavalieri] Univ Fed Minas Gerais, Inst Biol Sci, Dept Pathol, Belo Horizonte, MG, Brazil; [Diniz, Marina Goncalves; Orsine, Lissur Azevedo; Duarte, Alessandra Pires; Fonseca-Silva, Thiago; Pereira, Claudia Maria; Gomez, Ricardo Santiago] Univ Fed Minas Gerais, Dept Oral Surg & Pathol, Sch Dent, Belo Horizonte, MG, Brazil; [Conn, Brendan I.] Royal Infirm Edinburgh NHS Trust, Dept Pathol, Edinburgh, Midlothian, Scotland; [De Marco, Luiz] Univ Fed Minas Gerais, Dept Surg, Sch Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Royal Infirmary of Edinburgh; University of Edinburgh; Universidade Federal de Minas Gerais	Gomes, CC (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Pathol, Belo Horizonte, MG, Brazil.	carolinacgomes@ufmg.br	Pereira, Claudia/J-4359-2014; Gomes, Carolilna C/D-1807-2018; Gomez, Ricardo Santiago/G-1976-2012; GOMES, CAROLINA/C-9072-2015	Gomez, Ricardo Santiago/0000-0001-8770-8009; Goncalves Diniz, Marina/0000-0002-4212-1172; GOMES, CAROLINA/0000-0003-1580-4995	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein DJ, 2011, CURR OPIN ONCOL, V23, P249, DOI 10.1097/CCO.0b013e328344f59c; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Andrews GA, 2004, HEAD NECK-J SCI SPEC, V26, P870, DOI 10.1002/hed.20029; Augello C, 2006, J CELL PHYSIOL, V207, P654, DOI 10.1002/jcp.20601; Ben-Izhak O, 2009, CANCER BIOMARK, V5, P23, DOI 10.3233/CBM-2009-0567; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Castillo-Davis CI, 2005, TRENDS GENET, V21, P533, DOI 10.1016/j.tig.2005.08.001; de Oliveira FA, 2009, HEAD NECK PATHOL, V3, P271, DOI 10.1007/s12105-009-0139-9; Debaere D, 2011, B-ENT, V7, P1; El-Naggar AK, 2000, GENE CHROMOSOME CANC, V27, P162, DOI 10.1002/(SICI)1098-2264(200002)27:2<162::AID-GCC7>3.0.CO;2-9; Eveson JW, 2005, WORLD HLTH ORG CLASS, P212; Fowler MH, 2006, MODERN PATHOL, V19, P350, DOI 10.1038/modpathol.3800533; Gedlicka C, 2010, J SURG ONCOL, V101, P127, DOI 10.1002/jso.21444; Giefing M, 2008, NEOPLASMA, V55, P55; Gomes CC, 2011, ORAL DIS, V17, P564, DOI 10.1111/j.1601-0825.2011.01802.x; Hrstka R, 2009, J CELL MOL MED, V13, P440, DOI 10.1111/j.1582-4934.2008.00634.x; Ito FA, 2005, INT J ORAL MAX SURG, V34, P533, DOI 10.1016/j.ijom.2005.02.005; Johns MM, 1996, CANCER RES, V56, P1151; Kandel R, 2000, INT J CANCER, V87, P73, DOI 10.1002/1097-0215(20000701)87:1<73::AID-IJC11>3.0.CO;2-U; Karja VJ, 1997, J ORAL PATHOL MED, V26, P217, DOI 10.1111/j.1600-0714.1997.tb01227.x; Kishi M, 2005, ORAL ONCOL, V41, P161, DOI 10.1016/j.oraloncology.2004.08.004; Kiyoshima T, 2001, ORAL ONCOL, V37, P315, DOI 10.1016/S1368-8375(00)00083-X; Kontogeorgos G, 1999, Pituitary, V1, P207, DOI 10.1023/A:1009929704018; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lamolle G, 2006, MUTAT RES-FUND MOL M, V600, P102, DOI 10.1016/j.mrfmmm.2006.03.004; Leedham SJ, 2009, GASTROENTEROLOGY, V136, P542, DOI 10.1053/j.gastro.2008.10.086; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Matizonkas-Antonio Luciana Fasanella, 2005, Braz. Dent. J., V16, P162, DOI 10.1590/S0103-64402005000200014; Moore D, 1998, HISTOPATHOLOGY, V32, P35; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Renehan AG, 1999, BRIT J CANCER, V80, P1296, DOI 10.1038/sj.bjc.6690501; Rohan TE, 2006, CANCER EPIDEM BIOMAR, V15, P1316, DOI 10.1158/1055-9965.EPI-06-0195; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Ueno T, 2012, CANCER SCI, V103, P131, DOI 10.1111/j.1349-7006.2011.02105.x; van Houten VMM, 2000, CLIN CANCER RES, V6, P3803; Weber A, 2002, VIRCHOWS ARCH, V441, P428, DOI 10.1007/s00428-002-0705-y; Yamamoto Y, 1996, HUM PATHOL, V27, P782, DOI 10.1016/S0046-8177(96)90449-9; Yoshimoto T, 1998, J ENDOCRINOL, V159, P247, DOI 10.1677/joe.0.1590247	38	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41261	10.1371/journal.pone.0041261	http://dx.doi.org/10.1371/journal.pone.0041261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829934	gold, Green Published, Green Submitted			2022-12-27	WOS:000306956300073
J	Pound, LD; Sarkar, SA; Ustione, A; Dadi, PK; Shadoan, MK; Lee, CE; Walters, JA; Shiota, M; McGuinness, OP; Jacobson, DA; Piston, DW; Hutton, JC; Powell, DR; O'Brien, RM				Pound, Lynley D.; Sarkar, Suparna A.; Ustione, Alessandro; Dadi, Prasanna K.; Shadoan, Melanie K.; Lee, Catherine E.; Walters, Jay A.; Shiota, Masakazu; McGuinness, Owen P.; Jacobson, David A.; Piston, David W.; Hutton, John C.; Powell, David R.; O'Brien, Richard M.			The Physiological Effects of Deleting the Mouse Slc30a8 Gene Encoding Zinc Transporter-8 Are Influenced by Gender and Genetic Background	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELL; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; IN-VIVO; RISK LOCI; MICE; ZNT8; EXPRESSION; VARIANTS	Objective: The SLC30A8 gene encodes the islet-specific transporter ZnT-8, which is hypothesized to provide zinc for insulin-crystal formation. A polymorphic variant in SLC30A8 is associated with altered susceptibility to type 2 diabetes. Several groups have examined the effect of global Slc30a8 gene deletion but the results have been highly variable, perhaps due to the mixed 129SvEv/C57BL/6J genetic background of the mice studied. We therefore sought to remove the conflicting effect of 129SvEv-specific modifier genes. Methods: The impact of Slc30a8 deletion was examined in the context of the pure C57BL/6J genetic background. Results: Male C57BL/6J Slc30a8 knockout (KO) mice had normal fasting insulin levels and no change in glucose-stimulated insulin secretion (GSIS) from isolated islets in marked contrast to the similar to 50% and similar to 35% decrease, respectively, in both parameters observed in male mixed genetic background Slc30a8 KO mice. This observation suggests that 129SvEv-specific modifier genes modulate the impact of Slc30a8 deletion. In contrast, female C57BL/6J Slc30a8 KO mice had reduced (similar to 20%) fasting insulin levels, though this was not associated with a change in fasting blood glucose (FBG), or GSIS from isolated islets. This observation indicates that gender also modulates the impact of Slc30a8 deletion, though the physiological explanation as to why impaired insulin secretion is not accompanied by elevated FBG is unclear. Neither male nor female C57BL/6J Slc30a8 KO mice showed impaired glucose tolerance. Conclusions: Our data suggest that, despite a marked reduction in islet zinc content, the absence of ZnT-8 does not have a substantial impact on mouse physiology.	[Pound, Lynley D.; Ustione, Alessandro; Dadi, Prasanna K.; Shiota, Masakazu; McGuinness, Owen P.; Jacobson, David A.; Piston, David W.; O'Brien, Richard M.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Shadoan, Melanie K.; Powell, David R.] Lexicon Pharmaceut Inc, The Woodlands, TX USA; [Sarkar, Suparna A.; Lee, Catherine E.; Walters, Jay A.; Hutton, John C.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Hlth Sci Ctr, Aurora, CO USA	Vanderbilt University; Lexicon Pharmaceuticals; University of Colorado System; University of Colorado Anschutz Medical Campus	Pound, LD (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	richard.obrien@vanderbilt.edu		Jacobson, David A./0000-0003-1816-5375	National Institutes of Health (NIH) [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126, DK92589, DK052068, DK085064, DK043748, DK078188, DK080193, P60 DK20593]; American Diabetes Association [9901-116]; Juvenile Diabetes Research Association [4-2007-1056]; Barbara Davis Center Diabetes and Endocrinology Research Center [P30 DK57516]; JDRF [1-2008-1021]; Vanderbilt Molecular Endocrinology Training Program [5T32 DK07563];  [K01 DK081666]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, K01DK080193, P30DK057516, K01DK081666, R01DK043748, R01DK092589, R56DK043748, R01DK078188, R56DK052068, P30DK020593, U24DK059637, R01DK085064, U2CDK059637, R01DK052068, T32DK007563, P30DK058404, R29DK043748] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Association; Barbara Davis Center Diabetes and Endocrinology Research Center; JDRF(Juvenile Diabetes Research Foundation); Vanderbilt Molecular Endocrinology Training Program; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Vanderbilt Hormone Assay & Analytical Services Core and the Vanderbilt Islet Procurement and Analysis Core are both supported by National Institutes of Health (NIH) grants DK20593, to the Vanderbilt Diabetes Research Training Center (VDRTC), and DK59637, to the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC). The authors also thank personnel in the MMPC for advice on performing glucose tolerance tests and Mary Dawes for performing electron microscopy. The electron microscopy core is part of the VUMC Cell Imaging Shared Resource, which is supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126. Research in the laboratory of RO was supported by NIH grant DK92589. Research in the laboratory of JCH was supported by the American Diabetes Association (9901-116), NIH grant DK052068, Juvenile Diabetes Research Association grant 4-2007-1056 and the Barbara Davis Center Diabetes and Endocrinology Research Center (P30 DK57516). Research in the laboratory of DWP was supported by NIH grant DK085064. Research in the laboratory of DAJ was supported by K01 DK081666. Research in the laboratory of OPM was supported by NIH grants DK043748 and DK078188. SAS was supported by NIH grant DK080193 and JDRF grant 1-2008-1021. The Vanderbilt Hormone Assay & Analytical Services Core, the Vanderbilt Islet Procurement and Analysis Core and the Vanderbilt Cell Imaging Shared Resource are all supported by NIH grant P60 DK20593, to the Vanderbilt Diabetes Research Training Center (VDRTC). LDP was supported by the Vanderbilt Molecular Endocrinology Training Program grant 5T32 DK07563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; CIARALDI TP, 1990, HORM METAB RES, V22, P283, DOI 10.1055/s-2007-1004903; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; HAVU N, 1977, ACTA ENDOCRINOL-COP, V86, P570, DOI 10.1530/acta.0.0860570; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Klempt M, 2006, MAMM GENOME, V17, P93, DOI 10.1007/s00335-005-0119-7; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Pound LD, 2011, BIOCHEM J, V433, P95, DOI 10.1042/BJ20101488; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Rutter GA, 2010, ISLETS, V2, P49, DOI 10.4161/isl.2.1.10259; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Talchai C, 2009, DIABETES OBES METAB, V11, P38, DOI 10.1111/j.1463-1326.2009.01115.x; van de Bunt M, 2010, CURR DIABETES REP, V10, P452, DOI 10.1007/s11892-010-0150-2; Wenzlau JM, 2008, DIABETES, V57, P2693, DOI 10.2337/db08-0522; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Xu KF, 2011, DIABETES RES CLIN PR, V91, P195, DOI 10.1016/j.diabres.2010.11.012; Young GS, 2007, APPL PHYSIOL NUTR ME, V32, P161, DOI 10.1139/H06-082; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou HR, 2007, DIABETES, V56, P1107, DOI 10.2337/db06-1454	42	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40972	10.1371/journal.pone.0040972	http://dx.doi.org/10.1371/journal.pone.0040972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829903	Green Published, gold, Green Submitted			2022-12-27	WOS:000306956300041
J	Lagergren, J; Mattson, F				Lagergren, Jesper; Mattson, Fredrik			Diverging Trends in Recent Population-Based Survival Rates in Oesophageal and Gastric Cancer	PLOS ONE			English	Article							CARDIA CANCER; ADENOCARCINOMAS; SWEDEN; SEX	Background: Survival trends in oesophageal and gastric cancer need to be updated. A nationwide Swedish population-based study in 1961-2009 was based on registry data. Methodology/Principal Findings: Relative survival rate, i.e. the ratio of the observed to the expected survival, adjusted for age, sex, and calendar period, and presented with 95% confidence intervals (CI), was the main outcome measure. The expected survival was calculated using the corresponding Swedish general population with no exclusions. The relative survival rates in oesophageal and gastric cardia adenocarcinoma have improved since the 1990s (p for trend <0.001), but not in oesophageal squamous cell carcinoma or gastric non-cardia adenocarcinoma. The relative 5-year survival rates during the two recent periods 1990-1999 and 2000-2008 were 12.5% (95% CI 10.1%-14.9%) and 10.3% (95% CI 8.5-12.0%) for oesophageal squamous cell carcinoma, 12.5% (95% CI 10.1%-14.9%) and 14.6% (95% CI 12.6-16.6%) for oesophageal adenocarcinoma, 11.1% (95% CI 9.6%-12.6%) and 14.3% (95% CI 12.3-16.3%) for gastric cardia adenocarcinoma, and 20.2% (95% CI 19.2%-21.1%) and 19.0% (95% CI 17.7-20.2%) for gastric non-cardia adenocarcinoma. The 3-year survival in tumour stage III in 2004-2008 was about 25% for all four tumour types. Conclusions/Significance: The survival in oesophageal and cardia adenocarcinoma is increasing, but the lack of such increase in oesophageal squamous cell carcinoma and gastric non-cardia adenocarcinoma is a concern.	[Lagergren, Jesper; Mattson, Fredrik] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London, England	Karolinska Institutet; University of London; King's College London	Lagergren, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	jesper.lagergren@ki.se		Lagergren, Jesper/0000-0002-5143-5448	Swedish Research Council [80749601]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Swedish Research Council (ID 80749601), (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Crane SJ, 2008, MAYO CLIN PROC, V83, P1087, DOI 10.4065/83.10.1087; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; Davies AR, 2006, DIS ESOPHAGUS, V19, P496, DOI 10.1111/j.1442-2050.2006.00629.x; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114; Lagergren J, 2011, INT J CANCER, V129, P513, DOI 10.1002/ijc.25701; Lindblad M, 2006, ANN SURG, V243, P479, DOI 10.1097/01.sla.0000205825.34452.43; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Stitzenberg KB, 2010, ANN SURG ONCOL, V17, P2824, DOI 10.1245/s10434-010-1159-0; Sundelof M, 2002, INT J CANCER, V99, P751, DOI 10.1002/ijc.10420; Sundelof M, 2008, EUR J CANCER, V44, P1566, DOI 10.1016/j.ejca.2008.04.002; Whitson BA, 2010, J THORAC CARDIOV SUR, V139, P43, DOI 10.1016/j.jtcvs.2009.04.011; Wouters MWJM, 2009, ANN SURG ONCOL, V16, P1789, DOI 10.1245/s10434-009-0458-9	17	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41352	10.1371/journal.pone.0041352	http://dx.doi.org/10.1371/journal.pone.0041352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815994	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900112
J	Xu, Q; Ma, PQ; Hu, CF; Chen, LC; Xue, LY; Wang, ZZ; Liu, M; Zhu, HX; Xu, NZ; Lu, N				Xu, Qing; Ma, Peiqing; Hu, Chenfei; Chen, Lechuang; Xue, Liyan; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi; Lu, Ning			Overexpression of the DEC1 Protein Induces Senescence In Vitro and Is Related to Better Survival in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTION FACTOR; EXPRESSION; STRA13; CANCER; BARRIER; P21(WAF1/CIP1); GENE; DIFFERENTIATION; TUMORIGENESIS	Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related death in China and has limited effective therapeutic options except for early surgery, since the underlying molecular mechanism driving its precursor lesions towards invasive ESCC is not fully understood. Cellular senescence is the state of the permanent growth arrest of a cell, and is considered as the initial barrier of tumor development. Human differentiated embryo chondrocyte expressed gene 1 (Dec1) is an important transcription factor that related to senescence. In this study, DEC1 immunohistochemical analysis was performed on tissue microarray blocks constructed from ESCC combined with adjacent precursor tissues of 241 patients. Compared with normal epithelia, DEC1 expression was significantly increased in intraepithelial neoplasia and DEC1 expression was significantly decreased in ESCC in comparison with intraepithelial neoplasia. In vitro, DEC1 overexpression induced cellular senescence, and it inhibited cell growth and colony formation in ESCC cell line EC9706. Fresh esophagectomy tissue sections from five ESCC patients were detected by immunohistochemistry of DEC1 and senescence-associated beta-galactosidase (SA-beta-Gal) activity, and strongly positive expression of DEC1 was correlated to more senescent cells in these fresh tissue sections. Kaplan - Meier method analysis of the 241 patients revealed that DEC1 expression levels were significantly correlated with the survival of ESCC patients after surgery. The expression levels of DEC1 were also correlated with age, tumor embolus, depth of invasion of ESCC, lymph metastasis status and pTNMs. These results suggest that DEC1 overexpression in precursor lesions of ESCC is a protective mechanism by inducing cellular senescence in ESCC initiation, and DEC1 may be a potential prognostic marker of ESCC.	[Xu, Qing; Hu, Chenfei; Chen, Lechuang; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [Xu, Qing; Hu, Chenfei; Chen, Lechuang; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Xu, Qing; Ma, Peiqing; Hu, Chenfei; Chen, Lechuang; Xue, Liyan; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi; Lu, Ning] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Peiqing; Xue, Liyan; Lu, Ning] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xu, Q (corresponding author), Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	ningzhi.xu@gmail.com; nlu03@126.com	Chen, Lechuang/AAF-8351-2020; Wang, Chengshu/A-1656-2011; Xiao, Guohua/G-3083-2013	Wang, Chengshu/0000-0003-1477-1466; Xiao, Guohua/0000-0003-3407-2734	National Natural Science Foundation [81021061, 31171322, 30770973, 39925020]; 863 Project grant [2006AA02A403]; Basic Research Program of CICAMS [JK2011B26]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 863 Project grant; Basic Research Program of CICAMS	This work was funded by National Natural Science Foundation (81021061, 31171322, 30770973, 39925020) (http://www.nsfc.gov.cn/), 863 Project grant (2006AA02A403) (http://www.863.gov.cn/), Basic Research Program of CICAMS (JK2011B26) (http://www.cicams.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campo-Trapero J, 2008, ACTA ONCOL, V47, P1464, DOI 10.1080/02841860802183612; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Chandeck C, 2010, ADV ANAT PATHOL, V17, P42, DOI 10.1097/PAP.0b013e3181c66f4e; Chang MS, 2005, PATHOL RES PRACT, V201, P417, DOI 10.1016/j.prp.2005.04.005; Chen X, 2002, CELL RES, V12, P229, DOI 10.1038/sj.cr.7290129; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cohen DJ, 2011, EXPERT OPIN PHARMACO, V12, P225, DOI 10.1517/14656566.2010.517748; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Decottignies A, 2011, SEMIN CANCER BIOL, V21, P360, DOI 10.1016/j.semcancer.2011.09.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Guillaumond F, 2008, BIOCHEM BIOPH RES CO, V369, P1184, DOI 10.1016/j.bbrc.2008.03.009; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; OGASAWARA S, 1995, CANCER RES, V55, P891; Ohbu M, 2001, HISTOPATHOLOGY, V39, P589, DOI 10.1046/j.1365-2559.2001.01279.x; Ohtani N, 2012, EXP DERMATOL, V21, P1, DOI 10.1111/j.1600-0625.2012.01493.x; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Sakai N, 2010, DIS ESOPHAGUS, V23, P415, DOI 10.1111/j.1442-2050.2009.01026.x; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shi XH, 2011, WORLD J GASTROENTERO, V17, P2037, DOI 10.3748/wjg.v17.i15.2037; Shirakawa Y, 2000, CLIN CANCER RES, V6, P541; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Tsai MH, 2011, ANN SURG ONCOL, V18, P2662, DOI 10.1245/s10434-011-1603-9; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vallbohmer D, 2006, DIS ESOPHAGUS, V19, P425, DOI 10.1111/j.1442-2050.2006.00622.x; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Wang WB, 2010, BIOCHEM BIOPH RES CO, V401, P422, DOI 10.1016/j.bbrc.2010.09.070; Xue L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-296; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	57	34	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41862	10.1371/journal.pone.0041862	http://dx.doi.org/10.1371/journal.pone.0041862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22937093	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700160
J	Hosseinzadeh, F; Ebrahimi, M; Goliaei, B; Shamabadi, N				Hosseinzadeh, Faezeh; Ebrahimi, Mansour; Goliaei, Bahram; Shamabadi, Narges			Classification of Lung Cancer Tumors Based on Structural and Physicochemical Properties of Proteins by Bioinformatics Models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; ARTIFICIAL NEURAL-NETWORKS; GENE-EXPRESSION DATA; AMINO-ACID-SEQUENCE; SUBCELLULAR-LOCALIZATION; PREDICTION; HYDROPHOBICITY; MICROARRAY; FEATURES; FAMILY	Rapid distinction between small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) tumors is very important in diagnosis of this disease. Furthermore sequence-derived structural and physicochemical descriptors are very useful for machine learning prediction of protein structural and functional classes, classifying proteins and the prediction performance. Herein, in this study is the classification of lung tumors based on 1497 attributes derived from structural and physicochemical properties of protein sequences (based on genes defined by microarray analysis) investigated through a combination of attribute weighting, supervised and unsupervised clustering algorithms. Eighty percent of the weighting methods selected features such as autocorrelation, dipeptide composition and distribution of hydrophobicity as the most important protein attributes in classification of SCLC, NSCLC and COMMON classes of lung tumors. The same results were observed by most tree induction algorithms while descriptors of hydrophobicity distribution were high in protein sequences COMMON in both groups and distribution of charge in these proteins was very low; showing COMMON proteins were very hydrophobic. Furthermore, compositions of polar dipeptide in SCLC proteins were higher than NSCLC proteins. Some clustering models (alone or in combination with attribute weighting algorithms) were able to nearly classify SCLC and NSCLC proteins. Random Forest tree induction algorithm, calculated on leaves one-out and 10-fold cross validation) shows more than 86% accuracy in clustering and predicting three different lung cancer tumors. Here for the first time the application of data mining tools to effectively classify three classes of lung cancer tumors regarding the importance of dipeptide composition, autocorrelation and distribution descriptor has been reported.	[Hosseinzadeh, Faezeh] Univ Tehran, Lab Biophys & Mol Biol, Inst Biochem & Biophys, Tehran, Iran; [Ebrahimi, Mansour] Univ Qom, Dept Biol, Basic Sci Sch, Qom, Iran; [Ebrahimi, Mansour; Shamabadi, Narges] Univ Qom, Bioinformat Res Grp, Green Res Ctr, Qom, Iran; [Goliaei, Bahram] Iran Univ Med Sci, Dept Med Phys, Tehran, Iran	University of Tehran; Iran University of Medical Sciences	Hosseinzadeh, F (corresponding author), Univ Tehran, Lab Biophys & Mol Biol, Inst Biochem & Biophys, Tehran, Iran.	mebrahimi14@gmail.com	ebrahimi, mansour/D-9950-2011; hosseinzadeh, faezeh/GNH-2600-2022; Ebrahimi, Mansour/AAO-9096-2021; Ebrahimie, Esmaeil/AAN-2611-2020	Ebrahimi, Mansour/0000-0001-7011-2567; Ebrahimie, Esmaeil/0000-0002-4431-2861; Shamabadi, Narges Sadat/0000-0003-0906-9445; Hosseinzadeh, Faezeh/0000-0002-7990-3805				Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Alvarez-Chaver P, 2007, INT J BIOCHEM CELL B, V39, P529, DOI 10.1016/j.biocel.2006.10.001; Anagnostou VK, 2011, CANCER; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Balasubramanian D, 2007, P ANN INT IEEE EMBS, P2134, DOI 10.1109/IEMBS.2007.4352744; Barash O, 2011, NANOMEDICINE; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Bhaskaran, 1988, INT J PEPT PROTEIN R; BIGELOW CC, 1967, J THEOR BIOL, V16, P187, DOI 10.1016/0022-5193(67)90004-5; Bock JR, 2003, BIOINFORMATICS, V19, P125, DOI 10.1093/bioinformatics/19.1.125; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; BROTO P, 1984, EUR J MED CHEM, V19, P71; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Caballero J, 2007, J MOL GRAPH MODEL, V26, P166, DOI 10.1016/j.jmgm.2006.11.002; Cai CZ, 2004, PROTEINS, V55, P66, DOI 10.1002/prot.20045; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Chan EC, 2005, CANCER GENET CYTOGEN, V162, P10, DOI 10.1016/j.cancergencyto.2005.03.008; CHARTON M, 1981, J THEOR BIOL, V91, P115, DOI 10.1016/0022-5193(81)90377-5; CHARTON M, 1982, J THEOR BIOL, V99, P629, DOI 10.1016/0022-5193(82)90191-6; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 2006, J PROTEOME RES, V5, P316, DOI 10.1021/pr050331g; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Chou KC, 2006, BIOCHEM BIOPH RES CO, V347, P150, DOI 10.1016/j.bbrc.2006.06.059; CID H, 1992, PROTEIN ENG, V5, P373, DOI 10.1093/protein/5.5.373; Crimins F, 2003, CAMDA 03; Cui J, 2007, MOL IMMUNOL, V44, P866, DOI 10.1016/j.molimm.2006.04.001; Dayhoff H, 1987, ATLAS PROTEIN SEQUEN, P363; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Fu XJ, 2003, IEEE T SYST MAN CY B, V33, P399, DOI 10.1109/TSMCB.2003.810911; Furney SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-3; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gromiha MM, 2008, PROTEINS, V70, P1274, DOI 10.1002/prot.21616; Guan P, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-103; Guan PP, 2005, J MED CHEM, V48, P7418, DOI 10.1021/jm0505258; Guo J, 2006, BIOINFORMATICS, V22, P1784, DOI 10.1093/bioinformatics/btl180; Han LY, 2004, NUCLEIC ACIDS RES, V32, P6437, DOI 10.1093/nar/gkh984; Han LY, 2004, RNA, V10, P355, DOI 10.1261/rna.5890304; Hjertman M, 2001, BIOCHEM BIOPH RES CO, V288, P736, DOI 10.1006/bbrc.2001.5830; HORNE DS, 1988, BIOPOLYMERS, V27, P451, DOI 10.1002/bip.360270308; Hu YC, 2002, ONCOGENE, V21, P7289, DOI 10.1038/sj.onc.1205805; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kligerman S, 2010, AM J ROENTGENOL, V194, P562, DOI 10.2214/AJR.09.3354; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Lo SL, 2005, PROTEOMICS, V5, P876, DOI 10.1002/pmic.200401118; Marchevsky AM, 2004, J MOL DIAGN, V6, P28, DOI 10.1016/S1525-1578(10)60488-6; Markey MK, 2003, PROTEOMICS, V3, P1678, DOI 10.1002/pmic.200300521; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Nevins Joseph R, 2011, Proc Am Thorac Soc, V8, P180, DOI 10.1513/pats.201006-040MS; Nguyen AN, 2010, J AM MED INFORM ASSN, V17, P440, DOI 10.1136/jamia.2010.003707; Nie Guang-jin, 2009, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V27, P257; Nitta N, 1998, TISSUE ELASTICITY IM; Ong SAK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-300; Raj V, 2011, CURR PROBL DIAGN RAD, V40, P85, DOI 10.1067/j.cpradiol.2010.02.002; Rustici G. R., 2008, CURR PROTOC BIOINFOR; SCHNEIDER G, 1994, BIOPHYS J, V66, P335, DOI 10.1016/S0006-3495(94)80782-9; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Tanney A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-20; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; Travis WD, 2011, SEMIN ROENTGENOL, V46, P178, DOI 10.1053/j.ro.2011.02.003; van Rijt SH, 2010, J MED CHEM, V53, P840, DOI 10.1021/jm901556u; Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223; Wrona Anna, 2010, Pneumonol Alergol Pol, V78, P407; Xi LL, 2010, J THEOR BIOL, V264, P1159, DOI 10.1016/j.jtbi.2010.03.042; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yanagawa N, 2007, LUNG CANCER, V58, P131, DOI 10.1016/j.lungcan.2007.05.011; Yang Yan, 2008, Zhonghua Zhongliu Zazhi, V30, P616	76	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40017	10.1371/journal.pone.0040017	http://dx.doi.org/10.1371/journal.pone.0040017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	29161736	Green Published, Green Submitted, gold			2022-12-27	WOS:000306956300010
J	Jin, XM; Ishii, H; Bai, ZB; Itokazu, T; Yamashita, T				Jin, Xuemei; Ishii, Hiroshi; Bai, Zhongbin; Itokazu, Takahide; Yamashita, Toshihide			Temporal Changes in Cell Marker Expression and Cellular Infiltration in a Controlled Cortical Impact Model in Adult Male C57BL/6 Mice	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CERVICAL LYMPH-NODES; FUNCTIONAL RECOVERY; IMMUNE-RESPONSE; T-CELLS; INFLAMMATION; MICROGLIA; SYSTEM; CNS	Background: Traumatic injury to the central nervous system (CNS) triggers a robust inflammatory response that leads to axonal damage and secondary degeneration of spared tissue. In contrast, some immune responses have neuroprotective effects. However, detailed information regarding the dynamics of immune responses after traumatic CNS injury is still unavailable. Methods: In the present study, changes in the immune cells present in the injured brain, spleen, and cervical lymph nodes (CLNs), which are draining lymphatic organs from the CNS, were analyzed after controlled cortical impact (CCI) by flow cytometry and immunohistochemistry. Results: The number of neutrophils and macrophages that infiltrated the injured brain immediately increased 1 d post-injury and declined rapidly thereafter. In the injured brain, resident microglia showed a bimodal increase during the first week and in the chronic phase (>= 3 weeks) after injury. Increase in the Iba-1(+) microglia/macrophages was observed around the injured site. Morphologic analysis showed that Iba-1(+) cells were round at 1 week, whereas those at 3 weeks were more ramified. Furthermore, CD86(+)/CD11b(+) M1-like microglia increased at 4 weeks after CCI, whereas CD206(+)/CD11b(+) M2-like microglia increased at 1 week. These results suggest that different subsets of microglia increased in the acute and chronic phases after CCI. Dendritic cells and T cells increased transiently within 1 week in the injured brain. In the CLNs and the spleen, T cells showed dynamic changes after CCI. In particular, the alteration in the number of T cells in the CLNs showed a similar pattern, with a 1-week delay, to that of microglia in the injured brain. Conclusion: The data from this study provide useful information on the dynamics of immune cells in CNS injuries.	[Jin, Xuemei; Ishii, Hiroshi; Itokazu, Takahide; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Jin, Xuemei; Ishii, Hiroshi; Itokazu, Takahide; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan; [Bai, Zhongbin] Yunnan Agr Univ, Key Lab Puer Tea Sci, Minist Educ, Kunming, Peoples R China	Osaka University; Japan Science & Technology Agency (JST); Yunnan Agricultural University	Jin, XM (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	; Schierup, Mikkel Heide/F-1675-2010; Zhang, Guojie/J-7273-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; FANG, Xiaodong/K-6743-2018	Meng, Yuhuan/0000-0001-7464-3103; Schierup, Mikkel Heide/0000-0002-5028-1790; Zhang, Guojie/0000-0001-6860-1521; Wang, Jun/0000-0002-2113-5874; Yamashita, Toshihide/0000-0003-4559-7018; Wang, Jun/0000-0002-8540-8931; He, Mingze/0000-0002-8164-2480; Mailund, Thomas/0000-0001-6206-9239; Jin, Xin/0000-0001-7554-4975; Hvilsom, Christina/0000-0001-7870-6888; FANG, Xiaodong/0000-0001-7061-3337; Itokazu, Takahide/0000-0003-2977-7190	Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arneth BM, 2010, J NEUROIMMUNOL, V219, P123, DOI 10.1016/j.jneuroim.2009.12.011; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; Dardiotis E, 2012, BRAIN INJURY PATHOGE; De Haas AH, 2007, GLIA, V55, P1374, DOI 10.1002/glia.20554; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; FORD AL, 1995, J IMMUNOL, V154, P4309; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hatterer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003321; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Herz J, 2010, EXP NEUROL, V225, P9, DOI 10.1016/j.expneurol.2009.11.019; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nguyen HX, 2011, JOVE-J VIS EXP, DOI 10.3791/2698; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Sagar D, 2012, J NEUROIMMUNE PHARM, V7, P74, DOI 10.1007/s11481-011-9302-7; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Schwartz M, 2005, ACTA NEUROCHIR SUPPL, V93, P147; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Soares HD, 1995, J NEUROSCI, V15, P8223; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; WIDNER H, 1988, SCAND J IMMUNOL, V28, P563, DOI 10.1111/j.1365-3083.1988.tb01488.x; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; YAMADA S, 1991, AM J PHYSIOL, V261, pH1197, DOI 10.1152/ajpheart.1991.261.4.H1197; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	48	135	140	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41892	10.1371/journal.pone.0041892	http://dx.doi.org/10.1371/journal.pone.0041892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911864	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300081
J	Ou, JJ; Luan, W; Deng, J; Sa, R; Liang, HJ				Ou, Juanjuan; Luan, Wei; Deng, Jia; Sa, Rina; Liang, Houjie			alpha V Integrin Induces Multicellular Radioresistance in Human Nasopharyngeal Carcinoma via Activating SAPK/JNK Pathway	PLOS ONE			English	Article							CELL; INTEGRIN-ALPHA(V)BETA(3); RESISTANCE; APOPTOSIS; INVASION; THERAPY; STRESS; NECTIN; MATRIX; JNK	Background: Tumor cells acquire the capacity of resistance to chemotherapy or radiotherapy via cell-matrix and cell-cell crosstalk. Integrins are the most important cell adhesion molecules, in which alpha V integrin mainly mediating the tight contact between tumor cells. Methodology/Principal Findings: To investigate the role of alpha V integrin in multi-cellular radioresistance (MCR) of human nasopharyngeal carcinoma (NPC), we performed immunohistochemistry and Western blotting to find that the expression of alpha V integrin in the tumor tissue of radioresistant patients is much higher than that in radiosensitive patients. In vitro, we cultured human NPC cell line CNE-2 cells as multi-cellular spheroids (MCSs) or as monolayer cells (MCs), and found that the expression of alpha V integrin in MCSs is significantly higher than that in MCs. MTT, flow cytometry and clonogenic suvival assays showed that MCSs are less sensitive to X-ray irradiation than MCs while blocking of alpha V integrin in MCSs dramatically reversed their radioresistance. Furthermore, as detected by Western blotting, MCSs displayed sustained activation of the stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) pathway in presence of irradiation. Blocking of alpha V integrin in MCSs decreased the expression of phosphorylated JNK. Additionally, blocking of SAPK/JNK signaling pathway synergistically induced apoptosis of MCSs exposed to irradiation by increasing the expression of cleaved caspase-3. In vivo, we found that irradiation combined with alpha V integrin blocking treatment significantly enhanced the radiosensitivity of NPC xenografts. Conclusions: Our results indicate a novel role of alpha V integrin in multi-cellular radioresistance of NPCs.	[Ou, Juanjuan] Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Ou, JJ (corresponding author), Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China.	lianghoujie@sina.com	Liu, Juxiu/B-3400-2009; Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [81000965]; 973 Program, National Basic Research Program of China [2010cb529403]; Div Of Biological Infrastructure [0933958] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program, National Basic Research Program of China(National Basic Research Program of China); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grant number 81000965 from the National Natural Science Foundation of China, and by 973 Program No. 2010cb529403 from the National Basic Research Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Chen QM, 2007, CLIN CANCER RES, V13, P3689, DOI 10.1158/1078-0432.CCR-07-0026; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; He JM, 2009, CANCER LETT, V284, P182, DOI 10.1016/j.canlet.2009.04.023; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hwang R, 2004, HEMATOL ONCOL CLIN N, V18, P991, DOI 10.1016/j.hoc.2004.09.010; Jean C, 2011, ONCOGENE, V30, P2697, DOI 10.1038/onc.2011.27; Le Tourneau C, 2010, B CANCER, V97, P1453, DOI 10.1684/bdc.2010.1226; Leclerc D, 2008, J BIOL CHEM, V283, P3151, DOI 10.1074/jbc.M708598200; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Pauwels B, 2010, FUTURE ONCOL, V6, P1485, DOI 10.2217/FON.10.104; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Sakamoto Y, 2008, J BIOL CHEM, V283, P496, DOI 10.1074/jbc.M704195200; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sandfort V, 2007, INT J RADIAT BIOL, V83, P727, DOI 10.1080/09553000701694335; Stulic M, 2007, CYTOKINE, V37, P163, DOI 10.1016/j.cyto.2007.03.010; Sun HY, 2011, EXP BIOL MED, V236, P352, DOI 10.1258/ebm.2010.010106; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vellon L, 2006, MOL CARCINOGEN, V45, P795, DOI 10.1002/mc.20242; Zhang SY, 2004, CARCINOGENESIS, V25, P2191, DOI 10.1093/carcin/bgh234	31	90	102	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38737	10.1371/journal.pone.0038737	http://dx.doi.org/10.1371/journal.pone.0038737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22844484	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900045
J	Deng, Q; Hui, DF; Zhang, DQ; Zhou, GY; Liu, JX; Liu, SZ; Chu, GW; Li, J				Deng, Qi; Hui, Dafeng; Zhang, Deqiang; Zhou, Guoyi; Liu, Juxiu; Liu, Shizhong; Chu, Guowei; Li, Jiong			Effects of Precipitation Increase on Soil Respiration: A Three-Year Field Experiment in Subtropical Forests in China	PLOS ONE			English	Article							CO2 EFFLUX; CARBON-DIOXIDE; TERRESTRIAL ECOSYSTEMS; EXPERIMENTAL DROUGHT; GRASSLAND ECOSYSTEM; ORGANIC-CARBON; TEMPERATURE; RESPONSES; VARIABILITY; DEPENDENCE	Background: The aim of this study was to determine response patterns and mechanisms of soil respiration to precipitation increases in subtropical regions. Methodology/Principal Findings: Field plots in three typical forests [i.e. pine forest (PF), broadleaf forest (BF), and pine and broadleaf mixed forest (MF)] in subtropical China were exposed under either Double Precipitation (DP) treatment or Ambient Precipitation (AP). Soil respiration, soil temperature, soil moisture, soil microbial biomass and fine root biomass were measured over three years. We tested whether precipitation treatments influenced the relationship of soil respiration rate (R) with soil temperature (T) and soil moisture (M) using R=(a+cM)exp(bT), where a is a parameter related to basal soil respiration; b and c are parameters related to the soil temperature and moisture sensitivities of soil respiration, respectively. We found that the DP treatment only slightly increased mean annual soil respiration in the PF (15.4%) and did not significantly change soil respiration in the MF and the BF. In the BF, the increase in soil respiration was related to the enhancements of both soil fine root biomass and microbial biomass. The DP treatment did not change model parameters, but increased soil moisture, resulting in a slight increase in soil respiration. In the MF and the BF, the DP treatment decreased soil temperature sensitivity b but increased basal soil respiration a, resulting in no significant change in soil respiration. Conclusion/Significance: Our results indicate that precipitation increasing in subtropical regions in China may have limited effects on soil respiration.	[Deng, Qi; Zhang, Deqiang; Zhou, Guoyi; Liu, Juxiu; Liu, Shizhong; Chu, Guowei; Li, Jiong] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Deng, Qi] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Tennessee State University	Deng, Q (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	dhui@tnstate.edu	Liu, Juxiu/B-3400-2009; Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	National Basic Research Program of China [2009CB42110x]; Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences [XDA05050205]; Dinghushan Forest Ecosystem Research Station; National Science Foundation [0933958]; Div Of Biological Infrastructure [0933958] Funding Source: National Science Foundation	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences; Dinghushan Forest Ecosystem Research Station; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was financially supported by National Basic Research Program of China (2009CB42110x), Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences (XDA05050205), Dinghushan Forest Ecosystem Research Station, and the National Science Foundation (0933958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2006, GLOBAL CHANGE BIOL, V12, P177, DOI 10.1111/j.1365-2486.2005.001058.x; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Chen Xiao-mei, 2010, Yingyong Shengtai Xuebao, V21, P1210; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Deng Q, 2010, BIOGEOSCIENCES, V7, P315, DOI 10.5194/bg-7-315-2010; Deng Q, 2011, ENVIRON MANAGE, V48, P1182, DOI 10.1007/s00267-011-9732-2; Ding M. M., 2001, IITF17 USDA FOR SERV; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; [方运霆 Fang Yun], 2003, [生态学报, Acta Ecologica Sinica], V23, P1685; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; He C., 1982, TROPICAL SUBTROPICAL, V1, P25; Hui D., 1996, PRACTICAL SAS USAGE; Hui DF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002297; Hui DF, 2003, TREE PHYSIOL, V23, P433, DOI 10.1093/treephys/23.7.433; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; Jackson RB, 2009, ECOLOGY, V90, P3352, DOI 10.1890/08-1609.1; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jenerette GD, 2008, FUNCT ECOL, V22, P924, DOI 10.1111/j.1365-2435.2008.01450.x; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Liu JX, 2008, BIOGEOSCIENCES, V5, P1783, DOI 10.5194/bg-5-1783-2008; [刘申 LIU Shen], 2007, [生态科学, Ecologic Science], V26, P387; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Luo Y., 2006, SOIL RESP ENV, P35, DOI [10.1016/B978-012088782-8/50003-6, DOI 10.1016/B978-012088782-8/50003-6]; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Misson L, 2010, GLOBAL CHANGE BIOL, V16, P2461, DOI 10.1111/j.1365-2486.2009.02121.x; Noormets A, 2008, AGR FOREST METEOROL, V148, P216, DOI 10.1016/j.agrformet.2007.08.002; Palmroth S, 2005, GLOBAL CHANGE BIOL, V11, P421, DOI 10.1111/j.1365-2486.2005.00915.x; Peng Shao-Lin, 1995, Chinese Journal of Botany, V7, P75; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Schaefer K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001928; Schwendenmann L, 2005, ECOSYSTEMS, V8, P339, DOI 10.1007/s10021-003-0088-1; Scotta ED, 2007, GLOBAL CHANGE BIOL, V13, P546; Shen CD, 2001, RADIOCARBON, V43, P671; Shen WJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000685; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowerby A, 2008, GLOBAL CHANGE BIOL, V14, P2388, DOI 10.1111/j.1365-2486.2008.01643.x; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; van Straaten O, 2010, BIOGEOSCIENCES, V7, P1223, DOI 10.5194/bg-7-1223-2010; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang B. S., 1982, Tropical and Subtropical Forest Ecosystem, Ding Hu Shan Forest Ecosystem Reserve, China, P142; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yan J. H., 2009, SOIL BIOL BIOCHEM, V9, P1, DOI DOI 10.1016/J.S0ILBI0.2008.12.018; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zhang DQ, 2006, SCI CHINA SER D, V49, P139, DOI 10.1007/s11430-006-8139-z; Zhou T, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000850; Zhou XH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002526	61	90	102	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41493	10.1371/journal.pone.0041493	http://dx.doi.org/10.1371/journal.pone.0041493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844484	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700095
J	Martinez-Cerdeno, V; Cunningham, CL; Camacho, J; Antczak, JL; Prakash, AN; Cziep, ME; Walker, AI; Noctor, SC				Martinez-Cerdeno, Veronica; Cunningham, Christopher L.; Camacho, Jasmin; Antczak, Jared L.; Prakash, Anish N.; Cziep, Matthew E.; Walker, Anita I.; Noctor, Stephen C.			Comparative Analysis of the Subventricular Zone in Rat, Ferret and Macaque: Evidence for an Outer Subventricular Zone in Rodents	PLOS ONE			English	Article							RADIAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; MOUSE NEOCORTEX; CEREBRAL-CORTEX; NEURAL STEM; RHESUS-MONKEY; NEURONS ARISE; NUMBER; TRANSFORMATION	The mammalian cerebral cortex arises from precursor cells that reside in a proliferative region surrounding the lateral ventricles of the developing brain. Recent work has shown that precursor cells in the subventricular zone (SVZ) provide a major contribution to prenatal cortical neurogenesis, and that the SVZ is significantly thicker in gyrencephalic mammals such as primates than it is in lissencephalic mammals including rodents. Identifying characteristics that are shared by or that distinguish cortical precursor cells across mammalian species will shed light on factors that regulate cortical neurogenesis and may point toward mechanisms that underlie the evolutionary expansion of the neocortex in gyrencephalic mammals. We immunostained sections of the developing cerebral cortex from lissencephalic rats, and from gyrencephalic ferrets and macaques to compare the distribution of precursor cell types in each species. We also performed time-lapse imaging of precursor cells in the developing rat neocortex. We show that the distribution of Pax6+ and Tbr2+ precursor cells is similar in lissencephalic rat and gyrencephalic ferret, and different in the gyrencephalic cortex of macaque. We show that mitotic Pax6+ translocating radial glial cells (tRG) are present in the cerebral cortex of each species during and after neurogenesis, demonstrating that the function of Pax6+ tRG cells is not restricted to neurogenesis. Furthermore, we show that Olig2 expression distinguishes two distinct subtypes of Pax6+ tRG cells. Finally we present a novel method for discriminating the inner and outer SVZ across mammalian species and show that the key cytoarchitectural features and cell types that define the outer SVZ in developing primates are present in the developing rat neocortex. Our data demonstrate that the developing rat cerebral cortex possesses an outer subventricular zone during late stages of cortical neurogenesis and that the developing rodent cortex shares important features with that of primates.	[Martinez-Cerdeno, Veronica] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Martinez-Cerdeno, Veronica; Camacho, Jasmin] Shriners Hosp Children No Calif, Inst Pediat Regenerat Med, Sacramento, CA USA; [Cunningham, Christopher L.; Noctor, Stephen C.] Univ Calif Davis, Grad Program Neurosci, Davis, CA 95616 USA; [Antczak, Jared L.; Cziep, Matthew E.; Walker, Anita I.] Brigham Young Univ, Dept Biol, Rexburg, ID USA; [Prakash, Anish N.; Noctor, Stephen C.] Univ Calif Davis, Sch Med, Dept Psychiat, Sacramento, CA 95817 USA; [Martinez-Cerdeno, Veronica; Noctor, Stephen C.] Univ Calif Davis, Sch Med, Med Invest Neurodev Disorders MIND Inst, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; Brigham Young University; University of California System; University of California Davis; University of California System; University of California Davis	Martinez-Cerdeno, V (corresponding author), Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	vmartinezcerdeno@ucdavis.edu; scnoctor@ucdavis.edu	; De-Simone, Salvatore Giovanni/I-2989-2013	Alencar, Carlos Henrique/0000-0003-2967-532X; Cunningham, Christopher/0000-0002-9619-4190; De-Simone, Salvatore Giovanni/0000-0002-2172-656X; Fireman Dutra, Rosa Amalia/0000-0001-8314-4218; Camacho, Jasmin/0000-0001-6449-9224	UC Davis MIND Institute; Children's Miracle Network; UC Davis Department of Psychiatry; National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094681] Funding Source: NIH RePORTER	UC Davis MIND Institute; Children's Miracle Network; UC Davis Department of Psychiatry; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by UC Davis MIND Institute; Children's Miracle Network; UC Davis Department of Psychiatry; and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bayer S.A., 1991, NEOCORTICAL DEV; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Carney RSE, 2007, BRAIN STRUCT FUNCT, V212, P37, DOI 10.1007/s00429-007-0142-4; Christensen JR, 2007, ANAT REC, V290, P330, DOI 10.1002/ar.20504; Cunningham CL, 2011, HUM MOL GENET, V20, P64, DOI 10.1093/hmg/ddq432; DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Garcia-Moreno F, 2011, CEREB CORTEX; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Hevner RF, 2011, CEREB CORTEX; Judson MC, 2011, CEREB CORTEX, V21, P1613, DOI 10.1093/cercor/bhq223; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kelava I, 2011, CEREB CORTEX; KORBO L, 1990, J NEUROSCI METH, V31, P93, DOI 10.1016/0165-0270(90)90153-7; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Mikula S, 2011, DIGITAL STEREOTAXIC; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mooney SM, 2005, ALCOHOL CLIN EXP RES, V29, P683, DOI 10.1097/01.ALC.0000158936.40150.5A; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 1997, J COMP NEUROL, V387, P179; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Reillo I, 2011, CEREB CORTEX; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Samuelsen GB, 2003, CEREB CORTEX, V13, P115, DOI 10.1093/cercor/13.2.115; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; SMART IHM, 1973, J ANAT, V116, P67; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; TAKAHASHI T, 1990, J COMP NEUROL, V302, P15, DOI 10.1002/cne.903020103; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550	49	156	159	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30178	10.1371/journal.pone.0030178	http://dx.doi.org/10.1371/journal.pone.0030178			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272298	Green Submitted, gold, Green Published			2022-12-27	WOS:000301454400076
J	Kim, SJ; Peshkin, L; Mitchison, TJ				Kim, Sujeong; Peshkin, Leonid; Mitchison, Timothy J.			Vascular Disrupting Agent Drug Classes Differ in Effects on the Cytoskeleton	PLOS ONE			English	Article							5,6-DIMETHYLXANTHENONE-4-ACETIC ACID DMXAA; COMBRETASTATIN A4 PHOSPHATE; TUMOR-NECROSIS-FACTOR; FLAVONE ACETIC-ACID; MICROTUBULE DYNAMICS; ANTITUMOR-ACTIVITY; KNOCKOUT MICE; IN-VIVO; CANCER; CELLS	Vascular disrupting agents (VDAs), anti-cancer drugs that target established tumor blood vessels, fall into two main classes: microtubule targeting drugs, exemplified by combretastatin A4 (CA4), and flavonoids, exemplified by 5,6-dimethylxanthe-none-4-acetic acid (DMXAA). Both classes increase permeability of tumor vasculature in mouse models, and DMXAA in particular can cause massive tumor necrosis. The molecular target of CA4 is clearly microtubules. The molecular target(s) of DMXAA remains unclear. It is thought to promote inflammatory signaling in leukocytes, and has been assumed to not target microtubules, though it is not clear from the literature how carefully this assumption has been tested. An earlier flavone analog, flavone acetic acid, was reported to promote mitotic arrest suggesting flavones might possess anti-microtubule activity, and endothelial cells are sensitive to even mild disruption of microtubules. We carefully investigated whether DMXAA directly affects the microtubule or actin cytoskeletons of endothelial cells by comparing effects of CA4 and DMXAA on human umbilical vein endothelial cells (HUVEC) using time-lapse imaging and assays for cytoskeleton integrity. CA4 caused retraction of the cell margin, mitotic arrest and microtubule depolymerization, while DMXAA, up to 500 mu M, showed none of these effects. DMXAA also had no effect on pure tubulin nucleation and polymerization, unlike CA4. We conclude that DMXAA exhibits no direct anti-microtubule action and thus cleanly differs from CA4 in its mechanism of action at the molecular level.	[Kim, Sujeong; Peshkin, Leonid; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kim, SJ (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Sujeong_Kim@hms.harvard.edu		Mond, Jonathan/0000-0002-0410-091X; Hay, Phillipa/0000-0003-0296-6856; Peshkin, Leonid/0000-0002-6420-848X; MITCHISON, DEBORAH/0000-0002-6736-7937; Giannakakou, Paraskevi/0000-0001-7378-262X	Korea Research Foundation; Korean Government [KRF-2008-357-C00112];  [CA139980]; NATIONAL CANCER INSTITUTE [P01CA139980] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Korea Research Foundation Grant funded by the Korean Government [KRF-2008-357-C00112] and New Initiative Grant CA139980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley BC, 2003, LANCET ONCOL, V4, P141, DOI 10.1016/S1470-2045(03)01018-0; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; Ching LM, 1999, CANCER RES, V59, P3304; CUSHMAN M, 1991, J MED CHEM, V34, P2579, DOI 10.1021/jm00112a036; Dark GG, 1997, CANCER RES, V57, P1829; Eichhorn ME, 2007, LANGENBECK ARCH SURG, V392, P371, DOI 10.1007/s00423-007-0150-0; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Galbraith SM, 2001, ANTICANCER RES, V21, P93; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1; Head M, 2010, EXPERT OPIN INV DRUG, V19, P295, DOI 10.1517/13543780903540214; JORDAN MA, 1992, J CELL SCI, V102, P401; Kanthou C, 2002, BLOOD, V99, P2060, DOI 10.1182/blood.V99.6.2060; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Nam NH, 2003, CURR MED CHEM, V10, P1697, DOI 10.2174/0929867033457151; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Panaro NJ, 1999, BRIT J CANCER, V80, P1905, DOI 10.1038/sj.bjc.6690619; PLOWMAN J, 1986, CANCER TREAT REP, V70, P631; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Vincent L, 2005, J CLIN INVEST, V115, P2992, DOI 10.1172/JCI24586; Wang LCS, 2004, BIOCHEM PHARMACOL, V67, P937, DOI 10.1016/j.bcp.2003.10.023; Wu Q, 2012, J PHARMACOL EXP THER; Zhao L, 2002, BRIT J CANCER, V87, P465, DOI 10.1038/sj.bjc.6600479; Zweifel M, 2011, ANN ONCOL, V22, P2036, DOI 10.1093/annonc/mdq708; ZWI LJ, 1994, ONCOL RES, V6, P79	31	58	58	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40177	10.1371/journal.pone.0040177	http://dx.doi.org/10.1371/journal.pone.0040177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848372	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300007
J	Wang, YX; Zeng, X; Iyer, NJ; Bryant, DW; Mockler, TC; Mahalingam, R				Wang, Yixing; Zeng, Xin; Iyer, Niranjani J.; Bryant, Douglas W.; Mockler, Todd C.; Mahalingam, Ramamurthy			Exploring the Switchgrass Transcriptome Using Second-Generation Sequencing Technology	PLOS ONE			English	Article							MICROSATELLITE MARKERS; COMPARATIVE GENOMICS; MESSENGER-RNA; GENE; ARABIDOPSIS; PLANT; GERMINATION; RICE; IDENTIFICATION; ANNOTATION	Background: Switchgrass (Panicum virgatum L.) is a C4 perennial grass and widely popular as an important bioenergy crop. To accelerate the pace of developing high yielding switchgrass cultivars adapted to diverse environmental niches, the generation of genomic resources for this plant is necessary. The large genome size and polyploid nature of switchgrass makes whole genome sequencing a daunting task even with current technologies. Exploring the transcriptional landscape using next generation sequencing technologies provides a viable alternative to whole genome sequencing in switchgrass. Principal Findings: Switchgrass cDNA libraries from germinating seedlings, emerging tillers, flowers, and dormant seeds were sequenced using Roche 454 GS-FLX Titanium technology, generating 980,000 reads with an average read length of 367 bp. De novo assembly generated 243,600 contigs with an average length of 535 bp. Using the foxtail millet genome as a reference greatly improved the assembly and annotation of switchgrass ESTs. Comparative analysis of the 454-derived switchgrass EST reads with other sequenced monocots including Brachypodium, sorghum, rice and maize indicated a 70-80% overlap. RPKM analysis demonstrated unique transcriptional signatures of the four tissues analyzed in this study. More than 24,000 ESTs were identified in the dormant seed library. In silico analysis indicated that there are more than 2000 EST-SSRs in this collection. Expression of several orphan ESTs was confirmed by RT-PCR. Significance: We estimate that about 90% of the switchgrass gene space has been covered in this analysis. This study nearly doubles the amount of EST information for switchgrass currently in the public domain. The celerity and economical nature of second-generation sequencing technologies provide an in-depth view of the gene space of complex genomes like switchgrass. Sequence analysis of closely related members of the NAD(+)-malic enzyme type C4 grasses such as the model system Setaria viridis can serve as a viable proxy for the switchgrass genome.	[Wang, Yixing; Zeng, Xin; Iyer, Niranjani J.; Mahalingam, Ramamurthy] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Bryant, Douglas W.; Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Oklahoma State University System; Oklahoma State University - Stillwater; Donald Danforth Plant Science Center	Wang, YX (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	ramamurthy.mahalingam@okstate.edu	Mahalingam, Ramamurthy/AAP-5463-2020; Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775; Sung, Wen-Wei/0000-0002-2375-0029	National Science Foundation [EPS-0814361]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. EPS-0814361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Barbazuk WB, 2007, SNP MINING MAIZE 454; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Boe A, 2008, CROP SCI, V48, P1306, DOI 10.2135/cropsci2007.08.0482; Bouton Joe, 2008, P295, DOI 10.1007/978-0-387-70805-8_11; Bouton JH, 2007, CURR OPIN GENET DEV, V17, P553, DOI 10.1016/j.gde.2007.08.012; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chi KR, 2008, NAT METHODS, V5, P11, DOI 10.1038/NMETH1154; Christin PA, 2009, PLANT PHYSIOL, V149, P82, DOI 10.1104/pp.108.128553; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Furumoto T, 2011, NATURE, V476, P472, DOI 10.1038/nature10250; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hopkins AA, 1996, CROP SCI, V36, P1192, DOI 10.2135/cropsci1996.0011183X003600050021x; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mahalingam R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r20; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masumoto C, 2010, P NATL ACAD SCI USA, V107, P5226, DOI 10.1073/pnas.0913127107; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Muthukumar B, 2004, MOL GENET GENOMICS, V271, P308, DOI 10.1007/s00438-004-0980-1; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Puckette M, 2009, J PLANT PHYSIOL, V166, P1284, DOI 10.1016/j.jplph.2009.01.009; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; TANIGUCHI M, 1995, ARCH BIOCHEM BIOPHYS, V318, P295, DOI 10.1006/abbi.1995.1233; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Tobias CM, 2006, MOL ECOL NOTES, V6, P185, DOI 10.1111/j.1471-8286.2006.01187.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394	67	72	77	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34225	10.1371/journal.pone.0034225	http://dx.doi.org/10.1371/journal.pone.0034225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22848356	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400061
J	Wang, HK; Yan, YH; Wang, JM; Zhang, HP; Qi, W				Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Zhang, HePing; Qi, Wei			Production and Characterization of Antifungal Compounds Produced by Lactobacillus plantarum IMAU10014	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTIBIOTICS; SPOILAGE; BREAD; FOOD	Lactobacillus plantarum IMAU10014 was isolated from koumiss that produces a broad spectrum of antifungal compounds, all of which were active against plant pathogenic fungi in an agar plate assay. Two major antifungal compounds were extracted from the cell-free supernatant broth of L. plantarum IMAU10014. 3-phenyllactic acid and Benzeneacetic acid, 2-propenyl ester were carried out by HPLC, LC-MS, GC-MS, NMR analysis. It is the first report that lactic acid bacteria produce antifungal Benzeneacetic acid, 2-propenyl ester. Of these, the antifungal products also have a broad spectrum of antifungal activity, namely against Botrytis cinerea, Glomerella cingulate, Phytophthora drechsleri Tucker, Penicillium citrinum, Penicillium digitatum and Fusarium oxysporum, which was identified by the overlay and well-diffusion assay. F. oxysporum, P. citrinum and P. drechsleri Tucker were the most sensitive among molds.	[Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Qi, Wei] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China; [Zhang, HePing] Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Minist Educ, Hohhot, Peoples R China	Tianjin University Science & Technology; Inner Mongolia Agricultural University	Wang, HK (corresponding author), Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China.	haikuanwangcn@yahoo.com.cn; hepingdd@vip.sina.com	Zhang, He/GXN-0028-2022		National Natural Science Foundation of China [30900961, 20876116]; Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	This work was supported by the National Natural Science Foundation of China (No. 30900961 and No. 20876116), the Key Laboratory of Dairy Biotechnology, the Engineering, Ministry of Education, the Inner Mongolia Agricultural University for helpful contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2008, LETT APPL MICROBIOL, V47, P180, DOI 10.1111/j.1472-765X.2008.02412.x; Coloretti F, 2007, FEMS MICROBIOL LETT, V271, P245, DOI 10.1111/j.1574-6968.2007.00723.x; Dal Bello F, 2007, J CEREAL SCI, V45, P309, DOI 10.1016/j.jcs.2006.09.004; Dalie DKD, 2010, FOOD CONTROL, V21, P370, DOI 10.1016/j.foodcont.2009.07.011; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V87, P149; Gerez CL, 2009, FOOD CONTROL, V20, P144, DOI 10.1016/j.foodcont.2008.03.005; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; MATSUDA T, 1994, J JPN SOC FOOD SCI, V41, P687; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Niku-Paavola ML, 1999, J APPL MICROBIOL, V86, P29, DOI 10.1046/j.1365-2672.1999.00632.x; Prema P, 2010, FOOD BIOPROCESS TECH, V3, P379, DOI 10.1007/s11947-008-0127-1; Rouse S, 2008, J APPL MICROBIOL, V104, P915, DOI 10.1111/j.1365-2672.2007.03619.x; Schnurer J, 2005, TRENDS FOOD SCI TECH, V16, P70, DOI 10.1016/j.tifs.2004.02.014; Schwenninger SM, 2008, J FOOD PROTECT, V71, P2481, DOI 10.4315/0362-028X-71.12.2481; Sjogren J, 2003, APPL ENVIRON MICROB, V69, P7554, DOI 10.1128/AEM.69.12.7554-7557.2003; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; Sun TS, 2009, EUR FOOD RES TECHNOL, V228, P607, DOI 10.1007/s00217-008-0969-9; Vermeulen N, 2006, J AGR FOOD CHEM, V54, P3832, DOI 10.1021/jf052733e; Wang HK, 2011, ANN MICROBIOL, V61, P879, DOI 10.1007/s13213-011-0209-6; Yang LP, 2008, WORLD J MICROB BIOT, V24, P909, DOI 10.1007/s11274-007-9626-x	22	374	401	7	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29452	10.1371/journal.pone.0029452	http://dx.doi.org/10.1371/journal.pone.0029452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22844460	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200014
J	Chen, L; Huang, LZ; Min, DH; Phillips, A; Wang, SQ; Madgwick, PJ; Parry, MAJ; Hu, YG				Chen, Liang; Huang, Linzhou; Min, Donghong; Phillips, Andy; Wang, Shiqiang; Madgwick, Pippa J.; Parry, Martin A. J.; Hu, Yin-Gang			Development and Characterization of a New TILLING Population of Common Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; DETECT INDUCED MUTATIONS; GENE-FUNCTION; INSERTIONAL MUTAGENESIS; FUNCTIONAL GENOMICS; POINT MUTATIONS; INDUCED MUTANTS; DISCOVERY; RESOURCE; RICE	Mutagenesis is an important tool in crop improvement. However, the hexaploid genome of wheat (Triticum aestivum L.) presents problems in identifying desirable genetic changes based on phenotypic screening due to gene redundancy. TILLING (Targeting Induced Local Lesions IN Genomes), a powerful reverse genetic strategy that allows the detection of induced point mutations in individuals of the mutagenized populations, can address the major challenge of linking sequence information to the biological function of genes and can also identify novel variation for crop breeding. Wheat is especially well-suited for TILLING due to the high mutation densities tolerated by polyploids. However, only a few wheat TILLING populations are currently available in the world, which is far from satisfying the requirement of researchers and breeders in different growing environments. In addition, current TILLING screening protocols require costly fluorescence detection systems, limiting their use, especially in developing countries. We developed a new TILLING resource comprising 2610 M-2 mutants in a common wheat cultivar 'Jinmai 47'. Numerous phenotypes with altered morphological and agronomic traits were observed from the M-2 and M-3 lines in the field. To simplify the procedure and decrease costs, we use unlabeled primers and either non-denaturing polyacrylamide gels or agarose gels for mutation detection. The value of this new resource was tested using PCR with RAPD and Intron-spliced junction (ISJ) primers, and also TILLING in three selected candidate genes, in 300 and 512 mutant lines, revealing high mutation densities of 1/34 kb by RAPD/ISJ analysis and 1/47 kb by TILLING. In total, 31 novel alleles were identified in the 3 targeted genes and confirmed by sequencing. The results indicate that this mutant population represents a useful resource for the wheat research community. We hope that the use of this reverse genetics resource will provide novel allelic diversity for wheat improvement and functional genomics.	[Chen, Liang; Huang, Linzhou; Min, Donghong; Wang, Shiqiang; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andy; Madgwick, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Ctr Crop Genet Improvement, Harpenden, Herts, England; NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	Ministry of Science and Technology [2006AA100201, 2006AA100223, 2006CB708208]; 111 Program of Introducing Talents of Discipline to Universities P. R. China [111-2-16]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 Program of Introducing Talents of Discipline to Universities P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223), the pre-phase project of the 973 Program (2006CB708208) of the Ministry of Science and Technology, and the 111 Program of Introducing Talents of Discipline to Universities (111-2-16), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 1993, PLANT MOL BIOL REP, V11, P128, DOI DOI 10.1007/BF02670471; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bentley A, 2000, GENETICS, V156, P1169; Bibi S, 2009, PAK J BOT, V41, P1022; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chua NH, 2006, CURR OPIN BIOTECH, V17, P103, DOI 10.1016/j.copbio.2006.03.002; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Eversole K, 2009, ANN WHEAT N IN PRESS, P55; Fox JL, 2004, NAT BIOTECHNOL, V22, P1062, DOI 10.1038/nbt0904-1062; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HALLORAN GM, 1982, ANN BOT-LONDON, V49, P115, DOI 10.1093/oxfordjournals.aob.a086220; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Muth J, 2008, PLANT BIOTECHNOL J, V6, P576, DOI 10.1111/j.1467-7652.2008.00340.x; Naghavi Mohammad Reza, 2004, Iranian Journal of Biotechnology, V2, P195; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Przetakiewicz J, 2002, CELL MOL BIOL LETT, V7, P671; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rothe N, 2010, THESIS KANSASS STATE; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SONG WN, 1995, GENET RESOUR CROP EV, V42, P273, DOI 10.1007/BF02431262; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till B. J., 2007, GENOMICS ASSISTED CR, P333; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103	53	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41570	10.1371/journal.pone.0041570	http://dx.doi.org/10.1371/journal.pone.0041570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844501	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700113
J	Chen, L; Ma, YL; Kim, EY; Yu, W; Schwartz, RJ; Qian, L; Wang, J				Chen, Li; Ma, Yanlin; Kim, Eun Young; Yu, Wei; Schwartz, Robert J.; Qian, Ling; Wang, Jun			Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; NOTCH ACTIVATION; GENE-EXPRESSION; OUTFLOW-TRACT; BHLH FACTORS; CELL FATE; METHYLATION	Ezh2 is a histone trimethyltransferase that silences genes mainly via catalyzing trimethylation of histone 3 lysine 27 (H3K27Me3). The role of Ezh2 as a regulator of gene silencing and cell proliferation in cancer development has been extensively investigated; however, its function in heart development during embryonic cardiogenesis has not been well studied. In the present study, we used a genetically modified mouse system in which Ezh2 was specifically ablated in the mouse heart. We identified a wide spectrum of cardiovascular malformations in the Ezh2 mutant mice, which collectively led to perinatal death. In the Ezh2 mutant heart, the endocardial cushions (ECs) were hypoplastic and the endothelial-to-mesenchymal transition (EMT) process was impaired. The hearts of Ezh2 mutant mice also exhibited decreased cardiomyocyte proliferation and increased apoptosis. We further identified that the Hey2 gene, which is important for cardiomyocyte proliferation and cardiac morphogenesis, is a downstream target of Ezh2. The regulation of Hey2 expression by Ezh2 may be independent of Notch signaling activity. Our work defines an indispensible role of the chromatin remodeling factor Ezh2 in normal cardiovascular development.	[Chen, Li; Kim, Eun Young; Qian, Ling; Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Ma, Yanlin] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Yu, Wei; Schwartz, Robert J.] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA	Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Chen, L (corresponding author), Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA.	junwang@heart.thi.tmc.edu	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	American Heart Association; National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	American Heart Association(American Heart Association); National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the American Heart Association to JW. JW is also supported by a P30 grant from the National Health Institute as a Newly Independent Investigator (NII). LC is supported by a Postdoctoral Fellowship from the American Heart Association Southern Central Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Gordadze AV, 2001, J VIROL, V75, P5899, DOI 10.1128/JVI.75.13.5899-5912.2001; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu JC, 2004, CURR PROB CARDIOLOGY, V29, P641, DOI 10.1016/j.cpcardiol.2004.04.003; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180	61	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31005	10.1371/journal.pone.0031005	http://dx.doi.org/10.1371/journal.pone.0031005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22844501	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500025
J	Chen, LC; Hsu, C; Chiueh, CC; Lee, WS				Chen, Li-Ching; Hsu, Chin; Chiueh, Chuang Chin; Lee, Wen-Sen			Ferrous Citrate Up-Regulates the NOS2 through Nuclear Translocation of NF kappa B Induced by Free Radicals Generation in Mouse Cerebral Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; BRAIN-INJURY; PUTATIVE ROLE; IRON; ACTIVATION; EXPRESSION; FERRITIN	Previous studies indicate that the inducible nitric oxide synthase 2 (NOS2) of the brain vascular tissue in experimental subarachnoid hemorrhage (SAH) rats is a critical factor for inducing cerebral vasospasm. However, the underlying molecular mechanisms remain to be elucidated. Here, we applied ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cell (CEC) to mimic the SAH conditions and to address the issue how SAH-induced NOS2 up-regulation. Using immunocytochemical staining technique, we demonstrated that NOS2 was expressed in the cultured CEC. Treatment of the CEC with FC induced increases of the intracellular level of ROS, nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) nuclear translocation as well as NF kappa B binding onto the NOS promoter, and the levels of NOS2 mRNA and protein. These effects were abolished by pre-treatment of the cell with N-Acetyl-Cysteine (NAC), a reactive oxygen species (ROS) scavenger. In the present study, two previously predicted NFkB binding sites were confirmed in the NOS2 promoter within the range of -1529 bp to -1516 bp and -1224 bp to -1210 bp. Interestingly, both NF kappa B binding sites are involved in the FC-activated NOS2 transcriptional activity; the binding site located at -1529 bp to -1516 bp played a greater role than the other binding site located at -1224 bp to -1210 bp in the mouse CEC. These findings highlight the molecular mechanism underlying FC-induced up-regulation of NOS2 in the mouse CEC.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chiueh, Chuang Chin] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Sch Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	National Science Council of Taiwan [NSC-101-2320-B-038-005, NSC-101-2629-B-037-001, NSC-95-2320-B-037-032-MY2, NSC97-2314-B-037-039-MY2, NSC-95-2320-B-038-027-MY2]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the National Science Council of Taiwan (NSC-101-2320-B-038-005 and NSC-101-2629-B-037-001 to W. S. L.; NSC-95-2320-B-037-032-MY2 and NSC97-2314-B-037-039-MY2 to C. H.; NSC-95-2320-B-038-027-MY2 to C. C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Berra L V, 2007, J Neurosurg Sci, V51, P1; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Chiueh CC, 2000, NEUROTOX RES, V2, P293, DOI 10.1007/BF03033799; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Du WL, 2005, CHEST, V128, p556S, DOI 10.1378/chest.128.6_suppl.556S; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Taylor BS, 2001, PROG INFLAM RES, P1; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wong J M, 1995, Adv Pharmacol, V34, P155; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46239	10.1371/journal.pone.0046239	http://dx.doi.org/10.1371/journal.pone.0046239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	22844501	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900115
J	Wang, LH; Lv, XJ; Zhai, YG; Fu, SH; Wang, D; Rayner, S; Tang, Q; Liang, GD				Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Wang, David; Rayner, Simon; Tang, Qing; Liang, Guodong			Genomic Characterization of a Novel Virus of the Family Tymoviridae Isolated from Mosquitoes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-MOSAIC-VIRUS; MINUS-STRAND SYNTHESIS; RNA; GENUS; ORGANIZATION; INITIATION; MEMBER; LINE	Background: The family Tymoviridae comprises three plant virus genera, including Tymovirus, Marafivirus, and Maculavirus, which are found in most parts of the world and cause severe agricultural losses. We describe a putatively novel member of the family Tymoviridae, which is isolated from mosquitoes (Culex spp.), referred to as CuTLV. Methods and Results: The CuTLV was isolated by cell culture, which replicates and causes cytopathic effects in Aedes albopictus C6/36 cells, but not in mammalian BHK-21 or Vero cells. The complete 6471 nucleotide sequence of CuTLV was determined. The genome of CuTLV is predicted to contain three open reading frames (ORFs). The largest ORF1 is 5307 nucleotides (nt) in length and encodes a putative polypeptide of 1769 amino acids (aa), which contains the conserved motifs for the methyltransferase (MTR), Tymovirus endopeptidase (PRO), helicase (HEL), and RNA-dependent RNA polymerase (RdRp) of the replication-associated proteins (RPs) of positive-stranded RNA viruses. In contrast, the ORF1 sequence does not contain the so-called "tymobox'' or "marafibox'', the conserved subgenomic RNA promoter present in all tymoviruses or marafiviruses, respectively. ORF2 and ORF3 putatively encode a 248-aa coat protein (CP) and a proline-rich 149-aa polypeptide. The whole genomic nucleotide identity of CuTLV with other members of family Tymoviridae ranged from 46.2% (ChiYMV) to 52.4% (GFkV). Phylogenetic analysis based on the putative RP and CP genes of CuTLV demonstrated that the virus is most closely related to viruses in the genus Maculavirus. Conclusions: The CuTLV is a novel virus related to members of the family Tymoviridae, with molecular characters that are distinct from those of tymoviruses, marafiviruses, and other maculaviruses or macula-like viruses. This is the first report of the isolation of a Tymoviridae-like virus from mosquitoes. Further investigations are required to clarify the origin, replication strategy, and the public health or agricultural importance of the CuTLV.	[Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, David] Washington Univ, St Louis, MO USA; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Beijing 100864, Hubei, Peoples R China	Chinese Center for Disease Control & Prevention; Washington University (WUSTL); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, LH (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	Ministry of Science and Technology, People's Republic of China [2003BA712A08-01, 2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	Funding was provided by the Ministry of Science and Technology, People's Republic of China (no. 2003BA712A08-01 and 2011CB504702); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdullah A, 2010, VIRUS RES, V152, P10, DOI 10.1016/j.virusres.2010.05.010; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; DING S, 1990, NUCLEIC ACIDS RES, V18, P1181, DOI 10.1093/nar/18.5.1181; Dreher TW, 2004, MOL PLANT PATHOL, V5, P367, DOI 10.1111/j.1364-3703.2004.00236.X; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Hellendoorn K, 1996, NUCLEIC ACIDS RES, V24, P4910, DOI 10.1093/nar/24.24.4910; Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Izadpanah K, 2002, VIRUS GENES, V24, P131, DOI 10.1023/A:1014516515454; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; King AMQ, 2011, 9 INT COMM TAX VIR, P944; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Martelli GP, 2002, ARCH VIROL, V147, P1847, DOI 10.1007/s007050200046; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Sabanadzovic S, 2001, J GEN VIROL, V82, P2009, DOI 10.1099/0022-1317-82-8-2009; Sabanadzovic S, 2009, ARCH VIROL, V154, P1729, DOI 10.1007/s00705-009-0510-x; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Stephan D, 2008, VIRUS GENES, V36, P231, DOI 10.1007/s11262-007-0181-1; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39845	10.1371/journal.pone.0039845	http://dx.doi.org/10.1371/journal.pone.0039845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	23272162	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200014
J	Wang, L; Si, WN; Yao, YF; Tian, DC; Araki, H; Yang, SH				Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai			Genome-Wide Survey of Pseudogenes in 80 Fully Resequenced Arabidopsis thaliana Accessions	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; GENETIC DIVERSITY; DNA; ASSOCIATION; POLYMORPHISMS; EVOLUTIONARY; ANNOTATION; MECHANISMS; RESISTANCE; PATTERNS	Pseudogenes (Psi s), including processed and non-processed Psi s, are ubiquitous genetic elements derived from originally functional genes in all studied genomes within the three kingdoms of life. However, systematic surveys of non-processed Psi s utilizing genomic information from multiple samples within a species are still rare. Here a systematic comparative analysis was conducted of Psi s within 80 fully re-sequenced Arabidopsis thaliana accessions, and 7546 genes, representing similar to 28% of the genomic annotated open reading frames (ORFs), were found with disruptive mutations in at least one accession. The distribution of these Psi s on chromosomes showed a significantly negative correlation between Psi s/ORFs and their local gene densities, suggesting a higher proportion of Psi s in gene desert regions, e. g. near centromeres. On the other hand, compared with the non-Psi loci, even the intact coding sequences (CDSs) in the Psi loci were found to have shorter CDS length, fewer exon number and lower GC content. In addition, a significant functional bias against the null hypothesis was detected in the Psi s mainly involved in responses to environmental stimuli and biotic stress as reported, suggesting that they are likely important for adaptive evolution to rapidly changing environments by pseudogenization to accumulate successive mutations.	[Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Araki, Hitoshi] Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland	Nanjing University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Araki, H (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	Hitoshi.Araki@eawag.ch; sihaiyang@nju.edu.cn	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	National Natural Science Foundation of China [30970198, J1103512]; NSFC of Jiangsu province [BK2011015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC of Jiangsu province	This work was supported by National Natural Science Foundation of China (30970198 and J1103512) and NSFC of Jiangsu province (BK2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benovoy D, 2006, J MOL EVOL, V62, P511, DOI 10.1007/s00239-005-0045-z; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Du JC, 2008, GENE, V426, P1, DOI 10.1016/j.gene.2008.09.003; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Khachane AN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-38; Lafontaine I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-260; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sen K, 2010, FEBS LETT, V584, P4015, DOI 10.1016/j.febslet.2010.08.012; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yang S, 2012, P NATL ACAD SCI USA; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zhang YL, 2009, J MOL EVOL, V68, P393, DOI 10.1007/s00239-009-9217-6; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	43	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51769	10.1371/journal.pone.0051769	http://dx.doi.org/10.1371/journal.pone.0051769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272162	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600039
